# boehringer-ingelheim.com

> AI-optimized mirror of boehringer-ingelheim.com containing 8521 pages totalling 3,634,979 words of clean markdown content, structured data, and semantic HTML. Original source: https://boehringer-ingelheim.com. Last updated: 2026-08-03T22:53:57.862Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [annualreport/index.html](/content/annualreport/index.html) (564 words)
- [Home | Veterinary Scholars Program](/content/veterinaryscholars/index.html) (192 words)
- [Boehringer Ingelheim Karriere | Entdecken Sie Jobangebote](/content/jobs/index.html): Entdecken Sie eine Welt voller Möglichkeiten bei Boehringer Ingelheim. Werden Sie Teil unseres Teams und tragen Sie zur Verbesserung der Gesundheit von Menschen und Tieren weltweit bei. (349 words)
- [Boehringer Ingelheim - Life Forward | Boehringer Ingelheim](/content/site-root.html): Learn how we change life for the better for people and animals. (189 words)
- [Boehringer Ingelheim Portal for HealthCare Professionals](/content/pro/index.html): Boehringer Ingelheim Portal for Healthcare Professionals. Find everything you need to know in your local website about our medicines, next events and research. (74 words, Feb 28, 2024)

## Articles & Blog Posts

- [日本糖尿病財団 ベーリンガーインゲルハイム研究助成 | Boehringer Ingelheim JP](/content/jp/human-health/metabolic-diseases/diabetes/diabetes-award-application/index.html): 公益財団法人 日本糖尿病財団による「ベーリンガーインゲルハイム研究助成プログラム」は、糖尿病研究のより一層の発展に貢献することを目的に設立されました。 (13 words)
- [Heart Failure | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/heart-failure/index.html): Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction. (368 words)
- [Animal Health Products | Boehringer Ingelheim IN](/content/in/animal-health/products/index.html): Click here to view an overview of our animal health products here. We provide a wide range of products to help improve the lives of animals. (423 words)
- [Österreichische Karriereseite | Boehringer Ingelheim AT](/content/at/de/karriere/index.html): Schließen Sie sich einem globalen Team von mehr als 52.000 engagierten und talentierten Personen an, die sich der Verbesserung der Gesundheit von Menschen und Tieren weltweit verschrieben haben. (402 words)
- [Where to find us | Boehringer Ingelheim IN](/content/in/about-us/where-find-us/index.html): Find out about Boehringer Ingelheim's sites around the world. With 52,000 employees worldwide, we have sites in Ingelheim, Germany to Yamagata, Japan. (384 words)
- [Frank Hübler | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (161 words)
- [Terms of Use | Boehringer Ingelheim AT](/content/at/en/terms-use/index.html): Terms of Use (1,410 words)
- [More Green | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-green-our-planet/index.html): Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar. (87 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim IN](/content/in/about-us/quality/index.html): Quality at Boehringer Ingelheim (186 words)
- [Diabetes | Boehringer Ingelheim IN](/content/in/human-health/metabolic-diseases/diabetes/index.html): About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Learn more here. (244 words)
- [Положення про доступність | Boehringer Ingelheim UA](/content/ua/polozhennya-pro-dostupnist/index.html): Положення про доступність (474 words)
- [Client error | Ask Boehringer](/content/pro/ca/ask-boehringer/fr-ca/system/4xx/index.html) (74 words)
- [Imprint | Boehringer Ingelheim AT](/content/at/en/imprint/index.html): Imprint (204 words)
- [Haftungsausschluss | Diabetesherz.at](/content/patient/at/diabetesherz/external-link/index.html) (63 words)
- [Our Responsibility | Boehringer Ingelheim IN](/content/in/human-health/our-responsibility/index.html): Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here. (79 words)
- [Chronic Kidney Disease | Boehringer Ingelheim IN](/content/in/human-health/chronic-kidney-disease/index.html): Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population. (213 words)
- [Corporate Social Responsibility | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/corporate-social-responsibility/index.html): Boehringer Ingelheim is driven by a purpose to positively impact the lives of communities in India. Click here to learn more about our work in this area. (541 words)
- [Metabolic Diseases | Boehringer Ingelheim IN](/content/in/human-health/metabolic-diseases/index.html): Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide. (149 words)
- [慢性腎臓病（CKD） | Boehringer Ingelheim JP](/content/jp/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (43 words)
- [Switching market | Boehringer Ingelheim BG](/content/bg/disclaimer/market/index.html) (7 words)
- [Dr Paola Casarosa | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (153 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (134 words)
- [Ética e Compliance | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/index.html): Ética e Compliance (206 words)
- [Politique d’achats chez Boehringer Ingelheim | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/achats/index.html): Politique d’achats (196 words)
- [Diyabet | Boehringer Ingelheim TR](/content/tr/human-health/metabolic-diseases/diabetes/index.html): Dünya çapında yaklaşık 537 milyon yetişkin diyabetle yaşarken tüm vakaların yüzde 90-95'ini Tip 2 diyabet oluşturuyor. (53 words)
- [MASH | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-metabolice/mash/index.html): Aflați mai multe despre boala metabolică cunoscută sub numele de Steatohepatita asociată disfuncției metabolice (MASH), făcând clic aici și vizitând Boehringer Ingelheim. (140 words)
- [Dr Paola Casarosa | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (162 words)
- [ED, US HP Therapeutic Area Communication Job Details | BoehringerPRD](/content/jobs/job-invite/35951/index.html): Ridgefield, CT ED, US HP Therapeutic Area Communication - Unit (1,088 words)
- [Imagine: o nosso hub de histórias sobre sustentabilidade | Boehringer Ingelheim PT](/content/pt/imagine-o-nosso-hub-de-historias-sobre-sustentabilidade.html): Explore como estamos a impulsionar mudanças positivas e a promover cuidados de saúde para um futuro melhor. (96 words)
- [Pharmaziepraktikum Pharmaindustrie | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/pharmaziepraktikum-pharmaindustrie/index.html): Pharmaziepraktikantin und angehende Apothekerin Sarah Heil über ihre Eindrücke bei Boehringer Ingelheim. (91 words)
- [Chemiemeisterin im Endstufenbetrieb | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/chemiemeisterin-im-endstufenbetrieb/index.html): Die Chemikantin aus dem Endstufenbetrieb für pharmazeutische Wirkstoffe gibt Einblicke in ihre Arbeit. (871 words)
- [Maintenance Supervisor Job Details | BoehringerPRD](/content/jobs/job-invite/36080/index.html): Padua Maintenance Supervisor - Ital (569 words)
- [Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job/ingelheim-senior-sales-representative-specialty-care-dresden-cottbus-frankfurt-oder-mwd-deut/1271253201/hr-de-boehringer-ingelheim-com-c2-a0.html): Ingelheim Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) - Deut (525 words)
- [Duales Studium B. Eng. Elektrotechnik - Automation in Ingelheim 2027 Stellendetails | BoehringerPRD](/content/jobs/job-invite/33950/index.html): Ingelheim Duales Studium B. Eng. Elektrotechnik - Automation in Ingelheim 2027 - Deut (618 words)
- [DECIDE-CV programme | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/interets-partenaires/quebec/decide-cv-programme/index.html): Le programme DECIDE-CV est l'une des premières collaborations multidisciplinaires visant à utiliser des technologies basées sur l'IA pour soutenir les personnes atteintes de DT2. Apprenez-en plus. (249 words)
- [Policy and Market Access Manager Job Details | BoehringerPRD](/content/jobs/job-invite/36241/index.html): Taipei City Policy and Market Access Manager - Taiw (387 words)
- [Pardon Our Interruption](/content/tw/gougoudexinzangbingjianchayounaxie-quandexinbingzhenduan.html) (110 words)
- [Dr Armin Wiesler | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler — Membre du Conseil des directeurs principaux responsable de l’unité fonctionnelle de la santé animale (205 words)
- [德國 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/germany/index.html): 德國，是[site:name]起家的地方，仍然是我們全球營業總部。深入瞭解德國職位空缺機會或者深入瞭解在全球 170 個地方的機會。 (64 words)
- [價值故事屋｜最新文章 | Boehringer Ingelheim TW](/content/tw/jiazhigushiwuzuixinwenzhang/index.html): 價值故事屋-最新文章 (14 words)
- [Accessibility Statement | Boehringer Ingelheim IT](/content/it/accessibility-statement/index.html): Accessibility Statement (146 words)
- [Pardon Our Interruption](/content/tr/pdf/mpr-tr-100395unbranded-notspecified-2-0/index.html) (110 words)
- [Helping patients by addressing health system gaps | Boehringer Ingelheim CA](/content/ca/helping-patients-addressing-health-system-gaps-1/index.html): Helping patients by addressing health system gaps (334 words)
- [Frontline Plus M | Boehringer Ingelheim BR](/content/br/pdf/frontline-plus-mpdf/index.html): Bula FRONTLINE® Plus Cães (M). Ampla proteção em um produto seguro, eficaz e fácil de aplicar! (12 words)
- [Sr. AD, HCP Marketing (verducatib) - Peer-to-Peer / Speaker Bureau / Congress Job Details | BoehringerPRD](/content/jobs/job-invite/36227/index.html): Ridgefield, CT Sr. AD, HCP Marketing (verducatib) - Peer-to-Peer / Speaker Bureau / Congress - Unit (1,009 words)
- [Victor Emenike | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/victor-emenike/index.html): Victor Emenike, Data Scientist im operativen Bereich, speziell in der Markteinführungs- und Innovationsorganisation, fühlt sich bei neuen Ideen geschätzt und unterstützt. (101 words)
- [Olca Engin-Sarialtin | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/olca-engin-sarialtin/index.html): Olca Engin-Sarialtin (541 words)
- [Dr Armin Wiesler | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (152 words)
- [Dr Armin Wiesler | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (153 words)
- [Senior Manager Transfer Pricing Job Details | BoehringerPRD](/content/jobs/job-invite/35554/index.html): Ingelheim Senior Manager Transfer Pricing - Germ (745 words)
- [Lab Business Support | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/lab-business-support/index.html): Pavlina Gompper erzählt von ihrer wichtigen Tätigkeit im Laboratory Business Support in der Quality (53 words)
- [Praktikum - Learning & Development - Global CapEx PMO Stellendetails | BoehringerPRD](/content/jobs/job-invite/34971/index.html): Ingelheim Praktikum - Learning & Development - Global CapEx PMO - Deut (584 words)
- [Brand Manager ACT & MET, HP ROPU ASKAN Job Details | BoehringerPRD](/content/jobs/job-invite/35924/index.html): Singapore Brand Manager ACT & MET, HP ROPU ASKAN - Sing (499 words)
- [(Senior) Process Manager EHS Job Details | BoehringerPRD](/content/jobs/job-invite/35107/index.html): Ingelheim (Senior) Process Manager EHS - Germ (628 words)
- [我們尋找員工的五個特質 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/womenxunzhaoyuangongdewugetezhi/index.html): 了解我們在百靈佳殷格翰員工中尋找的技能、資格和經驗，並深入了解我們的人才宣言。 (25 words)
- [Animal Health | Boehringer Ingelheim MEA](/content/mea/animal-health/index.html): Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse. (209 words)
- [Research Spotlight | Veterinary Scholars Program](/content/veterinaryscholars/researchspotlight/index.html) (171 words)
- [Human Health Partnering | Boehringer Ingelheim TW](/content/tw/human-health-partnering/index.html): Find all our Partnering contact information here as well as the latest updates on where you can meet us virtually or in person. (142 words)
- [Dr Paola Casarosa | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (154 words)
- [Biopharma Auftragsherstellung | Boehringer Ingelheim AT](/content/at/de/partnerschaften/biopharma-auftragsherstellung/index.html): Wir sind eines der weltweit führenden Unternehmen in der biopharmazeutischen Auftragsherstellung (185 words)
- [Dr Paola Casarosa | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (678 words)
- [Transparency | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/transparency/index.html): We firmly believe in transparency. Click here to find out information on Boehringer Ingelheim's public disclosure of clinical trial data and more. (50 words)
- [Search | Boehringer Ingelheim HU](/content/hu/search/index.html) (12 words)
- [Michael Schmelmer | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (159 words)
- [Frank Hübler | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (132 words)
- [Shashank Deshpande | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (169 words)
- [Dr Paola Casarosa | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (14 words)
- [Practicante de Contabilidad Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/32294/index.html): Bogotá D.C. Practicante de Contabilidad - Colo (498 words)
- [Personvernerklæring for helsepersonell og veterinærer | Boehringer Ingelheim NO](/content/no/personvernerklaering-helsepersonell-og-veterinaerer.html): Personvernerklæring for helsepersonell og veterinærer (504 words)
- [Animal Health Partnering | Boehringer Ingelheim AU](/content/au/partnering/animal-health-partnering/index.html): Collaborations play an essential role in our ambition to find solutions to the biggest challenges in animal health. Click here to learn more. (61 words)
- [Automation & Cyber Security Manager Job Details | BoehringerPRD](/content/jobs/job-invite/35023/index.html): Pirbright Automation & Cyber Security Manager - Unit (701 words)
- [Pascal Haubert | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/pascal-haubert/index.html): Después de tres meses de pasantía con nosotros, Pascal Haubert habla sobre la importancia de asumir la responsabilidad, el aprendizaje y el apoyo mutuo. (412 words)
- [Pascal Haubert | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/pascal-haubert/index.html): After three months of interning with us, Pascal Haubert talks about the importance of taking responsibility, learning and mutual support. (414 words)
- [넥스가드 스펙트라 츄어블 정 | Boehringer Ingelheim KR](/content/kr/animal-health/products/negseugadeu-seupegteula-chyueobeul-jeong/index.html): 넥스가드 스펙트라 츄어블 정 (55 words)
- [메타캄® 1.0mg 츄어블정 | Boehringer Ingelheim KR](/content/kr/animal-health/products/metakam-10mg-chyueobeuljeong/index.html): 메타캄® 1.0mg 츄어블정 (50 words)
- [Solution Architect MDM Job Details | BoehringerPRD](/content/jobs/job-invite/35966/index.html): Sant Cugat del Vallès Solution Architect MDM - Spai (468 words)
- [データキャリア | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/data-careers/index.html): あなたのデータスキルを活かして、世界を変えてみませんか。データキャリアのチャンスを見つけ、今すぐ応募してください。 (68 words)
- [動物保健合作夥伴 | Boehringer Ingelheim TW](/content/tw/dongwubaojianhezuohuoban/index.html): 探索百靈佳殷格翰在動物保健領域的合作重點與策略方向，聯繫公司團隊方式。從傳染性與非傳染性疾病，到跨越疾病範疇的創新研究，我們持續尋找能共創動物福祉新未來的合作夥伴。 (37 words)
- [Frank Hübler | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/gouvernance/frank-hubler/index.html): Frank Hübler – Membre du Conseil d'administration en charge des Finances (128 words)
- [Benefits and wellbeing | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/benefits-and-wellbeing/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (246 words)
- [Work life wellness | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/work-life-wellness/index.html): 当社では、カウンセリング、エクササイズクラス、ソーシャルイベントなど、心も身体も健康に過ごせるよう、各種特典やサービスを用意しています。 (9 words)
- [Pardon Our Interruption](/content/br/saude-humana/doencas-cardiacas/avc/avc-sintomas-riscos-e-como-agir-rapido-para-salvar-vidas.html) (110 words)
- [Santé humaine | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/index.html): Boehringer Ingelheim's prescription product portfolio covers cardiovascular, oncology, respiratory, CNS, virology and metabolic diseases. (340 words)
- [COPD・喘息 | Boehringer Ingelheim JP](/content/jp/human-health/lung-diseases/copd-asthma/index.html): COPD & Asthma (8 words)
- [Afecțiuni pulmonare | Boehringer Ingelheim RO](/content/ro/medicina-umana/afectiuni-pulmonare/index.html): Boehringer Ingelheim are o experiență de peste 100 de ani în bolile respiratorii. Din 1921 ne-am poziționat ca lider în acest domeniu. (75 words)
- [Pardon Our Interruption](/content/sk/pdf/metodikazverejnovaniapodlaefpiadc2020bi-0/index.html) (110 words)
- [Pardon Our Interruption](/content/animal-health/animals-we-support/horses/west-nile-virus-learn-how-protect-your-horse/index.html) (110 words)
- [Harsha Deshmukh | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (153 words)
- [Dr Armin Wiesler | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler - Člen predstavenstva výkonných riaditeľov so zodpovednosťou za Animal Health Business Unit (149 words)
- [Mentions légales | Boehringer Ingelheim BE](/content/be/fr/mentions-legales/index.html): Corporate - Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim / Rhein, Germany, Trade Register of the Local Court of Mainz, HRB 21005 (90 words)
- [IT | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/it/index.html): Entdecken Sie neue Möglichkeiten in unserer Abteilung Informationstechnologie. (117 words)
- [Pardon Our Interruption](/content/at/de/humanmedizin/chronische-nierenerkrankung/zusammenhang-von-herz-kreislauf-nieren-stoffwechsel-und-dominoeffekt.html) (110 words)
- [Business Process Excellence Lead Job Details | BoehringerPRD](/content/jobs/job-invite/36178/index.html): Pirbright Business Process Excellence Lead - Unit (750 words)
- [Engineering & Technik | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/engineering-technik-0/index.html): Der Bereich Engineering & Technik ist für die Infrastruktur und Instandhaltung aller Gebäude und Anlagen bei Boehringer Ingelheim in Wien verantwortlich. (255 words)
- [Sales Representative Kärnten/nördliche Steiermark (m/w/d), Karenzvertretung Stellendetails | BoehringerPRD](/content/jobs/job-invite/34987/index.html): Kärnten Sales Representative Kärnten/nördliche Steiermark (m/w/d), Karenzvertretung - Öste (439 words)
- [USA | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/usa/index.html): Die USA sind eine unserer erfolgreichsten und innovativsten Regionen. Erkunden Sie Entwicklungsmöglichkeiten für Ihre Karriere in den USA oder an unseren 170 Standorten weltweit. (279 words)
- [Frankreich | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/frankreich/index.html): Boehringer Ingelheim ist seit 1967 in Frankreich präsent. Erkunden Sie Entwicklungsmöglichkeiten für Ihre Karriere in Frankreich oder an unseren 170 Standorten weltweit. (313 words)
- [Responsable qualité médical adjoint (H/F) - CDD 6 mois Job Details | BoehringerPRD](/content/jobs/job-invite/35266/index.html): Reims Responsable qualité médical adjoint (H/F) - CDD 6 mois - Fran (1,049 words)
- [Ein Arbeitsplatz, der zum Leben passt | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/ein-arbeitsplatz-der-zum-leben-passt/index.html): Ein Arbeitsplatz, der zum Leben passt (1,034 words)
- [China | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/china/index.html): Boehringer Ingelheim ist seit 1994 in China aktiv. Erkunden Sie Karrieremöglichkeiten in China oder an unseren 170 Standorten weltweit. (185 words)
- [Nachhaltigkeit | Karriere bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/nachhaltigkeit-karriere-bei-boehringer-ingelheim/index.html): Boehringer Ingelheim leistet einen wesentlichen Beitrag für eine nachhaltige Zukunft für Generationen. Umweltbewusstes Handeln steht dabei im Vordergrund. (640 words)
- [Projektmanagement Ingelheim | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/projektmanagement-ingelheim/index.html): Karriere bei Boehringer Ingelheim: Von der Pharmaziepraktikantin zur Projektmanagerin in der "Business Process Excellence" (528 words)
- [Unsere Mitarbeitenden | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/unsere-mitarbeitenden/index.html): Ehrgeiz. Leidenschaft. Integrität. Hingabe. Empathie. Individualität. Diese Qualitäten erwarten wir auf allen Ebenen. (392 words)
- [Praktikum in der biopharmazeutischen Entwicklung Stellendetails | BoehringerPRD](/content/jobs/job-invite/36274/index.html): Biberach Praktikum in der biopharmazeutischen Entwicklung - Deut (340 words)
- [同理心計劃 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/social-innovation-shehuichuangxin/tonglixinjihua/index.html): 同理心計劃 (64 words)
- [Doktoranden- und Postdoc-Netzwerk | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/doktoranden-und-postdoc-netzwerk/index.html): Doktorandin in der Forschung: Übers PhD-Programm bei Boehringer Ingelheim und das PhD- und Postdoc-Netzwerk (498 words)
- [Harsha Deshmukh | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/harsha-deshmukh/index.html): Harsha Deshmukh – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich IT und Global Business Services (170 words)
- [Postdoc Entwicklung | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/postdoc-entwicklung/index.html): Ein Gespräch mit Rudger Hess über seinen Werdegang – von Praktikum über Masterarbeit bis hin zum Postdoc (491 words)
- [New treatments for pulmonary fibrosis | Boehringer Ingelheim](/content/annualreport/2024/quality-of-life-pulmonary-fibrosis/index.html): Clinical trials indicate nerandomilast could transform treatment for pulmonary fibrosis and help stop its progression (1,431 words)
- [Lead Human Pharma Public & Government Affairs (Obesity and Metabolic Health) Job Details | BoehringerPRD](/content/jobs/job-invite/35667/index.html): Ingelheim Lead Human Pharma Public & Government Affairs (Obesity and Metabolic Health) - Germ (610 words)
- [新貓訓練 | Boehringer Ingelheim TW](/content/tw/xinmaoxunlian/index.html): 新貓訓練 (35 words)
- [跨界合作 | Boehringer Ingelheim TW](/content/tw/kuajiehezuo/index.html): 跨界合作 (33 words)
- [社會企業 | Boehringer Ingelheim TW](/content/tw/shehuiqiye/index.html): 社會企業 (47 words)
- [Accessibility Statement | Boehringer Ingelheim AT](/content/at/en/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (468 words)
- [Pardon Our Interruption](/content/tw/guanyubailingjiayingehan/gongsijieshao/guanyubailingjiayingehanxinwenxunxi/www-boehringer-ingelheim-com/tw/index.html) (110 words)
- [Brésil | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/bresil/index.html): Boehringer Ingelheim est présent au Brésil depuis plus de 70 ans. Explorez les opportunités de carrière au Brésil ou dans nos 170 centres à travers le monde. (202 words)
- [Formation et développement | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/formation-et-developpement/index.html): At Boehringer Ingelheim, we support people throughout their professional development – giving our employees room for learning and growth to achieve their career goals. (255 words)
- [Decouvrez nos opportunités | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/index.html): Découvrez les différentes opportunités d'emploi que nous proposons. Il s'agit pour nous de vous aider à vous développer professionnellement, tout en offrant un travail stimulant qui contribue à notre succès et à votre réussite. (316 words)
- [Nos centres | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-notre-entreprise/nos-sites/index.html): Nous offrons des opportunités de développement de carrière dans plus de 170 centres à travers le monde. Découvrez quelques-uns de nos principaux centres. (134 words)
- [Life Forward | Boehringer Ingelheim FR](/content/fr/carrieres/index.html): Rejoignez une équipe mondiale de plus de 52 000 personnes passionnées et talentueuses vouées à améliorer de la santé des humains et des animaux partout dans le monde. (643 words)
- [Les partenariats chez Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-humaine/nos-axes-de-partenariat/index.html): Les partenariats chez Boehringer Ingelheim (275 words)
- [Grass Roots | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/grass-roots/index.html): Grass Roots (56 words)
- [Vaccins | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-animale/vaccins-0/index.html): Vaccins (56 words)
- [Recherche et développement | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-animale/recherche/index.html): A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. To do this we employ a mix of sophisticated tools, technical capabilities and expertise – both at our Global Innovation (115 words)
- [Animaux de compagnie et chevaux | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/index.html): Chien, chat ou cheval, aujourd’hui plus que jamais, nos animaux de compagnie font partie intégrante de la famille et nous voulons qu’ils puissent bénéficier du même niveau de soins que nous (111 words)
- [La Qualité chez Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/propos/la-qualite/index.html): La Qualité chez Boehringer Ingelheim (299 words)
- [Cancer du poumon | Boehringer Ingelheim FR](/content/fr/sante-humaine/cancer/cancer-du-poumon/index.html): Boehringer Ingelheim concentre le développement de ses innovations dans des domaines où il existe des besoins importants encore non satisfaits pour transformer la prise en charge du cancer du poumon. (44 words)
- [Pardon Our Interruption](/content/pdf/annualreporthighlights2024eng/index.html) (110 words)
- [Schizophrenia | Boehringer Ingelheim TW](/content/tw/schizophrenia/index.html): 精神分裂症 (236 words)
- [MODALITÉS D’UTILISATION | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/modalites-dutilisation/index.html): MODALITÉS D’UTILISATION (1,265 words)
- [Ofev®抑肺纖® | Boehringer Ingelheim TW](/content/tw/products/ofev/index.html): Ofev®抑肺纖® (32 words)
- [Anna-Maria Lindahl | Boehringer Ingelheim SE](/content/se/karriar/anna-maria-lindahl/index.html): Regulatory Affairs & Quality Assurance (936 words)
- [Finance 財務 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/finance-caiwu/index.html): 深入了解我們的人力資源、財務和組織部門的新機會。 (113 words)
- [Micardis® 必康平® | Boehringer Ingelheim TW](/content/tw/products/micardis/index.html): Micardis® 必康平® (93 words)
- [Enlace Médico Científico (MSL) Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36261/index.html): Ciudad de Mexico Enlace Médico Científico (MSL) - Méxi (924 words)
- [Market Access 藥事政策暨專案客戶管理 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/market-access-yaoshizhengcejizhuanankehuguanli/index.html): 深入了解我們Market Access 藥事政策暨專案客戶管理部門的新機會。 (38 words)
- [Commercial Excellence 商業智能暨效能 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/commercial-excellence-shangyezhinengjixiaoneng/index.html): Commercial Excellence 商業智能暨效能 (33 words)
- [Salud financiera | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/salud-financiera/index.html): Revisamos constantemente nuestros salarios para que sigan siendo competitivos en cada mercado, además de brindar apoyo para mejorar tu salud financiera. (307 words)
- [Aprendizaje y desarrollo | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/aprendizaje-y-desarrollo/index.html): We help people grow professionally by maximizing our talent and giving them room to evolve within the company. (268 words)
- [Science Focus | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (95 words)
- [Certificação em Biosseguridade: saúde animal e humana interconectadas | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/certificacao-em-biosseguridade-saude-animal-e-humana-interconectadas.html): A Certificação em Biosseguridade para Fazendas de Leite (CBS) é um projeto feito em parceria com a Empresa Brasileira de Pesquisa Agropecuária (Embrapa) e que representa um marco na prevenção de zoonoses e na promoção de boas práticas de produção. (361 words)
- [Pardon Our Interruption](/content/br/imprensa-historias/press-releases/estudo-de-fase-3-mostra-perda-de-peso-relevante-em-obesidade.html) (110 words)
- [Horses | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/horses/index.html): Partnering with owners and vets, Boehringer Ingelheim’s Equine team brings deep expertise and a passion for the equestrian life to help all horses thrive (450 words)
- [Meer potentieel: Voor gemeenschappen en onze mensen | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/meer-potentieel-voor-gemeenschappen-en-onze-mensen/index.html): Voor gemeenschappen en onze mensen. De samenleving wordt voortdurend geconfronteerd met uitdagingen die variëren van gezondheid tot onderwijs (259 words)
- [Animal Health Partnering | Boehringer Ingelheim MEA](/content/mea/partnering/animal-health-partnering/index.html): Description Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team (278 words)
- [Accessibility Statement | Boehringer Ingelheim MEA](/content/mea/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (468 words)
- [Partnering Culture | Boehringer Ingelheim MEA](/content/mea/partnering/human-health-partnering/partnering-culture/index.html): Our partners are valued contributors in our global family of innovation. Our long-term research and investment focus means we can work together to realize their ideas by fully committing to lasting relationships and providing sustained investment for the (200 words)
- [What Our Partners Say | Boehringer Ingelheim MEA](/content/mea/partnering/human-health-partnering/what-our-partners-say/index.html): What our partners say We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us. (177 words)
- [Diabetes | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/diabetes/index.html): Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives. (295 words)
- [Vaccines | Boehringer Ingelheim MEA](/content/mea/science-innovation/animal-health-innovation/vaccines/index.html): We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here. (71 words)
- [Boehringer Ingelheim no Brasil | 70 anos em Saúde Integrada | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/historia/pdf/boehringer-ingelheim-no-brasil-70-anos-em-saude-integrada.html): Conheça os 70 anos da Boehringer Ingelheim no Brasil: saúde humana e animal, inovação, sustentabilidade e impacto social. (12 words)
- [Contact Us | Boehringer Ingelheim MEA](/content/mea/contact-us/index.html): To contact us at Boehringer Ingelheim please click here to fill out our contact request form. We welcome all queries and feedback. (274 words)
- [Fostering Science | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/fostering-science/index.html): Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here. (61 words)
- [COPD & Asthma | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/copd-asthma/index.html): Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives. (58 words)
- [Artrial Fibrillation | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/atrial-fibrillation/index.html): At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots. (168 words)
- [Veterinary Public Health | Boehringer Ingelheim MEA](/content/mea/animal-health/veterinary-public-health/index.html): Veterinary Public Health (123 words)
- [Clinical Studies | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/clinical-studies/index.html): Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored. (106 words)
- [History | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/history/index.html): Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim. (259 words)
- [Comunicados de prensa | Boehringer Ingelheim MX](/content/mx/comunicados-de-prensa/index.html): Comunicados de prensa (490 words)
- [Shashank Deshpande | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (168 words)
- [Вакансии во Франции | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/france/index.html): «Берингер Ингельхайм» работает во Франции с 1967 года. Узнайте про карьерные возможности во Франции или в 170 наших подразделениях по всему миру. (330 words)
- [Human Health Partnering Contact Form | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/how-connect/human-health-partnering-contact-form/index.html): Connect with Boehringer Ingelheim’s BD&L team to explore partnership opportunities and submit your inquiry to collaborate on innovative treatments. (557 words)
- [(Sr.)Clinical Trial Manager 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36334/index.html): 上海 (Sr.)Clinical Trial Manager - 中国 (272 words)
- [Scientist DS AI Team Job Details | BoehringerPRD](/content/jobs/job-invite/35971/index.html): Biberach Scientist DS AI Team - Germ (618 words)
- [Вакансии в Аргентине | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/argentina/index.html): Аргентина — важнейший для нас регион в Южной Америке. Узнайте про карьерные возможности в Аргентине или в 170 наших подразделениях по всему миру. (159 words)
- [Карьера в области данных | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/data-careers/index.html): Используйте свои навыки работы с данными, чтобы изменить мир к лучшему. Узнайте о вакансиях в области обработки данных и откликнитесь на вакансию сегодня. (118 words)
- [Исследования и разработки | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/research-development/index.html): Мы не только научная, но и производственная компания. Кроме сотрудников лаборатории, у нас есть инженеры, юристы, менеджеры по логистике и не только. (140 words)
- [Варгатеф® | Boehringer Ingelheim RU](/content/ru/human-health/products/vargatef/index.html): Варгатеф® (49 words)
- [BI 764524: Sema3A antibody | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-764524-sema3a-antibody/index.html): BI 764524: Sema3A antibody (211 words)
- [Беродуал® (Раствор для ингаляций) | Boehringer Ingelheim RU](/content/ru/human-health/products/berodual-rastvor-dlya-ingalyaciy/index.html): Беродуал® (55 words)
- [Актилизе® | Boehringer Ingelheim RU](/content/ru/human-health/products/aktilize/index.html): Актилизе® (130 words)
- [Вирамун® | Boehringer Ingelheim RU](/content/ru/human-health/products/viramun/index.html): Вирамун® (44 words)
- [Беротек® | Boehringer Ingelheim RU](/content/ru/human-health/products/berotek/index.html): Беротек® (38 words)
- [Oncology | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/oncology/index.html): Human Pharma Clinical Pipeline Oncology therapeutic area (212 words)
- [Nerandomilast (BI 1015550): PDE4B inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/nerandomilast-bi-1015550-pde4b-inhibitor-0/index.html): Nerandomilast (BI 1015550): PDE4B inhibitor (284 words)
- [Immunology | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/immunology/index.html): Human Pharma Clinical Pipeline Immunology therapeutic area (188 words)
- [Terms and Conditions of Sale | Boehringer Ingelheim IE](/content/ie/terms-and-conditions-sale/index.html): Here you can view our standard terms and conditions relating to the sale of goods from Boehringer Ingelheim. Click here to read our terms and conditions. (20 words)
- [Política de Privacidade Fornecedores, parceiros & Interessados | Boehringer Ingelheim PT](/content/pt/node/18231/index.html): This privacy notice explains how Boehringer Ingelheim Portugal, Lda. and/or its affiliated companies of the Boehringer Ingelheim (1,230 words)
- [Dr Armin Wiesler | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (161 words)
- [Умови користування | Boehringer Ingelheim UA](/content/ua/umovi-koristuvannya/index.html): Умови користування (1,363 words)
- [Bronchectasies | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-pulmonaires/bronchectasies/index.html): Bronchectasies (219 words)
- [Dr Paola Casarosa | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Д-р Paola Casarosa – Член на Управителния съвет с отговорност за направление „Иновации“ (162 words)
- [10 cose da sapere sulla rabbia | Boehringer Ingelheim IT](/content/it/salute-animale/la-nostra-responsabilita/10-cose-da-sapere-sulla-rabbia-0/index.html): 10 cose da sapere sulla rabbia (1,089 words)
- [Perfil do Paciente | Referência Científica](/content/pro/br/taxonomy/term/15/index.html) (672 words)
- [眼部相關疾病 | Boehringer Ingelheim TW](/content/tw/yanbuxiangguanjibing/index.html): 眼部相關疾病 (373 words)
- [Michael Schmelmer | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (163 words)
- [Imprint | Boehringer Ingelheim IN](/content/in/imprint/index.html): Here you can access contact details and information about Boehringer Ingelheim International GmbH. Click here to find out and learn more information. (64 words)
- [annualreport/2021/index.html](/content/annualreport/2021/index.html) (565 words)
- [Shashank Deshpande | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (196 words)
- [Maria Wlaschitz | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/maria-wlaschitz/index.html): Eva-Maria Wlaschitz, científica de desarrollo de Boehringer Ingelheim en Viena, Austria, habla sobre las numerosas oportunidades de crecimiento. (159 words)
- [China | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/china/index.html): Boehringer Ingelheim ha estado activo en China desde 1994. Explora las oportunidades de desarrollo profesional en China hoy. (213 words)
- [Brasil | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/brasil/index.html): La presencia de Boehringer Ingelheim en Brasil abarca más de 70 años. Explora las oportunidades profesionales que te brinda hoy BI Brasil. (195 words)
- [Privileged Access Management (PAM) Engineer Job Details | BoehringerPRD](/content/jobs/job-invite/35318/index.html): Sant Cugat del Vallès Privileged Access Management (PAM) Engineer - Spai (700 words)
- [Japón | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/japon/index.html): Nuestro equipo en Japón es reconocido por su compromiso con la innovación y la sostenibilidad. Mira las oportunidades de desarrollo profesional en Japón. (208 words)
- [Manifiesto | Boehringer Ingelheim ES](/content/es/manifiesto/index.html): Lee el Manifiesto: Desafíos del siglo XXI en prevención, bienestar y salud animal, de Boehringer Ingelheim. (264 words)
- [Microsoft Word - SF Recruiting Global Data Privacy Statement Version 1.1_PT.docx](/content/content/dam/53c5a1ab-8e62-4136-b177-b014006a7f96/successfactors_recruiting_global_data_privacy_statement_pt-pdf.html) (1,575 words)
- [División de Calidad | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/division-de-calidad/index.html): Descubre nuevas oportunidades en nuestra División de Calidad. Marca la difgerencia y únete hoy mismo al equipo de Boehringer Ingelheim. (180 words)
- [Data ofertas | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/data-ofertas/index.html): Utiliza tus conocimientos de Data para marcar la diferencia. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (181 words)
- [Técnico/a Automação Sr Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35689/index.html): Paulínia Técnico/a Automação Sr - Bras (581 words)
- [Taimi Sahlin | Boehringer Ingelheim BR](/content/br/carreiras/taimi-sahlin/index.html): Taimi Sahlin, especialista en terapia de Boehringer Ingelheim Canada, describe su carrera como desafiante y motivadora. (70 words)
- [Galym Zhunisbekov | Boehringer Ingelheim BR](/content/br/carreiras/galym-zhunisbekov/index.html): Galym Zhunisbekov, Gestor regional de Assuntos Regulamentares na Europa de Leste, fala sobre a nossa filosofia e impacto na vida dos doentes. (194 words)
- [Data Protection Complaints Process | Boehringer Ingelheim UK](/content/uk/data-protection-complaints-process/index.html): Data Protection Complaints Process (520 words)
- [Dr Paola Casarosa | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/dr-paola-casarosa/index.html): Dr Paola Casarosa - Az ügyvezető igazgatóság tagja, az Innovációs egység felelőse (119 words)
- [Lotario Halmar | Boehringer Ingelheim BR](/content/br/carreiras/lotario-halmar/index.html): O Dr. Lothar Halmer, o nosso Diretor Executivo de Qualidade com 25 anos de experiência na empresa, diz que a diferença é que cuidamos uns dos outros. (414 words)
- [Pessoas, Finanças & Organização | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/pessoas-financas-organizacao/index.html): Descubra novas oportunidades nos nossos departamentos de Pessoas, Finanças e Organização. (526 words)
- [Kontakt oss | Boehringer Ingelheim NO](/content/no/kontakt-oss/index.html): Takk for din interesse i Boehringer Ingelheim Norway KS. Dersom du har spørsmål om vår virksomhet er du velkommen til å kontakte oss. (202 words)
- [Terápiás területeink | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/index.html): Ismerje meg a Boehringer Ingelheim, egy kutatásközpontú vállalat termékeit a gyógyszerfejlesztés területén. (242 words)
- [Mer grønt: for planeten vår | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/mer-gront/index.html): Vår MORE GREEN-pillar omfatter miljøtiltak som tar hensyn til mange ulike aspekter: vedta tiltak for å unngå vann- og luftforurensning. (97 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (385 words)
- [Onkológia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/daganatos-betegsegek/index.html): Ismerje meg munkánkat a daganatos betegségek terén! A Boehringer Ingelheimnél új reményt adunk a rákos betegeknek az onkológia terén végzett munkánkkal. (99 words)
- [Sertés | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/haszonallatok/sertes/index.html): Többet szeretne tudni a Boehringer Ingelheim munkájáról a sertések egészségének területén? Olvassa el, milyen holisztikus megoldásokon dolgozunk! (136 words)
- [Tudományos hírek | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/tudomanyos-hirek/index.html): Kattintson ide a legújabb tudományos sikertörténeteink megtekintéséhez. Fontos, hogy elgondolkodjunk azon, hogy az új gyógyszerek milyen sikerrel teszik jelentősen jobbá a betegek életét. (67 words)
- [A mi felelősségünk | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/felelossegunk/index.html): Az emberek és állatok élete mélyen és szorosan kapcsolódik egymáshoz. Ha az állatok egészségesek, az emberek is egészségesebbek. Azáltal, hogy az innováción keresztül értéket teremtünk, mindkét faj jóllétét biztosítjuk. (67 words)
- [A tudomány szolgálatában | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/tudomany-szolgalataban/index.html): A tudomány előmozdítása a partnerségek és az együttműködés révén kulcsfontosságú a hatékony kezelések kifejlesztéséhez, amelyek megváltoztathatják a betegek életét. Tudjon meg többet itt. (57 words)
- [Humán egészségügy innováció | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/index.html): Fedezze fel, hogyan dolgozunk a betegek életének megváltoztatásán innováció által vezérelt pipelineunkon keresztül, és olvassa el az úttörő tudomány mögött meghúzódó történeteket. (32 words)
- [Különböző ráktípusok | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/daganatos-betegsegek/kulonbozo-raktipusok/index.html): Különböző ráktípusok (84 words)
- [A kutatási folyamat | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/globalis-innovacio-allategeszsegugy/kutatasi-folyamat/index.html): Küldetésünk kulcsfontosságú része az új vegyületek, vakcinák, technológiák, betegségfolyamatok és fertőző ágensek felfedezése vagy azonosítása. Ennek érdekében kifinomult eszközök, technikai képességek és szakértelem kombinációját alkalmazzuk - mind a glo (117 words)
- [Parazitaölők | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/globalis-innovacio-allategeszsegugy/parazitaolok/index.html): Olvasson a Boehringer Ingelheim globális innovációjáról és szakértelméről a társállatok és szarvasmarhák, például macskák, kutyák és lovak paraziticidjei terén. (55 words)
- [Supplier Support | Boehringer Ingelheim UK](/content/uk/supplier-support/index.html): Supplier Support (703 words)
- [Study Details | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/clinical-trials/nct05182840/index.html): Study Details (2,145 words)
- [Talentos Precoces | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/talentos-precoces/index.html): Empieza tu carrera profesional de la mano de Boehringer Ingelheim. Descubre interesantes oportunidades para estudiantes y recién graduados. ¡Únete ahora! (180 words)
- [Países Bajos | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/paises-bajos/index.html): Nuestra instalación de Ámsterdam es uno de nuestros principales centros de operaciones en Europa. Mira ahora las oportunidades disponibles en los Países Bajos. (212 words)
- [More Stories | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/more-stories/index.html): Stop Rabies - More Stories (282 words)
- [Conciliación de la vida laboral | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/conciliacion-de-la-vida-laboral/index.html): Es importante el equilibrio entre la vida profesional y personal. Así que ofrecemos varias opciones de permisos y horarios de trabajo flexibles. (509 words)
- [Dubái | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/dubai/index.html): Dubai está en el corazón de nuestra región IMETA. Explora las oportunidades de desarrollo profesional activas en los Emiratos Árabes Unidos. (226 words)
- [Technician | SR Technician Maintenance 2nd or 3rd Shift Job Details | BoehringerPRD](/content/jobs/job-invite/33112/index.html): Athens, GA Technician | SR Technician Maintenance 2nd or 3rd Shift - Unit (676 words)
- [SR Associate, Order to Cash Job Details | BoehringerPRD](/content/jobs/job-invite/36310/index.html): Athens, GA SR Associate, Order to Cash - Unit (803 words)
- [Movilidad global | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/movilidad-global/index.html): Somos una empresa con una perspectiva global. Damos la bienvenida a la amplitud de perspectivas que la experiencia internacional aporta a nuestros equipos. (542 words)
- [Japan | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/japan/index.html): Our team in Japan is regarded for commitment to innovation and sustainability. Explore career development opportunities in Japan or our 170 global locations. (256 words)
- [Thorsten von Goessel | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/thorsten-von-goessel/index.html): Thorsten von Gossel of Engineering & Facilities, describes Boehringer Ingelheim as family business with long-term perspective and wonderful leadership team. (20 words)
- [Líderes del mañana | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/lideres-del-manana/index.html): Invertimos en nuestros empleados brindándoles capacitación en liderazgo que mejore sus habilidades y los prepare para futuros roles dentro de la organización. (470 words)
- [¿Quiénes somos? | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/quienes-somos/index.html): Fundada en 1885 por Albert Boehringer, esta empresa familiar e independiente es ahora una de las principales contribuyentes de la salud humana y animal. (420 words)
- [聯絡我們 | Boehringer Ingelheim TW](/content/tw/lianluowomen/index.html): 您可透過線上平台或於產業活動中，與百靈佳殷格翰動物保健事業開發與授權團隊交流，提交您的合作提案或洽談潛在合作機會。 (51 words)
- [France | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/france/index.html): Boehringer Ingelheim has had a presence in France since 1967. Explore career development opportunities in France or our 170 locations around the globe. (331 words)
- [Meet our Team | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/meet-our-team/index.html): Unser Team (98 words)
- [AD MSL / Medical Science Liaison (ILD / Pulmonology)(Illinois, Wisconsin, Missouri) Job Details | BoehringerPRD](/content/jobs/job-invite/36287/index.html): Chicago AD MSL / Medical Science Liaison (ILD / Pulmonology)(Illinois, Wisconsin, Missouri) - Unit (1,231 words)
- [Boehringer Ingelheim Medicine PharmD & PhD Post-Doctoral Fellowship | Boehringer Ingelheim US](/content/us/careers/discover-our-careers/boehringer-ingelheim-medicine-pharmd-phd-post-doctoral-fellowship.html): Boehringer Ingelheim Medicine PharmD & PhD Post-Doctoral Fellowship (453 words)
- [Alliance® | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance/index.html): Alliance® - Productos Salud Animal - Colombia (270 words)
- [Nelli Milosch | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/nelli-milosch/index.html): Nelli Milosch, a team lead for our field-based medical team in Germany, says that the people is the best thing about working in Boehringer Ingelheim. (130 words)
- [Fra idé til lægemiddel | Boehringer Ingelheim DK](/content/dk/fra-ide-til-laegemiddel/index.html): Fra idé til lægemiddel (631 words)
- [Ingelvac CircoFLEX® | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/ingelvac-circoflex/index.html): Eficácia, proteção e segurança para matrizes e leitões (592 words)
- [Alliance® Respiratoria | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance-respiratoria-0/index.html): Alliance® Respiratoria - Productos Salud Animal - Argentina (96 words)
- [Databeskyttelseserklæring for sundhedspersonale og dyrlæger | Boehringer Ingelheim DK](/content/dk/databeskyttelseserklaering-sundhedspersonale-og-dyrlaeger.html): Databeskyttelseserklæring for sundhedspersonale og dyrlæger (636 words)
- [Dirk Esser | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/dirk-esser/index.html): Dirk Esser speaks about his 12 year career at Boehringer Ingelheim and the various growth opportunities. (23 words)
- [50 år i Danmark | Boehringer Ingelheim DK](/content/dk/50-ar-i-danmark/index.html): Et innovativt fællesskab med patienten i centrum (191 words)
- [Coordenador (a) de Território Ruminantes Pleno - Mato Grosso Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35838/index.html): Cuiabá Coordenador (a) de Território Ruminantes Pleno - Mato Grosso - Bras (593 words)
- [Medical Representative Job Details | BoehringerPRD](/content/jobs/job-invite/36278/index.html): Abu Dhabi Medical Representative - Unit (467 words)
- [Vores medarbejdere gør forskellen | Boehringer Ingelheim DK](/content/dk/vores-medarbejdere-gor-forskellen/index.html): Et tæt og godt samarbejde på tværs af virksomheden er topprioritet i HR-afdelingen. (274 words)
- [Vores kultur | Boehringer Ingelheim DK](/content/dk/vores-kultur/index.html): Sådan er det at arbejde hos os (244 words)
- [ciencia de datos | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/ciencia-de-datos/index.html): Use os seus conhecimentos sobre dados para fazer a diferença. Descubra excelentes oportunidades de carreiras na área dos dados e candidate-se hoje. (271 words)
- [Dr Armin Wiesler | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (154 words)
- [Últimos empregos em Singapura | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-em-singapura/index.html): A nossa sede em Singapura serve de centro para a Região do Pacífico. Explore as oportunidades de desenvolvimento de carreira em Singapura ou nas nossas 170 localizações em todo o mundo. (167 words)
- [Shashank Deshpande | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (196 words)
- [山形工場 〜山形から世界を変える。 | Boehringer Ingelheim JP](/content/jp/yamagata-plant/index.html): ベーリンガーインゲルハイム製薬株式会社山形工場の魅力を、「山形工場とは」、「今後の拡張計画について」、「社員紹介」、「福利厚生・山形での働き方」の観点から紹介。 (61 words)
- [Harsha Deshmukh | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (192 words)
- [Últimos empregos na Alemanha | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-na-alemanha/index.html): Alemanha, onde começou a história da Boehringer Ingelheim, e ainda é a nossa sede. Explore as oportunidades de carreira na Alemanha ou nas nossas 170 localizações globais. (143 words)
- [Últimos empregos em Espanha | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-em-espanha/index.html): As nossas instalações em Espanha são a base dos Serviços de Assuntos Regulamentares e de dois centros tecnológicos. Explore as oportunidades de carreira em Espanha ou nas nossas 170 localizações globais. (182 words)
- [Últimos empregos na Áustria | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-na-austria/index.html): Viena foi a nossa primeira localização fora da Alemanha. Explore as oportunidades de desenvolvimento de carreira na Áustria ou nas nossas 170 localizações em todo o mundo. (205 words)
- [Cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/index.html): Cancer (387 words)
- [Bronchiectasis | Boehringer Ingelheim US](/content/us/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis (170 words)
- [Curious to learn more about opportunities in Finance&HR?](/content/ca/careers/discover-our-career-areas/people-finance-organization/index.html): We invite you to learn more about the many functions and roles within Finance/HR/Sourcing, and to explore our current vacancies in locations around the world. (492 words)
- [Obesidad | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/obesidad/index.html): Obesidad (171 words)
- [Enfermedades metabólicas | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/index.html): En Boehringer Ingelheim entendemos la continua necesidad de investigar y desarrollar nuevos e innovadores medicamentos para la diabetes para mejorar la vida de los pacientes diabéticos. (145 words)
- [Etik og compliance | Boehringer Ingelheim DK](/content/dk/om-os/etik-og-compliance/index.html): Etik og compliance (108 words)
- [Más Potencial: para las comunidades y nuestra gente | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-potencial/index.html): Más Potencial: para las comunidades y nuestra gente (400 words)
- [Purchasing | Boehringer Ingelheim US](/content/us/about-us/purchasing/index.html): Suppliers are an integral part of our success. We are passionate about solutions and new opportunities to review, improve and optimize our supplier base. (157 words)
- [Bæredygtig udvikling - for generationer | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/index.html): Hos Boehringer Ingelheim er 'Bæredygtig Udvikling - for generationer' en rejse, der startede i 1885, og som, vi håber, aldrig slutter. (221 words)
- [Más salud: para personas y animales | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-salud/index.html): Más Salud: para personas y animales (239 words)
- [İş hayatında zindelik | Boehringer Ingelheim TR](/content/tr/kariyer/hayatinda-zindelik/index.html): Zihinsel ve fiziksel olarak zinde kalmanıza yardımcı olmak için danışmanlık, spor ve sosyal etkinlikler içeren çeşitli avantajlar ve hizmetler sunuyoruz. (197 words)
- [fransa | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/france/index.html): Boehringer Ingelheim 1967 yılından beri Fransa'da faaliyet göstermektedir. Fransa'da veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (281 words)
- [Aliados na Segurança do Paciente | Boehringer Ingelheim BR](/content/br/pdf/aliados-na-seguranca-do-paciente/index.html): Infográfico explica como profissionais de saúde podem notificar efeitos indesejáveis e contribuir para a segurança do paciente. (12 words)
- [İspanya | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/spain/index.html): İspanya tesisimiz Ruhsatlandırma Bölümü'ne ve iki teknoloji merkezine sahiptir. İspanya'da veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (223 words)
- [Bula Trayenta_Profissional da Saúde | Boehringer Ingelheim BR](/content/br/pdf/bula-trayentaprofissional-da-saude/index.html): Nova bula Trayenta Profissional (12 words)
- [Bula Praxbind (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/praxbindbulapaciente0pdf/index.html): Bula Praxbind (Paciente). Atualizada em 26/11/2025. (12 words)
- [OFEV (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/ofevbulaprofissional/index.html): Bula OFEV (Profissional) atualizada em 06/01/2026. (12 words)
- [Brezilya | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/brazil/index.html): Boehringer Ingelheim 70 yılı aşkın süredir Brezilya'da faaliyet göstermektedir. Brezilya veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (133 words)
- [ACTILYSE (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/actilyse-profissionalpdf/index.html): Bula Actilyse (Profissional) atualizada em (...). (12 words)
- [Giotrif - Bula Paciente | Boehringer Ingelheim BR](/content/br/saude-humana/produtos/pdf/giotrif-bula-paciente/index.html): Afatinibe (como dimaleato de afatinibe). (12 words)
- [Qual é a relação entre doenças reumatológicas e seus pulmões? | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/fibrose-pulmonar/qual-e-relacao-entre-doencas-reumatologicas-e-seus-pulmoes.html): Entenda por que os seus pulmões devem estar sempre em foco, já que podem ser afetados por condições que, à primeira vista, não parecem ter qualquer relação. (636 words)
- [İletişim ve Kurumsal İlişkiler | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/corporate-affairs/index.html): Kurumsal İlişkiler alanındaki fırsatları keşfedin. (220 words)
- [Araştırma ve Geliştirme | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/research-development/index.html): Araştırma Geliştirme alanındaki fırsatları keşfedin. (173 words)
- [İlaç ve Ruhsatlandırma | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/ilac-ve-ruhsatlandirma/index.html): Üretim ve Tedarik Zinciri alanındaki fırsatları keşfedin. (136 words)
- [Guia para tutores de pets: perguntas essenciais para a consulta veterinária | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/animais-de-estimacao/pdf/guia-para-tutores-de-pets-perguntas-essenciais-para-consulta-veterinaria.html): Guia prático com perguntas essenciais para tutores aproveitarem melhor a consulta veterinária e acompanharem a saúde e o bem-estar dos pets. (12 words)
- [Infográfico - O que é bronquiectasia? | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/bronquiectasia/pdf/infografico-o-que-e-bronquiectasia/index.html): Infográfico explica o que é bronquiectasia, seus sintomas, causas, impacto na saúde e desafios no tratamento dessa doença respiratória. (12 words)
- [Metabolik Hastalıklar | Boehringer Ingelheim TR](/content/tr/metabolik-hastaliklar/index.html): Metabolik Hastalıklar (67 words)
- [Metabolická onemocnění | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/index.html): V současné době má diabetes přibližně 425 milionů dospělých lidí na celém světě – v 90 až 95 % případů se jedná o diabetes 2. typu. Odhaduje se, že tento počet se do roku 2045 zvýší na 629 milionů lidí. (166 words)
- [Insuficiência cardíaca | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/insuficiencia-cardiaca/index.html): A insuficiência cardíaca afeta mais de 60 milhões de pessoas em todo o mundo. Saiba mais sobre como prevenir e tratar esta doença. (329 words)
- [Shashank Deshpande | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/shashank-deshpande/index.html): Shashank Deshpande – předseda představenstva odpovědný za divizi Human Pharma (180 words)
- [べーリンガープラス｜医療関係者向けの情報サイト](/content/pro/jp/index-2.html): ベーリンガープラスは、医療関係者の皆さまに向けて、医療・科学情報を無償提供しています。製品情報、疾患や副作用情報など、臨床に役立つ情報を提供し支援いたします。 (30 words)
- [annualreport/2022/index.html](/content/annualreport/2022/index.html) (566 words)
- [COPD & Asthma | Boehringer Ingelheim CA](/content/ca/human-health/lung-diseases/copd-asthma/index.html): COPD is a progressive, treatable disease characterised by limited airflow in and out of the lungs. Click here to learn more about both COPD and asthma. (195 words)
- [Shashank Deshpande | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (196 words)
- [News releases | Boehringer Ingelheim CA](/content/ca/news-releases/index.html): Here you can find the latest press releases from Boehringer Ingelheim on animal health, human health, corporate news, and more. Click here to learn more. (423 words)
- [Privacy Policy Vendors, partners & Interested Persons | Boehringer Ingelheim BE](/content/be/fr/privacy-policy-vendors-partners-interested-persons/index.html): Cette note de confidentialité explique comment SCS Boehringer Ingelheim Comm. V., Boehringer Ingelheim Centre S.A. et/ou ses entreprises affiliées. (1,510 words)
- [Post Doctoral Fellow: Amorphous Particle Engineering Job Details | BoehringerPRD](/content/jobs/job-invite/36015/index.html): Ridgefield, CT Post Doctoral Fellow: Amorphous Particle Engineering - Unit (916 words)
- [USA | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/usa/index.html): The USA is one of our most successful and innovative regions. Explore career development opportunities in the USA or our 170 locations around the globe. (296 words)
- [New material | Boehringer Ingelheim CA](/content/ca/new-material/index.html): Find the latest press releases from Boehringer Ingelheim or access our media pool to view Boehringer Ingelheim corporate news. Click here to find out more. (31 words)
- [Germany | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/germany/index.html): Germany, where the Boehringer Ingelheim story began, and still our global headquarters. Explore career opportunities in Germany or our 170 global locations. (217 words)
- [Brazil | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/brazil/index.html): Boehringer Ingelheim’s presence in Brazil spans over 70 years. Explore career development opportunities in Brazil or our 170 locations around the globe. (174 words)
- [Déclaration d'accessibilité | Boehringer Ingelheim BE](/content/be/fr/declaration-daccessibilite/index.html): Boehringer Ingelheim s'engage à fournir un site Web accessible au plus large public possible, quelle que soit la technologie ou l'aptitude. (509 words)
- [Davantage de potentiel pour les communautés et nos collaborateurs | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/davantage-de-potentiel/index.html): Pour les communautés et nos collaborateurs. La société demeure confrontée à des défis dans divers domaines: santé, éducation, perspectives d'emploi. (258 words)
- [Sales/SR/Lead Representative, Pets - Kalamazoo, MI Job Details | BoehringerPRD](/content/jobs/job-invite/36384/index.html): Kalamazoo Sales/SR/Lead Representative, Pets - Kalamazoo, MI - Unit (996 words)
- [Porcs | Boehringer Ingelheim BE](/content/be/fr/sante-animale/betail/porcs/index.html): Boehringer Ingelheim est un partenaire et un facilitateur de la production durable de porc et de protéines animales, garantissant le bien-être des (185 words)
- [Dirk Esser | Boehringer Ingelheim](/content/careers/discover-our-career-areas/dirk-esser/index.html): Diverse, caring, collaborative - Dirk Esser on Boehringer Ingelheim (38 words)
- [Développement durable - Notre engagement | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/notre-engagement/index.html): Nous voulons soutenir l'innovation, créer de la valeur dans des domaines où des besoins médicaux demeurent non satisfaits, et nous engager avec les (127 words)
- [動物保健 創新 | Boehringer Ingelheim TW](/content/tw/dongwubaojian-chuangxin/index.html): Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our (112 words)
- [Where to find us | Boehringer Ingelheim](/content/about-us/where-find-us/index.html): Where to find us (423 words)
- [Patients – Our priority | Boehringer Ingelheim](/content/human-health/patients/index.html): At Boehringer Ingelheim, patient insights guide our science as we develop meaningful medicines that address unmet needs and support those living with disease. (211 words)
- [Zmluvná biofarmaceutická výroba | Boehringer Ingelheim SK](/content/sk/partnering/boehringer-ingelheim-bioxcellence/index.html): Ako jedna z troch obchodných oblastí v rámci Boehringer Ingelheim ponúkame biofarmaceutický kontrakt na vývoj a výrobu odborných znalostí, od kultúr cicavčích buniek cez mikrobiálne a kvasinkové fermentácie až po farmaceutický a biotechnologický priemysel (78 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim](/content/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (500 words)
- [Vakcíny | Boehringer Ingelheim SK](/content/sk/science-innovation/animal-health-innovation/vaccines/index.html): V programe globálne inovácie (Global Innovation) pracujeme na bezpečných a účinných vakcínach pre spoločenské a hospodárske zvieratá. Spájame široké odborné znalosti v oblasti vakcinológie, molekulárnej biológie, bioprocesov, testov a klinického vývoja. (71 words)
- [Veterinárne verejné zdravie | Boehringer Ingelheim SK](/content/sk/animal-health/veterinary-public-health/index.html): Veterinárne verejné zdravie (133 words)
- [Inovácie v oblasti ľudského zdravia | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/index.html): Boehringer Ingelheim má vo svojich cieľoch jasno. Chceme dodať portfólio prelomových liekov, ktoré zlepšia životy pacientov na celom svete. Začína to inováciami. (27 words)
- [Naša zodpovednosť | Boehringer Ingelheim SK](/content/sk/human-health/our-responsibility/index.html): V spoločnosti Boehringer Ingelheim kladieme pacientov na prvé miesto vo všetkom, čo robíme. (73 words)
- [Hypertenzia | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/hypertension/index.html): Hypertenzia (vysoký krvný tlak) postihuje približne jednu miliardu ľudí na celom svete a očakáva sa, že toto číslo sa v budúcich rokoch zvýši. (88 words)
- [Udržateľný rozvoj | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/index.html): V Boehringer Ingelheim je motto „Udržateľný rozvoj – pre generácie“ súčasťou cesty, ktorá sa začala v roku 1885 a veríme tomu, že sa nikdy neskončí. (114 words)
- [Kultúra | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/culture/index.html): Od založenia spoločnosti Albertom Boehringerom pred viac ako 135 rokmi sa sústredíme na výsledky dosiahnuté z dlhodobého hľadiska a nie na krátkodobo dosiahnuté zisky. Viac ako 52.000 zamestnancov Boehringer Ingelheim každý deň vytvára hodnoty prostredníc (77 words)
- [Leaving site | Boehringer Ingelheim SK](/content/sk/disclaimer/external/index.html) (119 words)
- [Ausbildung als Pharmakant*in in Ingelheim 2027 Stellendetails | BoehringerPRD](/content/jobs/job-invite/33803/index.html): Ingelheim Ausbildung als Pharmakant*in in Ingelheim 2027 - Deut (595 words)
- [Geschichten aus der Wissenschaft | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/index.html): Geschichten aus der Wissenschaft (591 words)
- [Nadine Becker | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/nadine-becker/index.html): Nadine Becker, spricht über ihre Funktion im Bereich Stammdatenmanagement und ihre 20-jährige Karriere bei Boehringer Ingelheim. (125 words)
- [Wissenschaft & Innovation | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/index.html): Innovation (133 words)
- [Innovationen in der Tiergesundheit | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-tiergesundheit/index.html): Innovationen in der Tiergesundheit (129 words)
- [Ansätze für Partnerschaften | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-tiergesundheit/ansaetze-fuer-partnerschaften/index.html): Ansätze für Partnerschaften (83 words)
- [Depression | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/depression/index.html): Die Borderline-Persönlichkeitsstörung ist eine häufige psychische Störung, die mit schweren funktionellen und emotionalen Beeinträchtigungen einhergeht. (160 words)
- [新聞稿彙總與分類 Press Releases | Boehringer Ingelheim TW](/content/tw/xinwengaohuizongyufenlei-press-releases/index.html): 新聞稿彙總與分類 Press Releases (231 words)
- [Recherche et développement | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/recherche-et-developpement/index.html): Découvrez les nouvelles opportunités dans notre division Recherche et Développement. (216 words)
- [Neueste Jobs in Japan | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/neueste-jobs-japan/index.html): Unser Team in Japan ist bekannt für sein Engagement für Innovation und Nachhaltigkeit. Erkunde deine Karrieremöglichkeiten in Japan oder an unseren 170 Standorten weltweit. (197 words)
- [Richtig überzeugen beim Vorstellungsgespräch | Boehringer Ingelheim DE](/content/de/karriere/deine-bewerbung/richtig-ueberzeugen-beim-vorstellungsgespraech/index.html): Richtig überzeugen beim Vorstellungsgespräch (1,119 words)
- [Technologies de l’information - TI | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/technologies-de-linformation-ti/index.html): Découvrez les nouvelles opportunités dans notre département Technologies de l'information. (221 words)
- [Elektroniker | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/elektroniker/index.html): „Bei allen Themen, die die Prüftechnik betreffen, bin ich involviert. Es ist nicht so, dass uns das Engineering etwas diktiert. Ich erarbeite alles mit und werde auch gefragt.“ (665 words)
- [Niederlande | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/niederlande/index.html): Unsere Niederlassung in Amsterdam ist einer unserer Dreh- und Angelpunkte für unsere Geschäftstätigkeiten in Europa. Erkunde deine Karrieremöglichkeiten in den Niederlanden oder an unseren 170 Standorten weltweit. (168 words)
- [Neueste Jobs in China | Karriere bei Boehringer Ingelheim](/content/de/karriere/ueber-uns/standorte/china/index.html): Boehringer Ingelheim ist seit 1994 in China aktiv. Erkunde Karrieremöglichkeiten in China oder an unseren 170 Standorten weltweit. (200 words)
- [Medizin & Regulatory Affairs | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/medizin-regulatory-affairs/index.html): Entdecke neue Möglichkeiten in unseren Bereichen Medizin und Zulassungsangelegenheiten. (222 words)
- [Affaires d’entreprise | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/affaires-dentreprise/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Affaires commerciales. (174 words)
- [Perspectivas | Boehringer Ingelheim ES](/content/es/perspectivas/index.html): Obtén información sobre el sector de la salud animal y lea las opiniones de los expertos de Boehringer Ingelheim sobre la importancia de la colaboración para impulsar la innovación. (429 words)
- [Switching market | Boehringer Ingelheim AT](/content/at/de/disclaimer/market/index.html) (58 words)
- [FAQ | Boehringer Ingelheim CA](/content/ca/fr/emplois/comment-postuler/foire-aux-questions/index.html): Questions les plus fréquentes concernant le processus de candidature chez Boehringer Ingelheim. (1,700 words)
- [Imprint | Boehringer Ingelheim PL](/content/pl/imprint/index.html): Imprint (70 words)
- [Kultura partnerskiej współpracy | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/kultura-partnerskiej-wspolpracy/index.html): Nasi partnerzy są cenionymi uczestnikami naszej globalnej rodziny innowacji. Nasze długoterminowe badania i inwestycje oznaczają, że możemy wspólnie pracować nad realizacją ich pomysłów, w pełni angażując się w trwałe relacje i zapewniając (139 words)
- [Bezpieczeństwo pacjentów | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nasza-odpowiedzialnosc/bezpieczenstwo-pacjentow/index.html): Bezpieczeństwo pacjentów (90 words)
- [Opowieści ze świata nauki | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/opowiesci-ze-swiata-nauki/index.html): Kliknij tutaj, aby zobaczyć nasze ostatnie sukcesy naukowe. Ważne jest, aby zastanowić się nad sukcesem nowych leków, które znacząco poprawiają życie pacjentów. (75 words)
- [Ochrona weterynaryjnego zdrowia publicznego | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/ochrona-weterynaryjnego-zdrowia-publicznego/index.html): Ochrona weterynaryjnego zdrowia publicznego (116 words)
- [豬 Swine | Boehringer Ingelheim TW](/content/tw/animal-health/livestock/index.html): 豬 Swine (221 words)
- [Koncentracja na pacjentach | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nasza-odpowiedzialnosc/koncentracja-na-pacjentach/index.html): Pacjenci inspirują nas w naszej misji przewodzenia nauce, która tworzy przełomowe terapie, dzięki czemu nasze leki zmieniają życie pacjentów. (87 words)
- [Schizofrenia | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/zdrowie-psychiczne/schizophrenia/index.html): Schizofrenia (83 words)
- [Dokumenty | Boehringer Ingelheim PL](/content/pl/dokumenty/index.html): Dokumenty (40 words)
- [Interets Partenaires | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/interets-partenaires/index.html): Explorez nos partenariats axés sur la santé chez Boehringer Ingelheim. Une collaboration pour un avenir meilleur. (147 words)
- [Sklerodermie | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/sklerodermie/index.html): Sklerodermie (70 words)
- [Våra läkemedel | Boehringer Ingelheim SE](/content/se/manniskors-halsa/produkter/index.html): Våra läkemedel (74 words)
- [Processus de recherche | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-animale/processus-de-recherche/index.html): Découvrez notre recherche et l’innovation en santé animale chez Boehringer Ingelheim. Des avancées pour la santé de nos compagnons. (159 words)
- [Beatrice Wieland | Boehringer Ingelheim SE](/content/se/karriar/beatrice-wieland/index.html): Beatrice arbetar för att säkerställa att patienternas röster, behov och perspektiv genomsyrar allt vi gör. (806 words)
- [Volaille | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/volaille/index.html): Prenez soin de la santé des animaux d’élevage et des volailles avec Boehringer Ingelheim. Découvrez nos solutions pour des élevages prospères. (83 words)
- [巴金森病 Parkinson’s disease | Boehringer Ingelheim TW](/content/tw/human-health/zhongshushenjingjibing/index.html): 巴金森病 (35 words)
- [MPOC et asthme | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-pulmonaires/mpoc-et-asthme/index.html): Solutions innovantes pour les problèmes respiratoires avec Boehringer Ingelheim. Prenez soin de votre santé pulmonaire avec nos traitements avancés. (229 words)
- [認識我們 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/index.html): 認識我們 (328 words)
- [Nous contacter | Boehringer Ingelheim CA](/content/ca/fr/contactez-nous/index.html): Contactez-nous chez Boehringer Ingelheim. Nous sommes là pour répondre à vos questions et vous offrir notre assistance. (401 words)
- [Développement durable - Notre engagement | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/notre-engagement/index.html): Notre engagement envers le développement durable chez Boehringer Ingelheim. Découvrez comment nous œuvrons pour un avenir plus responsable. (45 words)
- [分佈全球的百靈佳殷格翰 | Boehringer Ingelheim TW](/content/tw/about-us/where-find-us/index.html): Sustainable Development (402 words)
- [以患者為中心 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/patient-centricity/index.html): 以患者為中心 (32 words)
- [Utvalda berättelser | Boehringer Ingelheim SE](/content/se/djurhalsa/berattelser/index.html): Djur och människors välbefinnande - vårt syfte, vår inspiration och vårt mål: Djurens och människornas liv hänger samman i djupt och komplext. (273 words)
- [Privacybeleid met betrekking tot PV | Boehringer Ingelheim BE](/content/be/nl/privacybeleid-met-betrekking-tot-pv/index.html): Hartelijk dank voor uw melding van een bijwerking of van overige relevante informatie voor geneesmiddelenbewaking met betrekking tot een (497 words)
- [Depression | Boehringer Ingelheim SE](/content/se/manniskors-halsa/mental-halsa/depression/index.html): Depression är en psykisk störning som orsakar en ihållande känsla av sorg och ointresse. (61 words)
- [Elektroniker*in für Automatisierungstechnik Stellendetails | BoehringerPRD](/content/jobs/job-invite/33782/index.html): Ingelheim Elektroniker*in für Automatisierungstechnik - Deut (560 words)
- [Akut ischemisk stroke | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/stroke/index.html): Akut ischemisk stroke är den vanligaste typen av stroke. Det inträffar när blodtillförseln till en del av hjärnan blockeras blodpropp i ett blodkärl. (72 words)
- [Hypertoni (högt blodtryck) | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/hogt-blodtryck/index.html): Hypertoni (högt blodtryck) är ett tillstånd som drabbar ungefär en miljard människor i världen, och antalet patienter förväntas öka under kommande åren. (99 words)
- [content/dam/7fe8a4a7-9ed3-41ef-a565-af1e0120af14/stiolto-20respimat-us-pi-pdf.html](/content/content/dam/7fe8a4a7-9ed3-41ef-a565-af1e0120af14/stiolto-20respimat-us-pi-pdf.html) (13,229 words)
- [Parasiticiden | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-diergezondheid/parasiticiden/index.html): Een belangrijk expertisegebied binnen Global Innovation is de ontdekking en ontwikkeling van nieuwe parasiticiden voor zowel gezelschapsdieren als vee (57 words)
- [Bevordering van de wetenschap | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-menselijke-gezondheid/wetenschapsverhalen/index.html): Het creëren van baanbrekende geneesmiddelen die het leven van patiënten veranderen, begint met een engagement om de gezondheidsuitdagingen. (75 words)
- [Grass Roots-innovatie | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-menselijke-gezondheid/fundamentele-innovatie/index.html): Onze Grass Roots-aanpak is geworteld in onze first4patients-innovatieambitie om baanbrekende therapieën te creëren die het leven van patiënten veranderen. (106 words)
- [content/dam/07c11f94-358a-439d-b0c8-af1e011f04c4/gilotrif-us-pi-pdf.html](/content/content/dam/07c11f94-358a-439d-b0c8-af1e011f04c4/gilotrif-us-pi-pdf.html) (9,729 words)
- [Patiënten assertiever maken | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/kanker/patienten-assertiever-maken/index.html): Het aanpakken van kanker houdt niet op bij het ontwikkelen van medicijnen. In samenwerking met de bredere gemeenschap ondersteunen we bewustwording. (105 words)
- [Retinale aandoeningen | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/retinale-aandoeningen/index.html): Retinale aandoeningen (130 words)
- [content/dam/736f603f-9560-470d-a627-af1e011edbcd/combivent-20respimat-us-pi-pdf.html](/content/content/dam/736f603f-9560-470d-a627-af1e011edbcd/combivent-20respimat-us-pi-pdf.html) (9,062 words)
- [¿Cómo aplicar? | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/como-aplicar/index.html): Mira nuestro vídeo para saber paso a paso cómo crear una cuenta y empezar a solicitar puestos de trabajo en Boehringer Ingelheim. (576 words)
- [Longaandoeningen | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/longaandoeningen/index.html): Boehringer Ingelheim heeft al 100 jaar ervaring in ademhalingsziekten. Sinds 1921 hebben we ons gemanifesteerd als een leider in dit ziektebeeld en hebben we verschillende behandelingen gelanceerd voor een reeks van longaandoeningen, zoals as (107 words)
- [content/dam/1e056dd2-1c86-4cdc-b2cb-af1e011f1fbe/glyxambi-us-pi-pdf.html](/content/content/dam/1e056dd2-1c86-4cdc-b2cb-af1e011f1fbe/glyxambi-us-pi-pdf.html) (15,539 words)
- [Imagine – Sustainability Story Hub | Boehringer Ingelheim | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/index.html): Erfahren Sie, wie wir positiven Wandel vorantreiben und gesundheitlich Chancengleichheit fördern. (693 words)
- [Patientensicherheit & Pharmakovigilanz | Boehringer Ingelheim DE](/content/de/humanmedizin/unsere-verantwortung/patientensicherheit/index.html): Boehringer Ingelheims Abteilung Patientensicherheit und Pharmakovigilanz trägt für die wirkungsvolle und sichere Anwendung von Medikamenten Sorge. (459 words)
- [Innovaciones en Salud | Terapias Innovadoras | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/innovacion-fundamental/index.html): Nos comprometemos a crear terapias innovadoras para mejorar la vida de los pacientes. Para eso invertimos en la ciencia emergente y la impulsamos. (133 words)
- [Enfermedades en Caballos | Productos para Caballos | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/index.html): Nuestras innovaciones en inmunología, parasitología y salud gástrica y metabólica han ayudado a que los caballos vivan más tiempo y estén más saludables. (253 words)
- [Innovación Médica | Medicamentos Innovadores | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/index.html): El objetivo de Boehringer Ingelheim es ofrecer medicamentos innovadores que mejoren la vida de los pacientes a través de la constante innovación médica. (40 words)
- [Antiparasitarios | Enfermedades Parasitarias | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-animal/parasiticidas/index.html): Al ser líderes en parasiticidas, nos comprometemos a seguir desarrollando innovaciones basadas en la ciencia para prevenir enfermedades parasitarias (61 words)
- [Partnerschappen in diergezondheid | Boehringer Ingelheim NL](/content/nl/samenwerking/partnerschappen-diergezondheid/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (492 words)
- [Enfermedades Metabólicas | Sistema Metabólico | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-metabolicas/index.html): Boehringer Ingelheim desarrolla tratamientos innovadores para las personas afectadas por enfermedades metabólicas, cardiovasculares y renales conectadas. (83 words)
- [Tratamiento para el Cáncer | Lucha contra el Cáncer | Boehringer Ingelheim MX](/content/mx/salud-humana/cancer/traves-de-los-tipos-de-cancer/index.html): En Boehringer Ingelheim damos una nueva esperanza a los pacientes al colaborar con la comunidad oncológica y ofrecer avances científicos contra el cáncer. (96 words)
- [Tierarzneimittel | Haustiere | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/index.html): Als führendes Unternehmen in den Bereichen Antiparasitika, Impfstoffe und Therapeutika wir sind ein zuverlässiger Partner für Tierärzte und Tierhalter. (298 words)
- [Producten voor menselijke gezondheid | Boehringer Ingelheim NL](/content/nl/voor-mens/producten/index.html): Producten voor de gezondheid van de mens - Elke dag verbeteren de 52.000 werknemers van Boehringer Ingelheim het leven van zowel mensen als dieren. (248 words)
- [Ansätze für Partnerschaften | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/ansaetze-fuer-partnerschaften/index.html): Mit Partnern arbeiten wir an Durchbrüchen, die Menschen mit bisher nur unzureichend behandelten Erkrankungen neue Therapiemöglichkeiten eröffnen. (125 words)
- [Klinische Studien | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/index.html): Klinische Studien sind wichtig, um die Wirksamkeit und Sicherheit eines Medikaments zu belegen. Wir initiieren und fördern Studien in über 60 Ländern. (210 words)
- [Innovationen in der Humanmedizin | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/index.html): Boehringer Ingelheim konzentriert sich in seinen Forschungsaktivitäten auf Krankheitsbereiche mit einem hohen ungedeckten medizinischen Bedarf. (152 words)
- [Parasiticiden | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-diergezondheid/parasiticiden/index.html): Een belangrijk expertisegebied binnen Global Innovation is de ontdekking en ontwikkeling van nieuwe anti-parasitica voor zowel gezelschapsdieren als vee. (57 words)
- [Boehringer Ingelheim Deutschland - Life Forward | Boehringer Ingelheim DE](/content/de/index.html): Erfahren Sie mehr darüber, wie wir das Leben von Mensch und Tier verbessern. (235 words)
- [Careers | Boehringer Ingelheim](/content/careers/index.html): Join a global team of over 54,000 talented people dedicated to improving human and animal health worldwide. Explore careers at Boehringer Ingelheim now! (745 words)
- [Herz-Kreislauf-Erkrankungen | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/index.html): Herzerkrankungen sind weltweit die häufigste Todesursache. Doch oft lassen sich Herz-Kreislauf-Erkrankungen durch richtige Vorbeugung vermeiden. (62 words)
- [Gezelschapsdieren | Boehringer Ingelheim NL](/content/nl/voor-dier/gezelschapsdieren/index.html): Bent u een dierenarts of heeft u een huisdier of een paard? Als een van de toonaangevende leveranciers ter wereld zorgt Boehringer Ingelheim voor een langer, (34 words)
- [Bronchiëctasieën | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/bronchiectasieen/index.html): Bronchiëctasieën (187 words)
- [HERNEXEOS® | Boehringer Ingelheim](/content/human-health/products/hernexeos/index.html): First orally-administered, targeted therapy for patients with HER2-mutant advanced non-small cell lung cancer (NSCLC). (41 words)
- [Kanker | Boehringer Ingelheim NL](/content/nl/voor-mens/kanker/index.html): Kanker vernietigt. Verkort levens. Berooft ons van dierbaren. Bij Boehringer bieden wij patiënten nieuwe hoop door de strijd met kanker aan te gaan. (126 words)
- [Empowerment van patiënten | Boehringer Ingelheim NL](/content/nl/voor-mens/kanker/patienten-mondiger-maken/index.html): Kanker aanpakken houdt niet op bij het ontwikkelen van geneesmiddelen. In samenwerking met de bredere gemeenschap ondersteunen wij bewustzijn, voorlichting (110 words)
- [Longfibrose | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/longfibrose/index.html): Longfibrose is een aandoening die leidt tot een opeenhoping van littekenweefsel in de longen. Na verloop van tijd verliezen de longen hun vermogen om zuurst (112 words)
- [Giotrif® | Boehringer Ingelheim](/content/human-health/products/giotrif/index.html): Giotrif treats patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have activating epidermal growth factor receptor (EGFR) mutations. (64 words)
- [Annual Press Conference 2026 | Boehringer Ingelheim](/content/about-us/annual-press-conference-2026/index.html): Boehringer Ingelheim presented the 2025 results and an outlook for 2026 at the Annual Press Conference on March 25, 2026. (204 words)
- [Ингельвак МикоФЛЕКС® | Boehringer Ingelheim RU](/content/ru/animal-health/products/ingelvak-mikofleks/index.html): Ингельвак МикоФЛЕКС® (213 words)
- [Berotec® | Boehringer Ingelheim](/content/human-health/products/berotec/index.html): Find information on how Berotec symptomatic treats acute asthma attacks, including allergic & non-allergic asthma bronchiale and other conditions. (49 words)
- [Aptivus® | Boehringer Ingelheim](/content/human-health/products/aptivus/index.html): Aptivus is indicated to treat HIV-1 patients, co-administered with 200mg of ritonavir and HIV-1 strains resistant to more than one protease inhibitor. (45 words)
- [Meer potentieel: voor gemeenschappen en onze medewerkers | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/meer-potentieel/index.html): De maatschappij wordt constant geconfronteerd met (nieuwe) uitdagingen, variërend van gezondheid tot onderwijs, werk, levensomstandigheden, ongelijkheden (185 words)
- [Matériel de presse | Boehringer Ingelheim BE](/content/be/fr/medias/index.html): Pool média, Dans notre pool de médias, vous trouverez une collection complète de contenus médiatiques liés à Boehringer Ingelheim. (264 words)
- [Ethiek en naleving | Boehringer Ingelheim NL](/content/nl/over-ons/ethiek-en-naleving/index.html): Ethiek en naleving (63 words)
- [Myocardinfarct (hartaanval) | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/myocardinfarct/index.html): Myocardinfarct (hartinfarct) is wereldwijd een van de belangrijkste doodsoorzaken. Ongeveer 42 procent van alle sterfgevallen ten gevolge van hart- en (117 words)
- [Acute ischemische beroerte | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/acute-ischemische-beroerte/index.html): De acute ischemische beroerte is het type beroerte dat het meest voorkomt. Deze ontstaat als de bloedtoevoer naar een deel van de hersenen geblokkeerd wordt door (96 words)
- [Leadership | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (157 words)
- [Media Overview | Boehringer Ingelheim MEA](/content/mea/media/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (174 words)
- [Duurzame ontwikkeling - voor alle toekomstige generaties | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/index.html): Bij Boehringer Ingelheim is 'Duurzame ontwikkeling - voor alle toekomstige generaties' een echte reis. Die reis begon in 1885 en zal - zoals wij hopen en geloven (173 words)
- [Ezabenlimab: PD-1 antibody | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/ezabenlimab-pd-1-antibody/index.html): Ezabenlimab, PD-1 antibody (182 words)
- [Sajtóközlemények | Boehringer Ingelheim HU](/content/hu/sajtokozlemenyek/index.html): A Boehringer Ingelheim legfrissebb sajtóközleményei az állatgyógyászatról, a vényköteles gyógyszerekről, a gyógyszerkészítményekről és a vállalati hírekről. (201 words)
- [Immunomodulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/immunomodulator-1/index.html): Immunomodulator (35 words)
- [Приватність даних | Boehringer Ingelheim UA](/content/ua/privatnist-danikh/index.html): Положення про захист персональних даних (2,649 words)
- [Human Health | Boehringer Ingelheim MEA](/content/mea/human-health/index.html): Read the latest human health articles by clicking here. From drug discovery to specific diseases such as heart, lung or eye diseases our information is vast. (203 words)
- [Партнерские проекты подразделения ветеринарных препаратов | Boehringer Ingelheim RU](/content/ru/partnering/animal-health-partnering/index.html): Узнайте о совместном подходе «Берингер Ингельхайм» к инновациям в ветеринарии, о наших интересах в области партнерства и о том, как связаться с нашей командой (503 words)
- [Инженерное дело и оборудование | «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/engineering-facilities/index.html): Узнайте о новых карьерных возможностях в нашем отделе инжиниринга и технического обслуживания. (206 words)
- [Our total rewards | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-total-rewards/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (290 words)
- [Accessibility Statement | Boehringer Ingelheim IE](/content/ie/accessibility-statement/index.html): Boehringer Ingelheim Ireland is committed to providing a website that is accessible to the widest possible audience. Click here to learn more. (411 words)
- [Partnering | Boehringer Ingelheim IE](/content/ie/partnering/index.html): At Boehringer Ingelheim diversity of minds & collaboration with expert community partnerships is paramount to developing new medical breakthroughs. (217 words)
- [Пресс-служба | Boehringer Ingelheim RU](/content/ru/press-sluzhba/index.html): Просмотрите и скачайте пресс-материалы компании или воспользуйтесь контактами отдела корпоративной коммуникации Boehringer Ingelheim (59 words)
- [Veterinary Public Health | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/veterinary-public-health/index.html): Click here to find out how Boehringer Ingelheim partners with health authorities, governments and NGO's to protect the World against emerging diseases. (344 words)
- [Partnership stories | Boehringer Ingelheim ZA](/content/za/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (219 words)
- [Human Health Partnering Interests | Boehringer Ingelheim IE](/content/ie/partnering/human-health-partnering/partnering-interests/index.html): Click here to find out what we’re looking for in our search to discover the next generation of breakthrough medicines. (87 words)
- [AFTOPOR®/AFTOVAXPUR®/AFTOVIS® | Boehringer Ingelheim](/content/animal-health/products/aftopor-aftovaxpur-aftovis/index.html): FMD vaccines with highly potent and purified antigens (AFTOPOR®/AFTOVAXPUR®/AFTOVIS®) allow differentiation between infected and vaccinated animals for endemic or emergency situations. (72 words)
- [Partnering | Boehringer Ingelheim ZA](/content/za/partnering/index.html): At Boehringer, diversity of minds and collaboration is paramount to developing new medical breakthroughs. Click to see how you can partner with us. (247 words)
- [Противопаразитарные препараты | Boehringer Ingelheim RU](/content/ru/science-innovation/animal-health-innovation/parasiticides/index.html): Ознакомьтесь с глобальными инновациями и опытом Boehringer Ingelheim в области паразитицидов для животных-компаньонов и крупного рогатого скота, таких как кошки, собаки или лошади. (55 words)
- [Развитие науки | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/fostering-science/index.html): Развитие науки через партнерство и сотрудничество имеет решающее значение для разработки эффективных методов лечения, которые могут изме (50 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim ZA](/content/za/partnering/biopharma-contract-manufacturing/index.html): Biopharma Contract Manufacturing (140 words)
- [Grass Roots | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators (84 words)
- [Science Focus | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (98 words)
- [Наш Фокус в науке | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (63 words)
- [The Research Process | Boehringer Ingelheim ZA](/content/za/science-innovation/animal-health-innovation/research-process/index.html): A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. To do this we employ a mix of sophisticated tools, technical capabilities and expertise – both at our Global Innovation r (130 words)
- [Human Health Innovation | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/index.html): Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline. (164 words)
- [ХОБЛ и астма | Boehringer Ingelheim RU](/content/ru/human-health/lung-diseases/copd-asthma/index.html): Хроническая обструктивная болезнь легких (ХОБЛ) — это серьезное прогрессирующее заболевание легких. ХОБЛ можно предотвратить, но полностью излечить невозможно. (20 words)
- [Руководство | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (559 words)
- [Sites Around the World | Boehringer Ingelheim ZA](/content/za/about-us/where-find-us/index.html): Sites Around the World (385 words)
- [Типы рака | Boehringer Ingelheim RU](/content/ru/human-health/cancer/across-cancer-types/index.html): Типы рака (63 words)
- [Unser Team | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-tiergesundheit/unser-team/index.html): Unser Team (66 words)
- [Partnerschaften in der Humanmedizin | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/index.html): Human Health Partnerning (178 words)
- [Sailboat for Health: Medizin Arztbesuche für griechische Inseln | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/gesundheit-griechische-inseln/index.html): Erfahren Sie, wie das „Sailboat for Health“ die Gesundheitsversorgung und Diabetesaufklärung auf abgelegenen griechischen Inseln verbessert. (1,481 words)
- [Острый ишемический инсульт | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/stroke/index.html): «Берингер Ингельхайм» поддерживает международные и российские программы по борьбе с инсультом, которые помогают врачам в организации и оптимизации процесса оказания помощи пациентам с острым нарушением мозгового кровообращения. (83 words)
- [Kontakt | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/kontakt/index.html): Kontakt (75 words)
- [Patientensicherheit und Pharmakovigilanz bei Boehringer Ingelheim | Boehringer Ingelheim CH](/content/ch/humanmedizin/unsere-verantwortung/patientensicherheit/index.html): Bei Boehringer Ingelheim wollen wir sicherstellen, dass Patientinnen und Patienten wirkungsvolle und sichere Therapien erhalten – heute, morgen und darüber hinaus. (412 words)
- [Grass Roots | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/grass-roots/index.html): Grass Roots (164 words)
- [About Us | Boehringer Ingelheim ZA](/content/za/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (193 words)
- [Media Overview | Boehringer Ingelheim ZA](/content/za/media/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (141 words)
- [Hypertension | Boehringer Ingelheim ZA](/content/za/human-health/heart-diseases/hypertension/index.html): Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke. (124 words)
- [Der Forschungsprozess | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-tiergesundheit/der-forschungsprozess/index.html): Der Forschungsprozess (115 words)
- [Больше возможностей | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-potential/index.html): В компании «Берингер Ингельхайм» программа «Устойчивое развитие — для поколений» посвящена путешествию. Тот, который начался в 1885 году, и тот, на который мы надеемся и верим (115 words)
- [Schizophrenie | Boehringer Ingelheim CH](/content/ch/humanmedizin/psychische-gesundheit/schizophrenie/index.html): Schizophrenie äußert sich in Form von drei unterschiedlichen Symptombereichen: Positivsymptome wie Halluzinationen oder Wahnvorstellungen, Negativsymptome wie Depression oder Antriebslosigkeit sowie kognitive Symptome, zu denen beispielsweise Gedächtnisst (158 words)
- [Tiergesundheit | Boehringer Ingelheim CH](/content/ch/tiergesundheit/index.html): Über uns Das Leben von Tieren und Menschen ist auf tiefe und komplexe Weise miteinander verbunden. Wir sind überzeugt: Wenn Tiere gesund sind, dann sind auch die Menschen gesünder. Weltweit setzen sich unsere Mitarbeitenden in der Tiergesundheit dafür ein (258 words)
- [COPD & Asthma | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/copd-asthma/index.html): Wichtige Therapieziele in der COPD-Behandlung sind die Verbesserung der Atemnot, der Lebensqualität und der Reduktion des Exazerbationsrisikos, so dass Patienten einen möglichst aktiven Lebensstil beibehalten können. (236 words)
- [Contratos de fabrico de produtos biofarmacêuticos | Boehringer Ingelheim PT](/content/pt/parcerias/contratos-de-fabrico-de-produtos-biofarmaceuticos/index.html): Sendo uma das três áreas de negócio da Boehringer Ingelheim, oferecemos competências em matéria de desenvolvimento e fabrico por contrato de produtos. (129 words)
- [Coach Exit: Mentoring für spanische Jugendliche | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/mentoring-spanien/index.html): Finden Sie heraus, wie das Mentoring-Programm „Coach Exit“ benachteiligte Jugendliche in Spanien unterstützt und Mitarbeitenden soziales Lernen ermöglicht. (417 words)
- [Capacitação dos doentes | Boehringer Ingelheim PT](/content/pt/saude-humana/cancro/capacitacao-dos-doentes/index.html): Assumir o cancro não se detém no desenvolvimento de medicamentos. Em parceria com a comunidade em geral (116 words)
- [Parcerias | Boehringer Ingelheim PT](/content/pt/parcerias/index.html): Acreditamos no poder das parcerias e da diversidade dos pensamentos nas comunidades dedicadas às ciências da vida e à saúde animal. (128 words)
- [Vacinas | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-animal/vacinas/index.html): Na Global Innovation, trabalhamos em vacinas seguras e eficazes para animais de companhia e gado. (77 words)
- [Geschichte | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/geschichte/index.html): Albert Boehringer gründete Boehringer Ingelheim 1885. Lesen Sie hier, wie sich das Unternehmen seitdem entwickelt hat. (67 words)
- [Animais de produção | Boehringer Ingelheim PT](/content/pt/saude-animal/gado/index.html): A Boehringer Ingelheim é um dos maiores fornecedores de soluções de saúde para estimar, prevenir e tratar doenças no gado. (82 words)
- [Obesidade | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-metabolicas/obesidade/index.html): A obesidade é uma doença crónica complexa que requer uma gestão a longo prazo. (92 words)
- [Лечение на интерстициални белодробни болести (ИББ) | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/lechenie-na-intersticialni-belodrobni-bolesti-ibb/index.html): Вижте списък на cпециализираните комисии за диагностика и лечение на интерстициални белодробни болести в извънболничната помощ. (141 words)
- [Партнерство в галузі здоров'я людей | Boehringer Ingelheim UA](/content/ua/partnering/human-health-partnering/index.html): Тут ви знайдете всю нашу партнерську контактну інформацію, а також останні новини про те, де ви можете зустрітися з нами віртуально або особисто. (95 words)
- [Qualidade na Boehringer Ingelheim | Boehringer Ingelheim PT](/content/pt/sobre-nos/qualidade/index.html): Na Boehringer Ingelheim, a Qualidade está profundamente integrada no ciclo de vida do produto. (225 words)
- [Контрактне виробництво біофармацевтичних препаратів | Boehringer Ingelheim UA](/content/ua/partnering/boehringer-ingelheim-bioxcellence/index.html): Контрактне виробництво біофармацевтичних препаратів (77 words)
- [Insuficiência Cardíaca | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/insuficiencia-cardiaca/index.html): A insuficiência cardíaca é uma condição progressiva e potencialmente fatal que está a afectar mais de 60 milhões de pessoas em todo o mundo. (250 words)
- [Ética e Compliance | Boehringer Ingelheim PT](/content/pt/sobre-nos/etica-e-compliance/index.html): Ética e Compliance (135 words)
- [Contacto | Boehringer Ingelheim PT](/content/pt/contacte-nos/index.html): Agradecemos o seu interesse na Boehringer Ingelheim. Os seus comentários e questão são bem-vindos. (203 words)
- [More Health: Für Menschen & Tiere | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-health/index.html): More Health: Für Menschen & Tiere Bei der übergreifenden Arbeit für die Gesundheit von Mensch und Tier haben wir einzigartige Möglichkeiten auf gefährdete Bevölkerungsgruppen positiv einzuwirken. Mit More Health erhöhen wir unseren Beitrag für eine gesünd (245 words)
- [З самих паростків | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/grass-roots/index.html): Інновації на місцях: Підтримка наступного покоління інноваторів у сфері медико-біологічних наук (61 words)
- [Інновації в галузі здоров'я людей | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/index.html): Дізнайтеся більше про нашу мету - покращити життя пацієнтів у всьому світі за допомогою медичних проривів та інновацій, включаючи понад 100 продуктів, що знаходяться в стадії розробки. (31 words)
- [ХОЗЛ і астма | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/copd-asthma/index.html): Основні цілі лікування ХОЗЛ полягають у обмеженні симптомів, зниженні ризику загострень та підтримці людей жити більш активним життям. (180 words)
- [Етика та Дотримання вимог | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/index.html): Етика та Дотримання вимог (129 words)
- [Пациентите преди всичко | Boehringer Ingelheim BG](/content/bg/human-health/our-responsibility/patient-centricity/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (156 words)
- [Партньорства | Boehringer Ingelheim BG](/content/bg/partnering/index.html): В Boehringer Ingelheim разнообразието от умове и сътрудничество е от първостепенно значение за разработването на нови медицински пробиви. Кликнете (86 words)
- [Захворювання легень | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/index.html): «Берінгер Інгельхайм» має 100-річну історію у сфері боротьби з респіраторними захворюваннями. З 1921 року ми стали лідером у цій галузі. (65 words)
- [Хуманна медицина | Boehringer Ingelheim BG](/content/bg/human-health/index.html): Прочетете най-новите статии за човешкото здраве, като кликнете тук. Информацията ни е огромна - от откриването на лекарства до специфични заболявания, като например сърдечни, белодробни или очни болести. (254 words)
- [Історія | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/history/index.html): Дізнайтеся більше про історію інноваційної фармацевтичної компанії «Берінгер Інгельхайм». (121 words)
- [Затлъстяване | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/obesity/index.html): Затлъстяването е сложно хронично заболяване, което изисква дългосрочен контрол. (89 words)
- [Більше здоров'я: для людей і тварин | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/more-health/index.html): Натисніть тут, щоб завантажити Маніфест компанії "Берінгер Інгельхайм" до 2025 року, в якому детально викладено довгострокову ініціативу щод (59 words)
- [Предсърдно мъждене | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/atrial-fibrillation/index.html): В Boehringer Ingelheim подобряваме лечението на пациенти, страдащи от редица сърдечносъдови заболявания - предсърдно мъждене, инсулт и тромбози. (45 words)
- [Animal Health Partnering | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (436 words)
- [Бронхиектазия | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/bronchiectasis/index.html): Бронхиектазия (140 words)
- [More Health: For People & Animals | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (160 words)
- [Purchasing & Suppliers | Boehringer Ingelheim AU](/content/au/about-us/purchasing/index.html): Click here to read information about Boehringer Ingelheim's purchasing and supplier relationships, and access useful resources for suppliers too. (189 words)
- [Diabetes | Type 2 Diabetes | Boehringer Ingelheim AU](/content/au/human-health/metabolic-diseases/diabetes/index.html): About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Read more here. (91 words)
- [Stroke | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/stroke/index.html): We developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. Read more here. (133 words)
- [Metabolic Diseases | Boehringer Ingelheim AU](/content/au/human-health/metabolic-diseases/index.html): Interconnected cardio-renal-metabolic conditions are the leading cause of mortality worldwide. Click here to read more about them and the work we do. (60 words)
- [Ethics and Compliance | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/index.html): Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner. (117 words)
- [Companion Animals | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/index.html): Companion Animals (94 words)
- [More Potential | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/index.html): More Potential works to provide the best conditions for our people, communities and partners. Click here to learn more about our More Potential initiative. (55 words)
- [Where to find us | Boehringer Ingelheim AT](/content/at/en/about-us/where-find-us/index.html): Where to find us (396 words)
- [La nostra Responsabilità | Boehringer Ingelheim IT](/content/it/salute-umana/la-nostra-responsabilita/index.html): our stories (94 words)
- [Condiciones de uso | Boehringer Ingelheim ES](/content/es/condiciones-de-uso/index.html): Estas Condiciones de uso regula el acceso y utilización de la página web que Boehringer Ingelheim España pone a disposición de los usuarios de Internet. (2,081 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/pulmonary-fibrosis/index.html): Reducing the risk of acute exacerbations is a key treatment goal to manage patients with Pulmonary Fibrosis. Learn how BI is helping. (184 words)
- [Salute Umana | Boehringer Ingelheim IT](/content/it/salute-umana/index.html): Human Health (340 words)
- [Ipertensione | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/ipertensione/index.html): Ipertensione (291 words)
- [More Health: For People & Animals | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/index.html): More Health: For People & Animals (311 words)
- [Obesity | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/obesity/index.html): Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here. (163 words)
- [More Green | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/index.html): More Green (104 words)
- [Switching market | Boehringer Ingelheim IT](/content/it/disclaimer/market/index.html) (36 words)
- [Julkaisutiedot | Boehringer Ingelheim FI](/content/fi/julkaisutiedot/index.html): Julkaisutiedot (57 words)
- [Biologisten lääkkeiden sopimusvalmistus | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/biologisten-laakkeiden-sopimusvalmistus/index.html): Yksi kolmesta Boehringer Ingelheimin liiketoiminta-alueista on biologisten lääkevalmisteiden sopimusvalmistus ja tuotannon asiantuntemus. (78 words)
- [Nuestra cultura de trabajo | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestra-cultura-de-trabajo/index.html): Nuestra cultura de trabajo (654 words)
- [Eläinlääkinnällinen terveys | Boehringer Ingelheim FI](/content/fi/elainterveys/elainlaakinnallinen-terveys/index.html): Eläinlääkinnällinen terveys (77 words)
- [Tutkimusprosessi | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/elainterveyden-innovaatiot/tutkimusprosessi/index.html): Lopuksi meidän on saatava tuotteillemme hyväksyntä asianmukaisilta valvontaviranomaisilta ja seurattava niitä, kun ne on tuotu markkinoille. (94 words)
- [Ruohonjuuressa | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/ihmisterveyden-innovaatiot/ruohonjuuressa/index.html): Grass Roots -lähestymistapamme perustuu first4patients-innovaatioiden tavoitteeseen luoda läpimurtohoitoja, jotka muuttavat potilaiden elämää. (60 words)
- [Eläinterveyden innovaatiot | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/elainterveyden-innovaatiot/index.html): Panostamme mahdollisimman paljon eläinten hyvinvointiin keskittymällä alueisiin, joilla on vaikutus suurimpaan määrään eläimiä. (48 words)
- [Explore nuestra compañía | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/index.html): Dá tu próximo paso profesional en Boehringer Ingelheim. Explora nuestras áreas para obtener más información sobre oportunidades laborales. (423 words)
- [caballos | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/caballos/index.html): Nuestra visión es desarrollar productos innovadores que permitan a nuestros clientes, aportar a los caballos el más alto nivel de cuidado posible. (273 words)
- [Salud pública veterinaria | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/index.html): A través de nuestro VPH nos asociamos con las autoridades sanitarias, los gobiernos y las ONG contra enfermedades transfronterizas y emergentes. (295 words)
- [More Green: Planeetallemme | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/more-green/index.html): Painopisteemme on luonnonvarojen, kuten puhtaan veden, suojeleminen sekä toimintojemme tie kohti hiilineutraaliutta. (155 words)
- [Seguridad del Paciente | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/seguridad-del-paciente-y-farmacovigilancia/index.html): Seguridad del Paciente y Farmacovigilancia (168 words)
- [More Health: para personas y animales | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (293 words)
- [Cáncer de pulmón | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/index.html): Nuestro objetivo es enfrentarnos al cáncer de pulmón, transformar el tratamiento y redefinir todos los cánceres de pulmón como curables. (291 words)
- [Collaborative-working | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/index.html): Click here to find out about collaborative working at Boehringer Ingelheim. This page contains information about our current partnerships and more. (1,136 words)
- [Compras | Boehringer Ingelheim ES](/content/es/sobre-nosotros/compras/index.html): Los proveedores son una parte fundamental de nuestro compromiso con el éxito. Revisar, mejorar y optimizar nuestra base de proveedores es fundamental. (391 words)
- [Obesidad | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/obesidad/index.html): Aprenda sobre la obesidad y vea lo que está haciendo Boehringer Ingelheim para desarrollar nuevos medicamentos para mejorar la vida de los pacientes. (143 words)
- [Aineisto lehdistöä varten | Boehringer Ingelheim FI](/content/fi/media/index.html): Tutustu mediakokoelmaamme ja eläinten terveyden lehdistöpakettiimme. (27 words)
- [Terms of Use | Boehringer Ingelheim UK](/content/uk/terms-use/index.html): Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/uk (1,708 words)
- [Speak Up Canal de comunicación de presuntos incumplimientos | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/speak-compliance-hotline/index.html): El portal Speak Up ofrece un entorno seguro para informar sobre posibles incumplimientos y está abierto a cualquier persona en todo el mundo. Nos tomamos muy en serio cualquier reporte de posibles incumplimientos. (376 words)
- [More Green | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-green/index.html): "Sustainable Development - For Generations" se trata de un viaje. Uno que comenzó en 1885, que nos da esperanza y en el que creemos. (163 words)
- [Kjæledyr | Boehringer Ingelheim NO](/content/no/dyrehelse/selskapsdyr/kjaeledyr/index.html): Vi er blant markedslederne innen parasittmidler, vaksiner og terapeutika og en pålitelig partner for veterinærer og kjæledyreiere over hele verden. (182 words)
- [Schizofreni | Boehringer Ingelheim NO](/content/no/menneskelig-helse/psykisk-helse/schizofreni/index.html): Schizofreni er kjennetegnet ved tre dominerende symptomer og berører 1% av den globale befolkningen. (197 words)
- [제품 관련 공지사항 | Boehringer Ingelheim KR](/content/kr/human-health/products/jepum-gwanlyeon-gongjisahang/index.html): 제품 관련 공지사항을 전해 드립니다. (348 words)
- [Kronisk nyresykdom | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kronisk-nyresykdom/index.html): Chronic Kidney Disease (218 words)
- [Depresjon | Boehringer Ingelheim NO](/content/no/menneskelig-helse/psykisk-helse/depresjon/index.html): Depresjon er en psykisk sykdom som forårsaker en vedvarende følelse av nedstemthet og tap av interesse. (115 words)
- [Dyrehelse: Vårt ansvar | Boehringer Ingelheim NO](/content/no/dyrehelse/vart-ansvar/index.html): Vi planlegger i generasjoner. Dette gjenspeiles i vår mer enn 100 år med suksessfull bedriftshistorie. Det står også i sentrum (139 words)
- [Selskapsdyr | Boehringer Ingelheim NO](/content/no/dyrehelse/selskapsdyr/index.html): Er du veterinær, eller har du et kjæledyr eller en hest? Som en av de ledende leverandørene globalt, hjelper Boehringer Ingelheim med å gi lengre (33 words)
- [Fedme | Boehringer Ingelheim NO](/content/no/menneskelig-helse/metabolske-sykdommer/fedme/index.html): Overvekt er en kompleks kronisk sykdom som krever langsiktig behandling. Det er blant de ledende risikofaktorene for flere kardiometabolske. (71 words)
- [Science & Innovation | Boehringer Ingelheim UK](/content/uk/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (328 words)
- [Shashank Deshpande | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (168 words)
- [Kulttuuri | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/kulttuuri/index.html): Boehringer Ingelheimin yli 52 000 työntekijää luovat arvoa innovaatiosta, johon sisältyy selkeä tavoite. (109 words)
- [Culture | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/culture/index.html): Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. (175 words)
- [Culture | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/culture/index.html): Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. (150 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (103 words)
- [Nuestras historias | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestras-historias/index.html): En BI, "Desarrollo sostenible por generaciones" se trata de un viaje. Uno que comenzó en 1885 y uno que nos da esperanza, y en el que creemos. (214 words)
- [한국분쉬의학상 | Boehringer Ingelheim KR](/content/kr/about-us/sustainable-development/hangugbunswiuihagsang/index.html): 한국베링거인겔하임은 한국 의학계의 학술 발전을 도모하고, 의학 분야에서 한국과 독일 양국의 친선을 증진시키기 위해 1990년 4월 대한의학회와 공동으로 "분쉬의학상"을 제정해 시상하고 있습니다. (129 words)
- [Våre historier | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/vare-historier/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (135 words)
- [As nossas histórias | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/nossas-historias/index.html): A Boehringer Ingelheim tem muitas iniciativas que gostaríamos de partilhar. Saiba mais sobre nós lendo as nossas histórias. (108 words)
- [스피리바 레스피맷 다회용 | Boehringer Ingelheim KR](/content/kr/human-health/products/spirivarespimat/index.html): 만성폐쇄성폐질환(COPD) 및 천식 치료제 스피리바 레스피맷 다회용 (65 words)
- [Purchasing | Boehringer Ingelheim KR](/content/kr/about-us/purchasing/index.html): Purchasing (153 words)
- [Our Stories | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (41 words)
- [한국베링거인겔하임 소개 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaim-sogae/index.html): 한국베링거인겔하임은 베링거인겔하임의 한국법인으로 1976년에 설립되어 인체의약품과 동물약품 분야에서 혁신적인 제품을 공급하고 있습니다. (84 words)
- [Newsbits | Boehringer Ingelheim](/content/media-stories/newsbits/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (398 words)
- [Leaving site | Boehringer Ingelheim IN](/content/in/disclaimer/external/index.html) (133 words)
- [연락처 | Boehringer Ingelheim KR](/content/kr/yeonlagcheo/index.html): 연락처 (80 words)
- [content/dam/624c8994-d6c3-4a63-b89d-b3240153771c/hernexeos-us-pi-pdf.html](/content/content/dam/624c8994-d6c3-4a63-b89d-b3240153771c/hernexeos-us-pi-pdf.html) (580 words)
- [Get in touch | Boehringer Ingelheim US](/content/us/careers/get-touch/index.html): Get in touch and learn more about the job application process. (654 words)
- [Press Material | Boehringer Ingelheim US](/content/us/media/press-material/index.html): Click here to find all of our press resources, including a comprehensive collection of Boehringer Ingelheim related media contents. (25 words)
- [Histoire | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/histoire/index.html): Découvrez-en plus à propos de nous et notre histoire chez Boehringer Ingelheim CA FR. Une trajectoire marquée par l’innovation et l’engagement. (62 words)
- [精選故事 | Boehringer Ingelheim TW](/content/tw/jingxuangushi/index.html): Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (135 words)
- [Nuestras Ubicaciones | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/index.html): Ofrecemos oportunidades de desarrollo profesional en más de 170 ubicaciones en todo el mundo. Explora ahora algunas de nuestras ubicaciones destacadas. (271 words)
- [To enkle tests kan hjælpe mennesker med kronisk nyresygdom | Boehringer Ingelheim DK](/content/dk/human-health/kronisk-nyresygdom/enkle-tests-kan-hjaelpe-mennesker-med-kronisk-nyresygdom.html): To enkle tests kan hjælpe mennesker med kronisk nyresygdom (497 words)
- [Produits de santé animale | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/produits/index.html): Découvrez nos produits de santé animale chez Boehringer Ingelheim. Contribuons au bien-être des animaux avec nos solutions de pointe. (1,397 words)
- [Lo que dicen nuestros socios | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-humana/lo-que-dicen-nuestros-socios/index.html): Lo que dicen nuestros socios (131 words)
- [Innovative partnerskaber | Boehringer Ingelheim DK](/content/dk/partnerskab/index.html): Stærke partnerskaber og tværfagligt tankesæt inden for life science og dyresundhed er noget, vi vægter højt. (138 words)
- [Global Biofarmaceutisk Virksomhed | Boehringer Ingelheim DK](/content/dk/partnerskab/biofarmaceutisk-virksomhed/index.html): Et af vores tre forretningsområder hos Boehringer Ingelheim er Biofarmaceutisk Virksomhed.Vores ekspertise spænder fra dyrkning af mammale, (102 words)
- [Partnerkultur | Boehringer Ingelheim DK](/content/dk/partnerskab/human-health-partnerskaber/partnerkultur/index.html): Vores partnere er værdsatte bidragydere i vores globale innovationsfamilie. Vores langsigtede forsknings- og investeringsfokus betyder, at vi kan arbejde sammen om at realisere deres ideer. Vi forpligter os til varige relationer og leverer vedvarende inv (154 words)
- [Partnering Interests | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/partnering-interests/index.html): Boehringer Ingelheim partners across a variety of human health therapeutic areas and beyond. We’re modality agnostic and prefer to partner early. (804 words)
- [Discover our careers | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/index.html): Discover our careers (298 words)
- [Nethindesygdomme | Boehringer Ingelheim DK](/content/dk/human-health/nethindesygdomme/index.html): Hos Boehringer Ingelheim har vi udvidet vores globale forsknings- og udviklingsaktiviteter for at kunne behandle øjensygdomme, specifikt dem der påvirker det bagerste af øjet. (374 words)
- [Videnskab og innovation | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/index.html): Hver dag udforsker vores forskere nye områder og viderefører vores engagement i innovation. (156 words)
- [Ruminants | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/ruminants/index.html): Across the lifespan of cattle and sheep, Boehringer Ingelheim delivers proactive solutions to help ruminant producers optimize herd health and productivity (577 words)
- [Seguridad del Paciente y Farmacovigilancia | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/seguridad-del-paciente/index.html): Seguridad del Paciente y Farmacovigilancia (357 words)
- [Human Health Partnering | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/index.html): Learn about Boehringer’s collaborative approach to human health innovation, our areas of partnering interest, and how to connect with our team. (339 words)
- [Equinos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/equinos/index.html): Equinos (142 words)
- [Související tiskové zprávy | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-zdravi-zvirat/oblasti-partnerstvi/index.html): Seznamte se se zájmy společnosti Boehringer Ingelheim v oblasti zdraví zvířat, včetně infekčních onemocnění, neinfekčních onemocnění a oblastí, které se nemocemi nezabývají. (772 words)
- [Sklerodermi | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/sklerodermi/index.html): Systemisk sclerose (SSc) er en vansirende, invaliderende og potentielt dødelig sjælden sygdom, der forårsager ardannelse i huden (sclerodermi), (202 words)
- [Our Science Focus | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-focus/index.html): BI's research into new medicines is focused on areas of science with significant medical need and where we continue to innovate and lead the science. (123 words)
- [Contact Us | Boehringer Ingelheim US](/content/us/contact-us/index.html): Get in touch with one of the Boehringer Ingelheim teams. We welcome your queries and feedback. (64 words)
- [Kontakt | Boehringer Ingelheim DK](/content/dk/kontakt/index.html): Hvis du har spørgsmål om vores virksomhed, er du velkommen til at kontakte os på nedenstående telefonnummer eller e-mail. (126 words)
- [Leadership | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Pressebereich | Boehringer Ingelheim CH](/content/ch/fr/pressebereich/index.html): Pressebereich (29 words)
- [Como se candidatar | Boehringer Ingelheim BR](/content/br/carreiras/como-se-candidatar/index.html): Saiba como se pode candidatar, o que esperar e o que preparar, quando iniciar a candidatura connosco. (422 words)
- [Explore our company | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/index.html): Make your next career step at Boehringer Ingelheim. Explore our various fields to find out more about employment opportunities in your area of interest. (380 words)
- [Povești de parteneriat | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-domeniul-medicinei-veterinare/povesti-de-parteneriat/index.html): Citiți despre unele dintre cele mai semnificative colaborări ale Boehringer Ingelheim în domeniul sănătății animale și auziți ce au de spus partenerii noștri despre experiențele lor de lucru cu noi (313 words)
- [Parcerias | Boehringer Ingelheim BR](/content/br/parcerias/index.html): Parcerias (215 words)
- [Parcerias na Saúde Humana | Boehringer Ingelheim BR](/content/br/parcerias/parcerias-na-saude-humana/index.html): Parcerias na Saúde Humana (102 words)
- [Esquizofrenia | Boehringer Ingelheim BR](/content/br/saude-humana/saude-mental/esquizofrenia/index.html): Esquizofrenia (519 words)
- [Global Careers Page | Boehringer Ingelheim JP](/content/jp/careers/index.html): Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide. (37 words)
- [MICARDIS (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/micardis-profissionalpdf/index.html): Nova bula Micardis - Profissional de Saúde. atualizada em 06/01/2026 (12 words)
- [ヒューマン・パートナリング・スコープ | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/index.html): 私たちは、アニマルヘルスにおける次世代の革新につながる新たなアイデアや新たなサイエンスを探し求めています。私たちのパートナーシップ活動は、以下のとおりです。 当社の重点疾患領域における新規かつ既存品より優れた医薬品の創製と開発 アンメットニーズの高い重点領域における治療の進展を支える新たな技術の探索 ヒト用医療用医薬品とのシナジーを探り、ヒト用医薬品の知見を動物用の新たなヘルスケアソリューションとして生かし得る可能性のある新規化合物やプロセスの特定 (21 words)
- [Cultura parteneriatului | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-pentru-medicina-umana/cultura-parteneriatului/index.html): Partenerii noștri sunt contribuitori valoroși în familia noastră globală de inovare. Faptul că ne concentrăm pe cercetare și investiții pe termen lung înseamnă că putem lucra împreună pentru a le realiza ideile, angajându-ne pe deplin în r (51 words)
- [Parteneriate în domeniul sănătății umane | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-pentru-medicina-umana/index.html): Găsiți aici toate informațiile de contact ale partenerilor noștri, precum și cele mai recente actualizări cu privire la locurile în care ne puteți întâlni virtual sau personal. (108 words)
- [The Research Process | Boehringer Ingelheim CA](/content/ca/science-innovation/animal-health-innovation/research-process/index.html): We discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. Learn more about our research process here. (129 words)
- [Podpora vědy | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/podporujeme-vedu/index.html): Podpora vědy prostřednictvím partnerství a spolupráce je zásadní pro vývoj účinných léčebných postupů, které mohou změnit životy pacientů. Více informací naleznete zde. (106 words)
- [Meet our Team | Boehringer Ingelheim HK](/content/hk/en/partnering/animal-health-partnering/meet-our-team/index.html): Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team (55 words)
- [Naše vědecké zaměření | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/nase-vedecke-zamereni/index.html): Zjistěte, na co se v současné době zaměřuje vědecký výzkum a investice společnosti Boehringer Ingelheim, včetně nemocí CNS, onemocnění sítnice a COVID-19. (72 words)
- [Şirketimizi keşfedin | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/index.html): Kariyerinize Boehringer Ingelheim'da devam edin. Alanınızdaki istihdam fırsatları hakkında daha fazla bilgi edinmek için sektörlerimizi keşfedin. (333 words)
- [Animal health innovation | Boehringer Ingelheim CA](/content/ca/science-innovation/animal-health-innovation/index.html): We pioneer the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health. Learn more. (71 words)
- [Inovație în medicina veterinară | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-globala-medicina-veterinara/index.html): Echipa noastră de Inovare Globală este un pionier al științei care îi ajută pe medicii veterinari, pe proprietarii de animale de companie și de animale de fermă și pe oficialii din domeniul sănătății publice din întreaga lume să îmbunătățească sănătatea a (87 words)
- [Bronchectasie | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/bronchectasie/index.html): Bronchectasie (236 words)
- [Human Health Partnering | Boehringer Ingelheim HK](/content/hk/en/partnering/human-health-partnering/index.html): Find all our Partnering contact information here as well as the latest updates on where you can meet us virtually or in person. (101 words)
- [Bulaşıcı olmayan hastalıklar | Boehringer Ingelheim TR](/content/tr/partnering/animal-health-partnering/connect-us/index.html): Teklif sunmak veya iş birliği fırsatlarını görüşmek için Boehringer Ingelheim Hayvan Sağlığı İş Geliştirme ve Lisanslama ekibiyle çevrimiçi veya etkinliklerde iletişime geçin. (358 words)
- [The Research Process | Boehringer Ingelheim HK](/content/hk/en/science-innovation/animal-health-innovation/research-process/index.html): A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. To do this we employ a mix of sophisticated tools, technical capabilities and expertise – both at our Global Innovation r (130 words)
- [Grass Roots | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/grass-roots/index.html): We support early-stage companies to progress their science through our unique global program of initiatives. Click here to find out and learn more. (75 words)
- [Paciente no Centro | Boehringer Ingelheim BR](/content/br/saude-humana/nossa-responsabilidade/paciente-no-centro/index.html): Centralidade no paciente (120 words)
- [アニマルヘルス・イノベーション | Boehringer Ingelheim JP](/content/jp/science-innovation/animal-health-innovation/index.html): 当社のGlobal Innovationチームは、世界中の獣医師やペットオーナー、畜産農家、そして公衆衛生当局による動物の健康向上に寄与するサイエンスの進展を切り開く努力をしています。私たちは社内のヒト用医療用医薬品部門や様々な社外パートナーと連携して、革新的な動物用医薬品を提供しています。私たちは、より大きなインパクトをもたらす領域に注力し、動物のウェルビーイング(動物福祉）向上を目指しています。 (5 words)
- [Fibrose pulmonaire | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/fibrose-pulmonaire/index.html): Ein wesentliches Ziel der Behandlung aller Patienten mit IPF ist es, das Risiko des Auftretens akuter IPF-Exazerbationen zu reduzieren. (160 words)
- [Parasiticides | Boehringer Ingelheim HK](/content/hk/en/science-innovation/animal-health-innovation/parasiticides/index.html): Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses. (55 words)
- [治療法 | Boehringer Ingelheim JP](/content/jp/science-innovation/animal-health-innovation/therapeutics/index.html): 私たちは、規制にのっとったサイエンスアプローチにより、コンパニオンアニマル分野と産業動物分野における治療薬の創薬、開発と販売をグローバル規模で行っています。当社の研究チー (3 words)
- [Maladies pulmonaires | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/index.html): Lungenerkrankungen (110 words)
- [臨床試験 | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/clinical-studies/index.html): Clinical Studies (3 words)
- [ヒューマンヘルス・イノベーション | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/index.html): ヒューマンヘルス・イノベーション (16 words)
- [Depressão | Boehringer Ingelheim BR](/content/br/saude-humana/saude-mental/depressao/index.html): Depressão (81 words)
- [Maladies cancéreuses | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cancereuses/index.html): Boehringer Ingelheim souhaite redonner espoir aux patients touchés et à leurs proches en relevant cet immense défi que représente le cancer. (237 words)
- [İş Birlikleri | Boehringer Ingelheim TR](/content/tr/partnering/index.html): Daha da fazla inovasyon yapmak ve yeni fikirlerin geliştirilmesine destek olmak için yaşam bilimleri ve hayvan sağlığı topluluklarında iş birliğinin gücünü ve fikir çeşitliliğini benimsiyoruz. (148 words)
- [Science Stories | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/science-stories/index.html): Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (72 words)
- [Grass Roots | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators (72 words)
- [Animal Health | Boehringer Ingelheim CA](/content/ca/animal-health/index.html): At Boehringer Ingelheim we’ve been keeping pets and livestock healthy for more than 50 years. Click here to find out more about our animal health work. (245 words)
- [率直に話す（Speak Up）– コンプライアンス・ホットライン | Boehringer Ingelheim JP](/content/jp/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Speak Up ポータルは、潜在的な違反行為を安心して報告できる環境を提供しており、全世界のすべての人がご利用いただけます。当社は、潜在的な違反に関するいかなる報告についても真摯に対応します。 (51 words)
- [Bojujeme proti různým typům rakoviny | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/rakovina/bojujeme-proti-ruznym-typum-rakoviny/index.html): Bojujeme proti různým typům rakoviny (81 words)
- [Εργασία στην Boehringer Ingelheim | Boehringer Ingelheim GR](/content/gr/careers/index.html): Ελάτε να γίνετε μέλος μας και να συμβάλλετε στην αποστολή μας να δημιουργούμε αξία μέσω της καινοτομίας για τους ασθενείς που εξυπηρετούμε. (168 words)
- [Antiparazitler | Boehringer Ingelheim TR](/content/tr/science-innovation/animal-health-innovation/parasiticides/index.html): Global İnovasyonun ana uzmanlık alanlarından biri, hem evcil hayvanlar hem besi hayvanları için yeni parazitisitlerin bulunması ve geliştirilmesidir. (49 words)
- [Medicină umană | Boehringer Ingelheim RO](/content/ro/medicina-umana/index.html): Boehringer Ingelheim este un grup de companii axate pe cercetare, dedicate descoperirii, dezvoltării, fabricării și comercializării de produse inovatoare pentru îngrijirea sănătății. (258 words)
- [Bilim Hikayeleri | Boehringer Ingelheim TR](/content/tr/science-innovation/human-health-innovation/science-stories/index.html): Hastalar için yeni ve daha iyi ilaçlar üretmek, yaptığımız işin merkezinde yer alıyor. Yaşamları değiştiren çığır açıcı tedaviler geliştirme misyonumuz da, bilime öncülük etmemiz ve asla pes etmememiz için bize ilham veriyor. (89 words)
- [ペット | Boehringer Ingelheim JP](/content/jp/animal-health/companion-animals-horses/pets/index.html): Companion Animals (19 words)
- [As nossas histórias | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/nossas-historias/index.html): Conheça nossa estratégia de sustentabilidade, iniciativas e histórias no Brasil e no mundo, e saiba como contribuímos para enfrentar desafios atuais. (269 words)
- [Tulburări psihice | Boehringer Ingelheim RO](/content/ro/medicina-umana/sanatate-mintala/index.html): Bolile sistemului nervos central (SNC), inclusiv schizofrenia sau boala Alzheimer, sunt un punct central al cercetării și dezvoltării de descoperire în cadrul Boehringer Ingelheim. (96 words)
- [Schizofrenie | Boehringer Ingelheim RO](/content/ro/medicina-umana/sanatate-mintala/schizofrenie/index.html): Schizofrenie (85 words)
- [Accident vascular cerebral | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/accident-vascular-cerebral-ischemic/index.html): Accident vascular cerebral (242 words)
- [Liderança | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/lideranca/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (639 words)
- [Kdo jsme | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/index.html): Boehringer Ingelheim je globální skupina společností, působících v mnoha různých kulturách a rozličných komunitách. Seznamte se s našimi finančními výsledky, s firemní vizí a organizační strukturou. (300 words)
- [More Potential: pour les communautés et nos collaborateurs | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-potential/index.html): More Potential: Für Communities & Mitarbeitende Die Gesellschaft steht weiterhin vor großen Herausforderungen, die von Gesundheit über Bildung, Arbeitsmöglichkeiten, Lebensbedingungen bis hin zu Ungleichheit und Armut reichen – und von denen benachteiligt (257 words)
- [Enfermedades Cardiacas | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-cardiometabolicas/index.html): Las enfermedades cardiacas son la principal causa de muerte y discapacidad en todo el mundo. (88 words)
- [Ιδιοπαθής πνευμονική ίνωση (IPF) | Boehringer Ingelheim GR](/content/gr/human-health/lung-diseases/pulmonary-fibrosis/index.html): Η πνευμονική ίνωση είναι μια κατάσταση που οδηγεί σε συσσώρευση ουλώδους ιστού στους πνεύμονες. (93 words)
- [Boehringer Ingelheim'da Kalite | Boehringer Ingelheim TR](/content/tr/about-us/quality/index.html): Boehringer Ingelheim'da Kalite (200 words)
- [Purchasing | Boehringer Ingelheim CA](/content/ca/about-us/purchasing/index.html): Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, and access useful resources for suppliers too. (316 words)
- [Cultura | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/cultura/index.html): Cultura (128 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (319 words)
- [Biz kimiz | Boehringer Ingelheim TR](/content/tr/about-us/who-we-are/index.html): Biz kimiz (225 words)
- [Calitatea la Boehringer Ingelheim | Boehringer Ingelheim RO](/content/ro/despre-noi/calitatea/index.html): Calitatea la Boehringer Ingelheim (228 words)
- [Maladies cardiaques | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladie-cardiaque/index.html): Prévention et traitement des maladies cardiovasculaires avec Boehringer Ingelheim. Découvrez nos solutions pour une santé cardiaque optimale. (100 words)
- [Heart Diseases | Boehringer Ingelheim HK](/content/hk/en/human-health/heart-diseases/index.html): Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right. (74 words)
- [Καρδιακές παθήσεις | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/index.html): Οι καρδιαγγειακές παθήσεις, συμπεριλαμβανομένων των καρδιοπαθειών και των εγκεφαλικών επεισοδίων. (87 words)
- [Kontakt | Boehringer Ingelheim CZ](/content/cz/kontakt/index.html): Kontakt (132 words)
- [Unternehmensbericht Story Hub | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/storyhub/index.html): Boehringer Ingelheims Fortschrittsstories in 2025 (180 words)
- [Δεοντολογία και συμμόρφωση | Boehringer Ingelheim GR](/content/gr/about-us/ethics-and-compliance/index.html): Δεοντολογία και συμμόρφωση (126 words)
- [Ethics and Compliance | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/index.html): Ethics and Compliance (110 words)
- [FAQ | Boehringer Ingelheim](/content/careers/your-application-process/faq/index.html): Frequently Asked Questions regarding the job application process at Boehringer Ingelheim. (1,852 words)
- [Boehringer Ingelheim � Gesch�ftsbericht 2025 Highlights](/content/de/unternehmensbericht/2025/files/boehringer-ingelheim-geschaeftsbericht-highlights-2025-pdf.html) (13,150 words)
- [Global Network | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/our-global-network/index.html): Our network of manufacturing facilities spans across the globe – from Fremont in the US to Biberach (Germany), Vienna (Austria) & Shanghai (China). (614 words)
- [Our Expertise | Boehringer Ingelheim](/content/animal-health/our-expertise/index.html): Our expertise is in key areas where animal and human health intersect: transboundary diseases, prevention, innovation, veterinary care, and societal impact (623 words)
- [Swine | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/index.html): Protecting pigs and sustaining the swine industry are top priorities for Boehringer Ingelheim as we partner with pork producers and swine veterinarians (625 words)
- [Switching market | Boehringer Ingelheim GR](/content/gr/disclaimer/market/index.html) (72 words)
- [Stanovisko k dostupnosti | Boehringer Ingelheim SK](/content/sk/stanovisko-k-dostupnosti/index.html): Boehringer Ingelheim je hrdý na to, že je dostupný pre naše publikum. Kliknite na ňu, aby ste videli, ako robíme našu webovú stránku čo najprívetivejšou pre používateľov. (410 words)
- [Vaccines | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/vaccines/index.html): We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here. (110 words)
- [Imprint | Boehringer Ingelheim SK](/content/sk/imprint/index.html): Imprint (70 words)
- [Prozessentwicklung für die Arzneimittelproduktion: ein Blick hinter die Kulissen mit Yassin | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/prozessentwicklung-fuer-die-arzneimittelproduktion-ein-blick-hinter-die-kulissen-mit-yassin.html): Yassin über Prozessentwicklung bei Boehringer Ingelheim: enge Teamarbeit, gemeinsame Entscheidungen und Freundschaften, die im Job entstehen. (424 words)
- [Deutsche Karriereseite | Boehringer Ingelheim DE](/content/de/karriere/index.html): Schließen Sie sich einem globalen Team von mehr als 54.000 engagierten und talentierten Personen an, die sich der Verbesserung der Gesundheit von Menschen und Tieren weltweit verschrieben haben (261 words)
- [Partnerska współpraca w obszarze zdrowia człowieka – dołącz do nas | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/dolacz-do-nas/index.html): Partnerska współpraca w obszarze zdrowia człowieka – dołącz do nas (103 words)
- [Partnering-Interessen in der Tiergesundheit | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/ansaetze-fuer-partnerschaften/index.html): Entdeckt die Partnering-Interessen von Boehringer Ingelheim im Bereich Tiergesundheit, einschließlich Infektionskrankheiten, nichtinfektiöser Erkrankungen und allgemeiner Schwerpunkte. (597 words)
- [Nos engagements | Boehringer Ingelheim FR](/content/fr/sante-humaine/nos-engagements/index.html): Nos engagements (143 words)
- [Partnerschaften in der Tiergesundheit | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/index.html): Erfahrt mehr über den kollaborativen Ansatz von Boehringer Ingelheim zur Innovation im Bereich Tiergesundheit, unsere Interessensgebiete für Partnerschaften und wie ihr mit unserem Team in Kontakt treten können. (361 words)
- [Essais cliniques | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/essais-cliniques/index.html): Découvrez notre science et innovation à travers nos essais cliniques chez Boehringer Ingelheim. Explorez nos avancées médicales prometteuses. (68 words)
- [Obrixtamig (BI 764532): DLL3/CD3 T-cell engager | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/obrixtamig-bi-764532-dll3-cd3-t-cell-engager-1/index.html): Obrixtamig (BI 764532): DLL3/CD3 T-cell engager | small cell lung cancer (146 words)
- [Ингельвак ®HP-1 | Boehringer Ingelheim RU](/content/ru/animal-health/products/ingelvak-hp-1/index.html): Ингельвак ®HP-1 (211 words)
- [COPD | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/copd/index.html): Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives. (101 words)
- [Media & Stories | Boehringer Ingelheim](/content/media-stories/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (674 words)
- [Poultry | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/index.html): We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here. (183 words)
- [Sostenibilidad | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/index.html): Haga clic aquí para descubrir nuestro viaje 'Desarrollo sostenible - Por generaciones'. (232 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim PT](/content/pt/index.html): Alguns dos nossos colegas contam as suas histórias pessoais e o que os motiva a contribuírem para um futuro melhor para as gerações vindouras. (192 words)
- [Συμμόρφωση – Μιλήστε ανοιχτά! | Boehringer Ingelheim GR](/content/gr/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Η Boehringer Ingelheim δεσμεύεται να διεξάγει τις επιχειρηματικές της δραστηριότητες με ακεραιότητα και να συμμορφώνεται με τους ισχύοντες νόμους (376 words)
- [Boehringer Ingelheim � Unternehmensbericht 2025: Die Perspektive der Gesellschafter](/content/de/unternehmensbericht/2025/files/boehringer-ingelheim-gesellschafterbrief-2025-pdf.html) (406 words)
- [History | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/history/index.html): Find out about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people. (51 words)
- [de/unternehmensbericht/2024/files/downloads-and-archive/highlights-2023/boe_gb23_highlights-2023_de_safe-pdf.html](/content/de/unternehmensbericht/2024/files/downloads-and-archive/highlights-2023/boe_gb23_highlights-2023_de_safe-pdf.html) (15,019 words)
- [Our Stories | Boehringer Ingelheim](/content/node/31986/index.html): Our Stories (444 words)
- [Storys Nachhaltigkeit | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/storys/index.html): Lesen Sie, wie Boehringer Ingelheim Gesundheitslösungen und Umweltschutz voranbringt, mit Berichten über unser Engagement rund um den Globus. (93 words)
- [Search | Boehringer Ingelheim DE](/content/de/search/index.html) (191 words)
- [Impressum | Boehringer Ingelheim DE](/content/de/impressum/index.html): Impressum Boehringer Ingelheim Pharma GmbH & Co. KG | Binger Strasse 173 | D-55216 Ingelheim am Rhein (80 words)
- [Biopharma Auftragsherstellung | Boehringer Ingelheim DE](/content/de/partnerschaften/biopharma-auftragsherstellung/index.html): Erfahren Sie mehr über Boehringer Ingelheim BioXcellence, eines der weltweit führenden Unternehmen in der biopharmazeutischen Auftragsherstellung. (126 words)
- [Bridging vet care deserts amid New World screwworm | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/bridging-vet-care-deserts-amid-new-world-screwworm/index.html): Boehringer Cares is donating animal medicines to help veterinarians, shelters and underserved communities prepare for and respond to New World screwworm. (735 words, Jul 22, 2026)
- [ベーリンガーインゲルハイム、日本の3法人共通で忌引き休暇の適用対象をペット（犬、猫）にも拡大 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0724/index.html): 日本ベーリンガーインゲルハイム株式会社は、日本におけるベーリンガーインゲルハイム3法人共通で、2026年7月より同居するペット（犬・猫）を対象とした忌引き休暇制度を導入しました。 (9 words, Jul 22, 2026)
- [Komisja Europejska zatwierdza nerandomilast, wprowadzając na rynek UE dobrze tolerowany, nowy lek doustny do stosowania w leczeniu IPF i PPF | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/wloknienie-pluc/komisja-europejska-zatwierdza-nerandomilast-wprowadzajac-na-rynek-ue-dobrze-tolerowany-nowy-lek.html): Nerandomilast to pierwszy doustny, preferencyjny inhibitor PDE4B dopuszczony do obrotu w Unii Europejskiej o nowym mechanizmie działania oraz efekcie przeciwwłóknieniowym i immunomodulującym. (1,024 words, Jul 20, 2026)
- [CiMUS y Boehringer Ingelheim se unen para impulsar la investigación en enfermedad hepática asociada a disfunción metabólica y alcohol (MetALD) | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/cimus-y-boehringer-ingelheim-se-unen-para-impulsar-la-investigacion-en-enfermedad-hepatica-metald.html): El acuerdo reafirma el compromiso de ambas entidades con la innovación y la investigación preclínica de vanguardia para mejorar el conocimiento científico de patologías que afectan a la calidad de vida de las personas. (685 words, Jul 20, 2026)
- [Neue EU-Zulassung zur Behandlung von Lungenfibrose (IPF und PPF) | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/neue-eu-zulassung-zur-behandlung-von-lungenfibrose-ipf-und-ppf.html): Neue EU-Zulassung zur Behandlung von Lungenfibrose (IPF und PPF) (1,139 words, Jul 17, 2026)
- [7 cosas que debes saber sobre la Ileítis | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/porcinos/7-cosas-que-debes-saber-sobre-la-ileitis/index.html): La Ileítis provoca bajo aumento de peso, diarrea e incluso muerte súbita en cerdos, lo que genera pérdidas económicas significativas para la industria porcina a nivel mundial (696 words, Jul 15, 2026)
- [A moment earlier: Zoonotic diseases and how we can help prevent them | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/moment-earlier-zoonotic-diseases-and-how-we-can-help-prevent-them.html): What are zoonotic diseases, how do they spread from animals to humans, and what can people do to help prevent them? On World Zoonoses Day, discover why acting a moment earlier matters, at home, in clinics, on farms and across national systems. (1,480 words, Jul 14, 2026)
- [日本ベーリンガーインゲルハイム、新たな肺線維症治療薬「ジャスケイド®錠」を発売 | Boehringer Ingelheim JP](/content/jp/press-26-0715/index.html): 日本ベーリンガーインゲルハイム株式会社（本社：東京都品川区、代表取締役 医薬事業ユニット統括社長：荻村正孝、以下、「日本ベーリンガーインゲルハイム」）は、抗繊維化作用および免疫調整作用を有する経口のホスホジエステラーゼ4B（PDE4B）阻害剤であるジャスケイド®錠18mgおよび9mg（一般名：ネランドミラスト、以下ジャスケイド®錠）を「特発性肺線維症」および「進行性肺線維症」を適応症として2026年7月15日に発売しました。 (210 words, Jul 13, 2026)
- [Grundstein für neues Bürogebäude​ in Wien | Boehringer Ingelheim AT](/content/at/de/presse/grundstein-fuer-neues-buerogebaeude-wien/index.html): Boehringer Ingelheim erweitert seinen Campus in Wien-Meidling, investiert mehr als 100 Mio. Euro und bekräftigt damit sein Bekenntnis zum Standort Wien. (664 words, Jul 8, 2026)
- [Um momento antes: Doenças zoonóticas e como podemos ajudar a preveni las | Boehringer Ingelheim PT](/content/pt/saude-animal/historias-em-destaque/um-momento-antes-doencas-zoonoticas-e-como-podemos-ajudar-preveni-las.html): O que são doenças zoonóticas, como se transmitem dos animais para os humanos e o que pode cada pessoa fazer para ajudar a preveni las? (1,609 words, Jul 3, 2026)
- [Zveme vás na diskusi: nový ideál dlouhověkosti na Colours of Ostrava | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/zveme-vas-na-diskusi-novy-ideal-dlouhovekosti-na-colours-ostrava.html): Jedete na Colours? My ano a rádi vás tam uvidíme. V pátek 17. července jsme pro vás připravili diskusi „Ideály dlouhověkosti: 80–62–80“, ve které otevřeme téma zdravého stárnutí a metabolického zdraví trochu jinak, než se o něm obvykle mluví. (393 words, Jul 2, 2026)
- [Neue Leitung am Boehringer Ingelheim Standort Biberach | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/neue-leitung-am-boehringer-ingelheim-standort-biberach.html): Neue Leitung am Boehringer Ingelheim Standort Biberach (304 words, Jun 30, 2026)
- [Parásitos en gatos: cómo mantenerlos alejados de ellos. | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/parasitos-en-gatos-como-mantenerlos-alejados-de-ellos.html): Find out how to keep fleas, ticks and worms away from your cat. Learn how! (921 words, Jun 26, 2026)
- [Viszerale Fettreduktion und Leberfettreduktion in einer Phase-III-Studie bei Adipositas | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/viszerale-fettreduktion-und-leberfettreduktion-einer-phase-iii-studie-bei-adipositas.html): Viszerale Fettreduktion und Leberfettreduktion in einer Phase-III-Studie bei Adipositas (2,419 words, Jun 9, 2026)
- [Lo que los veterinarios ven y tú no – y por qué es importante para todos | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/lo-que-los-veterinarios-ven-y-tu-no-y-por-que-es-importante-para-todos.html): Una nueva encuesta global demuestra que el trabajo de los veterinarios a menudo pasa desapercibido. (1,570 words, Jun 8, 2026)
- [AI bioprocess optimization | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/ai-bioprocess-optimization/index.html): Learn about digital process modeling that can improve commercial biopharma manufacturing efficiency while maintaining product quality & regulatory compliance. (742 words, Jun 5, 2026)
- [Téměř polovina Čechů cestuje s mazlíčky, na skrytá zdravotní rizika ale často nemyslí | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/temer-polovina-cechu-cestuje-s-mazlicky-na-skryta-zdravotni-rizika-ale-casto-nemysli.html): Téměř polovina Čechů cestuje s mazlíčky, na skrytá zdravotní rizika ale často nemyslí (845 words, Jun 4, 2026)
- [Adipositas und MASH: Risikofaktoren und klinische Ergebnisse | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/adipositas/adipositas-und-mash-risikofaktoren-und-klinische-ergebnisse.html): Wie hängen Adipositas, Fettlebererkrankungen und Risiko für Herz-Kreislauf-Erkrankungen zusammen? Risikofaktoren, Krankheitsverlauf, Prävention und mehr. (1,631 words, Jun 3, 2026)
- [What vets see that you don't ‒ and why it matters for us all | Boehringer Ingelheim AT](/content/at/en/about-us/what-vets-see-you-dont-and-why-it-matters-us-all/index.html): Global survey shows vets’ most critical work, like spotting hidden disease, preventing risk, and protecting food and public health, often goes unseen. (1,469 words, Jun 3, 2026)
- [Request Access | Portal HCP | Boehringer Ingelheim](/content/pro/ch/request-access/index.html): Request Access (118 words, May 29, 2026)
- [Swiss Biotech Day 2026 | Boehringer Ingelheim CH](/content/ch/fr/partenariats/swiss-biotech-day-2026/index.html): Swiss Biotech Day 2026: l’écosystème scientifique suisse, moteur de la promotion de l’innovation (858 words, May 27, 2026)
- [Positive CHMP-Empfehlung bei Lungenfibrose | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/positive-chmp-empfehlung-bei-lungenfibrose/index.html): Positive CHMP-Empfehlung bei Lungenfibrose (1,239 words, May 22, 2026)
- [The hidden impact of veterinary care: new insights from a global survey of veterinarians | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/hidden-impact-veterinary-care-new-insights-global-survey-veterinarians.html): Global survey of veterinarians reveals hidden impact of veterinary care, from detecting animal health issues to food safety and disease surveillance. (1,062 words, May 20, 2026)
- [Boehringer Presents Data Across Oncology Portfolio at ASCO | Boehringer Ingelheim US](/content/us/human-health/cancer/across-cancer-types/boehringer-presents-data-across-oncology-portfolio-asco.html): Boehringer Ingelheim presents new data across its oncology portfolio at the 2026 ASCO annual meeting, with research in NSCLC, ES-SCLC, and epNEC (2,397 words, May 19, 2026)
- [Pacientes, comunidad científica y Boehringer Ingelheim se unen para visibilizar el impacto de las enfermedades autoinmunes sistémicas y la necesidad de un abordaje integral | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/visibilizar-el-impacto-de-las-enfermedades-autoinmunes-sistemicas.html): Para concienciar sobre su impacto y la importancia de la red de apoyo, Boehringer Ingelheim, con el apoyo de distintas entidades, ha impulsado “Piezas que suman”. (1,268 words, May 19, 2026)
- [JASCAYD approved in Japan new IPF and PPF treatment | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/jascayd-approved-japan-new-ipf-and-ppf-treatment/index.html): JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment (1,470 words, May 15, 2026)
- [Linha Purevax amplia opções de vacinação felina no Brasil | Boehringer Ingelheim BR](/content/br/imprensa-historias/press-releases/purevax-amplia-portfolio-vacinas-felinas-brasil/index.html): Lançamento amplia opções de imunização felina, permitindo protocolos mais individualizados, com foco em proteção, segurança e conforto. (841 words, May 11, 2026)
- [Nieren- und Herz-Kreislauf-Erkrankungen frühzeitig erkennen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/nieren-und-herz-kreislauf-erkrankungen-fruehzeitig-erkennen.html): Menschen mit Bluthochdruck oder Typ-2-Diabetes leben mit einem erhöhten Risiko für Nieren- und Herz-Kreislauf-Erkrankungen – meist ohne es zu wissen. (326 words, May 11, 2026)
- [Davranış Kurallarımız | Boehringer Ingelheim TR](/content/tr/about-us/ethics-compliance/davranis-kurallarimiz/index.html): Davranış Kurallarımız, tüm iş faaliyetlerimize yön veren etik standartları belirlemektedir. Bu kurallar hepimizi ilgilendirir. Davranış Kurallarının hayata geçirilmesinde her bir çalışan hayati bir rol üstlenmektedir. (263 words, May 4, 2026)
- [Anwendung | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/jardiance/anwendung/index.html): Jardiance für Erwachsene mit Typ-2-Diabetes, senkt den Blutzuckerspiegel und zur Behandlung von Herzinsuffizienz und chronischer Niereninsuffizienz. (176 words, Apr 29, 2026)
- [glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement.html): Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of xxx% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial (1,663 words, Apr 27, 2026)
- [Campanha global reforça a relevância da medicina veterinária | Boehringer Ingelheim BR](/content/br/saude-animal/campanha-global-da-visibilidade-ao-trabalho-do-medico-veterinario.html): Campanha global destaca o papel essencial dos médicos-veterinários na saúde animal, pública e na conexão entre animais, pessoas e sociedade. (545 words, Apr 27, 2026)
- [Herzinsuffizienz | Boehringer Ingelheim | Portal HCP | Boehringer Ingelheim](/content/pro/ch/therapiegebiete-indikationen/herzinsuffizienz/index.html): Herzinsuffizienz/Herzschwäche mit reduzierter Ejektionsfraktion (HFrEF) und Herzinsuffizienz/Herzschwäche mit erhaltener Ejektionsfraktion (HFpEF). (214 words, Apr 24, 2026)
- [Jugend forscht junior 2026: Nachwuchsforschung in Ingelheim | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/jugend-forscht-junior-2026-nachwuchsforschung-ingelheim.html): Jugend forscht junior 2026: Nachwuchsforschung in Ingelheim (967 words, Apr 24, 2026)
- [Boehringer Ingelheim launches AI Accelerator in London | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/boehringer-ingelheim-launches-ai-accelerator-london.html): Boehringer Ingelheim has announced the launch of a new Computational Innovation AI Accelerator in King’s Cross, London. (392 words, Apr 20, 2026)
- [神戸医薬研究所でグローバルR&Dの一角を担う＿持続可能な医薬品開発とは？ 研究者が語る、環境とイノベーションの両立 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0014/index.html): 医薬品開発の領域では、「環境負荷を減らしながら、より早く患者さんへ医薬品を届ける」という挑戦が広がっています。ベーリンガーインゲルハイムは、サステナビリティの柱の一つ「MORE GREEN」のもと、医薬品ライフサイクル全体で環境負荷の低減に取り組んでいます。原薬開発から投薬後までエコデザインを適用し、世界中の拠点と連携して、持続可能な医薬品開発を推進しています。 (29 words, Apr 20, 2026)
- [The Atlanta Braves and Boehringer Ingelheim unveil 2026 “Dogout” to honor veterinarians | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/atlanta-braves-and-boehringer-ingelheim-unveil-2026-dogout-honor-veterinarians.html): The Braves' 2026 dugouts playfully honor veterinarians’ quiet dedication and extraordinary impact. (539 words, Apr 15, 2026)
- [Boehringer Ingelheim Athens Site Achieves Carbon Neutral Operations | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-athens-site-achieves-carbon-neutral-operations.html): Boehringer Ingelheim’s Animal Health manufacturing and research and development site in Athens, Georgia, and adjacent facility, has received Carbon Neutral Certification. (704 words, Apr 6, 2026)
- [Abertura, Respeito e Oportunidade | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/cultura/abertura-respeito-e-oportunidade/index.html): Nossas pessoas impulsionam a inovação – em um ambiente de trabalho onde todos podem prosperar. (303 words, Apr 2, 2026)
- [넥스가드 스펙트라, 2017년 출시 이후 누적 2천만 도스 이상 판매로 반려견 건강을 지켜온 대표 구충제 | Boehringer Ingelheim KR](/content/kr/negseugadeu-seupegteula-2017nyeon-chulsi-ihu-nujeog-2cheonman-doseu-isang-panmaelo-banlyeogyeon.html): 넥스가드 스펙트라, 2017년 출시 이후 누적 2천만 도스 이상 판매로 반려견 건강을 지켜온 대표 구충제 (368 words, Mar 31, 2026)
- [베링거인겔하임, 2025년 매출 7.3% 성장... 두 건의 혁신 신약 출시로 후기 임상 파이프라인 결실 | Boehringer Ingelheim KR](/content/kr/belinggeoingelhaim-2025nyeon-maechul-73-seongjang-du-geonui-hyeogsin-sinyag-chulsilo-hugi-imsang.html): 베링거인겔하임, 2025년 매출 7.3% 성장... 두 건의 혁신 신약 출시로 후기 임상 파이프라인 결실 (587 words, Mar 27, 2026)
- [Boehringer Ingelheim realizza la pipeline in fase avanzata con due lanci chiave e aumenta le vendite del 7,3%* in un 2025 di successo | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/boehringer-ingelheim-realizza-la-pipeline-fase-avanzata-con-due-lanci-chiave-e-aumenta-le-vendite.html): – Nel 2025, Boehringer Ingelheim ha portato a termine con successo i lanci chiave nel suo business Human Pharma (1,038 words, Mar 26, 2026)
- [Vaccine innovation boosts mastitis prevention for dairy cows | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/vaccine-innovation-boosts-mastitis-prevention-dairy-cows.html): New vaccine helps reduce clinical mastitis severity in cows and heifers, with simple dry-off dosing and early long lasting protection (567 words, Mar 25, 2026)
- [CDMO insights 2025 | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/cdmo-insights-2025-bioxcellence/index.html): Discover our 2025 highlights: key biologics market trends, CDMO services, microbial and mammalian capabilities, and updates on digital bioprocessing. (1,145 words, Mar 23, 2026)
- [CKD CV Risk Video | BIPI Medical & Clinical Resource](/content/pro/us/medinfo/diseases-conditions/crm/ckd/resources/cv-risk-video/index.html): Explore a CV and CKD narrative with script, storyboard, and video, designed to clearly present key clinical insights and patient journeys under CKD. (98 words, Mar 18, 2026)
- [百靈佳殷格翰 2026年線上+實體校園徵才–預見可能 共創未來 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/bailingjiayingehan-2026nianxianshangshitixiaoyuanzhengcai-yujiankeneng-gongchuangweilai.html): 百靈佳殷格翰 2026年線上+實體校園徵才–預見可能 共創未來 (38 words, Mar 10, 2026)
- [Boehringer Ingelheim’s Global Research Sites | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/boehringer-ingelheims-global-research-sites/index.html): Learn about Boehringer Ingelheim’s global research and development networks across Austria, Germany, United States and other areas around the world. (244 words, Mar 9, 2026)
- [Encuesta global revela que los tutores de animales de compañía desconocen los riesgos de los parásitos y exigen asesoramiento preventivo más claro | Boehringer Ingelheim SA](/content/sa/prensa/encuesta-global-revela-que-los-tutores-de-animales-de-compania-desconocen-los-riesgos-de-los.html): Encuesta global revela que los tutores de animales de compañía desconocen los riesgos de los parásitos y exigen asesoramiento preventivo más claro (920 words, Mar 9, 2026)
- [Openness, Respect and Opportunity | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (268 words, Feb 27, 2026)
- [Submit your animal health partnering opportunity | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/connect-us/submit-your-animal-health-partnering-opportunity/index.html): Information on how to submit your animal health innovation opportunity direct to Boehringer Ingelheim’s partnering team (165 words, Feb 20, 2026)
- [Partnering and Innovation Outlook Animal Health 2026 | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/partnering-and-innovation-outlook-animal-health-2026.html): Megan Grether and Peter Florian share their 2025 innovation and collaboration highlights and how internal and external partnerships advance animal health (1,066 words, Feb 20, 2026)
- [Boehringer Ingelheim e LEO Pharma firmam parceria estratégica em dermatologia | Boehringer Ingelheim BR](/content/br/imprensa-historias/comunicados-regulatorios/boehringer-ingelheim-e-leo-pharma-firmam-parceria-estrategica-em-dermatologia.html): Parceria transfere o licenciamento global de SPEVIGO® para a LEO Pharma, garantindo continuidade no acesso ao tratamento de PPG. (315 words, Feb 19, 2026)
- [Abfall als Ressource neu gedacht | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/abfall-als-ressource-neu-gedacht/index.html): Abfälle sind Ressourcen – sonst kosten sie Geld. Darum ist es entscheidend, dass wir sie richtig handhaben, analysieren und möglichst vermeiden. (606 words, Feb 12, 2026)
- [KI-Coach hilft Führungskräften beim Umgang mit sensiblen Situationen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/ki-coach-hilft-fuehrungskraeften-beim-umgang-mit-sensiblen.html): Das neue Trainingsprogramm für Führungskräfte verbindet eine durch Künstliche Intelligenz gestützte Simulation mit persönlichem Coaching – und schafft einen sicheren Raum zum Ausprobieren. (565 words, Feb 11, 2026)
- [ανοικτό πνεύμα, σεβασμός & ευκαιρίες | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/culture/anoikto-pneyma-sebasmos-eykairies/index.html): Αγκαλιάζουμε τις ποικίλες και μοναδικές συνεισφορές των εργαζομένων μας και καλλιεργούμε ένα περιβάλλον όπου μπορούν να αποδώσουν στο μέγιστο. (282 words, Feb 10, 2026)
- [Warum Biomarker‑Tests in der Krebsbehandlung wichtig sind | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/warum-biomarker-tests-der-krebsbehandlung-wichtig-sind.html): Erfahren Sie, wie Biomarker‑Tests helfen, fundierte Entscheidungen in der Krebsbehandlung zu treffen und finden Sie Antworten auf die wichtigsten Fragen. (1,181 words, Feb 3, 2026)
- [Openness, Respect and Opportunity | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): ベーリンガーインゲルハイムでは、人財こそがイノベーションの源泉と考えています。そのため、誰もが活躍できる職場環境づくりにコミットしています。 (39 words, Jan 28, 2026)
- [Conditions générales d'achat | Boehringer Ingelheim FR](/content/fr/propos/achats/conditions-generales-dachat/index.html): Conditions générales d'achat pour le groupe Boehringer Ingelheim (CGA). (28 words, Jan 27, 2026)
- [Boehringer Ingelheim nombrado Global Top Employer 2026 | Boehringer Ingelheim SA](/content/sa/prensa/boehringer-ingelheim-nombrado-global-top-employer-2026.html): . Reconocido por su destacado programa de bienestar que apoya la salud física, mental, social y financiera de sus colaboradores . Resultados sólidos en desarrollo profesional, beneficios y reconocimiento, y ambiente laboral (507 words, Jan 12, 2026)
- [Pitching for Partnerships in Animal Health | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/pitching-partnerships-animal-health/index.html): Early-stage partnerships are essential for driving innovation, yet startups face challenges in building connections. See our top tips for pitch success. (937 words, Dec 18, 2025)
- [Boehringer Ingelheim подкрепя проект на АПАЗ и приятели | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/apbz-project/index.html): С подкрепата на Boehringer Ingelheim, АПАЗ и приятели организира провеждането на безплатни прегледи за бъбречни заболявания в малки населени места. (426 words, Dec 18, 2025)
- [Boehringer Ingelheim Cares Foundation donates over two million doses of animal health medicines | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/boehringer-ingelheim-cares-foundation-donates-over-two-million-doses-animal-health-medicines.html): Strategic partnerships address veterinary care shortages and promote animal adoption with nonprofits. (754 words, Dec 12, 2025)
- [Kronik Böbrek Hastalığı ve Vücuttaki Etkileri | Boehringer Ingelheim TR](/content/tr/human-health/chronic-kidney-disease/kronik-bobrek-hastaligi-ve-vucuttaki-etkileri/index.html): Kronik Böbrek Hastalığı (KBH), dünya çapında yaklaşık 850 milyon insanı etkileyen ve ciddi yük yaratan bir hastalıktır. (78 words, Dec 12, 2025)
- [Richtlijnen als kompas: waarom we bij diabetes sneller moeten handelen | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/richtlijnen-als-kompas-waarom-we-bij-diabetes-sneller-moeten-handelen.html): Marieke Hendriksen - van Dongen, Hoofd Therapeutisch Gebied Cardio-Renaal-Metabool (327 words, Dec 4, 2025)
- [Openness, Respect & Opportunity | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/cultura/openness-respect-opportunity/index.html): Le nostre persone alimentano l’innovazione – in un ambiente di lavoro dove ciascuno può esprimersi al meglio. (295 words, Dec 4, 2025)
- [Zgłaszanie pytań lub wątpliwości | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/zglaszanie-pytan-lub-watpliwosci/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (170 words, Dec 1, 2025)
- [Prawo pracy i prawa człowieka | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/prawo-pracy-i-prawa-czlowieka/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (480 words, Dec 1, 2025)
- [Kodeks Postępowania Dostawców | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/kodeks-postepowania-dostawcow/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (380 words, Dec 1, 2025)
- [Boehringer announce new appointment to Board Managing Directors | Boehringer Ingelheim](/content/about-us/boehringer-announce-new-appointment-board-managing-directors.html): Boehringer Ingelheim announces appointment to Board of Managing Directors (450 words, Nov 28, 2025)
- [Nachhaltige Arzneimittel mit Ökodesign | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/nachhaltige-arzneimittel-mit-oekodesign/index.html): Unser Ziel ist es, die Umweltbelastung unserer Arzneimittel durch Ökodesign und grüne Chemie über den gesamten Lebenszyklus hinweg zu minimieren. (903 words, Nov 27, 2025)
- [Animal Health Partnering Contacts | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/connect-us/animal-health-partnering-contacts/index.html): Partnership and diversity of thought are powerful drivers of innovation. If you have a project you would like to discuss please reach out to us. (916 words, Nov 20, 2025)
- [Práticas Empresariais Éticas | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/praticas-empresariais-eticas/index.html): Os fornecedores devem conduzir seus negócios de maneira ética e agir com integridade. (2,033 words, Nov 17, 2025)
- [Meio ambiente | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/meio-ambiente/index.html): Os fornecedores devem operar de forma ecologicamente responsável e eficiente de forma a minimizar o impacto sobre o ambiente. (436 words, Nov 17, 2025)
- [Sistemas de Gerenciamento | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/sistemas-de-gerenciamento/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (397 words, Nov 17, 2025)
- [Unser Ziel: CO2-Neutralität 2030 | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/unser-ziel-co2-neutralitaet-2030/index.html): Wir setzen auf Photovoltaik, Grünstrom, E-Mobilität und mehr – CO2-Neutralität ist Teil unserer globalen Nachhaltigkeitsstrategie. (564 words, Nov 13, 2025)
- [Non-Small Cell Lung Cancer (NSCLC) | Boehringer Ingelheim CA](/content/ca/human-health/cancer/lung-cancer/non-small-cell-lung-cancer-nsclc/index.html): Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases. (1,126 words, Nov 11, 2025)
- [Cancer is One of Humanity’s Greatest Challenges | Boehringer Ingelheim CA](/content/ca/human-health/cancer/cancer-one-humanitys-greatest-challenges/index.html): Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care. (373 words, Nov 11, 2025)
- [Abfallwirtschaft im Unternehmen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/abfallwirtschaft-im-unternehmen-boehringer-ingelheim.html): Bei Boehringer Ingelheim versuchen wir mit sorgfältigem Abfallmanagement Abfälle zu vermeiden, zu reduzieren – oder sie wieder zu einem Rohstoff zu machen. (225 words, Nov 11, 2025)
- [FOCUS CKD in Edmonton Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/focus-ckd-edmonton-executive-summary/index.html): FOCUS CKD in Edmonton Executive Summary (302 words, Nov 10, 2025)
- [Le Code de conduite des fournisseurs | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/le-code-de-conduite-des-fournisseurs/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (580 words, Nov 7, 2025)
- [Boehringer announces Phase 2 results in FSGS rare kidney disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/boehringer-announces-phase-2-results-fsgs-rare-kidney-disease.html): Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial (1,275 words, Nov 6, 2025)
- [MFT- ILD Tier 2 Pathway Development Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/mft-ild-tier-2-pathway-development-executive-summary.html): MFT- ILD Tier 2 Pathway Development Executive Summary (485 words, Nov 3, 2025)
- [Le Code de conduite des fournisseurs | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/le-code-de-conduite-des-fournisseurs/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (489 words, Oct 31, 2025)
- [Environnement | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/environnement/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (503 words, Oct 28, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (448 words, Oct 24, 2025)
- [Environment | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/environment/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (399 words, Oct 24, 2025)
- [Our Expectations | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/our-expectations/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (607 words, Oct 22, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, Oct 22, 2025)
- [Understanding biomarker testing in lung cancer | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/understanding-biomarker-testing-lung-cancer/index.html): Discover the role of biomarkers in NSCLC care. Learn how biomarker testing provides crucial insights for personalizing your cancer management strategy. (1,469 words, Oct 16, 2025)
- [Bronchiectasis | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/bronchiectasis/index.html): Explore information on Bronchiectasis, including resources, clinical trials, congresses, and support tools. (325 words, Oct 14, 2025)
- [Labour & Human Rights | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/labour-human-rights/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (497 words, Oct 10, 2025)
- [Ruta 86 Catalunya | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-catalunya/index.html): Ruta 86 Catalunya (535 words, Oct 6, 2025)
- [Boehringer Ingelheim at the Vienna Children’s University | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-stories/boehringer-ingelheim-vienna-childrens-university/index.html): On the 16th of July, a team from Boehringer Ingelheim participated at the Vienna Children University, where children aged 7 to 12 can enjoy diverse educational activities for two weeks. (729 words, Oct 1, 2025)
- [Historias reales, impacto real: la lucha para terminar con la rabia | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/stop-rabies/historias-reales-impacto-real-la-lucha-para-terminar-con-la.html): El peligro que representa esta enfermedad y que a menudo es pasado por alto, así como la necesidad urgente de acción global. (229 words, Sep 28, 2025)
- [Echte Geschichten, echte Wirkung: Der Kampf gegen Tollwut | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/stop-rabies/echte-geschichten-echte-wirkung-der-kampf-gegen-tollwut.html): Die Gefahr der Tollwut wird oft übersehen. Die Notwendigkeit zum Handeln wird nicht gesehen. Erfahren Sie, wie wir die Tollwut durch Aufklärung und Hundeimpfungen ausrotten können. (283 words, Sep 23, 2025)
- [Boehringer Ingelheim gets approval for HERNEXEOS® in Japan​ | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/boehringer-ingelheim-gets-approval-hernexeos-japan/index.html): Boehringer Ingelheim gets approval for HERNEXEOS® in Japan​ (679 words, Sep 18, 2025)
- [Bem-vindo ao Referência Científica | Boehringer Ingelheim](/content/pro/br/sobre-nos/index.html): Acesse conteúdo científico, atualizações médicas e suporte ao paciente no portal Referência Científica. Tudo para sua atualização profissional num só lugar. (272 words, Sep 2, 2025)
- [La force d’innovation du réseau RCV | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/la-force-dinnovation-du-reseau-rcv/index.html): La force d’innovation du réseau RCV (716 words, Sep 2, 2025)
- [Mutirão Abraçar: uma iniciativa que transforma o diagnóstico de doenças respiratórias no SUS | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/mutirao-abracar-uma-iniciativa-que-transforma-o-diagnostico-de-doencas-respiratorias-no-sus.html): O mutirão é uma ação do Programa Abraçar que fortalece o sistema público de saúde com exames gratuitos de espirometria, capacitação profissional e organização de fluxos para doenças respiratórias como DPOC, asma e fibrose pulmonar. (642 words, Aug 26, 2025)
- [Chronische Nierenerkrankung bei Katzen | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/chronische-nierenerkrankung-bei-katzen-0/index.html): Erkennen und managen Sie chronische Nierenerkrankungen und hohen Blutdruck bei Katzen. (945 words, Aug 21, 2025)
- [Kleinzelligen Lungenkrebs verstehen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/lungenkrebs/kleinzelligen-lungenkrebs-verstehen/index.html): Small cell lung cancer (SCLC) is an aggressive form of cancer known for its rapid growth and early spread to other parts of the body. (361 words, Aug 7, 2025)
- [Zo vermijd je stress bij een bezoek aan de dierenarts | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/uitgelichte-verhalen/zo-vermijd-je-stress-bij-een-bezoek-aan-de-dierenarts.html): Een dierenarts en expert in kattengedrag deelt handige katvriendelijke tips. (254 words, Aug 7, 2025)
- [Advancing Biomedical Innovation Through Open Collaboration | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/advancing-biomedical-innovation-through-open-collaboration.html): In today’s dynamic research landscape, open innovation has emerged as a powerful strategy for addressing complex biomedical challenges. At Boehringer Ingelheim, this philosophy is embedded in our progressive R&D strategy—one that fosters collaboration, op (681 words, Aug 6, 2025)
- [Denk aan hondsdolheid voor je op vakantie vertrekt | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/uitgelichte-verhalen/denk-aan-hondsdolheid-voor-je-op-vakantie-vertrekt/index.html): Reis je naar een afgelegen gebied of een plek met veel zwerfdieren, dan kan een vaccin tegen hondsdolheid zorgen voor een veilige en zorgeloze reis. (404 words, Aug 5, 2025)
- [Christina Janista ist neue General Managerin von Boehringer Ingelheim Schweiz | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/christina-janista-ist-neue-general-managerin-von-boehringer-ingelheim-schweiz.html): Christina Janista ist neue General Managerin von Boehringer Ingelheim Schweiz (250 words, Aug 5, 2025)
- [Monarch magic: Ridgefield, CT pollinator event | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-green/monarch-magic-ridgefield-ct-pollinator-event/index.html): Ridgefield employees celebrated monarch butterflies with a live release, learning how sustainability supports pollinators and protects biodiversity. (258 words, Jul 30, 2025)
- [Inspiring Future Leaders in Veterinary Medicine and Research | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/inspiring-future-leaders-veterinary-medicine-and-research.html): At Boehringer Ingelheim, we are dedicated to supporting the future of veterinary medicine by investing in young scientists and vets. (507 words, Jul 28, 2025)
- [Oznámení o ochraně osobních údajů pro kamerový systém | Boehringer Ingelheim CZ](/content/cz/oznameni-o-ochrane-osobnich-udaju-pro-kamerovy-system.html): Oznámení o ochraně osobních údajů pro kamerový systém (750 words, Jul 28, 2025)
- [Parasiten: Krankheiten im geografischen Wandel | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/parasiten-krankheiten-im-geografischen-wandel/index.html): Way beyond ticks and flea bites in dogs and cats: climate change facilitates the spread of new pet parasites to different regions (878 words, Jul 28, 2025)
- [Social Engagement Fund invests in three new startups in Africa | Boehringer Ingelheim](/content/about-us/sustainable-development/social-engagement-fund-invests-three-new-startups-africa.html): Social Engagement Fund invests in three new startups to expand healthcare access across Africa (733 words, Jul 16, 2025)
- [Das 'dunkle Genom' für die Krebsimmuntherapie entschlüsseln | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/das-dunkle-genom-fuer-die-krebsimmuntherapie-entschluesseln.html): Unsere Wissenschaftler treiben die Entdeckung unerforschter Krebsantigene aus dem 'dunklen Genom' voran. Ziel ist es, neuartige Krebsimmuntherapien zu entwickeln. (357 words, Jul 16, 2025)
- [Bluthochdruck vorbeugen: Den stillen Killer früh erkennen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/bluthochdruck-vorbeugen-den-stillen-killer-frueh-erkennen.html): Bluthochdruck kann tödlich sein. Leider bleibt die Erkrankung oft unerkannt. Wir setzen uns dafür ein, mehr Menschen frühzeitig zu schützen. (555 words, Jul 8, 2025)
- [CRM Week 2025: Unterwegs im Auftrag der Nierengesundheit. | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/crm-week-2025-unterwegs-im-auftrag-der-nierengesundheit.html): Patientenzentriertheit in Aktion. im Rahmen der Herzkreislauf-Nieren- und Stoffwechsel-Woche haben wir über Nierengesundheit aufgeklärt und gleichzeitig Personen eine niederschwellige, kostenlose Möglichkeit geboten, Blutzucker & Blutdruck zu testen. (512 words, Jul 1, 2025)
- [AMRICC | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/amricc/index.html): Boehringer Ingelheim has maintained a strong partnership with Animal Management in Rural and Remote Indigenous Communities (AMRRIC) (448 words, Jun 30, 2025)
- [Ce qu’il faut savoir au sujet des médicaments de contrefaçon | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/plus-de-sante/ce-quil-faut-savoir-au-sujet-des-medicaments-de-contrefacon.html): Ce qu’il faut savoir au sujet des médicaments de contrefaçon (562 words, Jun 27, 2025)
- [¿Qué es la lengua azul? | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/que-es-la-lengua-azul/index.html): ¿Qué es la lengua azul? (516 words, Jun 26, 2025)
- [Turning Point for Immunotherapy: Monocytes Strengthen T Cells | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/turning-point-immunotherapy-monocytes-strengthen-t-cells.html): Immunotherapy boosts the immune system to fight cancer, but some tumors adapt and become resistant. The tumor’s microenvironment plays a complex role, sometimes blocking and sometimes aiding immune responses. (471 words, Jun 24, 2025)
- [Nouvelles perspectives : Les soins vétérinaires – bien plus qu’on pourrait croire | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/notre-responsabilite/nouvelles-perspectives-les-soins-veterinaires-bien-plus-quon-pourrait-croire.html): Comprenons-nous vraiment ce qu'il faut pour être vétérinaire ? Découvrez pourquoi il est important d'en apprendre davantage sur cette carrière ambitieuse. (557 words, Jun 23, 2025)
- [Adipositas und ihre Folgeerkrankungen: Es ist komplex | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/adipositas/adipositas-und-ihre-folgeerkrankungen-es-ist-komplex.html): Hintergründe zur Stoffwechselerkrankung Adipositas, Folgen des Übergewichts und Folgeerkrankungen (832 words, May 28, 2025)
- [Cat owners, here’s how to make veterinary check-ups less stressful | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-owners-heres-how-make-veterinary-check-ups-less-stressful.html): Does your cat get spooked at the vet clinic? A veterinarian and cat health expert shares tips on cat friendly interactions to help your cat relax. (311 words, May 21, 2025)
- [Proyecto de biodiversidad con abejas nativas | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/proyecto-de-biodiversidad-con-abejas-nativas/index.html): Proyecto de biodiversidad con abejas nativas (845 words, May 16, 2025)
- [To enkle tester kan hjelpe pasienter med kronisk nyresykdom | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kronisk-nyresykdom/enkle-tester-kan-hjelpe-pasienter-med-kronisk-nyresykdom.html): Kronisk nyresykdom gir ofte ingen symptomer før nyrene er nær ved å svikte. Det er derfor screening av risikopasienter er så viktig. (505 words, May 13, 2025)
- [Ruta 86 Madrid | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-madrid/index.html): Ruta 86 Madrid (934 words, May 13, 2025)
- [Ituverava se torna modelo internacional na promoção de cuidados do AVC com o “Programa Angels” | Boehringer Ingelheim BR](/content/br/imprensa-historias/press-releases/ituverava-se-torna-modelo-internacional-na-promocao-de-cuidados-do-avc-com-o-programa-angels.html): A iniciativa global, coordenada pela Boehringer Ingelheim com apoio da World Stroke Organization, visa capacitar serviços de saúde e ensinar crianças sobre a enfermidade por meio do “Fast Heróis” (885 words, Apr 25, 2025)
- [Researchers from industry and academic background come together. | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/researchers-industry-and-academic-background-come-together.html): Our colleagues from R&D invite scientists from academia to Biberach. There, the science community bridges fundamental research with industrial application. (378 words, Apr 21, 2025)
- [Code of Conduct | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (303 words, Apr 18, 2025)
- [Boehringer Ingelheim lanza SEMINTRA® 4 mg/ml para gatos con enfermedad renal crónica y/o hipertensión | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/boehringer-ingelheim-lanza-semintra-4-mg-ml-para-gatos-con-enfermedad-renal-cronica-y-o-hipertension.html): Boehringer Ingelheim lanza al mercado SEMINTRA® 4 mg/ml para gatos con enfermedad renal crónica y/o hipertensión (987 words, Apr 16, 2025)
- [Boehringer Ingelheim invirtió 105 millones de euros en I+D+i en España en 2024 | Boehringer Ingelheim ES](/content/es/prensa/boehringer-ingelheim-invirtio-105-millones-de-euros-en-idi-en-espana-en-2024.html): Boehringer Ingelheim invirtió 105 millones de euros en I+D+i en España en 2024 (781 words, Apr 10, 2025)
- [Better together: Teaming up to strengthen our supply chain | Boehringer Ingelheim](/content/about-us/who-we-are/better-together-teaming-strengthen-our-supply-chain.html): The article exemplifies how cross-border cooperation and teamwork are vital for maintaining and expanding the supply of essential medications. (813 words, Apr 4, 2025)
- [Eröffnung F&E-Zentrum für NBE Therapeutics in Basel | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/eroeffnung-fe-zentrum-fuer-nbe-therapeutics-basel/index.html): Boehringer Ingelheim verstärkt sein Antikörper-Wirkstoff-Konjugat-Portfolio mit der Eröffnung eines neuen F&E-Zentrums für NBE Therapeutics in Basel (692 words, Apr 2, 2025)
- [User Agreement & Legal Terms | Ask Boehringer](/content/pro/ca/ask-boehringer/terms-of-use/index.html): Our Terms of Service outline the rules for using our website, including user obligations, content policies, and dispute resolution. Read the full agreement here. (1,892 words, Mar 25, 2025)
- [An ongoing commitment to water stewardship: Fremont’s sustainable journey | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-green/ongoing-commitment-water-stewardship-fremonts-sustainable-journey.html): In celebration of World Water Day, Boehringer’s Fremont site proudly reaffirms its commitment to water management. (420 words, Mar 21, 2025)
- [Efficient protection against porcine circovirus isn’t one-size-fits-all | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/efficient-protection-against-porcine-circovirus-isnt-one-size-fits-all.html): Efficient protection against porcine circovirus isn’t one-size-fits-all (560 words, Mar 19, 2025)
- [A krónikus vesebetegségről | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kronikus-vesebetegsegrol/index.html): A krónikus vesebetegség (CKD) nagyon gyakori, és gyakran észrevétlen marad csendes természete miatt. A kockázati tényezők közé tartozik a magas vérnyomás és a 2-es típusú cukorbetegség. (362 words, Mar 19, 2025)
- [郭昭宏院長蒞臨演講，分享「雙軸轉型 邁向永續醫院」的寶貴經驗 | Boehringer Ingelheim TW](/content/tw/node/32562/index.html): 郭昭宏院長蒞臨演講，分享「雙軸轉型 邁向永續醫院」的寶貴經驗 (30 words, Mar 18, 2025)
- [O caso particular do diagnóstico da ICFEp I HoWM](/content/pro/pt/heart-of-what-matters/o-caso-particular-do-diagnostico-da-icfep/index.html): O diagnóstico da ICFEp é desafiador, exigindo parâmetros ecocardiográficos, clínicos e biomarcadores para estimar a probabilidade do diagnóstico. (334 words, Mar 13, 2025)
- [患者さんにいち早く新しい治療法を届けるひとつの開発パイプラインの司令塔として活躍する「アセットリード」 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0007/index.html): 日本ベーリンガーインゲルハイム株式会社は2024年、「アセット*チーム」体制を導入しました。医薬品の開発は、薬の候補について患者さんに対する有効性や安全性を確認する臨床試験、承認取得のための申請など、上市までにさまざまなフェーズがあります。 (30 words, Mar 10, 2025)
- [Opening doors with open science | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/opening-doors-open-science/index.html): Our open science mindset creates a collaborative scientific community that advances breakthrough therapies to meet unmet patient needs. (1,049 words, Mar 4, 2025)
- [New indication and extension OFEV® children adolescents | Boehringer Ingelheim](/content/human-health/lung-diseases/new-indication-and-extension-ofev-children-adolescents.html): European Commission approves a new indication and an indication extension for OFEV® in children and adolescents (1,408 words, Feb 27, 2025)
- [Oncology | Boehringer Ingelheim](/content/partnering/human-health-partnering/partnering-interests/oncology/index.html): We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in oncology. (381 words, Feb 16, 2025)
- [5 questions à Bénédicte Alexandre | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/5-questions-benedicte-alexandre/index.html): Vétérinaire de formation, Bénédicte a occupé différentes fonctions en santé animale chez Boehringer Ingelheim, avant d’intégrer l’activité santé humaine en 2023 (538 words, Feb 5, 2025)
- [О хронической болезни почек | Boehringer Ingelheim RU](/content/ru/human-health/o-khronicheskoy-bolezni-pochek/index.html): Хроническая болезнь почек (ХБП) очень распространена и часто остается незамеченной из-за своего бессимптомного характера. Факторы риска включают высокое кровяное давление и диабет 2 типа. (350 words, Feb 3, 2025)
- [First Contact of Sperm and Egg: Molecular Key to Fertilization | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/first-contact-sperm-and-egg-molecular-key-fertilization.html): Researchers at the Institute of Molecular Pathology (IMP) have discovered a “molecular key” that creates the first contact between sperm and egg. (769 words, Jan 29, 2025)
- [rcm metalyse 25mg](/content/pro/pt/bipdf/rcm-metalyse-25mg/index.html): A potência do tenecteplase é expressa em unidades (U) com um padrão exclusivo, não comparável às unidades de outros agentes trombolíticos. (19 words, Jan 29, 2025)
- [ライトビルトのエッセンス | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/culture/core-our-leitbild/index.html): 私たちは、株式を公開しない独立した企業であり、それは今後も変わりません (18 words, Jan 20, 2025)
- [Diabetescontrole met Jardiance | Patient Protal NL](/content/patient/nl/mijnjardiance/nederlands/index.html): Krijg inzicht in Jardiance en hoe het uw diabetes kan verbeteren. Bezoek onze website voor nuttige informatie en ervaringen van andere gebruikers. (200 words, Jan 17, 2025)
- [Rychlý test odhalí ohrožené srdce i ledviny | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/rychly-test-odhali-ohrozene-srdce-i-ledviny/index.html): Zvýšená hladina bílkoviny v moči ukazuje na řadu zdravotních problémů. Odhalit ji lze z rychlého testu ze vzorku moči, o který mohou pacienti požádat při preventivní prohlídce u svého praktika. (692 words, Jan 9, 2025)
- [Retinal health: All eyes on vision loss | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-stories/retinal-health-all-eyes-vision-loss/index.html): Discover how we want to prevent vision loss caused by diabetic retinopathy and other retinal diseases (659 words, Dec 20, 2024)
- [Computational Innovation | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/computational-innovation/index.html): Bei Boehringer Ingelheim investieren wir in die Leistungsfähigkeit von Computational Innovation, um den Weg zu bahnbrechenden Therapien zu beschleunigen. (1,243 words, Dec 16, 2024)
- [AI as an assistant in research and development | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/ai-assistant-research-and-development/index.html): Boehringer Ingelheim is helping to shape AI development as a pioneer. (752 words, Dec 12, 2024)
- [Postdoctoral Research Program | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/postdoctoral-research-program/index.html): Boehringer Ingelheim’s postdoctoral program in Regional Center Vienna (RCV) provides scientists with the opportunity to pursue research. (546 words, Dec 11, 2024)
- [Testing New Treatments for NF1 | Boehringer Ingelheim AT](/content/at/en/media/testing-new-treatments-nf1/index.html): The Medical University of Vienna and Boehringer Ingelheim have taken an innovative approach to the development of ways of treating NF1-associated tumors. (779 words, Dec 10, 2024)
- [Research Institute of Molecular Pathology IMP | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/fostering-science/research-institute-molecular-pathology-imp/index.html): Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria. (613 words, Dec 10, 2024)
- [Small Molecule Drug Discovery | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/small-molecule-drug-discovery/index.html): Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve. (1,390 words, Dec 10, 2024)
- [Programa Abraçar a Vida | Boehringer Ingelheim](/content/pro/br/abracar-a-vida/index.html): Abraçar a Vida é uma rede de suporte que proporciona benefícios e serviços adicionais ao tratamento medicamentoso; promovendo mais qualidade de vida (163 words, Nov 29, 2024)
- [Global Patient Partnership Initiative (GPPI) | Boehringer Ingelheim](/content/human-health/our-responsibility/patient-centricity/global-patient-partnership-initiative-gppi/index.html): Why the Global Patient Partnership Initiative is a flagship model for patient engagement: from its empowering GPPI Projects to its Research & Communities (1,007 words, Nov 28, 2024)
- [Patient:innen im Fokus | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/patientinnen-im-fokus/index.html): Mehr als 6 Millionen Patient*innen versorgt Boehringer Ingelheim RCV mit innovativen Therapien. Entscheidend dafür ist es, die Bedürfnisse der Betroffenen in jeder Phase punktgenau zu berücksichtigen. (552 words, Nov 26, 2024)
- [H Boehringer Ingelheim και η IBM συνεργάζονται για να προωθήσουν μοντέλα Τεχνητής Νοημοσύνης για την ανάπτυξη θεραπευτικών αντισωμάτων. | Boehringer Ingelheim GR](/content/gr/about-us/h-boehringer-ingelheim-kai-i-ibm-synergazontai-gia-na-proothisoyn-montela-tehnitis-noimosynis-gia.html): Η φαρμακευτική εταιρεία Boehringer Ingelheim και η IBM ήρθαν σε συμφωνία που θα επιτρέψει στην Boehringer Ingelheim να χρησιμοποιήσει τις βασικές τεχνολογίες της IBM για να ανακαλύψει νέα υποψήφια φάρμακα για την ανάπτυξη αποτελεσματικών θεραπευτικών μ (496 words, Nov 15, 2024)
- [Heart disease in dogs: things you should know | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/heart-disease-dogs-things-you-should-know/index.html): Heart disease in dogs is more common than many realize. Signs and symptoms of heart disease in dogs usually are not visible until the disease has progressed. Find out what you can do. (1,035 words, Nov 14, 2024)
- [Todos os Produtos | Boehringer Ingelheim](/content/pro/br/produtos/index.html): Explore a todos os produtos da Boehringer Ingelheim. Encontre informações detalhadas sobre nossos medicamentos para diversas áreas terapêuticas (100 words, Nov 11, 2024)
- [Portail Boehringer Ingelheim dédié aux professionnels de santé](/content/pro/fr/index-2.html): Retrouvez toutes les informations nécessaires sur notre site local concernant nos médicaments, les prochains événements et la recherche. (91 words, Nov 11, 2024)
- [Expert insights: the top online lung cancer questions answered | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/expert-insights-top-online-lung-cancer-questions-answered.html): As part of Big Little Things, we teamed up with top patient representatives from around the world to answer the most searched questions about lung cancer. (293 words, Oct 21, 2024)
- [World Mental Health Day: Der Komplexität von Schizophrenie gerecht werden | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/world-mental-health-day-der-komplexitaet-von-schizophrenie-gerecht-werden.html): World Mental Health Day: Der Komplexität von Schizophrenie gerecht werden (487 words, Oct 10, 2024)
- [Leben mit Schizophrenie: Geschichten über Hoffnung, Resilienz und die täglichen Herausforderungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/psychische-gesundheit/schizophrenie/leben-mit-schizophrenie-geschichten-ueber-hoffnung-resilienz-und-die-taeglichen-herausforderungen.html): Schizophrenie hat viele Facetten. Erfahren Sie hier, wie die schwere psychische Erkrankung unterschiedliche Aspekte des täglichen Lebens beeinflusst. (485 words, Oct 7, 2024)
- [The global $1 trillion mental health problem needs more funding | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/global-1-trillion-mental-health-problem-needs-more-funding.html): Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need. (708 words, Oct 1, 2024)
- [Das globale 1-Billionen-Dollar-Problem der psychischen Erkrankungen braucht eine bessere Finanzierung | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/das-globale-1-billionen-dollar-problem-der-psychischen-erkrankungen-braucht-eine-bessere.html): Neuer Bericht von Economist Impact zeigt: Fast eine Milliarde Menschen leiden an psychischen Erkrankungen. Aber 70% bekommen keine Unterstützung. (743 words, Oct 1, 2024)
- [Leptospirosis dogs pet owner guide | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/leptospirosis-dogs-pet-owner-guide/index.html): The disease can affect multiple organs in dogs, causing kidney damage, liver failure, and even death. The most effective prevention method is vaccination. (436 words, Sep 23, 2024)
- [Vereint im Kampf gegen den Tollwut-Virus | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/vereint-im-kampf-gegen-den-tollwut-virus/index.html): Wir arbeiten mit Gemeinden und Regierungen in ganz Südostasien zusammen, um die Tollwut durch verstärkte Impfungen, Aufklärungsprogramme und Partnerschaften zu bekämpfen. (755 words, Sep 19, 2024)
- [Інтерстиціальні захворювання легень - попередження про небезпеку. | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/pulmonary-fibrosis/intersticialni-zakhvoryuvannya-legen-poperedzhennya-pro-nebezpeku.html): Інтерстиціальні захворювання легень - попередження про небезпеку. (477 words, Sep 17, 2024)
- [Strengthening policy for CRM diseases: An action plan | Boehringer Ingelheim UK](/content/uk/human-health/metabolic-diseases/strengthening-policy-crm-diseases-action-plan/index.html): Strengthening the policy response to cardiovascular, renal and metabolic diseases: An action plan for a more integrated model of care (127 words, Sep 12, 2024)
- [Mereu alături - Angajamentul nostru față de Ucraina | Boehringer Ingelheim RO](/content/ro/mereu-alaturi/index.html): În inima Ucrainei, războiul continuă - aducând provocări zilnice și o nevoie urgentă de sprijin. La Boehringer Ingelheim, suntem fermi în angajamentul nostru față de Ucraina și poporul său. (393 words, Sep 9, 2024)
- [Plicní fibrózy berou plochu k dýchání | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/plicni-fibrozy-berou-plochu-k-dychani/index.html): Plicní fibrózu bohužel nelze vyléčit, léčba však může zpomalit její průběh, pokud se zahájí včas. (243 words, Sep 9, 2024)
- [Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/boehringer-ingelheim-acquires-saiba-animal-health-adding-innovative-technology-platform-its-pet.html): Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio (480 words, Sep 2, 2024)
- [NexGard Spectra Miat Uzatımı Bilgilendirme | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/nexgard-spectra-miat-uzatimi-bilgilendirme/index.html): NexGard Spectra Miat Uzatımı Bilgilendirme (221 words, Aug 29, 2024)
- [Are you missing the bigger picture on mental health? | Boehringer Ingelheim](/content/human-health/mental-health/are-you-missing-bigger-picture-mental-health/index.html): Revolutionizing our approach to serious mental health conditions is crucial for tailored care, placing those with lived experience at the center. (556 words, Aug 19, 2024)
- [Hraničné hodnoty pri diabete | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/diabetes/hranicne-hodnoty-pri-diabete/index.html): Hladina cukru v krvi sa v priebehu dňa mení u každého človeka. (416 words, Aug 7, 2024)
- [Objetivos de Desarrollo Sostenible (ODS) y Enfermedad Renal Crónica (ERC): Un llamado a la acción | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedad-renal-cronica/objetivos-de-desarrollo-sostenible-ods-y-enfermedad-renal-cronica-erc-un-llamado-la-accion.html): Objetivos de Desarrollo Sostenible (ODS) y Enfermedad Renal Crónica (ERC): Un llamado a la acción (763 words, Jul 23, 2024)
- [Im Einsatz für mehr Vielfalt in klinischen Studien: Ein globales Mandat | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/im-einsatz-fuer-mehr-vielfalt-klinischen-studien-ein-globales-mandat.html): Vielfalt in klinischen Studien: Der Schlüssel zu einer gerechteren Gesundheitsversorgung (1,016 words, Jul 19, 2024)
- [Нова електроцентрала на биомаса в Ингелхайм | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/more-green/nova-elektrocentrala-na-biomasa-v-ingelkhaym/index.html): Boehringer Ingelheim произвежда собствена зелена енергия (627 words, Jul 15, 2024)
- [Geographic Atrophy (GA) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/eye-health/ga/index.html): Explore clinical insights on Geographic Atrophy (GA), including visual impact, and treatment considerations. Access resources, clinical trials, and support tools. (628 words, Jul 15, 2024)
- [Gripe aviária? Vírus da língua azul? | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/gripe-aviaria-virus-da-lingua-azul/index.html): Saiba o que são doenças animais transfronteiriças e como elas podem nos impactar. (264 words, Jul 12, 2024)
- [CKD Support Tools | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/ckd/support-tools/index.html): Find support tools and links for patients, caregivers, and healthcare professionals to support the management of Chronic Kidney Disease (CKD). (113 words, Jul 9, 2024)
- [3 choses à savoir sur les zoonoses | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/3-choses-savoir-sur-les-zoonoses/index.html): Nous interagissons avec les animaux dans notre vie quotidienne et notre santé est liée à la leur. C’est pourquoi il est important d’en savoir plus sur les zoonoses et sur les mesures à prendre pour freiner leur diffusion. (645 words, Jul 5, 2024)
- [Enfermedades zoonósicas cosas que debes saber | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/enfermedades-zoonosicas-cosas-que-debes-saber/index.html): Enfermedades zoonósicas: 3 cosas que debes saber (755 words, Jul 4, 2024)
- [Bolile zoonotice: 3 lucruri pe care ar trebui să le știți | Boehringer Ingelheim RO](/content/ro/bolile-zoonotice-3-lucruri-pe-care-ar-trebui-sa-le-stiti.html): Natura este plină de relații - poate niciuna atât de fundamentală precum cea dintre oameni și animale. (626 words, Jul 2, 2024)
- [Les 5 choses à savoir sur l’Influenza aviaire | Boehringer Ingelheim FR](/content/fr/les-5-choses-savoir-sur-linfluenza-aviaire/index.html): Si les mesures de biosécurité et la surveillance sont actuellement les méthodes de prévention les plus courantes, la vaccination peut venir compléter les différentes mesures de contrôle. (470 words, Jun 26, 2024)
- [Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/boehringer-ingelheim-office-hours-2024-shaping-future-innovation-europe.html): Boehringer Ingelheim is actively supporting the next generation of innovators. (458 words, Jun 25, 2024)
- [Adalimumab ADBM US PI](/content/patient/us/products/cyltezo/bipdf/adalimumab-adbm-us-pi/index.html): Adalimumab ADBM US PI (104 words, Jun 24, 2024)
- [Tipy na cestování se psy | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/tipy-na-cestovani-se-psy/index.html): Tipy na cestování se psi nejenom v létě. Očkování, pas, prevence, lékárnička. (509 words, Jun 23, 2024)
- [Diversidad en ensayos clínicos | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/diversidad-en-ensayos-clinicos/index.html): Abrazando la diversidad en ensayos clínicos (1,225 words, Jun 22, 2024)
- [Biotherapeutics Discovery | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/biotherapeutics-discovery/index.html): Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough. (499 words, Jun 18, 2024)
- [Innovation Price | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/innovation-price/index.html): Der ‚Innovation Prize‘ von Boehringer Ingelheim wurde 2015 in Boston ins Leben gerufen, um die Herausforderung und das Engagement von Life-Science-Unternehmern bei der Förderung neuer Ideen und neuer Wissenschaft zu würdigen. (315 words, Jun 13, 2024)
- [How Boehringer Ingelheim is Supporting Grass Roots Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/grass-roots/how-boehringer-ingelheim-supporting-grass-roots-innovation.html): Our Grass Roots activities support life-science innovators with mentoring and networking opportunities (293 words, Jun 10, 2024)
- [Medical Congresses | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/scientific-congresses/index.html): Explore materials from past scientific meetings and upcoming conferences in cardiology, oncology, and more therapeutic areas. (382 words, Jun 4, 2024)
- [Oncology | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/index.html): Explore oncology information, including the education resources, and tools to support patient care across multiple cancers. (186 words, Jun 3, 2024)
- [Maladies pulmonaires interstitielles – détecter précocement, agir rapidement | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/fibrose-pulmonaire/maladies-pulmonaires-interstitielles-detecter-precocement-agir-rapidement.html): Il est crucial d’interpréter les signes précurseurs de la fibrose pulmonaire, qui peut être engendrée par une MPI. Un traitement rapide est à même d’apaiser les symptômes et de ralentir la progression de la maladie. (481 words, Jun 3, 2024)
- [Gjøre en forskjell i kliniske studier: betydningen av engasjement | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/kliniske-studier/gjore-en-forskjell-i-kliniske-studier-betydningen-av-engasjement.html): Vi er partnere med pasienter, omsorgspersoner og utprøverstab for å designe og gjennomføre våre kliniske studier for å gi en bedre opplevelse for alle. (850 words, May 17, 2024)
- [Positive results Diabetic Macular Ischemia treatment | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/positive-results-diabetic-macular-ischemia-treatment.html): HORNBILL Phase I/II study shows positive results for potentially first ever Diabetic Macular Ischemia treatment (1,151 words, May 2, 2024)
- [百靈佳殷格翰獨角獸2.0生醫加乘行動計畫 偕台灣生醫新創團隊站穩國際研發舞台 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuangdujiaoshouzhichijihua/bailingjiayingehandujiaoshou20shengyijiachengxingdongjihua.html): 百靈佳殷格翰獨角獸2.0生醫加乘行動計畫 偕台灣生醫新創團隊站穩國際研發舞台 (33 words, Apr 24, 2024)
- [Los veterinarios van (mucho) más allá | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/los-veterinarios-van-mucho-mas-alla/index.html): Los veterinarios van (mucho) más allá (930 words, Apr 23, 2024)
- [Dobrovolnický den ve prospěch přírody | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/zelena-reseni/dobrovolnicky-den-ve-prospech-prirody-0/index.html): Sázení u příležitosti Dne země se zúčastnilo téměř 40 dobrovolníků. Pomohli jsme tak obnovit část lesa zničenou kůrovcem. (287 words, Apr 22, 2024)
- [Sustainable medicines that help minimize environmental impact | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/sustainable-medicines-help-minimize-environmental-impact.html): How we collaborate with renowned experts to lead the way in reducing solvent waste, as part of our efforts to embed sustainability into our core business. (1,020 words, Apr 18, 2024)
- [Cómo ser amigable con los gatos: 10 consejos para veterinarios | Boehringer Ingelheim MX](/content/mx/salud-animal/como-ser-amigable-con-los-gatos-10-consejos-para-veterinarios.html): Te presentamos 10 sencillos pasos que puedes dar para que los pacientes felinos se sientan a gusto en su próxima consulta. Estos consejos se basan en la experiencia veterinaria interna, en consultas con un grupo de especialistas independientes en salud (440 words, Apr 11, 2024)
- [Internationale Tage Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/internationale-tage-ingelheim/index.html): Seit 1959 richtet Boehringer Ingelheim die Internationalen Tage Ingelheim aus. Die Kunstausstellung hat sich zu einer festen Institution entwickelt. (204 words, Apr 10, 2024)
- [貓美達佳口服液劑 | Boehringer Ingelheim TW](/content/tw/node/30756/index.html): 貓美達佳口服液劑 (40 words, Apr 9, 2024)
- [Results for Jardiance EMPACT-MI phase III trial | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/results-jardiance-empact-mi-phase-iii-trial/index.html): Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack (1,287 words, Apr 6, 2024)
- [Results announced from EMPACT-MI phase III trial | Boehringer Ingelheim US](/content/us/media/press-releases/results-announced-empact-mi-phase-iii-trial/index.html): Results announced from EMPACT-MI phase III trial in adults following a heart attack. (1,219 words, Apr 4, 2024)
- [Transboundary animal diseases and veterinary preparedness | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/transboundary-animal-diseases-and-veterinary-preparedness.html): What are transboundary animal diseases (TADs)? Bluetongue virus, foot-and-mouth disease and avian influenza are pathogens belonging to this group. (972 words, Apr 3, 2024)
- [La UNED y Boehringer Ingelheim presentan los resultados del mayor estudio sobre Salud Mental de los Veterinarios | Boehringer Ingelheim ES](/content/es/prensa/la-uned-y-boehringer-ingelheim-presentan-los-resultados-del-mayor-estudio-sobre-salud-mental-de-los.html): La UNED y Boehringer Ingelheim presentan los resultados del mayor estudio sobre Salud Mental de los Veterinarios (1,216 words, Mar 25, 2024)
- [Maladies cardiovasculaires et rénales dans le diabète de type 2 | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/diabete/maladies-cardiovasculaires-et-renales-dans-le-diabete-de-type-2.html): Comment le diabète, les maladies cardiovasculaires et les maladies rénales s'influencent-ils mutuellement ? (249 words, Mar 25, 2024)
- [Transboundary animal diseases (TADs) | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/transboundary-animal-diseases-tads/index.html): Avian influenza? Bluetongue virus? FMD? Learn what are transboundary animal diseases and how they can impact us (209 words, Mar 22, 2024)
- [Unser Verhaltenskodex | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/unser-verhaltenskodex/index.html): Unser Verhaltenskodex legt die ethischen Standards fest, die all unsere Aktivitäten leiten. Jeder Einzelne spielt eine entscheidende Rolle bei der Umsetzung des Verhaltenskodex. (318 words, Mar 21, 2024)
- [S optimismem hledíme do budoucnosti a říkáme: Life Forward | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/s-optimismem-hledime-do-budoucnosti-rikame-life-forward.html): Naše nová vizuální identita (432 words, Mar 19, 2024)
- [Medicina geral e Familiar | Jardiance (Empagliflozin)](/content/pro/pt/jardiance/ckd/medicina-geral-familiar/index.html): JARDIANCE pode ajudar a proteger os pacientes com doença renal crónica ao reduzir a progressão da doença renal ou o risco de morte cardiovascular. (567 words, Mar 19, 2024)
- [Datenschutzinformation Anfragen zu Humanarzneimitteln | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-anfragen-zu-humanarzneimitteln.html): Datenschutzinformation Anfragen zu Humanarzneimitteln (832 words, Feb 16, 2024)
- [Компанія «Берінгер Інгельхайм» на постійній основі долучається до благодійних проєктів | Boehringer Ingelheim UA](/content/ua/kompaniya-beringer-ingelkhaym-na-postiyniy-osnovi-doluchaetsya-do-blagodiynikh-proektiv.html): Компанія «Берінгер Інгельхайм» на постійній основі долучається до благодійних проєктів (127 words, Feb 14, 2024)
- [“My ultimate goal is to cure cancer” | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/my-ultimate-goal-cure-cancer/index.html): Norbert Kraut, Senior Executive Scientist in Discovery Research, shares how we are advancing science to bring new treatment options for people living with cancer. (885 words, Feb 1, 2024)
- [E-learnings | Boehringer Ingelheim Portugal](/content/pro/pt/e-learnings/index.html): Aprenda de forma interativa e teste os seus conhecimentos. Fique a saber mais sobre os tópicos mais relevantes do mundo do interstício pulmunar. (149 words, Jan 31, 2024)
- [百靈佳殷格翰 2024年線上校園徵才–Unlock Your Future | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/bailingjiayingehan-2024nianxianshangxiaoyuanzhengcai-unlock-your-future.html): 百靈佳殷格翰 2024年線上校園徵才–Unlock Your Future (52 words, Jan 30, 2024)
- [La certificación Global de Top Employer 2024 | Boehringer Ingelheim SA](/content/sa/nuestra-compania/perfil-corporativo/la-certificacion-global-de-top-employer-2024/index.html): Top Employers Institute certificó a Boehringer Ingelheim por cuarto año consecutivo como “Top Employer Global” (709 words, Jan 15, 2024)
- [NHS England Renal Network leadership | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/nhs-england-renal/index.html): Read about Implementation of a Leadership Development Programme for Renal Network Leaders with NHS England to support renal service transformation (405 words, Dec 19, 2023)
- [Conoce el GBS Center Buenos Aires: El Centro Global de Servicios de Boehringer Ingelheim Sudamérica | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/conoce-el-gbs-center-buenos-aires-el-centro-global-de-servicios-de-boehringer-ingelheim-sudamerica.html): Conoce el GBS Center Buenos Aires: El Centro Global de Servicios de Boehringer Ingelheim Sudamérica (580 words, Nov 28, 2023)
- [Empowering and Upskilling Patient Organizations in the IMETA Region | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/empowering-and-upskilling-patient-organizations-imeta-region.html): Boehringer Ingelheim held the first PULSE training programme in Dubai, bringing together over twenty representatives of patient organizations from across India, the Middle East, Turkey, and Africa. (491 words, Nov 21, 2023)
- [Targeting HER2 in cancer: The story of zongertinib | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/targeting-her2-cancer-story-zongertinib/index.html): We discovered zongertinib, an HER2 tyrosine kinase inhibitor, being developed as a potential oral treatment for people with HER2-mutated NSCLC (1,118 words, Nov 13, 2023)
- [Privacy Notice | Boehringer Ingelheim AT](/content/at/en/uber-uns/unternehmensprofil/data-privacy/privacy-notice/index.html): Privacy Notice (689 words, Nov 6, 2023)
- [巴金森病88問 | Boehringer Ingelheim TW](/content/tw/human-health/zhongshushenjingjibing/bajinsenbing88wen/index.html): 巴金森病88問 (23 words, Nov 1, 2023)
- [Unleashing the Truth 犬民運動GO了嗎？犬民健康夠不夠？！ | Boehringer Ingelheim TW](/content/tw/animal-health/companion-animals-horses/gou/unleashing-truth-quanminyundonggolemaquanminjiankanggoubugou.html): Unleashing the Truth 犬民運動GO了嗎？犬民健康夠不夠？！ (48 words, Nov 1, 2023)
- [New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec | Boehringer Ingelheim CA](/content/ca/new-collaboration-improve-detection-type-2-diabetes-high-risk-patients-starts-montreal-quebec.html): The project will use artificial intelligence (A.I.), wearable technologies and electronic health record systems to identify patients who may have type 2 diabetes in Montreal, Quebec (1,237 words, Oct 31, 2023)
- [品脈 | Boehringer Ingelheim TW](/content/tw/animal-health/vetmedin/index.html): 品脈 (34 words, Oct 31, 2023)
- [家禽疫苗全產品目錄 | Boehringer Ingelheim TW](/content/tw/animal-health/poultry/products/index.html): 家禽疫苗全產品目錄 (107 words, Oct 29, 2023)
- [百靈佳®豬環狀病毒不活化疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/ingelvac-circoflex/index.html): 百靈佳®豬環狀病毒不活化疫苗 (32 words, Oct 29, 2023)
- [威力克 VAXXITEK HVT+IBD | Boehringer Ingelheim TW](/content/tw/animal-health/vaxxitek-hvt-ibd/index.html): 威力克 VAXXITEK HVT+IBD (78 words, Oct 28, 2023)
- [Avinew NeO | Boehringer Ingelheim TW](/content/tw/animal-health/avinew-neo/index.html): Avinew NeO (214 words, Oct 26, 2023)
- [馬立克疫苗系列 | Boehringer Ingelheim TW](/content/tw/animal-health/cryomarex/index.html): 馬立克疫苗系列 (135 words, Oct 25, 2023)
- [synjardy-rcm](/content/pro/pt/bipdf/synjardy-rcm/index.html): synjardy-rcm (19 words, Sep 26, 2023)
- [ofev-rcm](/content/pro/pt/bipdf/ofev-rcm/index.html): ofev-rcm (19 words, Sep 26, 2023)
- [Zorgverleners | Informatie over Pradaxa®](/content/pro/nl/zorgverleners/pradaxa/index.html): Informatie over Pradaxa® (dabigatran etexilaat). Pradaxa® is een geneesmiddel dat wordt gebruikt om het ontstaan van bloedstolsels te voorkomen. (125 words, Sep 20, 2023)
- [Voorschrijfbevoegd | Informatie over Praxbind®](/content/pro/nl/voorschrijfbevoegd/pradaxa/praxbind/index.html): Informatie over Praxbind®. Praxbind® bevat de werkzame stof idarucizumab en is een specifiek antidotum (neutraliserend middel) voor Pradaxa® (dabigatran). (120 words, Sep 20, 2023)
- [Voorschrijfbevoegd | Kennisbank | Pradaxa®](/content/pro/nl/voorschrijfbevoegd/pradaxa/kennisbank/index.html): Lees de uitgebreide informatie over Pradaxa® (dabigatran) in de SPC, indicaties, dosering, contra-indicaties en wijze van toediening. (37 words, Sep 20, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Informatie VTE](/content/pro/nl/voorschrijfbevoegd/pradaxa/vte/index.html): Informatie over Pradaxa® (dabigatran) bij atriumfibrilleren, Diep Veneuze Trombose (DVT), longembolie en Veneuze Trombo-Embolische voorvallen (VTE) (70 words, Sep 15, 2023)
- [Voorschrijfbevoegd |Pradaxa® | DVT | longembolie](/content/pro/nl/voorschrijfbevoegd/pradaxa/dvt-le/index.html): Informatie over Pradaxa® (dabigatran) bij atriumfibrilleren, Diep Veneuze Trombose (DVT), longembolie en Veneuze Trombo-Embolische voorvallen (VTE) (53 words, Sep 15, 2023)
- [Youth programs shape future farmers for success | Boehringer Ingelheim AU](/content/au/animal-health/our-responsibility/youth-programs-shape-future-farmers-success/index.html): Livestock producers in New Zealand are facing challenges that make it hard for the next generation to succeed as farmers. Rising costs, production pressures, and changes in industry practices are causing difficulties. However, a group of young farmers cal (682 words, Sep 12, 2023)
- [Health Equity: No distance is too far | Boehringer Ingelheim](/content/about-us/sustainable-development/health-equity-no-distance-too-far/index.html): India is hosting the G20 summit. The leading theme of the G20 summit emphasizes health equity and sustainability as part of the agenda. How we provide access to healthcare for rural areas in India. (335 words, Sep 4, 2023)
- [Zorgverleners | Informatie over Trajenta®](/content/pro/nl/zorgverleners/trajenta/index.html): Trajenta® (linagliptine) behoort tot de DPP-4-remmers. Trajenta® is geïndiceerd bij volwassenen met diabetes mellitus type 2. (46 words, Aug 30, 2023)
- [如何照顧心臟病狗狗？犬的護心坊 | Boehringer Ingelheim TW](/content/tw/ruhezhaoguxinzangbinggougouquandehuxinfang/index.html): 如何照顧心臟病狗狗？犬的護心坊 (23 words, Jul 26, 2023)
- [貓慢性腎病QA懶人包 | Boehringer Ingelheim TW](/content/tw/maomanxingshenbingqalanrenbao/index.html): 貓慢性腎病QA懶人包 (80 words, Jul 26, 2023)
- [Das Biologicals Development Center (BDC) in Biberach | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/das-biologicals-development-center-bdc-biberach/index.html): Das Forschungs- und Entwicklungszentrum für Biopharmazeutika von Boehringer Ingelheim setzt neue Maßstäbe für die Biotechnologie in Deutschland. (97 words, Jul 10, 2023)
- [The Hidden Cost of Parasites in Cattle | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/hidden-cost-parasites-cattle/index.html): The Hidden Cost of Parasites in Cattle (638 words, Jul 3, 2023)
- [Salmonella in pigs, pork and people | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/salmonella-pigs-pork-and-people/index.html): Salmonella in pigs, pork and people (619 words, Jul 3, 2023)
- [Simple and straight to the source: tips for ileitis control | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/simple-and-straight-source-tips-ileitis-control/index.html): Simple and straight to the source: tips for ileitis control (489 words, Jul 3, 2023)
- [The wise choice in mastitis prevention | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/wise-choice-mastitis-prevention/index.html): The wise choice in mastitis prevention (252 words, Jul 3, 2023)
- [Plasmid DNA production | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/plasmid-dna-production-bioxcellence/index.html): Discover Boehringer Ingelheim BioXcellence™’s wide range of high-quality plasmid DNA (pDNA) manufacturing solutions from research to GMP production. (633 words, Jun 26, 2023)
- [75 Years Boehringer Ingelheim in Austria | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/history/75-years-boehringer-ingelheim-austria/index.html): 75 Years Boehringer Ingelheim in Austria (289 words, Jun 6, 2023)
- [The geography of pet parasites is changing | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/geography-pet-parasites-changing/index.html): Way beyond ticks and flea bites in dogs and cats: climate change facilitates the spread of new pet parasites to different regions (840 words, May 23, 2023)
- [La diarrea neonatale del vitello | Boehringer Ingelheim IT](/content/it/salute-animale/la-diarrea-neonatale-del-vitello/index.html): La diarrea neonatale del vitello (679 words, May 5, 2023)
- [Frauen in Führungspositionen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/frauen-fuehrungspositionen/index.html): Erfahren Sie von Dr. Dr. Saskia Kley mehr über ihren Weg zu Boehringer Ingelheim, Förderung von Frauen in Führungspositionen und Chancengleichheit. (902 words, Apr 19, 2023)
- [The impact of carbon reduction projects | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/impact-carbon-reduction-projects/index.html): We work continuously towards minimizing our environmental footprint, by reducing our greenhouse gas (GHG) emissions, fostering low-carbon solutions and implementing strategic projects to meet our sustainability commitments. For our currently unavoidab (1,028 words, Apr 18, 2023)
- [Solarpark in Ingelheim geht ans Netz | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/solarpark-ingelheim-geht-ans-netz/index.html): Solarpark in Ingelheim geht ans Netz (383 words, Apr 5, 2023)
- [FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/fibroneer-ph3-trials-patients-ipf-other-pf-ilds/index.html): Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis at Boehringer Ingelheim, discusses the unmet needs of patients with IPF and other forms of progressive fibrosing ILDs and the launch of the FIBRONEER™ global clinical pro (504 words, Mar 28, 2023)
- [Boehringer Ingelheim erreicht 2022 mehr Patienten als je zuvor | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/boehringer-ingelheim-erreicht-2022-mehr-patienten-als-je-zuvor.html): Boehringer Ingelheim erreicht 2022 mehr Patienten als je zuvor (758 words, Mar 28, 2023)
- [Cancer is One of Humanity’s Greatest Challenges | Boehringer Ingelheim](/content/human-health/cancer/cancer-one-humanitys-greatest-challenges/index.html): Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care. (481 words, Jan 30, 2023)
- [Hipertensão Arterial | Abraçar a Vida](/content/patient/br/abracar-a-vida/hipertensao-arterial/index.html): A hipertensão arterial sistêmica, mais conhecida como pressão alta, é uma doença caracterizada pela elevação sustentada dos níveis de pressão arterial. (1,439 words, Jan 23, 2023)
- [75 Jahre Boehringer Ingelheim in Österreich | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/geschichte/75-jahre-boehringer-ingelheim-oesterreich/index.html): 75 Jahre Boehringer Ingelheim in Österreich (292 words, Jan 17, 2023)
- [ベーリンガーインゲルハイムの軌跡（1885-1948年）：イノベーションの幕明け | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/history/1885-1948-innovative-beginnings/index.html): 製薬企業のベーリンガーインゲルハイムは1885年に創業されました。この年、アルベルト・ベーリンガー氏（1861-1939年）は、ラインヘッセン地方のニーダーインゲルハイム（現在はインゲルハイムの一部）にある小さな酒石酸工場を購入しました。ここからベーリンガーインゲルハイムの歴史が始まりました。 (52 words, Dec 23, 2022)
- [ベーリンガーインゲルハイム製薬株式会社 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/boehringer-ingelheim-seiyaku/index.html): ベーリンガーインゲルハイム製薬株式会社(Boehringer Ingelheim Seiyaku Co., Ltd.) (56 words, Dec 17, 2022)
- [Notre histoire en santé animale | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/notre-histoire-en-sante-animale/index.html): Depuis des décennies, nous nous engageons à améliorer la santé et le bien-être des animaux. Découvrez notre passion pour la santé animale. (338 words, Dec 14, 2022)
- [Boehringer Ingelheim Office Hours in Japan | Boehringer Ingelheim JP](/content/jp/boehringer-ingelheim-office-hours-japan/index.html): Boehringer Ingelheim Office Hours in Japan (49 words, Dec 12, 2022)
- [Las claves sobre la diabetes tipo 2 | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/diabetes/las-claves-sobre-la-diabetes-tipo-2/index.html): Conoce sus principales síntomas, factores de riesgo y cómo diagnosticarla. (528 words, Dec 7, 2022)
- [Ochrana osobních údajů - farmakovigilance - Animal Health | Boehringer Ingelheim CZ](/content/cz/ochrana-osobnich-udaju-farmakovigilance-animal-health.html): Ochrana osobních údajů - farmakovigilance - Animal Health (403 words, Nov 23, 2022)
- [Pro odborníky | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/bezpecnost-pacientu/pro-odborniky/index.html): informace o léčivých přípravcích společnosti Boehringer Ingelheim registrovaných v České republice. (332 words, Nov 23, 2022)
- [Notre stratégie d’innovation | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/notre-strategie-dinnovation/index.html): Notre stratégie d’innovation (628 words, Nov 18, 2022)
- [Arthrose canine : prise en charge de la douleur | Boehringer Ingelheim CA](/content/ca/fr/arthrose-canine-prise-en-charge-de-la-douleur/index.html): Améliorez la prise en charge de l’arthrose canine avec Boehringer Ingelheim. Contribuons au bien-être de nos amis à quatre pattes. (838 words, Nov 10, 2022)
- [Sales consultant about working with purpose | Boehringer Ingelheim](/content/about-us/who-we-are/culture/sales-consultant-about-working-purpose/index.html): Bok talks about how he found purpose in his career. After his father was diagnosed with cancer, he decided to work as an oncology sales consultant. (198 words, Nov 7, 2022)
- [総合受付 | Boehringer Ingelheim JP](/content/jp/contact-us/general/index.html): 総合受付 (11 words, Nov 2, 2022)
- [動物用医薬品の情報に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/animal-health/index.html): 動物用医薬品の情報に関するお問い合わせ (15 words, Nov 2, 2022)
- [Boehringer Ingelheim Office Hours in Japanを開催 | Boehringer Ingelheim JP](/content/jp/boehringer-ingelheim-office-hours-japan-to-told/index.html): Boehringer Ingelheim Office Hours in Japanを開催 (22 words, Oct 27, 2022)
- [日本の拠点 | Boehringer Ingelheim JP](/content/jp/about-us/where-find-us/japan/index.html): Locations (86 words, Oct 16, 2022)
- [Banco de Sangre Felino: contra la leucemia felina | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/banco-de-sangre-felino-contra-la-leucemia-felina/index.html): Banco de Sangre Felino: contra la leucemia felina (669 words, Oct 12, 2022)
- [celebramos 100 años en la atención de enfermedades respiratorias | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/celebramos-100-anos-en-la-atencion-de-enfermedades-respiratorias.html): celebramos 100 años en la atención de enfermedades respiratorias (796 words, Oct 12, 2022)
- [En la lucha contra la rabia, solo escuchar no es suficiente | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/en-la-lucha-contra-la-rabia-solo-escuchar-no-es-suficiente.html): En la lucha contra la rabia, solo escuchar no es suficiente (793 words, Oct 10, 2022)
- [El cuidado de las mascotas en la era digital | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/el-cuidado-de-las-mascotas-en-la-era-digital/index.html): El cuidado de las mascotas en la era digital (616 words, Oct 10, 2022)
- [Amar a las mascotas, no a sus parásitos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/amar-las-mascotas-no-sus-parasitos/index.html): Amar a las mascotas, no a sus parásitos (432 words, Oct 7, 2022)
- [핸디핼러 사용법 | Boehringer Ingelheim KR](/content/kr/human-health/products/spirivahandihaler-usage-guide/index.html): 핸디핼러 사용법 (23 words, Oct 3, 2022)
- [ベーリンガーインゲルハイム アニマルヘルス ジャパン株式会社 | Boehringer Ingelheim JP](/content/jp/animal-health/boeringer-ingelheim-animalhealth-japan/index.html): 会社概要・アクセス (126 words, Sep 28, 2022)
- [Trabajando con propósito: colegas comparten sus porqués. | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/trabajando-con-proposito-colegas-comparten-sus-porques.html): Trabajando con propósito: colegas comparten sus porqués (125 words, Sep 28, 2022)
- [メンタルヘルス障害および神経科学の分野の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/central-nervous-system-diseases/index.html): メンタルヘルス障害および神経科学の分野の提携 (23 words, Sep 26, 2022)
- [Our Purpose | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/our-purpose/index.html): Why we exist (48 words, Sep 26, 2022)
- [Hraničné hodnoty pri diabete | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/hranicne-hodnoty-pri-diabete/index.html): Hladina cukru v krvi sa v priebehu dňa mení u každého človeka. Kým u zdravých ľudí hraničné hodnoty neprekračujú isté hranice, v prípade cukrovkárov môžu byť výkyvy omnoho výraznejšie a časté kolísanie môže spôsobiť vážne zdravotné následky. (411 words, Sep 23, 2022)
- [Ako farmaceutický priemysel pomáha ekologickej udržateľnosti? | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/copd-asthma/ako-farmaceuticky-priemysel-pomaha-ekologickej-udrzatelnosti.html): Posunom vpred vo vývoji liečiv sa čím ďalej tým viac snažia farmaceutické spoločnosti znížiť spotrebu energie a celkový vplyv na životné prostredie. Vyrábať farmaceutické výrobky čo najudržateľnejším spôsobom je hlavným cieľom, na ktorom už veľmi veľa fir (271 words, Sep 23, 2022)
- [FSA-Transparenzkodex | Boehringer Ingelheim DE](/content/de/ueber-uns/fsa-transparenzkodex/index.html): Wir beteiligen uns am Transparenzkodex der European Federation of Pharmaceutical Industries and Associations für maximales Transparenz. Erfahren Sie mehr! (395 words, Sep 22, 2022)
- [SEDISA, la Academia de Ciencias Médicas de Bilbao y Boehringer Ingelheim aúnan esfuerzos para mejorar la atención de la Insuficiencia Cardiaca en el País Vasco | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/insuficiencia-cardiaca/sedisa-la-academia-de-ciencias-medicas-de-bilbao-y-boehringer-ingelheim-aunan-esfuerzos-para.html): SEDISA, la Academia de Ciencias Médicas de Bilbao y BI aúnan esfuerzos para mejorar la atención de la Insuficiencia Cardiaca en el País Vasco. (1,042 words, Sep 13, 2022)
- [1 de cada 3 españoles no sabe en qué consiste la insuficiencia cardiaca* | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/insuficiencia-cardiaca/1-de-cada-3-espanoles-no-sabe-en-que-consiste-la-insuficiencia-cardiaca.html): 1 de cada 3 españoles no sabe en qué consiste la insuficiencia cardiaca. (1,059 words, Sep 13, 2022)
- [What is the future of meat consumption? | Boehringer Ingelheim TW](/content/tw/trends-insights/what-future-meat-consumption/index.html): What is the future of meat consumption? (10 words, Sep 5, 2022)
- [GM 인사말 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaim-sogae/gm-insamal/index.html): Value through Innovation / 한국베링거인겔하임은 혁신적인 의약품 공급을 통해 환자에게 최상의 치료가치를 전달하고 있습니다. (262 words, Aug 30, 2022)
- [Boehringer Ingelheim reafirma su compromiso con la concienciación y la prevención para combatir la rabia | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/boehringer-ingelheim-reafirma-su-compromiso-con-la-concienciacion-y-la-prevencion-para-combatir-la.html): Boehringer Ingelheim reafirma su compromiso con la concienciación y la prevención para combatir la rabia. (822 words, Aug 23, 2022)
- [Digitale Therapieunterstützung bei Asthma und COPD | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/copd-asthma/digitale-therapieunterstuetzung-bei-asthma-und-copd.html): Boehringer Ingelheim und VisionHealth kooperieren künftig bei der Vermarktung der App Kata® zur Therapieunterstützung bei Asthma und COPD. (601 words, Aug 16, 2022)
- [Grüner Strom für Japan | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/nos-stories/gruner-strom-fur-japan/index.html): Durch grünen Strom in Japan sollen Energiekosten reduziert und Boehringer Ingelheims CO2-Fußabdruck in Japan minimiert werden. (57 words, Aug 3, 2022)
- [Mexiko-Stadt | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/mexiko-stadt/index.html): Willkommen in unserem Standort im mexikanischen Xochimilco, der sich auf die pharmazeutische Produktion konzentriert. Entdecken Sie unsere Aktivitäten! (186 words, Aug 3, 2022)
- [Protecting Communities from Disease | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/veterinary-public-health/protecting-communities-disease/index.html): Learn how our colleagues in Global Innovation & Veterinary Public Health constantly monitor & prepare for outbreaks to help protect communities from diseases. (377 words, Aug 1, 2022)
- [Our Businesses | Boehringer Ingelheim US](/content/us/about-us/who-we-are/our-businesses/index.html): Click here to find out where Boehringer Ingelheim's subsidiaries are located throughout the U.S and how you can get in contact with each of them. (202 words, Aug 1, 2022)
- [Boehringer Cares Patient Assistance Portal | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/boehringer-cares-patient-assistance-portal/index.html): Click here to find out more about Boehringer Ingelheim's BI Cares patient assistance program portal. (349 words, Aug 1, 2022)
- [Uppförandekod | Boehringer Ingelheim SE](/content/se/om-oss/uppforandekod/index.html): Vår uppförandekod visar för var och en natt integritet är "en del av vårt DNA". (32 words, Aug 1, 2022)
- [Boehringer Ingelheim 2022 half year results | Boehringer Ingelheim](/content/hk/en/about-us/who-we-are/first-half-2022-boehringer-ingelheim-continues-growth-pace-and-strengthens-research-pipeline.html): First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline (605 words, Aug 1, 2022)
- [DVT/LE | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/dvt-le/index.html): Η εν τω βάθει φλεβική θρόμβωση (DVT) είναι μια σοβαρή αλλά συνήθως θεραπεύσιμη κατάσταση. (190 words, Jul 29, 2022)
- [Un Legame Unico: non c’è niente così | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/sclerosi-sistemica/un-legame-unico-non-ce-niente-cosi/index.html): Si stima che oltre due milioni di persone in tutto il mondo soffrano di sclerodermia, una malattia che colpisce soprattutto le donne giovani. Non è (196 words, Jul 22, 2022)
- [Francesca Fedeli - Making More Health | Boehringer Ingelheim IT](/content/it/salute-umana/la-nostra-responsabilita/francesca-fedeli-making-more-health/index.html): Francesca Fedeli parla del suo progetto nato per aiutare i bambini con diagnosi di paralisi cerebrale infantile, sviluppato con il supporto di Boehri (51 words, Jul 22, 2022)
- [Borse di studio | Boehringer Ingelheim IT](/content/it/su-di-noi/borse-di-studio/index.html): Borse di studio (495 words, Jul 16, 2022)
- [Verklaring gegevensbescherming | Boehringer Ingelheim NL](/content/nl/verklaring-gegevensbescherming/index.html): In deze privacyverklaring wordt beschreven hoe Boehringer Ingelheim bv (hierna: 'Boehringer Ingelheim', 'wij', 'we', 'ons' of 'onze') via deze website (2,754 words, Jul 14, 2022)
- [Joint Venture gegen Antibiotikaresistenzen | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/joint-venture-gegen-antibiotikaresistenzen/index.html): Gründung eines Joint Ventures zur Entwicklung von antimikrobiellen Wirkstoffen und Diagnostika zur Bekämpfung Antibiotika Resistenzen. Erfahren Sie mehr! (737 words, Jul 6, 2022)
- [Een unieke band: Mens en dier samen dichter bij gezondheid | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/een-unieke-band-mens-en-dier-samen-dichter-bij-gezondheid.html): Bij Boehringer Ingelheim zetten we ons vol toewijding in voor de gezondheid van mens en dier. We weten als geen ander welke positieve invloed dieren kunnen (177 words, Jul 5, 2022)
- [Toegankelijkheidsverklaring | Boehringer Ingelheim NL](/content/nl/toegankelijkheidsverklaring/index.html): Boehringer Ingelheim is vastbesloten om een website te bieden die toegankelijk is voor de breedst mogelijke doelgroep, ongeacht technologie of vermogen. (475 words, Jun 28, 2022)
- [10000 Eichen für Bingen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/10000-eichen-fuer-bingen/index.html): Boehringer Ingelheim verstärkt sein Engagement für mehr Klimaschutz und Ressourcenschonung jetzt auch in der Logistik. Lesen Sie weiter! (564 words, Apr 20, 2022)
- [1948-1990: La globalización | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/historia/1948-1990-la-globalizacion/index.html): 1948-1990: La globalización (1,285 words, Apr 12, 2022)
- [1885-1948: начало инноваций | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/history/1885-1948-nachalo-innovaciy/index.html): 1885-1948: начало инноваций (1,099 words, Apr 12, 2022)
- [Poultry farming drives sustainability | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/poultry-farming-drives-sustainability/index.html): The Village Poultry Project & Making More Health strive to make poultry farming sustainable. Click here to find out more information about this. (813 words, Mar 24, 2022)
- [Our Approach | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-commitment/our-approach/index.html): As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here. (295 words, Mar 14, 2022)
- [1988-2015 | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/history/1988-2015/index.html): Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here. (1,648 words, Mar 14, 2022)
- [Company Video: Value through Innovation | Boehringer Ingelheim IN](/content/in/about-us/company-video-value-through-innovation/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Click here to watch our company video and learn about us. (39 words, Mar 14, 2022)
- [Trust Through Transparency | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/trust-through-transparency/index.html): Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust. (329 words, Mar 14, 2022)
- [Bluetongue disease | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/bluetongue-disease/index.html): The Bluetongue virus (BTV) is a worldwide infectious viral disease from the Reoviridae family known for its impact on domestic and wild ruminants' health and the economic loss it represents on trade. It doesn't affect humans, but it is a threat to animals (689 words, Mar 1, 2022)
- [Mujeres en STEM 2022 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestras-historias/mujeres-en-stem-2022/index.html): Mujeres en STEM 2022 (773 words, Feb 7, 2022)
- [Nurjanahs Story | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/nurjanahs-story/index.html): Nurjanah went from a sporty young woman to someone who no longer had the energy to do simple, everyday tasks. She was diagnosed with scleroderma. (1,161 words, Feb 2, 2022)
- [CHMP-Empfehlung für HI Behandlung | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/herzinsuffizienz/chmp-empfehlung-fuer-hi-behandlung/index.html): Der CHMP hat eine Zulassungsempfehlung zur Behandlung von Erwachsenen mit symptomatischer, chronischer Herzinsuffizienz ausgesprochen. Lesen Sie weiter! (1,071 words, Jan 31, 2022)
- [Knowing the enemy: PRRS and PCVD | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/knowing-enemy-prrs-and-pcvd/index.html): The swine industry is constantly vigilant of viruses such as PRRS and PCV2 (PCVD). Learn about prevention, symptoms knowledge, and control measures to make a difference. (748 words, Jan 14, 2022)
- [Mehr Gesundheit in benachteiligten Communities | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-potential/mehr-gesundheit-benachteiligten-communities/index.html): In Zeiten der Globalisierung und sozialen Vernetzung greifen eindimensionale Lösungsansätze oft nicht mehr. Komplexe Herausforderungen erfordern komplexe Lösungen. (794 words, Dec 14, 2021)
- [More Potential: Übersicht | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/more-potential-uebersicht/index.html): Die Gesellschaft steht vor vielfältigen Herausforderungen – benachteiligte Communities sind davon oft am stärksten betroffen. (617 words, Dec 14, 2021)
- [Nicht übertragbare Krankheiten | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-health/nicht-ubertragbare-krankheiten/index.html): Weltweit sind 70 Prozent aller Todesfälle auf nicht übertragbare Krankheiten zurückzuführen. Menschen aus Ländern mit geringem oder mittlerem Einkommen sind besonders betroffen. (557 words, Dec 13, 2021)
- [Rettung bei Schlaganfall | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-health/rettung-bei-schlaganfall/index.html): Kaum ein medizinischer Notfall ist so verheerend wie ein Schlaganfall – und jedes Jahr erleiden ihn weltweit über 15 Millionen Menschen. (587 words, Dec 13, 2021)
- [Rettung bei Schlaganfall | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-health/rettung-bei-schlaganfall/index.html): Kaum ein medizinischer Notfall ist so verheerend wie ein Schlaganfall – und jedes Jahr erleiden ihn weltweit über 15 Millionen Menschen. (747 words, Dec 13, 2021)
- [Grass Roots | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/grass-roots/index.html): Mit dem globalen “Grass-Roots”-Programm fördert Boehringer Ingelheim aufstrebende Biotech-Start-ups. (340 words, Nov 19, 2021)
- [Salud mental | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/empoderando-los-pacientes/salud-mental/index.html): Salud mental (295 words, Nov 9, 2021)
- [Our Health and Safety initiative - BE SAFE | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/our-health-and-safety-initiative-be-safe/index.html): Health and safety are of great importance to Boehringer Ingelheim. (338 words, Oct 7, 2021)
- [Our Partnering Culture | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/our-partnering-culture/index.html): We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Learn more about our partnering culture. (317 words, Oct 7, 2021)
- [More Health Overview | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/more-health-overview/index.html): Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. (496 words, Oct 7, 2021)
- [Tecnología de los deportes ecuestres | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/caballos/tecnologia-de-los-deportes-ecuestres/index.html): Tecnología de los deportes ecuestres (799 words, Oct 7, 2021)
- [Устойчиво развитие - за поколенията | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/our-commitment/ustoychivo-razvitie-za-pokoleniyata/index.html): Искаме да създаваме стойност в области с неудовлетворени медицински нужди и да се ангажираме с общностите и обществото, за да подобрим живота на хората и животните. (537 words, Oct 7, 2021)
- [Oncology Research & Clinical Trials | InOncology](/content/pro/us/inoncology/index.html): Explore Boehringer Ingelheim's Oncology Research Pipeline: Innovative cancer treatments through research and clinical trials, helping to transform lives. (156 words, Sep 29, 2021)
- [Behandlung des Typ-2-Diabetes | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/behandlung-des-typ-2-diabetes/index.html): Der CHMP hat einen positiven Bescheid für die Senkung der eGFR im Rahmen der Behandlung bei Typ-2-Diabetes mit kardiovaskulären Erkrankungen erteilt. (451 words, Sep 22, 2021)
- [2021 PRRS Research Award winners announced | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/2021-prrs-research-award-winners-announced/index.html): The 2021 European PRRS Research Award winners announced (535 words, Sep 17, 2021)
- [FDA- HFpEF-breakthrough-designation-EMPEROR-preserved | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/fda-hfpef-breakthrough-designation-emperor-preserved.html): U.S. FDA issues Breakthrough Therapy Designation for the treatment of adults with heart failure with preserved ejection fraction (1,679 words, Sep 9, 2021)
- [Diabetic macular edema and diabetic macular ischemia | Boehringer Ingelheim](/content/human-health/eye-health/diabetic-macular-edema-and-diabetic-macular-ischemia.html): Diabetic macular edema and diabetic macular ischemia are complications of diabetic retinopathy. (34 words, Jul 26, 2021)
- [Guía para principiantes para combatir los parásitos de los gatos | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/guia-para-principiantes-para-combatir-los-parasitos-de-los-gatos.html): Guía para principiantes para combatir los parásitos de los gatos (854 words, Jul 23, 2021)
- [Vienna | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/vienna/index.html): Viena, es la piedra angular dentro de la red de I+D global de la empresa, con un enfoque especial en la investigación contra el cancer. (390 words, Jul 9, 2021)
- [Шанхай | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/shankhay/index.html): Шанхай (337 words, Jul 9, 2021)
- [Ingelheim | Boehringer Ingelheim](/content/about-us/where-find-us/ingelheim/index.html): The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. (251 words, Jul 9, 2021)
- [GreenCanteen-Zertifizierung | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/greencanteen-zertifizierung/index.html): Als erstes Unternehmen in Deutschland erhält Boehringer Ingelheim das Siegel der neuen EU-Gewährleistungsmarke GreenCanteen. Lesen Sie weiter! (649 words, Jul 7, 2021)
- [Lungenkrebs: Folgebehandlung nach Immun-Chemotherapie | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/lungenkrebs/lungenkrebs-folgebehandlung-nach-immun-chemotherapie.html): ASCO 2021: Daten zur Folgebehandlung nach Immun-Chemotherapie bei Lungenkrebs vorgestellt. (387 words, Jun 7, 2021)
- [Términos de uso | Conectados](/content/pro/sa/terminos-de-uso/index.html): Términos de uso (1,148 words, May 7, 2021)
- [It is about saving lives Alexis Jaliquias feline blood bank | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/it-about-saving-lives-alexis-jaliquias-feline-blood-bank.html): Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America (791 words, Mar 2, 2021)
- [The Supplier Code of Conduct Download | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/supplier-code-conduct-download/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (172 words, Mar 2, 2021)
- [Supplier Code of Conduct Download | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/supplier-code-conduct-download/index.html): Auf dieser Seite können Sie den Verhaltenskodex für Lieferanten von Boehringer Ingelheim herunterladen, der im Jahr 2020 aktualisiert wurde. (72 words, Feb 3, 2021)
- [Clinical trial data disclosure | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/transparency/clinical-trial-data-disclosure/index.html): We believe in transparency. Learn more about our public disclosure of clinical trial data here. (139 words, Feb 1, 2021)
- [Cat parasites: Say no to the uninvited guests | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-parasites-say-no-uninvited-guests/index.html): Find out how to keep fleas, ticks and worms away from your cat. Learn how! (832 words, Jan 24, 2021)
- [Global Top Employer 2021 | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/global-top-employer-2021/index.html): Erstmals erhält Boehringer Ingelheim die Auszeichnung als Global Top Employer sowie Einzelauszeichnungen in insgesamt 27 Ländern. Lesen Sie weiter! (674 words, Jan 21, 2021)
- [Tabagismo e câncer de pulmão: entenda os riscos e como prevenir | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/cancer-do-pulmao/tabagismo-e-cancer-de-pulmao-entenda-os-riscos-e-como-prevenir.html): dec (558 words, Jan 18, 2021)
- [Cat vaccination 10 things you should know | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-vaccination-10-things-you-should-know/index.html): Find out how you can keep your feline companion happy and healthy. We’ve answered 10 important questions about cat vaccination, to help you make informed decisions about preserving your cat’s health. (835 words, Jan 6, 2021)
- [Managementsysteme | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/managementsysteme/index.html): Lieferanten sollen Managementsystem einführen um kontinuierliche Verbesserung und die Einhaltung der Vorgaben des Supplier Code of Conduct zu unterstützen. (354 words, Dec 14, 2020)
- [Gesundheit, Sicherheit und Umwelt | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/gesundheit-sicherheit-und-umwelt/index.html): Lieferanten sollen ein sicheres und gesundes Arbeitsumfeld sicherstellen und ökologisch und nachhaltig agieren. (441 words, Dec 14, 2020)
- [Health, Safety & Environment | Boehringer Ingelheim AT](/content/at/en/health-safety-environment/index.html): Suppliers aim to ensure a safe and healthy working environment and to act in an ecological and sustainable manner. (466 words, Dec 14, 2020)
- [Gesundheit, Sicherheit & Umwelt | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/gesundheit-sicherheit-umwelt/index.html): Lieferanten sollen ein sicheres und gesundes Arbeitsumfeld sicherstellen und ökologisch und nachhaltig agieren. (257 words, Dec 14, 2020)
- [Arbeits- und Menschenrechte | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/arbeits-und-menschenrechte/index.html): Gemäß unserem Verhaltenskodex für Lieferanten sie sollen die international verkündeten Menschenrechte unterstützen und respektieren. (465 words, Dec 11, 2020)
- [3 things you should know about avian influenza | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/poultry/3-things-you-should-know-about-avian-influenza/index.html): . (483 words, Dec 8, 2020)
- [Datenschutzinformation für Angehörige medizinischer Fachkreise in der Tiermedizin | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-fuer-angehoerige-medizinischer-fachkreise-der-tiermedizin.html): In dieser Datenschutzinformation finden Sie zusammengefasst welche Ihrer personenbezogenen Daten zu welchen Zwecken von Boehringer Ingelheim RCV GmbH & Co KG (im Folgenden „wir“ oder „Boehringer Ingelheim“) verarbeitet werden. (437 words, Nov 18, 2020)
- [Production Insights | Boehringer Ingelheim](/content/about-us/who-we-are/production-insights/index.html): Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals (414 words, Aug 24, 2020)
- [Managing calf pain during disbudding and dehorning | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/managing-calf-pain-during-disbudding-and-dehorning/index.html): Increasing calf comfort is not only better for farm animal well-being – it may also provide an economic return. Click here to find out and learn more. (559 words, Aug 20, 2020)
- [Cat care interview veterinarian Dr Susan Little | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-care-interview-veterinarian-dr-susan-little/index.html): We interviewed world-renowned feline healthcare specialist Dr. Susan Little to get her thoughts on cat care and what an owner can do to keep their cat happy. (823 words, Jul 20, 2020)
- [Leben mit COPD | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/copd-asthma/leben-mit-copd/index.html): Caroline hat eine ungewöhnlich enge Beziehung zu Snowball, die ihr dabei hilft, besser mit COPD umzugehen und ein selbstbestimmteres Leben zu führen. (134 words, Jul 15, 2020)
- [Die METAmorphose | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unsere-stories/die-metamorphose/index.html): Die Büros in der META-Region von Boehringer Ingelheim im Nahen Osten, in der Türkei und in Afrika sind bereits frei von Einweg-Kunststoff. (348 words, Jun 3, 2020)
- [Equines Asthma | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/equines-asthma/index.html): Der Kampf gegen Equines Asthma ist wichtig, um die Lebensqualität vieler Pferde weltweit zu verbessern. (815 words, Mar 21, 2020)
- [A Unique Bond: abogando por la salud humana y de los animales | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/cultura/unique-bond-abogando-por-la-salud-humana-y-de-los-animales.html): A Unique Bond: abogando por la salud humana y de los animales (147 words, Jan 22, 2019)
- [Uma ligação única: Phil & Vale | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/uma-ligacao-unica-phil-vale/index.html) (66 words, Jan 17, 2019)
- [Collaboration in Oncology | Boehringer Ingelheim](/content/collaboration-oncology/index.html): Oncology is a fast-moving, challenging and complex field and only with collaboration between different disciplines, we can be able to win the fight against cancer. (46 words, Apr 30, 2018)
- [Linha Recombitek® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/linha-recombitek/index.html): Linha Recombitek® (845 words, Mar 29, 2018)
- [Инсулт – рискови фактори и симптоми | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/stroke/stroke-risk-factors-symptoms/index.html): Stroke Risk Factors Symptoms (604 words, Mar 27, 2018)
- [Open Innovation at Boehringer Ingelheim | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/fostering-science/open-innovation-boehringer-ingelheim/index.html): Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines (1,003 words, Dec 14, 2017)
- [OUR FOCUS | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/kultur/our-focus/index.html) (117 words, Nov 28, 2017)
- [Наша амбіція 2025 | Boehringer Ingelheim UA](/content/ua/nasha-ambiciya-2025/index.html): Зобов'язання компанії "Берінгер Інгельхайм" служити людству може бути виконано, якщо ми станемо найкращим партнером і гідним конкурентом як № 1 в галузі охорони здоров'я тварин № 1 в біофармацевтичному контрактному виробництві № 1 за часткою вартості наши (59 words, Nov 21, 2017)
- [Naše chování (Our Behaviours) | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/nase-chovani-our-behaviours/index.html): Koncept Our FOCUS & hjak ve společnosti Boehringer Ingelheim prokazujeme odpovědnost za svá rozhodnutí, dozvíte se, co pro nás znamená odpovědnost, agilita a intrapodnikání. (155 words, Nov 20, 2017)
- [Odpowiedzialność, Zwinność, Intrapreneurship | Boehringer Ingelheim PL](/content/pl/odpowiedzialnosc-zwinnosc-intrapreneurship/index.html): W Boehringer Ingelheim koncentrujemy się na tym, jak wykazujemy odpowiedzialność za nasze decyzje. Dowiedz się, co oznacza dla nas odpowiedzialność, sprawność i intraprzedsiębiorczość. (203 words, Nov 20, 2017)
- [Podstata naší vize (Leitbild) | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/podstata-nasi-vize-leitbild/index.html): Podstata naší vize (Leitbild) -kdo jsme a o co usilujeme (131 words, Nov 20, 2017)
- [Ядро нашого "Leitbild" | Boehringer Ingelheim UA](/content/ua/yadro-nashogo-leitbild/index.html): Ядро нашого "Leitbild" - Хто ми і до чого прагнемо (151 words, Nov 20, 2017)
- [OUR FOCUS | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/our-focus/index.html): Náš koncept Our FOCUS vyjadřuje, kdo jsme a o co usilujeme, proč existujeme, jak spolupracujeme a čeho chceme dosáhnout. (48 words, Nov 20, 2017)
- [Nasze ukierunkowanie | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/kultura/nasze-ukierunkowanie/index.html): Nasze ukierunkowanie to ramy kulturowe dla naszej firmy. Opisuje kim jesteśmy i do czego dążymy, dlaczego istniejemy, jak pracujemy i co chcemy osiągnąć. (58 words, Nov 20, 2017)
- [Film o historii | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/film-o-historii/index.html): Film o historii (55 words, Jun 13, 2017)
- [Immunology Respiratory Research | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/immunology-respiratory-research/index.html): Find out more about our research and development in Immunology & Respiratory diseases (489 words, Jun 13, 2017)
- [Historienfilm | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/geschichte/historienfilm/index.html): Erfahren Sie mehr über die Geschichte des forschenden Pharmaunternehmens Boehringer Ingelheim im neuen „Stop Motion“-Film. (84 words, Jun 13, 2017)
- [Jardiance® (empagliflozin) Tablets Studied in CKD | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/media/press-releases/jardiance-empagliflozin-tablets-studied-ckd-boehringer-ingelheim-us.html): BI & Eli Lilly & Co. announce plans for a new trial investigating JARDIANCE for the treatment of CKD. View ISI, PI and Med Guide. (1,428 words, Jun 9, 2017)
- [Kazakhstan | Boehringer Ingelheim](/content/about-us/where-find-us/kazakhstan/index.html): Kazakhstan (42 words, Apr 18, 2017)
- [Deutsche Geschäftsführung | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/deutsche-geschaeftsfuehrung/index.html): Die fünfköpfige Geschäftsleitung lenkt die Geschäfte von Boehringer Ingelheim in Deutschland. Lernen Sie uns besser kennen. (98 words, Mar 24, 2017)
- [Basis Information | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/basis-information/index.html): Basis Informationen zu klinischen Studien bei Boehringer Ingelheim (446 words, Nov 11, 2016)
- [What is "Social Entrepreneurship?" | Boehringer Ingelheim](/content/hk/en/about-us/sustainable-development/more-potential/what-social-entrepreneurship/index.html): For new and better ways of improving health around the globe! (9 words, Oct 4, 2016)
- [Speak up! | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/speak-compliance-hotline/speak/index.html): Boehringer Ingelheim bekennt sich bei allen Geschäften zur Einhaltung der geltenden Gesetze, Vorschriften und Unternehmensrichtlinien und -verfahren. (387 words, Sep 30, 2016)
- [Lageplan | Map | Boehringer Ingelheim DE](/content/de/ueber-uns/einkauf/lageplan-map/index.html): Lageplan, Anfahrt, Map und Kontakdaten von Standorte Ingelheim, Biberach, Dortmund und Ochsenhausen. (153 words, Sep 7, 2016)
- [U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes | Boehringer Ingelheim US](/content/us/media/press-releases/us-fda-approves-synjardy-empagliflozin-metformin-hydrochloride-tablets-adults-type-2-diabetes.html): Read more about the FDA approval of SYNJARDY, based on multiple clinical trials proving the reductions of blood sugar levels in adults with T2D. (1,451 words, Aug 21, 2016)
- [Independența în viață | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/istorie/independenta-viata/index.html): Cultura corporativă a Boehringer Ingelheim se bazează pe valori care au fost aplicate încă de la înființarea companiei în 1885. (579 words, Aug 17, 2016)
- [Trang chủ | Boehringer Ingelheim](/content/pro/vn/index.html): Trang chủ (755 words, Invalid Date)
- [Свійська птиця | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/poultry/index.html): Ми надаємо вакцини, діагностику, дослідницькі послуги, технічну експертизу для забезпечення безпечного, доступного, багатого та сталого виробництва якісного м'яса птиці та яєць. (105 words)
- [Patient Centricity | Boehringer Ingelheim IN](/content/in/human-health/our-responsibility/patient-centricity/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (134 words)
- [Ethics and Compliance | Boehringer Ingelheim IN](/content/in/about-us/ethics-compliance/index.html): Find out about our ethical and compliance standards here. Access and view our Speak Up Policy, EFPIA disclosure, and Supplier Code of Conduct. (44 words)
- [Schizophrenia | Boehringer Ingelheim HK](/content/hk/en/human-health/mental-health/schizophrenia/index.html): Schizophrenia (78 words)
- [Shashank Deshpande | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (186 words)
- [Harsha Deshmukh | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (183 words)
- [Cancer | Boehringer Ingelheim CA](/content/ca/human-health/cancer/index.html): At Boehringer Ingelheim we are providing new hope for patients by taking cancer on. Click here to find out more about the work we are doing. (258 words)
- [Вихідні дані | Boehringer Ingelheim UA](/content/ua/vikhidni-dani/index.html): Вихідні дані (74 words)
- [Speak Up – Canal de Ética e Compliance | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/conformidade-speak/index.html): O portal Speak Up oferece um ambiente seguro para relatar possíveis violações e está aberto a qualquer pessoa no mundo. Levamos todos os relatos de possíveis violações a sério. (346 words)
- [Повече потенциал | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/more-potential/index.html): Boehringer Ingelheim засилва ангажимента си към устойчивото развитие, основавайки се на историческия си успех в посрещането на неудовлетворени здравни нужди. (148 words)
- [Michael Schmelmer | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (164 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/speak/index.html): Portál Speak Up je bezpečné místo, kde můžete upozornit na možné porušení pravidel. Je dostupný všem lidem po celém světě. Každé oznámení bereme vážně. (304 words)
- [Επιστήμη και καινοτομία | Boehringer Ingelheim GR](/content/gr/science-innovation/index.html): Κάθε μέρα οι επιστήμονές μας ανοίγουν νέους δρόμους και συνεχίζουν τη δέσμευσή μας στην καινοτομία, η οποία έχει δημιουργήσει εξαιρετικά φάρμακα. (153 words)
- [Benefits and wellbeing | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/benefits-and-wellbeing/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (51 words)
- [Lung Cancer | Boehringer Ingelheim CA](/content/ca/human-health/cancer/lung-cancer/index.html): Building on our experience in lung disease, our goal is to take lung cancer on, transform the treatment landscape and give new hope to patients. (330 words)
- [Farmacovigilância | Boehringer Ingelheim BR](/content/br/sobre-nos/farmacovigilancia/index.html): Como garantir que um medicamento é seguro? Conheça a farmacovigilância, ciência que identifica, avalia e monitora efeitos adversos de medicamentos. (282 words)
- [Cancer | Boehringer Ingelheim RO](/content/ro/medicina-umana/cancer/index.html): La Boehringer Ingelheim suntem dedicați să lucrăm la îmbunătățirea tratamentelor pentru pacienții cu cancer de pretutindeni, cu accent pe cancerele pulmonare și gastrointestinale. (58 words)
- [糖尿病 | Boehringer Ingelheim JP](/content/jp/human-health/metabolic-diseases/diabetes/index.html): 糖尿病 (12 words)
- [Kronik Böbrek Hastalığı | Boehringer Ingelheim TR](/content/tr/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (139 words)
- [Empowering Patients | Boehringer Ingelheim CA](/content/ca/human-health/cancer/empowering-patients/index.html): In partnership with the wider community, we support awareness, education, improved diagnosis and care for patients with cancer and their families. (80 words)
- [Fornecedores | Boehringer Ingelheim BR](/content/br/sobre-nos/fornecedores/index.html): Fornecedores são essenciais para nosso sucesso. Buscamos soluções inovadoras e oportunidades para melhorar e otimizar nossa base todos os dias. (255 words)
- [Etika a compliance | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/index.html): Etika a compliance (107 words)
- [Mental Health | Boehringer Ingelheim HK](/content/hk/en/human-health/mental-health/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (92 words)
- [Υγεία των ζώων | Boehringer Ingelheim GR](/content/gr/animal-health/index.html): Οι ζωές των ζώων και των ανθρώπων συνδέονται μεταξύ τους με βαθύ και σύνθετο τρόπο. (80 words)
- [Boala cronică de rinichi | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-renale/index.html): Boala cronică de rinichi, sau BCR, este cauzată de deteriorarea progresivă a rinichilor, afectând 10% din populație. (159 words)
- [Depression | Boehringer Ingelheim HK](/content/hk/en/human-health/mental-health/depression/index.html): Depression (62 words)
- [Doenças Cardiovasculares | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/index.html): As doenças cardiovasculares, incluindo cardiopatias e AVC, constituem uma grande preocupação de saúde em todo o mundo. (94 words)
- [Empowering Patients | Boehringer Ingelheim TW](/content/tw/empowering-patients/index.html): Empowering Patients (92 words)
- [Protecting the Yangtze: Water stewardship in action | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/water-stewardship/index.html): China’s Yangtze River Delta: Where community action + certified systems unite for water stewardship. (1,078 words)
- [Κατάθλιψη | Boehringer Ingelheim GR](/content/gr/human-health/mental-health/depression/index.html): Η κατάθλιψη είναι μια ψυχική διαταραχή που προκαλεί ένα επίμονο αίσθημα θλίψης και απώλειας ενδιαφέροντος. (68 words)
- [iGAL 2.0: Sustainability in pharma R&D | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/sustainable-medicines/index.html): A deceptively simple metric drives 98% waste cuts and 5x yield gains in Boehringer Ingelheim’s R&D—iGAL 2.0 (751 words)
- [2026 NEXGARD� (afoxolaner) Chewables Product Information PI](/content/docs/ah/nexgard_mono_pi-pdf.html) (1,605 words)
- [Nuestro Propósito | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestro-proposito/index.html): Comienza una carrera con propósito y explora nuevas oportunidades laborales en Boehringer Ingelheim. (75 words)
- [Client error | Ask Boehringer](/content/pro/ca/ask-boehringer/system/4xx/index.html) (74 words)
- [DECIDE-CV Program | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/quebec/decide-cv-program/index.html): The DECIDE-CV program is one of the first multi-disciplinary efforts aimed at using AI-based technologies to support people living with T2D. Find out more. (223 words)
- [Vídeo I+D | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/video-id/index.html): Prof. Eric Haaksma speaks about his career and the Boehringer Ingelheim mission to transform lives for generations. (66 words)
- [代謝相關疾病 | Boehringer Ingelheim TW](/content/tw/daixiexiangguanjibing/index.html): 代謝相關疾病 (255 words)
- [CONTINUUM | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/quebec/continuum/index.html): CONTINUUM, a collaborative project, investigates how digital technology can help healthcare professionals manage complex patient cases at home. Keep reading. (264 words)
- [Harsha Deshmukh | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (179 words)
- [癌症 | Boehringer Ingelheim TW](/content/tw/aizheng/index.html): 癌症從我們身上掠奪走許多東西，包括時間與我們的親人。我們在這一領域最想要提供給病人與家屬的是...希望!!! (209 words)
- [Ensho Health | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/western-canada/ensho-health/index.html): Boehringer Ingelheim Canada, community cardiologists, and Ensho Health collaborated to create a tool optimizing care for chronic conditions in Alberta. More info. (221 words)
- [Dr Paola Casarosa | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/gouvernance/dr-paola-casarosa/index.html): Dr. Paola Casarosa - Membre du Conseil d'administration en charge de l’Unité Innovation (130 words)
- [心臟/心血管 相關疾病 | Boehringer Ingelheim TW](/content/tw/xinzang-xinxueguan-xiangguanjibing/index.html): 心臟/心血管 相關疾病 (99 words)
- [Supplier code of conduct 2025 English | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/pdf/supplier-code-conduct-2025-english/index.html): The Boehringer Ingelheim Supplier Code of Conduct outlines the company's expectations for ethical and professional conduct from its suppliers. It emphasizes the importance of adhering to high ethical standards, respecting human rights, and promoting environmental sustainability. Suppliers are expected to comply with all applicable laws and integrate ethical principles into their management systems. (26 words)
- [肺部疾病 | Boehringer Ingelheim TW](/content/tw/feibujibing/index.html): 肺部疾病 (145 words)
- [Michael Schmelmer | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (203 words)
- [Disclaimer | Boehringer Ingelheim UK public portal](/content/public/uk/external-link/index.html) (102 words)
- [Harsha Deshmukh | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (152 words)
- [ヒト用医療用医薬品の情報、適正使用・販売情報提供活動 に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/human-health-contact-form/index.html): ヒト用医療用医薬品の情報、適正使用・販売情報提供活動 に関するお問い合わせ (67 words)
- [Senior Communications Manager ANZ Job Details | BoehringerPRD](/content/jobs/job-invite/35234/index.html): Sydney, AU Senior Communications Manager ANZ - Aust (845 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim IN](/content/in/animal-health/our-responsibility/index.html): The importance of sustainability and of the interconnection between human, animal and environmental health is firmly anchored in our philosophy. (260 words)
- [Post Doctoral Fellow - Clinical Pharmacology Job Details | BoehringerPRD](/content/jobs/job-invite/36490/index.html): Ridgefield, CT Post Doctoral Fellow - Clinical Pharmacology - Unit (705 words)
- [Dr Armin Wiesler | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/dr-armin-wiesler/index.html): Dr. Armin Wiesler – člen představenstva odpovědný za divizi Animal Health. (170 words)
- [Frank Hübler | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/frank-hubler/index.html): Frank Hübler – člen představenstva odpovědný za oblast financí (141 words)
- [Dr Armin Wiesler | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (199 words)
- [Dr Paola Casarosa | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/dr-paola-casarosa/index.html): Dr. Paola Casarosa – členka představenstva zodpovědná za Innovation Unit (162 words)
- [Principal Scientist Computational Biology Job Details | BoehringerPRD](/content/jobs/job-invite/35682/index.html): Biberach Principal Scientist Computational Biology - Germ (639 words)
- [Aquisições | Boehringer Ingelheim PT](/content/pt/sobre-nos/aquisicoes/index.html): Os fornecedores são parte integrante da nossa estratégia de sucesso. (132 words)
- [Harsha Deshmukh | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/harsha-deshmukh/index.html): Harsha Deshmukh – člen představenstva odpovědný za oblast IT a globálních podnikových služeb (156 words)
- [Shashank Deshpande | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (158 words)
- [Featured Stories | Boehringer Ingelheim IN](/content/in/animal-health/featured-stories/index.html): Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being. (50 words)
- [Medical & Clinical Trials | Clinical Research | BI Clinical Studies](/content/clinicalstudies/msw/datatransparency/index.html): Search and find clinical trials and studies to read on a variety of medical conditions with BI Clinical Studies. You can begin researching right away. (345 words)
- [BI Patent Policy_2022.pdf | Boehringer Ingelheim](/content/pdf/bi-patent-policy2022pdf/index.html) (29 words)
- [Diabetes-Artikel: Aktuelles zu Diabetes | Diabetesherz.at](/content/patient/at/diabetesherz/aktuelles/index.html): Entdecken Sie aktuelle Artikel von Expert:innen aus Österreich zum Thema Diabetes, Herz-Kreislauf-Erkrankungen und neueste Forschungsergebnisse zu Diabetes. (198 words)
- [Chemische Wirkstoffproduktion Endstufenbetrieb | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/chemische-wirkstoffproduktion-endstufenbetrieb/index.html): Job als Chemikant*in in der chemischen Wirkstoffproduktion Endstufenbetrieb (959 words)
- [Pharmazeutische Produktion | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/pharmazeutische-produktion/index.html): Starte deinen Job in der Pharma-Produktion bei Boehringer Ingelheim: hohes Gehalt, moderne Technik, klimatisierte Arbeitsplätze & starke Benefits. (720 words)
- [Schichtführer im Zwischenstufenbetrieb | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/schichtfuehrer-im-zwischenstufenbetrieb/index.html): Florian Kläs ist Schichtführer im Zwischenstufenbetrieb für pharmazeutische Wirkstoffe und gibt Einblicke in seine Arbeit. (861 words)
- [Chemikant für die Wirkstoffproduktion (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/34451/index.html): Ingelheim Chemikant für die Wirkstoffproduktion (m/w/d) - Deut (786 words)
- [INTERIM - Technicien(ne) Opération site H/F Détails du poste | BoehringerPRD](/content/jobs/job-invite/34571/index.html): Saint Vulbas INTERIM - Technicien(ne) Opération site H/F - Fran (625 words)
- [Bula - BOVIKALC® | Boehringer Ingelheim BR](/content/br/pdf/bula-bovikalc/index.html): Bula - BOVIKALC® (12 words)
- [Künstliche Intelligenz bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/kuenstliche-intelligenz-bei-boehringer-ingelheim/index.html): Innovation mit Verantwortung (470 words)
- [Start Green 永續綠行動 | Boehringer Ingelheim TW](/content/tw/start-green-yongxuluxingdong/index.html): Start Green 永續綠行動 (56 words)
- [阿根廷 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/argentina/index.html): 阿根廷是我們在南美洲地區業務的基石。深入瞭解阿根廷職位發展機會或者深入瞭解在全球 170 個地點的機會。 (79 words)
- [Press Kit Animal Health | Boehringer Ingelheim MEA](/content/mea/press-kit-animal-health/index.html): Boehringer Ingelheim animal health press kit for journalists - history, factsheet, presentation (224 words)
- [CONTINUUM | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/interets-partenaires/quebec/continuum/index.html): CONTINUUM, un projet de collaboration, évalue en quoi la technologie numérique peut aider les professionnels et professionnelles de la santé à prendre en charge des cas de patient complexes à domicile. Poursuivre la lecture. (321 words)
- [Pommeraie strategie collaborative MPOC | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/interets-partenaires/quebec/pommeraie-strategie-collaborative-mpoc/index.html): La stratégie collaborative relative à la MPOC de La Pommeraie, en collaboration avec la division d'accès aux patients de Boehringer Ingelheim Canada, vise à améliorer la santé des personnes atteintes de MPOC et à réduire le nombre d'hospitalisations. (384 words)
- [美國 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/usa/index.html): 美國是我們最成功且最具創新的區域。深入瞭解美國職位發展機會或者深入瞭解在全球 170 個地點的機會。 (111 words)
- [Ann-Kathrin Koller | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/ann-kathrin-koller/index.html): Career choices, culture, the future and more with Ann-Kathrin Koller. (133 words)
- [Award for Graduate Veterinarians | Veterinary Scholars Program](/content/veterinaryscholars/graduateveterinarians/index.html) (401 words)
- [墨西哥 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/mexico/index.html): 墨西哥是我們兩個現代化生產基地的所在地。深入瞭解墨西哥職位發展機會或者深入瞭解在全球 170 個地點的機會。 (89 words)
- [法國 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/france/index.html): [site:name]自 1967 年以來一直在法國開展業務。深入瞭解法國職位發展機會或者深入瞭解在全球 170 個地點的機會。 (92 words)
- [About Us | Veterinary Scholars Program](/content/veterinaryscholars/aboutus/index.html) (328 words)
- [USDA Scholars Application | Veterinary Scholars Program](/content/veterinaryscholars/usdascholars/index.html) (464 words)
- [tw/animal-health/purevax-rabies/index.html](/content/tw/animal-health/purevax-rabies/index.html) (110 words)
- [日本 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/japan/index.html): 我們在日本的團隊以致力於創新和永續發展而著稱。深入瞭解日本職位發展機會或者深入瞭解在全球 170 個地點的機會。 (95 words)
- [Historias de colaboración | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/historias-de-colaboracion/index.html): Conoce algunas de las colaboraciones más importantes de Boehringer Ingelheim en salud animal y escucha lo que nuestros socios tienen para decir sobre su experiencia trabajando con nosotros (282 words)
- [Data Privacy | Boehringer Ingelheim IN](/content/in/data-privacy/index.html): Boehringer Ingelheim International GmbH takes the protection of your personal data seriously. Click here to find out more about data privacy. (2,045 words)
- [Harsha Deshmukh | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/harsha-deshmukh/index.html): Harsha Deshmukh — Membre du Conseil des directeurs principaux responsable des services de TI et des services de l'entreprise mondiaux (GBS) (202 words)
- [荷蘭 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/netherlands/index.html): 我們的阿姆斯特丹據點是我們在歐洲的營運中心之一。深入瞭解荷蘭職位發展機會或者深入瞭解在全球 170 個地點的機會。 (33 words)
- [Privacy Notice | Boehringer Ingelheim AU](/content/au/privacy-notice/index.html): Click here to view the data privacy notice for Boehringer Ingelheim Australia and New Zealand. Learn about the types of information we collect, and more. (2,733 words)
- [Brigitte Fuhr | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/brigitte-fuhr/index.html): Brigitte Fuhr, directora de ciencia de datos central, está trabajando en un programa global que transformará nuestra capacidad para desarrollar tratamientos innovadores. (93 words)
- [巴西 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/baxi/index.html): [site:name]在巴西已有超過 70 年的歷史。深入瞭解巴西職位發展機會或者深入瞭解在全球 170 個地點的機會。 (68 words)
- [Program Directors | Veterinary Scholars Program](/content/veterinaryscholars/programdirector/index.html) (132 words)
- [Shashank Deshpande | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/shashank-deshpande/index.html): Shashank Deshpande – Président du Conseil des directeurs principaux responsable de l’unité fonctionnelle des produits pharmaceutiques pour les humains (74 words)
- [中國 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/china/index.html): [site:name]於西元1994 年在中國開展經營活動至今。 深入瞭解中國職位發展機會或者深入瞭解在全球 170 個地點的機會。 (49 words)
- [奧地利 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/austria/index.html): 維也納是在德國以外第一個業務據點。深入瞭解奧地利職位發展機會或者深入瞭解在全球 170 個地點的機會。 (19 words)
- [新加坡 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/singapore/index.html): 我們的新加坡總部是太平洋地區的樞紐。深入瞭解新加坡職位發展機會或者深入瞭解在全球 170 個地點的機會。 (49 words)
- [World Rabies Day | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/more-health/world-rabies-day/index.html): World Rabies Day (112 words)
- [Dr Paola Casarosa | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/dr-paola-casarosa/index.html): Dre Paola Casarosa — Membre du Conseil des directeurs principaux responsable de l’unité de l’innovation (148 words)
- [杜拜 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/dubai/index.html): 杜拜是我們 IMETA 地區的重心地點。 深入瞭解阿拉伯聯合大公國職位發展機會或者深入瞭解在全球 170 個地點的機會。 (41 words)
- [How to Connect | Boehringer Ingelheim AT](/content/at/en/partnering/human-health-partnering/how-connect/index.html): Connect with the Boehringer Ingelheim Human Pharma Business Development and Licensing team to discuss partnering opportunities. (487 words)
- [Collaborative Opportunities | Boehringer Ingelheim AT](/content/at/en/partnering/collaborative-opportunities/index.html): Are you looking to make an impact in health innovation? Partner with Boehringer through open research, digital labs, academic funding programs, and more. (599 words)
- [Cristian Torreblanca | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/cristian-torreblanca/index.html): Cristian Torreblanca Estrada, Senior Manager Controller Corporativo GFE en México habla sobre las oportunidades de moverse entre áreas profesionales y países. (367 words)
- [Perspectives | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (386 words)
- [Pardon Our Interruption](/content/tw/renleichufangyongyao/xinzang/xinxueguanjibing/xinshuaijie/index.html) (31 words)
- [Finance and Accounting Specialist Job Details | BoehringerPRD](/content/jobs/job-invite/30172/index.html): Taipei City Finance and Accounting Specialist - Taiw (439 words)
- [Partnership stories | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (270 words)
- [Dr Paola Casarosa | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (156 words)
- [Connect with us | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (365 words)
- [En unik vänskap: vid min sida | Boehringer Ingelheim SE](/content/se/en-unik-vanskap-vid-min-sida/index.html): En unik vänskap: vid min sida (47 words)
- [Media Overview | Boehringer Ingelheim IN](/content/in/media/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here for a media overview. (286 words)
- [História | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/historia/index.html): Em 1885, Albert Boehringer (1861–1939) fundou a empresa farmacêutica Boehringer Ingelheim em Nieder-Ingelheim, hoje parte de Ingelheim am Rhein. (112 words)
- [What our partners say | Boehringer Ingelheim AT](/content/at/en/partnering/human-health-partnering/what-our-partners-say/index.html): Read perspectives from Boehringer partners on their experience with us, what we have achieved together and how we’re making an impact. (592 words)
- [More Potential | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-potential-communities-our-people/index.html): Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Find out more here. (110 words)
- [Contact Us | Boehringer Ingelheim IN](/content/in/contact-us/index.html): To contact us at Boehringer Ingelheim click here to find our contact details and information, including our address, emails, and phone numbers. (123 words)
- [Stroke | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/stroke/index.html): Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. (209 words)
- [Pardon Our Interruption](/content/at/en/partnering/human-health-partnering/working-together/index.html) (110 words)
- [Більше потенціалу | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/more-potential/index.html): Суспільство продовжує стикатися з проблемами, починаючи від охорони здоров'я і закінчуючи освітою, перспективами працевлаштування, умовами життя, нерівністю та бідністю, які часто найбільше впливають на вразливі верстви населення. (151 words)
- [Pardon Our Interruption](/content/bg/about-us/purchasing/index.html) (110 words)
- [Informative privacy | Boehringer Ingelheim IT](/content/it/informative-privacy/index.html): Informativa privacy (82 words)
- [Terms of Use | Boehringer Ingelheim IT](/content/it/terms-use/index.html): Terms of Use (179 words)
- [Imprint | Boehringer Ingelheim IT](/content/it/imprint/index.html): Imprint (74 words)
- [Privacy sito | Boehringer Ingelheim IT](/content/it/privacy-sito/index.html): Privacy sito (11 words)
- [Грижа за пациентите | Boehringer Ingelheim BG](/content/bg/human-health/cancer/empowering-patients/index.html): Работим за повишаване на осведомеността, образованието, подобряването на диагностиката и грижите за пациентите с рак и техните семейства. (85 words)
- [Pommeraie collaborative COPD strategy | Boehringer Ingelheim CA](/content/ca/multidisciplinary-care-reduces-hospitalizations-chronic-obstructive-pulmonary-disease-copd-patients.html): La Pommeraie's Collaborative COPD Strategy, with Boehringer Ingelheim Canada's Patient Access division, focuses on enhancing COPD patients' health and reducing hospitalizations. (261 words)
- [生産技術職 / スタッフ～ノンラインマネージャー / 山形工場プロダクションテクノロジー部プロセスマネジメントグループ Job Details | BoehringerPRD](/content/jobs/job-invite/33342/index.html): Higashine 生産技術職 / スタッフ～ノンラインマネージャー / 山形工場プロダクションテクノロジー部プロセスマネジメントグループ - Japa (49 words)
- [Pardon Our Interruption](/content/science-innovation/human-health-innovation/science-focus/our-therapeutic-modalities-and-platforms/index.html) (110 words)
- [Pardon Our Interruption](/content/cz/zdravi-zvirat/psi-kocky/podcast-dogtori-miri-do-treti-sezony/index.html) (110 words)
- [Study Details | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/clinical-trials/nct02795156/index.html): Study Details (1,862 words)
- [Frank Hübler | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (161 words)
- [Alberta | Boehringer Ingelheim CA](/content/ca/partnering-boehringer-ingelheim-canada-0/index.html): Learn about Boehringer Ingelheim Canada's strategic partnerships with leading institutions in Alberta to advance quality healthcare. (147 words)
- [Frank Hübler | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (130 words)
- [metacam-20mg.pdf | Boehringer Ingelheim BR](/content/br/pdf/metacam-20mgpdf/index.html) (12 words)
- [Cancer pulmonar | Boehringer Ingelheim RO](/content/ro/medicina-umana/cancer/cancer-pulmonar/index.html): Cancer pulmonar (36 words)
- [Pharmazie-Praktikum | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/pharmazie-praktikum/index.html): Dein Praktisches Jahr (PJ) außerhalb der Apotheke, in der Pharmaindustrie (1,279 words)
- [Forschung mit Leidenschaft | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/forschung-mit-leidenschaft/index.html): Schon seit den frühen 1960er Jahren engagiert sich Boehringer Ingelheim in Wien für die Erforschung neuer Medikamente (509 words)
- [Director, Marketing - MASH/MASLD Job Details | BoehringerPRD](/content/jobs/job-invite/35990/index.html): Ridgefield, CT Director, Marketing - MASH/MASLD - Unit (1,053 words)
- [Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job/ingelheim-senior-sales-representative-specialty-care-dresden-cottbus-frankfurt-28oder-29-28mwd-29-deut/1271253201/hr-de-boehringer-ingelheim-com-c2-a0.html): Ingelheim Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) - Deut (650 words)
- [Die Biopharmazie | Karriere bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/die-biopharmazie-karriere-bei-boehringer-ingelheim/index.html): Boehringer Ingelheim spezialisiert sich in Wien auf die Herstellung von biopharmazeutischen Wirkstoffen mithilfe von Mikroorganismen und Zellkultur. (177 words)
- [Christina Yassouridis | Karriere bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/christina-yassouridis-karriere-bei-boehringer-ingelheim.html): Christina Yassouridis spricht über Ihren Job in der IT und ihre tägliche Motivation. (307 words)
- [Vidéo Affaires médicales et réglementaires | Boehringer Ingelheim CA](/content/ca/fr/emplois/video-affaires-medicales-et-reglementaires/index.html): Taimi Sahlin, spécialiste traitements chez Boehringer Ingelheim Canada, décrit sa carrière stimulante et motivante. (110 words)
- [Technische Assistentin Biberach | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/technische-assistentin-biberach/index.html): Ein Gespräch über den Einstieg als Praktikantin und ihre berufliche Laufbahn mit Elena Knieß (540 words)
- [Trainee Program DISCOVER | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/trainee-program-discover/index.html): Career Start as Trainee at Boehringer Ingelheim (145 words)
- [Marketing Head Inflammation, HP ROPU ASKAN Job Details | BoehringerPRD](/content/jobs/job-invite/34484/index.html): Singapore Marketing Head Inflammation, HP ROPU ASKAN - Sing (757 words)
- [Vom Praktikanten zum Prozessexperten | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/vom-praktikanten-zum-prozessexperten/index.html): Einstieg als Praktikant, dann Masterand und nun Junior Process Expert (483 words)
- [Prozessentwicklung für die Arzneimittelproduktion | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/prozessentwicklung-fuer-die-arzneimittelproduktion/index.html): Jobs in der Prozessentwicklung bei Boehringer Ingelheim: 3.600–4.300 € Gehalt, aseptische Fertigung, modernste Technik & spannende Projekte. (565 words)
- [Betriebsingenieurin chemische Produktion | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/betriebsingenieurin-chemische-produktion/index.html): Sonja Spohr-Derstroff über ihren verantwortungsvollen Job als Betriebsingenieurin in der chemischen Produktion. (99 words)
- [Recruiterin aus Leidenschaft | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/recruiterin-aus-leidenschaft/index.html): Nur die Pharmaindustrie kam für Recruiterin Teresa Glaab als Branche in Frage. Denn nur hier, so sagt sie, dient das Finden der bestpassenden Talente am Ende immer dem einen Ziel: mit Medikamenten Patient*innen zu helfen. (125 words)
- [Produktion und Verpackung von Arzneimitteln | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/produktion-und-verpackung-von-arzneimitteln/index.html): Jobs in der pharmazeutischen Produktion & Verpackung: 3.600–4.300 € Gehalt, Schichtzulagen, moderne Technik & Karrierechancen bei Boehringer Ingelheim. (457 words)
- [Scientist in Biberach | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/scientist-biberach/index.html): Scientist in der analytischen Entwicklung der Biopharmazie am Standort Biberach (63 words)
- [Chemische Wirkstoffproduktion Zwischenstufenbetrieb | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/chemische-wirkstoffproduktion-zwischenstufenbetrieb.html): Job als Chemikant*in in der chemischen Wirkstoffproduktion Zwischenstufenbetrieb am Standort Ingelheim (637 words)
- [Betriebsingenieurin Biopharmazie | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/betriebsingenieurin-biopharmazie/index.html): Herausfordernde Projekte leiten, ein tolles Team haben und in Teilzeit arbeiten – das kann ich hier als Betriebsingenieurin, sagt Petra Deuschle. (87 words)
- [Award for Veterinary Students | Veterinary Scholars Program](/content/veterinaryscholars/researchawards/index.html) (448 words)
- [HR Business Partner Bereich Innovation | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/hr-business-partner-bereich-innovation/index.html): Marie Penzold spricht über ihren Werdegang als HR Business Partner im Bereich Innovation hier bei Boehringer Ingelheim. (163 words)
- [Regional Senior Legal Counsel Job Details | BoehringerPRD](/content/jobs/job-invite/33336/index.html): Singapore Regional Senior Legal Counsel - Sing (475 words)
- [Jan-Erik Schäfer | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/jan-erik-schaefer/index.html): Jan Erik, Senior Teamleiter in der vorgelagerten pharmazeutischen Produktion, spricht über seine motivierende und spannende Karriere bei Boehringer Ingelheim. (146 words)
- [Prof. Eric Haaksma | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/prof-eric-haaksma/index.html): Prof. Eric Haaksma spricht über seine Karriere und die Mission von Boehringer Ingelheim, das Leben von Generationen zu verändern. (227 words)
- [organischer Chemiker Laborleitung | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/organischer-chemiker-laborleitung/index.html): Dr. Alexander Haydl arbeitet als Laborleiter eng mit der Produktion, aber auch der IT zusammen. (32 words)
- [Verfahrensingenieur biopharmazeutische Produktionsanlage | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/verfahrensingenieur-biopharmazeutische-produktionsanlage.html): Christian Betz berichtet über seine Erfahrungen als Leiter des Teams für Verfahrenstechnik am Boehringer Ingelheim Standort in Biberach, Deutschland. (72 words)
- [Praktikum/Abschlussarbeit in der technischen Gebäudeausrüstung Stellendetails | BoehringerPRD](/content/jobs/job-invite/36243/index.html): Biberach Praktikum/Abschlussarbeit in der technischen Gebäudeausrüstung - Deut (599 words)
- [Projektmanagement für Pharma | Boehringer Ingelheim DE Careers](/content/de/karriere/karrieremoeglichkeiten/projektmanagement/index.html): Die vielseitigen Aufgaben am „Device Center Operations“ in Dortmund. (65 words)
- [Liliana Montano | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/liliana-montano/index.html): Liliana Montano arbeitet als Wissenschaftlerin im Global Innovation and Alliance Management und spricht über ihren Werdegang bei Boehringer Ingelheim. (215 words)
- [Studentisches Praktikum | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/studentisches-praktikum/index.html): Entdecke studentische Praktika bei Boehringer Ingelheim: Pflicht‑ & freiwillige Praktika, viele Fachbereiche, faire Vergütung, echte Projektarbeit. (643 words)
- [Vom Ingenieur zum Bereich Biopharma Quality | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/vom-ingenieur-zum-bereich-biopharma-quality/index.html): Seit zehn Jahren bei Boehringer Ingelheim berichtet Kevin über seinen ungewöhnlichen Karriereweg und darüber, warum er so dankbar ist, hier zu arbeiten. (574 words)
- [Albert Paul | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/albert-paul/index.html): Albert Paul spricht über seine Rolle in der Fertigung und Lieferung und was für ihn die nächste Etappe in der Zukunft ist. (156 words)
- [Forschung NCE-Biberach | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/forschung-nce-biberach/index.html): Dirk Stenkamp, Senior Vice President des Forschungsstandorts in Deutschland, spricht über die Zusammenarbeit und die Leidenschaft für den Fortschritt, die uns zu dem machen, was wir sind. (336 words)
- [Automatisierungsingenieur Pharmaindustrie | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/automatisierungsingenieur-pharmaindustrie/index.html): Simon Heinrich, Automatisierungsingenieur im Bereich Maschinenbau und Anlagen, gibt einen tiefen Einblick in das Arbeitsleben bei Boehringer Ingelheim. (36 words)
- [Sugar Clinics: Rethinking diabetes care in Mexico | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/diabetes-care-in-mexico/index.html): How Sugar Clinics are improving access to affordable and integrated diabetes care across Mexico with a one-stop-shop model. (766 words)
- [Senior Manager Organizational Development Job Details | BoehringerPRD](/content/jobs/job-invite/35178/index.html): Ingelheim Senior Manager Organizational Development - Germ (727 words)
- [Praktikum HR Services - Payroll & Time Management Stellendetails | BoehringerPRD](/content/jobs/job-invite/35904/index.html): Ingelheim Praktikum HR Services - Payroll & Time Management - Deut (382 words)
- [Pharmaziepraktikum / Praktikum Qualitätskontrolle von Packmitteln Stellendetails | BoehringerPRD](/content/jobs/job-invite/30532/index.html): Biberach Pharmaziepraktikum / Praktikum Qualitätskontrolle von Packmitteln - Deut (488 words)
- [Lothar Halmar | Karriere bei Boehringer Ingelheim](/content/de/karriere/karrieremoeglichkeiten/lothar-halmer/index.html): Dr. Lothar Halmer, unser leitender Qualitätsverantwortlicher, der seit 25 Jahren im Unternehmen tätig ist, sagt, dass unser herausragendes Merkmal darin besteht, dass wir uns umeinander kümmern. (419 words)
- [Pharmaziepraktikum BioPharma Quality Drug Product Stellendetails | BoehringerPRD](/content/jobs/job-invite/29425/index.html): Biberach Pharmaziepraktikum BioPharma Quality Drug Product - Deut (470 words)
- [Abschlussarbeiten | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/abschlussarbeiten/index.html): Abschlussarbeiten (480 words)
- [Veterinary Scholars Symposium | Veterinary Scholars Program](/content/veterinaryscholars/veterinaryscholarssymposium/index.html) (208 words)
- [Technischer Assistent Forschung Biberach | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/technischer-assistent-forschung-biberach/index.html): Dennis Böttner, technischer Assistent in der Forschung am Standort Biberach über seinen Plan A (33 words)
- [Zwischen Forschung und IT | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/zwischen-forschung-und-it/index.html): Anna Dieckmann spricht über berufliche Erfüllung und Zukunftsmöglichkeiten in ihrer Funktion in der Informationstechnologie. (208 words)
- [Animal Health partnering interests | Boehringer Ingelheim MEA](/content/mea/partnering/animal-health-partnering/partnering-interests/index.html): In order to create the next generation of medical breakthroughs in animal health we need partners. Click here to view our animal health partnering interests. (772 words)
- [Yanina Donatini | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/yanina-donatini/index.html): Yanina Donatini, responsable ITM&S Content Production chez Boehringer Ingelheim, revient sur ses 20 ans de carrière dans l'entreprise, marquée par l'innovation et la diversité. (423 words)
- [Communication et Affaires commerciales | Travailler chez BI](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/affaires-publiques/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Affaires commerciales. (217 words)
- [Ein Herz für die IT | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/ein-herz-fuer-die-it/index.html): Von der Kauffrau für Bürokommunikation zur global tätigen IT-Systemingenieurin: Ein Gespräch über berufliche Erfüllung (85 words)
- [Pommeraie strategie collaborative MPOC | Boehringer Ingelheim CA](/content/ca/fr/les-soins-multidisciplinaires-permettent-de-reduire-les-hospitalisations-des-patientes-atteintes.html): La stratégie collaborative relative à la MPOC de La Pommeraie, en collaboration avec la division d'accès aux patients de Boehringer Ingelheim Canada, vise à améliorer la santé des personnes atteintes de MPOC et à réduire le nombre d'hospitalisations. (352 words)
- [Pardon Our Interruption](/content/ca/fr/partenariats-boehringer-ingelheim-canada-0/index.html) (110 words)
- [Conditions générales d'achat | Boehringer Ingelheim FR](/content/fr/pdf/conditionsgeneralesachatboehringeringelheimsept2021.html): conditions_generales_achat_boehringer_ingelheim_sept2021 (81 words)
- [Vom Lehramtsstudium zum Chemikant: Selim Yilmaz Karriereweg | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/vom-lehramtsstudium-zum-chemikant-selim-yilmaz-karriereweg.html): Selim Yilmaz ist seit 2018 bei Boehringer Ingelheim - die beste Entscheidung für ihn. Die Anstellung hat ihm schon viele Möglichkeiten eröffnet. (46 words)
- [AHEAD programme | Boehringer Ingelheim CA](/content/ca/fr/aider-les-patients-en-palliant-les-lacunes-du-systeme-de-sante-1.html): Ce partenariat dirigé par Boehringer Ingelheim Canada vise à combler les lacunes du système de santé canadien pour les personnes atteintes de diabète de type 2 et d'insuffisance cardiaque. Cliquez pour en apprendre davantage. (398 words)
- [Stop Rabies | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/stop-rabies/index.html): Stop Rabies (182 words)
- [COACH programme | Boehringer Ingelheim CA](/content/ca/fr/le-carrefour-de-soins-communautaires-de-lontario-contribue-ameliorer-lissue-de-linsuffisance.html): Le programme COACH se penche sur les besoins particuliers des personnes atteintes d'insuffisance cardiaque et donne des résultats prometteurs de part et autre en Ontario. Apprenez-en plus. (326 words)
- [(Senior) Medical Science Liaison Job Details | BoehringerPRD](/content/jobs/job-invite/34672/index.html): Taichung City (Senior) Medical Science Liaison - Taiw (498 words)
- [Aider les patients en palliant les lacunes du système de santé | Boehringer Ingelheim CA](/content/ca/fr/aider-les-patients-en-palliant-les-lacunes-du-systeme-de-sante-0.html): Aider les patients en palliant les lacunes du système de santé (389 words)
- [(Senior) Medical Science Liaison Job Details | BoehringerPRD](/content/jobs/job-invite/35140/index.html): Taipei City (Senior) Medical Science Liaison - Taiw (559 words)
- [Stel je voor: Onze verhalen over duurzaamheid op één plek | Boehringer Ingelheim BE](/content/be/nl/stel-je-voor-onze-verhalen-over-duurzaamheid-op-een-plek.html): Ontdek hoe wij positieve verandering stimuleren en de gezondheidszorg helpen verbeteren voor een betere toekomst. (118 words)
- [(Senior) Medical Science Liaison Job Details | BoehringerPRD](/content/jobs/job-invite/34493/index.html): Taipei City (Senior) Medical Science Liaison - Taiw (351 words)
- [Instructievideo’s Respimat® inhalator | Boehringer Ingelheim NL](/content/nl/instructievideos-respimat-inhalator/index.html): Instructievideo’s over het gebruik van de Respimat® inhalator (323 words)
- [Hannah Bussman | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/hannah-bussman/index.html): Hannah Bussmann 講到在百靈佳殷格翰全球內部調查部門中，作為企業法律與合規團隊一員的情形。 (428 words)
- [Data ofertas | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/data-ofertas/index.html): Utiliza tus conocimientos de Data para marcar la diferencia. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (216 words)
- [Día Mundial de la Lucha Contra la Rabia | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/dia-mundial-de-la-lucha-contra-la-rabia/index.html): Día Mundial de la Lucha Contra la Rabia (233 words)
- [Alison Barker | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/alison-barker/index.html): Nicole Niu (21 words)
- [Prof. de Ops y Serv. de calidad Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35804/index.html): Ciudad de Mexico Prof. de Ops y Serv. de calidad - Méxi (429 words)
- [Pardon Our Interruption](/content/tw/careers/discover-our-careers/brigitte-fuhr/index.html) (110 words)
- [Scholar Program | Veterinary Scholars Program](/content/veterinaryscholars/scholarprogram/index.html) (137 words)
- [Medical Advisor Head Office - Mumbai Job Details | BoehringerPRD](/content/jobs/job-invite/34886/index.html): Mumbai Medical Advisor Head Office - Mumbai - Indi (397 words)
- [Pardon Our Interruption](/content/human-health/metabolic-diseases/obesity/phase-ii-clinical-trial-weight-loss-result/index.html) (110 words)
- [Rahul Prasad | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/rahul-prasad/index.html): Rahul J. Prasad, consultor sénior de Corporate Strategy & Consulting, describe su trabajo como algo que se adapta a sus dos pasiones: el análisis de datos y la variedad. (488 words)
- [Pardon Our Interruption](/content/tw/taibeiyixuedaxueyuqinghuadaxue/index.html) (110 words)
- [About Us | Boehringer Ingelheim MEA](/content/mea/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (193 words)
- [西班牙 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/spain/index.html): 我們在西班牙的分公司是藥事法規服務中心和兩個技術樞紐的所在地。 深入瞭解西班牙職位發展機會或者深入瞭解在全球 170 個地點的機會。 (92 words)
- [Pardon Our Interruption](/content/mx/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-comparte-su-compromiso-de-sostenibilidad-para-el-2030.html) (110 words)
- [www-zealandpharma-com.html](/content/www-zealandpharma-com.html) (110 words)
- [Pillole di Consapevolezza. Farmaci: istruzioni per l’uso | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/more-health/pillole-di-consapevolezza-farmaci-istruzioni-luso/index.html): Una guida all’uso consapevole dei farmaci, in 5 lingue (446 words)
- [Veelvoorkomende hartritmestoornis | Boezemfibrilleren](/content/patient/nl/boezemfibrilleren/index.html): Er zijn verschillende vormen van hartritmestoornissen. Een daarvan is boezemfibrilleren, waarbij het bloed niet goed in het hart wordt rondgepompt. (422 words)
- [Zdrowie człowieka | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/index.html): Boehringer Ingelheim dba o zdrowie ludzi i zajmuje się opracowywaniem, rozwojem i produkcją innowacyjnych produktów leczniczych. Dowiedz się więcej. (266 words)
- [Early Access Treatments & Compassionate Use Programs | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/early-access-treatments-compassionate-use-programs/index.html): Explore how we facilitate patient access to investigational and/or unlicensed medicines through our individual requests and Compassionate Use programs (1,151 words)
- [Michael Schmelmer | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (202 words)
- [Dr Armin Wiesler | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (153 words)
- [RECOMBITEK®C8 | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/recombitekc8/index.html): RECOMBITEK®C8 (246 words)
- [Pardon Our Interruption](/content/science-innovation/human-health-innovation/fast-track-designation-nash/index.html) (110 words)
- [RECOMBITEK C6® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/recombitek-c6/index.html): RECOMBITEK C6® (548 words)
- [Nous contacter | Boehringer Ingelheim FR](/content/fr/carrieres/nous-contacter/index.html): Contactez-nous pour en apprendre plus sur le processus de candidature. (151 words)
- [RECOMBITEK® C4/Cv | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/recombitek-c4-cv/index.html): RECOMBITEK® C4/Cv (473 words)
- [Michael Schmelmer | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (163 words)
- [RECOMBITEK® ORAL BORDETELLA | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/recombitek-oral-bordetella/index.html): RECOMBITEK® ORAL BORDETELLA (204 words)
- [Voor mens | Boehringer Ingelheim NL](/content/nl/voor-mens/index.html): Boehringer Ingelheim is een onderzoeksgedreven bedrijf dat zich bezighoudt met de ontdekking, ontwikkeling, productie en marketing van innovatieve producten. (263 words)
- [Spark Innovation Challenge | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/western-canada/spark-innovation-challenge/index.html): The Type 2 Spark Innovation Challenge encourages innovation, collaboration and change in approaches to addressing T2D in British Columbia. Continue reading. (258 words)
- [Salud Humana | Productos para el Cuidado de la Salud | Boehringer Ingelheim MX](/content/mx/salud-humana/index.html): Boehringer Ingelheim se dedica al descubrimiento, el desarrollo, la fabricación y la comercialización de productos innovadores para el cuidado de la salud. (309 words)
- [Nous contacter | Boehringer Ingelheim CA](/content/ca/fr/emplois/communiquez-avec-nous/index.html): Contactez-nous pour en apprendre plus sur le processus de candidature. (154 words)
- [Shashank Deshpande | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (156 words)
- [Dr Paola Casarosa | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (137 words)
- [Ponte en Contacto con nosotros | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/contactanos/index.html): Ponte en contacto con Boehringer Ingelheim y obtendrás toda la información sobre el proceso de solicitud de empleo. Te atenderemos sin dilación. (122 words)
- [Kontakt | Boehringer Ingelheim AT](/content/at/de/karriere/kontakt/index.html): Kontaktiere uns und erfahre mehr über den Bewerbungsprozess. (254 words)
- [取得聯絡 | Boehringer Ingelheim TW](/content/tw/careers/get-touch/index.html): 聯絡我們，瞭解有關申請程序的詳情。 (28 words)
- [Human Health | Boehringer Ingelheim TW](/content/tw/human-health/index.html): Read the latest human health articles by clicking here. From drug discovery to specific diseases such as heart, lung or eye diseases our information is vast. (30 words)
- [Lungenkrankheiten | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/index.html): Lungenerkrankungen (154 words)
- [Människors hälsa | Boehringer Ingelheim SE](/content/se/manniskors-halsa/index.html): Boehringer Ingelheim är en forskningsdriven grupp av företag som ägnar sig åt upptäckt. (148 words)
- [COPD | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/copd/index.html): Wichtige Therapieziele in der COPD-Behandlung sind die Verbesserung der Atemnot, der Lebensqualität und der Reduktion des Exazerbationsrisikos, so dass Patienten einen möglichst aktiven Lebensstil beibehalten können. (153 words)
- [Подразделение ветеринарных препаратов: наша ответственность | Boehringer Ingelheim RU](/content/ru/podrazdelenie-veterinarnykh-preparatov-nasha-otvetstvennost.html): Одним из важнейших элементов работы компании Boehringer Ingelheim является наша ответственность за защиту связи между здоровьем человека, животных и окружающей среды. (145 words)
- [Harsha Deshmukh | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (179 words)
- [Harsha Deshmukh | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (154 words)
- [Сельскохозяйственные животные | Boehringer Ingelheim RU](/content/ru/selskokhozyaystvennye-zhivotnye/index.html): Наш бизнес в области животноводства охватывает сегменты птицеводства, свиноводства, жвачных животных и ветеринарного здравоохранения для удовлетворения потребностей животноводов, ветеринарных врачей, государственных чиновников и неправительственных органи (55 words)
- [Frank Hübler | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (130 words)
- [Harsha Deshmukh | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (192 words)
- [Harsha Deshmukh | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (153 words)
- [Harsha Deshmukh | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/gouvernance/harsha-deshmukh/index.html): Harsha Deshmukh – Membre du conseil d'administration en charge des technologies de l'information et des "Global Business Services". (196 words)
- [Dr Armin Wiesler | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (153 words)
- [Science Focus | Boehringer Ingelheim TW](/content/tw/science-focus/index.html): Science and Innovation - Human Health Innovation - Science Focus (97 words)
- [Press Kit Animal Health | Boehringer Ingelheim ZA](/content/za/press-kit-animal-health/index.html): Boehringer Ingelheim animal health press kit for journalists - history, factsheet, presentation (204 words)
- [Terms of Use | Boehringer Ingelheim AU](/content/au/terms-use/index.html): Here you can find the terms and conditions that apply to your use of this website. Click here to read the terms and conditions and to find out more. (2,174 words)
- [Human Health Partnering | Boehringer Ingelheim AT](/content/at/en/partnering/human-health-partnering/index.html): Learn about Boehringer’s collaborative approach to human health innovation, our areas of partnering interest, and how to connect with our team. (339 words)
- [Pardon Our Interruption](/content/pro/br/bi-addfav/flagitem/55/index.html) (110 words)
- [Financials | Boehringer Ingelheim IN](/content/in/about-us/financials/index.html): Financials (188 words)
- [Pardon Our Interruption](/content/pro/br/bi-addfav/unflagitem/6/index.html) (110 words)
- [Accessibility Statement | Boehringer Ingelheim AU](/content/au/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click here to read how we are making our website as user friendly as possible. (470 words)
- [Coordenador (a) de Território Ruminantes Pleno - Goiás Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35835/index.html): Goiânia Coordenador (a) de Território Ruminantes Pleno - Goiás - Bras (574 words)
- [Cinco cosas que buscamos en nuestras personas | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/cinco-cosas-que-buscamos-en-nuestras-personas/index.html): Descubre qué habilidades, cualificaciones y experiencia buscamos en nuestros colaboradores/as de Boehringer Ingelheim y conoce más sobre nuestra People Promise. (652 words)
- [Pardon Our Interruption](/content/es/sobre-nosotros/donde-encontrarnos/ridgefield/index.html) (110 words)
- [Disclaimer | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/external-link/index.html) (159 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim AT](/content/at/en/partnering/biopharma-contract-manufacturing/index.html): Biopharma Contract Manufacturing (174 words)
- [Gerente Regional Contas Especiais (Aves e Suínos) Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35611/index.html): Porto Alegre Gerente Regional Contas Especiais (Aves e Suínos) - Bras (554 words)
- [Clinical Studies | Boehringer Ingelheim AU](/content/au/clinical-studies/index.html): Clinical trials are an essential part of the development of new medicines. Click here to read about the clinical trials we conduct and sponsor. (60 words)
- [Dirk Stenkamp | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/dirk-stenkamp/index.html): Dirk Stenkamp, ​​Senior Vice President Research Site en Alemania, habla sobre la colaboración y la pasión por el progreso que nos hacen ser quienes somos. (276 words)
- [Personvernerklæring for legemiddelovervåking vedrørende dyrehelseprodukter | Boehringer Ingelheim NO](/content/no/personvernerklaering-legemiddelovervaking-vedrorende-dyrehelseprodukter.html): Personvernerklæring for legemiddelovervåking vedrørende dyrehelseprodukter (583 words)
- [Pardon Our Interruption](/content/es/sobre-nosotros/quienes-somos/boehringer-ingelheim-espana-nombra-la-doctora-marian-meeusen-como-directora-de-medicina-e-id.html) (110 words)
- [Shashank Deshpande | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (195 words)
- [Shashank Deshpande | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/shashank-deshpande/index.html): Shashank Deshpande – Presidente del Consejo de Dirección, con responsabilidad sobre la unidad de negocio de Salud Humana (156 words)
- [Welt-Tollwut-Tag | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/welt-tollwut-tag/index.html): Welt-Tollwut-Tag (139 words)
- [Frank Hübler | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/frank-hubler/index.html): Frank Hübler – Miembro del Consejo de Dirección con responsabilidad sobre Finanzas (134 words)
- [Limitação de responsabilidade | Boehringer Ingelheim Portugal](/content/pro/pt/external-link/index.html) (133 words)
- [Manager, Maintenance Excellence Job Details | BoehringerPRD](/content/jobs/job-invite/34917/index.html): Saint Joseph Manager, Maintenance Excellence - Unit (828 words)
- [INTERIM - Technicien(ne) de Maintenance H/F Détails du poste | BoehringerPRD](/content/jobs/job-invite/34573/index.html): Toulouse INTERIM - Technicien(ne) de Maintenance H/F - Fran (641 words)
- [Stop Rabies: join the global effort to save lives | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/stop-rabies/index.html): Learn how to stop rabies and save the lives of people and animals through vaccination, education, and surveillance. (1,686 words)
- [Michael Schmelmer | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/michael-schmelmer/index.html): Michael Schmelmer – Vicepresidente del Consejo de Dirección, con responsabilidad sobre las funciones corporativas del Grupo (162 words)
- [Dr Paola Casarosa | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/dr-paola-casarosa/index.html): Dra. Paola Casarosa – Miembro del Consejo de Dirección con responsabilidad sobre la Unidad de Innovación (148 words)
- [Dr Armin Wiesler | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/dr-armin-wiesler/index.html): Dr. Armin Wiesler – Miembro del Consejo de Dirección con responsabilidad sobre la unidad de negocio de Salud Animal (173 words)
- [Bivirkninger for produkter for dyr | Boehringer Ingelheim NO](/content/no/bivirkninger-produkter-dyr/index.html): Bivirkninger for produkter for dyr (173 words)
- [Spare Parts Warehouse Expert Job Details | BoehringerPRD](/content/jobs/job-invite/36100/index.html): Athens, GR Spare Parts Warehouse Expert - Gree (726 words)
- [Alexander Gunter | Boehringer Ingelheim BR](/content/br/carreiras/alexander-gunter/index.html): Alexander Guntur, responsável pela Segurança e Proteção da Informação em Singapura, descreve os seus 14 anos na empresa como satisfatórios. (92 words)
- [Harsha Deshmukh | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/harsha-deshmukh/index.html): Harsha Deshmukh – Miembro del Consejo de Dirección con responsabilidad sobre TI y Servicios Globales de Negocio (159 words)
- [Tereza Urbankova | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/tereza-urbankova/index.html): Tereza Urbankova, gerente sénior de Relaciones Globales con los Medios, dice que los equipos se sienten muy unidos y siempre se apoyan mutuamente. (82 words)
- [Christina Schmitt | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/christina-schmitt/index.html): A Christina Schmitt le encanta poder ser creativa todos los días como aprendiz de gestión biofarmacéutica en Boehringer Ingelheim. (73 words)
- [Animal health partnering in oral health | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/partnering-interests/pdf/animal-health-partnering-oral-health/index.html): Boehringer Ingelheim welcomes collaborations with partners in oral health, who share our passion for improving the health and wellbeing of animals. (20 words)
- [Bovela® | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/bovela/index.html): Bovela® (572 words)
- [World Rabies Day | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/world-rabies-day/index.html): The danger of rabies is often overlooked. The need for rabies control, unseen. Learn how vaccination, education and surveillance can eliminate the disease. (147 words)
- [Ingelvac® PRRS MLV | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/ingelvac-prrs-mlv/index.html): Ingelvac® PRRS MLV (323 words)
- [Operario/a Ajustador Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35785/index.html): Sant Cugat del Vallès Operario/a Ajustador - Espa (565 words)
- [갈리뮨 407 | Boehringer Ingelheim KR](/content/kr/animal-health/products/gallimyun-407/index.html): 갈리뮨 407 (74 words)
- [Stroke | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/stroke/index.html): A stroke can have a devastating physical and psychological impact and requires urgent treatment and management. (270 words)
- [Pardon Our Interruption](/content/gr/bipdf/code-conduct/index.html) (110 words)
- [메타캄® 2% | Boehringer Ingelheim KR](/content/kr/animal-health/products/metakam-2-0/index.html): 메타캄® 2% (88 words)
- [Pardon Our Interruption](/content/mx/salud-animal/productos/ingelvac-hp-1/index.html) (110 words)
- [Партньорства в областта на здравето на животните | Boehringer Ingelheim BG](/content/bg/partnorstva-v-oblastta-na-zdraveto-na-zhivotnite/index.html): Научете повече за съвместния подход на Boehringer Ingelheim към иновациите в областта на здравето на животните, нашия интерес за партньорства и как да се свържете с екипа ни. (497 words)
- [리콤비텍 C4 | Boehringer Ingelheim KR](/content/kr/animal-health/products/likombiteg-c4/index.html): 리콤비텍 C4 (71 words)
- [content/dam/24ba79af-5d54-43cf-8f35-af1e012105ce/synjardy-xr-us-pi-pdf.html](/content/content/dam/24ba79af-5d54-43cf-8f35-af1e012105ce/synjardy-xr-us-pi-pdf.html) (23,105 words)
- [메타캄® 2% | Boehringer Ingelheim KR](/content/kr/animal-health/products/metakam-2/index.html): 메타캄® 2% (88 words)
- [山形工場とは | Boehringer Ingelheim JP](/content/jp/about-yamagata-plant/index.html): ベーリンガーインゲルハイムのグローバル戦略工場として、未来への壮大なプロジェクトが進行している山形工場。その特徴と魅力をまとめた動画、山形工場のパフォーマンスを表現した各種数字データ、山形工場の歴史とこれから、フォトギャラリーによって、山形工場の概略を紹介。 (43 words)
- [리콤비텍 오랄KC | Boehringer Ingelheim KR](/content/kr/animal-health/products/likombiteg-olalkc/index.html): 리콤비텍 오랄KC (77 words)
- [메타캄® 현탁액 | Boehringer Ingelheim KR](/content/kr/animal-health/products/metakam-hyeontagaeg/index.html): 메타캄® 현탁액 (48 words)
- [네오콜리퍼 | Boehringer Ingelheim KR](/content/kr/animal-health/products/neokollipeo/index.html): 네오콜리퍼 (126 words)
- [Pardon Our Interruption](/content/pro/us/medinfo/index-php.html) (110 words)
- [What we do | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/what-we-do/index.html): Boehringer Ingelheim is a multinational corporation with divisions dedicated to Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. (65 words)
- [래비신 | Boehringer Ingelheim KR](/content/kr/animal-health/products/laebisin/index.html): 래비신 (39 words)
- [S706 네오 | Boehringer Ingelheim KR](/content/kr/animal-health/products/s706-neo/index.html): S706 네오 (50 words)
- [Ingelvac CircoFLEX® | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/ingelvac-circoflex/index.html): Vacuna inactivada contra circovirus porcino tipo 2 en Vector de Baculovirus (242 words)
- [Pardon Our Interruption](/content/about-us/sustainable-development/social-engagement-fund-invests-zuri-health-africa/index.html) (110 words)
- [Ingelvac® APP X | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/ingelvac-app-x/index.html): Vacuna que confiere protección contra los serotipos y toxinas más comunes de Actinobacillus pleuropneumoniae. (225 words)
- [Summer Internship Program | Boehringer Ingelheim US](/content/us/careers/discover-our-careers/summer-internship-program/index.html): Summer Internship Program (193 words)
- [Pardon Our Interruption](/content/sa/prensa/menos-de-la-mitad-de-los-veterinarios-sienten-que-su-profesion-es-valorada.html) (110 words)
- [Enterisol® Ileitis | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/enterisol-ileitis/index.html): Vacuna una dosis, efectiva, segura y conveniente contra Lawsonia intracellularis (lleitis), cepa B3903. (355 words)
- [Ingelvac MycoFLEX® | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/ingelvac-mycoflex/index.html): Ofrece eficacia y seguridad para el control de M. hyo, en una sola aplicación y con la flexibilidad única de ser mezclable con Ingelvac CircoFLEX® (223 words)
- [SAP PM System Analyst (Plant Maintenance) Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/31677/index.html): Sant Cugat del Vallès SAP PM System Analyst (Plant Maintenance) - Espa (525 words)
- [Medical Advisor RWE Japan Analyst/Non-Line Manager/Medicine Management Job Details | BoehringerPRD](/content/jobs/job-invite/35852/index.html): Shinagawa Medical Advisor RWE Japan Analyst/Non-Line Manager/Medicine Management - Japa (686 words)
- [Déclaration sur la protection des données | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/protection-des-donnees/index.html): Données (1,255 words)
- [AH Intern Job Details | BoehringerPRD](/content/jobs/job-invite/36281/index.html): Al Riyadh AH Intern - Saud (685 words)
- [Senior System Engineer - SAP Supply Chain Management Job Details | BoehringerPRD](/content/jobs/job-invite/27572/index.html): Sant Cugat del Vallès Senior System Engineer - SAP Supply Chain Management - Spai (743 words)
- [Support Assurance de stérilité H/F - CDD Détails du poste | BoehringerPRD](/content/jobs/job-invite/36144/index.html): Saint Priest Support Assurance de stérilité H/F - CDD - Fran (717 words)
- [Chef de Projet Ingénierie (H/F) - CDD 6 MOIS Job Details | BoehringerPRD](/content/jobs/job-invite/32626/index.html): Toulouse Chef de Projet Ingénierie (H/F) - CDD 6 MOIS - Fran (724 words)
- [Brigitte Fuhr | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/brigitte-fuhr/index.html): Brigitte Fuhr, Head of Central Data Science, is working on a global program that will transform our ability to develop breakthrough treatments. (599 words)
- [FRONTLINE PLUS® | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/frontline-plus-0/index.html): FRONTLINE PLUS® - Productos Salud Animal - Argentina (230 words)
- [복리후생 | Boehringer Ingelheim KR](/content/kr/boglihusaeng/index.html): Benefits at a glance (87 words)
- [Purevax® Fel V | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/purevax-fel-v/index.html): Purevax® Fel V - Productos Salud Animal - Argentina (324 words)
- [METACAM® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/metacam/index.html): METACAM® (276 words)
- [Medical Science Liaison (East Zone) - Hyderabad Job Details | BoehringerPRD](/content/jobs/job-invite/35855/index.html): Hyderabad Medical Science Liaison (East Zone) - Hyderabad - Indi (519 words)
- [Medical Science Liaison - North zone Delhi Job Details | BoehringerPRD](/content/jobs/job-invite/35233/index.html): Delhi Medical Science Liaison - North zone Delhi - Indi (519 words)
- [Pardon Our Interruption](/content/sa/salud-humana/acerca-de-la-enfermedad-renal-cronica/index.html) (110 words)
- [営業領域 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/commercial/index.html): 営業領域で新しいチャンスを見つけ、今すぐご応募ください。 (25 words)
- [Regional Technical & Marketing Lead Ruminant & VPH IMETA Job Details | BoehringerPRD](/content/jobs/job-invite/35758/index.html): Dubai Regional Technical & Marketing Lead Ruminant & VPH IMETA - Unit (459 words)
- [Sosyal sağlık ve iyilik | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/sosyal-saglik-ve-iyilik/index.html): Sosyal sağlık ve iyilik (245 words)
- [Benefits & Rewards | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/benefits-rewards/index.html): We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees. (251 words)
- [薬事申請業務 | BIの採用情報](/content/jp/careers/discover-our-careers/medicine-regulatory-affairs/index.html): 薬事申請業務で新しいチャンスを見つけてください。 (77 words)
- [Récompenses totales : nous investissons en vous | Boehringer Ingelheim CA](/content/ca/fr/recompenses-totales-nous-investissons-en-vous/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (390 words)
- [人事、財務および経営 | BI Careers](/content/jp/careers/discover-our-careers/people-finance-organization/index.html): 人事、財務および経営の各部門で新しいチャンスを見つけてください。 (55 words)
- [製造およびサプライチェーン | BIの採用情報](/content/jp/careers/discover-our-careers/manufacturing-supply-chain/index.html): 製造およびサプライチェーンで新たな可能性を見つけてください。 (40 words)
- [Kurum kültürü | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/kurum-kulturu/index.html): Kurum kültürü, hayalinizdeki iş için önemli bir faktör olabilir. Ekip ruhumuzu ve bunun önemini dinleyin. (17 words)
- [品質部門 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/quality/index.html): 品質部門で新たな可能性を見つけてください。 (70 words)
- [コミュニケーション＆コーポレートアフェアーズ | BIの採用情報](/content/jp/careers/discover-our-careers/corporate-affairs/index.html): コーポレートアフェアーズで新しいチャンスを見つけてください。 (45 words)
- [明日を変えていく | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/research-development/index.html): 研究開発部門のシニア・アソシエイト・ディレクターであるツツミマナミが、医薬品開発の最前線での仕事ぶりを紹介します。 (70 words)
- [企業戦略コンサルティング | BIの採用情報](/content/jp/careers/discover-our-careers/corporate-strategy-consulting/index.html): 企業戦略コンサルティングで新しいチャンスを見つけてください。 (63 words)
- [Alexandra Breiner | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/alexandra-breiner/index.html): Alexandra Breiner: Öğrenmenin ve gelişmenin yolları (56 words)
- [Colaboración en Salud Animal | Boehringer Ingelheim ES](/content/es/socios/asociaciones-en-materia-de-salud-animal/colaboracion-en-salud-animal/index.html): Conoce el enfoque colaborativo de Boehringer Ingelheim en materia de innovación en salud animal, nuestras áreas de interés para establecer colaboraciones y cómo ponerte en contacto con nuestro equipo. (502 words)
- [情報技術キャリア | BIの採用情報](/content/jp/careers/discover-our-careers/information-technology/index.html): 情報技術部門で新たな可能性を見つけてください。 (116 words)
- [Our culture | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/our-culture/index.html): Our culture reflects who we are and is reflected in Our FOCUS and strong belief in Diversity, Equity and Inclusion as well as Sustainable Development. (42 words)
- [ファシリティエンジニアリング | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/engineering-facilities/index.html): ファシリティエンジニアリング部門で新たな可能性を見つけてください。 (43 words)
- [FRONTLINE® PLUS CÃES (GG) | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/frontline-plus-caes-gg/index.html): FRONTLINE® PLUS CÃES (GG) (254 words)
- [Quebec | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-boehringer-ingelheim-canada/index.html): Boehringer Ingelheim Canada joins forces with top institutions in Quebec to foster excellence in healthcare. Find out more about our partnering activities. (133 words)
- [We are committed to your growth and development at BI](/content/ca/careers/explore-our-company/learning-and-growth/index.html): We empower and support our employees to grow and develop in a collaborative and inclusive environment, with access to many learning and development offerings. (243 words)
- [法務コンプライアンス | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/discover-our-careers/legal-compliance/index.html): 法務コンプライアンスチームで新しいチャンスを発見してください。 (70 words)
- [AVC | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/avc/index.html): A depender da gravidade, um AVC pode deixar uma pessoa incapaz ou mesmo levá-la à morte. Saiba mais sobre tratamentos inovadores para o derrame cerebral. (745 words)
- [Our people | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/our-people/index.html): 野心。情熱。誠実さ。献身。共感。個性。当社は、あらゆるレベルにおいてこれらの資質を期待しています。 (79 words)
- [Enterisol Ileitis | Boehringer Ingelheim BR](/content/br/pdf/enterisol-ileitis0pdf/index.html): Vacina recomendada para a vacinação de suínos saudáveis como um auxílio na prevenção de enteropatia proliferativa suína (Ileíte). (12 words)
- [BOVIKALC® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/bovikalc/index.html): BOVIKALC® (186 words)
- [Enterisol Salmonella | Boehringer Ingelheim BR](/content/br/pdf/enterisol-salmonella/index.html) (12 words)
- [Enterisol SC54 | Boehringer Ingelheim BR](/content/br/pdf/enterisol-sc54pdf/index.html): Bula ENTERISOL® SC54. Vacina para proteção contra a Salmonelose Suína. (12 words)
- [Commercial Engagement Liaison Job Details | BoehringerPRD](/content/jobs/job-invite/35105/index.html): Ankara Commercial Engagement Liaison - Turk (841 words)
- [Featured Stories | Boehringer Ingelheim HK](/content/hk/en/featured-stories/index.html): Featured Stories (50 words)
- [Western Canada | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/partnering-boehringer-ingelheim-canada/index.html): Boehringer Ingelheim Canada works hand in hand with prominent institutions in Western Canada. Find out more about our partnerships and their initiatives. (111 words)
- [DINDORAL SPF | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/dindoral-spf/index.html): DINDORAL SPF (66 words)
- [Benefits & Rewards | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/benefits-rewards/index.html): 当社は社員に投資をすることで、社員が定着し、当社と共に成長することができるよう目指します。社員が定着するよう、報奨金や能力開発の機会などの福利厚生を提供しています。 (21 words)
- [Raiva? Não no México | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/stop-rabies/raiva-nao-no-mexico/index.html): Leia como estamos ajudando autoridades a manter o país livre da raiva e nossas motivações. (1,041 words)
- [Compensation and rewards | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/compensation-and-rewards/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (269 words)
- [Financial health | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/financial-health/index.html): 当社は、各市場で競争力を維持するために給与の見直しを常に行うだけでなく、財務の健全性についても幅広く支援しています。 (6 words)
- [Rewards and recognition | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/rewards-and-recognition/index.html): 業績を上げると報賞される機会があります。当社では、ビジネスの節目には、従業員に目に見える形で報酬を提供するよう努めています。 (8 words)
- [Award winning employer | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/award-winning-employer/index.html): 当社は世界のトップ11企業の1つで、世界29か国でローカル賞を受賞、さらには欧州、南米、アジア太平洋地域ではリージョナル賞も受賞しています。 (20 words)
- [EQVALAN® PASTA | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/eqvalan-pasta/index.html): EQVALAN® PASTA (72 words)
- [FRONTLINE® Plus Cães (M) | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/frontline-plus-caes-m/index.html): FRONTLINE® Plus Cães (M) (161 words)
- [BURSA GUARD N-B-R® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/bursa-guard-n-b-r/index.html): Vacina contra a Doença de Gumboro, Doença de Newcastle, Bronquite Infecciosa e Reovírus Aviário. (220 words)
- [Learning and development | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/learning-and-development/index.html): 当社は、人材を最大限に活用し、社内で向上する余地を与えることで、プロフェッショナルとして成長できるよう支援します。 (8 words)
- [Vaxxitek® HVT+IBD+ILT | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/vaxxitek-hvtibdilt/index.html): Proteção clínica comprovada, com apenas uma aplicação. (341 words)
- [EQVALAN® GOLD | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/eqvalan-gold/index.html): EQVALAN® GOLD (130 words)
- [Data Privacy Statement | Boehringer Ingelheim](/content/careers/data-privacy-statement/index.html): This privacy statement of Boehringer Ingelheim International GmbH (hereafter "Boehringer Ingelheim") describes what personal data are collected by this website and how these data are processed. (2,846 words)
- [BDA BLEN | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/bda-blen/index.html): BDA BLEN (123 words)
- [Nós alimentamos o mundo | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/index.html): O movimento "Nós alimentamos o mundo", promovido pela Boehringer Ingelheim, reflete o compromisso da empresa com a qualidade, bem-estar e sustentabilidade na produção de carne suína e de frango. (306 words)
- [ENTERISOL® ILEITIS | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/enterisol-ileitis/index.html): ENTERISOL® ILEITIS (135 words)
- [Pardon Our Interruption](/content/tr/kariyer/brigitte-fuhr/index.html) (110 words)
- [Rahul Prasad | Boehringer Ingelheim TR](/content/tr/kariyer/rahul-prasad/index.html): Kurumsal Strateji ve Danışmanlık'ta Kıdemli Danışman olan Rahul J. Prasad, işinin veri analizi ve çeşitlilik gibi tutkularına uygun olduğunu belirtiyor. (349 words)
- [Lothar Halmar | Boehringer Ingelheim TR](/content/tr/kariyer/lothar-halmar/index.html): Kalite Şefimiz ve şirketin 25 yıllık emektarı Dr. Lothar Halmer, birbirimize özen göstermemizin bizi farklı kıldığını belirtiyor. (381 words)
- [Lidské zdraví | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/index.html): Přečtěte si nejnovější články o lidském zdraví. Naše informace jsou rozsáhlé - od objevování léků až po konkrétní onemocnění, jako jsou nemoci srdce, plic nebo očí. (286 words)
- [肺線維症 | Boehringer Ingelheim JP](/content/jp/human-health/lung-diseases/pulmonary-fibrosis/index.html): 間質性肺疾患 のうち、肺の間質に炎症が起こり、間質の壁が硬くなって（線維化）、呼吸がしづらくなる病気を、肺線維症といいます。また、肺がだんだんと硬くなり（進行性線維化）、呼吸機能が低下していく特徴のある病気を、進行性線維化を伴う間質性肺疾患といいます。 (9 words)
- [Amacımız | Boehringer Ingelheim TR](/content/tr/kariyer/amacimiz/index.html): Amaçlarımızı ve faaliyetlerimizi anlatan bir video. (47 words)
- [Mühendislik Tesisleri | Boehringer Ingelheim TR](/content/tr/kariyer/muhendislik-tesisleri/index.html): Mühendislik ve Tesisler departmanında otomasyon mühendisi olan Simon Heinrich, Boehringer Ingelheim'daki çalışma hayatına derinlemesine bir bakış sunuyor. (72 words)
- [Fibroza pulmonară | Boehringer Ingelheim RO](/content/ro/medicina-umana/afectiuni-pulmonare/fibroza-pulmonara/index.html): Fibroza pulmonară (269 words)
- [Patologías cardíacas | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/index.html): Las enfermedades cardiovasculares son un problema de salud mundial importante y la principal causa de muerte e incapacidad en todo el mundo. (162 words)
- [Irene Anindita | Boehringer Ingelheim TR](/content/tr/kariyer/irene-anindita/index.html): Irene Anindita, Hollanda'nın Amsterdam şehrinde Kardiyovasküler ve Metabolizma Ekibi için Çoklu Kanal Yöneticisi olarak çalışıyor, iş ortamından çok memnun. (32 words)
- [Christiane Wijsen | Boehringer Ingelheim TR](/content/tr/kariyer/christiane-wijsen/index.html): Christiane Wijsen, Kurumsal Strateji ve Danışmanlık bölümünün yönetimi hakkında bilgi veriyor. (33 words)
- [Animal Health | Boehringer Ingelheim HK](/content/hk/en/animal-health/index.html): Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse. (311 words)
- [Christian Betz | Boehringer Ingelheim TR](/content/tr/kariyer/christian-betz/index.html): Christian Betz, Almanya'nın Biberach şehrinde bulunan Boehringer Ingelheim tesisinin süreç mühendisliği ekibine liderlik etme deneyimini paylaşıyor. (37 words)
- [Pardon Our Interruption](/content/hk/en/human-health/our-responsibility/patient-centricity/index.html) (110 words)
- [Saúde Humana | Boehringer Ingelheim BR](/content/br/saude-humana/index.html): A Boehringer Ingelheim se dedica a pesquisa, fabricação e comercialização de produtos de saúde inovadores. Cuidamos da sua saúde e do seu bem-estar. (271 words)
- [Srdeční selhání | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/srdecni-selhani/index.html): Srdeční selhání (321 words)
- [Supplier Support | Boehringer Ingelheim](/content/about-us/purchasing/supplier-support/index.html): Supplier Support (869 words)
- [Pardon Our Interruption](/content/gr/science-innovation/human-health-innovation/science-focus/index.html) (110 words)
- [肺がん | Boehringer Ingelheim JP](/content/jp/human-health/cancer/lung-cancer/index.html): Lung Cancer (16 words)
- [Cévní mozkové příhody | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/cevni-mozkova-prihoda/index.html): Cévní mozkové příhody (133 words)
- [Kediler | Boehringer Ingelheim TR](/content/tr/kediler/index.html): Boehringer Ingelheim’ın kedi sağlığı alanındaki uzmanları, kedi bakımına özgü zorluklara yönelik inovatif çözümler geliştirerek, kediler ile sahipleri arasındaki bağı güçlendirmeye katkı sağlar. (66 words)
- [Maladies cardiaques | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/index.html): Boehringer Ingelheim développe des traitements innovants pour répondre aux besoins médicaux encore non satisfaits et améliorer la prise en charge des patients atteints de différentes maladies cardiovasculaires, telles que les troubles du rythme cardi (72 words)
- [Hypertenze | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/vysoky-krevni-tlak/index.html): Účinná léčba a léčba hypertenze jsou důležité, aby se předešlo dalším komplikacím nebo rizikům, jako je srdeční infarkt nebo mrtvice. (138 words)
- [Conditions d'utilisation | Boehringer Ingelheim BE](/content/be/fr/conditions-dutilisation/index.html): Les présentes conditions générales d’utilisation (CGU) ainsi que notre Avis de confidentialité s’appliquent à tous les utilisateurs de ce site. (1,605 words)
- [Bronchiectasis | Boehringer Ingelheim CA](/content/ca/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis (133 words)
- [Companion Animals | Boehringer Ingelheim HK](/content/hk/en/animal-health/companion-animals/index.html): At Boehringer Ingelheim we think that house pets and horses should have the same level of healthcare opportunity as you do, find out more about how. (35 words)
- [Επιστημονικές ιστορίες | Boehringer Ingelheim GR](/content/gr/science-innovation/human-health-innovation/science-stories/index.html): Η παραγωγή νέων και καλύτερων φαρμάκων για τους ασθενείς βρίσκεται στο επίκεντρο της δραστηριότητάς μας. (77 words)
- [La Qualité chez Boehringer Ingelheim | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qualite/index.html): La Qualité chez Boehringer Ingelheim (256 words)
- [Bronhopneumopatia Obstructivă Cronică (BPOC) | Boehringer Ingelheim RO](/content/ro/medicina-umana/afectiuni-pulmonare/bronhopneumopatia-obstructiva-cronica-bpoc-astm/index.html): Bronhopneumopatia Obstructivă Cronică (BPOC) (121 words)
- [İdiopatik Pulmoner Fibrozis | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/pulmonary-fibrosis/index.html): İdiyopatik Pulmoner Fibrozis İle Yaşamak (211 words)
- [呼吸器疾患 | Boehringer Ingelheim JP](/content/jp/human-health/lung-diseases/index.html): Lung Diseases (5 words)
- [Shashank Deshpande | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (206 words)
- [Conformité – Dites-le! | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/conformite-dites-le/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (257 words)
- [Éthique et compliance | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/index.html): Chez Boehringer Ingelheim, nous respectons toujours la loi et nos principes éthiques (161 words)
- [Fibrilace síní | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/fibrilace-sini/index.html): Ve společnosti Boehringer Ingelheim zdokonalujeme léčbu pacientů trpících řadou kardiovaskulárních onemocnění - fibrilací síní, mrtvicí a krevními sraženinami. (80 words)
- [がん患者さんへの取り組み | Boehringer Ingelheim JP](/content/jp/human-health/cancer/empowering-patients/index.html): Empowering Patients (5 words)
- [KOAH ve Astım | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/copd-asthma/index.html): KOAH ve Astım (166 words)
- [Scleroderma | Boehringer Ingelheim CA](/content/ca/human-health/lung-diseases/scleroderma/index.html): Systemic sclerosis (SSc) is a disfiguring, disabling and potentially fatal rare disease. Click here to learn more information about systemic sclerosis. (93 words)
- [Skleroderma | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/scleroderma/index.html): Skleroderma (76 words)
- [Hjärtsjukdomar | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/index.html): Kardiovaskulära sjukdomar, inklusive hjärtsjukdomar och stroke, är ett stort globalt hälsoproblem och den vanligaste dödsorsaken (64 words)
- [がんの種類を超えて | Boehringer Ingelheim JP](/content/jp/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (9 words)
- [がん | Boehringer Ingelheim JP](/content/jp/human-health/cancer/index.html): Cancer (22 words)
- [Προώθηση της επιστήμης | Boehringer Ingelheim GR](/content/gr/science-innovation/human-health-innovation/fostering-science/index.html): Η δημιουργία πρωτοποριακών φαρμάκων που αλλάζουν τη ζωή των ασθενών ξεκινά με τη δέσμευση για τον εντοπισμό μελλοντικών προκλήσεων για την υγεία. (68 words)
- [Avantages sociaux et bien-être | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-notre-entreprise/avantages-sociaux-et-bien-etre/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (324 words)
- [Retinal Diseases | Boehringer Ingelheim HK](/content/hk/en/human-health/retinal-diseases/index.html): At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. (55 words)
- [Pardon Our Interruption](/content/sk/pdf/aifpslovakia20190/index.html) (110 words)
- [Frank Hübler | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (121 words)
- [Dr Paola Casarosa | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (166 words)
- [Pardon Our Interruption](/content/about-us/who-we-are/leadership/dr-armin-wiesler/index.html) (110 words)
- [Our Responsibility | Boehringer Ingelheim HK](/content/hk/en/human-health/our-responsibility/index.html): Our Responsibility (79 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim CA](/content/ca/human-health/lung-diseases/pulmonary-fibrosis/index.html): Pulmonary fibrosis is a condition leading to a build-up of scar tissue in the lungs. Learn about pulmonary fibrosis, including its symptoms and more, here. (79 words)
- [Choroby układu krążenia | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/index.html): Dowiedz się więcej o innowacyjnych metodach leczenia chorób układu krążenia, jakie oferuje Boehringer Ingelheim. (87 words)
- [În toate tipurile de cancer | Boehringer Ingelheim RO](/content/ro/medicina-umana/cancer/toate-tipurile-de-cancer/index.html): În toate tipurile de cancer (76 words)
- [annualreport/2024/files/figures/boe_highlights_2024_en-pdf.html](/content/annualreport/2024/files/figures/boe_highlights_2024_en-pdf.html) (16,408 words)
- [Καινοτομία στην Υγεία των ανθρώπων | Boehringer Ingelheim GR](/content/gr/science-innovation/human-health-innovation/index.html): Η Boehringer Ingelheim είναι σαφής ως προς τους στόχους της. (39 words)
- [Lung Diseases | Boehringer Ingelheim CA](/content/ca/human-health/lung-diseases/index.html): Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Click here to find out more about lung diseases and our work in this area. (75 words)
- [Benefits and wellbeing | Boehringer Ingelheim](/content/careers/explore-our-company/benefits-and-wellbeing/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (259 words)
- [Simon Heinrich | Boehringer Ingelheim](/content/careers/discover-our-career-areas/simon-heinrich/index.html): Simon Heinrich: driven to make a difference (45 words)
- [Learning and growth | Boehringer Ingelheim](/content/careers/explore-our-company/learning-and-growth/index.html): At Boehringer Ingelheim, we support people throughout their professional development – giving our employees room for learning and growth to achieve their career goals. (242 words)
- [Thorsten von Gössel | Boehringer Ingelheim](/content/careers/discover-our-career-areas/thorsten-von-gossel/index.html): Thorsten von Gössel on breaking new ground (19 words)
- [馬 | Boehringer Ingelheim JP](/content/jp/horses/index.html): ベーリンガーインゲルハイムは、馬の健康に寄与するグローバルリーダーとして、馬のウェルビーイング（福祉）を支える革新的なソリューションの開発に取り組んでいます。 (15 words)
- [Compensation and rewards | Boehringer Ingelheim](/content/careers/explore-our-company/compensation-and-rewards/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (269 words)
- [Pardon Our Interruption](/content/pdf/diabeticretinopathypdf/index.html) (110 words)
- [Encourager la science | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/encourager-la-science/index.html): La création de médicaments révolutionnaires qui changent la vie des patients commence par un engagement à identifier les défis de santé du futur (79 words)
- [Shashank Deshpande | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande - Predseda predstavenstva výkonných riaditeľov so zodpovednosťou za divíziu Human Pharma (140 words)
- [Frank Hübler | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler - Člen predstavenstva výkonných riaditeľov so zodpovednosťou za financie (116 words)
- [Harsha Deshmukh | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh - Člen predstavenstva výkonných riaditeľov so zodpovednosťou za IT a Global Business Services (144 words)
- [Manufacturing Operator (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35970/index.html): Wien Manufacturing Operator (m/w/d) - Öste (561 words)
- [Manufacturing Operator (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/36006/index.html): Wien Manufacturing Operator (m/w/d) - Öste (457 words)
- [Berufseinsteigende | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/berufseinsteigende/index.html): Starte mit deiner Karriere bei Boehringer Ingelheim durch. Entdecke spannende Jobmöglichkeiten während oder nach dem Studium. (463 words)
- [Research Laboratory Scientist for Oncolytic Virus-based Cancer Immunology  (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/32034/index.html): Innsbruck Research Laboratory Scientist for Oncolytic Virus-based Cancer Immunology  (m/f/d) - Aust (665 words)
- [Principal Scientist (m/f/d) Biomedical Machine Learning Job Details | BoehringerPRD](/content/jobs/job-invite/35964/index.html): Vienna Principal Scientist (m/f/d) Biomedical Machine Learning - Aust (702 words)
- [Technician EMSR (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35659/index.html): Wien Technician EMSR (m/w/d) - Öste (612 words)
- [Associate Principal Scientist (m/f/d) Senior Machine Learning Engineer Job Details | BoehringerPRD](/content/jobs/job-invite/36056/index.html): Vienna Associate Principal Scientist (m/f/d) Senior Machine Learning Engineer - Aust (689 words)
- [Manufacturing Operator (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35479/index.html): Wien Manufacturing Operator (m/w/d) - Öste (462 words)
- [Principal System Analyst (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/35828/index.html): Vienna Principal System Analyst (m/f/d) - Aust (719 words)
- [Prozessleittechniker (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35548/index.html): Wien Prozessleittechniker (m/w/d) - Öste (563 words)
- [Manufacturing Operator (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/36103/index.html): Wien Manufacturing Operator (m/w/d) - Öste (500 words)
- [Produktion & Logistik | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/produktion-logistik/index.html): Entdecken Sie neue Möglichkeiten in unserer Abteilung Fertigung und Lieferkette. (370 words)
- [Operation Engineer (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/33126/index.html): Wien Operation Engineer (m/w/d) - Öste (439 words)
- [Technician ENG GFE (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35714/index.html): Wien Technician ENG GFE (m/w/d) - Öste (407 words)
- [Forschung und Entwicklung | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/forschung-und-entwicklung/index.html): Entdecken Sie neue Möglichkeiten in unserer Forschung und Entwicklung. (210 words)
- [People Growth Manager (m/w/d) - befristet auf 12 Monate Stellendetails | BoehringerPRD](/content/jobs/job-invite/35747/index.html): Wien People Growth Manager (m/w/d) - befristet auf 12 Monate - Öste (543 words)
- [Niederlande | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/niederlande/index.html): Unsere Niederlassung in Amsterdam ist einer unserer Dreh- und Angelpunkte für unsere Geschäftstätigkeiten in Europa. Erkunden Sie Karrieremöglichkeiten in den Niederlanden oder an unseren 170 Standorten weltweit. (163 words)
- [Quality | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/quality/index.html): Entdecken Sie neue Möglichkeiten in unserer Qualitätsabteilung. (215 words)
- [Unternehmensstrategie & Beratung | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/unternehmensstrategie-beratung/index.html): Entdecken Sie neue Möglichkeiten in unserer Unternehmensstrategie und -beratung. (158 words)
- [Pardon Our Interruption](/content/at/de/karriere/karrieremoeglichkeiten/unternehmenskommunikation/index.html) (110 words)
- [Global Learning Operations Associate (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/32488/index.html): Vienna Global Learning Operations Associate (m/f/d) - Aust (559 words)
- [Beruf und Privatleben | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/beruf-und-privatleben/index.html): Es ist wichtig, dass die Mitarbeiter Beruf und Privatleben in Einklang bringen können, deshalb bieten wir verschiedene Freistellungsmöglichkeiten und flexible Arbeitszeiten an. (352 words)
- [(Pharmazie-)Praktikum Pharmaceutical Dev. Biologicals - Primary Packaging & Process Dev. Parenterals Stellendetails | BoehringerPRD](/content/jobs/job-invite/34048/index.html): Biberach (Pharmazie-)Praktikum Pharmaceutical Dev. Biologicals - Primary Packaging & Process Dev. Parenterals - Deut (484 words)
- [QC Specialist 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36165/index.html): 上海 QC Specialist - 中国 (317 words)
- [Lernen entwicklung | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/lernen-entwicklung/index.html): Wir helfen Menschen, sich beruflich weiterzuentwickeln, indem wir unsere Fähigkeiten maximieren und ihnen Raum geben, sich innerhalb des Unternehmens zu entwickeln. (377 words)
- [Personal, Finanz und Organisation | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/personal-finanz-und-organisation/index.html): Entdecken Sie neue Möglichkeiten in unseren Abteilungen Menschen, Finanzen und Organisation. (102 words)
- [Biomasseheizkraftwerk treibt Energiewende voran | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/biomassekraftwerk/index.html): Erfahren Sie, wie das neue Biomasseheizkraftwerk von Boehringer Ingelheim den CO₂-Ausstoß reduziert und für mehr Energiesicherheit sorgt. (656 words)
- [Finanzielle Vorsorge | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/finanzielle-vorsorge/index.html): Wir überprüfen ständig unsere Gehälter, um sicherzustellen, dass sie in jedem Markt wettbewerbsfähig bleiben, aber wir bieten auch umfassendere Unterstützung für finanzielle Gesundheit. (156 words)
- [Gesundheit am Arbeitsplatz | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/gesundheit-am-arbeitsplatz/index.html): Wir bieten Ihnen eine Reihe von Vorteilen und Dienstleistungen, darunter Beratung, Trainingskurse und gesellschaftliche Veranstaltungen, damit Sie geistig und körperlich fit bleiben. (264 words)
- [Medizin & Regulatory Affairs | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/medizin-regulatory-affairs/index.html): Entdecken Sie neue Möglichkeiten in unseren Bereichen Medizin und Zulassungsangelegenheiten. (128 words)
- [Marketing & Sales | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/marketing-sales/index.html): Entdecken Sie neue Möglichkeiten in unserem kaufmännischen Bereich und bewerben Sie sich noch heute. (89 words)
- [Legal & Compliance | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/legal-compliance/index.html): Entdecken Sie neue Möglichkeiten in unserem Team für die Erfüllung gesetzlicher Vorgaben. (61 words)
- [Data Science | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/data-science/index.html): Nutzen Sie Ihre Datenkompetenz, um etwas zu bewirken. Entdecken Sie spannende Karrieremöglichkeiten im Datenbereich und bewerben Sie sich noch heute. (90 words)
- [de/ueber-uns/nachhaltige-entwicklung/more-green/biodiversitaet-fuer-artenvielfalt/index.html](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/biodiversitaet-fuer-artenvielfalt/index.html) (110 words)
- [Pardon Our Interruption](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/wasserressourcen-schuetzen-boehringer-ingelheim/index.html) (110 words)
- [actualites | Boehringer Ingelheim FR](/content/fr/actualites-0/index.html): actualites (136 words)
- [Actualites | Boehringer Ingelheim FR](/content/fr/actualites/index.html): Actualites (120 words)
- [Pardon Our Interruption](/content/ca/fr/search/index.html) (110 words)
- [Table-ronde : « Zoonoses, épizooties, virus : mieux se préparer pour mieux agir » | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/table-ronde-zoonoses-epizooties-virus-mieux-se-preparer-pour-mieux-agir.html): Invitation à la table-ronde : « Zoonoses, épizooties, virus : mieux se préparer pour mieux agir » (138 words)
- [Pasante de Calidad Comercial Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36221/index.html): Lima Pasante de Calidad Comercial - Perú (549 words)
- [Brasilien | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/brasilien/index.html): Die Präsenz von Boehringer Ingelheim in Brasilien erstreckt sich über mehr als 70 Jahre. Erkunden Sie Karrieremöglichkeiten in Brasilien oder an unseren 170 Standorten weltweit. (166 words)
- [Projektingenieurin Biopharmazie | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/projektingenieurin-biopharmazie/index.html): Mareike ist Projektingenieurin in der Biopharmazie in Biberach (36 words)
- [Dubai | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/dubai/index.html): Dubai liegt im Herzen unserer IMETA-Region. Erkunden Sie Karrieremöglichkeiten in den Vereinigten Arabischen Emiraten oder an unseren 170 Standorten weltweit. (222 words)
- [DE_Standard](/content/jobs/lp/de_standard/bd93e2b18d0e9b31/index.html) (98 words)
- [Japan | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/japan/index.html): Unser Team in Japan ist bekannt für sein Engagement für Innovation und Nachhaltigkeit. Erkunden Sie Karrieremöglichkeiten in Japan oder an unseren 170 Standorten weltweit. (194 words)
- [Spanien | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/spanien/index.html): Unsere Einrichtung in Spanien beherbergt Unternehmensbereiche für Zulassung und zwei Technologiezentren. Erkunden Sie Karrieremöglichkeiten in Spanien oder an unseren 170 Standorten weltweit. (247 words)
- [Mexiko | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/mexiko/index.html): In Mexiko befinden sich zwei unserer modernen Produktionsstätten. Erkunden Sie Karrieremöglichkeiten in Mexiko oder an unseren 170 Standorten weltweit. (230 words)
- [Österreich | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/oesterreich/index.html): Wien war unser erster Standort außerhalb Deutschlands. Erkunden Sie Karrieremöglichkeiten in Österreich oder an unseren 170 Standorten weltweit. (237 words)
- [Deutschland | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/deutschland/index.html): Deutschland, wo die Geschichte von Boehringer Ingelheim begann und das immer noch unser globaler Hauptsitz ist. Entdecken Sie Karrieremöglichkeiten in Deutschland oder an unseren 170 Standorten weltweit. (208 words)
- [Digital Content Designer and Developer (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/36081/index.html): Vienna Digital Content Designer and Developer (m/f/d) - Aust (794 words)
- [Argentinien | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/argentinien/index.html): Argentinien ist ein Eckpfeiler unserer Aktivitäten in Südamerika. Erkunden Sie Karrieremöglichkeiten in Argentinien oder an unseren 170 Standorten weltweit. (185 words)
- [Singapur | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/singapur/index.html): Unser Hauptsitz in Singapur dient als Dreh- und Angelpunkt für die pazifische Region. Erkunden Sie Karrieremöglichkeiten in Singapur oder an unseren 170 Standorten weltweit. (160 words)
- [Unsere Führungskultur | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/unsere-fuehrungskultur/index.html): Unsere Führungskultur bei Boehringer Ingelheim (483 words)
- [Fünf Dinge, die uns bei Bewerbenden begeistern | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/fuenf-dinge-die-uns-bei-bewerbenden-begeistern/index.html): Finde heraus, nach welchen Fähigkeiten, Qualifikationen & Erfahrungen wir bei Boehringer Ingelheim Mitarbeitenden suchen und erfahre mehr über unser "People Promise" (594 words)
- [INTERIM - Spécialiste Assurance et Contrôle Qualité (H/F) Détails du poste | BoehringerPRD](/content/jobs/job-invite/36340/index.html): Toulouse INTERIM - Spécialiste Assurance et Contrôle Qualité (H/F) - Fran (444 words)
- [Global QM Data Governance Manager (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/36111/index.html): Vienna Global QM Data Governance Manager (m/f/d) - Aust (616 words)
- [Production Services & Formulation Senior Technician Job Details | BoehringerPRD](/content/jobs/job-invite/34807/index.html): Pirbright Production Services & Formulation Senior Technician - Unit (394 words)
- [Pardon Our Interruption](/content/at/de/tiergesundheit/haustiere-und-pferde/pferde/wie-sie-ihr-pferd-vor-dem-west-nil-virus-schuetzen-koennen.html) (110 words)
- [Wir sind RCV | Karriere bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/wir-sind-rcv-karriere-bei-boehringer-ingelheim/index.html): Das Regional Center Vienna (kurz RCV) besteht seit 1957 in Wien Meidling, beschäftigt über 3.300 Kolleg*innen mit über 50 unterschiedlichen Nationalitäten. (326 words)
- [Das macht Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/das-macht-boehringer-ingelheim/index.html): Boehringer Ingelheim ist ein multinationales Unternehmen mit Geschäftsbereichen für Humanpharmazeutika, Tiergesundheit und biopharmazeutische Auftragsfertigung. (383 words)
- [Techniker-Jobs der Biopharmazie Biberach | Boehringer Ingelheim DE](/content/de/techniker-jobs-der-biopharmazie-biberach/index.html): Entdecke Elektroniker-, Mechatroniker- und Industriemechaniker-Jobs in der Pharmabranche bei Boehringer Ingelheim. Werde Teil unseres Teams! (926 words)
- [Pardon Our Interruption](/content/at/de/karriere/ueber-uns/benefits-und-zusatzleistungen/index.html) (31 words)
- [Next Level Research: Einblicke in das Postdoc-Programm bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/next-level-research-einblicke-das-postdoc-programm-bei-boehringer-ingelheim.html): Höre rein in den Podcast mit Postdoc Dr. Benedict-Tilman Berger (331 words)
- [Ingenieurs-Jobs der Biopharmazie Biberach | Boehringer Ingelheim DE](/content/de/ingenieur-jobs-der-biopharmazie-biberach/index.html): Werde Teil unseres Teams der Pharma-Ingenieure. Entdecke Projektingenieur- und Betriebsingenieur *innen-Jobs bei Boehringer Ingelheim (728 words)
- [New research building advances treatment of cancer | Boehringer Ingelheim](/content/annualreport/2024/treatment-cancer-research-vienna/index.html): New facility in Vienna named after researcher Angelika Amon will play a significant role in progressing the treatment of cancer (1,956 words)
- [Wer wir sind | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/wer-wir-sind/index.html): Dieses unabhängige Familienunternehmen wurde 1885 von Albert Boehringer gegründet und hat sich zu einem führenden Anbieter in den Bereichen Humanpharma und Tiergesundheit entwickelt. (310 words)
- [Senior Category Manager Job Details | BoehringerPRD](/content/jobs/job-invite/34511/index.html): Biberach Senior Category Manager - Germ (617 words)
- [Belohnung und Anerkennung | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/belohnung-und-anerkennung/index.html): Es gibt Leistungen und Anlässe, die nach Anerkennung verlangen. Wir geben uns alle Mühe, Mitarbeitern konkrete Belohnungen und mehr für geschäftliche Meilensteine zu geben. (237 words)
- [就這樣認識一個人 | Boehringer Ingelheim TW](/content/tw/jiuzheyangrenshiyigeren/index.html): 就這樣認識一個人 (183 words)
- [Distribution Manager Job Details | BoehringerPRD](/content/jobs/job-invite/36116/index.html): Milan Distribution Manager - Ital (644 words)
- [Process Manager - S2P Procurement Job Details | BoehringerPRD](/content/jobs/job-invite/35491/index.html): Ingelheim Process Manager - S2P Procurement - Germ (568 words)
- [Ausbildung als Fachinformatiker*in in Biberach 2026 Stellendetails | BoehringerPRD](/content/jobs/job-invite/36005/index.html): Biberach Ausbildung als Fachinformatiker*in in Biberach 2026 - Deut (422 words)
- [Transformative healthcare looks at the whole patient | Boehringer Ingelheim](/content/annualreport/2024/transformative-healthcare/index.html): Boehringer Ingelheim's long-time work on integrative approaches is laying the foundation for transformative healthcare (1,464 words)
- [Ausbildung als Fachinformatiker*in in Ingelheim 2027 Stellendetails | BoehringerPRD](/content/jobs/job-invite/33802/index.html): Ingelheim Ausbildung als Fachinformatiker*in in Ingelheim 2027 - Deut (621 words)
- [医药代表-糖尿病产品（DPP4& SGLT2）-郑州 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36426/index.html): 郑州 医药代表-糖尿病产品（DPP4& SGLT2）-郑州 - 中国 (77 words)
- [Marketing Lead Job Details | BoehringerPRD](/content/jobs/job-invite/33199/index.html): Ingelheim Marketing Lead - Germ (740 words)
- [Investments in mental health care benefit everyone | Boehringer Ingelheim](/content/annualreport/2024/mental-health-care/index.html): Wie verbessert man das Leben von Menschen, die psychologische Betreuung benötigen? Tipps aus der Praxis. (1,533 words)
- [人類處方用藥 產品介紹 | Boehringer Ingelheim TW](/content/tw/renleichufangyongyao-chanpinjieshao/index.html): 人類處方用藥 產品介紹 (176 words)
- [Internship Market Insights Job Details | BoehringerPRD](/content/jobs/job-invite/35878/index.html): Ingelheim Internship Market Insights - Germ (738 words)
- [Promotion | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/promotion/index.html): Deine Doktorarbeit in der Pharmaindustrie - ein Pluspunkt in Deinem Lebenslauf (311 words)
- [Shashank Deshpande | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors mit Verantwortung für den Geschäftsbereich Humanpharma (191 words)
- [Pardon Our Interruption](/content/ca/fr/emplois/decouvrez-notre-entreprise/simon-manyara/index.html) (110 words)
- [獸醫師小學堂 | Boehringer Ingelheim TW](/content/tw/shouyishixiaoxuetang/index.html): 獸醫師小學堂 (103 words)
- [Karrieren in Data Science | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/karrieren-data-science/index.html): Dr. Elica Kyoseva spricht über ihre Begeisterung für die Forschung im Bereich der Stammzellen und der Mathematik sowie über die Datenkarriere, die sie bei Boehringer Ingelheim gemacht hat. (165 words)
- [Trainee Program Global Supply | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/trainee-program-global-supply/index.html): Trainee Program Global Supply (386 words)
- [Promotion in der Biomedizin: Forschen in der Industrie bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/promotion-biomedizin/index.html): Frederik hat Bioanalytik und Biomedical Sciences studiert und sich bewusst für eine Industriepromotion bei Boehringer Ingelheim entschieden. (505 words)
- [Senior Laboratory Systems Integration Engineer Stellendetails | BoehringerPRD](/content/jobs/job-invite/35908/index.html): Ingelheim Senior Laboratory Systems Integration Engineer - Deut (603 words)
- [医药代表-心脑血管产品（溶栓）-武汉 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36363/index.html): 武汉 医药代表-心脑血管产品（溶栓）-武汉 - 中国 (20 words)
- [Karriere in IT - Content Production | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/karriere-it-content-production/index.html): Yanina Donatini, Leiterin von ITM&S Content Production bei Boehringer Ingelheim, spricht über ihre 20-jährige Tätigkeit im Unternehmen als innovativ und vielfältig. (426 words)
- [(Senior) Brand Manager (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35830/index.html): Ingelheim (Senior) Brand Manager (m/w/d) - Deut (729 words)
- [Senior System Engineer - SAP Supply Chain Management Job Details | BoehringerPRD](/content/jobs/job-invite/34645/index.html): Ingelheim Senior System Engineer - SAP Supply Chain Management - Germ (623 words)
- [Anwalt Recht Compliance | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/anwalt-recht-compliance/index.html): Andreas Lenk, Chef der Abteilung Recht und Compliance Deutschland, spricht über seine Rolle bei der Unterstützung des Humanpharma- und Tiergesundheitsgeschäfts in Rechts- und Compliance-Fragen. (202 words)
- [Compliance & Integrity Manager Job Details | BoehringerPRD](/content/jobs/job-invite/36053/index.html): Ingelheim Compliance & Integrity Manager - Germ (652 words)
- [工作犬 | Boehringer Ingelheim TW](/content/tw/gongzuoquan/index.html): 工作犬 (22 words)
- [Pharma-Außendienst | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/pharma-aussendienst/index.html): Pharma-Außendienst (491 words)
- [Rechtsreferendariat Stellendetails | BoehringerPRD](/content/jobs/job-invite/33146/index.html): Ingelheim Rechtsreferendariat - Deut (402 words)
- [Patricia Rangel | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/patricia-rangel/index.html): Patricia Rangel von Unternehmensstrategie und Beratung bezeichnet Boehringer Ingelheim als ein Familienunternehmen, das mit den höchsten Integritätsstandards arbeitet. (97 words)
- [Rahul Prasad | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/rahul-prasad/index.html): Rahul J. Prasad, Senior Consultant für Unternehmensstrategie und Beratung, beschreibt seinen Job als einen, der zu seinen beiden Leidenschaften passt: Datenanalyse und Abwechslung. (573 words)
- [Qualitätsmanager Dortmund | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/qualitaetsmanager-dortmund/index.html): Schützt die Patienten und nützt dem Unternehmen – Qualitätsmanagement bei Boehringer Ingelheim ist Teamleistung und tägliche Verantwortung, sagt André Schmitz, Teamleiter in der „Quality“ am microParts-Standort Dortmund. (60 words)
- [Nebenwirkungsmeldung Tiermedizin | Boehringer Ingelheim AT](/content/at/de/nebenwirkungsmeldung-tiermedizin/index.html): Nebenwirkungsmeldung Tiermedizin (177 words)
- [Nelli Milosch | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/nelli-milosch/index.html): Nelli Milosh, Teamleiterin unseres medizinischen Außendienstteams in Deutschland, sagt, dass die Menschen das Beste an der Arbeit bei Boehringer Ingelheim sind. (111 words)
- [Pardon Our Interruption](/content/de/ueber-uns/vision-werte/data-science-agiles-arbeiten-ux-design-neue-it-karrierepfade.html) (110 words)
- [Dr Armin Wiesler | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/dr-armin-wiesler/index.html): Dr Armin Wiesler – Mitglied der Unternehmensleitung mit Verantwortung für den Geschäftsbereich Tiergesundheit (42 words)
- [Brigitte Fuhr | Karriere bei Boehringer Ingelheim](/content/de/karriere/karrieremoeglichkeiten/brigitte-fuhr/index.html): Brigitte Fuhr, Leiterin von Central Data Science, arbeitet an einem globalen Programm, das unsere Fähigkeit zur Entwicklung bahnbrechender Behandlungen verändern wird. (613 words)
- [Victor Emenike | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/victor-emenike/index.html): Victor Emenike, Data Scientist im operativen Bereich, speziell in der Markteinführungs- und Innovationsorganisation, fühlt sich bei neuen Ideen geschätzt und unterstützt. (181 words)
- [Manager / Consultant Internal Consulting Job Details | BoehringerPRD](/content/jobs/job-invite/35546/index.html): Ingelheim Manager / Consultant Internal Consulting - Germ (465 words)
- [Dr Paola Casarosa | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/dr-paola-casarosa/index.html): Dr Paola Casarosa – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich Innovation (177 words)
- [Archivist (m/w/d) - Teilzeit 50% Stellendetails | BoehringerPRD](/content/jobs/job-invite/35881/index.html): Ingelheim Archivist (m/w/d) - Teilzeit 50% - Deut (618 words)
- [Actilyse 10 20 50mg_Ulotka_01.09.2024 | Boehringer Ingelheim PL](/content/pl/pdf/actilyse-10-20-50mgulotka01092024/index.html) (29 words)
- [被遺忘的島民 | Boehringer Ingelheim TW](/content/tw/beiyiwangdedaomin/index.html): 被遺忘的島民 (41 words)
- [Letter from the Board of Managing Directors | Boehringer Ingelheim](/content/annualreport/2024/letter-board-of-managing-directors/index.html): Letter from the Board of Managing Directors (657 words)
- [Senior HEOR Manager Job Details | BoehringerPRD](/content/jobs/job-invite/32222/index.html): Ingelheim Senior HEOR Manager - Germ (554 words)
- [Christiane Wijsen | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/christiane-wijsen/index.html): Christiane Wijsen spricht über die Leitung des Bereichs Unternehmensstrategie und Beratung. (114 words)
- [愛護之聲：生命教育與動物保護的先行者 | Boehringer Ingelheim TW](/content/tw/aihuzhishengshengmingjiaoyuyudongwubaohudexianxingzhe.html): 愛護之聲：生命教育與動物保護的先行者 (24 words)
- [Simon Manyara | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/simon-manyara/index.html): Simon Manyara arbeitet mit unserem Kultur- und Nachhaltigkeitsteam daran, einen positiven sozialen Einfluss zu nehmen und eine nachhaltige Zukunft zu schaffen. (106 words)
- [Frank Hübler | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/frank-huebler/index.html): Frank Hübler – Mitglied der Unternehmensleitung mit Verantwortung für Finanzen (129 words)
- [Michael Schmelmer | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/michael-schmelmer/index.html): Michael Schmelmer – Stellvertretender Vorsitzender der Unternehmensleitung mit Verantwortung für Konzernfunktionen (142 words)
- [超級豬隊友 | Boehringer Ingelheim TW](/content/tw/chaojizhuduiyou/index.html): 超級豬隊友 (35 words)
- [A Unique Bond | Boehringer Ingelheim TW](/content/tw/unique-bond/index.html): A Unique Bond (52 words)
- [Alex Breiner | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/alex-breiner/index.html): Alex Breiner, Senior Communications Manager in Corporate Affairs, berichtet über seine Karriere und die zahlreichen Entwicklungsprogramme bei Boehringer Ingelheim. (125 words)
- [合作故事 | Boehringer Ingelheim TW](/content/tw/hezuogushi/index.html): 探索百靈佳殷格翰在動物保健領域的重要合作案例，了解我們的夥伴分享與我們攜手合作、推動創新的真實經驗。 (48 words)
- [改變生命的創意 | Boehringer Ingelheim TW](/content/tw/gaibianshengmingdechuangyi/index.html): 改變生命的創意 (48 words)
- [Tereza Urbankova | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/tereza-urbankova/index.html): Tereza Urbankova, Seniorleiterin in Global Media Relations, sagt, dass sich die Teams sehr verbunden fühlen und sich gegenseitig immer unterstützen. (124 words)
- [Mit Data Science die Medizin revolutionieren | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/mit-data-science-die-medizin-revolutionieren/index.html): Höre rein in den Podcast mit Verena Endriß (22 words)
- [Data Science Biberach | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/data-science-biberach/index.html): Florian Rottach - Programmieren und Kommunizieren in Data Science (24 words)
- [Dirk Esser | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/dirk-esser/index.html): Dirk Esser spricht über seine 12-jährige Karriere bei Boehringer Ingelheim und die vielfältigen Entwicklungsmöglichkeiten. (128 words)
- [如果我們的孩子在流浪 | Boehringer Ingelheim TW](/content/tw/ruguowomendehaizizailiulang/index.html): 如果我們的孩子在流浪 (27 words)
- [FAQ | Boehringer Ingelheim FR](/content/fr/carrieres/votre-processus-de-candidature/faq/index.html): Questions les plus fréquentes concernant le processus de candidature chez Boehringer Ingelheim. (335 words)
- [企業的日常 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/social-innovation-shehuichuangxin/qiyederichang/index.html): 企業的日常 (26 words)
- [價值故事屋 | Boehringer Ingelheim TW](/content/tw/jiazhigushiwu/index.html): 價值故事屋 (16 words)
- [#謝謝大家一起愛浪浪 | Boehringer Ingelheim TW](/content/tw/xiexiedajiayiqiailanglang/index.html): #謝謝大家一起愛浪浪 (34 words)
- [爸爸老了嗎？ | Boehringer Ingelheim TW](/content/tw/babalaolema/index.html): 爸爸老了嗎？ (134 words)
- [領養不棄養 | Boehringer Ingelheim TW](/content/tw/lingyangbuqiyang/index.html): 領養不棄養 (134 words)
- [Sustainability stories | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/stories/index.html): Discover how Boehringer Ingelheim advances healthcare solutions and promotes environmental stewardship globally through engaging stories from around the world. (106 words)
- [月亮的孩子 | Boehringer Ingelheim TW](/content/tw/yueliangdehaizi/index.html): 月亮的孩子 (14 words)
- [Nos produits | Boehringer Ingelheim FR](/content/fr/sante-humaine/nos-produits/index.html): Médicaments de prescription et hospitaliers (436 words)
- [Our sustainability commitments and priotity programs](/content/about-us/sustainable-development/sustainability-hub/files/common/2030_boehringer_sustainability_commitments-pdf.html) (153 words)
- [Offres d'emploi récentes en France | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-en-france/index.html): Boehringer Ingelheim est implanté en France depuis 1967. Explorez les opportunités de carrière en France ou dans nos 170 centres à travers le monde. (235 words)
- [世界硬皮病日 | Boehringer Ingelheim TW](/content/tw/shijieyingpibingri/index.html): 世界硬皮病日 (15 words)
- [全國青年創意競賽 | Boehringer Ingelheim TW](/content/tw/quanguoqingnianchuangyijingsai/index.html): 全國青年創意競賽 (19 words)
- [Analista de Control de Calidad - Materiales de Empaque y Envase Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36200/index.html): Ciudad de Mexico Analista de Control de Calidad - Materiales de Empaque y Envase - Méxi (607 words)
- [Offres d'emploi récentes à Dubaï | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-dubai/index.html): Dubaï est au cœur de notre région IMETA. Explorez les opportunités de carrière aux EAU ou dans nos 170 centres à travers le monde. (185 words)
- [Offres d'emploi récentes Allemagne | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-allemagne/index.html): L’Allemagne, où l'histoire de Boehringer Ingelheim a commencé, est toujours notre siège mondial. Explorez les opportunités de carrière en Allemagne ou dans nos 170 centres à travers le monde. (246 words)
- [Offres d'emploi récentes Argentine | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-argentine/index.html): L’Argentine est notre principale base d'opérations en Amérique du Sud. Explorez les opportunités de carrière en Argentine ou dans nos 170 centres à travers le monde. (186 words)
- [Pardon Our Interruption](/content/fr/science-innovation/innovation-en-sante-humaine/boehringer-ingelheim-intensifie-ses-efforts-de-recherche-dans-trois-aires-therapeutiques-majeures.html) (110 words)
- [Offres d'emploi récentes en Espagne | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-en-espagne/index.html): Notre centre en Espagne abrite notre service Affaires réglementaires et deux pôles technologiques. Explorez les opportunités de carrière en Espagne ou dans nos 170 centres à travers le monde. (292 words)
- [Offres d'emploi récentes Pays-Bas | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-pays-bas/index.html): Notre centre d'Amsterdam est l'une de nos principales bases d'opérations en Europe. Explorez les opportunités de carrière aux Pays-Bas ou dans nos 170 centres à travers le monde. (206 words)
- [Singapour | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/singapour/index.html): Notre siège de Singapour est notre base d'opérations dans la région Pacifique. Explorez les opportunités de carrière à Singapour ou dans nos 170 centres à travers le monde. (193 words)
- [Offres d'emploi récentes au Mexique | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-au-mexique/index.html): Le Mexique abrite deux de nos usines de production modernes. Explorez les opportunités de carrière au Mexique ou dans nos 170 centres à travers le monde. (225 words)
- [福利與獎酬 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/fuliyujiangchou/index.html): 我們對員工進行投資，讓他們留下來一同成長。我們提供獎勵和發展機會等福利，藉以留住員工。 (9 words)
- [Chevaux | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/chevaux/index.html): Au service des athlètes de classe mondiale ou des compagnons fidèles de nos week-ends, nos innovations aident les chevaux à vivre plus longtemps et en meilleure santé. (772 words)
- [Offres d'emploi récentes en Chine | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-en-chine/index.html): Boehringer Ingelheim est actif en Chine depuis 1994. Explorez les opportunités de carrière en Chine ou dans nos 170 centres à travers le monde. (160 words)
- [Ingénierie et Installations | Travailler chez Boehringer Ingelheim](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/ingenierie-et-infrastructure-facility-management/index.html): Découvrez les nouvelles opportunités dans notre département Ingénierie et Installations. (206 words)
- [Integritetspolicy för Leverantörer, Besökare och intresserade Personer | Boehringer Ingelheim SE](/content/se/node/22739/index.html): Integritetspolicy för Leverantörer, Besökare och intresserade Personer (1,110 words)
- [Découvrez notre entreprise | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-notre-entreprise/index.html): Et si Boehringer Ingelheim était la prochaine étape de votre carrière ? Explorez nos différents champs d'activité et découvrez les opportunités d'emploi dans votre domaine. (548 words)
- [Avantages sociaux et bien-être | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/avantages-sociaux-et-bien-etre/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (318 words)
- [Partenariats en santé animale | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-animale/index.html): Découvrez l'approche collaborative de Boehringer Ingelheim en matière d'innovation en santé animale, nos axes de partenariat et comment nous rencontrer. (597 words)
- [Rémunération et reconnaissance | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/remuneration-et-reconnaissance/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (326 words)
- [Ecouter les patients | Boehringer Ingelheim FR](/content/fr/sante-humaine/nos-engagements/ecouter-les-patients/index.html): Ecouter les patients (298 words)
- [Offres d'emploi récentes Autriche | Boehringer Ingelheim CA](/content/ca/fr/emplois/offres-demploi-recentes-autriche/index.html): Vienne fut notre premier lieu d'implantation hors d'Allemagne. Explorez les opportunités de carrière en Autriche ou dans nos 170 centres à travers le monde. (103 words)
- [Notre regard sur le partenariat | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-animale/perspectives/index.html): Approfondissez vos connaissances sur l’industrie de la santé animale et découvrez les points de vue des experts de Boehringer Ingelheim sur l'importance de la collaboration pour stimuler l'innovation. (457 words)
- [Berichten | Boehringer Ingelheim NL](/content/nl/berichten/index.html): Persberichten : Press Releases - In dit gedeelte staat het laatste nieuws over Boehringer Ingelheim: persberichten, contactpersoon voor de media en beeldmateriaal. (356 words)
- [Comment postuler | Boehringer Ingelheim FR](/content/fr/carrieres/votre-processus-de-candidature/index.html): Apprenez comment postuler, à quoi vous attendre et comment préparer votre candidature auprès de nous. (393 words)
- [Offres d'emploi récentes aux É.-U. | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-aux-e-u/index.html): Les États-Unis sont l'une de nos régions les plus prospères et les plus innovantes. Explorez les opportunités de carrière aux États-Unis ou dans nos 170 centres à travers le monde. (30 words)
- [Total Rewards : nous investissons en vous | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-notre-entreprise/notre-politique-de-remuneration-globale/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (405 words)
- [Notre culture d'entreprise | Boehringer Ingelheim FR](/content/fr/carrieres/decouvrez-notre-entreprise/notre-culture-dentreprise/index.html): Notre culture d'entreprise (545 words)
- [Fibrose pulmonaire | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-respiratoires/fibroses-pulmonaires/index.html): Pulmonary Fibrosis (1,124 words)
- [Fabrication et Chaîne d'approvisionnement | Travailler chez BI](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/production-et-supply-chain/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Fabrication et Chaîne d'approvisionnement. (217 words)
- [Informatique | Travailler chez BI](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/technologies-de-linformation-it/index.html): Découvrez les nouvelles opportunités dans notre département Technologies de l'information. (127 words)
- [Médecine et Affaires réglementaires | Travailler chez BI](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/medical-affaires-reglementaires/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Médecine et Affaires réglementaires. (250 words)
- [Pardon Our Interruption](/content/fr/science-innovation/innovation-en-sante-animale/therapeutiques-0/index.html) (110 words)
- [Contactez-nous | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-animale/contactez-nous/index.html): Contactez notre équipe Développement commercial et licences en santé animale, en ligne ou lors d'un événement professionnel pour échanger sur l'opportunité d'un partenariat. (394 words)
- [Histoires de partenariats | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-animale/histoires-de-partenariats/index.html): Découvrez certaines des collaborations les plus marquantes de Boehringer Ingelheim en santé animale et écoutez nos partenaires parler de leur expérience à nos côtés. (276 words)
- [Domaine commercial | Travailler chez Boehringer Ingelheim](/content/fr/carrieres/decouvrez-nos-domaines-dactivites/commercial-ventes-et-marketing/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Commercial et postulez dès aujourd'hui. (313 words)
- [Innovation en Santé animale | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-animale/index.html): Innovation en Santé animale (268 words)
- [Chercher des offres et postuler | Boehringer Ingelheim FR](/content/fr/carrieres/recherche-demploi/index.html): Recherchez et postulez à des offres d'emploi chez Boehringer Ingelheim. (312 words)
- [MASH/MASLD | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-metaboliques/mash-masld/index.html): MASH/MASLD (150 words)
- [Santé animale : notre responsabilité | Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-engagements/index.html): L’importance de la durabilité et de l’interconnexion entre la santé des Hommes, des animaux et de la planète est solidement ancrée dans notre philosophie. (312 words)
- [Nous contacter | Boehringer Ingelheim FR](/content/fr/nous-contacter/index.html): Nous contacter (596 words)
- [Santé animale | Boehringer Ingelheim FR](/content/fr/sante-animale/index.html): Animal Health (333 words)
- [Partenariats | Boehringer Ingelheim FR](/content/fr/partenariats/index.html): Partnering (260 words)
- [Sécurité des patients et Pharmacovigilance chez Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/sante-humaine/nos-engagements/securite-des-patients/index.html): Sécurité des patients et Pharmacovigilance chez Boehringer Ingelheim (419 words)
- [自媒體與社群地圖 | Boehringer Ingelheim TW](/content/tw/zimeitiyushequndetu/index.html): 自媒體與社群地圖 (176 words)
- [Świadomy pacjent oraz bezpieczne stosowanie leków | Boehringer Ingelheim PL](/content/pl/pdf/swiadomy-pacjent-oraz-bezpieczne-stosowanie-lekow/index.html) (176 words)
- [Politique d’achats | Boehringer Ingelheim FR](/content/fr/propos/achats/index.html): Politique d’achats chez Boehringer Ingelheim (231 words)
- [Animaux de compagnie | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/index.html): Animaux de compagnie (500 words)
- [Notre engagement scientifique | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/engagements-scientifiques/index.html): Foster science (41 words)
- [Se connecter - Partenariats en Santé Humaine | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-humaine/se-connecter/index.html): Connect With Us (103 words)
- [Études cliniques | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/etudes-cliniques/index.html): Études cliniques (191 words)
- [Porcs | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/porcs/index.html): Porcs (325 words)
- [Histoires de science | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/nos-histoires-scientifiques/index.html): Histoires de science (106 words)
- [Science et Innovation | Boehringer Ingelheim FR](/content/fr/science-innovation/index.html): Science et Innovation (169 words)
- [Persmateriaal | Boehringer Ingelheim NL](/content/nl/persmateriaal/index.html): In dit gedeelte staat het laatste nieuws over Boehringer Ingelheim: persberichten, contactpersoon voor de media en beeldmateriaal. (40 words)
- [Nos domaines de recherche | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/domaines-de-recherche/index.html): Nos domaines de recherche (120 words)
- [Ruminants | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/index.html): Ruminants (72 words)
- [Innovation en santé humaine | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-humaine/index.html): Human_Health_Innovation (124 words)
- [Antiparasitaires | Boehringer Ingelheim FR](/content/fr/science-innovation/innovation-en-sante-animale/antiparasitaires-0/index.html): Antiparasitaires (97 words)
- [MORE HEALTH | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/more-health/index.html): MORE HEALTH: For People & Animals (546 words)
- [Accident vasculaire cérébral (AVC) | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/avc/index.html): Stroke (348 words)
- [BPCO et asthme | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-respiratoires/bpco-asthme/index.html): COPD & Asthma (405 words)
- [Animaux d'élevage | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/index.html): Animaux d'élevage (247 words)
- [Maladies de la rétine | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-de-la-retine/index.html): Retinal Diseases (245 words)
- [Maladies respiratoires | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-respiratoires/index.html): Lung Diseases (205 words)
- [Pardon Our Interruption](/content/fr/propos/qui-sommes-nous/gouvernance/index.html) (110 words)
- [Témoignages patients | Boehringer Ingelheim FR](/content/fr/sante-humaine/cancer/temoignages-patients/index.html): Empowering Patients (72 words)
- [MORE GREEN | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/more-green/index.html): Avec le pilier More Green, nous accordons une grande importance à la protection de l’environnement tout au long de notre chaîne de valeur, aussi bien dans nos activités de R&D, industrielles que commerciales. (313 words)
- [Articles à la une | Boehringer Ingelheim FR](/content/fr/sante-animale/articles-la-une/index.html): Articles à la une (191 words)
- [Dépression | Boehringer Ingelheim FR](/content/fr/sante-humaine/sante-mentale/depression/index.html): Dépression (163 words)
- [Troubles Mentaux | Boehringer Ingelheim FR](/content/fr/sante-humaine/sante-mentale/index.html): Troubles Mentaux (256 words)
- [Diabète | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-metaboliques/diabete/index.html): Diabetes (282 words)
- [Obésité | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-metaboliques/obesite/index.html): Obésité (150 words)
- [Schizophrénie | Boehringer Ingelheim FR](/content/fr/sante-humaine/sante-mentale/schizophrenie/index.html): Schizophrénie (131 words)
- [MORE POTENTIAL | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/more-potential/index.html): Nous sommes convaincus que nos collaborateurs ont la capacité d'impulser un changement positif, non seulement pour eux-mêmes et notre entreprise, mais aussi pour la société dans son ensemble. (367 words)
- [Notre engagement | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/notre-engagement/index.html): Our Commitment (558 words)
- [Sekretesspolicy angående farmakovigilans | Boehringer Ingelheim SE](/content/se/node/22738/index.html): Sekretesspolicy angående farmakovigilans (406 words)
- [À propos | Boehringer Ingelheim FR](/content/fr/propos/index.html): À propos (295 words)
- [Fibrillation atriale | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/fibrillation-atriale/index.html): Fibrillation Atriale (249 words)
- [Qui sommes-nous | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/index.html): Boehringer Ingelheim développe des thérapies innovantes pour améliorer la vie des hommes et des animaux. (102 words)
- [À travers tous les types de cancer | Boehringer Ingelheim FR](/content/fr/sante-humaine/cancer/autres-cancers/index.html): Across Cancer Types (127 words)
- [Zgłaszanie działań niepożądanych | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/dzialania-niepozadane/index.html): Formularz zgłaszania zdarzeń niepożądanych dotyczących produktów dla zwierząt firmy Boehringer Ingelheim zgodnie z obowiązującymi procedurami. (140 words)
- [Maladies métaboliques | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-metaboliques/index.html): Maladies métaboliques (130 words)
- [Hypertension | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/hypertension/index.html): Hypertension (145 words)
- [Éthique et Compliance | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/index.html): Ethics And Compliance (211 words)
- [Développement Durable | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/index.html): Développement Durable (247 words)
- [Pardon Our Interruption](/content/tw/animal-health/ingelvac-mycoflex-tp/index.html) (110 words)
- [Siedziba GBS we Wrocławiu | Boehringer Ingelheim PL](/content/pl/siedziba-gbs-we-wroclawiu/index.html): GBS (91 words)
- [04_Privacy Notice HP PV_PL | Boehringer Ingelheim PL](/content/pl/ochrona-danych-osobowych/pdf/04privacy-notice-hp-pvpl/index.html): 04_Privacy Notice HP PV_PL (39 words)
- [Histoire | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/histoire/index.html): L’histoire de Boehringer Ingelheim débute en 1885 lorsqu’Albert Boehringer achète une petite usine chimique d’acide tartrique à Ingelheim. (160 words)
- [Professionnels de santé | Boehringer Ingelheim FR](/content/fr/professionnels-de-sante/index.html): Professionnels de santé (135 words)
- [Leaving site | Boehringer Ingelheim FR](/content/fr/disclaimer/bi/index.html) (135 words)
- [Zrównoważony rozwój – nasze zobowiązanie | Boehringer Ingelheim PL](/content/pl/zrownowazony-rozwoj-nasze-zobowiazanie/index.html): Dążymy do poprawy zdrowia ludzi i zwierząt – teraz i w przyszłości. Dowiedz się więcej o naszym modelu: Zrównoważony rozwój – dla przyszłych pokoleń. (38 words)
- [Pardon Our Interruption](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/chevaux/tirez-le-meilleur-parti-du-prochain-controle-veterinaire-de-votre-cheval-principales-questions.html) (110 words)
- [Québec | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/intere-de-nouvelles-idees-nouvelle-science-0/index.html): Boehringer Ingelheim Canada s'associe à des établissements de premier ordre du Québec pour favoriser l'excellence en matière de soins de santé. Apprenez-en plus sur nos partenariats. (174 words)
- [Pardon Our Interruption](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/chevaux/prise-en-charge-et-traitement-de-larthrose-equine/index.html) (110 words)
- [Evan Tsai | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/evan-tsai/index.html): Evan Tsai (112 words)
- [Ouest Canada | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/partenariats-boehringer-ingelheim-canada/index.html): Boehringer Ingelheim Canada collabore étroitement avec d'importants établissements de l’Ouest du Canada. Apprenez-en plus sur nos partenariats et initiatives. (160 words)
- [Ontario | Boehringer Ingelheim CA](/content/ca/fr/partenariats-boehringer-ingelheim-canada/index.html): Boehringer Ingelheim Canada collabore avec des établissements renommés en Ontario afin de trouver des solutions novatrices afin d’assurer des soins de santé de haute qualité. Cliquez pour en apprendre davantage. (153 words)
- [Pardon Our Interruption](/content/tw/gaodawuchengbajinsenmoqibingfashizhizheng-zaoqiqingxuyouyuweizhengzhao.html) (110 words)
- [百靈佳殷格翰 2025在台五十週年 | Boehringer Ingelheim TW](/content/tw/bailingjiayingehan-2025zaitaiwushizhounian/index.html): 百靈佳殷格翰 2025在台五十週年 (36 words)
- [Joy Lai | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/joy-lai/index.html): Joy Lai (53 words)
- [Pardon Our Interruption](/content/about-us/sustainable-development/more-potential/boehringer-ingelheim-social-engagements/index.html) (110 words)
- [Pardon Our Interruption](/content/tw/shangbanzutangyouchedikandiaozhonglianjihua-jingyantan.html) (110 words)
- [Neville Ke | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/neville-ke/index.html): Neville Ke (68 words)
- [Disclaimer | Cyltezo® (adalimumab-adbm)](/content/patient/us/products/cyltezo/external-link/index.html) (67 words)
- [Pardon Our Interruption](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanhuojiangxiaoxi/sanduronghuozhuoyuezhichangrenzheng-bailingjiayingehanyirenweibenshijianzaishengji.html) (110 words)
- [Trajenta Duo® 糖倍平® | Boehringer Ingelheim TW](/content/tw/products/trajenta-duo/index.html): Trajenta Duo® 糖倍平® (48 words)
- [Pardon Our Interruption](/content/tw/7chengcusiweixinyinxingzhonghuaminguoxinluyixuehuixindongliechehuyuxiaoxinwuyujingxinlubuzhengcusiga.html) (110 words)
- [Microsoft Word - SF Recruiting Global Data Privacy Statement Version 1.1_IT.docx](/content/content/dam/9e0b11c9-077e-49be-8a7b-b014006a7bf6/successfactors_recruiting_global_data_privacy_statement_it-pdf.html) (2,252 words)
- [Lendormin®戀多眠® | Boehringer Ingelheim TW](/content/tw/products/lendormin/index.html): Lendormin®戀多眠® (23 words)
- [Jardiance Duo®恩美糖® | Boehringer Ingelheim TW](/content/tw/products/jardiance-duo/index.html): Jardiance Duo®恩美糖® (47 words)
- [Glyxambi® 糖順平® | Boehringer Ingelheim TW](/content/tw/products/glyxambi/index.html): Glyxambi® 糖順平® (34 words)
- [Trajenta® 糖漸平® | Boehringer Ingelheim TW](/content/tw/products/trajenta/index.html): Trajenta® (10 words)
- [Atrovent® 定喘樂® | Boehringer Ingelheim TW](/content/tw/products/atrovent/index.html): Atrovent® 定喘樂® (47 words)
- [Data Privacy Statement – OnlineAdBoard_NL | Boehringer Ingelheim NL](/content/nl/data-privacy-statement-onlineadboard-nl/index.html): This data privacy statement explain how Boehringer Ingelheim International GmbH (hereafter "Boehringer Ingelheim", "we", "us") processes which personal data (1,268 words)
- [Striverdi® Respimat®適維樂® | Boehringer Ingelheim TW](/content/tw/products/striverdi-respimat/index.html): Striverdi® Respimat®適維樂® (22 words)
- [Veterinärer gör allt och mer därtill | Boehringer Ingelheim SE](/content/se/djurhalsa/berattelser/veterinarer-gor-allt-och-mer-dartill/index.html): Veterinärer pressar sig ofta till det yttersta. Ger vi dem tillräckligt mycket uppskattning för det? (763 words)
- [Privacy verkopers, partners en geïnteresseerden | Boehringer Ingelheim NL](/content/nl/privacyverklaring-voor-verkopers-bezoekers-en-geinteresseerde-personen.html): Deze privacyverklaring legt uit hoe Boehringer Ingelheim Centre S.A. en/of aan haar verbonden ondernemingen van de Boehringer Ingelheim groep die optreden (1,202 words)
- [Berodual®備喘全® | Boehringer Ingelheim TW](/content/tw/products/berodual/index.html): Berodual®備喘全® (13 words)
- [Field Technical Service Manager, Ruminants Job Details | BoehringerPRD](/content/jobs/job-invite/36017/index.html): Amsterdam Field Technical Service Manager, Ruminants - Neth (915 words)
- [Berotec®備勞喘® | Boehringer Ingelheim TW](/content/tw/products/berotec/index.html): Berotec®備勞喘® (39 words)
- [Campus Recruitment 校園徵才 | Boehringer Ingelheim TW](/content/tw/careers/campus-recruitment-xiaoyuanzhengcai/index.html): 在Boehringer Ingelheim TW，我們知道在您的職位建立根基的重要性，並以此為基礎給予關懷與支持。 (46 words)
- [Spiriva®適喘樂® | Boehringer Ingelheim TW](/content/tw/products/spiriva/index.html): Spiriva®適喘樂® (34 words)
- [Spiolto® Respimat®適倍樂® | Boehringer Ingelheim TW](/content/tw/products/spiolto-respimat/index.html): Spiolto® Respimat®適倍樂® (29 words)
- [Personas, Finanzas y Organización | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/personas-finanzas-y-organizacion/index.html): Descubre nuevas oportunidades en nuestros departamentos de Personas, Finanzas y Organización. Descubre la oportunidad que te va a entusiasmar. (572 words)
- [Bättre tillgång till sjukvård för ursprungsbefolkningar | Boehringer Ingelheim SE](/content/se/battre-tillgang-till-sjukvard-ursprungsbefolkningar.html): Bättre tillgång till sjukvård för ursprungsbefolkningar (496 words)
- [Pardon Our Interruption](/content/tw/about-us/sustainable-development/more-green/shijiehuishouridazaofengbishixunhuanjingji/index.html) (110 words)
- [Ett livsverk för patienter med psykisk ohälsa | Boehringer Ingelheim SE](/content/se/ett-livsverk-patienter-med-psykisk-ohalsa/index.html): Ett livsverk för patienter med psykisk ohälsa (1,072 words)
- [GIOTRIF® 妥復克® | Boehringer Ingelheim TW](/content/tw/products/giotrif/index.html): GIOTRIF® 妥復克® (55 words)
- [Jardiance®恩排糖® | Boehringer Ingelheim TW](/content/tw/products/jardiance/index.html): Jardiance®恩排糖® (77 words)
- [Human Resources 人力資源 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/human-resources-renliziyuan/index.html): 深入了解我們Human Resources 人力資源部門的新機會。 (68 words)
- [Praxbind® 達栓普® | Boehringer Ingelheim TW](/content/tw/products/praxbind/index.html): Praxbind® 達栓普® (46 words)
- [經濟動物 | Boehringer Ingelheim TW](/content/tw/jingjidongwu/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs. (42 words)
- [Privacy Notice | Boehringer Ingelheim MEA](/content/mea/privacy-notice/index.html): Data Privacy (2,494 words)
- [Pradaxa®普栓達® | Boehringer Ingelheim TW](/content/tw/products/pradaxa/index.html): Pradaxa®普栓達® (61 words)
- [Benefits & Rewards | Boehringer Ingelheim US](/content/us/careers/explore-our-company/benefits-rewards/index.html): We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees. (361 words)
- [Harsha Deshmukh | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – 全球執行董事會成員，負責資訊科技與全球業務服務 (109 words)
- [Head of Commercial Excellence AH Job Details | BoehringerPRD](/content/jobs/job-invite/35982/index.html): Amsterdam Head of Commercial Excellence AH - Neth (954 words)
- [Staffan Gustavsson | Boehringer Ingelheim SE](/content/se/karriar/staffan-gustavsson/index.html): Head of Market Access & Public Affairs (937 words)
- [Dr Paola Casarosa | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/dr-paola-casarosa/index.html): Paola Casarosa 博士 – 全球執行董事會成員，負責創新事業 (114 words)
- [Vår partnerkultur | Boehringer Ingelheim SE](/content/se/var-partnerkultur/index.html): Vår partnerkultur (365 words)
- [Development Engineer - Laboratory Automation & Robotics Job Details | BoehringerPRD](/content/jobs/job/biberach-development-engineer-laboratory-automation-robotics-germ/1412855533/index.html): Biberach Development Engineer - Laboratory Automation & Robotics - Germ (640 words)
- [Dr Armin Wiesler | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/dr-armin-wiesler/index.html): Armin Wiesler 博士 –全球執行董事會成員，負責動物保健業務 (98 words)
- [Vårt sätt att arbeta | Boehringer Ingelheim SE](/content/se/vart-satt-att-arbeta/index.html): Vårt sätt att arbeta (300 words)
- [Jessica Sallander | Boehringer Ingelheim SE](/content/se/karriar/jessica-sallander/index.html): Möt Jessica Sallander, Medical Manager på Boehringer Ingelheim i Sverige. (889 words)
- [Demand Management Intern Job Details | BoehringerPRD](/content/jobs/job-invite/36304/index.html): Amsterdam Demand Management Intern - Neth (663 words)
- [Frank Hübler | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/frank-hubler/index.html): Frank Hübler – 全球執行董事會成員，負責財務 (65 words)
- [Twynsta® 倍必康平® | Boehringer Ingelheim TW](/content/tw/twynstar/index.html): Twynsta® 倍必康平® (68 words)
- [Animal Health 動物保健 | Boehringer Ingelheim TW職位](/content/tw/careers/explore-our-company/animal-health-dongwubaojian/index.html): 深入了解我們Animal Health 動物保健部門的新機會。 (80 words)
- [Hugo Mansfeld | Boehringer Ingelheim SE](/content/se/karriar/hugo-mansfeld/index.html): Möt Hugo Mansfeld, Territory Manager inom området kardiovaskulär hälsa och diabetes i Skåneregionen. (772 words)
- [Michael Schmelmer | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/michael-schmelmer/index.html): Michael Schmelmer –全球執行董事會副主席，負責集團職能 (95 words)
- [Hälso- och sjukvårdsstrategi: Tillgänglighet | Boehringer Ingelheim SE](/content/se/halso-och-sjukvardsstrategi-tillganglighet/index.html): Hållbar utveckling (203 words)
- [Microsoft Word - SF Recruiting Global Data Privacy Statement Version 1.2_ES.docx](/content/content/dam/4a20022e-6790-4485-9122-b014006a788f/successfactors_recruiting_global_data_privacy_statement_es-pdf.html) (710 words)
- [Medical 醫學服務 | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/medical-yixuefuwu/index.html): 深入了解我們Medical 醫學服務部門的新機會。 (103 words)
- [Legal & Compliance 法務暨法規遵循 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/legal-compliance-fawujifaguizunxun/index.html): 深入了解我們Legal & Compliance 法務暨法規遵循部門的新機會。 (86 words)
- [Student Applications | Veterinary Scholars Program](/content/veterinaryscholars/studentapplications/index.html) (349 words)
- [Enlace Médico Científico (MSL) Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35997/index.html): Ciudad de Mexico Enlace Médico Científico (MSL) - Méxi (824 words)
- [Marketing 行銷 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/marketing-xingxiao/index.html): 深入了解我們Marketing 行銷部門的新機會。 (48 words)
- [Sales 業務 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/sales-yewu/index.html): 深入了解我們的商業領域部門新機會並立即申請。 (104 words)
- [División de Calidad | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/division-de-calidad/index.html): Descubre nuevas oportunidades en nuestra División de Calidad. Marca la difgerencia y únete hoy mismo al equipo de Boehringer Ingelheim. (249 words)
- [Nevenwerking-melden | Boehringer Ingelheim BE](/content/be/nl/nevenwerking-melden/index.html): Nevenwerking-melden, U kan via onderstaand formulier een nevenwerking via e-mail melden - Naam, Voornaam, Land, Email, Nevenwerking (+ beschrijving). (154 words)
- [Pardon Our Interruption](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-andalucia-y-extremadura/index.html) (110 words)
- [Japón | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/japon/index.html): Our team in Japan is regarded for commitment to innovation and sustainability. Explore career development opportunities in Japan or our 170 global locations. (165 words)
- [France | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/france/index.html): Boehringer Ingelheim ha tenido presencia en Francia desde 1967. Explora las oportunidades de desarrollo profesional vigentes en Francia. (347 words)
- [Jessica Safir Bassan | Boehringer Ingelheim SE](/content/se/karriar/jessica-safir-bassan/index.html): Omnichannel Manager (1,025 words)
- [España | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/espana/index.html): Our facility in Spain is home to Regulatory Affairs Services and two technology hubs. Explore career opportunities in Spain or our 170 global locations. (312 words)
- [Communications & Public Affairs 企業傳播與公共事務 | Boehringer Ingelheim TW職位](/content/tw/careers/discover-our-careers/communications-public-affairs-qiyechuanboyugonggongshiwu.html): 深入了解我們的Communications & Public Affairs 企業傳播與公共事務部門新機會。 (39 words)
- [China | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/china/index.html): Boehringer Ingelheim ha estado activo en China desde 1994. Explora las oportunidades de desarrollo profesional en China hoy. (193 words)
- [Área Comercial | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/area-comercial/index.html): Descubre nuevas oportunidades en nuestra Área Comercial, y postúlate hoy. (473 words)
- [Fabricación y Cadena de Suministro | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/fabricacion-y-cadena-de-suministro/index.html): Descubre nuevas oportunidades en nuestra cadena de Fabricación y Suministro. ¡No pierdas esta oportunidad y únete hoy mismo! (262 words)
- [Ofertas en Legal | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/ofertas-en-legal/index.html): Descubre nuevas oportunidades en nuestro equipo de Legal. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (328 words)
- [Pardon Our Interruption](/content/mx/sobre-nosotros/donde-encontrarnos/boehringer-ingelheim-ridgefield/index.html) (110 words)
- [Pardon Our Interruption](/content/mx/sobre-nosotros/donde-encontrarnos/koropi/index.html) (110 words)
- [Pardon Our Interruption](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/singapur/index.html) (110 words)
- [México | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/mexico/index.html): Mexico is home to two of our modern production sites. Explore career development opportunities in Mexico or our 170 locations around the globe. (297 words)
- [Comunicación y Asuntos Corporativos | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/comunicacion-y-asuntos-corporativos/index.html): Descubre nuevas oportunidades en nuestros Asuntos Corporativos, y postúlate hoy. (310 words)
- [Argentina | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/argentina/index.html): Argentina es la piedra angular de nuestras operaciones en Sudamérica. Explora las oportunidades profesionales que te brinda hoy BI Argentina. (205 words)
- [Alemania | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/alemania/index.html): Alemania, donde comenzó la historia de Boehringer Ingelheim, sigue siendo nuestra sede mundial. Explora las oportunidades laborables disponibles en Alemania. (248 words)
- [Austria | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/austria/index.html): Viena fue nuestro primer sitio fuera de Alemania. Explora todas las oportunidades de desarrollo profesional activas hoy en Austria. (240 words)
- [Pardon Our Interruption](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/usa/index.html) (110 words)
- [Dubai | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/dubai/index.html): Dubai está en el corazón de nuestra región IMETA. Explora las oportunidades de desarrollo profesional activas en los Emiratos Árabes Unidos. (225 words)
- [Desarrollo Empresarial y Consultoría | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/desarrollo-empresarial-y-consultoria/index.html): Descubre nuevas oportunidades en nuestra Estrategia Corporativa y Consultoría, y postúlate hoy. (307 words)
- [Brazil | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/brazil/index.html): La presencia de Boehringer Ingelheim en Brasil abarca más de 70 años. Explora las oportunidades profesionales que te brinda hoy BI Brasil. (198 words)
- [Dogs | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/dogs/index.html): With products and solutions to protect dog health and improve well-being, Boehringer Ingelheim is committed to longer, happier lives for canine companions (734 words)
- [Talentos Precoces | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/talentos-precoces/index.html): En Boehringer Ingelheim, sabemos lo importante que es sentar las bases correctas en tu carrera y desarrollarlas con cuidado y apoyo. ¡Únete hoy mismo! (198 words)
- [Pardon Our Interruption](/content/mx/pdf/contratodesuministropdf/index.html) (110 words)
- [weBuy | Boehringer Ingelheim BE](/content/be/nl/webuy/index.html): WeBuy, de Source to Procure-oplossing voor Boehringer Ingelheim, is een belangrijk initiatief om wereldwijd een geïntegreerde oplossing te hebben. (290 words)
- [Verklaring gegevensbescherming | Boehringer Ingelheim BE](/content/be/nl/verklaring-gegevensbescherming/index.html): In deze privacyverklaring wordt beschreven hoe Boehringer Ingelheim Comm.V en Boehringer Ingelheim Centre S.A. (hierna: 'Boehringer Ingelheim' (1,060 words)
- [Comunicati stampa | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/index.html): Comunicati stampa (286 words)
- [Connect with us | Boehringer Ingelheim MEA](/content/mea/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (372 words)
- [por_que_es_importante_prevenir_enfermedades_de_aves_de_corral | Boehringer Ingelheim MX](/content/mx/pdf/porqueesimportanteprevenirenfermedadesdeavesdecorral.html) (34 words)
- [Prêmio Boehringer Ingelheim de Jornalismo | Boehringer Ingelheim BR](/content/br/imprensa-historias/premio-boehringer-ingelheim-de-jornalismo/index.html): 3ª edição do Prêmio Boehringer Ingelheim de Jornalismo agora inclui Saúde Animal, além da Humana, reforçando o compromisso com informação de qualidade. (553 words)
- [Conciliación de la vida laboral | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/conciliacion-de-la-vida-laboral/index.html): Es importante el equilibrio entre la vida profesional y personal. Así que ofrecemos varias opciones de permisos y horarios de trabajo flexibles. (96 words)
- [Qué hacemos | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/que-hacemos/index.html): Como corporación multinacional fabricamos productos farmacéuticos para seres humanos, salud animal y productos biofarmacéuticos. ¡Sigue leyendo para +info! (499 words)
- [Terms of Use | Boehringer Ingelheim MEA](/content/mea/terms-use/index.html): Terms of Use (1,409 words)
- [Wie wij zijn | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/index.html): Boehringer Ingelheim werkt aan baanbrekende therapieën die de levens van patiënten nu en voor de komende generaties transformeren. (194 words)
- [Bienestar en la vida laboral | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/bienestar-en-la-vida-laboral/index.html): Brindamos una variedad de beneficios y servicios: asesoramiento, clases de gimnasia y eventos sociales, para mantenerte mental y físicamente en forma. (261 words)
- [protege_a_tu_perro | Boehringer Ingelheim MX](/content/mx/pdf/protegeatuperro/index.html) (72 words)
- [Perspectives | Boehringer Ingelheim MEA](/content/mea/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (360 words)
- [Partnership stories | Boehringer Ingelheim MEA](/content/mea/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (262 words)
- [Iniciativa Angels: uma nova era no cuidado do AVC | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/iniciativa-angels-uma-nova-era-no-cuidado-do-avc/index.html): A Iniciativa transforma o cuidado ao AVC com capacitação, diagnóstico rápido, cidades certificadas e educação para salvar vidas e reduzir desigualdades. (562 words)
- [Premios y reconocimientos | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/premios-y-reconocimientos/index.html): Hay logros y ocasiones que exigen reconocimiento. Hacemos todo lo posible para dar a los empleados recompensas tangibles y más con los hitos comerciales. (305 words)
- [Top Employer de nuevo | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/top-employer-de-nuevo/index.html): Somos uno de los principales empleadores del mundo con premios locales en 29 países, además de títulos regionales en Europa, América Latina y Asia-Pacífico. (302 words)
- [Ingeniería e Instalaciones | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/ingenieria-e-instalaciones/index.html): Descubre nuevas oportunidades en nuestro departamento de Ingeniería e Instalaciones. ¡Únete hoy mismo! (395 words)
- [Contact | Boehringer Ingelheim BE](/content/be/nl/samenwerking/boehringer-ingelheim-bioxcellence/neem-contact-op/index.html): Contactgegevens in België - Indien u specifieke vragen of opmerkingen heeft, kan u ons via onderstaande manieren bereiken.. (160 words)
- [OVER ONS | Boehringer Ingelheim BE](/content/be/nl/over-ons/index.html): OVER ONS Een succesvol en onderzoeksgericht bedrijf Boehringer Ingelheim is een wereldwijde bedrijvengroep die vele culturen en diverse samenlevingen omarmt. (203 words)
- [Onze betrokkenheid | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/onze-betrokkenheid/index.html): Onze reis gaat over het stimuleren van innovatie, het creëren van waarde op gebieden waar nog geen medische behoefte bestaat en het samenwerken. (124 words)
- [Poultry | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/poultry/index.html): As trusted partners to poultry producers, Boehringer Ingelheim provides industry-leading vaccines and expertise to protect both flock health and businesses (404 words)
- [Meer groen: voor onze planeet | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/meer-groen-voor-onze-planeet/index.html): Onze pijler MEER GROEN omvat milieu-initiatieven waarbij veel verschillende aspecten aan bod komen: maatregelen nemen om water- en luchtverontreiniging (188 words)
- [Geschiedenis | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/geschiedenis/index.html): Albert Boehringer (1861-1939) richtte in 1885 het farmaceutische bedrijf Boehringer Ingelheim op in Nieder-Ingelheim, tegenwoordig onderdeel van Ingelheim. (151 words)
- [Cats | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/cats/index.html): By advancing innovation for the unique challenges of cat care, Boehringer Ingelheim’s feline experts help strengthen the bond between cats and their people (711 words)
- [Where to find us | Boehringer Ingelheim MEA](/content/mea/about-us/where-find-us/index.html): Sites Around the World (384 words)
- [Meer gezondheid: voor mens en dier | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/meer-gezondheid-voor-mens-en-dier/index.html): Een langetermijninitiatief met als doel het verbeteren van de gezondheid in gemeenschappen over de hele wereld door de meest veelbelovende (157 words)
- [de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/nachhaltige-medikamente/index.html](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/nachhaltige-medikamente/index.html) (108 words)
- [onze verhalen | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/index.html): Boehringer Ingelheim heeft veel initiatieven die we graag willen delen. Kom meer over ons te weten door onze verhalen te lezen (96 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim MEA](/content/mea/animal-health/our-responsibility/index.html): One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health. (241 words)
- [Hypertension | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/hypertension/index.html): Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke. (124 words)
- [Heart Failure | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/heart-failure/index.html): Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction. (387 words)
- [Lung Diseases | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/index.html): Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer. (292 words)
- [Animal Health Innovation | Boehringer Ingelheim MEA](/content/mea/science-innovation/animal-health-innovation/index.html): Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our (193 words)
- [Switching market | Boehringer Ingelheim NL](/content/nl/disclaimer/market/index.html) (121 words)
- [Switching market | Boehringer Ingelheim BE](/content/be/nl/disclaimer/market/index.html) (65 words)
- [Metabolic Diseases | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 20451. Type 2 diabetes is a chronic, (282 words)
- [Scleroderma | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/scleroderma/index.html): Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs (246 words)
- [Leaving site | Boehringer Ingelheim BE](/content/be/nl/disclaimer/bi/index.html) (65 words)
- [Human Health Partnering Interests | Boehringer Ingelheim MEA](/content/mea/partnering/human-health-partnering/partnering-interests/index.html): Click here to discover what we like to witness at Boehringer Ingelheim from our partners and what our partnering activities encompass. (118 words)
- [Animals We Support | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/index.html): We’re committed to the health of the world’s most important animals: beloved dogs, cats, and horses, plus valued livestock like swine, ruminants, and poultry (388 words)
- [Human Health Partnering Connect with Us | Boehringer Ingelheim MEA](/content/mea/partnering/human-health-partnering/connect-us/index.html): Human Health Partnering - Connect with Us (333 words)
- [The Research Process | Boehringer Ingelheim MEA](/content/mea/science-innovation/animal-health-innovation/research-process/index.html): A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. To do this we employ a mix of sophisticated tools, technical capabilities and expertise – both at our Global Innovation r (130 words)
- [Boehringer Ingelheim corporate history | Boehringer Ingelheim](/content/annualreport/2025/history-140-years/index.html): Learn more about Boehringer Ingelheim’s corporate history (826 words)
- [Médica y Asuntos Regulatorios | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/medica-y-asuntos-regulatorios/index.html): Descubre nuevas oportunidades en nuestra área de Medicina y Asuntos Regulatorios. Descubre interesantes oportunidades hoy. (330 words)
- [Stroke | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/stroke/index.html): Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. (286 words)
- [Human Health Partnering | Boehringer Ingelheim MEA](/content/mea/partnering/human-health-partnering/index.html): Find all our Partnering contact information here as well as the latest updates on where you can meet us virtually or in person. (133 words)
- [Science Stories | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/science-stories/index.html): Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (71 words)
- [Leadership | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (187 words)
- [Science & Innovation | Boehringer Ingelheim MEA](/content/mea/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (176 words)
- [Purchasing | Boehringer Ingelheim MEA](/content/mea/about-us/purchasing/index.html): Sourcing (230 words)
- [Grass Roots | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators (50 words)
- [Dr. Paola Casarosa | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/dr-paola-casarosa/index.html): Dr Paola Casarosa – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich Innovation (164 words)
- [Partnering | Boehringer Ingelheim MEA](/content/mea/partnering/index.html): At Boehringer Ingelheim diversity of minds & collaboration is paramount to developing new medical breakthroughs. Click here see how you can partner with us. (193 words)
- [Pardon Our Interruption](/content/mea/about-us/sustainable-development/index.html) (110 words)
- [Therapeutics | Boehringer Ingelheim MEA](/content/mea/science-innovation/animal-health-innovation/therapeutics/index.html): We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species. Our dedicated Research teams work together with our human pharma and animal health colleagues, as well as with (61 words)
- [Pardon Our Interruption](/content/mea/about-us/ethics-and-compliance/index.html) (31 words)
- [Nuestra cultura | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestra-cultura/index.html): Nuestra cultura refleja quiénes somos y se refleja en nuestra firme creencia en la Diversidad, la Equidad y la Inclusión, así como en el Desarrollo Sostenible. (729 words)
- [Human Health Innovation | Boehringer Ingelheim MEA](/content/mea/science-innovation/human-health-innovation/index.html): Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline. (138 words)
- [Obesity | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/obesity/index.html): Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here. (189 words)
- [Chronic Kidney Disease | Boehringer Ingelheim MEA](/content/mea/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (119 words)
- [Parasiticides | Boehringer Ingelheim MEA](/content/mea/science-innovation/animal-health-innovation/parasiticides/index.html): Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses. (55 words)
- [Ruminants | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/ruminants/index.html): Across the lifespan of cattle and sheep, Boehringer Ingelheim delivers proactive solutions to help ruminant producers optimize herd health and productivity (519 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (33 words)
- [Ofertas en Tecnología de la Información | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/ofertas-en-tecnologia-de-la-informacion/index.html): Descubre nuevas oportunidades en nuestro departamento de Tecnologías de la Información. Entra a formar parte de BI. (242 words)
- [More Health: For People & Animals | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (50 words)
- [Our Responsibility | Boehringer Ingelheim MEA](/content/mea/human-health/our-responsibility/index.html): Human Health Our Responsibility (79 words)
- [More Potential | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (110 words)
- [Trends & Insights | Boehringer Ingelheim MEA](/content/mea/animal-health/trends-insights/index.html): Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (57 words)
- [More Green | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (194 words)
- [Frank Hübler | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/frank-huebler/index.html): Frank Hübler – Mitglied der Unternehmensleitung mit Verantwortung für Finanzen (126 words)
- [Harsha Deshmukh | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/harsha-deshmukh/index.html): Harsha Deshmukh – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich IT und Global Business Services (149 words)
- [Addressing the bigger picture in obesity and metabolic dysfunction-associated steatohepatitis | Boehringer Ingelheim](/content/annualreport/2025/survodutide-peptide-obesity-glp-glucagon/index.html): For people living with obesity or metabolic dysfunction-associated steatohepatitis, they are at risk of metabolic dysfunction. We’re committed to treating them holistically. (1,099 words)
- [Dr. Armin Wiesler | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/dr-armin-wiesler/index.html): Dr Armin Wiesler – Mitglied der Unternehmensleitung mit Verantwortung für den Geschäftsbereich Tiergesundheit (133 words)
- [How we’re helping vets detect heart murmurs in dogs earlier | Boehringer Ingelheim](/content/annualreport/2025/detect-heart-murmur-dog-early/index.html): Around ten percent of dogs suffer from heart disease. With early detection of heart murmurs in dogs, Boehringer Ingelheim is enabling dog owners to spend more time with their pet. (1,135 words)
- [Michael Schmelmer | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (146 words)
- [Who we are | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (49 words)
- [Beneficios y recompensas | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/beneficios-y-recompensas/index.html): Invertimos en nuestra gente para que se quede y crezcan con nosotros. Ofrecemos beneficios, recompensas y oportunidades que contribuyan a su fidelización. (278 words)
- [Unlocking the Dark Genome | New Cancer Antigens for Next-Generation Immunotherapies | Boehringer Ingelheim](/content/annualreport/2025/dark-genome/index.html): Researchers at Boehringer Ingelheim explore the dark genome to discover tumor-specific cryptic antigens that could power next-generation cancer immunotherapies, including therapeutic vaccines and T-cell engagers. (1,154 words)
- [nl/pdf/sifrol-mva-spc/index.html](/content/nl/pdf/sifrol-mva-spc/index.html) (110 words)
- [How to improve the patient experience in healthcare | Boehringer Ingelheim](/content/annualreport/2025/improve-patient-experience/index.html): At Boehringer Ingelheim, looking at how to improve the patient experience informs our decision-making, transforming treatment design and how people experience healthcare. (1,146 words)
- [Pandemic Preparedness: How vaccine banks protect animal health | Boehringer Ingelheim](/content/annualreport/2025/pandemic-preparedness/index.html): How antigen and vaccine banks strengthen pandemic preparedness: delivering FMD vaccines in about seven working days to protect livestock health, farm incomes and global trade. (1,051 words)
- [Exploring the latest treatment for pulmonary fibrosis | Boehringer Ingelheim | Boehringer Ingelheim](/content/annualreport/2025/pulmonary-fibrosis-treatments/index.html): Boehringer Ingelheim is pursuing new research hypotheses and the latest treatment for pulmonary fibrosis to one day halt or even reverse the debilitating disease. (1,121 words)
- [Annual Report Story Hub | Boehringer Ingelheim](/content/annualreport/2025/storyhub/index.html): Boehringer Ingelheim’s progress stories of 2025 (173 words)
- [Unternehmensbericht-Magazin 2024 | Boehringer Ingelheim](/content/de/unternehmensbericht/2024/index.html): Der Boehringer-Unternehmensbericht 2024 zeigt, wie Investitionen von heute Medikamente von morgen gestalten und globale Gesundheitsinnovation vorantreiben. (567 words)
- [Pardon Our Interruption](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/verbesserung-der-versorgung-bei-schizophrenie/index.html) (110 words)
- [Social Business Report 2025 | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/social-business-report/index.html): Explore how Boehringer Ingelheim addresses the needs of local communities across the globe by further scaling social startups through impact-first funding. (1,041 words)
- [Veterinary Mentorship Program: Supporting Future Veterinary Scientists | Boehringer Ingelheim](/content/annualreport/2025/veterinary-mentorship-program/index.html): The Boehringer Ingelheim Veterinary Scholars Program gives veterinary students early hands-on research experience, mentorship and insight into careers in biomedical science. (1,157 words)
- [Pardon Our Interruption](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/unsere-forschungsstandorte/index.html) (110 words)
- [Unterstützung für Lieferanten | Boehringer Ingelheim DE](/content/de/unterstuetzung-fuer-lieferanten/index.html): Auf dieser Seite finden Sie Informationen und Erklärvideos zu unserem Einkaufssystem SAP Ariba. Lesen Sie weiter! (647 words)
- [Pardon Our Interruption](/content/de/humanmedizin/chronische-nierenkrankheit/was-ist-eine-chronische-nierenkrankheit-ckd/index.html) (110 words)
- [A call for integrated care to tackle noncommunicable diseases | Boehringer Ingelheim](/content/annualreport/2025/multimorbidity-call-integrated-care-tackle-non-communicable-diseases-ckm.html):  NCDs are the deadliest group of diseases. At the 80th session of the UN General Assembly, we’re advocating for the integrated care of CKM conditions. (959 words)
- [Intervisiegroepen: een waardevolle manier om bij te dragen aan betere diergezondheid | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/intervisiegroepen-een-waardevolle-manier-om-bij-te-dragen-aan-betere.html): Al 25 jaar lang faciliteert Boehringer Ingelheim laagdrempelige intervisiegroepen voor dierenartsen, waardoor samenwerking en kennisuitwisseling plaatsvindt ten behoeve van diergezondheid en welzijn. (1,123 words)
- [Facts and figures | Boehringer Ingelheim](/content/annualreport/2025/facts-and-figures/index.html): Highlights of the Boehringer Ingelheim Annual Report 2025 in numbers (711 words)
- [Klimaatverandering: ook van invloed op parasieten bij onze huisdieren? | Boehringer Ingelheim NL](/content/nl/voor-dier/klimaatverandering-ook-van-invloed-op-parasieten-bij-onze-huisdieren.html): Klimaatverandering: ook van invloed op parasieten bij onze huisdieren? (1,017 words)
- [Letter from the Board of Managing Directors | Boehringer Ingelheim](/content/annualreport/2025/letter-board-of-managing-directors/index.html): Letter from the Board of Managing Directors (513 words)
- [Nieuwe perspectieven: Waarom diergeneeskundige zorg zoveel meer is dan je denkt | Boehringer Ingelheim NL](/content/nl/voor-dier/onze-verantwoordelijkheid/nieuwe-perspectieven-waarom-diergeneeskundige-zorg-zoveel-meer-dan-je-denkt.html): Begrijpen we echt wat er komt kijken bij het werk van een dierenarts? Ontdek waarom het belangrijk is om meer te leren over dit inspirerende beroep. (460 words)
- [Boehringer Ingelheim � Annual Report 2025: The Board of Managing Directors](/content/annualreport/2025/files/boehringer-ingelheim-key-achievements-2025-pdf.html) (467 words)
- [Boehringer Ingelheim � Annual Report 2025: The Shareholders Perspective](/content/annualreport/2025/files/boehringer-ingelheim-shareholders-letter-2025-pdf.html) (412 words)
- [Harsha Deshmukh | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/harsha-deshmukh/index.html): Harsha Deshmukh – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich IT und Global Business Services (197 words)
- [Michael Schmelmer | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors mit Verantwortung für Konzernfunktionen (184 words)
- [Dr. Armin Wiesler | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/dr-armin-wiesler/index.html): Dr Armin Wiesler – Mitglied der Unternehmensleitung mit Verantwortung für den Geschäftsbereich Tiergesundheit (170 words)
- [Shashank Deshpande | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors mit Verantwortung für den Geschäftsbereich Humanpharma (187 words)
- [Frank Hübler | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/frank-huebler/index.html): Frank Hübler – Mitglied der Unternehmensleitung mit Verantwortung für Finanzen (164 words)
- [Een beginnershandleiding bij de bestrijding van parasieten bij katten | Boehringer Ingelheim NL](/content/nl/voor-dier/een-beginnershandleiding-bij-de-bestrijding-van-parasieten-bij-katten.html): Een beginnershandleiding bij de bestrijding van parasieten bij katten (854 words)
- [Patiëntenwaarschuwingskaart Pradaxa Capsules | Boehringer Ingelheim NL](/content/nl/voor-mens/pdf/patientenwaarschuwingskaart-pradaxa-capsules/index.html): feb 20026 (7 words)
- [Standortprofil Dortmund | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/pdf/standortprofil-dortmund/index.html): Standortprofil Dortmund (31 words)
- [Communiqués de presse | Boehringer Ingelheim FR](/content/fr/communiques-de-presse/index.html): Press Releases (218 words)
- [Communiqués de presse | Boehringer Ingelheim CA](/content/ca/fr/communiques-de-presse/index.html): Consultez nos communiqués de presse chez Boehringer Ingelheim. Restez informé des dernières actualités et avancées dans le domaine de la santé. (475 words)
- [PAIA_Manual_Boehringer_Ingelheim_PTY_LTD | Boehringer Ingelheim ZA](/content/za/pdf/paiamanualboehringeringelheimptyltd/index.html): PAIA_Manual_Boehringer_Ingelheim_PTY_LTD (53 words)
- [Annual Press Conference 2024 | Boehringer Ingelheim](/content/about-us/annual-press-conference-2024/index.html): Boehringer Ingelheim presents the 2023 results and an outlook for 2024 at the Annual Press Conference on April 16, 2024. (277 words)
- [Biberach Our Location | Boehringer Ingelheim](/content/careers/biberach/index.html): Explore Boehringer Ingelheim in Biberach and join us to step up in your life sciences career. Find jobs in Biberach and the Ulm area now! (723 words)
- [Michael Schmelmer | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (207 words)
- [Press Releases | Boehringer Ingelheim PL](/content/pl/press-releases/index.html): Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (143 words)
- [Descargo de responsabilidad | Conectados | Conectados](/content/pro/sa/external-link/index.html) (73 words)
- [Press Releases | Boehringer Ingelheim MEA](/content/mea/press-releases/index.html): Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (182 words)
- [Contacto para medios | Boehringer Ingelheim MX](/content/mx/contacto-para-medios/index.html): Contacto para medios (44 words)
- [Annual Results Press Conference 2022 | Boehringer Ingelheim MEA](/content/mea/annual-results-press-conference-2022/index.html): Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year. (134 words)
- [Harsha Deshmukh | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (200 words)
- [Вакансии в США | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/usa/index.html): Для нашей компании США является одним из самых успешных и инновационных регионов. Узнайте про карьерные возможности в США или в 170 наших подразделениях по всему миру. (347 words)
- [Frank Hübler | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (148 words)
- [Boehringer Ingelheim Business Services Philippines Inc. | Careers | Boehringer Ingelheim](/content/careers/boehringer-ingelheim-business-services-philippines-inc-careers.html): Boehringer Ingelheim Business Services Philippines Inc. | Careers (17 words)
- [Dr Paola Casarosa | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (137 words)
- [Dr Armin Wiesler | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/leiderschap/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (161 words)
- [Stel je voor: Onze verhalen over duurzaamheid op één plek. | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/stel-je-voor-onze-verhalen-over-duurzaamheid-op-een-plek.html): Ontdek hoe wij positieve verandering stimuleren en de gezondheidszorg vooruitbrengen voor een betere toekomst. (77 words)
- [COVID-19 | Boehringer Ingelheim](/content/hk/en/stop-treatment-covid-19-study/index.html): Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19. (64 words)
- [Press Material | Boehringer Ingelheim MEA](/content/mea/press-material/index.html): Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view BI corporate news. (54 words)
- [Люди, финансы и организация | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/people-finance-organization/index.html): Узнайте о новых карьерных возможностях в области HR, финансов и организации. (408 words)
- [AD, Compliance Operations AH Job Details | BoehringerPRD](/content/jobs/job-invite/36148/index.html): Johns Creek, GA AD, Compliance Operations AH - Unit (930 words)
- [Scientific Director Group Leader (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/35595/index.html): Vienna Scientific Director Group Leader (m/f/d) - Aust (790 words)
- [CPT Specialist / Senior CPT Expert (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35026/index.html): Ingelheim CPT Specialist / Senior CPT Expert (m/w/d) - Deut (748 words)
- [Hilfskraft Wirtschaftsbetriebe Asia (50%) (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/31465/index.html): Biberach Hilfskraft Wirtschaftsbetriebe Asia (50%) (m/w/d) - Deut (551 words)
- [Senior Compliance Process Technologist (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/34587/index.html): Ingelheim Senior Compliance Process Technologist (m/w/d) - Deut (632 words)
- [Boehringer Ingelheim � Annual Report 2025 Highlights](/content/annualreport/2025/files/boehringer-ingelheim-annual-report-highlights-2025-pdf.html) (13,127 words)
- [Вакансии в Китае | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/china/index.html): «Берингер Ингельхайм» работает в Китае с 1994 года. Узнайте про карьерные возможности в Китае или в 170 наших подразделениях по всему миру. (224 words)
- [Senior Scientist - Computational Pathology Job Details | BoehringerPRD](/content/jobs/job-invite/35062/index.html): Biberach Senior Scientist - Computational Pathology - Germ (674 words)
- [Pharmaziepraktikum Arzneimittelherstellung Stellendetails | BoehringerPRD](/content/jobs/job-invite/18819/index.html): Ingelheim Pharmaziepraktikum Arzneimittelherstellung - Deut (423 words)
- [Talent Acquisition Manager (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/36186/index.html): Wien Talent Acquisition Manager (m/w/d) - Öste (622 words)
- [Praktikum / Abschlussarbeit - Drug Substance Biologicals / Zelllinienentwicklung Stellendetails | BoehringerPRD](/content/jobs/job-invite/36421/index.html): Biberach Praktikum / Abschlussarbeit - Drug Substance Biologicals / Zelllinienentwicklung - Deut (509 words)
- [Recruiting Manager (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35931/index.html): Biberach Recruiting Manager (m/w/d) - Deut (582 words)
- [Вакансии в Японии | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/japan/index.html): Сотрудники в Японии известны своим интересом к инновациям и устойчивому развитию. Узнайте про карьерные возможности в Японии или в 170 других наших подразделениях. (165 words)
- [Вакансии в Германии | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/germany/index.html): Германия - место, где началась история «Берингер Ингельхайм». Узнайте про карьерные возмоaжности в Германии или в 170 наших подразделениях по всему миру. (222 words)
- [Вакансии в Нидерландах | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/netherlands/index.html): Предприятие в Амстердаме является центром нашей деятельности в Европе. Узнайте про карьерные возможности в Нидерландах или в 170 наших подразделениях по всему миру. (161 words)
- [Clinical Trial Manager Stellendetails | BoehringerPRD](/content/jobs/job-invite/35486/index.html): Biberach Clinical Trial Manager - Deut (544 words)
- [Вакансии в Испании | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/spain/index.html): В Испании есть Центр регистрации и два технологических центра. Узнайте про карьерные возможности в Испании или в 170 наших подразделениях по всему миру. (232 words)
- [Вакансии в Сингапуре | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/singapore/index.html): Офис в Сингапуре является центром нашего бизнеса в Тихоокеанском регионе. Узнайте про карьерные возможности в Сингапуре или в 170 наших подразделениях по всему миру. (176 words)
- [Вакансии в Мексике | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/mexico/index.html): В Мексике находятся два наших современных производственных предприятия. Узнайте про карьерные возможности в Мексике или в 170 наших подразделениях по всему миру. (207 words)
- [Правовое обеспечение и соблюдение нормативных требований | «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/legal-compliance/index.html): Узнайте о новых карьерных возможностях в нашем отделе по правовым вопросам и вопросам этического ведения бизнеса. (208 words)
- [Согласие на обработку персональных данных | Boehringer Ingelheim RU](/content/ru/soglasie-na-obrabotku-personalnykh-dannykh/index.html): Согласие на обработку персональных данных (212 words)
- [Вакансии в Дубае | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/dubai/index.html): Дубай — это центр нашей деятельности в регионе IMETA. Узнайте про карьерные возможности в ОАЭ или в 170 наших подразделений по всему миру. (171 words)
- [Корпоративные отношения | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/corporate-affairs/index.html): Узнайте о новых карьерных возможностях в сфере корпоративных коммуникаций. (502 words)
- [Вакансии в Бразилии | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/brazil/index.html): «Берингер Ингельхайм» работает в Бразилии более 70 лет. Узнайте про карьерные возможности в Бразилии или в 170 наших подразделениях по всему миру. (139 words)
- [Качество | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/quality/index.html): Узнайте о новых карьерных возможностях в нашем отделе качества. (95 words)
- [Корпоративная стратегия и консалтинг | «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/corporate-strategy-consulting/index.html): Узнайте о новых карьерных возможностях в сфере корпоративной стратегии и консалтинга. (105 words)
- [Vicadrostat (BI 690517) / empagliflozin | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/vicadrostat-bi-690517-empagliflozin-0/index.html): Vicadrostat (BI 690517) / empagliflozin (168 words)
- [Eye Health | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/eye-health/index.html): Human Pharma Clinical Pipeline Eye Health therapeutic area (189 words)
- [Пресс-релизы | Boehringer Ingelheim RU](/content/ru/press-relizy/index.html): Пресс-релизы (66 words)
- [Vicadrostat (BI 690517) / empagliflozin | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/vicadrostat-bi-690517-empagliflozin-1/index.html): Vicadrostat (BI 690517) / empagliflozin (135 words)
- [Vicadrostat (BI 690517) / empagliflozin | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/vicadrostat-bi-690517-empagliflozin/index.html): Vicadrostat (BI 690517) / empagliflozin (149 words)
- [BI 3032950: TREM-1 antagonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-3032950-trem-1-antagonist/index.html): BI 3032950: TREM-1 antagonist | inflammatory bowl disease (40 words)
- [Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-bi-1810631-her2-tyrosine-kinase-inhibitor-tki-2.html): Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) (130 words)
- [Гиотриф® | Boehringer Ingelheim RU](/content/ru/human-health/products/giotrif/index.html): Гиотриф® (63 words)
- [BI 771716: Antibody fragment | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-771716-antibody-fragment/index.html): Antibody fragment (255 words)
- [BI 1584862: Phospholipid modulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-1584862-phospholipid-modulator/index.html): Phospholipid modulator (262 words)
- [Pardon Our Interruption](/content/science-innovation/human-health-innovation/clinical-pipeline/respiratory/index.html) (110 words)
- [Vicadrostat (BI 690517) / empagliflozin | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/vicadrostat-bi-690517-empagliflozin-2/index.html): Vicadrostat (BI 690517) / empagliflozin (132 words)
- [Гликсамби® | Boehringer Ingelheim RU](/content/ru/human-health/products/gliksambi/index.html): Гликсамби® (39 words)
- [BI 1815368: Oral vascular modulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-1815368-oral-vascular-modulator/index.html): BI 1815368: Oral vascular modulator | Diabetic macular edema (309 words)
- [Атровент® | Boehringer Ingelheim RU](/content/ru/human-health/products/atrovent/index.html): Атровент® (38 words)
- [Глюренорм® | Boehringer Ingelheim RU](/content/ru/human-health/products/glyurenorm/index.html): Глюренорм® (30 words)
- [BI 3000202: Immunomodulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/bi-3000202-immunomodulator-0/index.html): BI 3000202: Immunomodulator | systemic lupus erythematosus (SLE) (576 words)
- [Беродуал® Н | Boehringer Ingelheim RU](/content/ru/human-health/products/berodual-n/index.html): Беродуал® Н (60 words)
- [Атровент® Н | Boehringer Ingelheim RU](/content/ru/human-health/products/atrovent-n/index.html): Атровент® Н (37 words)
- [Wereldwijde Biopharma Contract Manufacturing | Boehringer Ingelheim NL](/content/nl/samenwerking/biopharma-contract-manufacturing/index.html): Als een van de drie bedrijfsgebieden binnen Boehringer Ingelheim bieden wij de farmaceutische en biotechnologische industrie expertise op het gebied (96 words)
- [Nerandomilast (BI 1015550): PDE4B inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/nerandomilast-bi-1015550-pde4b-inhibitor/index.html): Nerandomilast (BI 1015550): PDE4B inhibitor (381 words)
- [Tenecteplase: Fibrinolytic | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/tenecteplase-fibrinolytic/index.html): Tenecteplase: Fibrinolytic | Acute ischemic stroke >4.5 h (50 words)
- [Pardon Our Interruption](/content/ru/schizophrenia/index.html) (110 words)
- [Pardon Our Interruption](/content/science-innovation/human-health-innovation/clinical-pipeline/cardiovascular-renal-metabolic/index.html) (110 words)
- [Survodutide (BI 456906): GCGR/GLP1 agonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/survodutide-bi-456906-gcgr-glp1-agonist/index.html): Survodutide (BI 456906): GCGR/GLP1 agonist | MASH (160 words)
- [Search | Boehringer Ingelheim BR](/content/br/search/index.html) (82 words)
- [Apecotrep (BI 764198): TRPC6 inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/apecotrep-bi-764198-trpc6-inhibitor/index.html): Apecotrep (BI 764198): TRPC6 inhibitor | Focal segmental glomerulosclerosis (204 words)
- [Nerandomilast (BI 1015550): PDE4B inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/nerandomilast-bi-1015550-pde4b-inhibitor-1/index.html): Nerandomilast (BI 1015550) (19 words)
- [Search | Boehringer Ingelheim CA](/content/ca/search/index.html) (339 words)
- [Survodutide (BI 456906): GCGR/GLP1 agonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/survodutide-bi-456906-gcgr-glp1-agonist-0/index.html): Survodutide (BI 456906): GCGR/GLP1 agonist | obesity (90 words)
- [Mental Health | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/mental-health/index.html): Human Pharma Clinical Pipeline Mental Health therapeutic area (214 words)
- [Pardon Our Interruption](/content/se/samarbete/kontraktstillverkning-av-biologiska-lakemedel/index.html) (110 words)
- [Verducatib (BI 1291583): DPP1/CatC Inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/verducatib-bi-1291583-dpp1-catc-inhibitor/index.html): BI 1291583: DPP1/CatC Inhibitor (36 words)
- [Apecotrep (BI 764198): TRPC6 inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/apecotrep-bi-764198-trpc6-inhibitor-0/index.html): Apecotrep (BI 764198): TRPC6 inhibitor | proteinuric kidney diseases (27 words)
- [Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-bi-1810631-her2-tyrosine-kinase-inhibitor-tki.html): Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) (158 words)
- [Informe de Sostenibilidad 2025 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/pdf/informe-de-sostenibilidad-2025/index.html): Informe de sostenibilidad Boehringer Ingelheim España 2025 (29 words)
- [Fabrication biopharmaceutique pour le compte de tiers | Boehringer Ingelheim FR](/content/fr/partenariats/fabrication-biopharmaceutique-pour-le-compte-de-tiers.html): Biopharma Contract Manufacturing (163 words)
- [General terms and Conditions | Boehringer Ingelheim IN](/content/in/general-terms-and-conditions/index.html): General terms and Conditions (3,819 words)
- [RECOMBITEK®C8 | Boehringer Ingelheim BR](/content/br/pdf/recombitekc8/index.html): Bula - RECOMBITEK®C8 (12 words)
- [Recombitek®C6/CV | Boehringer Ingelheim BR](/content/br/pdf/recombitekc6-cv/index.html): Bula Recombitek® C6 (12 words)
- [Recombitek®C4/Cv | Boehringer Ingelheim BR](/content/br/pdf/recombitekc4-cv/index.html): Nova bula atualizada. (12 words)
- [Recombitek Oral Bordetella | Boehringer Ingelheim BR](/content/br/pdf/recombitekoral-bordetella/index.html): Bula Recombitek® Oral Bordetella para o proprietário. Vacina contra Bordetella bronchiseptica, Cultivo Vivo Atenuado. (12 words)
- [Produkcja kontraktowa biofarmaceutyków | Boehringer Ingelheim PL](/content/pl/wspolpraca/produkcja-kontraktowa-biofarmaceutykow/index.html): Produkcja kontraktowa biofarmaceutyków (116 words)
- [Boehringer Ingelheim debate o papel da Inteligência Artificial no futuro da saúde | Boehringer Ingelheim PT](/content/pt/sobre-nos/boehringer-ingelheim-debate-o-papel-da-inteligencia-artificial-no-futuro-da-saude.html): No âmbito da comemoração dos 65 anos de vida e história em Portugal (750 words)
- [Fabrication contractuelle de produits biopharmaceutiques | Boehringer Ingelheim CA](/content/ca/fr/partenariats/fabrication-contractuelle-de-produits-biopharmaceutiques.html): Excellence biotechnologique avec Bioxcellence de Boehringer Ingelheim. Découvrez nos solutions de pointe pour la production de médicaments biologiques. (151 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim MEA](/content/mea/partnering/biopharma-contract-manufacturing/index.html): Biopharma Contract Manufacturing (102 words)
- [Frank Hübler | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (160 words)
- [Veterinary Product Adverse Events | Boehringer Ingelheim IE](/content/ie/contact-us/veterinary-product-adverse-events/index.html): Veterinary Product Adverse Events (247 words)
- [Психические заболевания | Boehringer Ingelheim RU](/content/ru/psikhicheskie-zabolevaniya/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (171 words)
- [Frank Hübler | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (121 words)
- [Press Releases | Boehringer Ingelheim UA](/content/ua/press-releases/index.html): Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (110 words)
- [Frank Hübler | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (168 words)
- [Dr Paola Casarosa | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (165 words)
- [Clinical Collaborations | Boehringer Ingelheim ZA](/content/za/clinical-collaborations/index.html): Clinical Collaborations (88 words)
- [Harsha Deshmukh | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (153 words)
- [Shashank Deshpande | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (187 words)
- [Michael Schmelmer | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (164 words)
- [Dr Armin Wiesler | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (154 words)
- [Annual Results Press Conference 2022 | Boehringer Ingelheim ZA](/content/za/annual-results-press-conference-2022/index.html): Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year. (140 words)
- [Press Releases | Boehringer Ingelheim ZA](/content/za/press-releases/index.html): Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (63 words)
- [Ветеринарні препарати для здоров'я тварин | Boehringer Ingelheim UA](/content/ua/veterinarni-preparati-dlya-zdorovya-tvarin/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products below. (154 words)
- [Aviso de Privacidade sobre Farmacovigilância | Boehringer Ingelheim PT](/content/pt/node/18230/index.html): Muito obrigado por notificar à Boehringer Ingelheim Portugal (Av. de Pádua nº 111800-294 Lisboa) eventos adversos (510 words)
- [Press Material | Boehringer Ingelheim ZA](/content/za/press-material/index.html): Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view BI corporate news. (54 words)
- [Michael Schmelmer | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (190 words)
- [Haftungsausschluss | Portal HCP | Boehringer Ingelheim](/content/pro/ch/external-link/index.html) (90 words)
- [Frank Hübler | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (161 words)
- [Dr Paola Casarosa | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (128 words)
- [Harsha Deshmukh | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (161 words)
- [Dia Mundial da Terra | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/mais-ambientalismo/dia-mundial-da-terra/index.html): Na Boehringer Ingelheim, o nosso pilar More Green, do nosso compromisso "Desenvolvimento Sustentável ao longo de Gerações", é um programa de longo prazo que engloba uma série de actividades implementadas há mais de uma década. (279 words)
- [Questions to ask to your doctor_BG | Boehringer Ingelheim BG](/content/bg/pdf/questions-ask-your-doctorbg/index.html) (66 words)
- [Press Releases | Boehringer Ingelheim IN](/content/in/press-releases/index.html): Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (106 words)
- [臨床試驗 Clinical Studies | Boehringer Ingelheim TW](/content/tw/linchuangshiyan-clinical-studies/index.html): 臨床試驗 (98 words)
- [Bronkiektasier | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/bronkiektasier/index.html): Bronkiektasier (154 words)
- [Science Stories | Boehringer Ingelheim TW](/content/tw/science-stories/index.html): Science and Innovation - Human Health Innovation - Science Stories (206 words)
- [Βρογχεκτασίες | Boehringer Ingelheim GR](/content/gr/human-health/lung-diseases/broghektasies/index.html): Οι βρογχεκτασίες είναι μια προοδευτική φλεγμονώδης αναπνευστική νόσος που χαρακτηρίζεται από μη αναστρέψιμη διεύρυνση των αεραγωγών, η οποία εμποδίζει την σωστή απομάκρυνση της βλέννας. (206 words)
- [Bronchiëctasieën | Boehringer Ingelheim BE](/content/be/nl/bronchiectasieen/index.html): Bronchiëctasieën (187 words)
- [Bronquiectasias | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-pulmonares/bronquiectasias/index.html): Bronquiectasias (254 words)
- [Supplier Support | Boehringer Ingelheim AU](/content/au/supplier-support/index.html): Supplier Support (693 words)
- [Dr Armin Wiesler | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Д-р Armin Wiesler – Член на Управителния съвет с отговорност за бизнес направлението „Здравеопазване на животните“ (157 words)
- [Informed Decision and safe use of medications BG | Boehringer Ingelheim BG](/content/bg/pdf/informed-decision-and-safe-use-medications-bg/index.html) (66 words)
- [What is being done for patient safety BG | Boehringer Ingelheim BG](/content/bg/pdf/what-being-done-patient-safety-bg/index.html) (66 words)
- [Press Kit Animal Health | Boehringer Ingelheim IN](/content/in/press-kit-animal-health/index.html): This press kit page comprises of downloads available for journalists looking for the latest information about the Boehringer Ingelheim Animal Health. (224 words)
- [Harsha Deshmukh | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Член на Управителния съвет с отговорност за ИТ и глобалните бизнес услуги (159 words)
- [Possesso Responsabile: educare oggi per prenderci cura del domani | Boehringer Ingelheim IT](/content/it/possesso-responsabile-educare-oggi-prenderci-cura-del-domani.html): Il rapporto tra persone e animali da compagnia è sempre più centrale nella nostra società: nelle famiglie italiane vivono quasi 21 milioni tra cani e gatti, segno di un legame profondo fatto di quotidianità, cura e dedizione. (483 words)
- [Ileite nel suino | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/suini/ileite-nel-suino/index.html): Ileite da Lawsonia intracellularis nel suino (1,299 words)
- [Сталий розвиток — наше зобов'язання | Boehringer Ingelheim UA](/content/ua/staliy-rozvitok-nashe-zobovyazannya/index.html): Ми хочемо створити цінність у сферах незадоволених медичних потреб і співпрацювати зі спільнотами та суспільством для покращення життя людей і тварин. (262 words)
- [Shashank Deshpande | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Председател на Управителния съвет с отговорност за бизнес направлението „Хуманна медицина“ (156 words)
- [Across Cancer Types | Boehringer Ingelheim TW](/content/tw/across-cancer-types/index.html): Across Cancer Types (148 words)
- [Michael Schmelmer | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Заместник-председател на Управителния съвет с отговорност за корпоративните функции (159 words)
- [Frank Hübler | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Член на Управителния съвет с отговорност за финансите (118 words)
- [За нас | Boehringer Ingelheim BG](/content/bg/about-us/index.html): Boehringer Ingelheim е глобална група от компании, чиято цел е да подобри живота на хората и животните. (214 words)
- [Partnering Interests | Boehringer Ingelheim AT](/content/at/en/partnering/human-health-partnering/partnering-interests/index.html): Boehringer Ingelheim partners across a variety of human health therapeutic areas and beyond. We’re modality agnostic and prefer to partner early. (814 words)
- [Nuove prospettive: perché la medicina veterinaria è molto più di quanto si possa pensare | Boehringer Ingelheim IT](/content/it/salute-animale/la-nostra-responsabilita/nuove-prospettive-perche-la-medicina-veterinaria-e-molto-piu-di-quanto-si-possa-pensare.html): Nuove prospettive: perché la medicina veterinaria è molto più di quanto si possa pensare (321 words)
- [Filariosi cardiopolmonare nel gatto: perché è diversa dal cane e cosa ci insegna lo studio epidemiologico | Boehringer Ingelheim IT](/content/it/filariosi-cardiopolmonare-nel-gatto-perche-e-diversa-dal-cane-e-cosa-ci-insegna-lo-studio.html): La filariosi cardiopolmonare è una malattia causata da un parassita (Dirofilaria immitis) che viene trasmesso dalle zanzare. È molto conosciuta nel cane, ma può colpire anche il gatto. (771 words)
- [Le voci delle Associazioni pazienti | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/fibrosi-polmonare/le-voci-delle-associazioni-pazienti/index.html): Le voci delle Associazioni pazienti (402 words)
- [Le Fibrosi polmonari | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/fibrosi-polmonare/le-fibrosi-polmonari/index.html): La fibrosi polmonare è il termine medico per indicare un accumulo di tessuto cicatriziale nel polmone. Nelle persone affette da fibrosi polmonare, i polmoni diventano cicatrizzati, ispessiti e rigidi. (1,372 words)
- [Новини | Boehringer Ingelheim BG](/content/bg/novini/index.html): Boehringer Ingelheim е една от водещите фармацевтични компании в света със 130-годишен опит в областта на научните изследвания. (232 words)
- [Хронічна хвороба нирок | Boehringer Ingelheim UA](/content/ua/human-health/khronichna-khvoroba-nirok/index.html): Chronic Kidney Disease (155 words)
- [Sobre nós | Boehringer Ingelheim PT](/content/pt/sobre-nos/index.html): A Boehringer Ingelheim é um grupo de empresas global, envolvendo diversas culturas e sociedades. Saiba mais sobre os destaques financeiros (256 words)
- [Humanmedizin | Boehringer Ingelheim CH](/content/ch/humanmedizin/index.html): Das verschreibungspflichtige Produktportfolio von Boehringer Ingelheim umfasst Herz-Kreislauf-, Onkologie-, Atemwegs-, ZNS-, Virologie- und Stoffwechselerkrankungen. (249 words)
- [Контакти | Boehringer Ingelheim UA](/content/ua/kontakti/index.html): Щоб зв'язатися з нами в компанії Boehringer Ingelheim, будь ласка, натисніть тут, щоб заповнити нашу контактну форму. Ми вітаємо всі запитання та відгуки. (107 words)
- [Сърдечна недостатъчност | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/heart-failure/index.html): Информационни и обучителни материали за сърдечна недостатъчност с намалена (СНнФИ) или запазена (СНзФИ) фракция на изтласкване. (255 words)
- [Pets | Boehringer Ingelheim IN](/content/in/animal-health/companion-animals/pets/index.html): We continuously innovate and expand our pet health solutions to address unmet needs. Click here to learn more about our work on pet health here. (280 words)
- [Кои сме ние | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/index.html): Подобряването на здравето и качеството на живот на хората и животните е цел на фармацевтичната компания Boehringer Ingelheim, която се занимава с научни изследвания. (89 words)
- [Accessibility Statement | Boehringer Ingelheim IN](/content/in/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible. (467 words)
- [Leadership | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (175 words)
- [Our FOCUS | Boehringer Ingelheim IN](/content/in/our-focus/index.html): Here we look at the importance of knowing your source when purchasing medicines to protect yourself. Click here to learn more about what you can do. (70 words)
- [ХОББ и астма | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/copd-asthma/index.html): Основните цели на лечението на ХОББ са да се ограничат симптомите, да се намали рискът от екзацербации и да се помогне на хората да водят по- (217 words)
- [Преса | Boehringer Ingelheim UA](/content/ua/media-0/index.html): Преса (18 words)
- [Tratamentos | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-animal/tratamentos/index.html): Proporcionamos uma abordagem científica disciplinada à descoberta global, desenvolvimento e entrega de terapêutica para animais de companhia e gado. (68 words)
- [Press Material | Boehringer Ingelheim AU](/content/au/press-material/index.html): Here you can access our Animal Health Press Kit and media pool with a comprehensive collection of Boehringer Ingelheim related media contents. (43 words)
- [Segurança | Referência Científica](/content/pro/br/taxonomy/term/6/index.html) (772 words)
- [Diretrizes | Referência Científica](/content/pro/br/taxonomy/term/58/index.html) (624 words)
- [Carreras más allá de las fronteras | Boehringer Ingelheim ES](/content/es/empleo/carreras-mas-alla-de-las-fronteras/index.html): Pia Schall ha visto la mobilidad como una oportunidad (649 words)
- [Responsable de Sistemas Informatizados de Laboratorio Job Details | BoehringerPRD](/content/jobs/job-invite/35051/index.html): Sant Cugat del Vallès Responsable de Sistemas Informatizados de Laboratorio - Spai (630 words)
- [Thorsten Von Gossel | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/thorsten-von-gossel/index.html): Thorsten Von Gossel, de Ingeniería e Instalaciones, describe a Boehringer Ingelheim como una empresa familiar con una perspectiva a largo plazo y un maravilloso equipo de liderazgo. (29 words)
- [Cumplimiento de Calidad de Producto - Validaciones asépticas Job Details | BoehringerPRD](/content/jobs/job-invite/35050/index.html): Sant Cugat del Vallès Cumplimiento de Calidad de Producto - Validaciones asépticas - Spai (616 words)
- [Representante Técnico Comercial- Canal Veterinario (GBA Sur) Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36288/index.html): Buenos Aires Representante Técnico Comercial- Canal Veterinario (GBA Sur) - Arge (473 words)
- [Process Expert Aseptics Project Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35527/index.html): Sant Cugat del Vallès Process Expert Aseptics Project - Espa (631 words)
- [Sr Risk and Compliance Analyst (Third Party Risk) Job Details | BoehringerPRD](/content/jobs/job-invite/36086/index.html): Buenos Aires Sr Risk and Compliance Analyst (Third Party Risk) - Arge (646 words)
- [Experto/a en Proceso Sólidos Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35407/index.html): Sant Cugat del Vallès Experto/a en Proceso Sólidos - Espa (504 words)
- [Jan-Erik Schafer | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/jan-erik-schafer/index.html): Jan Erik, líder sénior del equipo en la producción farmacéutica upstream, habla sobre su carrera motivadora y divertida en Boehringer Ingelheim. (115 words)
- [Key Institutional Manager (KIM) - Bs. As. Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35539/index.html): Buenos Aires Key Institutional Manager (KIM) - Bs. As. - Arge (603 words)
- [SR Risk and Compliance Analyst (Third Party Risk) Job Details | BoehringerPRD](/content/jobs/job-invite/36085/index.html): Buenos Aires SR Risk and Compliance Analyst (Third Party Risk) - Arge (670 words)
- [Dominik Huber | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/dominik-huber/index.html): Nuestro Jefe de Upstream Manufacturing en Viena, Dominik Huber, ha desarrollado toda su carrera de alto nivel en Boehringer Ingelheim. (532 words)
- [Senior Internal Investigator Job Details | BoehringerPRD](/content/jobs/job-invite/36089/index.html): Buenos Aires Senior Internal Investigator - Arge (631 words)
- [Bok Oh | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/bok-oh/index.html): Impactando millones de personas con Bok Oh (116 words)
- [Georgina Perez | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/georgina-perez/index.html): Georgina Perez nos cuenta su día a día como becario en el departamento de Trade (295 words)
- [Accounts Payable Analyst Job Details | BoehringerPRD](/content/jobs/job-invite/35890/index.html): Buenos Aires Accounts Payable Analyst - Arge (434 words)
- [Albert Paul | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/albert-paul/index.html): Albert Paul habla sobre su papel en Fabricación y Suministro y lo que sigue para él en el futuro. (29 words)
- [Carreras tempranas | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/carreras-tempranas/index.html): Empieza tu carrera profesional de la mano de Boehringer Ingelheim. Descubre interesantes oportunidades para estudiantes y recién graduados. ¡Únete ahora! (218 words)
- [Dr Paola Casarosa | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (154 words)
- [Harsha Deshmukh | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (161 words)
- [Dr Armin Wiesler | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (190 words)
- [Frank Hübler | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (160 words)
- [Michael Schmelmer | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (202 words)
- [Metabolik Hastalıklar | Boehringer Ingelheim TR](/content/tr/human-health/metabolic-diseases/metabolik-hastaliklar/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 20451. Type 2 diabetes is a chronic, (66 words)
- [Francia | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/francia/index.html): Boehringer Ingelheim ha tenido presencia en Francia desde 1967. Explora las oportunidades de desarrollo profesional vigentes en Francia. (334 words)
- [Salesforce Marketing Cloud Lead Job Details | BoehringerPRD](/content/jobs/job-invite/34011/index.html): Barcelona Salesforce Marketing Cloud Lead - Spai (471 words)
- [Yanina Donatini | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/yanina-donatini/index.html): Yanina Donatini, directora de producción de contenido de ITM&S en Boehringer Ingelheim habla de sus 20 años en la empresa como innovadores y diversos. (494 words)
- [EE. UU. | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/ee-uu/index.html): Estados Unidos es una de nuestras regiones más exitosas e innovadoras. Explora ahora qué oportunidades de desarrollo profesional hay disponibles en los EE. UU. (361 words)
- [Proposito Video Instalaciones Ingenieria | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/proposito-video-instalaciones-ingenieria/index.html): Simon Heinrich, ingeniero de automatización nos habla del departamento de Ingeniería e Instalaciones de Boehringer Ingelheim. (75 words)
- [Galym Zhunisbekov | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/galym-zhunisbekov/index.html): Galym Zhunisbekov, Gerente Regional de Asuntos Regulatorios en Europa del Este, habla sobre nuestra filosofía y el impacto en la vida de los pacientes. (212 words)
- [Matthias Muenks | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/matthias-muenks/index.html): Matthias Muenks, Global Engineering Process and Data Manager de Boehringer Ingelheim, habla sobre la innovación y la cultura de nuestra compañía. (331 words)
- [México | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/mexico/index.html): México alberga dos de nuestras modernas plantas de producción. Explora ahora las oportunidades de desarrollo profesional en México. (257 words)
- [IT Laboratory Data & Digital Solutions Specialist Job Details | BoehringerPRD](/content/jobs/job-invite/35324/index.html): Sant Cugat del Vallès IT Laboratory Data & Digital Solutions Specialist - Spai (783 words)
- [Proposito Video Regulacion Medicina | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/proposito-video-regulacion-medicina/index.html): Taimi Sahlin, especialista en terapia de Boehringer Ingelheim Canada, describe su carrera como desafiante y motivadora. (73 words)
- [Nelli Milosch | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/nelli-milosch/index.html): Nelli Milosch, líder de nuestro equipo médico de campo en Alemania, dice que la gente es lo mejor de trabajar en Boehringer Ingelheim. (140 words)
- [Sobre Salud Animal | Boehringer Ingelheim ES](/content/es/sobre-salud-animal/index.html): BI Salud Animal es el segundo negocio de salud animal más grande del mundo. Destacamos especialmente en vacunas y productos farmacológicos. (168 words)
- [Christian Betz | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/christian-betz/index.html): Christian Betz comparte su experiencia al frente del equipo de ingeniería de procesos en el site de Boehringer Ingelheim en Biberach, Alemania. (94 words)
- [Singapur | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/singapur/index.html): Nuestra sede en Singapur es el centro de la región del Pacífico. Explora las oportunidades activas de desarrollo profesional hoy en Singapur. (176 words)
- [España | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/espana/index.html): La sede de España alberga los Servicios de Asuntos Regulatorios y dos centros tecnológicos. Explora qué oportunidades profesionales te ofrece España. (262 words)
- [Alemania | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/alemania/index.html): Alemania, donde comenzó la historia de Boehringer Ingelheim, sigue siendo nuestra sede mundial. Explora las oportunidades laborables disponibles en Alemania. (242 words)
- [Países Bajos | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/paises-bajos/index.html): Nuestra instalación de Ámsterdam es uno de nuestros principales centros de operaciones en Europa. Mira ahora las oportunidades disponibles en los Países Bajos. (180 words)
- [Dubái | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/dubai/index.html): Dubai está en el corazón de nuestra región IMETA. Explora las oportunidades de desarrollo profesional activas en los Emiratos Árabes Unidos. (232 words)
- [Kroonisesta munuaistaudista | Boehringer Ingelheim FI](/content/fi/kroonisesta-munuaistaudista/index.html): Kroonisesta munuaistaudista (381 words)
- [Propósito Video IT | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/proposito-video-it/index.html): Agustina Rojo, analista de sistemas en Buenos Aires, Argentina, explica las numerosas oportunidades profesionales que Boehringer Ingelheim ofrece a sus empleados. (76 words)
- [Anna Race | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/anna-race/index.html): La directora de ventas de Human Pharma para el Reino Unido e Irlanda, Anna Race, comenta cómo le gusta marcar la diferencia dentro de la empresa. (506 words)
- [Delegado/a Visita Médica - Guipúzcoa Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35774/index.html): San Sebastián Delegado/a Visita Médica - Guipúzcoa - Espa (510 words)
- [Austria | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/austria/index.html): Viena fue nuestro primer sitio fuera de Alemania. Explora todas las oportunidades de desarrollo profesional activas hoy en Austria. (158 words)
- [Tu compensación | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/tu-compensacion/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (318 words)
- [Proposito Video Comercial | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/proposito-video-comercial/index.html): Un video que explora nuestro propósito y por qué hacemos lo que hacemos. (107 words)
- [NASH | Boehringer Ingelheim TW](/content/tw/nash/index.html): 非酒精性脂肪性肝炎 (162 words)
- [Dirk Esser | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/dirk-esser/index.html): Dirk Esser habla sobre su carrera de 12 años en Boehringer Ingelheim y las diversas oportunidades de crecimiento. (63 words)
- [Tu formación y desarrollo | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/tu-formacion-y-desarrollo/index.html): At Boehringer Ingelheim, we support people throughout their professional development – giving our employees room for learning and growth to achieve their career goals. (258 words)
- [Irene Anindita | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/irene-anindita/index.html): Irene Anindita es directora multicanal del equipo cardiovascular y de metabolismo en Ámsterdam, Países Bajos, y le encanta el ambiente. (18 words)
- [Tus beneficios y bienestar | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/tus-beneficios-y-bienestar/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (284 words)
- [Thorsten Von Gossel | Boehringer Ingelheim BR](/content/br/carreiras/thorsten-von-gossel/index.html): Thorsten von Gossel, da área de Engenharia e Instalações, descreve a Boehringer Ingelheim como um negócio familiar com perspetiva de longo prazo e uma maravilhosa equipa de liderança. (134 words)
- [Trastornos psicóticos | Boehringer Ingelheim ES](/content/es/node/31372/index.html): Trastornos psicóticos (985 words)
- [Mobile World Congress 2024 | Boehringer Ingelheim ES](/content/es/mobile-world-congress-2024/index.html): Mobile World Congress 2024 (221 words)
- [Instalaciones Ingeniería | Boehringer Ingelheim BR](/content/br/carreiras/instalaciones-ingenieria/index.html): Simon Heinrich, ingeniero de automatización nos habla del departamento de Ingeniería e Instalaciones de Boehringer Ingelheim. (91 words)
- [Imagine: sivusto kestävän kehityksen tarinoillemme | Boehringer Ingelheim FI](/content/fi/imagine-sivusto-kestavan-kehityksen-tarinoillemme/index.html): Tutustu miten edistämme myönteistä muutosta ja kehitämme terveydenhuoltoa kohti parempaa tulevaisuutta. (60 words)
- [Matías Muenks | Boehringer Ingelheim BR](/content/br/carreiras/matias-muenks/index.html): Matthias Muenks, Gestor de dados e do processo de engenharia global na Boehringer Ingelheim, fala sobre a inovação e a cultura da empresa farmacêutica. (313 words)
- [Asesoría Jurídica y Cumplimiento | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/asesoria-juridica-y-cumplimiento/index.html): Asesoría Jurídica y Cumplimiento (244 words)
- [Consultoria Estrategia Corporativa | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/consultoria-estrategia-corporativa/index.html): Descubre nuevas oportunidades en nuestra Estrategia Corporativa y Consultoría, y postúlate hoy. (251 words)
- [Recursos Humanos, Finanzas y Organización | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/recursos-humanos-finanzas-y-organizacion/index.html): Descubre nuevas oportunidades en nuestros departamentos de Recursos Humanos, Finanzas y Organización. Descubre la oportunidad que te va a entusiasmar. (139 words)
- [Comunicación Asuntos Corporativos | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/comunicacion-asuntos-corporativos/index.html): Descubre nuevas oportunidades en nuestros Asuntos Corporativos, y postúlate hoy. (223 words)
- [Harsha Deshmukh | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (192 words)
- [Investigación y Desarrollo | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/investigacion-y-desarrollo/index.html): Descubre nuevas oportunidades en nuestro departamento de Investigación y Desarrollo. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (219 words)
- [Dr Paola Casarosa | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (165 words)
- [Shashank Deshpande | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (184 words)
- [Michael Schmelmer | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (202 words)
- [Dr Armin Wiesler | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (161 words)
- [Analista de Processos de Embalagens Sr Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/33584/index.html): Paulínia Analista de Processos de Embalagens Sr - Bras (545 words)
- [Analista de Melhoria Contínua Sênior Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/34286/index.html): Paulínia Analista de Melhoria Contínua Sênior - Bras (517 words)
- [Yanina Donatini | Boehringer Ingelheim BR](/content/br/carreiras/yanina-donatini/index.html): Yanina Donatini, Responsável pela produção de conteúdos TI e M&S na Boehringer Ingelheim fala dos seus 20 anos na empresa como sendo inovadores e diversificados. (358 words)
- [Vídeo ID | Boehringer Ingelheim BR](/content/br/carreiras/video-id/index.html): El Prof. Eric Haaksma habla sobre su carrera y la misión de Boehringer Ingelheim de transformar vidas para las generaciones futuras. (114 words)
- [Nuestro Propósito | Boehringer Ingelheim BR](/content/br/carreiras/nuestro-proposito/index.html): Comienza una carrera con propósito y explora nuevas oportunidades laborales en Boehringer Ingelheim. (75 words)
- [Maria Wlaschitz | Boehringer Ingelheim BR](/content/br/carreiras/maria-wlaschitz/index.html): Eva-Maria Wlaschitz, cientista de desenvolvimento na Boehringer Ingelheim em Viena, Áustria, fala sobre as inúmeras oportunidades de crescimento. (161 words)
- [Anna Race | Boehringer Ingelheim BR](/content/br/carreiras/anna-race/index.html): A Diretora de Vendas da área da Indústria Farmacêutica Humana para o Reino Unido e Irlanda, Anna Race, diz como gosta de fazer a diferença dentro da empresa. (463 words)
- [Jan Erik Schafer | Boehringer Ingelheim BR](/content/br/carreiras/jan-erik-schafer/index.html): Jan Erik, Líder sénior de equipa na produção farmacêutica a montante fala sobre a sua motivação e na agradável carreira na Boehringer Ingelheim. (170 words)
- [Dominik Huber | Boehringer Ingelheim BR](/content/br/carreiras/dominik-huber/index.html): O nosso Responsável pelo fabrico a montante em Viena, Dominik Huber, construiu toda a sua carreira de alto nível na Boehringer Ingelheim. (492 words)
- [Albert Paul | Boehringer Ingelheim BR](/content/br/carreiras/albert-paul/index.html): Albert Paul fala sobre o seu papel na área da Fabrico & Abastecimento e sobre o que futuro próximo lhe reserva. (83 words)
- [Banco exclusivo para profissionais com deficiência (negócio Saúde Humana) Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/32261/index.html): São Paulo Banco exclusivo para profissionais com deficiência (negócio Saúde Humana) - Bras (516 words)
- [Consultor(a) de Real World Evidence (RWE) e External Collaboration Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35981/index.html): São Paulo Consultor(a) de Real World Evidence (RWE) e External Collaboration - Bras (479 words)
- [Gerente Sr. de Assuntos Médicos - Obesidade Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35803/index.html): São Paulo Gerente Sr. de Assuntos Médicos - Obesidade - Bras (507 words)
- [Boehringer Ingelheim Pro | HCP Portal | Medical Information](/content/pro/uk/index.html): Medical information for HCPs by Boehringer Ingelheim Pro. Enhance your practice & patient consultation. UK HCPs only. (160 words)
- [Veterinærer gir alt og litt til | Boehringer Ingelheim NO](/content/no/dyrehelse/fremhevede-historier/veterinaerer-gir-alt-og-litt-til/index.html): Veterinærer presser seg ofte til det ytterste. Gir vi dem nok anerkjennelse for dette? (784 words)
- [Nelli Milosh | Boehringer Ingelheim BR](/content/br/carreiras/nelli-milosh/index.html): Nelli Milosch, líder da equipa médica no terreno na Alemanha, diz que as pessoas são a melhor parte de trabalhar na Boehringer Ingelheim. (67 words)
- [“Dette er en arbeidsplass som er tilpasset menneskene” | Boehringer Ingelheim NO](/content/no/dette-er-en-arbeidsplass-som-er-tilpasset-menneskene.html): Karrierer (850 words)
- [Aviso legal | Referência Científica](/content/pro/br/external-link/index.html) (85 words)
- [PPG Ahora | Boehringer Ingelheim México](/content/pro/mx/ppg-ahora/index.html): Bienvenido al sitio especializado en Psoriasis Pustular Generalizada (PPG). Encuentre recursos útiles para su práctica clínica diaria. (512 words)
- [Dirk Stenkamp | Boehringer Ingelheim BR](/content/br/carreiras/dirk-stenkamp/index.html): Dirk Stenkamp, Vice-Presidente Sénior da Unidade de Investigação na Alemanha, fala sobre a colaboração e a paixão pelo progresso que fazem de nós quem somos. (250 words)
- [Michael Schmelmer | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/michael-schmelmer/index.html): Michael Schmelmer - az ügyvezető igazgatóság alelnöke, a vállalatcsoporti funkciókért felelős vezető (187 words)
- [Edda Dankmeyer | Boehringer Ingelheim BR](/content/br/carreiras/edda-dankmeyer/index.html): Edda Dankmeyer lidera a divisão de Comunicações de Desenvolvimento Sustentável e explica como o desenvolvimento sustentável pode ser um diferenciador chave para a empresa. (636 words)
- [Tereza Urbankova | Boehringer Ingelheim BR](/content/br/carreiras/tereza-urbankova/index.html): Tereza Urbankova, gestora sénior em Relações com os meios de comunicação globais, diz que as equipas sentem-se muito unidas e apoiam-se sempre mutuamente. (110 words)
- [Karla Alvarez | Boehringer Ingelheim BR](/content/br/carreiras/karla-alvarez/index.html): Karla Alvarez fala sobre a sua carreira na área dos dados em Barcelona, Espanha, e sobre o ambiente vibrante e internacional na Boehringer Ingelheim. (137 words)
- [Shannon Rountos | Boehringer Ingelheim BR](/content/br/carreiras/shannon-rountos/index.html): Shannon Rountos, Chefe de Imprensa sobre Assuntos Corporativos, fala sobre a sua carreira gratificante e satisfatória na Boehringer Ingelheim. (101 words)
- [Ο συνεργάτης σας στην καθημερινή πρακτική](/content/pro/gr/index.html): Καλωσορίσατε στη σελίδα της Boehringer Ingelheim για Επαγγελματίες Υγείας. (104 words)
- [Simon Manyara | Boehringer Ingelheim BR](/content/br/carreiras/simon-manyara/index.html): Simon Manhara trabalha com a nossa equipa de cultura e sustentabilidade para ter um impacto social positivo e criar um futuro sustentável. (140 words)
- [Alex Breiner | Boehringer Ingelheim BR](/content/br/carreiras/alex-breiner/index.html): Alex Breiner, Gestor Sénior de Comunicações em Assuntos Corporativos, destaca a sua carreira e os muitos programas de desenvolvimento na Boehringer Ingelheim. (124 words)
- [Il portale medico esclusivo per il settore sanitario | Medaffairs](/content/pro/it/medaffairs/index.html): Med Affairs: il portale medico per aggiornamenti su aree terapeutiche come fibrosi progressive, oncologia, cardio renale, psichiatria e dermatologia. (401 words)
- [Patricia Rangel | Boehringer Ingelheim BR](/content/br/carreiras/patricia-rangel/index.html): Patricia Rangel, da divisão de Consultoria e Estratégia Corporativa, descreve a Boehringer Ingelheim como uma empresa familiar que opera com os mais elevados padrões de integridade. (109 words)
- [Raúl Prasad | Boehringer Ingelheim BR](/content/br/carreiras/raul-prasad/index.html): Rahul J. Prasad, Consultor Sénior na área de Consultoria e Estratégia Corporativa, descreve o seu trabalho como um trabalho que se adequa às suas duas paixões: análise de dados e variedade. (440 words)
- [Christiane Wijsen | Boehringer Ingelheim BR](/content/br/carreiras/christiane-wijsen/index.html): Christiane Wijsen fala sobre a chefia da divisão de Consultoria e Estratégia Corporativa. (109 words)
- [Dr Armin Wiesler | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/dr-armin-wiesler/index.html): Dr Armin Wiesler - Az ügyvezető igazgatóság tagja, az Állategészségügyi üzletágért felelős üzlei egység vezető (182 words)
- [Harsha Deshmukh | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/harsha-deshmukh/index.html): Harsha Deshmukh - Az ügyvezető igazgatóság tagja, az Információs technológiai területért és a globális üzleti szolgáltatásokért felelős vezető (154 words)
- [Shashank Deshpande | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/shashank-deshpande/index.html): Shashank Deshpande – az ügyvezető igazgatóság elnöke, a Human Pharma üzletágért felelős vezető (154 words)
- [Frank Hübler | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/frank-hubler/index.html): Frank Hübler - Az ügyvezető igazgatóság tagja, a pénzügyi területért felelős vezető. (125 words)
- [Side Effects Reporting | Boehringer Ingelheim](/content/side-effects-reporting/index.html): Side Effects Reporting (244 words)
- [Anna Mistrioti | Boehringer Ingelheim BR](/content/br/carreiras/anna-mistrioti/index.html): Anna Mistrioti fala sobre trabalhar como Responsável pela Conformidade do Controlo de Qualidade na Boehringer Ingelheim, na fábrica de Koropi na Grécia. (104 words)
- [Partnerség az állategészségügyi innovációért | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-allatgyogyaszat/partnererdekek-allatgyogyaszat/index.html): Fedezze fel a Boehringer Ingelheim állategészségügyi partnerségi területeit, beleértve a fertõzõ betegségeket, a nem fertõzõ betegségeket és a nem betegségspecifikus fókuszterületeket. (655 words)
- [Hasznalati Szabalyzat | Boehringer Ingelheim HU](/content/hu/hasznalati-szabalyzat/index.html): Hasznalati Szabalyzat (1,113 words)
- [Állategészségügyi partnerség | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-allatgyogyaszat/index.html): Ismerje meg a Boehringer Ingelheim együttműködésen alapuló megközelítését az állategészségügyi innováció terén, partnerségi érdeklődési területeinket, valamint azt, hogyan veheti fel a kapcsolatot csapatunkkal. (424 words)
- [Kvalitet hos Boehringer Ingelheim | Boehringer Ingelheim NO](/content/no/om-oss/kvalitet/index.html): Kvalitet hos Boehringer Ingelheim (221 words)
- [Boehringer Ingelheim Cares Foundation | Boehringer Ingelheim US](/content/us/boehringer-ingelheim-cares-foundation/index.html): Boehringer Cares works to strengthen communities by improving the health and well-being of people and animals. (349 words)
- [Partnerségi történetek | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-allatgyogyaszat/partnersegi-tortenetek/index.html): Olvasson Boehringer Ingelheim néhány legjelentősebb állategészségügyi együttműködéséről, és hallgassa meg, mit mondanak partnereink a velünk való közös munkáról (316 words)
- [Om oss | Boehringer Ingelheim NO](/content/no/om-oss/index.html): Boehringer Ingelheim er en global gruppe av selskaper som omfatter mange kulturer og ulike samfunn. (237 words)
- [Christian Betz | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/christian-betz/index.html): Christian Betz shares his experience leading the process engineering team at Boehringer Ingelheim site in Biberach, Germany. (36 words)
- [Her finner du oss | Boehringer Ingelheim NO](/content/no/om-oss/her-finner-du-oss/index.html): Med 54 000 ansatte over hele verden har Boehringer Ingelheim et forsknings- og produksjonsnettverk over hele verden. Her er våre største avdelinger. (331 words)
- [Stretnime sa | Boehringer Ingelheim SK](/content/sk/stretnime-sa/index.html): Náš globálny partnerský tím je prítomný vo všetkých regiónoch sveta. (61 words)
- [Daniel Kiesenhofer | Boehringer Ingelheim BR](/content/br/carreiras/daniel-kiesenhofer/index.html): Daniel Kiesenhofer fala sobre o seu papel como Gestor de projeto na área de Controlo da Qualidade na Boehringer Ingelheim em Viena, Áustria. (77 words)
- [Our FOCUS: il nostro modello culturale | Boehringer Ingelheim IT](/content/it/our-focus-il-nostro-modello-culturale/index.html): Our FOCUS (283 words)
- [Transparency | Boehringer Ingelheim UK](/content/uk/about-us/ethics-compliance/transparency/index.html): We firmly believe in transparency. Click here to find out information on Boehringer Ingelheim's public disclosure of clinical trial data and more. (68 words)
- [Etikk og compliance | Boehringer Ingelheim NO](/content/no/om-oss/etikk-og-etterlevelse/index.html): Ethics & Compliance Åpenhet og samarbeid For Boehringer Ingelheim er det viktig å sikre at allmennheten har tillit til våre relasjoner til helsepersonell. (214 words)
- [Hjertesvikt | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/hjertesvikt/index.html): Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction. (189 words)
- [Perspektívák | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-allatgyogyaszat/perspektivak/index.html): Nyerjen betekintést az állategészségügyi ágazatba, és olvassa el a Boehringer Ingelheim szakértőinek nézőpontjait az együttműködés fontosságáról az innováció előmozdításában. (338 words)
- [Kapcsolatba lép velünk | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-allatgyogyaszat/kapcsolatba-lep-velunk/index.html): Lépjen kapcsolatba a Boehringer Ingelheim Állategészségügyi Üzletfejlesztési és Engedélyezési csapatával online vagy rendezvényeken, hogy javaslatot nyújtson be, vagy megvitassa a partnerségi lehetőségeket. (257 words)
- [Menneskelig helse | Boehringer Ingelheim NO](/content/no/menneskelig-helse/index.html): Boehringer Ingelheim er en forskningsdrevet gruppe selskaper som er dedikert til oppdagelse, produksjon og markedsføring av innovative helseprodukter. (106 words)
- [Hvem vi er | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/index.html): Boehringer Ingelheim jobber med banebrytende behandlinger som forvandler liv, i dag og i generasjoner fremover. (130 words)
- [Veterinary Product Adverse Events | Boehringer Ingelheim](/content/contact-us/veterinary-product-adverse-events/index.html): Veterinary Product Adverse Events (189 words)
- [Innkjøp hos Boehringer Ingelheim | Boehringer Ingelheim NO](/content/no/om-oss/innkjop/index.html): Leverandører er en integrert del av vår forpliktelse til suksess. Vi brenner for å finne innovative løsninger og nye muligheter for å vurdere. (119 words)
- [MER HELSE for mennesker og dyr | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/mer-helse/index.html): Et langsiktig initiativ med mål om å forbedre helsen i lokalsamfunn rundt om i verden ved å identifisere og støtte de mest lovende løsningene. (151 words)
- [Vårt engasjement | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/vart-engasjement/index.html): Vår reise handler om å drive innovasjon, å skape verdier på områder med udekkede medisinske behov og engasjere oss i lokalsamfunn. (66 words)
- [Bærekraftig utvikling | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/index.html): Hos Boehringer Ingelheim handler «Bærekraftig utvikling – for generasjoner» om reisen. En reise som startet i 1885 og som vi håper, og tror, (120 words)
- [Leadership | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Større potensial: for samfunn og våre mennesker | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/storre-potensial/index.html): For samfunn og våre mennesker. Samfunnet fortsetter å møte utfordringer fra helse, til utdanning, arbeidsutsikter, levekår, ulikheter og fattigdom. (131 words)
- [Über uns | Boehringer Ingelheim CH](/content/ch/ueber-uns/index.html): Über uns (195 words)
- [Historie | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/historie/index.html): I 1885 grunnla Albert Boehringer (1861–1939) det farmasøytiske selskapet Boehringer Ingelheim i Nieder-Ingelheim, i dag en del av Ingelheim am Rhein. (70 words)
- [Állatgyógyászat | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/index.html): Ismerje meg a Boehringer Ingelheim állatgyógyászat terén végzett tevékenységét és állatgyógyászati termékeit! (259 words)
- [COPD & Asztma | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/copdasztma/index.html): Olvassa el a Boehringer Ingelheim legfrissebb cikkeit a COPD és asztma témakörben! Tudjon meg többet a területen végzett munkánkról! (215 words)
- [Kutatás és fejlesztés | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/index.html): Olvasson a Boehringer Ingelheim tudományos munkájáról, valamint a kutatás és fejlesztés terén hozott innovációinkról! (129 words)
- [Együttműködés - Humángyógyászat | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-humangyogyaszat-teruleten/index.html): Itt megtalálja összes elérhetőségünket, valamint a legfrissebb híreket arról, hogy hol találkozhat velünk virtuálisan vagy személyesen. Továbbá megtudhatja, hogyan nyújthatja be kérelmét üzletfejlesztési és engedélyezési csapatunk egyikének. (121 words)
- [Switching market | Boehringer Ingelheim NO](/content/no/disclaimer/market/index.html) (27 words)
- [Tüdőfibrózis | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/tudofibrozis/index.html): Olvasson a tüdőfibrózis területén végzett munkánkról! A tüdőfibrózis egy élethosszig tartó tüdőbetegség, mely során a tüdőben lévő szövet megvastagodik. (164 words)
- [Mentális betegségek | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/mentalis-egeszseg/index.html): Ismerje meg a mentális egészséggel foglalkozó részlegünk munkáját, és tudjon meg többet innovatív megoldásainkról a mentális betegségekkel élők számára! (160 words)
- [Compliance és etika | Boehringer Ingelheim HU](/content/hu/rolunk/compliance-es-etika/index.html): Compliance és etika (74 words)
- [Együttműködés | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/index.html): Üdvözöljük a Boehringer Ingelheim „Együttműködés” oldalán, ahol megismerheti a kutatás-fejlesztés terén végzett munkánkat a humán- és állatgyógyászatban! (124 words)
- [Szembetegségek/ retinális betegségek | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/retina-betegsegek/index.html): A Boehringer Ingelheimnél kiterjesztettük globális kutatási és fejlesztési tevékenységünket a szembetegségekkel való harc felvételére. A látássérülés és a vakság mélyreható és pusztító hatással van az érintett személy életére. (115 words)
- [Bronchiectasia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/bronchiectasia/index.html): Bronchiectasia (172 words)
- [Szívelégtelenség | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/szivelegtelenseg/index.html): Tudjon meg többet a szívelégtelenségről és a koszorúér-betegségről, valamint a Boehringer Ingelheim ezen a területen végzett munkájáról! (168 words)
- [szélütés | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/szelutes/index.html): Olvasson a Boehringer Ingelheim szélütéssel kapcsolatos munkájáról. Az egyik leggyakoribb stroke az agyi érben található vérrög következtében történik. (105 words)
- [Állatgyógyászat: a Mi Felelősségünk | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/allategeszsegugy-mi-felelossegunk/index.html): One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health. (118 words)
- [Anyagcsere betegségek | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/index.html): Tudjon meg többet munkánkról a diabetológia területén! Holisztikus szemlélettel közelítjük meg az anyagcsere-betegséggel élők terápiás szükségleteit. (64 words)
- [Klinikai vizsgálatok | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/klinikai-vizsgalatok/index.html): Kattintson ide, hogy megtudja, milyen fontosak a klinikai vizsgálatok az új gyógyszerek kifejlesztésében, és nézzen meg néhányat a Boehringer Ingelheim által szponzorált klinikai vizsgálatok közül. (52 words)
- [Amit a partnereink mondanak | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-humangyogyaszat-teruleten/amit-partnereink-mondanak/index.html): Partnereink véleménye Partnereinkkel közös elképzelésünk, hogy változtatni akarunk, és olyan új, korszerű gyógyszereket akarunk kifejleszteni, amelyek valódi hatást gyakorolnak a betegek életére. Hallgassa meg, mit mondanak a velünk közös partneri útjukró (53 words)
- [Haszonállatok | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/haszonallatok/index.html): Ismerje meg a Boehringer Ingelheim munkáját a haszonállatok egészségének területén. Világszerte az élelmiszerbiztonság javításán dolgozunk. (28 words)
- [Tüdőgyógyászat | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/index.html): A Boehringer Ingelheim már 100 éves tapasztalattal bír a tüdőgyógyászat terén. Fókuszunk a légúti betegségben szenvedő betegek életminőségének javítása. (63 words)
- [Állategészségügy innováció | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/globalis-innovacio-allategeszsegugy/index.html): Globális innovációs csapatunk úttörő szerepet tölt be abban a tudományban, amely világszerte segít az állatorvosoknak, a kisállat- és állattartóknak, valamint a közegészségügyi tisztviselőknek az állatok egészségének javításában ma és a jövőben. (66 words)
- [Szkleroderma | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/szkleroderma/index.html): Szkleroderma | Szisztémás szklerózis | Boehringer Ingelheim HU (85 words)
- [Szarvasmarha | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/haszonallatok/szarvasmarha/index.html): Kérdései vannak a szarvasmarhák egészségéről? Tudja meg, mit tesz a Boehringer Ingelheim a marhahús fogyasztásának biztonsága érdekében világszerte! (44 words)
- [Diabetológia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/diabetesz/index.html): Tudta, hogy a cukorbetegség a világon 425 millió embert érint? Ismerje meg a Boehringer Ingelheim termékeit és a diabétesz területén végzett munkáját! (114 words)
- [Együttműködési kultúránk | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-humangyogyaszat-teruleten/egyuttmukodesi-kulturank/index.html): Partnereink értékes közreműködők globális innovációs családunkban. Hosszú távú kutatási és beruházási fókuszunk azt jelenti, hogy együtt dolgozhatunk az ötleteik megvalósításán azáltal, hogy teljes mértékben elkötelezzük magun (49 words)
- [Szárnyasok | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/haszonallatok/szarnyasok/index.html): Ismerje meg a Boehringer Ingelheim tevékenységét a baromfibetegségek megelőzése és kezelése területén: diagnosztika, vakcinák, kutatás stb. (96 words)
- [MASH | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/mash/index.html): Tudjon meg többet a nem alkoholos steatohepatitis (NASH) nevű anyagcsere-betegségről, ha ide kattintva ellátogat a Boehringer Ingelheim oldalára. (109 words)
- [Lovak | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/tarsallatok/lovak/index.html): A Boehringer Ingelheim vezető szerepet tölt be a lovak egészségében, és innovatív megoldásokat fejleszt a lóbetegségek elleni harc érdekében világszerte. (61 words)
- [Fejlesztések | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/fejlesztesek/index.html): Grass Roots innováció: Az élettudományi innovátorok következő generációjának támogatása (53 words)
- [Állatorvosi közegészségügy | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/allatorvosi-kozegeszsegugy/index.html): Veterinary Public Health (81 words)
- [Skizofrénia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/mentalis-egeszseg/skizofrenia/index.html): Skizofrénia (85 words)
- [Betegközpontúság | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/felelossegunk/betegkozpontusag/index.html): A betegek inspirálnak minket abban a küldetésünkben, hogy vezető szerepet töltsünk be az áttörést jelentő terápiákat létrehozó tudományban, hogy gyógyszereink megváltoztassák a betegek életét. (81 words)
- [Tudományos fókuszunk | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/innovacio-humangyogyaszatban/tudomanyos-fokuszunk/index.html): Fedezze fel, hogy a Boehringer Ingelheim tudományos kutatási erőfeszítései és befektetései jelenleg mire összpontosulnak, beleértve a CNS betegségeket, a retina egészségét és a COVID-19-et. (49 words)
- [Elhízás | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/elhizas/index.html): Olvasson az elhízásról, mint krónikus betegségről, és tudja meg, mit tesz a Boehringer Ingelheim az elhízás kezelése érdekében! (63 words)
- [Depresszió | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/mentalis-egeszseg/depresszio/index.html): Depresszió (60 words)
- [Csatlakozzon hozzánk - Humángyógyászat | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-humangyogyaszat-teruleten/csatlakozzon-hozzank/index.html): Csatlakozzon hozzánk - Humángyógyászat (38 words)
- [Kiemelt történetek | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/kiemelt-tortenetek/index.html): Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (47 words)
- [Vakcinák | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/globalis-innovacio-allategeszsegugy/vakciak/index.html): Számos betegségben és fajban dolgozunk, hogy robusztus és hatékony vakcinákat fejlesszünk ki és szállítsunk háziállatok, háziállatok és szarvasmarhák számára, bővebben itt olvashat. (76 words)
- [Háziállatok | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/tarsallatok/haziallatok/index.html): Tudja meg, hogyan támogatjuk az állatorvosokat munkánkkal a Boehringer Ingelheimnél! Parazitaölők, vakcinák és terápiák háziállatok számára. (33 words)
- [Terápiák | Boehringer Ingelheim HU](/content/hu/kutatas-es-fejlesztes/globalis-innovacio-allategeszsegugy/terapiak/index.html): Fegyelmezett tudományos megközelítést biztosítunk a terápiás készítmények globális felfedezéséhez, fejlesztéséhez és szállításához valamennyi releváns állatfaj számára. Elkötelezett kutatócsoportjaink együttműködnek humángyó (51 words)
- [Pitvarfibrilláció | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/pitvarfibrillacio/index.html): Ismerje meg a pitvarfibrilláció és a stroke kockázata közötti összefüggést! A Boehringer Ingelheim ezzel foglalkozó részlegének fő célja stroke megelőzése. (61 words)
- [Társállatok | Boehringer Ingelheim HU](/content/hu/allatgyogyaszat/tarsallatok/index.html): Fedezze fel a Boehringer Ingelheim társállatok egészségével kapcsolatos munkáját, és hogy hogyan segítünk hosszabb életet biztosítani a házi kedvenceknek! (27 words)
- [Bok Oh | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/bok-oh/index.html): Un video que explora nuestro propósito y por qué hacemos lo que hacemos. (56 words)
- [Ann Kathrin Koller | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/ann-kathrin-koller/index.html): Career choices, culture, the future and more with Ann-Kathrin Koller. (60 words)
- [Vídeo I+D | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/video-id/index.html): El Prof. Eric Haaksma habla sobre su carrera y la misión de Boehringer Ingelheim de transformar vidas para las generaciones futuras. (65 words)
- [Senior BD&L Manager, AH GI China Job Details | BoehringerPRD](/content/jobs/job-invite/35928/index.html): Shanghai Senior BD&L Manager, AH GI China - Chin (632 words)
- [Request to Be a New Supplier | Boehringer Ingelheim UK](/content/uk/request-be-new-supplier/index.html): Here you can find a form to fill out your company and contact details if you wish to be considered as a new supplier. Click here to learn more. (251 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (415 words)
- [Our FOCUS : Notre cadre de travail culturel | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/culture/our-focus-notre-cadre-de-travail-culturel/index.html): « Our FOCUS » est le cadre de travail culturel de la compagnie qui comprend notre identité commune, une explication de notre raison d’être. Il propose des directives en ce qui concerne comment nous souhaitons interagir et décrit quels sont nos objectifs. (495 words)
- [Rafał Rybicki | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/rafal-rybicki/index.html): Rafał Rybicki, Jefe de Servicios Legales y de Cumplimiento en el Centro de Servicios Comerciales Globales (GBS) en Wroclaw, reflexiona sobre su primer año en la empresa. (392 words)
- [Dr Armin Wiesler | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (161 words)
- [Principal Engineer, Automation II Job Details | BoehringerPRD](/content/jobs/job-invite/35537/index.html): Saint Joseph Principal Engineer, Automation II - Unit (590 words)
- [Dr Paola Casarosa | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (128 words)
- [Den internasjonale dagen for kvinner og jenter i vitenskapen | Boehringer Ingelheim NO](/content/no/den-internasjonale-dagen-kvinner-og-jenter-i-vitenskapen-0.html): Intervju med Margrete V. Bjurstrøm, Local Head of CD&O, Global Clinical Development & Operations, Boehringer Ingelheim DENOR (Norge) (498 words)
- [Frank Hübler | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (121 words)
- [Michael Schmelmer | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (168 words)
- [Harsha Deshmukh | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (152 words)
- [Veterinary Product Adverse Events | Boehringer Ingelheim UK](/content/uk/contact-us/veterinary-product-adverse-events/index.html): Veterinary Product Adverse Events (247 words)
- [USA | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/usa/index.html): Estados Unidos es una de nuestras regiones más exitosas e innovadoras. Explora ahora qué oportunidades de desarrollo profesional hay disponibles en los EE. UU. (357 words)
- [Fabricación y Cadena de Suministro | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/fabricacion-y-cadena-de-suministro/index.html): Descubre nuevas oportunidades en nuestra cadena de Fabricación y Suministro. ¡No pierdas esta oportunidad y únete hoy mismo! (236 words)
- [Head of Production Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36300/index.html): Sant Cugat del Vallès Head of Production - Espa (815 words)
- [SAP Security Administrator Job Details | BoehringerPRD](/content/jobs/job-invite/35735/index.html): Sant Cugat del Vallès SAP Security Administrator - Spai (476 words)
- [Austria | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/austria/index.html): Viena fue nuestro primer sitio fuera de Alemania. Explora todas las oportunidades de desarrollo profesional activas hoy en Austria. (206 words)
- [Recursos Humanos y Finanzas | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/recursos-humanos-y-finanzas/index.html): Descubre nuevas oportunidades en nuestros departamentos de Personas, Finanzas y Organización. Descubre la oportunidad que te va a entusiasmar. (494 words)
- [Ofertas en Legal | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/ofertas-en-legal/index.html): Descubre nuevas oportunidades en nuestro equipo de Legal. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (253 words)
- [Propósito Commercial | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/proposito-commercial/index.html): Descubre nuevas oportunidades en nuestra Área Comercial, y postúlate hoy. (329 words)
- [Francia | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/francia/index.html): Boehringer Ingelheim ha tenido presencia en Francia desde 1967. Explora las oportunidades de desarrollo profesional vigentes en Francia. (369 words)
- [Investigación y Desarrollo | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/investigacion-y-desarrollo/index.html): Descubre nuevas oportunidades en nuestro departamento de Investigación y Desarrollo. Descubre la oportunidad que te va a entusiasmar. ¡Únete hoy mismo! (274 words)
- [Ruminant Product Information | Boehringer Ingelheim UK](/content/uk/ruminant-product-information/index.html): Click here to view a list of our ruminant products. Here we list the product names, species, and product information for our veterinary medicines. (307 words)
- [Swine Product Information | Boehringer Ingelheim UK](/content/uk/swine-product-information/index.html): Click here to view a list of our swine products. Here we list the product names, species, and product information for our veterinary medicines. (151 words)
- [Software Engineer AI Job Details | BoehringerPRD](/content/jobs/job-invite/33178/index.html): Ridgefield, CT Software Engineer AI - Unit (1,055 words)
- [Comunicación y Asuntos Corporativos | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/comunicacion-y-asuntos-corporativos/index.html): Descubre nuevas oportunidades en nuestros Asuntos Corporativos, y postúlate hoy. (209 words)
- [Horses Product Information | Boehringer Ingelheim UK](/content/uk/horses-product-information/index.html): Click here to view a list of our horse products. Here we list the product names, species, and product information for our veterinary medicines. (193 words)
- [Calidad | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/calidad/index.html): Descubre nuevas oportunidades en nuestra División de Calidad. Marca la difgerencia y únete hoy mismo al equipo de Boehringer Ingelheim. (116 words)
- [Desarrollo Empresarial y Consultoría | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/desarrollo-empresarial-y-consultoria/index.html): Descubre nuevas oportunidades en nuestra Estrategia Corporativa y Consultoría, y postúlate hoy. (277 words)
- [Brasil | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/brasil/index.html): La presencia de Boehringer Ingelheim en Brasil abarca más de 70 años. Explora las oportunidades profesionales que te brinda hoy BI Brasil. (199 words)
- [España | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/espana/index.html): La sede de España alberga los Servicios de Asuntos Regulatorios y dos centros tecnológicos. Explora qué oportunidades profesionales te ofrece España. (276 words)
- [Sr AD, IT Lead Business Consultant II Job Details | BoehringerPRD](/content/jobs/job-invite/36128/index.html): Ridgefield, CT Sr AD, IT Lead Business Consultant II - Unit (864 words)
- [México | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/mexico/index.html): México alberga dos de nuestras modernas plantas de producción. Explora ahora las oportunidades de desarrollo profesional en México. (231 words)
- [China | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/china/index.html): Boehringer Ingelheim ha estado activo en China desde 1994. Explora las oportunidades de desarrollo profesional en China hoy. (179 words)
- [Singapur | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/singapur/index.html): Nuestra sede en Singapur es el centro de la región del Pacífico. Explora las oportunidades activas de desarrollo profesional hoy en Singapur. (166 words)
- [IT Rotation Specialist / Trail Blazer Job Details | BoehringerPRD](/content/jobs/job-invite/35842/index.html): Ridgefield, CT IT Rotation Specialist / Trail Blazer - Unit (915 words)
- [Team Leader, Maintenance  (3rd shift) Job Details | BoehringerPRD](/content/jobs/job-invite/36074/index.html): Athens, GA Team Leader, Maintenance  (3rd shift) - Unit (600 words)
- [Director, Capability Team Lead Job Details | BoehringerPRD](/content/jobs/job-invite/35888/index.html): Ridgefield, CT Director, Capability Team Lead - Unit (848 words)
- [Principal Engineer, Process Inst. & Cont Job Details | BoehringerPRD](/content/jobs/job-invite/35868/index.html): Saint Joseph Principal Engineer, Process Inst. & Cont - Unit (597 words)
- [Human Health Partnering Contact Form | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/connect-us/human-health-partnering-contact-form/index.html): Connect with Boehringer Ingelheim’s BD&L team to explore partnership opportunities and submit your inquiry to collaborate on innovative treatments. (573 words)
- [USA | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/usa/index.html): The USA is one of our most successful and innovative regions. Explore career development opportunities in the USA or our 170 locations around the globe. (386 words)
- [Argentina | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/argentina/index.html): Argentina es la piedra angular de nuestras operaciones en Sudamérica. Explora las oportunidades profesionales que te brinda hoy BI Argentina. (223 words)
- [Poultry Product Information | Boehringer Ingelheim UK](/content/uk/poultry-product-information/index.html): Click here to view a list of our poultry products. Here we list the product names, species, and product information for our veterinary medicines. (116 words)
- [Dyrlæger gør lidt ekstra og mere til | Boehringer Ingelheim DK](/content/dk/animal-health/udvalgte-historier/dyrlaeger-gor-lidt-ekstra-og-mere-til/index.html): Veterinære teams presser ofte sig selv til det yderste. Spørgsmålet er, om vi anerkender dette nok? (861 words)
- [Shape the future of rheumatology | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/shape-future-rheumatology/index.html): Join our rheumatology team: Drive impact through customer engagement (636 words)
- [Creciendo en conjunto | Boehringer Ingelheim SA](/content/sa/carreras/contactanos/creciendo-en-conjunto/index.html): Reconocemos los beneficios del aprendizaje y hemos creado un entorno en el que se fomenta el aprendizaje permanente y el crecimiento personal para todos. (878 words)
- [Therapeutics | Boehringer Ingelheim TW](/content/tw/therapeutics/index.html): Science and Innovation - Animal Health Innovation - Therapeutics (61 words)
- [Meet our Team | Boehringer Ingelheim US](/content/us/meet-our-team/index.html): BI's team are leveraging scientific and commercial insights to identify partnerships that can help us accelerate the delivery of innovative solutions. (231 words)
- [Patricia Rangel | Boehringer Ingelheim Careers | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/patricia-rangel-boehringer-ingelheim-careers/index.html): Patricia Rangel of Corporate Strategy & Consulting describes Boehringer Ingelheim as a family company that operates with the highest integrity standards. (93 words)
- [Свържете се с нас | Boehringer Ingelheim BG](/content/bg/svrzhete-se-s-nas-0/index.html): Свържете се с екипа на Boehringer Ingelheim Animal Health Business Development and Licensing онлайн или на събития, за да изпратите предложение или да обсъдите възможности за партньорство. (371 words)
- [Meet our Team | Boehringer Ingelheim TW](/content/tw/meet-our-team/index.html): Meet our Team (94 words)
- [Simon Heinrich | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/simon-heinrich/index.html): Simon Heinrich, an automation engineer in the Engineering and Facilities department, provides an in-depth look at working life at Boehringer Ingelheim. (21 words)
- [Kontakt os | Boehringer Ingelheim DK](/content/dk/kontakt-os/index.html): Tak for din interesse for Boehringer Ingelheim. Tak fordi du kontaktede os og for din feedback. (20 words)
- [The Work That You Do | Meaningful Careers at Boehringer | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-working-culture/work-you-do-meaningful-careers-boehringer/index.html): Discover how patient perspectives connect every role at Boehringer Ingelheim to meaningful work, purpose, and lasting impact. (381 words)
- [Clinical trials deliver medical breakthroughs – but how do they happen? | Boehringer Ingelheim US](/content/us/careers/explore-our-company/clinical-trials-deliver-medical-breakthroughs-how-do-they-happen.html): Clinical trials deliver medical breakthroughs – but how do they happen? Prof. Dr Martina Brueckmann talks about her role getting new drugs to trial. (621 words)
- [Dubai | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/dubai/index.html): Dubai is at the heart of our IMETA region. Explore career development opportunities in the UAE or our 170 locations around the globe. (244 words)
- [Christiane Wijsen | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/christiane-wijsen/index.html): Christiane Wijsen speaks about heading the division in Corporate Strategy & Consulting. (32 words)
- [AVINEW® | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/avinew/index.html): AVINEW® - Productos Salud Animal - Perú (741 words)
- [Simon Manyara | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/simon-manyara/index.html): Simon Manhara works with our culture and sustainability team towards making a positive social impact and creating a sustainable future. (32 words)
- [Netherlands | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/netherlands/index.html): Our Amsterdam facility is one of our hubs for operations in Europe. Explore career development opportunities in the Netherlands or our 170 global locations. (197 words)
- [Наша команда | Boehringer Ingelheim RU](/content/ru/nasha-komanda/index.html): Здесь вы найдете всю нашу контактную информацию, а также информацию о том, где вы можете встретиться с нами виртуально или лично. Вы также можете узнать, как представить свою возможность нашей команде BD&L (35 words)
- [AVINEW® FROZEN | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/avinew-frozen/index.html): AVINEW® FROZEN - Productos Salud Animal - Perú (245 words)
- [When patients share their stories, our purpose comes to life | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-working-culture/when-patients-share-their-stories-our-purpose-comes-life.html): Patient advocates shared their experiences at the Human Resources Summit, highlighting how every role contributes to improving lives. (393 words)
- [Recompensas y reconocimiento | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/recompensas-y-reconocimiento/index.html): Hay logros y ocasiones que exigen reconocimiento. Hacemos todo lo posible para dar a los empleados recompensas tangibles y más con los hitos comerciales. (284 words)
- [Faceți cunoștință cu echipa noastră | Boehringer Ingelheim RO](/content/ro/faceti-cunostinta-cu-echipa-noastra/index.html): Faceți cunoștință cu echipa noastră (69 words)
- [Germany | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/germany/index.html): Germany, where the Boehringer Ingelheim story began, and still our global headquarters. Explore career opportunities in Germany or our 170 global locations. (252 words)
- [Mexico | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/mexico/index.html): Mexico is home to two of our modern production sites. Explore career development opportunities in Mexico or our 170 locations around the globe. (213 words)
- [Meet our Team | Boehringer Ingelheim CA](/content/ca/meet-our-team/index.html): Our global partnering team is present in all regions of the world. Click here to find out more about our global partnering team and the work they do. (85 words)
- [Rencontrez notre équipe | Boehringer Ingelheim CA](/content/ca/fr/rencontrez-notre-equipe/index.html): Découvrez nos partenariats et rencontrez notre équipe chez Boehringer Ingelheim. Une collaboration au service de la santé. (103 words)
- [¡Top Employer de nuevo! | Boehringer Ingelheim SA](/content/sa/carreras/top-employer-de-nuevo/index.html): Somos uno de los principales empleadores del mundo con premios locales en 29 países, además de títulos regionales en Europa, América Latina y Asia-Pacífico. (301 words)
- [Aprendizaje y desarrollo | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/aprendizaje-y-desarrollo/index.html): Ayudamos a las personas a crecer profesionalmente maximizando su talento y dándoles espacio para evolucionar dentro de la empresa. (301 words)
- [Svin og kvæg | Boehringer Ingelheim DK](/content/dk/svin-og-kvaeg/index.html): Svin og kvæg (287 words)
- [Hest | Boehringer Ingelheim DK](/content/dk/hest/index.html): Hest (220 words)
- [Singapore | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/singapore/index.html): Our Singapore HQ serves as the hub for the Pacific Region. Explore career development opportunities in Singapore or our 170 locations around the globe. (173 words)
- [Austria | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/austria/index.html): Vienna was our first site outside Germany. Explore career development opportunities in Austria or our 170 locations around the globe. (157 words)
- [Brazil | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/brazil/index.html): Boehringer Ingelheim’s presence in Brazil spans over 70 years. Explore career development opportunities in Brazil or our 170 locations around the globe. (173 words)
- [Kæledyr: Hund og kat | Boehringer Ingelheim DK](/content/dk/kaeledyr-hund-og-kat/index.html): Kæledyr: Hund og kat (207 words)
- [Hannah Bussmann | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/hannah-bussmann/index.html): Get an inside view of life at Boehringer Ingelheim with Hannah Bussmann. (53 words)
- [Medical External Funding Team Member (Hybrid) Job Details | BoehringerPRD](/content/jobs/job-invite/36342/index.html): Ridgefield, CT Medical External Funding Team Member (Hybrid) - Unit (998 words)
- [Argentina | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/argentina/index.html): Argentina is a keystone of our operations in South America. Explore career development opportunities in Argentina or our 170 locations around the globe. (197 words)
- [Conecta con nosotros | Boehringer Ingelheim ES](/content/es/conecta-con-nosotros/index.html): Ponte en contacto con el equipo de Desarrollo Empresarial y Licencias de Boehringer Ingelheim Animal Health para enviar una propuesta o discutir oportunidades de colaboración. (404 words)
- [Disclaimer](/content/pro/us/medinfo/external-link/index.html) (19 words)
- [Ponte en contacto | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/ponte-en-contacto/index.html): Conecta online o en eventos con el equipo de Business Development and Licensing de Salud Animal de Boehringer Ingelheim para enviar una propuesta o conversar sobre oportunidades de colaboración. (384 words)
- [Aminolite® | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/aminolite/index.html): Aminolite® - Productos Salud Animal - Uruguay - Rumiantes (165 words)
- [Emerging Talent | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/emerging-talent/index.html): Your future with us, our future with you (236 words)
- [Aminolite® | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/aminolite-0/index.html): Aminolite® - Productos Salud Animal - Uruguay - Equinos (164 words)
- [Specialist/SR Specialist, PV Sys & Data Analysis Job Details | BoehringerPRD](/content/jobs/job-invite/36315/index.html): Johns Creek, GA Specialist/SR Specialist, PV Sys & Data Analysis - Unit (693 words)
- [Videnskabelige forsøg | Boehringer Ingelheim DK](/content/dk/videnskabelige-forsog/index.html): Hvad vil det sige at deltage i et videnskabeligt forsøg? (362 words)
- [Director, Clinical Trial Team Lead - Immunology Job Details | BoehringerPRD](/content/jobs/job-invite/32384/index.html): Ridgefield, CT Director, Clinical Trial Team Lead - Immunology - Unit (851 words)
- [Metacam® | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/metacam/index.html): Metacam® é a solução à base de meloxicam que diminui os efeitos indesejados da inflamação, como o inchaço, a dor e a febre, sem comprometer outras funções fisiológicas importantes. (745 words)
- [Corporate Affairs | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/corporate-affairs/index.html): Discover new opportunities in our Corporate Affairs. (279 words)
- [Alliance® Respiratoria | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance-respiratoria/index.html): Alliance® Respiratoria - Productos Salud Animal - Uruguay (228 words)
- [Alliance® Plus | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance-plus/index.html): Alliance® Plus - Productos Salud Animal - Uruguay (249 words)
- [Avinew® Frozen | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/avinew-frozen-0/index.html): Avinew® Frozen - Productos Salud Animal - Colombia (159 words)
- [People, Finance & Organization | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/people-finance-organization/index.html): Discover new opportunities in our People, Finance and Organisation departments. (484 words)
- [SR QC Associate, QC Lab General, Fremont CA Job Details | BoehringerPRD](/content/jobs/job-invite/35959/index.html): Fremont, CA SR QC Associate, QC Lab General, Fremont CA - Unit (769 words)
- [Research & Development | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/research-development/index.html): Discover new opportunities in our Research Development. (322 words)
- [Legal & Compliance | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/legal-compliance/index.html): Discover new opportunities in our Legal Compliance team. (243 words)
- [Alliance® Reproductiva | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance-reproductiva/index.html): Alliance® Reproductiva - Productos Salud Animal - Argentina (106 words)
- [Acarex® NF | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/acarex-nf/index.html): Acarex® NF - Productos Salud Animal - Uruguay (156 words)
- [動物保健合作重點領域 | Boehringer Ingelheim TW](/content/tw/dongwubaojianhezuozhongdianlingyu/index.html): 深入了解百靈佳殷格翰於動物保健領域的合作重點，涵蓋傳染性疾病、非傳染性疾病，以及其他非疾病領域的創新研究焦點。我們致力於推動跨領域合作，攜手開創更健康、更永續的動物未來。 (102 words)
- [Alliance® Plus | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/alliance-plus-0/index.html): Alliance® Plus - Productos Salud Animal - Argentina (162 words)
- [Vaccines | Boehringer Ingelheim TW](/content/tw/vaccines/index.html): Science and Innovation - Animal Health Innovation - Vaccines (71 words)
- [Bok Oh | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/bok-oh/index.html): Touching millions of lives with Bok Oh (8 words)
- [Galym Zhunisbekov | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/galym-zhunisbekov/index.html): Galym Zhunisbekov, a Regional Regulatory Affairs Manager in Eastern Europe, talks about our philosophy and impact on patients’ lives. (195 words)
- [Quality | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/quality/index.html): Discover new opportunities in our Quality Division department. (169 words)
- [Data Careers | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/data-careers/index.html): Use your data skills to make a difference. Discover exciting data careers opportunities and apply today. (189 words)
- [Medicine & Regulatory Video | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/medicine-regulatory-video/index.html): Taimi Sahlin, a therapeutic specialist with Boehringer Ingelheim Canada describes her career as challenging and motivating. (23 words)
- [Dominik Huber | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/dominik-huber/index.html): Our Head of Upstream Manufacturing in Vienna, Dominik Huber, has built his entire, senior-level career with Boehringer Ingelheim. (506 words)
- [Colaboración en Salud Animal | Boehringer Ingelheim ES](/content/es/socios/asociaciones-en-materia-de-salud-animal/socios/colaboracion-en-salud-animal/index.html): Descubre las áreas de interés de Boehringer Ingelheim para la colaboración en salud animal, que incluyen enfermedades infecciosas, enfermedades no infecciosas y áreas no relacionadas con enfermedades. (793 words)
- [Maria Wlaschitz | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/maria-wlaschitz/index.html): Eva-Maria Wlaschitz, a development scientist at Boehringer Ingelheim in Vienna, Austria, speaks about the numerous growth opportunities. (94 words)
- [Интереси за партньорства в областта на здравето на животните | Boehringer Ingelheim BG](/content/bg/interesi-za-partnorstva-v-oblastta-na-zdraveto-na-zhivotnite.html): Научете за интересите на Boehringer Ingelheim за партньорства в областта на здравето на животните, включително инфекциозни заболявания, неинфекциозни заболявания и области, които не са свързани със заболявания. (732 words)
- [Alexander Guntur | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/alexander-guntur/index.html): Alexander Guntur, Information Protection and Security officer in Singapore, describes his 14 years with the company as fulfilling. (52 words)
- [Benefits and wellbeing | Boehringer Ingelheim US](/content/us/careers/explore-our-company/benefits-and-wellbeing/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (293 words)
- [Jan-Erik Schafer | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/jan-erik-schafer/index.html): Jan Erik, Senior Team Leader in the upstream pharmaceutical production talks about his motivating and fun career at Boehringer Ingelheim. (26 words)
- [Albert Paul | Boehringer Ingelheim Careers | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/albert-paul-boehringer-ingelheim-careers/index.html): Albert Paul speaks about his role in Manufacturing & Supply and and what’s next for him in the future. (31 words)
- [Learning and growth | Boehringer Ingelheim US](/content/us/careers/explore-our-company/learning-and-growth/index.html): At Boehringer Ingelheim, we support people throughout their professional development – giving our employees room for learning and growth to achieve their career goals. (245 words)
- [Compensation and rewards | Boehringer Ingelheim US](/content/us/careers/explore-our-company/compensation-and-rewards/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (269 words)
- [Vores virksomhed fordømmer det militære angreb mod #Ukraine | Boehringer Ingelheim DK](/content/dk/vores-virksomhed-fordommer-det-militaere-angreb-mod-ukraine.html): Vores virksomhed fordømmer det militære angreb mod #Ukraine (295 words)
- [Contact Us | Boehringer Ingelheim](/content/pro/us/bi-druginforequest/index.html): Get in touch with Boehringer Ingelheim and access forms for general and medical information requests, product availability requests and product complaints. (63 words)
- [Medical Advisor/Non-line manager or Staff/MA Group1, Medicine Dept.1, CDMA Inflammation Job Details | BoehringerPRD](/content/jobs/job-invite/34391/index.html): Shinagawa Medical Advisor/Non-line manager or Staff/MA Group1, Medicine Dept.1, CDMA Inflammation - Japa (259 words)
- [¿Qué es la farmacovigilancia y cuál es su rol en la seguridad del paciente? | Boehringer Ingelheim SA](/content/sa/pdf/que-es-la-farmacovigilancia/index.html): ¿Qué es la farmacovigilancia y cuál es su rol en la seguridad del paciente? (8 words)
- [Accountant / Senior Accountant | スタッフ（シニア）| 財務本部財務・経理部 Job Details | BoehringerPRD](/content/jobs/job-invite/35668/index.html): Shinagawa Accountant / Senior Accountant | スタッフ（シニア）| 財務本部財務・経理部 - Japa (330 words)
- [豚 | Boehringer Ingelheim JP](/content/jp/swine/index.html): 生産コストの上昇、人手不足の深刻化、さらに、感染症の脅威も続き、市場環境も常に変化しています。 こうした不確実性の中で、養豚農家の方々は、長期的な安定経営のため、有効性の高いワクチンと、より広い視点に立つ戦略設計を提供するベーリンガーインゲルハイムの豚チームに信頼を寄せています。 (12 words)
- [Katte er ligesom mig, og jeg vil gerne have, at mine katte stortrives | Boehringer Ingelheim DK](/content/dk/katte-er-ligesom-mig-og-jeg-vil-gerne-have-mine-katte-stortrives.html): Katte er ligesom mig, og jeg vil gerne have, at mine katte stortrives (1,174 words)
- [Familien Bruggeman | Boehringer Ingelheim DK](/content/dk/familien-bruggeman/index.html): Sådan bragte en sjælden sygdom familien Bruggeman sammen (1,191 words)
- [Anton arbejder med salg og har patienten i centrum | Boehringer Ingelheim DK](/content/dk/anton-arbejder-med-salg-og-har-patienten-i-centrum/index.html): Anton arbejder med salg og har patienten i centrum (691 words)
- [Consultor/a Revenue Growth Management (RGM) Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/36124/index.html): São Paulo Consultor/a Revenue Growth Management (RGM) - Bras (519 words)
- [Coordenador/a de Facilities Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/36071/index.html): Paulínia Coordenador/a de Facilities - Bras (631 words)
- [Gerente de Produto - Oncologia (Pulmão) Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35368/index.html): São Paulo Gerente de Produto - Oncologia (Pulmão) - Bras (422 words)
- [Studentermedhjælper | Boehringer Ingelheim DK](/content/dk/studentermedhjaelper/index.html): Studiejobs er et plus for studerende – og for os (870 words)
- [Forløbet for patienter med systemisk sklerodermi følger som regel ikke en lige vej, især ikke hvis sygdommen også berører lungerne | Boehringer Ingelheim DK](/content/dk/forlobet-patienter-med-systemisk-sklerodermi-folger-som-regel-ikke-en-lige-vej-isaer-ikke-hvis.html): Forløbet for patienter med systemisk sklerodermi følger som regel ikke en lige vej, især ikke hvis sygdommen også berører lungerne (787 words)
- [Engagement and Innovation Lead/Manager/Global ExpMED Inflammation Job Details | BoehringerPRD](/content/jobs/job-invite/35654/index.html): Shinagawa Engagement and Innovation Lead/Manager/Global ExpMED Inflammation - Japa (680 words)
- [Michael Schmelmer | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (164 words)
- [動物事業 我們的職責 | Boehringer Ingelheim TW](/content/tw/dongwushiye-womendezhize/index.html): One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health. (227 words)
- [医薬情報担当者（MR）| スタッフ | オンコロジー＆エマージング領域事業本部オンコロジー領域営業部 Job Details | BoehringerPRD](/content/jobs/job-invite/35702/index.html): Shinagawa 医薬情報担当者（MR）| スタッフ | オンコロジー＆エマージング領域事業本部オンコロジー領域営業部 - Japa (43 words)
- [Dr Armin Wiesler | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (191 words)
- [Frank Hübler | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (161 words)
- [Shashank Deshpande | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (186 words)
- [Expanded Access Programs | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/clinical-studies/expanded-access-programs/index.html): Expanded Access Programs (763 words)
- [Informe de Eventos Adversos | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/seguridad-del-paciente/informe-de-eventos-adversos/index.html): Informe de Eventos Adversos (318 words)
- [Cats | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/cats/index.html): By advancing innovation for the unique challenges of cat care, Boehringer Ingelheim’s feline experts help strengthen the bond between cats and their people (764 words)
- [Shashank Deshpande | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/shashank-deshpande/index.html): Shashank Deshpande - Presidente de la Junta Directiva con responsabilidad para la Unidad de Negocio de Salud Humana (210 words)
- [Harsha Deshmukh | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (192 words)
- [Sklerodermipatient opfinder smart blisterpakkeåbner | Boehringer Ingelheim DK](/content/dk/sklerodermipatient-opfinder-smart-blisterpakkeabner.html): Sklerodermipatient opfinder smart blisterpakkeåbner (289 words)
- [Michael Schmelmer | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/michael-schmelmer/index.html): Michael Schmelmer – Vicepresidente del Consejo de Administración con responsabilidad para las funciones del Grupo (190 words)
- [Frank Hübler | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/frank-hubler/index.html): Frank Hübler – Miembro de la Junta Directiva con responsabilidad para Finanzas (159 words)
- [Dr Armin Wiesler | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/dr-armin-wiesler/index.html): Dr Armin Wiesler - Miembro de la Junta Directiva con responsabilidad para la unidad de negocio de Salud Animal (205 words)
- [Dr Paola Casarosa | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/dr-paola-casarosa/index.html): Dr Paola Casarosa – Miembro de la Junta Directiva con responsabilidad para la Unidad de Innovación (166 words)
- [Médica y Asuntos Regulatorios | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/medica-y-asuntos-regulatorios/index.html): Descubre nuevas oportunidades en nuestra área de Medicina y Asuntos Regulatorios. Descubre interesantes oportunidades hoy. (256 words)
- [Harsha Deshmukh | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/harsha-deshmukh/index.html): Harsha Deshmukh - Miembro de la Junta Directiva con responsabilidad para IT y Global Business Services (149 words)
- [Engenharia e instalações | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/engenharia-e-instalacoes/index.html): Descubre nuevas oportunidades en nuestro departamento de Ingeniería e Instalaciones. ¡Únete hoy mismo! (322 words)
- [Imagine: Vores historier om bæredygtighed | Boehringer Ingelheim DK](/content/dk/imagine-vores-historier-om-baeredygtighed/index.html): Find ud af, hvordan vi skaber positiv forandring og styrker sundhedssektoren for en bedre fremtid. (84 words)
- [Últimos empregos no México | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-no-mexico/index.html): O México é a base de duas das nossas instalações de produção modernas. Explore as oportunidades de desenvolvimento de carreira no México ou nas nossas 170 localizações em todo o mundo. (180 words)
- [Nuestra cultura | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestra-cultura/index.html): Nuestra cultura refleja quiénes somos y se refleja en nuestra firme creencia en la Diversidad, la Equidad y la Inclusión, así como en el Desarrollo Sostenible. (731 words)
- [Employ People with Disabilities | Boehringer Ingelheim JP](/content/jp/employ-people-disabilities/index.html): Employ People with Disabilities (120 words)
- [Últimos empregos nos Países Baixos | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-nos-paises-baixos/index.html): As nossas instalações em Amesterdão são um dos nossos centros de operações na Europa. Explore as oportunidades de desenvolvimento de carreiras nos Países Baixos ou nas nossas 170 localizações globais. (178 words)
- [Når gigt rammer lungerne | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/lungefibrose/nar-gigt-rammer-lungerne/index.html): Når man som patient får en sjælden sygdom, der går på tværs af specialer, kan vejen gennem sundhedsvæsenet opleves uoverskuelig. (278 words)
- [Ofertas en Tecnología de la Información | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/ofertas-en-tecnologia-de-la-informacion/index.html): Descubre nuevas oportunidades en nuestro departamento de Tecnologías de la Información. Entra a formar parte de BI. (170 words)
- [Dogs | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/dogs/index.html): With products and solutions to protect dog health and improve well-being, Boehringer Ingelheim is committed to longer, happier lives for canine companions (740 words)
- [Beneficios y recompensas | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/beneficios-y-recompensas/index.html): Invertimos en nuestra gente para que se quede y crezcan con nosotros. Ofrecemos beneficios, recompensas y oportunidades que contribuyan a su fidelización. (319 words)
- [Últimos empregos nos EUA | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-nos-eua/index.html): Os EUA são uma das nossas regiões mais bem-sucedidas e inovadoras. Explore as oportunidades de desenvolvimento de carreira nos EUA ou nas nossas 170 localizações em todo o mundo. (168 words)
- [Últimos empregos em França | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-em-franca/index.html): A Boehringer Ingelheim tem uma presença em França desde 1967. Explore as oportunidades de desenvolvimento de carreira em França ou nas nossas 170 localizações em todo o mundo. (328 words)
- [Dr Paola Casarosa | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (163 words)
- [Nuestra gente | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestra-gente/index.html): Ambición. Pasión. Integridad. Compromiso. Empatía. Individualidad. Esperamos estas cualidades en todos los niveles de nuestra organización. (334 words)
- [Últimos empregos no Japão | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-no-japao/index.html): A nossa equipa no Japão é reconhecida pelo compromisso com a inovação e a sustentabilidade. Explore as oportunidades de desenvolvimento de carreira no Japão ou nas nossas 170 localizações globais. (169 words)
- [Últimos empregos na Argentina | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-na-argentina/index.html): A Argentina é a pedra angular das nossas operações na América do Sul. Explore as oportunidades de desenvolvimento de carreira na Argentina ou nas nossas 170 localizações em todo o mundo. (200 words)
- [Michael Schmelmer | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (203 words)
- [Últimos empregos na China | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-na-china/index.html): A Boehringer Ingelheim está ativa na China desde 1994. Explore as oportunidades de desenvolvimento de carreira na China ou nas nossas 170 localizações em todo o mundo. (173 words)
- [Frank Hübler | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (160 words)
- [Bivirkninger for produkter til dyr | Boehringer Ingelheim DK](/content/dk/bivirkninger-produkter-til-dyr/index.html): Bivirkninger for produkter til dyr (167 words)
- [Notre culture d'entreprise | Boehringer Ingelheim CA](/content/ca/fr/notre-culture-dentreprise/index.html): Notre culture d'entreprise (561 words)
- [Últimos empregos no Brasil | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-no-brasil/index.html): A presença de Boehringer Ingelheim no Brasil abrange mais de 70 anos. Explore as oportunidades de desenvolvimento de carreira no Brasil ou nas nossas 170 localizações em todo o mundo. (124 words)
- [Enfermedad Renal Crónica | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedad-renal-cronica/index.html): Enfermedad Renal Crónica: Esta condición es causada por el daño progresivo en los riñones, lo que impide que funcionen como deberían. (1,005 words)
- [Últimos empregos no Dubai | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/ultimos-empregos-no-dubai/index.html): O Dubai está no coração da nossa região IMETA (Índia, Médio Oriente, Turquia e África). Explore as oportunidades de desenvolvimento de carreira nos Emirados Árabes Unidos ou nas nossas 170 localizações em todo o mundo. (130 words)
- [Latest jobs in USA | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/usa/index.html): The USA is one of our most successful and innovative regions. Explore career development opportunities in the USA or our 170 locations around the globe. (287 words)
- [Esclerodermia | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-pulmonares/esclerodermia/index.html): Esclerodermia (138 words)
- [Bilingual Medical Information Specialist Job Details | BoehringerPRD](/content/jobs/job-invite/34550/index.html): Burlington, CA Bilingual Medical Information Specialist - Cana (661 words)
- [Latest jobs in Japan | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/japan/index.html): Our team in Japan is regarded for commitment to innovation and sustainability. Explore career development opportunities in Japan or our 170 global locations. (200 words)
- [Latest jobs in Mexico | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/mexico/index.html): Mexico is home to two of our modern production sites. Explore career development opportunities in Mexico or our 170 locations around the globe. (265 words)
- [Medicine & Regulatory Video | Boehringer Ingelheim CA](/content/ca/careers/discover-our-career-areas/medicine-regulatory-video/index.html): Taimi Sahlin, a therapeutic specialist with Boehringer Ingelheim Canada describes her career as challenging and motivating. (55 words)
- [Latest jobs in Austria | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/austria/index.html): Vienna was our first site outside Germany. Explore career development opportunities in Austria or our 170 locations around the globe. (182 words)
- [Latest jobs in France | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/france/index.html): Boehringer Ingelheim has had a presence in France since 1967. Explore career development opportunities in France or our 170 locations around the globe. (301 words)
- [Patient Safety & Pharmacovigilance at Boehringer Ingelheim | Boehringer Ingelheim US](/content/us/human-health/our-responsibility/patient-safety/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (287 words)
- [Latest jobs in Dubai| Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/dubai/index.html): Dubai is at the heart of our IMETA region. Explore career development opportunities in the UAE or our 170 locations around the globe. (194 words)
- [Latest jobs in Singapore | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/singapore/index.html): Our Singapore HQ serves as the hub for the Pacific Region. Explore career development opportunities in Singapore or our 170 locations around the globe. (142 words)
- [Latest jobs in China| Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/china/index.html): Boehringer Ingelheim has been active in China since 1994. Explore career development opportunities in China or our 170 locations around the globe. (170 words)
- [Latest jobs in Germany| Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/germany/index.html): Germany, where the Boehringer Ingelheim story began, and still our global headquarters. Explore career opportunities in Germany or our 170 global locations. (195 words)
- [Latest jobs in Argentina | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/argentina/index.html): Argentina is a keystone of our operations in South America. Explore career development opportunities in Argentina or our 170 locations around the globe. (203 words)
- [Latest jobs in Spain | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/spain/index.html): Our facility in Spain is home to Regulatory Affairs Services and two technology hubs. Explore career opportunities in Spain or our 170 global locations. (186 words)
- [Animals We Support | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/index.html): We’re committed to the health of the world’s most important animals: beloved dogs, cats, and horses, plus valued livestock like swine, ruminants, and poultry (420 words)
- [Trends & Insights | Boehringer Ingelheim US](/content/us/animal-health/trends-insights/index.html): Click here to find out more about the latest animal health news from Boehringer Ingelheim, including heart-warming stories and scientific advancements. (225 words)
- [Mental Health | Boehringer Ingelheim US](/content/us/human-health/mental-health/index.html): Mental Disorders (335 words)
- [Latest jobs in Netherlands | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/netherlands/index.html): Our Amsterdam facility is one of our hubs for operations in Europe. Explore career development opportunities in the Netherlands or our 170 global locations. (150 words)
- [Across Cancer Types | Boehringer Ingelheim US](/content/us/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (298 words)
- [Calidad en Boehringer Ingelheim | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/calidad/index.html): Calidad en Boehringer Ingelheim (327 words)
- [Human Health | Boehringer Ingelheim US](/content/us/human-health/index.html): Human Health (343 words)
- [Patient Centricity | Boehringer Ingelheim US](/content/us/human-health/our-responsibility/patient-centricity/index.html): Click here to read more about BI's patient centricity. Patients inspire us in our mission to lead the science that creates breakthrough therapies. (78 words)
- [Esquizofrenia | Boehringer Ingelheim SA](/content/sa/salud-humana/salud-mental/esquizofrenia/index.html): Esquizofrenia (192 words)
- [Veterinary Public Health | Boehringer Ingelheim US](/content/us/animal-health/veterinary-public-health/index.html): Veterinary Public Health (199 words)
- [Where to find us | Boehringer Ingelheim US](/content/us/about-us/where-find-us/index.html): Click here to view our biggest sites. With 54,300+ employees worldwide, Boehringer Ingelheim has a research and production network across the globe. (401 words)
- [Animal Health | Boehringer Ingelheim US](/content/us/animal-health/index.html): Click here to read more on Boehringer Ingelheim's commitment to animal health, with innovative preventative medicine, vaccines & treatments for all animals. (242 words)
- [Lung Cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/lung-cancer/index.html): Lung Cancer (254 words)
- [Støtte til patienter | Boehringer Ingelheim DK](/content/dk/human-health/kraeft/stotte-til-patienter/index.html): Bekæmpelse af kræft stopper ikke ved at udvikle lægemidler. I samarbejde med det bredere samfund støtter vi bevidsthed, uddannelse, (109 words)
- [Kræft | Boehringer Ingelheim DK](/content/dk/human-health/kraeft/index.html): Kræft tager. Tager af tiden. Tager vores kære fra os. Hos Boehringer Ingelheim giver vi nyt håb til patienter ved at tage kampen op med kræft. (88 words)
- [Bronquiectasia | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-pulmonares/bronquiectasia/index.html): Bronquiectasia (213 words)
- [EPOC & Asma | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-pulmonares/epoc-asma/index.html): EPOC & Asma (299 words)
- [Chronic Kidney Disease | Boehringer Ingelheim US](/content/us/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (234 words)
- [Cáncer | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/index.html): Cáncer (243 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim US](/content/us/human-health/lung-diseases/pulmonary-fibrosis/index.html): Pulmonary fibrosis is a condition leading to a build-up of scar tissue in the lungs. Over time, the lungs lose their ability to take in and transfer oxygen into the bloodstream. (149 words)
- [Kronisk nyresygdom | Boehringer Ingelheim DK](/content/dk/human-health/kronisk-nyresygdom/index.html): Kronisk nyresygdom (157 words)
- [Her du finder os | Boehringer Ingelheim DK](/content/dk/om-os/her-du-finder-os/index.html): Med 52.000 ansatte verden over har Boehringer Ingelheim et forsknings- og produktionsnetværk over hele kloden. Her er vores største arbejdspladser. (348 words)
- [Empowering Patients | Boehringer Ingelheim US](/content/us/human-health/cancer/empowering-patients/index.html): Empowering Patients (291 words)
- [Salud mental | Boehringer Ingelheim SA](/content/sa/salud-humana/salud-mental/index.html): Salud mental (83 words)
- [Metabolic Diseases | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/index.html): CardioMetabolic Disease Research (229 words)
- [COPD & Asthma | Boehringer Ingelheim US](/content/us/human-health/lung-diseases/copd-asthma/index.html): copd (220 words)
- [Lungekræft | Boehringer Ingelheim DK](/content/dk/human-health/kraeft/lungekraeft/index.html): Med udgangspunkt i vores erfaring inden for lungesygdomme er vores mål at bekæmpe lungekræft, ændre behandlingslandskabet og i sidste ende omdefinere (62 words)
- [Diabetes | Boehringer Ingelheim DK](/content/dk/human-health/stofskiftesygdomme/diabetes/index.html): Omkring 425 millioner voksne mennesker i verden lever med diabetes, og type 2-diabetes tegner sig for 90-95 procent af alle tilfælde. (186 words)
- [Diabetes | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/diabetes/index.html): Diabetes (316 words)
- [Retinal Diseases | Boehringer Ingelheim US](/content/us/human-health/retinal-diseases/index.html): At BI, we have expanded our global research and development activities to address eye diseases, specifically those affecting the back of the eye. (112 words)
- [Lung Diseases | Boehringer Ingelheim US](/content/us/human-health/lung-diseases/index.html): Our Therapeutic Areas (213 words)
- [Om kræfttyper | Boehringer Ingelheim DK](/content/dk/human-health/kraeft/forskellige-typer-kraeft/index.html): Vi er engageret i vores fokusområder for lungekræft og mave-tarmkræft, men vi lader os lede af videnskaben og forfølger muligheder inden for andre (77 words)
- [Kvalitet hos Boehringer Ingelheim | Boehringer Ingelheim DK](/content/dk/om-os/kvalitet/index.html): Kvalitet hos Boehringer Ingelheim (220 words)
- [Diabetes | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/diabetes/index.html): Diabetes (169 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim DK](/content/dk/om-os/etik-og-compliance/compliance-sig-frem/index.html): Speak Up-portalen tilbyder en tryg måde at indberette potentielle overtrædelser på og er åben for alle verden over. Alle indberetninger om mulige overtrædelser tages alvorligt. (298 words)
- [Our Responsibility | Boehringer Ingelheim US](/content/us/human-health/our-responsibility/index.html): Read more on how Boehringer Ingelheim's mission is always to put patients first, transforming lives through new therapies and healthcare solutions. (79 words)
- [MERE GRØN for vores planet | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/mere-gron/index.html): En sund planet er en forudsætning for sunde mennesker, dyr og samfund. MERE GRØN fokuserer på at reducere miljøpåvirkningen fra vores aktiviteter for at beskytte sundheden for nuværende og fremtidige generationer og sikre deres udsigter til en sund (195 words)
- [NASH | Boehringer Ingelheim DK](/content/dk/human-health/stofskiftesygdomme/nash/index.html): Ikke-alkoholisk steatohepatitis (NASH) er forårsaget af en metabolisk induceret betændelse i leveren og er en af de vigtigste årsager til leverfibrose (121 words)
- [Fibrosis pulmonar | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/index.html): Fibrosis pulmonar (169 words)
- [A través de los tipos de cáncer | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/traves-de-los-tipos-de-cancer/index.html): A través de los tipos de cáncer (103 words)
- [Scleroderma | Boehringer Ingelheim US](/content/us/human-health/lung-diseases/scleroderma/index.html): Scleroderma (100 words)
- [Obesity | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/obesity/index.html): Obesity (104 words)
- [Stofskiftesygdomme | Boehringer Ingelheim DK](/content/dk/human-health/stofskiftesygdomme/index.html): Kardio-renale metaboliske tilstande, der påvirker hjerte, nyrer og stofskifte, er den hyppigste dødsårsag på verdensplan og er skyld i op mod (96 words)
- [Cáncer de pulmón | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/cancer-de-pulmon/index.html): Cáncer de pulmón (174 words)
- [Fedme | Boehringer Ingelheim DK](/content/dk/human-health/stofskiftesygdomme/fedme/index.html): Fedme er en kompleks kronisk sygdom, der kræver langsigtet behandling. Den er blandt de førende risikofaktorer for flere kardio-metaboliske sygdomme (74 words)
- [Salud Humana | Boehringer Ingelheim SA](/content/sa/salud-humana/index.html): El portafolio de productos de Boehringer Ingelheim's abarca las enfermedades cardiovasculares, oncológicas, respiratorias, SNC, virológicas y metabólicas. (292 words)
- [Human Health | Boehringer Ingelheim DK](/content/dk/human-health/index.html): BI er en forskningsdrevet virksomhed, der er dedikeret til at opdage, udvikle, fremstille og markedsføre innovative lægemidler og sundhedsprodukter. (206 words)
- [Enfermedades pulmonares | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-pulmonares/index.html): Enfermedades pulmonares (79 words)
- [Compras | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/compras/index.html): Compras (298 words)
- [EHNA | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/ehna/index.html): EHNA (163 words)
- [Heart Failure | Boehringer Ingelheim US](/content/us/human-health/heart-diseases/heart-failure/index.html): Heart Failure (408 words)
- [Akut iskæmisk slagtilfælde | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/slagtilfaelde/index.html): Akut iskæmisk slagtilfælde er den mest almindelige type slagtilfælde. Det opstår, når blodforsyningen til en del af hjernen blokeres (85 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/index.html): Read more on BI's longstanding commitment to improving the health & wellbeing of people and animals, both around the world and in local communities. (218 words)
- [Ética y Compliance | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/index.html): Ética y Compliance (253 words)
- [Dónde encontrarnos | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/donde-encontrarnos/index.html): Dónde encontrarnos (429 words)
- [Nuestras historias | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestras-historias/index.html): Nuestras historias (369 words)
- [Forebyggelse af slagtilfælde ved atrieflimren | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/atrieflimren/index.html): Et slagtilfælde opstår, når blodforsyningen til en del af hjernen afbrydes. Personer med uregelmæssig hjerterytme (også kaldet "atrieflimren") (85 words)
- [Ethics and Compliance | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/index.html): BI is committed to excellence in everything we do. Our goal is to produce results for our customers, shareholders & the communities in which we operate. (79 words)
- [MORE HEALTH | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-health/index.html): Read more on Boehringer Ingelheim's long-term initiative, 'More Health', with the aim of improving the health solutions across the globe. (32 words)
- [Hypertension | Boehringer Ingelheim US](/content/us/human-health/heart-diseases/hypertension/index.html): Hypertension (91 words)
- [Stroke | Boehringer Ingelheim US](/content/us/human-health/heart-diseases/stroke/index.html): Stroke (56 words)
- [Speak Up - Canal de Denuncias de Compliance | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/speak/index.html): El portal Speak Up está abierto a todo el mundo y ofrece un entorno seguro para reportar potenciales denuncias. Cada reporte se toma muy en serio. (370 words)
- [Mere Potentiale: For samfundsgrupper og vores medarbejdere | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/mere-potentiale/index.html): Samfundet står fortsat over for udfordringer inden for både sundhed, uddannelse, jobmuligheder, levevilkår, ulighed og fattigdom. (252 words)
- [Insuficiencia cardíaca | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-cardiacas/insuficiencia-cardiaca/index.html): Insuficiencia cardíaca (268 words)
- [Curious to learn more about opportunities in Quality?](/content/ca/careers/discover-our-career-areas/quality/index.html): We invite you to learn more about the many functions and roles within Quality, and to explore our current vacancies in locations around the world. (200 words)
- [Indkøb hos Boehringer Ingelheim | Boehringer Ingelheim DK](/content/dk/om-os/indkob/index.html): Leverandører er en integreret del af vores fokus på succes. Vi gå meget op i at afsøge innovative løsninger og nye muligheder. (163 words)
- [Ledelsen I Boehringer Ingelheim Danmark | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/lokal-ledelsesgruppe/index.html): Ledelsen I Boehringer Ingelheim Danmark (83 words)
- [Atrial Fibrillation | Boehringer Ingelheim US](/content/us/human-health/heart-diseases/atrial-fibrillation/index.html): Atrial Fibrillation (45 words)
- [Hypertension (forhøjet blodtryk) | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/hypertension/index.html): Hypertension (forhøjet blodtryk) er en tilstand, der rammer ca. en milliard mennesker i verden, og antallet af patienter forventes at stige (97 words)
- [Accidente cerebrovascular | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-cardiacas/accidente-cerebrovascular/index.html): Accidente cerebrovascular (293 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (324 words)
- [Más Verde: para nuestro planeta | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-verde/index.html): Más Verde: para nuestro planeta (292 words)
- [Curious to learn more about opportunities in Strategy?](/content/ca/careers/discover-our-career-areas/corporate-strategy-consulting/index.html): We invite you to learn more about the many functions and roles within Strategy & Consulting, and to explore our current vacancies in locations around the world. (219 words)
- [Hjertesvigt | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/hjertesvigt/index.html): Hjertesvigt er en progressiv og potentielt dødelig tilstand, der rammer over 60 millioner mennesker på verdensplan, og som forventes at stige i takt med, (160 words)
- [Curious to learn more about opportunities in Legal?](/content/ca/careers/discover-our-career-areas/legal-compliance/index.html): We invite you to learn more about the many functions and roles within Legal & Compliance, and to explore our current vacancies in locations around the world. (245 words)
- [Fibrilación auricular | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-cardiacas/fibrilacion-auricular/index.html): Fibrilación auricular (131 words)
- [Curious to learn more about opportunities in Data?](/content/ca/careers/discover-our-career-areas/data-careers/index.html): We invite you to learn more about the many functions and roles within Data Science, and to explore our current vacancies in locations around the world. (209 words)
- [MORE POTENTIAL | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-potential/index.html): MORE POTENTIAL works to provide the best conditions for our people, communities & partners along our chain to enable them to reach their full potential. (116 words)
- [アルゼンチンでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/argentina/index.html): アルゼンチンは、南米における当社事業の中心拠点です。アルゼンチンや世界中にわたる170か所の当社拠点で、キャリア開発のチャンスを見つけてください。 (73 words)
- [フランスでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/france/index.html): ベーリンガーインゲルハイムは、1967年からフランスに進出しています。フランスや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (83 words)
- [Culture | Boehringer Ingelheim US](/content/us/about-us/who-we-are/culture/index.html): Click here to find out about our vision & values; For over 135 years, our focus is on long-term performance rather than being limited by short-term profits (207 words)
- [Vores Historier | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/vores-historier/index.html): Hos Boehringer Ingelheim har vi mange initiativer, vi gerne vil dele med dig. Få mere at vide om os ved at læse vores historier. (99 words)
- [Kultur | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/kultur/index.html): Boehringer Ingelheim blev grundlagt for 135 år siden af Albert Boehringer, og lige siden har vi fokuseret på langsigtede resultater. (175 words)
- [Our Stories | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-stories/index.html): Click here to learn more about Boehringer Ingelheim's many initiatives that we would like to share. Find out more about us by reading our stories. (37 words)
- [Vi forpligter os | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/vi-forpligter-os/index.html): Vi arbejder for at fremme innovation og skabe værdi på områder med udækkede medicinske behov. (121 words)
- [Hipertensión | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-cardiacas/hipertension/index.html): Hipertensión (112 words)
- [スペインでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/spain/index.html): スペインの施設には、薬事規制関連業務サービスと2つの技術拠点があります。 スペインや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (74 words)
- [シンガポールでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/singapore/index.html): シンガポール本社は、太平洋地域の事業拠点として機能しています。シンガポールや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (48 words)
- [米国での最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/usa/index.html): 米国は、当社が最も成功している革新的な地域です。米国や世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (85 words)
- [Mere Sundhed: For mennesker og dyr | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/mere-sundhed/index.html): Et langsigtet initiativ, hvor målet er at forbedre sundheden lokalt verden over. Vi identificerer og støtter mest lovende løsninger sundhedsproblemer. (141 words)
- [Curious to learn more about roles in Communications?](/content/ca/careers/discover-our-career-areas/corporate-affairs/index.html): We invite you to learn more about the many functions and roles within Communications, and to explore our current vacancies in locations around the world. (220 words)
- [Belonging | Boehringer Ingelheim US](/content/us/about-us/who-we-are/belonging/index.html): Belonging (109 words)
- [Sustainable Development | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/index.html): At BI, Sustainable Development – For Generations is about a journey. One that started in 1885 and one that we hope, and believe, will never end. (117 words)
- [メキシコでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/mexico/index.html): メキシコには、2か所の当社最新の生産拠点があります。メキシコや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (75 words)
- [COACH Program | Boehringer Ingelheim CA](/content/ca/cardiovascular-optimization-and-community-hub-coach.html): The COACH Program addresses the unique needs of people living with heart failur and it's yielding promising results across Ontario. Find out more. (276 words)
- [Benefícios & Recompensas | Boehringer Ingelheim BR](/content/br/carreiras/beneficios-recompensas/index.html): Investimos nos nossos colaboradores para que fiquem e cresçam connosco. Oferecemos benefícios tais como recompensas e oportunidades de desenvolvimento para ajudar a manter os colaboradores. (280 words)
- [ドイツでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/germany/index.html): ドイツは、ベーリンガーインゲルハイムの物語の始まりの地であり、現在もグローバル本社がある場所です。ドイツや世界中170か所にわたるベーリンガーインゲルハイム拠点で、キャリア開発のチャンスを見つけてください。 (61 words)
- [Helping patients by addressing health system gaps | Boehringer Ingelheim CA](/content/ca/helping-patients-addressing-health-system-gaps-0/index.html): Helping patients by addressing health system gaps (329 words)
- [Desenvolvimento e crescimento | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/desenvolvimento-e-crescimento/index.html): Na Boehringer Ingelheim, apoiamos as pessoas em todo o seu desenvolvimento profissional, oferecendo aos nossos colaboradores espaço para aprendizado e crescimento, a fim de que alcancem seus objetivos de carreira. (262 words)
- [中国での最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/china/index.html): ベーリンガーインゲルハイムは、1994年から中国で事業を行っています。 中国や世界中170か所にわたる拠点で、キャリア開発のチャンスを見つけてください。 (41 words)
- [オーストリアでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/austria/index.html): ウィーンはドイツ以外では初の国外拠点です。オーストリアや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (60 words)
- [オランダでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/netherlands/index.html): アムステルダムの施設は、欧州における事業の1拠点です。オランダや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (39 words)
- [ドバイでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/dubai/index.html): ドバイは当社のIMETA地域の中核です。 UAEや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (35 words)
- [Medly Program | Boehringer Ingelheim CA](/content/ca/successful-virtual-care-model-grows-thanks-collaboration.html): Learn more about the Medly Program and the partnership between Toronto’s UHN and Boehringer Ingelheim Canada to expand it to additional communities. (225 words)
- [Benefícios e bem-estar | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/beneficios-e-bem-estar/index.html): Nós nos preocupamos com o bem-estar e o equilíbrio entre vida pessoal e profissional dos nossos funcionários. Na Boehringer Ingelheim, oferecemos benefícios como diversas opções de licença e horários flexíveis. (272 words)
- [Ödüller ve Takdir | Boehringer Ingelheim TR](/content/tr/kariyer/oduller-ve-takdir/index.html): Başarılar ve takdir gerektiren durumlar vardır. Çalışanlarımızı ödüllendirmek için elimizden gelenin en iyisini yapıyor ve ticari başarılarını kutluyoruz. (207 words)
- [is yasam dengesi | Boehringer Ingelheim TR](/content/tr/kariyer/yasam-dengesi/index.html): Çalışanların profesyonel ve kişisel yaşamlarını dengelemeleri önemlidir, bu bağlamda farklı izin seçenekleri ve esnek çalışma programları sunuyoruz. (348 words)
- [ブラジルでの最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/brazil/index.html): ベーリンガーインゲルハイムは、70年以上にわたってブラジルを事業拠点としています。ブラジルや世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (56 words)
- [Matthias Muenks | Boehringer Ingelheim TR](/content/tr/kariyer/matthias-muenks/index.html): Boehringer Ingelheim Küresel Mühendislik Süreci ve Veri Müdürü Matthias Muenks, ilaç şirketinin inovasyonları ve kültürü üzerine görüşlerini paylaşıyor. (254 words)
- [Öğrenme ve Gelişim | Boehringer Ingelheim TR](/content/tr/kariyer/ogrenme-ve-gelisim/index.html): Çalışanlarımızın yeteneklerini üst düzeye çıkararak ve şirket içinde gelişmelerine olanak tanıyarak profesyonel açıdan ilerlemelerine yardımcı oluyoruz. (239 words)
- [Finansal sağlık | Boehringer Ingelheim TR](/content/tr/kariyer/finansal-saglik/index.html): Maaşları piyasada rekabet gücünün korunması adına düzenli olarak gözden geçiriyoruz ve finansal sağlık için de kapsamlı destek sağlıyoruz. (217 words)
- [Connect with us | Boehringer Ingelheim HK](/content/hk/en/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (372 words)
- [Brief der Unternehmensleitung | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/brief-der-unternehmensleitung/index.html): Brief der Unternehmensleitung (544 words)
- [Erken kariyer | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/erken-kariyer/index.html): Kariyer hayatınıza Boehringer Ingelheim ile başlayın. Öğrenciler ve yeni mezunlar için heyecan verici fırsatları keşfedin. (139 words)
- [abd | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/usa/index.html): ABD en başarılı ve inovatif bölgelerimizden biridir. ABD'de veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (249 words)
- [Dubai | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/dubai/index.html): Dubai, IMETA bölgesinin kalbinde yer almaktadır. BAE'de veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (183 words)
- [Japonya | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/japan/index.html): Japonya ekibimiz inovasyon ve sürdürülebilirliğe olan bağlılığı ile tanınır. Japonya'da veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (131 words)
- [Material educativo: criança, seja um guardião da saúde! | Boehringer Ingelheim BR](/content/br/human-health/patients/patient-safety/pdf/material-educativo-crianca-seja-um-guardiao-da-saude.html): Ajude seu filho a aprender sobre o uso seguro de medicamentos com esta cartilha educativa, perfeita para atividades em família e orientação responsável. (12 words)
- [Cuidados seguros para todas as gestantes e todos os recém-nascidos | Boehringer Ingelheim BR](/content/br/saude-humana/nossa-responsabilidade/pdf/cuidados-seguros-para-todas-gestantes-e-todos-os-recem-nascidos.html): Fornecimento seguro de medicamentos (12 words)
- [O que é Farmacovigilância? | Boehringer Ingelheim BR](/content/br/pdf/infografico-1-o-que-e-farmacovigilancianew-brandpdf.html): Infográfico explica o que é farmacovigilância e como ela monitora a segurança dos medicamentos para proteger pacientes. (12 words)
- [Almanya | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/germany/index.html): Almanya, Boehringer Ingelheim serüvenin başladığı küresel merkezimizdir. Almanya veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (155 words)
- [Reportando Efeitos Indesejaveis | Boehringer Ingelheim BR](/content/br/pdf/infografico-2-reportando-efeitos-indesejaveisnew-brandpdf.html): Infográfico orienta como identificar e reportar efeitos indesejáveis, reforçando a segurança do paciente e o uso responsável de medicamentos. (12 words)
- [Decisões Informadas e Uso Seguro de Medicamentos | Boehringer Ingelheim BR](/content/br/pdf/infografico-3-decisoes-informadas-e-uso-seguro-de-medicamentosnew-brandpdf.html): Infográfico apresenta orientações para decisões informadas e uso seguro de medicamentos, promovendo cuidado responsável. (12 words)
- [O que está sendo feito pela Segurança do Paciente? | Boehringer Ingelheim BR](/content/br/pdf/infografico-4-o-que-esta-sendo-feito-pela-seguranca-do-pacientenew-brandpdf.html): Infográfico destaca ações e iniciativas adotadas para fortalecer a segurança do paciente e aprimorar a qualidade do cuidado. (12 words)
- [Çalışanlar, Maliye ve Organizasyon | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/people-finance-organization/index.html): Çalışanlarımız, Finans ve Organizasyon bölümlerindeki fırsatları keşfedin. (397 words)
- [Paciente: O personagem principal do tratamento | Boehringer Ingelheim BR](/content/br/pdf/paciente-o-personagem-principal-do-tratamento/index.html): Dicas de como tornar o uso de medicamentos mais seguro em todas as etapas de jornada de cuidado. (12 words)
- [O que é um evento adverso? | Boehringer Ingelheim BR](/content/br/pdf/o-que-e-um-evento-adverso/index.html): Infográfico explica o que são eventos adversos, como identificá-los e a importância de notificar para garantir segurança no uso de medicamentos. (12 words)
- [Você sabe usar medicamentos? Descubra boas práticas e cuidados | Boehringer Ingelheim BR](/content/br/pdf/voce-sabe-usar-medicamentos/index.html): Infográfico sobre farmacovigilância, eventos adversos e orientações para o uso correto e seguro de medicamentos em casa e hospitais. (12 words)
- [Trayenta Duo (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/trayenta-duo-profissional0pdf/index.html): Bula Trayenta DUO (Profissionais de Saúde) atualizada em 05/01/2026. (12 words)
- [Singapur | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/singapore/index.html): Singapur merkezli şirketimiz Pasifik Bölgesi'nin kalbi olarak hizmet verir. Singapur veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (156 words)
- [Jardiance (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/jardiance-paciente-0/index.html): Bula de Jardiance (Paciente) atualizada em 06/01/2026. (12 words)
- [Extrapulmonary Neuroendocrine Cancers | Boehringer Ingelheim](/content/human-health/cancer/neuroendocrine-cancers/extrapulmonary-neuroendocrine-cancers/index.html): Learn more about extrapulmonary neuroendocrine carcinomas, a rare and highly aggressive type of neuroendocrine cancer that occurs outside of the lungs. (821 words)
- [Trayenta Duo (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/trayenta-duo-paciente0pdf/index.html): Bula Trayenta Duo (Paciente) atualizada em 05/01/2026. (12 words)
- [MICARDIS HCT (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/micardis-hct-pacientepdf/index.html): Bula Micardis HCT (Paciente) atualizada em 06/01/2026. (12 words)
- [Hollanda | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/netherlands/index.html): Amsterdam tesisimiz, Avrupa'daki faaliyetlerimizin merkezlerinden biridir. Hollanda veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (148 words)
- [SPIRIVA RESPIMAT (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/20-spirivabulaprofissional/index.html): Bula Spiriva Respimat Profissionais de Saúde. (12 words)
- [Metalyse (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/metalyse-pacientepdf/index.html): Bula Metalyse para paciente. (12 words)
- [Bula Trayenta_Paciente | Boehringer Ingelheim BR](/content/br/pdf/bula-trayentapaciente/index.html): Atualização da bula Trayenta paciente; código novo: 11-7319108/C25-01 (11 words)
- [2.0 Striverdi Respimat_Bula_Profissional da Saúde | Boehringer Ingelheim BR](/content/br/pdf/20-striverdi-respimatbulaprofissional-da-saude/index.html): Nova bula Striverdi Respimat - Profissionais de Saúde. (12 words)
- [Pradaxa (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/pradaxaprofissional-da-saude/index.html): Atualizado em 06/01/2026. (12 words)
- [2.0 Spiolto_Bula_Profissional | Boehringer Ingelheim BR](/content/br/pdf/20-spioltobulaprofissional/index.html): Nova bula Spiolto - Profissionais de Saúde. (12 words)
- [1.0 Spiolto_Bula_Paciente | Boehringer Ingelheim BR](/content/br/pdf/10-spioltobulapaciente/index.html): Nova bula Spiolto - Paciente. (12 words)
- [MICARDIS HCT (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/micardis-hct-profissionalpdf/index.html): Nova bula Micardis HCT - Profissional de Saúde. (12 words)
- [Spiriva Respimat (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/10-spirivabulapaciente/index.html): Bula Spiriva Respimat (Paciente). Atualizado em 23/02/2026. (12 words)
- [Bula Praxbind (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/praxbindbulaprofissionalpdf/index.html): Bula Praxbind (Profissional). Atualizada em 25/11/2025. (12 words)
- [Pradaxa (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/bula-pradaxapaciente/index.html): Atualizado em 06/01/2026 (12 words)
- [MICARDIS ANLO (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/micardis-anlo-profissionalpdf/index.html): Bula Micardis Anlo (Profissional de Saúde) atualizada em 06/01/2026. (12 words)
- [OFEV (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/ofevbulapaciente/index.html): Bula Ofev (Paciente) atualizada em 06/01/2026. (12 words)
- [Çin | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/china/index.html): Boehringer Ingelheim 1994 yılından beri Çin'de faaliyet göstermektedir. Çin'de veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (161 words)
- [Jascayd - Bula Paciente | Boehringer Ingelheim BR](/content/br/saude-humana/produtos/pdf/jascayd-bula-paciente/index.html): Nerandomilaste (12 words)
- [Metalyse (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/metalyse-profissional-da-saudepdf/index.html): Bula de Metalyse para profissionais de saúde. (11 words)
- [MICARDIS (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/micardis-pacientepdf/index.html): Nova bula Micardis - Paciente. (12 words)
- [Jascayd - Bula Profissional de Saúde | Boehringer Ingelheim BR](/content/br/saude-humana/produtos/pdf/jascayd-bula-profissional-de-saude/index.html): Nerandomilaste (12 words)
- [Jardiance (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/jardiance-profisonais-de-saude/index.html): Bula Jardiance (Profissional da Saúde) atualizada em 06/01/2026. (12 words)
- [Glyxambi (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/glyxambibulaprofissionalpdf/index.html): Nova bula Glyxambi - Profissional de Saúde. Atualizado em 06/01/2026. (12 words)
- [Atrovent_Bula_Profissional.pdf | Boehringer Ingelheim BR](/content/br/pdf/atroventbulaprofissionalpdf/index.html): Nova bula Atrovent - Profissionais de Saúde (12 words)
- [Berotec (Profissional) | Boehringer Ingelheim BR](/content/br/pdf/berotecbulaprofissional/index.html): Nova bula Berotec - Profissional. Atualizado em 06/01/2026. (12 words)
- [Giotrif - Bula Profissional de Saúde | Boehringer Ingelheim BR](/content/br/saude-humana/produtos/pdf/giotrif-bula-profissional-de-saude/index.html): Afatinibe (como dimaleato de afatinibe). (12 words)
- [Berotec (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/berotecbulapaciente/index.html): Nova bula Berotec - Paciente. Atualizado em 06/01/2026. (12 words)
- [Atrovent_Bula_Paciente.pdf | Boehringer Ingelheim BR](/content/br/pdf/atroventbulapacientepdf/index.html): Nova bula Atrovent - Paciente (12 words)
- [Glyxambi (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/glyxambibulapacientepdf/index.html): Nova bula Glyxambi - Paciente. atualizado em 06/01/2026. (12 words)
- [Arjantin | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/argentina/index.html): Arjantin, Güney Amerika'daki faaliyetlerimizin temel taşlarındandır. Arjantin veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (127 words)
- [ACTILYSE (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/actilyse-pacientepdf/index.html): Bula Actilyse (Paciente) atualizada em (...). (12 words)
- [The Research Process | Boehringer Ingelheim TW](/content/tw/research-process/index.html): Science and Innovation - Animal Health Innovation - Parasiticides (130 words)
- [Nelli Milosh | Boehringer Ingelheim TR](/content/tr/kariyer/nelli-milosh/index.html): Almanya'daki medikal saha ekibimizin lideri Nelli Milosch, Boehringer Ingelheim'da çalışmanın en iyi yanının çalışan kadrosu olduğunu belirtiyor. (41 words)
- [Hukuk ve Uyumluluk | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/legal-compliance/index.html): Yasal Uyumluluk ekibimizde yer almak için fırsatları keşfedin. (205 words)
- [Fibrose Pulmonar Progressiva: como é feito o diagnóstico? | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/fibrose-pulmonar/fibrose-pulmonar-progressiva-como-e-feito-o-diagnostico.html): A identificação precoce da doença é essencial para preservar a função dos pulmões. (606 words)
- [What Our Partners Say | Boehringer Ingelheim TW](/content/tw/what-our-partners-say/index.html): What Our Partners Say (178 words)
- [Öğrenme ve Kariyer Gelişimin | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/learning-and-growth/index.html): At Boehringer Ingelheim, we support people throughout their professional development – giving our employees room for learning and growth to achieve their career goals. (212 words)
- [Information Technology | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/information-technology/index.html): Bilgi Teknolojileri birimimizdeki fırsatları keşfedin. (140 words)
- [Veri Kariyerleri | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/data-careers/index.html): Veri becerilerinizi kullanarak fark yaratın. Heyecan dolu veri alanındaki kariyer fırsatlarını keşfedin ve hemen başvurun. (173 words)
- [Depression | Boehringer Ingelheim TW](/content/tw/depression/index.html): Depression (133 words)
- [Human Health Partnering Connect with Us | Boehringer Ingelheim TW](/content/tw/human-health-partnering-connect-us/index.html): Human Health Partnering Connect with Us (123 words)
- [Kurumsal Strateji ve Danışmanlık | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/corporate-strategy-consulting/index.html): Kurumsal Strateji ve Danışmanlık alanındaki fırsatları keşfedin. (200 words)
- [Kazancın | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/compensation-and-rewards/index.html): Some achievements demand employee recognition. At Boehringer Ingelheim, we go out of our way to mark milestones with compensation packages and bonus programs (201 words)
- [Programa de desconto e apoio ao paciente | Abraçar a Vida](/content/patient/br/abracar-a-vida/index.html): Abraçar a Vida é uma rede de apoio que oferece benefícios e serviços complementares ao tratamento medicamentoso.. Abraçar a Vida, este é o nosso propósito. (404 words)
- [Yan Haklar ve Esenliğin | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/benefits-and-wellbeing/index.html): We care about our employees' wellbeing and work-life balance. At Boehringer Ingelheim, we offer benefits such as various leave options and flexible schedules. (218 words)
- [Guia para tutores de cavalos: perguntas essenciais para a consulta veterinária | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/equinos/pdf/guia-para-tutores-de-cavalos-perguntas-essenciais-para-consulta-veterinaria.html): Guia prático com perguntas essenciais para tutores acompanharem a saúde, o conforto e os cuidados preventivos dos cavalos durante a consulta veterinária. (12 words)
- [Parasiticides | Boehringer Ingelheim TW](/content/tw/parasiticides/index.html): Science and Innovation - Animal Health Innovation - Parasiticides (55 words)
- [Kalite | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/quality/index.html): Kalite Departmanı birimimizdeki fırsatları keşfedin. (95 words)
- [Köpekler | Boehringer Ingelheim TR](/content/tr/kopekler/index.html): Köpek sağlığını korumaya ve yaşam kalitesini artırmaya yönelik ürün ve çözümlerimizle, Boehringer Ingelheim olarak patili dostlarımızın daha uzun ve mutlu bir yaşam sürmesi için çalışıyoruz. (539 words)
- [セーブペットプロジェクト | Boehringer Ingelheim JP](/content/jp/node/32496/index.html): “うちの子を守ることは助けを待つ子を救うこと”をキーワードに、病院などで処方、または販売されるベーリンガーインゲルハイム アニマルヘルス ジャパンの犬猫用寄生虫駆除薬と犬用デンタルガムの売り上げの一部を、毎年、日本獣医師会とアニマル・ドネーションに寄付しています。 (29 words)
- [Horses | Boehringer Ingelheim TW](/content/tw/horses/index.html): horse (134 words)
- [Apoio ativo em caso de desastres e situações emergenciais | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-potencial/apoio-ativo-em-caso-de-desastres-e-situacoes-emergenciais.html): Em desastres, atuamos com agilidade e responsabilidade para apoiar comunidades afetadas por meio de ações emergenciais, doações e voluntariado. (354 words)
- [私たちが支援する動物たち | Boehringer Ingelheim JP](/content/jp/animal-health/animals-we-support/index.html): 私たちは日々、さまざまな形で動物とかかわりながら暮らしています。 (44 words)
- [Η ευθύνη μας | Boehringer Ingelheim GR](/content/gr/i-eythyni-mas/index.html): Στην Boehringer Ingelheim, θέτουμε τους ασθενείς σε προτεραιότητα σε ό,τι κάνουμε. (84 words)
- [Checklist de medidas de biosseguridade | Boehringer Ingelheim BR](/content/br/saude-animal/nossa-responsabilidade/pdf/checklist-de-medidas-de-biosseguridade/index.html): Checklist de biosseguridade em granjas com ações internas e externas para controle sanitário, prevenção de doenças, higiene, pragas e boas práticas. (12 words)
- [地域医療の取り組み | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-stories/regional-healthcare/index.html): 私たちベーリンガーインゲルハイムは、地域社会の皆さまのより良く健康な生活の推進を目指し、地域医療の活動支援に取り組んでいます。 (46 words)
- [Destek Sağladığımız Hayvanlar | Boehringer Ingelheim TR](/content/tr/hayvan-sagligi/hayvancilik/ruminantlar/index.html): Sevimli köpekler, kediler ve atlar ile birlikte geviş getirenler ve kanatlılar gibi değerli çiftlik hayvanlarının sağlığını korumaya kararlıyız. (64 words)
- [O voluntariado como parte viva da nossa cultura | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-potencial/o-voluntariado-como-parte-viva-da-nossa-cultura/index.html): Na Boehringer Ingelheim, acreditamos que transformar o mundo em um lugar melhor para viver é possível. Para isso, no entanto, é preciso trabalhar em conjunto. Por isso, incentivamos frequentemente nossas pessoas a se engajarem em causas sociais. (320 words)
- [Programa Abraçar busca reduzir jornada do paciente respiratório crônico | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/programa-abracar-busca-reduzir-jornada-do-paciente-respiratorio-cronico.html): Focado em condições como a DPOC (Doença Pulmonar Obstrutiva Crônica) e a asma, o programa atua junto à rede pública de saúde, por meio da capacitação de profissionais, doação de materiais e implantação de protocolos clínicos, visando reduzir a jornada do (354 words)
- [Obesity | Boehringer Ingelheim TW](/content/tw/obesity/index.html): 肥胖 (161 words)
- [Criando um mundo livre da raiva | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/criando-um-mundo-livre-da-raiva/index.html): O nosso compromisso é proteger os seres humanos, os animais e as comunidades, salvar vidas e criar um futuro melhor para todos. Junte-se à nossa luta para cruzar fronteiras e eliminar a raiva. (165 words)
- [Como repensamos nossos eventos para que se tornassem referência em sustentabilidade | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/como-repensamos-nossos-eventos-para-que-se-tornassem-referencia-em-sustentabilidade.html): Eventos são oportunidades de gerar impacto positivo para clientes, pacientes e o planeta. Desde 2019, repensamos a forma como os realizamos. (189 words)
- [Construindo diariamente um lugar de pertencimento, propósito e realização | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-potencial/construindo-diariamente-um-lugar-de-pertencimento-proposito-e-realizacao.html): Para nós, promover um ambiente de trabalho saudável, equitativo e inspirador é um objetivo diário. Dessa forma, buscamos evoluir constantemente o conceito de ser uma empresa onde nossas pessoas querem estar (264 words)
- [Akciğer Hastalıkları | Boehringer Ingelheim TR](/content/tr/akciger-hastaliklari/index.html): Akciğer Hastalıkları (17 words)
- [AVC, quels sont les 3 signes pour sauver ? | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/avc/avc-quels-sont-les-3-signes-pour-sauver/index.html): Découvre-en plus sur l'AVC, cette maladie qui continue de toucher 150 000 personnes par an. Quels sont les symptômes ? Comment réagir ? Comment l'éviter ? (741 words)
- [ペイシェントセイフティー＆ファーマコビジランス | Boehringer Ingelheim JP](/content/jp/human-health/our-responsibility/patient-safety/index.html): ペイシェントセイフティー＆ファーマコビジランスはベーリンガーインゲルハイムで，患者さんの安全性をけん引しています。 (22 words)
- [Como trabalhamos para um futuro melhor para as novas gerações | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/como-trabalhamos-para-um-futuro-melhor-para-novas-geracoes.html): Reforçamos nosso compromisso com a sustentabilidade por meio de iniciativas e programas de longa data que enfrentam juntos desafios ambientais e de saúde. (77 words)
- [Definindo comunidades com necessidades não atendidas | Boehringer Ingelheim BR](/content/br/pdf/definindo-comunidades-carentes/index.html): Definição de comunidades com necessidades não atendidas e os desafios no acesso à saúde. (12 words)
- [Pet Hayvanlar | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/index.html): Antiparazitler, aşılar ve ilaçlarımızla pet hayvan sağlığı pazarının liderleri arasında yer alıyoruz. Dünyanın her yanında veteriner hekimler ve pet hayvan sahipleri için güvenilir bir iş ortağı olarak karşılanmamış ihtiyaçlara yanıt vermek amacıyla sürek (238 words)
- [Lungcancer | Boehringer Ingelheim SE](/content/se/manniskors-halsa/cancer/lungcancer/index.html): Med utgångspunkt i vår erfarenhet av lungsjukdomar är vårt mål att ta oss an lungcancer, förändra behandlingslandskapet och i slutändan omdefiniera. (27 words)
- [Alla cancertyper | Boehringer Ingelheim SE](/content/se/manniskors-halsa/cancer/alla-cancertyper/index.html): Vi är engagerade i våra fokusområden lungcancer och gastrointestinal cancer, men vi låter oss styras av vetenskapen och söker möjligheter. (72 words)
- [Obezita | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/obezita/index.html): Přečtěte si o obezitě a zjistěte, co společnost Boehringer Ingelheim dělá pro vývoj nových léků, které zlepší život pacientů. Přečtěte si nejnovější články o obezitě zde. (243 words)
- [患者さんを中心に | Boehringer Ingelheim JP](/content/jp/human-health/our-responsibility/patient-centricity/index.html): Patient Centricity (35 words)
- [Obesidade | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-metabolicas/obesidade/index.html): Obesidade (92 words)
- [Die Unternehmensgeschichte von Boehringer Ingelheim | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/geschichte-140-jahre/index.html): Erfahren Sie mehr über die Unternehmensgeschichte von Boehringer Ingelheim (887 words)
- [プレスリリース | Boehringer Ingelheim JP](/content/jp/press-releases/index.html): Press Releases (93 words)
- [メンタルヘルス | Boehringer Ingelheim JP](/content/jp/human-health/mental-health/index.html): 統合失調症やアルツハイマー病などの中枢神経系疾患は、ベーリンガーインゲルハイムの探索的研究開発の焦点の1つとなっています。 (3 words)
- [Microsoft Word - SF Recruiting Global Data Privacy Statement Version 1.1_CHs.docx](/content/content/dam/8d15727f-c893-4d91-98b1-b014006a738c/successfactors_recruiting_global_data_privacy_statement_cn_simp-pdf.html) (326 words)
- [SAC Saúde Humana | Boehringer Ingelheim BR](/content/br/contato-saude-humana/sac-saude-humana/index.html): SAC Saúde Humana (1,870 words)
- [Herzerkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/index.html): Boehringer Ingelheim entwickelt innovative Behandlungsmöglichkeiten, um auf den noch ungedeckten medizinischen Bedarf einzugehen und die Versorgung von Patienten mit unterschiedlichen kardiovaskulären Erkrankungen, wie Herzrhythmusstörungen (z. B. Vorh (62 words)
- [Teknik Ürün Şikayet Bildirim Formu | Boehringer Ingelheim TR](/content/tr/technical-product-complaint-notification-form/index.html): Teknik Ürün Şikayet Bildirim Formu (857 words)
- [Cukrovka | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/cukrovka/index.html): Zjistěte více o cukrovce a o tom, jak společnost Boehringer Ingelheim pracuje na výzkumu a vývoji nových, inovativních léků na cukrovku, aby zlepšila život pacientů. (271 words)
- [役員 | Boehringer Ingelheim JP](/content/jp/leadership/index.html): Leadership (198 words)
- [Scleroza sistemică | Boehringer Ingelheim RO](/content/ro/medicina-umana/afectiuni-pulmonare/scleroza-sistemica/index.html): Scleroza sistemică (95 words)
- [Θεραπευτικά | Boehringer Ingelheim GR](/content/gr/science-innovation/animal-health-innovation/therapeutics/index.html): Παρέχουμε μια πειθαρχημένη επιστημονική προσέγγιση στην παγκόσμια ανακάλυψη, ανάπτυξη και εμπορευματοποίηση. (73 words)
- [Bronșiectazie | Boehringer Ingelheim RO](/content/ro/medicina-umana/afectiuni-pulmonare/bronsiectazie/index.html): Bronșiectazie (186 words)
- [Michael Schmelmer | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/michael-schmelmer/index.html): Michael Schmelmer – místopředseda představenstva zodpovědný za Group Functions (180 words)
- [代謝性疾患 | Boehringer Ingelheim JP](/content/jp/human-health/metabolic-diseases/index.html): Metabolic Diseases (24 words)
- [私たちの責任 | Boehringer Ingelheim JP](/content/jp/human-health/our-responsibility/index.html): Our Responsibility (10 words)
- [Document](/content/sites/default/files/2025-11/privacy02_20251201-docx.html) (98 words)
- [Hypertension | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/hypertension/index.html): Hypertension (95 words)
- [Schizophrenia | Boehringer Ingelheim CA](/content/ca/human-health/mental-health/schizophrenia/index.html): Schizophrenia is characterised by three symptom domains and affects ~1% of global population. Click here to learn and find out more information. (78 words)
- [İnme | Boehringer Ingelheim TR](/content/tr/human-health/heart-diseases/stroke/index.html): En yaygın inme tipi olan akut iskemik inme, beynin bir kısmına giden kan akışının bir beyin damarındaki pıhtı veya ateroskleroz (damar duvarlarındaki yağ birikintileri veya plaklar) nedeniyle tıkanmasıyla ortaya çıkar. (70 words)
- [annualreport/2024/files/downloads-and-archive/financial-report-2022/boe_ar22_financial-report_en_safe-pdf.html](/content/annualreport/2024/files/downloads-and-archive/financial-report-2022/boe_ar22_financial-report_en_safe-pdf.html) (27,667 words)
- [Doenças metabólicas | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-metabolicas/index.html): Doenças metabólicas (188 words)
- [Horses | Boehringer Ingelheim HK](/content/hk/en/animal-health/companion-animals/horses/index.html): We develop leading solutions for the wellbeing of horses in immunology, parasitology, gastric and metabolic health. (69 words)
- [annualreport/2024/files/downloads-and-archive/key-aspects-2024/boe_key_aspects_2024-pdf.html](/content/annualreport/2024/files/downloads-and-archive/key-aspects-2024/boe_key_aspects_2024-pdf.html) (647 words)
- [Infarto Agudo do Miocárdio | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/infarto-agudo-do-miocardio/index.html): Saiba tudo sobre infarto: causas, sintomas e tratamento. (451 words)
- [Захворювання серця | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/index.html): Серцево-судинні захворювання, включно з хворобами серця та інсультом, є серйозною глобальною проблемою здоров’я людства та основною причиною смерті та інвалідності в усьому світі. (79 words)
- [Öne Çıkan Hikayeler | Boehringer Ingelheim TR](/content/tr/animal-health/trends-insights/index.html): Hayvan ve insan refahı bizim amacımız, ilham kaynağımız ve hedefimizdir. Hayvan ve insan yaşamı birbirine derin ve karmaşık şekillerde bağlıdır. (43 words)
- [Facts and figures | Boehringer Ingelheim](/content/annualreport/2024/facts-and-figures/index.html): Highlights of the Boehringer Ingelheim Annual Report 2024 in numbers (676 words)
- [Veterinary Public Health | Boehringer Ingelheim HK](/content/hk/en/animal-health/veterinary-public-health/index.html): Veterinary Public Health (91 words)
- [Diabetes | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-metabolicas/diabetes/index.html): O diabetes é uma condição crônica, cujo diagnóstico se dá pela avaliação da taxa de glicemia. Entenda as características da doença e as formas de tratá-la. (167 words)
- [Evcil Hayvanlar | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/index.html): Veteriner hekim misiniz? Evcil hayvanınız veya atınız mı var? Dünyanın önde gelen ilaç şirketleri arasında yer alan Boehringer Ingelheim evcil hayvanların daha uzun, daha sağlıklı ve daha mutlu yaşamasına yardımcı oluyor. (66 words)
- [Καινοτομία στην υγεία των ζώων | Boehringer Ingelheim GR](/content/gr/science-innovation/animal-health-innovation/index.html): Η παγκόσμια ομάδα καινοτομίας μας είναι η πρωτοποριακή επιστήμη που βοηθά τους κτηνιάτρους, τους ιδιοκτήτες κατοικίδιων ζώων και ζώων εκτροφής. (88 words)
- [Κλινικές μελέτες | Boehringer Ingelheim GR](/content/gr/science-innovation/human-health-innovation/clinical-studies/index.html): Οι κλινικές δοκιμές αποτελούν ουσιαστικό μέρος της ανάπτυξης νέων φαρμάκων. (59 words)
- [脳卒中 | Boehringer Ingelheim JP](/content/jp/human-health/heart-diseases/stroke/index.html): 脳卒中のなかでも最も多い急性虚血性脳卒中は、脳血管に血液の塊が詰まったり、動脈硬化（血管壁にプラークと呼ばれる脂肪の塊ができる疾患）が生じたため、脳の一部への血流が途切れることによって現れる疾患です。脳卒中は、身体障害を引き起こしたり、死亡に至ることもあるため、速やかな治療が必要です。ベーリンガーインゲルハイムは、同疾患の治療をリードしました。現在は、この医薬品は世界中の脳卒中センターで用いられています。（以下の翻訳は日本に該当しないため削除） (4 words)
- [強皮症 | Boehringer Ingelheim JP](/content/jp/human-health/lung-diseases/scleroderma/index.html): 全身性強皮症（SSc）は、皮膚や全身の様々な臓器がだんだんと硬くなっていくことが特徴の病気です。皮膚が硬くなる変化を代表的な症状とする疾患ですが、皮膚以外の肺（全身性強皮症に伴う間質性肺疾患:SSC-ILD)やその他の全身の臓器にも症状が現れます。全身性強皮症の患者数は全世界で200万人以上で、25～55歳の女性に好発します。全身性強皮症は複雑でまれな疾患で、症状や経過は患者さんによって大きく異なります。複数の臓器に病変が現れるために気づくのが難しく、正確な早期診断は難しいのが現状です。 (7 words)
- [Pets | Boehringer Ingelheim HK](/content/hk/en/animal-health/companion-animals/pets/index.html): Boehringer Ingelheim has multiple products and research elements working to ensure that your pets health and wellbeing is number one. (40 words)
- [Βασικές ρίζες | Boehringer Ingelheim GR](/content/gr/science-innovation/human-health-innovation/grass-roots/index.html): Το μοναδικό μας παγκόσμιο πρόγραμμα πρωτοβουλιών Grass Roots έχει σχεδιαστεί για να δώσει τη δυνατότητα στην αναδυόμενη επιστήμη και τεχνολογί (15 words)
- [役員 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/jp-leadership/index.html): Leadership (145 words)
- [Shashank Deshpande | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/shashank-deshpande/index.html): シャシャンク・デシュパンデ 取締役会会長 兼 医療用医薬品事業ユニット担当取締役 (194 words)
- [Dr Paola Casarosa | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): パオラ・カサロッサ イノベーションユニット担当取締役 (165 words)
- [Analyst III/SR Analyst, Revenue Management Job Details | BoehringerPRD](/content/jobs/job-invite/35381/index.html): Johns Creek, GA Analyst III/SR Analyst, Revenue Management - Unit (1,072 words)
- [5º Relatório de Transparência Salarial - 1º Semestre de 2026 | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/pdf/5o-relatorio-de-transparencia-salarial-1o-semestre-de-2026.html): A Boehringer Ingelheim do Brasil compartilha o Relatório de Transparência e Igualdade Salarial entre homens e mulheres conduzido pelo Governo Federal. (12 words)
- [DÉCLARATION DE CONFIDENTIALITÉ BI | Boehringer Ingelheim BE](/content/be/fr/declaration-de-confidentialite-bi/index.html): SCS Boehringer Ingelheim Comm.V., Boehringer Ingelheim Centre S.A. ainsi que Boehringer Ingelheim Pharma GmbH & Co. KG et les sociétés du groupe. (3,428 words)
- [ベルツ賞 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/herutsushang/index.html): ベルツ賞 (30 words)
- [Animal Health hlášení podezření na nežádoucí účinek | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/zdravi-zvirat/boehringer-ingelheim-animal-health/index.html): Formulář hlášení nežádoucích účinků u veterinárních léčivých přípravků společnosti Boehringer Ingelheim (182 words)
- [Dr Armin Wiesler | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): アーミン・ヴァイスナーアニマルヘルス事業ユニット担当取締役 (190 words)
- [Fortschritte bei der Schlaganfallversorgung | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/schlaganfallversorgung/index.html): Erfahren Sie, wie Boehringer Ingelheim mit der „Angels Initiative“ die Schlaganfallversorgung verbessert. (432 words)
- [Commercial Technology and Analytics Manager / Staff or Non-line Manager / Commercial Excellence Dep 求人詳細 | BoehringerPRD](/content/jobs/job-invite/35091/index.html): 品川 Commercial Technology and Analytics Manager / Staff or Non-line Manager / Commercial Excellence Dep - 日本 (538 words)
- [Michael Schmelmer | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/michael-schmelmer/index.html): ミヒャエル・シュメルマー取締役会バイスプレジデント 兼 グループファンクション担当取締役 (202 words)
- [Harsha Deshmukh | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/harsha-deshmukh/index.html): ハルシャ・デシュムク IT＆グローバルビジネスサービス担当取締役 (192 words)
- [Frank Hübler | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/frank-hubler/index.html): フランク・ヒューブラー財務担当取締役 (148 words)
- [SR AD, Revenue Management - Retail Deal Desk Job Details | BoehringerPRD](/content/jobs/job-invite/31604/index.html): Johns Creek, GA SR AD, Revenue Management - Retail Deal Desk - Unit (834 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim TR](/content/tr/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (290 words)
- [Shashank Deshpande | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (184 words)
- [Sürdürülebilirlik | Boehringer Ingelheim TR](/content/tr/surdurulebilirlik/index.html): Sürdürülebilirlik (4 words)
- [バイオ医薬品受託製造に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/biopharma-form/index.html): バイオ医薬品受託製造に関するお問い合わせ (42 words)
- [Humánní medicína hlášení podezření na nežádoucí účinek | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/lidske-zdravi/boehringer-ingelheim-human-health/index.html): Formulář hlášení podezření na nežádoucí účinek humánních léčivých přípravků společnosti Boehringer Ingelheim. (273 words)
- [Saskia Venne | Boehringer Ingelheim](/content/careers/explore-our-company/saskia-venne/index.html): Saskia Venne (57 words)
- [Medical & Clinical Trials | Clinical Research | BI Clinical Studies](/content/clinicalstudies/trials/disease/completed/1/all/index.html): Search and find clinical trials and studies to read on a variety of medical conditions with BI Clinical Studies. You can begin researching right away. (1,774 words)
- [Comunicados de imprensa | Boehringer Ingelheim BR](/content/br/imprensa-historias/press-releases/index.html): Press releases com as últimas notícias sobre a Boehringer Ingelheim do Brasil. Leia os comunicados e entre em contato com nossos profissionais da área. (427 words)
- [annualreport/2024/files/downloads-and-archive/highlights-2023/boe_ar23_highlights_2023_en_safe-pdf.html](/content/annualreport/2024/files/downloads-and-archive/highlights-2023/boe_ar23_highlights_2023_en_safe-pdf.html) (16,474 words)
- [annualreport/2024/files/downloads-and-archive/highlights-2024/boe_highlights_2024_en-pdf.html](/content/annualreport/2024/files/downloads-and-archive/highlights-2024/boe_highlights_2024_en-pdf.html) (16,408 words)
- [SAC Saúde Animal | Boehringer Ingelheim BR](/content/br/sac-saude-animal-0/index.html): SAC Saúde Animal (592 words)
- [報道関係者向け素材 | Boehringer Ingelheim JP](/content/jp/media-resources/index.html): Press Material (14 words)
- [Ruminantlar | Boehringer Ingelheim TR](/content/tr/ruminantlar/index.html): Sığır ve koyunların tüm yaşam döngüsü boyunca Boehringer Ingelheim, ruminant üreticilerinin sürü sağlığını ve verimliliğini optimize etmelerine yardımcı olmak için proaktif çözümler sunar. (42 words)
- [Dr Paola Casarosa | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (154 words)
- [Vice President, Clinical Development Medical Affairs - Oncology Job Details | BoehringerPRD](/content/jobs/job-invite/29685/index.html): Ridgefield, CT Vice President, Clinical Development Medical Affairs - Oncology - Unit (1,006 words)
- [FOCUSUL NOSTRU | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/cultura/focusul-nostru/index.html): FOCUSUL NOSTRU exprimă cine suntem și care sunt obiectivele noastre, cum lucrăm și ce dorim să realizăm. (386 words)
- [Shashank Deshpande | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors responsabil de Human Pharma Business Unit (203 words)
- [Mexico | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/mexico/index.html): Mexico is home to two of our modern production sites. Explore career development opportunities in Mexico or our 170 locations around the globe. (265 words)
- [Harsha Deshmukh | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (191 words)
- [Dr Armin Wiesler | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (190 words)
- [Comunicados Regulatórios | Boehringer Ingelheim BR](/content/br/imprensa-historias/comunicados-regulatorios/index.html): Comunicados Regulatórios (143 words)
- [Frank Hübler | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (161 words)
- [Michael Schmelmer | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (203 words)
- [Associate Director / Senior Associate Director, Clinical Pharmacology Lead Job Details | BoehringerPRD](/content/jobs/job-invite/36160/index.html): Ridgefield, CT Associate Director / Senior Associate Director, Clinical Pharmacology Lead - Unit (1,304 words)
- [Materiais para a imprensa | Boehringer Ingelheim BR](/content/br/imprensa-historias/material-para-imprensa/index.html): Comunicação institucional da Boehringer Ingelheim. Tenha acesso aos conteúdos disponibilizados para consulta em inglês e alemão. (34 words)
- [Was wir tun | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/was-wir-tun/index.html): Boehringer Ingelheim ist ein multinationales Unternehmen mit Geschäftsbereichen für Humanpharmazeutika, Tiergesundheit und biopharmazeutische Auftragsfertigung. (386 words)
- [Dr. Armin Wiesler | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/dr-armin-wiesler/index.html): Dr. Armin Wiesler – Member of the Board of Managing Directors responsabil de Animal Health Business Unit (196 words)
- [Harsha Deshmukh | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors responsabil de IT and Global Business Services (191 words)
- [Director, Patient & Provider Solutions- Oncology Job Details | BoehringerPRD](/content/jobs/job-invite/35386/index.html): Ridgefield, CT Director, Patient & Provider Solutions- Oncology - Unit (987 words)
- [PCP/Endo Business Specialist - Dover, DE Job Details | BoehringerPRD](/content/jobs/job-invite/36416/index.html): Dover, DE PCP/Endo Business Specialist - Dover, DE - Unit (1,011 words)
- [Dr. Paola Casarosa | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/dr-paola-casarosa/index.html): Dr. Paola Casarosa – Member of the Board of Managing Directors responsabil de Innovation Unit (160 words)
- [Michael Schmelmer | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors responsabil de Group Functions (208 words)
- [Associate Director, Culture and Employee Engagement Job Details | BoehringerPRD](/content/jobs/job-invite/35841/index.html): Johns Creek, GA Associate Director, Culture and Employee Engagement - Unit (934 words)
- [Frank Hübler | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors responsabil de Finance (149 words)
- [Histórias | Boehringer Ingelheim BR](/content/br/imprensa-historias/historias/index.html): Histórias (17 words)
- [Sales/Senior/Lead Sales Representative, Pets - Chandler/Gilbert/Mesa, AZ Job Details | BoehringerPRD](/content/jobs/job-invite/35268/index.html): Mesa, AZ Sales/Senior/Lead Sales Representative, Pets - Chandler/Gilbert/Mesa, AZ - Unit (997 words)
- [Human Health Partnering Contact Form | Boehringer Ingelheim](/content/partnering/human-health-partnering/how-connect/human-health-partnering-contact-form/index.html): Connect with Boehringer Ingelheim’s BD&L team to explore partnership opportunities and submit your inquiry to collaborate on innovative treatments. (570 words)
- [Representante de Promoción Hospitales - Estado de México Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36162/index.html): Ciudad de Mexico Representante de Promoción Hospitales - Estado de México - Méxi (678 words)
- [Five things we look for in our employees | Boehringer Ingelheim](/content/careers/explore-our-company/five-things-we-look-our-employees/index.html): Find out what skills, qualifications and experience we look for in our Boehringer Ingelheim employees and learn more about our People Promise. (666 words)
- [Obésité | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-metaboliques/obesite/index.html): L'obésité est une maladie chronique complexe qui nécessite une prise en charge à long terme. Elle est l'un des principaux facteurs de risque de (93 words)
- [Imagine : Ο κόμβος των ιστοριών μας για τη βιωσιμότητα | Boehringer Ingelheim GR](/content/gr/imagine-o-kombos-ton-istorion-mas-gia-ti-biosimotita.html): Ανακαλύψτε πώς δημιουργούμε θετική αλλαγή και ενισχύουμε τον τομέα της υγείας, χτίζοντας ένα καλύτερο μέλλον για όλους. (118 words)
- [Director Asociado GTM Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35743/index.html): Ciudad de Mexico Director Asociado GTM - Méxi (795 words)
- [Avis de confidentialité concernant la PV | Boehringer Ingelheim BE](/content/be/fr/avis-de-confidentialite-concernant-la-pv/index.html): Nous vous remercions d’avoir rapporté des événements indésirables ou d’autres informations pertinentes pour la pharmacovigilance. (541 words)
- [Cardiovascular-Renal Sales Consultant - Utica, MI Job Details | BoehringerPRD](/content/jobs/job-invite/36438/index.html): Detroit Cardiovascular-Renal Sales Consultant - Utica, MI - Unit (886 words)
- [Finance Manager, Controlling Job Details | BoehringerPRD](/content/jobs/job-invite/36386/index.html): Johns Creek, GA Finance Manager, Controlling - Unit (714 words)
- [Medical Science Liaison Job Details | BoehringerPRD](/content/jobs/job-invite/36364/index.html): Algiers Medical Science Liaison - Alge (610 words)
- [France | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/france/index.html): Boehringer Ingelheim has had a presence in France since 1967. Explore career development opportunities in France or our 170 locations around the globe. (312 words)
- [Argentina | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/argentina/index.html): Argentina is a keystone of our operations in South America. Explore career development opportunities in Argentina or our 170 locations around the globe. (184 words)
- [Japan | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/japan/index.html): Our team in Japan is regarded for commitment to innovation and sustainability. Explore career development opportunities in Japan or our 170 global locations. (200 words)
- [Santé animale | Boehringer Ingelheim BE](/content/be/fr/sante-animale/index.html): Les vies humaines et animales sont interconnectées de bien des façons, profondes et complexes. Nous savons que quand les animaux sont en bonne santé (359 words)
- [Netherlands | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/netherlands/index.html): Our Amsterdam facility is one of our hubs for operations in Europe. Explore career development opportunities in the Netherlands or our 170 global locations. (150 words)
- [Frank Hübler | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (121 words)
- [Spain | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/spain/index.html): Our facility in Spain is home to Regulatory Affairs Services and two technology hubs. Explore career opportunities in Spain or our 170 global locations. (185 words)
- [Singapore | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/singapore/index.html): Our Singapore HQ serves as the hub for the Pacific Region. Explore career development opportunities in Singapore or our 170 locations around the globe. (159 words)
- [China | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/china/index.html): Boehringer Ingelheim has been active in China since 1994. Explore career development opportunities in China or our 170 locations around the globe. (156 words)
- [Michael Schmelmer | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (175 words)
- [Dubai | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/dubai/index.html): Dubai is at the heart of our IMETA region. Explore career development opportunities in the UAE or our 170 locations around the globe. (193 words)
- [Harsha Deshmukh | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/harsha-deshmukh/index.html): Harsha Deshmukh – Member of the Board of Managing Directors with responsibility for IT and Global Business Services (161 words)
- [Dr Armin Wiesler | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/dr-armin-wiesler/index.html): Dr Armin Wiesler – Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit (153 words)
- [Articles spécialisés | Boehringer Ingelheim BE](/content/be/fr/sante-animale/articles-specialises/index.html): Le bien-être humain et animal - notre objectif, notre inspiration et notre but: les vies des animaux et des humains sont intimement liées (330 words)
- [Sécurité des patients et Pharmacovigilance chez Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/notre-responsabilite/securite-des-patients/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (339 words)
- [Business Analyst | Non-line Manager | IT Marketing & Sales, M&S Japan Job Details | BoehringerPRD](/content/jobs/job-invite/34927/index.html): Shinagawa Business Analyst | Non-line Manager | IT Marketing & Sales, M&S Japan - Japa (782 words)
- [Qualité chez Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qualite/index.html): Qualité chez Boehringer Ingelheim (262 words)
- [Où nous trouver | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/ou-nous-trouver/index.html): Avec 52 000 collaborateurs de par le monde, Boehringer Ingelheim dispose d'un réseau de recherche et de production mondial (440 words)
- [PCP/Endo Business Specialist-Elgin, IL Job Details | BoehringerPRD](/content/jobs/job-invite/36440/index.html): Chicago PCP/Endo Business Specialist-Elgin, IL - Unit (1,169 words)
- [Corporate Affairs | Boehringer Ingelheim](/content/careers/discover-our-career-areas/corporate-affairs/index.html): Discover new opportunities in our Corporate Affairs. (249 words)
- [Études cliniques | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/etudes-cliniques/index.html): Les essais cliniques sont un élément essentiel du développement de nouveaux médicaments. Ils sont la traduction de notre expertise scientifique en thérapies. (117 words)
- [Le processus de la recherche | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-animale/le-processus-de-la-recherche/index.html): Nous découvrons ou identifions de nouveaux composés, vaccins, technologies, processus pathologiques et agents infectieux. (148 words)
- [Travailler à Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/fr/carrieres/index.html): Rejoignez-nous et contribuez à notre mission de création de valeur par l'innovation pour les patients que nous servons. Boehringer Ingelheim (161 words)
- [Racines | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/racines/index.html): Notre programme mondial unique d'initiatives Grass Roots est conçu pour favoriser l'émergence de la science et de la technologie en soutenant les jeunes. (102 words)
- [Science & Innovation | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/index.html): SCIENCE & INNOVATION Science et Innovation Jour après jour, nos scientifiques explorent de nouveaux territoires et poursuivent notre engagement envers (146 words)
- [Articles scientifiques | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/articles-scientifiques/index.html): La création de nouveaux et meilleurs médicaments pour les patients est au cœur de notre action. Ils nous inspirent dans notre mission. (94 words)
- [Vaccins | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-animale/vaccins/index.html): Dans le cadre de l'innovation mondiale, nous travaillons sur des vaccins sûrs et efficaces pour les animaux de compagnie et le bétail. (93 words)
- [医药代表-糖尿病产品（DPP4& SGLT2）-武汉 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36452/index.html): 武汉 医药代表-糖尿病产品（DPP4& SGLT2）-武汉 - 中国 (41 words)
- [Innovation en santé humaine | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/index.html): Les objectifs de Boehringer Ingelheim sont clairs. Nous voulons proposer un portefeuille de médicaments de pointe qui améliorent la vie des patients (80 words)
- [Legal & Compliance | Boehringer Ingelheim](/content/careers/discover-our-career-areas/legal-compliance/index.html): Discover new opportunities in our Legal Compliance team. (254 words)
- [Parasiticides | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-animale/parasiticides/index.html): L'un des principaux domaines d'expertise de Global Innovation est la découverte et le développement de nouveaux parasiticides pour les (69 words)
- [Notre responsabilité | Boehringer Ingelheim BE](/content/be/fr/sante-animale/notre-responsabilite/index.html): Nous planifions sur plusieurs générations. Cela se reflète dans les plus de 100 ans d'histoire fructueuse de notre entreprise. (176 words)
- [Thérapeutique | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-animale/therapeutique/index.html): Nous proposons une approche scientifique rigoureuse de la découverte, du développement et de la fourniture de produits thérapeutiques pour les (79 words)
- [SR Reporting Analyst, Data Management Job Details | BoehringerPRD](/content/jobs/job-invite/34988/index.html): Johns Creek, GA SR Reporting Analyst, Data Management - Unit (800 words)
- [Volaille | Boehringer Ingelheim BE](/content/be/fr/sante-animale/betail/volaille/index.html): Grâce à nos vaccins neufs et existants, nos diagnostics, nos services de recherche, notre expertise technique et notre passion sans (147 words)
- [Histoire | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/histoire/index.html): En 1885, Albert Boehringer (1861-1939) a fondé l'entreprise pharmaceutique Boehringer Ingelheim à Nieder-Ingelheim, qui fait aujourd'hui partie d'Ingelhei (135 words)
- [Maladies pulmonaires | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-pulmonaires/index.html): Boehringer Ingelheim a une longue tradition de 100 ans dans la gestion des maladies respiratoires. (127 words)
- [Contactez-nous | Boehringer Ingelheim BE](/content/be/fr/partenariats/boehringer-ingelheim-bioxcellence/contactez-nous/index.html): Nous vous remercions de votre intérêt pour Boehringer Ingelheim. N'hésitez pas à nous faire part de vos requêtes et retours. (198 words)
- [À propos de nous | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/index.html): Boehringer Ingelheim est une société pharmaceutique mondiale axée sur la recherche englobant de nombreuses cultures et des sociétés diverses. (215 words)
- [Principal System Analyst | Staff or Non-line Manager | IT Marketing & Sales Japan, IT Japan Job Details | BoehringerPRD](/content/jobs/job-invite/36246/index.html): Shinagawa Principal System Analyst | Staff or Non-line Manager | IT Marketing & Sales Japan, IT Japan - Japa (1,007 words)
- [Focalisation sur la science | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-humaine/focalisation-sur-la-science/index.html): Notre recherche de nouveaux médicaments se concentre sur les domaines scientifiques où les besoins médicaux sont importants et où nous continuons. (88 words)
- [L’insuffisance rénale chronique | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/linsuffisance-renale-chronique/index.html): L’insuffisance rénale chronique (121 words)
- [Senior Pricing & Access Manager - Survodutide Job Details | BoehringerPRD](/content/jobs/job-invite/35672/index.html): Ingelheim Senior Pricing & Access Manager - Survodutide - Germ (685 words)
- [Early Careers | Boehringer Ingelheim](/content/careers/discover-our-career-areas/early-careers/index.html): Launch with your career with Boehringer Ingelheim. Discover exciting opportunities for students and recent graduates. (178 words)
- [People, Finance & Organization | Boehringer Ingelheim](/content/careers/discover-our-career-areas/people-finance-organization/index.html): Discover new opportunities in our People, Finance and Organisation departments. (454 words)
- [Santé publique vétérinaire | Boehringer Ingelheim BE](/content/be/fr/sante-animale/sante-publique-veterinaire/index.html): Santé publique vétérinaire (105 words)
- [Achats | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/achats/index.html): Les fournisseurs font intégralement partie de notre engagement en vue de la réussite. Nous sommes passionnés par la recherche de solutions. (126 words)
- [Analista Sr. de Marketing Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/35922/index.html): Bogotá D.C. Analista Sr. de Marketing - Colo (547 words)
- [Ruminants | Boehringer Ingelheim BE](/content/be/fr/sante-animale/betail/ruminants/index.html): Notre unité stratégique dédiée aux ruminants se concentre sur les parasiticides, les vaccins et les thérapies pour nos vétérinaires et éleveurs bovins. (68 words)
- [Responsabiliser les patients | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/cancer/responsabiliser-les-patients/index.html): La lutte contre le cancer ne se limite pas à la mise au point de médicaments. En partenariat avec la communauté au sens large (134 words)
- [Chevaux | Boehringer Ingelheim BE](/content/be/fr/sante-animale/animaux-de-compagnie/chevaux/index.html): Boehringer Ingelheim, leader de la santé équine, développe des solutions novatrices pour le bien-être des chevaux du monde entier. (83 words)
- [Approches orientées sur le patient | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/notre-responsabilite/centricite-des-patients/index.html): À Boehringer Ingelheim, nous accordons la priorité aux patients dans tout ce que nous faisons. Les patients nous inspirent dans notre mission de mener (137 words)
- [Maladies de la rétine | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-de-la-retine/index.html): Maladies de la rétine (160 words)
- [Corporate Strategy & Consulting | Boehringer Ingelheim](/content/careers/discover-our-career-areas/corporate-strategy-consulting/index.html): Discover new opportunities in our Corporate Strategy and Consulting. (248 words)
- [Notre responsabilité | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/notre-responsabilite/index.html): Chez Boehringer Ingelheim, le patient est au centre de tout ce que nous faisons. Les patients nous inspirent dans notre mission. (108 words)
- [Diabète | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-metaboliques/diabete/index.html): Environ 425 millions d'adultes dans le monde vivent avec le diabète, le diabète de type 2 représentant 90 à 95 % de tous les cas. Ce nombre (173 words)
- [Types de cancer | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/cancer/types-de-cancer/index.html): Nous sommes engagés dans nos domaines de prédilection que sont le cancer du poumon et de l'intestin, mais nous sommes motivés par la science et (98 words)
- [Nos histoires | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/nos-histoires/index.html): Chez Boehringer Ingelheim, nous avons de nombreuses initiatives que nous souhaitons partager. (112 words)
- [Animaux de compagnie | Boehringer Ingelheim BE](/content/be/fr/sante-animale/animaux-de-compagnie/animaux-de-compagnie/index.html): Nous sommes parmi les leaders du marché en parasiticides, vaccins et thérapies, et nous sommes un partenaire privilégié des vétérinaires (53 words)
- [Πώς το πλύσιμο των χεριών οδήγησε σε λιγότερες μολύνσεις | Boehringer Ingelheim GR](/content/gr/pos-plysimo-ton-herion-odigise-se-ligoteres-molynseis.html): Πώς το πλύσιμο των χεριών οδήγησε σε λιγότερες μολύνσεις (451 words)
- [Senior Master Data Management Process Specialist (Business Analyst - Veeva Network) Job Details | BoehringerPRD](/content/jobs/job-invite/36373/index.html): Wrocław Senior Master Data Management Process Specialist (Business Analyst - Veeva Network) - Pola (754 words)
- [Cancer du poumon | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/cancer/cancer-du-poumon/index.html): En nous appuyant sur notre expérience dans le domaine des maladies pulmonaires, notre objectif est de nous attaquer au cancer du poumon (43 words)
- [Éthique et conformité | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/ethique-et-conformite/index.html): Éthique et conformité (105 words)
- [A workplace that fits in with life | Boehringer Ingelheim](/content/careers/explore-our-company/workplace-fits-life/index.html): A workplace that fits in with life (996 words)
- [Anna Race | Boehringer Ingelheim](/content/careers/discover-our-career-areas/anna-race/index.html): Anna Race, Sales Director, Human Pharma, UK & Ireland, tells us how a career in our Commercial Division helps her to make a difference. (440 words)
- [Plus vert pour notre planète | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/davantage-plus-vert/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (210 words)
- [Une meilleure santé pour l'homme et l'animal | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/une-meilleure-sante/index.html): Une initiative sur le long terme, en vue d'améliorer la santé au sein des communautés du monde entier, en identifiant et en soutenant les solutions. (159 words)
- [Imagine – sustainability story hub | Boehringer Ingelheim | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/index.html): Learn how Boehringer Ingelheim drives positive change and promotes health equity for a better future. (661 words)
- [Senior Specialist / Principal Specialist, Investigation Job Details | BoehringerPRD](/content/jobs/job-invite/36383/index.html): Saint Joseph Senior Specialist / Principal Specialist, Investigation - Unit (827 words)
- [Careers beyond borders | Boehringer Ingelheim](/content/careers/discover-our-career-areas/careers-beyond-borders/index.html): Careers beyond borders (653 words)
- [Coordenador/a Melhoria Continua Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/34653/index.html): Paulínia Coordenador/a Melhoria Continua - Bras (660 words)
- [Switching market | Boehringer Ingelheim BE](/content/be/fr/disclaimer/market/index.html) (70 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (381 words)
- [IT Solution Architect (m/f/d) Job Details | BoehringerPRD](/content/jobs/job-invite/36217/index.html): Vienna IT Solution Architect (m/f/d) - Aust (506 words)
- [Yanina Donatini | Boehringer Ingelheim](/content/careers/discover-our-career-areas/yanina-donatini/index.html): Yanina Donatini, Head of ITM&S Content Production, jumped at the chance to fulfill her dreams within the Information Technology division at Boehringer Ingelheim. (357 words)
- [UNION Central Services EU Operator LG4 M-F 7:00am - 3:30pm Job Details | BoehringerPRD](/content/jobs/job-invite/36267/index.html): Saint Joseph UNION Central Services EU Operator LG4 M-F 7:00am - 3:30pm - Unit (777 words)
- [Manager, Biological Production Job Details | BoehringerPRD](/content/jobs/job-invite/36117/index.html): Athens, GA Manager, Biological Production - Unit (656 words)
- [Field Engineer, Utilities Maintenance (11am - 7:30pm) Job Details | BoehringerPRD](/content/jobs/job-invite/36258/index.html): Saint Joseph Field Engineer, Utilities Maintenance (11am - 7:30pm) - Unit (647 words)
- [Dominik Huber | Boehringer Ingelheim](/content/careers/discover-our-career-areas/dominik-huber/index.html): Our Head of Upstream Manufacturing in Vienna, Dominik Huber, has built his entire, senior-level career with Boehringer Ingelheim. (501 words)
- [Associate III, Quality Systems Job Details | BoehringerPRD](/content/jobs/job-invite/36445/index.html): Athens, GA Associate III, Quality Systems - Unit (613 words)
- [Oliver Sluke | Boehringer Ingelheim](/content/careers/explore-our-company/oliver-sluke/index.html): Oliver Sluke on global business with a world of perspectives (54 words)
- [Data Careers | Boehringer Ingelheim](/content/careers/discover-our-career-areas/data-careers/index.html): Use your data skills to make a difference. Discover exciting data careers opportunities and apply today. (228 words)
- [Ochorenia sietnice | Boehringer Ingelheim SK](/content/sk/human-health/retinal-diseases/index.html): V spoločnosti Boehringer Ingelheim sme rozšírili naše globálne výskumné a vývojové aktivity na riešenie očných chorôb, konkrétne tých, ktoré postihujú zadnú časť oka. (165 words)
- [Patient Partnership | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/index.html): At Boehringer Ingelheim, we collaborate with patient organizations to advance patient‑powered progress through meaningful partnership and lived experience. (381 words)
- [Administering Pet Medication | Boehringer Ingelheim](/content/annualreport/2024/tips-tricks-giving-pet-medication/index.html): Tips, tricks, tactics, and tasty options for administering pet medication to cats and dogs   (973 words)
- [Jan-Erik Schäfer | Boehringer Ingelheim](/content/careers/discover-our-career-areas/jan-erik-schafer/index.html): Jan-Erik Schäfer looks at a career with purpose (36 words)
- [Jessica Bürner | Boehringer Ingelheim](/content/careers/explore-our-company/jessica-burner/index.html): Independent, authentic, bold - Jessica Bürner’s career path (20 words)
- [Bok Oh | Boehringer Ingelheim](/content/careers/discover-our-career-areas/bok-oh/index.html): Touching millions of lives with Bok Oh (21 words)
- [Eva-Maria Wlaschitz | Boehringer Ingelheim](/content/careers/discover-our-career-areas/eva-maria-wlaschitz/index.html): Eva-Maria Wlaschitz: ways to learn and grow (19 words)
- [MORE POTENTIAL for Communities & our People | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (687 words)
- [Research & Development | Boehringer Ingelheim](/content/careers/discover-our-career-areas/research-development/index.html): Discover new opportunities in our Research Development. (187 words)
- [Michael Schmelmer | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer – Vice Chairman of the Board of Managing Directors with responsibility for Group Functions (202 words)
- [Taimi Sahlin | Boehringer Ingelheim](/content/careers/discover-our-career-areas/taimi-sahlin/index.html): Independent, authentic, bold - Taimi Sahlin’s career path (40 words)
- [Qui sommes-nous | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/index.html): Boehringer Ingelheim travaille sur des thérapies de pointe qui transforment les vies, aujourd'hui et demain. Nous sommes une entreprise biopharmaceutique. (181 words)
- [Bezpečnosť pacienta | Boehringer Ingelheim SK](/content/sk/human-health/our-responsibility/bezpecnost-pacienta/index.html): Sme lídrami v oblasti bezpečnosti pacientov. Neustále zbierame a analyzujeme bezpečnostné údaje, (294 words)
- [Cardiovascular Renal and Metabolic Health | Boehringer Ingelheim](/content/human-health/crm-health/index.html): Learn more about how cardiovascular, renal and metabolic diseases are interconnected and affect organs such as the heart, kidneys and liver. (554 words)
- [MORE GREEN for our planet | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (525 words)
- [Nelli Milosch | Boehringer Ingelheim](/content/careers/discover-our-career-areas/nelli-milosch/index.html): Nelli Milosch on what makes our people different (53 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim](/content/about-us/quality/index.html): Quality at Boehringer Ingelheim (209 words)
- [Lung Cancer | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/index.html): Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC) (390 words)
- [Stop Rabies | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/world-rabies-day/index.html): Stop Rabies (192 words)
- [Living With Cancer | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/index.html): Every cancer journey is unique. Listen to the first-hand experiences of people living with cancer. (339 words)
- [Quality | Boehringer Ingelheim](/content/careers/discover-our-career-areas/quality/index.html): Discover new opportunities in our Quality Division department. (186 words)
- [MORE HEALTH for People & Animals | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (411 words)
- [Across Cancer Types | Boehringer Ingelheim](/content/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (145 words)
- [Patient Safety & Pharmacovigilance | Boehringer Ingelheim](/content/human-health/patients/patient-safety/index.html): Guided by science, Boehringer Ingelheim integrates safety at every step, evaluating risks and benefits to deliver safe treatments for patients worldwide. (278 words)
- [Zdravie zvierat - naša zodpovednosť | Boehringer Ingelheim SK](/content/sk/animal-health/our-responsibility/index.html): Jedným z najdôležitejších piliérov v spoločnosti Boehringer Ingelheim je naša zodpovednosť za ochranu spojenia medzi zdravím ľudí, zvierat a životného prostredia. (157 words)
- [Spolupráca v oblasti ľudského zdravia | Boehringer Ingelheim SK](/content/sk/partnering/human-health-partnering/index.html): Základom toho, čo robíme, je výroba nových a lepších liekov pre pacientov. Spolupráca s kolegami v celej komunite vied o živote hrá dôležitú úlohu, keď sa spájame s cieľom napredovať v inováciách pre pacientov. (122 words)
- [Christian Betz | Boehringer Ingelheim](/content/careers/discover-our-career-areas/christian-betz/index.html): Prioritizing development with Christian Betz (50 words)
- [Liver Health | Boehringer Ingelheim](/content/human-health/crm-health/liver-health/index.html): Learn more about liver diseases, such as MASH, and how liver health directly affects other cardiovascular, renal and metabolic organs. (232 words)
- [Kone | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/horses/index.html): Vyvíjame špičkové riešenia pre pohodu koní v oblasti imunológie, parazitológie, zdravia žalúdka a metabolizmu. (115 words)
- [Fostering Science | Boehringer Ingelheim TW](/content/tw/fostering-science/index.html): Science and Innovation - Human Health Innovation - Fostering Science (61 words)
- [Sustainable Development | Boehringer Ingelheim](/content/about-us/sustainable-development/index.html): Click here to discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (321 words)
- [Partnerstvo | Boehringer Ingelheim SK](/content/sk/partnering/index.html): Prijímame silu partnerstva a rozmanitosti myslí v rámci komunít v oblasti vedy o živote a zdravia zvierat, aby sme realizovali ešte viac inovácií a inkubovali nové nápady. (131 words)
- [Hydina | Boehringer Ingelheim SK](/content/sk/animal-health/livestock/poultry/index.html): Vďaka našim existujúcim a novým vakcínam, diagnostike, výskumným službám, technickým znalostiam a nekompromisnej vášni pre podnikanie našich zákazníkov sme hrdí na to, že môžeme zohrávať rozhodujúcu úlohu pri zásobovaní sveta bezp (168 words)
- [Etika a kompliancia | Boehringer Ingelheim SK](/content/sk/about-us/ethics-and-compliance/index.html): Etika a kompliancia (133 words)
- [Veterinárna medicína | Boehringer Ingelheim SK](/content/sk/animal-health/index.html): Zistite, ako sa Boehringer Ingelheim snaží zabezpečiť, aby váš domáci maznáčik dostal rovnakú úroveň zdravotnej starostlivosti ako ľudia, či už ide o bežného domáceho maznáčika alebo koňa. (282 words)
- [Grass Roots | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/grass-roots/index.html): Základom toho, čo robíme, je výroba nových a lepších liekov pre pacientov. Tí nás inšpirujú v našom poslaní vytvárať prelomové terapie, ktoré menia ich životy a tiež, aby sme rozvíjali vedu a nikdy sa nevzdávali. (107 words)
- [Contact Us | Boehringer Ingelheim](/content/contact-us/index.html): To contact us at Boehringer Ingelheim please click here to fill out our contact request form. We welcome all queries and feedback. (175 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (323 words)
- [Domáce zvieratá | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/pets/index.html): Patríme medzi lídrov na trhu s antiparazitikami, vakcínami a liekmi a sme dôveryhodným partnerom pre veterinárnych lekárov a majiteľov domácich zvierat na celom svete. (137 words)
- [Výskumný proces | Boehringer Ingelheim SK](/content/sk/science-innovation/animal-health-innovation/research-process/index.html): Objavujeme alebo identifikujeme nové zlúčeniny, vakcíny, technológie, chorobné procesy a infekčné agens. Na tento účel využívame kombináciu sofistikovaných nástrojov, technických schopností a odborných znalostí – na našich výskumných a vývojových pracovis (115 words)
- [Ošípané | Boehringer Ingelheim SK](/content/sk/animal-health/livestock/swine/index.html): Spoločnosť Boehringer Ingelheim je partnerom a podporovateľom udržateľnej produkcie bravčového mäsa a živočíšnych bielkovín, pričom zabezpečuje dobré životné podmienky zvierat prostredníctvom prevencie a integrovanej zdravotnej starostl (183 words)
- [Empowering Patients | Boehringer Ingelheim](/content/human-health/cancer/empowering-patients/index.html): Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients. (80 words)
- [Culture | Boehringer Ingelheim](/content/about-us/who-we-are/culture/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (317 words)
- [Leadership | Boehringer Ingelheim](/content/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (187 words)
- [Veda a inovácia | Boehringer Ingelheim SK](/content/sk/science-innovation/index.html): Naši vedci každý deň mapujú nové územia a pokračujú v našom záväzku prispieť v oblastiach inovácií, ktoré budú viesť k výnimočným liekom a zmenia životy miliónov pacientov. (131 words)
- [Hospodárske zvieratá | Boehringer Ingelheim SK](/content/sk/animal-health/livestock/index.html): Spoločnosť Boehringer Ingelheim je jedným z popredných poskytovateľov zdravotných riešení na predpovedanie, prevenciu a liečbu chorôb hospodárskych zvierat. Týmto spôsobom pomáhame poľnohospodárom na celom svete zlepšovať kvalitu a bezpe (79 words)
- [Purchasing | Boehringer Ingelheim](/content/about-us/purchasing/index.html): Sourcing (217 words)
- [History | Boehringer Ingelheim](/content/about-us/who-we-are/history/index.html): Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim. (270 words)
- [Spojte sa s nami | Boehringer Ingelheim SK](/content/sk/partnering/human-health-partnering/connect-us/index.html): Tu nájdete všetky naše kontaktné informácie, ako aj najnovšie informácie o tom, kde sa s nami môžete virtuálne alebo osobne stretnúť. (13 words)
- [Príbehy z vedy | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/science-stories/index.html): Základom toho, čo robíme, je výroba nových a lepších liekov pre pacientov. Tí nás inšpirujú v našom poslaní vytvárať prelomové terapie, ktoré menia ich životy a tiež, aby sme rozvíjali vedu a nikdy sa nevzdávali. (66 words)
- [Dr Paola Casarosa | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa - členka Predstavenstva výkonných riaditeľov so zodpovednosťou za inovačnú jednotku (122 words)
- [Inovácie vo veterinárnej medicíne | Boehringer Ingelheim SK](/content/sk/science-innovation/animal-health-innovation/index.html): Náš globálny tím zameraný na inovácie je priekopníkom vedy, ktorá pomáha veterinárom i majiteľom domácich a hospodárskych zvierat ale aj predstaviteľom verejného zdravotn9ctva na celom svete zlepšovať zdravie zvierat dnes aj v budúcnosti. (74 words)
- [Michael Schmelmer | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/michael-schmelmer/index.html): Michael Schmelmer - Podpredseda predstavenstva výkonných riateľov so zodpovednosťou za Group Functions (159 words)
- [Terapeutiká | Boehringer Ingelheim SK](/content/sk/science-innovation/animal-health-innovation/therapeutics/index.html): Poskytujeme disciplinovaný vedecký prístup ku globálnemu objavovaniu, vývoju a dodávaniu terapeutík pre spoločenské a hospodárske zvieratá. Naše špecializované výskumné tímy spolupracujú s našimi humánnymi farmaceutickými kolegami, ako aj s mnohými extern (54 words)
- [Naše vedecké zameranie | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/science-focus/index.html): Náš výskum nových liekov sa zameriava na oblasti vedy s významnými medicínskymi potrebami, kde pokračujeme v inováciách a zaujímame vedúce miesto na trhu. Naše výskumné úsilie a investície sústreďujeme na kardiometabolické ochorenia, o (63 words)
- [Prežúvavce | Boehringer Ingelheim SK](/content/sk/animal-health/livestock/ruminants/index.html): V našej strategickej obchodnej jednotke zameranej na prežúvavcov sme zacielaní na antiparazitiká, vakcíny a lieky, ktoré ponúkame našim veterinárnym lekárom a farmárom (na farmách na mlieko a mäso). (105 words)
- [Antiparazitiká | Boehringer Ingelheim SK](/content/sk/science-innovation/animal-health-innovation/parasiticides/index.html): Objavujeme alebo identifikujeme nové zlúčeniny, vakcíny, technológie, chorobné procesy a infekčné agens. Na tento účel využívame kombináciu sofistikovaných nástrojov, technických schopností a odborných znalostí – na našich výskumných a vývojových pracovis (50 words)
- [Podpora vedy | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/fostering-science/index.html): Výroba prevratných liekov, ktoré menia životy pacientov, sa začína záväzkom identifikovať zdravotné výzvy budúcnosti a pokročiť v rozvíjajúcej sa vede. Ako nezávislá a rodinná spoločnosť máme slobodu realizovať svoju dlhodobú vízi (50 words)
- [Klinické štúdie | Boehringer Ingelheim SK](/content/sk/science-innovation/human-health-innovation/clinical-studies/index.html): Klinické skúšky sú nevyhnutnou súčasťou vývoja nových liekov. Sú prekladom našej vedeckej expertízy do prelomových terapií pre pacientov. (43 words)
- [Mentálne poruchy | Boehringer Ingelheim SK](/content/sk/human-health/mental-health/index.html): V spoločnosti Boehringer Ingelheim v oblasti mentálnych poruúch nanovo definujeme duševné zdravie, aby sme ľuďom umožnili prosperovať. (168 words)
- [Who we are | Boehringer Ingelheim](/content/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (206 words)
- [Spoločenské zvieratá | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/index.html): V spoločnosti Boehringer Ingelheim si myslíme, že domáce zvieratá a kone by mali mať rovnakú úroveň možností zdravotnej starostlivosti ako vy. Zistite viac o tom. (70 words)
- [Zamerané na pacienta | Boehringer Ingelheim SK](/content/sk/human-health/our-responsibility/patient-centricity/index.html): V spoločnosti Boehringer Ingelheim kladieme pacientov na prvé miesto vo všetkom, čo robíme. Pacienti nás inšpirujú v našom poslaní viesť vedu, ktorá vytváraúplne nové terapie. (71 words)
- [Srdcové zlyhávanie | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/heart-failure/index.html): Srdcové zlyhávanie je progresívny a potenciálne smrteľný stav, ktorý postihuje viac ako 60 miliónov ľudí na celom svete a očakáva sa, že sa bude zvyšovať, keď populácia starne. Srdcové zlyhávanie sa týka neschopnosti srdca pumpovať dostatočné množstvo krv (170 words)
- [Diabetes | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/diabetes/index.html): Asi 537 miliónov dospelých ľudí na svete žije s cukrovkou, pričom cukrovka 2. typu predstavuje 90–95 percent všetkých prípadov. Predpokladá sa, že tento počet vzrastie na 783 miliónov ľudí do roku 2045 (1). (213 words)
- [Príbehy | Boehringer Ingelheim SK](/content/sk/animal-health/trends-insights/index.html): Pozrite si najnovšie príbehy spoločnosti Boehringer Ingelheim. Preskúmajte naše obľúbené príbehy zdôrazňujúce zložité spojenie medzi zvieratami a ľuďmi. (44 words)
- [CHOCHP a astma | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/copd-asthma/index.html): Chronická obštrukčná choroba pľúc (CHOCHP) je progresívne, liečiteľné ochorenie charakterizované obmedzeným prietokom vzduchu do a von z pľúc, čo sťažuje dýchanie. V roku 2016 postihovalo viac ako 250 miliónov ľudí na celom svete, pričom sa predpokladá, ž (176 words)
- [Humánna medicína | Boehringer Ingelheim SK](/content/sk/human-health/index.html): Boehringer Ingelheim je skupina spoločností riadená výskumom, ktorá sa venuje objavovaniu, vývoju, výrobe a marketingu inovatívnych produktov zdravotnej starostlivosti. (208 words)
- [Produkty pre humánnu medicínu | Boehringer Ingelheim SK](/content/sk/human-health/products/index.html): Ste zdravotnícky pracovník? Prejdite na naše globálne stránky, kde budete mať dostupný príslušný obsah. (29 words)
- [Metabolické ochorenia | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/index.html): Vzájomne prepojené kardio-renálne-metabolické stavy – postihujúce srdce, obličky a metabolický systém – sú hlavnou príčinou úmrtnosti na celom svete a spôsobujú až 20 miliónov úmrtí ročne. (126 words)
- [Pľúcna fibróza | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/pulmonary-fibrosis/index.html): Pľúcna fibróza je stav vedúci k vytváraniu zjazveného tkaniva v pľúcach. Pľúca časom strácajú schopnosť prijímať a prenášať kyslík do krvného obehu. (87 words)
- [Rakovina pľúc | Boehringer Ingelheim SK](/content/sk/human-health/cancer/lung-cancer/index.html): Vychádzajúc z našich skúseností s pľúcnymi ochoreniami je naším cieľom liečiť rakovinu pľúc, transformovať terapeutické oblasti a v konečnom dôsledku predefinovať všetky rakoviny pľúc ako liečiteľné. (126 words)
- [Speak Up - Compliance linka na nahlasovanie | Boehringer Ingelheim SK](/content/sk/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Portál Speak Up poskytuje bezpečné prostredie na nahlasovanie možných porušení a je dostupný osobám na celom svete.Každé hlásenie berieme vážne. (262 words)
- [Cievna mozgová príhoda | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/stroke/index.html): Akútna ischemická cievna mozgová príhoda, najbežnejší typ cievnej mozgovej príhody, nastáva vtedy, keď je prívod krvi do časti mozgu blokovaný buď krvnou zrazeninou v mozgovej cieve alebo aterosklerózou (tukové usadeniny alebo plaky lemujúce steny ciev). (126 words)
- [Schizofrénia | Boehringer Ingelheim SK](/content/sk/human-health/mental-health/schizophrenia/index.html): Schizofrénia je charakterizovaná tromi rôznymi skupinami symptómov a postihuje približne 1 %celosvetovej populácie. (72 words)
- [Fibrilácia predsiení | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/atrial-fibrillation/index.html): Mŕtvica nastane, keď sa preruší prívod krvi do časti mozgu. U pacientov s nepravidelným srdcovým rytmom (známym ako fibrilácia predsiení) existuje zvýšené riziko mozgovej príhody. Prevencia mozgovej príhody u týchto pacientov je kľúčovým zameraním nášho k (85 words)
- [Sklerodermia | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/scleroderma/index.html): Systémová skleróza (SSc) je znetvorujúce, invalidizujúce a potenciálne smrteľné zriedkavé ochorenie, ktoré spôsobuje zjazvenie kože (sklerodermia), pľúc (SSc-ILD) a iných orgánov. (79 words)
- [Rakovina | Boehringer Ingelheim SK](/content/sk/human-health/cancer/index.html): Rakovina berie. Uberá čas. Odnáša milovaných. V spoločnosti Boehringer Ingelheim poskytujeme pacientom sa snažíme dávať novú nádej. (78 words)
- [Depresia | Boehringer Ingelheim SK](/content/sk/human-health/mental-health/depression/index.html): Depresia je duševná porucha, ktorá spôsobuje pretrvávajúci pocit smútku a straty záujmu. Tiež nazývaná veľká depresívna porucha. (58 words)
- [NASH | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/mash/index.html): Nealkoholická steatohepatitída (NASH) je spôsobená metabolickým zápalom pečene a je jednou z hlavných príčin fibrózy a cirhózy pečene. Jej príznaky sú často tiché alebo nešpecifické pre NASH, čo sťažuje diagnostiku. (97 words)
- [Spolupráca s pacientami | Boehringer Ingelheim SK](/content/sk/human-health/cancer/empowering-patients/index.html): Liečba rakoviny nie je len vývoj a podávanie liekov. V partnerstve so širšou komunitou podporujeme osvetu, vzdelávanie, zlepšenie diagnostiky a starostlivosti o pacientov s rakovinou a ich rodiny. (71 words)
- [Naprieč typmi rakoviny | Boehringer Ingelheim SK](/content/sk/human-health/cancer/across-cancer-types/index.html): Zaviazali sme sa zamerať sa na oblasti chorôb pľúc a tráviaceho traktu, ale riadime sa vedou a využívame príležitosti v iných oblastiach neuspokojených potrieb, aby sme poskytli prvotriednu liečbu, ktorá môže zmeniť životy pacientov. (67 words)
- [Obezita | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/obesity/index.html): Nealkoholická steatohepatitída (NASH) je spôsobená metabolickým zápalom pečene a je jednou z hlavných príčin fibrózy a cirhózy pečene. Jej príznaky sú často tiché alebo nešpecifické pre NASH, čo sťažuje diagnostiku. (95 words)
- [História | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/history/index.html): V roku 1855 založil Albert Boehringer (1861-1939) farmaceutickú spoločnosť Boehringer Ingelheim v Nieder-Ingelheim-e, ktorý je dnes súčasťou Ingelheimu nad Rýnom. (100 words)
- [Väčší potenciál | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/more-potential/index.html): Pre verejnosť a našich ľudí. Spoločnosť naďalej čelí problémom, od zdravotných cez vzdelávanie, pracovné výzvy, životné podmienky, až po nerovnosť a chudobu, čo má často najväčší dopad na tých najzraniteľnejších. (114 words)
- [Vedenie | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/leadership/index.html): Prečítajte si viac o predstavenstve výkonných riaditeľov spoločnosti Boehringer Ingelheim s informáciami o všetkých piatich členoch a ich príslušných zodpovednostiach. (84 words)
- [Obstarávanie | Boehringer Ingelheim SK](/content/sk/about-us/purchasing/index.html): Obstarávanie (102 words)
- [Naše príbehy | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/our-stories/index.html): Boehringer Ingelheim má mnoho iniciatív, o ktoré sa s Vami chceme podeliť. Zistite viac informácií z našich príbehov. Nižšie sa uvádzajú najnovšie tlačové vyhlásenia, príbehy a viac informácií o našej rodine z celého sveta. (32 words)
- [Kde nás nájdete | Boehringer Ingelheim SK](/content/sk/about-us/where-find-us/index.html): Kde nás nájdete (52 words)
- [Iniciatíva Viac zelene | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/more-green/index.html): Iniciatíva MORE GREEN (Viac zelene) zahŕňa aktivity v oblasti životného prostredia, ktoré sa týkajú mnohých aspektov: prijímania opatrení, ktoré majú predchádzať znečisteniu vody a ovzdušia, využívania obnoviteľnej energie, znižovania množstva odpadov a v (91 words)
- [Iniciatíva More Health: Pre ľudí aj zvieratá | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/more-health/index.html): Dlhodobá iniciatíva s cieľom zlepšiť zdravotný stav komunít po celom svete tak, že si určíme a podporíme najsľubnejšie riešenia kritických zdravotných problémov. (39 words)
- [Kto sme | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/index.html): Boehringer Ingelheim je skupinou spoločností s celosvetovou pôsobnosťou, ktorá zahŕňa mnohé kultúry a rôznorodé komunity. (77 words)
- [Udržateľný rozvoj-Náš záväzok | Boehringer Ingelheim SK](/content/sk/about-us/sustainable-development/our-commitment/index.html): Naša cesta je o inováciách, o vytváraní hodnôt v oblastiach, v ktorých sú zatiaľ nepokryté medicínske potreby a o spolupráci s komunitami a spoločnosťami, aby bol život lepším – pre ľudí aj pre zvieratá. (37 words)
- [Kontaktujte nás | Boehringer Ingelheim SK](/content/sk/kontakt/index.html): Ak nás chcete kontaktovať v spoločnosti Boehringer Ingelheim, kliknite sem a vyplňte náš kontaktný formulár žiadosti. Vítame všetky otázky a spätnú väzbu. (37 words)
- [Switching market | Boehringer Ingelheim SK](/content/sk/disclaimer/market/index.html) (54 words)
- [Média | Boehringer Ingelheim SK](/content/sk/media/index.html): Boehringer Ingelheim je jednou z popredných svetových farmaceutických spoločností riadených výskumom so 130-ročnými skúsenosťami. (12 words)
- [Singapur | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/singapur/index.html): Unser Hauptsitz in Singapur dient als Dreh- und Angelpunkt für die pazifische Region. Erkunde deine Karrieremöglichkeiten in Singapur oder an unseren 170 Standorten weltweit. (160 words)
- [Neueste Jobs in Dubai| Karriere bei Boehringer Ingelheim](/content/de/karriere/ueber-uns/standorte/dubai/index.html): Dubai liegt im Herzen unserer IMETA-Region. Erkunde Karrieremöglichkeiten in den Vereinigten Arabischen Emiraten oder an unseren 170 Standorten weltweit. (207 words)
- [Manufacturing Operator (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35567/index.html): Wien Manufacturing Operator (m/w/d) - Öste (545 words)
- [Nachhaltige Entwicklung | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/index.html): Unser Engagement Auf unserem Weg geht es darum, Innovationen voranzutreiben, Werte in Bereichen mit ungedecktem medizinischem Bedarf zu schaffen und mit Communities und Gesellschaft in Kontakt zu treten, um Leben zum Besseren zu verändern. (574 words)
- [Praktikum - Digitalisierung & Innovation in der pharmazeutischen Produktion Stellendetails | BoehringerPRD](/content/jobs/job-invite/36051/index.html): Ingelheim Praktikum - Digitalisierung & Innovation in der pharmazeutischen Produktion - Deut (756 words)
- [Packaging Process Expert (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35222/index.html): Ingelheim Packaging Process Expert (m/w/d) - Deut (641 words)
- [Jobs finden | Boehringer Ingelheim AT](/content/at/de/karriere/jobs-finden/index.html): Suchen Sie Jobs und bewerben Sie sich bei Boehringer Ingelheim. (435 words)
- [Unsere Kultur | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/unsere-kultur/index.html): Unsere Unternehmenskultur spiegelt wider, wer wir sind, und wird durch unsere our focus auf und unser starkes Bekenntnis zu Vielfalt, Gleichberechtigung und Integration sowie zu nachhaltiger Entwicklung unterstrichen. (316 words)
- [(Pharmazie-)Praktikum Medical in-use, Pharmaceutical Dev. Biologicals Stellendetails | BoehringerPRD](/content/jobs/job-invite/33481/index.html): Biberach (Pharmazie-)Praktikum Medical in-use, Pharmaceutical Dev. Biologicals - Deut (515 words)
- [Deine Bewerbung | Boehringer Ingelheim AT](/content/at/de/karriere/bewerbung/index.html): Erfahre hier, wie du dich bewirbst, was dich erwartet und worauf du dich vorbereiten solltest. (566 words)
- [Nutzungsbedingungen | Boehringer Ingelheim AT](/content/at/de/nutzungsbedingungen/index.html): Nutzungsbedingungen (1,205 words)
- [Deine Karriere bei uns | Boehringer Ingelheim AT](/content/at/de/karriere/karrieremoeglichkeiten/index.html): Du suchst nach einer spannenden Aufgabe? Wir bieten Jobs in vielen verschiedenen Bereichen. (345 words)
- [Pharmaziepraktikum - Complaint Management Stellendetails | BoehringerPRD](/content/jobs/job-invite/36206/index.html): Ingelheim Pharmaziepraktikum - Complaint Management - Deut (461 words)
- [Reinigungskraft (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/36247/index.html): Ingelheim Reinigungskraft (m/w/d) - Deut (470 words)
- [Produktionsmitarbeiter Einwaageprozess (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35457/index.html): Ingelheim Produktionsmitarbeiter Einwaageprozess (m/w/d) - Deut (497 words)
- [FAQ | Boehringer Ingelheim AT](/content/at/de/karriere/bewerbung/faq/index.html): Häufig gestellte Fragen zum Bewerbungsprozess bei Boehringer Ingelheim. (841 words)
- [Kontakt zu uns | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-tiergesundheit/kontakt-zu-uns/index.html): Nehmen Sie online oder bei Veranstaltungen Kontakt mit dem Team für Geschäftsentwicklung und Lizenzierung von Boehringer Ingelheim Animal Health auf, um einen Vorschlag einzureichen oder Möglichkeiten für eine Partnerschaft zu besprechen. (377 words)
- [Innovationen in der Humanmedizin | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/index.html): Boehringer Ingelheim konzentriert sich in seinen Forschungsaktivitäten auf Krankheitsbereiche mit einem hohen ungedeckten medizinischen Bedarf. (290 words)
- [Standorte | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/standorte/index.html): Wir bieten Karriereentwicklungsmöglichkeiten an über 170 Standorten auf der ganzen Welt. Erkunden Sie einige unserer vorgestellten Standorte. (212 words)
- [Pharmaziepraktikum in der 3PQM Job Details | BoehringerPRD](/content/jobs/job-invite/28486/index.html): Ingelheim Pharmaziepraktikum in der 3PQM - Germ (751 words)
- [Unsere Verantwortung | Boehringer Ingelheim AT](/content/at/de/humanmedizin/unsere-verantwortung/index.html): Durch die Erforschung von Krankheiten wollen wir den Betroffenen eine positive Perspektive bieten. Erfahren Sie mehr über unsere medizinische Forschung! (307 words)
- [Haustiere | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/index.html): Hunde (153 words)
- [Partnerschaften | Boehringer Ingelheim AT](/content/at/de/partnerschaften/index.html): Partnerschaften Wir sind davon überzeugt, dass durch Diversität und Austausch in der Wissenschaft Innovationen geboren werden. Aus diesem Grund sind Partnerschaften ein wichtiger Bestand unserer Innovationsstrategie. (145 words)
- [Lungenfibrose | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/lungenfibrose/index.html): Ein wesentliches Ziel der Behandlung aller Patienten mit IPF ist es, das Risiko des Auftretens akuter IPF-Exazerbationen zu reduzieren. (260 words)
- [Partnerschaften in der Humanmedizin | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/index.html): Human Health Partnerning (226 words)
- [Impressum | Boehringer Ingelheim AT](/content/at/de/impressum/index.html): Impressum (180 words)
- [Patientensicherheit und Pharmakovigilanz bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/humanmedizin/unsere-verantwortung/patientensicherheit/index.html): Boehringer Ingelheims Abteilung Patientensicherheit und Pharmakovigilanz trägt für die wirkungsvolle und sichere Anwendung von Medikamenten Sorge. (242 words)
- [Tiergesundheit | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/index.html): Tiergesundheit (267 words)
- [Entdecke unser Unternehmen | Boehringer Ingelheim AT](/content/at/de/karriere/ueber-uns/index.html): Starte deine Karriere bei Boehringer Ingelheim. Lerne unsere verschiedenen Bereiche kennen und erfahre mehr über unsere Karrieremöglichkeiten. (139 words)
- [Pferde | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/pferde/index.html): Pferde (225 words)
- [Chronische Nierenkrankheit | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/index.html): Chronic Kidney Disease (371 words)
- [Schizophrenie | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/schizophrenie/index.html): Schizophrenie äußert sich in Form von drei unterschiedlichen Symptombereichen: Positivsymptome wie Halluzinationen oder Wahnvorstellungen, Negativsymptome wie Depression oder Antriebslosigkeit sowie kognitive Symptome, zu denen beispielsweise Gedächtnisst (284 words)
- [Postdoc | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/postdoc/index.html): Dein Berufseinstieg in der Pharmaindustrie nach der Promotion (583 words)
- [Unsere Stories | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/unsere-stories/index.html): Unsere Stories (155 words)
- [Von der technischen Assistenz zur Laborleitung | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/von-der-technischen-assistenz-zur-laborleitung/index.html): Von der technischen Assistenz zur Laborleitung – Susanne Zach (CNS) hat einen beeindruckenden Karrieresprung hingelegt. (557 words)
- [Fokusgebiete | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/index.html): Unser Fokus liegt auf den Bereichen Herz- und Stoffwechsel, ZNS, Immunologie und Atemwege, Onkologie und Immunonkologie sowie Netzhauterkrankungen. (154 words)
- [Supply Chain Analyst Job Details | BoehringerPRD](/content/jobs/job-invite/35388/index.html): Singapore Supply Chain Analyst - Sing (455 words)
- [Global Engineering - Karriere als Ingenieur | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/global-engineering-karriere-als-ingenieur/index.html): Thorsten von Gossel aus der Abteilung Ingenieurwissenschaften und Anlagen beschreibt Boehringer Ingelheim als Familienunternehmen mit langfristiger Perspektive und einem hervorragenden Führungsteam. (158 words)
- [Psychische Erkrankungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/index.html): Boehringer Ingelheim setzt neue Maßstäbe im Bereich der psychischen Gesundheit. Wir wollen Menschen mit psychischen Erkrankungen dabei unterstützen, ein positiveres und erfülltes Leben zu führen. (238 words)
- [Lungenkrebs | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/lungenkrebs/index.html): Lungenkrebs ist ein besonderes Fokusgebiet von uns, in dem wir das Ziel verfolgen, die Perspektiven für Patienten immer weiter zu verbessern. (354 words)
- [Klinische Studien | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/index.html): Klinische Studien sind wichtig, um die Wirksamkeit und Sicherheit eines Medikaments zu belegen. Wir initiieren und fördern Studien in über 60 Ländern. (190 words)
- [Grass Roots | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/index.html): Grass Roots (183 words)
- [Wissenschaftsförderung | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/index.html): Wissenschaftsförderung (126 words)
- [Automatisierungstechnik – Podcast Johannes Wenzel | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/automatisierungstechnik-podcast-johannes-wenzel/index.html): Erfahre mehr über die Bedeutung von Automatisierungsprozessen in der Pharmaindustrie und entdecke die vielfältigen Einstiegs- und Entwicklungsmöglichkeiten für Automatisierungsingenieur*innen bei Boehringer Ingelheim. (38 words)
- [Unser Team | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-tiergesundheit/unser-team/index.html): Unser Team (101 words)
- [Stimmen unserer Partnerorganisationen | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/stimmen-unserer-partnerorganisationen/index.html): What our partners say We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us. (121 words)
- [Partnerschaften in der Tiergesundheit | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-tiergesundheit/index.html): Partnerschaften in der Tiergesundheit (101 words)
- [Netzhauterkrankungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/netzhauterkrankungen/index.html): Netzhauterkrankungen (136 words)
- [Warum wir an Partnerschaften glauben | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/warum-wir-partnerschaften-glauben/index.html): Our partners are valued contributors in our global family of innovation. Our long-term research and investment focus means we can work together to realize their ideas by fully committing to lasting relationships and providing sustained investment for the (133 words)
- [Nutztiere | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/nutztiere/index.html): Wir bieten unseren Kund*innen innovative Gesundheitslösungen, um Krankheiten und Leiden bei Nutztieren vorzubeugen oder diese zu lindern und damit das Tierwohl zu fördern. (139 words)
- [Wiederkäuer | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/nutztiere/wiederkaeuer/index.html): Wiederkäuer (85 words)
- [Ansätze für Partnerschaften | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/ansaetze-fuer-partnerschaften/index.html): Ansätze für Partnerschaften (117 words)
- [Impfstoffe | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-tiergesundheit/impfstoffe/index.html): Impfstoffe (78 words)
- [Schweine | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/nutztiere/schweine/index.html): Tiergesundheit von Boehringer Ingelheim für Schweine (139 words)
- [Kontakt zu uns | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/kontakt-zu-uns/index.html): Kontakt zu uns (74 words)
- [Der Forschungsprozess | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-tiergesundheit/der-forschungsprozess/index.html): Der Forschungsprozess (115 words)
- [Geflügel | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/nutztiere/gefluegel/index.html): Hier finden Sie hilfreiche Informationen zu den Themen Gesundheit und Krankheiten von Geflügel und Hühnern (79 words)
- [Therapeutika | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-tiergesundheit/therapeutika/index.html): Therapeutika (60 words)
- [Parasitizide | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-tiergesundheit/parasitizide/index.html): Parasitizide (50 words)
- [Bronchiektase | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/bronchiektase/index.html): Bronchiektase (145 words)
- [Adipositas | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/adipositas/index.html): Obesity is a complex chronic disease that requires long term management. It is among the leading risk factors for several cardio-metabolic diseases such as heart disease, ischemic stroke, liver diseases incl. (306 words)
- [医药代表-罕见病产品（呼吸科）-重庆 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/35552/index.html): 重庆 医药代表-罕见病产品（呼吸科）-重庆 - 中国 (26 words)
- [Über unsere Schwerpunktbereiche hinaus | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/ueber-unsere-schwerpunktbereiche-hinaus/index.html): Über unsere Schwerpunktbereiche hinaus (125 words)
- [Ausbildung als Fachinformatiker*in in Ingelheim 2026 Stellendetails | BoehringerPRD](/content/jobs/job-invite/34363/index.html): Ingelheim Ausbildung als Fachinformatiker*in in Ingelheim 2026 - Deut (584 words)
- [隱私權聲明 | Boehringer Ingelheim TW](/content/tw/yinsiquanshengming/index.html): 隱私權聲明 Privacy Notice (3,515 words)
- [RH, Finance et Organisation | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/rh-finance-et-organisation/index.html): Découvrez les nouvelles opportunités dans nos départements RH, Finance et Organisation. (526 words)
- [Erster Berufseinstieg | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/erster-berufseinstieg/index.html): Wir bei Boehringer Ingelheim wissen, wie wichtig es ist, die richtigen Grundlagen in Ihrer Karriere zu legen und darauf mit Betreuung und Unterstützung aufzubauen. (483 words)
- [Qualität bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/ueber-uns/qualitaet/index.html): Qualität bei Boehringer Ingelheim (263 words)
- [Diabetes | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/diabetes/index.html): Weltweit leben circa 415 Millionen Erwachsene mit Diabetes. Typ-2-Diabetes ist mit 90-95 Prozent die häufigste Form. (290 words)
- [MASH: Metabolische Dysfunktion-assoziierte Steatohepatitis | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/mash/index.html): Non-alcoholic steatohepatitis (NASH) is caused by a metabolic-induced inflammation of the liver and is one of the major causes of liver fibrosis and cirrhosis. Its symptoms are often silent or non-specific to NASH, making it difficult to diagnose. (259 words)
- [USA | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/usa/index.html): Die USA sind eine unserer erfolgreichsten und innovativsten Regionen. Erkunde deine Entwicklungsmöglichkeiten für Ihre Karriere in den USA oder an unseren 170 Standorten weltweit. (285 words)
- [Spanien | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/spanien/index.html): Unsere Einrichtung in Spanien beherbergt Unternehmensbereiche für Zulassung und zwei Technologiezentren. Erkunde deine Karrieremöglichkeiten in Spanien oder an unseren 170 Standorten weltweit. (249 words)
- [Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/29142/index.html): Ingelheim Senior Sales Representative Specialty Care - Dresden / Cottbus / Frankfurt (Oder) (m/w/d) - Deut (646 words)
- [Juridique et conformité | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/juridique-et-conformite/index.html): Découvrez les nouvelles opportunités dans notre équipe Conformité juridique. (294 words)
- [Wo Sie uns finden | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wo-sie-uns-finden/index.html): Boehringer Ingelheim verfügt über globale Forschungs- und Produktionsnetzwerke, mit Standorten in Europa, Amerika und Asien/Ozeanien. (409 words)
- [Qualité | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/qualite/index.html): Découvrez les nouvelles opportunités dans notre département Qualité. (180 words)
- [Österreich | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/oesterreich/index.html): Wien war unser erster Standort außerhalb Deutschlands. Erkunde deine Karrieremöglichkeiten in Österreich oder an unseren 170 Standorten weltweit. (151 words)
- [Médecine et Affaires réglementaires | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/medecine-et-affaires-reglementaires/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Médecine et Affaires réglementaires. (259 words)
- [Herzinsuffizienz | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/herzinsuffizienz/index.html): Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction. (292 words)
- [Geschichte | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/geschichte/index.html): Albert Boehringer gründete Boehringer Ingelheim 1885. Lesen Sie hier, wie sich das Unternehmen seitdem entwickelt hat. (150 words)
- [Forschung Entwicklung | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/forschung-entwicklung/index.html): Entdecke neue Möglichkeiten in unserer Forschung und Entwicklung. (357 words)
- [Personal Finanzen Organisation | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/personal-finanzen-organisation/index.html): Entdecke neue Möglichkeiten in unseren Abteilungen Menschen, Finanzen und Organisation. (473 words)
- [Ulotki dla pacjentów z niepełnosprawnościami | Boehringer Ingelheim PL](/content/pl/ulotki-dla-pacjentow-z-niepelnosprawnosciami/index.html): Ulotki dla pacjentów z niepełnosprawnościami (513 words)
- [Produktion Supply-Chain-Management | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/produktion-supply-chain-management/index.html): Entdecke neue Möglichkeiten in unserer Abteilung "Produktion und Supply-Chain-Management". (215 words)
- [IT | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/it/index.html): Entdecke neue Möglichkeiten in unserer Abteilung Informationstechnologie. (222 words)
- [Engineering Technik | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/engineering-technik/index.html): Entdecke neue Möglichkeiten in unserer Abteilung Engineering & Technik. (382 words)
- [More Health: Für Menschen & Tiere | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/index.html): More Health: Für Menschen & Tiere Bei der übergreifenden Arbeit für die Gesundheit von Mensch und Tier haben wir einzigartige Möglichkeiten auf gefährdete Bevölkerungsgruppen positiv einzuwirken. Mit More Health erhöhen wir unseren Beitrag für eine gesünd (270 words)
- [More Green: Für unseren Planeten | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/index.html): More Green: Für unseren Planeten Unsere Säule More Green umfasst Umweltinitiativen, die viele verschiedene Aspekte berücksichtigen: Maßnahmen zur Vermeidung von Wasser- und Luftverschmutzung, die Nutzung erneuerbarer Energiequellen, die Reduktion von Abfä (209 words)
- [Production chaîne d’approvisionnement | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/production-chaine-dapprovisionnement/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Fabrication et Chaîne d'approvisionnement. (169 words)
- [Ausbildung, Duales Studium & Schülerpraktika | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/ausbildung-duales-studium-schuelerpraktika/index.html): Ausbildung, Duales Studium & Schülerpraktika (159 words)
- [Wer wir sind | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/index.html): Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen. Schwerpunkte sind die Forschung, Entwicklung, Produktion sowie das Marketing neuer Medikamente. (342 words)
- [Mexiko | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/mexiko/index.html): In Mexiko befinden sich zwei unserer modernen Produktionsstätten. Erkunde deine Karrieremöglichkeiten in Mexiko oder an unseren 170 Standorten weltweit. (216 words)
- [Stoffwechselerkrankungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/index.html): Weltweit leben circa 425 Millionen Erwachsene mit Diabetes - 90 bis 95 Prozent davon mit Diabetes-Typ-2. Schätzungen nach wird die Anzahl an Diabeteserkrankungen bis zum Jahr 2045 auf etwa 629 Millionen ansteigen. (128 words)
- [Nachhaltige Entwicklung - Unser Engagement | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/nachhaltige-entwicklung-unser-engagement/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (448 words)
- [Quality | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/quality-0/index.html): Entdecke neue Möglichkeiten in unserer Qualitätsabteilung. (185 words)
- [Vorhofflimmern | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/vorhofflimmern/index.html): Vorhofflimmern ist eine Herzrhythmusstörung, bei der es zur Bildung von Blutgerinnseln im Herzen und dadurch zu einem folgenschweren Schlaganfall kommen kann. Aktuelle Informationen zum Thema erhalten Sie hier. (146 words)
- [More Potential: Für Communities & Mitarbeitende | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/index.html): More Potential: Für Communities & Mitarbeitende Die Gesellschaft steht weiterhin vor großen Herausforderungen, die von Gesundheit über Bildung, Arbeitsmöglichkeiten, Lebensbedingungen bis hin zu Ungleichheit und Armut reichen – und von denen benacht (304 words)
- [Ethik & Compliance | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/index.html): Bei Boehringer Ingelheim halten wir uns stets an das Gesetz und unsere ethischen Grundsätze (156 words)
- [l’Ingénierie et installations | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/lingenierie-et-installations/index.html): Découvrez les nouvelles opportunités dans notre département Ingénierie et Installations. (356 words)
- [Bluthochdruck | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/bluthochdruck/index.html): Bluthochdruck (128 words)
- [Sales Representative TA CRM - Gebiet Konstanz-Tuttlingen-Albstadt (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35727/index.html): Ingelheim Sales Representative TA CRM - Gebiet Konstanz-Tuttlingen-Albstadt (m/w/d) - Deut (619 words)
- [Schlaganfall | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/schlaganfall/index.html): Boehringer Ingelheim hat das einzige derzeit zugelassene Therapeutikum bei ischämischem Schlaganfall entwickelt. Es wird weltweit eingesetzt. (187 words)
- [Einkauf | Boehringer Ingelheim AT](/content/at/de/ueber-uns/einkauf/index.html): Einkauf bei (347 words)
- [Praktikum oder Abschlussarbeit bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/praktikum-oder-abschlussarbeit-bei-boehringer-ingelheim.html): Praktikum oder Abschlussarbeit? Entdecke vielfältige Einsatzbereiche bei Boehringer Ingelheim und sammle Erfahrungen, die dich weiterbringen. (347 words)
- [Données | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/donnees/index.html): Mettez à profit vos compétences en matière de données. Découvrez les nouvelles opportunités dans nos postes orientés données et postulez dès aujourd'hui. (152 words)
- [Stratégie d’entreprise et consultation | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/strategie-dentreprise-et-consultation/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Stratégie d'entreprise et Consulting et postulez dès aujourd'hui. (178 words)
- [Außendienstmitarbeiter Onkologie | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/aussendienstmitarbeiter-onkologie/index.html): Ärzt*innen benötigen eine Vielzahl an Informationen, um die besten Entscheidungen für ihre Patient*innen zu treffen. Unser Kollege Bok unterstützt sie dabei. (220 words)
- [Frankreich | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/frankreich/index.html): Boehringer Ingelheim ist seit 1967 in Frankreich präsent. Erkunde Entwicklungsmöglichkeiten für deine Karriere in Frankreich oder an unseren 170 Standorten weltweit. (255 words)
- [Deutschland | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/deutschland/index.html): Deutschland, wo die Geschichte von Boehringer Ingelheim begann und das immer noch unser globaler Hauptsitz ist. EntdeckeKarrieremöglichkeiten in Deutschland oder an unseren 170 Standorten weltweit. (303 words)
- [Top Employer: Ein Arbeitsplatz, der zum Leben passt | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/top-employer-ein-arbeitsplatz-der-zum-leben-passt-0.html): Was uns als Global Top Employer 2025 auszeichnet (1,055 words)
- [Leadership | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (665 words)
- [Wecke Begeisterung in deinem Vorstellungsgespräch | Boehringer Ingelheim DE](/content/de/karriere/deine-bewerbung/wecke-begeisterung-deinem-vorstellungsgespraech/index.html): Wie du deine Chancen beträchtlich steigerst, zu einem Vorstellungsgespräch eingeladen zu werden. (1,165 words)
- [Die besten Tipps fürs Assessment Center | Boehringer Ingelheim DE](/content/de/karriere/deine-bewerbung/die-besten-tipps-fuers-assessment-center/index.html): Sei-einfach-du-selbst (975 words)
- [Kontakt | Boehringer Ingelheim AT](/content/at/de/kontakt/index.html): Kontakt (293 words)
- [Shannon Rountos | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/shannon-rountos/index.html): Shannon Rountos, Leiterin der Nachrichtenabteilung im Bereich Corporate Affairs, spricht über ihre lohnende und erfüllende Karriere bei Boehringer Ingelheim. (127 words)
- [Trainee insights – Let’s talk about our program DISCOVER | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/trainee-insights-lets-talk-about-our-program-discover.html): Trainee insights – Let’s talk about our program DISCOVER (99 words)
- [Día Mundial de la Lucha contra la Rabia | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-salud/dia-mundial-de-la-lucha-contra-la-rabia/index.html): Día Mundial de la Lucha contra la Rabia (137 words)
- [Trainee insights – Let’s talk about tips for your application | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/trainee-insights-lets-talk-about-tips-your-application.html): Trainee insights – Let’s talk about tips for your application (89 words)
- [Senior Sales Representative für Kliniken | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/senior-sales-representative-fuer-kliniken/index.html): Im Interview erzählt Lisa Samek über ihren Neustart in der Pharma-Branche und was sie im Klinik-Außendienst gelernt hat. (590 words)
- [Trainee insights – Let’s talk about our assessment center | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/trainee-insights-lets-talk-about-our-assessment-center.html): Trainee insights – Let’s talk about our assessment center (69 words)
- [Recht Compliance | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/recht-compliance/index.html): Entdecken Sie neue Möglichkeiten in unserem Team für die Erfüllung gesetzlicher Vorgaben. (216 words)
- [Brasilien | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/brasilien/index.html): Die Präsenz von Boehringer Ingelheim in Brasilien erstreckt sich über mehr als 70 Jahre. Erkunde Karrieremöglichkeiten in Brasilien oder an unseren 170 Standorten weltweit. (136 words)
- [Commercial, Ventes et Marketing | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/commercial-ventes-et-marketing/index.html): Découvrez les nouvelles opportunités dans notre domaine d'activité Commercial et postulez dès aujourd'hui. (316 words)
- [Unternehmensstrategie Beratung | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/unternehmensstrategie-beratung/index.html): Entdecke neue Möglichkeiten in unserer Unternehmensstrategie und -beratung. (259 words)
- [Protection des données | Boehringer Ingelheim BE](/content/be/fr/protection-des-donnees/index.html): Cet avis de confidentialité décrit comment SCS Boehringer Ingelheim SComm & Boehringer Ingelheim Centre S.A. (ci-après « Boehringer Ingelheim ») (1,078 words)
- [Перспективи | Boehringer Ingelheim BG](/content/bg/perspektivi/index.html): Получете информация за индустрията, посветена на здравето на животните и прочетете мненията на експертите от Boehringer Ingelheim относно значението на сътрудничеството за стимулиране на иновациите. (383 words)
- [Unternehmensleitung | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/fuehrung/index.html): Die Mitglieder der Unternehmensleitung stellen sich mit ihren Aufgabenbereichen vor. Lernen Sie unser Familienunternehmen besser kennen. (83 words)
- [Pharmareferent im Außendienst bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/pharmareferent-im-aussendienst-bei-boehringer-ingelheim.html): Sales Representative Mario Schäfer verrät im Interview, wie er mit seiner Arbeit im Boehringer-Außendienst echte Veränderungen bewirkt. (521 words)
- [Argentinien | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/argentinien/index.html): Argentinien ist ein Eckpfeiler unserer Aktivitäten in Südamerika. Erkunde Karrieremöglichkeiten in Argentinien oder an unseren 170 Standorten weltweit. (206 words)
- [Karriere Data Science | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/karriere-data-science/index.html): Nutzen deine Datenkompetenz, um etwas zu bewirken. Entdecke spannende Karrieremöglichkeiten im Datenbereich und bewirb dich noch heute. (239 words)
- [Leki dla ludzi | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/leki-dla-ludzi/index.html): Troszczymy się o zdrowie ludzi. Boehringer Ingelheim stawia na badania naukowe, opracowując, rozwijając i produkując innowacyjne leki. Dowiedz się więcej. (454 words)
- [Nos axes de partenariat en santé animale | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-animale/axes-de-partenariat/index.html): Explorez les axes de partenariats de Boehringer Ingelheim en matière de santé animale : maladies infectieuses, maladies non transmissibles et autres domaines non liés à la maladie. (940 words)
- [Perspectives | Boehringer Ingelheim HK](/content/hk/en/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (356 words)
- [專家觀點 | Boehringer Ingelheim TW](/content/tw/zhuanjiaguandian/index.html): 從百靈佳殷格翰的專家視角，深入探索動物保健產業的發展趨勢。了解為何「合作」是推動創新的關鍵力量，並如何攜手塑造動物健康的未來。 (25 words)
- [Perspectivas | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/perspectivas/index.html): Obten información sobre la industria de la salud animal y leé las perspectivas de los expertos de Boehringer Ingelheim sobre la importancia de la colaboración para impulsar la innovación. (427 words)
- [Kommunikation Unternehmenskommunikation | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/kommunikation-unternehmenskommunikation/index.html): Entdecken Sie neue Möglichkeiten in unseren Corporate Affairs. (236 words)
- [Produktion und Verpackung von Arzneimitteln: ein Blick hinter die Kulissen mit Florian | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/produktion-und-verpackung-von-arzneimitteln-ein-blick-hinter-die-kulissen-mit-florian.html): Ein Blick hinter die Kulissen: Florian erzählt von moderner Pharma-Produktion, starkem Zusammenhalt und dem Stolz, Herausforderungen im Team zu meistern. (519 words)
- [Partenariats en santé animale | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-en-sante-animale/partenariats-dinterets/index.html): Découvrez les partenariats d’intérêt de Boehringer Ingelheim en santé animale, y compris ceux portant sur les maladies infectieuses, les maladies non infectieuses et les domaines non liés aux maladies. (1,016 words)
- [Développement durable | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/developpement-durable/index.html): Chez Boehringer Ingelheim, le "Développement durable - Pour les générations" est un voyage. Ce voyage a commencé en 1885, et nous sommes convaincus. (202 words)
- [Kaufmännischer Bereich | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/kaufmaennischer-bereich/index.html): Entdecke neue Möglichkeiten in unserem kaufmännischen Bereich und bewirb dich noch heute. (257 words)
- [Annual Report Magazine 2024 | Boehringer Ingelheim](/content/annualreport/2024/index.html): Boehringer Ingelheim’s 2024 Annual Report shows how today’s investments shape tomorrow’s medicines and drive global health innovation. (632 words)
- [Données personnelles & cookies | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/donnees-personnelles-cookies/index.html): Nous respectons la règlementation en vigueur relative à la protection des données à caractère personnel (1,644 words)
- [Warunki korzystania | Boehringer Ingelheim PL](/content/pl/warunki-korzystania/index.html): Warunki korzystania (1,194 words)
- [Imagine – Progress | Boehringer Ingelheim](/content/about-us/sustainable-development/sustainability-hub/progress/index.html): This overview of key performance figures demonstrates Boehringer’s impact across our three sustainability pillars. (396 words)
- [Aviaire | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/aviaire/index.html): Aviaire (394 words)
- [Offres d'emploi récentes au Japon | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/offres-demploi-recentes-au-japon/index.html): Notre équipe au Japon est réputée pour son engagement envers l'innovation et la durabilité. Explorez les opportunités de carrière au Japon ou dans nos 170 centres à travers le monde. (229 words)
- [Haustiere und Pferde | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/index.html): Haustiere und Pferde Hunde, Katzen und Pferde – sie teilen eine enge Verbindung mit uns und für viele Menschen sind sie echte Familienmitglieder oder treue Freunde. Umso wichtiger ist es, dass die Tiere gesund sind und gut versorgt werden. (320 words)
- [社會創新 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/social-innovation-shehuichuangxin/index.html): Social Innovation 社會創新 (109 words)
- [Bétail | Boehringer Ingelheim BE](/content/be/fr/sante-animale/betail/index.html): Boehringer Ingelheim est l'un des plus grands fournisseurs de solutions de santé novatrices permettant de prévoir, prévenir et traiter (45 words)
- [新聞素材與資料一覽 Press Material | Boehringer Ingelheim TW](/content/tw/xinwensucaiyuziliaoyilan-press-material/index.html): 新聞素材與資料一覽 Press Material (42 words)
- [Datenschutz | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/index.html): Datenschutz In einer immer stärker digitalisierten Welt spielt der effektive Schutz persönlicher Daten und der Privatsphäre jedes Einzelnen eine immer wichtigere Rolle. Aus diesem Grund ist am 25. Mai 2018 die neue EU-Datenschutz-Grundverordnung (DSGVO) (152 words)
- [Conditions générales d'utilisation | Boehringer Ingelheim FR](/content/fr/conditions-generales-dutilisation/index.html): Conditions générales d'utilisation (771 words)
- [content/dam/2dbf5ff7-8be0-48f5-8b00-af1e01235736/atrovent-us-pi-pdf.html](/content/content/dam/2dbf5ff7-8be0-48f5-8b00-af1e01235736/atrovent-us-pi-pdf.html) (3,041 words)
- [Insuffisance Cardiaque | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/insuffisance-cardiaque/index.html): Insuffisance Cardiaque (211 words)
- [Oświadczenie w sprawie dostępności | Boehringer Ingelheim PL](/content/pl/oswiadczenie-w-sprawie-dostepnosci/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (418 words)
- [Zaangażowanie Społeczne – nasze kampanie edukacyjne | Boehringer Ingelheim PL](/content/pl/zaangazowanie-spoleczne-nasze-kampanie-edukacyjne/index.html): Jesteśmy firmą zaangażowaną społecznie, prowadzimy liczne kampanie edukacyjne skierowane zarówno do pacjentów, ale także ich bliskich i całego społeczeństwa (366 words)
- [Clinical Collaborations | Boehringer Ingelheim](/content/clinical-collaborations/index.html): Clinical Collaborations (140 words)
- [FAQ | Boehringer Ingelheim TW](/content/tw/careers/how-apply/faq/index.html): 有關在[site:name]申請職位空缺時的常見問題。 (146 words)
- [Research Collaborations | Boehringer Ingelheim](/content/research-collaborations/index.html): When it comes to taking cancer on, we’re brighter together. We are collaborating with leading centers of excellence from around the world. (99 words)
- [Animaux de compagnie | Boehringer Ingelheim BE](/content/be/fr/sante-animale/animaux-de-compagnie/index.html): Vous êtes vétérinaire, avez un animal de compagnie ou un cheval? Boehringer Ingelheim, fournisseur d'envergure mondiale. (35 words)
- [Santé Publique Vétérinaire | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/index.html): L’équipe VPH est le partenaire de confiance des gouvernements et des organisations internationales chargées de protéger la santé publique vétérinaire et les communautés agricoles mondiales et nationales (332 words)
- [content/dam/2508fc3b-b209-468f-bb56-af1e0120214c/praxbind-us-pi-pdf.html](/content/content/dam/2508fc3b-b209-468f-bb56-af1e0120214c/praxbind-us-pi-pdf.html) (3,979 words)
- [使用條款 | Boehringer Ingelheim TW](/content/tw/shiyongtiaokuan/index.html): 使用條款 Terms of Use (1,472 words)
- [Search | Boehringer Ingelheim IN](/content/in/search/index.html) (27 words)
- [Confidentialité des données | Boehringer Ingelheim CA](/content/ca/fr/confidentialite-des-donnees/index.html): Votre confidentialité des données est primordiale chez Boehringer Ingelheim. Nous protégeons vos informations avec la plus grande rigueur. (1,213 words)
- [Microsoft Word - SF Recruiting Global Data Privacy Statement Version 1.2_DE.docx](/content/content/dam/720e5610-aa23-4a40-a82e-b014006a7595/successfactors_recruiting_global_data_privacy_statement_de-pdf.html) (3,173 words)
- [Partenariats en Santé Humaine | Boehringer Ingelheim FR](/content/fr/partenariats/partenariats-en-sante-humaine/index.html): Human Health Partnering (194 words)
- [Accessibility Statement | Boehringer Ingelheim FR](/content/fr/accessibility-statement/index.html): Accessibility Statement (93 words)
- [Unsere Mitarbeitenden | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/unsere-mitarbeitenden/index.html): Ehrgeiz. Leidenschaft. Integrität. Hingabe. Empathie. Individualität. Diese Qualitäten erwarten wir auf allen Ebenen. (343 words)
- [Zdrowie zwierząt | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/index.html): Jako jeden z największych dostawców weterynaryjnych produktów leczniczych Boehringer Ingelheim dba o zdrowie zwierząt. Dowiedz się więcej. (242 words)
- [Partnerska współpraca w obszarze zdrowia zwierząt | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-zwierzat/index.html): Tutaj znajdziesz wszystkie nasze dane kontaktowe oraz najnowsze informacje o tym, gdzie możesz nas spotkać wirtualnie lub osobiście. Możesz również dowiedzieć się, jak zgłosić swoją szansę członkowi naszego zespołu ds. rozwoju biznesu i lice (167 words)
- [Bovins | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/index.html): Santé animale : Améliorez le bien-être des bovins d’élevage avec nos solutions chez Boehringer Ingelheim. Contribuons à leur santé et productivité. (469 words)
- [Partnerska współpraca w obszarze zdrowia człowieka | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/index.html): Tu znajdziesz wszystkie niezbędne dane kontaktowe oraz aktualne informacje o możliwości spotkania wirtualnego lub osobistego. Dowiesz się także, jak przedstawić ofertę osobie z naszego zespołu Business Development & Licensing. (131 words)
- [Gebruiksvoorwaarden | Boehringer Ingelheim BE](/content/be/nl/gebruiksvoorwaarden/index.html): Deze website is een internationale informatiebron van ons hoofdkantoor in Ingelheim, Duitsland en is bedoeld om informatie te verstrekken over onze (1,130 words)
- [Life Forward | Boehringer Ingelheim CA](/content/ca/fr/emplois/index.html): Rejoignez une équipe mondiale de plus de 52 000 personnes passionnées et talentueuses vouées à améliorer de la santé des humains et des animaux partout dans le monde. (903 words)
- [Chercher des offres et postuler | Boehringer Ingelheim CA](/content/ca/fr/emplois/recherchez-un-poste-et-postulez/index.html): Recherchez et postulez à des offres d'emploi chez Boehringer Ingelheim. (610 words)
- [Dbanie o zdrowie zwierząt | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/nasza-odpowiedzialnosc/index.html): Planujemy w pokoleniach. Znajduje to odzwierciedlenie w naszej ponad 100-letniej, pełnej sukcesów historii przedsiębiorstwa. Jest to również sedno zrównoważonego rozwoju. (174 words)
- [Trzoda chlewna | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-gospodarskie/trzoda-chlewna/index.html): Jesteśmy partnerem i animatorem zrównoważonej produkcji wieprzowiny i białka zwierzęcego, zapewniając dobrostan zwierząt poprzez profilaktykę i zintegrowaną opiekę zdrowotną. (152 words)
- [Partnerska współpraca w obszarze zdrowia zwierząt – obszary współpracy | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-zwierzat/obszary-wspolpracy/index.html): Aby stworzyć kolejną generację przełomowych rozwiązań medycznych w dziedzinie zdrowia zwierząt, potrzebujemy partnerów. Kliknij tutaj, aby zobaczyć nasze zainteresowania partnerskie w zakresie zdrowia zwierząt. (91 words)
- [Partnerska współpraca w obszarze zdrowia człowieka – obszary współpracy | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/obszary-wspolpracy/index.html): Kliknij tutaj, aby dowiedzieć się, co w firmie Boehringer Ingelheim lubimy od naszych partnerów i co obejmuje nasza działalność partnerska. (84 words)
- [Współpraca | Boehringer Ingelheim PL](/content/pl/wspolpraca/index.html): Boeringer Ingelheim stawia na współpracę partnerską celem rozwoju innowacyjnych rozwiązań w obszarze zdrowia ludzi i zwierząt. Dowiedz się więcej. (133 words)
- [Nos centres | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/decouvrez-nos-centres/index.html): Nous offrons des opportunités de développement de carrière dans plus de 170 centres à travers le monde. Découvrez quelques-uns de nos principaux centres. (292 words)
- [Nauka i innowacje | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/index.html): Dowiedz się, jak firma Boehringer Ingelheim podejmuje wyzwania naukowe, robiąc rzeczy inaczej. Kliknij tutaj, aby przeczytać nasze najnowsze artykuły na temat nauki i innowacji. (125 words)
- [Partenariats en santé animale | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-en-sante-animale/index.html): En savoir plus sur l’approche collaborative de Boehringer Ingelheim en matière d’innovation en santé animale, nos domaines d’intérêt en matière de partenariat et la façon de communiquer avec notre équipe (568 words)
- [Leadership | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (617 words)
- [Zwierzęta przeżuwające | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-gospodarskie/zwierzeta-przezuwajace/index.html): Nasza działalność w zakresie przeżuwaczy skupia się na środkach przeciwpasożytniczych, szczepionkach i lekach, które są oferowane naszym lekarzom weterynarii i hodowcom bydła mlecznego i mięsnego. (60 words)
- [Proces badawczy | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-zwierzat/proces-badawczy/index.html): Kluczową częścią naszej misji jest odkrywanie lub identyfikowanie nowych związków, szczepionek, technologii, procesów chorobowych i czynników zakaźnych. W tym celu wykorzystujemy kombinację zaawansowanych narzędzi, możliwości technicznych i wiedzy - zarów (125 words)
- [Découvrez notre entreprise | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-notre-entreprise/index.html): Et si Boehringer Ingelheim était la prochaine étape de votre carrière ? Explorez nos différents champs d'activité et découvrez les opportunités d'emploi dans votre domaine. (522 words)
- [Grass Roots | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/grass-roots/index.html): Innowacje u podstaw: Mistrzowie następnej generacji innowatorów nauk przyrodniczych (101 words)
- [Działania na rzecz nauki | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/dzialania-na-rzecz-nauki/index.html): Wspieranie nauki poprzez partnerstwo i współpracę jest kluczowe dla rozwoju skutecznych metod leczenia, które mogą zmienić życie pacjentów. Dowiedz się więcej tutaj. (58 words)
- [Szczepionki | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-zwierzat/szczepionki/index.html): Pracujemy nad wieloma chorobami i gatunkami, aby opracować i dostarczyć solidne, skuteczne szczepionki dla zwierząt towarzyszących, zwierząt domowych i bydła, czytaj więcej tutaj. (74 words)
- [Innowacje w obszarze leków dla ludzi | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/index.html): Dowiedz się, jak działamy, by zmieniać życie pacjentów dzięki nowo opracowywanym innowacyjnym lekom i poczytaj o pionierskich badaniach naukowych, stojącymi za przełomowymi odkryciami, z których skorzystają chorzy dziś i w kolejnych pokoleniach (71 words)
- [Qualité chez Boehringer Ingelheim | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qualite/index.html): Qualité chez Boehringer Ingelheim (310 words)
- [Poznaj nasz zespół | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-zwierzat/poznaj-nasz-zespol/index.html): Tutaj znajdziesz wszystkie nasze dane kontaktowe oraz informacje o tym, gdzie możesz nas spotkać wirtualnie lub osobiście. Możesz również dowiedzieć się, jak zgłosić swoją szansę do naszego zespołu BD&L (49 words)
- [Kierunki działalności naukowej | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/kierunki-dzialalnosci-naukowej/index.html): Odkryj, na czym obecnie koncentrują się wysiłki i inwestycje firmy Boehringer Ingelheim w zakresie badań naukowych, w tym chorób OUN, zdrowia siatkówki i COVID-19. (87 words)
- [Innowacje w obszarze leków dla zwierząt | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-zwierzat/index.html): Nasz zespół Global Innovation prowadzi pionierskie badania naukowe, które pomagają lekarzom weterynarii, właścicielom zwierząt domowych i gospodarskich oraz organom zdrowia publicznego dbać o zdrowie zwierząt teraz i w przyszłości. (75 words)
- [Frank Hübler | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/frank-hubler/index.html): Frank Hübler — Membre du Conseil des directeurs principaux responsable de l’unité fonctionnelle des finances (188 words)
- [Choroby psychiczne | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/zdrowie-psychiczne/index.html): Boehringer Ingelheim stawia na badania naukowe i rewolucjonizuje dziedzinę zdrowia psychicznego, opracowując nowe terapie i leki. Dowiedz się więcej. (93 words)
- [Środki przeciwpasożytnicze | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-zwierzat/srodki-przeciwpasozytnicze/index.html): Przeczytaj o globalnej innowacji firmy Boehringer Ingelheim i wiedzy specjalistycznej w zakresie środków przeciwpasożytniczych dla zwierząt towarzyszących i bydła, takich jak koty, psy czy konie. (53 words)
- [Środki lecznicze | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-zwierzat/srodki-lecznicze/index.html): Zapewniamy zdyscyplinowane podejście naukowe do globalnego odkrywania, rozwoju i dostarczania terapii dla wszystkich istotnych gatunków zwierząt. Nasze dedykowane zespoły badawcze współpracują z kolegami z branży farmaceutycznej i zdrowia zwierzą (61 words)
- [Drób | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-gospodarskie/drob/index.html): Dostarczamy szczepionki, diagnostykę, usługi badawcze, wiedzę techniczną, aby zapewnić bezpieczną, przystępną cenowo, obfitą i zrównoważoną jakość mięsa drobiowego i jaj. (115 words)
- [Badania kliniczne | Boehringer Ingelheim PL](/content/pl/nauka-i-innowacje/innowacje-w-obszarze-lekow-dla-ludzi/badania-kliniczne/index.html): Kliknij, aby poznać znaczenie badań klinicznych dla rozwoju nowych leków i zobaczyć niektóre z badań klinicznych sponsorowanych przez firmę Boehringer Ingelheim. (53 words)
- [Articles | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/articles/index.html): Découvrez la santé animale avec Boehringer Ingelheim. Nos articles vous offrent des solutions pour le bien-être de vos compagnons. (399 words)
- [Connectez-vous avec nous | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-en-sante-animale/connectez-vous-avec-nous/index.html): Communiquez avec l'équipe de développement des affaires et de délivrance de permis de Boehringer Ingelheim en ligne ou lors d'événements pour soumettre une proposition ou discuter des possibilités de partenariat (427 words)
- [Jakość w Boehringer Ingelheim | Boehringer Ingelheim PL](/content/pl/o-nas/jakosc/index.html): Jakość w Boehringer Ingelheim (254 words)
- [Etyka i zgodność z przepisami | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/index.html): Etyka i zgodność z przepisami (208 words)
- [Choroby siatkówki | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-siatkowki/index.html): Boehringer Ingelheim poszerzył zakres globalnej działalności badawczo-rozwojowej o walkę z chorobami narządu wzroku. Niedowidzenie i ślepota mają katastrofalny wpływ na jakość życia chorego. (117 words)
- [Historia | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/index.html): Boehringer Ingelheim to rodzinna firma farmaceutyczna założona w 1885 r. w Niemczech przez Alberta Boehringera. Dowiedz się więcej o historii naszej firmy. (201 words)
- [Włóknienie płuc | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/wloknienie-pluc/index.html): Włóknienie płuc to choroba powodująca narastanie tkanki bliznowatej w płucach. Dowiedz się więcej o naszych działaniach w zakresie jej leczenia. (180 words)
- [O nas | Boehringer Ingelheim PL](/content/pl/o-nas/index.html): Boehringer Ingelheim to globalny koncern farmaceutyczny stawiający na badania naukowe. Nasza firma zrzesza wiele kultur i społeczności. Dowiedz się więcej. (143 words)
- [Annonces juridiques | Boehringer Ingelheim CA](/content/ca/fr/annonces-juridiques/index.html): Découvrez nos conditions d’utilisation chez Boehringer Ingelheim. Une transparence totale pour votre tranquillité d’esprit. (669 words)
- [Kontakt | Boehringer Ingelheim PL](/content/pl/kontakt/index.html): Masz pytania lub chcesz dowiedzieć się więcej o Boehringer Ingelheim? Skontaktuj się z nami. (264 words)
- [Rak płuca | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nowotwory/rak-pluca/index.html): Boehringer Ingelheim zapewnia innowacyjne leczenie raka płuca za pomocą specjalistycznych produktów dla 1 i 2 linii niedrobnokomórkowego raka płuca (NSCLC) (233 words)
- [Michael Schmelmer | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/michael-schmelmer/index.html): Michael Schmelmer — Vice-président du Conseil des directeurs principaux responsable des fonctions de groupe (209 words)
- [Zwierzęta domowe | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-towarzyszace/zwierzeta-domowe/index.html): Firma Boehringer Ingelheim posiada wiele produktów i elementów badawczych pracujących nad tym, aby zdrowie i samopoczucie Twoich zwierząt było numerem jeden. (44 words)
- [Zwierzęta gospodarskie | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-gospodarskie/index.html): Nasza działalność w zakresie zwierząt gospodarskich obejmuje segmenty drobiu, trzody chlewnej, przeżuwaczy i weterynaryjnego zdrowia publicznego, aby zaspokoić potrzeby producentów zwierząt gospodarskich, lekarzy weterynarii, urzędników państwo (36 words)
- [Konie | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-towarzyszace/konie/index.html): Opracowujemy wiodące rozwiązania dla dobrego samopoczucia koni w zakresie immunologii, parazytologii, zdrowia żołądka i metabolizmu. (79 words)
- [Otyłość | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-metaboliczne/otylosc/index.html): Otyłość jest złożoną chorobą przewlekłą wymagającą długofalowego leczenia. Dowiedz się więcej na temat działań Boehringer Ingelheim na tym polu. (106 words)
- [Choroby płuc | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/index.html): Boehringer Ingelheim od ponad stu lat zajmuje się chorobami układu oddechowego i opracowuje leki na choroby płuc. Dowiedz się więcej. (99 words)
- [POChP i astma | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/pochp-i-astma/index.html): Boehringer Ingelheim opracował wiele metod leczenia chorób układu oddechowego, w tym astmy i POChP. Dowiedz się więcej. (194 words)
- [Nasza odpowiedzialność | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nasza-odpowiedzialnosc/index.html): Życie zwierząt i ludzi są ze sobą wzajemnie powiązane w dużym i złożonym stopniu. Wiemy, że gdy zwierzęta są zdrowe, ludzie także są zdrowsi. Dostarczając wartość poprzez wprowadzanie innowacji, poprawiamy komfort i dobrostan jednych i drugich. (101 words)
- [Énoncé relatif à l’accessibilité | Boehringer Ingelheim CA](/content/ca/fr/enonce-relatif-laccessibilite/index.html): Engagement envers l’accessibilité chez Boehringer Ingelheim. Découvrez comment nous rendons nos traitements et services plus accessibles pour tous. (723 words)
- [Polecane historie | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/polecane-historie/index.html): Dowiedz się więcej o tym, jak możemy poprawić zdrowie i samopoczucie zwierząt towarzyszących i hodowlanych. (49 words)
- [Zwierzęta towarzyszące | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/zwierzeta-towarzyszace/index.html): Czy masz zwierzę domowe lub konia? Jeśli chcesz, aby otrzymały one taki sam poziom opieki zdrowotnej jak ty sam, nie jesteś sam: więcej ludzi niż kiedykolwiek wcześniej uważa zwierzęta towarzyszące za integralną część rodziny. (30 words)
- [Zaopatrzenie | Boehringer Ingelheim PL](/content/pl/o-nas/zaopatrzenie/index.html): Dostawcy są nieodłącznym elementem sukcesu Boehringer Ingelheim. Zależy nam, aby nasi partnerzy biznesowi podzielali nasze wartości. Dowiedz się więcej. (99 words)
- [Perspectives | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-en-sante-animale/perspectives/index.html): Obtenez des informations sur l'industrie de la santé animale et lisez les perspectives des experts de Boehringer Ingelheim sur l'importance de la collaboration pour stimuler l'innovation (497 words)
- [Histoires de partenariat | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-en-sante-animale/histoires-de-partenariat/index.html): Découvrez quelques-unes des collaborations les plus importantes de Boehringer Ingelheim dans le domaine de la santé animale et écoutez ce que nos partenaires ont à dire sur leur expérience de travail avec nous (359 words)
- [Kim jesteśmy | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/index.html): Boehringer Ingelheim pracuje nad przełomowymi terapiami i wprowadza innowacje medyczne, które odmieniają życie ludzi i zwierząt. Dowiedz się więcej. (292 words)
- [Wzmacniamy pozycję pacjentów | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nowotwory/wzmacniamy-pozycje-pacjentow/index.html): Radzenie sobie z rakiem może być trudne dla wszystkich zainteresowanych. Tutaj przedstawiliśmy liczne zasoby dedykowanych porad dostarczonych przez pacjentów, dla pacjentów. (80 words)
- [Integritetspolicy | Boehringer Ingelheim SE](/content/se/integritetspolicy/index.html): Data Privacy Statement (2,647 words)
- [Depresja | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/zdrowie-psychiczne/depresja/index.html): Depresja (59 words)
- [Comment postuler | Boehringer Ingelheim CA](/content/ca/fr/emplois/comment-postuler/index.html): Apprenez comment postuler, à quoi vous attendre et comment préparer votre candidature auprès de nous. (402 words)
- [content/dam/c80c5a27-3094-4744-97e7-af1e011f85f7/micardis-us-pi-pdf.html](/content/content/dam/c80c5a27-3094-4744-97e7-af1e011f85f7/micardis-us-pi-pdf.html) (1,279 words)
- [MASH | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-metaboliczne/mash/index.html): Niealkoholowe stłuszczeniowe zapalenie wątroby (NASH) jest jedną z głównych przyczyn włóknienia i marskości wątroby. Dowiedz się więcej. (125 words)
- [Różne rodzaje nowotworów | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nowotwory/rozne-rodzaje-nowotworow/index.html): Boehringer Ingelheim pracuje nad pionierskimi metodami leczenia. Dowiedz się więcej o naszych działaniach w ramach badań nad immunologią nowotworów. (81 words)
- [Przewlekła choroba nerek | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/przewlekla-choroba-nerek/index.html): Chronic Kidney Disease (139 words)
- [Migotanie przedsionków | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/migotanie-przedsionkow/index.html): Boehringer Ingelheim opracował doustny lek chroniący pacjentów z niezastawkowym migotaniem przedsionków przed udarem. Dowiedz się więcej. (123 words)
- [Niewydolność serca | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/niewydolnosc-serca/index.html): Niewydolność serca jest główną przyczyną leczenia szpitalnego w USA i Europie. Dowiedz się więcej o tym, jak ważne jest, aby mieć zdrowe serce. (201 words)
- [Cukrzyca | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-metaboliczne/cukrzyca/index.html): Dowiedz się więcej o cukrzycy i o tym, jak firma Boehringer Ingelheim pracuje nad badaniami i rozwojem nowszych, innowacyjnych leków na cukrzycę, aby poprawić życie pacjentów. (120 words)
- [Twardzina układowa | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/twardzina-ukladowa/index.html): Twardzina układowa (92 words)
- [Zrównoważony rozwój | Boehringer Ingelheim PL](/content/pl/o-nas/zrownowazony-rozwoj/index.html): Z myślą o przyszłych pokoleniach Boehringer Ingelheim dba o zrównoważony rozwój, chcąc przyczyniać się do poprawy sytuacji na świecie. Dowiedz się więcej. (136 words)
- [Nadciśnienie tętnicze | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/nadcisnienie-tetnicze/index.html): Nadciśnienie tętnicze (wysokie ciśnienie krwi) to przypadłość, na którą cierpi około miliarda ludzi na świecie. Dowiedz się więcej. (100 words)
- [Éthique et conformité | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/index.html): Éthique et conformité au cœur de Boehringer Ingelheim. Découvrez nos pratiques responsables pour une conduite exemplaire et éthique. (177 words)
- [Udar mózgu | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/udar-mozgu/index.html): Boehringer Ingelheim jako pionier w opiece nad osobami po udarach opracował preparat rozpuszczający zakrzepy. Dowiedz się więcej o naszych działaniach. (114 words)
- [Choroby metaboliczne | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-metaboliczne/index.html): Boeringer Ingelheim opracowuje innowacyjne leki i metody leczenia chorób metabolicznych takich jak cukrzyca. Dowiedz się więcej. (74 words)
- [Användarvillkor | Boehringer Ingelheim SE](/content/se/anvandarvillkor/index.html): Användarvillkor (908 words)
- [Sclérodermie | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-respiratoires/sclerodermie/index.html): Scleroderma (227 words)
- [Ochrona danych osobowych | Boehringer Ingelheim PL](/content/pl/ochrona-danych-osobowych/index.html): Ochrona danych osobowych (146 words)
- [搜尋與申請 | Boehringer Ingelheim TW](/content/tw/careers/search-and-apply/index.html): 搜尋及申請[site:name]的職位空缺。 (428 words)
- [Porcs | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/index.html): Solutions santé pour porcs d’élevage chez Boehringer Ingelheim. Améliorez bien-être et productivité grâce à notre expertise en santé animale. (286 words)
- [Transparentność | Boehringer Ingelheim PL](/content/pl/o-nas/transparentnosc/index.html): Transparentność (26 words)
- [歡迎加入舒噴噴家族！ | Boehringer Ingelheim TW](/content/tw/huanyingjiarushupenpenjiazu/index.html): 舒沛噴(Respimat)吸入器衛教影片 (132 words)
- [Switching market | Boehringer Ingelheim PL](/content/pl/disclaimer/market/index.html) (66 words)
- [Mirapex®樂伯克® | Boehringer Ingelheim TW](/content/tw/products/mirapex/index.html): Mirapex®樂伯克® (38 words)
- [百靈佳殷格翰 生醫新創火種 opnMe 資源平台 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuanghuozhong-opnme-ziyuanpingtai/index.html): 百靈佳殷格翰 生醫新創火種 opnMe 資源平台 (89 words)
- [Leaving site | Boehringer Ingelheim PL](/content/pl/disclaimer/bi/index.html) (137 words)
- [Témoignages de nos partenaires | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/temoignages-de-nos-partenaires/index.html): Découvrez nos partenariats en santé humaine chez Boehringer Ingelheim CA. Lisez les témoignages inspirants sur nos collaborations pour une meilleure santé. (117 words)
- [Où nous trouver | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ou-nous-trouver/index.html): Découvrez nos sites à travers le monde chez Boehringer Ingelheim. Une présence mondiale pour offrir des solutions de santé de qualité. (474 words)
- [Plus de santé : Pour les humains et les animaux | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/plus-de-sante/index.html): Engagement envers le développement durable et la santé chez Boehringer Ingelheim. Découvrez comment nous œuvrons pour un avenir meilleur. (158 words)
- [Chevaux | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/chevaux/index.html): Prenez soin de la santé des chevaux avec Boehringer Ingelheim. Découvrez nos solutions dédiées pour le bien-être et la protection de vos compagnons équins. (175 words)
- [Notre responsabilité | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/notre-responsabilite/index.html): Chez Boehringer Ingelheim, nous assumons notre responsabilité envers la santé animale. Découvrez comment nous nous engageons pour leur bien-être. (315 words)
- [Cancer du poumon | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/cancer-du-poumon/index.html): Boehringer Ingelheim s’engage dans l’oncologie pour lutter contre le cancer du poumon, en proposant des traitements novateurs et prometteurs. (300 words)
- [Partenariats | Boehringer Ingelheim CA](/content/ca/fr/partenariats/index.html): Découvrez nos partenariats chez Boehringer Ingelheim. Ensemble, nous nous engageons à promouvoir la santé et le bien-être. (152 words)
- [Partenariats axés sur la santé humaine | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/index.html): Découvrez nos partenariats en santé humaine chez Boehringer Ingelheim. Ensemble, nous œuvrons pour promouvoir la santé et le bien-être de tous. (129 words)
- [貓 Cat | Boehringer Ingelheim TW](/content/tw/animal-health/companion-animals-horses/mao/index.html): 貓 Cat (74 words)
- [我們的企業文化 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/our-working-culture/index.html): 我們的企業文化 (70 words)
- [SDGs在臺灣 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/sdgszaitaiwan/index.html): 人類正站在全球氣候劇烈變遷、自然資源漸枯竭、生物多樣性耗損、疾病頻仍等關鍵十字路口上。為此，2015 年時，聯合國發布了「永續發展目標」(Sustainable Develpoment Goals, SDGs)，敦促全世界在 2030 年以前為地球與人類社會努力，邁向永續。 (114 words)
- [商務採購 | Boehringer Ingelheim TW](/content/tw/about-us/purchasing/index.html): Purchasing (243 words)
- [Culture de partenariat | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/culture-de-partenariat/index.html): Découvrez nos partenariats en culture et santé humaine chez Boehringer Ingelheim. Collaboration pour promouvoir la santé et le bien-être. (54 words)
- [Communiquez avec nous | Boehringer Ingelheim CA](/content/ca/fr/partenariats/partenariats-axes-sur-la-sante-humaine/communiquez-avec-nous/index.html): Explorez nos partenariats et communiquez avec nous chez Boehringer Ingelheim. Ensemble, nous travaillons pour un avenir plus sain. (5 words)
- [了解我們的辦公地點 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/see-our-locations/index.html): 我們在全球提供超過 170 個營業地點的職位發展入了解我們的一些特色地點。機會。深 (76 words)
- [狗 Dog | Boehringer Ingelheim TW](/content/tw/animal-health/companion-animals-horses/gou/index.html): 狗 Dog (64 words)
- [Science et innovation | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/index.html): Découvrez notre science et notre innovation chez Boehringer Ingelheim CA. Explorez nos avancées pour améliorer la santé et le bien-être. (139 words)
- [Vaccins | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-animale/vaccins/index.html): Découvrez la science et l’innovation en santé animale avec les vaccins de Boehringer Ingelheim. Protégez la santé de vos animaux grâce à nos avancées. (98 words)
- [Contact Us | Boehringer Ingelheim TW](/content/tw/contact-us/index.html): Contact Us Thank You page (23 words)
- [Accent sur la science | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/accent-sur-la-science/index.html): Explorez notre innovation en santé humaine et notre expertise scientifique. Des avancées pour améliorer la vie et la santé des personnes. (84 words)
- [Animaux domestiques | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/animaux-de-compagnie/index.html): Prenez soin de vos animaux de compagnie avec Boehringer Ingelheim. Nous offrons des solutions pour leur bien-être et leur santé. (193 words)
- [Innovation à la base | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/innovation-la-base/index.html): Science et innovation : Découvrez les avancées scientifiques chez Boehringer Ingelheim. Améliorer la santé grâce à l’innovation constante. (93 words)
- [Leadership | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/leadership/index.html): Apprenez-en davantage sur le Conseil des directeurs principaux de Boehringer Ingelheim, avec des renseignements sur ses cinq membres et leurs responsabilités respectives. (187 words)
- [Actilyse® 栓體舒® | Boehringer Ingelheim TW](/content/tw/products/actilyse/index.html): Actilyse® 栓體舒® (30 words)
- [Promotion de la science | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/promotion-de-la-science/index.html): Découvrez notre science et notre innovation en santé humaine chez Boehringer Ingelheim. Des avancées pour une meilleure qualité de vie. (81 words)
- [Innovation en santé animale | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-animale/index.html): Explorez la science et l’innovation chez Boehringer Ingelheim. Des avancées pour améliorer la santé et le bien-être. (95 words)
- [Produits thérapeutiques | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-animale/produits-therapeutiques/index.html): Découvrez notre science et innovation dans nos produits thérapeutiques chez Boehringer Ingelheim. Des avancées pour votre bien-être. (88 words)
- [舒沛噴(Respimat)吸入器使用說明 | Boehringer Ingelheim TW](/content/tw/shupeipenrespimatxiruqishiyongshuoming/index.html): 舒沛噴(Respimat)吸入器使用説明 (45 words)
- [Articles scientifiques | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/articles-scientifiques/index.html): Découvrez la science et l’innovation à travers nos articles scientifiques chez Boehringer Ingelheim. Explorez les avancées médicales passionnantes. (76 words)
- [Innovation en santé humaine | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-humaine/index.html): Explorez notre pipeline de science et d’innovation en santé humaine chez Boehringer Ingelheim. Découvrez nos avancées pour une meilleure santé. (73 words)
- [Nos médicaments - Au service des patients | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/produits/index.html): Découvrez nos produits de qualité chez Boehringer Ingelheim. Des solutions innovantes pour votre santé et votre bien-être. (224 words)
- [Antiparasitaires | Boehringer Ingelheim CA](/content/ca/fr/science-et-innovation/innovation-en-sante-animale/antiparasitaires/index.html): Découvrez notre innovation en santé animale chez Boehringer Ingelheim. Des avancées pour le bien-être et la santé des animaux. (70 words)
- [Santé animale | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/index.html): Prenez soin de la santé animale avec Boehringer Ingelheim. Découvrez nos solutions pour le bien-être et la protection de vos animaux de compagnie. (299 words)
- [KOL och Astma | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/kol-och-astma/index.html): Kronisk obstruktiv lungsjukdom (KOL) är en progressiv, behandlingsbar sjukdom som kännetecknas av begränsat luftflöde in och ut ur lungorna. (504 words)
- [Habiliter les patients | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/habiliter-les-patients/index.html): Découvrez notre engagement en oncologie chez Boehringer Ingelheim. Des solutions pour rendre les patients plus forts dans leur combat contre le cancer. (115 words)
- [Animaux d’élevage | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/index.html): Découvrez notre engagement en santé animale et animaux d’élevage chez Boehringer Ingelheim. Solutions pour une production animale saine et durable. (40 words)
- [網站無障礙聲明 | Boehringer Ingelheim TW](/content/tw/wangzhanwuzhangaishengming/index.html): 網站無障礙聲明 Accessibility Statement (506 words)
- [Troubles mentaux | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/sante-mentale/index.html): Améliorez la santé du système nerveux central avec Boehringer Ingelheim. Découvrez nos solutions pour un meilleur bien-être neurologique. (213 words)
- [sante humaine - Notre responsabilité | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/notre-responsabilite/index.html): Découvrez notre responsabilité envers la santé humaine chez Boehringer Ingelheim. Un engagement fort pour votre bien-être. (96 words)
- [Privacyverklaring voor Verkopers, Bezoekers en geïnteresseerde Personen | Boehringer Ingelheim BE](/content/be/nl/privacyverklaring-voor-verkopers-bezoekers-en-geinteresseerde-personen.html): Deze privacyverklaring legt uit hoe SCS Boehringer Ingelheim Comm. V., Boehringer Ingelheim Centre S.A. en/of aan haar verbonden ondernemingen van de (1,212 words)
- [糖尿病 Diabetes | Boehringer Ingelheim TW](/content/tw/human-health/metabolic-diseases/index.html): 糖尿病 Diabetes (208 words)
- [Diabète | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-metaboliques/diabete/index.html): Traitements avancés des maladies métaboliques et du diabète avec Boehringer Ingelheim. Découvrez nos solutions pour une santé métabolique optimale. (152 words)
- [À PROPOS DE NOUS | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/index.html): Découvrez à propos de nous chez Boehringer Ingelheim. Une entreprise engagée dans l’innovation et la santé pour un meilleur avenir. (210 words)
- [Schizophrénie | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/sante-mentale/schizophrenie/index.html): Solutions pour la schizophrénie avec Boehringer Ingelheim. Découvrez nos avancées pour améliorer la qualité de vie des patients. (100 words)
- [Accent sur le patient | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/notre-responsabilite/centre-sur-le-patient/index.html): Nous plaçons le bien-être du patient au cœur de nos préoccupations. Chez Boehringer Ingelheim, notre engagement envers la santé humaine est inébranlable. (98 words)
- [Maladies rétiniennes | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-retiniennes/index.html): Explorez notre expertise en santé humaine et santé de la rétine chez Boehringer Ingelheim CA FR. Des avancées médicales pour préserver votre vision. (160 words)
- [Tillgänglighetsförklaring | Boehringer Ingelheim SE](/content/se/tillganglighetsforklaring/index.html): Boehringer Ingelheim har åtagit sig att tillhandahålla webbplatser som tillgängliga för bredast möjliga populationen, oavsett teknik och funktionalitet. (344 words)
- [家禽 Poultry | Boehringer Ingelheim TW](/content/tw/animal-health/livestock/poultry/index.html): 家禽 Poultry (169 words)
- [病人安全與藥物安全監視 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/patient-safety/index.html): 病人安全與藥物安全監視 (55 words)
- [Bronchectasie | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-pulmonaires/bronchectasie/index.html): Bronchectasie (161 words)
- [肺阻塞與氣喘 COPD & Asthma | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/copd-asthma/index.html): COPD & Asthma (226 words)
- [Dépression | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/sante-mentale/depression/index.html): Solutions pour les maladies mentales, dont la dépression, avec Boehringer Ingelheim CA. Traitements pour un bien-être mental optimal. (68 words)
- [深入了解我們公司 | Boehringer Ingelheim TW](/content/tw/careers/explore-our-company/index.html): 在百靈佳殷格翰開始您的下一步職位。深入瞭解各個領域，尋找在當地您有興趣的職位空缺。 (43 words)
- [Staffan Gustavsson | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/staffan-gustavsson/index.html): Läkemedelsbranschen ses ofta endast som en kostnad, men är en av Sveriges mest produktiva och exportstarka industrier. (93 words)
- [Sclérodermie | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-pulmonaires/sclerodermie/index.html): Explorez notre expertise en santé humaine et maladies des poumons chez Boehringer Ingelheim. Des solutions innovantes pour une meilleure santé. (104 words)
- [Maladies pulmonaires | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-pulmonaires/index.html): Améliorez votre respiration avec Boehringer Ingelheim. Découvrez nos solutions pour une meilleure santé pulmonaire. (83 words)
- [如何應徵 | Boehringer Ingelheim TW](/content/tw/careers/how-apply/index.html): 在開始向我們提交申請時，了解申請方法、您的期望以及需要準備的內容。 (43 words)
- [Qui sommes-nous | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/index.html): Découvrez à propos de nous et notre profil d’entreprise chez Boehringer Ingelheim. Une histoire d’innovation et d’engagement au service de la santé. (135 words)
- [Fibrose pulmonaire | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-pulmonaires/fibrose-pulmonaire/index.html): Améliorez la respiration des patients atteints de fibrose pulmonaire idiopathique (IPF) avec Boehringer Ingelheim. Découvrez nos solutions innovantes. (93 words)
- [Fibrillation auriculaire | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladie-cardiaque/fibrillation-auriculaire/index.html): Engagé dans la prévention des AVC, Boehringer Ingelheim offre des solutions pour réduire les risques et protéger la santé cérébrale. (90 words)
- [Accident vasculaire cérébral ou AVC | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladie-cardiaque/avc/index.html): Prévention et traitement de l’accident vasculaire cérébral (AVC) avec Boehringer Ingelheim. Découvrez nos solutions pour une meilleure santé cérébrale. (116 words)
- [Insuffisance cardiaque | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladie-cardiaque/insuffisance-cardiaque/index.html): Solutions avancées pour les maladies du cœur avec Boehringer Ingelheim. Découvrez nos traitements pour une meilleure santé cardiovasculaire. (199 words)
- [Plus de vert: Pour notre planète | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/plus-de-vert/index.html): Engagement pour le développement durable et la transition verte chez Boehringer Ingelheim. Découvrez nos actions pour un avenir plus durable. (119 words)
- [Imprint | Boehringer Ingelheim TW](/content/tw/imprint/index.html): 版权印记 | 勃林格殷格翰中国 (67 words)
- [硬皮病 Scleroderma | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/scleroderma/index.html): Scleroderma (143 words)
- [Hypertension | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladie-cardiaque/hypertension/index.html): Traitements avancés pour les maladies cardiaques et l’hypertension. Découvrez nos solutions pour une meilleure santé cardiovasculaire. (115 words)
- [Maladies métaboliques | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/maladies-metaboliques/index.html): Traitements avancés des maladies métaboliques avec Boehringer Ingelheim. Découvrez nos solutions pour une santé métabolique optimale. (88 words)
- [Privacybeleid met betrekking tot PV | Boehringer Ingelheim NL](/content/nl/privacybeleid-met-betrekking-tot-pv/index.html): U kunt uw melding van een bijwerking of van overige relevante informatie voor geneesmiddelenbewaking met betrekking tot een Boehringer Ingelheim product (477 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/womendechengnuo/index.html): Sustainable Development - Our Commitment (49 words)
- [神經內分泌癌 | Boehringer Ingelheim TW](/content/tw/human-health/cancer/shenjingneifenmiai/index.html): 神經內分泌癌是一組可發生於全身各器官的癌症。在百靈佳殷格翰，我們正探索新的治療標靶，以改善患者的治療成效。 (267 words)
- [Djurhälsa | Boehringer Ingelheim SE](/content/se/djurhalsa/index.html): Djurs och människors liv är sammankopplade på djupa och komplexa sätt. Vi vet att när djur är friska är också människor friskare. (254 words)
- [Josefin Skogsberg | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/josefin-skogsberg/index.html): Kliniska studier är avgörande för att framtidens behandlingar ska nå patienter. Sverige har starka förutsättningar för klinisk forskning. (80 words)
- [肺纖維化 Idiopathic Pulmonary Fibrosis (IPF) | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/index.html): Pulmonary Fibrosis (92 words)
- [Ansvarig utgivare | Boehringer Ingelheim SE](/content/se/ansvarig-utgivare/index.html): Ansvarig utgivare (30 words)
- [Switching market | Boehringer Ingelheim CA](/content/ca/fr/disclaimer/market/index.html) (133 words)
- [MicardisPlus® 複必康平® | Boehringer Ingelheim TW](/content/tw/products/micardisplus/index.html): MicardisPlus® 複必康平® (76 words)
- [百靈佳殷格翰 生醫新創獨角獸支持計劃 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuangdujiaoshouzhichijihua/index.html): 百靈佳殷格翰 生醫新創獨角獸支持計劃 (34 words)
- [心房顫動 Atrial Fibrillation | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/atrial-fibrillation/index.html): Atrial Fibrillation (105 words)
- [支氣管擴張症 | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/bronchiectasis/index.html): 支氣管擴張症 (139 words)
- [Shashank Deshpande | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/shashank-deshpande/index.html): Shashank Deshpande –全球執行董事會主席，負責人類處方用藥業務 (132 words)
- [心衰竭 Heart Failure | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/index.html): 心衰竭 Heart Failure (211 words)
- [Samarbete för innovation | Boehringer Ingelheim SE](/content/se/samarbete/index.html): Genom samarbete och mångfald kan vi tillsammans med andra aktörer inom biovetenskap och djurhälsa förverkliga ännu fler innovationer och utveckla idéer. (104 words)
- [Vetenskap och innovation | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/index.html): Det finns ett stort engagemang hos våra forskare, som ständigt hittar nya lösningar och bidrar till innovation på företaget. (155 words)
- [慢性腎臟病 Chronic Kidney Disease | Boehringer Ingelheim TW](/content/tw/human-health/chronic-kidney-disease/index.html): 慢性腎臟病 Chronic Kidney Disease (123 words)
- [心理健康 Mental Health | Boehringer Ingelheim TW](/content/tw/human-health/mental-health/index.html): 中樞神經系統與精神健康相關疾病 (104 words)
- [Vacciner | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-djurs-halsa/vacciner/index.html): Inom Global Innovation arbetar vi med säkra och effektiva vacciner för sällskapsdjur och boskap. Vi samlar bred expertis inom vaccinologi. (68 words)
- [研發與創新 Science & Innovation | Boehringer Ingelheim TW](/content/tw/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (19 words)
- [Forskningsprocessen | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-djurs-halsa/forskningsprocessen/index.html): Vi upptäcker eller identifierar nya föreningar, vacciner, tekniker, sjukdomsprocesser och smittämnen. (121 words)
- [Animal Health | Boehringer Ingelheim TW](/content/tw/animal-health/index.html): Animal health (17 words)
- [Biverkningar för djurhälsoprodukter (produkter till djur) | Boehringer Ingelheim SE](/content/se/biverkningar-djurhalsoprodukter-produkter-till-djur.html): Rapportera misstänkta biverkningar för djurhälsoprodukter (produkter till djur) (167 words)
- [中風 Stroke | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/stroke/index.html): Stroke (156 words)
- [我們的職責 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/index.html): Human Health Our Responsibility (9 words)
- [Vårt forskningsfokus | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-mansklig-halsa/vart-forskningsfokus/index.html): Vår forskning om nya läkemedel är inriktad på vetenskapsområden med stora medicinska behov och fortsätter att vara innovativa och ledande vetenskapen. (59 words)
- [Global innovation inom djurhälsa | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-djurs-halsa/index.html): Vårt team för global innovation är pionjärer inom vetenskapen som hjälper veterinärer (71 words)
- [Gris | Boehringer Ingelheim SE](/content/se/djurhalsa/lantbruksdjur/gris/index.html): Boehringer Ingelheim är en partner och möjliggör hållbar produktion av fläsk och animaliskt protein och säkerställer djurens välbefinnande. (138 words)
- [伴侶動物 | Boehringer Ingelheim TW](/content/tw/animal-health/companion-animals-horses/index.html): At Boehringer Ingelheim we think that house pets and horses should have the same level of healthcare opportunity as you do, find out more about how. (41 words)
- [T2D och psykisk ohälsa | Boehringer Ingelheim SE](/content/se/t2d-och-psykisk-ohalsa/index.html): T2D och psykisk ohälsa (18 words)
- [Parasitmedel | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-djurs-halsa/parasitmedel/index.html): Ett viktigt expertområde inom Global Innovation är upptäckt och utveckling av nya parasitidsmedel för både sällskapsdjur och boskap. (50 words)
- [Metabola sjukdomar | Boehringer Ingelheim SE](/content/se/manniskors-halsa/metabola-sjukdomar/index.html): Associerade hjärt-, njur- och metabola sjukdomar - som påverkar hjärtat, njurarna och det metabola systemet är den vanligaste dödsorsaken. (177 words)
- [Innovation för mänsklig hälsa | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-mansklig-halsa/index.html): Boehringer Ingelheim är tydliga med sina mål. Vi vill leverera en portfölj med banbrytande läkemedel. (140 words)
- [百靈佳殷格翰的品質理念 | Boehringer Ingelheim TW](/content/tw/about-us/quality/index.html): 百靈佳殷格翰的品質理念 (31 words)
- [肺癌 Lung Cancer | Boehringer Ingelheim TW](/content/tw/human-health/cancer/index.html): Lung Cancer (67 words)
- [Djurhälsa: Vårt ansvar | Boehringer Ingelheim SE](/content/se/djurhalsa/vart-ansvar/index.html): Vi planerar för generationer. Detta återspeglas i vår mer än 100-åriga framgångsrika företagshistoria. Det är också kärnan för hållbarhet. (134 words)
- [Kliniska studier | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-mansklig-halsa/kliniska-studier/index.html): Kliniska prövningar är en viktig del av utvecklingen av nya läkemedel. De är översättningen av vår vetenskapliga expertis till banbrytande. (46 words)
- [Främjande av forskning | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-mansklig-halsa/framjande-av-forskning/index.html): Att skapa banbrytande läkemedel som förändrar patienternas liv börjar med ett engagemang för att identifiera framtidens hälsoutmaningar. (62 words)
- [Behandlingar | Boehringer Ingelheim SE](/content/se/vetenskap-och-innovation/innovation-djurs-halsa/behandlingar/index.html): Vi erbjuder ett disciplinerat vetenskapligt tillvägagångssätt för global upptäckt, utveckling och leverans av terapier för sällskapsdjur och boskap. (55 words)
- [Psykiska sjukdomar | Boehringer Ingelheim SE](/content/se/manniskors-halsa/mental-halsa/index.html): På Boehringer Ingelheim Mental Health omdefinierar vi psykisk hälsa för att ge människor möjlighet att utvecklas. (175 words)
- [Fjäderfä | Boehringer Ingelheim SE](/content/se/djurhalsa/lantbruksdjur/fjaderfa/index.html): Vi har ambitionen att skapa framtidens välbefinnande för fjäderfä genom förebyggande vård och att bidra till att vinna kampen mot sjukdomar. (115 words)
- [BI PRIVACYVERKLARING | Boehringer Ingelheim BE](/content/be/nl/bi-privacyverklaring/index.html): SCS Boehringer Ingelheim Comm.V., Boehringer Ingelheim Centre S.A. en Boehringer Ingelheim Pharma GmbH & Co. KG en zijn bedrijvengroep (verder aangeduid (622 words)
- [Idisslare | Boehringer Ingelheim SE](/content/se/djurhalsa/lantbruksdjur/idisslare/index.html): Inom vår Strategic Business Unit för Idisslare fokuserar vi på parasiticider, vacciner och terapier som erbjuds våra veterinärer och lantbrukare. (120 words)
- [Een familieportret - Leven met diabetes type 2 | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/stofwisselingsziekten/diabetes/een-familieportret-leven-met-diabetes-type-2/index.html): “Ik wil alles doen voor een lang, gezond en gelukkig leven met mijn gezin” (827 words)
- [More Green: For Our Planet | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-green/index.html): More Green: For Our Planet | [site:name] (71 words)
- [永續經營與發展 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/index.html): 永續經營與發展 (137 words)
- [Lantbruksdjur | Boehringer Ingelheim SE](/content/se/djurhalsa/lantbruksdjur/index.html): Boehringer Ingelheim är en av de ledande leverantörerna av hälsolösningar för att förutse, förebygga och behandla sjukdomar hos lantbruksdjur. (37 words)
- [More Potential: For Communities & Our People | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/index.html): More Potential: For Communities & Our People (91 words)
- [Metabolt associerad steatotisk leversjukdom (MASH) | Boehringer Ingelheim SE](/content/se/manniskors-halsa/metabola-sjukdomar/metabolt-associerad-steatotisk-leversjukdom-mash/index.html): Icke-alkoholisk steatohepatit (NASH) orsakas av en metaboliskt inducerad inflammation i levern (129 words)
- [MORE HEALTH for People & Animals | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-health/index.html): MORE HEALTH for People & Animals (105 words)
- [Systemisk skleros | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/systemisk-skleros/index.html): Systemisk skleros (SSc) är en sällsynt sjukdom som kan vara vanställande, handikappande och potentiellt dödlig och som orsakar ärrbildning i huden. (106 words)
- [Hästar | Boehringer Ingelheim SE](/content/se/djurhalsa/sallskapsdjur/hastar/index.html): Boehringer Ingelheim är ledande inom hästhälsa och utvecklar innovativa lösningar för hästars välbefinnande världen över. (70 words)
- [誠信與法規遵循 | Boehringer Ingelheim TW](/content/tw/about-us/ethics-and-compliance/index.html): 誠信與法規遵循 Ethics and Compliance (87 words)
- [高血壓 Hypertension | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/hypertension/index.html): 高血壓 Hypertension (111 words)
- [Lungsjukdomar | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/index.html): Boehringer Ingelheim har ett 100-årigt arv inom respiratoriska sjukdomar. Sedan 1921 har vi framträtt som ledande inom detta sjukdomsområde. (100 words)
- [Sällskapsdjur | Boehringer Ingelheim SE](/content/se/djurhalsa/sallskapsdjur/index.html): Är du veterinär eller har du ett husdjur eller en häst? Som en av de ledande globala leverantörerna bidrar Boehringer Ingelheim (32 words)
- [Lungfibros | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/lungfibros/index.html): Lungfibros är ett tillstånd som leder till att ärrvävnad byggs upp i lungorna. (101 words)
- [Vårt ansvar | Boehringer Ingelheim SE](/content/se/manniskors-halsa/vart-ansvar/index.html): På Boehringer Ingelheim sätter vi alltid patienten i första rummet. (76 words)
- [Scientist I OR Scientist II, DevOps Drug Substance, ONSITE, Fremont CA Job Details | BoehringerPRD](/content/jobs/job-invite/36158/index.html): Fremont, CA Scientist I OR Scientist II, DevOps Drug Substance, ONSITE, Fremont CA - Unit (953 words)
- [Förebyggande av stroke vid förmaksflimmer | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/formaksflimmer/index.html): En stroke inträffar när blodtillförseln till en del av hjärnan avbryts. Personer med oregelbundna hjärtslag (även kallat förmaksflimmer). (83 words)
- [Diabetes | Boehringer Ingelheim SE](/content/se/manniskors-halsa/metabola-sjukdomar/diabetes/index.html): Omkring 425 miljoner vuxna människor i världen lever med diabetes, och typ 2-diabetes står för 90-95 procent av alla fall. (149 words)
- [Production Planner Support Dettagli lavoro | BoehringerPRD](/content/jobs/job-invite/36372/index.html): Noventa Padovana Production Planner Support - Ital (694 words)
- [content/dam/7e63d875-6ffb-407d-a561-af1e012045e5/spiriva-20handihaler-us-pi-pdf.html](/content/content/dam/7e63d875-6ffb-407d-a561-af1e012045e5/spiriva-20handihaler-us-pi-pdf.html) (415 words)
- [Här hittar du oss | Boehringer Ingelheim SE](/content/se/om-oss/har-hittar-du-oss/index.html): Boehringer Ingelheim har 52 000 anställda världen över och har ett världsomspännande forsknings- och produktionsnätverk. Här är våra största anläggningar. (330 words)
- [Fetma | Boehringer Ingelheim SE](/content/se/manniskors-halsa/metabola-sjukdomar/fetma/index.html): Fetma är en komplex kronisk sjukdom som kräver långsiktig behandling. (70 words)
- [Engenheiro/a de Utilidades SR Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35884/index.html): Paulínia Engenheiro/a de Utilidades SR - Bras (602 words)
- [Hållbar utveckling - för generationer | Boehringer Ingelheim SE](/content/se/om-oss/hallbar-utveckling/index.html): På Boehringer Ingelheim handlar "Hållbar utveckling - för generationer" om en resa. (307 words)
- [Kvalitet hos Boehringer Ingelheim | Boehringer Ingelheim SE](/content/se/om-oss/kvalitet/index.html): Kvalitet hos Boehringer Ingelheim (186 words)
- [領導團隊 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/leadership/index.html): 了解更多關於百靈佳殷格翰全球執行董事會的資訊，包含五位成員及其各自的職責。 (175 words)
- [content/dam/c669f898-0c4e-45a2-ba55-af1e011fdf63/pradaxa-20capsules-us-pi-pdf.html](/content/content/dam/c669f898-0c4e-45a2-ba55-af1e011fdf63/pradaxa-20capsules-us-pi-pdf.html) (19,079 words)
- [Contact Us | Boehringer Ingelheim TW](/content/tw/yuwomenlianxi/index.html): 联系我们 (103 words)
- [Frågor och synpunkter | Boehringer Ingelheim SE](/content/se/kontakta-oss/index.html): Tack för ditt intresse. Vi välkomnar dina frågor och synpunkter. (314 words)
- [Ledning | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/ledning/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (588 words)
- [了解我們的職業生涯 | Boehringer Ingelheim TW](/content/tw/careers/discover-our-careers/index.html): 了解我們的職業生涯 (102 words)
- [Development Engineer - Laboratory Automation & Robotics Stellendetails | BoehringerPRD](/content/jobs/job-invite/35493/index.html): Biberach Development Engineer - Laboratory Automation & Robotics - Deut (601 words)
- [Etik och regelefterlevnad | Boehringer Ingelheim SE](/content/se/om-oss/etik-och-efterlevnad/index.html): I enlighet med kärnan i vårt uppdrag och uppförandekod, agerar vi med integritet och bedriver vår verksamhet på ett lagligt och etiskt sätt. (86 words)
- [Toegankelijkheidsverklaring | Boehringer Ingelheim BE](/content/be/nl/toegankelijkheidsverklaring/index.html): Boehringer Ingelheim streeft ernaar om een website aan te bieden die toegankelijk is voor de breedst mogelijke doelgroep, ongeacht technologie vaardigheden. (481 words)
- [校園徵才活動 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/index.html): 校園徵才活動 (18 words)
- [Hjärtsvikt | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/hjartsvikt/index.html): Hjärtsvikt är ett progressivt och potentiellt dödligt tillstånd som drabbar över 60 miljoner människor i världen och som förväntas öka i takt. (194 words)
- [Preguntas frecuentes | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/como-aplicar/preguntas-frecuentes/index.html): Visita nuestro aparatdo de preguntas frecuentes sobre el proceso de solicitud de empleo en Boehringer Ingelheim. No te quedes con ninguna duda. (2,193 words)
- [Países Bajos | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/paises-bajos/index.html): Nuestra instalación de Ámsterdam es uno de nuestros principales centros de operaciones en Europa. Mira ahora las oportunidades disponibles en los Países Bajos. (196 words)
- [歷史沿革 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/history/index.html): 歷史沿革 (128 words)
- [Bättre hälsa: För människor och djur | Boehringer Ingelheim SE](/content/se/om-oss/hallbar-utveckling/battre-halsa/index.html): Ett långsiktigt initiativ med målet att förbättra hälsan i samhället runt om i världen genom att identifiera och stödja de lovande lösningarna. (138 words)
- [content/dam/cb0bec34-6e3b-41c2-8376-af1e0120d4bb/striverdi-20respimat-us-pi-pdf.html](/content/content/dam/cb0bec34-6e3b-41c2-8376-af1e0120d4bb/striverdi-20respimat-us-pi-pdf.html) (10,089 words)
- [Site informatie | Boehringer Ingelheim BE](/content/be/nl/site-informatie/index.html): Site-informatie Gepubliceerd door SCS Boehringer Ingelheim Comm. V Avenue Arnaud Fraiteur 15-23 Arnaud Fraiteurlaan 1050 Brussel/Bruxelles (80 words)
- [Ingeniero/a Sr. De Proyectos Detalles del puesto | BoehringerPRD](/content/jobs/job-invite/36220/index.html): Ciudad de Mexico Ingeniero/a Sr. De Proyectos - Méxi (641 words)
- [關於我們 | Boehringer Ingelheim TW](/content/tw/about-us/index.html): 關於我們 About Us (23 words)
- [content/dam/24ba79af-5d54-43cf-8f35-af1e012105ce/synjardy-20xr-us-pi-pdf.html](/content/content/dam/24ba79af-5d54-43cf-8f35-af1e012105ce/synjardy-20xr-us-pi-pdf.html) (23,105 words)
- [content/dam/b3a3077a-bbbe-419d-8994-aee400f91b61/aptivus-us-pi-pdf.html](/content/content/dam/b3a3077a-bbbe-419d-8994-aee400f91b61/aptivus-us-pi-pdf.html) (16,270 words)
- [Mer potential: För samhällen och våra medarbetare | Boehringer Ingelheim SE](/content/se/om-oss/hallbar-utveckling/mer-potential/index.html): För samhällen och våra medmänniskor. Samhället fortsätter att stå inför utmaningar som sträcker sig från hälsa till utbildning, arbetsmöjligheter. (131 words)
- [Arbeta på Boehringer Ingelheim | Boehringer Ingelheim SE](/content/se/karriar/index.html): Kom med oss och bidra till vårt uppdrag att skapa värde genom innovation för de patienter vi betjänar. (472 words)
- [content/dam/60f7a616-66fd-4405-a275-af1e01211cc5/tradjenta-us-pi-pdf.html](/content/content/dam/60f7a616-66fd-4405-a275-af1e01211cc5/tradjenta-us-pi-pdf.html) (12,363 words)
- [Om Oss | Boehringer Ingelheim SE](/content/se/om-oss/index.html): Boehringer Ingelheim är en global företagsgrupp som omfattar många olika kulturer och samhällen. (175 words)
- [Samenwerken voor innovatie | Boehringer Ingelheim BE](/content/be/nl/samenwerking/index.html): Wij omarmen de kracht van partnerschap en diversiteit in denkwijzen binnen de gemeenschappen voor biowetenschap en diergezondheid (120 words)
- [content/dam/53ff8c4d-b71e-4879-9145-afac01099275/cyltezo-us-ifu-pdf.html](/content/content/dam/53ff8c4d-b71e-4879-9145-afac01099275/cyltezo-us-ifu-pdf.html) (1,316 words)
- [content/dam/2be58b14-52f6-41bf-9ba8-af1e01213295/trijardy-20xr-us-pi-pdf.html](/content/content/dam/2be58b14-52f6-41bf-9ba8-af1e01213295/trijardy-20xr-us-pi-pdf.html) (20,513 words)
- [Vilka vi är | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/index.html): Boehringer Ingelheim arbetar med banbrytande behandlingar som förändrar liv idag och för kommande generationer. (131 words)
- [Waar ons te vinden | Boehringer Ingelheim BE](/content/be/nl/over-ons/waar-ons-te-vinden/index.html): Met 52.000 werknemers over de hele wereld heeft Boehringer Ingelheim een wereldwijd onderzoeks- en productienetwerk. Dit zijn onze grootste locaties. (408 words)
- [More Green: För vår planet | Boehringer Ingelheim SE](/content/se/om-oss/hallbar-utveckling/mer-gront/index.html): Vår pelare MORE GREEN omfattar miljöinitiativ som tar hänsyn till många olika aspekter: vidta åtgärder för att undvika vatten. (111 words)
- [人才招募 | Boehringer Ingelheim TW](/content/tw/careers/index.html): 加入一個由超過 52,000 位充滿熱情又才華洋溢的人員所組成的全球團隊，一個致力於增進全球人類和動物健康的團隊。 (32 words)
- [Werken bij Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/carrieres/index.html): Kom bij ons werken en draag bij aan onze missie om waarde te creëren door innovatie voor de patiënten die we dienen. Boehringer Ingelheim (143 words)
- [Klinische onderzoeken | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-menselijke-gezondheid/klinische-onderzoeken/index.html): Klinische onderzoeken zijn een essentieel onderdeel van de ontwikkeling van nieuwe geneesmiddelen. Met deze proeven vertalen we onze wetenschappelijke. (112 words)
- [content/dam/497b8bfc-0fec-484a-bae7-af1e0120edba/synjardy-us-pi-pdf.html](/content/content/dam/497b8bfc-0fec-484a-bae7-af1e0120edba/synjardy-us-pi-pdf.html) (23,051 words)
- [content/dam/f8b1cb8b-5201-4311-b856-af1e011f4cbb/jentadueto-20xr-us-pi-pdf.html](/content/content/dam/f8b1cb8b-5201-4311-b856-af1e011f4cbb/jentadueto-20xr-us-pi-pdf.html) (15,436 words)
- [Patiëntveiligheid en farmacovigilantie bij Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/onze-verantwoordelijkheid/patientveiligheid/index.html): Wij, bij Boehringer Ingelheim Patiëntveiligheid en farmacovigilantie, zijn leiders op het gebied van patiëntveiligheid. (271 words)
- [Historia | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/historia/index.html): 1885 grundade Albert Boehringer (1861-1939) läkemedelsföretaget Boehringer Ingelheim i Nieder-Ingelheim. (41 words)
- [content/dam/cbea30f2-3eb4-498f-8be8-af1e012002df/pradaxa-pellets-us-pi-pdf.html](/content/content/dam/cbea30f2-3eb4-498f-8be8-af1e012002df/pradaxa-pellets-us-pi-pdf.html) (12,602 words)
- [lideres del manana | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/lideres-del-manana/index.html): Invertimos en nuestros empleados brindándoles capacitación en liderazgo que mejore sus habilidades y los prepare para futuros roles dentro de la organización. (467 words)
- [Switching market | Boehringer Ingelheim SE](/content/se/disclaimer/market/index.html) (108 words)
- [Het onderzoeksproces | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-diergezondheid/het-onderzoeksproces/index.html): We ontdekken of identificeren nieuwe verbindingen, vaccins, technologieën, ziekteprocessen en infectieuze agentia. Hiervoor maken we gebruik. (140 words)
- [Vaccins | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-diergezondheid/vaccins/index.html): In Global Innovation werken we aan veilige en effectieve vaccins voor gezelschapsdieren en vee. We brengen brede expertise samen op het gebied van (77 words)
- [Declaración de privacidad de datos | Boehringer Ingelheim MX](/content/mx/declaracion-de-privacidad-de-datos/index.html): Declaración de privacidad de datos (1,208 words)
- [Condiciones de Uso | Nota de Privacidad | Boehringer Ingelheim MX](/content/mx/condiciones-de-uso-nota-de-privacidad/index.html): Estas condiciones generales de uso, como nuestra nota de privacidad, se aplican a cada usuario de este sitio web proporcionado por Boehringer Ingelheim. (1,579 words)
- [Therapeutische middelen | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-diergezondheid/therapeutische-middelen/index.html): We bieden een gedisciplineerde wetenschappelijke benadering van de wereldwijde ontdekking, ontwikkeling en levering van therapieën voor gezelschapsdiere (55 words)
- [content/dam/66c510b8-be37-4b54-9277-aee4014a7ad8/jentadueto-us-pi-pdf.html](/content/content/dam/66c510b8-be37-4b54-9277-aee4014a7ad8/jentadueto-us-pi-pdf.html) (14,988 words)
- [Diergezondheid | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/index.html): De levens van mensen en dieren zijn op diepe en complexe manieren met elkaar verbonden. We weten dat als dieren gezond zijn. (393 words)
- [Wereldwijde innovatie ten aanzien van diergezondheid | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-diergezondheid/index.html): De leden van ons wereldwijde innovatieteam zijn voortrekkers in de wetenschap die dierenartsen, huisdiereigenaren, veehouders en functionarissen. (91 words)
- [Nuestras Ubicaciones | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestras-ubicaciones/index.html): Ofrecemos oportunidades de desarrollo profesional en más de 170 ubicaciones en todo el mundo. Explora ahora algunas de nuestras ubicaciones destacadas. (266 words)
- [Focus op wetenschap | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-menselijke-gezondheid/focus-op-wetenschap/index.html): Ons onderzoek naar nieuwe geneesmiddelen is gericht op die gebieden van de wetenschap waar een aanzienlijke medische behoefte bestaat en waar wij blijven (65 words)
- [WETENSCHAP EN INNOVATIE | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/index.html): Onze wetenschappers doen elke dag nieuwe ontdekkingen en zetten zich doorlopend in voor innovatie waaruit uitzonderlijke medicijnen zijn voortgekomen. (164 words)
- [content/dam/68a8a6b5-4e9a-4508-85d3-af1e01205009/spiriva-20respimat-us-pi-pdf.html](/content/content/dam/68a8a6b5-4e9a-4508-85d3-af1e01205009/spiriva-20respimat-us-pi-pdf.html) (13,178 words)
- [Diergezondheid: onze verantwoordelijkheid | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/onze-verantwoordelijkheid/index.html): We plannen in generaties. Dat blijkt wel uit onze meer dan 100 jaar succesvolle bedrijfsgeschiedenis. Het vormt tevens de kern van duurzaamheid. (157 words)
- [Dónde encontrarnos | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/index.html): Con 52.000 empleados en todo el mundo, Boehringer Ingelheim tiene una gran red global de investigación y producción. (592 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim MEA](/content/mea/about-us/quality/index.html): Quality at Boehringer Ingelheim (219 words)
- [content/dam/c5f823b8-796d-4bbf-9019-af1e0125dddc/mirapex-20er-us-pi-pdf.html](/content/content/dam/c5f823b8-796d-4bbf-9019-af1e0125dddc/mirapex-20er-us-pi-pdf.html) (10,725 words)
- [Innovatie ten aanzien van menselijke gezondheid | Boehringer Ingelheim BE](/content/be/nl/wetenschap-en-innovatie/innovaties-voor-menselijke-gezondheid/index.html): Boehringer Ingelheim is duidelijk over haar doelen. We willen een portefeuille met baanbrekende geneesmiddelen aanbieden die de levens van patiënten. (88 words)
- [Notas de prensa | Boehringer Ingelheim ES](/content/es/notas-de-prensa/index.html): Consulta todas las notas de prensa de Boehringer Ingelheim España de la categoría de negocio de Salud Animal. (151 words)
- [Varkens | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/vee/varkens/index.html): Boehringer Ingelheim is een partner en stimulator van duurzame productie van varkensvlees en dierlijke eiwitten, die het welzijn van dieren waarborgt. (156 words)
- [Socios de Negocios | Proveedores Globales | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/compras/index.html): Los proveedores son una parte integral de nuestro compromiso con el éxito, y buscamos socios de negocios con nuestros valores sociales y ambientales. (507 words)
- [Supplier Support | Boehringer Ingelheim IE](/content/ie/supplier-support/index.html): Supplier Support - guidance on SAP Ariba and other topics relating to purchasing. (701 words)
- [Pluimvee | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/vee/pluimvee/index.html): Door onze bestaande en nieuwe vaccins, diagnostiek, onderzoeksdiensten, technische expertise en compromisloze passie voor de zaken van onze klanten. (121 words)
- [Uitgelichte verhalen | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/uitgelichte-verhalen/index.html): Het welzijn van mens en dier - ons streven, onze inspiratie en ons doel: de levens van mensen en dieren zijn op diepe en complexe manieren. (286 words)
- [content/dam/b5d67da8-329b-4fa4-a732-af1e011fc0a5/ofev-us-pi-pdf.html](/content/content/dam/b5d67da8-329b-4fa4-a732-af1e011fc0a5/ofev-us-pi-pdf.html) (13,084 words)
- [Kwaliteit bij Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/over-ons/kwaliteit/index.html): Kwaliteit bij Boehringer Ingelheim (207 words)
- [Herkauwers | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/vee/herkauwers/index.html): In onze strategische business unit Herkauwers richten wij ons op parasiticiden, vaccins en therapeutica die worden aangeboden aan onze melk. (61 words)
- [Descubre nuestras Ofertas | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/descubre-nuestras-ofertas/index.html): Conoce las diversas carreras que ofrecemos, diseñadas para ayudarte a crecer profesionalmente, brindandote un trabajo desafiante que contribuye al éxito. (305 words)
- [Veterinaire volksgezondheid | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/veterinaire-volksgezondheid/index.html): Veterinaire volksgezondheid (85 words)
- [Shashank Deshpande | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors mit Verantwortung für den Geschäftsbereich Humanpharma (187 words)
- [Patient Centricity | Boehringer Ingelheim MEA](/content/mea/human-health/our-responsibility/patient-centricity/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (170 words)
- [Inkopen bij Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/over-ons/aankoop/index.html): Leveranciers zijn een integraal onderdeel van ons streven naar succes. We hebben een passie voor het zoeken naar innovatieve oplossingen. (169 words)
- [Patiëntgerichtheid | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/onze-verantwoordelijkheid/patientgerichtheid/index.html): Bij Boehringer Ingelheim staan patiënten op de eerste plaats bij alles wat we doen. Patiënten inspireren ons in onze missie om voorloper. (127 words)
- [Request to Be a New Supplier | Boehringer Ingelheim IE](/content/ie/request-be-new-supplier/index.html): Here you can find a form to fill out your company and contact details if you wish to be considered as a new supplier. Click here to learn more. (229 words)
- [Paarden | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/gezelschapsdieren/paarden/index.html): Als leider in paardengezondheid ontwikkelt Boehringer Ingelheim innovatieve oplossingen voor het welzijn van paarden over de hele wereld. (73 words)
- [Gezelschapsdieren | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/gezelschapsdieren/index.html): Bent u een dierenarts of heeft u een huisdier of een paard? Als een van de toonaangevende aanbieders wereldwijd, helpt Boehringer Ingelheim een langer. (34 words)
- [Huisdieren | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/gezelschapsdieren/huisdieren/index.html): Wij behoren tot de marktleiders in parasiticiden, vaccins en therapeutica en zijn een betrouwbare partner voor dierenartsen en huisdiereigenaren. (44 words)
- [Onze verantwoordelijkheid | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/onze-verantwoordelijkheid/index.html): Bij Boehringer Ingelheim staan patiënten op de eerste plaats bij alles wat we doen. Patiënten inspireren ons in onze missie om de wetenschap te leiden. (99 words)
- [Aves | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/aves-de-corral/index.html): Aves (422 words)
- [Liderazgo | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/liderazgo/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (590 words)
- [Switching market | Boehringer Ingelheim MEA](/content/mea/disclaimer/market/index.html) (69 words)
- [Diabetes | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/stofwisselingsziekten/diabetes/index.html): Ongeveer 425 miljoen volwassenen over de hele wereld leven met diabetes, waarbij diabetes type 2 goed is voor 90-95 procent van alle gevallen. De verwachting is dat dit aantal tegen het jaar 2045 zal stijgen naar 629 miljoen mensen. (151 words)
- [Andere kankersoorten | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/kanker/andere-kankersoorten/index.html): We zetten ons in voor de strijd tegen long- en maagkanker (onze focusgebieden), waarbij we ons laten leiden door de wetenschap en streven naar (83 words)
- [Declaración de accesibilidad | Boehringer Ingelheim MX](/content/mx/declaracion-de-accesibilidad/index.html): Declaración de accesibilidad (521 words)
- [Nuestra gente | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/nuestra-gente/index.html): Ambición. Pasión. Integridad. Compromiso. Empatía. Individualidad. Esperamos estas cualidades en todos los niveles de nuestra organización. (330 words)
- [Estrategia de Investigación | Desarrollo de Fármacos | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-humana/cultura-de-realizacion-de-alianzas/index.html): Nos asociamos en nuestra estrategia de investigación para poder desarrollar la siguiente generación de fármacos innovadores. (112 words)
- [Chronische nierinsufficiëntie | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/chronische-nierinsufficientie/index.html): Chronische Nierziekte (107 words)
- [Über uns | Boehringer Ingelheim AT](/content/at/de/ueber-uns/index.html): Über uns (288 words)
- [Samenwerkingsinteresses in diergezondheid | Boehringer Ingelheim NL](/content/nl/samenwerking/partnerschappen-diergezondheid/partnerbelangen-samenwerkingsinteresses/index.html): Ontdek de samenwerkingsinteresses van Boehringer Ingelheim op het gebied van diergezondheid, inclusief infectieziekten, niet-infectieziekten en andere focusgebieden. (824 words)
- [Ethiek en naleving | Boehringer Ingelheim BE](/content/be/nl/over-ons/ethiek-en-naleving/index.html): Ethics and Compliance | Boehringer Ingelheim (97 words)
- [Rumiantes | Parasiticidas | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/rumiantes/index.html): Nuestra unidad de negocios de rumiantes se centra en parasiticidas, vacunas y terapias para veterinarios y ganaderos productores de lácteos y carne. (253 words)
- [Obesitas | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/stofwisselingsziekten/obesitas/index.html): Obesitas is een complexe chronische ziekte die langdurige behandeling vereist. (79 words)
- [Buscar Ofertas y Aplicar | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/busqueda-solicitud-de-empleo/index.html): Ahora puedes buscar y solicitar empleos en Boehringer Ingelheim de una manera fácil y sencilla. ¡Tu próxima oportunidad a tan solo unas páginas de distancia! (190 words)
- [content/dam/9d0e3bae-9a17-4979-91bc-af1e011eeb8a/cyltezo-us-pi-pdf.html](/content/content/dam/9d0e3bae-9a17-4979-91bc-af1e011eeb8a/cyltezo-us-pi-pdf.html) (27,257 words)
- [Cuidado de Mascotas | Salud de las Mascotas | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/index.html): Estamos entre los líderes del mercado en parasiticidas, vacunas y terapias, y ofrecemos soluciones innovadoras para mejorar la salud de las mascotas. (304 words)
- [Explora nuestra empresa | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/explora-nuestra-empresa/index.html): Dá tu próximo paso profesional en Boehringer Ingelheim. Explora nuestras áreas para obtener más información sobre oportunidades laborales. (212 words)
- [Longkanker | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/kanker/longkanker/index.html): Voortbouwend op onze ervaring met longziekten is het ons doel longkanker aan te pakken, het behandelingslandschap te veranderen en uiteindelijk (28 words)
- [Stofwisselingsziekten | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/stofwisselingsziekten/index.html): Gecombineerde hart-nier-metabole aandoeningen, die het hart, de nieren en het metabolisme aantasten, zijn wereldwijd de belangrijkste doodsoorzaak en jaarlijks verantwoordelijk voor wel 20 miljoen sterfgevallen. (74 words)
- [Porcinos | Bienestar Animal | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/porcinos/index.html): Boehringer Ingelheim garantiza el bienestar animal mediante la prevención y el cuidado integral de la salud de los porcinos. (400 words)
- [Aviso legal | Boehringer Ingelheim MX](/content/mx/aviso-legal/index.html): Aviso legal (53 words)
- [Salud Animal | Enfermedades en Animales | Boehringer Ingelheim MX](/content/mx/salud-animal/index.html): Con una fuerte presencia en los segmentos de animales de compañía y ganado, cuidamos la salud animal y ayudamos a tratar las enfermedades en animales. (366 words)
- [Desarrollo Sostenible | Cuidado de la Salud | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/index.html): La compañía se esfuerza por ser mejor: desarrollar mejores terapias, generar mejores soluciones para el cuidado de la salud y contribuir a un mundo mejor. (244 words)
- [Conocimiento e Innovación | Tratamientos para Animales | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-animal/index.html): Descubra cómo estamos trabajando juntos con conocimiento e innovación para la predicción, la prevención y el tratamiento de enfermedades en animales. (136 words)
- [Productos Veterinarios | Salud Pública Veterinaria | Boehringer Ingelheim MX](/content/mx/salud-animal/salud-publica-veterinaria/index.html): Nuestro objetivo es aportar un cuidado de la salud animal avanzado y preventivo, y desarrollar soluciones eficaces para quienes crían y cuidan animales. (309 words)
- [Innovación en Salud | Innovación y Descubrimiento | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-humana/index.html): Queremos conectarnos e impulsar la innovación, y recorrer nuevos terrenos de descubrimiento, para poder poner primero a los pacientes. (150 words)
- [Información de Contacto | Enlaces Útiles | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-humana/contactos/index.html): Conéctese con nosotros. Puede encontrar toda nuestra información de contacto y algunos enlaces útiles aquí. (66 words)
- [Innovación Científica | Innovación en Salud | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/index.html): Gracias a nuestro compromiso de innovación creamos medicamentos excepcionales que nos ayudan a cambiar la vida de los pacientes. (173 words)
- [Investigación y Desarrollo | Enfermedades en Animales | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-animal/el-proceso-de-investigacion/index.html): Investigación y desarrollo: Boehringer Ingelheim lleva a cabo estudios exhaustivos para evaluar la efectividad y seguridad de nuestros productos. (150 words)
- [Animales de compañía | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/index.html): Animales de compañía (182 words)
- [Salud en Animales | Alianzas Globales | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-animal/intereses-de-la-asociacion/index.html): Realizamos alianzas globales en busca de nuevas ideas y nueva ciencia en la investigación para hallar la siguiente generación de avances en salud animal. (93 words)
- [Innovaciones Médicas | Cultura de Colaboración | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-humana/lo-que-dicen-nuestros-socios/index.html): Trabajamos en conjunto con nuestros socios con el compromiso de mantener una relación duradera para la siguiente generación de innovaciones médicas. (51 words)
- [Socios Estratégicos | Asociación Estratégica | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-humana/nuestro-enfoque-de-realizacion-de-alianzas/index.html): Compartimos una visión común con nuestros socios. Escuche lo que dicen nuestros socios sobre nuestra asociación estratégica. (61 words)
- [Vacunas Veterinarias | Vacunas para Animales | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-animal/vacunas/index.html): Conozca cómo Boehringer Ingelheim trabaja en el desarrollo de vacunas seguras y efectivas para animales de compañía y ganado. (85 words)
- [Calidad en Boehringer Ingelheim | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/calidad/index.html): Calidad en Boehringer Ingelheim (269 words)
- [Salud Animal: nuestra responsabilidad | Boehringer Ingelheim MX](/content/mx/salud-animal/nuestra-responsabilidad/index.html): Salud Animal: nuestra responsabilidad (172 words)
- [Estudios Clínicos | Ensayos Clínicos | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/estudios-clinicos/index.html): Cada año realizamos o patrocinamos cientos de ensayos clínicos con miles de pacientes para impulsar otro nuevo tratamiento y ayudar a los pacientes. (68 words)
- [Soluciones Innovadoras | Equipo Global | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/alianzas-en-materia-de-salud-animal/conoce-nuestros-aliados/index.html): Nuestro equipo global de alianzas está presente en todas las regiones del mundo buscando soluciones innovadoras para mejorar la salud de los animales. (62 words)
- [Bienestar de los Animales | Salud de los Animales | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-animal/index.html): Somos pioneros en la ciencia que ayuda a veterinarios, dueños de mascotas y ganado y funcionarios de salud pública a mejorar la salud de los animales. (83 words)
- [Historias de Ciencia | Fabricación de Medicamentos | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/historias-de-ciencia/index.html): La fabricación de nuevos y mejores medicamentos para pacientes ocupa el centro de nuestra labor. Descubra más aquí a través de las historias de ciencia. (98 words)
- [Medicamentos Innovadores | Ciencia Emergente | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/fomento-de-la-ciencia/index.html): Elaboramos medicamentos innovadores que cambian la vida de los pacientes al identificar los desafíos sanitarios futuros e impulsar la ciencia emergente. (75 words)
- [Medicamentos Veterinarios | Tratamientos Terapéuticos | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-animal/terapeutica/index.html): Brindamos un enfoque científico disciplinado al descubrimiento, desarrollo y suministro globales de tratamientos terapéuticos para mascotas y ganado. (65 words)
- [Industria Farmacéutica | Empresa Farmacéutica | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/index.html): Conozca más sobre esta empresa farmacéutica exitosa e impulsada por la investigación y su trabajo dentro de la industria farmacéutica. (226 words)
- [Enfermedades del Ganado | Productos para el Ganado | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/index.html): Boehringer Ingelheim es uno de los principales proveedores de soluciones de salud para predecir, prevenir y tratar enfermedades en el ganado. (84 words)
- [Desarrollos Científicos | Investigación de Enfermedades | Boehringer Ingelheim MX](/content/mx/ciencia-e-innovacion/innovacion-en-salud-humana/enfoque-cientifico/index.html): Boehringer Ingelheim continúa innovando y liderando la ciencia a través de investigación y desarrollos científicos en áreas de necesidad médica. (70 words)
- [Perspectieven | Boehringer Ingelheim NL](/content/nl/samenwerking/partnerschappen-diergezondheid/perspectieven/index.html): Krijg inzicht in de diergezondheidssector en lees de perspectieven van Boehringer Ingelheim‑experts over het belang van samenwerking bij het stimuleren van innovatie (415 words)
- [Salud Mental | Trastornos Mentales | Boehringer Ingelheim MX](/content/mx/salud-humana/salud-mental/index.html): Boehringer Ingelheim desarrolla terapias dirigidas que puedan aliviar la carga de estas condiciones, no sólo los síntomas, para que las personas prosperen. (197 words)
- [Global Careers Page | Boehringer Ingelheim MX](/content/mx/trabaja-con-nosotros/index.html): Únete a un equipo global de más de 52.000 apasionadas y talentosas personas dedicadas a mejorar la salud humana y animal en todo el mundo. (287 words)
- [Diversidad e Inclusión | Compromiso con el Desarrollo Sostenible | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-potential-para-las-comunidades-y-nuestra-gente.html): More Potential: para proporcionar las mejores condiciones para nuestra gente, nuestras comunidades y nuestros socios a lo largo de nuestra cadena de valor. (316 words)
- [Neem contact met ons op | Boehringer Ingelheim NL](/content/nl/samenwerking/partnerschappen-diergezondheid/neem-contact-met-ons-op/index.html): Neem online of tijdens evenementen contact op met het Business Development‑ en Licensing‑team van Boehringer Ingelheim Animal Health om een voorstel in te dienen of samenwerkingsmogelijkheden te bespreken (385 words)
- [Fibrosis Pulmonar | Fibrosis Pulmonar Idiopática, Progresiva y por Esclerodermia | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/index.html): La fibrosis pulmonar idiopática es una enfermedad que provoca la acumulación de tejido cicatrizal en los pulmones y puede poner en riesgo la vida. (276 words)
- [Mejorar la Salud | Investigación de Enfermedades | Boehringer Ingelheim MX](/content/mx/salud-humana/nuestra-responsabilidad/index.html): Estamos comprometidos con la investigación de enfermedades con necesidades insatisfechas y el aporte de nuevas terapias y soluciones para cuidar la salud. (102 words)
- [Bienestar Animal | Bienestar Humano | Boehringer Ingelheim MX](/content/mx/salud-animal/historias-destacadas/index.html): El bienestar animal y el bienestar humano son nuestro objetivo. Al aportar valor a través de la innovación mejoramos el bienestar de personas y animales. (54 words)
- [Cancer | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/index.html): Oncologie : Découvrez notre engagement chez Boehringer Ingelheim. Lutte contre le cancer avec des innovations prometteuses. (319 words)
- [Bienestar de las Personas | Bienestar de los Animales | Boehringer Ingelheim MX](/content/mx/alianza-para-innovar/index.html): Creemos en las alianzas para acelerar el desarrollo de la próxima generación de avances que mejorarán la salud y el bienestar de personas y animales. (166 words)
- [Compliance & Integrity | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/etica-y-compliance/index.html): Integridad y ética: Durante más de 130 años, Boehringer Ingelheim se ha conducido con altos estándares éticos, plasmados en su Código de Conducta. (194 words)
- [Enfermedades Oculares | Pérdida de la Visión | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-de-la-retina/index.html): Aspiramos a prevenir la pérdida de la visión en personas en riesgo y preservar o restaurar la visión en personas con enfermedades de la retina. (147 words)
- [Contact | Contact information | Boehringer Ingelheim MX](/content/mx/contactanos/index.html): Póngase en contacto con Boehringer Ingelheim. Puede enviar sus consultas o comentarios aquí. (444 words)
- [Mejorar la Salud | Innovación en Medicina | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/index.html): Nuestro compromiso con las comunidades y la sociedad es cambiar las vidas para mejor, tanto en humanos como en animales, ahora y en el futuro. (516 words)
- [COPD & Asthma | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/copd-asthma/index.html): Wissenwertes und hilfreiche Tipps rund um das Thema COPD und Asthma. Informieren Sie sich jetzt um Sie sich besser zu fühlen! (286 words)
- [Nutztiere | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/index.html): Wir bieten innovative Gesundheitslösungen, um Krankheiten und Leiden bei Nutztieren vorzubeugen oder diese zu lindern und damit das Tierwohl zu fördern. (274 words)
- [Depresión | Trastorno Depresivo | Boehringer Ingelheim MX](/content/mx/salud-humana/salud-mental/depresion/index.html): La depresión (también denominada trastorno depresivo) es un trastorno mental que causa una sensación permanente de tristeza y pérdida de interés. (68 words)
- [Atención Sanitaria | Atención al Paciente | Boehringer Ingelheim MX](/content/mx/salud-humana/nuestra-responsabilidad/centralizacion-en-el-paciente/index.html): En Boehringer Ingelheim damos prioridad a los pacientes en todo lo que hacemos. Ellos nos inspiran en nuestra misión de mejorar la atención sanitaria. (92 words)
- [Asma | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/esclerodermia/index.html): El asma bronquial es un trastorno inflamatorio crónico de las vías respiratorias. Los pacientes sufren sibilancias, disnea y tos, sobre todo por la noche y a primera hora de la mañana (99 words)
- [Cáncer | Oncología | Boehringer Ingelheim MX](/content/mx/salud-humana/cancer/index.html): Boehringer Ingelheim da una nueva esperanza a los pacientes al ayudar a la comunidad oncológica para ofrecer avances científicos y transformar sus vidas. (155 words)
- [Nowotwory | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nowotwory/index.html): Boehringer Ingelheim współpracuje ze środowiskiem onkologicznym, aby zrewolucjonizować leczenie nowotworów. Dowiedz się więcej. (37 words)
- [Obesidad | Sobrepeso | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-metabolicas/obesidad/index.html): La obesidad es una enfermedad crónica compleja que requiere gestión a largo plazo. Es un factor de riesgo para ciertas enfermedades cardiometabólicas. (93 words)
- [Fibrilación Auricular | Problemas Cardíacos | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-cardiometabolicas/fibrilacion-auricular/index.html): Los pacientes con un latido cardíaco irregular (conocido como fibrilación auricular) tienen mayor riesgo de sufrir un accidente cerebrovascular (ACV). (79 words)
- [Protección Ambiental | Iniciativas Ambientales | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/index.html): More Green: el enfoque es proteger los recursos naturales, incluida el agua limpia y nuestro camino hacia la neutralidad del carbón en las operaciones. (167 words)
- [Insuficiencia Cardíaca | Insuficiencia Cardíaca Crónica | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-cardiometabolicas/insuficiencia-cardiaca/index.html): Se trata de una enfermedad progresiva y potencialmente mortal. Es la incapacidad del corazón para bombear suficiente cantidad de sangre al cuerpo. (205 words)
- [Pacientes con Cáncer | Cuidado de Pacientes | Boehringer Ingelheim MX](/content/mx/salud-humana/cancer/capacitar-los-pacientes/index.html): En Boehringer Ingelheim damos apoyo a la concienciación, la educación, la mejora de los diagnósticos y el cuidado de pacientes con cáncer y sus familias. (89 words)
- [Infarto al miocardio | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-cardiometabolicas/accidente-cerebrovascular/index.html): Es una condición médica grave que ocurre cuando el flujo sanguíneo a una parte del corazón se bloquea repentinamente, generalmente por un coágulo en una arteria coronaria. (181 words)
- [Tiergesundheit | Boehringer Ingelheim DE](/content/de/tiergesundheit/index.html): Wir entwickeln innovative Produkte zur Prävention und Behandlung von Tierkrankheiten an. Erfahren Sie, warum uns die Tiergesundheit wichtig ist. (363 words)
- [Acceso a la Salud | Soluciones de Salud | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/index.html): More Health: una iniciativa de largo plazo para mejorar la salud de personas y animales en las comunidades de todo el mundo. (171 words)
- [Quiénes somos | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/index.html): Como biofarmacéutica líder impulsada por la investigación, aportamos valor a través de la innovación en áreas de alta necesidad médica insatisfecha. (187 words)
- [Diabetes | Diabetes Tipo 2 | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-metabolicas/diabetes/index.html): La diabetes tipo 2 es una enfermedad crónica y progresiva con complicaciones a largo plazo como accidente cerebrovascular, infarto y muerte cardiovascular. (116 words)
- [Hipertensión | Presión Arterial Alta | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-cardiometabolicas/hipertension/index.html): La hipertensión (presión arterial alta) afecta a alrededor de mil millones de personas en todo el mundo, con complicaciones como el infarto o el ACV. (114 words)
- [Cáncer de Pulmón | Cáncer Pulmonar | Boehringer Ingelheim MX](/content/mx/salud-humana/cancer/cancer-de-pulmon/index.html): El objetivo de Boehringer Ingelheim se centra en la lucha contra el cáncer de pulmón, para poder redefinir los cánceres de pulmón como cánceres tratables. (43 words)
- [Werken bij Boehringer Ingelheim | Boehringer Ingelheim NL](/content/nl/carriere/index.html): Als een onderzoeksgedreven farmaceutisch bedrijf streeft Boehringer Ingelheim ernaar om de gezondheid en het welzijn van mens en dier te verbeteren, (208 words)
- [Pferdegesundheit | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/index.html): Wir entwickeln innovative Lösungen für die Gesundheit von Pferden in den Bereichen Immunologie, Parasitologie, Magen- und Stoffwechselgesundheit. (277 words)
- [Partnerschaften in der Humanmedizin | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/index.html): Mit gebündelter Innovationskraft arbeiten wir in unseren Fokusgebieten und an der Entwicklung innovativer Therapien mit Durchbruchspotenzial. (211 words)
- [Dr. Paola Casarosa | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/dr-paola-casarosa/index.html): Dr Paola Casarosa – Mitglied der Unternehmensleitung mit Verantwortung für den Unternehmensbereich Innovation (166 words)
- [Humanmedizin | Boehringer Ingelheim DE](/content/de/humanmedizin/index.html): Boehringer Ingelheim ist ein fortschrittliches international tätiges Unternehmen, das sich der Erforschung und Entwicklung innovativer Arzneimittel widmet. (247 words)
- [Historia | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/historia/index.html): Conozca la historia de esta empresa global con tres áreas de negocios: salud humana, salud animal y fabricación por contrato de biofarmacéuticos. (148 words)
- [Kanker | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/kanker/index.html): Kanker neemt weg. Neemt tijd. Neemt dierbaren. Bij Boehringer Ingelheim geven we patiënten nieuwe hoop door de strijd tegen kanker aan te gaan (115 words)
- [Cancer | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/cancer/index.html): Le cancer est un voleur. Un voleur de temps. Un voleur d'êtres chers. Chez Boehringer Ingelheim, nous redonnons espoir aux patients en défiant le cancer. (106 words)
- [Krebserkrankungen & Behandlung | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/index.html): Boehringer Ingelheim ist weltweit führend in der Behandlung von Krebserkrankungen. Mit innovativen Behandlungsmöglichkeiten setzen wir neue Standards. (229 words)
- [Tierarzneimittel | Wiederkäuer | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/wiederkaeuer/index.html): Wir konzentrieren uns auf Impfstoffe, Therapeutika und Antiparasitika für Milchkühe, Fleischrinder und kleine Wiederkäuer. Erfahren Sie mehr. (241 words)
- [Partnerverhalen | Boehringer Ingelheim NL](/content/nl/samenwerking/partnerschappen-diergezondheid/verhalen-over-partnerschappen/index.html): Lees meer over enkele van de meest betekenisvolle samenwerkingen van Boehringer Ingelheim in diergezondheid en zie wat onze partners zeggen over hun ervaringen met ons (284 words)
- [Lungenkrebs Informationen | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/index.html): Boehringer Ingelheim forscht an neuen Medikamenten für die Behandlung von Lungenkrebs. Jetzt informieren und aktuelle Studienergebnisse erfahren. (198 words)
- [Wissenschaftsförderung | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/index.html): Als unabhängiges Familienunternehmen haben wir die Freiheit, unsere langfristige Vision zu verfolgen und nach einzigartigen Ansätzen zu suchen. (135 words)
- [Partnerfirmen | Boehringer Ingelheim DE](/content/de/partnerschaften/index.html): Durch Diversität und Austausch werden in der Wissenschaft Innovationen geboren. Partnerfirmen sind ein wichtiger Bestand unserer Innovationsstrategie. (177 words)
- [Unsere Storys | Boehringer Ingelheim DE](/content/de/tiergesundheit/unsere-stories/index.html): Das Wohl von Mensch und Tier ist unser Purpose, unsere Inspiration und unser Ziel. Erfahren Sie mehr über unser Glaubensbekenntnis. (206 words)
- [Idiopatische Lungenfibrose | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/index.html): Lungenfibrose ist eine Erkrankung, die das Leben stark beeinträchtigen kann. Hier finden Sie wertvolle Informationen über diese Lungenkrankheit. (180 words)
- [Tiererzneimittel | Schweine | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/schweine/index.html): Als führender Partner in der nachhaltigen Produktion von Schweine- und Tierproteinen, unser Ziel ist, das Wohlergehen der Tiere zu gewährleisten. (239 words)
- [Schizophrenie | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/index.html): Was ist Schizophrenie? Hier finden Sie ausführliche Informationen über die Krankheit, ihre Symptombereiche und Behandlungsmöglichkeiten. (218 words)
- [Parasitizide | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-tiergesundheit/parasitizide/index.html): Erfahren Sie mehr über die Entdeckung und Entwicklung neuer Parasitizide für Haus- und Nutztiere bei Boehringer Ingelheim. (50 words)
- [Netzhauterkrankungen | Boehringer Ingelheim DE](/content/de/humanmedizin/netzhauterkrankungen/index.html): Erfahren Sie mehr über unsere Forschungs- und Entwicklungsaktivitäten zur Behandlung von Netzhauterkrankungen. (136 words)
- [Sklerodermie | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/sklerodermie/index.html): Sklerodermie ist eine chronische Erkrankung, bei der sich die Haut und andere Organe verhärten. Wie kann man damit am besten umgehen? Tipps und Infos hier. (134 words)
- [Warum wir an Partnerschaften glauben | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/warum-wir-partnerschaften-glauben/index.html): Aus der Überzeugung heraus, dass durch Diversität und Austausch innerhalb der Life Science Community Innovationen geboren werden, arbeiten wir gemeinsam mit Partnern an neuen Lösungsansätzen entlang der gesamten Wertschöpfungskette. Wir ergänzen unsere E (107 words)
- [Site-informatie | Boehringer Ingelheim NL](/content/nl/site-informatie/index.html): Imprint (184 words)
- [Geschichten aus der Wissenschaft | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/index.html): Auf dieser Seite können Sie Interviews mit unseren Forschern über unsere interessantesten Innovationen und Erfolge lesen. (152 words)
- [Chronische Nierenkrankheit | Boehringer Ingelheim DE](/content/de/humanmedizin/chronische-nierenkrankheit/index.html): Chronic Kidney Disease (213 words)
- [Angels & FAST Heroes: Schlaganfall-Symptome erkennen | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/schlaganfall-erkennen/index.html): Was tun bei einem Schlaganfall? FAST Heroes klärt Kinder über Symptome auf. Die Angels Initiative verbessert die Schlaganfallversorgung weltweit. (1,282 words)
- [Psychische Erkrankungen | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/index.html): Wir setzen uns für die Erforschung von innovative Therapiemöglichkeiten für psychische Erkrankungen ein. Erfahren Sie mehr über unsere Ergebnisse! (190 words)
- [Innovation | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/index.html): Seit über 130 Jahren entwickeln wir zukunftsweisende Therapien, durch die wir die Gesundheit von Menschen und Tieren verbessern. Erfahren Sie mehr. (158 words)
- [Tierarzneimittel | Geflügel | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/gefluegel/index.html): Hier finden Sie hilfreiche Informationen zu den Themen Gesundheit und Krankheiten von Geflügel und Hühnern. (166 words)
- [Bronchiektase | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/bronchiektase/index.html): Bronchiektase (145 words)
- [Kontakt zu uns | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/kontakt-zu-uns/index.html): Informationen über unsere Partnerschaftsaktivitäten im Bereich der menschlichen Gesundheit. Kontaktieren Sie uns. (75 words)
- [Adipositas Informationen | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/adipositas/index.html): Informationen zu Adipositas: Warum ist es wichtig, starkes Übergewicht zu behandeln? Wie können Sie Ihr Gewicht reduzieren? Informieren Sie sich hier! (203 words)
- [Partners voor innovatie | Boehringer Ingelheim NL](/content/nl/samenwerking/index.html): At Boehringer Ingelheim diversity of minds & collaboration is paramount to developing new medical breakthroughs.Click here see how you can partner with us. (138 words)
- [Fokusgebiete | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/index.html): Unser Fokus liegt auf den Bereichen Herz- und Stoffwechsel, ZNS, Immunologie und Atemwege, Onkologie und Immunonkologie sowie Netzhauterkrankungen. (113 words)
- [Boehringer Ingelheim – Annual Report Magazine 2025 | Boehringer Ingelheim](/content/annualreport/2025/index.html): Annual Report by Boehringer Ingelheim 2025, exploring how finding connections drives progress. (559 words)
- [Vaccins | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-diergezondheid/vaccins/index.html): In Global Innovation werken we aan veilige en effectieve vaccins voor gezelschapsdieren en vee. Wij brengen brede expertise in vaccinologie, moleculaire, (76 words)
- [Depression | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/depression/index.html): Depressionen sind weit verbreitet und können jeden treffen. Doch es gibt Hoffnung! Boehringer Ingelheim setzt sich für die Forschung zur Depression ein. (154 words)
- [Der Forschungsprozess | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-tiergesundheit/der-forschungsprozess/index.html): Informationen über unsere Forschungsprozesse, Forschungs- und Entwicklungsstandorten sowie unsere Kooperationen mit externen Partnern. (114 words)
- [Tierimpfstoffe | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-tiergesundheit/impfstoffe/index.html): Erfahren Sie mehr über unsere Aktivitaten zur Entwicklung wirksamer und sicherer Impfstoffe für Haus- und Nutztiere. (78 words)
- [Innovationen in der Tiergesundheit | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-tiergesundheit/index.html): Erfahren Sie mehr über wie wir Tierärzte, Tierhalter und Gesundheitsbehörden dabei unterstützen, die Gesundheit von Tieren zu verbessern. (63 words)
- [Medizinische Forschung | Boehringer Ingelheim DE](/content/de/humanmedizin/unsere-verantwortung/index.html): Durch die Erforschung von Krankheiten wollen wir den Betroffenen eine positive Perspektive bieten. Erfahren Sie mehr über unsere medizinische Forschung! (73 words)
- [Grass Roots | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/index.html): Boehringer Ingelheim fördert aufstrebende Life-Science-Unternehmen und Entrepreneurs. Erfahren Sie mehr über das globale Grass Roots-Programm. (55 words)
- [Het onderzoeksproces | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-diergezondheid/het-onderzoeksproces/index.html): We ontdekken of identificeren nieuwe verbindingen, vaccins, technologieën, ziekteprocessen en infectieuze agentia. Om dit te doen, mixen we geavanceerde (135 words)
- [Therapeutika | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-tiergesundheit/therapeutika/index.html): Informieren Sie sich über Forschung, Entwicklung und Vermarktung von therapeutischen Produkten für Pferde, Haus- und Nutztiere. (58 words)
- [Patient_innen im Mittelpunkt | Boehringer Ingelheim DE](/content/de/humanmedizin/unsere-verantwortung/patientinnen-im-mittelpunkt/index.html): Patient_innen im Mittelpunkt (74 words)
- [MASH: Metabolische Dysfunktion-assoziierte Steatohepatitis | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/mash/index.html): Alles über MASH: Ursachen, Symptome und Behandlungsmöglichkeiten der nichtalkoholischen Fettlebererkrankung. Erfahren Sie mehr! (163 words)
- [Diabetes Informationen | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/diabetes/index.html): Typ-2-Diabetes ist eine der häufigsten chronischen Krankheiten weltweit. Lesen Sie hier mehr über die Behandlungsmöglichkeiten mit oralen Antidiabetika. (217 words)
- [Ischämischer Schlaganfall | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/schlaganfall/index.html): Boehringer Ingelheim ist ein Vorreiter in der ischämischen Schlaganfallbehandlung durch ihre innovative Thrombolyse-Therapie. Erfahren Sie mehr! (211 words)
- [Wo Sie uns finden | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/index.html): Boehringer Ingelheim verfügt über globale Forschungs- und Produktionsnetzwerke, mit Standorten in Europa, Amerika und Asien/Ozeanien. Erfahren Sie mehr! (394 words)
- [Wie man die Patientenerfahrung im Gesundheitswesen verbessern kann | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/verbesserung-patientenerfahrung/index.html): Für Boehringer Ingelheim ist die Frage, wie wir die Patientenerfahrung verbessern können, ausschlaggebend für unsere Entscheidungen. Sie beeinflusst die Gestaltung von Behandlungen und die Art und Weise, wie Menschen das Gesundheitswesen erleben. (1,335 words)
- [Press Releases | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/media/press-releases/index.html): Press Releases (325 words)
- [Products | Boehringer Ingelheim](/content/products/index.html): See our extensive range of human pharmaceutical and animal health products, see how our medicals products are improving patient lives human or animal. (143 words)
- [Boehringer Ingelheim - Life forward | Boehringer Ingelheim TW](/content/tw/index.html): 更多了解百靈佳殷格翰，以及為什麼它是擁有130年經驗的全球領先的以研究為驅動的制藥公司之一。 (67 words)
- [EHS & Ethik & Compliance | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/index.html): Bei Boehringer Ingelheim halten wir uns stets an das Gesetz und unsere ethischen Grundsätze. Informieren Sie sich über unsere Ethik und Compliance. (297 words)
- [Unternehmenskultur | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/index.html): Werte schaffen durch Innovation ist die Unternehmensvision und damit auch das zentrale Konzept von Boehringer Ingelheim. Erfahren Sie mehr! (239 words)
- [Speak Up | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/speak/index.html): Das „Speak Up“-Portal ermöglicht weltweit die sichere Meldung möglicher Verstöße. Jede Meldung wird ernst genommen. (275 words)
- [Therapeutica | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-diergezondheid/therapeutica/index.html): Wij bieden een gedisciplineerde wetenschappelijke aanpak voor de wereldwijde ontdekking, ontwikkeling en levering van geneesmiddelen voor gezelschapsdieren (61 words)
- [Verhalen | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/index.html): See Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (539 words)
- [Qualität bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/qualitaet/index.html): Verantwortung trifft Innovation: Erfahren Sie, wie Boehringer Ingelheim Qualität entlang des gesamten Produktzyklus sicherstellt. (247 words)
- [Datenschutz | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutz/index.html): Data Privacy (114 words)
- [Vorhofflimmern | Herzrythmusstörungen | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/vorhofflimmern/index.html): Leben mit Vorhofflimmern muss nicht eingeschränkt sein. Wir setzen uns für die Reduktion des Risikos für einen Schlaganfall. Lesen Sie mehr! (87 words)
- [Onze wetenschappelijke focus | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/wetenschappelijke-focus/index.html): Ons onderzoek naar nieuwe geneesmiddelen is gericht op die gebieden van de wetenschap waar een aanzienlijke medische behoefte bestaat en waar wij blijven (64 words)
- [Chronic Kidney Disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chronic-kidney-disease/index.html): Chronic kidney disease can have serious consequences the heart as well as the kidneys. (331 words)
- [Unternehmensleitung | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmensleitung/index.html): Die Mitglieder der Unternehmensleitung stellen sich mit ihren Aufgabenbereichen vor. Lernen Sie unser Familienunternehmen besser kennen. (191 words)
- [Diergezondheid: onze verantwoordelijkheid | Boehringer Ingelheim NL](/content/nl/voor-dier/onze-verantwoordelijkheid/index.html): Wij plannen in generaties. Dit wordt weerspiegeld in onze succesvolle bedrijfsgeschiedenis van meer dan 100 jaar. Het vormt ook de kern voor duurzaamheid. (246 words)
- [More Potential: Communitys & Mitarbeitende | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/index.html): Erfahren Sie mehr darüber, wie Boehringer Ingelheim tagtäglich für die Gesundheit von Communities und Mitarbeitende arbeiten. (366 words)
- [WETENSCHAP EN INNOVATIE | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/index.html): WETENSCHAP EN INNOVATIE Wetenschap en innovatie Onze wetenschappers brengen elke dag nieuwe gebieden in kaart en zetten ons streven naar innovatie voort (165 words)
- [Geschäftspartner | Boehringer Ingelheim DE](/content/de/ueber-uns/einkauf/index.html): Auf dieser Seite finden Partnerfirmen und Lieferanten alle relevanten Informationen für die Zusammenarbeit mit Boehringer Ingelheim. (228 words)
- [Diergezondheid | Boehringer Ingelheim NL](/content/nl/voor-dier/index.html): Het leven van dieren en mensen is op diepe en complexe wijzen met elkaar verbonden. Wij weten dat wanneer dieren gezond zijn, mensen ook gezonder zijn. (341 words)
- [Patiëntveiligheid en farmacovigilantie bij Boehringer Ingelheim | Boehringer Ingelheim NL](/content/nl/voor-mens/onze-verantwoordelijkheid/patientveiligheid/index.html): Wij, bij Boehringer Ingelheim Patiëntveiligheid en farmacovigilantie, zijn leiders op het gebied van patiëntveiligheid. (294 words)
- [Varkens | Boehringer Ingelheim NL](/content/nl/voor-dier/vee/varkens/index.html): Boehringer Ingelheim is partner en stimulator van een duurzame productie van varkensvlees en dierlijke eiwitten en zorgt voor dierenwelzijn door preventie (193 words)
- [Wetenschappelijke verhalen | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/wetenschapsverhalen/index.html): Het maken van nieuwe en betere geneesmiddelen voor patiënten is de kern van wat wij doen. Zij inspireren ons in onze missie om baanbrekende therapieën te (94 words)
- [Wereldwijde innovatie voor diergezondheid | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-diergezondheid/index.html): Ons Global Innovation-team verricht baanbrekend werk op het gebied van de wetenschap. Dit helpt dierenartsen, eigenaren van huisdieren en vee en (85 words)
- [Additioneel Risicominimalisatie-materiaal | Boehringer Ingelheim NL](/content/nl/voor-mens/additioneel-risicominimalisatie-materiaal/index.html): Additioneel Risicominimalisatie-materiaal (142 words)
- [Bluthochdruck | Hypertonie | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/bluthochdruck/index.html): Bluthochdruck ist eine ernste Erkrankung, die unbehandelt zu schweren Folgeerkrankungen führen kann. Informieren Sie sich rund ums Thema Hypertonie. (82 words)
- [Gras Wortel Innovatie | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/fundamentele-innovatie/index.html): Ons unieke, wereldwijde programma "Grass Roots" is ontworpen om opkomende wetenschap en technologie mogelijk te maken door jonge biowetenschappelijke (88 words)
- [Cardiovascular Health | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/index.html): Cardiovascular diseases, including heart failure and stroke, are part of a group of connected conditions known as cardiovascular, renal and metabolic diseases (293 words)
- [Aan de slag vóór de beste nierzorg | Boehringer Ingelheim NL](/content/nl/voor-mens/chronische-nierziekte/aan-de-slag-voor-de-beste-nierzorg/index.html): “Stel dat er een politieke partij was voor uw nieren” (537 words)
- [Nachhaltige Entwicklung | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/index.html): Informieren Sie sich über das Engagement und Initiativen von Boehringer Ingelheim im Bereich von nachhaltige Entwicklung. (201 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim BE](/content/be/fr/index.html): Des collègues racontent leur histoire personnelle et ce qui les pousse à contribuer à un meilleur avenir pour les générations futures. (219 words)
- [Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim ZA](/content/za/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (238 words)
- [Kwaliteit bij Boehringer Ingelheim | Boehringer Ingelheim NL](/content/nl/over-ons/kwaliteit/index.html): Kwaliteit bij Boehringer Ingelheim (249 words)
- [Klinische studies | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/klinische-onderzoeken/index.html): Klinische proeven vormen een essentieel onderdeel van de ontwikkeling van nieuwe geneesmiddelen. Ze vertalen onze wetenschappelijke expertise in baanbre (88 words)
- [Hypertension | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/hypertension/index.html): Hypertension (high blood pressure) can lead to further complications like heart attack or stroke. (289 words)
- [More Green: Für unseren Planeten | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/index.html): Erfahren Sie mehr darüber, wie Boehringer Ingelheim tagtäglich für den Schutz unseres Planeten, seiner Ressourcen und Lebewesen arbeiten. (237 words)
- [Geschichte | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/geschichte/index.html): Albert Boehringer gründete Boehringer Ingelheim 1885. Lesen Sie hier, wie sich das Unternehmen seitdem entwickelt hat. (161 words)
- [Boehringer Ingelheim Österreich - Werte schaffen durch Innovation | Boehringer Ingelheim AT](/content/at/de/index.html): Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen mit über 130 Jahren Erfahrung. (243 words)
- [About us | Boehringer Ingelheim](/content/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (288 words)
- [Pressebereich | Boehringer Ingelheim AT](/content/at/de/presse/index.html): Pressebereich (288 words)
- [Pluimvee | Boehringer Ingelheim NL](/content/nl/voor-dier/vee/pluimvee/index.html): Met onze nieuwe vaccins, diagnoses, wetenschappelijk onderzoek, technische expertise en onverzettelijke passie voor de business van onze klanten, (150 words)
- [Huisdieren | Boehringer Ingelheim NL](/content/nl/voor-dier/gezelschapsdieren/huisdieren/index.html): Als wereldwijd leider in de diergezondheidssector werken wij aan toonaangevende innovaties om dierziekten te voorspellen, voorkomen en behandelen. (61 words)
- [Combivent® Respimat® | Boehringer Ingelheim](/content/human-health/products/combivent-respimat/index.html): Discover Combivent Respimat a anticholinergic & beta-adrenergic for patients requiring more than one bronchodilator, to manage reversible bronchospasms. (57 words)
- [Стойност чрез иновации | Boehringer Ingelheim BG](/content/bg/index.html): Boehringer Ingelheim е водеща фармацевтична компания със 130-годишен опит в областта на научните изследвания. (295 words)
- [Vee | Boehringer Ingelheim NL](/content/nl/voor-dier/vee/index.html): Boehringer Ingelheim is dé toonaangevende leverancier van gezondheidszorgoplossingen om ziekten bij vee te voorspellen, te voorkomen en te behandelen. (108 words)
- [Herkauwers | Boehringer Ingelheim NL](/content/nl/voor-dier/vee/herkauwers/index.html): Binnen ons team voor herkauwers concentreren wij ons op anti-parasitica, vaccins en therapeutica die aan onze melkvee- en rundveedierenartsenBinnen ons (107 words)
- [Интересы в области партнерства подразделения ветеринарных препаратов | Boehringer Ingelheim RU](/content/ru/partnering/animal-health-partnering/partnering-interests/index.html): Узнайте об интересах компании «Берингер Ингельхайм» в отношении партнерства в области ветеринарии, включая инфекционные и неинфекционные заболевания, а также ключевые направления, не связанные с заболеваниями. (803 words)
- [Innovaties voor menselijke gezondheid | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/index.html): Boehringer Ingelheim heeft duidelijke doelen. We willen een portefeuille van baanbrekende geneesmiddelen afleveren die het leven van patiënten verbeteren. (68 words)
- [Wie wij zijn | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/index.html): Boehringer Ingelheim werkt aan baanbrekende therapieën die levens veranderen, vandaag en voor de komende generaties. Als toonaangevend, onderzoeksgedreven, (342 words)
- [Geestelijke stoornissen | Boehringer Ingelheim NL](/content/nl/voor-mens/mentale-gezondheid/index.html): Bij Boehringer Ingelheim definiëren wij geestelijke gezondheid opnieuw zodat mensen weer kunnen groeien en bloeien. Wij koppelen gedrag aan onderliggende (201 words)
- [Animal Health Partnering Interests | Boehringer Ingelheim ZA](/content/za/partnering/animal-health-partnering/partnering-interests/index.html): Explore Boehringer Ingelheim’s partnering interests in animal health, including infectious diseases, non-infectious diseases, and non-disease areas of focus. (646 words)
- [COPD & Astma | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/copd-astma/index.html): Chronic Obstructive Pulmonary Disease (COPD) is een progressieve, behandelbare ziekte die wordt gekenmerkt door een beperkte luchtstroom in en uit de long (259 words)
- [Часто задаваемые вопросы | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/how-apply/faq/index.html): Часто задаваемые вопросы | Карьера в «Берингер Ингельхайм» (1,560 words)
- [Paarden | Boehringer Ingelheim NL](/content/nl/voor-dier/gezelschapsdieren/paarden/index.html): Als marktleider binnen de paardengezondheid ontwikkelt Boehringer Ingelheim innovatieve oplossingen voor het welzijn van paarden overal ter wereld. (72 words)
- [Survol des médias | Boehringer Ingelheim CA](/content/ca/fr/media/index.html): Découvrez le monde des médias avec Boehringer Ingelheim. Un aperçu complet qui vous plonge dans l’univers captivant de la santé. (482 words)
- [Waar u ons kunt vinden | Boehringer Ingelheim NL](/content/nl/over-ons/waar-u-ons-kunt-vinden/index.html): Met 52.000 werknemers wereldwijd beschikt Boehringer Ingelheim over een onderzoeks- en productienetwerk dat de gehele wereld omvat. Dit zijn onze grootste vestigingen. (401 words)
- [Atrovent® | Boehringer Ingelheim](/content/human-health/products/atrovent/index.html): Prevents & treats shortness of breath in patients with COPD, bronchial asthma or a supplement to beta-agonists in cases of acute asthma, learn more here. (61 words)
- [Retinale aandoeningen | Boehringer Ingelheim NL](/content/nl/voor-mens/retinale-aandoeningen/index.html): At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. (126 words)
- [Patiëntgerichtheid | Boehringer Ingelheim NL](/content/nl/voor-mens/onze-verantwoordelijkheid/patientgerichtheid/index.html): Bij Boehringer Ingelheim komt de patiënt bij alles wat we doen op de eerste plaats. Patiënten inspireren ons in onze missie om de wetenschap te leiden die (128 words)
- [Depressie | Boehringer Ingelheim NL](/content/nl/voor-mens/mentale-gezondheid/depressie/index.html): Depressie is een psychische stoornis die een aanhoudend gevoel van verdriet en verlies van belangstelling veroorzaakt. Ook wel major depressive disorder genoemd, beïnvloedt het hoe je je voelt, (106 words)
- [Diabetes | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/diabetes/index.html): In Nederland hebben ruim 1,2 miljoen mensen diabetes type 2. De verwachting is dat er in 2040 1,5 miljoen mensen diabetes hebben. Diabetes type 2 is een (123 words)
- [Specialist, Payroll - US Job Details | BoehringerPRD](/content/jobs/job-invite/35738/index.html): Muntinlupa Specialist, Payroll - US - Phil (579 words)
- [Onze verantwoordelijkheid | Boehringer Ingelheim NL](/content/nl/voor-mens/onze-verantwoordelijkheid/index.html): Bij alles wat wij doen bij Boehringer Ingelheim, staan patiënten op de eerste plaats. Patiënten inspireren ons in onze missie om voorloper te zijn bij (95 words)
- [Presse | Boehringer Ingelheim FR](/content/fr/presse/index.html): Media (325 words)
- [Inkoop bij Boehringer Ingelheim | Boehringer Ingelheim NL](/content/nl/over-ons/inkoop/index.html): Leveranciers spelen een cruciale rol in van ons streven naar succes. Wij zoeken gepassioneerd naar innovatieve oplossingen en nieuwe mogelijkheden voor (377 words)
- [Schizofrenie | Boehringer Ingelheim NL](/content/nl/voor-mens/mentale-gezondheid/schizofrenie/index.html): Schizofrenie wordt gekenmerkt door drie symptoomgebieden en treft ~1% van de wereldbevolking. Ten eerste en vooral bekend zijn de positieve symptomen zoals (95 words)
- [Obesity | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/obesity/index.html): Obesity isn’t just about weight. It's a complex disease linked to how the body manages energy and metabolism. (474 words)
- [Human Health Products | Boehringer Ingelheim HK](/content/hk/en/human-health/products/index.html): Products Overview of our products. (8 words)
- [Luchtwegen | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/index.html): Luchtwegaandoeningen : Ons doel is om patiënten met invaliderende luchtwegaandoeningen een zelfstandiger bestaan met een betere kwaliteit van leven te geven. (107 words)
- [Obesitas | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/obesitas/index.html): Obesitas is een complexe chronische ziekte die een langetermijnbeheer vereist. Het is een van de belangrijkste risicofactoren voor verschillende cardio (72 words)
- [Glyxambi® | Boehringer Ingelheim](/content/human-health/products/glyxambi/index.html): Glyxambi helps improve glycaemic control in adults treating type 2 diabetes mellitus, when treatment with both empagliflozin and linagliptin is appropriate (US). (42 words)
- [Chronische nierziekte | Boehringer Ingelheim NL](/content/nl/voor-mens/chronische-nierziekte/index.html): Chronic Kidney Disease (146 words)
- [Áreas de actuación | Boehringer Ingelheim ES](/content/es/areas-de-actuacion/index.html): En Boehringer Ingelheim Salud Animal nos preocupamos por los animales. (116 words)
- [Heidelberg Transforming Science Day 2025 | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/heidelberg-transforming-science-day-2025/index.html): The Heidelberg Transforming Science Day profiles what makes our innovation different including our ground-breaking research and our diverse pipeline. (504 words)
- [Catapresan® | Boehringer Ingelheim](/content/human-health/products/catapresan/index.html): Catapresan / Catapres is a tablet indicated for treatment of hypertension, with the active ingredient clonidine hydrochloride. Learn more about Catapres here. (26 words)
- [Berodual® | Boehringer Ingelheim](/content/human-health/products/berodual/index.html): Berodual is indicated to prevent and treat symptoms of chronic obstructive airway disorders such as bronchial asthma and chronic bronchitis. (50 words)
- [Longkanker | Boehringer Ingelheim NL](/content/nl/voor-mens/kanker/longkanker/index.html): Kanker vernietigt. Verkort levens. Berooft ons van dierbaren. Bij Boehringer bieden wij patiënten nieuwe hoop door de strijd met kanker aan te gaan. (59 words)
- [Stofwisseling | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/index.html): In Nederland hebben ruim 1 miljoen mensen diabetes type 2. De verwachting is dat er in 2040 1,5 miljoen mensen diabetes hebben1. Diabetes type 2 is een chronische, (117 words)
- [Recruiter with Spanish Job Details | BoehringerPRD](/content/jobs/job-invite/36314/index.html): Wrocław Recruiter with Spanish - Pola (521 words)
- [de/unternehmensbericht/2024/files/downloads-and-archive/highlights-2024/boe_highlights_2024_de-pdf.html](/content/de/unternehmensbericht/2024/files/downloads-and-archive/highlights-2024/boe_highlights_2024_de-pdf.html) (15,140 words)
- [Истории партнерств | Boehringer Ingelheim RU](/content/ru/partnering/animal-health-partnering/partnership-stories/index.html): Узнайте о наиболее значимых коллаборациях «Берингер Ингельхайм» в сфере ветеринарии и о том, что говорят наши партнеры о своем опыте работы с нами. (232 words)
- [Aggrenox® | Boehringer Ingelheim](/content/human-health/products/aggrenox/index.html): Aggrenox is indicated for the prevention of stroke following an initial first stroke, or transient ischaemic attacks (TIA), learn more about this product here. (44 words)
- [Media Overview | Boehringer Ingelheim HK](/content/hk/en/media-overview/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (194 words)
- [Voor alle soorten kanker | Boehringer Ingelheim NL](/content/nl/voor-mens/kanker/andere-kankersoorten/index.html): Wij zetten ons in voor onze aandachtsgebieden long- en maagdarmkanker, maar laten ons leiden door de wetenschap en zoeken naar mogelijkheden in andere (79 words)
- [Вакансии в Австрии | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/austria/index.html): Наш первый международный офис был открыт именно в Австрии. Узнайте про карьерные возможности в Австрии или в 170 наших подразделениях по всему миру. (166 words)
- [Alesion® | Boehringer Ingelheim](/content/human-health/products/alesion/index.html): Prophylactic treatment of patients with bronchial asthma. Prophylaxis and symptomatic treatment of allergic rhinitis. (36 words)
- [Comunicados de Prensa | Press Releases | Boehringer Ingelheim MX](/content/mx/prensa-0/index.html): Encuentre en esta sección los últimos comunicados de prensa (press releases) y materiales relacionados para descarga. (286 words)
- [Over ons | Boehringer Ingelheim NL](/content/nl/over-ons/index.html): Boehringer Ingelheim is een wereldwijde groep bedrijven die vele culturen en diverse gemeenschappen omarmt. Lees de belangrijkste financiële cijfers (225 words)
- [Media | Boehringer Ingelheim PL](/content/pl/media/index.html): Hub firmy Boehringer Ingelheim zawierający najnowsze informacje prasowe i dalsze materiały prasowe do pobrania. Zobacz więcej. (101 words)
- [Leaving site | Boehringer Ingelheim CH](/content/ch/disclaimer/bi/index.html) (90 words)
- [Beroertepreventie bij boezemfibrilleren | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/beroertepreventie-bij-boezemfibrilleren/index.html): Een beroerte treedt op wanneer de bloedtoevoer naar een deel van de hersenen wordt onderbroken. Mensen met een onregelmatige hartslag hebben meer kans op (67 words)
- [Geschiedenis | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/geschiedenis/index.html): In 1885, Albert Boehringer founded the pharmaceutical company Boehringer Ingelheim in Nieder-Ingelheim, which today is part of Ingelheim am Rhein. (76 words)
- [Actilyse® | Boehringer Ingelheim](/content/human-health/products/actilyse/index.html): Actilyse is indicated for fibrinolytic treatment of acute ischaemic stroke, acute myocardial infarction, acute massive pulmonary embolism and occluded catheters. (51 words)
- [Hypertensie (hoge bloeddruk) | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/hypertensie/index.html): Hypertensie is een aandoening die ongeveer een miljard mensen in de wereld treft en het aantal patiënten zal naar verwachting in de komende jaren nog verder stijgen. (113 words)
- [De bestuurders van Boehringer Ingelheim | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/boehringer-ingelheim-nederland/index.html): De bestuurders van Boehringer Ingelheim (172 words)
- [Persmateriaal | Boehringer Ingelheim BE](/content/be/nl/media/index.html): Toegang tot onze mediapool en Animal Health perskit. In onze mediapool vindt u een uitgebreide collectie Boehringer Ingelheim gerelateerde media-inhoud. (148 words)
- [Terms of Use | Boehringer Ingelheim IE](/content/ie/terms-use/index.html): Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/ie (1,698 words)
- [Een betere gezondheid: voor mensen en dieren | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/een-betere-gezondheid/index.html): Een project voor de lange termijn met als doel de gezondheid in gemeenschappen overal ter wereld te verbeteren door het ontwikkelen en ondersteunen (135 words)
- [Onze verbintenis | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-toezegging/index.html): Wij willen innovatie stimuleren, waarde creëren voor onvervulde medische behoeften en samen met gemeenschappen en de maatschappij levens verbeteren - voor (88 words)
- [Поиск открытых вакансий и отклик на вакансию | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/job-search/index.html): Поиск открытых вакансий и отклик на вакансию | Карьера в «Берингер Ингельхайм» (481 words)
- [Groener: voor onze planeet | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/groener/index.html): De pijler "Meer Groen" omvat milieuprojecten die rekening houden met vele verschillende aspecten: treffen van maatregelen ter voorkoming van water- en (142 words)
- [Humanmedizin | Boehringer Ingelheim AT](/content/at/de/humanmedizin/index.html): Das verschreibungspflichtige Produktportfolio von Boehringer Ingelheim umfasst Herz-Kreislauf-, Onkologie-, Atemwegs-, ZNS-, Virologie- und Stoffwechselerkrankungen. (407 words)
- [Правила пользования сайтом | Boehringer Ingelheim RU](/content/ru/pravila-polzovaniya-saytom/index.html): Правила пользования сайтом (618 words)
- [Switching market | Boehringer Ingelheim CH](/content/ch/disclaimer/market/index.html) (94 words)
- [SIRPα antagonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/sirpa-antagonist/index.html): SIRPα antagonist (252 words)
- [Second generation STING agonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/second-generation-sting-agonist/index.html): Second generation STING agonist (79 words)
- [Уведомление за поверителност | Boehringer Ingelheim BG](/content/bg/uvedomlenie-za-poveritelnost/index.html): Настоящото Уведомление за поверителност описва как и за какви цели Бьорингер Ингелхайм обработва личните данни. (996 words)
- [B7-H6/CD3 T-Cell Engager | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/b7-h6-cd3-t-cell-engager/index.html): B7-H6/CD3 T-Cell Engager (131 words)
- [Privacy Policy | Boehringer Ingelheim IE](/content/ie/privacy-policy/index.html): Boehringer Ingelheim Ireland Limited are committed to protecting and respecting your privacy through this privacy policy. Read our privacy policy here. (1,882 words)
- [CD137/FAP agonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/cd137-fap-agonist/index.html): CD137/FAP agonist (122 words)
- [(Senior) Clinical Data Engineer Job Details | BoehringerPRD](/content/jobs/job-invite/32789/index.html): Biberach (Senior) Clinical Data Engineer - Germ (1,026 words)
- [Anti-inflammatory agent | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/anti-inflammatory-agent/index.html): Anti-inflammatory agent (59 words)
- [Anti-fibrotic agent | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/anti-fibrotic-agent-0/index.html): Anti-fibrotic agent (22 words)
- [Pharmaziepraktikant_in SOL Stellendetails | BoehringerPRD](/content/jobs/job-invite/33151/index.html): Ingelheim Pharmaziepraktikant_in SOL - Deut (501 words)
- [Side effects | Adverse events | Boehringer Ingelheim IE](/content/ie/side-effects-adverse-events/index.html): Click here to find out more about reporting suspected side effects and other adverse events for Boehringer Ingelheim medicinal products in Ireland. (795 words)
- [Obrixtamig: DLL3/CD3 T-cell engager | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/obrixtamig-dll3-cd3-t-cell-engager/index.html): DLL3/CD3 T-cell engager (190 words)
- [Immunological fusion protein | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/immunological-fusion-protein/index.html): Immunological fusion protein (40 words)
- [Clinical Program Lead Job Details | BoehringerPRD](/content/jobs/job-invite/33750/index.html): Ingelheim Clinical Program Lead - Germ (707 words)
- [Acyltransferase inhibitor | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/acyltransferase-inhibitor/index.html): Acyltransferase inhibitor (52 words)
- [Unsere Kultur | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/unsere-kultur/index.html): Unsere Unternehmenskultur spiegelt wider, wer wir sind, und wird durch "Our Focus" auf und unser starkes Bekenntnis zu Vielfalt, Gleichberechtigung und Integration sowie zu nachhaltiger Entwicklung unterstrichen. (360 words)
- [Modified yersinia | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/modified-yersinia/index.html): Modified yersinia (49 words)
- [Obrixtamig (BI 764532): DLL3/CD3 T-cell engager | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/obrixtamig-bi-764532-dll3-cd3-t-cell-engager/index.html): BI 764532: DLL3/CD3 T-cell engager | ep-NEC (205 words)
- [Glutamate receptor modulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/glutamate-receptor-modulator/index.html): Glutamate receptor modulator (81 words)
- [Receptor agonist | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/receptor-agonist/index.html): Receptor agonist (51 words)
- [How to Connect | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/how-connect/index.html): Connect with the Boehringer Ingelheim Human Pharma Business Development and Licensing team to discuss partnering opportunities. (458 words)
- [Praktikum - Chromatographie / Entwicklung einer Ausbildungsmethode (ÄKTA-System) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35095/index.html): Biberach Praktikum - Chromatographie / Entwicklung einer Ausbildungsmethode (ÄKTA-System) - Deut (531 words)
- [Collaborative Opportunities | Boehringer Ingelheim ZA](/content/za/partnering/collaborative-opportunities/index.html): Are you looking to make an impact in health innovation? Partner with Boehringer through open research, digital labs, academic funding programs, and more. (463 words)
- [Santé humaine | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/index.html): Boehringer Ingelheim est un groupe d'entreprises axé sur la recherche et la découverte, le développement, la fabrication et la commercialisation de (149 words)
- [Partnering Interests | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/partnering-interests/index.html): Boehringer Ingelheim partners across a variety of human health therapeutic areas and beyond. We’re modality agnostic and prefer to partner early. (948 words)
- [Откройте для себя наши вакансии | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/index.html): Откройте для себя наши вакансии (268 words)
- [PD-1 antibody | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/pd-1-antibody/index.html): PD-1 antibody (24 words)
- [T-cell engager | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/t-cell-engager/index.html): T-cell engager (32 words)
- [Anti-fibrotic agent | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/anti-fibrotic-agent-1/index.html): Anti-fibrotic agent (42 words)
- [Glutamate receptor modulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/glutamate-receptor-modulator-0/index.html): Glutamate receptor modulator (42 words)
- [Targeted cancer immunotherapy | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/targeted-cancer-immunotherapy/index.html): Targeted cancer immunotherapy (27 words)
- [Digital Expert - Drug Discovery Sciences Job Details | BoehringerPRD](/content/jobs/job-invite/36007/index.html): Biberach Digital Expert - Drug Discovery Sciences - Germ (659 words)
- [Soziale Gesundheit und Wohlbefinden | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/soziale-gesundheit-und-wohlbefinden/index.html): Soziale Gesundheit und Wohlbefinden (295 words)
- [Immunomodulator | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/immunomodulator/index.html): Immunomodulator (21 words)
- [Menselijke gezondheid | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/index.html): Boehringer Ingelheim is een op onderzoek gerichte bedrijvengroep, toegewijd aan het ontdekken, ontwikkelen, vervaardigen en op de markt brengen. (160 words)
- [Anti-fibrotic agent | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/anti-fibrotic-agent/index.html): Anti-fibrotic agent (42 words)
- [Беротек® Н | Boehringer Ingelheim RU](/content/ru/human-health/products/berotek-n/index.html): Беротек® Н (53 words)
- [Перспективы | Boehringer Ingelheim RU](/content/ru/partnering/animal-health-partnering/perspectives/index.html): Узнайте больше об индустрии ветеринарии и ознакомьтесь с мнением экспертов «Берингер Ингельхайм» о том, почему сотрудничество является ключом к развитию инноваций. (388 words)
- [Santé Humaine | Boehringer Ingelheim FR](/content/fr/sante-humaine/index.html): Santé humaine (282 words)
- [Our Working Culture | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-working-culture/index.html): Explore the unique workplace culture and values that define working at Boehringer Ingelheim, from fostering innovation to creating a sense of belonging for our employees. (529 words)
- [Оставайтесь на связи | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/get-touch/index.html): Оставайтесь на связи | Карьера в «Берингер Ингельхайм» (145 words)
- [Führungskräfte von morgen | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/fuehrungskraefte-von-morgen/index.html): Wir investieren in unsere Mitarbeiter, indem wir ihnen Führungsschulungen anbieten, die ihre Fähigkeiten verbessern und sie auf zukünftige Aufgaben innerhalb der Organisation vorbereiten. (295 words)
- [Откройте нашу компанию |Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/index.html): Откройте нашу компанию |Карьера в «Берингер Ингельхайм» (204 words)
- [Triple agonist peptide | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/triple-agonist-peptide/index.html): Triple agonist peptide (21 words)
- [Наши местоположения | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/explore-our-company/our-locations/index.html): Наши местоположения | Карьера в «Берингер Ингельхайм» (289 words)
- [Вольвак® AC Плюс | Boehringer Ingelheim RU](/content/ru/animal-health/products/volvak-ac-plyus/index.html): Вольвак® AC Плюс (218 words)
- [НексгарД Спектра® | Boehringer Ingelheim RU](/content/ru/animal-health/products/neksgard-spektra/index.html): НексгарД Спектра® (328 words)
- [Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/index.html): Карьера в «Берингер Ингельхайм» (542 words)
- [Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-bi-1810631-her2-tyrosine-kinase-inhibitor-tki-1.html): Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (131 words)
- [Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-bi-1810631-her2-tyrosine-kinase-inhibitor-tki-3.html): Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) (147 words)
- [Wereldwijde contractproductie biofarma | Boehringer Ingelheim BE](/content/be/nl/samenwerking/boehringer-ingelheim-bioxcellence/index.html): Als een van de drie werkgebieden binnen Boehringer Ingelheim, bieden we deskundigheid op het gebied van biofarmaceutische (81 words)
- [Диндораль | Boehringer Ingelheim RU](/content/ru/animal-health/products/dindoral/index.html): Диндораль (161 words)
- [Свяжитесь с нами | Boehringer Ingelheim RU](/content/ru/partnering/animal-health-partnering/connect-us/index.html): Свяжитесь с командой по развитию бизнеса и лицензированию в подразделении ветеринарных препаратов «Берингер Ингельхайм» через онлайн-портал или на отраслевых мероприятиях, чтобы оставить заявку или обсудить возможности сотрудничества (334 words)
- [Dogs | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/dogs/index.html): With products and solutions to protect dog health and improve well-being, Boehringer Ingelheim is committed to longer, happier lives for canine companions (819 words)
- [IL-11 antibody (BI 765423) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/il-11-antibody-bi-765423/index.html): IL-11 antibody (BI 765423) (199 words)
- [Production biopharmaceutique contractuelle | Boehringer Ingelheim BE](/content/be/fr/partenariats/boehringer-ingelheim-bioxcellence/index.html): Nous sommes l'un des trois domaines d'activité de Boehringer Ingelheim, et nous proposons notre expertise en matière de production et de développement (90 words)
- [Ингельвак ЦиркоФЛЕКС® | Boehringer Ingelheim RU](/content/ru/animal-health/products/ingelvak-cirkofleks/index.html): Ингельвак ЦиркоФЛЕКС® (268 words)
- [Lysophospholipase inhibitor (BI 1819479) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/lysophospholipase-inhibitor-bi-1819479/index.html): Lysophospholipase inhibitor (37 words)
- [Как откликнуться на вакансию | «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/how-apply/index.html): Как откликнуться на вакансию | «Берингер Ингельхайм» (351 words)
- [Santé humaine | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/index.html): Découvrez notre engagement envers la santé humaine chez Boehringer Ingelheim. Des solutions innovantes pour améliorer votre bien-être. (41 words)
- [Метакам® | Boehringer Ingelheim RU](/content/ru/animal-health/products/metakam/index.html): Метакам® (318 words)
- [БИОРАЛЬ Н120 | Boehringer Ingelheim RU](/content/ru/animal-health/products/bioral-n120/index.html): БИОРАЛЬ Н 120 (223 words)
- [Авиффа RTI | Boehringer Ingelheim RU](/content/ru/animal-health/products/aviffa-rti/index.html): Авиффа RTI (206 words)
- [Working together | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/working-together/index.html): Discover our approach to partnering – why we’re motivated to work with others and how we collaborate across biotech, academia, and more. (432 words)
- [Галлимун SE+ST | Boehringer Ingelheim RU](/content/ru/animal-health/products/gallimun-sest/index.html): ГАЛЛИМУН SE+ST (229 words)
- [Галлимун MG | Boehringer Ingelheim RU](/content/ru/animal-health/products/gallimun-mg/index.html): Галлимун MG (227 words)
- [Коммерция, продажи и маркетинг | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/commercial-sales-marketing/index.html): Узнайте о карьерных возможностях в коммерческом департаменте и откликнитесь на вакансию сегодня. (254 words)
- [Информационные технологии | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/information-technology/index.html): Узнайте о новых карьерных возможностях в нашем отделе информационных технологий. (136 words)
- [Медицина и нормативно-правовое регулирование | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/medicine-regulatory-affairs/index.html): Узнайте о новых карьерных возможностях в нашем медицинском департаменте и отделе регистрации препаратов. (152 words)
- [Ветмедин®S | Boehringer Ingelheim RU](/content/ru/animal-health/products/vetmedins/index.html): Ветмедин®S (151 words)
- [Производство и цепочки поставок | Карьера в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/careers/discover-our-careers/manufacturing-supply-chain/index.html): Узнайте о новых карьерных возможностях в нашем отделе производства и цепей поставок. (134 words)
- [Our FOCUS | Boehringer Ingelheim IE](/content/ie/our-focus/index.html): Our FOCUS - our company's global vision - defines Boehringer Ingelheim’s road to innovation and growth for the years to come. Learn more here. (396 words)
- [Supplier Support | Boehringer Ingelheim ZA](/content/za/supplier-support/index.html): Supplier Support (759 words)
- [Imprint | Boehringer Ingelheim IE](/content/ie/imprint/index.html): Here you can find details of the registered office, contact details, and director details about Boehringer Ingelheim Ireland Ltd. Find out more. (43 words)
- [Animal Health Innovation | Boehringer Ingelheim IE](/content/ie/science-innovation/animal-health-innovation/index.html): Click here to learn how our Animal Health Global Innovation team promotes the science that helps improve animal and human health around the world. (141 words)
- [Cats | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/cats/index.html): By advancing innovation for the unique challenges of cat care, Boehringer Ingelheim’s feline experts help strengthen the bond between cats and their people (625 words)
- [Human Health Partnering | Boehringer Ingelheim IE](/content/ie/partnering/human-health-partnering/index.html): Learn how to partner with Boehringer Ingelheim to innovate and find solutions to improve the health and well-being of humans, click here to find out more. (136 words)
- [Animal Health Partnering | Boehringer Ingelheim ZA](/content/za/partnering/animal-health-partnering/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (469 words)
- [Рецептурные препараты | Boehringer Ingelheim RU](/content/ru/human-health/products/index.html): Обзор нашей продукции. (88 words)
- [Science & Innovation | Boehringer Ingelheim IE](/content/ie/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (276 words)
- [Perspectives | Boehringer Ingelheim ZA](/content/za/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (371 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim IE](/content/ie/about-us/quality/index.html): Quality at Boehringer Ingelheim (200 words)
- [What our partners say | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/what-our-partners-say/index.html): Read perspectives from Boehringer partners on their experience with us, what we have achieved together and how we’re making an impact. (530 words)
- [Lung Cancer | Boehringer Ingelheim IE](/content/ie/human-health/cancer/lung-cancer/index.html): Overcoming stigma and advancing lung cancer advocacy. (446 words)
- [Nutzungsbedingungen | Boehringer Ingelheim CH](/content/ch/nutzungsbedingungen/index.html): Nutzungsbedingungen (852 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim IE](/content/ie/animal-health/our-responsibility/index.html): Our responsibility here at Boehringer Ingelheim is to protect the connection between human, animal and environmental health. Click here to find out more. (148 words)
- [BTV PUR® | Boehringer Ingelheim](/content/animal-health/products/btv-pur/index.html): BTV PUR is indicated for active immunization of sheep to prevent viraemia and reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8. (119 words)
- [ENTERISOL® SALMONELLA T/C | Boehringer Ingelheim](/content/animal-health/products/enterisol-salmonella-t-c/index.html): Indicated for swine Salmonella in pigs (112 words)
- [Poultry | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/poultry/index.html): As trusted partners to poultry producers, Boehringer Ingelheim provides industry-leading vaccines and expertise to protect both flock health and businesses (603 words)
- [Animal Health Partnering | Boehringer Ingelheim IE](/content/ie/partnering/animal-health-partnering/index.html): Click here to find out and learn about our collaborations with partners who share our passion for improving the health and wellbeing of animals. (90 words)
- [Connect with us | Boehringer Ingelheim ZA](/content/za/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (350 words)
- [Сотрудничество в области рецептурных препаратов | Boehringer Ingelheim RU](/content/ru/partnering/human-health-partnering/index.html): Find all our Partnering contact information here as well as the latest updates on where you can meet us virtually or in person. (63 words)
- [Featured Stories | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/index.html): Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being. (141 words)
- [Swine | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/swine/index.html): We are a partner and enabler of sustainable pork and animal protein production, ensuring animal welfare through prevention and integrated health care. (144 words)
- [ENTERICOLIX® | Boehringer Ingelheim](/content/animal-health/products/entericolix/index.html): Sow vaccine (111 words)
- [Datenschutzerklärung | Boehringer Ingelheim CH](/content/ch/ueber-uns/datenschutz/index.html): Datenschutzerklärung (2,366 words)
- [Poultry | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/poultry/index.html): We provide vaccines, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs. (109 words)
- [Eprinex® | Boehringer Ingelheim](/content/animal-health/products/eprinex/index.html): Depending on formulation, the product is for the treatment of nematodes, lice, mites, ticks, flies and lungworms in cattle and sheep. (42 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim IE](/content/ie/partnering/biopharma-contract-manufacturing/index.html): Global biopharma contract development and manufacturing expertise is one of Boehringer Ingelheim's main business areas, click here to learn more. (39 words)
- [BULTAVO® 3 | Boehringer Ingelheim](/content/animal-health/products/bultavo-3/index.html): Indicated for bluetongue disease serotype 3 in sheep and cattle (96 words)
- [CANINEBEAT® AI | Boehringer Ingelheim](/content/animal-health/products/caninebeat-ai/index.html): CANINEBEAT® AI helps veterinarians detect, visualize, and grade heart murmurs in dogs. (98 words)
- [Human Health Innovation | Boehringer Ingelheim IE](/content/ie/science-innovation/human-health-innovation/index.html): Boehringer Ingelheim want to deliver a portfolio of innovative, breakthrough medicines that will improve the lives of patients. (37 words)
- [Bovela® | Boehringer Ingelheim](/content/animal-health/products/bovela/index.html): Reduces hyperthermia and minimizes the reduction of leukocyte count caused by BVD virus; reduces virus shedding and viraemia caused by BVDV-2. (72 words)
- [Avinew | Boehringer Ingelheim](/content/animal-health/products/avinew/index.html): Avinew gives active immunization in broiler chickens from day one, reducing mortality and clinical signs associated with Newcastle disease (ND). (90 words)
- [Livestock | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers. (79 words)
- [Broadline® | Boehringer Ingelheim](/content/animal-health/products/broadline/index.html): Discover how Broadline protects cats against a range of internal & external parasites including fleas, flea larvae, ticks, heartworms, roundworms, & tapeworms. (60 words)
- [Where to find us | Boehringer Ingelheim IE](/content/ie/about-us/where-find-us/index.html): Learn about Boehringer Ingelheim's sites around the world. With 52,000 employees worldwide, our sites include Bracknell, UK, and Ingelheim, Germany. (361 words)
- [Партнерство | Boehringer Ingelheim RU](/content/ru/partnering/index.html): В компании Boehringer Ingelheim разнообразие умов и сотрудничество имеют первостепенное значение для разработки новых прорывов в медицине. Нажмите (131 words)
- [Сотрудничество в области рецептурных препаратов | Boehringer Ingelheim RU](/content/ru/partnering/human-health-partnering/connect-us/index.html): Сотрудничество в области рецептурных препаратов (32 words)
- [Enterisol® Ileitis | Boehringer Ingelheim](/content/animal-health/products/enterisol-ileitis/index.html): For active immunisation of pigs from the age of three weeks against intestinal lesions caused by Lawsonia intracellularis infection and to reduce growth variability and weight loss associated with the disease. (63 words)
- [Arti-Cell® FORTE | Boehringer Ingelheim](/content/animal-health/products/arti-cell-forte/index.html): Arti-Cell® FORTE Used to treat mild to moderate lameness linked to non-infective joint inflammation in horses. It contains stem cells which are obtained from equine blood. Stem cells can develop into other types of cells. The stem cells in the active subs (114 words)
- [Pets | Boehringer Ingelheim IE](/content/ie/animal-health/companion-animals/pets/index.html): Boehringer Ingelheim are market leaders in parasiticides, vaccines and therapeutics to help maintain the health and wellbeing of your companion pets (145 words)
- [Ethics & Compliance | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/index.html): Learn about our Global Code of Conduct and our ethical and compliance standards here. View our Ethics and Compliance Policy, Speak Up Policy, and more. (455 words)
- [Animal Health | Boehringer Ingelheim IE](/content/ie/animal-health/index.html): Boehringer Ingelheim are passionate about animal health. We believe that when animals are healthy, humans are healthier too. Click here to find out more (162 words)
- [Партнерские проекты в области рецептурных препаратов | Boehringer Ingelheim RU](/content/ru/partnering/human-health-partnering/partnering-interests/index.html): Нажмите здесь, чтобы узнать, что мы в Boehringer Ingelheim хотим видеть от наших партнеров и что включает в себя наша партнерская деятельность. (85 words)
- [Культура партнерства | Boehringer Ingelheim RU](/content/ru/partnering/human-health-partnering/partnering-culture/index.html): Наши партнеры являются ценными участниками нашей глобальной инновационной семьи. Наша ориентация на долгосрочные исследования и инвестиции означает, что мы можем работать вместе для реализации их идей, полностью посвящая себя долгосрочным отношениям и пре (34 words)
- [Horses | Boehringer Ingelheim IE](/content/ie/animal-health/companion-animals/horses/index.html): Boehringer Ingelheim develops innovative solutions for the well-being of horses in immunology, parasitology, gastric and metabolic health. (43 words)
- [Отзывы партнеров | Boehringer Ingelheim RU](/content/ru/partnering/human-health-partnering/what-our-partners-say/index.html): Что говорят наши партнеры Мы разделяем общее видение с нашими партнерами в желании изменить ситуацию и разработать новые и передовые лекарственные препараты, которые окажут реальное влияние на жизнь пациентов. Послушайте, что они говорят о своем партнерст (33 words)
- [Cookie Policy | Boehringer Ingelheim IE](/content/ie/cookie-policy/index.html): Our websites use cookies to distinguish you from other users of our website. Click here to find out about what cookies are and how we use them. (1,681 words)
- [Контрактное биофармацевтическое производство | Boehringer Ingelheim RU](/content/ru/partnering/boehringer-ingelheim-bioxcellence/index.html): Контрактное биофармацевтическое производство (78 words)
- [Процесс исследования | Boehringer Ingelheim RU](/content/ru/science-innovation/animal-health-innovation/research-process/index.html): Ключевой частью нашей миссии является открытие или выявление новых соединений, вакцин, технологий, процессов заболеваний и инфекционных агентов. Для этого мы используем комплекс сложных инструментов, технических возможностей и опыта - как на наших научно- (109 words)
- [Lung Diseases | Boehringer Ingelheim IE](/content/ie/human-health/lung-diseases/index.html): At Boehringer Ingelheim, our focus is on improving the quality of life of patients suffering from respiratory diseases. (150 words)
- [Инновации в области ветеринарных препаратов | Boehringer Ingelheim RU](/content/ru/science-innovation/animal-health-innovation/index.html): Наша группа глобальных инноваций является первопроходцем в области науки, которая помогает ветеринарам, владельцам домашних животных и скота, а также представителям органов здравоохранения во всем мире улучшать здоровье животных сегодня и в будущем. Мы ра (65 words)
- [Our Responsibility | Boehringer Ingelheim IE](/content/ie/human-health/our-responsibility/index.html): Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here. (82 words)
- [Human Health Partnering | Boehringer Ingelheim ZA](/content/za/partnering/human-health-partnering/index.html): Learn about Boehringer’s collaborative approach to human health innovation, our areas of partnering interest, and how to connect with our team. (299 words)
- [Cancer | Boehringer Ingelheim IE](/content/ie/human-health/cancer/index.html): At Boehringer Ingelheim we are dedicated to working on improving lifestyles with treatments for cancer patients. (259 words)
- [Заболевания сетчатки глаз | Boehringer Ingelheim RU](/content/ru/zabolevaniya-setchatki-glaz/index.html): At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. (217 words)
- [Вакцины | Boehringer Ingelheim RU](/content/ru/science-innovation/animal-health-innovation/vaccines/index.html): Мы работаем с различными заболеваниями и видами животных, разрабатывая и поставляя надежные эффективные вакцины для животных-компаньонов, домашних животных и крупного рогатого скота, подробнее читайте здесь. (75 words)
- [Mental Health | Boehringer Ingelheim IE](/content/ie/human-health/mental-health/index.html): At Boehringer Ingelheim, we aspire to provide mental health treatment approaches that places an individual’s specific needs at the centre. (101 words)
- [Science Stories | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/science-stories/index.html): Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (71 words)
- [Методы терапии | Boehringer Ingelheim RU](/content/ru/science-innovation/animal-health-innovation/therapeutics/index.html): Мы обеспечиваем дисциплинированный научный подход к глобальному открытию, разработке и поставке терапевтических препаратов для всех соответствующих видов животных. (58 words)
- [Retinal Diseases | Boehringer Ingelheim IE](/content/ie/human-health/retinal-diseases/index.html): Learn how Boehringer Ingelheim has expanded its research and development efforts globally to tackle eye diseases, visual impairment and blindness. (127 words)
- [Companion Animals | Boehringer Ingelheim IE](/content/ie/animal-health/companion-animals/index.html): At Boehringer Ingelheim we think that pets and horses should have the same level of healthcare opportunity as you do, find out more about how. (35 words)
- [Imprint | Boehringer Ingelheim ZA](/content/za/imprint/index.html): Imprint (53 words)
- [Клинические исследования | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/clinical-studies/index.html): Нажмите, чтобы узнать о важности клинических исследований для разработки новых лекарств и ознакомиться с некоторыми клиническими исследо (43 words)
- [Подразделение ветеринарных препаратов | Boehringer Ingelheim RU](/content/ru/animal-health/index.html): Узнайте, как Boehringer Ingelheim стремится к тому, чтобы ваш питомец-компаньон получал такое же медицинское обслуживание, как и люди, будь то обычный домашний питомец или лошадь. (275 words)
- [Chronic Kidney Disease | Boehringer Ingelheim IE](/content/ie/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (141 words)
- [Patient Centricity | Boehringer Ingelheim IE](/content/ie/human-health/our-responsibility/patient-centricity/index.html): Read about how patients inspire our mission to lead the science that creates breakthrough therapies and create medicines that transform patients’ lives. (82 words)
- [Grass Roots | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots Innovation: Поддержка следующего поколения инноваторов в области науки о жизни (44 words)
- [Human Health | Boehringer Ingelheim IE](/content/ie/human-health/index.html): Click here to read about human health from Boehringer Ingelheim. (259 words)
- [Metabolic Diseases | Boehringer Ingelheim IE](/content/ie/human-health/metabolic-diseases/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. (166 words)
- [Science Stories | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/science-stories/index.html): Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (53 words)
- [Наука и инновации | Boehringer Ingelheim RU](/content/ru/science-innovation/index.html): Узнайте, как компания Boehringer Ingelheim решает научные задачи, действуя по-другому. Нажмите здесь, чтобы прочитать наши последние статьи о науке и инновациях. (94 words)
- [COPD & Asthma | Boehringer Ingelheim ZA](/content/za/human-health/lung-diseases/copd-asthma/index.html): Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives. (487 words)
- [Animal Health Innovation | Boehringer Ingelheim ZA](/content/za/science-innovation/animal-health-innovation/index.html): Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our (177 words)
- [Swine | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/swine/index.html): Protecting pigs and sustaining the swine industry are top priorities for Boehringer Ingelheim as we partner with pork producers and swine veterinarians (506 words)
- [Horses | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/horses/index.html): Partnering with owners and vets, Boehringer Ingelheim’s Equine team brings deep expertise and a passion for the equestrian life to help all horses thrive (423 words)
- [Птицеводство | Boehringer Ingelheim RU](/content/ru/animal-health/veterinary-public-health/index.html): Птицеводство (116 words)
- [Собаки | Boehringer Ingelheim RU](/content/ru/animal-health/companion-animals-horses/index.html): Важная часть нашей работы – создание инновационных препаратов для защиты собак от паразитов. (257 words)
- [Свиноводство | Boehringer Ingelheim RU](/content/ru/animal-health/trends-insights/index.html): Свиноводство (168 words)
- [Лошади | Boehringer Ingelheim RU](/content/ru/animal-health/our-responsibility/index.html): Лошади (86 words)
- [Крупный рогатый скот | Boehringer Ingelheim RU](/content/ru/animal-health/livestock/index.html): Крупный рогатый скот (77 words)
- [Zugänglichkeitserklärung | Boehringer Ingelheim CH](/content/ch/zugaenglichkeitserklaerung/index.html): Zugänglichkeitserklärung (435 words)
- [Ruminants | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/ruminants/index.html): Across the lifespan of cattle and sheep, Boehringer Ingelheim delivers proactive solutions to help ruminant producers optimize herd health and productivity (459 words)
- [Инновации для здоровья пациентов | Boehringer Ingelheim RU](/content/ru/science-innovation/human-health-innovation/index.html): Узнайте, как наши разработки инновационных препаратов меняют жизнь пациентов сейчас и для будущих поколений. (30 words)
- [Animal Health | Boehringer Ingelheim ZA](/content/za/animal-health/index.html): Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse. (303 words)
- [Swine | Boehringer Ingelheim ZA](/content/za/animal-health/livestock/swine/index.html): We are a partner and enabler of sustainable pork and animal protein production, ensuring animal welfare through prevention and integrated health care. (254 words)
- [Animals We Support | Boehringer Ingelheim ZA](/content/za/animal-health/animals-we-support/index.html): We’re committed to the health of the world’s most important animals: beloved dogs, cats, and horses, plus valued livestock like swine, ruminants, and poultry (389 words)
- [content/dam/6fd144e0-7eb2-4ab3-9fca-af1e011f41a6/jardiance-us-mg-pdf.html](/content/content/dam/6fd144e0-7eb2-4ab3-9fca-af1e011f41a6/jardiance-us-mg-pdf.html) (1,698 words)
- [Science & Innovation | Boehringer Ingelheim ZA](/content/za/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (188 words)
- [Fostering Science | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/fostering-science/index.html): Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here. (61 words)
- [MORE POTENTIAL for Communities & our People | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (125 words)
- [Vaccines | Boehringer Ingelheim ZA](/content/za/science-innovation/animal-health-innovation/vaccines/index.html): We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here. (71 words)
- [Therapeutics | Boehringer Ingelheim ZA](/content/za/science-innovation/animal-health-innovation/therapeutics/index.html): We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species. Our dedicated Research teams work together with our human pharma and animal health colleagues, as well as with (61 words)
- [Parasiticides | Boehringer Ingelheim ZA](/content/za/science-innovation/animal-health-innovation/parasiticides/index.html): Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses. (55 words)
- [Leadership | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Clinical Studies | Boehringer Ingelheim ZA](/content/za/science-innovation/human-health-innovation/clinical-studies/index.html): Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored. (82 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim ZA](/content/za/animal-health/our-responsibility/index.html): One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health. (211 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (85 words)
- [MORE GREEN for our planet | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (46 words)
- [Contact Us | Boehringer Ingelheim IE](/content/ie/contact-us/index.html): Please click here to contact us at Boehringer Ingelheim with our contact request form, or to get our contact details. We welcome all queries and feedback. (219 words)
- [Прозрачность в сфере взаимодействия со специалистами здравоохранения | Boehringer Ingelheim RU](/content/ru/about-us/prozrachnost-v-sfere-vzaimodeystviya-so-specialistami-zdravookhraneniya.html): Прозрачность в сфере взаимодействия со специалистами здравоохранения (503 words)
- [Who we are | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. Learn more. (140 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim ZA](/content/za/human-health/lung-diseases/pulmonary-fibrosis/index.html): Reducing the risk of acute exacerbations is a key treatment goal to manage patients with Idiopathic Pulmonary Fibrosis (IPF), learn how BI is helping. (242 words)
- [About Us | Boehringer Ingelheim IE](/content/ie/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to learn more about us. (204 words)
- [Featured Stories | Boehringer Ingelheim ZA](/content/za/animal-health/featured-stories/index.html): Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (146 words)
- [MORE HEALTH for People & Animals | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (33 words)
- [Sustainable Development | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/index.html): Learn about our 'Sustainable Development - For Generations' journey. One that started in 1885 and one that we hope, and believe, will never end. (123 words)
- [Заболевания ЦНС | Boehringer Ingelheim RU](/content/ru/human-health/mental-health/index.html): Заболевания центральной нервной системы (77 words)
- [Метаболические заболевания | Boehringer Ingelheim RU](/content/ru/human-health/metabolic-diseases/index.html): Метаболические заболевания Около 425 миллионов взрослых людей в мире живут с диабетом, при этом на диабет 2 типа приходится 90–95 процентов вс (126 words)
- [Рецептурное подразделение | Boehringer Ingelheim RU](/content/ru/human-health/index.html): Прочтите последние статьи о здоровье человека, нажав здесь. От открытия лекарств до конкретных заболеваний, таких как болезни сердца, легких или глаз, наша информация обширна. (271 words)
- [Хроническая сердечная недостаточность | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/heart-failure/index.html): Хроническая сердечная недостаточность (333 words)
- [Взаимодействие с пациентскими организациями | Boehringer Ingelheim RU](/content/ru/about-us/vzaimodeystvie-s-pacientskimi-organizaciyami/index.html): Взаимодействие с пациентскими организациями (332 words)
- [Наша ответственность | Boehringer Ingelheim RU](/content/ru/human-health/our-responsibility/index.html): Наша ответственность (66 words)
- [Пациентоориентированность | Boehringer Ingelheim RU](/content/ru/human-health/our-responsibility/patient-centricity/index.html): Пациенты вдохновляют нас на нашу миссию возглавить науку, создающую революционные методы лечения, чтобы наши лекарства изменили жизнь пациентов. (62 words)
- [Poultry | Boehringer Ingelheim ZA](/content/za/animal-health/livestock/poultry/index.html): We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs. (158 words)
- [Horses | Boehringer Ingelheim ZA](/content/za/animal-health/companion-animals/horses/index.html): We develop leading solutions for the wellbeing of horses in immunology, parasitology, gastric and metabolic health. (150 words)
- [Ruminants | Boehringer Ingelheim ZA](/content/za/animal-health/livestock/ruminants/index.html): Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers. (120 words)
- [Идиопатический легочный фиброз | Boehringer Ingelheim RU](/content/ru/human-health/lung-diseases/pulmonary-fibrosis/index.html): Идиопатический легочный фиброз (ИЛФ) — это тяжелое, постоянно прогрессирующее заболевание, при котором легочная ткань теряет эластичность и со временем происходит ее утолщение и рубцевание. (84 words)
- [Scleroderma | Boehringer Ingelheim ZA](/content/za/human-health/lung-diseases/scleroderma/index.html): Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs (203 words)
- [Karriere | Boehringer Ingelheim CH](/content/ch/karriere/index.html): Boehringer Ingelheim ist ein Pharmaunternehmen im Familienbesitz - starten Sie Ihre Karriere in einem globalen und innovativen Umfeld bei uns noch heute. (209 words)
- [History | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/history/index.html): Read about the history of Boehringer Ingelheim here, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people. (52 words)
- [Partnerschaften in der Tiergesundheit | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-tiergesundheit/index.html): Partnerschaften in der Tiergesundheit (98 words)
- [Условия за ползване | Boehringer Ingelheim BG](/content/bg/usloviya-za-polzvane/index.html): Запознайте се с условия за ползване на този сайт (1,961 words)
- [Companion Animals | Boehringer Ingelheim ZA](/content/za/animal-health/companion-animals/index.html): At Boehringer Ingelheim we think that house pets and horses should have the same level of healthcare opportunity as you do, find out more about how. (113 words)
- [Pets | Boehringer Ingelheim ZA](/content/za/animal-health/companion-animals/pets/index.html): Boehringer Ingelheim has multiple products and research elements working to ensure that your pets health and wellbeing is number one. (172 words)
- [Lung Diseases | Boehringer Ingelheim ZA](/content/za/human-health/lung-diseases/index.html): Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer. (212 words)
- [Switching market | Boehringer Ingelheim IE](/content/ie/disclaimer/market/index.html) (32 words)
- [Veterinary Public Health | Boehringer Ingelheim ZA](/content/za/animal-health/veterinary-public-health/index.html): Veterinary Public Health (160 words)
- [Livestock | Boehringer Ingelheim ZA](/content/za/animal-health/livestock/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs. (40 words)
- [Где нас найти | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/index.html): Где нас найти (287 words)
- [Заболевания органов дыхания | Boehringer Ingelheim RU](/content/ru/human-health/lung-diseases/index.html): Найдите информацию о различных респираторных заболеваниях, таких как астма, ХОБЛ, идиопатический легочный фиброз (ИЛФ), склеродермия и рак легких. (67 words)
- [Бронхиальная астма | Boehringer Ingelheim RU](/content/ru/human-health/lung-diseases/bronkhialnaya-astma/index.html): Бронхиальная астма (33 words)
- [Purchasing | Boehringer Ingelheim ZA](/content/za/about-us/purchasing/index.html): Sourcing (211 words)
- [Качество в «Берингер Ингельхайм» | Boehringer Ingelheim RU](/content/ru/about-us/quality/index.html): Качество в «Берингер Ингельхайм» (233 words)
- [Ansätze für Partnerschaften | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-tiergesundheit/ansaetze-fuer-partnerschaften/index.html): Ansätze für Partnerschaften (127 words)
- [Ireland Careers | Boehringer Ingelheim IE](/content/ie/careers/index.html): Find out information about careers in Ireland at Boehringer Ingelheim here. Learn about why this is a great place to work, vacancies, and more. (79 words)
- [Patient Centricity | Boehringer Ingelheim ZA](/content/za/human-health/our-responsibility/patient-centricity/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (118 words)
- [Across Cancer Types | Boehringer Ingelheim ZA](/content/za/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (132 words)
- [Поддержка пациентов | Boehringer Ingelheim RU](/content/ru/human-health/cancer/empowering-patients/index.html): Борьба с раком может быть трудной для всех заинтересованных сторон. Здесь мы предоставили многочисленные ресурсы специальных советов, предоставленных пациентами для пациентов. (55 words)
- [Онкологические заболевания | Boehringer Ingelheim RU](/content/ru/human-health/cancer/index.html): В Берингер Ингельхайм мы стремимся работать над улучшением методов лечения онкологических больных во всем мире, уделяя особое внимание раку легких и желудочно-кишечного тракта. (126 words)
- [Инфаркт миокарда | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/infarkt-miokarda/index.html): Инфаркт миокарда (108 words)
- [Partnerschaften | Boehringer Ingelheim CH](/content/ch/partnerschaften/index.html): Partnerschaften Wir sind davon überzeugt, dass durch Diversität und Austausch in der Wissenschaft Innovationen geboren werden. Aus diesem Grund sind Partnerschaften ein wichtiger Bestand unserer Innovationsstrategie. (144 words)
- [Biopharma Auftragsherstellung | Boehringer Ingelheim CH](/content/ch/partnerschaften/biopharma-auftragsherstellung/index.html): Wir sind eines der weltweit führenden Unternehmen in der biopharmazeutischen Auftragsherstellung (87 words)
- [Diabetes | Boehringer Ingelheim ZA](/content/za/human-health/metabolic-diseases/diabetes/index.html): Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives. (209 words)
- [Lung Cancer | Boehringer Ingelheim ZA](/content/za/human-health/cancer/lung-cancer/index.html): Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC) (129 words)
- [Взаимодействие с поставщиками | Boehringer Ingelheim RU](/content/ru/about-us/purchasing/index.html): Взаимодействие с поставщиками (148 words)
- [Stimmen unserer Partnerorganisationen | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/stimmen-unserer-partnerorganisationen/index.html): What our partners say We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us. (30 words)
- [65 anos de Boehringer Ingelheim em Portugal: uma história de paixão, inovação e compromisso | Boehringer Ingelheim PT](/content/pt/65-anos-de-boehringer-ingelheim-em-portugal-uma-historia-de-paixao-inovacao-e-compromisso.html): A Boehringer Ingelheim começou a escrever parte da sua história há 140 anos, com apenas 28 colaboradores e o fundador Albert Boehringer (1861-1939). (566 words)
- [Нейтрализация антикоагулянтного эффекта | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/neytralizaciya-antikoagulyantnogo-effekta/index.html): Нейтрализация антикоагулянтного эффекта (65 words)
- [Cancer | Boehringer Ingelheim ZA](/content/za/human-health/cancer/index.html): At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers. (195 words)
- [Human Health | Boehringer Ingelheim ZA](/content/za/human-health/index.html): Read the latest human health articles by clicking here. From drug discovery to specific diseases such as heart, lung or eye diseases our information is vast. (196 words)
- [Согласие на передачу ПДн третьим лицам | Boehringer Ingelheim RU](/content/ru/soglasie-na-peredachu-pdn-tretim-licam/index.html): Согласие на передачу ПДн третьим лицам (владельцам сторонних ресурсов) (286 words)
- [Adverse Events | Boehringer Ingelheim UK](/content/uk/about-us/adverse-events/index.html): Click here to find out more about reporting suspected side effects and other adverse events for Boehringer Ingelheim medicinal products in the UK. (829 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim ZA](/content/za/about-us/quality/index.html): Quality at Boehringer Ingelheim (186 words)
- [Профилактика инсульта | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/atrial-fibrillation/index.html): Профилактика инсульта при фибрилляции предсердий (45 words)
- [Ansätze für Partnerschaften | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/ansaetze-fuer-partnerschaften/index.html): Ansätze für Partnerschaften (83 words)
- [Our Responsibility | Boehringer Ingelheim ZA](/content/za/human-health/our-responsibility/index.html): Human Health Our Responsibility (79 words)
- [Stroke | Boehringer Ingelheim ZA](/content/za/human-health/heart-diseases/stroke/index.html): Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. (251 words)
- [Медіа | Boehringer Ingelheim UA](/content/ua/media/index.html): Берінгер Інгельхайм - одна з провідних світових фармацевтичних компаній, що спеціалізується на дослідженнях та має 130-річний досвід роботи. (232 words)
- [Artrial Fibrillation | Boehringer Ingelheim ZA](/content/za/human-health/heart-diseases/atrial-fibrillation/index.html): At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots. (188 words)
- [Leadership | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (187 words)
- [Ethics and Compliance | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/index.html): Ethics and Compliance (134 words)
- [Kontakt | Boehringer Ingelheim CH](/content/ch/kontakt/index.html): Kontakt (674 words)
- [ТГВ/ТЭЛА | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/tgv-tela/index.html): Тромбоз глубоких вен и тромбоэмболия легочной артерии (82 words)
- [Артериальная гипертензия | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/hypertension/index.html): Эффективное лечение гипертонии важно для предотвращения дальнейших осложнений или рисков, таких как сердечный приступ или инсульт. (105 words)
- [Besserer Zugang zu sauberem Wasser in Mexiko | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/wasser-mexiko/index.html): Erfahren Sie, wie Boehringer Ingelheim den Zugang zu sauberem Wasser in Mexiko mit nachhaltigen Wassermanagement-Projekten fördert. (741 words)
- [Wo Sie uns finden | Boehringer Ingelheim CH](/content/ch/ueber-uns/wo-sie-uns-finden/index.html): Boehringer Ingelheim verfügt über globale Forschungs- und Produktionsnetzwerke, mit Standorten in Europa, Amerika und Asien/Ozeanien. (364 words)
- [Contact Us | Boehringer Ingelheim ZA](/content/za/contact-us/index.html): To contact us at Boehringer Ingelheim please click here to fill out our contact request form. We welcome all queries and feedback. (83 words)
- [More Green | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (87 words)
- [보도자료 | Boehringer Ingelheim KR](/content/kr/bodojalyo/index.html): 한국베링거인겔하임의 최신 보도자료를 확인하실 수 있습니다. (166 words)
- [Metabolic Diseases | Boehringer Ingelheim ZA](/content/za/human-health/metabolic-diseases/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 20451. Type 2 diabetes is a chronic, (71 words)
- [More Health: For People & Animals | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (32 words)
- [Klinische Studien | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/klinische-studien/index.html): Klinische Studien sind wichtig, um die Wirksamkeit und Sicherheit eines Medikaments zu belegen. Wir initiieren und fördern Studien in über 60 Ländern. (75 words)
- [Geschichten aus der Wissenschaft | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/index.html): Geschichten aus der Wissenschaft (71 words)
- [Innovation | Boehringer Ingelheim CH](/content/ch/innovation/index.html): Innovation (143 words)
- [More Potential | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (110 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (33 words)
- [Impfstoffe | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-tiergesundheit/impfstoffe/index.html): Impfstoffe (78 words)
- [History | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/history/index.html): History (134 words)
- [Who we are | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (190 words)
- [Projecto HÉRCULES | Boehringer Ingelheim PT](/content/pt/sobre-nos/projecto-hercules/index.html): um marco que reforça o compromisso com o conhecimento da Doença Renal Crónica (DRC) em Portugal (798 words)
- [Sustainable Development | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/index.html): Click here to discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (223 words)
- [Parasitizide | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-tiergesundheit/parasitizide/index.html): Parasitizide (50 words)
- [Innovationen in der Humanmedizin | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/index.html): Boehringer Ingelheim konzentriert sich in seinen Forschungsaktivitäten auf Krankheitsbereiche mit einem hohen ungedeckten medizinischen Bedarf. (125 words)
- [О нас | Boehringer Ingelheim RU](/content/ru/about-us/index.html): Берингер Ингельхайм - это глобальная группа компаний, целью которой является улучшение жизни людей и животных. Нажмите здесь, чтобы узнать (181 words)
- [Устойчивое развитие | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/index.html): Ценности и принципы, которым компания привержена более 130 лет, лежат в основе нашего корпоративного видения. (112 words)
- [Wissenschaftsförderung | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/index.html): Wissenschaftsförderung (88 words)
- [Этика и соблюдение законодательства | Boehringer Ingelheim RU](/content/ru/about-us/ethics-and-compliance/index.html): Этика и соблюдение законодательства (31 words)
- [Haustiere und Pferde | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/index.html): Hunde, Katzen und Pferde – sie teilen eine enge Verbindung mit uns und für viele Menschen sind sie echte Familienmitglieder oder treue Freunde. Umso wichtiger ist es, dass die Tiere gesund sind und gut versorgt werden. (261 words)
- [Einsatz für gerechte Gesundheitsversorgung in den USA | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/gesundheitsversorgung-usa/index.html): Erfahren Sie, wie sich Boehringer Cares gemeinsam mit Partnern in den USA für einen besseren Zugang zur Gesundheitsversorgung einsetzt. (949 words)
- [Innovationen in der Tiergesundheit | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-tiergesundheit/index.html): Innovationen in der Tiergesundheit (61 words)
- [Fokusgebiete | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/fokusgebiete/index.html): Unser Fokus liegt auf den Bereichen Herz- und Stoffwechsel, ZNS, Immunologie und Atemwege, Onkologie und Immunonkologie sowie Netzhauterkrankungen. (102 words)
- [Schweine | Boehringer Ingelheim CH](/content/ch/tiergesundheit/nutztiere/schweine/index.html): Schweine (209 words)
- [More Green | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-green/index.html): В компании «Берингер Ингельхайм» программа «Устойчивое развитие — для поколений» посвящена путешествию. Тот, который начался в 1885 году, и тот, на который мы надеемся и верим (99 words)
- [Устойчивое развитие - Наша миссия | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (124 words)
- [Контакты | Boehringer Ingelheim RU](/content/ru/kontakty/index.html): Чтобы связаться с нами в Boehringer Ingelheim, пожалуйста, нажмите здесь, чтобы заполнить нашу форму запроса контактов. Мы рады всем запросам и отзывам. (99 words)
- [«More Health»: для людей и животных | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-health/index.html): «More Health»: для людей и животных (49 words)
- [Geflügel | Boehringer Ingelheim CH](/content/ch/tiergesundheit/nutztiere/gefluegel/index.html): Hier finden Sie hilfreiche Informationen zu den Themen Gesundheit und Krankheiten von Geflügel und Hühnern (146 words)
- [Declaração de Privacidade de Dados | Boehringer Ingelheim PT](/content/pt/declaracao-de-privacidade-de-dados/index.html): Esta Declaração de Privacidade descreve como a Boehringer Ingelheim International GmbH (doravante denominada “Boehringer Ingelheim”, “nós”, “nosso”). (1,718 words)
- [Pferde | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/pferde/index.html): Pferde (101 words)
- [Безпека Пацієнта та Фармаконагляд у «Берінгер Інгельхайм» | Boehringer Ingelheim UA](/content/ua/human-health/our-responsibility/bezpeka-pacienta/index.html): Безпека Пацієнта та Фармаконагляд у «Берінгер Інгельхайм» (329 words)
- [Histórias em destaque | Boehringer Ingelheim PT](/content/pt/saude-animal/historias-em-destaque/index.html): Bem-estar animal e humano — o nosso propósito, a nossa inspiração e o nosso objetivo. (263 words)
- [Nutztiere | Boehringer Ingelheim CH](/content/ch/tiergesundheit/nutztiere/index.html): Wir bieten unseren Kund*innen innovative Gesundheitslösungen, um Krankheiten und Leiden bei Nutztieren vorzubeugen oder diese zu lindern und damit das Tierwohl zu fördern. (144 words)
- [Haustiere | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/haustiere/index.html): Hunde (143 words)
- [Кто мы | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/index.html): «Берингер Ингельхайм» – международная группа компаний, объединяющая множество культур и различных обществ. Узнайте больше об организации, финансовых показателях и корпоративном видении. (76 words)
- [Saúde Animal | Boehringer Ingelheim PT](/content/pt/saude-animal/index.html): As vidas dos animais e dos seres humanos estão interligadas de formas profundas e complexas. (366 words)
- [Livestock | Boehringer Ingelheim TR](/content/tr/animal-health/livestock/livestock/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs. (56 words)
- [Understanding MASH: A Global Health Challenge | Boehringer Ingelheim](/content/human-health/crm-health/liver-health/understanding-mash-global-health-challenge/index.html): Roughly one-third of people with obesity have liver disease MASH (metabolic dysfunction-associated steatohepatitis), often without realizing it. Click here to find out more about how obesity and liver health are connected. (418 words)
- [Wiederkäuer | Boehringer Ingelheim CH](/content/ch/tiergesundheit/nutztiere/wiederkaeuer/index.html): Wiederkäuer (95 words)
- [Unsere Verantwortung | Boehringer Ingelheim CH](/content/ch/humanmedizin/unsere-verantwortung/index.html): Unsere Verantwortung (73 words)
- [Netzhauterkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/netzhauterkrankungen/index.html): Netzhauterkrankungen (136 words)
- [Psychische Erkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/psychische-gesundheit/index.html): Boehringer Ingelheim setzt neue Maßstäbe im Bereich der psychischen Gesundheit. Wir wollen Menschen mit psychischen Erkrankungen dabei unterstützen, ein positiveres und erfülltes Leben zu führen. (119 words)
- [Lungenkrebs | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/lungenkrebs/index.html): Lungenkrebs ist ein besonderes Fokusgebiet von uns, in dem wir das Ziel verfolgen, die Perspektiven für Patienten immer weiter zu verbessern. (175 words)
- [Chronische Nierenerkrankung | Boehringer Ingelheim CH](/content/ch/humanmedizin/chronische-nierenerkrankung/index.html): Chronische Nierenerkrankung wird durch fortschreitende Schäden an den Nieren verursacht und betrifft 10% der Bevölkerung. (88 words)
- [Diabetes | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/diabetes/index.html): Weltweit leben circa 415 Millionen Erwachsene mit Diabetes. Typ-2-Diabetes ist mit 90-95 Prozent die häufigste Form. (148 words)
- [Switching market | Boehringer Ingelheim RU](/content/ru/disclaimer/market/index.html) (56 words)
- [Geschäftspartner | Boehringer Ingelheim CH](/content/ch/ueber-uns/geschaeftspartner/index.html): Geschäftspartner (346 words)
- [Patient_innen im Mittelpunkt | Boehringer Ingelheim CH](/content/ch/humanmedizin/unsere-verantwortung/patientinnen-im-mittelpunkt/index.html): Patient_innen im Mittelpunkt (74 words)
- [Stoffwechselerkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/index.html): Miteinander zusammenhängende Erkrankungen, die Herz, Niere und das gesamte Stoffwechselsystem betreffen, verursachen jährlich bis zu 20 Millionen Todesfälle weltweit. (142 words)
- [Bronchiektase | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/bronchiektase/index.html): Bronchiektase (144 words)
- [Depression | Boehringer Ingelheim CH](/content/ch/humanmedizin/psychische-gesundheit/depression/index.html): Die Borderline-Persönlichkeitsstörung ist eine häufige psychische Störung, die mit schweren funktionellen und emotionalen Beeinträchtigungen einhergeht. (67 words)
- [Sklerodermie | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/sklerodermie/index.html): Sklerodermie (70 words)
- [Qualität bei Boehringer Ingelheim | Boehringer Ingelheim CH](/content/ch/ueber-uns/qualitaet/index.html): Qualität bei Boehringer Ingelheim (256 words)
- [Schlaganfall | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/schlaganfall/index.html): Boehringer Ingelheim hat das einzige derzeit zugelassene Therapeutikum bei ischämischem Schlaganfall entwickelt. Es wird weltweit eingesetzt. (132 words)
- [Shashank Deshpande | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (207 words)
- [EHS & Ethik & Compliance | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/index.html): Bei Boehringer Ingelheim halten wir uns stets an das Gesetz und unsere ethischen Grundsätze (119 words)
- [Lungenfibrose | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/lungenfibrose/index.html): Ein wesentliches Ziel der Behandlung aller Patienten mit IPF ist es, das Risiko des Auftretens akuter IPF-Exazerbationen zu reduzieren. (130 words)
- [Leaving site | Boehringer Ingelheim RU](/content/ru/disclaimer/bi/index.html) (130 words)
- [Lungenerkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/index.html): Lungenerkrankungen (91 words)
- [Herzinsuffizienz | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/herzinsuffizienz/index.html): Herzinsuffizienz ist eine progressive und potenziell tödliche Erkrankung, von der weltweit über 60 Millionen Menschen betroffen sind. (173 words)
- [Adipositas | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/adipositas/index.html): Adipositas ist eine komplexe chronische Krankheit, die eine langfristige Behandlung erfordert. Sie gehört zu den führenden Risikofaktoren für mehrere kardio-metabolische Erkrankungen wie Herzkrankheiten, ischämische Schlaganfälle und Lebererkrankungen. (92 words)
- [Nachhaltige Entwicklung - Unser Engagement | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unser-engagement/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (394 words)
- [Trabalhar na Boehringer Ingelheim](/content/pt/trabalhar-na-boehringer-ingelheim/index.html): Venha juntar-se a nós e contribuir para a nossa missão de criar Valor Através da Inovação para os doentes que servimos. (161 words)
- [Menções legais | Boehringer Ingelheim PT](/content/pt/mencoes-legais/index.html): Boehringer Ingelheim Portugal, Lda Avenida de Pádua, 11 1800-294 Lisboa, Portugal (42 words)
- [Bluthochdruck | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/bluthochdruck/index.html): Bluthochdruck (83 words)
- [More Potential: Für Communities & Mitarbeitende | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/index.html): More Potential: Für Communities & Mitarbeitende Die Gesellschaft steht weiterhin vor großen Herausforderungen, die von Gesundheit über Bildung, Arbeitsmöglichkeiten, Lebensbedingungen bis hin zu Ungleichheit und Armut reichen – und von denen benachteiligt (163 words)
- [Über unsere Schwerpunktbereiche hinaus | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/ueber-unsere-schwerpunktbereiche-hinaus/index.html): Über unsere Schwerpunktbereiche hinaus (78 words)
- [Ensaios clínicos | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-humana/ensaios-clinicos/index.html): Os ensaios clínicos são uma parte essencial do desenvolvimento de novos medicamentos. São a tradução dos nossos conhecimentos científicos em terapias. (98 words)
- [Ciência e inovação | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/index.html): Todos os dias os nossos cientistas exploram novos territórios, dando continuidade ao nosso compromisso para com a inovação. (181 words)
- [Wer wir sind | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/index.html): Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen. Schwerpunkte sind die Forschung, Entwicklung, Produktion sowie das Marketing neuer Medikamente. (175 words)
- [Vorhofflimmern | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/vorhofflimmern/index.html): Vorhofflimmern ist eine Herzrhythmusstörung, bei der es zur Bildung von Blutgerinnseln im Herzen und dadurch zu einem folgenschweren Schlaganfall kommen kann. Aktuelle Informationen zum Thema erhalten Sie hier. (50 words)
- [Doenças Metabólicas | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-metabolicas/index.html): As doenças cardio-reno-metabólicas interligadas — que afetam o coração, os rins e o sistema metabólico — são a principal causa de mortalidade (317 words)
- [Esclerodermia | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-pulmonares/esclerodermia/index.html): A esclerose sistémica (SSc) é uma doença rara desfigurante, incapacitante e potencialmente fatal que provoca cicatrizes na pele (escleroderma). (174 words)
- [Animal Health Products Australia | Boehringer Ingelheim AU](/content/au/animal-health/products/animal-health-product-australia/index.html): Animal Health Products (468 words)
- [Здоров'я тварин | Boehringer Ingelheim UA](/content/ua/animal-health/index.html): Дізнайтеся, як компанія Boehringer Ingelheim прагне забезпечити вашому домашньому улюбленцю такий самий рівень охорони здоров'я, як і людям, незалежно від того, чи це звичайна домашня тварина, чи кінь. (306 words)
- [Inovação na Saúde Animal | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-animal/index.html): A nossa equipa de Inovação global lidera a ciência que ajuda veterinários, donos de animais de estimação. (69 words)
- [Suínos | Boehringer Ingelheim PT](/content/pt/saude-animal/gado/suinos/index.html): A Boehringer Ingelheim é um parceiro e promotor de produção sustentável de carne de porco e proteína animal, assegurando o bem-estar animal através. (197 words)
- [Equinos | Boehringer Ingelheim PT](/content/pt/saude-animal/animais-de-companhia/equinos/index.html): Como um dos líderes em saúde equina, a Boehringer Ingelheim desenvolve soluções inovadoras para o bem-estar de equinos em todo o mundo. (87 words)
- [A nossa responsabilidade | Boehringer Ingelheim PT](/content/pt/saude-animal/nossa-responsabilidade/index.html): Planeamos a pensar em várias gerações. Tal reflete-se na nossa história de sucesso com mais de 100 anos e motiva a nossa preocupação com sustentabilidade. (207 words)
- [More Green: Für unseren Planeten | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-green/index.html): More Green: Für unseren Planeten Unsere Säule More Green umfasst Umweltinitiativen, die viele verschiedene Aspekte berücksichtigen: Maßnahmen zur Vermeidung von Wasser- und Luftverschmutzung, die Nutzung erneuerbarer Energiequellen, die Reduktion von Abfä (74 words)
- [Nachhaltige Entwicklung | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/index.html): Unser Engagement Auf unserem Weg geht es darum, Innovationen voranzutreiben, Werte in Bereichen mit ungedecktem medizinischem Bedarf zu schaffen und mit Communities und Gesellschaft in Kontakt zu treten, um Leben zum Besseren zu verändern. (78 words)
- [O Processo de Investigação | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-animal/o-processo-de-investigacao/index.html): Descobrimos ou identificamos novos compostos, vacinas, tecnologias, processos de doenças, e agentes infecciosos. (135 words)
- [Aves | Boehringer Ingelheim PT](/content/pt/saude-animal/gado/aves/index.html): Através das nossas vacinas, ferramentas de diagnóstico, serviços de investigação, competências técnicas e a inabalável dedicação às atividades comerciais. (157 words)
- [Tipos de Cancro | Boehringer Ingelheim PT](/content/pt/saude-humana/cancro/tipos-de-cancro/index.html): Estamos empenhados nas nossas áreas de doenças focais de cancros pulmonares e gastrointestinais. (78 words)
- [Doenças da retina | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-da-retina/index.html): Doenças da retina (135 words)
- [Докладване на нежелани събития | Boehringer Ingelheim BG](/content/bg/dokladvane-na-nezhelani-sbitiya/index.html): Данни за контакт за докладване на нежелано събитие/информация, касаеща безопасността на пациента/продуктови дефекти (601 words)
- [Партнерські інтереси в галузі здоров'я тварин | Boehringer Ingelheim UA](/content/ua/partnering/animal-health-partnering/partnering-interests/index.html): In order to create the next generation of medical breakthroughs in animal health we need partners. Click here to view our animal health partnering interests. (94 words)
- [Inovação na Saúde Humana | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-humana/index.html): A Boehringer Ingelheim tem os seus objectivos muito bem definidos. Queremos disponibilizar um conjunto de medicamentos revolucionários. (79 words)
- [Foco no Doente | Boehringer Ingelheim PT](/content/pt/saude-humana/nossa-responsabilidade/centralidade-no-doente/index.html): Na Boehringer Ingelheim, colocamos os pacientes em primeiro lugar em tudo o que fazemos. (127 words)
- [Cancro | Boehringer Ingelheim PT](/content/pt/saude-humana/cancro/index.html): O cancro rouba. Rouba tempo. Rouba entes queridos. Na Boehringer Ingelheim, estamos a dar uma nova esperança aos doentes na luta contra o cancro. (108 words)
- [Inovação científica | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-humana/inovacao-cientifica/index.html): A criação de medicamentos inovadores que mudam a vida dos pacientes começa com um compromisso de identificar os desafios de saúde do futuro. (128 words)
- [Parasiticidas | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-animal/parasiticidas/index.html): Uma de especialização dentro da Inovação Global é a descoberta e desenvolvimento de novos parasiticidas tanto para animais de companhia como para gado. (58 words)
- [Onde estamos | Boehringer Ingelheim PT](/content/pt/sobre-nos/onde-estamos/index.html): Com 52 000 colaboradores a nível mundial, a Boehringer Ingelheim dispõe de uma rede de investigação e produção espalhada pelo globo. (448 words)
- [Ruminantes | Boehringer Ingelheim PT](/content/pt/saude-animal/gado/ruminantes/index.html): Na nossa unidade de negócios estratégica dedicada aos ruminantes, centramos as nossas atenções em parasiticidas. (102 words)
- [Foco na ciência | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-humana/foco-na-ciencia/index.html): A nossa investigação sobre novos medicamentos está centrada nas áreas da ciência com necessidades médicas significativas e onde continuamos a inovar. (65 words)
- [Desenvolvimento sustentável | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/index.html): Na Boehringer Ingelheim, “Desenvolvimento sustentável — para gerações futuras” representa uma jornada. (251 words)
- [Animais de companhia | Boehringer Ingelheim PT](/content/pt/saude-animal/animais-de-companhia/index.html): É veterinário ou tem um animal de estimação ou um cavalo? Sendo um dos maiores fornecedores mundiais de soluções de saúde. (45 words)
- [Mais ambientalismo: pelo nosso planeta | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/mais-ambientalismo/index.html): O nosso pilar MAIS AMBIENTALISMO abrange iniciativas ambientais que têm em consideração diferentes aspetos. (242 words)
- [Animais de estimação | Boehringer Ingelheim PT](/content/pt/saude-animal/animais-de-companhia/animais-de-estimacao/index.html): Estamos entre os líderes de mercado em parasiticidas, vacinas e agentes terapêuticos, e somos um parceiro de confiança para os médicos veterinários. (84 words)
- [Fibrose Pulmonar | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-pulmonares/fibrose-pulmonar/index.html): A fibrose pulmonar é uma condição que leva a uma acumulação de tecido cicatricial nos pulmões. (114 words)
- [A Nossa Responsabilidade | Boehringer Ingelheim PT](/content/pt/saude-humana/nossa-responsabilidade/index.html): Na Boehringer Ingelheim, colocamos os doentes em primeiro lugar em tudo o que fazemos. (95 words)
- [Doença Renal Crónica | Boehringer Ingelheim PT](/content/pt/saude-humana/doenca-renal-cronica/index.html): Doença Renal Crónica (144 words)
- [Cancro do Pulmão | Boehringer Ingelheim PT](/content/pt/saude-humana/cancro/cancro-do-pulmao/index.html): Com base na nossa experiência em doenças pulmonares, o nosso objectivo é levar o cancro do pulmão, transformar a paisagem. (70 words)
- [Diabetes | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-metabolicas/diabetes/index.html): Cerca de 425 milhões de pessoas adultas no mundo vivem com diabetes, com a diabetes Tipo 2 a representar 90 - 95% de todos os casos. (196 words)
- [Познайомтеся з нашою командою | Boehringer Ingelheim UA](/content/ua/partnering/animal-health-partnering/meet-our-team/index.html): Тут ви знайдете всю нашу контактну інформацію, а також інформацію про те, де ви можете зустрітися з нами віртуально або особисто. (63 words)
- [Партнерство в галузі здоров'я тварин | Boehringer Ingelheim UA](/content/ua/partnering/animal-health-partnering/index.html): Тут ви знайдете всю нашу контактну інформацію, а також інформацію про те, де ви можете зустрітися з нами віртуально або особисто. (54 words)
- [Партнерство | Boehringer Ingelheim UA](/content/ua/partnering/index.html): У компанії Boehringer Ingelheim розмаїття думок та співпраця мають першорядне значення для розробки нових медичних проривів. Натисніть тут, щоб дізнатися, як ви можете стати нашим партнером. (203 words)
- [EHNA | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-metabolicas/ehna/index.html): A esteato-hepatite não alcoólica (EHNA) é causada por uma inflamação do fígado induzida pelo metabolismo e é uma das principais causas de fibrose (132 words)
- [Що кажуть наші партнери | Boehringer Ingelheim UA](/content/ua/partnering/human-health-partnering/what-our-partners-say/index.html): Що кажуть наші партнери Ми поділяємо спільне бачення з нашими партнерами, прагнучи змінювати світ на краще та розробляти нові та вдосконалені лікарські засоби, які справді впливають на життя пацієнтів. Послухайте, що вони розповідають про свій партнерськи (54 words)
- [Партнерські інтереси | Boehringer Ingelheim UA](/content/ua/partnering/human-health-partnering/partnering-interests/index.html): Натисніть тут, щоб дізнатися, що ми любимо бачити в компанії Boehringer Ingelheim від наших партнерів і що охоплює наша партнерська діяльність. (88 words)
- [Search | Boehringer Ingelheim UA](/content/ua/search/index.html) (16 words)
- [Де нас знайти | Boehringer Ingelheim UA](/content/ua/about-us/where-find-us/index.html): Zatrudniając 52 tys. pracowników w różnych krajach, Boehringer Ingelheim tworzy sieć badawczo-produkcyjną na całym świecie. Oto nasze największe zakłady. (382 words)
- [Mais potencial: para as comunidades e as nossas pessoas | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/mais-potencial/index.html): Para comunidades e as nossas pessoas. A sociedade continua a enfrentar desafios, variando desde a saúde até à educação, perspetivas de trabalho. (279 words)
- [Saúde Humana | Boehringer Ingelheim PT](/content/pt/saude-humana/index.html): A Boehringer Ingelheim é um grupo de empresas focado na investigação, que se dedica à descoberta, desenvolvimento. (176 words)
- [Mais saúde: para as pessoas e os animais. | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/mais-saude/index.html): Uma iniciativa a longo prazo que visa melhorar a saúde das comunidades de todo o mundo, através da identificação e promoção de soluções promissoras. (171 words)
- [Human Health | Boehringer Ingelheim IN](/content/in/human-health/index.html): Boehringer Ingelheim is dedicated to the discovery, development, manufacture and marketing of innovative health care products. Click here to learn more. (324 words)
- [Prevenção do AVC na Fibrilhação Auricular | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/fibrilhacao-auricular/index.html): Um AVC ocorre quando o fornecimento de sangue a parte do cérebro é interrompido. (91 words)
- [Acidente vascular cerebral isquémico agudo | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/acidente-vascular-cerebral/index.html): O AVC isquémico agudo é o tipo de AVC mais comum. Ocorre quando o fornecimento de sangue a parte do cérebro é bloqueado. (104 words)
- [Культура партнерства | Boehringer Ingelheim UA](/content/ua/partnering/human-health-partnering/partnering-culture/index.html): Наші партнери є цінними членами нашої глобальної інноваційної родини. Наша довгострокова дослідницька та інвестиційна спрямованість означає, що ми можемо працювати разом над реалізацією їхніх ідей, повністю віддаючись довгостроковим відносинам і забезпечу (43 words)
- [Terms of Use | Boehringer Ingelheim IN](/content/in/terms-use/index.html): Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/in, whether as a visitor or a registered user. (1,410 words)
- [Hipertensão | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/hipertensao/index.html): A hipertensão (tensão arterial elevada) é uma condição que afecta aproximadamente mil milhões de pessoas no mundo. (136 words)
- [Декларация за достъпност | Boehringer Ingelheim BG](/content/bg/deklaraciya-za-dostpnost/index.html): Научете как правим нашия уебсайт възможно най-удобен за потребителите. (504 words)
- [Leadership | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/lideranca/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Дослідницький процес | Boehringer Ingelheim UA](/content/ua/science-innovation/animal-health-innovation/research-process/index.html): Ключовою частиною нашої місії є відкриття або ідентифікація нових сполук, вакцин, технологій, хворобливих процесів та інфекційних агентів. Для цього ми використовуємо поєднання складних інструментів, технічних можливостей і досвіду - як у наших глобальних (115 words)
- [Human Health Products New Zealand | Boehringer Ingelheim AU](/content/au/human-health/products/human-health-products-new-zealand/index.html): Here you can find Consumer Medicine Information (CMI) and product information for our human health products for New Zealand. Click here to find out more. (236 words)
- [Приєднуйтеся до нас | Boehringer Ingelheim UA](/content/ua/partnering/human-health-partnering/connect-us/index.html): Приєднуйтеся до нас (44 words)
- [Підтримка розвитку науки | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/fostering-science/index.html): Розвиток науки через партнерство та співпрацю має вирішальне значення для розробки ефективних методів лікування, які можуть змінити життя пацієнтів. Дізнайтеся більше тут. (57 words)
- [Керівництво | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (467 words)
- [Свині | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/swine/index.html): Ми є партнером і сприяємо сталому виробництву свинини та тваринного білка, забезпечуючи добробут тварин шляхом профілактики та комплексної охорони здоров'я. (164 words)
- [Коні | Boehringer Ingelheim UA](/content/ua/animal-health/companion-animals-horses/horses/index.html): Ми розробляємо провідні рішення для благополуччя коней в галузі імунології, паразитології, шлунково-кишкового тракту та метаболізму. (74 words)
- [Animal Health Partnering Interests | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/partnering-interests/index.html): Explore Boehringer Ingelheim’s partnering interests in animal health, including infectious diseases, non-infectious diseases, and non-disease areas of focus. (753 words)
- [Здоров'я тварин: Наша відповідальність | Boehringer Ingelheim UA](/content/ua/animal-health/our-responsibility/index.html): Ми плануємо в поколіннях. Це відображено в нашій більш ніж 100-річній успішній історії компанії. Це також є основою стійкості. (151 words)
- [Безопасност на пациентите и фармакологична бдителност | Boehringer Ingelheim BG](/content/bg/human-health/our-responsibility/bezopasnost-na-pacientite/index.html): Пациентите ни вдъхновяват в мисията ни да бъдем начело на научноизследователската дейност, която създава революционни терапии, за да могат нашите лекарства да променят живота на пациентите. (333 words)
- [Наука та інновації | Boehringer Ingelheim UA](/content/ua/science-innovation/index.html): Дізнайтеся, як компанія Boehringer Ingelheim приймає наукові виклики, роблячи все по-новому. Натисніть тут, щоб прочитати наші останні статті про науку та інновації. (138 words)
- [Клінічні дослідження | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/clinical-studies/index.html): Натисніть, щоб дізнатися про важливість клінічних досліджень для розробки нових лікарських засобів та переглянути деякі з клінічних досліджень, які спонсорувала компанія "Берінгер Інгельхайм". (47 words)
- [Desenvolvimento sustentável — O nosso compromisso | Boehringer Ingelheim PT](/content/pt/sobre-nos/desenvolvimento-sustentavel/o-nosso-compromisso/index.html): A nossa jornada consiste em promover a inovação, criando valor em áreas em que existem necessidades médicas por colmatar e envolvendo as comunidades. (131 words)
- [Вакцини | Boehringer Ingelheim UA](/content/ua/science-innovation/animal-health-innovation/vaccines/index.html): Ми працюємо з різними захворюваннями та видами тварин, розробляючи та постачаючи надійні ефективні вакцини для тварин-компаньйонів, домашніх тварин та великої рогатої худоби, докладніше читайте тут. (69 words)
- [Science Stories | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/index.html): Science Stories (592 words)
- [Інновації в галузі здоров'я тварин | Boehringer Ingelheim UA](/content/ua/science-innovation/animal-health-innovation/index.html): Наш підрозділ Глобальних інновацій є першопрохідником у галузі науки, яка допомагає ветеринарам, власникам домашніх тварин та худоби, а також громадським установам з охорони здоров'я у всьому світі покращувати здоров'я тварин сьогодні та в майбутньому. (74 words)
- [Терапевтичні препарати | Boehringer Ingelheim UA](/content/ua/science-innovation/animal-health-innovation/therapeutics/index.html): Ми забезпечуємо дисциплінований науковий підхід до глобального відкриття, розробки та доставки терапевтичних засобів для всіх відповідних видів тварин. (63 words)
- [Animal Health Products New Zealand | Boehringer Ingelheim AU](/content/au/animal-health/products/animal-health-product-new-zealand/index.html): Animal Health Products New Zealand (392 words)
- [Наукові історії | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/science-stories/index.html): Натисніть тут, щоб переглянути наші останні історії наукового успіху. Важливо замислитися над успіхом нових ліків, які значно покращують життя пацієнтів. (60 words)
- [Паразитоциди | Boehringer Ingelheim UA](/content/ua/science-innovation/animal-health-innovation/parasiticides/index.html): Дізнайтеся про глобальні інновації та досвід компанії "Берінгер Інгельхайм" у виробництві паразитоцидів для тварин-компаньйонів і великої рогатої худоби, таких як коти, собаки та коні. (51 words)
- [Захворювання сітківки ока | Boehringer Ingelheim UA](/content/ua/human-health/retinal-diseases/index.html): Компанія «Берінгер Інгельхайм» розширила свою глобальну діяльність у галузі досліджень та розробок, спрямовану на боротьбу із захворюваннями очей. (119 words)
- [Наша відповідальність | Boehringer Ingelheim UA](/content/ua/human-health/our-responsibility/index.html): Життя тварин і людей взаємопов'язане глибоким та складним чином. Ми знаємо, що коли тварини здорові, здорові й люди. Створюючи цінність завдяки інноваціям, ми підвищуємо рівень життя і для тих, і для інших. (79 words)
- [Ветеринарна охорона здоров'я | Boehringer Ingelheim UA](/content/ua/animal-health/veterinary-public-health/index.html): Ветеринарна охорона здоров'я (87 words)
- [Тварини-компаньйони | Boehringer Ingelheim UA](/content/ua/animal-health/companion-animals-horses/index.html): Ви ветеринар? Маєте домашнього улюбленця? Чи, може, тримаєте коней? Компанія «Берінгер Інгельхайм», будучи одним з лідерів міжнародного рівня у своїй сфері, допоможе вашим тваринам жити довше та краще. (30 words)
- [Свійські тварини | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/index.html): «Берінгер Інгельхайм» є одним із провідних постачальників медичних рішень для прогнозування, профілактики та лікування захворювань худоби. Таким чином, ми допомагаємо фермерам у всьому світі покращувати якість та безпечність наших харчових продуктів. (37 words)
- [Науковий фокус | Boehringer Ingelheim UA](/content/ua/science-innovation/human-health-innovation/science-focus/index.html): Дізнайтеся, на чому наразі зосереджені науково-дослідницькі зусилля та інвестиції компанії "Берінгер Інгельхайм", включаючи захворювання (56 words)
- [Declaração sobre acessibilidade | Boehringer Ingelheim PT](/content/pt/declaracao-sobre-acessibilidade/index.html): A Boehringer Ingelheim está empenhada em proporcionar um website que seja acessível à maior audiência possível, independentemente da tecnologia. (520 words)
- [Material de Imprensa | Boehringer Ingelheim PT](/content/pt/meios-de-comunicacao/index.html): Aceder ao nosso repositório de meios de comunicação e ao kit de imprensa sobre Saúde Animal. (60 words)
- [Жуйні тварини | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/ruminants/index.html): Наш бізнес жуйних тварин зосереджений на паразитоцидах, вакцинах і терапевтичних засобах, які пропонуються ветеринарам і фермерам молочного та м'ясного скотарства. (60 words)
- [Домашні тварини | Boehringer Ingelheim UA](/content/ua/animal-health/companion-animals-horses/pets/index.html): Компанія Boehringer Ingelheim має безліч продуктів і дослідницьких елементів, які працюють над тим, щоб гарантувати здоров'я та благополуччя ваших д (46 words)
- [Белодробна фиброза | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/index.html): Намаляването на риска от остри екзацербации е основна цел на лечението на пациенти с идиопатична белодробна фиброза (IPF). (186 words)
- [Легеневий фіброз | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/pulmonary-fibrosis/index.html): Зменшення ризику гострих загострень є ключовою метою лікування пацієнтів з легеневим фіброзом. (104 words)
- [Бронхоектазія | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/bronchiectasis/index.html): Бронхоектазія (123 words)
- [Депресія | Boehringer Ingelheim UA](/content/ua/human-health/mental-health/depression/index.html): Депресія (62 words)
- [Къде да ни намерите | Boehringer Ingelheim BG](/content/bg/about-us/where-find-us/index.html): Boehringer Ingelheim има 52 000 служители и глобална изследователска и производствена мрежа. (388 words)
- [Хронично бъбречно заболяване | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/index.html): Хронично бъбречно заболяване (217 words)
- [Switching market | Boehringer Ingelheim PT](/content/pt/disclaimer/market/index.html) (58 words)
- [Импринт | Boehringer Ingelheim BG](/content/bg/imprint/index.html): Публикувано от Бьорингер Ингелхайм РЦВ ГмбХ И Ко КГ. – клон България КЧТ. (104 words)
- [Who we are | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (72 words)
- [Метаболитни заболявания | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/index.html): Заболяванията засягащи сърцето, бъбреците и метаболитната система са водеща причина за смъртност в световен мащаб. Научете повече. (125 words)
- [Ветеринарна медицина | Boehringer Ingelheim BG](/content/bg/animal-health/index.html): Открийте как Boehringer Ingelheim се стреми да гарантира, че вашият домашен любимец получава същото ниво на здравни грижи като хората, независимо дали е обикновен домашен любимец или кон. (217 words)
- [Якість Boehringer Ingelheim | Boehringer Ingelheim UA](/content/ua/about-us/quality/index.html): Якість Boehringer Ingelheim (168 words)
- [Leaving site | Boehringer Ingelheim PT](/content/pt/disclaimer/bi/index.html) (152 words)
- [Шизофренія | Boehringer Ingelheim UA](/content/ua/human-health/mental-health/schizophrenia/index.html): Шизофренія (70 words)
- [Здоров'я людей | Boehringer Ingelheim UA](/content/ua/human-health/index.html): Берінгер Інгельхайм - це група компаній, що займається дослідженнями, спрямованими на відкриття, розробку, виробництво та маркетинг інноваційних продуктів для охорони здоров'я. (223 words)
- [Психічні розлади | Boehringer Ingelheim UA](/content/ua/human-health/mental-health/index.html): Захворювання центральної нервової системи (ЦНС), включаючи шизофренію або хворобу Альцгеймера, перебувають у центрі уваги досліджень і розробок компанії «Берінгер Інгельхайм». (95 words)
- [Human Health Products Australia | Boehringer Ingelheim AU](/content/au/human-health/products/human-health-product-australia/index.html): Products Overview of our products. (383 words)
- [Нашата отговорност | Boehringer Ingelheim BG](/content/bg/human-health/our-responsibility/index.html): В Boehringer Ingelheim поставяме пациентите в центъра на всичко, което вършим. (129 words)
- [Хто ми | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (204 words)
- [Закупівлі | Boehringer Ingelheim UA](/content/ua/about-us/purchasing/index.html): Постачальники є невіддільною частиною нашої спрямованості на успіх. Ми захоплені пошуком інноваційних рішень та нових можливостей для перегляду, покращення та оптимізації нашої бази постачальників. (266 words)
- [Култура на качеството в Boehringer Ingelheim | Boehringer Ingelheim BG](/content/bg/about-us/quality/index.html): Култура на качеството в Boehringer Ingelheim (256 words)
- [По всіх типах раку | Boehringer Ingelheim UA](/content/ua/human-health/cancer/across-cancer-types/index.html): По всіх типах раку (70 words)
- [Диабет | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/diabetes/index.html): Научете повече за диабета и за това как Boehringer Ingelheim работи, за да подобри живота на пациентите. (180 words)
- [Інсульт | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/stroke/index.html): Компанія "Берінгер Інгельхайм" розробила єдиний ліцензований препарат для розчинення тромбів (тромболітик) для лікування гострого ішемічного інсульту, який зараз використовується у всьому світі. (99 words)
- [Научна дейност и иновации | Boehringer Ingelheim BG](/content/bg/science-innovation/index.html): Разберете как Boehringer Ingelheim се справя с научните предизвикателства, като прави нещата по различен начин. Кликнете тук, за да прочетете последните ни статии за наука и иновации. (67 words)
- [Шизофрения | Boehringer Ingelheim BG](/content/bg/human-health/mental-health/schizophrenia/index.html): Шизофренията се характеризира от три групи симптоми и засяга ~1% от населението на света. (84 words)
- [Про нас | Boehringer Ingelheim UA](/content/ua/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (201 words)
- [Sustainable Development | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/index.html): Discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (228 words)
- [Розширення можливостей для пацієнтів | Boehringer Ingelheim UA](/content/ua/human-health/cancer/empowering-patients/index.html): Розширення можливостей для пацієнтів (72 words)
- [Склеродермія | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/scleroderma/index.html): Системна склеродермія - це складне рідкісне захворювання з варіабельним перебігом. Воно проявляється низкою симптомів, що охоплюють кілька різних органів (83 words)
- [Серцева недостатність | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/heart-failure/index.html): Серцева недостатність (153 words)
- [Діабет | Boehringer Ingelheim UA](/content/ua/human-health/metabolic-diseases/diabetes/index.html): Дізнайтеся більше про діабет і про те, як компанія Boehringer Ingelheim працює над дослідженнями та розробкою нових, інноваційних ліків від діабету для покращення життя пацієнтів. (97 words)
- [Ожиріння | Boehringer Ingelheim UA](/content/ua/human-health/metabolic-diseases/obesity/index.html): Ожиріння (80 words)
- [Заболявания на ретината | Boehringer Ingelheim BG](/content/bg/human-health/retinal-diseases/index.html): В Boehringer Ingelheim разширихме глобалната си научноизследователска и развойна дейност, за да се справим с очните заболявания, по-специално тези, които засягат задната част на окото. (136 words)
- [Метаболічні захворювання | Boehringer Ingelheim UA](/content/ua/human-health/metabolic-diseases/index.html): Близько 425 мільйонів дорослих людей у ​​світі живуть з діабетом, причому діабет 2 типу становить 90–95% усіх випадків. За прогнозами, до 2045 ро (68 words)
- [Гіпертонія | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/hypertension/index.html): Гіпертонія (87 words)
- [Инсулт | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/stroke/index.html): Научете повече за инсулта, как да се предпазите и как разпознаването на признаците и симптомите може да спаси живот. (129 words)
- [Рак | Boehringer Ingelheim UA](/content/ua/human-health/cancer/index.html): Рак забирає. Забирає час. Забирає близьких. У компанії «Берінгер Інгельхайм» ми даруємо пацієнтам нову надію, беручи участь у лікуванні раку. (35 words)
- [Психиатрични заболявания | Boehringer Ingelheim BG](/content/bg/human-health/mental-health/index.html): Boehringer Ingelheim разработва редица нови препарати за лечение на заболявания на централната нервна система (ЦНС), някои от които са в напреднала к (112 words)
- [Различните видове рак | Boehringer Ingelheim BG](/content/bg/human-health/cancer/across-cancer-types/index.html): Разработихме солиден набор от клинични активи, включително имуноонкологични изследователски терапии, които могат да донесат полза за хората, болни от рак. (93 words)
- [Метаболитно-асоцииран стеатохепатит | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/mash/index.html): Неалкохолният стеатохепатит се дължи на провокирано от метаболизма възпаление на черния дроб и е една от основните причини за чернодробна фиброза и цироза. (122 words)
- [Ракови заболявания | Boehringer Ingelheim BG](/content/bg/human-health/cancer/index.html): В Boehringer Ingelheim сме се посветили на работата по подобряване на лечението на пациенти с рак навсякъде по света, като се фокусираме върху рака на белия дроб и стомашно-чревния тракт. (111 words)
- [Системна склероза | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/scleroderma/index.html): Системната склероза е сложно рядко заболяване с променлив ход. То се проявява с редица симптоми, засягащи няколко различни органа (92 words)
- [Swine | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/swine/index.html): Protecting pigs and sustaining the swine industry are top priorities for Boehringer Ingelheim as we partner with pork producers and swine veterinarians (415 words)
- [Рак легень | Boehringer Ingelheim UA](/content/ua/human-health/cancer/lung-cancer/index.html): Рак легень (34 words)
- [Хипертония | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/hypertension/index.html): Ефективните лечение и контрол на хипертонията са важни с оглед предотвратяване на усложнения като сърдечен удар или инсулт. (100 words)
- [Депресия | Boehringer Ingelheim BG](/content/bg/human-health/mental-health/depression/index.html): Boehringer Ingelheim съсредоточава изследователската си работа върху депресията, за да намери потенциални нови лечения за пациентите и характерните им обстоятелства. (59 words)
- [Фібриляція передсердь | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/atrial-fibrillation/index.html): Фібриляція передсердь (69 words)
- [Сталий розвиток | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/index.html): Цінності та принципи, яких компанія «Берінгер Інгельхайм» дотримується протягом понад 130 років, надійно закладені в нашу корпоративну філософію. (120 words)
- [Animal Health | Boehringer Ingelheim IN](/content/in/animal-health/index.html): We care for animals, and are a global leader in the animal health industry. Click here to learn more about Boehringer Ingelheim's animal health work. (338 words)
- [Рак на белия дроб | Boehringer Ingelheim BG](/content/bg/human-health/cancer/lung-cancer/index.html): Стремим се да променим живота на хората, живеещи с рак на белия дроб, второто най-често срещано онкологично заболяване в света. (44 words)
- [Purchasing | Boehringer Ingelheim IN](/content/in/about-us/purchasing/index.html): Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too. (79 words)
- [DPOC e Asma | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-pulmonares/dpoc-e-asma/index.html): A Doença Pulmonar Obstrutiva Crónica (DPOC) é uma doença progressiva e tratável caracterizada por um fluxo de ar limitado dentro e fora dos pulmões. (350 words)
- [Нашият ангажимент | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/our-commitment/index.html): Вижте ангажимента за устойчиво развитие на Boehringer Ingelheim тук. Нашата цел е да си сътрудничим с различни общности, за да променим живота към по- (112 words)
- [Повече зелени практики | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/more-green/index.html): Фокусът ни е върху опазването на природните ресурси, включително чистата вода и постигането на въглеродна неутралност в дейността ни. (140 words)
- [Dogs | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/index.html): With products and solutions to protect dog health and improve well-being, Boehringer Ingelheim is committed to longer, happier lives for canine companions (768 words)
- [Ръководство | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/leadership/index.html): Научете повече за Управителния съвет на Boehringer Ingelheim – с информация за петимата членове и техните съответни отговорности. (85 words)
- [История | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/history/index.html): Научете повече за историята на иновативната фармацевтична компания Boehringer Ingelheim. (90 words)
- [Устойчиво развитие | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/index.html): Кликнете тук, за да се запознаете с нашето послание "Устойчиво развитие - за поколенията". То включва не само сегашното поколение, но и бъдещите поколения. (150 words)
- [НАСГ | Boehringer Ingelheim UA](/content/ua/human-health/metabolic-diseases/mash/index.html): НАСГ (103 words)
- [Companion Animals | Boehringer Ingelheim IN](/content/in/animal-health/companion-animals/index.html): Boehringer Ingelheim Animal Health helps provide longer, healthier and happier lives for companion animals. Click here to learn and find out more. (160 words)
- [Ruminants | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/ruminants/index.html): Across the lifespan of cattle and sheep, Boehringer Ingelheim delivers proactive solutions to help ruminant producers optimize herd health and productivity (469 words)
- [Повече здраве | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/more-health/index.html): Кликнете тук, за да изтеглите Манифеста на Boehringer Ingelheim за 2025 г., в който е описана дългосрочната инициатива за подобряване на здравето по све (34 words)
- [Белодробни заболявания | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/index.html): Намерете информация за различни респираторни заболявания, като астма, ХОББ, идиопатична белодробна фиброза (IPF), склеродермия и рак на белия дроб. (77 words)
- [Human Health Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/index.html): Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need. (230 words)
- [About Us | Boehringer Ingelheim IN](/content/in/about-us/index.html): Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to learn and find out more about us. (192 words)
- [History | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/history/index.html): Learn about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people. (111 words)
- [Horses | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/horses/index.html): Partnering with owners and vets, Boehringer Ingelheim’s Equine team brings deep expertise and a passion for the equestrian life to help all horses thrive (446 words)
- [Patient Safety & Pharmacovigilance at Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/human-health/our-responsibility/patient-safety/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (442 words)
- [Doenças Pulmonares | Boehringer Ingelheim PT](/content/pt/saude-humana/doencas-pulmonares/index.html): A Boehringer Ingelheim tem 100 anos de experiência no campo das doenças respiratórias. Desde 1921 que somos um dos líderes nesta área. (103 words)
- [Science Focus | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (184 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim AU](/content/au/partnering/biopharma-contract-manufacturing/index.html): As one of three business areas within Boehringer Ingelheim we are offering biopharmaceutical contract development and manufacturing expertise. Learn more. (39 words)
- [Етичен кодекс и съответсвие | Boehringer Ingelheim BG](/content/bg/about-us/ethics-and-compliance/index.html): Нашият ФОКУС изразява кои сме, как работим и какво искаме да постигнем. (64 words)
- [Більше зеленого | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/more-green/index.html): Більше зеленого (110 words)
- [Partnering | Boehringer Ingelheim AU](/content/au/partnering/index.html): We embrace the power of partnership and diversity of minds to realise even more innovation and incubate new ideas. Read more about our partnering. (193 words)
- [Ruminants Health | Boehringer Ingelheim AU](/content/au/animal-health/livestock/ruminants/index.html): Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers. Learn more. (197 words)
- [Imprint | Boehringer Ingelheim AU](/content/au/imprint/index.html): Here you can view contact details and information about Boehringer Ingelheim International GmbH. Click here to read and find out more information. (86 words)
- [Cats | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/cats/index.html): By advancing innovation for the unique challenges of cat care, Boehringer Ingelheim’s feline experts help strengthen the bond between cats and their people (632 words)
- [Switching market | Boehringer Ingelheim IN](/content/in/disclaimer/market/index.html) (70 words)
- [Animal Health Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/animal-health-innovation/index.html): Innovationen in der Tiergesundheit (186 words)
- [Horses | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/cavalli/index.html): Horses (284 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim AU](/content/au/animal-health/our-responsibility/index.html): We plan in generations. This is reflected in our more than 100 years of successful company history. Read about our responsibility to animal health here. (213 words)
- [Transparency | Boehringer Ingelheim AU](/content/au/about-us/transparency/index.html): Boehringer Ingelheim is committed to ethical and transparent interactions with healthcare professionals that supports the quality use of medicines and trust with stakeholders (533 words)
- [Partnering | Boehringer Ingelheim AT](/content/at/en/partnering/index.html): We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy. (170 words)
- [Animal Health | Boehringer Ingelheim AU](/content/au/animal-health/index.html): Animal Health (246 words)
- [Veterinary Public Health | Boehringer Ingelheim AU](/content/au/animal-health/veterinary-public-health/index.html): Veterinary Public Health (188 words)
- [Leaving site | Boehringer Ingelheim UA](/content/ua/disclaimer/bi/index.html) (74 words)
- [Where to find us | Boehringer Ingelheim AU](/content/au/about-us/where-find-us/index.html): With 52,000 employees worldwide, Boehringer Ingelheim has a research and production network across the globe. Click here to see our biggest sites. (389 words)
- [The Research Process | Boehringer Ingelheim AT](/content/at/en/science-innovation/animal-health-innovation/research-process/index.html): The Research Process (130 words)
- [Poultry | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/poultry/index.html): As trusted partners to poultry producers, Boehringer Ingelheim provides industry-leading vaccines and expertise to protect both flock health and businesses (395 words)
- [Chronic Kidney Disease | Boehringer Ingelheim AU](/content/au/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (156 words)
- [Salute animale: la nostra responsabilità | Boehringer Ingelheim IT](/content/it/salute-animale/la-nostra-responsabilita/index.html): Our responsibilty (262 words)
- [Livestock Health | Boehringer Ingelheim AU](/content/au/animal-health/livestock/index.html): Boehringer Ingelheim is one of the leading providers of health solutions to predict, prevent and treat diseases in livestock animals. Find out more. (76 words)
- [Pet Health | Boehringer Ingelheim AU](/content/au/animal-health/companion-animals/pets/index.html): Boehringer Ingelheim has multiple products and research elements working to ensure that your pet's health and wellbeing is number one. Find out more. (135 words)
- [Swine Health | Boehringer Ingelheim AU](/content/au/animal-health/livestock/swine/index.html): We are a partner and enabler of sustainable pork and animal protein production, ensuring animal welfare through prevention and integrated health care. (176 words)
- [Grass Roots | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots (180 words)
- [Partnering | Boehringer Ingelheim IT](/content/it/parternariato/index.html): Partnering (168 words)
- [Clinical Studies | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/clinical-studies/index.html): Clinical Studies (91 words)
- [Vaccines | Boehringer Ingelheim AT](/content/at/en/science-innovation/animal-health-innovation/vaccines/index.html): Vaccines (71 words)
- [Fostering Science | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/fostering-science/index.html): Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here. (194 words)
- [COPD & Asthma | Boehringer Ingelheim AU](/content/au/human-health/lung-diseases/copd-asthma/index.html): COPD is a progressive, treatable disease characterised by limited airflow in and out of the lungs. Click here to read more about both COPD and asthma. (196 words)
- [Animals We Support | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/index.html): We’re committed to the health of the world’s most important animals: beloved dogs, cats, and horses, plus valued livestock like swine, ruminants, and poultry (420 words)
- [Lavorare insieme per la salute degli animali | Boehringer Ingelheim IT](/content/it/parternariato/parternariato-nella-salute-degli-animali/index.html): Lavorare insieme per la salute degli animali (77 words)
- [Ruminants | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/ruminanti/index.html): Ruminants (343 words)
- [Companion Animals Health | Boehringer Ingelheim AU](/content/au/animal-health/companion-animals/index.html): As one of the leading providers globally, Boehringer Ingelheim helps provide longer, healthier and happier lives for companion animals. Learn more here. (131 words)
- [Therapeutics | Boehringer Ingelheim AT](/content/at/en/science-innovation/animal-health-innovation/therapeutics/index.html): Therapeutics (61 words)
- [Veterinary Product Adverse Events | Boehringer Ingelheim AT](/content/at/en/veterinary-product-adverse-events/index.html): Veterinary Product Adverse Events (189 words)
- [Lavorare insieme per la salute delle persone | Boehringer Ingelheim IT](/content/it/parternariato/parternariato-nella-salute-delle-persone/index.html): Lavorare insieme per la salute delle persone (100 words)
- [Pets | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/pets/index.html): Pets (380 words)
- [Parasiticides | Boehringer Ingelheim AT](/content/at/en/science-innovation/animal-health-innovation/parasiticides/index.html): Parasiticides (55 words)
- [Scleroderma (SSc) | Boehringer Ingelheim AU](/content/au/human-health/lung-diseases/scleroderma/index.html): Systemic sclerosis (SSc) is a disfiguring, disabling and potentially fatal rare disease. Click here to read more information about systemic sclerosis. (90 words)
- [Our Responsibility | Boehringer Ingelheim AT](/content/at/en/human-health/our-responsibility/index.html): Human Health Our Responsibility (318 words)
- [Boehringer Ingelheim BioXcellence™ | Boehringer Ingelheim IT](/content/it/parternariato/produzione-biofarmaceutica-contratto/index.html): Produzione biofarmaceutica globale a contratto (66 words)
- [Science & Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/index.html): Innovation (205 words)
- [Cookie policy | Boehringer Ingelheim IT](/content/it/cookie-policy/index.html): Cookie policy (1,977 words)
- [Human Health | Boehringer Ingelheim AU](/content/au/human-health/index.html): Here you can find Consumer Medicine Information (CMI) and product information for our human health products. Click here to view our products. (285 words)
- [Horses Health | Boehringer Ingelheim AU](/content/au/animal-health/companion-animals/horses/index.html): As a leader in equine health, Boehringer Ingelheim develops innovative solutions for the well-being of horses around the world. Click here to read more. (104 words)
- [Metabolic dysfunction-associated steatohepatitis (MASH) | Boehringer Ingelheim AU](/content/au/human-health/metabolic-diseases/mash/index.html): Read and learn about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting the Boehringer Ingelheim site. (121 words)
- [The Research Process | Boehringer Ingelheim IT](/content/it/science-innovation/animal-health-innovation/il-processo-di-ricerca/index.html): The Research Process (138 words)
- [Contact Us | Boehringer Ingelheim AU](/content/au/contact-us/index.html): To contact us at Boehringer Ingelheim click here to get our contact details or fill out our contact request form. We welcome your queries and feedback. (145 words)
- [Suini | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/suini/index.html): swine (194 words)
- [Käyttöehdot | Boehringer Ingelheim FI](/content/fi/kayttoehdot/index.html): Tämä verkkosivusto on kansainvälinen tietokanta pääkonttoristamme (Ingelheim, Saksa), ja sen tarkoitus tietoja maailmanlaajuisesta liiketoiminnastamme. (1,072 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim AU](/content/au/about-us/quality/index.html): Quality at Boehringer Ingelheim (236 words)
- [Featured Stories | Boehringer Ingelheim AT](/content/at/en/animal-health/featured-stories/index.html): Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans. (292 words)
- [Vaccines | Boehringer Ingelheim IT](/content/it/science-innovation/animal-health-innovation/vaccini/index.html): Vaccines (79 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim AU](/content/au/human-health/lung-diseases/pulmonary-fibrosis/index.html): Pulmonary fibrosis is a condition leading to a build-up of scar tissue in the lungs. Read about pulmonary fibrosis, including its symptoms and more, here. (114 words)
- [Science and Innovation | Boehringer Ingelheim IT](/content/it/science-innovation/index.html): Science and Innovation (140 words)
- [Animal Health Innovation | Boehringer Ingelheim IT](/content/it/science-innovation/animal-health-innovation/index.html): Animal Health Global Innovation (81 words)
- [Lung Diseases | Boehringer Ingelheim AU](/content/au/human-health/lung-diseases/index.html): Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Click here to learn more about lung diseases and our work in this area. (100 words)
- [Parasiticides | Boehringer Ingelheim IT](/content/it/science-innovation/animal-health-innovation/antiparassitari/index.html): Parasiticides (60 words)
- [Human Health Innovation | Boehringer Ingelheim IT](/content/it/science-innovation/human-health-innovation/index.html): Human Health Innovation (34 words)
- [Therapeutics | Boehringer Ingelheim IT](/content/it/science-innovation/animal-health-innovation/terapeutici/index.html): Prodotti terapeutici (69 words)
- [Leadership | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (175 words)
- [Atrial Fibrillation | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/atrial-fibrillation/index.html): Patients with an irregular heart beat (known as atrial fibrillation) are at increased risk of stroke. Learn more about our work on atrial fibrillation. (80 words)
- [Poultry | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/avicoli/index.html): Poultry (302 words)
- [About Us | Boehringer Ingelheim AU](/content/au/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here and find out more about us. (178 words)
- [Obesity | Boehringer Ingelheim AU](/content/au/human-health/metabolic-diseases/obesity/index.html): Obesity is a complex chronic disease that requires long term management. Click here to find out more about obesity and how it is becoming more commonplace. (66 words)
- [Animal Health | Boehringer Ingelheim AT](/content/at/en/animal-health/index.html): Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse. (294 words)
- [MORE HEALTH for People & Animals | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-health/index.html): More Health is a long-term initiative with the goal to improve health in communities around the world. Click here and learn more about this initiative. (76 words)
- [Media Overview | Boehringer Ingelheim AU](/content/au/media/index.html): We are one of the world's leading research-driven pharmaceutical companies with over 130 years of experience. Click here and view our media overview. (144 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/our-commitment/index.html): Read and learn about our sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (398 words)
- [Il nostro impegno | Boehringer Ingelheim IT](/content/it/salute-animale/il-nostro-impegno/index.html): Il nostro impegno (277 words)
- [Heart Failure | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/heart-failure/index.html): Heart failure refers to the inability of the heart to pump sufficient blood through the body. Click here to find out and learn more information. (157 words)
- [Diabetes | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/diabetes/index.html): Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives. (253 words)
- [More Green | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-green/index.html): Our More Green pillar encompasses environmental initiatives that consider many different aspects. Learn about our More Green pillar by clicking here. (124 words)
- [Animal Health | Boehringer Ingelheim IT](/content/it/salute-animale/index.html): animal health (286 words)
- [Hypertension (High Blood Pressure) | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/hypertension/index.html): Hypertension affects approximately one billion people worldwide and that number is expected to increase in future years. Click here to find out more. (79 words)
- [Perspektiivit | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/kumppanuudet-elainterveyden-alalla/perspektiivit/index.html): Lue näkemyksiä eläinterveyden toimialasta ja Boehringer Ingelheimin asiantuntijoiden näkemyksiä yhteistyön tärkeydestä innovaatioiden edistämisessä (277 words)
- [Leadership | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (583 words)
- [Malattie Mentali | Boehringer Ingelheim IT](/content/it/salute-umana/salute-mentale/index.html): Mental Disorders (215 words)
- [Lung Cancer | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/lung-cancer/index.html): Building on our experience in lung disease, our goal is to take lung cancer on, transform the treatment landscape and ultimately, redefine all lung cancers as curable. (276 words)
- [Who we are | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/index.html): Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. Click here to find out more. (387 words)
- [Mental Health | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (240 words)
- [Sustainable Development | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/index.html): Read about our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (158 words)
- [Cancer | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/index.html): At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers. (345 words)
- [Patient Centricity | Boehringer Ingelheim IT](/content/it/salute-umana/la-nostra-responsabilita/patient-centricity/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (113 words)
- [Retinal Diseases | Boehringer Ingelheim AT](/content/at/en/human-health/retinal-diseases/index.html): At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. (137 words)
- [BPCO e Asma | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/bpco-e-asma/index.html): BPCO e Asma (517 words)
- [Mistä löydät meidät | Boehringer Ingelheim FI](/content/fi/tietoa-meista/mista-loydat-meidat/index.html): Boehringer Ingelheimin 52 000 työntekijää muodostavat maailmanlaajuisen tutkimus- ja tuotantoverkoston. Tässä ovat suurimmat toimipaikkamme. (304 words)
- [Livestock | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/index.html): Livestock (40 words)
- [Fibrosi Polmonare | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/fibrosi-polmonare/index.html): Pulmonary fibrosis (214 words)
- [Schizophrenia | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/schizophrenia/index.html): Schizophrenia (233 words)
- [Veterinary Public Health | Boehringer Ingelheim IT](/content/it/salute-animale/salute-pubblica-veterinaria/index.html): Veterinary Public Health (105 words)
- [Contact Us | Boehringer Ingelheim AT](/content/at/en/contact-us/index.html): Contact Us (478 words)
- [History | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/history/index.html): Click here to read about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people. (119 words)
- [La Qualità in Boehringer Ingelheim | Boehringer Ingelheim IT](/content/it/su-di-noi/qualita/index.html): La Qualità in Boehringer Ingelheim (272 words)
- [Bronchiectasis | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis (175 words)
- [Bronchiectasia | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/bronchiectasia/index.html): Bronchiectasia (152 words)
- [Area respiratoria | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/index.html): Lung Diseases (87 words)
- [Scleroderma | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/scleroderma/index.html): Scleroderma (93 words)
- [Depression | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/depression/index.html): Depression (62 words)
- [Privacidad y Política de cookies | Boehringer Ingelheim ES](/content/es/privacidad-y-politica-de-cookies/index.html): Política de Boehringer Ingelheim España, en cumplimiento de lo dispuesto en la legislación aplicable en materia de protección de datos de carácter personal. (1,466 words)
- [Retinopatie | Boehringer Ingelheim IT](/content/it/salute-umana/retinopatie/index.html): Retinal Diseases (134 words)
- [Chronic Kidney Disease | Boehringer Ingelheim AT](/content/at/en/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (223 words)
- [Depressione | Boehringer Ingelheim IT](/content/it/salute-umana/salute-mentale/depressione/index.html): Depression (65 words)
- [Dove trovarci | Boehringer Ingelheim IT](/content/it/su-di-noi/dove-trovarci/index.html): Dove trovarci (413 words)
- [Schizophrenia | Boehringer Ingelheim IT](/content/it/salute-umana/salute-mentale/schizofrenia/index.html): Schizophrenia (92 words)
- [Preguntas frecuentes | Boehringer Ingelheim ES](/content/es/empleo/proceso-de-solicitud-de-empleo/preguntas-frecuentes/index.html): Visita nuestro aparatdo de preguntas frecuentes sobre el proceso de solicitud de empleo en Boehringer Ingelheim. No te quedes con ninguna duda. (1,793 words)
- [Sclerosi sistemica | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/sclerosi-sistemica/index.html): Sclerosi sistemica (142 words)
- [Privacy Notice | Boehringer Ingelheim KR](/content/kr/privacy-notice/index.html): Privacy Notice (2,551 words)
- [Producten voor diergezondheid | Boehringer Ingelheim NL](/content/nl/voor-dier/producten/index.html): Innovatie is de drijvende kracht in alles wat wij doen. Ons doel is geavanceerde, preventieve gezondheidszorg voor dieren te bieden en intelligente en (2,369 words)
- [Il Purchasing | Boehringer Ingelheim IT](/content/it/su-di-noi/il-purchasing/index.html): Purchasing (219 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (468 words)
- [Fibrillazione Atriale | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/fibrillazione-atriale/index.html): Atrial Fibrillation (273 words)
- [MASH | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/mash/index.html): Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim. (248 words)
- [Across Cancer Types | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (110 words)
- [Ethics & Compliance | Boehringer Ingelheim IT](/content/it/su-di-noi/ethics-compliance-0/index.html): Ethics & Compliance (148 words)
- [MASH | Boehringer Ingelheim IT](/content/it/salute-umana/patologie-metaboliche/nash/index.html): MASH (127 words)
- [Human Health | Boehringer Ingelheim AT](/content/at/en/human-health/index.html): Human Health (363 words)
- [Tumore del polmone | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/tumore-al-polmone/index.html): Tumore del polmone (203 words)
- [Contattaci | Boehringer Ingelheim IT](/content/it/contatti/index.html): Contact Us (193 words)
- [Sviluppo Sostenibile | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/index.html): Sustainable Development (369 words)
- [Cancro | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/index.html): Cancer (175 words)
- [Attraverso le varie Tipologie di Tumore | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/attraverso-le-varie-tipologie-di-tumore/index.html): Across Cancer Types (83 words)
- [Chi siamo | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/index.html): Corporate profile (312 words)
- [Al fianco dei Pazienti | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/al-fianco-dei-pazienti/index.html): Al fianco dei Pazienti (86 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/about-us/quality/index.html): Quality at Boehringer Ingelheim (200 words)
- [Ictus | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/ictus/index.html): stroke (163 words)
- [Saavutettavuusseloste | Boehringer Ingelheim FI](/content/fi/saavutettavuusseloste/index.html): Boehringer Ingelheim on sitoutunut tekemään sivustostaan helppokäyttöisen mahdollisimman laajalle käyttäjäjoukolle riippumatta käytössä olevasta. (327 words)
- [Malattia Renale Cronica | Boehringer Ingelheim IT](/content/it/salute-umana/malattia-renale-cronica/index.html): Chronic Kidney Disease (113 words)
- [Area stampa | Boehringer Ingelheim IT](/content/it/media/index.html): Area stampa (156 words)
- [Ch. Frontline Tri-Act (10.2024) | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/leki-dla-zwierzat/pdf/ch-frontline-tri-act-102024/index.html): Charakterystyka Weterynaryjnego Produktu Weterynaryjnego - Frontline Tri-Act (30 words)
- [Purchasing | Boehringer Ingelheim AT](/content/at/en/about-us/purchasing/index.html): Purchasing at Boehringer Ingelheim (409 words)
- [Stroke | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/stroke/index.html): Stroke (158 words)
- [Ethics and Compliance | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/index.html): Ethics and Compliance (188 words)
- [Porcino | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/porcino/index.html): Somos un socio y facilitador de la producción sostenible de carne de cerdo y proteína animal, asegurando el bienestar animal. (277 words)
- [Who we are | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (259 words)
- [Eläinterveyden yhteistyökiinnostukset | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/kumppanuudet-elainterveyden-alalla/elainterveyden-yhteistyokiinnostukset/index.html): Tutustu Boehringer Ingelheimin yhteistyökiinnostuksiin eläinterveyden alalla, mukaan lukien tartuntataudit, ei‑tarttuvat sairaudet sekä muut painopistealueet, jotka eivät liity tiettyihin sairauksiin. (280 words)
- [Fabricación y cadena de suministro | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/fabricacion-y-cadena-de-suministro/index.html): Descubre nuevas oportunidades en nuestra cadena de Fabricación y Suministro. ¡No pierdas esta oportunidad y únete hoy mismo! (260 words)
- [Obesità | Boehringer Ingelheim IT](/content/it/salute-umana/patologie-metaboliche/obesita/index.html): Obesity (84 words)
- [Kumppanuudet eläinterveyden alalla | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/kumppanuudet-elainterveyden-alalla/index.html): Lue lisää Boehringer Ingelheimin yhteistyöhön perustuvasta lähestymistavasta eläinterveyden innovaatioihin, kumppanuusalueistamme ja siitä, miten voit ottaa yhteyttä tiimiimme (338 words)
- [Alexander Guntur | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/alexander-guntur/index.html): Alexander Guntur, responsable de seguridad y protección de la información en Singapur, describe sus 14 años en la empresa como satisfactorios. (142 words)
- [Yhteistyötarinoita | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/kumppanuudet-elainterveyden-alalla/yhteistyotarinoita/index.html): Lue Boehringer Ingelheimin merkittävimmistä yhteistyöprojekteista eläinterveyden alalla ja siitä, mitä kumppanimme kertovat kokemuksistaan kanssamme työskentelystä (217 words)
- [More potential per le comunità e le nostre persone | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/more-potential/index.html): More Potential: For Communities & Our People (194 words)
- [Su di noi | Boehringer Ingelheim IT](/content/it/su-di-noi/index.html): Chi siamo (197 words)
- [Patologie Metaboliche | Boehringer Ingelheim IT](/content/it/salute-umana/patologie-metaboliche/index.html): Metabolic Diseases (108 words)
- [Metabolic Diseases | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/index.html): Weltweit leben circa 425 Millionen Erwachsene mit Diabetes - 90 bis 95 Prozent davon mit Diabetes-Typ-2. Schätzungen nach wird die Anzahl an Diabeteserkrankungen bis zum Jahr 2045 auf etwa 629 Millionen ansteigen. (129 words)
- [Diabete | Boehringer Ingelheim IT](/content/it/salute-umana/patologie-metaboliche/diabete/index.html): Diabetes (141 words)
- [Storia | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/storia/index.html): La nostra storia (207 words)
- [Heart Failure | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/heart-failure/index.html): Heart Failure (247 words)
- [Scompenso cardiaco | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/scompenso-cardiaco/index.html): Heart Failure (188 words)
- [More green per il nostro pianeta | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/more-green/index.html): More Green: For Our Planet (149 words)
- [Ota meihin yhteyttä | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/kumppanuudet-elainterveyden-alalla/ota-meihin-yhteytta/index.html): Ota yhteyttä Boehringer Ingelheim Animal Healthin liiketoiminnan kehittämisen ja lisensoinnin tiimiin verkossa tai tapahtumissa lähettääksesi ehdotuksen tai keskustellaksesi yhteistyömahdollisuuksista (225 words)
- [More Potential: For Communities & Our People | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/index.html): More Potential: For Communities & Our People (213 words)
- [Data Privacy | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/index.html): Data protection In an increasingly digitalized world, the effective protection of personal data and the privacy of each individual plays an increasingly important role. For this reason, on May 25, 2018, the new EU General Data Protection Regulation GDPR (201 words)
- [Stroke Prevention in Atrial Fibrillation - Cardiovascular | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/atrial-fibrillation/index.html): At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots. (69 words)
- [Argentina | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/argentina/index.html): Argentina es la piedra angular de nuestras operaciones en Sudamérica. Explora las oportunidades profesionales que te brinda hoy BI Argentina. (208 words)
- [ELÄINTEN TERVEYS | Boehringer Ingelheim FI](/content/fi/elainterveys/index.html): Ihmisten ja eläinten elämä on syvästi ja moniulotteisesti sidoksissa toisiinsa. Tiedämme, että kun eläimet ovat terveitä. (213 words)
- [Hypertension | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/hypertension/index.html): Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke. (91 words)
- [Keitä olemme | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/index.html): Boehringer Ingelheim kehittää uraauurtavia hoitoja, joilla muutetaan nykyisten ja tulevien sukupolvien elämää. (327 words)
- [Sustainable Development | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/index.html): Sustainable Development (228 words)
- [Press Releases | Boehringer Ingelheim AT](/content/at/en/media/index.html): Press Releases (153 words)
- [Leki dla zwierząt | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/leki-dla-zwierzat/index.html): Troszczymy się o zdrowie zwierząt. Dowiedz się więcej o lekach weterynaryjnych opracowywanych i produkowanych przez firmę Boehringer Ingelheim. (1,193 words)
- [Descubre nuestras trayectorias profesionales | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/index.html): Conoce las diversas carreras que ofrecemos, diseñadas para ayudarte a crecer profesionalmente, brindandote un trabajo desafiante que contribuye al éxito. (328 words)
- [Leadership | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Il nostro impegno | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/il-nostro-impegno/index.html): Our Commitment (37 words)
- [History | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/history/index.html): History (164 words)
- [Reseptilääkkeet | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/tuotteet/index.html): See our extensive range of human pharmaceutical and animal health products, see how our medicals products are improving patient lives human or animal. (144 words)
- [Työskentely Boehringer Ingelheimilla | Boehringer Ingelheim FI](/content/fi/tyoskentely-boehringer-ingelheimilla/index.html): Liity joukkoomme ja osallistu tehtäviimme luoda arvoa innovaatioiden avulla potilaille, joita palvelemme. (98 words)
- [Partneriyhteistyö | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/index.html): Uskomme partneriyhteistyöhön ja monimuotoisen ajattelun voimaan kaikissa luonnontiede- ja eläinterveysyhteisöissä. (91 words)
- [Suositellut tarinat | Boehringer Ingelheim FI](/content/fi/elainterveys/suositellut-tarinat/index.html): Tiedämme, että kun eläimet ovat terveitä, ihmisetkin ovat terveempiä. Luomalla arvoa innovaatiosta edistämme molempien hyvinvointia. (157 words)
- [Tiede ja innovaatiot | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/index.html): Tutkijamme laajentavat tutkittavia alueita jatkuvasti ja toteuttavat yhtiön jatkuvaa sitoutumista innovaatioihin. (102 words)
- [Leaving site | Boehringer Ingelheim IT](/content/it/disclaimer/bi/index.html) (93 words)
- [Tutustu yritykseemme | Boehringer Ingelheim FI](/content/fi/tyoura-meilla/index.html): Tutustu yritykseemme (35 words)
- [Siat | Boehringer Ingelheim FI](/content/fi/elainterveys/karja/siat/index.html): Boehringer Ingelheim mahdollistaa yhtäaikaisesti sekä kestävän sianliha- ja eläinproteiinien tuotannon että eläinten hyvinvoinnin ennaltaehkäisevän. (133 words)
- [Declaración de accesibilidad | Boehringer Ingelheim ES](/content/es/declaracion-de-accesibilidad/index.html): BI se enorgullece de ser accesible a nuestra audiencia. Haga clic para ver cómo estamos haciendo que nuestro sitio web sea lo más fácil de usar posible. (452 words)
- [Como Aplicar | Boehringer Ingelheim ES](/content/es/empleo/proceso-de-solicitud-de-empleo/index.html): ¿Quieres saber cómo presentar una solicitud, qué esperar y qué tienes que preparar para el proceso? ¡Sigue leyendo y no pierdas detalle! (458 words)
- [Siipikarja | Boehringer Ingelheim FI](/content/fi/elainterveys/karja/siipikarja/index.html): Olemme ylpeitä avainroolistamme, jonka avulla mahdollistamme maapallon väestön ruokkimisen turvallisella, edullisella, riittävällä ja laadukkaalla. (114 words)
- [Christian Betz | Boehringer Ingelheim BR](/content/br/carreiras/christian-betz/index.html): Christian Betz partilha a sua experiência à frente da equipa de engenharia de processos na unidade da Boehringer Ingelheim em Biberach, Alemanha. (133 words)
- [Märehtijät | Boehringer Ingelheim FI](/content/fi/elainterveys/karja/marehtijat/index.html): Märehtijöiden liiketoimintayksikkömme keskittyy eläinlääkäreille sekä maito- ja lihakarjatilallisille tarjottaviin loislääkkeisiin. (60 words)
- [Ihmisterveyden innovaatiot | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/ihmisterveyden-innovaatiot/index.html): Boehringer Ingelheim on selkeä tavoitteissaan. Haluamme tarjota uraauurtavia lääkkeitä, jotka parantavat potilaiden elämää maailmanlaajuisesti. (51 words)
- [Verkkokalvosairaudet | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/verkkokalvosairaudet/index.html): Verkkokalvosairaudet (88 words)
- [Lemmikit | Boehringer Ingelheim FI](/content/fi/elainterveys/seuraelaimet/lemmikit/index.html): Kuulumme markkinajohtajiin loislääkkeissä, rokotteissa ja lääkehoidoissa, minkä lisäksi olemme yhteistyökumppani. (51 words)
- [Switching market | Boehringer Ingelheim AT](/content/at/en/disclaimer/market/index.html) (69 words)
- [Ingeniería e Instalaciones | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/ingenieria-e-instalaciones/index.html): Descubre nuevas oportunidades en nuestro departamento de Ingeniería e Instalaciones. ¡Únete hoy mismo! (296 words)
- [Kliiniset tutkimukset | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/ihmisterveyden-innovaatiot/kliiniset-tutkimukset/index.html): Kliiniset tutkimukset ovat olennainen osa uusien lääkkeiden kehittämistä. Niissä tieteellinen asiantuntemuksemme muunnetaan läpimurtohoidoiksi potilaille. (71 words)
- [Tieteen edistäminen | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/ihmisterveyden-innovaatiot/tiedetarinat/index.html): CPotilaiden elämää muuttavien läpimurtolääkkeiden luominen alkaa sitoutumisesta tulevaisuuden terveyshaasteiden tunnistamiseen. (91 words)
- [Medicina Asuntos Regulatorios | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/medicina-y-asuntos-regulatorios/index.html): Descubre nuevas oportunidades en nuestra área de Medicina y Asuntos Regulatorios. Descubre interesantes oportunidades hoy. (240 words)
- [Yhteistyö ihmisten terveyden alalla | Boehringer Ingelheim FI](/content/fi/partneriyhteistyo/ihmislaakinnan-yhteistyo/index.html): Yhteistyö ihmisten terveyden alalla (44 words)
- [Skleroderma | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/keuhkosairaudet/skleroderma/index.html): Systeeminen skleroosi (SSc) on rumentava, invalidisoiva ja mahdollisesti kuolemaan johtava harvinainen sairaus, joka aiheuttaa ihon (skleroderma). (139 words)
- [Potilaskeskeisyys | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/vastuumme/potilaskeskeisyys/index.html): BI potilaat ovat etusijalla kaikessa toiminnassamme. Potilaat innoittavat meitä tehtävässämme johtaa tiedettä, joka luo läpimurtohoitoja. (79 words)
- [Masennus | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/mielenterveys/masennus/index.html): Masennus on mielenterveyden häiriö, joka aiheuttaa jatkuvaa surua ja mielenkiinnon menetystä. (96 words)
- [Vastuumme | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/vastuumme/index.html): Potilaat inspiroivat meitä tehtävässämme luoda tiedettä, joka johtaa uraauurtaviin hoitoihin. (61 words)
- [Hoidot | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/elainterveyden-innovaatiot/hoidot/index.html): Tarjoamme kurinalaisen tieteellisen lähestymistavan seura- ja kotieläimille tarkoitettujen terapeuttisten lääkkeiden maailmanlaajuiseen löytämiseen. (44 words)
- [Karja | Boehringer Ingelheim FI](/content/fi/elainterveys/karja/index.html): Boehringer Ingelheim on yksi johtavista yrityksistä, joka tarjoaa terveysratkaisuja, joiden avulla voidaan ennustaa, ehkäistä ja hoitaa karjan sairauksia. (58 words)
- [Fokuksena tiede | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/ihmisterveyden-innovaatiot/fokuksena-tiede/index.html): Uusia lääkkeitä koskeva tutkimuksemme keskittyy tieteenaloille, joilla on merkittävä lääketieteellinen tarve ja joilla jatkamme innovointia. (48 words)
- [Mielenterveyshäiriöt | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/mielenterveys/index.html): Boehringer Ingelheim Mental Health määrittelee mielenterveyden uudelleen ja auttaa ihmisiä kukoistamaan. (150 words)
- [Loislääkkeet | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/elainterveyden-innovaatiot/loislaakkeet/index.html): Global Innovationin keskeinen osaamisalue on uusien loismyrkkyjen löytäminen ja kehittäminen sekä seura- että kotieläimille. (39 words)
- [Frank Hübler | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/frank-hubler/index.html): Frank Hübler – Member of the Board of Managing Directors with responsibility for Finance (147 words)
- [Laatu Boehringer Ingelheimilla | Boehringer Ingelheim FI](/content/fi/tietoa-meista/laatu/index.html): Boehringer Ingelheimilla laatu on olennainen osa tuotteen koko elinkaarta. (191 words)
- [Tecnología de la Información | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/tecnologias-de-la-informacion/index.html): Descubre nuevas oportunidades en nuestro departamento de Tecnologías de la Información. Entra a formar parte de BI. (213 words)
- [Impressum | Boehringer Ingelheim ES](/content/es/impressum/index.html): La información médica o de productos ofrecida en esta web está sólo dirigida a residentes en España y es solamente de carácter formativo o educativo. (100 words)
- [Hevoset | Boehringer Ingelheim FI](/content/fi/elainterveys/seuraelaimet/hevoset/index.html): Boehringer Ingelheim, johtava toimija hevosterveyden alalla, kehittää innovatiivisia ratkaisuja hevosten hyvinvointiin ympäri maailmaa. (50 words)
- [Seuraeläimet | Boehringer Ingelheim FI](/content/fi/elainterveys/seuraelaimet/index.html): Boehringer Ingelheim auttaa takaamaan seuraeläimille pitemmän, terveemmän ja onnellisemman elämän. (24 words)
- [Keuhkoahtaumatauti ja astma | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/keuhkosairaudet/keuhkoahtaumatauti-ja-astma/index.html): Krooninen obstruktiivinen keuhkosairaus (COPD) on etenevä, hoidettavissa oleva sairaus, jolle on ominaista, että ilman virtaus keuhkoihin. (167 words)
- [Skitsofrenia | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/mielenterveys/skitsofrenia/index.html): Skitsofrenialle on ominaista kolme oirealuetta, ja sitä sairastaa noin 1% maailman väestöstä. Positiivisten oireiden hoitoon on jo olemassa monia lääkkeitä (77 words)
- [Potilaiden voimaannuttaminen | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/syopa/potilaiden-voimaannuttaminen/index.html): Yhdessä laajemman yhteisön kanssa tuemme syöpäpotilaiden ja heidän perheidensä tietoisuutta, koulutusta, parempaa diagnosointia ja hoitoa. (77 words)
- [Irene Anindita | Boehringer Ingelheim BR](/content/br/carreiras/irene-anindita/index.html): Irene Anindita é uma Gestora multicanal para a equipa Cardiovascular e Metabolismo em Amesterdão, Países Baixos, e realmente adora a energia. (166 words)
- [Nuestras Ubicaciones | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/nuestras-sedes/index.html): Ofrecemos oportunidades de desarrollo profesional en más de 170 ubicaciones en todo el mundo. Explora ahora algunas de nuestras ubicaciones destacadas. (188 words)
- [Rumiantes | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/index.html): Nuestro negocio de rumiantes se centra en los parasiticidas, las vacunas y las terapias ofrecidos a nuestros veterinarios y ganaderos de vacuno y lechero. (381 words)
- [Keuhkosairaudet | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/keuhkosairaudet/index.html): Tavoitteenamme on kohentaa invalidisoivista hengityselinsairauksista kärsivien potilaiden elämänlaatua ja mahdollistaa itsenäisempi arki. (73 words)
- [Comercial | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestras-areas-profesionales/comercial-ventas-y-marketing/index.html): Descubre nuevas oportunidades en nuestra Área Comercial, y postúlate hoy. (119 words)
- [WeBuy | Boehringer Ingelheim FI](/content/fi/tietoa-meista/hankinnat/index.html): Toimittajat ovat olennainen osa sitoutumisestamme menestykseen. Meille on tärkeää, että liikekumppanit jakavat kanssamme samat yhteisö- ja ympäristöarvot. (216 words)
- [Ihmisten terveys | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/index.html): Boehringer Ingelheim on tutkimuslähtöinen konserni, joka on sitoutunut löytämään, kehittämään ja valmistamaan lääkkeitä. (128 words)
- [Keuhkofibroosi | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/keuhkosairaudet/keuhkofibroosi/index.html): Keuhkofibroosi on tila, joka johtaa arpikudoksen kertymiseen keuhkoihin. Ajan myötä keuhkot menettävät kykynsä ottaa happea ja siirtää sitä verenkiertoon. (72 words)
- [Propósito Commercial | Boehringer Ingelheim BR](/content/br/carreiras/proposito-commercial/index.html): Un video que explora nuestro propósito y por qué hacemos lo que hacemos. (84 words)
- [Diabetes | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/aineenvaihduntasairaudet/diabetes/index.html): ANoin 425 miljoonaa aikuista ihmistä maailmassa sairastaa diabetesta, ja tyypin 2 diabeteksen osuus kaikista tapauksista on 90-95 prosenttia. (163 words)
- [More Potential: Yhteisöille ja ihmisillemme | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/more-potential/index.html): More Potential merkitsee parhaiden olosuhteiden tarjoamista niin ihmisille, yhteisöille kuin yhteistyökumppaneillekin läpi koko arvoketjumme. (173 words)
- [Syöpä | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/syopa/index.html): Syöpä vaatii veronsa. Se vie aikaa. Se vie läheisiä ihmisiä. Boehringer Ingelheim tuo potilaille uutta toivoa keskittymällä syöpien hoitoon. (83 words)
- [Compensación y beneficios: Invertimos en ti | Boehringer Ingelheim ES](/content/es/empleo/descubre-nuestra-compania/compensacion-y-beneficios/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (313 words)
- [Pulmonary fibrosis | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/index.html): Reducir el riesgo de exacerbaciones agudas es objetivo clave del tratamiento para tratar a los pacientes con fibrosis pulmonar idiopática (FPI). (293 words)
- [Aineenvaihduntasairaudet | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/aineenvaihduntasairaudet/index.html): Olemme asiantuntijoita innovatiivisten hoitojen kehittämisessä moniin sydän-, verisuoni- ja aineenvaihduntasairauksiin. (66 words)
- [Krooninen munuaistauti | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/krooninen-munuaistauti/index.html): Krooninen munuaistauti (88 words)
- [Eri syöpätyypit | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/syopa/eri-syopatyypit/index.html): Olemme sitoutuneet painopistealueisiimme, keuhko- ja ruoansulatuskanavan syöpiin, mutta tieteen ohjaamina pyrimme löytämään mahdollisuuksia myös alueilta. (61 words)
- [Keuhkosyöpä | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/syopa/keuhkosyopa/index.html): Keuhkosairauksista saamamme kokemuksen pohjalta tavoitteenamme on tarttua keuhkosyöpään, muuttaa hoitomuotoja. (42 words)
- [Socios | Boehringer Ingelheim ES](/content/es/socios/index.html): En Boehringer Ingelheim, la diversidad y la colaboración son fundamentales para desarrollar nuevos avances médicos. Lea cómo puede asociarse con nosotros. (183 words)
- [Alkoholiin liittymätön rasvamaksatulehdus | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/aineenvaihduntasairaudet/alkoholiin-liittymaton-rasvamaksatulehdus/index.html): Ei-alkoholipitoinen steatohepatiitti (NASH) johtuu metabolisen aineenvaihdunnan aiheuttamasta maksatulehduksesta, ja se on yksi maksan fibroosin. (97 words)
- [Busca y solicita empleos | Boehringer Ingelheim ES](/content/es/empleo/busqueda-de-empleo/index.html): Ahora puedes buscar y solicitar empleos en Boehringer Ingelheim de una manera fácil y sencilla. ¡Tu próxima oportunidad a tan solo unas páginas de distancia! (141 words)
- [Enfermedades pulmonares | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/index.html): Información sobre enfermedades respiratorias como asma, EPOC, fibrosis pulmonar idiopática (FPI), esclerodermia y cáncer de pulmón. (313 words)
- [Salud Animal | Boehringer Ingelheim ES](/content/es/salud-animal/index.html): Las vidas de los animales y los seres humanos están interconectadas de un modo profundo y complejo. Cuando los animales están sanos, las personas también. (368 words)
- [Tietosuojalausunto | Boehringer Ingelheim FI](/content/fi/tietosuojalausunto/index.html): Tässä tietosuojailmoituksessa kerrotaan, kuinka Boehringer Ingelheim Boehringer Ingelheim Finland Ky (tästä lähtien ”Boehringer Ingelheim”, ”me”) (716 words)
- [Avicultura | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/avicultura/index.html): Brindamos vacunas, diagnósticos, servicios de investigación y experiencia técnica para garantizar carne y huevos de aves de corral seguros y sostenibles. (219 words)
- [Salud Animal: nuestra responsabilidad | Boehringer Ingelheim ES](/content/es/salud-animal/nuestra-responsabilidad/index.html): Uno de los elementos más importantes de Boehringer Ingelheim es nuestra responsabilidad de proteger la conexión entre la salud humana, animal y ambiental. (225 words)
- [Eettisyys ja vaatimustenmukaisuus | Boehringer Ingelheim FI](/content/fi/tietoa-meista/vastuullisuus-ja-compliance/index.html): Leitbild- ja Code of Conduct -toimintaperiaatteidemme mukaisesti toimimme rehellisesti ja sitoudumme liiketoimintaan lakeja noudattaen ja eettisesti. (97 words)
- [CIENCIA E INNOVACIÓN | Boehringer Ingelheim ES](/content/es/ciencia-e-innovacion/index.html): Gracias nuestro fuerte compromiso con la innovación se han desarrollado soluciones médicas excepcionales que han cambiado la vida de millones de pacientes. (119 words)
- [TIETOA MEISTÄ | Boehringer Ingelheim FI](/content/fi/tietoa-meista/index.html): Boehringer Ingelheim on maailmanlaajuinen konserni, jonka toimintaympäristöön kuuluu lukuisia erilaisia kulttuureja ja yhteisöjä. (195 words)
- [More Health: Ihmisille ja eläimille | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/more-health/index.html): Pitkäaikainen hanke, jonka tavoitteena on saavuttaa parempaa terveyttä yhteisöissä ympäri maailmaa tunnistamalla ja tukemalla lupaavimpia ratkaisuja. (103 words)
- [Engenharia & Facilities | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/engenharia-facilities/index.html): Descubra novas oportunidades no nosso departamento de Engenharia e Instalações. (333 words)
- [Kestävä kehitys | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/index.html): Boehringer Ingelheimilla “Kestävä kehitys” merkitsee matkaa. Tämä matka alkoi vuonna 1885, ja me toivomme ja uskomme, ettei se pääty milloinkaan. (154 words)
- [Eteisvärinä | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/eteisvarina/index.html): Aivohalvauksen ehkäiseminen (aivohalvauksen ennaltaehkäisy) näillä potilailla on tärkeä tavoite sydän- ja verisuonitautiryhmällemme. (57 words)
- [Lihavuus | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/aineenvaihduntasairaudet/lihavuus/index.html): Lihavuus on monimutkainen krooninen sairaus, joka vaatii pitkäaikaista hoitoa. Se on yksi johtavista riskitekijöistä useille sydän (64 words)
- [El paciente, nuestra prioridad | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/el-paciente-nuestra-prioridad/index.html): Los pacientes nos inspiran en nuestra misión de liderar la ciencia que crea terapias innovadoras, para que nuestros medicamentos transformen sus vidas. (184 words)
- [Kestävä kehitys – sitoumuksemme | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/sitoumuksemme/index.html): Yhtiön toiminta perustuu innovaatioihin, täyttymättömiin terveydenhoitotarpeisiin vastaamiseen sekä yhteisölliseen ja yhteiskunnalliseen sitoutumiseen. (104 words)
- [Personvernerklæring for leverandører | Boehringer Ingelheim NO](/content/no/personvernerklaering-leverandorer/index.html): Denne personvernerklæringen forklarer hvordan Boehringer Ingelheim Norge KS og/eller tilknyttede selskaper i samarbeid med Boehringer Ingelheim. (1,209 words)
- [Sydämen vajaatoiminta | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/sydamen-vajaatoiminta/index.html): Sydämen vajaatoiminta on johtava sairaalahoidon syy Yhdysvalloissa ja Euroopassa, ja myös Aasiassa potilaiden määrä on kasvussa. (143 words)
- [Esclerodermia | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/esclerodermia/index.html): La esclerosis sistémica es desfigurante, incapacitante y potencialmente mortal que causa cicatrices en la piel, los pulmones y otros órganos. (213 words)
- [EPOC y asma | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/epoc-y-asma/index.html): Los objetivos clave del tratamiento de la EPOC son limitar los síntomas, reducir el riesgo de exacerbaciones y ayudar a las personas a vivir activamente. (484 words)
- [Historias destacadas | Boehringer Ingelheim ES](/content/es/salud-animal/historias-destacadas/index.html): Haga clic aquí para explorar las grandes historias que destacan la compleja conexión entre animales y humanos. (300 words)
- [Aivohalvaus | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/aivohalvaus/index.html): Aivohalvaus voi olla invalidisoiva tai jopa kuolemaan johtava, ja se on aina hoidettava välittömästi. (69 words)
- [Empoderando a los pacientes | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/empoderando-los-pacientes/index.html): Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients. (306 words)
- [Animales de compañía y equino | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/index.html): Como uno de los principales proveedores mundiales, BI ayuda a proporcionar vidas más largas, saludables y felices a los animales de compañía. (259 words)
- [Enfermedades de la retina | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-de-la-retina/index.html): En Boehringer Ingelheim, hemos ampliado nuestras actividades globales de investigación y desarrollo para abordar las enfermedades oculares. (330 words)
- [Carreras | Boehringer Ingelheim ES](/content/es/empleo/index.html): Únete a un equipo global de más de 52.000 apasionadas y talentosas personas dedicadas a mejorar la salud humana y animal en todo el mundo. (856 words)
- [Hypertensio | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/kohonnut-verenpaine/index.html): Verenpainetauti (korkea verenpaine) on sairaus, josta kärsii noin miljardi ihmistä maailmassa, ja potilaiden määrän odotetaan kasvavan tulevina vuosina. (82 words)
- [Analista de Laboratorio Sênior (Prazo determinado por 1 ano) Detalhes da vaga | BoehringerPRD](/content/jobs/job-invite/35424/index.html): Paulínia Analista de Laboratorio Sênior (Prazo determinado por 1 ano) - Bras (381 words)
- [Animales de producción | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/index.html): Nuestro negocio abarca las aves de corral, los cerdos, los rumiantes y la Salud Pública Veterinaria para abordar las necesidades de los ganaderos. (122 words)
- [Depresión | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/depresion/index.html): BI está centrando sus esfuerzos de investigación en la depresión para encontrar nuevos tratamientos para los pacientes afectados por esta dolencia. (441 words)
- [Trastornos mentales graves | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/index.html): Boehringer Ingelheim tiene una gama de diferentes compuestos en desarrollo para enfermedades del Sistema Nervioso Central (SNC), algunos en fases avanzadas. (201 words)
- [Speak Up - canale di segnalazione | Boehringer Ingelheim IT](/content/it/su-di-noi/ethics-compliance/compliance-speak/index.html): Il portale "Speak Up" offre un ambiente sicuro per segnalare potenziali violazioni ed è aperto a qualsiasi persona in tutto il mondo. Prendiamo seriamente tutte le segnazioni di potenziali violazioni. (1,437 words)
- [Yritysjohto | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/yritysjohto/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (110 words)
- [Hannah Bussman | Boehringer Ingelheim BR](/content/br/carreiras/hannah-bussman/index.html): Hannah Bussman speaks about working in Global Internal Investigations as part of corporate legal and compliance at Boehringer Ingelheim. (91 words)
- [Ética y Compliance | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/index.html): Ética y cumplimiento (248 words)
- [A través de los tipos de cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/traves-de-los-tipos-de-cancer/index.html): Estamos adoptando un enfoque riguroso y amplio en algunas de las áreas más desafiantes, pero potencialmente de mayor impacto, de la investigación oncológica. (218 words)
- [Insuficiencia cardíaca | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/insuficiencia-cardiaca/index.html): Información y material didáctico sobre la insuficiencia cardíaca con fracción de eyección reducida (HFrEF) o preservada (HFpEF). (308 words)
- [Área Comercial | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/area-comercial/index.html): Descubra novas oportunidades na nossa área Comercial e candidate-se hoje. (434 words)
- [Enfermedad Renal Crónica | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedad-renal-cronica/index.html): Chronic Kidney Disease (176 words)
- [Dónde encontrarnos | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/index.html): ¿Conoces todas nuestras ubicaciones? Descubre donde se encuentran localizadas todas las oficinas de BI en el mundo. (429 words)
- [Fibrilación auricular | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/fibrilacion-auricular/index.html): En Boehringer Ingelheim estamos mejorando los tratamientos para pacientes que padecen una variedad de afecciones cardiovasculares y fibrilación auricular. (90 words)
- [Personvernerklæring i forbindelse med legemiddelovervåking | Boehringer Ingelheim NO](/content/no/personvernerklaering-i-forbindelse-med-legemiddelovervaking.html): Takk for at du har meldt fra til Boehringer Ingelheim Norway KS om bivirkninger eller annen informasjon som er relevant for legemiddelovervåking (700 words)
- [Nuestra responsabilidad | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/index.html): En BI damos prioridad a los pacientes en todo lo que hacemos. Ellos nos inspiran en nuestra misión de liderar la ciencia que crea terapias innovadoras. (91 words)
- [Speak Up – Compliance‑ilmoituskanava | Boehringer Ingelheim FI](/content/fi/tietoa-meista/vastuullisuus-ja-compliance/vaatimustenmukaisuus-speak/index.html): Speak Up ‑portaali tarjoaa turvallisen tavan ilmoittaa rikkomuksista ja on avoin maailmanlaajuisesti. Kaikki ilmoitukset käsitellään vakavasti. (230 words)
- [Speak Up – Linha de Apoio à Conformidade | Boehringer Ingelheim PT](/content/pt/sobre-nos/etica-e-compliance/speak/index.html): O portal Speak Up oferece uma forma segura de denunciar potenciais violações e está aberto globalmente. Todas as denúncias são tratadas com seriedade. (361 words)
- [Ota meihin yhteyttä | Boehringer Ingelheim FI](/content/fi/ota-meihin-yhteytta/index.html): Kiitos kiinnostuksestasi Boehringer Ingelheimia kohtaan. Kommenttinne ja kysymyksenne ovat tervetulleita. (118 words)
- [Psykiske sykdommer | Boehringer Ingelheim NO](/content/no/menneskelig-helse/psykisk-helse/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (286 words)
- [More Potential | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-potential/index.html): En Boehringer Ingelheim, "Desarrollo sostenible - por generaciones" se trata de un viaje. Uno que comenzó en 1885 y uno que esperamos, y creemos (387 words)
- [Salud Humana | Boehringer Ingelheim ES](/content/es/salud-humana/index.html): Lea los últimos artículos de salud humana haciendo clic. Desde el descubrimiento de fármacos hasta enfermedades específicas, nuestra información es vasta. (314 words)
- [Висловлюйтеся! | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Ми прагнемо вести бізнес доброчесно та відповідно до чинного законодавства, нормативно-правових актів, політики та процедур компанії. (424 words)
- [Sobre nosotros | Boehringer Ingelheim ES](/content/es/sobre-nosotros/index.html): Boehringer Ingelheim es un grupo global de empresas cuyo objetivo es mejorar la vida de humanos y animales. Haga clic aquí para obtener más información. (271 words)
- [Notas de prensa | Boehringer Ingelheim ES](/content/es/prensa/index.html): Encuentre los últimos comunicados de prensa de Boehringer Ingelheim sobre salud animal, medicamentos recetados, pipeline y noticias corporativas. (338 words)
- [MASH | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/ehmet/index.html): Más información sobre la enfermedad metabólica conocida como esteatohepatitis no alcohólica (EHNA) haciendo clic aquí y visitando Boehringer Ingelheim. (165 words)
- [Vilkår for bruk | Boehringer Ingelheim NO](/content/no/vilkar-bruk/index.html): Dette nettstedet er en internasjonal informasjonsressurs fra konsernets hovedkontor i Ingelheim i Tyskland, og skal gi informasjon om vår globale drift. (915 words)
- [Ictus | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/ictus/index.html): El único tratamiento trombolítico autorizado para el tratamiento del accidente cerebrovascular isquémico agudo. Ahora se usa mundialmente. (217 words)
- [Personvernerklæring | Boehringer Ingelheim NO](/content/no/personvernerklaering/index.html): Denne personvernerklæringen beskriver hvordan Boehringer Ingelheim Norway KS (heretter kalt “Boehringer Ingelheim”, “vi”, “vår”, “oss”). (1,220 words)
- [Leaving site | Boehringer Ingelheim FI](/content/fi/disclaimer/bi/index.html) (50 words)
- [Contacta con nosotros | Boehringer Ingelheim ES](/content/es/contacto/index.html): Para ponerse en contacto con nosotros, haga clic aquí para rellenar nuestro formulario de contacto. Damos la bienvenida a todas las consultas y comentarios. (196 words)
- [Switching market | Boehringer Ingelheim FI](/content/fi/disclaimer/market/index.html) (51 words)
- [Diabetes | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/diabetes/index.html): Más información sobre diabetes y cómo BI está trabajando para investigar y desarrollar medicamentos innovadores que mejoren la vida de los pacientes. (158 words)
- [Quiénes somos | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/index.html): Mejorar la salud y la calidad de vida de humanos y animales es el objetivo de la compañía farmacéutica Boehringer Ingelheim, impulsada por la investigación. (310 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (324 words)
- [Patologías metabólicas | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/index.html): Alrededor de 425 millones de personas adultas en el mundo viven con diabetes, y la diabetes tipo 2 representa entre el 90% y el 95% de todos los casos. (90 words)
- [Speak Up - 法規遵循通報專線 | Boehringer Ingelheim TW](/content/tw/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Speak Up 平台提供一個安全的環境，開放全球任何人士通報可能的違規行為。本公司對於所有潛在違規事項的通報，皆秉持審慎與負責的態度處理。 (43 words)
- [Regelefterlevnad – Speak Up! | Boehringer Ingelheim SE](/content/se/om-oss/etik-och-efterlevnad/regelefterlevnad-speak/index.html): Speak Up‑portalen erbjuder en säker kanal för att rapportera överträdelser globalt. Vi tar alla rapporter om möjliga överträdelser på största allvar. (320 words)
- [Liderazgo | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/liderazgo/index.html): Lee más sobre el Consejo de Dirección de Boehringer Ingelheim, con información sobre sus cinco miembros y sus respectivas responsabilidades. (150 words)
- [Speak Up – Ligne d’alerte Conformité | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/speak/index.html): Le portail Speak Up est un dispositif sécurisé, accessible à tous dans le monde, permettant de signaler toute violation potentielle. Chaque signalement fait l’objet de la plus grande attention. (335 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim IN](/content/in/about-us/ethics-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (319 words)
- [Carreiras em Tecnologia da Informação | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/carreiras-em-tecnologia-da-informacao/index.html): Descubra novas oportunidades no nosso departamento de Tecnologia da Informação. (237 words)
- [Hipertensión | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/hipertension/index.html): El tratamiento y el manejo efectivos de la hipertensión son importantes para evitar complicaciones o riesgos adicionales. (129 words)
- [Calidad en Boehringer Ingelheim | Boehringer Ingelheim ES](/content/es/sobre-nosotros/calidad/index.html): Calidad en Boehringer Ingelheim (264 words)
- [Produção & Supply Chain | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/producao-supply-chain/index.html): Descubra novas oportunidades no nosso departamento de Fabrico e Cadeia de Abastecimento. (263 words)
- [Speak Up – съобщавайте за нередностите! | Boehringer Ingelheim BG](/content/bg/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Порталът „Speak Up“ е поверителна и сигурна платформа за подаване на сигнали за потенциални нарушения, достъпна за всеки по света, по всяко време – 24/7. (355 words)
- [Портал «Не молчи» | Boehringer Ingelheim RU](/content/ru/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): Горячая линия для обращения в Отдел по вопросам этического ведения бизнеса «Берингер Ингельхайм» (205 words)
- [Producten voor diergezondheid | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/producten/index.html): Producten voor diergezondheid (1,080 words)
- [Speak Up! – si ifra! | Boehringer Ingelheim NO](/content/no/om-oss/etikk-og-etterlevelse/speak-si-ifra/index.html): Speak Up-portalen er et trygt sted å rapportere mulige brudd, og er åpen for alle i hele verden. Vi tar alle meldinger på alvor. (266 words)
- [Assuntos Médicos & Regulamentares | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/assuntos-medicos-regulamentares/index.html): Descubra novas oportunidades no nosso departamento de Assuntos Médicos e Regulamentares. (280 words)
- [Conformité - Speak Up! | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/ethique-et-conformite/conformite-speak/index.html): Conformité - Speak Up! (398 words)
- [Dites-le – Assistance en ligne sur la conformité | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/conformite-dites-le/index.html): Dites-le est un portail sûr pour signaler toute infraction potentielle accessible partout dans le monde. Nous prenons très au sérieux tout signalement. (378 words)
- [Historia | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/historia/index.html): Conoce más sobre la historia de la innovadora empresa farmacéutica Boehringer Ingelheim. Su cultura corporativa se basa en valores fundacionales. (151 words)
- [Naleving - Speak Up! | Boehringer Ingelheim BE](/content/be/nl/over-ons/ethiek-en-naleving/naleving-speak/index.html): Naleving - Speak Up! (388 words)
- [Compliance – Speak up! | Boehringer Ingelheim NL](/content/nl/over-ons/ethiek-en-naleving/compliance-speak/index.html): Boehringer Ingelheim wil integer zaken doen en geldende wet- en regelgeving, bedrijfsbeleid en -procedures naleven. Dit streven wordt ondersteund door de Speak Up-cultuur, die is bekrachtigd door de raad van bestuur van Boehringer Ingelheim. (291 words)
- [Pesquisa & Desenvolvimento | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/pesquisa-desenvolvimento/index.html): Descubra novas oportunidades no nosso departamento de Investigação e Desenvolvimento. (285 words)
- [Desarrollo sostenible - Nuestro compromiso | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/index.html): Vea el compromiso de desarrollo sostenible de BI aquí. Nuestro objetivo es involucrarnos con diferentes comunidades para cambiar vidas para mejor. (86 words)
- [Carreiras na área dos Dados | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/carreiras-na-area-dos-dados/index.html): Use os seus conhecimentos sobre dados para fazer a diferença. Descubra excelentes oportunidades de carreiras na área dos dados e candidate-se hoje. (236 words)
- [Comunicações e Assuntos Corporativos | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/comunicacoes-e-assuntos-corporativos/index.html): Conheça as várias carreiras que oferecemos, concebidas para ajudá-lo a crescer profissionalmente, ao mesmo tempo que proporcionam um trabalho desafiante que contribui para o sucesso. (255 words)
- [DIABETES TYPE 2 | Boehringer Ingelheim NO](/content/no/diabetes-type-2/index.html): Vi møtes for å diskutere hvordan vi kan redusere risiko for hjerte-og karsykdom hos pasienter med diabetes type 2 (88 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (290 words)
- [Tilgjengelighetserklæring | Boehringer Ingelheim NO](/content/no/tilgjengelighetserklaering/index.html): Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. (467 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (324 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/speak-compliance-hotline/index.html): Das „Speak Up“-Portal bietet einen sicheren Rahmen für die Meldung möglicher Verstöße und steht allen Personen weltweit offen. Wir nehmen alle Meldungen über mögliche Verstöße ernst. (295 words)
- [Speak up! | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/compliance-speak/index.html): Boehringer Ingelheim bekennt sich bei allen Geschäften zur Einhaltung der geltenden Gesetze, Vorschriften und Unternehmensrichtlinien und -verfahren. (32 words)
- [Jobber hos Boehringer Ingelheim | Boehringer Ingelheim NO](/content/no/karrierer/index.html): Bli med oss ​​og bidra til vårt oppdrag om å skape verdi gjennom innovasjon for pasientene vi betjener. (165 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (324 words)
- [Reseptbelagte legemidler | Boehringer Ingelheim NO](/content/no/menneskelig-helse/produkter/index.html): Boehringer Ingelheim Norway KS er ansvarlig for markedsføring, salg og informasjon om reseptbelagte legemidler. Medikamentene våre har en viktig plass (80 words)
- [Human Health Partnering | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/index.html): Learn how to partner with Boehringer Ingelheim to innovate and find solutions to improve the health and well-being of humans, click here to find out more. (521 words)
- [Fremhevede historier | Boehringer Ingelheim NO](/content/no/dyrehelse/fremhevede-historier/index.html): Dyrs og menneskers velvære – vårt formål, vår inspirasjon og vårt mål: Livet til dyr og mennesker henger sammen på dype og komplekse måter. (320 words)
- [Betegbiztonság és farmakovigilancia a Boehringer Ingelheimnél | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/felelossegunk/betegbiztonsag/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (473 words)
- [Dyrehelse | Boehringer Ingelheim NO](/content/no/dyrehelse/index.html): Livet til dyr og mennesker henger sammen på dype og komplekse måter. Vi vet at når dyr er sunne, så er mennesker også sunnere. (282 words)
- [Kliniske studier | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/kliniske-studier/index.html): kliniske-studier-Kliniske studier, eller utprøvende behandling, handler om å dokumentere effekt og sikkerhet av legemidler eller andre behandlingsmetoder. (313 words)
- [Consultoria & Estratégia Corporativa | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/consultoria-estrategia-corporativa/index.html): Descubra novas oportunidades na nossa Consultoria e Estratégia Corporativa. (231 words)
- [Privacy Policy | Boehringer Ingelheim UK](/content/uk/privacy-policy/index.html): Boehringer Ingelheim Limited and Boehringer Ingelheim Animal Health UK Limited are committed to protecting and respecting your privacy through this privacy policy. (1,357 words)
- [Switching market | Boehringer Ingelheim ES](/content/es/disclaimer/market/index.html) (28 words)
- [Conformidade Legal | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/conformidade-legal/index.html): Descubra novas oportunidades na nossa equipa de Conformidade Legal. (203 words)
- [Vitenskap og innovasjon | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/index.html): Hver dag kartlegger forskerne våre nye territorier og fortsetter vårt engasjement for innovasjon som har skapt eksepsjonelle medisiner. (146 words)
- [Retinasykdom | Boehringer Ingelheim NO](/content/no/menneskelig-helse/retinasykdom/index.html): At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. (207 words)
- [På tvers av krefttyper | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kreft/ulike-krefttyper/index.html): Vi har en iherdig og bred tilnærming til noen av de mest krevende, men også potensielt mest betydningsfulle områder av kreftforskning. (199 words)
- [Imprint | Boehringer Ingelheim NO](/content/no/imprint/index.html): Imprint / Ansvarlig - Boehringer Ingelheim Norway KS - Hagaløkkveien 26, Asker Tilhørende domstol: - Asker og Bærum Tingrett Lokal ledelse: Merethe Off (39 words)
- [Estás abandonando esta página | Boehringer Ingelheim ES](/content/es/disclaimer/bi/index.html) (86 words)
- [Partnerskap | Boehringer Ingelheim NO](/content/no/partnerskap/index.html): Vi verdsetter kraften i partnerskap og mangfoldet av sinn på tvers av livsvitenskap og dyrehelsemiljøer for å realisere enda mer innovasjon. (117 words)
- [Rólunk | Boehringer Ingelheim HU](/content/hu/rolunk/index.html): Ismerje meg a Boehringer Ingelheim munkáját! Globális csoportként fő fókuszunk a kutatás és a vállalati innovációk a humán- és állatgyógyászat területén. (204 words)
- [Svin | Boehringer Ingelheim NO](/content/no/dyrehelse/husdyr/svin/index.html): Boehringer Ingelheim er en samarbeidspartner og muliggjører for bærekraftig produksjon av svinekjøtt og animalsk protein, som sikrer dyrevelferd (142 words)
- [Global biofarmasøytisk kontraktproduksjon | Boehringer Ingelheim NO](/content/no/partnerskap/biofarmasoytisk-kontraktproduksjon/index.html): Som ett av tre forretningsområder innen Boehringer Ingelheim tilbyr vi biofarmasøytisk kontraktutvikling og produksjonsekspertise, (69 words)
- [Vaksiner | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/dyrehelseinnovasjon/vaksiner/index.html): I Global Innovation jobber vi med trygge og effektive vaksiner for selskapsdyr og husdyr. (70 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (382 words)
- [Minőség a Boehringer Ingelheimnél | Boehringer Ingelheim HU](/content/hu/rolunk/minoseg/index.html): Minőség a Boehringer Ingelheimnél (209 words)
- [Parasittmidler | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/dyrehelseinnovasjon/parasittmidler/index.html): Et sentralt ekspertiseområde innen Global Innovation er oppdagelsen og utviklingen av nye parasittmidler for både selskapsdyr og husdyr. (49 words)
- [Forskningsprosessen | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/dyrehelseinnovasjon/forskningsprosessen/index.html): Vi oppdager eller identifiserer nye forbindelser, vaksiner, teknologier, sykdomsprosesser og smittestoffer. (119 words)
- [Bronkiektasier | Boehringer Ingelheim NO](/content/no/menneskelig-helse/lungesykdommer/bronkiektasier/index.html): Bronkiektasier (172 words)
- [Kapcsolat | Boehringer Ingelheim HU](/content/hu/kapcsolat/index.html): Ha kapcsolatba szeretne lépni velünk a Boehringer Ingelheimnél, kérjük, kattintson ide a kapcsolatfelvételi űrlapunk kitöltéséhez. Minden kérdést és visszajelzést szívesen fogadunk. (61 words)
- [Terapeutiske midler | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/dyrehelseinnovasjon/terapeutiske-midler/index.html): Vi tilbyr en disiplinert vitenskapelig tilnærming til global oppdagelse, utvikling og levering av terapeutiske midler for selskapsdyr og husdyr. (60 words)
- [Fremme vitenskap | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/fremme-vitenskap/index.html): Å skape banebrytende medisiner som endrer pasientenes liv starter med en forpliktelse til å identifisere fremtidens helseutfordringer og fremme . (59 words)
- [Pasientstøtte | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kreft/pasientstotte/index.html): Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients. (159 words)
- [Vårt vitenskapsfokus | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/fokus-pa-vitenskap/index.html): Vår forskning på nye medisiner er fokusert på områder innen vitenskap med betydelig medisinsk behov og hvor vi fortsetter å innovere lede vitenskapen. (58 words)
- [Global dyrehelseinnovasjon | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/dyrehelseinnovasjon/index.html): Vårt globale innovasjonsteam er pionerer innen vitenskapen som hjelper veterinærer, kjæledyr- og husdyreiere og offentlige helsemyndigheter. (67 words)
- [Vitenskapshistorier | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/vitenskapshistorier/index.html): Å lage nye og bedre medisiner for pasienter er kjernen i det vi gjør. De inspirerer oss i vårt oppdrag for å skape banebrytende terapier som endrer liv (68 words)
- [Speak Up – Megfelelőségi forródrót | Boehringer Ingelheim HU](/content/hu/rolunk/compliance-es-etika/vallalati-megfeleloseg-szolalj-fel/index.html): A Speak Up portál biztonságos és bizalmas módot kínál világszerte bárki számára jogsértések bejelentésére, melyeket minden esetben komolyan veszünk. (294 words)
- [Fjærkre | Boehringer Ingelheim NO](/content/no/dyrehelse/husdyr/fjaerkre/index.html): Gjennom våre eksisterende og nye vaksiner, diagnostikk, forskningstjenester, teknisk ekspertise og kompromissløs lidenskap (98 words)
- [Kols og Astma | Boehringer Ingelheim NO](/content/no/menneskelig-helse/lungesykdommer/kols-og-astma/index.html): Kronisk obstruktiv lungesykdom (Kols) er en progressiv, behandlingsbar sykdom karakterisert ved begrenset luftstrøm inn og ut av lungene. (186 words)
- [Menneskelig helseinnovasjon | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/index.html): Boehringer Ingelheim er tydelig om målene sine. Vi ønsker å levere en portefølje av banebrytende legemidler som vil forbedre livene til pasienter. (62 words)
- [Grasrotinnovasjon | Boehringer Ingelheim NO](/content/no/vitenskap-og-innovasjon/menneskelig-helseinnovasjon/grasrot/index.html): Vårt unike globale program med Grass Roots-initiativer er designet for å muliggjøre fremvoksende vitenskap og teknologi ved å forkjempe unge. (54 words)
- [Vezetőség | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/vezetoseg/index.html): Tudjon meg többet a Boehringer Ingelheim igazgatóságáról, mind az öt tagról és az egyes tagok feladatköreiről. (86 words)
- [Lungekreft | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kreft/lungekreft/index.html): Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC) (100 words)
- [Diabetes | Boehringer Ingelheim NO](/content/no/menneskelig-helse/metabolske-sykdommer/diabetes/index.html): Omtrent 425 millioner voksne mennesker i verden lever med diabetes, med diabetes type 2 som står for 90 – 95 prosent av alle tilfeller. (158 words)
- [Produksjonsdyr | Boehringer Ingelheim NO](/content/no/dyrehelse/husdyr/index.html): Boehringer Ingelheim er en ledende leverandør av helseløsninger for å forutsi, forebygge og behandle sykdommer hos husdyr. (112 words)
- [Pasientsentrisitet | Boehringer Ingelheim NO](/content/no/menneskelig-helse/vart-ansvar/pasientsentrisitet/index.html): Pasienter inspirerer oss i vårt oppdrag om å lede vitenskapen som skaper banebrytende terapier. (76 words)
- [Hester | Boehringer Ingelheim NO](/content/no/dyrehelse/selskapsdyr/hester/index.html): Som en leder innen hestehelse utvikler Boehringer Ingelheim innovative løsninger for hesters velvære rundt om i verden. (90 words)
- [Drøvtyggere | Boehringer Ingelheim NO](/content/no/dyrehelse/husdyr/drovtyggere/index.html): I vår strategiske forretningsenhet for drøvtyggere fokuserer vi på parasittmidler, vaksiner og terapeutiske midler som tilbys til våre melke (89 words)
- [Partnereink | Boehringer Ingelheim HU](/content/hu/rolunk/partnereink/index.html): A Boehringer Ingelheim innovatív megoldásokon dolgozik, és fontos számunkra, hogy a partnerek is épp olyan elkötelezettek legyenek értékeink iránt. (100 words)
- [Divisão de Qualidade | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/divisao-de-qualidade/index.html): Descubra novas oportunidades no nosso departamento de Divisão de Qualidade. (147 words)
- [Lungesykdommer | Boehringer Ingelheim NO](/content/no/menneskelig-helse/lungesykdommer/index.html): Boehringer Ingelheim har 100 års erfaring innen luftveissykdommer. Siden 1921 har vi vokst frem som ledende innen dette sykdomsområdet (103 words)
- [Vårt ansvar | Boehringer Ingelheim NO](/content/no/menneskelig-helse/vart-ansvar/index.html): Hos Boehringer Ingelheim setter vi pasientene først i alt vi gjør. Pasienter inspirerer oss i vårt oppdrag om å lede vitenskapen som skaper (76 words)
- [Sklerodermi | Boehringer Ingelheim NO](/content/no/menneskelig-helse/lungesykdommer/sklerodermi/index.html): Systemisk sklerose (SSc) er en skjemmende, invalidiserende og potensielt dødelig sjelden sykdom som forårsaker arrdannelse i huden (sklerodermi). (99 words)
- [Kik vagyunk | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/index.html): Az emberek és állatok egészségének és életminőségének javítása a Boehringer Ingelheim kutatásorientált gyógyszeripari vállalat célja. (96 words)
- [Partnerérdekek - Humángyógyászat | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/egyuttmukodes-humangyogyaszat-teruleten/partnererdekek-humanegeszsegugy/index.html): Kattintson ide, hogy megtudja, mit szeretünk látni a Boehringer Ingelheimnél a partnereinktől, és mit foglalnak magukban a partneri tevékenységeink. (85 words)
- [NASH | Boehringer Ingelheim NO](/content/no/menneskelig-helse/metabolske-sykdommer/ikke-alkoholisk-fettleversykdom-nash/index.html): Ikke-alkoholisk steatohepatitt (NASH) er forårsaket av en metabolsk-indusert betennelse i leveren og er en av hovedårsakene til leverfibrose. (113 words)
- [Metabolske sykdommer | Boehringer Ingelheim NO](/content/no/menneskelig-helse/metabolske-sykdommer/index.html): Sammenkoblede kardio-nyre-metabolske tilstander – som påvirker hjertet, nyrene og det metabolske systemet – er den viktigste årsaken til dødelighet. (75 words)
- [Lungefibrose | Boehringer Ingelheim NO](/content/no/menneskelig-helse/lungesykdommer/lungefibrose/index.html): Lungefibrose er en tilstand som fører til oppbygging av arrvev i lungene. Over tid mister lungene evnen til å ta inn og overføre oksygen til blodet. (72 words)
- [Accessibility Statement | Boehringer Ingelheim UK](/content/uk/accessibility-statement/index.html): Boehringer Ingelheim Ireland is committed to providing a website that is accessible to the widest possible audience. Click here to learn more. (412 words)
- [Hjerteinfarkt | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/hjerteinfarkt/index.html): Hjerteinfarkt er en progressiv og potensielt dødelig tilstand som påvirker over 60 millioner mennesker over hele verden og forventes å øke etter. (73 words)
- [Akutt iskemisk slag | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/akutt-iskemisk-slag/index.html): Akutt iskemisk slag er den vanligste typen slag. Det oppstår når blodtilførselen til en del av hjernen blokkeres av en blodpropp i en blodåre (77 words)
- [Impresszum | Boehringer Ingelheim HU](/content/hu/impresszum/index.html): Impresszum (66 words)
- [Hypertensjon (høyt blodtrykk) | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/hypertensjon/index.html): Hypertensjon er en tilstand som rammer omtrent en milliard mennesker i verden, og antallet pasienter forventes å øke i årene som kommer. (89 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (383 words)
- [Slagforebygging ved hjerteflimmer | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/slagforebygging-ved-hjerteflimmer/index.html): Et hjerneslag oppstår når blodtilførselen til en del av hjernen blir avbrutt. (37 words)
- [Még több lehetőség | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/meg-tobb-lehetoseg/index.html): A társadalomnak továbbra is kihívásokkal kell szembenéznie az egészségügytől kezdve az oktatáson át a munkalehetőségekig, az életkörülményekig, az egyenlőtlenségekig és a szegénységig, amelyek gyakran a legkiszolgáltatottabb közösségeket érintik a leginká (120 words)
- [Pets | Boehringer Ingelheim UK](/content/uk/animal-health/companion-animals/pets/index.html): Boehringer Ingelheim are market leaders in parasiticides, vaccines and therapeutics to help maintain the health and wellbeing of your companion pets (209 words)
- [Tüdőrák | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/daganatos-betegsegek/tudorak/index.html): Fedezze fel a Boehringer Ingelheim tüdőrák területén végzett munkáját! Célunk a tüdőrák elleni küzdelem és a rák gyógyítása. (120 words)
- [Még több zöld | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/meg-tobb-zold/index.html): A Boehringer Ingelheimnél a "Fenntartható fejlődés - Nemzedékekért" egy utazásról szól. Egy olyan útról, amely 1885-ben kezdődött, és amelyről reméljük és hisszük. (76 words)
- [Our FOCUS | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/culture/our-focus/index.html): Our FOCUS - our company's global vision - defines Boehringer Ingelheim’s road to innovation and growth for the years to come. Learn more here. (396 words)
- [Történetünk | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/tortenet/index.html): Ismerje meg a Boehringer Ingelheim vállalat történetét! A Németországban családi vállalkozásként indult cég mára globális vállalattá nőtt. (61 words)
- [Fenntartható fejlődés | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/index.html): Azok az értékek és elvek, amelyek mellett a Boehringer Ingelheim több mint 130 éve elköteleződött, szilárd részét képezik vállalati filozófiánknak. (81 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (382 words)
- [Elköteleződésünk | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/elkotelezodesunk/index.html): Olyan területeken szeretnénk értéket termeteni az innováció segítségével, melyeken még nincsen kilégítő terápia - az emberek és állatok számára. (50 words)
- [Ethics & Compliance | Boehringer Ingelheim UK](/content/uk/about-us/ethics-compliance/index.html): Learn about our Global Code of Conduct and our ethical and compliance standards here. View our Ethics and Compliance Policy, Speak Up Policy, and more. (463 words)
- [Animal Health | Boehringer Ingelheim UK](/content/uk/animal-health/index.html): Boehringer Ingelheim are passionate about animal health. We believe that when animals are healthy, humans are healthier too. Click here to find out more. (245 words)
- [Egészség: az emberek és állatok számára | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/egeszseg/index.html): Egészség: az emberek és állatok számára (40 words)
- [Swine | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/swine/index.html): We are a partner and enabler of sustainable pork and animal protein production, ensuring animal welfare through prevention and integrated health care. (145 words)
- [Poultry | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/poultry/index.html): We provide vaccines, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs. (113 words)
- [Культура | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/culture/index.html): Кожного дня 52 000 працівників «Берінгер Інгельхайм» покращують життя як людей, так і тварин. Наш ФОКУС чітко формулює, хто ми і чого прагнемо, заради якої мети ми існуємо, як працюємо та чого хочемо досягти. (133 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim UK](/content/uk/animal-health/our-responsibility/index.html): Our responsibility here at Boehringer Ingelheim is to protect the connection between human, animal and environmental health. Click here to find out more. (147 words)
- [Lung Cancer | Boehringer Ingelheim UK](/content/uk/human-health/cancer/lung-cancer/index.html): Overcoming stigma and advancing lung cancer advocacy. (447 words)
- [Veterinary Public Health | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/veterinary-public-health/index.html): Click here to find out how Boehringer Ingelheim partners with health authorities, governments and NGO's to protect the World against emerging diseases. (344 words)
- [Cookie Policy | Boehringer Ingelheim UK](/content/uk/cookie-policy/index.html): Our websites use cookies to distinguish you from other users of our website. Click here to find out about what cookies are and how we use them. (1,385 words)
- [企業文化 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/company-culture/index.html): 企業文化 (108 words)
- [Lung Diseases | Boehringer Ingelheim UK](/content/uk/human-health/lung-diseases/index.html): At Boehringer Ingelheim, our focus is on improving the quality of life of patients suffering from respiratory diseases. (194 words)
- [Animal Health Innovation | Boehringer Ingelheim UK](/content/uk/science-innovation/animal-health-innovation/index.html): Click here to learn how our Animal Health Global Innovation team promotes the science that helps improve animal and human health around the world. (140 words)
- [Cultura | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/cultura/index.html): Los objetivos y creencias de BI se pueden resumir en una sola frase: Valor a través de la innovación, el concepto central de nuestra visión corporativa. (143 words)
- [Livestock | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers. (79 words)
- [Switching market | Boehringer Ingelheim HU](/content/hu/disclaimer/market/index.html) (61 words)
- [Culture | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/index.html): Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. (307 words)
- [Human Health Partnering Interests | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/index.html): Click here to find out what we’re looking for in our search to discover the next generation of breakthrough medicines. (98 words)
- [Leaving site | Boehringer Ingelheim HU](/content/hu/disclaimer/bi/index.html) (60 words)
- [Kultur | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/kultur/index.html): I över 135 år, sedan Albert Boehringer grundade oss, har vi fokuserat på långsiktiga resultat snarare än att begränsas av kortsiktiga vinster. (87 words)
- [Culture | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/index.html): Culture (385 words)
- [Human Health Innovation | Boehringer Ingelheim UK](/content/uk/science-innovation/human-health-innovation/index.html): Boehringer Ingelheim want to deliver a portfolio of innovative, breakthrough medicines that will improve the lives of patients. (43 words)
- [Animal Health Partnering | Boehringer Ingelheim UK](/content/uk/partnering/animal-health-partnering/index.html): Click here to find out and learn about our collaborations with partners who share our passion for improving the health and wellbeing of animals. (87 words)
- [Культура | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/culture/index.html): Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. (68 words)
- [Where to find us | Boehringer Ingelheim UK](/content/uk/about-us/where-find-us/index.html): Learn about Boehringer Ingelheim's sites around the world. With 54,000 employees worldwide, our sites include Dublin, Republic of Ireland, and Ingelheim, Germany. (420 words)
- [Featured Stories | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/index.html): Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being. (147 words)
- [Produits de santé animale | Boehringer Ingelheim BE](/content/be/fr/sante-animale/produits/index.html): Tout ce que nous faisons est alimenté par l'innovation. Notre objectif est de fournir des soins de santé préventifs perfectionnés et (1,186 words)
- [3FLEX® | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/3flex/index.html): Única vacuna aprobada por la USDA contra PRRS, M. hyo y PCV2. (497 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim UK](/content/uk/partnering/biopharma-contract-manufacturing/index.html): Global biopharma contract development and manufacturing expertise is one of Boehringer Ingelheim's main business areas, click here to learn more. (39 words)
- [Heart Diseases | Boehringer Ingelheim UK](/content/uk/human-health/heart-diseases/index.html): Boehringer Ingelheim provides innovative treatments that help treat patients suffering from a range of cardiovascular conditions. (108 words)
- [Kultur | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/kultur/index.html): Kultur (104 words)
- [Ruminants | Boehringer Ingelheim UK](/content/uk/animal-health/livestock/ruminants/index.html): Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers. (61 words)
- [Cultura | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/cultura/index.html): Por mais de 135 anos, desde a nossa fundação por Albert Boehringer, o nosso foco tem sido o desempenho a longo prazo e não os lucros no curto prazo. (165 words)
- [Horses | Boehringer Ingelheim UK](/content/uk/animal-health/companion-animals/horses/index.html): Boehringer Ingelheim develops innovative solutions for the well-being of horses in immunology, parasitology, gastric and metabolic health. (60 words)
- [Cultuur | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/cultuur/index.html): Al meer dan 135 jaar, sinds ons bedrijf werd opgericht door Albert Boehringer, richten we ons op langetermijnprestaties in plaats van onszelf. (165 words)
- [Cultura | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/cultura/index.html): Cultura (228 words)
- [Kultur | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/kultur/index.html): I over 135 år, siden vi ble grunnlagt av Albert Boehringer, har vårt fokus vært på langsiktig ytelse i stedet for å være begrenset av kortsiktig. (85 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim UK](/content/uk/about-us/quality/index.html): Quality at Boehringer Ingelheim (200 words)
- [Kultura | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/kultura/index.html): Każdego dnia 52 tysiące pracowników Boehringer Ingelheim dba o lepsze życie ludzi i zwierząt. Nasze UKIERUNKOWANIE pokazuje kim jesteśmy, jak działamy i do czego dążymy. (104 words)
- [Cultuur | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/cultuur/index.html): De waarden en principes die Boehringer Ingelheim al ruim 130 jaar nastreeft, zijn stevig verankerd in onze bedrijfsfilosofie: waarde door innovatie. (133 words)
- [Cancer | Boehringer Ingelheim UK](/content/uk/human-health/cancer/index.html): At Boehringer Ingelheim we are dedicated to working on improving lifestyles with treatments for cancer patients. (273 words)
- [Cultura | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/cultura/index.html): El objetivo de Boehringer Ingelheim es claro: proporcionar más salud y mejorar la vida tanto de humanos como de animales. (227 words)
- [Human Health | Boehringer Ingelheim UK](/content/uk/human-health/index.html): Click here to read the latest topics about human health from Boehringer Ingelheim. (259 words)
- [Companion Animals | Boehringer Ingelheim UK](/content/uk/animal-health/companion-animals/index.html): At Boehringer Ingelheim we think that pets and horses should have the same level of healthcare opportunity as you do, find out more about how. (35 words)
- [Culture | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/culture/index.html): Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. (117 words)
- [Culture | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/culture/index.html): Our objectives and beliefs can be summed up in a single phrase: Value Through Innovation, the central concept of our corporate vision. Find out more. (108 words)
- [Metabolic Diseases | Boehringer Ingelheim UK](/content/uk/human-health/metabolic-diseases/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. (194 words)
- [Patient Centricity | Boehringer Ingelheim UK](/content/uk/human-health/our-responsibility/patient-centricity/index.html): Read about how patients inspire our mission to lead the science that creates breakthrough therapies and create medicines that transform patients’ lives. (82 words)
- [Chronic Kidney Disease | Boehringer Ingelheim UK](/content/uk/human-health/chronic-kidney-disease/index.html): Chronic Kidney Disease (140 words)
- [Kultur | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/index.html): Kultur (231 words)
- [Our Responsibility | Boehringer Ingelheim UK](/content/uk/human-health/our-responsibility/index.html): Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here. (82 words)
- [Purchasing | Boehringer Ingelheim UK](/content/uk/about-us/purchasing/index.html): Here you can find out about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too. (181 words)
- [Mental Health | Boehringer Ingelheim UK](/content/uk/human-health/mental-health/index.html): At Boehringer Ingelheim, we aspire to provide mental health treatment approaches that places an individual’s specific needs at the centre. (101 words)
- [Retinal Diseases | Boehringer Ingelheim UK](/content/uk/human-health/retinal-diseases/index.html): Learn how Boehringer Ingelheim has expanded its research and development efforts globally to tackle eye diseases, visual impairment and blindness. (119 words)
- [Our Stories | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/index.html): Boehringer Ingelheim has many initiatives we would like to share. Find out more about us here by reading our press releases, news stories, and more. (292 words)
- [Intereses de alianzas en Salud Animal | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/areas-de-interes/index.html): Explora los intereses de alianzas de Boehringer Ingelheim en salud animal, que incluyen enfermedades infecciosas, enfermedades no infecciosas y áreas foco fuera del ámbito de las enfermedades. (778 words)
- [Contact Us | Boehringer Ingelheim UK](/content/uk/contact-us/index.html): Please click here to contact us at Boehringer Ingelheim with our contact request form, or to get our contact details. We welcome all queries and feedback. (230 words)
- [Culture | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/culture/index.html): Découvrez nos visions et valeurs chez Boehringer Ingelheim. Une entreprise guidée par l’innovation et l’éthique pour améliorer la santé. (212 words)
- [Culture | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/culture/index.html): Depuis plus de 135 ans, depuis la fondation de notre entreprise par Albert Boehringer, nous visons des performances sur le long terme plutôt que les (156 words)
- [Culture | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/culture/index.html): Our objectives and beliefs can be summed up in a single phrase: Value Through Innovation, the central concept of our corporate vision. Find out more. (107 words)
- [Culture | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/culture/index.html): Our focus is on long-term performance rather than being limited by short-term profits. Click here to read and learn more about our vision and values. (172 words)
- [Databeskyttelsesmeddelelse til leverandører, besøgende og interessenter | Boehringer Ingelheim DK](/content/dk/databeskyttelsesmeddelelse-til-leverandorer-besogende-og-interessenter.html): Databeskyttelsesmeddelelse forklarer, hvordan Boehringer Ingelheim Danmark A/S og/eller virksomheder i Boehringer Ingelheim-koncernen fungerer som data (1,632 words)
- [메타캄® 주사액 | Boehringer Ingelheim KR](/content/kr/animal-health/products/metakam-jusaaeg/index.html): 메타캄® 주사액 (61 words)
- [About Us | Boehringer Ingelheim UK](/content/uk/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to learn more about us. (204 words)
- [Our Stories | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (249 words)
- [Leadership | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [바헬바 레스피맷 다회용 | Boehringer Ingelheim KR](/content/kr/human-health/products/vahelvarespimat/index.html): 만성폐쇄성폐질환(COPD) 치료제 바헬바 레스피맷 다회용 (93 words)
- [Terms of Use | Boehringer Ingelheim US](/content/us/terms-use/index.html): Terms of Use (3,072 words)
- [MORE POTENTIAL for Communities & our People | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (140 words)
- [Kultúra | Boehringer Ingelheim HU](/content/hu/rolunk/kik-vagyunk/kultura/index.html): A Boehringer Ingelheimnél nap mint nap 52,000 alkalmazott teremt értéket az innováció segítségével. A FÓKUSZunk megfogalmazza, hogy kik vagyunk, mire törekszünk, hogyan dolgozunk és mit szeretnénk elérni. (42 words)
- [베링거인겔하임의 품질 | Boehringer Ingelheim KR](/content/kr/about-us/quality/index.html): 베링거인겔하임의 품질 (216 words)
- [UK Careers | Boehringer Ingelheim UK](/content/uk/careers/index.html): Find out information about careers in Ireland at Boehringer Ingelheim here. Learn about why this is a great place to work, vacancies, and more. (93 words)
- [Nuestras historias | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/nuestras-historias/index.html): Nuestras historias (213 words)
- [Onze verhalen | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/index.html): Boehringer Ingelheim heeft vele initiatieven, die wij graag delen. Zo leer je ons beter kennen. Hieronder staan de meest recente pers- en nieuwsberichten (180 words)
- [Betingelser for brug | Boehringer Ingelheim DK](/content/dk/betingelser-brug/index.html): Dette websted er en international kilde til oplysninger fra vores globale hovedkontor i Ingelheim, Tyskland (947 words)
- [Who we are | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. Learn more. (128 words)
- [Our Stories | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (286 words)
- [Impressum | Boehringer Ingelheim CH](/content/ch/impressum/index.html): Impressum (33 words)
- [History | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/history/index.html): Read about the history of Boehringer Ingelheim here, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people. (52 words)
- [Unsere Stories | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unsere-stories/index.html): Unsere Stories Nachhaltige Entwicklung geht Hand in Hand mit unseren Grundsätzen der Planung in Generationen, der Innovation, der Übernahme von Verantwortung für unsere Gemeinschaften und die Umwelt und dem Dienst an der Menschheit - heute und morgen. (119 words)
- [액티라제주사 | Boehringer Ingelheim KR](/content/kr/human-health/products/actilyse/index.html): 혈전용해제 액티라제주사 (61 words)
- [오페브 연질캡슐 | Boehringer Ingelheim KR](/content/kr/human-health/products/ofev/index.html): 항 섬유화제 오페브 (42 words)
- [Switching market | Boehringer Ingelheim UK](/content/uk/disclaimer/market/index.html) (33 words)
- [Il nostro contributo | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/il-nostro-contributo/index.html): Il nostro contributo (138 words)
- [Unsere Storys | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/unsere-storys/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (229 words)
- [에스글리토정 | Boehringer Ingelheim KR](/content/kr/human-health/products/esgliteo/index.html): 제 2형 당뇨병 치료제 에스글리토정 (37 words)
- [Animal Health Partnering Interests | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/partnering-interests/index.html): Explore Boehringer Ingelheim’s partnering interests in animal health, including infectious diseases, non-infectious diseases, and non-disease areas of focus. (776 words)
- [Our Stories | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (115 words)
- [Alemania | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/alemania/index.html): Alemania, donde comenzó la historia de Boehringer Ingelheim, sigue siendo nuestra sede mundial. Explora las oportunidades laborables disponibles en Alemania. (246 words)
- [SR Technician, Calibration Job Details | BoehringerPRD](/content/jobs/job-invite/35648/index.html): Saint Joseph SR Technician, Calibration - Unit (613 words)
- [Unsere Storys | Boehringer Ingelheim DE](/content/de/unsere-storys/index.html): Wir übernehmen Verantwortung nicht nur für die heutige, sondern für alle kommenden Generationen. Erfahren Sie mehr zu unseren Initiativen. (174 words)
- [미라펙스정 | Boehringer Ingelheim KR](/content/kr/human-health/products/mirapex/index.html): 파킨슨 병/하지불안증후군 치료제 미라펙스정 (45 words)
- [Our Focus | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/our-focus/index.html): Our FOCUS는 베링거인겔하임의 정체성, 기업미션, 기업 운영 방식, 그리고 달성 목표를 정의합니다. (52 words)
- [Tarinamme | Boehringer Ingelheim FI](/content/fi/tietoa-meista/kestava-kehitys/tarinamme/index.html): Boehringer Ingelheim on käynnistänyt lukuisia aloitteita, joista haluamme kertoa. Saat lisätietoa lukemalla tarinoitamme. (103 words)
- [스피리바 흡입용캡슐 | Boehringer Ingelheim KR](/content/kr/human-health/products/spirivahandihaler/index.html): 만성폐쇄성폐질환(COPD) 치료제 스피리바 흡입용캡슐 (38 words)
- [Preguntas frecuentes | Boehringer Ingelheim SA](/content/sa/carreras/como-aplicar/preguntas-frecuentes/index.html): Visita nuestro aparatdo de preguntas frecuentes sobre el proceso de solicitud de empleo en Boehringer Ingelheim. No te quedes con ninguna duda. (2,211 words)
- [동물약품 제품 | Boehringer Ingelheim KR](/content/kr/animal-health/products/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products below. (79 words)
- [Japón | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/nuestras-locaciones/japon/index.html): Nuestro equipo en Japón es reconocido por su compromiso con la innovación y la sostenibilidad. Mira las oportunidades de desarrollo profesional en Japón. (228 words)
- [Our Stories | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (256 words)
- [아트로벤트 흡입액 유디비 | Boehringer Ingelheim KR](/content/kr/human-health/products/atrovent-udv/index.html): 기도폐쇄 장애 치료제 아트로벤트 흡입액 유디비 (46 words)
- [Boehringer Ingelheim Cares Foundation US Privacy Statement | Boehringer Ingelheim US](/content/us/boehringer-ingelheim-cares-foundation-us-privacy-statement.html): Boehringer Ingelheim Cares Foundation US Privacy Statement (2,983 words)
- [Our Stories | Boehringer Ingelheim](/content/our-stories-0/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (248 words)
- [한국베링거인겔하임동물약품 소개 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaimdongmulyagpum-sogae/index.html): 한국베링거인겔하임동물약품(주)는 1996년 베링거인겔하임동물약품(주)으로 국내에 설립된 이래 산업동물 및 반려동물의 질병예방과 치료를 위한 혁신적인 동물용 의약품을 공급하고 있습니다. (193 words)
- [미카르디스플러스정 | Boehringer Ingelheim KR](/content/kr/human-health/products/micardis-plus/index.html): 고혈압 치료제 미카르디스플러스정 (34 words)
- [미카르디스정 | Boehringer Ingelheim KR](/content/kr/human-health/products/micardis/index.html): 고혈압 치료제 마카르디스정 (70 words)
- [Leaving site | Boehringer Ingelheim CH](/content/ch/disclaimer/external/index.html) (158 words)
- [Leaving site | Boehringer Ingelheim PL](/content/pl/disclaimer/external/index.html) (137 words)
- [Our Stories | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (38 words)
- [Productos para Salud Animal | Boehringer Ingelheim MX](/content/mx/salud-animal/productos/index.html): Productos para Salud Animal (112 words)
- [메탈라제주사 | Boehringer Ingelheim KR](/content/kr/human-health/products/metalyse/index.html): 성인 급성 허혈성 뇌졸중 치료제 메탈라제주사 (58 words)
- [모빅캡슐 | Boehringer Ingelheim KR](/content/kr/human-health/products/mobic/index.html): COX-2 선택성 소염진통제 모빅캡슐 (29 words)
- [Our Stories | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (172 words)
- [Leaving site | Boehringer Ingelheim PT](/content/pt/disclaimer/external/index.html) (152 words)
- [Explore our company | Boehringer Ingelheim US](/content/us/careers/explore-our-company/index.html): Make your next career step at the company Boehringer Ingelheim. Explore our fields to find out more about employment opportunities in your area of interest. (326 words)
- [Kezdeményezéseink | Boehringer Ingelheim HU](/content/hu/rolunk/fenntarthato-fejlodes/kezdemenyezeseink/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (30 words)
- [Nos articles | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/nos-articles/index.html): Découvrez nos articles sur le développement durable chez Boehringer Ingelheim. Explorez nos initiatives pour un avenir plus responsable. (142 words)
- [Términos de uso | Boehringer Ingelheim SA](/content/sa/terminos-de-uso/index.html): Términos de Uso (1,632 words)
- [Farmacovigilancia | Boehringer Ingelheim SA](/content/sa/salud-animal/farmacovigilancia/index.html): Farmacovigilancia (356 words)
- [Leaving site | Boehringer Ingelheim IT](/content/it/disclaimer/external/index.html) (93 words)
- [Animal Health Products | Boehringer Ingelheim US](/content/us/animal-health/products/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products below. (463 words)
- [Нашите истории | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/our-stories/index.html): Научете повече за нас, като прочетете нашите истории. (39 words)
- [Databeskyttelseserklæring vedrørende lægemiddelovervågning | Boehringer Ingelheim DK](/content/dk/databeskyttelseserklaering-vedrorende-laegemiddelovervagning.html): Informasjon om beskyttelse av personopplysninger ved rapportering av bivirkninger eller andre hendelser knyttet til et produkt (737 words)
- [weBuy | Boehringer Ingelheim GR](/content/gr/webuy/index.html): Μια επιτυχημένη και ανεξάρτητη επιχείρηση (266 words)
- [Leaving site | Boehringer Ingelheim FR](/content/fr/disclaimer/external/index.html) (52 words)
- [비전 및 가치 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/index.html): 베링거인겔하임의 목표와 신념은 기업 비전의 핵심인 '혁신을 통한 가치 창출(Value through Innovation)'의 한마디로 요약됩니다. (80 words)
- [Busca y solicita empleos | Boehringer Ingelheim SA](/content/sa/carreras/busca-y-solicita-empleos/index.html): Ahora puedes buscar y solicitar empleos en Boehringer Ingelheim de una manera fácil y sencilla. ¡Tu próxima oportunidad a tan solo unas páginas de distancia! (600 words)
- [베링거인겔하임에서의 커리어 | Boehringer Ingelheim KR](/content/kr/injaechaeyong/index.html): 베링거인겔하임에서 일하는 방식 (89 words)
- [Spain | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/spain/index.html): Our facility in Spain is home to Regulatory Affairs Services and two technology hubs. Explore career opportunities in Spain or our 170 global locations. (254 words)
- [content/dam/7d9c411c-ec33-4f82-886f-af1e011f35bb/jardiance-us-pi-pdf.html](/content/content/dam/7d9c411c-ec33-4f82-886f-af1e011f35bb/jardiance-us-pi-pdf.html) (20,154 words)
- [Leaving site | Boehringer Ingelheim AT](/content/at/de/disclaimer/external/index.html) (124 words)
- [China | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/china/index.html): Boehringer Ingelheim has been active in China since 1994. Explore career development opportunities in China or our 170 locations around the globe. (191 words)
- [Switching market | Boehringer Ingelheim KR](/content/kr/disclaimer/market/index.html) (28 words)
- [Leaving site | Boehringer Ingelheim KR](/content/kr/disclaimer/bi/index.html) (150 words)
- [Eläinterveyteen liittyvät tuotteet | Boehringer Ingelheim FI](/content/fi/elainterveys/tuotteet/index.html): Innovaatiot ohjaavat kaikkea toimintaamme. Tavoitteemme on tarjota edistyksellistä ja ennaltaehkäisevää terveydenhuoltoa eläimille sekä kehittää. (15 words)
- [Animal Health Products | Boehringer Ingelheim UK](/content/uk/animal-health/products/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products. (60 words)
- [Descubre nuestras Ofertas | Boehringer Ingelheim SA](/content/sa/carreras/descubre-nuestras-oportunidades/index.html): Conoce las diversas carreras que ofrecemos, diseñadas para ayudarte a crecer profesionalmente, brindandote un trabajo desafiante que contribuye al éxito. (319 words)
- [Therapeutika | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-tiergesundheit/therapeutika/index.html): Therapeutika (60 words)
- [Hvad er bluetongue? | Boehringer Ingelheim DK](/content/dk/animal-health/udvalgte-historier/hvad-er-bluetongue/index.html): Bluetongue er en virussygdom, der smitter drøvtyggere som for eksempel kvæg, får, geder og hjorte. Sygdommen påvirker dyrets sundhed og den internationale handel. Bluetongue rammer ikke mennesker, men er farlig for drøvtyggere. (524 words)
- [Animal Health partnerskabsinteresser | Boehringer Ingelheim DK](/content/dk/partnerskab/animal-health-partnerskaber/interesseomrader-partnerskaber/index.html): Vi leder efter nye ideer og ny videnskab i vores søgen efter at opdage den næste generation af gennembrud inden for dyresundhed. (141 words)
- [Cómo aplicar | Boehringer Ingelheim SA](/content/sa/carreras/como-aplicar/index.html): ¿Quieres saber cómo presentar una solicitud, qué esperar y qué tienes que preparar para el proceso? ¡Sigue leyendo y no pierdas detalle! (626 words)
- [Erklæring om tilgængelighed | Boehringer Ingelheim DK](/content/dk/erklaering-om-tilgaengelighed/index.html): Boehringer-Ingelheim bestræber sig på at stille et websted til rådighed, der er tilgængeligt for det bredest mulige publikum uanset teknologi. (424 words)
- [Produits | Santé animale | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-produits/produits-sante-animale/index.html): Products (21 words)
- [Engineering & Facilities | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/engineering-facilities/index.html): Discover new opportunities in our Engineering and Facilities department. (332 words)
- [Animal Health Products | Boehringer Ingelheim AU](/content/au/animal-health/products/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. Click here to view the products. (82 words)
- [Declaración de accesibilidad | Boehringer Ingelheim SA](/content/sa/declaracion-de-accesibilidad/index.html): Declaración de accesibilidad (514 words)
- [Stop Rabies | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/index.html): Stop Rabies (192 words)
- [Alianzas en Salud Animal | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/index.html): Conoce el abordaje colaborativo de Boehringer Ingelheim para la innovación en salud animal, nuestras áreas de interés para alianzas estratégicas y cómo ponerse en contacto con nuestro equipo (569 words)
- [Anna Race | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/anna-race/index.html): Human Pharma Sales Director for UK & Ireland, Anna Race discusses how she enjoys making a difference within the company. (478 words)
- [Corporate Strategy & Consulting | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/corporate-strategy-consulting/index.html): Discover new opportunities in our Corporate Strategy and Consulting. (226 words)
- [Mød vores team | Boehringer Ingelheim DK](/content/dk/partnerskab/animal-health-partnerskaber/mod-vores-team/index.html): Vores globale partnerskabsteam er til stede i alle regioner i verden. (244 words)
- [Cookie Statement | Boehringer Ingelheim US](/content/us/cookie-statement/index.html): Cookie Statement (932 words)
- [Contacta con nosotros | Boehringer Ingelheim SA](/content/sa/carreras/contactanos/index.html): Ponte en contacto con Boehringer Ingelheim y obtendrás toda la información sobre el proceso de solicitud de empleo. Te atenderemos sin dilación. (123 words)
- [content/dam/28229472-fcc9-47bb-9a74-b32401562bdd/hernexeos-us-ppi-pdf.html](/content/content/dam/28229472-fcc9-47bb-9a74-b32401562bdd/hernexeos-us-ppi-pdf.html) (535 words)
- [Imprint | Boehringer Ingelheim DK](/content/dk/imprint/index.html): Kolofon (95 words)
- [Press Material | Boehringer Ingelheim](/content/media-stories/press-material/index.html): Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view BI corporate news. (78 words)
- [Purpose Video IT | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/purpose-video-it/index.html): Agustina Rojo, System Analyst in Buenos Aires, Argentina explains the many career opportunities Boehringer Ingelheim provides its employees. (109 words)
- [Imprint | Boehringer Ingelheim SA](/content/sa/imprint/index.html): Imprint (87 words)
- [Databeskyttelseserklæring vedrørende lægeovervågning af dyresundhedsprodukter | Boehringer Ingelheim DK](/content/dk/databeskyttelseserklaering-vedrorende-laegeovervagning-af-dyresundhedsprodukter.html): Databeskyttelseserklæring vedrørende lægeovervågning af dyresundhedsprodukter (596 words)
- [Explora nuestra empresa | Boehringer Ingelheim SA](/content/sa/carreras/explora-nuestra-compania/index.html): Dá tu próximo paso profesional en Boehringer Ingelheim. Explora nuestras áreas para obtener más información sobre oportunidades laborales. (275 words)
- [FAQ | Boehringer Ingelheim US](/content/us/careers/your-application-process/faq/index.html): Frequently Asked Questions regarding the job application process at Boehringer Ingelheim. (1,514 words)
- [Animal Health partnerskaber | Boehringer Ingelheim DK](/content/dk/partnerskab/animal-health-partnerskaber/index.html): Samarbejdet med partnere, der deler vores passion for at forbedre dyrenes sundhed og velvære, spiller en afgørende rolle for vores ambition om at finde løsninger på de største udfordringer. (248 words)
- [Consumer Health Data Privacy Statement | Boehringer Ingelheim US](/content/us/consumer-health-data-privacy-statement/index.html): This Consumer Health Data Privacy Statement applies to “Consumer Health Data,” as that term has been defined under applicable law. (830 words)
- [US Privacy Statement | Boehringer Ingelheim US](/content/us/us-privacy-statement/index.html): Our updated Privacy Statement is designed to provide greater transparency into our privacy practices and principles. (923 words)
- [Search | Boehringer Ingelheim US](/content/us/search/index.html) (472 words)
- [How to Connect | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/how-connect/index.html): Connect with the Boehringer Ingelheim Human Pharma Business Development and Licensing team to discuss partnering opportunities. (475 words)
- [Dette mener vores partnere | Boehringer Ingelheim DK](/content/dk/partnerskab/human-health-partnerskaber/dette-mener-vores-partnere/index.html): Vi deler en fælles vision med vores partnere om at ville gøre en forskel og udvikle ny og avanceret medicin, der har en reel indflydelse på patienternes liv. Hør, hvad de har at sige om deres partnerskabsrejse med os. (187 words)
- [Jessica Bürner | Boehringer Ingelheim US](/content/us/careers/explore-our-company/jessica-burner/index.html): Independent, authentic, bold - Jessica Bürner’s career path (54 words)
- [Fabricación por contrato de biofarmacéuticos | Boehringer Ingelheim SA](/content/sa/asociaciones/fabricacion-de-biofarmaceuticos-por-contrato/index.html): Fabricación por contrato de biofarmacéuticos (133 words)
- [Accessibility Statement | Boehringer Ingelheim US](/content/us/accessibility-statement/index.html): Boehringer Ingelheim endeavors to make https://www.boehringer-ingelheim.com accessible to any and all users. (665 words)
- [Udvalgte historier | Boehringer Ingelheim DK](/content/dk/animal-health/udvalgte-historier/index.html): Dyrevelfærd og menneskers trivsel – vores formål, vores inspiration og vores mål: Dyrs og menneskers liv er forbundet på dybe og komplekse måder. (440 words)
- [Aves | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/aves/index.html): Aves (361 words)
- [Human Health Interesseområder for partnerskaber | Boehringer Ingelheim DK](/content/dk/partnerskab/human-health-partnerskaber/interesseomrader-partnerskaber/index.html): Human Health interesseområder for partnerskaber (121 words)
- [Samarbejd med os | Boehringer Ingelheim DK](/content/dk/partnerskab/human-health-partnerskaber/samarbejd-med-os/index.html): Human Health Partnering - Samarbejd med os (145 words)
- [Human Health Partnerskaber | Boehringer Ingelheim DK](/content/dk/partnerskab/human-health-partnerskaber/index.html): At skabe ny og bedre medicin til patienter er kernen i det, vi gør. Og samarbejdet med kolleger på tværs af life-science-miljøet spiller en afgørende rolle, når vi sammen fremmer innovation for patienter. (145 words)
- [Asociaciones en Salud Humana | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-humana/index.html): Asociaciones en Salud Animal (153 words)
- [See our Boehringer Ingelheim locations | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-locations/index.html): We offer career development opportunities in over 170 locations across the world. Explore some of our featured Boehringer Ingelheim locations. (216 words)
- [Leaving site | Boehringer Ingelheim DK](/content/dk/disclaimer/external/index.html) (127 words)
- [Asociaciones | Boehringer Ingelheim SA](/content/sa/asociaciones/index.html): Partnering (179 words)
- [Conoce al equipo | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-animal/conoce-nuestro-equipo/index.html): Conoce nuestro equipo (160 words)
- [Collaborative Opportunities | Boehringer Ingelheim US](/content/us/partnering/collaborative-opportunities/index.html): Are you looking to make an impact in health innovation? Partner with Boehringer through open research, digital labs, academic funding programs, and more. (597 words)
- [Animales de compañía | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/index.html): Somos líderes globales en los mercados de animales de compañía y equinos, ayudamos a que los animales vivan más tiempo y con más salud. Más que nunca (401 words)
- [Search and apply | Boehringer Ingelheim US](/content/us/careers/job-search/index.html): Search and apply for Boehringer Ingelheim jobs. (404 words)
- [Vacunas | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-animal/vacunas/index.html): Vacunas (80 words)
- [Productos | Boehringer Ingelheim SA](/content/sa/salud-animal/productos/index.html): Productos de Salud Animal (239 words)
- [Produkter | Boehringer Ingelheim DK](/content/dk/produkter/index.html): Produkter (118 words)
- [El proceso de investigación | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-animal/el-proceso-de-investigacion/index.html): El proceso de investigación (132 words)
- [Connect with us | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (356 words)
- [Conéctate con nosotros | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-humana/contactanos/index.html): Contáctanos (129 words)
- [Nuestras Asociaciones en Salud Humana | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-humana/intereses-de-la-asociacion/index.html): Intereses de la asociación (91 words)
- [Forskningsprocess | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-dyresundhed/forskningsprocessen/index.html): Vi opdager eller identificerer nye stoffer, vacciner, teknologier, sygdomsprocesser og smittefremkaldende agenser. Til dette formål anvender (127 words)
- [Vacciner | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-dyresundhed/vacciner/index.html): I Global Innovation arbejder vi på sikre og effektive vacciner til husdyr og husdyr. Vi samler bred ekspertise inden for vaccinologi, molekylærbiologi, (71 words)
- [Videnskabshistorier | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/historier-om-videnskab/index.html): At skabe ny og bedre medicin til patienterne er kernen i vores arbejde. (89 words)
- [Our Working Culture | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-working-culture/index.html): Explore the unique workplace culture and values that define working at Boehringer Ingelheim, from fostering innovation to creating a sense of belonging for our employees. (609 words)
- [Parasiticider | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-dyresundhed/parasiticider/index.html): Et vigtigt ekspertiseområde inden for Global Innovation er opdagelse og udvikling af nye parasitmidler til både husdyr og husdyr. (49 words)
- [Kliniske studier | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/kliniske-studier/index.html): Kliniske forsøg er en vigtig del af udviklingen af nye lægemidler. De er oversættelsen af vores videnskabelige ekspertise til banebrydende behandlinger. (152 words)
- [Global innovation inden for dyresundhed | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-dyresundhed/index.html): Vores globale innovationsteam baner vejen for ny videnskab, der forbedrer dyresundhed verden over. En videnskab, der hjælper dyrlæger, kæledyrsejere, (76 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim US](/content/us/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (414 words)
- [Behandlinger | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-dyresundhed/behandlinger/index.html): Vi tilbyder en disciplineret videnskabelig tilgang til den globale opdagelse, udvikling og levering af terapeutiske lægemidler til husdyr og husdyrhold (67 words)
- [Innovation inden for menneskers sundhed | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/index.html): Boehringer Ingelheim har helt klare mål. Vi ønsker at levere en portefølje af banebrydende lægemidler, der vil forbedre livet for patienter (97 words)
- [Commercial | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/commercial-sales-marketing/index.html): Discover new opportunities in our Commercial area and apply today. (342 words)
- [Medicine & Regulatory Affairs | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/medicine-regulatory-affairs/index.html): Discover new opportunities in our Medicine and Regulatory Affairs. (276 words)
- [US Careers | Boehringer Ingelheim US](/content/us/careers/index.html): Join a global team of over 54,000 talented people dedicated to improving human and animal health worldwide. Explore careers at Boehringer Ingelheim now! (642 words)
- [Perspectives | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (332 words)
- [Parasiticidas | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-animal/parasiticidas/index.html): Parasiticidas (62 words)
- [How to apply | Boehringer Ingelheim US](/content/us/careers/your-application-process/index.html): Learn how to apply, what to expect, and what to prepare, when you begin the application with us. (416 words)
- [Programa Grass Roots | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/programa-grass-roots/index.html): Programa Grass Roots (101 words)
- [Porcinos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/index.html): Porcinos (268 words)
- [Suínos | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/suinos/index.html): A suinocultura brasileira é hoje uma das maiores do mundo. Conheça soluções e produtos veterinários que contribuíram para este crescimento. (379 words)
- [ANIMAL HEALTH | Boehringer Ingelheim DK](/content/dk/animal-health/index.html): Dyr og mennesker er forbundet med hinanden på dybe og komplekse måder. Vi ved, at når dyr er sunde, er mennesker også sundere. (325 words)
- [Græsrøddernes innovation | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/graesrodder/index.html): Vores unikke globale program af Grass Roots-initiativer er designet til at fremme ny videnskab og teknologi ved at støtte unge virksomheder inden . (61 words)
- [Vi fremmer videnskaben | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/vi-fremmer-videnskab/index.html): At skabe banebrydende lægemidler, der ændrer patienters liv, starter med en forpligtelse til at identificere fremtidens sundhedsudfordringer (118 words)
- [Innovación en Salud Animal | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-animal/index.html): Innovación en Salud Animal (91 words)
- [Terapéuticos | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-animal/terapeuticos/index.html): Terapéuticos (67 words)
- [Animal Health Partnering | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/index.html): BI's collaborations with partners who share our passion for improving the health and wellbeing of animals play an essential role in our ambitions. (502 words)
- [Ciencia e innovacion | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/index.html): Boehringer Ingelheim BioXcellence™ es líder mundial en fabricación biofarmacéutica por contrato. Ofrecemos el desarrollo de contratos a medida y de s (204 words)
- [Dr Paola Casarosa | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (170 words)
- [Information Technology | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/information-technology/index.html): Discover new opportunities in our Information Technology department. (143 words)
- [Vores videnskabelige fokus | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/videnskabeligt-fokus/index.html): Vores forskning i nye lægemidler er fokuseret på videnskabelige områder med et betydeligt medicinsk behov, og hvor vi fortsat er innovative og (63 words)
- [Imprint | Boehringer Ingelheim US](/content/us/imprint/index.html): Here you can access contact details and information about Boehringer Ingelheim (15 words)
- [Manufacturing & Supply Chain | Boehringer Ingelheim US](/content/us/careers/discover-our-career-areas/manufacturing-supply-chain/index.html): Discover new opportunities in our Manufacturing and Supply Chain. (206 words)
- [Animal Health: Vores ansvar | Boehringer Ingelheim DK](/content/dk/animal-health/vores-ansvar/index.html): Vi planlægger i generationer. Dette afspejler sig i vores mere end 100 års succesfulde virksomhedshistorie og i vores fokus på bæredygtighed. (183 words)
- [Estudios clínicos | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/estudios-clinicos/index.html): Estudios clínicos (118 words)
- [Salud Animal: nuestra responsabilidad | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/index.html): Salud Animal: nuestra responsabilidad (321 words)
- [Historias de ciencia | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/historias-de-ciencia/index.html): Historias de ciencia (56 words)
- [Produktionsdyr | Boehringer Ingelheim DK](/content/dk/animal-health/produktionsdyr/index.html): Boehringer Ingelheim er en af de førende leverandører af sundhedsløsninger, der kan forudsige, forebygge og behandle sygdomme hos produktionsdyr. (227 words)
- [動物衛生の提携の関心 | Boehringer Ingelheim JP](/content/jp/partnering/animal-health-partnering/partnering-interests/index.html): 感染症、非感染症、非疾患の重点分野を含む、ベーリンガーインゲルハイムの動物衛生に関する提携の関心を探ります。 (79 words)
- [Total Rewards | Boehringer Ingelheim Careers | Boehringer Ingelheim US](/content/us/careers/explore-our-company/our-total-rewards/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (224 words)
- [Veterinær folkesundhed | Boehringer Ingelheim DK](/content/dk/animal-health/veterinaer-folkesundhed/index.html): Veterinær folkesundhed (186 words)
- [What our partners say | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/what-our-partners-say/index.html): Read perspectives from Boehringer partners on their experience with us, what we have achieved together and how we’re making an impact. (542 words)
- [Animales de compañía | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/index.html): Animales de compañía (364 words)
- [Fjerkræ | Boehringer Ingelheim DK](/content/dk/animal-health/produktionsdyr/fjerkrae/index.html): Vi er stolte af at spille en afgørende rolle i at tilbyde hele verden sikkert og bæredygtigt fjerkrækød og æg af høj kvalitet til overkommendelige (108 words)
- [Partnership stories | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (269 words)
- [Enfoque científico | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/enfoque-cientifico/index.html): Enfoque científico (69 words)
- [Keeping 27 billion livestock free from animal diseases | Boehringer Ingelheim](/content/annualreport/2024/livestock-animal-disease/index.html): The responsibility of protecting 27 billion farm animals and tackling transboundary animal disease is a huge and tricky task (1,494 words)
- [Newsletter | Boehringer Ingelheim US](/content/us/newsletter/index.html): Click here to find out more on how you can sign up for our newsletter. Please choose the topics you want Boehringer Ingelheim to inform you about. (265 words)
- [Fomentando la ciencia | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/fomentando-la-ciencia/index.html): Fomentando la ciencia (71 words)
- [Svin | Boehringer Ingelheim DK](/content/dk/animal-health/produktionsdyr/svin/index.html): Boehringer Ingelheim er forkæmper for bæredygtig produktion af svinekød og animalsk protein. Vi sikrer dyrevelfærd gennem forebyggelse og integreret . (146 words)
- [Animales de producción | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/index.html): Animales de producción (220 words)
- [Rumiantes | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/rumiantes/index.html): Rumiantes (179 words)
- [Kvæg | Boehringer Ingelheim DK](/content/dk/animal-health/produktionsdyr/kvaeg/index.html): I vores Kvæg Team fokuserer vi strategisk på parasiticider, vacciner og terapeutiske produkter. Produkterne tilbydes til landmænd og dyrlæger i deres (97 words)
- [Innovación en Salud Humana | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/index.html): Innovación en Salud Humana (31 words)
- [Skizofreni | Boehringer Ingelheim DK](/content/dk/human-health/mental-sundhed/skizofreni/index.html): Skizofreni er kendetegnet ved tre symptomdomæner og rammer ~1% af verdens befolkning. Det første og mest kendte er de positive symptomer som (172 words)
- [Heste | Boehringer Ingelheim DK](/content/dk/animal-health/kaeledyr-og-heste/heste/index.html): Boehringer Ingelheim er førende inden for hestesundhed og udvikler innovative løsninger til heste verden over.Uanset om der er tale om en konkurrencehest (115 words)
- [Perguntas mais frequentes | Boehringer Ingelheim BR](/content/br/carreiras/como-se-candidatar/perguntas-frequentes/index.html): Perguntas frequentes sobre o processo de candidatura a vagas de emprego na Boehringer Ingelheim. (1,680 words)
- [Kæledyr | Boehringer Ingelheim DK](/content/dk/animal-health/kaeledyr-og-heste/kaeledyr/index.html): Vi er blandt de førende på markedet inden for parasiticider, vacciner og terapeutiske produkter. Vi er en betroet partner for dyrlæger og kæledyrsejere (95 words)
- [Kæledyr og heste | Boehringer Ingelheim DK](/content/dk/animal-health/kaeledyr-og-heste/index.html): Er du dyrlæge, eller har du et kæledyr eller en hest? Som en af de førende udbydere på det globale marked, hjælper Boehringer Ingelheim med (36 words)
- [Løsninger med patienten i centrum | Boehringer Ingelheim DK](/content/dk/human-health/vores-ansvar/patienten-i-centrum/index.html): Patienten kommer i første række i alt, hvad vi gør hos Boehringer Ingelheim. Patienterne inspirerer os i vores mission om at lede den videnskab. (118 words)
- [Working together | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/working-together/index.html): Discover our approach to partnering – why we’re motivated to work with others and how we collaborate across biotech, academia, and more. (402 words)
- [Salud Animal | Boehringer Ingelheim SA](/content/sa/salud-animal/index.html): El bienestar de los animales y las personas es nuestro propósito, nuestra inspiración y nuestro objetivo. Las vidas de las personas y los animales es (416 words)
- [Gizlilik Bildirimi | Boehringer Ingelheim TR](/content/tr/gizlilik-bildirimi/index.html): Gizlilik Bildirimi (456 words)
- [Salud pública veterinaria | Boehringer Ingelheim SA](/content/sa/salud-animal/salud-publica-veterinaria/index.html): Salud pública veterinaria (161 words)
- [Erklæring om beskyttelse af personoplysninger | Boehringer Ingelheim DK](/content/dk/erklaering-om-beskyttelse-af-personoplysninger/index.html): Denne meddelelse om beskyttelse af personoplysninger beskriver, hvordan Boehringer Ingelheim Danmark A/S (herefter "Boehringer Ingelheim", "vi", "os") (712 words)
- [Interese de parteneriat în domeniul sănătății animalelor | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-domeniul-medicinei-veterinare/interese-de-parteneriat/index.html): Explorați interesele de parteneriat ale Boehringer Ingelheim în domeniul sănătății animalelor, inclusiv bolile infecțioase, bolile neinfecțioase și ariile de interes care nu sunt legate de boli. (873 words)
- [Vores ansvar | Boehringer Ingelheim DK](/content/dk/human-health/vores-ansvar/index.html): Patienten kommer i første række i alt, hvad vi gør hos Boehringer Ingelheim. Patienterne inspirerer os i vores mission om at lede den videnskab, (88 words)
- [Swine | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/swine/index.html): Protecting pigs and sustaining the swine industry are top priorities for Boehringer Ingelheim as we partner with pork producers and swine veterinarians (538 words)
- [Partnering | Boehringer Ingelheim US](/content/us/partnering/index.html): Making new medicines for patients is at the heart of who we are. Find out how collaborations with colleagues in the science community plays a vital role. (204 words)
- [Hvem vi er | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/index.html): Boehringer Ingelheim arbejder på banebrydende behandlinger, der ændrer liv - i dag og for de kommende generationer. (343 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim US](/content/us/about-us/quality/index.html): Quality at Boehringer Ingelheim (217 words)
- [Human Health Innovation | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/index.html): BI's pipeline has the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance. (284 words)
- [Poultry | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/poultry/index.html): As trusted partners to poultry producers, Boehringer Ingelheim provides industry-leading vaccines and expertise to protect both flock health and businesses (458 words)
- [Depression | Boehringer Ingelheim DK](/content/dk/human-health/mental-sundhed/depression/index.html): Depression er en psykisk lidelse, der forårsager en vedvarende følelse af tristhed og tab af interesse. Den kaldes også major depressiv lidelse og (115 words)
- [Historias destacadas | Boehringer Ingelheim SA](/content/sa/salud-animal/historias-destacadas/index.html): Historias destacadas (193 words)
- [Podmínky použití | Boehringer Ingelheim CZ](/content/cz/podminky-pouziti/index.html): Podmínky použití (1,244 words)
- [Latest jobs in Brazil | Boehringer Ingelheim Careers](/content/ca/careers/explore-our-company/our-locations/brazil/index.html): Boehringer Ingelheim's presence in Brazil spans over 70 years. Explore career development opportunities in Brazil or our 170 locations around the globe. (169 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/index.html): Boehringer Ingelheim's commitment to animal health is reflected in our more than 100 years of successful company history. It is also at the core of sustainability. (255 words)
- [Cultura | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/index.html): Impulsados por la investigación y la entrega de valor desde nuestra fundación, pensamos en generaciones y en enfocarnos en el valor a largo plazo para los pacientes. Esto define de manera fundamental nuestra cultura y la forma en que operamos. (276 words)
- [Horses | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/horses/index.html): Partnering with owners and vets, Boehringer Ingelheim’s Equine team brings deep expertise and a passion for the equestrian life to help all horses thrive (465 words)
- [Vaccines | Boehringer Ingelheim US](/content/us/science-innovation/animal-health-innovation/vaccines/index.html): At Boehringer Ingelheim, we bring together a broad expertise in vaccinology & molecular biology to improve the effectiveness of our animal vaccines. (126 words)
- [Aviso de privacidad de datos | Boehringer Ingelheim SA](/content/sa/aviso-de-privacidad-de-datos/index.html): Aviso de Privacidad (1,003 words)
- [Science Stories | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-stories/index.html): Making new and better medicines for patients is at the heart of Boehringer Ingelheim does. Patients inspire us to lead the science and never give up. (71 words)
- [Fostering Science | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/fostering-science/index.html): Find out how creating breakthrough medicines to change patients’ lives starts with a commitment to identify the challenges of the future & emerging science. (114 words)
- [Contáctanos | Boehringer Ingelheim SA](/content/sa/contactanos/index.html): Contáctenos vía correo electrónico Boehringer Ingelheim S.A.Boehringer Ingelheim ArgentinaComplejo Empresarial UrbanaCazadores de Coquimbo 2841 Pis (220 words)
- [Leadership | Boehringer Ingelheim US](/content/us/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Psykiske sygdomme | Boehringer Ingelheim DK](/content/dk/human-health/mental-sundhed/index.html): Hos Boehringer Ingelheim Mental Sundhed redefinerer vi mental sundhed for at få mennesker til at have det godt. (219 words)
- [Curious to learn more about opportunities in Research?](/content/ca/careers/discover-our-career-areas/research-development/index.html): We invite you to learn more about the many functions and roles within Research, and to explore our current vacancies in locations around the world. (225 words)
- [Arbejde hos Boehringer Ingelheim | Boehringer Ingelheim DK](/content/dk/karriere/index.html): Kom og vær med og bidrag til vores mission om at skabe værdi gennem innovation for de patienter, vi betjener. (313 words)
- [Interesses de Parceria em Saúde Animal | Boehringer Ingelheim BR](/content/br/parcerias/parcerias-na-saude-animal/interesses-para-parceria/index.html): Explore os interesses de parceria da Boehringer Ingelheim em saúde animal, incluindo doenças infecciosas, doenças não infecciosas e áreas de foco não relacionadas a doenças. (791 words)
- [Quiénes somos | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/index.html): Quiénes somos (354 words)
- [KOL og astma | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/kol-og-astma/index.html): Kronisk obstruktiv lungesygdom (KOL) er en progressiv, behandlelig sygdom, der er kendetegnet ved begrænset luftstrøm ind og ud af lungerne, (218 words)
- [Parasiticides | Boehringer Ingelheim US](/content/us/science-innovation/animal-health-innovation/parasiticides/index.html): Read more on how the discovery and development of new parasiticides for both companion animals and livestock is key for global innovation. (55 words)
- [Bronkiektasier | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/bronkiektasier/index.html): Bronkiektasier (165 words)
- [日本での最新求人情報 | ベーリンガーインゲルハイムの採用情報](/content/jp/careers/japan/index.html): 日本のチームは、イノベーションとサステナビリティへのコミットメントが高く評価されています。日本や世界中170か所にわたる当社拠点で、キャリア開発のチャンスを見つけてください。 (89 words)
- [The Research Process | Boehringer Ingelheim US](/content/us/science-innovation/animal-health-innovation/research-process/index.html): Read more on how our research process informs our ability to new compounds, vaccines, technologies, disease processes, and infectious agents. (130 words)
- [FAQ | Boehringer Ingelheim CA](/content/ca/careers/your-application-process/faq/index.html): FAQ (1,667 words)
- [Om os | Boehringer Ingelheim DK](/content/dk/om-os/index.html): Boehringer Ingelheim er en global virksomhed, der favner mange forskellige kulturer og fællesskaber. (231 words)
- [About Us | Boehringer Ingelheim US](/content/us/about-us/index.html): Click here to discover more about Boehringer Ingelheim and our headquarters and largest U.S subsidiary in Connecticut. (227 words)
- [Liderazgo | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/liderazgo/index.html): Conoce más sobre la Junta Directiva de Boehringer Ingelheim, con información sobre los cinco miembros y sus respectivas responsabilidades. (179 words)
- [Lungesygdomme | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/index.html): Boehringer Ingelheim har 100 års erfaring inden for luftvejssygdomme. Siden 1921 har vi været førende inden for dette sygdomsområde og har lanceret, (109 words)
- [Animal Health Innovation | Boehringer Ingelheim US](/content/us/science-innovation/animal-health-innovation/index.html): We collaborate with our colleagues in human health to pioneer the science that helps veterinarians, pet and livestock owners and public health officials (71 words)
- [Clinical Studies | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/clinical-studies/index.html): BI's clinical trials are an essential part of the development of new medicines, being the translation of our expertise into breakthrough therapies. (79 words)
- [Conditions d’utilisation | Boehringer Ingelheim CH](/content/ch/fr/conditions-dutilisation/index.html): Nutzungsbedingungen (1,006 words)
- [Science & Innovation | Boehringer Ingelheim US](/content/us/science-innovation/index.html): Click here to learn more on why BI looks at things differently, to take the path scientifically less-travelled as we pursue the next big breakthrough. (138 words)
- [FAQ | Boehringer Ingelheim JP](/content/jp/careers/how-apply/faq/index.html): FAQ (102 words)
- [Therapeutics | Boehringer Ingelheim US](/content/us/science-innovation/animal-health-innovation/therapeutics/index.html): Find out more on how the discovery, development and delivery of therapeutics for companion animals & livestock is key for advancements in therapeutics. (61 words)
- [Nuestro compromiso | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/index.html): NUESTRO COMPROMISO (177 words)
- [Carreras | Boehringer Ingelheim SA](/content/sa/carreras/index.html): Únete a un equipo global de más de 52.000 apasionadas y talentosas personas dedicadas a mejorar la salud humana y animal en todo el mundo. (247 words)
- [MORE GREEN | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-green/index.html): Our MORE GREEN pillar encompasses initiatives that consider many different aspects: adopting measures to avoid water and air pollution, & much more. (87 words)
- [Terms of Use | Boehringer Ingelheim CA](/content/ca/terms-use/index.html): This Terms of Use pertains to Boehringer Ingelheim (Canada) Ltd./Ltée. and Boehringer Ingelheim Animal Health Canada Inc. Click here to read it. (1,019 words)
- [Historie | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/historie/index.html): I 1885 grundlagde Albert Boehringer (1861-1939) medicinalvirksomheden Boehringer Ingelheim i Nieder-Ingelheim, som i dag er en del af Ingelheim am Rhein. (140 words)
- [Lungefibrose | Boehringer Ingelheim DK](/content/dk/human-health/lungesygdomme/lungefibrose/index.html): Lungefibrose er en tilstand, der fører til en ophobning af arvæv i lungerne. Med tiden mister lungerne deres evne til at optage og overføre ilt til . (109 words)
- [Nuestra responsabilidad | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/index.html): Nuestra responsabilidad (87 words)
- [Nuestra compañía | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/index.html): Boehringer Ingelheim es un grupo de compañías global que abarca diversas culturas y comunidades. Acceda a información sobre los principales datos fin (273 words)
- [Foco en el paciente | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/foco-en-el-paciente/index.html): Foco en el paciente (84 words)
- [Enfermedades de la retina | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-de-la-retina/index.html): Enfermedades de la retina (144 words)
- [History | Boehringer Ingelheim US](/content/us/about-us/who-we-are/history/index.html): Click here to read more on the history of Boehringer Ingelheim, founded by Albert Boehringer in 1885. Today the company has become a global enterprise. (162 words)
- [MASH | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/mash/index.html): nash (164 words)
- [Empoderando a pacientes | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/capacitando-los-pacientes/index.html): Empoderando a pacientes (125 words)
- [Who we are | Boehringer Ingelheim US](/content/us/about-us/who-we-are/index.html): Read more on Boehringer Ingelheim, where we strive to better understand breakthrough therapies that transform the lives of patients across the globe. (274 words)
- [Déclaration d’accessibilité | Boehringer Ingelheim CH](/content/ch/fr/declaration-daccessibilite/index.html): Zugänglichkeitserklärung (524 words)
- [Historia | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/historia/index.html): Conoce más sobre la historia de la compañía farmacéutica innovadora Boehringer Ingelheim. (157 words)
- [Our Working Culture | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/our-working-culture/index.html): Explore the unique workplace culture and values that define working at Boehringer Ingelheim, from fostering innovation to creating a sense of belonging for our employees. (618 words)
- [Consulte as nossas localizações | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/consulte-nossas-localizacoes/index.html): Oferecemos oportunidades de desenvolvimento de carreira em mais de 170 localizações em todo o mundo. Explore algumas das nossas localizações em destaque. (299 words)
- [Pressemateriale | Boehringer Ingelheim DK](/content/dk/presse/index.html): Få adgang til vores mediepulje og vores pressesæt om dyresundhed. (56 words)
- [Depresión | Boehringer Ingelheim SA](/content/sa/salud-humana/salud-mental/depresion/index.html): Depresión (67 words)
- [Accessibility Statement | Boehringer Ingelheim CA](/content/ca/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click here to find out how we are making our website as user friendly as possible. (604 words)
- [Produtos | Boehringer Ingelheim BR](/content/br/produtos/index.html): Produtos (83 words)
- [Menções legais | Boehringer Ingelheim BR](/content/br/mencoes-legais/index.html): Menções legais (162 words)
- [Termeni și Condiții | Boehringer Ingelheim RO](/content/ro/termeni-si-conditii/index.html): Termeni și Condiții (1,308 words)
- [Switching market | Boehringer Ingelheim DK](/content/dk/disclaimer/market/index.html) (59 words)
- [Search and apply | Boehringer Ingelheim CA](/content/ca/careers/job-search/index.html): Search and apply (381 words)
- [Culture & Benefits | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/culture-benefits/index.html): 【日本特集】ベーリンガーインゲルハイムのカルチャー/人/キャリア情報 (65 words)
- [Termos de uso | Boehringer Ingelheim BR](/content/br/termos-de-uso/index.html): Consulte os termos de uso e as políticas de uso do site da Boehringer Ingelheim. (743 words)
- [Explore a nossa empresa | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/index.html): Dê o próximo passo da sua carreira na Boehringer Ingelheim. Explore as nossas várias áreas para saber mais sobre oportunidades de emprego na sua área de interesse. (466 words)
- [Partenariats | Boehringer Ingelheim CH](/content/ch/fr/partenariats/index.html): Nous sommes convaincus que l'innovation naît de la diversité et de l'échange dans le domaine scientifique. C'est pourquoi les partenariats sont un élément important de notre stratégie d'innovation. (170 words)
- [Animal Health Partnering Interests | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/partnering-interests/index.html): Explore Boehringer Ingelheim’s partnering interests in animal health, including infectious diseases, non-infectious diseases, and non-disease areas of focus. (783 words)
- [Canada Careers | Boehringer Ingelheim CA](/content/ca/careers/index.html): Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide. (748 words)
- [Partnership stories | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (274 words)
- [Curious to learn more about opportunities in Facilities?](/content/ca/careers/discover-our-career-areas/engineering-facilities/index.html): We invite you to learn more about the many functions and roles within Facilities, and to explore our current vacancies in locations around the world. (264 words)
- [Carrières | Boehringer Ingelheim CH](/content/ch/fr/carriere/index.html): Boehringer Ingelheim ist ein Pharmaunternehmen im Familienbesitz - starten Sie Ihre Karriere in einem globalen und innovativen Umfeld bei uns noch heute. (208 words)
- [How to apply | Boehringer Ingelheim CA](/content/ca/careers/your-application-process/index.html): How to apply (414 words)
- [Entre em contato | Boehringer Ingelheim BR](/content/br/carreiras/entre-em-contato/index.html): Entre em contato e saiba mais sobre o processo de candidatura a vagas de emprego. (103 words)
- [acessibilidade-bi | Boehringer Ingelheim BR](/content/br/acessibilidade-bi/index.html): A Boehringer Ingelheim promove a inclusão e a acessibilidade digital. Consulte a lista de ferramentas que facilitam a vida de pessoas com deficiências. (294 words)
- [Curious to learn more about opportunities in Medicine?](/content/ca/careers/discover-our-career-areas/medicine-regulatory-affairs/index.html): We invite you to learn more about the many functions and roles within Medicine, and to explore our current vacancies in locations around the world. (227 words)
- [Switching market | Boehringer Ingelheim SA](/content/sa/disclaimer/market/index.html) (69 words)
- [Produits biopharmaceutiques à façon | Boehringer Ingelheim CH](/content/ch/fr/partenariats/produits-biopharmaceutiques-facon/index.html): Wir sind eines der weltweit führenden Unternehmen in der biopharmazeutischen Auftragsherstellung (119 words)
- [Curious to learn more about opportunities within IT?](/content/ca/careers/discover-our-career-areas/information-technology/index.html): We invite you to learn more about functions and roles within Information Technology, and to explore our current vacancies in locations around the world. (172 words)
- [Opportunités de partenariat | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/opportunites-de-partenariat/index.html): Avec nos partenaires, nous travaillons sur des percées qui ouvrent de nouvelles possibilités thérapeutiques aux personnes souffrant de maladies jusqu'ici insuffisamment traitées. (167 words)
- [Podrobné informace o ochraně soukromí | Boehringer Ingelheim CZ](/content/cz/podrobne-informace-o-ochrane-soukromi/index.html): Podrobné informace o ochraně soukromí (220 words)
- [See our Locations | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/our-locations/index.html): We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations. (223 words)
- [Nossa Cultura de Trabalho | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/nossa-cultura-de-trabalho/index.html): Descubra a cultura e os valores únicos que definem o trabalho na Boehringer Ingelheim, desde o incentivo à inovação até a criação de um senso de pertencimento para nossos funcionários. (596 words)
- [Terms of Use | Boehringer Ingelheim HK](/content/hk/en/terms-use/index.html): Terms of Use (1,410 words)
- [Produkte | Boehringer Ingelheim CH](/content/ch/fr/produkte/index.html): product (10 words)
- [Opportunités de partenariat | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-animale/opportunites-de-partenariat/index.html): Opportunités de partenariat (94 words)
- [Perspektivy | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-zdravi-zvirat/perspektivy/index.html): Získejte hlubší vhled do odvětví zdraví zvířat a přečtěte si názory odborníků ze společnosti Boehringer Ingelheim na to, proč je spolupráce klíčová pro podporu inovací. (392 words)
- [Curious to learn more about opportunities in Commercial?](/content/ca/careers/discover-our-career-areas/commercial-sales-marketing/index.html): We invite you to learn more about the many functions and roles within Commercial, and to explore our current vacancies in locations around the world. (294 words)
- [Partenariats en santé humaine | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/index.html): Les partenariats sont un élément central de notre stratégie d'entreprise et font donc partie de notre succès en matière d'innovation. (224 words)
- [Partenariats en santé animale | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-animale/index.html): Partenariats en santé animale (111 words)
- [Curious to learn more about roles in Supply Chain?](/content/ca/careers/discover-our-career-areas/manufacturing-supply-chain/index.html): We invite you to learn more about the many functions and roles within Supply Chain, and to explore our current vacancies in locations around the world. (199 words)
- [Total rewards | Boehringer Ingelheim BR](/content/br/carreiras/conheca-nossa-empresa/nossas-recompensas-totais/index.html): Na Boehringer Ingelheim, oferecemos recompensas e oportunidades de desenvolvimento para ajudar a reter nossos funcionários. Investimos em nossos colaboradores para que permaneçam conosco e cresçam junto com a gente. (322 words)
- [Le processus de recherche | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-animale/le-processus-de-recherche/index.html): Der Forschungsprozess (144 words)
- [Discover our careers | Boehringer Ingelheim CA](/content/ca/careers/discover-our-career-areas/index.html): Discover our careers (227 words)
- [Antiparasitaires | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-animale/antiparasitaires/index.html): Antiparasitaires (81 words)
- [Spolupráce v oblasti zdraví zvířat | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-zdravi-zvirat/index.html): Seznamte se s přístupem společnosti Boehringer Ingelheim k inovacím v oblasti zdraví zvířat, který staví na spolupráci napříč obory. Seznamte se s našimi oblastmi a zjistěte, jak se můžete spojit s naším týmem. (530 words)
- [Bewegung bei Lungenfibrose: Therapie für mehr Lebensqualität | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/bewegung-bei-lungenfibrose/index.html): Erfahren Sie, wie Initiativen in Frankreich, Spanien und den Niederlanden Bewegung als festen Bestandteil der Lungenfibrose-Therapie etablieren. (1,412 words)
- [Animal Health Partnering Interests | Boehringer Ingelheim HK](/content/hk/en/partnering/animal-health-partnering/partnering-interests/index.html): In order to create the next generation of medical breakthroughs in animal health we need partners. Click here to view our animal health partnering interests. (558 words)
- [Conectați-vă cu noi | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-domeniul-medicinei-veterinare/contacteaza-ne/index.html): Conectați-vă cu echipa Boehringer Ingelheim Animal Health Business Development and Licensing online sau la evenimente pentru a trimite o propunere sau pentru a discuta despre oportunitățile de parteneriat (391 words)
- [Parcerias em Saúde Animal | Boehringer Ingelheim BR](/content/br/parcerias/parcerias-na-saude-animal/index.html): Conheça a abordagem colaborativa da Boehringer Ingelheim para impulsionar a inovação em saúde animal, nossas áreas de interesse para parcerias e como entrar em contato com nossa equipe. (531 words)
- [Carreiras | Boehringer Ingelheim BR](/content/br/carreiras/index.html): Junte-se a uma equipe global de mais de 54.000 pessoas talentosas dedicadas a melhorar a saúde humana e animal em todo o mundo. Explore as oportunidades de carreira na Boehringer Ingelheim agora mesmo! (808 words)
- [Notre équipe | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-animale/notre-equipe/index.html): Notre équipe (60 words)
- [Nous contacter | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/nous-contacter/index.html): Nous contacter (86 words)
- [Témoignages de nos partenaires | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/temoignages-de-nos-partenaires/index.html): What our partners say We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us. (34 words)
- [Vaccins | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-animale/vaccins/index.html): Vaccins (105 words)
- [Spojte se s námi | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-zdravi-zvirat/spojte-se-s-nami/index.html): Spojte se s týmem Boehringer Ingelheim pro rozvoj podnikání a licencování v oblasti zdraví zvířat (online nebo na oborových akcích). Předložte nám svůj návrh nebo diskutujme možnosti spolupráce. (368 words)
- [Perspectives | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (455 words)
- [Související tiskové zprávy | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-zdravi-zvirat/pribehy-spoluprace/index.html): Seznamte se s nejvýznamnějšími ukázkami spolupráce Boehringer Ingelheim v oblasti zdraví zvířat. Zjistěte, co o společné práci říkají naši partneři. (239 words)
- [Pesquisar vagas e candidatar-se | Boehringer Ingelheim BR](/content/br/carreiras/trabalhe-conosco/index.html): Procure e candidate-se a empregos na Boehringer Ingelheim. (149 words)
- [Grass Roots | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/grass-roots/index.html): Grass Roots (205 words)
- [See our Locations | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/see-our-locations/index.html): We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations. (57 words)
- [Partnership - Ontorio | Boehringer Ingelheim CA](/content/ca/partnering-boehringer-ingelheim-canada/index.html): Boehringer Ingelheim Canada collaborates with premier institutions in Ontario to drive innovative solutions for high-quality healthcare. Click to read more. (131 words)
- [Perspective | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-domeniul-medicinei-veterinare/perspective/index.html): Obțineți informații despre industria sănătății animalelor și citiți perspectivele experților Boehringer Ingelheim cu privire la importanța colaborării în stimularea inovării (440 words)
- [Innovations en santé humaine | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/index.html): Boehringer Ingelheim konzentriert sich in seinen Forschungsaktivitäten auf Krankheitsbereiche mit einem hohen ungedeckten medizinischen Bedarf. (144 words)
- [Innovations en santé animale | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-animale/index.html): Innovations en santé animale (73 words)
- [Études cliniques | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/etudes-cliniques/index.html): Les études cliniques sont une composante essentielle du développement de nouveaux médicaments. (67 words)
- [Favoriser la recherche | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/favoriser-la-recherche/index.html): Favoriser la recherche (134 words)
- [Imprint | Boehringer Ingelheim RO](/content/ro/imprint/index.html): Imprint (47 words)
- [BIORAL H-120 NEO | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/bioral-h-120-neo/index.html): BIORAL H-120 NEO (117 words)
- [Sıkça sorulan sorular | Boehringer Ingelheim TR](/content/tr/kariyer/how-apply/faq/index.html): FAQ (1,394 words)
- [Histoires scientifiques | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/histoires-scientifiques/index.html): Histoires scientifiques (86 words)
- [Data Privacy | Boehringer Ingelheim HK](/content/hk/en/data-privacy/index.html): Data Privacy (892 words)
- [ENTERISOL® Salmonella T/C | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/enterisol-salmonella-t-c/index.html): Enterisol Salmonella (171 words)
- [Innovation | Boehringer Ingelheim CH](/content/ch/fr/innovation/index.html): Innovation (153 words)
- [ENTERISOL® SC54 | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/enterisol-sc54/index.html): ENTERISOL® SC54 (105 words)
- [Hayvan Sağlığında İş Birliği Alanları | Boehringer Ingelheim TR](/content/tr/partnering/animal-health-partnering/partnering-interests/index.html): Hayvan sağlığında Boehringer Ingelheim’in iş birliği önceliklerini keşfedin: bulaşıcı hastalıklar, bulaşıcı olmayan hastalıklar ve diğer odak alanları. (651 words)
- [Discover our careers | Boehringer Ingelheim JP](/content/jp/careers/discover-our-careers/index.html): Discover our careers (99 words)
- [Our total rewards | Boehringer Ingelheim CA](/content/ca/careers/explore-our-company/our-total-rewards/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (182 words)
- [Search and apply | Boehringer Ingelheim JP](/content/jp/careers/search-and-apply/index.html): Search and apply (405 words)
- [Parteneriat în domeniul sănătății animalelor | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-domeniul-medicinei-veterinare/index.html): Aflați despre abordarea colaborativă a Boehringer Ingelheim privind inovația în sănătatea animală, domeniile noastre de interes pentru parteneriate și cum să luați legătura cu echipa noastră. (465 words)
- [Disciplines de pointe | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/disciplines-de-pointe/index.html): Nous nous concentrons sur les domaines du cœur et du métabolisme, du SNC, de l'immunologie et des voies respiratoires, de l'oncologie et de l'immuno-oncologie ainsi que des maladies de la rétine. (137 words)
- [Connect with us | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (357 words)
- [Declarația de accesibilitate | Boehringer Ingelheim RO](/content/ro/declaratia-de-accesibilitate/index.html): Boehringer Ingelheim se mândrește cu faptul că este accesibil publicului nostru. Faceți clic pe ea pentru a vedea cum facem ca site-ul nostru să fie cât mai ușor de utilizat. (458 words)
- [Get in touch | Boehringer Ingelheim JP](/content/jp/careers/get-touch/index.html): Get in touch (35 words)
- [Kullanım Kuralları | Boehringer Ingelheim TR](/content/tr/kullanim-kurallari/index.html): Kullanım Kuralları (356 words)
- [Porcs | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-rente/porcs/index.html): Porcs (221 words)
- [Volaille | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-rente/volaille/index.html): Vous trouverez ici des informations utiles sur les thèmes de la santé et des maladies des volailles et des poulets (159 words)
- [Meksika | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/mexico/index.html): Meksika, modern üretim tesislerimizden ikisine ev sahipliği yapmaktadır. Meksika'da veya dünya genelinde 170 tesisimizdeki kariyer fırsatlarını keşfedin. (181 words)
- [Animal Health Partnering | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (433 words)
- [人類處方用藥 創新 | Boehringer Ingelheim TW](/content/tw/renleichufangyongyao-chuangxin/index.html): Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline. (182 words)
- [Erişim Raporu | Boehringer Ingelheim TR](/content/tr/erisim-raporu/index.html): Erişim Raporu (470 words)
- [Cultura de parcerias | Boehringer Ingelheim BR](/content/br/parcerias/parcerias-na-saude-humana/cultura-de-parcerias/index.html): Cultura de parcerias (66 words)
- [Interesses para parceria Humana | Boehringer Ingelheim BR](/content/br/parcerias/parcerias-na-saude-humana/interesses-para-parceria/index.html): Interesses para parceria (101 words)
- [Baskı | Boehringer Ingelheim TR](/content/tr/baski/index.html): Baskı (82 words)
- [Fabricação por Contrato de Biofarma | Boehringer Ingelheim BR](/content/br/parcerias/fabricacao-por-contrato-de-produtos-biofarmaceuticos.html): Fabricação por Contrato de Biofarma (55 words)
- [Human Health Partnering Interests | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-interests/index.html): Find out about our partnering activities, including collaborating on solutions co-created to serve patients and their families and caregivers, and more. (121 words)
- [Leaving site | Boehringer Ingelheim JP](/content/jp/disclaimer/external/index.html) (9 words)
- [Avusturya | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/austria/index.html): Viyana, Almanya dışındaki ilk tesisimizdi. Avusturya veya dünya genelinde 170 tesisimizdeki fırsatları keşfedin. (150 words)
- [Ruminants | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-rente/ruminants/index.html): Ruminants (134 words)
- [Estudos Clínicos | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/estudos-clinicos/index.html): Estudos Clínicos (304 words)
- [Όροι Χρήσης | Boehringer Ingelheim GR](/content/gr/oroi-hrisis/index.html): Αυτός ο ιστότοπος είναι μια πηγή διεθνών πληροφοριών από τα κεντρικά γραφεία της εταιρείας μας στο Ingelheim της Γερμανίας. (1,554 words)
- [O Processo de Pesquisa | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-animal/o-processo-de-pesquisa/index.html): O Processo de Pesquisa (142 words)
- [Produtos de Saúde Animal | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/index.html): Promover a saúde e o bem-estar animal sempre foi um dos maiores objetivos da Boehringer Ingelheim. Conheça nossos produtos inovadores para animais. (130 words)
- [Explore our company | Boehringer Ingelheim JP](/content/jp/careers/explore-our-company/index.html): Make your next career step at Boehringer Ingelheim. Explore our various fields to find out more about employment opportunities in your area of interest. (99 words)
- [Animaux de rente | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-rente/index.html): Wir bieten unseren Kund*innen innovative Gesundheitslösungen, um Krankheiten und Leiden bei Nutztieren vorzubeugen oder diese zu lindern und damit das Tierwohl zu fördern. (144 words)
- [Animaux de compagnie et chevaux | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/index.html): Haustiere und Pferde Hunde, Katzen und Pferde – sie teilen eine enge Verbindung mit uns und für viele Menschen sind sie echte Familienmitglieder oder treue Freunde. Umso wichtiger ist es, dass die Tiere gesund sind und gut versorgt werden. (305 words)
- [Chevaux | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/chevaux/index.html): Chevaux (136 words)
- [Animaux de compagnie | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/index.html): Hunde (180 words)
- [Vacinas | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-animal/vacinas/index.html): Vacinas (88 words)
- [Názory našich partnerů | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/nazory-nasich-partneru/index.html): S našimi partnery sdílíme společnou vizi, že chceme něco změnit a vyvíjet nové a pokročilé léky, které budou mít skutečný dopad na životy pacientů. Poslechněte si, co říkají o své partnerské cestě s námi. (58 words)
- [Parasiticidas | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-animal/parasiticidas/index.html): Parasiticidas (72 words)
- [How to apply | Boehringer Ingelheim JP](/content/jp/careers/how-apply/index.html): How to apply (33 words)
- [Biofarmaceutická smluvní výroba | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/biofarmaceuticka-smluvni-vyroba/index.html): Biofarmaceutická smluvní výroba (132 words)
- [MICARDIS ANLO (Paciente) | Boehringer Ingelheim BR](/content/br/pdf/micardis-anlo-pacientepdf/index.html): Bula Micadis Anlo (Paciente) atualizada em 06/01/2026. (12 words)
- [Partnerská spolupráce | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/index.html): Ve společnosti Boehringer Ingelheim je pro vývoj nových průlomových objevů v medicíně nejdůležitější rozmanitost názorů a spolupráce. Klikněte zde a podívejte se, jak s námi můžete spolupracovat. (157 words)
- [Accessibility Statement | Boehringer Ingelheim HK](/content/hk/en/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (463 words)
- [Terapêuticos | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-animal/terapeuticos/index.html): Terapêuticos (77 words)
- [Nos Stories | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/nos-stories/index.html): Unsere Stories (176 words)
- [Partnerská spolupráce v oblasti lidského zdraví | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/index.html): Zde naleznete všechny kontaktní informace pro partnery a nejnovější informace o tom, kde se s námi můžete setkat virtuálně nebo osobně. (133 words)
- [What Our Partners Say | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/what-our-partners-say/index.html): We share a common vision with our partners in wanting to develop new and advanced medicines. Hear from some of our global partners by clicking here. (115 words)
- [Sécurité des patients | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/notre-responsabilite/securite-des-patients/index.html): Sécurité des patients et pharmacovigilance chez Boehringer Ingelheim (280 words)
- [Oblasti partnerské spolupráce v oboru lidského zdraví | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/oblasti-partnerske-spoluprace-v-oboru-lidskeho-zdravi.html): Kliknutím sem zjistíte, čeho jsme v Boehringer Ingelheim rádi svědky u našich partnerů a co naše partnerské aktivity zahrnují. (90 words)
- [Kultura partnerské spolupráce | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/kultura-partnerske-spoluprace/index.html): Naši partneři jsou cennými přispěvateli v naší globální rodině inovací. Naše dlouhodobé zaměření na výzkum a investice znamená, že můžeme spolupracovat na realizaci jejich nápadů tím, že se plně zavážeme k trvalým vztahům a p (54 words)
- [Ticari Alan | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/commercial-sales-marketing/index.html): Ticari alandaki fırsatları keşfedin ve hemen başvurun. (257 words)
- [Santé animale | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/index.html): Über uns Das Leben von Tieren und Menschen ist auf tiefe und komplexe Weise miteinander verbunden. Wir sind überzeugt: Wenn Tiere gesund sind, dann sind auch die Menschen gesünder. Weltweit setzen sich unsere Mitarbeitenden in der Tiergesundheit dafür ein (322 words)
- [Inovação na Saúde Animal | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-animal/index.html): Inovação na Saúde Animal (90 words)
- [Aves | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/aves/index.html): Equilibrar produtividade e qualidade de vida é um dos grandes desafios da avicultura. Saiba mais soluções veterinárias para aves, como remédios e vacinas. (315 words)
- [1.0 Striverdi Respimat_Bula_Paciente | Boehringer Ingelheim BR](/content/br/pdf/10-striverdi-respimatbulapaciente/index.html): Nova bula Striverdi Respimat - Paciente. (12 words)
- [Spojme síly – partnerská spolupráce v oblasti lidského zdraví | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/spojme-sily/index.html): Spojme síly – partnerská spolupráce v oblasti lidského zdraví (96 words)
- [Imprint | Boehringer Ingelheim HK](/content/hk/en/imprint/index.html): Imprint (53 words)
- [Nasıl başvurulur | Boehringer Ingelheim TR](/content/tr/kariyer/how-apply/index.html): Başvuru yaparken izlenmesi gereken yolları, yapılması ve hazırlanması gerekenleri öğrenin. (392 words)
- [Mühendislik ve Tesisler | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/engineering-facilities/index.html): Mühendislik ve Tesisler bölümündeki fırsatları keşfedin. (263 words)
- [A partir das bases | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/inovacao-atraves-de-parcerias/index.html): A partir das bases (179 words)
- [Animal Health Partnering | Boehringer Ingelheim HK](/content/hk/en/partnering/animal-health-partnering/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (426 words)
- [Ce spun partenerii noștri | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-pentru-medicina-umana/ce-spun-partenerii-nostri/index.html): Ceea ce spun partenerii noștri Împărtășim o viziune comună cu partenerii noștri în ceea ce privește dorința de a face o diferență și de a dezvolta medicamente noi și avansate care să aibă un impact real asupra vieții pacienților. Ascultați ce au de spus d (73 words)
- [Ciência e Inovação | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/index.html): CIÊNCIA E INOVAÇÃO (193 words)
- [Boehringer Ingelheim – Unternehmensbericht 2025 | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/index.html): Unternehmensbericht von Boehringer Ingelheim 2025: Wie das Erkennen von Zusammenhängen den Fortschritt vorantreibt. (579 words)
- [Δήλωση απορρήτου δεδομένων για πελάτες, συνεργάτες, επισκέπτες, διανομείς και ενδιαφερόμενα άτομα | Boehringer Ingelheim GR](/content/gr/dilosi-aporritoy-dedomenon-gia-pelates-synergates-episkeptes-dianomeis-kai-endiaferomena-atoma.html): Η παρούσα δήλωση περί απορρήτου επεξηγεί τον τρόπο με τον οποίο η Boehringer Ingelheim Ellas A.E. (881 words)
- [Partnering Culture | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/partnering-culture/index.html): Our partners are valued contributors in our global family of innovation. Click here to find out more about our partnering culture at Boehringer Ingelheim. (46 words)
- [Parteneriate | Boehringer Ingelheim RO](/content/ro/parteneriate/index.html): La Boehringer Ingelheim, diversitatea minților și colaborarea sunt esențiale pentru dezvoltarea de noi descoperiri medicale. Faceți clic aici pentru a vedea cum vă puteți asocia cu noi. (174 words)
- [Inovação científica | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/inovacao-cientifica/index.html): Inovação científica (77 words)
- [Fabricație globală pe bază de contract Biopharma | Boehringer Ingelheim RO](/content/ro/parteneriate/productia-prin-contract-biofarmaceutica/index.html): Fabricație globală pe bază de contract Biopharma (127 words)
- [Foco Científico | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/foco-cientifico/index.html): Foco Científico (83 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim CA](/content/ca/partnering/biopharma-contract-manufacturing/index.html): We are a global leader in biopharmaceutical contract manufacturing with more than 35 years of biotechnology experience. Click here to find out more. (85 words)
- [Interese de parteneriat pentru medicina umană | Boehringer Ingelheim RO](/content/ro/parteneriate/parteneriate-pentru-medicina-umana/interese-de-parteneriat/index.html): Faceți clic aici pentru a descoperi ce ne place să vedem la Boehringer Ingelheim de la partenerii noștri și ce cuprind activitățile noastre de parteneriat. (97 words)
- [Zdraví zvířat | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/index.html): Zjistěte, jak se Boehringer Ingelheim snaží zajistit, aby váš domácí mazlíček dostal stejnou zdravotní péči jako lidé, ať už jde o běžného domácího mazlíčka nebo koně. (259 words)
- [Inovação na Saúde Humana | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/index.html): Inovação na Saúde Humana (47 words)
- [アニマルヘルス パートナリング チームへのコンタクト | Boehringer Ingelheim JP](/content/jp/partnering/animal-health-partnering/connect-us/index.html): ベーリンガーインゲルハイムのアニマルヘルス事業開発およびライセンスチームとオンラインまたはイベントでつながり、提案書を提出したり、提携の機会について話し合ったりすることができます。 (35 words)
- [Human Health Partnering | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/index.html): Making new and better medicines for patients is at the heart of what we do. Click here to learn about the role of partnering in helping us to do this. (65 words)
- [Inovace v oblasti zdraví zvířat | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-zdravi-zvirat/index.html): Náš tým pro globální inovace je průkopníkem vědy, která pomáhá veterinářům, majitelům domácích zvířat a hospodářských zvířat a pracovníkům veřejného zdravotnictví na celém světě zlepšit zdraví zvířat dnes i v budoucnu. (86 words)
- [Segurança do Paciente e Farmacovigilância na Boehringer Ingelheim | Boehringer Ingelheim BR](/content/br/saude-humana/nossa-responsabilidade/seguranca-do-paciente/index.html): Os pacientes nos inspiram em nossa missão de liderar a ciência que cria terapias inovadoras, para que nossos medicamentos transformem a vida dos pacientes. (532 words)
- [Ειδοποίηση απορρήτου HCPs και πελάτες | Boehringer Ingelheim GR](/content/gr/eidopoiisi-aporritoy-hcps-kai-pelates/index.html): Η Boehringer Ingelheim Ελλάς Α.Ε. και η Boehringer Ingelheim Pharma GmbH & Co. KG και οι εταιρείες του ομίλου (467 words)
- [Věda a inovace | Boehringer Ingelheim CZ](/content/cz/veda-inovace/index.html): Prozkoumejte, jak společnost Boehringer Ingelheim řeší vědecké výzvy tím, že dělá věci jinak. Klikněte zde a přečtěte si naše nejnovější články o vědě a inovacích. (115 words)
- [Bovine | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/index.html): We are passionately committed to raising all livestock, including cattle, in ways that focus on animal welfare and productivity. Find out more. (441 words)
- [Kariyerleri keşfedin | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/index.html): Kariyerleri keşfedin (194 words)
- [Produtos Para a Saúde Humana | Boehringer Ingelheim BR](/content/br/saude-humana/produtos/index.html): A inovação farmacêutica garante a produção de medicamentos cada vez mais eficazes. Conheça a linha de produtos para saúde humana da Boehringer Ingelheim. (300 words)
- [動物の健康のための未来のイノベーション | Boehringer Ingelheim JP](/content/jp/partnering/animal-health-partnering/index.html): イノベーションとコラボレーションは動物の健康に迅速に変革をもたらします。動物医療の未解決の課題に取り組むためには、サイエンスコミュニティ全体のパートナーとの連携は不可欠です。共にサイエンスとソリューションを追求し、動物のより健やかな未来を築きませんか (29 words)
- [Human Health Partnering Connect with Us | Boehringer Ingelheim CA](/content/ca/partnering/human-health-partnering/connect-us/index.html): Collaborations play a vital role as we connect to advance innovation. Visit this page to find out how you can connect with Boehringer Ingelheim. (14 words)
- [iletisime-geçin | Boehringer Ingelheim TR](/content/tr/kariyer/get-touch/index.html): İletişime geçin ve iş başvuru süreci hakkında daha fazla bilgi edinin. (80 words)
- [Klinické studie | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/klinicke-studie/index.html): Kliknutím zjistíte, jaký význam mají klinické studie pro vývoj nových léků, a prohlédnete si některé klinické studie, které společnost Boehringer Ingelheim sponzorovala. (58 words)
- [Saúde Animal: A Nossa Responsabilidade | Boehringer Ingelheim BR](/content/br/saude-animal/nossa-responsabilidade/index.html): Saúde Animal: A Nossa Responsabilidade (240 words)
- [展望 | Boehringer Ingelheim JP](/content/jp/partnering/animal-health-partnering/perspectives/index.html): 動物医療業界に関する洞察を得て、イノベーションを推進する上でのコラボレーションの重要性についてベーリンガーインゲルハイムの専門家の見解を読んでください。 (6 words)
- [Featured Articles | Boehringer Ingelheim CA](/content/ca/animal-health/featured-articles/index.html): Click here to see Boehringer Ingelheim's latest featured articles to help provide inspiration for both human and animal health and well-being. (391 words)
- [Animais de produção | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/index.html): A manutenção da saúde é uma preocupação constante para criadores de gado. Conheça nossas soluções avançadas e preventivas de saúde animal. (127 words)
- [Partnering | Boehringer Ingelheim CA](/content/ca/partnering/index.html): We embrace the power of partnership and diversity of minds to realise even more innovation and incubate new ideas. Learn more about our partnering. (135 words)
- [Pets | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/animais-de-estimacao/index.html): Boehringer Ingelheim has multiple products and research elements working to ensure that your pets health and wellbeing is number one. (185 words)
- [Příběhy vědy | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/pribehy-vedy/index.html): Kliknutím sem si můžete prohlédnout naše nejnovější úspěchy v oblasti vědy. Je důležité zamyslet se nad úspěchy nových léků, které výrazně zlepšují život pacientů. (67 words)
- [İlaç ve Ruhsatlandırma | Boehringer Ingelheim TR](/content/tr/kariyer/discover-our-careers/medicine-regulatory-affairs/index.html): İlaç ve Ruhsatlandırma alanındaki fırsatları keşfedin. (191 words)
- [Çalışma kültürümüz | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-working-culture/index.html): Explore the unique workplace culture and values that define working at Boehringer Ingelheim, from fostering innovation to creating a sense of belonging for our employees. (447 words)
- [Lokasyonlarımızı görün | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-locations/index.html): We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations. (221 words)
- [Procesul de cercetare | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-globala-medicina-veterinara/procesul-de-cercetare/index.html): O parte esențială a misiunii noastre este de a descoperi sau de a identifica noi compuși, vaccinuri, tehnologii, procese de boală și agenți infecțioși. Pentru a face acest lucru, utilizăm o combinație de instrumente sofisticate, capacități tehnice și expe (136 words)
- [Equinos | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/equinos/index.html): A Boehringer Ingelheim é líder em soluções para a saúde de cavalos e equinos em geral. Conheça mais sobre nossa linhas de medicamentos e suplementos. (149 words)
- [İş Birliği Hikâyeleri | Boehringer Ingelheim TR](/content/tr/partnering/animal-health-partnering/partnership-stories/index.html): Boehringer Ingelheim’ın hayvan sağlığındaki en önemli iş birliklerinden bazılarını okuyun ve ortaklarımızın bizimle çalışma deneyimleri hakkında neler söylediklerini keşfedin. (326 words)
- [Ruminantes | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/bovinos/index.html): Com uma unidade dedicada a ruminantes, a Boehringer Ingelheim produz diversos remédios para gado. Saiba mais sobre produtos como parasiticidas e vacinas. (131 words)
- [パートナーシップのストーリー | Boehringer Ingelheim JP](/content/jp/partnering/animal-health-partnering/partnership-stories/index.html): ベーリンガーインゲルハイムの動物医療分野における最も重要なコラボレーションのいくつかについて読んで、私たちと協力した経験についてパートナーが語る内容を聞いてください。 (5 words)
- [Saúde Animal | Boehringer Ingelheim BR](/content/br/saude-animal/index.html): A Boehringer Ingelheim é líder mundial no setor de saúde animal. Conheça nossos medicamentos veterinários para animais companhia e de produção. (333 words)
- [Priorité aux patients | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/notre-responsabilite/priorite-aux-patients/index.html): Priorité aux patients (97 words)
- [Zdraví zvířat: Naše odpovědnost | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/nase-odpovednost/index.html): Plánujeme v horizontu generací, což dokazuje více než sto let úspěšného působení naší společnosti. Takový způsob plánování je zároveň jedním z pilířů udržitelnosti. (162 words)
- [Bezpečnost pacientů a farmakovigilance | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/bezpecnost-pacientu/index.html): Bezpečnost pacientů je naší prioritou. Neustále sledujeme a vyhodnocujeme bezpečnost našich léčiv, abychom minimalizovali rizika a poskytli pacientům a zdravotníkům co nejvíce informací. (318 words)
- [Paraziticide | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-globala-medicina-veterinara/paraziticide/index.html): Citiți despre inovația globală și expertiza Boehringer Ingelheim în domeniul paraziticidelor pentru animalele de companie și bovine, cum ar fi pisicile, câinii sau caii. (61 words)
- [Partnering Culture | Boehringer Ingelheim HK](/content/hk/en/partnering/human-health-partnering/partnering-culture/index.html): Our partners are valued contributors in our global family of innovation. Our long-term research and investment focus means we can work together to realize their ideas by fully committing to lasting relationships and providing sustained investment for the (46 words)
- [Vaccines | Boehringer Ingelheim CA](/content/ca/science-innovation/animal-health-innovation/vaccines/index.html): We work on safe and effective vaccines for companion animals and livestock. Click here to find out more information about our work on vaccines. (71 words)
- [What Our Partners Say | Boehringer Ingelheim HK](/content/hk/en/partnering/human-health-partnering/what-our-partners-say/index.html): What our partners say We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us. (45 words)
- [Inovace v oblasti lidského zdraví | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/index.html): Zjistěte, jak se snažíme měnit životy pacientů k lepšímu prostřednictvím našeho výzkumu. (33 words)
- [Mobile Gesundheitsversorgung schließt Lücken in Rumänien | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/gesundheitsversorgung-rumaenien/index.html): Mobiles Diabetes-Screening im ländlichen Raum verbessert den Zugang zur Gesundheitsversorgung in Rumänien und sorgt für mehr Gesundheitsgerechtigkeit. (957 words)
- [Vaccinuri | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-globala-medicina-veterinara/vaccinuri/index.html): Lucrăm la mai multe boli și specii pentru a dezvolta și furniza vaccinuri robuste și eficiente pentru animale de companie, animale de companie și bovine, citiți mai multe aici. (79 words)
- [Human Health Partnering Interests | Boehringer Ingelheim HK](/content/hk/en/partnering/human-health-partnering/partnering-interests/index.html): Click here to discover what we like to witness at Boehringer Ingelheim from our partners and what our partnering activities encompass. (88 words)
- [Notre responsabilité | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/notre-responsabilite/index.html): Notre responsabilité (96 words)
- [Partnering | Boehringer Ingelheim HK](/content/hk/en/partnering/index.html): At Boehringer Ingelheim diversity of minds & collaboration is paramount to developing new medical breakthroughs. Click here see how you can partner with us. (232 words)
- [Drůbež | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/hospodarska-zvirata/drubez/index.html): Poskytujeme vakcíny, diagnostiku, výzkumné služby a technické znalosti, abychom zajistili bezpečné, cenově dostupné, hojné a udržitelné kvalitní drůbeží maso a vejce. (108 words)
- [Prasata | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/hospodarska-zvirata/prasata/index.html): Jsme partnerem a podporovatelem udržitelné produkce vepřového masa a živočišných bílkovin a zajišťujeme dobré životní podmínky zvířat prostřednictvím prevence a integrované zdravotní péče. (151 words)
- [お問い合わせ | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/connect-us/index.html): お問い合わせ (23 words)
- [Parasiticides | Boehringer Ingelheim CA](/content/ca/science-innovation/animal-health-innovation/parasiticides/index.html): Click here to read and find out about Boehringer Ingelheim's global innovation and expertise in parasiticides for companion animals and livestock. (55 words)
- [私たちのパートナー | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/what-our-partners-say/index.html): What Our Partners Say (3 words)
- [Human Health Partnering Connect with Us | Boehringer Ingelheim HK](/content/hk/en/partnering/human-health-partnering/connect-us/index.html): Human Health Partnering - Connect with Us (46 words)
- [Dépression | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/sante-mentale/depression/index.html): Dépression (73 words)
- [ヒューマンヘルス パートナリング | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/index.html): Human Health Partnering (14 words)
- [Therapeutics | Boehringer Ingelheim CA](/content/ca/science-innovation/animal-health-innovation/therapeutics/index.html): We provide a disciplined scientific approach to the discovery, development and delivery of therapeutics for companion animals and livestock. Learn more. (61 words)
- [Terapeutică | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-globala-medicina-veterinara/terapeutica/index.html): Oferim o abordare științifică disciplinată pentru descoperirea, dezvoltarea și furnizarea la nivel global de produse terapeutice pentru toate speciile de animale relevante. (70 words)
- [パートナリング・カルチャー | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-culture/index.html): Partnering Culture (3 words)
- [Schizophrénie | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/sante-mentale/schizophrenie/index.html): Schizophrénie (172 words)
- [Promovarea științei | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/promovarea-stiintei/index.html): Promovarea științei prin intermediul parteneriatelor și al colaborării este esențială pentru dezvoltarea unor tratamente eficiente care pot transforma viața pacienților. Aflați mai multe aici. (123 words)
- [Studii clinice | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/studii-clinice/index.html): Studii clinice (104 words)
- [Společenská zvířata | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/spolecenska-zvirata/index.html): Máte domácího mazlíčka nebo koně? Jestliže chcete, aby se jim dostalo stejné úrovně zdravotní péče jako vám, rozhodně nejste sami. Stále více lidí totiž dnes považuje společenská zvířata za nedílnou součást rodiny. (195 words)
- [Psi a kočky | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/index.html): Boehringer Ingelheim má několik produktů a výzkumných prvků, které zajišťují, že zdraví a pohoda vašich mazlíčků je na prvním místě. (215 words)
- [Toplam Kazanç Paketi: Size deger veriyoruz | Boehringer Ingelheim TR](/content/tr/kariyer/explore-our-company/our-total-rewards/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (250 words)
- [Animais de Companhia | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/index.html): Estamos entre os líderes de mercado em parasiticidas, vacinas e agentes terapêuticos, e somos um parceiro de confiança para veterinários e tutores de animais de estimação em todo o mundo. Como tal, inovamos e expandimos continuamente as nossas soluções de (101 words)
- [パートナリング | Boehringer Ingelheim JP](/content/jp/partnering/index.html): Partnering (21 words)
- [バイオ医薬品受託製造 | Boehringer Ingelheim JP](/content/jp/partnering/boehringer-ingelheim-bioxcellence/index.html): ベーリンガーインゲルハイムは、事業分野の１つとして、バイオ医薬品の受託開発と製造を行っています。哺乳類細胞由来および微生物、酵母由来のバイオ医薬品を、製薬企業やバイオ医薬品企業に提供しています。 (18 words)
- [Maladies psychiques | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/sante-mentale/index.html): Boehringer Ingelheim pose de nouveaux jalons dans le domaine de la santé psychique. Nous souhaitons aider les personnes souffrant de maladies psychiques à vivre une vie active et satisfaisante. (144 words)
- [BPCO et asthme | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/bpco-et-asthme/index.html): Wichtige Therapieziele in der COPD-Behandlung sind die Verbesserung der Atemnot, der Lebensqualität und der Reduktion des Exazerbationsrisikos, so dass Patienten einen möglichst aktiven Lebensstil beibehalten können. (377 words)
- [Bakış Açıları | Boehringer Ingelheim TR](/content/tr/partnering/animal-health-partnering/perspectives/index.html): Hayvan sağlığı sektörüne dair içgörüler edinin ve inovasyonu yönlendirmede iş birliğinin önemine ilişkin Boehringer Ingelheim uzmanlarının görüşlerini okuyun. (332 words)
- [Přežvýkavci | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/hospodarska-zvirata/skot-prezvykavci/index.html): Naše podnikání v oblasti přežvýkavců se zaměřuje na parazitika, vakcíny a léčiva, která jsou nabízena našim veterinárním lékařům a farmářům zabývajícím se chovem dojnic a hovězího dobytka. (60 words)
- [Global Kariyer Sayfası | Boehringer Ingelheim TR](/content/tr/kariyer/index.html): Dünya çapında insan ve hayvan sağlığının iyileştirilmesine yönelik 52.000'den fazla tutkulu ve yetenekli bireyden oluşan küresel ekibimize katılın. (459 words)
- [Science Stories | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/science-stories/index.html): View our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (62 words)
- [Veterinární aspekty veřejného zdraví | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/veterinarni-aspekty-verejneho-zdravi/index.html): Veterinární aspekty veřejného zdraví (101 words)
- [Inovație de la zero | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/inovatie-de-la-zero/index.html): Inovație de la zero: Promovarea următoarei generații de inovatori în domeniul științelor vieții. (95 words)
- [Știință și inovație | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/index.html): Explorați modul în care Boehringer Ingelheim abordează provocările științifice făcând lucrurile diferit. Faceți clic aici pentru a citi cele mai recente articole despre știință și inovare. (144 words)
- [Histórias em destaque | Boehringer Ingelheim BR](/content/br/saude-animal/historias-em-destaque/index.html): Histórias em destaque (65 words)
- [Sănătatea animalelor: Responsabilitatea noastră | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/responsabilitatea-noastra/index.html): Unul dintre cele mai importante elemente la Boehringer Ingelheim este responsabilitatea noastră de a proteja legătura dintre sănătatea umană, animală și cea a mediului. (250 words)
- [Clinical Studies | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/clinical-studies/index.html): Clinical trials are an essential part of the development of new medicines. Click here to learn more about the clinical trials we conduct and sponsor. (61 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim HK](/content/hk/en/partnering/biopharma-contract-manufacturing/index.html): Biopharma Contract Manufacturing (39 words)
- [Koně | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/kone/index.html): Vyvíjíme špičková řešení pro dobré zdraví koní v oblasti imunologie, parazitologie, zdraví žaludku a metabolismu. (75 words)
- [Inovație în medicina umană | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/index.html): Aflați cum ne străduim să schimbăm viețile pacienților prin intermediul proiectului nostru bazat pe inovație și citiți poveștile din spatele științei de pionierat care alimentează descoperirile care vor transforma viețile pacienților acum și în generațiil (73 words)
- [Hayvan Sağlığı Ortaklığı | Boehringer Ingelheim TR](/content/tr/partnering/animal-health-partnering/index.html): Hayvan sağlığı inovasyonunda Boehringer Ingelheim’in iş birliği yaklaşımını, iş birliği önceliklerimizi ve ekibimizle bağlantı kurma yollarını keşfedin. (336 words)
- [Hospodářská zvířata | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/hospodarska-zvirata/index.html): Našim zákazníkům nabízíme řešení v oblasti predikce, prevence a léčby onemocnění hospodářských zvířat. Pomáháme tak chovatelům produkovat kvalitnější potraviny a zároveň šetřit přírodní zdroje. (29 words)
- [İlan arama ve başvuru | Boehringer Ingelheim TR](/content/tr/kariyer/search-and-apply/index.html): Search and apply (132 words)
- [Human health innovation | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/index.html): We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. Click here to find out more. (79 words)
- [Fostering Science | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/fostering-science/index.html): Creating breakthrough medicines starts with a commitment to identify the health challenges of the future and advance emerging science. Learn more. (62 words)
- [Δήλωση προσβασιμότητας | Boehringer Ingelheim GR](/content/gr/dilosi-prosbasimotitas/index.html): Η Boehringer Ingelheim έχει δεσμευτεί να προσφέρει έναν ιστότοπο που είναι προσβάσιμος στο ευρύτερο δυνατό κοινό. (494 words)
- [Domeniile științifice pe care ne concentrăm | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/domeniile-stiintifice-pe-care-ne-concentram/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (73 words)
- [Duševní zdraví | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/dusevni-zdravi/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (176 words)
- [研究プロセス | Boehringer Ingelheim JP](/content/jp/science-innovation/animal-health-innovation/research-process/index.html): 当社は、新たな化合物、ワクチン、テクノロジー、疾患の発現プロセス、病原体の発見・特定を行っています。Global Innovationの研究開発拠点における最新のツール、技術力と専門知識を活用し、社外パートナーとも協力して、顧客ニーズを満たす新たな動物用医薬品やワクチンを創出しています。私たちは疾病や病理プロセス、および加齢に伴う変化を研究し、疾病を予防し動物の健康を改善する医薬品を開発します。開発にあたっては幅広く試験を行い、有効性と安全性を評価し、適切な用量、剤形と投与方法を決定します。そして承認申請 (4 words)
- [Pacienti na prvním místě | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/pacienti-na-prvnim-miste/index.html): Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives. (186 words)
- [Swine | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/index.html): The Boehringer Ingelheim Swine Team is committed to provide you innovative solutions to produce healthy and profitable pigs. Click here to learn more. (193 words)
- [Kvalita v Boehringer Ingelheim | Boehringer Ingelheim SK](/content/sk/about-us/quality-boehringer-ingelheim/index.html): Kvalita v Boehringer Ingelheim (235 words)
- [Fibrose pulmonar | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/fibrose-pulmonar/index.html): A fibrose pulmonar afeta a capacidade de absorção de oxigênio pelos pulmões. Conheça mais sobre a doença e fique alerta aos sintomas de fibrose pulmonar. (620 words)
- [ワクチン | Boehringer Ingelheim JP](/content/jp/science-innovation/animal-health-innovation/vaccines/index.html): Global Innovationでは、ワクチン、分子生物学、バイオプロセス、分析と臨床開発における幅広い知識を結集し、コンパニオンアニマル分野および産業動物分野における安全で有効性の高いワクチンの研究を進めています。私たちは、グローバル化や気候変動による疾病の変化に対応してワクチン株を更新するほか、今までにない新しい感染症や越境性の感染症、細菌性疾病に対応し、粘膜免疫に関与する革新的なワクチンソリューションの創出を進めています。 (4 words)
- [サイエンス・ストーリーズ | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/science-stories/index.html): 私たちは患者さんのために、新しいより良い医薬品を作り出したいという熱意をもって活動しています。患者さんの生活を変える画期的な医薬品や治療法の創出につながるサイエンスをリードし、決してあきらめないという私たちのミッションの源は、患者さんです。私たちは、次の画期的な医薬品につながる新たな探索の旅に向かう意気込みを、日々新たにしています。私たちのサイエンスストーリーをご覧ください。 (23 words)
- [寄生虫駆除薬 | Boehringer Ingelheim JP](/content/jp/science-innovation/animal-health-innovation/parasiticides/index.html): Global Innovationは、コンパニオンアニマル分野および産業動物分野での新たな寄生虫駆除薬の創薬と開発に注力しています。寄生虫駆除薬のリーダーとして、寄生虫予防において、薬剤耐性、利便性や持続可能性などの様々なアンメットニーズに満たすサイエンスによりイノベーションの創出を目指す取組みを続けています。 (4 words)
- [Sclérodermie | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/sclerodermie/index.html): Sklerodermie (77 words)
- [Science Focus | Boehringer Ingelheim CA](/content/ca/science-innovation/human-health-innovation/science-focus/index.html): Discover where our scientific research efforts and investment is currently focused on including cardio metabolic diseases, CNS diseases, and more. (71 words)
- [Vaccines - Animal Health | Boehringer Ingelheim HK](/content/hk/en/science-innovation/animal-health-innovation/vaccines/index.html): We work across multiple diseases and species to develop and deliver robust effective animal vaccines for companion animal, pets and cattle, read more here. (71 words)
- [Naše odpovědnost | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/index.html): Naše odpovědnost (84 words)
- [Science & Innovation | Boehringer Ingelheim CA](/content/ca/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (156 words)
- [Schizophrenia | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/dusevni-zdravi/schizofrenie/index.html): Schizophrenia (215 words)
- [Our Responsibility | Boehringer Ingelheim CA](/content/ca/animal-health/our-responsibility/index.html): We plan in generations. This is reflected in our more than 100 years of successful company history. Learn about our responsibility to animal health here. (288 words)
- [Medicamente de uz veterinar | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/produse/index.html): Tot ceea ce facem este alimentat de inovație. Scopul nostru este de a oferi asistență medicală avansată și preventivă pentru animale și de a dezvolta soluții inteligente și eficiente pentru cei care cresc și îngrijesc animale. (56 words)
- [A nossa responsabilidade | Boehringer Ingelheim BR](/content/br/saude-humana/nossa-responsabilidade/index.html): A nossa responsabilidade (106 words)
- [Imprint | Boehringer Ingelheim GR](/content/gr/imprint/index.html): Imprint (48 words)
- [CHOPN a astma | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/chopn-astma/index.html): Hlavním cílem léčby CHOPN je omezit příznaky, snížit riziko exacerbací a podpořit lidi v aktivnějším životě. (193 words)
- [Onemocnění sítnice | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-sitnice/index.html): Ve společnosti Boehringer Ingelheim jsme v celosvětovém měřítku rozšířili kapacity v oblasti výzkumu a vývoje s cílem zaměřit se na oční choroby. Poškození zraku a slepota mají zásadní a zničující dopad na životy osob postižených těmito chorobami. (140 words)
- [Păsări de curte | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-ferma/pasari-de-curte/index.html): Oferim vaccinuri, diagnostice, servicii de cercetare, expertiză tehnică pentru a asigura o carne de pasăre și ouă de calitate sigură, accesibilă, abundentă și durabilă. (139 words)
- [Bronquiectasia | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/bronquiectasia/index.html): Entenda a bronquiectasia: doença respiratória inflamatória que causa acúmulo de muco, infecções e impacto na qualidade de vida. (192 words)
- [Transtornos Mentais | Boehringer Ingelheim BR](/content/br/saude-humana/saude-mental/index.html): Transtornos mentais (215 words)
- [Siguranta pacientilor și farmacovigilența în cadrul companiei Boehringer Ingelheim | Boehringer Ingelheim RO](/content/ro/medicina-umana/responsabilitatea-noastra/siguranta-pacientilor/index.html): Boehringer Ingelheim este lider în domeniul siguranței pacienților și a farmacovigilenței. (273 words)
- [サイエンスの追求 | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/fostering-science/index.html): Fostering Science (25 words)
- [Therapeutics | Boehringer Ingelheim HK](/content/hk/en/science-innovation/animal-health-innovation/therapeutics/index.html): We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species. Our dedicated Research teams work together with our human pharma and animal health colleagues, as well as with (60 words)
- [Animal Health Innovation | Boehringer Ingelheim HK](/content/hk/en/science-innovation/animal-health-innovation/index.html): Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our (71 words)
- [Porcine | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-ferma/porcine/index.html): Suntem un partener și un facilitator al producției durabile de carne de porc și de proteine animale, asigurând bunăstarea animalelor prin prevenire și îngrijire integrată a sănătății. (163 words)
- [DPOC e asma | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/dpoc-e-asma/index.html): A asma e a doença pulmonar obstrutiva crônica (DPOC) estão entre as doenças respiratórias mais comuns em todo o mundo. Conheça mais sobre cada uma. (245 words)
- [Grass Roots Innovation | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/grass-roots/index.html): グラス・ルーツ・イノベーション (14 words)
- [注力する研究開発領域 | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/science-focus/index.html): 私たちは、メディカルニーズが高く、画期的な医薬品や治療法を開発し、科学の進歩をもたらすことができる領域で創薬研究行っています。心血管代謝系領域、中枢神経系領域、免疫・呼吸 (9 words)
- [Rumegătoare | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-ferma/rumegatoare/index.html): Activitatea noastră în domeniul rumegătoarelor se concentrează pe paraziticide, vaccinuri și produse terapeutice care sunt oferite medicilor veterinari și fermierilor noștri din sectorul produselor lactate și de carne de vită. (75 words)
- [アニマルヘルス製品 | Boehringer Ingelheim JP](/content/jp/animal-health/products/index.html): アニマルヘルス製品 (28 words)
- [Esclerodermia | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/esclerodermia/index.html): Esclerodermia (157 words)
- [Poultry | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/poultry/index.html): The Boehringer Ingelheim Avian Team is committed to providing you with innovative solutions to produce healthy and profitable chickens. Find out more here. (68 words)
- [Bronchiektázie | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/bronchiektazie/index.html): Bronchiektázie (181 words)
- [Au-delà de nos domaines de prédilection | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cancereuses/au-dela-de-nos-disciplines-de-pointe/index.html): Au-delà de nos domaines de prédilection (94 words)
- [イノベーション | Boehringer Ingelheim JP](/content/jp/science-innovation/index.html): サイエンス＆イノベーション (10 words)
- [Où nous trouver | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ou-nous-trouver/index.html): Boehringer Ingelheim verfügt über globale Forschungs- und Produktionsnetzwerke, mit Standorten in Europa, Amerika und Asien/Ozeanien. (573 words)
- [Cancer du poumon | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cancereuses/maladies-pulmonaires/index.html): Le cancer du poumon est un domaine dans lequel nous nous concentrons particulièrement et dans lequel nous avons pour objectif d'améliorer sans cesse les perspectives des patients. (92 words)
- [Deprese | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/dusevni-zdravi/deprese/index.html): Deprese (57 words)
- [Clinical Studies | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/clinical-studies/index.html): Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored. (60 words)
- [Sănătate publică veterinară | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/sanatate-publica-veterinara/index.html): Sănătate publică veterinară (133 words)
- [Ruminants | Boehringer Ingelheim TW](/content/tw/ruminants/index.html): Ruminants (195 words)
- [Pets | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/index.html): Boehringer Ingelheim has multiple products and research elements working to ensure that your pets health and wellbeing is number one. Learn more. (211 words)
- [Fostering Science | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/fostering-science/index.html): Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here. (62 words)
- [Leaving site | Boehringer Ingelheim GR](/content/gr/disclaimer/external/index.html) (71 words)
- [Bizi nerede bulabilirsiniz | Boehringer Ingelheim TR](/content/tr/about-us/where-find-us/index.html): Bizi nerede bulabilirsiniz (368 words)
- [Equine | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/equine/index.html): For over 20 years, Boehringer Ingelheim Animal Health has been helping veterinarians and horse owners prevent and treat equine diseases. Learn more here. (150 words)
- [アニマルヘルス：私たちの責任 | Boehringer Ingelheim JP](/content/jp/animal-health/our-responsibility/index.html): 私たちは、世代を超えて将来を見通しています。これは100年超にわたる当社の歴史を反映するものであり、サステナビリティの中核となる考え方です。サステナビリティを重んじ、One Healthすなわち人‐動物‐環境は互いに密接に関連しており、いずれの健康/健全さも重要であるという信念は、当社の哲学の根幹にあります。私たちは、責任感をもってこの領域に取り組み、当社の事業戦略にサステナビリティの考え方を積極的に取り入れています。製造拠点における環境保全、限りある資源を意識した製品設計、感染症予防や食の安全・安心への (12 words)
- [Araştırma Süreci | Boehringer Ingelheim TR](/content/tr/science-innovation/animal-health-innovation/research-process/index.html): Yeni bileşikler, aşılar, teknolojiler, hastalık süreçleri ve bulaşıcı ajanlar keşfediyor veya tespit ediyoruz. Bunun için sofistike araçlardan, teknik yetkinliklerimizden ve uzmanlığımızdan yararlanıyoruz. (116 words)
- [Maladie rénale chronique | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladie-renale-chronique/index.html): La maladie rénale chronique, ou MRC, est causée par des dommages progressifs aux reins, affectant 10 % de la population. (143 words)
- [Animale de fermă | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-ferma/index.html): Activitatea noastră în domeniul zootehnic cuprinde segmentele de păsări de curte, porcine, rumegătoare și sănătate publică veterinară pentru a răspunde nevoilor crescătorilor de animale, ale medicilor veterinari, ale oficialilor guvernamentali (42 words)
- [Our Responsibility | Boehringer Ingelheim CA](/content/ca/human-health/our-responsibility/index.html): We put patients first in everything we do. Patients inspire us in our mission to lead the science that creates breakthrough therapies. Learn more here. (291 words)
- [Plicní fibróza | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/index.html): Plicní fibróza je onemocnění, při němž vznikají jizvy v plicní tkáni. Plíce časem ztrácejí schopnost vstřebávat kyslík a předávat jej do krevního oběhu. Včasné odhalení plicní fibrózy a zahájení odpovídající léčby, je ale (188 words)
- [Systémová sklerodermie | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/systemova-sklerodermie/index.html): Systémová sklerodermie (154 words)
- [Science Focus | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (69 words)
- [Chronické onemocnění ledvin | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin-0/index.html): Chronické onemocnění ledvin, nebo CKD, je způsobeno postupným poškozením ledvin a postihuje 10 % populace. (253 words)
- [Medicină veterinară | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/index.html): Descoperiți modul în care Boehringer Ingelheim își propune să se asigure că animalul dumneavoastră de companie beneficiază de același nivel de asistență medicală ca și oamenii, indiferent dacă este vorba de un animal de casă sau de un cal. (259 words)
- [Science & Innovation | Boehringer Ingelheim HK](/content/hk/en/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (150 words)
- [Cai | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-companie-si-cai/cai/index.html): Dezvoltăm soluții de vârf pentru bunăstarea cailor în domeniul imunologiei, parazitologiei, sănătății gastrice și metabolice. (76 words)
- [Hayvan Sağlığında İnovasyon | Boehringer Ingelheim TR](/content/tr/science-innovation/animal-health-innovation/index.html): Global İnovasyon ekibimiz, dünyanın her yerindeki veteriner hekimlerin, evcil hayvan sahiplerinin, besicilerin ve halk sağlığı yetkililerinin hayvan sağlığını iyileştirmesine yardımcı olan bilime öncülük ediyor. (92 words)
- [Câncer do pulmão | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/cancer-do-pulmao/index.html): O câncer de pulmão é terceiro tipo de câncer mais frequente no Brasil, mas o que mais causa mortes. Entenda as opções de tratamento após o diagnóstico. (165 words)
- [鶏 | Boehringer Ingelheim JP](/content/jp/animal-health/livestock/poultry/index.html): Poultry (2 words)
- [Onemocnění plic | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/index.html): Boehringer Ingelheim se léčbou respiračních onemocnění úspěšně zabývá již 100 let. V této oblasti zastáváme vedoucí pozici již od roku 1921. (131 words)
- [Livestock | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/index.html): Boehringer Ingelheim is one of the leading providers of health solutions to predict, prevent and treat diseases in livestock animals. Find out more here. (36 words)
- [Diabète | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/diabete/index.html): Diabète (199 words)
- [Animale de companie | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-companie-si-cai/animale-de-companie/index.html): Boehringer Ingelheim are mai multe produse și elemente de cercetare care lucrează pentru a se asigura că sănătatea și bunăstarea animalelor dumneavoastră de companie sunt pe primul loc. (49 words)
- [豚 | Boehringer Ingelheim JP](/content/jp/animal-health/livestock/swine/index.html): Swine (8 words)
- [トレンド＆インサイト | Boehringer Ingelheim JP](/content/jp/animal-health/trends-insights/index.html): "動物が健康であれば、人間も健康になれる、そう信じています。 人間と動物のさらなる健康に寄与することで動物用医薬品の発展に貢献していきます。" (22 words)
- [Human Health Innovation | Boehringer Ingelheim HK](/content/hk/en/science-innovation/human-health-innovation/index.html): Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline. (34 words)
- [Disturbi cardiaci | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/index.html): Heart Diseases (813 words)
- [Animale de companie și Cai | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/animale-de-companie-si-cai/index.html): La Boehringer Ingelheim credem că animalele de casă și caii ar trebui să beneficieze de același nivel de asistență medicală ca și dumneavoastră, aflați mai multe despre cum. (48 words)
- [Doenças pulmonares | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/index.html): A Boehringer Ingelheim é líder no tratamento de doenças pulmonares e respiratórias. Conheça mais sobre algumas doenças que afetam os pulmões. (100 words)
- [Maladies métaboliques | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/index.html): Environ 425 millions d'adultes dans le monde vivent avec le diabète, dont 90 à 95 % avec le diabète de type 2. On estime que le nombre de diabétiques atteindra environ 629 millions d'ici 2045. (137 words)
- [Câncer | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/index.html): Descobrir novas formas para o tratamento do câncer é um dos grandes desafios da medicina. Conheça mais recentes avanços na luta contra o câncer. (140 words)
- [牛 | Boehringer Ingelheim JP](/content/jp/animal-health/livestock/ruminants/index.html): Ruminants (3 words)
- [アニマルヘルス | Boehringer Ingelheim JP](/content/jp/animal-health/index.html): 私たちはアニマルヘルス業界のグローバルリーダーとして、動物の疾患の予測、予防、そして治療において、ファースト・イン・クラスのイノベーションをもたらす医薬品や治療法の開発に取り組んでいます。 (31 words)
- [Obésité | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/obesite/index.html): Apprenez-en plus sur l'obésité et voyez ce que Boehringer Ingelheim fait pour développer de nouveaux médicaments afin d'améliorer la vie des patients. Lisez les derniers articles sur l'obésité ici. (108 words)
- [Hayvan Sağlığı | Boehringer Ingelheim TR](/content/tr/animal-health/index.html): Hayvanların ve insanların yaşamları birbirine derin ve karmaşık şekillerde bağlıdır. Hayvanlar sağlıklı olduğunda insanların da daha sağlıklı olduğunun bilincindeyiz. (238 words)
- [Kde nás najdete | Boehringer Ingelheim CZ](/content/cz/o-nas/kde-nas-najdete/index.html): S 52 000 zaměstnanci po celém světě má Boehringer Ingelheim výzkumnou a produkční síť po celém světě. Zde jsou naše největší stránky. (333 words)
- [Empoderando pacientes | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/empoderamento-dos-pacientes/index.html): Empoderando pacientes (89 words)
- [Klinik Araştırmalar | Boehringer Ingelheim TR](/content/tr/science-innovation/human-health-innovation/clinical-studies/index.html): Klinik araştırmalar yeni ilaç geliştirme sürecinin temel bir parçasıdır ve bilimsel uzmanlığımızın hastalar için çığır açıcı tedavilere dönüştürülmesini sağlar. (92 words)
- [ライブストック（牛・豚・鶏） | Boehringer Ingelheim JP](/content/jp/animal-health/livestock/index.html): ベーリンガーインゲルハイムは、ライブストックにおいて、疾病の予測・予防と治療のためのヘルスソリューションを提供しているグローバルリーダー企業の一つです。私たちは世界中の畜 (3 words)
- [Tipos de câncer | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/tipos-de-cancer/index.html): Tipos de câncer (94 words)
- [Bilim Odağımız | Boehringer Ingelheim TR](/content/tr/science-innovation/human-health-innovation/science-focus/index.html): Yeni ilaç araştırmalarımızda ciddi tıbbi ihtiyacın olduğu, bizim de inovasyon yapmayı ve bilime öncülük etmeyi sürdürdüğümüz bilim alanlarına odaklanıyoruz. (75 words)
- [Nádory trávicí trubice a zažívacích orgánů | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/rakovina/nadory-travici-trubice-zazivacich-organu/index.html): Nádory trávicí trubice a zažívacích orgánů (58 words)
- [Βιοφάρμακο Σύμβαση Κατασκευή | Boehringer Ingelheim GR](/content/gr/partnering/boehringer-ingelheim-bioxcellence/index.html): Ως ένας από τους τρεις επιχειρηματικούς τομείς εντός της Boehringer Ingelheim, προσφέρουμε τεχνογνωσία στην ανάπτυξη βιοφαρμακευτικών συμβολαίων. (85 words)
- [Bilimi Destekleme | Boehringer Ingelheim TR](/content/tr/science-innovation/human-health-innovation/fostering-science/index.html): Hastaların yaşamlarını değiştiren çığır açıcı ilaçlar geliştirme süreci, geleceğin sağlık sorunlarını tespit etme ve yükselişteki bilimi ilerletme taahhüdüyle başlar. (65 words)
- [獣医公衆衛生 | Boehringer Ingelheim JP](/content/jp/animal-health/veterinary-public-health/index.html): 獣医公衆衛生 (2 words)
- [Animal Health: Our Responsibility | Boehringer Ingelheim HK](/content/hk/en/animal-health/our-responsibility/index.html): One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health. (147 words)
- [Σύμπραξη | Boehringer Ingelheim GR](/content/gr/partnering/index.html): Αγκαλιάζουμε τη δύναμη της συνεργασίας και την ποικιλομορφία της σκέψης στις κοινότητες των βιοεπιστημών και της υγείας των ζώων για να πα (139 words)
- [Fibrilação atrial | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/fibrilacao-atrial/index.html): Fibrilação atrial (105 words)
- [Bronchiectasis | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis (218 words)
- [Responsabilitatea noastră | Boehringer Ingelheim RO](/content/ro/medicina-umana/responsabilitatea-noastra/index.html): Viața animalelor și cea a oamenilor sunt interconectate la un nivel profund și complex. Știm că atunci când animalele sunt sănătoase, oamenii sunt mai sănătoși. (102 words)
- [Kalp Hastalıkları | Boehringer Ingelheim TR](/content/tr/kalp-hastaliklari/index.html): Kalp hastalıkları (52 words)
- [馬 | Boehringer Ingelheim JP](/content/jp/animal-health/companion-animals-horses/horses/index.html): Horses (2 words)
- [Kvalita ve společnosti Boehringer Ingelheim | Boehringer Ingelheim CZ](/content/cz/o-nas/kvalita/index.html): Ve společnosti Boehringer Ingelheim je kvalita hluboce zakořeněna v životním cyklu produktu: od výzkumu a vývoje až po doručení našim pacientům. (181 words)
- [Swine | Boehringer Ingelheim HK](/content/hk/en/animal-health/livestock/swine/index.html): We are a partner and enabler of sustainable pork and animal protein production, ensuring animal welfare through prevention and integrated health care. (147 words)
- [Boli ale retinei | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-ale-retinei/index.html): La Boehringer Ingelheim, ne-am extins activitățile globale de cercetare și dezvoltare pentru a aborda bolile oculare. Deficiența de vedere și orbirea au un impact profund și devastator asupra vieții persoanei afectate. (131 words)
- [Rakovina | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/rakovina/index.html): Ve společnosti Boehringer Ingelheim se věnujeme práci na zlepšení léčby pacientů s rakovinou po celém světě se zaměřením na rakovinu plic a gastrointestinálního traktu. (75 words)
- [Poultry | Boehringer Ingelheim HK](/content/hk/en/animal-health/livestock/poultry/index.html): We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs. (109 words)
- [Nákup | Boehringer Ingelheim CZ](/content/cz/o-nas/nakup/index.html): Nákup (183 words)
- [Patient Centricity | Boehringer Ingelheim CA](/content/ca/human-health/our-responsibility/patient-centricity/index.html): At Boehringer Ingelheim, we put patients first in everything we do. Click here and learn more about patient centricity at Boehringer Ingelheim. (79 words)
- [ヒューマンヘルス | Boehringer Ingelheim JP](/content/jp/human-health/index.html): ベーリンガーインゲルハイムは、革新的なヘルスケア製品の創出と開発、製造、販売に取り組む研究開発主導型の製薬会社です。 (23 words)
- [Doença Renal Crônica | Boehringer Ingelheim BR](/content/br/saude-humana/doenca-renal-cronica/index.html): Chronic Kidney Disease (104 words)
- [Nos stories | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/nos-stories/index.html): Unsere Stories Nachhaltige Entwicklung geht Hand in Hand mit unseren Grundsätzen der Planung in Generationen, der Innovation, der Übernahme von Verantwortung für unsere Gemeinschaften und die Umwelt und dem Dienst an der Menschheit - heute und morgen. (199 words)
- [Εμβόλια | Boehringer Ingelheim GR](/content/gr/science-innovation/animal-health-innovation/vaccines/index.html): Στον τομέα της παγκόσμιας καινοτομίας, εργαζόμαστε πάνω σε ασφαλή και αποτελεσματικά εμβόλια για τα ζώα συντροφιάς και το ζωικό κεφάλαιο. (81 words)
- [Ruminants | Boehringer Ingelheim HK](/content/hk/en/animal-health/livestock/ruminants/index.html): Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers. (59 words)
- [Η ερευνητική διαδικασία | Boehringer Ingelheim GR](/content/gr/science-innovation/animal-health-innovation/research-process/index.html): Ανακαλύπτουμε ή εντοπίζουμε νέες ενώσεις, εμβόλια, τεχνολογίες, διαδικασίες ασθενειών και μολυσματικούς παράγοντες. (148 words)
- [Accident vasculaire cérébral | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/accident-vasculaire-cerebral/index.html): Boehringer Ingelheim a développé le seul médicament actuellement autorisé pour le traitement de l'AVC ischémique. Il est utilisé dans le monde entier. (115 words)
- [倫理・コンプライアンス | Boehringer Ingelheim JP](/content/jp/about-us/ethics-and-compliance/index.html): 倫理・コンプライアンス (8 words)
- [Rakovina plic | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/rakovina/rakovina-plic/index.html): Rakovina plic (39 words)
- [Mais Saúde para pessoas e animais | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/index.html): Promovemos mais saúde para pessoas e animais com inovação, prevenção e iniciativas que ampliam equidade, bem-estar e acesso aos cuidados. (459 words)
- [心房細動 | Boehringer Ingelheim JP](/content/jp/human-health/heart-diseases/atrial-fibrillation/index.html): 脳卒中は、脳の一部への血流がとぎれることで生じる疾患です。不整脈（心房細動など）の患者さんは、脳卒中のリスクが高いことが知られています。このような患者さんにおける脳卒中の予防することは、私たちの心血管チームの重要なテーマです。 (7 words)
- [Παρασιτοκτόνα | Boehringer Ingelheim GR](/content/gr/science-innovation/animal-health-innovation/parasiticides/index.html): Ένας βασικός τομέας εξειδίκευσης στο πλαίσιο της Παγκόσμιας Καινοτομίας είναι η ανακάλυψη και ανάπτυξη νέων φυτοφαρμάκων. (61 words)
- [Heart Diseases | Boehringer Ingelheim US](/content/us/human-health/heart-diseases/index.html): Heart Diseases (226 words)
- [Qualidade na Boehringer Ingelheim | Boehringer Ingelheim BR](/content/br/sobre-nos/qualidade/index.html): Qualidade na Boehringer Ingelheim (249 words)
- [Obezitate | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-metabolice/obezitate/index.html): Obezitate (107 words)
- [Insuffisance cardiaque | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/insuffisance-cardiaque/index.html): Insuffisance cardiaque (206 words)
- [Mais Verde: pelo nosso planeta | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/index.html): Nosso pilar Mais Verde busca reduzir o impacto ambiental das operações para proteger as gerações de hoje e de amanhã, garantindo futuro saudável. (320 words)
- [Depresie | Boehringer Ingelheim RO](/content/ro/medicina-umana/sanatate-mintala/depresie/index.html): Depresie (66 words)
- [MASH | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/mash/index.html): Více informací o metabolickém onemocnění známém jako nealkoholická steatohepatitida (NASH) získáte kliknutím sem a návštěvou společnosti Boehringer Ingelheim. (140 words)
- [コンパニオンアニマル | Boehringer Ingelheim JP](/content/jp/animal-health/companion-animals-horses/index.html): ベーリンガーインゲルハイムは、アニマルヘルス業界のグローバルリーダーの一つとして、コンパニオンアニマル（小動物/ペット）にとって、より長く、健康に、幸福な生活を実現すべく、獣医師、ペットオーナーや馬のオーナーを支援しています。 (4 words)
- [EHNA | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-metabolicas/ehna/index.html): EHNA (130 words)
- [Scleroderma | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/scleroderma/index.html): Scleroderma (93 words)
- [Hart- en vaatziekten | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/index.html): Hart- en vaatziekten, waaronder hartaanvallen en beroertes, zijn wereldwijd een groot probleem en de hoofdoorzaak van sterfte en invaliditeit. (137 words)
- [Retinal Diseases | Boehringer Ingelheim CA](/content/ca/human-health/retinal-diseases/index.html): Our ambition is clear - prevent vision loss in people at risk and preserve or restore vision in those with retinal diseases. Click here to learn more. (126 words)
- [Сердечно-сосудистые заболевания | Boehringer Ingelheim RU](/content/ru/human-health/heart-diseases/index.html): Примечание. На этой веб-странице размещен контент для широкой публики, а также для медицинских работников, журналистов и работников средст (99 words)
- [Mental Health | Boehringer Ingelheim CA](/content/ca/human-health/mental-health/index.html): Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases. (171 words)
- [Diabet | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-metabolice/diabet/index.html): Aflați mai multe despre diabet și despre modul în care Boehringer Ingelheim lucrează la cercetarea și dezvoltarea de noi medicamente inovatoare pentru diabet pentru a îmbunătăți viața pacienților. (194 words)
- [Livestock | Boehringer Ingelheim HK](/content/hk/en/animal-health/livestock/index.html): Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs. (40 words)
- [心不全 | Boehringer Ingelheim JP](/content/jp/human-health/heart-diseases/heart-failure/index.html): Heart Failure (5 words)
- [AD, Data Architecture & Strategy Job Details | BoehringerPRD](/content/jobs/job-invite/35382/index.html): Johns Creek, GA AD, Data Architecture & Strategy - Unit (1,196 words)
- [Fibrillation auriculaire | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/fibrillation-auriculaire/index.html): La fibrillation auriculaire est un trouble du rythme cardiaque qui peut entraîner la formation de caillots de sang dans le cœur et provoquer ainsi une attaque cérébrale aux conséquences graves. Vous trouverez ici des informations actuelles sur le sujet. (67 words)
- [İnsan Sağlığında İnovasyon | Boehringer Ingelheim TR](/content/tr/science-innovation/human-health-innovation/index.html): Boehringer Ingelheim olarak açık ve net hedeflerimiz var. Dünyanın her yanındaki hastaların yaşamlarını iyileştirecek çığır açıcı ilaçlardan oluşan bir portföy sunmak istiyoruz. Bu da inovasyonla başlıyor. (30 words)
- [Σχιζοφρένεια | Boehringer Ingelheim GR](/content/gr/human-health/mental-health/schizophrenia/index.html): Η σχιζοφρένεια χαρακτηρίζεται από τρεις τομείς συμπτωμάτων και προσβάλλει το ~1% του παγκόσμιου πληθυσμού. (87 words)
- [Naše příběhy | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/nase-pribehy/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (133 words)
- [ΧΑΠ και άσθμα | Boehringer Ingelheim GR](/content/gr/human-health/lung-diseases/copd-asthma/index.html): Η Χρόνια Αποφρακτική Πνευμονοπάθεια (ΧΑΠ) είναι μια προοδευτική, θεραπεύσιμη ασθένεια που χαρακτηρίζεται από περιορισμένη ροή του αέρα μέσα. (201 words)
- [Depression | Boehringer Ingelheim CA](/content/ca/human-health/mental-health/depression/index.html): Depression is a mental disorder that causes a persistent feeling of sadness and loss of interest. Click here to learn more about depression and our work. (62 words)
- [Hipertensão | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/hipertensao/index.html): A hipertensão é uma doença silenciosa, que pode não apresentar sintomas. Entenda as causas da pressão alta e conheça formas eficazes de evitar a doença. (109 words)
- [More Green (Zelená řešení) | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/zelena-reseni/index.html): More Green (Zelená řešení) (160 words)
- [Hjertesykdommer | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/index.html): Hjerte- og karsykdommer, inkludert hjertesykdom og hjerneslag, er et stort globalt helseproblem og den ledende årsaken til død og funksjonshemming (67 words)
- [Kalp Yetersizliği | Boehringer Ingelheim TR](/content/tr/human-health/heart-diseases/heart-failure/index.html): Dünya çapında 60 milyondan fazla insanı etkileyen ve nüfus yaşlandıkça artması beklenen kalp yetersizliği ilerleyici ve potansiyel olarak ölümcül bir hastalıktır. Kalp yetersizliği, kalbin vücuda yeterli miktarda kan pompalayamaması anlamına gelir. (142 words)
- [高血圧症 | Boehringer Ingelheim JP](/content/jp/human-health/heart-diseases/hypertension/index.html): Hypertension (3 words)
- [Diabetes | Boehringer Ingelheim CA](/content/ca/human-health/metabolic-diseases/diabetes/index.html): About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Find out more here. (118 words)
- [Data Privacy | Boehringer Ingelheim CA](/content/ca/data-privacy/index.html): Click here to view the privacy policy that pertains to Boehringer Ingelheim (Canada) Ltd./Ltée. and Boehringer Ingelheim Animal Health Canada Inc. (3,866 words)
- [Atriyal Fibrilasyon | Boehringer Ingelheim TR](/content/tr/human-health/heart-diseases/atrial-fibrillation/index.html): İnme, beynin bir kısmına giden kan akışının kesilmesiyle meydana gelir. Kalp atışının düzensiz olduğu atriyal fibrilasyonu olan hastaların inme riski daha yüksektir. Bu hastalarda inmeyi önlemek, kardiyovasküler ekibimizin temel odağını oluşturuyor. (42 words)
- [Desenvolvimento sustentável | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/index.html): Sustentabilidade guiada por valores de 130 anos, com foco em saúde, equidade e impacto positivo para pessoas, animais e o planeta. (380 words)
- [Speak Up – Uyum Hattı | Boehringer Ingelheim TR](/content/tr/about-us/ethics-compliance/speak-compliance-hotline/index.html): Speak Up portalı, olası ihlallerin bildirilmesi için güvenli bir ortam sağlar ve dünya genelindeki herkesin kullanımına açıktır. Olası ihlallere ilişkin tüm bildirimleri ciddiyetle ele alıyoruz. (258 words)
- [Att stärka patienter | Boehringer Ingelheim SE](/content/se/manniskors-halsa/cancer/att-starka-patienter/index.html): Att ta itu med cancer är inte bara en fråga om att utveckla läkemedel. I samarbete med samhället i stort stöder vi medvetenhet, utbildning. (80 words)
- [İnsan Sağlığı | Boehringer Ingelheim TR](/content/tr/human-health/index.html): Boehringer Ingelheim araştırma odaklı bir şirketler grubu olarak çalışmalarını yenilikçi sağlık ürünlerinin bulunmasına, geliştirilmesine, üretimine ve pazarlanmasına yoğunlaştırmaktadır. (48 words)
- [Hipertansiyon | Boehringer Ingelheim TR](/content/tr/human-health/heart-diseases/hypertension/index.html): Hipertansiyon (yüksek kan basıncı) dünya çapında yaklaşık bir milyar insanı etkiliyor ve bu sayının gelecek yıllarda artacağı öngörülüyor. (83 words)
- [Σκληρόδερμα | Boehringer Ingelheim GR](/content/gr/human-health/lung-diseases/scleroderma/index.html): Η συστηματική σκλήρυνση (SSc) είναι μια παραμορφωτική, αναπηρική και δυνητικά θανατηφόρα σπάνια ασθένεια που προκαλεί ουλές στο δέρμα (σκληρόδερμα) (106 words)
- [Větší Potenciál | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/vetsi-potencial/index.html): Větší Potenciál (202 words)
- [Annual Report Story Hub | Boehringer Ingelheim](/content/annualreport/2024/storyhub/index.html): Boehringer Ingelheim's progress stories of 2024 (50 words)
- [循環器疾患 | Boehringer Ingelheim JP](/content/jp/human-health/heart-diseases/index.html): Heart Diseases (14 words)
- [Onde nos encontrar | Boehringer Ingelheim BR](/content/br/sobre-nos/onde-nos-encontrar/index.html): A Boehringer Ingelheim é uma empresa de presença global voltada para a pesquisa e inovação farmacêutica. Conheça um pouco mais sobre a nossa estrutura. (41 words)
- [COPD & Asthma | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/copd-asthma/index.html): Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives. (194 words)
- [Mais Potencial | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-potencial/index.html): Mais Potencial se baseia na nossa cultura para mobilizar colaboradores e parceiros em prol do impacto real. (185 words)
- [O nosso compromisso | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/o-nosso-compromisso/index.html): Inovação em saúde para pessoas e animais em comunidades com acesso limitado, promovendo um futuro mais sustentável e equitativo. (432 words)
- [MORE POTENTIAL ― 社会と社員のために | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-potential/index.html): 社会と社員のために。社会は、健康のみならず教育、仕事、生活環境、不平等や貧困に至るまで、様々な課題に直面し続けており、しばしば、これらの課題の(悪)影響は、脆弱な社会で最も強く現れます。ベーリンガーインゲルハイムは、135年以上前に始めた旅を続け、持続可能な開発への取り組みにさらに力を入れ、その長い歴史におけるアンメットヘルスニーズへの取り組みの成功をもとに、世界の健康と社会的課題への取り組みに関してさらに高い目標を掲げています。「More Potential」は、社員、コミュニティ、パートナーやバリュー (35 words)
- [Udržitelný rozvoj – náš závazek | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/index.html): Každým dnem se Boehringer Ingelheim stává udržitelnější společností – naše závazky jsou nedílnou součástí našeho fungování a jsou v souladu s cíli udržitelného rozvoje Organizace spojených národů a Pařížskou dohodou o klimatu. (193 words)
- [Boli metabolice | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-metabolice/index.html): Aproximativ 425 de milioane de adulți din întreaga lume trăiesc cu diabet, diabetul zaharat de tip 2 reprezentând 90-95% din total. Se estimează că această cifră va crește la 629 de milioane de oameni până în 2045. (75 words)
- [Heart Diseases | Boehringer Ingelheim ZA](/content/za/human-health/heart-diseases/index.html): Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right. (81 words)
- [Udržitelný rozvoj – náš závazek | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/nas-zavazek/index.html): Chceme vytvářet hodnoty na poli neřešených potřeb v oblasti zdravotní péče a ve spolupráci s komunitami a celou společností zlepšovat životy lidí i zvířat. (143 words)
- [Metabolic Diseases | Boehringer Ingelheim CA](/content/ca/human-health/metabolic-diseases/index.html): Interconnected cardio-renal-metabolic conditions are the leading cause of mortality worldwide. Click here to learn more about them and the work we do. (71 words)
- [Satın Alma | Boehringer Ingelheim TR](/content/tr/about-us/purchasing/index.html): Boehringer Ingelheim'da Satın Alma (159 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/pulmonary-fibrosis/index.html): Reducing the risk of acute exacerbations is a key treatment goal to manage patients with Idiopathic Pulmonary Fibrosis (IPF), learn how BI is helping. (80 words)
- [ベーリンガーインゲルハイムの品質 | Boehringer Ingelheim JP](/content/jp/about-us/quality/index.html): ベーリンガーインゲルハイムの品質 (28 words)
- [拠点 | Boehringer Ingelheim JP](/content/jp/about-us/where-find-us/index.html): 拠点 (14 words)
- [Πνευμονικές παθήσεις | Boehringer Ingelheim GR](/content/gr/human-health/lung-diseases/index.html): Η Boehringer Ingelheim έχει 100 χρόνια κληρονομιάς στις αναπνευστικές παθήσεις. (81 words)
- [annualreport/2024/files/downloads-and-archive/shareholders-perspective-2024/boe_the_shareholders_perspective_2024-pdf.html](/content/annualreport/2024/files/downloads-and-archive/shareholders-perspective-2024/boe_the_shareholders_perspective_2024-pdf.html) (304 words)
- [Our Story | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/index.html): BI Story (30 words)
- [Vorbește deschis! | Boehringer Ingelheim RO](/content/ro/despre-noi/etica-si-complianta/vorbeste-deschis/index.html): Boehringer Ingelheim se dedică modelului de conducere a afacerii cu integritate și în conformitate cu legile aplicate, cu reglementări și politici și proceduri ale companiei. (492 words)
- [Leadership | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (672 words)
- [Insuficiență cardiacă | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/insuficienta-cardiaca/index.html): Insuficiență cardiacă (209 words)
- [Lung Diseases | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/index.html): Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer. (74 words)
- [Více zdraví: Pro lidi i zvířata | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/vice-zdravi/index.html): Více zdraví: Pro lidi i zvířata (82 words)
- [More Green: pour notre planète | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-green/index.html): More Green: Für unseren Planeten Unsere Säule More Green umfasst Umweltinitiativen, die viele verschiedene Aspekte berücksichtigen: Maßnahmen zur Vermeidung von Wasser- und Luftverschmutzung, die Nutzung erneuerbarer Energiequellen, die Reduktion von Abfä (87 words)
- [私たちのコミットメント | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-commitment/index.html): 私たちは、イノベーションを牽引し、アンメットメディカルニーズの高い分野で価値を創造し、コミュニティや社会と協働して人と動物の生活を向上していく旅を続けていきます。 (24 words)
- [Etik ve Uyum | Boehringer Ingelheim TR](/content/tr/about-us/ethics-compliance/index.html): Leitbild’imizin özü ve Davranış Kurallarımızla tutarlı olarak, dürüstlükle hareket ederiz ve işimizi yasalara uygun ve etik bir şekilde yürütmeye kararlıyız. (54 words)
- [Hipertensiune arterială | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/hipertensiune/index.html): Tratamentul și gestionarea eficientă a hipertensiunii arteriale sunt importante pentru a evita alte complicații sau riscuri, cum ar fi atacul de cord sau accidentul vascular cerebral. (112 words)
- [MORE GREEN ―地球環境のために | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-green/index.html): 「MORE GREEN」は、様々な局面を考慮した環境イニシアチブから構成されています。水や大気の汚染防止対策を採用する、再生可能エネルギーを用いる、廃棄物を減らし製品を環境に配慮したものとする、自然環境になるべく近い施設を建設し、様々な動植物を育む場所とする、社員が環境に配慮した行動をとれるよう促す、環境保全とエネルギー管理の効果が認められているシステムを導入するなど、様々な取り組みを展開しています。私たちは、水資源などの天然資源を守り、事業活動におけるカーボンニュートラルの実現に向けた道筋をつけることを (27 words)
- [Stroke | Boehringer Ingelheim CA](/content/ca/human-health/heart-diseases/stroke/index.html): We developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. Learn more here. (116 words)
- [Fibrilație atrială | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/fibrilatie-arteriala/index.html): La Boehringer Ingelheim îmbunătățim tratamentele pentru pacienții care suferă de o serie de afecțiuni cardiovasculare: fibrilație atrială, accident vascular cerebral și cheaguri de sânge. (85 words)
- [More Health: pour les humains et les animaux | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-health/index.html): More Health: pour les humains et les animaux (231 words)
- [サステナブル・ディベロップメント | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/index.html): ベーリンガーインゲルハイムの「Sustainable Development – for Generations (世代を超えたまたぐ持続可能な開発)」は、1885年の創業以来、長年に渡り受け継がれており、その旅路に終わりはありません。私たちは、常に革新的な解決策を探求し、世の中に新たな価値を提供することを目指しています。より良い医薬品を開発し、より良いヘルスケアソリューションを提供し、より良い世界の実現に貢献すべく、日々挑戦を続けています。ベーリンガーインゲルハイムは、社員、患者さん、地域社会、そしてビ (34 words)
- [Σε όλους τους τύπους καρκίνου | Boehringer Ingelheim GR](/content/gr/human-health/cancer/across-cancer-types/index.html): Δεσμευόμαστε στους τομείς των ασθενειών εστίασής μας, τον καρκίνο του πνεύμονα και του γαστρεντερικού (84 words)
- [Empowering Patients | Boehringer Ingelheim HK](/content/hk/en/human-health/cancer/empowering-patients/index.html): Empowering Patients (70 words)
- [Ενδυνάμωση των ασθενών | Boehringer Ingelheim GR](/content/gr/human-health/cancer/empowering-patients/index.html): Η αντιμετώπιση του καρκίνου δεν σταματά στην ανάπτυξη φαρμάκων. (85 words)
- [Cancer | Boehringer Ingelheim HK](/content/hk/en/human-health/cancer/index.html): At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers. (109 words)
- [Atrial Fibrillation | Boehringer Ingelheim CA](/content/ca/human-health/heart-diseases/atrial-fibrillation/index.html): Learn more about Boehringer Ingelheim's innovative work in protecting patients with an irregular heart beat (atrial fibrillation) from a stroke. (68 words)
- [Our FOCUS | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/culture/our-focus/index.html): Our FOCUSは、ベーリンガーインゲルハイムの文化的フレームワークです。「私たちは誰なのか、私たちは何を目指しているのか」「私たちは、なぜ存在するのか」「私たちは、いかに行動するのか」「私たちは、何を成し遂げたいのか」を表しています。 (13 words)
- [Boli cardiovasculare | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/index.html): Bolile cardiovasculare, inclusiv bolile de inimă și accidentul vascular cerebral, reprezintă o problemă majoră de sănătate la nivel mondial și principala cauză de deces și invaliditate la nivel mondial. (93 words)
- [Kultura | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/index.html): Každý den se 52 000 zaměstnanců společnosti Boehringer Ingelheim podílí na zlepšování zdraví lidí i zvířat. Koncept OUR FOCUS (naše zaměření) vyjadřuje,kdo jsme,o co usilujeme,co je smyslem existence naší společnosti,jak pracujeme a čeho chceme dosáhnout. (76 words)
- [Notre engagement | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/notre-engagement/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (518 words)
- [Achiziții | Boehringer Ingelheim RO](/content/ro/despre-noi/achizitii/index.html): Furnizorii sunt o parte integrantă a angajamentului nostru pentru succes. Suntem pasionați să căutăm soluții inovatoare și noi oportunități de a revizui, îmbunătăți și optimiza baza noastră de furnizori. (128 words)
- [História | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/historia/index.html): A Boehringer Ingelheim investe em saúde animal e humana com pesquisas científicas e fabricação de medicamentos. Conheça mais sobre a nossa história. (340 words)
- [Heart Diseases | Boehringer Ingelheim IE](/content/ie/human-health/heart-diseases/index.html): Boehringer Ingelheim provides innovative treatments that help treat patients suffering from a range of cardiovascular conditions. (108 words)
- [Hypertension | Boehringer Ingelheim CA](/content/ca/human-health/heart-diseases/hypertension/index.html): Hypertension affects approximately one billion people worldwide and that number is expected to increase in future years. Click here to learn more. (91 words)
- [MORE HEALTH ― 人と動物の健康のために | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-health/index.html): 直面する医療課題に対して最も有望な解決策を見出し、長期的視野に基づき世界中のコミュニティにおける健康改善を支援していきます。 (23 words)
- [Gezegenimiz İçin Daha Çevreci | Boehringer Ingelheim TR](/content/tr/about-us/sustainable-development/more-green/index.html): DAHA ÇEVRECİ eksenimiz pek çok farklı unsuru dikkate alan çevresel girişimleri kapsıyor. (165 words)
- [Across Cancer Types | Boehringer Ingelheim HK](/content/hk/en/human-health/cancer/across-cancer-types/index.html): Across Cancer Types (74 words)
- [Vedení | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/vedeni/index.html): Přečtěte si více o představenstvu společnosti Boehringer Ingelheim, seznamte se se všemi pěti členy představenstva a jejich odpovědnostmi (65 words)
- [Heart Failure | Boehringer Ingelheim CA](/content/ca/human-health/heart-diseases/heart-failure/index.html): Heart failure refers to the inability of the heart to pump sufficient blood through the body. Click here to learn and find out more information. (173 words)
- [Unde ne găsiți | Boehringer Ingelheim RO](/content/ro/despre-noi/unde-ne-gasiti/index.html): Unde ne găsiți (390 words)
- [Liderlik | Boehringer Ingelheim TR](/content/tr/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (451 words)
- [Heart Diseases | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/index.html): Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right. (94 words)
- [O nás | Boehringer Ingelheim CZ](/content/cz/o-nas/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (200 words)
- [Ethics and Compliance | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/index.html): Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner. (158 words)
- [NASH | Boehringer Ingelheim HK](/content/hk/en/human-health/metabolic-diseases/nash/index.html): Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim. (121 words)
- [Maladies cardiovasculaires | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/index.html): Maladies Cardiovasculaires (269 words)
- [Lung Cancer | Boehringer Ingelheim HK](/content/hk/en/human-health/cancer/lung-cancer/index.html): Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC) (30 words)
- [Développement durable | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/index.html): Unser Engagement Auf unserem Weg geht es darum, Innovationen voranzutreiben, Werte in Bereichen mit ungedecktem medizinischem Bedarf zu schaffen und mit Communities und Gesellschaft in Kontakt zu treten, um Leben zum Besseren zu verändern. (86 words)
- [Culture | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/culture/index.html): Culture (191 words)
- [Καρκίνος του πνεύμονα | Boehringer Ingelheim GR](/content/gr/human-health/cancer/lung-cancer/index.html): Βασιζόμενοι στην εμπειρία μας στις πνευμονοπάθειες, στόχος μας είναι να αναμετρηθούμε με τον καρκίνο του πνεύμονα (36 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim CA](/content/ca/about-us/quality/index.html): Quality at Boehringer Ingelheim (219 words)
- [Human Health | Boehringer Ingelheim CA](/content/ca/human-health/index.html): Boehringer Ingelheim is dedicated to the discovery, development, manufacture and marketing of innovative health care products. Click here and learn more. (32 words)
- [Kardiológia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/index.html): A szív- és érrendszeri betegségek jelentős globális problémát jelentenek. A Boehringer Ingelheim a kardiológia területén innovatív terápiákat ajánl. (78 words)
- [Καρκίνος | Boehringer Ingelheim GR](/content/gr/human-health/cancer/index.html): Ο καρκίνος αφαιρεί. Αφαιρεί χρόνο. Αφαιρεί αγαπημένα πρόσωπα. (42 words)
- [Historie | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/historie/index.html): Seznamte se s historií inovativní farmaceutické společnosti Boehringer Ingelheim. (82 words)
- [Obesity | Boehringer Ingelheim HK](/content/hk/en/human-health/metabolic-diseases/obesity/index.html): Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here. (93 words)
- [Etică și Complianță | Boehringer Ingelheim RO](/content/ro/despre-noi/etica-si-complianta/index.html): Etică și Complianță (101 words)
- [Where to find us | Boehringer Ingelheim CA](/content/ca/about-us/where-find-us/index.html): With 52,000 employees worldwide, Boehringer Ingelheim has a research and production network across the globe. Click here to view our biggest sites. (384 words)
- [NASH | Boehringer Ingelheim GR](/content/gr/human-health/metabolic-diseases/mash/index.html): Η μη αλκοολική στεατοηπατίτιδα (NASH) προκαλείται από μια μεταβολικά επαγόμενη φλεγμονή του ήπατος και είναι μία από τις κύριες αιτίες. (128 words)
- [Diabetes | Boehringer Ingelheim HK](/content/hk/en/human-health/metabolic-diseases/diabetes/index.html): Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives. (114 words)
- [Sobre nós | Boehringer Ingelheim BR](/content/br/sobre-nos/index.html): A Boehringer Ingelheim investe na pesquisa e na inovação na produção de medicamentos. Conheça mais esta empresa de destaque na indústria farmacêutica. (214 words)
- [İnsanlar ve Hayvanlar İçin Daha Fazla Sağlık | Boehringer Ingelheim TR](/content/tr/about-us/sustainable-development/more-health/index.html): Zorlayıcı sağlık sorunlarına en umut veren çözümleri tespit ederek ve destekleyerek dünyanın her yanındaki topluluklarda sağlığı iyileştirmeyi amaçlayan uzun vadeli bir girişim. (55 words)
- [ベーリンガーインゲルハイムについて | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/index.html): ベーリンガーインゲルハイムは、今日そして次世代にわたり、暮らし生活に変革をもたらす画期的な医薬品や治療法の開発に取り組んでいます。 研究開発主導型のバイオ製薬企業のリーディンクカンパニーとして、アンメットメディカルニーズの高い分野において、イノベーションによる価値の創出に日々取り組んでいます。 1885年の創業以来、ベーリンガーインゲルハイムは、株式を公開しない独立した企業形態により、長期的な視野を維持しています。 医療用医薬品、アニマルヘルスおよびバイオ医薬品受託製造の3つの事業分野において、52,00 (24 words)
- [歴史 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/history/index.html): 約140年前、ベーリンガーインゲルハイムは創業者アルベルト・ベーリンガー氏（1861-1939年）とわずか28人の社員でその歴史を刻み始めました。当時、乳酸を製造していた小さな化学薬品工場は、今や世界130カ国以上でビジネスを展開し、5万4,500人を超える社員が働くグローバル企業に成長しました。 (23 words)
- [Παχυσαρκία | Boehringer Ingelheim GR](/content/gr/human-health/metabolic-diseases/obesity/index.html): Η παχυσαρκία είναι μια σύνθετη χρόνια ασθένεια που απαιτεί μακροχρόνια διαχείριση. (82 words)
- [Qui sommes-nous | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/index.html): Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen. Schwerpunkte sind die Forschung, Entwicklung, Produktion sowie das Marketing neuer Medikamente. (249 words)
- [Nesiller Boyu Sürdürülebilir Kalkınma | Boehringer Ingelheim TR](/content/tr/about-us/sustainable-development/index.html): “Nesiller Boyu Sürdürülebilir Kalkınma” Boehringer Ingelheim için bir yolculuk anlamına geliyor. 1885'te başlayan bu yolculuğun asla sona ermeyeceğini umuyor ve buna inanıyoruz. Çünkü Boehringer Ingelheim daima daha iyisi için çalışıyor. (136 words)
- [The Vital but Stressful Role of Veterinarians | Boehringer Ingelheim](/content/annualreport/2024/role-of-veterinarians/index.html): Burnout, poor pay, and lack of appreciation make the role of veterinarians stressful (1,661 words)
- [お知らせ | Boehringer Ingelheim JP](/content/jp/about-us/news/index.html): お知らせ (17 words)
- [会社情報 | Boehringer Ingelheim JP](/content/jp/about-us/index.html): ベーリンガーインゲルハイムは、「人と動物の健康を向上することで人類に奉仕する」という目標を掲げています。家族経営の会社として、世代単位誠実かつ長期的な視点に立ちで計画を立 (24 words)
- [役員 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/leadership/index.html): Leadership (98 words)
- [牛 | Boehringer Ingelheim JP](/content/jp/ruminants/index.html): ベーリンガーインゲルハイムは、現在だけでなく将来を見据えて、牛を取り巻くこうした課題に応えるため、予防を重視した積極的なソリューションで、養牛農家を支えています。 (12 words)
- [企業文化 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/culture/index.html): アルベルト・ベーリンガーによる創業以来、私たちは135年以上にわたり長期的な成長を見据えて活動しています。ベーリンガーインゲルハイムでは約53,000人の社員が働いており、「人と動物の健康を向上させる」という明確な目標を掲げて、日々、イノベーションによる価値を創出しています。 (25 words)
- [Quem somos | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/index.html): Quem somos (119 words)
- [Sydänsairaudet | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/index.html): Sydän- ja verisuonitaudit, esimerkiksi sydänsairaudet ja aivohalvaus, aiheuttavat maailmanlaajuisesti merkittäviä terveysongelmia. (61 words)
- [Sustainable Development | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/index.html): Learn about our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (200 words)
- [Διαβήτης | Boehringer Ingelheim GR](/content/gr/human-health/metabolic-diseases/diabetes/index.html): Περίπου 425 εκατομμύρια ενήλικοι άνθρωποι στον κόσμο ζουν με διαβήτη, με τον διαβήτη τύπου 2 να αντιπροσωπεύει το 90-95% όλων των περιπτώσεων. (83 words)
- [Sözümüz | Boehringer Ingelheim TR](/content/tr/about-us/sustainable-development/our-commitment/index.html): Sürekli inovasyon yapma, karşılanmamış tıbbi ihtiyaç alanlarında değer yaratma ve hem insanların hem de hayvanların yaşamlarını iyileştirmek için topluluklar ve toplumla etkileşim kurma taahhüdüyle yolumuza devam ediyoruz. (91 words)
- [Doenças Cardíacas | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/index.html): Problemas no coração são a principal causa de morte e incapacitação no mundo. Conheça tratamentos inovadores para doenças cardiovasculares. (389 words)
- [Μεταβολικά νοσήματα | Boehringer Ingelheim GR](/content/gr/human-health/metabolic-diseases/index.html): Οι αλληλένδετες καρδιο-νεφρο-μεταβολικές παθήσεις – που επηρεάζουν την καρδιά, τους νεφρούς και το μεταβολικό σύστημα (78 words)
- [Metabolic Diseases | Boehringer Ingelheim HK](/content/hk/en/human-health/metabolic-diseases/index.html): Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 20451. Type 2 diabetes is a chronic, p (71 words)
- [Hjertesygdomme | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/index.html): Hjertekarsygdomme, herunder hjertesygdomme og stroke (slagtilfælde), er et stort, globalt sundhedsproblem - og det er den hyppigste årsag til dødsfald (71 words)
- [Kültür | Boehringer Ingelheim TR](/content/tr/about-us/who-we-are/culture/index.html): Kültür (109 words)
- [Hakkımızda | Boehringer Ingelheim TR](/content/tr/about-us/index.html): Hakkımızda (215 words)
- [Kardiovaskulární onemocnění | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/index.html): Kardiovaskulární onemocnění včetně srdečního onemocnění a cévní mozkové příhody jsou významným celosvětovým zdravotním problémem a jednou z hlavních příčin úmrtí a invalidity na světě. (111 words)
- [Υπέρταση | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/hypertension/index.html): Η υπέρταση μπορεί επίσης να εμφανιστεί κατά τη διάρκεια της εγκυμοσύνης ή να υποδηλώνει την παρουσία μιας άλλης, πιο σοβαρής πάθησης. (107 words)
- [Histoire | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/histoire/index.html): Albert Boehringer gründete Boehringer Ingelheim 1885. Lesen Sie hier, wie sich das Unternehmen seitdem entwickelt hat. (85 words)
- [Stroke | Boehringer Ingelheim HK](/content/hk/en/human-health/heart-diseases/stroke/index.html): Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide. (117 words)
- [Εγκεφαλικό επεισόδιο | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/stroke/index.html): Ένα εγκεφαλικό επεισόδιο μπορεί να προκαλέσει αναπηρία ή ακόμη και θάνατο και πρέπει πάντα να αντιμετωπίζεται αμέσως. (103 words)
- [Boehringer Ingelheim � Unternehmensbericht 2025: Die Unternehmensleitung](/content/de/unternehmensbericht/2025/files/boehringer-ingelheim-wesentliche-erfolge-2025-pdf.html) (481 words)
- [Human Health | Boehringer Ingelheim HK](/content/hk/en/human-health/index.html): Read the latest human health articles by clicking here. From drug discovery to specific diseases such as heart, lung or eye diseases our information is vast. (238 words)
- [Protecția datelor cu caracter personal | Boehringer Ingelheim RO](/content/ro/protectia-datelor-cu-caracter-personal/index.html): Protecția datelor (1,301 words)
- [CRM Supervisor 职位详细信息 | BoehringerPRD](/content/jobs/job-invite/36361/index.html): 上海 CRM Supervisor - 中国 (415 words)
- [Un potențial mai bun: pentru comunitățile și oamenii noștri | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/un-potential-mai-bun/index.html): Societatea continuă să se confrunte cu provocări care variază de la sănătate, la educație, perspective de muncă, condiții de viață, inegalități și sărăcie, având adesea cel mai mare impact asupra comunităților vulnerabile. (138 words)
- [Key Account Manager/SR KAM, Poultry - Field Job Details | BoehringerPRD](/content/jobs/job-invite/36316/index.html): Huntsville Key Account Manager/SR KAM, Poultry - Field - Unit (1,346 words)
- [More Potential | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/more-potential/index.html): Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Learn more here. (111 words)
- [Κολπική μαρμαρυγή | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/atrial-fibrillation/index.html): Ένα εγκεφαλικό επεισόδιο συμβαίνει όταν διακόπτεται η παροχή αίματος σε τμήμα του εγκεφάλου. (58 words)
- [Speak Up – Compliance Hotline | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/speak-compliance-hotline/index.html): The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously. (323 words)
- [Hypertension | Boehringer Ingelheim HK](/content/hk/en/human-health/heart-diseases/hypertension/index.html): Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke. (91 words)
- [Atrial Fibrillation | Boehringer Ingelheim HK](/content/hk/en/human-health/heart-diseases/atrial-fibrillation/index.html): At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots. (69 words)
- [Poveștile noastre | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/povestile-noastre/index.html): Boehringer Ingelheim are multe inițiative pe care am dori să le împărtășim. Aflați mai multe despre noi citindu-ne poveștile. Mai jos sunt cele mai recente comunicate de presă, știri și multe altele de la familia noastră din întreaga lume. (42 words)
- [More Green | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/more-green/index.html): Our More Green pillar encompasses environmental initiatives that consider many different aspects. Click here and learn more about our More Green pillar. (88 words)
- [プレスルーム | Boehringer Ingelheim JP](/content/jp/pressroom/index.html): ベーリンガーインゲルハイムの最新のプレスリリースをご覧ください。報道関係者向け素材もこのページからダウンロードいただけます。 (47 words)
- [Сърдечносъдови заболявания | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/index.html): Сърдечносъдовите заболявания са сериозен здравен проблем в глобален мащаб и са водещата причина за смъртност и увреждания. (83 words)
- [Ruminants | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/index.html): Across the lifespan of cattle and sheep, Boehringer Ingelheim delivers proactive solutions to help ruminant producers optimize herd health and productivity (679 words)
- [O sănătate mai bună: pentru oameni și pentru animale | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/o-sanatate-mai-buna/index.html): O sănătate mai bună: pentru oameni și pentru animale (82 words)
- [Quality at Boehringer Ingelheim | Boehringer Ingelheim HK](/content/hk/en/about-us/quality/index.html): Quality at Boehringer Ingelheim (216 words)
- [Καρδιακή ανεπάρκεια | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/heart-failure/index.html): Η καρδιακή ανεπάρκεια είναι η κύρια αιτία νοσηλείας στις ΗΠΑ και την Ευρώπη, ενώ ο αριθμός των ασθενών σε όλη την Ασία αυξάνεται επίσης. (178 words)
- [Herzerkrankungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/index.html): Boehringer Ingelheim entwickelt innovative Behandlungsmöglichkeiten, um auf den noch ungedeckten medizinischen Bedarf einzugehen und die Versorgung von Patienten mit unterschiedlichen kardiovaskulären Erkrankungen, wie Herzrhythmusstörungen (z. B. Vorh (150 words)
- [Where to find us | Boehringer Ingelheim HK](/content/hk/en/about-us/where-find-us/index.html): Where to find us (385 words)
- [Contato SAC Saúde Humana | Boehringer Ingelheim BR](/content/br/contato-saude-humana/index.html): Contato SAC Saúde Humana (349 words)
- [More Health: For People & Animals | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/more-health/index.html): More Health is a long-term initiative with the goal to improve health in communities around the world. Click here to learn more about this initiative. (110 words)
- [İletişim Formu | Boehringer Ingelheim TR](/content/tr/iletisim/index.html): İletişim bilgilerini kullanarak Boehringer Ingelheim şirketine ulaşın. (256 words)
- [Angajamentul nostru | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/angajamentul-nostru/index.html): Dorim să creăm valoare în zonele cu nevoi medicale neacoperite și să interacționăm cu comunitățile și cu societatea pentru a îmbunătăți viața oamenilor și a animalelor. (38 words)
- [Heart Diseases | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/index.html): Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right. (90 words)
- [Boehringer Ingelheim Haberler, Basın Bültenleri & Bilgiler | Boehringer Ingelheim TR](/content/tr/medya-1/index.html): Boehringer Ingelheim Haberler, Basın Bültenleri & Bilgiler (428 words)
- [Contato SAC Saúde Animal | Boehringer Ingelheim BR](/content/br/contato-saude-animal/index.html): Contato SAC Saúde Animal (203 words)
- [Switching market | Boehringer Ingelheim JP](/content/jp/disclaimer/market/index.html) (4 words)
- [Πού θα μας βρείτε | Boehringer Ingelheim GR](/content/gr/about-us/where-find-us/index.html): Με 52.000 εργαζόμενους παγκοσμίως, η Boehringer Ingelheim διαθέτει δίκτυο έρευνας και παραγωγής σε όλο τον κόσμο. (494 words)
- [Dezvoltare durabilă | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/index.html): Valorile și principiile care au motivat Boehringer Ingelheim de peste 130 de ani sunt ferm încorporate în filosofia noastră corporatistă. (147 words)
- [Balance zwischen Beruf und Leben | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/balance-zwischen-beruf-und-leben/index.html): Es ist wichtig, dass die Mitarbeiter Beruf und Privatleben in Einklang bringen können, deshalb bieten wir verschiedene Freistellungsmöglichkeiten und flexible Arbeitszeiten an. (181 words)
- [Sustainable Development - Our Commitment | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (34 words)
- [Termos de Utilização | Boehringer Ingelheim PT](/content/pt/termos-de-utilizacao/index.html): O presente site constitui um recurso de informações internacional da nossa sede institucional em Ingelheim (1,483 words)
- [お問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/index.html): お問い合わせ (117 words)
- [Η Ποιότητα στην Boehringer Ingelheim | Boehringer Ingelheim GR](/content/gr/about-us/quality/index.html): Η Ποιότητα στην Boehringer Ingelheim (272 words)
- [Dr Paola Casarosa | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/dr-paola-casarosa/index.html): Dr Paola Casarosa – Member of the Board of Managing Directors with responsibility for the Innovation Unit (165 words)
- [Ochrana osobných údajov | Boehringer Ingelheim SK](/content/sk/ochrana-osobnych-udajov/index.html): Ochrana osobných údajov (1,257 words)
- [Zahlen und Fakten | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/zahlen-und-fakten/index.html): Highlights des Boehringer Ingelheim Unternehmensberichts 2025 in Zahlen (663 words)
- [Média | Boehringer Ingelheim CZ](/content/cz/pro-media/index.html): Boehringer Ingelheim je jednou z předních světových farmaceutických společností zaměřených na výzkum se 130 lety zkušeností. (152 words)
- [Einen Schlaganfall vorbeugen | Boehringer Ingelheim DE](/content/de/einen-schlaganfall-vorbeugen/index.html): Wir haben das erste Nicht-Vitamin-K-Antagonisten orale Gerinnungshemmer entwickelt, zur Vorbeugung von Schlaganfällen bei Menschen mit Vorhofflimmern. (145 words)
- [Gesundheit am Arbeitsplatz | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/gesundheit-am-arbeitsplatz/index.html): Wir bieten Ihnen eine Reihe von Vorteilen und Dienstleistungen, darunter Beratung, Trainingskurse und gesellschaftliche Veranstaltungen, damit Sie geistig und körperlich fit bleiben. (408 words)
- [Shashank Deshpande | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/shashank-deshpande/index.html): Shashank Deshpande – Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit (207 words)
- [Purchasing | Boehringer Ingelheim HK](/content/hk/en/about-us/purchasing/index.html): Sourcing (120 words)
- [Cultura | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/cultura/index.html): Zi de zi, cei 52.000 de angajați ai Boehringer Ingelheim îmbunătățesc atât viața oamenilor, cât și a animalelor. FOCUS-ul nostru articulează cine suntem și pentru ce ne străduim, de ce existăm, cum lucrăm și ce vrem să realizăm. (89 words)
- [Austria | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/austria/index.html): Vienna was our first site outside Germany. Explore career development opportunities in Austria or our 170 locations around the globe. (153 words)
- [Mídia | Boehringer Ingelheim BR](/content/br/imprensa-historias/index.html): Acesse os materiais da sala de imprensa da Boehringer Ingelheim do Brasil. Você também pode entrar em contato com nossos profissionais de comunicação. (322 words)
- [Istorie | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/istorie/index.html): Aflați mai multe despre istoria companiei farmaceutice inovatoare Boehringer Ingelheim. (114 words)
- [医療関係者の皆様 | Boehringer Ingelheim JP](/content/jp/healthcare-professionals/index.html): 医療関係者の皆様 (5 words)
- [Leadership | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (111 words)
- [Heart Diseases | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/index.html): Cardiovascular disease, including heart disease and stroke, is a major global health concern. Click here to learn about our work in this area. (81 words)
- [Enfermedades cardíacas | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-cardiacas/index.html): Enfermedades cardíacas (93 words)
- [Leadership | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/leadership/index.html): Aflați mai multe despre Consiliul de Administrație al Boehringer Ingelheim, cu informații despre toți cei cinci membri și responsabilitățile lor respective. (103 words)
- [Finanzielle Vorsorge | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/finanzielle-vorsorge/index.html): Wir überprüfen ständig unsere Gehälter, um sicherzustellen, dass sie in jedem Markt wettbewerbsfähig bleiben, aber wir bieten auch umfassendere Unterstützung für finanzielle Gesundheit. (176 words)
- [Heart Diseases | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/index.html): Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right. (155 words)
- [Early Detection and Chronic Kidney Disease Management | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/early-detection-and-chronic-kidney-disease-management.html): Early detection and management of kidney disease is key to helping protect kidney health (583 words)
- [Switching market | Boehringer Ingelheim BR](/content/br/disclaimer/market/index.html) (79 words)
- [Oblasti partnerstva | Boehringer Ingelheim SK](/content/sk/partnering/animal-health-partnering/partnering-interests/index.html): Hľadáme nové nápady a novú vedu, aby sme objavili novú generáciu objavov v oblasti zdravia zvierat. (710 words)
- [Partenariats | Boehringer Ingelheim BE](/content/be/fr/partenariats/index.html): Nous embrassons la force du partenariat et de la diversité des esprits dans les sciences du vivant et les communautés de (115 words)
- [Media Overview | Boehringer Ingelheim CA](/content/ca/media/index.html): We are one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to view our media overview. (321 words)
- [Get in touch | Boehringer Ingelheim](/content/careers/get-touch/index.html): Get in touch and learn more about the job application process. (646 words)
- [Who we are | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/index.html): Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. Click here to learn more. (72 words)
- [患者さんとご家族に役立つ情報 | Boehringer Ingelheim JP](/content/jp/patients/index.html): このページでは、日本ベーリンガーインゲルハイムが販売する医療用医薬品を適正にご使用いただくための情報を提供しております。そのため、ページの閲覧を患者さんご本人、ならびにご家族の皆さまに限らせていただいております。 (12 words)
- [How to Connect | Boehringer Ingelheim](/content/partnering/human-health-partnering/how-connect/index.html): Connect with the Boehringer Ingelheim Human Pharma Business Development and Licensing team to discuss partnering opportunities. (491 words)
- [Benefits & zusätzliche Leistungen | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/benefits-zusaetzliche-leistungen/index.html): Es gibt Leistungen und Anlässe, die nach Anerkennung verlangen. Wir geben uns alle Mühe, Mitarbeitern konkrete Belohnungen und mehr für geschäftliche Meilensteine zu geben. (96 words)
- [Leadership | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (618 words)
- [Maladies métaboliques | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-metaboliques/index.html): Les affections cardio-rénales métaboliques interconnectées - qui touchent le coeur, les reins et le système métabolique - sont la principale cause (86 words)
- [Switching market | Boehringer Ingelheim CZ](/content/cz/disclaimer/market/index.html) (69 words)
- [More Potential | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/more-potential/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (262 words)
- [Cine suntem | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/index.html): Boehringer Ingelheim este un grup global de companii care cuprinde mai multe culturi și societăți diverse. Aflați mai multe despre informațiile financiare, viziunea corporatistă și organizație. (161 words)
- [Mammalian Expertise | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/mammalian-expertise/index.html): Boehringer Ingelheim BioXcellence™ has exceptional manufacturing expertise in mammalian cell culture techniques. Learn more about our CDMO capabilities. (981 words)
- [Collaborative Opportunities | Boehringer Ingelheim](/content/partnering/collaborative-opportunities/index.html): Are you looking to make an impact in health innovation? Partner with Boehringer through open research, digital labs, academic funding programs, and more. (509 words)
- [Microbial Expertise | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/microbial-expertise/index.html): Boehringer Ingelheim BioXcellence™ in Vienna has outstanding development and manufacturing experience. We're proud to be pioneers in the microbial field. (1,150 words)
- [Contact Us | Boehringer Ingelheim CA](/content/ca/contact-us/index.html): To contact us at Boehringer Ingelheim click here to fill out our contact request form or to get our contact details. We welcome your queries and feedback. (437 words)
- [Saindo do site | Boehringer Ingelheim BR](/content/br/disclaimer/bi/index.html) (12 words)
- [Agustina Rojo | Boehringer Ingelheim](/content/careers/discover-our-career-areas/agustina-rojo/index.html): Agustina Rojo: ways to learn and grow (17 words)
- [About Us | Boehringer Ingelheim CA](/content/ca/about-us/index.html): Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to find out and learn more about us. (172 words)
- [Media & Insights | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/index.html): Explore the latest industry trends & news in global biopharmaceutical contract manufacturing with our BioXcellence Media & Insights. Don't miss out! (632 words)
- [More Green | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (88 words)
- [Search and apply | Boehringer Ingelheim](/content/careers/job-search/index.html): Search and apply for Boehringer Ingelheim jobs. (586 words)
- [What our partners say | Boehringer Ingelheim](/content/partnering/human-health-partnering/what-our-partners-say/index.html): Read perspectives from Boehringer partners on their experience with us, what we have achieved together and how we’re making an impact. (633 words)
- [Cats | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/index.html): By advancing innovation for the unique challenges of cat care, Boehringer Ingelheim’s feline experts help strengthen the bond between cats and their people (894 words)
- [Anfahrtsplan Biberach | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/pdf/anfahrtsplan-biberach/index.html): Anfahrtsplan nach Biberach für Stakeholder die Boehringer Ingelheim besuchen (171 words)
- [Leadership | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/leadership/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (187 words)
- [Περισσότερο πράσινο | Boehringer Ingelheim GR](/content/gr/about-us/sustainable-development/more-green/index.html): Ο πυλώνας μας MORE GREEN περιλαμβάνει περιβαλλοντικές πρωτοβουλίες που εξετάζουν πολλές διαφορετικές πτυχές (121 words)
- [ΣΧΕΤΙΚΑ ΜΕ ΕΜΑΣ | Boehringer Ingelheim GR](/content/gr/about-us/index.html): Η Boehringer Ingelheim είναι ένας παγκόσμιος όμιλος εταιρειών που ενστερνίζεται πολλές κουλτούρες και διαφορετικές κοινωνίες. (232 words)
- [See our Boehringer Ingelheim locations | Boehringer Ingelheim](/content/careers/explore-our-company/our-locations/index.html): We offer career development opportunities in over 170 locations across the world. Explore some of our featured Boehringer Ingelheim locations. (198 words)
- [Advancing Vet Care | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/index.html): In the face of global veterinary shortages, Boehringer Ingelheim works to champion these passionate professionals and improve access to animal care worldwide (792 words)
- [Animal Health Partnering | Boehringer Ingelheim](/content/partnering/animal-health-partnering/index.html): Learn about Boehringer Ingelheim’s collaborative approach to animal health innovation, our areas of partnering interest, and how to connect with our team (563 words)
- [Περισσότερες δυνατότητες | Boehringer Ingelheim GR](/content/gr/about-us/sustainable-development/more-potential/index.html): Για τις κοινότητες και τους ανθρώπους μας. Η κοινωνία εξακολουθεί να αντιμετωπίζει προκλήσεις που εκτείνονται από την υγεία, την εκπαίδευση (177 words)
- [Partnering Interests | Boehringer Ingelheim](/content/partnering/human-health-partnering/partnering-interests/index.html): Boehringer Ingelheim partners across a variety of human health therapeutic areas and beyond. We’re modality agnostic and prefer to partner early. (801 words)
- [Perspectives | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/index.html): Gain insights into the animal health industry and read perspectives from Boehringer Ingelheim experts on the importance of collaboration in driving innovation (455 words)
- [Innovation en santé animale | Boehringer Ingelheim BE](/content/be/fr/science-et-innovation/innovation-en-sante-animale/index.html): Notre équipe Global Innovation explore la science qui vient en aide aux vétérinaires, éleveurs et propriétaires d'animaux de compagnie, mais aussi (86 words)
- [Atlar | Boehringer Ingelheim TR](/content/tr/atlar-0/index.html): Sahipler ve veteriner hekimlerle iş birliği içinde çalışan ekibimiz, tüm atların en iyi şekilde gelişip güçlenmesine destek olmak için derin uzmanlığını ve binicilik tutkusunu ortaya koyuyor. (77 words)
- [More Health: For People & Animals | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (112 words)
- [Περισσότερη υγεία: Ζώα | Boehringer Ingelheim GR](/content/gr/about-us/sustainable-development/more-health/index.html): Μια μακροπρόθεσμη πρωτοβουλία με στόχο τη βελτίωση της υγείας στις κοινότητες σε όλο τον κόσμο μέσω της (65 words)
- [Discover our careers | Boehringer Ingelheim](/content/careers/discover-our-career-areas/index.html): Learn about the various careers we offer, designed to help you grow professionally, while also providing challenging work that contributes to success. (261 words)
- [Commercial | Boehringer Ingelheim](/content/careers/discover-our-career-areas/commercial-sales-marketing/index.html): Discover new opportunities in our Commercial area and apply today. (371 words)
- [Switching market | Boehringer Ingelheim RO](/content/ro/disclaimer/market/index.html) (68 words)
- [Culture | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/culture/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (226 words)
- [Ποιοί είμαστε | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/index.html): Η Boehringer Ingelheim εργάζεται για πρωτοποριακές θεραπείες που μεταμορφώνουν ζωές, σήμερα και για τις επόμενες γενιές. (139 words)
- [Βιώσιμη ανάπτυξη - Η δέσμευσή μας | Boehringer Ingelheim GR](/content/gr/about-us/sustainable-development/our-commitment/index.html): Η διαδρομή μας αφορά την προώθηση της καινοτομίας, τη δημιουργία αξίας σε τομείς με ανεκπλήρωτες ιατρικές ανάγκες (74 words)
- [Αειφόρος ανάπτυξη | Boehringer Ingelheim GR](/content/gr/about-us/sustainable-development/index.html): Στην Boehringer Ingelheim, «Αειφόρος ανάπτυξη – Για γενιές» αφορά μια διαδρομή. (137 words)
- [Our Commitment | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/our-commitment/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (34 words)
- [Newsletter | Boehringer Ingelheim](/content/newsletter/index.html): Newsletter (158 words)
- [Leaving site | Boehringer Ingelheim RO](/content/ro/disclaimer/bi/index.html) (139 words)
- [Information Technology | Boehringer Ingelheim](/content/careers/discover-our-career-areas/information-technology/index.html): Discover new opportunities in our Information Technology department. (240 words)
- [Our Working Culture | Boehringer Ingelheim](/content/careers/explore-our-company/our-working-culture/index.html): Explore the unique workplace culture and values that define working at Boehringer Ingelheim, from fostering innovation to creating a sense of belonging for our employees. (537 words)
- [Explore our company | Boehringer Ingelheim](/content/careers/explore-our-company/index.html): Make your next career step at the company Boehringer Ingelheim. Explore our fields to find out more about employment opportunities in your area of interest. (452 words)
- [Our Focus: Cultural Framework | Boehringer Ingelheim](/content/about-us/who-we-are/culture/our-focus-cultural-framework/index.html): Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve. (382 words)
- [About Us | Boehringer Ingelheim | Boehringer Ingelheim HK](/content/hk/en/about-us/index.html): Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us. (175 words)
- [Sustainable Development | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/index.html): Click here to discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come. (95 words)
- [Working together | Boehringer Ingelheim](/content/partnering/human-health-partnering/working-together/index.html): Discover our approach to partnering – why we’re motivated to work with others and how we collaborate across biotech, academia, and more. (438 words)
- [Επικοινωνήστε μαζί μας | Boehringer Ingelheim GR](/content/gr/epikoinoniste-mazi-mas/index.html): Επικοινωνήστε μαζί μας (149 words)
- [Presă | Boehringer Ingelheim RO](/content/ro/presa/index.html): Boehringer Ingelheim este una dintre cele mai importante companii farmaceutice din lume, axată pe cercetare, cu o experiență de 130 de ani. (14 words)
- [Manufacturing & Supply Chain | Boehringer Ingelheim](/content/careers/discover-our-career-areas/manufacturing-supply-chain/index.html): Discover new opportunities in our Manufacturing and Supply Chain. (256 words)
- [Human Health Partnering | Boehringer Ingelheim](/content/partnering/human-health-partnering/index.html): Learn about Boehringer’s collaborative approach to human health innovation, our areas of partnering interest, and how to connect with our team. (404 words)
- [Κουλτούρα | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/culture/index.html): Για πάνω από 135 χρόνια, από την ίδρυσή μας από τον Albert Boehringer, εστιάζουμε στις μακροπρόθεσμες επιδόσεις και δεν περιοριζόμαστε. (90 words)
- [History | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/history/index.html): Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim. (52 words)
- [Societal Impact of Animal Health | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/index.html): From zoonotic diseases to environmental effects to the human-animal bond, Boehringer Ingelheim is focused on the ways that animal health impacts society. (498 words)
- [Who we are | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/index.html): Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. (73 words)
- [Medicine & Regulatory Affairs | Boehringer Ingelheim](/content/careers/discover-our-career-areas/medicine-regulatory-affairs/index.html): Discover new opportunities in our Medicine and Regulatory Affairs. (218 words)
- [Animal Health Innovation | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/index.html): Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our (326 words)
- [Ιστορία | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/history/index.html): Το 1885, ο Albert Boehringer (1861-1939) ίδρυσε τη φαρμακευτική εταιρεία Boehringer Ingelheim στο Nieder-Ingelheim (77 words)
- [Dogs | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/index.html): With products and solutions to protect dog health and improve well-being, Boehringer Ingelheim is committed to longer, happier lives for canine companions (753 words)
- [Driving Innovation | Boehringer Ingelheim](/content/animal-health/our-expertise/driving-innovation/index.html): With science-driven R&D, strategic partnering, and synergies across animal and human medicine, Boehringer Ingelheim is driving innovation in animal health (845 words)
- [Contact Us | Boehringer Ingelheim HK](/content/hk/en/contact-us/index.html): To contact us at Boehringer Ingelheim please click here to fill out our contact request form. We welcome all queries and feedback. (41 words)
- [Partnership stories | Boehringer Ingelheim](/content/partnering/animal-health-partnering/partnership-stories/index.html): Read about some of Boehringer Ingelheim’s most significant collaborations in animal health and hear what our partners have to say about their experiences working with us (268 words)
- [Imprint | Boehringer Ingelheim](/content/imprint/index.html): Imprint (76 words)
- [Prečítajte si viac | Boehringer Ingelheim SK](/content/sk/partnering/animal-health-partnering/perspectives/index.html): Získajte poznatky o odvetví zdravia zvierat a prečítajte si pohľady odborníkov z Boehringer Ingelheim na dôležitosť spolupráce pri podpore inovácií (380 words)
- [Connect with us | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/index.html): Connect with the Boehringer Ingelheim Animal Health Business Development and Licensing team online or at events to submit a proposal or discuss partnering opportunities (354 words)
- [Human Health Innovation | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/index.html): Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, with over 80 pre-clinical and clinical projects in the pipeline. (283 words)
- [Engineering & Facilities | Boehringer Ingelheim](/content/careers/discover-our-career-areas/engineering-facilities/index.html): Discover new opportunities in our Engineering and Facilities department. (254 words)
- [How to apply | Boehringer Ingelheim](/content/careers/your-application-process/index.html): Learn how to apply, what to expect, and what to prepare, when you begin the application with us. (414 words)
- [Horses | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/index.html): Partnering with owners and vets, Boehringer Ingelheim’s Equine team brings deep expertise and a passion for the equestrian life to help all horses thrive (624 words)
- [Science Stories | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/index.html): Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better. (71 words)
- [Partnerstvo v oblasti zdravia zvierat | Boehringer Ingelheim SK](/content/sk/partnering/animal-health-partnering/index.html): Zistite viac o spolupracujúcom prístupe Boehringer Ingelheim k inováciám v oblasti zdravia zvierat, o našich oblastiach záujmu vo vytváraní partnerstiev a o tom, ako sa spojiť s naším tímom (417 words)
- [Transboundary Animal Diseases | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/index.html): Through vaccines, partnerships, and more, Boehringer Ingelheim helps fight transboundary animal diseases that threaten livestock health and food security (467 words)
- [Our total rewards | Boehringer Ingelheim](/content/careers/explore-our-company/our-total-rewards/index.html): At Boehringer Ingelheim, we offer rewards and development opportunities to help retain employees. We invest in our people so they stay and grow with us. (182 words)
- [Partnering | Boehringer Ingelheim](/content/partnering/index.html): At Boehringer, diversity of minds and collaboration is paramount to developing new medical breakthroughs. Click to see how you can partner with us. (245 words)
- [Animals We Support | Boehringer Ingelheim](/content/animal-health/animals-we-support/index.html): We’re committed to the health of the world’s most important animals: beloved dogs, cats, and horses, plus valued livestock like swine, ruminants, and poultry (583 words)
- [Pravidlá používania | Boehringer Ingelheim SK](/content/sk/pravidla-pouzivania/index.html): Pravidlá používania (944 words)
- [Search | Boehringer Ingelheim](/content/search/index.html) (77 words)
- [Leaving site | Boehringer Ingelheim GR](/content/gr/disclaimer/bi/index.html) (172 words)
- [Science Focus | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/index.html): Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19. (146 words)
- [Eye Health | Boehringer Ingelheim](/content/human-health/eye-health/index.html): We have built an innovative and diverse clinical pipeline in retinal conditions and further expanded our research to areas of greatest unmet need in eye health. (112 words)
- [Fostering Science | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/fostering-science/index.html): Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here. (167 words)
- [Human Health Partnering Interests | Boehringer Ingelheim TW](/content/tw/human-health-partnering-interests/index.html): 人类健康合作利益 (131 words)
- [Science & Innovation | Boehringer Ingelheim](/content/science-innovation/index.html): Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles. (181 words)
- [COPD & Asthma | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/index.html): Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives. (408 words)
- [Scleroderma | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/index.html): Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs (290 words)
- [Grass Roots | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/grass-roots/index.html): Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators (117 words)
- [Neuroendocrine Cancers | Boehringer Ingelheim](/content/human-health/cancer/neuroendocrine-cancers/index.html): Neuroendocrine cancers are a group of cancers that can occur across the body. At Boehringer, we’re exploring new targets to improve outcomes. (429 words)
- [Príbehy o partnerstve | Boehringer Ingelheim SK](/content/sk/partnering/animal-health-partnering/partnership-stories/index.html): Prečítajte si o niektorých z najvýznamnejších spoluprác Boehringer Ingelheim v oblasti zdravia zvierat a vypočujte si, čo naši partneri hovoria o svojich skúsenostiach s nami (247 words)
- [Parasiticides | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/parasiticides/index.html): Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses. (55 words)
- [Spojte sa s nami | Boehringer Ingelheim SK](/content/sk/partnering/animal-health-partnering/connect-us/index.html): Spojte sa s tímomspoločnosti Boehringer Ingelheim, ktorý má na starosti rozvoj podnikania a licencovanie vrámci oblasti zdravia zvierat online alebo na podujatiach, aby ste predložili návrh alebo diskutovali o príležitostiach na partnerstvá (276 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/index.html): Reducing the risk of acute exacerbations is a key treatment goal to manage patients with Idiopathic Pulmonary Fibrosis (IPF), learn how BI is helping. (364 words)
- [Therapeutics | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/therapeutics/index.html): We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species. Our dedicated Research teams work together with our human pharma and animal health colleagues, as well as with (61 words)
- [Bronchiectasis | Boehringer Ingelheim](/content/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis (211 words)
- [Čo hovoria naši partneri | Boehringer Ingelheim SK](/content/sk/partnering/human-health-partnering/what-our-partners-say/index.html): S našimi partnermi zdieľame spoločnú víziu v snahe niečo zmeniť a vyvinúť nové a pokročilé lieky, ktoré majú skutočný vplyv na životy pacientov. Vypočujte si, čo hovoria o svojej partnerskej ceste s nami. (66 words)
- [Záujmy partnerstva | Boehringer Ingelheim SK](/content/sk/partnering/human-health-partnering/partnering-interests/index.html): Nové nápady. Nová veda. To je to, čo hľadáme pri našom hľadaní objavenia novej generácie prelomových liekov. (83 words)
- [Kultúra partnerstva | Boehringer Ingelheim SK](/content/sk/partnering/human-health-partnering/partnering-culture/index.html): Naši partneri sú váženými prispievateľmi do našej globálnej rodiny inovácií. (44 words)
- [Search | Boehringer Ingelheim FR](/content/fr/search/index.html) (445 words)
- [Pressemitteilungen | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/index.html): Hier finden Sie auf einen Blick aktuelle Pressemitteilungen. Informieren Sie sich über die neuesten Nachrichten von Boehringer Ingelheim. (264 words)
- [Infotag der Ausbildung | Boehringer Ingelheim DE](/content/de/presse/infotag-der-ausbildung/index.html): Am 4. Juli 2026 öffnet Boehringer Ingelheim, Biberachs größter Arbeitgeber, seine Türen für einen spannenden Infotag der Ausbildung. (215 words)
- [Infotag der Ausbildung | Boehringer Ingelheim DE](/content/de/ueber-uns/infotag-der-ausbildung/index.html): Am 13. Mai 2026 öffnet Boehringer Ingelheim, seine Türen für einen spannenden Infotag der Ausbildung. Von 15:30 bis 19:30 Uhr (214 words)
- [Jahrespressekonferenz 2026 | Boehringer Ingelheim DE](/content/de/ueber-uns/jahrespressekonferenz-2026/index.html): Boehringer Ingelheim wird seine Jahrespressekonferenz 2026 am 25. März 2026 (42 words)
- [Privacy Notice | Boehringer Ingelheim](/content/privacy-notice/index.html): Data Privacy (3,419 words)
- [Pulmonary Fibrosis | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/index.html): Reducing the risk of acute exacerbations is a key treatment goal to manage patients with Idiopathic Pulmonary Fibrosis (IPF), learn how BI is helping. (291 words)
- [So bewirbst du dich | Boehringer Ingelheim DE](/content/de/karriere/deine-bewerbung/index.html): Erfahre, wie du dich bewerben kannst, was dich erwartet und was du vorbereiten musst, wenn du mit der Bewerbung bei uns beginnst. (568 words)
- [Unsere Standorte | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/standorte/index.html): Wir bieten Karriereentwicklungsmöglichkeiten an über 170 Standorten auf der ganzen Welt. Erkunde einige unserer vorgestellten Standorte. (223 words)
- [Leiderschap | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/leiderschap/index.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (590 words)
- [FAQ | Boehringer Ingelheim DE](/content/de/karriere/deine-bewerbung/faq/index.html): Häufig gestellte Fragen zum Bewerbungsprozess bei Boehringer Ingelheim (1,666 words)
- [Perspektiven | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/perspektiven/index.html): Gewinnen Sie tiefere Einblicke in die Tiergesundheit und erfahren Sie, warum Expertinnen und Experten von Boehringer Ingelheim Kollaborationen als wichtige Treiber für Innovation schätzen. (395 words)
- [Krebserkrankungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/index.html): Krebserkrankungen (368 words)
- [Decouvrez nos opportunités | Boehringer Ingelheim CA](/content/ca/fr/emplois/decouvrez-nos-carrieres/index.html): Découvrez les différentes opportunités d'emploi que nous proposons. Il s'agit pour nous de vous aider à vous développer professionnellement, tout en offrant un travail stimulant qui contribue à notre succès et à votre réussite. (301 words)
- [Achats | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/achat/index.html): Découvrez qui nous sommes et comment acheter chez Boehringer Ingelheim. Engagés pour votre santé et votre bien-être. (336 words)
- [Human health products | Boehringer Ingelheim CA](/content/ca/human-health/products/index.html): We are proud to offer innovative prescription and non-prescription medicines for a wide range of conditions. Click here to find out about our products. (406 words)
- [weBuy | Boehringer Ingelheim NL](/content/nl/webuy/index.html): weBuy: De Source to Procure-oplossing voor Boehringer Ingelheim op basis van SAP Ariba®. (300 words)
- [Deine Karriere bei uns | Boehringer Ingelheim DE](/content/de/karriere/karrieremoeglichkeiten/index.html): Informiere dich über die verschiedenen Karrieren, die wir anbieten und die dir die Möglichkeit bieten, dich beruflich weiterzuentwickeln und gleichzeitig anspruchsvolle Aufgaben zu übernehmen, die zum Erfolg beitragen. (180 words)
- [Entdecke unser Unternehmen | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/index.html): Mache deinen nächsten Karriereschritt bei Boehringer Ingelheim. Lerne unsere verschiedenen Bereiche kennen und erfahre mehr über die Beschäftigungsmöglichkeiten in deinem Interessengebiet. (303 words)
- [Chronische Nierenerkrankung: Früherkennung dank SPOT CKD | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/chronische-nierenerkrankung/index.html): Eine chronische Nierenerkrankung bleibt oft unbemerkt. In Großbritannien zeigt SPOT CKD, wie Früherkennung und Prävention die Versorgung verbessern. (1,351 words)
- [Nos sites | Boehringer Ingelheim FR](/content/fr/propos/nos-sites/index.html): Nos sites (141 words)
- [Duurzame ontwikkeling – Voor generaties | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/index.html): Bij Boehringer Ingelheim gaat “Duurzame ontwikkeling - Voor generaties” over een reis. Een reis die in 1885 is begonnen en waarvan we hopen, en (218 words)
- [Nutzungsbedingungen | Boehringer Ingelheim DE](/content/de/nutzungsbedingungen/index.html): Diese Nutzungsbedingungen gelten für jeden Nutzer dieser von Boehringer Ingelheim angebotenen Website, unabhängig vom Zugangsort. (1,204 words)
- [Développement durable | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/index.html): Engagés dans le développement durable, découvrez nos actions chez Boehringer Ingelheim CA FR. Une responsabilité envers l’environnement et la société. (209 words)
- [Husdjur | Boehringer Ingelheim SE](/content/se/djurhalsa/sallskapsdjur/husdjur/index.html): Vi är bland marknadsledarna när det gäller parasiticider, vacciner och behandlingar en pålitlig partner för veterinärer och djurägare runt om i världen. (137 words)
- [Enfermedades Respiratorias | Enfermedades Pulmonares | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/index.html): Buscamos mejorar la calidad de vida de los pacientes con enfermedades respiratorias debilitantes y permitirles mantener una vida más independiente. (237 words)
- [Unsere Partnerschaften | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/unsere-partnerschaften/index.html): Erfahrt mehr über einige wichtige Kooperationen von Boehringer Ingelheim im Bereich Tiergesundheit und lest, was unsere Partner über ihre Erfahrungen in der Zusammenarbeit mit uns berichten. (245 words)
- [Kontakt mit unserem Partnering-Team aufnehmen | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/kontakt-mit-uns-auf/index.html): Nehmt online oder bei Veranstaltungen Kontakt mit dem Business Development- und Licensing-Team der Boehringer Ingelheim Tiergesundheit auf, um einen Vorschlag einzureichen oder Partnerschaftsmöglichkeiten zu besprechen. (217 words)
- [Kontaktaufnahme | Boehringer Ingelheim DE](/content/de/karriere/kontakt/index.html): Nimm Kontakt mit uns auf und erfahre mehr über den Bewerbungsprozess. (131 words)
- [Esteatohepatitis no Alcohólica | Fibrosis Hepática | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-metabolicas/enfermedad-del-higado-graso-no-alcoholico-nash/index.html): La EHNA se produce por la inflamación inducida por el metabolismo del hígado y es una de las principales causas de la fibrosis hepática y la cirrosis. (176 words)
- [Plus de potentiel : Pour nos communautés et leurs habitants | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/plus-de-potentiel/index.html): Boehringer Ingelheim explore son potentiel dans le développement durable. Découvrez comment nous contribuons à un avenir plus durable et responsable. (150 words)
- [Patientcentrering | Boehringer Ingelheim SE](/content/se/manniskors-halsa/vart-ansvar/patientcentrering/index.html): På Boehringer Ingelheim sätter vi patienterna i första rummet i allt vi gör. Patienterna inspirerar oss i vårt uppdrag att leda vetenskapen. (76 words)
- [Vee | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/vee/index.html): Boehringer Ingelheim is een van de toonaangevende aanbieders van oplossingen in de gezondheidszorg om ziekten bij vee te voorspellen, voorkomen behandelen. (45 words)
- [Schizofreni | Boehringer Ingelheim SE](/content/se/manniskors-halsa/mental-halsa/schizofreni/index.html): Schizofreni kännetecknas av tre symtomområden och drabbar ~1 % av världens befolkning. Det första och mest kända är de positiva symtomen. (76 words)
- [Lutte contre le cancer : une affaire personnelle pour Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/sante-humaine/cancer/index.html): Cancer (403 words)
- [Erforschung der neuesten Behandlungsmethoden für Lungenfibrose | Boehringer Ingelheim | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/lungenfibrose-behandlung/index.html): Boehringer Ingelheim verfolgt neue Forschungshypothesen und die neuesten Behandlungsmethoden für Lungenfibrose, um diese schwerwiegende Erkrankung eines Tages aufzuhalten oder umzukehren. (1,213 words)
- [Gebärdensprach-Avatar: Inklusion durch Barrierefreiheit | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/gebaerdensprach-avatar/index.html): Wie der Gebärdensprach-Avatar Gesundheitsinformationen barrierefrei macht und Inklusion für Gehörlose fördert – für mehr Teilhabe im Gesundheitswesen (1,149 words)
- [Newsletter | Boehringer Ingelheim DE](/content/de/newsletter/index.html): Abonnieren Sie den Newsletter von Boehringer Ingelheim und seien Sie der Erste, der über pharmazeutische Neuigkeiten informiert wird! (467 words)
- [Imprint | Boehringer Ingelheim MEA](/content/mea/imprint/index.html): Imprint (53 words)
- [EPOC | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/epoc-y-asma/index.html): Tanto el EPOC como el asma pueden gestionarse de manera adecuada, y Boehringer Ingelheim trabaja para que las personas puedan tener una vida más activa. (136 words)
- [Terms of Use | Boehringer Ingelheim ZA](/content/za/terms-use/index.html): Terms of Use (1,409 words)
- [Produkte | Boehringer Ingelheim DE](/content/de/produkte/index.html): Boehringer Ingelheim bietet Pharmaprodukte für Menschen und Tiere. Informieren Sie sich jetzt über unsere Produkte für Tiergesundheit und Human Pharma! (10 words)
- [Dark Genome entschlüsseln | Neue Krebsantigene für die nächste Generation der Immuntherapie | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/dark-genome/index.html): Forschende bei Boehringer Ingelheim untersuchen das Dark Genome, um tumorspezifische kryptische Antigene zu identifizieren, die neue Ansätze für Krebsimmuntherapien wie therapeutische Impfstoffe und T-Zell-Engager ermöglichen könnten. (997 words)
- [Kontakt | Boehringer Ingelheim DE](/content/de/kontakt/index.html): Wir bei Boehringer Ingelheim freuen uns auf Ihre Anfragen und Feedback. Nehmen Sie Kontakt mit uns auf. (324 words)
- [Stimmen unserer Partnerorganisationen | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/stimmen-unserer-partnerorganisationen/index.html): Wir arbeiten mit unseren Partnern zusammen, um das Leben von Patientinnen und Patienten mit neue innovative Medikamente verbessern. (47 words)
- [Ethics and Compliance | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/index.html): Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner. (500 words)
- [Haustiere und Pferde | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/index.html): Wir glauben, dass Haustiere und Pferde die gleichen Möglichkeiten der Gesundheitsfürsorge haben sollten wie Sie - erfahren Sie mehr darüber. (324 words)
- [新聞中心 Media Overview | Boehringer Ingelheim TW](/content/tw/xinwenzhongxin/index.html): 新聞中心 Media Overview (89 words)
- [Conheça nossa Política de Privacidade | Boehringer Ingelheim BR](/content/br/conheca-nossa-politica-de-privacidade/index.html): Conheça a política de privacidade da Boehringer Ingelheim e como ocorre o tratamento de dados pessoais de pessoas que acessam nosso site. (3,628 words)
- [Kreft | Boehringer Ingelheim NO](/content/no/menneskelig-helse/kreft/index.html): At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers. (409 words)
- [Boehringer Ingelheim France | Boehringer Ingelheim FR](/content/fr/index.html): Découvrez comment nous améliorons la vie des hommes et des animaux. (261 words)
- [Берінгер Інгельхайм - цінність через інновації | Boehringer Ingelheim UA](/content/ua/index.html): Берінгер Інгельхайм - одна з провідних світових фармацевтичних компаній, що спеціалізується на дослідженнях та має 130-річний досвід роботи. (317 words)
- [VSV-GP | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/vsv-gp/index.html): VSV-GP (240 words)
- [Overzicht van de media | Boehringer Ingelheim NL](/content/nl/media/index.html): Download hier de laatste persberichten en ander persmateriaal van Boehringer IngelheimDownload hier de laatste persberichten en ander persmateriaal van (261 words)
- [Annual Press Conference 2025 | Boehringer Ingelheim](/content/about-us/annual-press-conference-2025/index.html): Boehringer Ingelheim presents the 2024 results and an outlook for 2025 at the Annual Press Conference on April 2, 2025. (210 words)
- [Boehringer Ingelheim - Z pasją działamy na rzecz poprawy zdrowia | Boehringer Ingelheim PL](/content/pl/index.html): Boehringer Ingelheim to wiodąca firma farmaceutyczna, stawiająca na innowacje i kierująca się chęcią poprawy zdrowia ludzi i zwierząt. Dowiedz się węcej. (156 words)
- [Deine Benefits | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/deine-benefits/index.html): Wir investieren in unsere Mitarbeitenden, damit sie bei uns bleiben und sich gemeinsam mit uns weiterentwickeln. Wir bieten Vorteile wie Prämien und Entwicklungsmöglichkeiten, um die Bindung der Mitarbeitenden an das Unternehmen zu fördern. (281 words)
- [Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim CA](/content/ca/fr/index.html): Découvrez la page de Boehringer Ingelheim, le leader pharmaceutique au Canada. Cliquez pour en découvrir plus. (234 words)
- [Sclerodermie | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/sclerodermie/index.html): Systemische sclerose (SSc) is een ontsierende, invaliderende en potentieel dodelijke zeldzame ziekte die littekens veroorzaakt in de huid (sclerodermie), (130 words)
- [Bevordering van de wetenschap | Boehringer Ingelheim NL](/content/nl/wetenschap-innovatie/innovaties-voor-menselijke-gezondheid/wetenschap-stimuleren/index.html): Het creëren van baanbrekende geneesmiddelen die het leven van patiënten veranderen, begint met een engagement om de gezondheidsuitdagingen van de toekomst te (129 words)
- [Adipositas und metabolisch dysfunktionsassoziierte Steatohepatitis ganzheitlich angehen | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/survodutide-adipositas-peptide-glp-glucagon/index.html): Für Menschen, die mit Adipositas oder metabolisch dysfunktionsassoziierter Steatohepatitis leben, besteht ein erhöhtes Risiko für metabolische Dysfunktionen. Wir setzen uns dafür ein, sie ganzheitlich zu behandeln. (1,076 words)
- [Biopharma Contract Manufacturing | Boehringer Ingelheim TW](/content/tw/biopharma-contract-manufacturing/index.html): Biopharma Contract Manufacturing (153 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim SE](/content/se/index.html): Några av våra kollegor berättar sina personliga historier om vad som motiverar dem att bidra till en bättre framtid för kommande generationer. (333 words)
- [Nachhaltiges Wassermanagement mit AWS-Zertifizierung in China | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/wassermanagement/index.html): Wie Boehringer Ingelheim Wasserrisiken im Jangtse-Delta in China begegnet: AWS-zertifiziertes Wassermanagement mit nachhaltiger Wirkung (893 words)
- [Kalibriertechniker (m/w/d) Stellendetails | BoehringerPRD](/content/jobs/job-invite/35675/index.html): Biberach Kalibriertechniker (m/w/d) - Deut (530 words)
- [한국베링거인겔하임 - 혁신을 통한 가치 창조 | Boehringer Ingelheim KR](/content/kr/index.html): 한국베링거인겔하임은 연구 중심의 글로벌 제약 기업의 한국법인으로 혁신적인 의약품 공급을 통해 인류의 건강 증진에 기여하고 있습니다. (66 words)
- [Human Health Products | Boehringer Ingelheim US](/content/us/human-health/products/index.html): Click here to read more on Boehringer Ingelheim's commitment to providing innovative prescription medication to a wide range of patients and their families. (427 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim BE](/content/be/nl/index.html): Boehringer Ingelheim - Value Through Innovation (204 words)
- [Valor a través de la innovación | Boehringer Ingelheim ES](/content/es/index.html): Nuestro compromiso es impulsar la innovación, crear valor en áreas de necesidad médica no cubierta y comprometernos con las comunidades, la sociedad y el planeta, para mejorar la vida, tanto de las personas como de los animales. (240 words)
- [Quem somos | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/index.html): A Boehringer Ingelheim trabalha em medicamentos inovadores que transformam vidas hoje e nas gerações seguintes. (305 words)
- [NASH | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/nash/index.html): Niet-alcoholische steatohepatitis (NASH) wordt veroorzaakt door een door metabolisme veroorzaakte ontsteking van de lever en is een van de belangrijkste (116 words)
- [Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-bi-1810631-her2-tyrosine-kinase-inhibitor-tki-4.html): Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) (147 words)
- [Stoffwechselerkrankungen & Therapie | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/index.html): Stoffwechselerkrankungen: Boehringer Ingelheim bietet effektive Behandlungsoptionen. Informieren Sie sich jetzt über die Möglichkeiten der Therapie. (237 words)
- [Unser Bekenntnis | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/unser-bekenntnis/index.html): View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better. (35 words)
- [Bem-vindos ao website | Boehringer Ingelheim BR](/content/br/index.html): Bem-vindos ao website (219 words)
- [Veterinärmedizinisches Förderprogramm: Nachwuchswissenschaftler fördern | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/veterinarmedizin-stipendium/index.html): Das Boehringer Ingelheim Veterinary Scholars Program bietet Veterinärstudierenden frühzeitig praktische Forschungserfahrung, enge Begleitung und Einblicke in biomedizinische Karrierewege. (1,222 words)
- [Unternehmensleitung | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/fuehrung/index.html): Die Mitglieder der Unternehmensleitung stellen sich mit ihren Aufgabenbereichen vor. Lernen Sie unser Familienunternehmen besser kennen. (173 words)
- [Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim MEA](/content/mea/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (217 words)
- [Zongertinib: HER2 Tyrosine Kinase Inhibitor (TKI) | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/zongertinib-her2-tyrosine-kinase-inhibitor-tki/index.html): HER2 Tyrosine Kinase Inhibitor (TKI), Zongertinib (86 words)
- [Empowering Patients | Boehringer Ingelheim ZA](/content/za/human-health/cancer/empowering-patients/index.html): Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients. (182 words)
- [Boehringer Ingelheim MX | Boehringer Ingelheim MX México | Boehringer Ingelheim MX](/content/mx/index.html): Conozca más acerca de Boehringer Ingelheim, empresa farmacéutica líder en el mundo, y el trabajo que realiza con integridad, coraje y honestidad. (239 words)
- [Purchasing | Boehringer Ingelheim IE](/content/ie/about-us/purchasing/index.html): Here you can find out about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too. (218 words)
- [About Us | Boehringer Ingelheim AT](/content/at/en/about-us/index.html): About Us (369 words)
- [Cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/index.html): En BI trabajamos para mejorar los tratamientos para pacientes oncológicos en todo el mundo con especial atención en la afectación de pulmón. (445 words)
- [Unsere Stories | Boehringer Ingelheim CH](/content/ch/tiergesundheit/unsere-stories/index.html): Unsere Stories (189 words)
- [История | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/history/index.html): История (91 words)
- [Кошки | Boehringer Ingelheim RU](/content/ru/animal-health/koshki/index.html): Мы разрабатываем и производим препараты для кошек в трех направлениях: вакцины, препараты для лечения хронических заболеваний и противопаразитарные препараты. (154 words)
- [MASH | Boehringer Ingelheim](/content/human-health/crm-health/liver-health/mash/index.html): MASH (metabolic dysfunction-associated steatohepatitis) is a condition where excess fat in the liver leads to inflammation and scarring. (236 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim NL](/content/nl/index.html): Boehringer Ingelheim is één van de toonaangevende, onderzoeksgedreven farmaceutische bedrijven in de wereld met 130 jaar ervaring. (218 words)
- [Boehringer Ingelheim | Boehringer Ingelheim ANZ | Boehringer Ingelheim AU](/content/au/index.html): Boehringer Ingelheim is one of the world’s leading family-owned pharmaceutical companies, developing medicines to address unmet needs in human and animal health. (135 words)
- [Erklärung zum Datenschutz | Boehringer Ingelheim DE](/content/de/karriere/erklaerung-zum-datenschutz/index.html): Erklärung zum Datenschutz (1,146 words)
- [Human Health Products | Boehringer Ingelheim](/content/human-health/products/index.html): Products Overview of our products. (109 words)
- [Perros y gatos | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/index.html): Tenemos múltiples productos y elementos de investigación que trabajan para garantizar que la salud y el bienestar de sus mascotas sean lo primero. (292 words)
- [Krebserkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/index.html): Krebserkrankungen (161 words)
- [Рак легкого | Boehringer Ingelheim RU](/content/ru/human-health/cancer/lung-cancer/index.html): Берингер Ингельхайм предлагает инновационные методы лечения рака легких с помощью специализированных продуктов для немелкоклеточного рака легкого (НМРЛ) 1-й и 2-й линии. (103 words)
- [Ruminants | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/ruminants/index.html): Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers. (59 words)
- [Atrial Fibrillation | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/atrial-fibrillation/index.html): Click here to learn more information about Boehringer Ingelheim's innovative work in protecting patients with an irregular heart beat from a stroke. (184 words)
- [Metabolic Health | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/index.html): Metabolic diseases such as obesity and diabetes are part of a group of connected conditions known as cardiovascular, renal and metabolic diseases. (226 words)
- [Terms of Use | Boehringer Ingelheim](/content/terms-use/index.html): Terms of Use (1,410 words)
- [Grass Roots | Boehringer Ingelheim PT](/content/pt/ciencia-e-inovacao/inovacao-na-saude-humana/partir-das-bases/index.html): O nosso programa global único de iniciativas Grass Roots foi concebido apoiar a ciência e tecnologia emergentes (56 words)
- [Human Pharma Clinical Pipeline | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-pipeline/index.html): Boehringer Ingelheim Human Pharma Clinical Pipeline (439 words)
- [Esquizofrenia | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/esquizofrenia/index.html): La esquizofrenia se caracteriza por tres dominios sintomáticos y afecta a un 1% de la población mundia. Sigue leyendo. (527 words)
- [Lokal ledergruppe | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/lokal-ledergruppe/index.html): Lokal ledergruppe (79 words)
- [Vastuumme | Boehringer Ingelheim FI](/content/fi/elainterveys/vastuumme/index.html): Suunnittelemme sukupolvissa. Se näkyy yrityksemme yli satavuotiaassa menestyneessä historiassa. Se on myös kestävyyden ydin. (132 words)
- [Boehringer Ingelheim România - Îmbunătățim cu entuziasm domeniul sănătății | Boehringer Ingelheim RO](/content/ro/index.html): Boehringer Ingelheim în România este una dintre cele mai importante companii farmaceutice din lume, axată pe cercetare, cu o experiență de 130 de ani. (145 words)
- [India | Boehringer Ingelheim IN](/content/in/about-us/india/index.html): In India, Boehringer Ingelheim is one the fastest growing multinational pharmaceutical companies. Find out more about our presence in India here. (160 words)
- [Historia | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/historia/index.html): Albert Boehringer (1861–1939) perusti lääkeyritys Boehringer Ingelheimin vuonna 1885 Nieder-Ingelheimissa, joka kuuluu nykyään Ingelheim am Rheiniin. (112 words)
- [Берингер Ингельхайм - Ценность через инновации | Boehringer Ingelheim RU](/content/ru/index.html): Посетите сайт международной фармацевтической компании Boehringer Ingelheim (61 words)
- [Biologics CDMO | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/index.html): Boehringer Ingelheim BioXcellence™ – your trusted biologics CDMO partner for biopharmaceutical contract manufacturing. Experience our world-class service. (1,439 words)
- [Aydınlatma metni | Boehringer Ingelheim TR](/content/tr/aydinlatma-metni/index.html): Aydınlatma metni (1,015 words)
- [Human Health Products | Boehringer Ingelheim IN](/content/in/human-health/products/index.html): Click here to view an overview of our human health products. We provide a wide range of products to help improve the lives of humans. Learn more. (43 words)
- [Ponte en contacto con nosotros | Boehringer Ingelheim ES](/content/es/empleo/contactanos/index.html): Ponte en contacto con Boehringer Ingelheim y obtendrás toda la información sobre el proceso de solicitud de empleo. Te atenderemos sin dilación. (127 words)
- [Search | Boehringer Ingelheim AT](/content/at/en/search/category-all/index.html) (194 words)
- [Animal Health | Boehringer Ingelheim](/content/animal-health/index.html): Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse. (298 words)
- [More Health per le persone e l’ambiente | Boehringer Ingelheim IT](/content/it/su-di-noi/sviluppo-sostenibile/more-health/index.html): More Health: For People & Animals (96 words)
- [Human Health | Boehringer Ingelheim](/content/human-health/index.html): Boehringer Ingelheim is a global, research-driven pharmaceutical company committed to discovering and developing innovative healthcare solutions that improve lives. (231 words)
- [Lung Diseases | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/index.html): Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer. (85 words)
- [Weiterbildung & Entwicklung | Boehringer Ingelheim DE](/content/de/karriere/ueber-uns/weiterbildung-entwicklung/index.html): Wir helfen Menschen, sich beruflich weiterzuentwickeln, indem wir unsere Fähigkeiten maximieren und ihnen Raum geben, sich innerhalb des Unternehmens zu entwickeln. (392 words)
- [Animal Health Products | Boehringer Ingelheim](/content/animal-health/products/index.html): Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products below. (121 words)
- [Biopharma szerződéses gyártás | Boehringer Ingelheim HU](/content/hu/egyuttmukodes/nemzetkozi-biogyogyszereszeti-gyartas/index.html): A biofarmáciai szerződéses gyártás globális vezetőjeként, több mint 35 éves biotechnológiai tapasztalattal és biofarmáciai gyártóüzemek globális hálózatával, eredményeink önmagukért beszélnek. Tudjon meg többet a velünk való partnerségről. (99 words)
- [Média | Boehringer Ingelheim HU](/content/hu/media/index.html): A Boehringer Ingelheim a világ egyik vezető kutatásorientált gyógyszeripari vállalata, amely 130 éves tapasztalattal rendelkezik. (144 words)
- [Rokotteet | Boehringer Ingelheim FI](/content/fi/tiede-ja-innovaatiot/elainterveyden-innovaatiot/rokotteet/index.html): Global Innovation -yksikössä kehitämme turvallisia ja tehokkaita rokotteita seura- ja kotieläimille. Yhdistämme laajan asiantuntemuksen rokoteknologian. (53 words)
- [Human Health Partnering | Boehringer Ingelheim AU](/content/au/partnering/human-health-partnering/index.html): Making new and better medicines for patients is at the heart of what we do. Click here to read about the role of partnering in helping us to do this. (77 words)
- [Ветеринарные препараты | Boehringer Ingelheim RU](/content/ru/animal-health/products/index.html): Ветеринарные препараты (117 words)
- [Accessibility Statement | Boehringer Ingelheim ZA](/content/za/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (468 words)
- [Value Through Innovation | Boehringer Ingelheim IE](/content/ie/index.html): Learn more about Boehringer Ingelheim and why it's one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (103 words)
- [Comunicados de Prensa | Boehringer Ingelheim SA](/content/sa/prensa/index.html): Encuentre los últimos comunicados de prensa de Boehringer Ingelheim sobre salud humana, salud animal, productos y noticias corporativas. (453 words)
- [Boehringer Ingelheim Schweiz - Werte schaffen durch Innovation | Boehringer Ingelheim CH](/content/ch/index.html): Boehringer Ingelheim zählt weltweit zu den 20 führenden Pharmaunternehmen mit über 130 Jahren Erfahrung. (221 words)
- [Απόρρητο δεδομένων | Boehringer Ingelheim GR](/content/gr/aporrito-dedomenon/index.html): Η παρούσα Πολιτική Προστασίας Προσωπικών Δεδομένων περιγράφει τον τρόπο με τον οποίο η Boehringer Ingelheim Ελλάς Α.Ε. (574 words)
- [Press Releases | Boehringer Ingelheim](/content/media-stories/press-releases/index.html): Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. (346 words)
- [Value Through Innovation | Boehringer Ingelheim UK](/content/uk/index.html): Learn more about Boehringer Ingelheim and why it's one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (188 words)
- [미디어 | Boehringer Ingelheim KR](/content/kr/midieo/index.html): 한국베링거인겔하임의 최신 미디어 자료를 확인하실 수 있습니다. (65 words)
- [Култура | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/culture/index.html): Целите и убежденията на Boehringer Ingelheim могат да бъдат обобщени в една фраза: Стойност чрез иновации - централната концепция на нашата корпоративна визия. (148 words)
- [Partnering | Boehringer Ingelheim UK](/content/uk/partnering/index.html): At Boehringer Ingelheim diversity of minds & collaboration with expert community partnerships is paramount to developing new medical breakthroughs. (205 words)
- [Human Health Products | Boehringer Ingelheim AU](/content/au/human-health/products/index.html): Product (99 words)
- [Boehringer Ingelheim - Life Forward | Boehringer Ingelheim IN](/content/in/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to learn more. (203 words)
- [Boehringer Ingelheim Austria - Value through Innovation | Boehringer Ingelheim AT](/content/at/en/index.html): Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience. (232 words)
- [Wer wir sind | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/index.html): Boehringer Ingelheim zählt weltweit zu den führenden Pharmaunternehmen mit Schwerpunkte Forschung, Entwicklung und Produktion. Erfahren Sie mehr über uns! (210 words)
- [Über uns | Boehringer Ingelheim DE](/content/de/ueber-uns/index.html): Erfahren Sie mehr über unsere Geschäftsergebnisse, Unternehmensleitung, Geschichte und Unternehmensvision sowie über unser Engagement für Wissenschaft . (288 words)
- [Boehringer Ingelheim - Life forward | Boehringer Ingelheim IT](/content/it/index.html): Boehringer Ingelheim - Valore attraverso l’innovazione (295 words)
- [Magas vérnyomás | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/magas-vernyomas/index.html): A hipertónia (magas vérnyomás) körülbelül egymilliárd embert érint világszerte. Ismerje meg a Boehringer Ingelheim munkáját! (72 words)
- [Sustainable Development | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/index.html): Learn about our 'Sustainable Development - For Generations' journey. One that started in 1885 and one that we hope, and believe, will never end. (128 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim FI](/content/fi/index.html): Kollegat kertovat henkilökohtaisia tarinoitaan ja siitä, mikä motivoi heitä työskentelemään tulevien sukupolvien paremman tulevaisuuden puolesta. (116 words)
- [Leaving site | Boehringer Ingelheim HU](/content/hu/disclaimer/external/index.html) (60 words)
- [MORE GREEN for our planet | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/more-green/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (88 words)
- [Descubra as nossas Carreiras | Boehringer Ingelheim BR](/content/br/carreiras/descubra-nossas-carreiras/index.html): Conheça as várias carreiras que oferecemos, concebidas para ajudá-lo a crescer profissionalmente, ao mesmo tempo que proporcionam um trabalho desafiante que contribui para o sucesso. (202 words)
- [Tarihçe | Boehringer Ingelheim TR](/content/tr/about-us/who-we-are/history/index.html): Albert Boehringer (1861-1939), Boehringer Ingelheim ilaç şirketini 1885 yılında günümüzde Ingelheim am Rhein'ın bir parçası olan Nieder-Ingelheim'da kurdu. 1885'te sadece 28 çalışanı olan şirket, bugün İnsan Sağlığı, Hayvan Sağlığı ve biyofarmasötikler o (130 words)
- [More Health For People & Animals | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/more-health/index.html): Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities (33 words)
- [Media Overview | Boehringer Ingelheim US](/content/us/media/index.html): Click here to view all of Boehringer Ingelheim's latest press releases, with stories and breaking news on everything in the biopharmaceuticals industry. (203 words)
- [Diabetes | Boehringer Ingelheim](/content/human-health/metabolic-diseases/diabetes/patient-documentary-diagnosis-everyday-living/index.html): Type 2 diabetes is a chronic, progressive condition and long-term complications include stroke, heart attack and cardiovascular death as well as kidney disease. (320 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim NO](/content/no/index.html): Noen av våre kolleger forteller sine personlige historier og hva som motiverer dem til å bidra til en bedre fremtid for kommende generasjoner. (199 words)
- [Animal Health partnering interests | Boehringer Ingelheim](/content/partnering/animal-health-partnering/partnering-interests/index.html): Explore Boehringer Ingelheim’s partnering interests in animal health, including infectious diseases, non-infectious diseases, and non-disease areas of focus. (716 words)
- [Υγεία των ανθρώπων | Boehringer Ingelheim GR](/content/gr/human-health/index.html): Η Boehringer Ingelheim είναι ένας όμιλος εταιρειών με κινητήρια δύναμη την έρευνα (177 words)
- [Contact | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/contact-bioxcellence/index.html): Connect with our team of industry experts to discuss how we can support your biopharmaceutical contract manufacturing needs. (571 words)
- [Desarrollo sostenible | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/index.html): En Boehringer Ingelheim, “Sustainable Development – For Generations” trata sobre un recorrido. Uno que comenzó en 1885 y uno que esperamos y creemos (168 words)
- [À propos de nous | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/index.html): À propos de nous (229 words)
- [Boehringer Ingelheim - Life Forward | Boehringer Ingelheim US](/content/us/index.html): Boehringer Ingelheim is one of the world’s leading familyowned pharmaceutical companies,developing medicines to address unmet needs in human and animal (279 words)
- [Mai verde: Pentru Planeta Noastră | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/mai-verde/index.html): La Boehringer Ingelheim, "Dezvoltare durabilă - pentru generații" este o călătorie. Una care a început în 1885 și pe care sperăm și credem că va continua. (124 words)
- [Accessibility Statement | Boehringer Ingelheim](/content/accessibility-statement/index.html): Boehringer Ingelheim prides itself on being accessible to our audience. Click her to see how we are making our website as user friendly as possible. (468 words)
- [Boehringer Ingelheim - Gyógyítás a szenvedélyünk | Boehringer Ingelheim HU](/content/hu/index.html): Üdvözöljük a Boehringer Ingelheim magyarországi honlapján! Fedezze fel a legújabb híreinket! (206 words)
- [Topluluklar ve Çalışanlarımız için Daha Fazla Potansiyel | Boehringer Ingelheim TR](/content/tr/about-us/sustainable-development/more-potential/index.html): Topluluklar ve çalışanlarımız için. Toplum olarak sağlıktan eğitime, iş imkanlarından yaşam koşullarına, eşitsizliklerden yoksulluğa kadar uzanan ve çoğu zaman en fazla dezavantajlı toplulukları etkileyen zorluklarla karşı karşıya kalmaya devam ediyoruz (322 words)
- [Wie wir Tierärzten helfen, Herzgeräusche bei Hunden früher zu erkennen | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/fruehzeitig-erkennung-herzgeraeusche-hund/index.html): Rund zehn Prozent aller Hunde leiden an Herzerkrankungen. Durch die frühzeitige Erkennung von Herzgeräuschen bei Hunden ermöglicht Boehringer Ingelheim Hundebesitzern, mehr Zeit mit ihrem Tier zu verbringen. (1,145 words)
- [Cultura de Asociación | Boehringer Ingelheim SA](/content/sa/asociaciones/asociaciones-en-salud-humana/cultura-de-asociacion/index.html): Cultura de asociación (56 words)
- [Despre noi | Boehringer Ingelheim RO](/content/ro/despre-noi/index.html): Boehringer Ingelheim este un grup global de companii al cărui scop este de a îmbunătăți viața oamenilor și a animalelor. Faceți clic aici pentru a afla mai multe despre noi. (197 words)
- [Mental Health | Boehringer Ingelheim](/content/human-health/mental-health/index.html): At Boehringer, we are committed to advancing mental health care through focused neuroscience research - always guided by the diverse needs of patients. (353 words)
- [Culture | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/culture/index.html): Our focus is on long-term performance rather than being limited by short-term profits. Click here to learn more about our vision and values. (127 words)
- [購買基本方針 | Boehringer Ingelheim JP](/content/jp/about-us/purchasing/index.html): サプライヤーは、私たちの成功に向けた取り組みに不可欠な存在です。私たちは、既存のサプライヤーベースの見直し、改善や最適化につがる革新的なソリューションや新たな機会を常に探 (58 words)
- [Imprint | Boehringer Ingelheim UK](/content/uk/imprint/index.html): Here you can access contact details and information about Boehringer Ingelheim Limited and Boehringer Ingelheim Animal Health UK Limited. Find out more. (50 words)
- [Mentions légales | Boehringer Ingelheim CH](/content/ch/fr/mentions-legales/index.html): Impressum (27 words)
- [Heart Diseases | Boehringer Ingelheim CA](/content/ca/human-health/heart-diseases/index.html): Cardiovascular disease, including heart disease and stroke, is a major global health concern. Click here to find out more about our work in this area. (80 words)
- [Our Stories | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/our-stories/index.html): Boehringer Ingelheim has many initiatives we would like to share. Find out more about us here by reading our news releases, news stories, and more. (123 words)
- [Náš program "Grass Roots" | Boehringer Ingelheim CZ](/content/cz/veda-inovace/inovace-v-oblasti-lidskeho-zdravi/podpora-inovaci-od-zakladu/index.html): Náš program "Grass Roots" (72 words)
- [Switching market | Boehringer Ingelheim TR](/content/tr/disclaimer/market/index.html) (92 words)
- [Saindo do site | Boehringer Ingelheim BR](/content/br/disclaimer/external/index.html) (69 words)
- [인체의약품 제품 | Boehringer Ingelheim KR](/content/kr/human-health/products/index.html): 인체 건강 제품 (109 words)
- [Retinopatias | Boehringer Ingelheim BR](/content/br/saude-humana/retinopatias/index.html): Retinopatias (161 words)
- [Προμηθευτές | Boehringer Ingelheim GR](/content/gr/about-us/purchasing/index.html): Οι προμηθευτές αποτελούν αναπόσπαστο μέρος της δέσμευσής μας για επιτυχία. (109 words)
- [Heart Failure | Boehringer Ingelheim HK](/content/hk/en/human-health/heart-diseases/heart-failure/index.html): Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction. (173 words)
- [Ψυχικές διαταραχές | Boehringer Ingelheim GR](/content/gr/human-health/mental-health/index.html): Στον τομέα ψυχικής υγείας της Boehringer Ingelheim, επαναπροσδιορίζουμε την ψυχική υγεία δίνοντας τη δυνατότητα στους ανθρώπους να ευημερούν. (103 words)
- [Pandemieprävention: Wie Impfstoffbanken die Tiergesundheit schützen | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/pandemiepraevention/index.html): Wie Antigen- und Impfstoffbanken die Pandemieprävention stärken: FMD-Impfstoffe in rund sieben Arbeitstagen verfügbar – zum Schutz von Tiergesundheit, landwirtschaftlichen Einkommen und globalem Handel. (1,054 words)
- [Animal Health Products | Boehringer Ingelheim CA](/content/ca/animal-health/products/index.html): Here you can find an overview of our animal health products. We provide a wide range of products to help improve the lives of animals. Find out more. (1,068 words)
- [Médicaments | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-animale/medicaments/index.html): Médicaments (78 words)
- [Our Stories | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/our-stories/index.html): At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe (38 words)
- [Prevention in Animal Health | Boehringer Ingelheim](/content/animal-health/our-expertise/prevention/index.html): Our industry-leading vaccines, parasiticides, and other solutions demonstrate Boehringer Ingelheim’s longtime commitment to prevention in animal health. (610 words)
- [Boehringer Ingelheim | Boehringer Ingelheim SA](/content/sa/index.html): Boehringer Ingelheim es una de las compañías farmacéuticas líderes comprometidas con la investigación con 130 años de experiencia. (448 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim DK](/content/dk/index.html): Nogle af vores kolleger fortæller deres personlige historier om, hvad der motiverer dem til at bidrage til en bedre fremtid for kommende generationer. (230 words)
- [Poultry | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/index.html): As trusted partners to poultry producers, Boehringer Ingelheim provides industry-leading vaccines and expertise to protect both flock health and businesses (486 words)
- [Imagine – Fortschritte | Boehringer Ingelheim | Boehringer Ingelheim](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/fortschritte/index.html): Die Übersicht über unsere Erfolgskennzahlen zeigt, welche Fortschritte Boehringer Ingelheim in den drei Nachhaltigkeitsbereichen erzielt. (406 words)
- [Boehringer Ingelheim Suisse - Créer de la valeur grâce à l'innovation | Boehringer Ingelheim CH](/content/ch/fr/index.html): Boehringer Ingelheim compte parmi les 20 premières entreprises pharmaceutiques mondiales avec plus de 130 ans d'expérience. (247 words)
- [Boehringer Ingelheim | Boehringer Ingelheim TR](/content/tr/index.html): Boehringer Ingelheim hakkında tüm bilgilere ulaşmak için ana sayfayı kullanın. (199 words)
- [Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim CA](/content/ca/index.html): Boehringer Ingelheim - Value Through Innovation (153 words)
- [Boehringer Ingelheim - pro lepší zdraví lidí a zvířat | Boehringer Ingelheim CZ](/content/cz/index.html): S optimismem hledíme do budoucnosti. Zjistěte více o naší nové vizuální podobě (271 words)
- [Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim HK](/content/hk/en/index.html): Learn more about Boehringer Ingelheim and why it's one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (81 words)
- [ホームページ | Boehringer Ingelheim JP](/content/jp/index.html): Learn more about Boehringer Ingelheim and why it's one of the world's leading research-driven pharmaceutical companies with 130 years of experience . (65 words)
- [Boehringer Ingelheim | Life Forward | Boehringer Ingelheim GR](/content/gr/index.html): Μερικοί από τους συναδέλφους μας διηγούνται τις προσωπικές τους ιστορίες και τι τους παρακινεί να (136 words)
- [Ochorenia srdca | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/index.html): Kardiovaskulárne ochorenia, vrátane srdcových chorôb a mŕtvice, sú hlavným globálnym zdravotným problémom a hlavnou príčinou úmrtí a invalidity na celom svete. (87 words)
- [Heart Failure | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/heart-failure/index.html): Find out more about heart failure and how it’s linked to other cardiovascular, renal and metabolic conditions (CRM) (394 words)
- [Ein Aufruf zur Bekämpfung nichtübertragbarer Krankheiten | Boehringer Ingelheim](/content/de/unternehmensbericht/2025/aufruf-intergrieter-versorgung-cardio-kidney-metabolic-syndrome.html): NCDs sind die Hauptursache für Todesfälle. Auf der 80. Sitzung der UN Generalversammlung setzen wir uns für eine integrierte Versorgung bei CRM-Erkrankungen ein. (807 words)
- [Lung Diseases | Boehringer Ingelheim](/content/human-health/lung-diseases/index.html): Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer. (314 words)
- [O nás | Boehringer Ingelheim SK](/content/sk/about-us/index.html): Boehringer Ingelheim je skupinou spoločností s celosvetovou pôsobnosťou, ktorá zahŕňa mnohé kultúry a rôznorodé komunity. (201 words)
- [More Health: Für Menschen & Tiere | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/index.html): Erfahren Sie mehr darüber, wie Boehringer Ingelheim tagtäglich für die Gesundheit von Menschen und Tieren arbeiten. (314 words)
- [Leaving site | Boehringer Ingelheim SK](/content/sk/disclaimer/bi/index.html) (53 words)
- [Boehringer Ingelheim & Cancer Care is Personal | Boehringer Ingelheim](/content/human-health/cancer/index.html): At Boehringer, our vision is to transform the lives of people with cancer by delivering breakthrough therapies, with the ultimate goal of curing a range of cancers. (452 words)
- [Jobs Suchen und Bewerben | Boehringer Ingelheim DE](/content/de/karriere/jobs-finden/category-it/index.html): Suchen Sie Jobs und bewerben Sie sich bei Boehringer Ingelheim. (209 words)
- [Kidney Health | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/index.html): Kidney diseases, including chronic kidney disease, are part of a group of connected conditions known as cardiovascular, renal and metabolic diseases. (403 words)
- [Clinical Studies | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-studies/index.html): Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored. (182 words)
- [Produkty veterinárnej medicíny | Boehringer Ingelheim SK](/content/sk/animal-health/products/index.html): Naše produkty pre zdravie zvierat sú poháňané inováciami s cieľom poskytovať pokročilé preventívne inteligentné riešenia. (46 words)
- [Ochorenia pľúc | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/index.html): Boehringer Ingelheim má 100-ročné dedičstvo v oblasti respiračných chorôb. Od roku 1921 sme lídrom v tejto oblasti, keď sme spustili niekoľko liečebných postupov v rade respiračných stavov vrátane astmy, (72 words)
- [The Research Process | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/research-process/index.html): A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents. To do this we employ a mix of sophisticated tools, technical capabilities and expertise – both at our Global Innovation (130 words)
- [Herzinsuffizienz | Herzschwäche | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/herzinsuffizienz/index.html): Herzinsuffizienz - Wissenswertes über die Anzeichen, Symptome, Typen und Behandlungsmöglichkeiten der Herzschwäche. Jetzt informieren! (277 words)
- [2025_Boehringer_SD4G_Master Presentation External_Update_18022025](/content/de/ueber-uns/nachhaltige-entwicklung/nachhaltigkeits-hub/files/common/2025_boehringer_nachhaltigkeitsziele-pdf.html) (113 words)
- [Boehringer Ingelheim - Hodnota prostredníctvom inovácie | Boehringer Ingelheim SK](/content/sk/index.html): Boehringer Ingelheim je jednou z popredných svetových farmaceutických spoločností riadených výskumom so 130-ročnými skúsenosťami. (95 words)
- [Leaving site | Boehringer Ingelheim DE](/content/de/disclaimer/external/index.html) (122 words)
- [Pressematerial | Boehringer Ingelheim DE](/content/de/presse/pressematerial/index.html): Umfangreiches Fotomaterial und weiteres Informationsmaterial steht in unserem Pressebereich zum Download bereit. (49 words)
- [Newsbits | Boehringer Ingelheim DE](/content/de/presse/newsbits/index.html): Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. (47 words)
- [Pressebereich | Boehringer Ingelheim DE](/content/de/presse/index.html): Pressebereich (167 words)
- [Lungenkrankheiten | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/index.html): Boehringer Ingelheim ist ein weltweit führendes Unternehmen im Bereich der Forschung und Entwicklung von Therapien gegen Lungenerkrankungen. (163 words)
- [Leaving site | Boehringer Ingelheim DE](/content/de/disclaimer/bi/index.html) (122 words)
- [Switching market | Boehringer Ingelheim DE](/content/de/disclaimer/market/index.html) (58 words)
- [Boehringer Ingelheim ondersteunt Purpose Dogs vzw, dat zich inzet voor assistentiehonden | Boehringer Ingelheim BE](/content/be/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/boehringer-ingelheim-ondersteunt-purpose-dogs-vzw-dat-zich-inzet-voor-assistentiehonden.html): Bij Boehringer Ingelheim geloven we dat gezondheid en welzijn verder reiken dan geneesmiddelen alleen. Daarom ondersteunen we initiatieven die een tastbare impact hebben op het leven van dieren én mensen. (490 words, Aug 3, 2026)
- [Zoonózy: Ochranou zdraví svého mazlíčka chráníte celou rodinu | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/zoonozy-ochranou-zdravi-sveho-mazlicka-chranite-celou-rodinu.html): Zoonózy: Ochranou zdraví svého mazlíčka chráníte celou rodinu (465 words, Jul 31, 2026)
- [Ruta 86 Etapa final | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-etapa-final/index.html): Ruta 86 Etapa final (64 words, Jul 28, 2026)
- [My Pet's Heart2Heart App | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/my-pets-heart2heart-app/index.html): On 7 May, utilising to show the canine cardiology app, Boehringer innovated, to track dogs heart health. (358 words, Jul 27, 2026)
- [My Pet's Heart2Heart App | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/my-pets-heart2heart-app/index.html): On 7 May, utilising to show the canine cardiology app, Boehringer innovated, to track dogs heart health. (359 words, Jul 27, 2026)
- [Eko Vet+™ | CANINEBEAT® AI | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/eko-vet-caninebeat-ai/index.html): On 5 May, post launch Eko Vet+™ | CANINEBEAT® AI in partnership with Eko Health , explaining the device and Boehringer's messaging around it (611 words, Jul 26, 2026)
- ["To join Boehringer Ingelheim was the best ever decision" | Boehringer Ingelheim US](/content/us/about-us/who-we-are/culture/join-boehringer-ingelheim-was-best-ever-decision/index.html): Pharmacologist Michael Mark worked for us for 34 years. He played a key role in the research and development of several medications. Watch our video and discover our job opportunities. (236 words, Jul 24, 2026)
- [Boehringer Ingelheim bei der Kinderuni Wien 2026 | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/boehringer-ingelheim-bei-der-kinderuni-wien-2026/index.html): Neugier trifft Wissenschaft: Bei der Kinderuni Wien begeisterte Boehringer Ingelheim junge Menschen für Forschung und Gesundheit. (610 words, Jul 24, 2026)
- [Boehringer Ingelheim at the Vienna Children’s University 2026 | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/boehringer-ingelheim-vienna-childrens-university-2026.html): On July 24th, more than 150 children discovered cancer research, patient safety and biomedical science with Boehringer Ingelheim in Vienna. (635 words, Jul 24, 2026)
- [Eko Vet+™ | CANINEBEAT® AI | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/eko-vet-caninebeat-ai/index.html): On 5 May, post launch Eko Vet+™ | CANINEBEAT® AI in partnership with Eko Health , explaining the device and Boehringer's messaging around it (607 words, Jul 23, 2026)
- [Anteprima del cortometraggio “Compagni per la vita”: cuore, reni e metabolismo tra musica, cinema e connessioni | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/anteprima-del-cortometraggio-compagni-la-vita-cuore-reni-e-metabolismo-tra-musica-cinema-e.html): Anteprima del cortometraggio “Compagni per la vita”: cuore, reni e metabolismo tra musica, cinema e connessioni (1,251 words, Jul 23, 2026)
- [ジャスケイド®錠（一般名：ネランドミラスト）が新たな経口の肺線維症治療薬として欧州連合での承認を取得 | Boehringer Ingelheim JP](/content/jp/press-26-0727/index.html): ベーリンガーインゲルハイムは7月17日、欧州委員会（EC）より、特発性肺線維症（IPF）および進行性肺線維症（PPF）の成人患者に向けた治療薬として、ジャスケイド®錠（一般名：ネランドミラスト）の製造販売承認を取得しました。 (41 words, Jul 23, 2026)
- [ベーリンガーインゲルハイム、日本の3法人共通で忌引き休暇の適用対象をペット（犬、猫）にも拡大 | Boehringer Ingelheim JP](/content/jp/press-26-0724/index.html): 日本ベーリンガーインゲルハイム株式会社（本社：東京都品川区、代表取締役会長 兼社長：マーク・ハッソン、以下、日本ベーリンガーインゲルハイム）は、日本におけるベーリンガーインゲルハイム3法人共通で2026年7月より、同居するペット（犬、猫）の忌引き休暇を導入いたしました。 (21 words, Jul 22, 2026)
- [Boehringer Ingelheim stärkt seine Adipositas-Pipeline | Boehringer Ingelheim DE](/content/de/humanmedizin/boehringer-ingelheim-staerkt-seine-adipositas-pipeline.html): Boehringer Ingelheim stärkt seine Adipositas-Pipeline (960 words, Jul 21, 2026)
- [ベーリンガーインゲルハイム、2026年上半期の業績を発表 ジャディアンス®および米国での新製品上市が成長を牽引 | Boehringer Ingelheim JP](/content/jp/press-26-0722/index.html): ベーリンガーインゲルハイムは、ジャディアンス®（一般名：エンパグリフロジン）に対する需要の拡大と、新製品の順調な上市を背景とした米国での力強い成長に牽引され、2026年上半期も継続的な売上成長を達成しました。グループ全体の売上高は158億ユーロ（前年同期比16.2％*増）となり、このうち医療用医薬品事業は131億ユーロ、アニマルヘルス事業は26億ユーロでした。 (42 words, Jul 21, 2026)
- [Agir un instant plus tôt : Les zoonoses et comment nous pouvons contribuer à leur prévention | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/developpement-durable/agir-un-instant-plus-tot-les-zoonoses-et-comment-nous-pouvons-contribuer-leur-prevention.html): À l’occasion de la Journée mondiale des zoonoses, découvrez comment elles se transmettent et pourquoi il est crucial d’agir plus tôt. (1,455 words, Jul 20, 2026)
- [Boehringer Ingelheim registra una crescita delle vendite nel primo semestre 2026, trainata da empagliflozin e dal lancio di nuovi prodotti negli Stati Uniti. | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/boehringer-ingelheim-registra-una-crescita-delle-vendite-nel-primo-semestre-2026-trainata-da.html): Boehringer Ingelheim ha registrato una crescita costante delle vendite nel primo semestre del 2026 (559 words, Jul 17, 2026)
- [La Comisión Europea aprueba JASCAYD® (nerandomilast), un nuevo tratamiento oral con un perfil de tolerabilidad favorable para la fibrosis pulmonar idiopática (FPI) y la fibrosis pulmonar progresiva (FPP) | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/la-comision-europea-aprueba-jascayd-nerandomilast-un-nuevo-tratamiento-oral.html): Como inhibidor oral preferente de la fosfodiesterasa 4B (PDE4B) es el primero en su clase y responde a una necesidad no cubierta crítica para los pacientes con FPI y FPP. (1,351 words, Jul 17, 2026)
- [Boehringer Ingelheim registra un crecimiento de ventas en el primer semestre de 2026, impulsado por JARDIANCE® y el lanzamiento de nuevos productos en EE.UU. | Boehringer Ingelheim ES](/content/es/sobre-nosotros/boehringer-ingelheim-registra-un-crecimiento-de-ventas-en-el-primer-semestre-de-2026.html): La sólida demanda en EE. UU. y el lanzamiento de nuevos productos impulsan las ventas del primer semestre en Salud Humana. (1,380 words, Jul 16, 2026)
- [European Commission approves JASCAYD novel treatment IPF PPF | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/european-commission-approves-jascayd-novel-treatment-ipf-ppf.html): European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU (990 words, Jul 16, 2026)
- [Innovation and Growth Drive First-Half 2026 Performance | Boehringer Ingelheim US](/content/us/media/press-releases/innovation-and-growth-drive-first-half-2026-performance.html): Strong first-half 2026 performance driven by U.S. demand, new medicine launches, and continued advancement of the company’s research pipeline. (1,110 words, Jul 15, 2026)
- [Parásitos resistentes: una amenaza creciente que pone en riesgo la productividad ganadera | Boehringer Ingelheim SA](/content/sa/prensa/parasitos-resistentes-una-amenaza-creciente-que-pone-en-riesgo-la-productividad-ganadera.html): Garrapatas, sarna bovina e infecciones causadas por larvas de moscas generan pérdidas sanitarias y económicas significativas en los sistemas de producción. (741 words, Jul 15, 2026)
- [FIBRONEER™ 臨床試驗新分析顯示 nerandomilast 可望為 IPF 與 PPF 帶來延長存活期的效益 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/fibroneer-linchuangshiyanxinfenxixianshi-nerandomilast-kewangwei-ipf-yu-ppf.html): FIBRONEER™ 臨床試驗新分析顯示 nerandomilast 可望為 IPF 與 PPF帶來延長存活期的效益 (179 words, Jul 15, 2026)
- [Más allá de la influenza aviar: La amenaza de las enfermedades respiratorias en aves | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/aves-de-corral/mas-alla-de-la-influenza-aviar-la-amenaza-de-las-enfermedades-respiratorias-en-aves.html): Aunque la influenza aviar suele acaparar los titulares en la industria avícola, en realidad es solo una de las muchas enfermedades respiratorias que pueden afectar la salud de las aves y reducir la rentabilidad de los productores (1,074 words, Jul 15, 2026)
- [Boehringer Ingelheim half-year results 2026 | Boehringer Ingelheim](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2026/index.html): Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S. (1,065 words, Jul 14, 2026)
- [Boehringer Ingelheim steigert Umsatz im ersten Halbjahr | Boehringer Ingelheim DE](/content/de/ueber-uns/boehringer-ingelheim-steigert-umsatz-im-ersten-halbjahr.html): Boehringer Ingelheim steigert Umsatz im ersten Halbjahr (1,073 words, Jul 14, 2026)
- [Cinco cosas que debes saber sobre el control de parásitos en rumiantes | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/rumiantes/cinco-cosas-que-debes-saber-sobre-el-control-de-parasitos-en-rumiantes.html): A medida que la sostenibilidad adquiere mayor importancia, el antiguo enfoque exclusivo basado en medicamentos para combatir los parásitos está quedando obsoleto (744 words, Jul 13, 2026)
- [Brasil refuerza la bioseguridad en las granjas lecheras | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/rumiantes/brasil-refuerza-la-bioseguridad-en-las-granjas-lecheras.html): ¿Sabías que Brasil tiene más ganado que habitantes? Nada menos que 238.6 millones de cabezas, y un hato de tal magnitud requiere planes de prevención sólidos (688 words, Jul 13, 2026)
- [¿Qué es la enfermedad de la lengua azul? | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/rumiantes/que-es-la-enfermedad-de-la-lengua-azul/index.html): El virus de la lengua azul (BTV) es una enfermedad transfronteriza en animales que afecta la salud de rumiantes domésticos y silvestres, y representa pérdidas económicas significativas en el comercio. (651 words, Jul 13, 2026)
- [Vacunas para cerdos que protegen a los animales y al planeta | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/porcinos/vacunas-para-cerdos-que-protegen-los-animales-y-al-planeta.html): Farmers care about their pig’s health and the environment; learn how vaccines can support them in protecting both. (625 words, Jul 13, 2026)
- [Conociendo al enemigo: PRRS y PCVD | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/porcinos/conociendo-al-enemigo-prrs-y-pcvd/index.html): La industria porcina vive en constante vigilancia frente a virus que pueden infectar sus piaras. Estos virus no solo dañan la salud de los cerdos, también provocan enormes pérdidas económicas. (570 words, Jul 13, 2026)
- [Anvisa aprova medicamento inovador da Boehringer Ingelheim para o tratamento de doenças fibrosantes do pulmão | Boehringer Ingelheim BR](/content/br/imprensa-historias/anvisa-aprova-medicamento-inovador-da-boehringer-ingelheim-para-o-tratamento-de-doencas-fibrosantes.html): JASCAYD® (nerandomilaste) representa uma nova opção para pacientes e médicos que aguardavam uma inovação terapêutica em FPI e mais de cinco anos em FPP (939 words, Jul 13, 2026)
- [Contato | Boehringer Ingelheim](/content/pro/br/contato/index.html): Se você tiver dúvidas, sugestões de conteúdo ou precisar de mais informações, não hesite em entrar em contato. Nossa equipe está pronta para responder rapidamente e garantir que sua experiência com o Referência Científica seja a melhor possível. (316 words, Jul 13, 2026)
- [Walking many paths, scaling many peaks | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/walking-many-paths-scaling-many-peaks/index.html): Walking many paths, scaling many peaks (631 words, Jul 12, 2026)
- [Boehringer startet drei neue Phase-III-Studien in D | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/boehringer-startet-drei-neue-phase-iii-studien-d/index.html): Präzisionsonkologie: Boehringer startet drei neue Phase-III-Studien in D (1,045 words, Jul 10, 2026)
- [Understanding brain metastasis risk in lung cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/lung-cancer/understanding-brain-metastasis-risk-lung-cancer/index.html): Explore how brain metastases affect people with NSCLC, key symptoms to recognize, and the importance of regular brain monitoring. (545 words, Jul 9, 2026)
- [boehringer-fund-backs-healthcare-innovators-africa-mexico | Boehringer Ingelheim](/content/about-us/sustainable-development/boehringer-fund-backs-healthcare-innovators-africa-mexico.html): Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico (872 words, Jul 9, 2026)
- [Een moment eerder: zoönotische ziekten en hoe we ze kunnen helpen voorkomen | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/een-moment-eerder-zoonotische-ziekten-en-hoe-we-ze-kunnen-helpen-voorkomen.html): Wat zijn zoönotische ziekten, hoe verspreiden ze zich van dieren naar mensen en wat kunnen mensen doen om ze te helpen voorkomen? (1,005 words, Jul 9, 2026)
- [Boehringer Ingelheim lanza la campaña “Un momento antes” para promover la prevención de las zoonosis con motivo del Día Mundial de la Zoonosis | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/boehringer-ingelheim-lanza-la-campana-un-momento-antes-para-promover-la-prevencion-de-las-zoonosis.html): La compañía refuerza su compromiso con la prevención como herramienta clave para proteger la salud animal y humana. (720 words, Jul 9, 2026)
- [KVV Interview - Florian Erny | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/kvv-interview-florian-erny/index.html): KVV Interview in FR mit Florian Erny (810 words, Jul 8, 2026)
- [Boehringer Ingelheim avanza en la investigación de la oncología de precisión con el inicio de tres ensayos de fase III en cánceres difíciles de tratar | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/boehringer-ingelheim-avanza-en-la-investigacion-de-la-oncologia-de-precision.html): La compañía mantiene su compromiso de mejorar los resultados de las personas que se enfrentan a cánceres agresivos para los que actualmente existen pocas opciones terapéuticas. (1,871 words, Jul 8, 2026)
- [Revmatoidní artritida nepostihuje jen klouby. Věnujte pozornost i svým plicím | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/revmatoidni-artritida-nepostihuje-jen-klouby-venujte-pozornost-i-svym-plicim.html): Revmatoidní artritida nepostihuje jen klouby. Věnujte pozornost i svým plicím (427 words, Jul 8, 2026)
- [„Chwila wcześniej”: choroby odzwierzęce i jak możemy im zapobiegać | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/chwila-wczesniej-choroby-odzwierzece-i-jak-mozemy-im-zapobiegac.html): „Chwila wcześniej”: choroby odzwierzęce i jak możemy im zapobiegać (909 words, Jul 6, 2026)
- [Führungswechsel am Boehringer Ingelheim Standort Dortmund | Boehringer Ingelheim DE](/content/de/ueber-uns/fuehrungswechsel-am-boehringer-ingelheim-standort-dortmund.html): Führungswechsel am Boehringer Ingelheim Standort Dortmund (304 words, Jul 6, 2026)
- [Interdisziplinärer Roundtable zur Verbesserung der Versorgungssituation | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/diabetes/interdisziplinaerer-roundtable-zur-verbesserung-der-versorgungssituation.html): Interdisziplinärer Roundtable zur Verbesserung der Versorgungssituation (884 words, Jul 6, 2026)
- [Clinical Trials Day -治験参加患者さんの声を聴く- | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0708/index.html): ベーリンガーインゲルハイムの開発部門では、株式会社QLifeとの共催で治験参加経験のある患者さんをお招きし、治験に参加したご体験やお気持ちを聴き、患者さんが参加しやすい治験の計画・遂行・結果共有などを検討する社内イベントを2026年6月5日に開催いたしました。 (35 words, Jul 6, 2026)
- [Een moment eerder: zoönotische ziekten en hoe we ze kunnen helpen voorkomen | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/een-moment-eerder-zoonotische-ziekten-en-hoe-we-ze-kunnen-helpen-voorkomen.html): Wat zijn zoönotische ziekten, hoe verspreiden ze zich van dieren naar mensen en wat kunnen mensen doen om ze te helpen voorkomen? (1,006 words, Jul 6, 2026)
- [Un momento antes: enfermedades zoonóticas y cómo podemos ayudar a prevenirlas | Boehringer Ingelheim MX](/content/mx/salud-animal/un-momento-antes-enfermedades-zoonoticas-y-como-podemos-ayudar-prevenirlas.html): Un momento antes: enfermedades zoonóticas y cómo podemos ayudar a prevenirlas (920 words, Jul 3, 2026)
- [Que sont les zoonoses | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/que-sont-les-zoonoses/index.html): Que sont les zoonoses et comment les prévenir, en agissant, « un instant plus tôt » (1,684 words, Jul 3, 2026)
- [World Zoonoses Day 2026 | Boehringer Ingelheim CH](/content/ch/ueber-uns/world-zoonoses-day-2026/index.html): World Zoonoses Day 2026 (1,353 words, Jul 3, 2026)
- [Giving Innovation a Second Chance | Boehringer Ingelheim](/content/partnering/collaborative-opportunities/giving-innovation-second-chance/index.html): Through open innovation, opnMe helps strengthen pharmaceutical research by accelerating drug discovery through scientific collaboration, academic-industry partnerships and access to shared compounds. (951 words, Jul 3, 2026)
- [Un momento antes: cómo podemos ayudar a prevenir las enfermedades zoonóticas | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/zoonosis-enfermedad-prevencion/index.html): En el Día Mundial de las Zoonosis, descubre por qué actuar un momento antes marca la diferencia: en el hogar, en las clínicas, en el campo y en los sistemas de salud a nivel nacional. (1,858 words, Jul 2, 2026)
- [Un momento antes: enfermedades zoonóticas y cómo podemos ayudar a prevenirlas | Boehringer Ingelheim MX](/content/mx/salud-animal/salud-publica-veterinaria/un-momento-antes-enfermedades-zoonoticas-y-como-podemos-ayudar-prevenirlas.html): Un momento antes: enfermedades zoonóticas y cómo podemos ayudar a prevenirlas (1,309 words, Jul 2, 2026)
- [Filariosi felina: al Congresso SoIPa 2026 i nuovi dati dello studio coordinato dall’Università di Sassari | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/filariosi-felina-al-congresso-soipa-2026-i-nuovi-dati-dello-studio-coordinato-dalluniversita-di.html): Sono stati presentati al XXXIV Congresso Nazionale della Società Italiana di Parassitologi, i risultati dello studio. (452 words, Jul 2, 2026)
- [Que sont les zoonoses et comment les prévenir, en agissant, « un instant plus tôt » | Boehringer Ingelheim FR](/content/fr/sante-animale/prevention-zoonoses/index.html): Que sont les zoonoses, comment se transmettent-elles de l’animal à l’humain, et que peut-on faire pour les prévenir ? (1,749 words, Jul 2, 2026)
- [Oncologia | Boehringer Ingelheim](/content/pro/br/area-terapeutica/oncologia/index.html): A oncologia é uma área complexa da medicina. Os avanços científicos ampliam o entendimento do câncer e impulsionam tratamentos cada vez mais inovadores. (348 words, Jul 2, 2026)
- [“自分で選ぶ”キャリアが、働き方をつくる Top Employerの背景にある一人ひとりの選択 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0015/index.html): ベーリンガーインゲルハイムは、日本法人として初めて「Top Employer 2026」に認定されました。今回高く評価されたのは、社員一人ひとりが自分らしく働き、学び、挑戦し続けられる「職場環境」と、それを支える「人財開発」が、現場で実際に活用され、個々人の成長につながっている点でした。 今回は、自身の価値観やライフイベントのなかで、上司とのコミュニケーションと制度を活用して自分らしいキャリアを築いている2名の社員をご紹介します。 (51 words, Jul 2, 2026)
- [KVV Interview - Florian Erny | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/kvv-interview-florian-erny/index.html): Interview Florian Erny KVV Reivision (627 words, Jul 1, 2026)
- [Un momento antes: qué son las zoonosis y cómo podemos prevenirlas | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/un-momento-antes-que-son-las-zoonosis-y-como-podemos-prevenirlas.html): ¿Qué son las zoonosis? ¿Cómo se transmiten? ¿Qué podemos hacer para ayudar a prevenirlas? (1,328 words, Jul 1, 2026)
- [【台灣新「視」代攝影徵件行動】用鏡頭留下超高齡台灣的真實日常 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxieshouhezuo/taiwanxinshi-daisheyingzhengjianxingdong-0/index.html): 【台灣新「視」代攝影徵件行動】用鏡頭留下超高齡台灣的真實日常 (42 words, Jul 1, 2026)
- [【台灣新「視」代攝影徵件行動】用鏡頭留下超高齡台灣的真實日常 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxieshouhezuo/taiwanxinshi-daisheyingzhengjianxingdong/index.html): 【台灣新「視」代攝影徵件行動】用鏡頭留下超高齡台灣的真實日常 (37 words, Jul 1, 2026)
- [Zoonotische Krankheiten und wie wir helfen können, sie zu verhindern | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/unsere-storys/zoonotische-krankheiten-verhindern/index.html): Wie sich zoonotische Krankheiten auf Menschen und Tiere auswirken und warum Prävention, Aufklärung & Zusammenarbeit wichtig für den Gesundheitsschutz sind. (1,451 words, Jun 30, 2026)
- [Understanding zoonotic diseases and why prevention matters | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-stories/zoonotic-disease-prevention/index.html): Learn how zoonotic diseases affect people and animals and why prevention, awareness and collaboration are key to protecting health. (1,368 words, Jun 30, 2026)
- [Nuevos resultados a partir de los ensayos FIBRONEER™ sugieren que nerandomilast* podría mejorar la supervivencia en pacientes con fibrosis pulmonar idiopática (FPI) y fibrosis pulmonar progresiva (FPP) | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/nuevos-resultados-partir-de-los-ensayos-fibroneer/index.html): Según el modelo de supervivencia realizado, la molécula aumentó de forma consistente la mediana de supervivencia tanto en la FPI como en la FPP. (1,370 words, Jun 30, 2026)
- [A moment earlier: Zoonotic diseases and how we can help prevent them | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/zoonotic-disease-prevention/index.html): Learn how zoonotic diseases affect people and animals and why prevention, awareness and collaboration are key to protecting health. (1,426 words, Jun 30, 2026)
- [Vielen Dank für Ihre Registrierung | Portal HCP | Boehringer Ingelheim](/content/pro/ch/request-access/confirmation/index.html): Vielen Dank für Ihre Registrierung (44 words, Jun 29, 2026)
- [Biomarker testing and precision medicine in lung cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/empowering-patients/biomarker-testing-and-precision-medicine-lung-cancer.html): Learn how biomarker testing can help guide treatment decisions for non-small cell lung cancer. (1,130 words, Jun 29, 2026)
- [Boehringer Ingelheim Missouri Western State University Bio-Process Certificate Program | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/boehringer-ingelheim-missouri-western-state-university-bio-process-certificate-program.html): Boehringer Ingelheim and Missouri Western State University (MoWest) have launched a new program to build the technical skills needed for careers in biomanufacturing. (594 words, Jun 26, 2026)
- [Rabies Vaccination in Kenya: Reduce the Risk Globally | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/rabies-vaccination-kenya-reduce-risk-globally/index.html): Learn how rabies vaccination programs in Kenya reduce the risk of disease, save lives, and drive global progress toward eliminating rabies. (1,475 words, Jun 26, 2026)
- [Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/emirates-drug-establishment-approves-new-lung-disease-treatment-boehringer-ingelheim.html): Making the UAE the first in the region to register innovative medication, Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim. (590 words, Jun 26, 2026)
- [Page d’accueil | Portal HCP | Boehringer Ingelheim](/content/pro/ch/fr/node/170/index.html): Le portail d’information et de services dédié aux produits et aux domaines thérapeutiques de Boehringer Ingelheim. De nombreux services pour vous, votre cabinet et vos patients. (69 words, Jun 26, 2026)
- [Somos la segunda farmacéutica más importante de México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/somos-la-segunda-farmaceutica-mas-importante-de-mexico.html): Somos la segunda farmacéutica más importante de México (229 words, Jun 25, 2026)
- [Human health therapeutic strategies and modalities toolbox | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/human-health-therapeutic-strategies-and-modalities-toolbox.html): Discover the modalities driving our human pharma portfolio—from small molecules to innovative gene therapy. (1,515 words, Jun 25, 2026)
- [Rethinking feline care: Carterton nurse recognised for clinical excellence | Boehringer Ingelheim AU](/content/au/rethinking-feline-care/index.html): Aoife Everton, a veterinary nurse at Horse & Cat Vet in Carterton, has been recognised with the 2026 Boehringer Ingelheim Clinical Excellence Award for her work improving the in-clinic experience and outcomes for feline patients. (613 words, Jun 24, 2026)
- [The hidden impact of veterinary care | Boehringer Ingelheim CA](/content/ca/hidden-impact-veterinary-care/index.html): The hidden impact of veterinary care: new insights from a global survey of veterinarians (1,501 words, Jun 22, 2026)
- [Le rôle méconnu des soins vétérinaires | Boehringer Ingelheim CA](/content/ca/fr/le-role-meconnu-des-soins-veterinaires/index.html): Le rôle méconnu des soins vétérinaires : les nouvelles révélations d’une enquête mondiale menée auprès de médecins vétérinaires (2,014 words, Jun 22, 2026)
- [Modellbasierte Analysen aus den FIBRONEER™ Studien deuten auf positive Entwicklung bei IPF und PPF hin | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/modellbasierte-analysen-aus-den-fibroneer-studien-deuten-auf-positive-entwicklung-bei-ipf-und-ppf.html): Modellbasierte Analysen aus den FIBRONEER™ Studien deuten auf positive Entwicklung bei IPF und PPF hin (1,151 words, Jun 22, 2026)
- [Nuevos datos/análisis de los estudios FIBRONEER™ sugieren beneficios en la sobrevida con nerandomilast | Boehringer Ingelheim SA](/content/sa/prensa/nuevos-datos-analisis-de-los-estudios-fibroneer-sugieren-beneficios-en-la-sobrevida-con.html): En pacientes con fibrosis pulmonar idiopática (FPI) y fibrosis pulmonar progresiva (FPP) (1,183 words, Jun 19, 2026)
- [Obesity potential first-in-class triple receptor agonist Phase 2 | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/obesity-potential-first-class-triple-receptor-agonist-phase-2.html): Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development (1,024 words, Jun 19, 2026)
- [Three Phase 3 trials in hard-to-treat cancers initiated | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/three-phase-3-trials-hard-treat-cancers-initiated/index.html): Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers (1,524 words, Jun 19, 2026)
- [HANDI’CHIENS lance « L’École de la 2nde Chance » pour former des chiens de soutien en France | Boehringer Ingelheim FR](/content/fr/sante-humaine/nos-engagements/handi-chiens-ecole-2nde-chance/index.html): HANDI’CHIENS lance un projet unique en France : une école de formation pour les chiens de soutien, destinés à accompagner les personnes en situation de fragilité ou atteintes de maladies chroniques. (855 words, Jun 19, 2026)
- [What happens when growth crosses borders | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/what-happens-when-growth-crosses-borders/index.html): At Boehringer Ingelheim, growth often begins with curiosity, the willingness to step into unfamiliar environments, embrace new perspectives, and learn from people whose experiences differ from our own. (733 words, Jun 19, 2026)
- [Nueva encuesta revela aspectos desconocidos de la atención veterinaria | Boehringer Ingelheim SA](/content/sa/prensa/nueva-encuesta-revela-aspectos-desconocidos-de-la-atencion-veterinaria.html): Boehringer Ingelheim publicó hoy nuevos resultados de una encuesta global a veterinarios que revelan los aspectos de la atención veterinaria. (1,707 words, Jun 18, 2026)
- [Apprendre et oser : le parcours de Lenaïg en alternance | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/alternance-lenaig/index.html): Arrivée en septembre 2025 sur le site de Toulouse, Lenaïg Elegoet évolue comme alternante Support Projet. Elle nous partage une expérience à la fois formatrice, responsabilisante et riche humainement. (390 words, Jun 17, 2026)
- [Rheumatologie | Portal HCP | Boehringer Ingelheim](/content/pro/ch/rheumatology/index.html): Rheumatologie (1,716 words, Jun 17, 2026)
- [Etický kódex | Boehringer Ingelheim SK](/content/sk/about-us/ethics-and-compliance/eticky-kodex/index.html): Náš Etický kódex stanovuje etické štandardy, ktorými sa riadia všetky naše obchodné aktivity. Týka sa každého z nás. Každý jednotlivec zohráva kľúčovú úlohu pri dodržiavaní Etického kódexu v praxi. (270 words, Jun 16, 2026)
- [Diagnosis and Management | Portal HCP | Boehringer Ingelheim](/content/pro/ch/diagnosis-and-management-challenges/index.html): Diagnosis and
Management Challenges (775 words, Jun 16, 2026)
- [Кодекс поведінки | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/kodeks-povedinki/index.html): Наш Кодекс поведінки встановлює етичні стандарти, які спрямовують усю нашу бізнес-діяльність. Він стосується кожного з нас. Кожен співробітник відіграє важливу роль у впровадженні Кодексу поведінки в життя. (297 words, Jun 16, 2026)
- [Konsequenzen | Portal HCP | Boehringer Ingelheim](/content/pro/ch/consequences/index.html): Konsequenzen (292 words, Jun 16, 2026)
- [Boehringer advances three phase III trials in oncology | Boehringer Ingelheim US](/content/us/human-health/cancer/across-cancer-types/boehringer-advances-three-phase-iii-trials-oncology.html): Boehringer announces initiation of three Phase III trials in hard-to-treat cancers, advancing biomarker-driven approaches and precision oncology treatments (1,245 words, Jun 15, 2026)
- [Über IPF und PPF | Portal HCP | Boehringer Ingelheim](/content/pro/ch/about-ipf-and-ppf/index.html): Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) are chronic, progressive interstitial lung diseases characterized by irreversible scarring of lung tissue.2-5 (541 words, Jun 15, 2026)
- [FIBRONEER™ trials survival benefit nerandomilast IPF and PPF | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/fibroneer-trials-survival-benefit-nerandomilast-ipf-and-ppf.html): New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF (1,065 words, Jun 15, 2026)
- [Landing Page | Portal HCP | Boehringer Ingelheim](/content/pro/ch/advancing-pf/index.html): Bridging gaps in pulmonary fibrosis (91 words, Jun 15, 2026)
- [El agonista dual de glucagón/GLP1 de Boehringer muestra una reducción del 34% de la grasa visceral y del 63 % de la grasa hepática, minimizando la pérdida de masa magra en un ensayo clínico de fase III, respaldando una mejor salud metabólica en personas c | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/obesidad/el-agonista-dual-de-glucagon-glp1-de-boehringer-muestra-una-reduccion-del-34-de-la-grasa-visceral.html): Los resultados demuestran el potencial de este nuevo agonista dual para favorecer la pérdida de peso y, con ello, mejorar la salud metabólica. (2,625 words, Jun 15, 2026)
- [Progression | Portal HCP | Boehringer Ingelheim](/content/pro/ch/progression/index.html): Progression (405 words, Jun 15, 2026)
- [report zur ctd ild leitlinie herunterladen](/content/pro/ch/bipdf/report-zur-ctd-ild-leitlinie-herunterladen/index.html): report zur ctd ild leitlinie herunterladen (63 words, Jun 15, 2026)
- [Ressourcen | Portal HCP | Boehringer Ingelheim](/content/pro/ch/downloadable-resources/index.html): Downloadable resources (81 words, Jun 15, 2026)
- [百靈佳殷格翰創新glucagon/GLP-1 雙重受體促效劑 survodutide 於第三期試驗達成 16.6% 顯著減重，展現改善肥胖症或過重成人代謝健康的臨床潛力 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/bailingjiayingehanchuangxinglucagon-glp-1-shuangzhongshouticuxiaoji-survodutide.html): 百靈佳殷格翰創新glucagon/GLP-1 雙重受體促效劑 survodutide 於第三期試驗達成 16.6% 顯著減重，展現改善肥胖症或過重成人代謝健康的臨床潛力 (714 words, Jun 15, 2026)
- [L'Association du diabète lance un kit d'auto-soin primé pour prévenir les complications du pied diabétique | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/lassociation-du-diabete-lance-un-kit-dauto-soin-prime-pour-prevenir-les-complications-du-pied.html): Une personne diabétique sur quatre développera des complications au niveau des pieds au cours de sa vie. (1,053 words, Jun 11, 2026)
- [Association du Diabète wordt bekroond met een zelfzorgpakket om voetproblemen te voorkomen | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/association-du-diabete-wordt-bekroond-met-een-zelfzorgpakket-om-voetproblemen-te-voorkomen.html): Een op de vier diabetespatiënten krijgt in de loop van zijn of haar leven te maken met voetcomplicaties . (928 words, Jun 11, 2026)
- [El agonista dual de glucagón/GLP1 de Boehringer Ingelheim muestra una reducción del 34% de la grasa visceral y del 63 % de la grasa hepática, minimizando la pérdida de masa magra en un ensayo clínico de fase III | Boehringer Ingelheim SA](/content/sa/prensa/el-agonista-dual-de-glucagon-glp1-de-boehringer-ingelheim-muestra-una-reduccion-del-34-de-la-grasa-0.html): respaldando una mejor salud metabólica en personas con obesidad (2,109 words, Jun 10, 2026)
- [What is New World screwworm US Outbreak | Boehringer Ingelheim US](/content/us/animal-health/trends-insights/what-new-world-screwworm-us-outbreak/index.html): New World screwworm has been detected in the U.S. Learn what it is, how it spreads, symptoms to watch for, and what veterinarians and animal owners should do. (963 words, Jun 10, 2026)
- [A collective path to healthier futures | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/collective-path-healthier-futures/index.html): Boehringer Ingelheim’s Christie Bloomquist on the value of prioritizing early detection and disease management (1,547 words, Jun 10, 2026)
- [Ce que les vétérinaires voient et que vous ne voyez pas | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-engagements/ce-que-les-veterinaires-voient-et-que-vous-ne-voyez-pas.html): Cette enquête dresse un constat clair : les aspects les plus essentiels des soins vétérinaires restent souvent les moins visibles. (914 words, Jun 9, 2026)
- [L’impact caché des soins vétérinaires : nouvelles perspectives issues d’une enquête mondiale menée auprès de vétérinaires | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-engagements/impact-cache-soins-veterinaires/index.html): L’impact caché des soins vétérinaires : nouvelles perspectives issues d’une enquête mondiale menée auprès de vétérinaires (1,693 words, Jun 9, 2026)
- [Rheumatoide Arthritis | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/lungenfibrose/rheumatoide-arthritis/index.html): Bei rheumatoider Arthritis denken wir zuerst an Schmerzen, Schwellungen oder Einschränkungen in den Gelenken. Doch Rheuma kann auch die Lunge betreffen. (444 words, Jun 9, 2026)
- [Planning certainty is the foundation for innovation | Boehringer Ingelheim](/content/about-us/who-we-are/planning-certainty-foundation-innovation/index.html): Why planning certainty is crucial for investment, innovation and supply - and what the consequences of uncertain framework conditions are. (733 words, Jun 9, 2026)
- [ILD-Zentren in Österreich | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/lungenfibrose/ild-zentren-oesterreich/index.html): Um Betroffenen die bestmögliche Versorgung zu bieten, gibt es in Österreich spezialisierte Lungenzentren für interstitielle Lungenerkrankungen (ILD). (432 words, Jun 9, 2026)
- [Israel | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/israel/index.html): Boehringer Ingelheim RCV in Israel (35 words, Jun 9, 2026)
- [Press release | Boehringer Ingelheim CA](/content/ca/press-release-0/index.html): Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction (1,749 words, Jun 8, 2026)
- [Communiqué de presse | Boehringer Ingelheim CA](/content/ca/fr/communique-de-presse-0/index.html): L’essai Phase 3 sur le survodutide de Boehringer Ingelheim a montré une réduction ciblée de 34 % de la graisse viscérale et de 63 % de la graisse hépatique (2,923 words, Jun 8, 2026)
- [Estudo de Fase III de Survodutida para perda de peso | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-metabolicas/estudo-de-fase-iii-de-survodutida-para-perda-de-peso.html): Boehringer Ingelheim avança com a Survodutida para três estudos globais de Fase III em obesidade (2,677 words, Jun 8, 2026)
- [Innovation und Wertschöpfung beginnt mit Planungssicherheit | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/innovation-und-wertschoepfung-beginnt-mit-planungssicherheit.html): Warum Planungssicherheit für Investitionen, Innovation und Versorgung entscheidend ist – und welche Folgen unsichere Rahmenbedingungen haben. (746 words, Jun 7, 2026)
- [Integrated metabolic health and obesity as a policy priority | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/obesity/integrated-metabolic-health-and-obesity-policy-priority.html): Explore why integrated metabolic health must become a policy priority and how connecting obesity, liver disease and metabolism can improve outcomes. (1,067 words, Jun 5, 2026)
- [Partnering with Human Pharma at BIO International 2026 | Boehringer Ingelheim US](/content/us/partnering/human-health-partnering/how-connect/partnering-human-pharma-bio-international-2026/index.html): Meet our human pharma partnering team, learn about our partnering interests and how we can advance innovation together at BIO International 2026 (599 words, Jun 5, 2026)
- [Boehringer Ingelheim Parasitologie Award naar malariaonderzoek | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/boehringer-ingelheim-parasitologie-award-naar-malariaonderzoek.html): Dr. Rajagopal Murugan heeft de Boehringer Ingelheim Parasitologie Award 2026 gewonnen. (432 words, Jun 5, 2026)
- [Praktický rádce pro majitele psů: příprava na veterinární prohlídku | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/prakticky-radce-pro-majitele-psu-priprava-na-veterinarni-prohlidku.html): Praktický rádce pro majitele psů: příprava na veterinární prohlídku (241 words, Jun 4, 2026)
- [Positive data from two Phase III SYNCHRONIZE obesity trials | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/positive-data-two-phase-iii-synchronize-obesity-trials.html): Detailed findings from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD trials presented at the American Diabetes Association Scientific Sessions (2,329 words, Jun 3, 2026)
- [Boehringer Ingelheim impulsa, junto a 70 expertos, el primer consenso Delphi que redefine el abordaje del síndrome cardiovascular-renal-metabólico (CRM) en España | Boehringer Ingelheim ES](/content/es/salud-humana/boehringer-ingelheim-impulsa-junto-70-expertos-el-primer-consenso-delphi-que-redefine-el-abordaje.html): El síndrome CRM engloba enfermedades cardiovasculares, renales y metabólicas, que progresan y se amplifican entre sí. Afecta actualmente a un alto porcentaje de la población y representa una de las principales causas de mortalidad en el mundo. (979 words, Jun 3, 2026)
- [Was Tierärzt*innen sehen, was Sie nicht sehen – und warum es für uns alle wichtig ist | Boehringer Ingelheim AT](/content/at/de/ueber-uns/was-tieraerztinnen-sehen-was-sie-nicht-sehen-und-warum-es-fuer-uns-alle-wichtig-ist.html): Eine weltweite Umfrage zeigt, dass die wichtigste Arbeit von Tierärzt*innen oft im Verborgenen bleibt. (754 words, Jun 3, 2026)
- [Boehringer Ingelheim presenta en ASCO 2026 nuevos datos de moléculas en investigación en distintos tipos de cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/boehringer-ingelheim-presenta-en-asco-2026-nuevos-datos-de-moleculas-en-investigacion.html): Esta molécula, tanto en monoterapia como en combinación, muestra señales tempranas prometedoras en tumores sólidos con alteraciones en HER2, como los cánceres de mama, colorrectal y de esófago. (2,155 words, Jun 3, 2026)
- [survodutide-phase-3-fat-loss-obesity-dual-agonist-data | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/survodutide-phase-3-fat-loss-obesity-dual-agonist-data.html): Boehringer’s Phase III survodutide trial showed 34% visceral and 63% liver fat reduction with limited lean mass loss, improved metabolic health in obesity (2,305 words, Jun 2, 2026)
- [Atferdskodeks | Boehringer Ingelheim NO](/content/no/om-oss/etikk-og-etterlevelse/atferdskodeks/index.html): Vår atferdskodeks fastsetter de etiske standardene for all vår virksomhet. Den gjelder for oss alle. Hver enkelt medarbeider spiller en viktig rolle i å bringe adferdskodeksen til live. (307 words, May 29, 2026)
- [Code of Conduct | Boehringer Ingelheim DK](/content/dk/om-os/etik-og-compliance/code-conduct/index.html): Vores Code of Conduct fastlægger de etiske standarder, som ligger til grund for alle vores forretningsaktiviteter. Den gælder os alle sammen. Hver enkelt medarbejder spiller en afgørende rolle i at omsætte Code of Conduct til praksis. (322 words, May 29, 2026)
- [Leishmaniosis: prevenir para proteger la salud animal y la salud pública | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/leishmaniosis-prevenir-para-proteger-la-salud-animal-y-la-salud-publica.html): Cada 1 de junio se celebra el Día Mundial de la Leishmaniosis, una fecha clave para concienciar sobre los riesgos de una enfermedad zoonósica que afecta tanto a los animales como a las personas. (470 words, May 29, 2026)
- [Boehringer Ingelheim reúne a expertos e instituciones para impulsar el enfoque One Health como eje estratégico para prevenir futuras crisis sanitarias | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-reune-expertos-e-instituciones-para-impulsar-el-enfoque-one-health.html): La jornada ha puesto el foco en la necesidad de evolucionar desde modelos reactivos hacia estrategias basadas en la prevención, incorporando de forma transversal la salud animal, humana y medioambiental en la toma de decisiones. (1,001 words, May 28, 2026)
- [The New England Journal of Medicine publica los resultados del estudio Beamion LUNG-1 en pacientes con cáncer de pulmón de célula no pequeña avanzado con mutación de HER2 | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/new-england-journal-medicine-publica-los-resultados-del-estudio-beamion-lung-1.html): Este tratamiento oral dirigido se perfila como una alternativa eficaz a la quimioterapia en esta enfermedad de curso agresivo. (1,277 words, May 28, 2026)
- [What vets see that you don't ‒ and why it matters for us all | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/what-vets-see-you-dont-and-why-it-matters-us-all/index.html): Global survey shows vets’ most critical work, like spotting hidden disease, preventing risk, and protecting food and public health, often goes unseen. (1,452 words, May 27, 2026)
- [Abierta la convocatoria de los European PRRS Research Awards 2026 de Boehringer Ingelheim | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/porcino/abierta-la-convocatoria-de-los-european-prrs-research-awards-2026-de-boehringer-ingelheim.html): La compañía financiará tres proyectos de investigación sobre PRRS con 25.000 € cada uno. (478 words, May 27, 2026)
- [Boehringer Ingelheim presenta Lenzelta®: una nueva vacuna que impulsa la prevención de la mastitis | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/boehringer-ingelheim-presenta-lenzelta-una-nueva-vacuna-que-impulsa-la-prevencion-de-la-mastitis.html): Lenzelta® reduce significativamente la incidencia y la gravedad de las mastitis clínicas en vacas y novillas vacunadas. (671 words, May 27, 2026)
- [Swiss Biotech Day 2026 | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/swiss-biotech-day-2026/index.html): Swiss Biotech Day 2026: l’écosystème scientifique suisse, moteur de la promotion de l’innovation (689 words, May 27, 2026)
- [Zoonotische Krankheiten Dinge, die Sie wissen sollten | Boehringer Ingelheim AT](/content/at/de/ueber-uns/zoonotische-krankheiten-dinge-die-sie-wissen-sollten.html): Krankheiten, die zwischen Tieren und Menschen übertragen werden können, kommen häufiger vor, als man denkt. Erfahren Sie, wie sich das auf Sie auswirkt. (522 words, May 26, 2026)
- [L'impatto nascosto delle cure veterinarie: nuovi dati da un'indagine globale tra i medici veterinari | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/limpatto-nascosto-delle-cure-veterinarie-nuovi-dati-da-unindagine-globale-tra-i-medici-veterinari.html): I proprietari di animali potrebbero pensare di sapere cosa accade durante una visita veterinaria, ma una nuova indagine globale condotta su oltre 1.000 veterinari in 51 paesi dimostra che c’è molto più di ciò che si pensa. (1,531 words, May 26, 2026)
- [Nerandomilast uzyskał pozytywną opinię Komitetu CHMP Europejskiej Agencji Leków | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/wloknienie-pluc/nerandomilast-uzyskal-pozytywna-opinie-komitetu-chmp-europejskiej-agencji-lekow.html): CHMP wydaje pozytywną opinię dla preparatu nerandomilast. To krok w stronę udostępnienia nowej metody leczenia IPF oraz PPF pacjentom w UE. (1,037 words, May 26, 2026)
- [Zoonotic diseases things you should know | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-stories/zoonotic-diseases-things-you-should-know/index.html): Diseases that can be transmitted between animals and humans are more common than you may think – and they are on the rise. Find out how this affects you. (551 words, May 26, 2026)
- [Lebergesundheit ist messbar | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/lebergesundheit-ist-messbar/index.html): Lebergesundheit ist messbar – ein einfacher Test schafft Klarheit (689 words, May 26, 2026)
- [Lo que pueden ver los veterinarios y nosotros no (y por qué nos importa a todos) | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/lo-que-pueden-ver-los-veterinarios-y-nosotros-no-y-por-que-nos-importa-todos.html): Lo que pueden ver los veterinarios y nosotros no (y por qué nos importa a todos) (825 words, May 23, 2026)
- [China approves HERNEXEOS initial treatment lung cancer | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/china-approves-hernexeos-initial-treatment-lung-cancer.html): China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis (1,267 words, May 21, 2026)
- [CHMP issues positive opinion for JASCAYD IPF and PPF in EU | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/chmp-issues-positive-opinion-jascayd-ipf-and-ppf-eu.html): CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU (1,023 words, May 21, 2026)
- [Entwicklung des Logos | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/geschichte/entwicklung-des-logos/index.html): Das Firmenlogo von Boehringer Ingelheim hat sich seit Bestehen des Unternehmens stetig weiterentwickelt. (245 words, May 21, 2026)
- [La sanidad española encara su futuro: expertos apuntan a la prevención, la digitalización y la equidad como claves ante el reto de la longevidad y la cronicidad | Boehringer Ingelheim ES](/content/es/la-sanidad-espanola-encara-su-futuro/index.html): La iniciativa ‘Ruta 86’ de Boehringer Ingelheim cierra en el Ateneo de Madrid un año de encuentros de diálogo por España, conectando el legado de la Ley de 1986 con los desafíos sociales, éticos y tecnológicos de la sanidad del futuro. (1,333 words, May 21, 2026)
- [行動指針 | Boehringer Ingelheim JP](/content/jp/about-us/ethics-and-compliance/code-conduct/index.html): 「私たちの行動指針」は、すべての事業活動における倫理基準を明確に示すものです。その実践は、私たち全員の責任であり、行動指針を現実のものとするために、一人ひとりが重要な役割を果たしています。 (34 words, May 20, 2026)
- [Por que desenvolver um medicamento leva mais de 10 anos | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/por-que-desenvolver-um-medicamento-leva-mais-de-10-anos.html): Entenda por que o desenvolvimento de medicamentos leva anos, com etapas de pesquisa científica, estudos clínicos e avaliação de segurança. (545 words, May 20, 2026)
- [Až 90 % funkce ledvin může odejít bez povšimnutí.⁸ Většina lidí to však neví, ukázal průzkum. | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/az-90-funkce-ledvin-muze-odejit-bez-povsimnuti8-vetsina-lidi-vsak-nevi-ukazal-pruzkum.html): Až 90 % funkce ledvin může odejít bez povšimnutí.⁸ Většina lidí to však neví, ukázal průzkum (914 words, May 20, 2026)
- [When listening is more than a word | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/when-listening-more-word/index.html): Siba Prasad Rao on the Boehringer Ingelheim India culture that turned a job into a calling, and a Business Development Manager into a leader of three states. (799 words, May 19, 2026)
- [Grande partecipazione per “Le Oasi della Salute” 2026: la prevenzione cardiovascolare in 15 città del Piemonte | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/grande-partecipazione-le-oasi-della-salute-2026-la-prevenzione-cardiovascolare-15-citta-del-piemonte.html): Screening gratuiti e attività di sensibilizzazione hanno coinvolto cittadini di tutte le età, confermando il ruolo chiave della prevenzione per la salute pubblica e la sostenibilità del sistema sanitario (597 words, May 19, 2026)
- [Stage Free: A Podcast for the Cancer Community | Boehringer Ingelheim US](/content/us/human-health/cancer/stage-free-podcast-cancer-community/index.html): Stage Free, a podcast series hosted by survivor and advocate Loriana Hernández-Aldama, explores the cancer journey through meaningful conversations. (334 words, May 19, 2026)
- [Oncology portfolio across multiple cancers ASCO 2026 | Boehringer Ingelheim](/content/human-health/cancer/oncology-portfolio-across-multiple-cancers-asco-2026.html): Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 (1,977 words, May 19, 2026)
- [Vaccinez votre chien | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/vaccinez-votre-chien/index.html): Pour son bien-être et sa santé, adoptez la PPP attitude pour votre chien : Personnaliser - Prévenir - Protéger. (620 words, May 18, 2026)
- [Dites non aux sales bêtes avant qu’elles ne s’installent ! | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/dites-non-aux-sales-betes-avant-quelles-ne-sinstallent.html): De nombreuses espèces de parasites peuvent être nocives pour votre chien ou votre chat. Adoptez une prévention adaptée pour éviter les infestations. (1,028 words, May 18, 2026)
- [Vaccinez votre chat, pour le protéger des virus et bactéries | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/vaccinez-votre-chat-pour-le-proteger-des-virus-et-bacteries.html): Pour son bien-être et sa santé, adoptez la PPP attitude pour votre chat : Personnaliser - Prévenir - Protéger. (548 words, May 18, 2026)
- [Adoptez la PPP attitude | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/adoptez-la-ppp-attitude/index.html): Pour éviter d’exposer votre chien ou votre chat à des problèmes de santé, dites non aux sales bêtes avant qu’elles ne s’installent. (307 words, May 18, 2026)
- [Obesity: breaking stigma and driving change | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/obesity/breaking-obesity-stigma-beyond-weight/index.html): Learn how obesity stigma affects people’s health and why obesity is more than weight. Real patient voices on metabolic health and long term care. (661 words, May 18, 2026)
- [Code de Conduite | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/code-de-conduite/index.html): Notre Code de Conduite définit les normes éthiques qui guident l’ensemble de nos activités commerciales. Il nous concerne tous. Chaque personne joue un rôle essentiel dans la mise en application du Code de Conduite. (344 words, May 15, 2026)
- [Código de Conduta | Boehringer Ingelheim PT](/content/pt/sobre-nos/etica-e-compliance/codigo-de-conduta/index.html): O nosso Código de Conduta define os padrões éticos que orientam a empresa. Cada pessoa tem um papel essencial em pô-lo em prática. (308 words, May 15, 2026)
- [Code of Conduct | Boehringer Ingelheim FI](/content/fi/tietoa-meista/vastuullisuus-ja-compliance/code-conduct/index.html): Code of Conduct -toimintaperiaatteemme ohjaavat ja varmistavat liiketoimintamme eettisyyden. Ne koskevat meitä kaikkia, ja ovat kaikille yhtä tärkeitä. (211 words, May 15, 2026)
- [Codice di Condotta | Boehringer Ingelheim IT](/content/it/su-di-noi/ethics-compliance/codice-di-condotta/index.html): Il nostro Codice di Condotta stabilisce gli standard etici che guidano tutte le nostre attività aziendali. Riguarda tutti noi. Ogni individuo svolge un ruolo fondamentale nel dare vita al Codice di Condotta. (305 words, May 15, 2026)
- [Ruta 86 Galicia | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-galicia/index.html): Ruta 86 Galicia (816 words, May 12, 2026)
- [Boehringer licenses Immunitas‘ novel antibody program | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/boehringer-licenses-immunitas-novel-antibody-program.html): Boehringer and Immunitas Therapeutics partner on a preclinical antibody program aimed at delivering more durable inflammatory disease control. (653 words, May 12, 2026)
- [Entendiendo la diabetes felina: desde la concientización a la acción | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/entendiendo-la-diabetes-felina-desde-la-concientizacion-la-accion.html): Entendiendo la diabetes felina: desde la concientización a la acción (1,038 words, May 11, 2026)
- [Ciencia compartida para el mejor manejo de la diabetes en gatos | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/ciencia-compartida-para-el-mejor-manejo-de-la-diabetes-en-gatos.html): Ciencia compartida para el mejor manejo de la diabetes en gatos (1,182 words, May 10, 2026)
- [Cómo mantener a tu gato saludable en cada etapa de su vida. | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/como-mantener-tu-gato-saludable-en-cada-etapa-de-su-vida.html): Cómo mantener a tu gato saludable en cada etapa de su vida. (690 words, May 9, 2026)
- [Prevención: Por qué debes llevar a tu gato al veterinario. | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/prevencion-por-que-debes-llevar-tu-gato-al-veterinario.html): Prevención: Por qué debes llevar a tu gato al veterinario. (629 words, May 9, 2026)
- [PPDI equino: común, grave y tratable | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/ppdi-equino-comun-grave-y-tratable/index.html): PPDI equino: común, grave y tratable (1,151 words, May 9, 2026)
- [FIBRONEER‑ILD e FIBRONEER‑IPF | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/dpi/primeira-meta-analise-sobre-nerandomilaste-nos-estudos-fibroneer-ild-e-fibroneer-ipf.html): A publicação no American Journal of Therapeutics traz a 1ª meta-análise sobre nerandomilaste em FPI e FPP, baseada nos estudos fase III FIBRONEER-IPF e FIBRONEER-ILD. (252 words, May 7, 2026)
- [Diretrizes da ERS e da EULAR | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/dpi/diretrizes-de-pratica-clinica-da-ers-e-da-eular-para-doenca-pulmonar-intersticial-associada-a-doencas-do-tecido-conjuntivo-em-2025.html): Diretrizes de prática clínica da ERS e da EULAR para doença pulmonar intersticial associada a doenças do tecido conjuntivo em 2025. (1,129 words, May 7, 2026)
- [Novas recomendações ERS/ATS 2025 | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/dpi/desenho-do-estudo-fibroneer-on-estudo-de-extensao-open-label-de-nerandomilaste.html): Novas recomendações ERS/ATS 2025: principais mudanças para a prática clínica entre pneumologistas, reumatologistas, patologistas e radiologistas. (590 words, May 7, 2026)
- [Escore de risco poligênico | Boehringer Ingelheim](/content/pro/br/newscenter/escore-risco-poligenico-na-pratica-clinica/index.html): Como interpretar o escore de risco poligênico (PRS), suas aplicações na medicina personalizada e os limites na avaliação clínica de doenças complexas. (595 words, May 7, 2026)
- [Anwendung - Jardiance_Met | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/jardiancemet/anwendung/index.html): Jardiance für Erwachsene mit Typ-2-Diabetes, senkt den Blutzuckerspiegel und zur Behandlung von Herzinsuffizienz und chronischer Niereninsuffizienz. (145 words, May 6, 2026)
- [Jardiance Met® | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/jardiancemet/index.html): Jardiance Met® (157 words, May 6, 2026)
- [Mehr Informationen zum Kurzfachinformation Jardiance® | Portal HCP | Boehringer Ingelheim](/content/pro/ch/kurzfachinformation-jardiance/index.html): Jardiance Juli 2025_d_Neue Indikation - Pediatrie plus CKD - Ketoazidose_2 (522 words, May 5, 2026)
- [Mehr Informationen zum Kurzfachinformation Jardiance Met® | Portal HCP | Boehringer Ingelheim](/content/pro/ch/kurzfachinformation-jardiance-met/index.html): Jardiance Met Dezember 2025_d (672 words, May 5, 2026)
- [Carcinoma neuroendocrino de alto grado: biología tumoral, necesidades no cubiertas y DLL3 como biomarcador | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/carcinoma-neuroendocrino-de-alto-grado/index.html): Los carcinomas neuroendocrinos (NECs) de alto grado, incluidos los extrapulmonares (epNECs), son una de las neoplasias malignas más agresivas y menos comprendidas en oncología. (1,648 words, May 5, 2026)
- [Produkte | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/index.html): Finden Sie umfassende Informationen wie Anwendung, Wirksamkeit, Sicherheit und Wechselwirkungen zu allen Produkten von Boehringer Ingelheim. (46 words, May 5, 2026)
- [El estrés de los veterinarios en España: un problema creciente que afecta a la salud y el bienestar de los profesionales | Boehringer Ingelheim ES](/content/es/salud-animal/historias-destacadas/el-estres-de-los-veterinarios-en-espana/index.html): Más del 80% de los veterinarios en España sufre agotamiento mental. (608 words, May 5, 2026)
- [Datenschutzerklärung | Portal HCP | Boehringer Ingelheim](/content/pro/ch/datenschutz/index.html): Datenschutzerklärung (760 words, May 5, 2026)
- [Kontakt | Portal HCP | Boehringer Ingelheim](/content/pro/ch/kontakt/index-2.html): Kontakt (130 words, May 5, 2026)
- [Impressum | Portal HCP | Boehringer Ingelheim](/content/pro/ch/impressum/index.html): Impressum (42 words, May 5, 2026)
- [Nutzungsbedingungen | Portal HCP | Boehringer Ingelheim](/content/pro/ch/nutzungsbedingungen/index.html): Nutzungsbedingungen (852 words, May 4, 2026)
- [Етичен кодекс | Boehringer Ingelheim BG](/content/bg/about-us/ethics-and-compliance/etichen-kodeks/index.html): Етиченият ни кодекс определя стандарта на нашите бизнес дейности. Той е за всички нас. Всеки играе ключова роля, за да вдъхне живот на Етичния кодекс. (279 words, Apr 30, 2026)
- [Zapište si do diářů: 20. – 22. květen patří vašim ledvinám | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/zapiste-si-do-diaru-20-22-kveten-patri-vasim-ledvinam.html): Zapište si do diářů: 20. – 22. květen patří vašim ledvinám (460 words, Apr 30, 2026)
- [Referenzen Jardiance® | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/jardiance/referenzen/index.html): Referenzen Jardiance® (58 words, Apr 30, 2026)
- [Rozšíření screeningu karcinomu plic otevřelo cestu k dřívější diagnostice plicních fibróz | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/rozsireni-screeningu-karcinomu-plic-otevrelo-cestu-k-drivejsi-diagnostice-plicnich-fibroz.html): Rozšíření screeningu karcinomu plic otevřelo cestu k dřívější diagnostice plicních fibróz (898 words, Apr 29, 2026)
- [Communiqué de presse | Boehringer Ingelheim CA](/content/ca/fr/communique-de-presse/index.html): Boehringer Ingelheim a annoncé aujourd’hui les premiers résultats, positifs, de l’étude de phase III SYNCHRONIZE-1 (958 words, Apr 29, 2026)
- [Startseite | Portal HCP | Boehringer Ingelheim](/content/pro/ch/index-2.html): Das Informations- und Serviceportal rund um die Produkte und Therapiegebiete von Boehringer Ingelheim. Zahlreiche Services für Sie, Ihre Praxis und Ihre Patienten. (202 words, Apr 29, 2026)
- [Startseite | Boehringer Platform](/content/pro/ch/en/node/170/index.html): Das Informations- und Serviceportal rund um die Produkte und Therapiegebiete von Boehringer Ingelheim. Zahlreiche Services für Sie, Ihre Praxis und Ihre Patienten. (154 words, Apr 29, 2026)
- [Green initiative in the district | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/our-stories/green-initiative-district/index.html): More Green in Meidling: Boehringer Ingelheim Plants 25 Trees Equipped with Sensors for a Better Urban Climate and a Higher Quality of Life. (611 words, Apr 29, 2026)
- [Recomendações ERS/ATS 2025 | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/biblioteca-cientifica/novas-recomendacoes-ers-ats-2025/index.html): Novas recomendações ERS/ATS 2025: principais mudanças para a prática clínica entre pneumologistas, reumatologistas, patologistas e radiologistas (194 words, Apr 29, 2026)
- [Testes genéticos cardiovasculares | Boehringer Ingelheim](/content/pro/br/newscenter/teste-genetico-acionavel-pratica-cardiovascular/index.html): Nem todo resultado genético leva a mudanças clínicas. Entenda o que torna um achado acionável e como interpretar VUS na prática. (852 words, Apr 29, 2026)
- [PPP attitude | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/ppp-attitude/index.html): Chez Boehringer Ingelheim, nous sommes convaincus d’une chose : la prévention est le meilleur soin que l’on puisse offrir à nos animaux. (535 words, Apr 29, 2026)
- [Press release | Boehringer Ingelheim CA](/content/ca/press-release/index.html): oehringer Ingelheim today announced positive topline results from the Phase III SYNCHRONIZE-1 trial (1,711 words, Apr 29, 2026)
- [Boehringer Ingelheims neuartiger dualer Glukagon/GLP-1-Agonist zeigte eine signifikante Gewichtsreduktion | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/adipositas/boehringer-ingelheims-neuartiger-dualer-glukagon-glp-1-agonist-zeigte-eine-signifikante.html): Boehringer Ingelheims neuartiger dualer Glukagon/GLP-1-Agonist zeigte eine signifikante Gewichtsreduktion (1,702 words, Apr 29, 2026)
- [El nuevo agonista dual de glucagón/GLP1 de Boehringer Ingelheim ha conseguido una pérdida de peso significativa del 16,6% | Boehringer Ingelheim SA](/content/sa/prensa/el-nuevo-agonista-dual-de-glucagon-glp1-de-boehringer-ingelheim-ha-conseguido-una-perdida-de-peso.html): Una mejora metabólica clínicamente relevante en personas con obesidad o sobrepeso en un ensayo de fase III. (1,984 words, Apr 28, 2026)
- [Research Beyond Borders | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/fostering-science/research-beyond-borders/index.html): We’re exploring emerging science to discover opportunities for better medicines for patients. (957 words, Apr 28, 2026)
- [Erhalten Sie Basisinformation zu Jardiance® | Portal HCP | Boehringer Ingelheim](/content/pro/ch/produkte/jardiance/index.html): Hier finden Sie Basisinformationen: von der Fach- und Gebrauchsinformation über die Applikationsformen bis zu den Packungsgrößen. (139 words, Apr 28, 2026)
- [Niereninsuffizienz | Portal HCP | Boehringer Ingelheim](/content/pro/ch/therapiegebiete-indikationen/niereninsuffizienz/index.html): Bei einer Niereninsuffizienz liegt eine Unterfunktion einer oder beider Nieren vor. Man unterscheidet zwischen akuter und chronischer Niereninsuffizienz. (231 words, Apr 28, 2026)
- [Results from Phase III SYNCHRONIZE-1 obesity trial | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/results-phase-iii-synchronize-1-obesity-trial/index.html): Phase III SYNCHRONIZE-1 trial in people living with obesity or overweight without type 2 diabetes met its primary endpoints (1,647 words, Apr 27, 2026)
- [KI-gestützte Lösung wird Herzgeräusche bei Hunden früher erkennbar machen | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/ki-gestuetzte-loesung-wird-herzgeraeusche-bei-hunden-frueher-erkennbar-machen.html): KI-gestützte Lösung wird Herzgeräusche bei Hunden früher erkennbar machen (833 words, Apr 27, 2026)
- [AI Tool Detects Heart Murmurs in Dogs for Early Care | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/ai-tool-detects-heart-murmurs-dogs-early-care/index.html): AI-based solution helps veterinarians detect, visualize and grade heart murmurs in dogs, enabling earlier diagnosis and treatment of heart disease. (1,077 words, Apr 27, 2026)
- [元従業員のメールアドレス等の漏えい可能性に関するお知らせ | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0501/index.html): このたび、委託先である米国のCRO（開発業務受託機関。以下「米国CRO」といいます。）において、外部からの不正アクセスが発生し、2015年から2016年にかけて当社に在籍していた一部従業員の個人情報が漏えいしたおそれがある事象が確認されました。現時点において、対象者となる従業員について、個人情報の漏えいおよび二次被害の事実は確認されておりません。 (26 words, Apr 27, 2026)
- [Úlceras gástricas equinas: Cómo tratarlas y prevenirlas para una mejor salud del caballo | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/ulceras-gastricas-equinas-como-tratarlas-y-prevenirlas-para-una-mejor-salud-del-caballo.html): Úlceras gástricas equinas: Cómo tratarlas y prevenirlas para una mejor salud del caballo (1,241 words, Apr 24, 2026)
- [Aprende cómo proteger fácilmente a tu caballo del virus del Nilo Occidental (VNO) | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/aprende-como-proteger-facilmente-tu-caballo-del-virus-del-nilo-occidental-vno.html): Aprende cómo proteger fácilmente a tu caballo del virus del Nilo Occidental (VNO) (1,049 words, Apr 24, 2026)
- [我們的行為守則 秉持誠信和熱情 | Boehringer Ingelheim TW](/content/tw/about-us/ethics-and-compliance/womendexingweishouze-bingchichengxinhereqing/index.html): 我們的行為守則訂立了指引所有業務活動的倫理標準，這與每一個人都息息相關。每位成員都在實踐行為守則的過程中，扮演著不可或缺的重要角色。 (32 words, Apr 24, 2026)
- [Therapiegebiete & Indikationen | Portal HCP | Boehringer Ingelheim](/content/pro/ch/therapiegebiete-indikationen/index.html): Therapiegebiete & Indikationen (161 words, Apr 24, 2026)
- [Entrevista e adesão medicamentosa | Boehringer Ingelheim](/content/pro/br/newscenter/entrevista-motivacional-adesao-doencas-cronicas/index.html): Veja como a entrevista motivacional pode melhorar a adesão medicamentosa e o manejo de fatores de risco em pacientes com doenças crônicas. (715 words, Apr 24, 2026)
- [Typ-2-Diabetes | Portal HCP | Boehringer Ingelheim](/content/pro/ch/therapiegebiete-indikationen/diabetes/index.html): Typ-2-Diabetes (141 words, Apr 24, 2026)
- [Por qué es importante la prevención en salud animal y cómo puedes beneficiarte de ella | Boehringer Ingelheim MX](/content/mx/salud-animal/salud-publica-veterinaria/por-que-es-importante-la-prevencion-en-salud-animal-y-como-puedes-beneficiarte-de-ella.html): Por qué es importante la prevención en salud animal y cómo puedes beneficiarte de ella (1,203 words, Apr 23, 2026)
- [Mozos de cuadra: una profesión que alza la voz | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/mozos-de-cuadra-una-profesion-que-alza-la-voz/index.html): Mozos de cuadra: una profesión que alza la voz (962 words, Apr 23, 2026)
- [Boehringer Ingelheim logra su cifra récord de inversión en I+D+i en España, alcanzando los 114,8 millones de euros en 2025 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/boehringer-ingelheim-logra-su-cifra-record-de-inversion-en-idi-en-espana-en-2025.html): La inversión en investigación, desarrollo e innovación (I+D+i) de la compañía en España incrementó en un 9% respecto al ejercicio anterior. (1,037 words, Apr 23, 2026)
- [Make the most of your horse’s next veterinary check-up | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/make-most-your-horses-next-veterinary-check/index.html): Top questions to consider (306 words, Apr 23, 2026)
- [Ask these 10 questions to your cat's or dog's veterinarian | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/ask-these-10-questions-your-cats-or-dogs-veterinarian.html): Make the most of your pet’s next veterinary check-up. Ask about comfort and wellbeing, physical checks, medical history, and preventive care. (254 words, Apr 23, 2026)
- [Nuestro poder en acción: Actuar con el corazón. Cuidar a través de la ciencia. | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/nuestro-poder-en-accion-actuar-con-el-corazon-cuidar-traves-de-la-ciencia.html): Nuestro poder en acción: Actuar con el corazón. Cuidar a través de la ciencia. (1,340 words, Apr 22, 2026)
- [Współpraca Boehringer Ingelheim Polska z Warszawskim Uniwersytetem Medycznym | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/niewydolnosc-serca/wspolpraca-boehringer-ingelheim-polska-z-warszawskim-uniwersytetem-medycznym.html): Współpraca Boehringer Ingelheim Polska z Warszawskim Uniwersytetem Medycznym (172 words, Apr 22, 2026)
- [Czym jest niewydolność serca? | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/niewydolnosc-serca/czym-jest-niewydolnosc-serca/index.html): Niewydolność serca to postępująca choroba, w której serce nie pracuje prawidłowo i nie jest w stanie przepompować ilości krwi wystarczającej do zaspokojenia potrzeb organizmu. (125 words, Apr 22, 2026)
- [Code of Conduct | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (300 words, Apr 21, 2026)
- [Code of Conduct | Boehringer Ingelheim IN](/content/in/about-us/ethics-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (304 words, Apr 21, 2026)
- [Progreso en descarbonización, gestión responsable del agua y ecodiseño | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-verde/progreso-en-descarbonizacion-gestion-responsable-del-agua-y-ecodiseno.html): Creemos que la innovación conlleva responsabilidad y que el cuidado del medioambiente no es algo separado de la salud: es parte de ella. (1,419 words, Apr 21, 2026)
- [Tirez le meilleur parti du prochain contrôle vétérinaire de votre chien ou chat : 10 questions à considérer | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/animaux-de-compagnie/tirez-le-meilleur-parti-du-prochain-controle-veterinaire-de-votre-chien-ou-chat-10.html): Decouvrez comment vous tirez le meilleur parti du prochain contrôle vétérinaire de votre chien ou chat, et let questions que vous pourriez souhaiter poser à votre médecin (326 words, Apr 21, 2026)
- [Atlanta Braves and Boehringer Ingelheim “Dogout” honors veterinarians - Photos | Boehringer Ingelheim US](/content/us/media/press-releases/atlanta-braves-and-boehringer-ingelheim-dogout-honors-veterinarians-photos.html): The Braves' 2026 dugouts feature veterinarians’ own dogs, to playfully honor veterinary professionals’ dedication and impact. (115 words, Apr 21, 2026)
- [Make the most of your horse’s next veterinary check-up: Top questions to consider | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/equine/make-most-your-horses-next-veterinary-check-top-questions-consider.html): Find out how to make the most of your horse's next veterinary check-up, and the top questions to consider. (309 words, Apr 21, 2026)
- [Ökologische Nachhaltigkeit bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/oekologische-nachhaltigkeit-bei-boehringer-ingelheim.html): Entdecken Sie, wie Boehringer Ingelheim ökologische Nachhaltigkeit umsetzt – mit Maßnahmen zu Umweltauswirkungen, Wassermanagement und Ökodesign in der Arzneimittelinnovation. (824 words, Apr 21, 2026)
- [Make the most of your dog or cat’s next veterinary check-up: 10 questions to consider | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/make-most-your-dog-or-cats-next-veterinary-check-10-questions-consider.html): Find out which steps to follow ahead of your pet's next check-up, and what questions you may wish to ask your veterinary professional. (278 words, Apr 21, 2026)
- [So treiben wir Nachhaltigkeit voran | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/so-treiben-wir-nachhaltigkeit-voran/index.html): Fortschritte in ökologischer Nachhaltigkeit: CO₂-neutrale Standorte, verantwortungsvoller Umgang mit Wasser, Ökodesign bei der Entwicklung von Medikamenten (863 words, Apr 21, 2026)
- [Environmental sustainability at Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/environmental-sustainability-boehringer-ingelheim/index.html): Explore Boehringer Ingelheim’s progress in environmental sustainability: carbon‑neutral sites, water stewardship and eco‑design in medicine innovation. (1,163 words, Apr 21, 2026)
- [CIBER y Boehringer Ingelheim se unen para impulsar la investigación en enfermedades pulmonares intersticiales | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/ciber-y-boehringer-ingelheim-se-unen-para-impulsar-la-investigacion-en-enfermedades-pulmonares.html): La colaboración aplicará modelos experimentales in vitro y caracterización multiómica de muestras de pacientes para entender mejor los mecanismos profibróticos y el riesgo de progresión. (749 words, Apr 21, 2026)
- [Heart of Australia’s National Lung Health Partner | Boehringer Ingelheim AU](/content/au/hoa-lung-health-partner/index.html): Boehringer Ingelheim becomes Heart of Australia’s National Lung Health Partner to close gaps in respiratory care (673 words, Apr 21, 2026)
- [Building a network of support for neuroendocrine cancer communities: Susan’s story | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/building-network-support-neuroendocrine-cancer-communities-susans-story.html): Susan shares her story of becoming a carer for her husband, Larry, who lived with extrapulmonary neuroendocrine carcinoma (epNEC). (535 words, Apr 20, 2026)
- [The challenges of facing neuroendocrine cancer: Jim’s story | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/challenges-facing-neuroendocrine-cancer-jims-story/index.html): Discover Jim’s story and the impact extrapulmonary neuroendocrine carcinoma (epNEC) has had on his life. (518 words, Apr 20, 2026)
- [Respeto e Igualdad de Oportunidades | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/cultura/respeto-e-igualdad-de-oportunidades/index.html): En Boehringer Ingelheim, nuestras personas son el motor de la innovación, en un entorno basado en el respeto y la igualdad de oportunidades, donde todos pueden desarrollarse y prosperar. (298 words, Apr 20, 2026)
- [Openness, Respect & Opportunity | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/openness-respect-opportunity/index.html): Nuestra gente empodera la innovación: en un lugar de trabajo donde todas las personas puedan prosperar. (276 words, Apr 17, 2026)
- [Investment in computational innovation AI Accelerator UK Knowledge Quarter | Boehringer Ingelheim](/content/about-us/investment-computational-innovation-ai-accelerator-uk-knowledge-quarter.html): Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter (186 words, Apr 17, 2026)
- [«Берінгер Інгельхайм» реалізує два ключові запуски нових лікарських засобів і демонструє зростання продажів на 7,3 % у 2025 році | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/beringer-ingelkhaym-realizue-dva-klyuchovi-zapuski-novikh-likarskikh-zasobiv-i-demonstrue-zrostannya.html): Компанія «Берінгер Інгельхайм» зміцнює позиції своїх інноваційних розробок завдяки двом ключовим запускaм нових лікарських засобів та демонструє зростання продажів на 7,3%* у 2025 році (685 words, Apr 16, 2026)
- [WhatsApp na prática clínica: até onde é seguro?](/content/pro/br/newscenter/whatsapp-na-pratica-clinica-e-seguro/index.html): Limites da orientação médica por WhatsApp: quando o uso é aceitável, quais são os riscos e como garantir confidencialidade e LGPD. (772 words, Apr 16, 2026)
- [Manejo da DPOC: Convergência entre GOLD 2026 e PCDT 2025](/content/pro/br/area-terapeutica/doencas-pulmonares/dpoc-asma/abordagem-contemporanea-dpoc-gold-2026-pcdt-2025/index.html): Entenda as mudanças do GOLD 2026 e PCDT 2025 na DPOC: foco na atividade da doença e dupla broncodilatação como base do cuidado. (352 words, Apr 16, 2026)
- [Храната като лекарство | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/diabetes/food-medicine/index.html): „Храната като лекарство“ предлага образователни насоки за здравословно хранене при захарен диабет тип 2 и съпътстващи заболявания. (264 words, Apr 15, 2026)
- [​​Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas​ | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/boehringer-ingelheim-and-zai-lab-announce-collaboration-dll3-targeting-t-cell-engager-and-adc.html): Boehringer Ingelheim to evaluate innovative combination of obrixtamig its DLL3 targeting T-cell engager Zai Lab’s DLL3-targeting ADC in in small cell lung cancer (882 words, Apr 15, 2026)
- [Study results zongertinib HER2-mutant advanced NSCLC published NEJM | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/study-results-zongertinib-her2-mutant-advanced-nsclc-published-nejm.html): Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine (1,229 words, Apr 15, 2026)
- [Fièvre catarrhale ovine : une maladie toujours présente, une prévention essentielle | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/prevention-fievre-catarrhale-ovine/index.html): La fièvre catarrhale ovine continue de représenter une menace sanitaire et économique majeure pour les troupeaux en France et en Europe. (682 words, Apr 14, 2026)
- [Boehringer Ingelheim France et Ikambere s’unissent pour renforcer l’accès aux soins des populations précaires | Boehringer Ingelheim FR](/content/fr/propos/developpement-durable/more-health/ikambere-acces-soins-populations-precaires/index.html): Boehringer Ingelheim France annonce son soutien à l’association Ikambere, pionnière de la médiation en santé, pour permettre de former 200 médiateurs d’ici fin 2027. (939 words, Apr 14, 2026)
- [Neuer Impfstoff zur Mastitis-Kontrolle bei Milchkühen | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/wiederkaeuer/neuer-impfstoff-zur-mastitis-kontrolle-bei-milchkuehen.html): Neuer Impfstoff zur Mastitis-Kontrolle bei Milchkühen (324 words, Apr 13, 2026)
- [한국베링거인겔하임동물약품, 한강에서 더욱 확장된 '킁킁쿵쿵 캠페인 시즌3' 개최 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaimdongmulyagpum-hangangeseo-deoug-hwagjangdoen-keungkeungkungkung-kaempein.html): 한국베링거인겔하임동물약품, 한강에서 더욱 확장된 '킁킁쿵쿵 캠페인 시즌3' 개최 (388 words, Apr 13, 2026)
- [“March for Better Care” －慢性腎臓病＆肥満症の理解を深めよう－ 世界腎臓病デー・世界肥満デー合同社内イベントを開催しました | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0414/index.html): －慢性腎臓病（CKD）と肥満症－ ベーリンガーインゲルハイムでは、国際的に定められている世界腎臓病デー（毎年3月の第2木曜日）および世界肥満デー（毎年3月4日）にあわせて、生活習慣と深くかかわるこのふたつの疾患について社員一人ひとりがより理解を深め、主体的な行動意識を持ち、社会全体に「診断の重要性を継続的に広く啓発していく」という共通目的のもと“March for Better Care” と題した社内イベントを開催いたしました。 (48 words, Apr 13, 2026)
- [El proyecto Ecuador Libre de Rabia acelera el avance hacia la eliminación de la rabia transmitida por perros, mediante el apoyo del programa Stop Rabies de Boehringer Ingelheim | Boehringer Ingelheim SA](/content/sa/prensa/el-proyecto-ecuador-libre-de-rabia-acelera-el-avance-hacia-la-eliminacion-de-la-rabia-transmitida.html): Ecuador aspira a convertirse en uno de los primeros países libres de rabia en América Latina. (917 words, Apr 9, 2026)
- [Ruta 86 La Rioja | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-la-rioja/index.html): Ruta 86 La Rioja (969 words, Apr 9, 2026)
- [Boehringer-BioNTech partnership to advance SCLC therapy | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/boehringer-biontech-partnership-advance-sclc-therapy.html): Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer. (765 words, Apr 9, 2026)
- [Boehringer and Click Announce CT-155 Funding and Investment | Boehringer Ingelheim US](/content/us/human-health/mental-health/schizophrenia/boehringer-and-click-announce-ct-155-funding-and-investment.html): Boehringer Ingelheim and Click Therapeutics Announce Series D Investment and Funding to Advance Commercialization of CT-155 (1,143 words, Apr 8, 2026)
- [Ruta 86 Castilla-La Mancha | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-castilla-la-mancha/index.html): Ruta 86 Castilla-La Mancha (1,406 words, Apr 8, 2026)
- [Collaboration for innovation in parasitic diseases | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/collaboration-innovation-parasitic-diseases/index.html): Boehringer Ingelheim is a global leader in preventing and treating parasitic diseases in pets, livestock and horses, through innovation and collaboration (745 words, Apr 8, 2026)
- [Ecuador Accelerates Efforts to Eliminate Dog‑Mediated Rabies | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/vaccines/ecuador-accelerates-efforts-eliminate-dog-mediated-rabies.html): Learn how Ecuador is advancing dog-mediated rabies elimination through coordinated vaccination and community efforts improving public health and safety. (77 words, Apr 8, 2026)
- [IA organiza dados clínicos e facilita acompanhamento](/content/pro/br/newscenter/ia-organiza-dados-clinicos/index.html): Ferramentas de IA organizam dados clínicos em gráficos claros, facilitando o acompanhamento de doenças crônicas e a conversa entre médico e paciente. (952 words, Apr 7, 2026)
- [Boehringer Ingelheim impulsa su portafolio con dos terapias innovadoras y crece un 7.3%* en un exitoso 2025 | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/boehringer-ingelheim-impulsa-su-portafolio-con-dos-terapias-innovadoras-y-crece-un-73-en-un-exitoso.html): Boehringer Ingelheim impulsa su portafolio con dos terapias innovadoras y crece un 7.3%* en un exitoso 2025 (1,006 words, Apr 6, 2026)
- [Computational Innovation | Boehringer Ingelheim UK](/content/uk/science-innovation/computational-innovation/index.html): Pioneering computational innovation in pharmaceutical research & development (350 words, Apr 4, 2026)
- [NEJM publishes results for patients with HER2-mutant NSCLC | Boehringer Ingelheim US](/content/us/human-health/cancer/lung-cancer/nejm-publishes-results-patients-her2-mutant-nsclc/index.html): Beamion LUNG-1 study results for treatment-naïve patients with HER2 (ERBB2)-mutant advanced NSCLC published in The New England Journal of Medicine (1,512 words, Apr 3, 2026)
- [La mammite chez les vaches laitières | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/la-mammite-chez-les-vaches-laitieres/index.html): La santé des vaches est essentielle au sein de chaque exploitation laitière. Lorsque la santé du troupeau se détériore, leur bien-être en est affecté, ainsi que celui de l’éleveur qui prend soin au quotidien de ses animaux. (878 words, Apr 2, 2026)
- [Boehringer Ingelheim launches STEM Innovation Lab in CT | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-launches-stem-innovation-lab-ct.html): Boehringer Ingelheim and Connecticut Science Center launch an Innovation Lab to expand STEM education and inspire future scientists across Connecticut. (706 words, Apr 1, 2026)
- [글로벌 PRRS 저감 전략 한자리에… 한국베링거인겔하임동물약품(주), 'PRRS ARC Forum 2026' 성황리 개최 | Boehringer Ingelheim KR](/content/kr/geullobeol-prrs-jeogam-jeonlyag-hanjalie-hangugbelinggeoingelhaimdongmulyagpumju-prrs-arc-forum-2026.html): 글로벌 PRRS 저감 전략 한자리에… 한국베링거인겔하임동물약품(주), 'PRRS ARC Forum 2026' 성황리 개최 (373 words, Apr 1, 2026)
- [Cosas que debes saber sobre los parásitos en perros | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/cosas-que-debes-saber-sobre-los-parasitos-en-perros.html): Un perro trae alegría a todos los hogares, pero a veces también parásitos. (483 words, Mar 31, 2026)
- [한국베링거인겔하임동물약품(주), Asian PRRSpective 2026 국제 심포지엄 및 한국베링거인겔하임 창립 50주년 기념 갈라 디너 성료 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaimdongmulyagpumju-asian-prrspective-2026-gugje-simpojieom-mich.html): 한국베링거인겔하임동물약품(주), Asian PRRSpective 2026 국제 심포지엄 및 한국베링거인겔하임 창립 50주년 기념 갈라 디너 성료 (580 words, Mar 31, 2026)
- [Vídeňské regionální centrum (RCV) společnosti Boehringer Ingelheim, pod které spadá i Česko, významně roste v oblasti humánní i veterinární medicíny | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/vetsi-potencial/videnske-regionalni-centrum-rcv-spolecnosti-boehringer-ingelheim-pod-ktere-spada-i-cesko-vyznamne.html): Vídeňské regionální centrum (RCV) společnosti Boehringer Ingelheim, pod které spadá i Česko, významně roste v oblasti humánní i veterinární medicíny (484 words, Mar 31, 2026)
- [Küresel araştırma; pet ebeveynlerinin parazit riskleri konusunda yeterli farkındalığa sahip olmadığını ve korunma yöntemlerine dair daha net yönlendirmelere ihtiyaç duyduğunu ortaya koyuyor. | Boehringer Ingelheim TR](/content/tr/kuresel-arastirma-pet-ebeveynlerinin-parazit-riskleri-konusunda-yeterli-farkindaliga-sahip.html): Küresel araştırma; pet ebeveynlerinin parazit riskleri konusunda yeterli farkındalığa sahip olmadığını ve korunma yöntemlerine dair daha net yönlendirmelere ihtiyaç duyduğunu ortaya koyuyor. (758 words, Mar 31, 2026)
- [Enfermedades zoonóticas: 3 cosas que debes saber | Boehringer Ingelheim MX](/content/mx/salud-animal/salud-publica-veterinaria/enfermedades-zoonoticas-3-cosas-que-debes-saber/index.html): Enfermedades zoonóticas: 3 cosas que debes saber (537 words, Mar 31, 2026)
- [Proteção contra parasitas: prevenção essencial para pets | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/animais-de-estimacao/protecao-contra-parasitas-prevencao-essencial-para-pets.html): Descubra por que a prevenção contra parasitas é vital para a saúde dos pets e como orientações veterinárias ajudam a protegê‑los durante todo o ano. (1,119 words, Mar 30, 2026)
- [Boehringer Ingelheim Academy à Lausanne | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/grass-roots/boehringer-ingelheim-academy-lausanne/index.html): Innovation et collaboration dans l’écosystème suisse des sciences de la vie (639 words, Mar 30, 2026)
- [Environmental sustainability at Boehringer Ingelheim | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/environmental-sustainability-boehringer-ingelheim/index.html): Explore Boehringer Ingelheim’s progress in environmental sustainability: carbon‑neutral sites, water stewardship and eco‑design in medicine innovation. (1,171 words, Mar 30, 2026)
- [Boehringer Ingelheim Türkiye’den Global Atama Mustafa: Yeşiloğlu, Kuveyt, Katar, Umman ve Bahreyn Satış Direktörü Oldu | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-turkiyeden-global-atama-mustafa-yesiloglu-kuveyt-katar-umman-ve-bahreyn-satis.html): Boehringer Ingelheim Türkiye’den Global Atama: Mustafa Yeşiloğlu, Kuveyt, Katar, Umman ve Bahreyn Satış Direktörü Oldu (292 words, Mar 30, 2026)
- [Nurdan Gürsoy Işık, Boehringer Ingelheim Türkiye’nin Kardiyo Renal Metabolik İş Birim Direktörü Oldu | Boehringer Ingelheim TR](/content/tr/nurdan-gursoy-isik-boehringer-ingelheim-turkiyenin-kardiyo-renal-metabolik-birim-direktoru-oldu.html): Nurdan Gürsoy Işık, Boehringer Ingelheim Türkiye’nin Kardiyo Renal Metabolik İş Birim Direktörü Oldu (285 words, Mar 30, 2026)
- [Boehringer Ingelheim Türkiye ve İç Hastalıkları Uzmanlık Eğitim Araştırma Derneği’nden Diyabet Farkındalığına Yönelik Proje, Mavi Yeryüzü: Diyabetin Evrensel Simgesine Sanatsal Bir Bakış | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-turkiye-ve-ic-hastaliklari-uzmanlik-egitim-arastirma-derneginden-diyabet.html): Boehringer Ingelheim Türkiye ve İç Hastalıkları Uzmanlık Eğitim Araştırma Derneği’nden Diyabet Farkındalığına Yönelik Proje, Mavi Yeryüzü: Diyabetin Evrensel Simgesine Sanatsal Bir Bakış (810 words, Mar 30, 2026)
- [Barış Torun, Boehringer Ingelheim Türkiye İnsan Sağlığı Litik İş Birimi Direktörü Oldu | Boehringer Ingelheim TR](/content/tr/baris-torun-boehringer-ingelheim-turkiye-insan-sagligi-litik-birimi-direktoru-oldu.html): Barış Torun, Boehringer Ingelheim Türkiye İnsan Sağlığı Litik İş Birimi Direktörü Oldu (296 words, Mar 30, 2026)
- [Boehringer Ingelheim Türkiye’den Global Atama: Fatih Kaya, Boehringer Ingelheim IMETA İnsan Sağlığı Kamu & Resmi İlişkiler ve İnovasyon Direktörü Oldu | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-turkiyeden-global-atama-fatih-kaya-boehringer-ingelheim-imeta-insan-sagligi.html): Boehringer Ingelheim Türkiye’den Global Atama Fatih Kaya, Boehringer Ingelheim IMETA İnsan Sağlığı Kamu & Resmi İlişkiler ve İnovasyon Direktörü Oldu (335 words, Mar 30, 2026)
- [Boehringer Ingelheim, Altıncı Kez “Global En İyi İşveren” Seçildi | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-altinci-kez-global-en-iyi-isveren-secildi.html): Boehringer Ingelheim, Altıncı Kez “Global En İyi İşveren” Seçildi (605 words, Mar 30, 2026)
- [Boehringer Ingelheim Türkiye’ye Altın Lider Ödülleri’nden İki Ödül | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-turkiyeye-altin-lider-odullerinden-iki-odul.html): Boehringer Ingelheim Türkiye’ye Altın Lider Ödülleri’nden İki Ödül (401 words, Mar 30, 2026)
- [Türk Nefroloji Derneği’nden Dünya Böbrek Günü’nde Uyarı: “Hayatta Uzatmalar Yok, Şimdi Önlemini Al” | Boehringer Ingelheim TR](/content/tr/turk-nefroloji-derneginden-dunya-bobrek-gununde-uyari-hayatta-uzatmalar-yok-simdi-onlemini-al.html): Türk Nefroloji Derneği’nden Dünya Böbrek Günü’nde Uyarı: “Hayatta Uzatmalar Yok, Şimdi Önlemini Al” (1,102 words, Mar 30, 2026)
- [新企業動画「かけがえのない毎日のために。」 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0407/index.html): ベーリンガーインゲルハイムは、新企業動画「かけがえのない毎日のために。」を制作しました。 本動画は、「Life forward」という企業スローガンに込めた、ベーリンガーインゲルハイムの想いを映し出したブランドムービーです。 (34 words, Mar 27, 2026)
- [Boehringer Ingelheim Academy in Lausanne | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/grass-roots/boehringer-ingelheim-academy-lausanne/index.html): Wo Schweizer Biotech-Innovation und Pharma-Expertise zusammenkommen (502 words, Mar 26, 2026)
- [2025 г. – развитие на портфолиото, ключови лансирания и растеж на продажбите | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/2025-pipeline-key-product-launches-sales-growth/index.html): Boehringer Ingelheim отбелязва силна 2025 г. с представяне на две ключови нови терапии в късен етап на разработка и ръст на продажбите от 7,3%* (879 words, Mar 26, 2026)
- [Boehringer Ingelheim cumple con dos lanzamientos clave en fase avanzada, incrementando las ventas un 7,3%* en un exitoso 2025 | Boehringer Ingelheim SA](/content/sa/prensa/boehringer-ingelheim-cumple-con-dos-lanzamientos-clave-en-fase-avanzada-incrementando-las-ventas-un.html): Las ventas netas del grupo aumentaron un 7,3%* alcanzando los 27.800 millones de euros en 2025. (977 words, Mar 25, 2026)
- [ベーリンガーインゲルハイム、2025年は後期開発パイプラインから2つの重要な上市を実現し、売上高7.3％の成長を達成 | Boehringer Ingelheim JP](/content/jp/press-26-0326-01/index.html): 2025年、ベーリンガーインゲルハイムは医療用医薬品事業において重要な上市を着実に進め、肺がんおよび肺線維症においてFDAよりブレークスルーセラピー指定を受けた2つの医薬品を同年下半期に上市しました。 (37 words, Mar 25, 2026)
- [百靈佳殷格翰 2025 年表現亮眼 兩重磅新藥上市 全年銷售成長 7.3%* | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/bailingjiayingehan-2025-nianbiaoxianliangyan-liangzhongbangxinyaoshangshi.html): 百靈佳殷格翰 2025 年表現亮眼 兩重磅新藥上市 全年銷售成長 7.3%* (133 words, Mar 25, 2026)
- [Boehringer Ingelheim RCV wächst deutlich und stärkt Position in Humanpharma und Tiergesundheit | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-rcv-waechst-deutlich-und-staerkt-position-humanpharma-und-tiergesundheit.html): Jahrespressekonferenz von Boehringer Ingelheim RCV (Regional Center Vienna) für das Geschäftsjahr 2025. (94 words, Mar 25, 2026)
- [Boehringer Ingelheim Reports 2025 Growth and Pipeline Progress | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-reports-2025-growth-and-pipeline-progress.html): Boehringer Ingelheim reports 7.3% sales growth in 2025 driven by key launches and increased R&D investment, reaching 70 million patients worldwide. (865 words, Mar 24, 2026)
- [Boehringer Ingelheim präsentiert Jahresergebnisse 2025 | Boehringer Ingelheim DE](/content/de/ueber-uns/boehringer-ingelheim-praesentiert-jahresergebnisse-2025.html): Boehringer Ingelheim präsentiert Jahresergebnisse 2025 (872 words, Mar 24, 2026)
- [2025 pipeline key product launches sales growth | Boehringer Ingelheim](/content/about-us/who-we-are/2025-pipeline-key-product-launches-sales-growth/index.html): Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025 (836 words, Mar 24, 2026)
- [Non solo leishmaniosi: dalle “nuove” zanzare arrivano nuove emergenze sanitarie. Il valore dell’approccio One Health per proteggere animali e umani | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/non-solo-leishmaniosi-dalle-nuove-zanzare-arrivano-nuove-emergenze-sanitarie-il-valore-dellapproccio.html): Non solo leishmaniosi: dalle “nuove” zanzare arrivano nuove emergenze sanitarie. Il valore dell’approccio One Health per proteggere animali e umani (1,004 words, Mar 24, 2026)
- [Световен ден на Земята: Здрава планета за бъдещите поколения | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/world-earth-day/index.html): Световен ден на Земята в Boehringer Ingelheim: ангажимент към устойчивото развитие и грижа за здравето на хората, животните и планетата. (380 words, Mar 24, 2026)
- [Nová prevence má zachytit selhání srdce a ledvin dříve | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nova-prevence-ma-zachytit-selhani-srdce-ledvin-drive.html): Nová prevence má zachytit selhání srdce a ledvin dříve (705 words, Mar 23, 2026)
- [SPOT CKD: Helping Every Community Catch Risk Earlier | Boehringer Ingelheim UK](/content/uk/human-health/chronic-kidney-disease/spot-ckd-helping-every-community-catch-risk-earlier.html): SPOT CKD: Bringing Fairer, Earlier Kidney Care to the Communities Who Need It Most (947 words, Mar 23, 2026)
- [West Yorkshire Chronic Kidney Disease Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/west-yorkshire-chronic-kidney-disease-executive-summary.html): West Yorkshire Chronic Kidney Disease Executive Summary (416 words, Mar 21, 2026)
- [Encuesta global revela que los tutores de mascotas desconocen los riesgos de parásitos y piden orientación más clara sobre la prevención. | Boehringer Ingelheim MX](/content/mx/prensa/encuesta-global-revela-que-los-tutores-de-mascotas-desconocen-los-riesgos-de-parasitos-y-piden.html): Encuesta global revela que los tutores de mascotas desconocen los riesgos de parásitos y piden orientación más clara sobre la prevención. (829 words, Mar 20, 2026)
- [World Parasite Awareness Day 2026 | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/world-parasite-awareness-day-2026/index.html): Why parasite prevention matters on World Parasite Awareness Day and beyond (60 words, Mar 20, 2026)
- [De petits gestes d’amour. De grands moments de vie. | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/de-petits-gestes-damour-de-grands-moments-de-vie/index.html): La prévention antiparasitaire est essentielle, et pas uniquement le jour de la Journée mondiale de sensibilisation aux parasites! (1,507 words, Mar 20, 2026)
- [Kleine Liebesbeweise. Grosse Momente. | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/haustiere/kleine-liebesbeweise-grosse-momente/index.html): Warum Parasitenprävention am World Parasite Awareness Day und darüber hinaus wichtig ist. (1,194 words, Mar 20, 2026)
- [Protegiendo a las mascotas de los parásitos | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/protegiendo-las-mascotas-de-los-parasitos/index.html): Protegiendo a las mascotas de los parásitos (1,450 words, Mar 19, 2026)
- [Policy | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/policy/index.html): We are committed to working with governments and healthcare systems to bring more health to patients and animals. (119 words, Mar 19, 2026)
- [Proteggere gli animali domestici dai parassiti | Boehringer Ingelheim IT](/content/it/salute-animale/proteggere-gli-animali-domestici-dai-parassiti-0/index.html): Proteggere gli animali domestici dai parassiti (100 words, Mar 19, 2026)
- [When growth is shared, ‘we’ comes before ‘I’ | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/when-growth-shared-we-comes-i/index.html): When growth is shared, ‘we’ comes before ‘I’ (463 words, Mar 19, 2026)
- [Ensemble, protégeons ce qui nous rassemble | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-engagements/ensemble-protegeons-ce-qui-nous-rassemble/index.html): Alors que les enjeux de santé publique évoluent rapidement dans le monde, la santé vétérinaire, très présente dans ces enjeux, révèle le caractère essentiel des missions des vétérinaires. (765 words, Mar 19, 2026)
- [Paraziti nejsou maličkost. Majitelé mazlíčků často netuší rizika a tápou v prevenci | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/paraziti-nejsou-malickost-majitele-mazlicku-casto-netusi-rizika-tapou-v-prevenci.html): Paraziti nejsou maličkost. Majitelé mazlíčků často netuší rizika a tápou v prevenci (761 words, Mar 19, 2026)
- [Small acts of love. Big moments of life. | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/small-acts-love-big-moments-life/index.html): On 20 March, World Parasite Day brings the role of parasite prevention into focus. (386 words, Mar 18, 2026)
- [World Parasite Awareness Day 2026 | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/world-parasite-awareness-day-2026/index.html): Why parasite prevention matters on World Parasite Awareness Day and beyond (1,005 words, Mar 18, 2026)
- [Parasites 101: How to help protect your pet from fleas, ticks & more | Boehringer Ingelheim US](/content/us/animal-health/trends-insights/parasites-101-how-help-protect-your-pet-fleas-ticks-more.html): Fleas, ticks and other parasites can cause serious illness in pets and expose your household to avoidable risks. (527 words, Mar 18, 2026)
- [Parasitenrisiken werden unterschätzt | Boehringer Ingelheim DE](/content/de/tiergesundheit/parasitenrisiken-werden-unterschaetzt/index.html): Parasitenrisiken werden unterschätzt (1,122 words, Mar 18, 2026)
- [Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice | Boehringer Ingelheim CA](/content/ca/global-survey-reveals-pet-owners-lack-awareness-parasite-risks-and-seek-clearer-prevention-advice.html): World Parasite Awareness Day, held annually on March 20, is an important reminder that parasites such as fleas, ticks and worms are among the most common health threats for pets around the world, yet they can easily be prevented. (823 words, Mar 18, 2026)
- [Intereses de colaboración en oncología e inmunología del cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/intereses-de-colaboracion-en-oncologia-e-inmunologia-del-cancer.html): Boehringer Ingelheim está liderando el camino en la búsqueda de nuevos conceptos terapéuticos, biomarcadores, candidatos a fármacos y modalidades de tratamiento en oncología e inmunología del cáncer. (432 words, Mar 18, 2026)
- [UACR and eGFR Screening Infographic](/content/pro/us/medinfo/diseases-conditions/crm/ckd/resources/screening-infographic-guidelines/index.html): UACR and eGFR Screening Infographic (100 words, Mar 18, 2026)
- [Mi objetivo final es curar el cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/mi-objetivo-final-es-curar-el-cancer/index.html): Norbert Kraut, científico ejecutivo senior en Investigación en Investigación, comparte cómo estamos impulsando la ciencia para ofrecer nuevas opciones de tratamiento a las personas que viven con cáncer. (397 words, Mar 18, 2026)
- [AHA/ACC 2025 Guidelines Update Infographic](/content/pro/us/medinfo/diseases-conditions/crm/ckd/resources/aha-acc-guidelines/index.html): AHA/ACC 2025 Guidelines Update Infographic (116 words, Mar 18, 2026)
- [Küçük Sevgi Adımları Hayatın Büyük Anları | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/kucuk-sevgi-adimlari-hayatin-buyuk-anlari/index.html): Küçük Sevgi Adımları, Hayatın Büyük Anları (1,296 words, Mar 18, 2026)
- [Protéger les animaux de compagnie contre les parasites | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/animaux-de-compagnie/proteger-les-animaux-de-compagnie-contre-les-parasites.html): L’importance de la prévention : bien plus qu’une simple Journée mondiale de sensibilisation aux parasites (1,956 words, Mar 17, 2026)
- [Innovación en la investigación del cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/innovacion-en-la-investigacion-del-cancer/index.html): En Boehringer Ingelheim, el cuidado del cáncer es algo personal. Nuestros científicos sienten una gran pasión por avanzar en la investigación oncológica y descubrir nuevos tratamientos. (527 words, Mar 17, 2026)
- [El cáncer es uno de los mayores desafíos de la humanidad | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/el-cancer-es-uno-de-los-mayores-desafios-de-la-humanidad.html): La oncología presenta una de las mayores necesidades médicas no cubiertas en toda la industria sanitaria. (526 words, Mar 17, 2026)
- [Comprender el cáncer de pulmón microcítico | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/comprender-el-cancer-de-pulmon-microcitico/index.html): Conoce más sobre el cáncer de pulmón microcítico, incluidos sus síntomas y opciones de tratamiento. (398 words, Mar 17, 2026)
- [New Christian Doppler Laboratory for Lung Cancer Research | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/new-christian-doppler-laboratory-lung-cancer-research.html): A new Christian Doppler Laboratory is advancing next‑generation therapies for NSCLC by studying immunogenic cell death to accelerate benefits for patients. (990 words, Mar 17, 2026)
- [Neues Christian-Doppler-Labor zur Lungenkrebsforschung | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/neues-christian-doppler-labor-zur-lungenkrebsforschung.html): Neues Christian-Doppler-Labor erforscht Therapien der nächsten Generation gegen NSCLC und immunogenen Zelltod für schnelleren Patient*innennutzen. (878 words, Mar 17, 2026)
- [Wie steht es um die Versorgung interstitieller Lungenerkrankungen in Deutschland? | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/wie-steht-es-um-die-versorgung-interstitieller-lungenerkrankungen-deutschland.html): Wie steht es um die Versorgung interstitieller Lungenerkrankungen in Deutschland? (823 words, Mar 17, 2026)
- [2025 Africa investments Social Engagement Fund | Boehringer Ingelheim](/content/about-us/sustainable-development/2025-africa-investments-social-engagement-fund/index.html): Three investments mark a strong finish to 2025 for Social Engagement Fund (670 words, Mar 16, 2026)
- [Capabilities Update March 26 | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/capabilities-update-march-26-bioxcellence/index.html): Discover how Boehringer Ingelheim BioXcellence™ advances large‑molecule programs with global manufacturing expertise. Watch the 2026 capabilities update. (278 words, Mar 16, 2026)
- [Patiënten met chronische nierschade onder behandeld | Boehringer Ingelheim NL](/content/nl/voor-mens/chronische-nierziekte/patienten-met-chronische-nierschade-onder-behandeld.html): Op Wereld Nieren Dag organiseerde Boehringer Ingelheim een stakeholdersevent over chronische nierschade voor Kamerleden en zorgprofessionals. (570 words, Mar 13, 2026)
- [Where ideas take root: Get a glimpse into our Grass Roots efforts | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/where-ideas-take-root-get-glimpse-our-grass-roots-efforts.html): Boehringer’s Grass Roots programs supports biotech innovators and entrepreneurs with resources, mentoring, and opportunities to advance emerging science. (210 words, Mar 12, 2026)
- [Comprender el cáncer de pulmón no microcítico (NSCLC) | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/comprender-el-cancer-de-pulmon-no-microcitico-nsclc.html): Conoce más sobre el cáncer de pulmón no microcítico, incluidos sus síntomas y opciones de tratamiento. (451 words, Mar 12, 2026)
- [Networking opportunities for biotech startups and innovators | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/networking-opportunities-biotech-startups-and-innovators.html): Boehringer’s Grass Roots programs support biotech innovators and entrepreneurs with resources, mentoring, and opportunities to advance emerging science. (406 words, Mar 12, 2026)
- [O papel das pequenas ações no cuidado ao paciente](/content/pro/br/newscenter/pequenas-acoes-cuidado-ao-paciente/index.html): Ajustes de dose, checagem de interações e reforço da adesão podem reduzir internações quando aplicados de forma sistemática no plano de cuidados. (531 words, Mar 11, 2026)
- [한국베링거인겔하임-유한양행, 세계 콩팥의 날 기념 '당-장 바로 알기' 토크쇼 개최... 콩팥 조기 진단 중요성 강조 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaim-yuhanyanghaeng-segye-kongpatui-nal-ginyeom-dang-jang-balo-algi-tokeusyo.html): 한국베링거인겔하임-유한양행, 세계 콩팥의 날 기념 '당-장 바로 알기' 토크쇼 개최... 콩팥 조기 진단 중요성 강조 (471 words, Mar 11, 2026)
- [Alrededor de 50 hospitales y centros de salud se suman a la iniciativa del Día Mundial del Riñón | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedad-renal-cronica/alrededor-de-50-hospitales-y-centros-de-salud-se-suman-la-iniciativa-del-dia-mundial-del-rinon.html): Bajo el paraguas de la campaña “Conexiones (In)visibles”, esta iniciativa recorre el país durante la semana del Día Mundial del Riñón para poner el foco en la enfermedad renal crónica (ERC). (1,219 words, Mar 10, 2026)
- [Protegiendo a los animales de compañía de los parásitos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/protegiendo-los-animales-de-compania-de-los-parasitos.html): Por qué la prevención de parásitos importa en el Día Mundial de Concientización sobre los Parásitos y durante todo el año. (1,761 words, Mar 9, 2026)
- [Veterinary Professionals | Boehringer Ingelheim IE](/content/ie/partnering/animal-health-partnering/veterinary-professionals/index.html): We work alongside vets, vet nurses and practice staff to predict, prevent and treat disease, improving life for animals and the people who love them. (96 words, Mar 7, 2026)
- [Pequeños actos de amor, grandes momentos para toda la vida | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/pequenos-actos-de-amor-grandes-momentos-para-toda-la-vida.html): Pequeños actos de amor, grandes momentos para toda la vida: la importancia de la prevención antiparasitaria en mascotas. (1,033 words, Mar 6, 2026)
- [1,8 miljoen Nederlanders leven met chronische nierschade - vaak zonder het te weten | Boehringer Ingelheim NL](/content/nl/voor-mens/chronische-nierziekte/18-miljoen-nederlanders-leven-met-chronische-nierschade-vaak-zonder-het-te-weten.html): Chronische nierschade (CNS) treft 1,8 miljoen Nederlanders, maar veel mensen leven hiermee zonder dat ze het weten. (427 words, Mar 6, 2026)
- [New parasitology residency program tackles heartworm as an emerging health risk for dogs in Atlantic Canada | Boehringer Ingelheim CA](/content/ca/new-parasitology-residency-program-tackles-heartworm-emerging-health-risk-dogs-atlantic-canada.html): Atlantic Veterinary College, Mitacs and Boehringer Ingelheim Canada partner to launch Veterinary Parasitology Residency Program (803 words, Mar 5, 2026)
- [Unterschätzte Parasitenrisiken und klarere Präventionsempfehlungen | Boehringer Ingelheim AT](/content/at/de/presse/unterschaetzte-parasitenrisiken-und-klarere-praeventionsempfehlungen.html): Globale Umfrage zeigt: Tierhalterinnen und Tierhalter unterschätzen Parasitenrisiken und wünschen sich klarere Präventionsempfehlungen (580 words, Mar 5, 2026)
- [awareness of parasite risks and prevention advice​ | Boehringer Ingelheim AT](/content/at/en/media/awareness-parasite-risks-and-prevention-advice/index.html): ​​Global survey reveals pet owners lack awareness of parasite risks and demand clearer prevention advice​ (714 words, Mar 5, 2026)
- [Otyłość i MASH: wspólne czynniki ryzyka i dane kliniczne | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-metaboliczne/otylosc/otylosc-i-mash-wspolne-czynniki-ryzyka-i-dane-kliniczne-0.html): Przedstawienie powiązań między otyłością, stłuszczeniową chorobą wątroby a ryzykiem chorób układu sercowo-naczyniowego, z uwzględnieniem zmian stylu życia i metod leczenia MASH. (1,014 words, Mar 4, 2026)
- [Openness, Respect and Opportunity | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (271 words, Mar 4, 2026)
- [Veterinary Professionals | Boehringer Ingelheim UK](/content/uk/partnering/animal-health-partnering/veterinary-professionals/index.html): We work alongside vets, vet nurses and practice staff to predict, prevent and treat disease, improving life for animals and the people who love them. (112 words, Mar 3, 2026)
- [Protecting pets from parasites | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/protecting-pets-parasites/index.html): Learn why parasite prevention protects pets and communities, and how World Parasite Awareness Day raises awareness for evolving parasite risks. (1,528 words, Mar 3, 2026)
- [Boehringer Ingelheim India recognized among the Top 10 Best Companies for Women in India - Emerging Icons 2025 | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/boehringer-ingelheim-india-recognized-among-top-10-best-companies-women-india-emerging-icons-2025.html): Boehringer Ingelheim India recognized among the Top 10 Best Companies for Women in India - Emerging Icons 2025 (479 words, Mar 2, 2026)
- [A passion for research which addresses unmet medical needs | Boehringer Ingelheim HK](/content/hk/en/about-us/who-we-are/culture/passion-research-which-addresses-unmet-medical-needs.html): Eric Haaksma, Head of Global Innovation Animal Health, explains why his professional purpose is rooted in helping drive advancements in scientific research (178 words, Feb 27, 2026)
- [Idiopathic Pulmonary Fibrosis (IPF): Ron and Maxine’s Story | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/idiopathic-pulmonary-fibrosis-ipf-ron-and-maxines-story.html): Learn more about Ron and Maxine’s experiences of living with IPF and navigating the condition together. (686 words, Feb 27, 2026)
- [Eski Standart Hüküm ve Koşullar | Boehringer Ingelheim TR](/content/tr/about-us/purchasing/eski-standart-hukum-ve-kosullar/index.html): Eski Standart Hüküm ve Koşullar (10,707 words, Feb 26, 2026)
- [Ruta 86 Comunitat Valenciana | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-comunitat-valenciana/index.html): Ruta 86 Comunitat Valenciana (1,381 words, Feb 26, 2026)
- [High-grade neuroendocrine carcinoma: biology, unmet needs, and DLL3 biomarker in epNEC & SCLC | Boehringer Ingelheim](/content/human-health/cancer/high-grade-neuroendocrine-carcinoma-biology-unmet-needs-and-dll3-biomarker-epnec-sclc.html): High-grade neuroendocrine carcinomas (epNEC and SCLC) remain among the most aggressive malignancies. Experts explore the unmet need and the emerging role of DLL3 biomarker. (1,832 words, Feb 25, 2026)
- [Adipositas und die Verbindung zur Leber | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/adipositas/adipositas-und-die-verbindung-zur-leber/index.html): Hier beschreibt Susanne Raupach ihr Leben mit Adipositas. Sie rät, frühzeitig Hilfe zu suchen und erklärt die Wichtigkeit von Leberwerten wie FIB-4. (767 words, Feb 25, 2026)
- [Историята на Лин: живот със сърдечносъдово и бъбречно заболяване | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/lynns-story-cvd-and-ckd/index.html): Защитете бъбреците си, за да защитите сърцето си. Ранното изследване на uACR за хронични бъбречни и сърдечно‑съдови заболявания може да спаси живота ви. (417 words, Feb 24, 2026)
- [Bronchiectasis | Boehringer Ingelheim IE](/content/ie/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis is a progressive inflammatory respiratory disease characterised by irreversible enlarged airways, which prevent proper mucus drainage. (173 words, Feb 23, 2026)
- [Bronchiectasis | Boehringer Ingelheim UK](/content/uk/human-health/lung-diseases/bronchiectasis/index.html): Bronchiectasis is a progressive inflammatory respiratory disease characterised by irreversible enlarged airways, which prevent proper mucus drainage. (175 words, Feb 23, 2026)
- [Grüner Antrieb für die Zukunft mit nachhaltiger Mobilität | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/gruener-antrieb-fuer-die-zukunft-mit-nachhaltiger-mobilitaet.html): Nachhaltigkeit ist zentrales Element unserer globalen Strategie. Ein Hebel ist die Umstellung der Unternehmensflotte auf umweltfreundliche Mobilität. (664 words, Feb 23, 2026)
- [Histoire de Beverly Moir | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/habiliter-les-patients/histoire-de-beverly-moir/index.html): Beverly Moir, une Canadienne atteinte de cancer du poumon, encourage les personnes ayant récemment reçu un tel diagnostic à en apprendre davantage sur les options thérapeutiques à leur disposition. Découvrez son histoire et restez au fait. (618 words, Feb 20, 2026)
- [Beverly Moir’s Story | Boehringer Ingelheim CA](/content/ca/human-health/cancer/empowering-patients/beverly-moirs-story/index.html): Beverly Moir, Canadian living with lung cancer, inspires newly diagnosed individuals to learn more about their treatment options. Discover her story and stay informed. (419 words, Feb 20, 2026)
- [保護猫・保護犬への継続支援＿セーブペットプロジェクト2025年度寄付を実施 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0302/index.html): ベーリンガーインゲルハイム アニマルヘルス ジャパンは、日本全薬工業株式会社と共同で推進する「セーブペットプロジェクト（SPP）」を通じ、2025年度も保護犬・保護猫の支援に向けた寄付金の贈呈を行いました。 (33 words, Feb 20, 2026)
- [Les Voix des champs : les podcasts qui ruminent la santé ! | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/les-voix-des-champs-les-podcasts-qui-ruminent-la-sante.html): Pensés comme un espace d’échange direct et spontané entre vétérinaires et éleveurs, "Les Voix des champs" reflètent au plus près les réalités du terrain autour de la santé et du bien-être des animaux d’élevage. (451 words, Feb 18, 2026)
- [Pavol Dobrocky bei Teach For Austria 2026 | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/pavol-dobrocky-bei-teach-austria-2026/index.html): Teach For Austria Woche 2026: Boehringer Ingelheim Austria unterstützt Bildungsfairness. Pavol Dobrocky zeigt Schüler*innen mögliche Karrierepfade. (148 words, Feb 17, 2026)
- [Pavol Dobrocky at Teach For Austria 2026 | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/pavol-dobrocky-teach-austria-2026/index.html): Teach For Austria Week 2026: Boehringer Ingelheim Austria supports educational equity as Pavol Dobrocky discusses career paths with students. (440 words, Feb 17, 2026)
- [Mastitis in cows: risks, early signs, and prevention tips | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/mastitis-cows-risks-early-signs-and-prevention-tips.html): Learn about mastitis in dairy cows: key signs, risks, and practical prevention steps to support udder health and strengthen farm sustainability. (1,069 words, Feb 17, 2026)
- [Ranking gold EcoVadis sustainability assessment | Boehringer Ingelheim](/content/about-us/sustainable-development/ranking-gold-ecovadis-sustainability-assessment/index.html): Boehringer Ingelheim achieves EcoVadis sustainability gold rating (438 words, Feb 16, 2026)
- [Geschichte des IMP | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/geschichte-des-imp/index.html): 2025 wurde das Forschungsinstitut für Molekulare Pathologie (IMP) Jahr 40 Jahre alt. Ein Blick auf seine Geschichte und die Rolle für Boehringer Ingelheim. (640 words, Feb 16, 2026)
- [History of the IMP | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/history-imp/index.html): The Research Institute of Molecular Pathology (IMP) celebrated its 40th anniversary. Let's look at its achievements and its role for Boehringer Ingelheim (710 words, Feb 16, 2026)
- [Women in STEM: Passion for science | Boehringer Ingelheim HK](/content/hk/en/about-us/sustainable-development/more-potential/women-stem-passion-science/index.html): Discover how our women excelling in STEM careers can improve health equity and create sustainable healthcare solutions. (741 words, Feb 13, 2026)
- [Ouverture, Respect & Égalité des chances | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/ouverture-respect-egalite-des-chances/index.html): Chez Boehringer Ingelheim, nos collaborateurs sont le moteur de notre innovation, dans un environnement de travail ouvert, respectueux, offrant l'égalité des chances, et où chacun peut s'épanouir. (306 words, Feb 13, 2026)
- [“自分ごと”から始まるサステナビリティ - 神戸医薬研究所 日本拠点初のドイツ認証機関による脱炭素化認証取得からその先へ | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0013/index.html): ベーリンガーインゲルハイムでは、サステナビリティ戦略の柱の一つ、「MORE GREEN（地球環境のために）」のもと、2030年までに事業活動におけるカーボンニュートラルを達成するというグローバル目標に向け、世界各地の拠点でカーボンニュートラル認証取得を進めています。 (34 words, Feb 12, 2026)
- [Rethinking Waste as a Resource | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/rethinking-waste-resource/index.html): Waste is a resource, otherwise it just costs money. So it’s important to analyze and deal with it properly, and to avoid it as much as possible. (663 words, Feb 11, 2026)
- [El bienestar animal como elemento esencial de la sustentabilidad | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/el-bienestar-animal-como-elemento-esencial-de-la-sustentabilidad.html): ¿Podemos decir que existe una relación directa entre el bienestar animal y la sustentabilidad? El Dr. Xavier Manteca, Médico Veterinario español, habla sobre tendencias en bienestar animal. (876 words, Feb 11, 2026)
- [Öppenhet, respekt och möjligheter | Boehringer Ingelheim SE](/content/se/om-oss/vilka-vi-ar/kultur/oppenhet-respekt-och-mojligheter/index.html): Vi värdesätter våra medarbetares varierande och unika bidrag och skapar en miljö där de kan göra sitt bästa arbete. Vi ser styrkan i våra olikheter. (253 words, Feb 11, 2026)
- [Köpeklerin Kalbini 25 Yıldır Güçlendiriyoruz | Boehringer Ingelheim TR](/content/tr/kopeklerin-kalbini-25-yildir-guclendiriyoruz/index.html): Dünya genelindeki köpekler ve onların ebeveynleri için, sevgiyle yaşanacak daha fazla hayat sunmaya devam ediyoruz. (449 words, Feb 11, 2026)
- [AI Coach Helps Supervisors Deal With Sensitive Situations | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/ai-coach-helps-supervisors-deal-sensitive-situations.html): The new training program for supervisors links an AI-based simulation with personal coaching, while creating a safe space for trying it out. (545 words, Feb 11, 2026)
- [Der Beipackzettel ist wichtig für die Patientensicherheit | Boehringer Ingelheim DE](/content/de/humanmedizin/unsere-verantwortung/patientensicherheit/der-beipackzettel-ist-wichtig-fuer-die-patientensicherheit.html): Warum es wichtig ist, den Beipackzettel zu lesen? Dort stehen wichtige Hinweise zu Einnahme, Verabreichung, Aufbewahrung und Sicherheit von Medikamenten. (290 words, Feb 11, 2026)
- [Ouverture, Respect et Opportunité | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/culture/ouverture-respect-et-opportunite/index.html): Chez Boehringer Ingelheim, nos collaborateurs sont le moteur de l’innovation – dans un environnement fondé sur l’ouverture, le respect et l’égalité des chances, où chacun peut s’épanouir. (326 words, Feb 10, 2026)
- [Lot Number Pop up Content | Bi-Drug Information Requests](/content/pro/us/bi-druginforequest/lot-number-help/index.html): For Boehringer Ingelheim products, the Lot Number can usually be found:On the box (carton): Printed near the expiration date, typically on the top, bottom, or side panels of the carton.On the bottle: Printed on the label or directly on the bottle, often on the side panel near the product name or expiration date.On blister packs: Printed on the foil backing or blister cavity, alongside the expiration date.On devices (e.g., inhalers or injectables): Printed on the front panel of the de (148 words, Feb 9, 2026)
- [Grüner Beitrag im Bezirk | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/unsere-storys/gruener-beitrag-im-bezirk/index.html): Mehr Grün für Meidling: Boehringer Ingelheim pflanzt 25 Smart Trees mit Sensoren – für besseres Stadtklima, effiziente Bewässerung und mehr Lebensqualität. (441 words, Feb 9, 2026)
- [Allgemeine Einkaufsbedingungen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/einkauf/allgemeine-einkaufsbedingungen/index.html): Allgemeine Einkaufsbedingungen für die Boehringer Ingelheim Gruppe (AEB) (21 words, Feb 9, 2026)
- [Cosas que debes de saber sobre las enfermedades cardíacas en perros | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/cosas-que-debes-de-saber-sobre-las-enfermedades-cardiacas-en-perros.html): Si eres un amante de los animales, seguro que la idea de que tu perro padezca una enfermedad cardíaca puede ser aterradora. (724 words, Feb 9, 2026)
- [陪可鬆 | Boehringer Ingelheim TW](/content/tw/node/33821/index.html): 陪可鬆 (73 words, Feb 5, 2026)
- [Diabetic Macular Edema (DME) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/eye-health/diabetic-macular-edema/index.html): Explore clinical insights on Diabetic Macular Edema (DME), and access resources, clinical trials, congresses, and support tools. (119 words, Feb 4, 2026)
- [Neuroendocrine Carcinomas | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/neuroendocrine-carcinoma/index.html): Access clinical insights on Neuroendocrine Carcinomas, including evolving treatment approaches. Explore resources, clinical trials, and congresses. (533 words, Feb 4, 2026)
- [Journée mondiale contre le cancer 2026 : penser aussi à l’après | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/cancer/journee-mondiale-contre-le-cancer-2026-penser-aussi-lapres.html): Le 4 février, c’est la Journée mondiale contre le cancer. Un moment pour sensibiliser à l’impact du cancer, pendant et après le traitement. (270 words, Feb 4, 2026)
- [Wereldkankerdag 2026: aandacht voor wie leeft met en na kanker | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/kanker/wereldkankerdag-2026-aandacht-voor-wie-leeft-met-en-na-kanker.html): Op 4 februari is het Wereldkankerdag. Een dag die wereldwijd aandacht vraagt voor de impact van kanker. Niet alleen tijdens de behandeling, maar ook ervoor en erna. (294 words, Feb 4, 2026)
- [Pourquoi les tests de biomarqueurs sont importants dans la prise en charge du cancer | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cancereuses/pourquoi-les-tests-de-biomarqueurs-sont-importants-dans-la-prise-en-charge-du-cancer.html): Découvrez comment les tests de biomarqueurs aident à prendre des décisions éclairées dans la prise en charge du cancer et trouvez des réponses aux questions les plus importantes (1,524 words, Feb 3, 2026)
- [Gebärdensprach-Avatar: Teilhabe von Gehörlosen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/gebaerdensprach-avatar-teilhabe-von-gehoerlosen/index.html): Der Gebärdensprach-Avatar von Boehringer Ingelheim macht Gesundheitsinformationen barrierefrei verständlich und stärkt digitale Inklusion. Erfahre mehr! (888 words, Feb 2, 2026)
- [Abertura, Respeito e Oportunidade | Boehringer Ingelheim PT](/content/pt/sobre-nos/quem-somos/cultura/abertura-respeito-e-oportunidade/index.html): Valorizamos as contribuições diversas e únicas dos nossos colaboradores e promovemos um ambiente onde eles possam dar o seu melhor. Vemos força nas nossas diferenças. (260 words, Feb 2, 2026)
- [General Terms and Conditions of Purchase | Boehringer Ingelheim IN](/content/in/about-us/purchasing/general-terms-and-conditions-purchase/index.html): General Terms and Conditions of Purchase for the Boehringer Ingelheim Group (GTC-P) (39 words, Jan 30, 2026)
- [Wildlife Habitat Council certification at Ridgefield | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-green/wildlife-habitat-council-certification-ridgefield/index.html): Our Ridgefield site earned Wildlife Habitat Council certification, recognizing ongoing biodiversity, conservation education, and habitat restoration efforts. (375 words, Jan 30, 2026)
- [Openness, Respect and Opportunity | Boehringer Ingelheim ZA](/content/za/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (271 words, Jan 30, 2026)
- [일과 삶의 균형 중시하는 조직문화... 한국베링거인겔하임, '가족친화인증기업' 선정 | Boehringer Ingelheim KR](/content/kr/ilgwa-salmui-gyunhyeong-jungsihaneun-jojigmunhwa-hangugbelinggeoingelhaim-gajogchinhwainjeunggieob.html): 일과 삶의 균형 중시하는 조직문화... 한국베링거인겔하임, '가족친화인증기업' 선정 (316 words, Jan 30, 2026)
- [한국베링거인겔하임, 비만 환자의 간 건강 중요성 알리기 위해 365mc와 맞손 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaim-biman-hwanjaui-gan-geongang-jungyoseong-alligi-wihae-365mcwa-majson.html): 한국베링거인겔하임, 비만 환자의 간 건강 중요성 알리기 위해 365mc와 맞손 (391 words, Jan 30, 2026)
- [CRM CONNECTIONS Grant | Boehringer Ingelheim AU](/content/au/crm-connections-grant/index.html): Boehringer Ingelheim CRM CONNECTIONS Grant (680 words, Jan 29, 2026)
- [General Terms and Conditions of Purchase | Boehringer Ingelheim ZA](/content/za/about-us/purchasing/general-terms-and-conditions-purchase/index.html): General Terms and Conditions of Purchase for the Boehringer Ingelheim Group (GTC-P) (43 words, Jan 29, 2026)
- [General Terms and Conditions of Purchase | Boehringer Ingelheim AT](/content/at/en/about-us/purchasing/general-terms-and-conditions-purchase/index.html): General Terms and Conditions of Purchase for the Boehringer Ingelheim Group (GTC-P) (38 words, Jan 29, 2026)
- [Testen! Biomarker bei NSCLC | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/lungenkrebs/testen-biomarker-bei-nsclc/index.html): Warum der Biomarker-Test beim fortgeschrittenen nicht kleinzelligen Lungenkrebs entscheidend für die Behandlung ist (818 words, Jan 28, 2026)
- [Boehringer Ingelheim подкрепя АПАЗ в усилията за системна промяна и по-добра грижа на пациентите със сърдечна недостатъчност | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/heart-failure/boehringer-ingelheim-supports-apad-hf/index.html): Инициативата на АПАЗ с подкрепата на Boehringer Ingelheim подобрява грижата за пациентите със сърдечна недостатъчност чрез анализ, препоръки и системни решения. (491 words, Jan 28, 2026)
- [医療アクセスの課題：どこでも同じ治療が受けられる社会へ | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/news-26-cdk/index.html): 慢性腎臓病（CKD：シーケーディー、Chronic Kidney Disease）は、腎臓の機能が低下したり、タンパク尿が出たりするなどの異常が続けて認められる病気で、現在、日本にはCKDの患者さんが約2,000万人（成人の5人に1人）いるとされています* (54 words, Jan 28, 2026)
- [Por qué las pruebas de biomarcadores son importantes en la atención del cáncer | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/cancer-de-pulmon/por-que-las-pruebas-de-biomarcadores-son-importantes-en-la-atencion-del-cancer.html): Conoce cómo las pruebas de biomarcadores ayudan a tomar decisiones informadas en la atención del cáncer y encuentra respuestas a las preguntas más relevantes. (1,501 words, Jan 27, 2026)
- [Elektronische Produktinformationen – das Ende der gedruckten Beipackzettel? | Boehringer Ingelheim AT](/content/at/de/humanmedizin/unsere-verantwortung/patientensicherheit/elektronische-produktinformationen-das-ende-der-gedruckten-beipackzettel.html): Elektronische Produktinformationen (ePI) über Medikamente können die Sicherheit erhöhen sowie Zugänglichkeit und Aktualität von Informationen verbessern. (465 words, Jan 27, 2026)
- [Electronic product information: Is this the end of the paper leaflets? | Boehringer Ingelheim AT](/content/at/en/human-health/our-responsibility/patient-safety/electronic-product-information-end-paper-leaflets/index.html): Electronic product information (ePI) enhances safety, access, and speed, offering significant benefits for both pharmaceutical companies and patients. (473 words, Jan 27, 2026)
- [Avoimuus, kunnioitus ja mahdollisuudet | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/kulttuuri/avoimuus-kunnioitus-ja-mahdollisuudet/index.html): Arvostamme työntekijöidemme moninaisia ja ainutlaatuisia panoksia ja luomme ympäristön, jossa he voivat tehdä parhaansa. Näemme vahvuuksia eroavaisuuksissamme. (195 words, Jan 27, 2026)
- [購買取引約款 | Boehringer Ingelheim JP](/content/jp/about-us/purchasing/goumaiquyinyuekuan/index.html): ベーリンガーインゲルハイムグループ購買取引約款（GTC-P) (26 words, Jan 26, 2026)
- [Åpenhet, respekt & mulighet | Boehringer Ingelheim NO](/content/no/om-oss/hvem-vi-er/kultur/apenhet-respekt-mulighet/index.html): Hos Boehringer Ingelheim tror vi at innovasjon ikke skjer i siloer. Den oppstår når ulike ideer, perspektiver, erfaringer, kunnskap og ferdigheter møtes. (251 words, Jan 26, 2026)
- [Åbenhed, respekt og muligheder | Boehringer Ingelheim DK](/content/dk/om-os/hvem-vi-er/kultur/abenhed-respekt-og-muligheder/index.html): Hos Boehringer Ingelheim tror vi på, at innovation ikke sker, når vi er hver for sig. Den opstår, når forskellige idéer, perspektiver, erfaringer, viden og færdigheder mødes. (269 words, Jan 26, 2026)
- [Amikor minden levegővétel küzdelem | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/tudofibrozis/amikor-minden-levegovetel-kuzdelem/index.html): „Amikor minden levegővétel küzdelem” – Egy ritka, nehezen diagnosztizálható betegség, amely lassan felemészti a tüdőt. (806 words, Jan 26, 2026)
- [Új kutatási együttműködés a cukorbetegség okozta vakság elleni küzdelemben | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/uj-kutatasi-egyuttmukodes-cukorbetegseg-okozta-vaksag-elleni-kuzdelemben.html): Új kutatási együttműködés a cukorbetegség okozta vakság elleni küzdelemben. (717 words, Jan 26, 2026)
- [Nem csak a vércukor számít | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/nem-csak-vercukor-szamit/index.html): Sokan nincsenek tisztában azzal, hogy a cukorbetegség nemcsak emelkedett vércukorszinttel jár, hanem számos, sokszor rejtett társbetegséggel is. (590 words, Jan 26, 2026)
- [Ruta 86 Cantabria, País Vasco y Navarra | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86-cantabria-pais-vasco-y-navarra/index.html): Ruta 86 Cantabria, País Vasco y Navarra (1,213 words, Jan 23, 2026)
- [Improving early detection of heart murmur in dogs with AI-powered tool | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/improving-early-detection-heart-murmur-dogs-ai-powered-tool.html): Learn how AI-powered tools help veterinarians to spot canine heart murmurs early, reducing missed diagnoses and improving treatment outcomes. (1,213 words, Jan 22, 2026)
- [Why we lift up the patient voice: When patients speak, systems change | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/why-we-lift-patient-voice-when-patients-speak-systems-change.html): “We all have agency,” says Steve Jones of Action for Pulmonary Fibrosis. For patient advocates, that means translating lived experience into policy outcomes. (1,191 words, Jan 22, 2026)
- [Our FOCUS: Nuestro marco cultural | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/our-focus-nuestro-marco-cultural/index.html): Our FOCUS es el marco cultural de nuestra compañía. Abarca nuestra identidad, la explicación de por qué existimos, brinda orientación sobre cómo queremos interactuar y describe cuáles son nuestros objetivos. (429 words, Jan 21, 2026)
- [Kardiyo-renal-metabolik hastalıklar hakkında | Boehringer Ingelheim TR](/content/tr/human-health/chronic-kidney-disease/kardiyo-renal-metabolik-hastaliklar-hakkinda/index.html): Kardiyovasküler, renal ve metabolik sistemler birbirleriyle sıkı sıkıya bağlantılıdır ve aynı risk faktörlerinin çoğunu paylaşırlar.1,2 (320 words, Jan 21, 2026)
- [Kronik Böbrek Hastalığı Hakkında | Boehringer Ingelheim TR](/content/tr/human-health/chronic-kidney-disease/kronik-bobrek-hastaligi-hakkinda/index.html): Böbrekler vücudun en çok çalışan organlarından biridir. İçlerinde "nefron" adı verilen milyonlarca küçük filtre bulunur. Bu filtreler birlikte çalışarak kanı temizler; atık maddeleri ve fazla sıvıyı idrara dönüştürerek vücuttan atar. (416 words, Jan 21, 2026)
- [Emergency Use Authorization to Help Protect Cattle Against New World Screwworm | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/ruminants/emergency-use-authorization-help-protect-cattle-against-new-world-screwworm.html): This is the first EUA for any over-the-counter drug for the prevention of infestations caused by NWS in cattle. (786 words, Jan 20, 2026)
- [How biologics are made | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/how-biologics-are-made-bioxcellence/index.html): Learn how biological medicines are created – from cell modification and cultivation to purification and final aseptic filling. (366 words, Jan 20, 2026)
- [Green driving to the future: Boehringer Ingelheim RCV goes for sustainable mobility | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/green-driving-future-boehringer-ingelheim-rcv-goes-sustainable-mobility.html): Sustainability is a key pillar of our global strategy. A major lever in achieving this is the shift toward environmentally friendly mobility solutions. (516 words, Jan 19, 2026)
- [Addressing unmet inflammatory bowel disease needs | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/addressing-unmet-inflammatory-bowel-disease-needs/index.html): Boehringer partners with Simcere to develop a bispecific antibody that simultaneously inhibits two drivers of inflammatory bowel disease. (622 words, Jan 19, 2026)
- [Why biomarker testing matters in cancer care | Boehringer Ingelheim](/content/human-health/cancer/why-biomarker-testing-matters-cancer-care/index.html): Learn how biomarker testing helps make informed decisions in cancer care and find answers to the most relevant questions. (932 words, Jan 19, 2026)
- [ベーリンガーインゲルハイム、日本でも「Top Employer」に初認定。職場環境、人財育成やキャリア開発が高評価 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-26-0116/index.html): 日本ベーリンガーインゲルハイム株式会社は、日本におけるベーリンガーインゲルハイムとして、Top Employers Institute（トップ・エンプロイヤー・インスティテュート、本部：オランダ・アムステルダム）より、「Top Employer 2026 （トップ・エンプ ロイヤー 2026）」に認定されました。 (35 words, Jan 15, 2026)
- [Boehringer Ingelheim es reconocida como Top Employer por 11º año consecutivo en España y 6º a nivel global | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/boehringer-ingelheim-es-reconocida-como-top-employer-por-11o-ano-consecutivo-en-espana-y-6o-nivel.html): La compañía farmacéutica destaca en las categorías de formación y desarrollo profesional, fomento de un entorno laboral saludable e impulso de cultura, valores y propósito corporativos. (677 words, Jan 15, 2026)
- [Animal Health Partnering Contacts | Boehringer Ingelheim AT](/content/at/en/partnering/animal-health-partnering/connect-us/animal-health-partnering-contacts/index.html): Partnership and diversity of thought are powerful drivers of innovation. If you have a project you would like to discuss please reach out to us. (1,005 words, Jan 15, 2026)
- [Virtuelle Praxis für klinische Studien – Einfach. Zugänglich. Informativ. | Boehringer Ingelheim DE](/content/de/humanmedizin/virtuelle-praxis-fuer-klinische-studien-einfach-zugaenglich-informativ.html): Virtuelle Praxis für klinische Studien – Einfach. Zugänglich. Informativ. (403 words, Jan 15, 2026)
- [Boehringer Ingelheim ist Top-Arbeitgeber | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/boehringer-ingelheim-ist-top-arbeitgeber/index.html): Boehringer Ingelheim ist zum 6. Mal „Global Top Employer“. Mit einem Arbeitsumfeld, das berufliche Entwicklung und Wohlbefinden in den Mittelpunkt stellt. (459 words, Jan 14, 2026)
- [Openheid, Respect en Kansen | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/cultuur/openheid-respect-en-kansen/index.html): Onze mensen stimuleren innovatie – in een werkomgeving waar iedereen kan groeien. (258 words, Jan 14, 2026)
- [Ouverture, Respect & Opportunités | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/qui-sommes-nous/culture/ouverture-respect-opportunites/index.html): Notre personnel est le moteur de l'innovation – dans un environnement de travail où chacun peut évoluer. (235 words, Jan 14, 2026)
- [Openheid, Respect en Kansen | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/cultuur/openheid-respect-en-kansen/index.html): Bij Boehringer Ingelheim geloven we dat innovatie niet geïsoleerd plaatsvindt, maar samen met anderen. Innovatie ontstaat wanneer verschillende ideeën, perspectieven, ervaringen, kennis en vaardigheden samenkomen. (266 words, Jan 14, 2026)
- [Jaime's Story | Boehringer Ingelheim AU](/content/au/human-health/chronic-kidney-disease/jaimes-story/index.html): CKD Patient Story Jaime (512 words, Jan 13, 2026)
- [Boehringer Ingelheim: italiana e donna, Sara Frattini alla guida di Bidachem SPA, polo chimico lombardo del Gruppo mondiale | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/boehringer-ingelheim-italiana-e-donna-sara-frattini-alla-guida-di-bidachem-spa-polo-chimico-lombardo.html): Un percorso professionale costruito nella ricerca scientifica e consolidato attraverso ruoli di crescente responsabilità porta oggi Sara Frattini alla guida di Bidachem S.p.A (649 words, Jan 13, 2026)
- [New trial explores advancements in IPF treatment | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/new-trial-explores-advancements-ipf-treatment/index.html): Boehringer launches clinical trial exploring interleukin-11’s potential to go beyond slowing IPF and restore lung function. (441 words, Jan 13, 2026)
- [Extrapulmonales neuroendokrines Karzinom | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/extrapulmonales-neuroendokrines-karzinom/index.html): Symptome, Diagnose und Behandlungsmöglichkeiten von extrapulmonalen neuroendokrinen Karzinomen (epNEC) und wie Betroffene diesen aggressiven Krebs erleben (1,271 words, Jan 13, 2026)
- [Partnering and Innovation Outlook Animal Health 2026 | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/partnering-and-innovation-outlook-animal-health-2026.html): Megan Grether and Peter Florian share their 2025 innovation and collaboration highlights and how internal and external partnerships advance animal health (1,113 words, Jan 7, 2026)
- [Boehringer erhält positive EU Zulassung für zwei Vogelgrippe-Impfstoffe | Boehringer Ingelheim DE](/content/de/tiergesundheit/boehringer-erhaelt-positive-eu-zulassung-fuer-zwei-vogelgrippe-impfstoffe.html): Boehringer erhält positive EU Zulassung für zwei Vogelgrippe-Impfstoffe (780 words, Jan 6, 2026)
- [General Terms and Conditions of Purchase | Boehringer Ingelheim](/content/about-us/purchasing/general-terms-and-conditions-purchase/index.html): General Terms and Conditions of Purchase for the Boehringer Ingelheim Group (GTC-P) (40 words, Jan 6, 2026)
- [Global Top Employer 2026 | Boehringer Ingelheim](/content/about-us/global-top-employer-2026/index.html): This year’s certification underpins the company’s commitment to creating an attractive work environment, with employee well-being at its core. (440 words, Jan 6, 2026)
- [「やってみたい！」が社会とつながる。 ベーリンガーインゲルハイムの社員ボランティア | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0012/index.html): ベーリンガーインゲルハイムは、独自のサステナビリティの枠組み「世代を超えた持続可能な開発SD4G（Sustainable Development for Generations) 」を展開しています。その柱の一つ、MORE POTENTIAL（社員と社会のために）では、社員が自分の興味に基づき積極的に社会貢献できるよう、ボランティア活動を支援しています。先日大崎本社で実施された3つの活動をレポートします。 (53 words, Jan 5, 2026)
- [百靈佳殷格翰致力全球永續經營，啟動呼吸道產品綠色轉型 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/bailingjiayingehanzhiliquanqiuyongxujingyingqidonghuxidaochanpinlusezhuanxing.html): 百靈佳殷格翰致力全球永續經營，啟動呼吸道產品綠色轉型 (59 words, Dec 25, 2025)
- [Comprendre le cancer du poumon à petites cellules | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/cancer-du-poumon/comprendre-le-cancer-du-poumon-petites-cellules/index.html): Apprenez-en davantage sur le cancer du poumon à petites cellules, notamment ses symptômes et ses options de traitement. (485 words, Dec 18, 2025)
- [Elisa López, Mafalda Pedro y Annalisa Scollo, ganadoras de los European PRRS Research Awards | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/porcino/elisa-lopez-mafalda-pedro-y-annalisa-scollo-ganadoras-de-los-european-prrs-research-awards.html): Sus propuestas recibirán 25.000€ con el objetivo de impulsar el desarrollo de métodos prácticos para el control del PRRS y reconocer los logros científicos (396 words, Dec 18, 2025)
- [Los Premios BVDZero España 2025 reconocen al veterinario Federico Prieto como primer clasificado | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/los-premios-bvdzero-espana-2025-reconocen-al-veterinario-federico-prieto-como-primer-clasificado.html): El objetivo de los Premios BVDZero es el de promover el interés por la Diarrea Vírica Bovina en todos sus aspectos y su investigación con ánimo divulgativo (326 words, Dec 18, 2025)
- [Advancing animal health with innovation and collaboration | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/advancing-animal-health-innovation-and-collaboration.html): Our infographic shows how we’re investing in the future by applying R&D and external collaboration to accelerate innovation and advance animal health. (262 words, Dec 16, 2025)
- [新生血管性加齢黄斑変性症（ウェットAMD） | Boehringer Ingelheim JP](/content/jp/node/33700/index.html): 当社は、加齢黄斑変性症（AMD）などの網膜疾患を有する、またはそのリスクがある方々の網膜を保護し、視力の喪失を防ぐことを目指しています。 (58 words, Dec 16, 2025)
- [Boehringer Ingelheim est partenaire du Hub Prévention Cardiovasculaire mis en place par les Hospices Civils de Lyon | Boehringer Ingelheim FR](/content/fr/sante-humaine/maladies-cardiovasculaires/boehringer-ingelheim-est-partenaire-du-hub-prevention-cardiovasculaire-mis-en-place-par-les-hospices.html): Le 16 octobre 2025, les Hospices Civils de Lyon ont ouvert le premier Hub Prévention Cardiovasculaire à l’Hôpital Louis Pradel, afin de réduire les facteurs de risque cardio-vasculaire et métabolique. (612 words, Dec 15, 2025)
- [Полезна информация за живот с ИББ | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/helpful-information-about-living-ild/index.html): Полезна информация за живот с ИББ – симптоми, диагноза, лечение и подкрепа. Свалете брошурата за практически съвети и насоки. (375 words, Dec 15, 2025)
- [Boehringer Ingelheim Expands Research and Development in Athens, Georgia | Boehringer Ingelheim US](/content/us/animal-health/trends-insights/boehringer-ingelheim-expands-research-and-development-athens-georgia.html): As the largest animal health company in Georgia, this Boehringer state-of-the-art facility reflects the company's commitment to innovation and improving the health and well-being of animals. (642 words, Dec 12, 2025)
- [Strengthening Communities Through Animal Health: Boehringer Ingelheim Cares Foundation Provides Critical Medicine Donations | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/strengthening-communities-through-animal-health-boehringer-ingelheim-cares-foundation-provides.html): Working with 169 nonprofit organizations and shelters nationwide, the Foundation distributed vital medicines including vaccines, parasite treatments, and pain medications to areas facing substantial veterinary care shortages. (386 words, Dec 12, 2025)
- [Building tomorrow's leaders through STEM | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/building-tomorrows-leaders-through-stem/index.html): STEM Day, powered by the Boehringer Ingelheim Cares Foundation, connects students with hands-on science and technology, inspiring innovation and empowering future leaders. (514 words, Dec 12, 2025)
- [Animal Health Partnering Contacts | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/connect-us/animal-health-partnering-contacts/index.html): Partnership and diversity of thought are powerful drivers of innovation. If you have a project you would like to discuss please reach out to us. (524 words, Dec 12, 2025)
- [Código de Conducta | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/codigo-de-conducta/index.html): Nuestro Código de Conducta establece los estándares éticos que guían todas nuestras actividades comerciales. Se trata de todos nosotros. Cada persona desempeña un papel fundamental para dar vida al Código de Conducta. (323 words, Dec 11, 2025)
- [FDA approves HERNEXEOS first line lung cancer | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/fda-approves-hernexeos-first-line-lung-cancer/index.html): FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option (1,402 words, Dec 11, 2025)
- [Umwelt | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/umwelt/index.html): Lieferanten sollen umweltbewusst und effizient handeln, Ressourcen schonen, Wiederverwendung und Recycling fördern und möglichst Gefahrstoffe vermeiden. (386 words, Dec 10, 2025)
- [Pitching for Partnerships in Animal Health | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/pitching-partnerships-animal-health-0/index.html): Early-stage partnerships are essential for driving innovation, yet startups face challenges in building connections. See our top tips for pitch success. (1,050 words, Dec 10, 2025)
- [Investigadores, autoridades y profesionales analizan el avance de la influenza aviar en España | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/avicultura/investigadores-autoridades-y-profesionales-analizan-el-avance-de-la-influenza-aviar-en-espana.html): El encuentro, celebrado bajo el título “Unidos frente al desafío” y organizado por Boehringer Ingelheim, puso de relieve la necesidad de reforzar la coordinación entre todos los agentes implicados para mejorar la preparación ante futuros brotes. (724 words, Dec 10, 2025)
- [Offenheit, Respekt und Chancengleichheit | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/offenheit-respekt-und-chancengleichheit/index.html): Bei Boehringer Ingelheim treiben unsere Mitarbeitenden Innovationen voran – in einem von Offenheit, Respekt und Chancengleichheit geprägten Arbeitsumfeld. (331 words, Dec 9, 2025)
- [Krebsforschung | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/krebsforschung/index.html): Find out more about our research and development in oncology and cancer immunology. (626 words, Dec 9, 2025)
- [神戸医薬研究所 国際的な第三者機関 テュフ ラインランドより、カーボンニュートラル認証（脱炭素化認証）を取得 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-1212/index.html): 日本ベーリンガーインゲルハイムの神戸医薬研究所は、このたび、ISO 14064-1規格および温室効果ガス・プロトコルに準拠した枠組みに基づき、国際的な第三者機関であるテュフ ラインランド（TÜV Rheinland、本部ドイツ）の審査を経て、当研究所の事業活動におけるカーボンニュートラル（Scope1・2）の認証を取得しました。 (33 words, Dec 9, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (255 words, Dec 8, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (254 words, Dec 8, 2025)
- [Samenwerken aan paraatheid: wat blauwtong ons leert over grensoverschrijdende dierziekten | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/samenwerken-aan-paraatheid-wat-blauwtong-ons-leert-over-grensoverschrijdende-dierziekten.html): Kars ten Have, Head of Animal Health bij Boehringer Ingelheim Nederland (573 words, Dec 8, 2025)
- [Digitale Innovation | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/digitale-innovation/index.html): Digitale Innovationen und künstliche Intelligenz (KI) treiben Arzneimittelforschung und pharmazeutische Entwicklung an. (732 words, Dec 8, 2025)
- [Digital bioproduction | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/digital-bioproduction-bioxcellence/index.html): Discover how digital innovation, process design & strategic facility planning are redefining biologics manufacturing & the future of downstream processing. (217 words, Dec 8, 2025)
- [Understanding feline diabetes: from awareness to action | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/understanding-feline-diabetes-awareness-action/index.html): Learn about early signs of feline diabetes and protect your cat’s health. Discover risk factors, prevention tips, and practical steps for early detection. (845 words, Dec 8, 2025)
- [Boehringer advances obesity treatment to mid-stage development | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/boehringer-advances-obesity-treatment-mid-stage-development.html): Boehringer advances long‑acting potential first-in-class triple‑agonist peptide obesity compound BI 3034701 (404 words, Dec 8, 2025)
- [FDA Approves Targeted Therapy for HER2-Mutant Advanced NSCLC | Boehringer Ingelheim US](/content/us/human-health/cancer/lung-cancer/fda-approves-targeted-therapy-her2-mutant-advanced-nsclc.html): U.S. FDA grants accelerated approval to first targeted therapy for treatment-naive patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (1,159 words, Dec 5, 2025)
- [Nuestras Expectativas | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/nuestras-expectativas/index.html): Esperamos una adhesión ejemplar a una conducta ética y profesional tanto dentro de la compañía como por parte de nuestros socios comerciales. (685 words, Dec 5, 2025)
- [Prácticas Comerciales Éticas | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/practicas-comerciales-eticas/index.html): Los proveedores deberán llevar a cabo sus actividades comerciales de manera ética y actuar con integridad. (2,049 words, Dec 5, 2025)
- [Derechos Laborales y Derechos Humanos | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/derechos-laborales-y-derechos-humanos/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (581 words, Dec 5, 2025)
- [Medio ambiente | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/medio-ambiente/index.html): Los proveedores deberán operar de manera responsable y eficiente para minimizar los impactos adversos sobre el medio ambiente. (508 words, Dec 5, 2025)
- [Salud y seguridad | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/salud-y-seguridad/index.html): Los proveedores deberán proporcionar un entorno de trabajo seguro y saludable, lo que también incluirá cualquier alojamiento proporcionado por la empresa. (307 words, Dec 5, 2025)
- [Sistemas de gestión | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/sistemas-de-gestion/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (435 words, Dec 5, 2025)
- [Preguntas e inquietudes | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/preguntas-e-inquietudes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (212 words, Dec 5, 2025)
- [Código de Conducta para Proveedores | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/codigo-de-conducta-para-proveedores/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (575 words, Dec 5, 2025)
- [Código de Conducta para Proveedores | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/etica-y-compliance/codigo-de-conducta-para-proveedores-0/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (90 words, Dec 5, 2025)
- [한국베링거인겔하임, 특발성 폐섬유증 치료 환경 개선 위한 환자 간담회 개최 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaim-teugbalseong-pyeseomyujeung-chilyo-hwangyeong-gaeseon-wihan-hwanja.html): 한국베링거인겔하임, 특발성 폐섬유증 치료 환경 개선 위한 환자 간담회 개최 (569 words, Dec 5, 2025)
- [Richtlijnen als kompas: waarom we bij diabetes sneller moeten handelen | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/richtlijnen-als-kompas-waarom-we-bij-diabetes-sneller-moeten-handelen-0.html): Marieke Hendriksen - van Dongen, Hoofd Therapeutisch Gebied Cardio-Renaal-Metabool (336 words, Dec 4, 2025)
- [Medizinische Versorgung für Menschen mit Lungenfibrose | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/medizinische-versorgung-fuer-menschen-mit-lungenfibrose.html): Dr. Traugott Gruppe spricht über die zu späte Diagnose der Lungenfibrose, die unzureichende Versorgungslage und wie neue Therapieansätze Hoffnung geben. (528 words, Dec 4, 2025)
- [ESNEFT ILD Tier 2 Pathway Development Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/esneft-ild-tier-2-pathway-development-executive-summary.html): ESNEFT ILD Tier 2 Pathway Development Executive Summary (490 words, Dec 3, 2025)
- [Educazione al Possesso Responsabile al via il progetto nelle scuole di Roma | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/educazione-al-possesso-responsabile-al-il-progetto-nelle-scuole-di-roma.html): È stato presentato oggi in Campidoglio, nella Sala Carroccio, il progetto “Possesso Responsabile” (765 words, Dec 3, 2025)
- [5 cosas que debes saber sobre la influenza aviar. | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/aves-de-corral/5-cosas-que-debes-saber-sobre-la-influenza-aviar/index.html): Una y otra vez, comunidades en todo el mundo enfrentan brotes de gripe aviar. En Boehringer Ingelheim acompañamos a los productores avícolas y veterinarios, apoyando los esfuerzos contra esta enfermedad infecciosa. (217 words, Dec 2, 2025)
- [Influenza aviar: La necesidad de prevenir desde el origen | Boehringer Ingelheim MX](/content/mx/salud-animal/ganado/aves-de-corral/influenza-aviar-la-necesidad-de-prevenir-desde-el-origen.html): La influenza aviar, un virus zoonótico persistente y en constante evolución, se ha propagado por casi todas las regiones, afectando tanto a las poblaciones de aves silvestres como a la avicultura en todo el mundo. (88 words, Dec 2, 2025)
- [Boehringer Ingelheim obtiene dos dictámenes positivos del CVMP de la Agencia Europea de Medicamentos para las vacunas frente a la gripe aviar | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/avicultura/boehringer-ingelheim-obtiene-dos-dictamenes-positivos-del-cvmp-de-la-agencia-europea-de-medicamentos.html): El Comité de Medicamentos Veterinarios (CVMP) de la Agencia Europea de Medicamentos (EMA) ha emitido dictámenes positivos para dos vacunas avícolas de Boehringer Ingelheim contra el virus de la gripe aviar subtipo H5 altamente patógeno (889 words, Dec 2, 2025)
- [Representation in Clinical Research | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/representation-clinical-research/index.html): We aim to foster trust, engagement, and inclusion across all aspects of clinical research. (103 words, Dec 1, 2025)
- [Systemy zarządzania | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/systemy-zarzadzania/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (357 words, Dec 1, 2025)
- [Zdrowie i bezpieczeństwo | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/zdrowie-i-bezpieczenstwo/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (253 words, Dec 1, 2025)
- [Środowisko | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/srodowisko/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (394 words, Dec 1, 2025)
- [Etyka w biznesie | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/etyka-w-biznesie/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (1,703 words, Dec 1, 2025)
- [Nasze Oczekiwania | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/nasze-oczekiwania/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (554 words, Dec 1, 2025)
- [The Supplier Code of Conduct Download | Boehringer Ingelheim PL](/content/pl/o-nas/etyka-i-zgodnosc-z-przepisami/supplier-code-conduct-download/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (58 words, Dec 1, 2025)
- [Representation in Clinical Research | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/representation-clinical-research/index.html): We aim to foster trust, engagement, and inclusion across all aspects of clinical research. (220 words, Nov 29, 2025)
- [Wie man sich in jeder Lebensphase um sein Pferd kümmert | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/pferde/wie-man-sich-jeder-lebensphase-um-sein-pferd-kuemmert.html): Wie man sich in jeder Lebensphase um sein Pferd kümmert (1,518 words, Nov 28, 2025)
- [Boehringer Ingelheim Türkiye, Great Place To Work® 2025 En İyi İnsan ve Kültür Liderleri Listesinde Yer Aldı | Boehringer Ingelheim TR](/content/tr/boehringer-ingelheim-turkiye-great-place-work-2025-en-iyi-insan-ve-kultur-liderleri-listesinde-yer.html): Boehringer Ingelheim Türkiye, Great Place To Work® 2025 En İyi İnsan ve Kültür Liderleri Listesinde Yer Aldı (413 words, Nov 28, 2025)
- [Apertura, Respeto y Oportunidad | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/cultura/apertura-respeto-y-oportunidad/index.html): En Boehringer Ingelheim, nuestra gente es el motor de la innovación, en un lugar de trabajo abierto, respetuoso y con igualdad de oportunidades en el que todo el mundo puede prosperar. (291 words, Nov 28, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim AU](/content/au/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (271 words, Nov 26, 2025)
- [Boehringer Ingelheim impulsa nuevas clínicas especializadas en diabetes en México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-impulsa-nuevas-clinicas-especializadas-en-diabetes-en-mexico.html): Boehringer Ingelheim impulsa nuevas clínicas especializadas en diabetes en México (1,047 words, Nov 26, 2025)
- [Outlook for 2025 – Partnering for Innovation in Animal Health | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/perspectives/outlook-2025-partnering-innovation-animal-health/index.html): Megan Grether, Global Head of Business Development and Licensing, Animal Health, shares her perspectives on partnering for innovation in 2025 (1,215 words, Nov 26, 2025)
- [Therapeutic Vaccines in Animal Health for Chronic Disease in Pets | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/perspectives/therapeutic-vaccines-animal-health-chronic-disease-pets.html): Boehringer Ingelheim scientists are exploring how therapeutic vaccines in animal health could hold the key to tackling chronic disease in pets. (1,339 words, Nov 26, 2025)
- [Partnering for Animal Health Innovation | Boehringer Ingelheim CA](/content/ca/partnering/animal-health-partnering/connect-us/partnering-animal-health-innovation/index.html): Meet our animal health partnering team, explore our partnering interests and learn how we can advance innovation together at BIO International 2025 (500 words, Nov 26, 2025)
- [Nachhaltige Arzneimittel für weniger Umweltbelastung | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/nachhaltige-arzneimittel-fuer-weniger-umweltbelastung.html): Wie wir mit renommierten Expert*innen zusammenarbeiten, um bei der Reduktion von Lösungsmittelabfällen eine Vorreiterrolle einzunehmen, als Teil unserer Bemühungen, Nachhaltigkeit in unser Kerngeschäft zu integrieren. (139 words, Nov 26, 2025)
- [Sustainable medicines that help minimize environmental impact | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/sustainable-medicines-help-minimize-environmental-impact.html): How we collaborate with renowned experts to lead the way in reducing solvent waste, as part of our efforts to embed sustainability into our core business. (1,004 words, Nov 26, 2025)
- [Unsere Initiative für Gesundheit und Sicherheit – BE SAFE | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/unsere-initiative-fuer-gesundheit-und-sicherheit-be-safe.html): Gesundheit und Sicherheit sind für Boehringer Ingelheim von großer Bedeutung. (464 words, Nov 26, 2025)
- [Our Health and Safety initiative - BE SAFE | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/our-health-and-safety-initiative-be-safe/index.html): Health and safety are of great importance to Boehringer Ingelheim. (373 words, Nov 26, 2025)
- [百靈佳殷格翰-母豬使用CircoFLEX之效益 | Boehringer Ingelheim TW](/content/tw/bailingjiayingehan-muzhushiyongcircoflexzhixiaoyi/index.html): 百靈佳殷格翰-母豬使用CircoFLEX之效益 (106 words, Nov 26, 2025)
- [Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/footballs-yellow-card-becomes-call-action-cardiovascular-renal-and-metabolic-health-boehringer.html): Boehringer Ingelheim’s CRM United event in Dubai used football’s universal language to raise awareness about the interconnectivity between cardiovascular, renal, and metabolic (CRM) diseases. (658 words, Nov 25, 2025)
- [제35회 분쉬의학상 본상에 서울의대 오도연 교수 선정 | Boehringer Ingelheim KR](/content/kr/je35hoe-bunswiuihagsang-bonsange-seouluidae-odoyeon-gyosu-seonjeong.html): 제35회 분쉬의학상 본상에 서울의대 오도연 교수 선정 (613 words, Nov 25, 2025)
- [한국베링거인겔하임, '폐암 인식 증진의 달' 맞아 비소세포폐암 환자 일상 체험… 'A Life in a Day' 진행 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaim-pyeam-insig-jeungjinui-dal-maja-bisosepopyeam-hwanja-ilsang-cheheom-life.html): 한국베링거인겔하임, '폐암 인식 증진의 달' 맞아 비소세포폐암 환자 일상 체험… 'A Life in a Day' 진행 (565 words, Nov 25, 2025)
- [Boehringer Ingelheim unterstützt VETHiLFE-Hotline​ | Boehringer Ingelheim DE](/content/de/tiergesundheit/boehringer-ingelheim-unterstuetzt-vethilfe-hotline/index.html): Boehringer Ingelheim unterstützt VETHiLFE-Hotline​ (618 words, Nov 24, 2025)
- [Cancer du poumon non à petites cellules | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/cancer-du-poumon/cancer-du-poumon-non-petites-cellules/index.html): Apprenez-en davantage sur le cancer du poumon non à petites cellules, notamment ses symptômes et ses options de traitement. (672 words, Nov 21, 2025)
- [Le cancer est l’un des plus grands défis de l’humanité | Boehringer Ingelheim CA](/content/ca/fr/sante-humaine/cancer/le-cancer-est-lun-des-plus-grands-defis-de-lhumanite.html): L’oncologie est l’un des domaines où les besoins non satisfaits sont les plus importants dans l’ensemble du secteur des soins de santé. (459 words, Nov 21, 2025)
- [Royal Free Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/royal-free-executive-summary/index.html): Royal Free Executive Summary (638 words, Nov 20, 2025)
- [Nachhaltigkeit im Unternehmen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/nachhaltigkeit-im-unternehmen/index.html): Wir fördern nachhaltige Projekte bei Boehringer Ingelheim – mit bis zu 7,5 Millionen Euro jährlich aus unserem Green Fund und dem Ziel CO₂-Neutralität 2030. (1,002 words, Nov 20, 2025)
- [Кодекс поведінки постачальника | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (494 words, Nov 20, 2025)
- [Think Lungs. Think Ahead. | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/think-lungs-think-ahead/index.html): Why awareness of Interstitial Lung Disease matters now more than ever. (1,019 words, Nov 20, 2025)
- [Системи управління | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (341 words, Nov 20, 2025)
- [Питання та проблеми | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (179 words, Nov 20, 2025)
- [Can Healthcare Drive the UK’s Economic Growth? | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/can-healthcare-drive-uks-economic-growth/index.html): How can we demonstrate the economic value for investment in healthcare? Explore insights from senior experts in our Healthy Returns report (331 words, Nov 19, 2025)
- [Vielfalt im Unternehmen | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/vielfalt-im-unternehmen/index.html): Generationenvielfalt, kulturelle Vielfalt, Geschlechtervielfalt: Erfahre, wie Boehringer Ingelheim Vielfalt im Unternehmen lebt. (373 words, Nov 19, 2025)
- [ベーリンガーインゲルハイム社との提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/partnering-boehringer-ingelheim/index.html): 患者さんのために新しく優れた医薬品を作ること、これが当社の取り組みの中心にあります。そして、患者さんのため先進的なイノベーションを達成するうえで 、ライフサイエンス分野のパートナーとの提携は重要な役割を果たしています (6 words, Nov 19, 2025)
- [境界を越えた研究の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/research-beyond-borders-partnering/index.html): 「境界を超える」とは、科学研究 を実施する方法にも当てはまります。 (34 words, Nov 19, 2025)
- [Kodex chování dodavatelů | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/kodex-chovani-dodavatelu/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (449 words, Nov 19, 2025)
- [Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/boehringer-ingelheim-obtains-two-eu-cvmp-positive-opinions-avian-influenza-vaccines.html): The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Veterinary Use (CVMP) has adopted positive opinions for two Boehringer poultry vaccines against the highly pathogenic H5 avian influenza virus. (667 words, Nov 18, 2025)
- [Exeter and Torbay Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/exeter-and-torbay-executive-summary/index.html): Exeter and Torbay Executive Summary (484 words, Nov 18, 2025)
- [Zdraví a bezpečnost | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/zdravi-bezpecnost/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (243 words, Nov 18, 2025)
- [Nuestras Expectativas | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/nuestras-expectativas/index.html): Esperamos una adhesión ejemplar a una conducta ética y profesional tanto dentro de la empresa como por parte de nuestros socios comerciales. (691 words, Nov 18, 2025)
- [Prácticas Comerciales Éticas | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/practicas-comerciales-eticas/index.html): Los proveedores deberán llevar a cabo su actividad de manera ética y actuar con integridad. (2,067 words, Nov 18, 2025)
- [Systém řízení | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/system-rizeni/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (339 words, Nov 18, 2025)
- [Derechos Laborales y Derechos Humanos | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/derechos-laborales-y-derechos-humanos/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (557 words, Nov 18, 2025)
- [Medio ambiente | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/medio-ambiente/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (482 words, Nov 18, 2025)
- [Kladení otázek | Boehringer Ingelheim CZ](/content/cz/o-nas/etika-compliance/kladeni-otazek/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (183 words, Nov 18, 2025)
- [Salud y seguridad | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/salud-y-seguridad/index.html): Los proveedores deberán proporcionar un entorno de trabajo seguro y saludable, lo que también incluirá cualquier alojamiento proporcionado por la empresa. (283 words, Nov 18, 2025)
- [Sistemas de gestión | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/sistemas-de-gestion/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (409 words, Nov 18, 2025)
- [Preguntas e inquietudes | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/preguntas-e-inquietudes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (219 words, Nov 18, 2025)
- [Descargar el Código de Conducta para Proveedores | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/descargar-el-codigo-de-conducta-para-proveedores/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (163 words, Nov 18, 2025)
- [Beats of Change: Lynn’s story with CVD and CKD | Boehringer Ingelheim IE](/content/ie/human-health/chronic-kidney-disease/beats-change-lynns-story-cvd-and-ckd/index.html): Protecting your kidneys can protect your heart. Discover why early urine (UACR) testing for chronic kidney and cardiovascular diseases could save your life. (466 words, Nov 18, 2025)
- [About Chronic Kidney Disease | Boehringer Ingelheim IE](/content/ie/human-health/chronic-kidney-disease/about-chronic-kidney-disease/index.html): CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes. (435 words, Nov 18, 2025)
- [Beats of Change: Lynn’s story with CVD and CKD | Boehringer Ingelheim UK](/content/uk/human-health/chronic-kidney-disease/beats-change-lynns-story-cvd-and-ckd/index.html): Protecting your kidneys can protect your heart. Discover why early urine (UACR) testing for chronic kidney and cardiovascular diseases could save your life. (466 words, Nov 18, 2025)
- [About Chronic Kidney Disease | Boehringer Ingelheim UK](/content/uk/human-health/chronic-kidney-disease/about-chronic-kidney-disease/index.html): CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes. (439 words, Nov 18, 2025)
- [Código de Conducta para Proveedores | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/codigo-de-conducta-para-proveedores/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (626 words, Nov 18, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/openness-respect-and-opportunity/index.html): 우리의 혁신은 사람으로부터, 그리고 모두가 성장할 수 있는 일터에서 시작됩니다. (216 words, Nov 18, 2025)
- [為天空的守護者而跑｜2025國家地理雜誌野生動物路跑 | Boehringer Ingelheim TW](/content/tw/xinwenzhongxin/weitiankongdeshouhuzheerpao2025guojiadelizazhiyeshengdongwulupao.html): 為天空的守護者而跑｜2025國家地理雜誌野生動物路跑 (30 words, Nov 18, 2025)
- [Fábrica de Saúde Animal em Paulínia (SP) conquista Selo Ouro Carbono Zero | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/fabrica-de-saude-animal-em-paulinia-sp-conquista-selo-ouro-carbono-zero.html): Um passo de ouro rumo a um futuro carbono zero: a unidade de Saúde Animal em Paulínia recebeu o Selo Ouro Carbono Zero, reforçando seu compromisso com emissões zeradas e sustentabilidade. (436 words, Nov 17, 2025)
- [Código de Conduta do Fornecedor | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/codigo-de-conduta-do-fornecedor/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (598 words, Nov 17, 2025)
- [Nossas Expectativas | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/nossas-expectativas/index.html): Esperamos a adesão a uma conduta ética e profissional exemplar, tanto dentro da empresa quanto por parte de nossos parceiros de negócios. (659 words, Nov 17, 2025)
- [Direitos Humanos & Trabalhistas | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/direitos-humanos-trabalhistas/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (542 words, Nov 17, 2025)
- [L’importanza del test dei biomarcatori nel tumore al polmone | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/limportanza-del-test-dei-biomarcatori-nel-tumore-al-polmone.html): L’importanza di conoscere lo stato dei biomarcatori è indispensabile per prendere decisioni mediche informate. (2,126 words, Nov 17, 2025)
- [Saúde e Segurança | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/saude-e-seguranca/index.html): Os fornecedores devem oferecer um ambiente de trabalho seguro e saudável, incluindo quaisquer dependências fornecidas pela empresa. (270 words, Nov 17, 2025)
- [Capacity Update Oct 25 | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/capacity-update-oct-25-bioxcellence/index.html): Discover in this webinar how Boehringer Ingelheim BioXcellence™ turns biologic innovations into commercial successes with global manufacturing services. (243 words, Nov 17, 2025)
- [Dúvidas ou Preocupações | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/duvidas-ou-preocupacoes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (221 words, Nov 17, 2025)
- [Baixe o Código de Conduta do Fornecedor | Boehringer Ingelheim BR](/content/br/sobre-nos/etica-e-compliance/baixe-o-codigo-de-conduta-do-fornecedor/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (60 words, Nov 17, 2025)
- [FOCUS CKD in GPS Healthcare Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/focus-ckd-gps-healthcare-executive-summary/index.html): FOCUS CKD in GPS Healthcare Executive Summary (302 words, Nov 16, 2025)
- [Partnering for innovation in animal health | Boehringer Ingelheim CA](/content/ca/partnering/partnering-innovation-animal-health/index.html): Discover Boehringer Ingelheim’s animal health partnering interests and explore collaboration opportunities to advance veterinary innovation. (765 words, Nov 14, 2025)
- [Umweltschutz im Unternehmen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/umweltschutz-im-unternehmen/index.html): Bei Boehringer Ingelheim stärken wir das Umweltbewusstsein unserer Mitarbeitenden – für gelebte Nachhaltigkeit in unserem Unternehmen und im Alltag. (594 words, Nov 14, 2025)
- [Driving mental health reform through collective action | Boehringer Ingelheim](/content/human-health/mental-health/driving-mental-health-reform-through-collective-action.html): To turn real voices and personal experience data (PED) into lasting change, mental health must be embedded in a holistic approach to care. (807 words, Nov 13, 2025)
- [Geschlechtervielfalt | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/geschlechtervielfalt/index.html): Bei Boehringer Ingelheim fördern wir Chancengleichheit – unabhängig von Geschlecht oder sexueller Orientierung. Erfahren Sie mehr über unsere Vision. (36 words, Nov 13, 2025)
- [External Research Studies (IIS/ECR) | Boehringer Ingelheim](/content/pro/funding/external-research-studies/index.html): Learn about Investigator-Initiated Studies (IIS/ECR) opportunities and Boehringer Ingelheim's key areas of scientific interest for external research. (299 words, Nov 13, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): Our people power innovation – in a workplace where everyone can thrive. (266 words, Nov 12, 2025)
- [Transparence, Respect et Occasion | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/culture/transparence-respect-et-occasion/index.html): Nos employé·e·s stimulent l’innovation – dans un milieu de travail où chacun·e peut s’épanouir. (308 words, Nov 12, 2025)
- [Therapeutische Modalitäten und Plattformen | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/therapeutische-modalitaeten-und-plattformen/index.html): Wir verfolgen einen biologisch orientierten, modalitätenoffenen Ansatz – nach Bedürfnissen der Patient*innen, unter Berücksichtigung biologischer Aspekte. (384 words, Nov 12, 2025)
- [Our therapeutic modalities and platforms | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/our-therapeutic-modalities-and-platforms/index.html): Boehringer takes a biology-first, modality-open path—starting with patient need and letting biology guide therapeutic choices. (405 words, Nov 12, 2025)
- [Nobelpreis-Forschung inspiriert Pharmaindustrie | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/nobelpreis-forschung-inspiriert-pharmaindustrie/index.html): Nobelpreis-Forschung inspiriert die Pharmaindustrie: Wie bahnbrechende Erkenntnisse die Entwicklung neuer Therapien vorantreiben. (676 words, Nov 12, 2025)
- [Phase III AIRTIVITY trial | Boehringer Ingelheim HK](/content/hk/en/human-health/lung-diseases/phase-iii-airtivity-trial/index.html): Dr Wiebke Sauter, Clinical Development Lead for bronchiectasis, discusses the unmet needs of patients and introduces the Phase III AIRTIVITY trial (607 words, Nov 12, 2025)
- [Understanding Small Cell Lung Cancer | Boehringer Ingelheim CA](/content/ca/human-health/cancer/lung-cancer/understanding-small-cell-lung-cancer/index.html): Small cell lung cancer (SCLC) is an aggressive form of cancer known for its rapid growth and early spread to other parts of the body. (366 words, Nov 11, 2025)
- [Wasserressourcen schützen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/wasserressourcen-schuetzen/index.html): Sauberes Wasser ist ein Menschenrecht. Deshalb schützen wir bei Boehringer Ingelheim wertvolle Wasserressourcen mit Initiativen und Partnerschaften. (533 words, Nov 11, 2025)
- [Teilhabe am Arbeitsleben | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/teilhabe-am-arbeitsleben/index.html): Wir setzen uns für Teilhabe und Barrierefreiheit ein. Entdecke, wie wir bei Boehringer Ingelheim Chancengleichheit für unsere Mitarbeitenden schaffen. (874 words, Nov 11, 2025)
- [Empowering Patients to Advocate with Patient Experience Data (PED) | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/empowering-patients-advocate-patient-experience-data-ped.html): PED and lived experience-led policy go hand-in-hand. When patients are at the table, they need evidence to advocate for patient-centric interventions. (974 words, Nov 10, 2025)
- [Umwelt | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/umwelt/index.html): Umwelt (403 words, Nov 10, 2025)
- [Ethische Geschäftspraktiken | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/ethische-geschaeftspraktiken/index.html): Lieferanten sollen ihre Geschäfte auf ethische Art und Weise betreiben und mit Integrität handeln. (1,796 words, Nov 10, 2025)
- [Boehringer received FDA Commissioner’s National Priority Voucher | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/boehringer-received-fda-commissioners-national-priority-voucher.html): Boehringer awarded FDA Commissioner’s National Priority Voucher for zongertinib in patients with HER2-mutant NSCLC (1,020 words, Nov 10, 2025)
- [Nobelpreis-Forschung inspiriert Pharmaindustrie | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/nobelpreis-forschung-inspiriert-pharmaindustrie/index.html): Nobelpreis-Forschung inspiriert die Pharmaindustrie: Wie bahnbrechende Erkenntnisse die Entwicklung neuer Therapien vorantreiben. (676 words, Nov 10, 2025)
- [Nobel Prize Research Inspires Pharmaceutical Industry | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/nobel-prize-research-inspires-pharmaceutical-industry.html): Discover how Nobel Prize-winning research is shaping pharmaceutical innovation and advancing healthcare for patients worldwide. (680 words, Nov 10, 2025)
- [Computational Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/computational-innovation-0/index.html): we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies. (1,171 words, Nov 10, 2025)
- [Computational Innovation | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/computational-innovation-0/index.html): Bahnbrechende computergestützte Innovationen in der pharmazeutischen Forschung und Entwicklung (709 words, Nov 10, 2025)
- [Krebsforschung | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/krebsforschung/index.html): Find out more about our research and development in oncology and cancer immunology. (842 words, Nov 10, 2025)
- [CKD_NZ | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-health/ckdnz/index.html): Tackling the real cost of chronic kidney disease in New Zealand (732 words, Nov 9, 2025)
- [Extrapulmonary neuroendocrine carcinomas (epNEC): a rare and aggressive cancer explained | Boehringer Ingelheim](/content/human-health/cancer/extrapulmonary-neuroendocrine-carcinomas-epnec-rare-and-aggressive-cancer-explained.html): Experts discuss the realities and challenges of extrapulmonary neuroendocrine carcinomas (epNEC) and how Boehringer is working towards a better future (1,384 words, Nov 7, 2025)
- [Télécharger le Code de conduite des fournisseurs | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/telecharger-le-code-de-conduite-des-fournisseurs/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (81 words, Nov 7, 2025)
- [Formulation de questions et d’inquiétudes | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/formulation-de-questions-et-dinquietudes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (212 words, Nov 7, 2025)
- [Systèmes de gestion | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/systemes-de-gestion/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (464 words, Nov 7, 2025)
- [Santé et sécurité | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/sante-et-securite/index.html): Santé et sécurité (320 words, Nov 7, 2025)
- [Cancer research | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/cancer-research/index.html): Find out more about our research and development in oncology and cancer immunology. (875 words, Nov 7, 2025)
- [Environnement | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/environnement/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (503 words, Nov 7, 2025)
- [Droits du travail et droits de l’Homme | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/droits-du-travail-et-droits-de-lhomme/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (648 words, Nov 7, 2025)
- [Pratiques commerciales Éthiques | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/pratiques-commerciales-ethiques/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (2,354 words, Nov 7, 2025)
- [Nos attentes | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/nos-attentes/index.html): Nos attentes (745 words, Nov 7, 2025)
- [Відкритість, повага та можливості | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/culture/vidkritist-povaga-ta-mozhlivosti/index.html): Наші люди — рушійна сила інновацій. Ми будуємо робоче середовище, де кожен може розкривати свій потенціал. (258 words, Nov 7, 2025)
- [The impact of biomarker testing in stage 4 lung cancer | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/impact-biomarker-testing-stage-4-lung-cancer/index.html): Hear from Jenny how knowing biomarker status was essential for informed healthcare decisions in advanced lung cancer. (794 words, Nov 6, 2025)
- [Advancing animal health with innovation and collaboration | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/advancing-animal-health-innovation-and-collaboration.html): Our infographic shows how we’re investing in the future by applying R&D and external collaboration to accelerate innovation and advance animal health. (262 words, Nov 6, 2025)
- [Management Systems | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (375 words, Nov 6, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (185 words, Nov 6, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (559 words, Nov 6, 2025)
- [Descontinuidade da Vacina Recombitek® Max | Boehringer Ingelheim | Boehringer Ingelheim BR](/content/br/imprensa-historias/comunicados-regulatorios/descontinuidade-da-vacina-recombitek-max-boehringer-ingelheim.html): Informamos a descontinuidade da vacina Recombitek® Max por revisão estratégica do portfólio. Conheça Recombitek® C8. (292 words, Nov 5, 2025)
- [Descontinuidade da Vacina Feline®-4 | Boehringer Ingelheim | Boehringer Ingelheim BR](/content/br/imprensa-historias/comunicados-regulatorios/descontinuidade-da-vacina-feline-4-boehringer-ingelheim.html): Informamos a descontinuidade da vacina Feline®-4. Conheça a linha Purevax®. (310 words, Nov 5, 2025)
- [Kostenlose Gesundheitschecks in Niederösterreich | Boehringer Ingelheim AT](/content/at/de/presse/kostenlose-gesundheitschecks-niederoesterreich/index.html): Kostenlose Tests in NÖ: Eine Früherkennung der chronischen Nierenkrankheit (CKD) senkt das Risiko für Herzinfarkt, Schlaganfall und Stoffwechselprobleme. (487 words, Nov 5, 2025)
- [한국베링거인겔하임, 비 이펙트 (B-EFFECT) 캠페인 통해 희귀질환 아동 대상 정서 지원 | Boehringer Ingelheim KR](/content/kr/hangugbelinggeoingelhaim-bi-ipegteu-b-effect-kaempein-tonghae-huigwijilhwan-adong-daesang-jeongseo.html): 한국베링거인겔하임, 비 이펙트 (B-EFFECT) 캠페인 통해 희귀질환 아동 대상 정서 지원 (393 words, Nov 5, 2025)
- [Le cancer est l’un des plus grands défis de l’humanité | Boehringer Ingelheim | Boehringer Ingelheim FR](/content/fr/sante-humaine/cancer/le-cancer-est-lun-des-plus-grands-defis-de-lhumanite.html): L’oncologie constitue l’un des domaines de la santé pour lequel les besoins non satisfaits sont les plus importants. Malgré les avancées thérapeutiques, le cancer continue d’emporter des vies prématurément. (376 words, Nov 4, 2025)
- [Chancengleichheit und Vielfalt | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/chancengleichheit-und-vielfalt/index.html): Bei Boehringer Ingelheim setzen wir auf Chancengleichheit und ein respektvolles Miteinander. Erfahren Sie, wie wir Vielfalt im Unternehmen fördern. (892 words, Nov 4, 2025)
- [Chesterfield Royal Hospital Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/chesterfield-royal-hospital-executive-summary/index.html): Chesterfield Royal Hospital Executive Summary (336 words, Nov 3, 2025)
- [The Realities of epNEC: A Rare and Aggressive Cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/realities-epnec-rare-and-aggressive-cancer/index.html): Experts discuss the realities and challenges of extrapulmonary neuroendocrine carcinomas (epNEC) and how Boehringer is working towards a better future (1,368 words, Nov 3, 2025)
- [Boehringer licenses novel antibody for autoimmune diseases | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/boehringer-licenses-novel-antibody-autoimmune-diseases.html): Boehringer has licensed CDR111 from CDR-Life, an antibody-based trispecific M-gager® for autoimmune diseases. (469 words, Nov 3, 2025)
- [Formulation de questions et d’inquiétudes | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/formulation-de-questions-et-dinquietudes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (215 words, Nov 3, 2025)
- [Systèmes de gestion | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/systemes-de-gestion/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (465 words, Nov 3, 2025)
- [Wolverhampton Project Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/wolverhampton-project-executive-summary/index.html): Wolverhampton Project Executive Summary (380 words, Nov 2, 2025)
- [Rother Valley South PCN Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/rother-valley-south-pcn-executive-summary/index.html): Rother Valley South PCN Executive Summary (312 words, Nov 2, 2025)
- [Improving access to veterinary vaccines for shelter animals | Boehringer Ingelheim US](/content/us/media/press-releases/improving-access-veterinary-vaccines-shelter-animals.html): As part of a new collaboration with Boehringer Ingelheim, Shelters United members will have access to the company’s canine and feline vaccines. (774 words, Oct 31, 2025)
- [Understanding equine pain | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/understanding-equine-pain/index.html): Equine pain can arise from injury, or illness and affects the horse’s wellbeing. Because they hide signs of weakness, discomfort is often overlooked. (1,149 words, Oct 31, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim MEA](/content/mea/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (265 words, Oct 31, 2025)
- [Nos attentes | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/nos-attentes/index.html): Nos attentes (745 words, Oct 31, 2025)
- [Großprojekt im Gesundheitsbereich: Kostenfreies Diabetes-Screening für 11.000 Rumän*innen in ländlichen Gebieten | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/grossprojekt-im-gesundheitsbereich-kostenfreies-diabetes-screening-fuer-11000.html): Gratis Diabetes-Vorsorgeuntersuchungen für 11.000 Rumän*innen in ländlichen Gebieten – Boehringer Ingelheim und Caravana cu Medici ermöglichen landesweit den Zugang zu lebenswichtiger Gesundheitsversorgung. (704 words, Oct 31, 2025)
- [Télécharger le Code de conduite des fournisseurs | Boehringer Ingelheim FR](/content/fr/propos/ethique-et-compliance/telecharger-le-code-de-conduite-des-fournisseurs-0/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (81 words, Oct 31, 2025)
- [Major Healthcare Project: Free Diabetes Screening for 11,000 Rural Romanians | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/major-healthcare-project-free-diabetes-screening-11000-rural-romanians.html): Free diabetes screening for 11,000 rural Romanians—Boehringer Ingelheim and Caravana cu Medici bring vital healthcare access nationwide. (607 words, Oct 31, 2025)
- [Verhaltenskodex für Lieferanten | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/verhaltenskodex-fuer-lieferanten/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (407 words, Oct 31, 2025)
- [Proiect major în domeniul sănătății | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/o-sanatate-mai-buna/proiect-major-domeniul-sanatatii/index.html): Proiect major în domeniul sănătății: 11.000 de români din mediul rural vor beneficia de screening grautuit pentru diabet zaharat (767 words, Oct 30, 2025)
- [Timpul înseamnă viață. Fiecare minut contează în lupta cu accidentul vascular cerebral | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/accident-vascular-cerebral-ischemic/timpul-inseamna-viata-fiecare-minut-conteaza-lupta-cu-accidentul-vascular.html): Timpul înseamnă viață. Fiecare minut contează în lupta cu accidentul vascular cerebral (879 words, Oct 30, 2025)
- [Kleinzelliger Lungenkrebs (SCLC): Symptome, Diagnose, Therapie | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/kleinzelliger-lungenkrebs-sclc-symptome-diagnose-therapie.html): Small cell lung cancer (SCLC) is an aggressive form of cancer known for its rapid growth and early spread to other parts of the body. (492 words, Oct 29, 2025)
- [Nicht-kleinzelliger Lungenkrebs, NSCLC | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/nicht-kleinzelliger-lungenkrebs-nsclc/index.html): Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases. (659 words, Oct 29, 2025)
- [Boehringer licenses autoimmune disease small molecule program | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/boehringer-licenses-autoimmune-disease-small-molecule-program.html): Boehringer has licensed a small molecule program from Kyowa Kirin focused on developing potential treatments for autoimmune diseases. (618 words, Oct 29, 2025)
- [Offenheit, Respekt und Chancengleichheit | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/offenheit-respekt-und-chancengleichheit/index.html): Bei Boehringer Ingelheim treiben unsere Mitarbeiter*innen Innovationen voran – in einem Umfeld, das von Offenheit, Respekt und Chancengleichheit geprägt ist und in dem sich jede*r entfalten kann. (379 words, Oct 29, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (409 words, Oct 29, 2025)
- [H5N1: Vogelgrippe erneut im Fokus | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/gefluegel/h5n1-vogelgrippe-erneut-im-fokus/index.html): Der Vogelgrippevirus H5N1 breitet sich weiter aus. Erfahren Sie mehr über Symptome und Risiken der Geflügelpest, einer grenzüberschreitenden Tierseuche. (455 words, Oct 28, 2025)
- [Vogelgrippe aktuell: Prävention an der Quelle | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/gefluegel/vogelgrippe-aktuell-praevention-der-quelle/index.html): Vogelgrippe: Erfahren Sie mehr über Risiken für Tiere und Menschen, Vorbeugung und mögliche Impfstoffe gegen aviäre Influenza (Geflügelpest) (1,215 words, Oct 28, 2025)
- [Testen! Biomarker bei NSCLC | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/testen-biomarker-bei-nsclc/index.html): Warum der Biomarker-Test beim fortgeschrittenen nicht kleinzelligen Lungenkrebs entscheidend für die Behandlung ist (704 words, Oct 28, 2025)
- [La importancia de las pruebas de biomarcadores en el cáncer de pulmón | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/la-importancia-de-las-pruebas-de-biomarcadores-en-el-cancer-de-pulmon.html): La importancia de las pruebas de biomarcadores en el cáncer de pulmón (1,109 words, Oct 28, 2025)
- [Le Code de conduite des fournisseurs | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/le-code-de-conduite-des-fournisseurs/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (563 words, Oct 28, 2025)
- [Nos attentes | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/nos-attentes/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (745 words, Oct 28, 2025)
- [Pratiques commerciales Éthiques | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/pratiques-commerciales-ethiques/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (2,354 words, Oct 28, 2025)
- [Droits du travail et droits de l’Homme | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/droits-du-travail-et-droits-de-lhomme/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (686 words, Oct 28, 2025)
- [Santé et sécurité | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/sante-et-securite/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (320 words, Oct 28, 2025)
- [Systèmes de gestion | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/systemes-de-gestion/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (482 words, Oct 28, 2025)
- [Formulation de questions et d’inquiétudes | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/formulation-de-questions-et-dinquietudes/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (216 words, Oct 27, 2025)
- [Wie Sie Ihr Pferd vor dem West-Nil-Virus schützen können | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/wie-sie-ihr-pferd-vor-dem-west-nil-virus-schuetzen-koennen.html): Schützen Sie Ihr Pferd vor dem West Nil Virus (WNV). Aufmerksamkeit, Mückenbekämpfung und Impfung bewahren Ihren tierischen Begleiter vor schweren Folgen. (126 words, Oct 27, 2025)
- [Ansprechen von Fragen oder Bedenken | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/ansprechen-von-fragen-oder-bedenken/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (173 words, Oct 27, 2025)
- [Télécharger le Code de Conduite des fournisseurs | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/telecharger-le-code-de-conduite-des-fournisseurs/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (101 words, Oct 27, 2025)
- [Fremont spotlight | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/fremont-spotlight-bioxcellence/index.html): In this interview, Lilith Baczynski, Director of Boehringer Ingelheim BioXcellence™ in the U.S., shares more about the strengths of the Fremont facility. (856 words, Oct 24, 2025)
- [Our Expectations | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/our-expectations/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (607 words, Oct 24, 2025)
- [Ethical Business Practices | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/ethical-business-practices/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (1,835 words, Oct 24, 2025)
- [Health & Safety | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/health-safety/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (227 words, Oct 24, 2025)
- [Management Systems | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (362 words, Oct 24, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, Oct 24, 2025)
- [The Supplier Code of Conduct Download | Boehringer Ingelheim ZA](/content/za/about-us/ethics-and-compliance/supplier-code-conduct-download/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (58 words, Oct 24, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (519 words, Oct 23, 2025)
- [Our Expectations | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/our-expectations/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (607 words, Oct 23, 2025)
- [ADC manufacturing | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/adc-manufacturing/index.html): Discover how collaboration advances antibody-drug conjugate manufacturing & get insights into the large-volume making of novel biological cancer medicines. (145 words, Oct 23, 2025)
- [DPOC e tabagismo: descubra se seus pulmões estão bem | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/dpoc-e-asma/dpoc-e-tabagismo-descubra-se-seus-pulmoes-estao-bem.html): Fumante ou ex-fumante? Saiba como a DPOC afeta seus pulmões e descubra um exame simples e indolor que pode ajudar no diagnóstico precoce. (397 words, Oct 23, 2025)
- [Management Systems | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (375 words, Oct 23, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, Oct 23, 2025)
- [Onkolytische Viren: Vom Labor zur Klinik | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/onkolytische-viren-vom-labor-zur-klinik/index.html): Onkolytische Viren wie VSV-GP zielen auf Krebszellen und triggern eine Immunantwort - mit diesem Ansatz treiben wir die klinische Forschung bei Krebs voran (510 words, Oct 23, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (469 words, Oct 23, 2025)
- [Our Expectations | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/our-expectations/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (607 words, Oct 23, 2025)
- [Ethical Business Practices | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/ethical-business-practices/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (1,836 words, Oct 23, 2025)
- [Labor & Human Rights | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/labor-human-rights/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (495 words, Oct 23, 2025)
- [Environment | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/environment/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (399 words, Oct 23, 2025)
- [Health & Safety | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/health-safety/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (227 words, Oct 23, 2025)
- [Management Systems | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (362 words, Oct 23, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, Oct 23, 2025)
- [The Supplier Code of Conduct Download | Boehringer Ingelheim HK](/content/hk/en/about-us/ethics-and-compliance/supplier-code-conduct-download/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (75 words, Oct 23, 2025)
- [Carreras en la industria farmacéutica | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/carreras-en-la-industria-farmaceutica/index.html): ¿Es Boehringer Ingelheim un lugar de trabajo para ti? (1,057 words, Oct 22, 2025)
- [Nicht-kleinzelliger Lungenkrebs | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/lungenkrebs/nicht-kleinzelliger-lungenkrebs/index.html): Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases. (646 words, Oct 22, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (457 words, Oct 22, 2025)
- [Ethical Business Practices | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/ethical-business-practices/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (1,835 words, Oct 22, 2025)
- [Health & Safety | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/health-safety/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (227 words, Oct 22, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (181 words, Oct 22, 2025)
- [The Supplier Code of Conduct Download | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/supplier-code-conduct-download/index.html): Our Values - Your Values. Download the Supplier Code of Conduct. (58 words, Oct 22, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (472 words, Oct 22, 2025)
- [Management Systems | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (375 words, Oct 22, 2025)
- [Dog parasites: What you should know | Boehringer Ingelheim MEA](/content/mea/animal-health/animals-we-support/dog-parasites-what-you-should-know/index.html): From ticks, fleas, and mites to worms: there are many different parasite species that can harm your dog. Find out how to prevent and treat them here. (977 words, Oct 21, 2025)
- [objektive Ansprechrate bei therapienaiven Patient*innen mit fortgeschrittenem HER2 | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/objektive-ansprechrate-bei-therapienaiven-patientinnen-mit-fortgeschrittenem-her2.html): objektive Ansprechrate bei therapienaiven Patient*innen mit fortgeschrittenem HER2 (1,316 words, Oct 21, 2025)
- [Serkan Erkovan, Boehringer Ingelheim Türkiye’nin Hayvan Sağlığı Ülke Müdürü Oldu | Boehringer Ingelheim TR](/content/tr/serkan-erkovan-boehringer-ingelheim-turkiyenin-hayvan-sagligi-ulke-muduru-oldu.html): Serkan Erkovan, Boehringer Ingelheim Türkiye’nin Hayvan Sağlığı Ülke Müdürü Oldu (376 words, Oct 21, 2025)
- [Brookside Group Practice Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/brookside-group-practice-executive-summary/index.html): Read about FOCUS CKD in Brookside Group Practice: Facilitating Optimal Care Using Smart technologies in Chronic Kidney Disease (303 words, Oct 20, 2025)
- [Social impact investing in Africa | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/social-impact-investing-africa/index.html): Through Boehringer Ingelheim’s social impact investment fund, Farm Alert, a visionary social enterprise is transforming animal care in West Africa. (1,078 words, Oct 20, 2025)
- [Biotherapeutics Discovery | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-focus/biotherapeutics-discovery/index.html): Driven by patients, Boehringer Ingelheim pioneers biotherapeutics to tackle unmet needs through innovation, precision, and collaborative science. (526 words, Oct 17, 2025)
- [Linda Clemons kicks off Boehringer Ingelheim’s CABLE Speaker Series | Boehringer Ingelheim US](/content/us/about-us/who-we-are/culture/linda-clemons-kicks-boehringer-ingelheims-cable-speaker-series.html): Boehringer’s new Culture and Belonging Leadership & Employee Speaker Series launches with body language expert Linda Clemons. (253 words, Oct 17, 2025)
- [Openness, Respect and Opportunity | Boehringer Ingelheim](/content/about-us/who-we-are/culture/openness-respect-and-opportunity/index.html): At Boehringer Ingelheim, our people power innovation – in a workplace of openness, respect and equal opportunity where everyone can thrive. (271 words, Oct 17, 2025)
- [Electronic product information: Is this the end of the paper leaflets? | Boehringer Ingelheim](/content/human-health/patients/patient-safety/electronic-product-information-end-paper-leaflets/index.html): Electronic product information (ePI) enhances safety, access, and speed, offering significant benefits for both pharmaceutical companies and patients. (474 words, Oct 17, 2025)
- [Wie sichern wir Deutschlands Innovationskraft? | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/wie-sichern-wir-deutschlands-innovationskraft/index.html): Wie sichern wir Deutschlands Innovationskraft? (583 words, Oct 17, 2025)
- [Zongertinib 77 percent response rate advanced HER2 mutant NSCLC | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/zongertinib-77-percent-response-rate-advanced-her2-mutant-nsclc.html): Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC (1,227 words, Oct 15, 2025)
- [Zobacz, Usłysz, Działaj poza Bliznami – miesiąc świadomości Włóknienia Płuc | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/zobacz-uslysz-dzialaj-poza-bliznami-miesiac-swiadomosci-wloknienia-pluc.html): Zobacz, Usłysz, Działaj poza Bliznami – miesiąc świadomości Włóknienia Płuc (15 words, Oct 15, 2025)
- [Breast Cancer | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/breast-cancer/index.html): Explore information on Breast Cancer, including resources, clinical trials, congresses, and support tools. (588 words, Oct 14, 2025)
- [Head and Neck Squamous Cell Carcinoma | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/hnscc/index.html): Explore information on Head and Neck Squamous Cell Carcinoma (HNSCC), including resources, clinical trials, congresses, and support tools. (411 words, Oct 14, 2025)
- [Small Cell Lung Cancer Clinical Trials | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/small-cell-lung-cancer/clinical-trials/index.html): Discover completed and ongoing clinical trials on investigational treatments for Small Cell Lung Cancer (SCLC). (1,256 words, Oct 14, 2025)
- [Gastrointestinal Cancers | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/gastrointestinal-cancers/index.html): Explore information on Gastrointestinal (GI) Cancers, including resources, clinical trials, congresses, and support tools. (1,321 words, Oct 14, 2025)
- [Was stellen Hakenwürmer bei Hunden an? | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/was-stellen-hakenwuermer-bei-hunden/index.html): Hakenwürmer sind Haustierparasiten, die im Verdauungssystem Ihres Hundes (oder Ihrer Katze!) leben und den Boden kontaminieren können, was uns möglicherweise infiziert. (560 words, Oct 13, 2025)
- [Going Beyond: Celebrating the essential role of veterinary technicians | Boehringer Ingelheim US](/content/us/animal-health/trends-insights/going-beyond-celebrating-essential-role-veterinary-technicians.html): These highly skilled professionals are the backbone of veterinary medicine, working on the front lines of animal care with expertise that parallels registered nurses in human healthcare. (1,127 words, Oct 13, 2025)
- [The Supplier Code of Conduct | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (487 words, Oct 13, 2025)
- [Our Expectations | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/our-expectations/index.html): We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. (87 words, Oct 13, 2025)
- [Management Systems | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (362 words, Oct 13, 2025)
- [Raising Questions or Concerns | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, Oct 13, 2025)
- [Rundwürmer bei Hunden und Katzen: 5 Fakten, die du kennen musst | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/rundwuermer-bei-hunden-und-katzen-5-fakten-die-du-kennen-musst.html): Tierparasiten: Achtung! Rundwürmer bei Katzen und Hunden sind ziemlich verbreitet und können auch Menschen infizieren. (679 words, Oct 13, 2025)
- [Impfung bei Katzen | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/impfung-bei-katzen/index.html): Find out how you can keep your feline companion happy and healthy. We’ve answered 10 important questions about cat vaccination, to help you make informed decisions about preserving your cat’s health. (770 words, Oct 13, 2025)
- [Chronische Nierenkrankheit bei Katzen | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/chronische-nierenkrankheit-bei-katzen/index.html): So erkennt man Bluthochdruck und diagnostiziert und behandelt die chronische Nierenkrankheit bei Katzen. (710 words, Oct 13, 2025)
- [Hundeparasiten: Was Sie wissen sollten | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/hundeparasiten-was-sie-wissen-sollten/index.html): Ob Zecken, Flöhe, Milben oder gar Würmer: Es gibt viele Parasitenarten, die Ihrem Hund schaden können. Hier erfahren Sie, was Sie dagegen tun können (913 words, Oct 13, 2025)
- [5 fatores surpreendentes que afetam seu coração | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/5-fatores-surpreendentes-que-afetam-seu-coracao/index.html): Dormir pouco, poluição, estresse, boca e intestino: descubra fatores pouco falados que aumentam o risco de doenças cardíacas e como se proteger. (698 words, Oct 10, 2025)
- [#jevaccinemonchat : Saison 5 de la campagne nationale de sensibilisation de Boehringer Ingelheim à la vaccination féline | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/jevaccinemonchat-saison-5-de-la-campagne-nationale-de-sensibilisation-de.html): Boehringer Ingelheim poursuit son engagement auprès de la profession vétérinaire dans sa mission d’information et de sensibilisation à la vaccination féline (1,078 words, Oct 9, 2025)
- [Onkolytische Viren: Vom Labor zur Klinik | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/onkolytische-viren-vom-labor-zur-klinik/index.html): Oncolytic viruses like VSV-GP target cancer cells and activate immune response; Boehringer & ViraTherapeutics advance clinical research in oncology. (526 words, Oct 8, 2025)
- [Oncolytic viruses: From the lab to the clinic | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/oncolytic-viruses-lab-clinic/index.html): Oncolytic viruses like VSV-GP target cancer cells and activate immune response; Boehringer & ViraTherapeutics advance clinical research in oncology. (559 words, Oct 8, 2025)
- [Rabies prevention through education and vaccination | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/rabies-prevention-through-education-and-vaccination.html): Learn how to prevent rabies through Boehringer Ingelheim’s education and vaccination programs, protecting people and pets worldwide. (1,129 words, Oct 7, 2025)
- [Eye Health Research | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-focus/eye-health-research/index.html): Our research is targeting key mechanisms in the pathogenesis of retinal diseases – vascular dysfunction, neuronal dysfunction and neuronal inflammation. (359 words, Oct 6, 2025)
- [Non-Small Cell Lung Cancer (NSCLC) | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/lung-cancer/non-small-cell-lung-cancer-nsclc/index.html): Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases. (705 words, Oct 6, 2025)
- [Understanding Small Cell Lung Cancer | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/lung-cancer/understanding-small-cell-lung-cancer/index.html): Small cell lung cancer (SCLC) is an aggressive form of cancer known for its rapid growth and early spread to other parts of the body. (353 words, Oct 6, 2025)
- [Cancer is One of Humanity’s Greatest Challenges | Boehringer Ingelheim AT](/content/at/en/human-health/cancer/cancer-one-humanitys-greatest-challenges/index.html): Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care. (482 words, Oct 6, 2025)
- [Blauzungenkrankheit bei Rindern und Schafen | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/wiederkaeuer/blauzungenkrankheit-bei-rindern-und-schafen/index.html): The Bluetongue virus (BTV) is a worldwide infectious viral disease from the Reoviridae family known for its impact on domestic and wild ruminants' health and the economic loss it represents on trade. It doesn't affect humans, but it is a threat to animals (628 words, Oct 6, 2025)
- [Karriere in der Pharmaindustrie: Passt Boehringer zu dir? | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/karriere-der-pharmaindustrie-passt-boehringer-zu-dir.html): Falls ja – dann kann das richtig kraftvoll sein. Erfahre von unseren Mitarbeitenden, was sie zu uns geführt hat und was ihren Job außergewöhnlich macht. (988 words, Oct 6, 2025)
- [Nieuwe survey: Nederlandse huisdiereigenaren vertrouwen hun dierenarts, maar onderschatten hoe veeleisend het vak is | Boehringer Ingelheim NL](/content/nl/voor-dier/nieuwe-survey-nederlandse-huisdiereigenaren-vertrouwen-hun-dierenarts-maar-onderschatten-hoe.html): 84% van de Nederlandse huisdiereigenaren vertrouwt volledig op hun dierenarts voor het welzijn van hun huisdier, maar slechts de helft realiseert zich hoeveel emotionele veerkracht het vak vraagt. (598 words, Oct 2, 2025)
- [From the ground up: Driving rabies elimination through community action | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/ground-driving-rabies-elimination-through-community-action.html): Meet Dr. Lee Huay Tay, World Rabies Day Award winner: A veterinarian illustrating how grassroots care can protect communities from rabies. (1,135 words, Oct 1, 2025)
- [Social Engagement Fund invests in Clínicas del Azúcar in Mexico | Boehringer Ingelheim](/content/about-us/sustainable-development/social-engagement-fund-invests-clinicas-del-azucar-mexico.html): Social Engagement Fund invests in Clínicas del Azúcar in Mexico to expand their network of specialized diabetes care clinics (892 words, Oct 1, 2025)
- [West Nile virus. Learn how to protect your horse | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/horses/west-nile-virus-learn-how-protect-your-horse/index.html): Protect your horse from West Nile virus (WNV). Learn how vaccination, mosquito control, and awareness can safeguard your equine companion. (961 words, Oct 1, 2025)
- [Transforming Science: Why Research Also Means Cooperation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/transforming-science-why-research-also-means-cooperation.html): Boehringer Ingelheim invests around 25 percent of its worldwide sales revenue in research and development. But innovation cannot merely be bought. The development of promising therapies requires talented scientists, solid cooperation, and an open exchange (521 words, Oct 1, 2025)
- [CRM Week 2025: On the Road with Kidney Health | Boehringer Ingelheim AT](/content/at/en/human-health/chronic-kidney-disease/crm-week-2025-road-kidney-health/index.html): See our patient focus in action. During the CRM (Cardiovascular, Renal, and Metabolic) Week we provided information about kidney health and offered a free, low-threshold opportunity for measuring blood sugar and blood pressure. (892 words, Oct 1, 2025)
- [From Vienna to the world: New beacon of hope for lung cancer receives approval in the US, China and Japan | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/vienna-world-new-beacon-hope-lung-cancer-receives-approval-us-china-and-japan.html): A compound developed in Vienna to treat lung cancer has been approved in the United States of America, China and Japan. This not only offers new treatment perspectives but also sends a strong message regarding Austria’s position as a research hub. (706 words, Oct 1, 2025)
- [Boehringer Ingelheim RCV bei der Kinderuni Wien 2025 | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/unsere-storys/boehringer-ingelheim-rcv-bei-der-kinderuni-wien-2025.html): On the 16th of July, a team from Boehringer Ingelheim participated at the Vienna Children University, where children aged 7 to 12 can enjoy diverse educational activities for two weeks. (174 words, Oct 1, 2025)
- [Aus Wien in die Welt: Neuer Hoffnungsträger bei Lungenkrebs erhält Zulassung in den USA, China und Japan | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/aus-wien-die-welt-neuer-hoffnungstraeger-bei-lungenkrebs.html): Ein in Wien entwickelter Wirkstoff zur Behandlung von Lungenkrebs hat die Zulassung in den USA, China und Japan erhalten. Das bedeutet nicht nur neue Therapieperspektiven und neue Hoffnung für Betroffene weltweit, sondern auch ein starkes Signal fü (682 words, Oct 1, 2025)
- [百靈佳殷格翰-從源頭處理PCV2問題 | Boehringer Ingelheim TW](/content/tw/bailingjiayingehan-congyuantouchulipcv2wenti/index.html): 百靈佳殷格翰-從源頭處理PCV2問題 (91 words, Oct 1, 2025)
- [Cidades Abraçar: transformando o cuidado respiratório | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/cidades-abracar-transformando-o-cuidado-respiratorio.html): Descubra como as Cidades Abraçar fortalecem a saúde pública, ampliam diagnósticos e melhoram o cuidado de pacientes respiratórios. (542 words, Sep 30, 2025)
- [Sobre Doença Renal Crônica | Boehringer Ingelheim BR](/content/br/saude-humana/doenca-renal-cronica/sobre-doenca-renal-cronica/index.html): A DRC é muito comum e frequentemente passa despercebida devido à sua natureza silenciosa. Os fatores de risco incluem pressão alta e diabetes tipo 2. (615 words, Sep 30, 2025)
- [Doença renal crônica: conheça os riscos e exames | Boehringer Ingelheim BR](/content/br/saude-humana/doenca-renal-cronica/doenca-renal-cronica-conheca-os-riscos-e-exames/index.html): Entenda os fatores de risco para doença renal crônica e como exames simples podem contribuir para o cuidado com a saúde dos rins. (500 words, Sep 30, 2025)
- [Teste SAMU: saiba reconhecer os sintomas do AVC | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/avc/teste-samu-saiba-reconhecer-os-sintomas-do-avc/index.html): Identifique sinais de AVC com o teste SAMU: Sorriso, Abraço, Mensagem e Urgência. Aja rápido e ligue 192. Tempo é essencial para salvar vidas. (366 words, Sep 30, 2025)
- [Verständnis von Biomarker-Tests bei Lungenkrebs | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/lungenkrebs/verstaendnis-von-biomarker-tests-bei-lungenkrebs/index.html): Verständnis von Biomarker-Tests bei Lungenkrebs (691 words, Sep 30, 2025)
- [Careers in pharma: Is working at Boehringer for you? | Boehringer Ingelheim](/content/about-us/who-we-are/culture/careers-pharma-working-boehringer-you/index.html): When it does – it’s powerful. Learn from our colleagues what brought them to us and how a job with purpose shapes their work and career path in pharma. (972 words, Sep 30, 2025)
- [Empowering future veterinarians, serving the community | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/empowering-future-veterinarians-serving-community/index.html): Read to see how collaboration, trust, and shared goals are making a difference for people and animals and what it means for the next generation of vets. (1,038 words, Sep 26, 2025)
- [Rabies prevention: Rabies kills, we can stop it now | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/rabies-prevention-rabies-kills-we-can-stop-it-now/index.html): Hear from Dr. Armin Wiesler, member of our Board of Managing Directors, as he shares what it takes to overcome the complex challenges posed by rabies. (751 words, Sep 26, 2025)
- [Beats of Change: Lynn’s story with CVD and CKD | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chronic-kidney-disease/beats-change-lynns-story-cvd-and-ckd/index.html): Protecting your kidneys can protect your heart. Discover why early urine (UACR) testing for chronic kidney and cardiovascular diseases could save your life. (429 words, Sep 25, 2025)
- [Holistic CRM care: Saving lives by breaking silos | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/holistic-crm-care-saving-lives-breaking-silos/index.html): A call for integrated care in tackling some of the most devastating conditions, by Shashank Deshpande, Chairman of the Board of Managing Directors (972 words, Sep 25, 2025)
- [What´s new in pulmonary fibrosis? | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/whats-new-pulmonary-fibrosis/index.html): Interview with Martin Beck focusing on the unmet need in pulmonary fibrosis and linking it to PFAM in September (1,099 words, Sep 25, 2025)
- [STOP RABIES: Una iniciativa global para eliminar la rabia | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/stop-rabies-una-iniciativa-global-para-eliminar-la-rabia.html): STOP RABIES: Una iniciativa global para eliminar la rabia (326 words, Sep 25, 2025)
- [社員のつながりが生む力：ベーリンガーインゲルハイムのERGとは | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0011/index.html): ベーリンガーインゲルハイムは、企業のパーパスとして「Transforming lives for generations」を掲げ、医療の枠を超えて、社会全体にポジティブな変化をもたらすことを目指しています。 (67 words, Sep 25, 2025)
- [Pet Owners Survey | Boehringer Ingelheim AU](/content/au/pet-owners-survey/index.html): The nationwide survey of almost 1,100 pet owners (926 words, Sep 25, 2025)
- [BEST Program Welcomes Graduate Talent to Ridgefield | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/best-program-welcomes-graduate-talent-ridgefield/index.html): Empowering Future Innovators: Boehringer’s BEST program welcomed 10 students to Ridgefield for a week of R&D, networking, and career growth. (444 words, Sep 24, 2025)
- [Feline Hyperthyreose Schilddrüsenüberfunktion bei Katzen | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/feline-hyperthyreose-schilddruesenueberfunktion-bei-katzen.html): Die feline Hyperthyreose kann schwerwiegende gesundheitliche Folgen haben – muss aber kein Grund zur Sorge sein, wenn sie frühzeitig erkannt und richtig behandelt wird. (615 words, Sep 24, 2025)
- [Vorsorgeuntersuchung für Katzen ab sieben | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/vorsorgeuntersuchung-fuer-katzen-ab-sieben/index.html): Ab einem Alter von 7 Jahren steigt bei Katzen das Risiko für chronische Erkrankungen dramatisch an. Diese Krankheiten entwickeln sich oft schleichend und zeigen erst auffällige Symptome, wenn sie bereits fortgeschritten sind. (766 words, Sep 24, 2025)
- [More Green計畫概要 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-green/more-greenjihuagaiyao-0/index.html): More Green計畫概要 (8 words, Sep 24, 2025)
- [親愛的！為了環境永續，我們把疫苗變成發泡錠了！ | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-green/qinaideweilehuanjingyongxuwomenbayimiaobianchengfapaodingle.html): 親愛的！為了環境永續，我們把疫苗變成發泡錠了！ (346 words, Sep 24, 2025)
- [La prevención de la rabia a través de la educación y la vacunación. | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/stop-rabies/la-prevencion-de-la-rabia-traves-de-la-educacion-y-la.html): Aprende como prevenir la rabia a través de los programas de educación y vacunación de Boehringer Ingelheim, para proteger a las personas y mascotas en todo el mundo. (1,311 words, Sep 24, 2025)
- [在全球布局的投資計畫中，蘊藏著推動創新與永續的基石 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-green/zaiquanqiubujudetouzijihuazhongyuncangzhetuidongchuangxinyuyongxudejishi.html): 在全球布局的投資計畫中，蘊藏著推動創新與永續的基石 (51 words, Sep 23, 2025)
- [永續藥品，守護地球 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-green/yongxuyaopinshouhudeqiu/index.html): 永續藥品，守護地球 (101 words, Sep 23, 2025)
- [Por un futuro libre de rabia | Boehringer Ingelheim SA](/content/sa/prensa/por-un-futuro-libre-de-rabia/index.html): Día Mundial de la Lucha contra la rabia (706 words, Sep 22, 2025)
- [Prevención de la rabia en Ecuador: cómo la educación y la vacunación están salvando vidas | Boehringer Ingelheim SA](/content/sa/salud-animal/historias-destacadas/prevencion-de-la-rabia-en-ecuador-como-la-educacion-y-la-vacunacion-estan-salvando-vidas.html): Descubre cómo estamos plantando las semillas del cambio en la próxima generación a través de la educación. (255 words, Sep 22, 2025)
- [Mehr Wertschätzung für den Tierarzt-Beruf: „Einfach mal Danke sagen“ | Boehringer Ingelheim DE](/content/de/tiergesundheit/unsere-stories/mehr-wertschaetzung-fuer-den-tierarzt-beruf-einfach-mal-danke-sagen.html): Interview mit Dr. Jutta Donhauser über Wertschätzung, Herausforderungen und Leidenschaft im Alltag von Tierärztinnen und Tierärzten. (813 words, Sep 22, 2025)
- [Pulmoner Fibrozis'i Sesinden Tanıyoruz | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/pulmonary-fibrosis/pulmoner-fibrozisi-sesinden-taniyoruz/index.html): Pulmoner Fibrozis'i Sesinden Tanıyoruz (32 words, Sep 22, 2025)
- [Addressing multimorbidity: A call for integrated care to tackle NCDs | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/addressing-multimorbidity-call-integrated-care-tackle-ncds.html): Noncommunicable diseases are the deadliest group of diseases. At the 80th UN General Assembly, we’re calling for integrated care of CKM conditions. (882 words, Sep 19, 2025)
- [Entwurmung bei Wiederkäuern: Wissenswertes über Parasiten | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/wiederkaeuer/entwurmung-bei-wiederkaeuern-wissenswertes-ueber-parasiten.html): Prof. Ray Kaplan (USA) erklärt die fünf wichtigen Erkenntnisse für eine nachhaltige Entwurmung bei Rindern und Schafen (612 words, Sep 19, 2025)
- [El compromiso de Boehringer Ingelheim con el agua | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/el-compromiso-de-boehringer-ingelheim-con-el-agua/index.html): El compromiso de Boehringer Ingelheim con el agua (711 words, Sep 19, 2025)
- [Conseils à l’intention des médecins vétérinaires pour bien prendre soin des chats : Comment apaiser le stress des chats dans votre clinique | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/animaux-de-compagnie/conseils-lintention-des-medecins-veterinaires-pour-bien-prendre-soin-des-chats.html): Des interactions adaptées aux chats peuvent-elles transformer votre clinique? Une collègue vétérinaire et experte en matière de chats partage son savoir et des conseils. (437 words, Sep 18, 2025)
- [Aux propriétaires de chat – voici comment rendre les visites à la clinique vétérinaire moins stressantes. | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/animaux-de-compagnie/aux-proprietaires-de-chat-voici-comment-rendre-les-visites-la-clinique-veterinaire.html): Une vétérinaire et experte en matière de chats partage des conseils sur les comportements adaptés aux chats. (339 words, Sep 18, 2025)
- [Cat care tips for veterinarians: How to de-stress cats at your clinic | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/cat-care-tips-veterinarians-how-de-stress-cats-your-clinic.html): How can cat friendly interactions transform your pet clinic? A fellow veterinarian and cat expert shares insights and easy tips. (332 words, Sep 18, 2025)
- [Cat owners, here’s how to make veterinary check-ups less stressful | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/cat-owners-heres-how-make-veterinary-check-ups-less-stressful.html): A veterinarian and cat health expert shares tips on cat friendly behaviors. (282 words, Sep 18, 2025)
- [Beskytt kjæledyr mot parasitter | Boehringer Ingelheim NO](/content/no/dyrehelse/fremhevede-historier/beskytt-kjaeledyr-mot-parasitter/index.html): Forebygging av parasitter er et av de viktigste tiltakene innen dyrehelse. Det bidrar til å beskytte dyr mot sykdommer som kan unngås. (1,393 words, Sep 18, 2025)
- [Plicní fibróza: skryté jizvy plic | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/plicni-fibroza-skryte-jizvy-plic/index.html): Během září upozorňujeme na závažné onemocnění plic. (508 words, Sep 17, 2025)
- [Welttag der Patientensicherheit: Medikamentensicherheit für Schwangere und Stillende | Boehringer Ingelheim AT](/content/at/de/humanmedizin/unsere-verantwortung/patientensicherheit/welttag-der-patientensicherheit-medikamentensicherheit-fuer-schwangere-und-stillende.html): Am Welttag für Patientensicherheit steht sichere Anwendung von Medikamenten bei Schwangeren und Stillenden im Mittelpunkt. Erfahren Sie, warum klinische Studien diese Gruppen oft ausschließen. (324 words, Sep 17, 2025)
- [Всесвітній день безпеки пацієнтів | Boehringer Ingelheim UA](/content/ua/human-health/our-responsibility/bezpeka-pacienta/vsesvitniy-den-bezpeki-pacientiv/index.html): Всесвітній день безпеки пацієнтів (140 words, Sep 16, 2025)
- [Fábrica em Paulínia tem Selo Verde de sustentabilidade | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/fabrica-em-paulinia-tem-selo-verde-de-sustentabilidade.html): Unidade de Saúde Animal da Boehringer Ingelheim é modelo em práticas sustentáveis e certificada com o Selo Verde por seu compromisso ambiental. (541 words, Sep 16, 2025)
- [Variation of management and treatment of ILD across England | Boehringer Ingelheim UK](/content/uk/human-health/lung-diseases/variation-management-and-treatment-ild-across-england.html): llustrating the variation of management and treatment of interstitial lung disease (ILD) across England (104 words, Sep 14, 2025)
- [N-1 perfusion webinar | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/n-1-perfusion-webinar-bioxcellence/index.html): Learn from Boehringer Ingelheim BioXcellence™ experts about N-1 perfusion strategies for commercial-ready biologics in this on-demand webinar. (243 words, Sep 12, 2025)
- [Hoe positief denken en creativiteit elkaar versterken | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/hoe-positief-denken-en-creativiteit-elkaar-versterken.html): Het verhaal van Joep Welling, een doorzetter met sclerodermie (255 words, Sep 11, 2025)
- [2024年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2024/index.html): 弊社が2024年度（2024年1月から12月）に行った資金提供の情報についてご報告致します。 (62 words, Sep 11, 2025)
- [More Potential 計畫概要 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/more-potential-jihuagaiyao/index.html): More Potential 計畫概要 (600 words, Sep 10, 2025)
- [我們的健康與安全倡議 – BE SAFE健康守護計畫 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/womendejiankangyuanquanchangyi-be-safejiankangshouhujihua.html): 我們的健康與安全倡議 – BE SAFE健康守護計畫 (314 words, Sep 10, 2025)
- [Tierärzte geben alles: Zwischen Berufung und Belastung | Boehringer Ingelheim DE](/content/de/tiergesundheit/unsere-stories/tieraerzte-geben-alles-zwischen-berufung-und-belastung.html): Tierärzte leisten Außergewöhnliches – oft ohne die verdiente Anerkennung. Unsere Kampagne zeigt, warum der Tierarzt-Beruf mehr Wertschätzung verdient. (498 words, Sep 10, 2025)
- [國際婦女節：「沒有性別平等，永續未來終將遙不可及。」 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/guojifunujiemeiyouxingbiepingdengyongxuweilaizhongjiangyaobukeji.html): 國際婦女節：「沒有性別平等，永續未來終將遙不可及。」 (1,356 words, Sep 10, 2025)
- [百靈佳殷格翰志工擴大社會影響力──讓所有人都是贏家 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/bailingjiayingehanzhigongkuodashehuiyingxiangli-rangsuoyourendoushiyingjia.html): 百靈佳殷格翰志工擴大社會影響力──讓所有人都是贏家 (192 words, Sep 10, 2025)
- [女性投身 STEM：以科學熱情實踐更永續的醫療方案 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-potential/nuxingtoushen-stemyikexuereqingshijiangengyongxudeyiliaofangan.html): 女性投身 STEM：以科學熱情實踐更永續的醫療方案 (87 words, Sep 10, 2025)
- [Health Economic Evaluation of Chronic Kidney Disease in South East London | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/health-economic-evaluation-chronic-kidney-disease-south-east-london.html): Health Economic Service Evaluation of a point of care chronic kidney disease model in South East London Executive summary (158 words, Sep 9, 2025)
- [Distributing medicine globally with pharmaceutical logistics | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/our-commitment/distributing-medicine-globally-pharmaceutical-logistics.html): From Germany to Australia, here’s what it takes from operations and logistics to ensure patients get their medicine on time, every time. (453 words, Sep 9, 2025)
- [Manaar: gedreven, betrokken en thuis | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/manaar-gedreven-betrokken-en-thuis/index.html): Vanaf de eerste stagedag voelde het voor Manaar alsof ze thuiskwam. Niet alleen omdat ze hartelijk werd ontvangen, maar vooral omdat ze merkte dat er ruimte was voor haar ideeën, haar groei en haar eigen stem. (816 words, Sep 5, 2025)
- [Advancing digital health through secure data collaboration | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/fostering-science/advancing-digital-health-through-secure-data-collaboration.html): DNAnexus and Boehringer Ingelheim are finalists for the Prix Galien USA, recognized for advancing digital health through secure data collaboration. (209 words, Sep 4, 2025)
- [HERNEXEOS shows intracranial responses in HER2 NSCLC patients | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/hernexeos-shows-intracranial-responses-her2-nsclc-patients.html): New HERNEXEOS® data demonstrated promising intracranial responses in patients with advanced HER2-mutant NSCLC with brain metastases (1,281 words, Sep 4, 2025)
- [About Chronic Kidney Disease | Boehringer Ingelheim AU](/content/au/human-health/chronic-kidney-disease/about-chronic-kidney-disease/index.html): CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes. (415 words, Sep 3, 2025)
- [Interview A. Rothmaler | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/interview-rothmaler-bioxcellence/index.html): Boehringer Ingelheim BioXcellence™ has become one of biopharma’s most trusted contract manufacturers. Our global Head Andrea Rothmaler explains why. (195 words, Sep 3, 2025)
- [Poultry disease prevention includes strong immune health | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/poultry-disease-prevention-includes-strong-immune-health.html): A strong immune system is crucial for poultry health. With the help of vaccines, farmers prevent disease and deliver high-quality meat and eggs. (565 words, Sep 2, 2025)
- [Pig vaccines that protect the animals and the planet | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/pig-vaccines-protect-animals-and-planet/index.html): Farmers care about their pig’s health and the environment; learn how vaccines can support them in protecting both. (504 words, Sep 2, 2025)
- [Le projet « Happy Chickens » | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/aviaire/le-projet-happy-chickens/index.html): Notre équipe argentine aide les personnes aux capacités diverses à trouver de la joie et un but grâce à l'élevage de poulets. (684 words, Sep 2, 2025)
- [Innovationskraft im RCV-Netzwerk | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/innovationskraft-im-rcv-netzwerk/index.html): Innovationskraft im RCV-Netzwerk (578 words, Sep 2, 2025)
- [More Health 計畫概要 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-health/more-health-jihuagaiyao/index.html): More Health 計畫概要 (47 words, Sep 2, 2025)
- [推動原住民族健康平權與疾病防治 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-health/tuidongyuanzhuminzujiankangpingquanyujibingfangzhi/index.html): 推動原住民族健康平權與疾病防治 (136 words, Sep 2, 2025)
- [以健康平權為核心 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-health/yijiankangpingquanweihexin/index.html): 以健康平權為核心 (882 words, Sep 2, 2025)
- [Wenn die Lunge versteinert | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/wenn-die-lunge-versteinert/index.html): Wenn die Lunge versteinert (772 words, Sep 1, 2025)
- [東南亞狂犬病防治行動，現正進行中 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/more-health/dongnanyakuangquanbingfangzhixingdongxianzhengjinxingzhong.html): 東南亞狂犬病防治行動，現正進行中 (38 words, Sep 1, 2025)
- [NBE-Therapeutics nomme Olof Prause au poste de Chief Operating Officer | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/nbe-therapeutics-nomme-olof-prause-au-poste-de-chief-operating-officer.html): NBE-Therapeutics nomme Olof Prause au poste de Chief Operating Officer (329 words, Sep 1, 2025)
- [NBE-Therapeutics ernennt Olof Prause zum Chief Operating Officer | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/nbe-therapeutics-ernennt-olof-prause-zum-chief-operating-officer.html): NBE-Therapeutics ernennt Olof Prause zum Chief Operating Officer (314 words, Sep 1, 2025)
- [Our Stop Rabies initiative in Ecuador | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/our-stop-rabies-initiative-ecuador/index.html): Our Stop Rabies program improves veterinary care through vaccination and education, improving lives of people and animals in Cotacachi, Ecuador. (230 words, Aug 29, 2025)
- [Boehringer launches swine vaccine with advanced protection against PCV2 | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-launches-swine-vaccine-advanced-protection-against-pcv2.html): INGELVAC CIRCOFLEX® AD is the first vaccine to combine both PCV2a and PCV2d antigens in a single dose for optimized pig herd health. (638 words, Aug 29, 2025)
- [HERNEXEOS® approved China targeted therapy NSCLC | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/hernexeos-approved-china-targeted-therapy-nsclc/index.html): Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC (231 words, Aug 29, 2025)
- [Atınızın Yaşamının Her Aşamasında Bakımı Nasıl Yapılır | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/horses/atinizin-yasaminin-her-asamasinda-bakimi-nasil-yapilir.html): Atınızın Yaşamının Her Aşamasında Bakımı Nasıl Yapılır (1,067 words, Aug 29, 2025)
- [İAH Hasta Yolculuğu | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/pulmonary-fibrosis/iah-hasta-yolculugu/index.html): İAH Hasta Yolculuğu (63 words, Aug 29, 2025)
- [亞東醫院與百靈佳殷格翰藥廠簽署合作備忘錄 深化臨床研究合作 推動糖心腎創新療法落地 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxieshouhezuo/yadongyiyuanyubailingjiayingehanyaochangqianshuhezuobeiwanglu.html): 亞東醫院與百靈佳殷格翰藥廠簽署合作備忘錄 深化臨床研究合作 推動糖心腎創新療法落地 (46 words, Aug 29, 2025)
- [我們始終遵守尊重人權的承諾 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/womendechengnuo/womenshizhongzunshouzunzhongrenquandechengnuo/index.html): 我們始終遵守尊重人權的承諾 (106 words, Aug 27, 2025)
- [別讓他們被遺漏——重新看見資源不足的社群 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/womendechengnuo/bierangtamenbeiyilou-zhongxinkanjianziyuanbuzudeshequn.html): 別讓他們被遺漏——重新看見資源不足的社群 (279 words, Aug 27, 2025)
- [Die Lebensphasen von Pferden | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/pferde/die-lebensphasen-von-pferden/index.html): Egal, ob Sie ein Fohlen auf wackeligen Beinen in der Welt willkommen heißen oder Ihrem weisen alten Wallach einen schönen Lebensabend schenken, die Pflege Ihres Pferdes ist eine lebenslange Reise voller Lernen, Freude und dem gelegentlichen Missgeschick. (1,113 words, Aug 26, 2025)
- [NSCLC and brain metastasis: understanding the hidden journey from lungs to brain | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/nsclc-and-brain-metastasis-understanding-hidden-journey-lungs-brain.html): Explore the hidden journey of Non-Small Cell Lung Cancer (NSCLC) to brain metastasis and its impact on patients' lives (1,020 words, Aug 26, 2025)
- [Fast Heróis: iniciativa que ensina crianças a reconhecer os sinais do AVC e salvar vidas | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-cardiacas/avc/fast-herois-iniciativa-que-ensina-criancas-reconhecer-os-sinais-do-avc-e-salvar-vidas.html): Conheça a iniciativa Fast Heróis que ensina crianças a identificar os sintomas do AVC e agir rápido. (642 words, Aug 26, 2025)
- [Value Your Vet | Boehringer Ingelheim AU](/content/au/animal-health/our-responsibility/value-your-vet/index.html): Our commitment to the veterinary profession (378 words, Aug 26, 2025)
- [Oncolytic viruses: From the lab to the clinic | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/oncolytic-viruses-lab-clinic/index.html): Oncolytic viruses like VSV-GP target cancer cells and activate immune response; Boehringer & ViraTherapeutics advance clinical research in oncology. (567 words, Aug 22, 2025)
- [「社員の小さな一歩が、社会に前向きな変化をもたらす」ベーリンガーインゲルハイムの社員ボランティアが生み出す価値 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0010/index.html): ベーリンガーインゲルハイムでは、人と動物の健康を支える企業として、当社独自のサステナビリティの枠組み「SD4G：Sustainable Development for Generations（世代を超えた持続可能な開発）」を掲げ、３つの柱すなわち「MORE HEALTH（人と動物のために）」「MORE POTENTIAL(社会と社員のために）」「MORE GREEN（地球環境のために）」を軸に、当社の活動のあらゆる側面にサステナビリティを組み込んでいます。 (33 words, Aug 22, 2025)
- [Chronic kidney disease in cats | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/cats/chronic-kidney-disease-cats/index.html): Detect and manage chronic kidney disease and high blood pressure in cats (753 words, Aug 21, 2025)
- [How Boehringer Ingelheim is shaping Austria’s pharma success | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/how-boehringer-ingelheim-shaping-austrias-pharma-success.html): How we are shaping the pharma landscape in Austria with research, investments, and innovation – Insights from the PHARMIG Report 2025. (744 words, Aug 21, 2025)
- [Att skydda våra husdjur från parasiter | Boehringer Ingelheim SE](/content/se/djurhalsa/berattelser/att-skydda-vara-husdjur-fran-parasiter/index.html): Parasitprevention är en av de viktigaste aspekterna inom djurhälsa. Det skyddar djur från onödiga sjukdomar. (1,336 words, Aug 21, 2025)
- [Tussen klei, klanten en kwetsbaarheid | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/tussen-klei-klanten-en-kwetsbaarheid/index.html): Op een erf ergens in Heino, omringd door pony’s, kippen, honden, schapen en het zachte geruis van de wind, woont Ernst Jan Grootenhuis. (773 words, Aug 21, 2025)
- [Starke Herzen für unsere treuen Begleiter seit 25 Jahren | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/starke-herzen-fuer-unsere-treuen-begleiter-seit-25-jahren.html): Hunde besitzen eine einzigartige Gabe – sie erobern unsere Herzen im Sturm. (453 words, Aug 21, 2025)
- [Heart disease in dogs: things you should know | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/heart-disease-dogs-things-you-should-know/index.html): Heart disease in dogs is more common than many realize. Signs and symptoms of heart disease in dogs usually are not visible until the disease has progressed. Find out what you can do. (969 words, Aug 20, 2025)
- [Strengthening dogs’ hearts for 25 years | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/strengthening-dogs-hearts-25-years/index.html): For pet owners and dogs around the world, we keep giving more life to love. (496 words, Aug 20, 2025)
- [Quand avez-vous lu la notice pour la dernière fois ? | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/notre-responsabilite/securite-des-patients/quand-avez-vous-lu-la-notice-pour-la-derniere-fois/index.html): La notice est malheureusement souvent mise de côté ou seulement parcourue rapidement, alors qu’elle contient des informations essentielles pour utiliser un médicament de manière sûre et efficace. (341 words, Aug 20, 2025)
- [Interstitielle Lungenerkrankungen - Lösen Sie den "ILD-Alarm" aus | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/interstitielle-lungenerkrankungen-loesen-sie-den-ild-alarm-aus.html): Erfahren Sie mehr über ILDs und warum es wichtig ist, den "ILD-Alarm" zu schlagen", um eine frühzeitige Erkennung und Behandlung zu ermöglichen. (586 words, Aug 20, 2025)
- [Wann haben Sie das letzte Mal die Packungsbeilage gelesen? | Boehringer Ingelheim CH](/content/ch/humanmedizin/unsere-verantwortung/patientensicherheit/wann-haben-sie-das-letzte-mal-die-packungsbeilage-gelesen.html): Die Packungsbeilage wird leider oft achtlos beiseitegelegt oder überflogen, doch sie enthält wichtige Informationen, die helfen, Medikamente sicher und effektiv anzuwenden. (276 words, Aug 20, 2025)
- [What we look for when we explore strategic partnerships | Boehringer Ingelheim](/content/partnering/human-health-partnering/what-we-look-when-we-explore-strategic-partnerships.html): Read about how Boehringer connects with partners at networking events or in one-on-one meetings to explore strategic alliances with innovators working on emerging science. (406 words, Aug 20, 2025)
- [山形から世界へ ― 山形工場 採用特集ページがオープン | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0822/index.html): ベーリンガーインゲルハイムのアジア・オセアニア地域のリージョナルハブ（中心となる製造拠点）である山形工場は、革新的な医薬品を日本および世界の患者さんに届けるため、新製造棟の建設など未来を見据えたプロジェクトを推進しています。 (17 words, Aug 20, 2025)
- [HGF gene therapy product | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/hgf-gene-therapy-product/index.html): Boehringer Ingelheim and AnGes sign manufacturing agreement for PAD gene therapy (638 words, Aug 19, 2025)
- [2019年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2019/index.html): 弊社が2019年度（2019年1月から12月）に行った資金提供の情報についてご報告致します。 (91 words, Aug 19, 2025)
- [2020年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2020/index.html): 弊社が2020年度（2020年1月から12月）に行った資金提供の情報についてご報告致します。 (71 words, Aug 19, 2025)
- [2021年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2021/index.html): 弊社が2021年度（2021年1月から12月）に行った資金提供の情報についてご報告致します。 (79 words, Aug 19, 2025)
- [2022年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2022/index.html): 弊社が2022年度（2022年1月から12月）に行った資金提供の情報についてご報告致します。 (91 words, Aug 19, 2025)
- [Postdoc research program in human health | Boehringer Ingelheim](/content/partnering/collaborative-opportunities/postdoc-research-program-human-health/index.html): Boehringer’s postdoc research program gives scientists the chance to explore cutting-edge science with industry-leading experts. (759 words, Aug 19, 2025)
- [Advancing open innovation through life science partnerships | Boehringer Ingelheim](/content/partnering/human-health-partnering/biomedx-bringing-together-emerging-scientific-talent-and-industry-expertise.html): Boehringer is advancing drug discovery through open collaboration with BioMedX, an institute that blends global crowdsourcing with local incubation. (346 words, Aug 19, 2025)
- [Bridging health, hope, and sustainability in Nandurbar | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/bridging-health-hope-and-sustainability-nandurbar/index.html): Bridging health, hope, and sustainability in Nandurbar (1,032 words, Aug 18, 2025)
- [癌症研究的創新之路 | Boehringer Ingelheim TW](/content/tw/aizhengyanjiudechuangxinzhilu/index.html): 癌症研究的創新之路 (355 words, Aug 15, 2025)
- [Beskyt kæledyr mod parasitter | Boehringer Ingelheim DK](/content/dk/animal-health/udvalgte-historier/beskyt-kaeledyr-mod-parasitter/index.html): Forebyggelse af parasitter er en vigtig del af dyresundhed. Det hjælper med at beskytte dyr mod sygdomme. (1,561 words, Aug 14, 2025)
- [Computational Innovation | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/computational-innovation/index.html): Pioneering computational innovation in pharmaceutical research & development (647 words, Aug 13, 2025)
- [Computational Innovation | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-focus/computational-innovation/index.html): How AI and computational science are accelerating drug discovery (646 words, Aug 13, 2025)
- [社員の家族が企業を知る日！大崎本社で「Family Day」を開催 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0820/index.html): 2025年8月1日（金）、ベーリンガーインゲルハイムは、東京・大崎本社にて「Family Day」を開催しました。日ごろ社員の働きがいを支えてくださっているご家族やパートナーに感謝の気持ちを伝えるとともに、仕事への理解を深めていただく機会として、また職場の雰囲気や仲間との連携を感じていただける特別な一日として、社員とそのご家族・パートナー、社員ボランティアなど約300名が参加しました。 (28 words, Aug 13, 2025)
- [Chronické pľúcne ochorenia a sezónne infekcie | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/pulmonary-fibrosis/chronicke-plucne-ochorenia-sezonne-infekcie/index.html): Pacienti s chronickými pľúcnymi ochoreniami sú častejšie náchylní na infekciu dýchacích ciest. Infekcia vedie k zúženiu dýchacích ciest v dôsledku opuchu a zvýšenej tvorby hlienu. (344 words, Aug 12, 2025)
- [Interstitielle Lungenerkrankungen - Lösen Sie den "ILD-Alarm" aus | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/lungenfibrose/interstitielle-lungenerkrankungen-loesen-sie-den-ild-alarm-aus.html): Erfahren Sie mehr über ILDs und warum es wichtig ist, den "ILD-Alarm" zu schlagen", um eine frühzeitige Erkennung und Behandlung zu ermöglichen. (533 words, Aug 12, 2025)
- [Small Cell Lung Cancer | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/small-cell-lung-cancer/index.html): Small cell lung cancer (SCLC) is an aggressive form of cancer known for its rapid growth and early spread to other parts of the body. (350 words, Aug 12, 2025)
- [Boehringer celebrates next generation of biomedical researchers at 2025 Veterinary Scholars Symposium | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-celebrates-next-generation-biomedical-researchers-2025-veterinary-scholars-symposium.html): Now in its 36th year, the Veterinary Scholars Program introduces veterinary students to biomedical research through immersive, hands-on projects during the summer. (708 words, Aug 7, 2025)
- [Boehringer Ingelheim refuerza su compromiso con México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/boehringer-ingelheim-refuerza-su-compromiso-con-mexico.html): Inversión multianual de 3,500 millones de pesos (548 words, Aug 7, 2025)
- [Krebs ist eine der größten Herausforderungen der Menschheit | Boehringer Ingelheim AT](/content/at/de/humanmedizin/krebserkrankungen/krebs-ist-eine-der-groessten-herausforderungen-der-menschheit.html): Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care. (453 words, Aug 7, 2025)
- [Zo vermijd je stress bij een bezoek aan de dierenarts | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/zo-vermijd-je-stress-bij-een-bezoek-aan-de-dierenarts.html): Kattenliefhebbers, zo vermijd je stress bij een bezoek aan de dierenarts Een dierenarts en expert in kattengedrag deelt handige katvriendelijke tips. (267 words, Aug 7, 2025)
- [DPOC | Asma | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/dpoc-asma/index.html): Encontre aqui os mais recentes artigos, vídeos e apresentações que oferecemos para a sua atualização profissional sobre DPOC e asma (322 words, Aug 6, 2025)
- [Biomedizinische Innovation durch offene Zusammenarbeit vorantreiben | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/biomedizinische-innovation-durch-offene-zusammenarbeit-vorantreiben.html): In der heutigen dynamischen Forschungslandschaft hat sich Open Innovation als wirkungsvolle Strategie zur Bewältigung komplexer biomedizinischer Herausforderungen etabliert. (584 words, Aug 6, 2025)
- [Rendre la visite chez le vétérinaire moins stressante pour votre chat | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/rendre-la-visite-chez-le-veterinaire-moins-stressante-pour-votre-chat.html): La Dre Teresa Baur-Rehme, vétérinaire et experte en santé féline, partage des conseils pratiques pour des visites plus sereines. (319 words, Aug 6, 2025)
- [So wird der Tierarztbesuch für Ihre Katze weniger stressig | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/haustiere/so-wird-der-tierarztbesuch-fuer-ihre-katze-weniger-stressig.html): Dr. Teresa Baur-Rehme, Tierärztin und Katzengesundheitsexpertin, gibt praktische Tipps für entspanntere Tierarztbesuche. (254 words, Aug 6, 2025)
- [Transforming Science: Warum Forschung auch Kooperation bedeutet | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/transforming-science-warum-forschung-auch-kooperation-bedeutet.html): Wir investieren rund 25 Prozent unserer weltweiten Umsatzerlöse in Forschung und Entwicklung. Doch um zukunftsweisende Therapien zu entwickeln, braucht es talentierte Wissenschaftler*innen, starke Kooperationen und eine Kultur offenen Austauschs. (476 words, Aug 5, 2025)
- [Was stellen Hakenwürmer bei Hunden an? | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/was-stellen-hakenwuermer-bei-hunden/index.html): Hakenwürmer sind Haustierparasiten, die im Verdauungssystem Ihres Hundes (oder Ihrer Katze!) leben und den Boden kontaminieren können, was uns möglicherweise infiziert. (556 words, Aug 5, 2025)
- [What are hookworms in dogs? | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/what-are-hookworms-dogs/index.html): Hookworms are pet parasites that live in the digestive system of your dog (or cat!) and can contaminate the soil, possibly infecting us. (687 words, Aug 5, 2025)
- [Horse care: health tips from foals to senior years | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/horse-care-health-tips-foals-senior-years/index.html): In this guide, we’ll share horse care tips to help you keep your horse happy, healthy and thriving, from their first steps to the golden years. (1,535 words, Aug 5, 2025)
- [Pensez à la rage avant de partir en vacances | Boehringer Ingelheim BE](/content/be/fr/sante-animale/articles-specialises/pensez-la-rage-avant-de-partir-en-vacances/index.html): Si vous voyagez dans une région isolée ou un endroit avec beaucoup d’animaux errants, un vaccin contre la rage peut vous assurer un voyage sûr et sans souci. (476 words, Aug 5, 2025)
- [Veteriner hekimler için kedi bakımı ipuçları: Klinik ortamında kedilerin stresini azaltmak | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/veteriner-hekimler-icin-kedi-bakimi-ipuclari-klinik-ortaminda-kedilerin-stresini-azaltmak.html): Veteriner hekimler için kedi bakımı ipuçları: Klinik ortamında kedilerin stresini azaltmak (284 words, Aug 5, 2025)
- [Christina Janista est la nouvelle General Manager de Boehringer Ingelheim Suisse | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/christina-janista-est-la-nouvelle-general-manager-de-boehringer-ingelheim-suisse.html): Christina Janista est la nouvelle General Manager de Boehringer Ingelheim Suisse (306 words, Aug 5, 2025)
- [So wird der Tierarztbesuch für Ihre Katze weniger stressig | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/so-wird-der-tierarztbesuch-fuer-ihre-katze-weniger-stressig.html): Dr. Teresa Baur-Rehme, Tierärztin und Katzengesundheitsexpertin, gibt praktische Tipps für entspanntere Tierarztbesuche. (351 words, Aug 4, 2025)
- [Veterinarios de felinos: Cómo reducir el estrés que sufren los gatos en la clínica | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/veterinarios-de-felinos-como-reducir-el-estres-que-sufren-los-gatos-en-la-clinica.html): Día Mundial del Gato (409 words, Aug 1, 2025)
- [Tutores de gatos: cómo hacer que las visitas al veterinario sean menos estresantes | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/tutores-de-gatos-como-hacer-que-las-visitas-al-veterinario-sean-menos-estresantes.html): Día Mundial del Gato (352 words, Aug 1, 2025)
- [Tipps für Tierärzt*innen – Katzen beim Tierarztbesuch | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/tipps-fuer-tieraerztinnen-katzen-beim-tierarztbesuch.html): Wie können katzenfreundliche Interaktionen Ihre Tierarztpraxis verändern? Katzenspezialistin Dr. Teresa Baur-Rehme teilt ihre Erfahrungen und einfache Tipps. (318 words, Aug 1, 2025)
- [Mit der Katze zum Tierarzt: Tipps gegen Stress bei Katzen | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/mit-der-katze-zum-tierarzt-tipps-gegen-stress-bei-katzen.html): Dr. Teresa Baur-Rehme, Tierärztin und Katzengesundheitsexpertin, gibt praktische Tipps für entspanntere Tierarztbesuche. (244 words, Aug 1, 2025)
- [Ictus | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/ictus/ictus/index.html): Ictus (373 words, Aug 1, 2025)
- [Înțelegerea insuficienței cardiace | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/insuficienta-cardiaca/intelegerea-insuficientei-cardiace/index.html): Cum este legată de alte afecțiuni cronice și ce puteți face în privința ei? (762 words, Jul 31, 2025)
- [藥業首家響應賑災！百靈佳殷格翰率先捐款500萬元 力挺南部風災救援 展現企業社會責任與在地承諾 | Boehringer Ingelheim TW](/content/tw/yaoyeshoujiaxiangyingzhenzaibailingjiayingehanluxianjuankuan500wanyuan-litingnanbufengzaijiuyuan.html): 藥業首家響應賑災！百靈佳殷格翰率先捐款500萬元 力挺南部風災救援 展現企業社會責任與在地承諾 (35 words, Jul 31, 2025)
- [Sobre la Enfermedad Renal Crónica | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedad-renal-cronica/sobre-la-enfermedad-renal-cronica/index.html): Sobre la Enfermedad Renal Crónica (1,112 words, Jul 30, 2025)
- [За хроничното бъбречно заболяване | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/za-khronichnoto-bbrechno-zabolyavane/index.html): ХБЗ се среща често и често остава незабелязано поради тихия си характер. Рисковите фактори включват високо кръвно налягане и диабет тип 2. (436 words, Jul 30, 2025)
- [2023年度 医療関係者・医療機関等への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure-2023/index.html): 弊社が2023年度（2023年1月から12月）に行った資金提供の情報についてご報告致します。 (83 words, Jul 30, 2025)
- [Cat owners, here’s how to make veterinary check-ups less stressful | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/cat-owners-heres-how-make-veterinary-check-ups-less-stressful.html): Does your cat get spooked at the vet clinic? A veterinarian and cat health expert shares tips on cat friendly interactions to help your cat relax. (302 words, Jul 29, 2025)
- [百靈佳殷格翰 2025上半年穩健成長 積極佈局產品線，兩項新藥預計下半年上市 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/bailingjiayingehan-2025shangbannianwenjianchengzhang.html): 百靈佳殷格翰 2025上半年穩健成長 積極佈局產品線，兩項新藥預計下半年上市 (1,197 words, Jul 29, 2025)
- [豬用害獲滅 IVOMEC INJECTION | Boehringer Ingelheim TW](/content/tw/node/33122/index.html): 豬用害獲滅 IVOMEC INJECTION (581 words, Jul 29, 2025)
- [患者団体への資金提供等の情報 | Boehringer Ingelheim JP](/content/jp/about-us/patient-group/index.html): 弊社が実施した、患者団体への資金提供の情報についてご報告いたします。 (21 words, Jul 29, 2025)
- [Inspiring Future Leaders in Veterinary Medicine and Research | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/inspiring-future-leaders-veterinary-medicine-and-research.html): At Boehringer Ingelheim, we are dedicated to supporting the future of veterinary medicine by investing in young scientists and vets. (507 words, Jul 28, 2025)
- [The geography of pet parasites is changing | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/geography-pet-parasites-changing/index.html): Way beyond ticks and flea bites in dogs and cats: climate change facilitates the spread of new pet parasites to different regions (831 words, Jul 28, 2025)
- [La dirofilariosis canina, una amenaza cada vez más presente | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/la-dirofilariosis-canina-una-amenaza-cada-vez-mas-presente.html): La dirofilariosis canina, una amenaza cada vez más presente: Boehringer Ingelheim aborda su avance clínico con veterinarios a través de la iniciativa “Una mirada real” (644 words, Jul 28, 2025)
- [百靈佳殷格翰-效益看得見的疫苗選擇 | Boehringer Ingelheim TW](/content/tw/bailingjiayingehan-xiaoyikandejiandeyimiaoxuanze/index.html): 百靈佳殷格翰-效益看得見的疫苗選擇 (126 words, Jul 28, 2025)
- [Supply reliability | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/supply-reliability-bioxcellence/index.html): Boehringer Ingelheim BioXcellence™ operates large-scale biopharma manufacturing facilities in the U.S. and Europe, providing flexibility and reliability. (259 words, Jul 28, 2025)
- [Rundwürmer bei Hunden und Katzen: fünf wichtige Fakten | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/rundwuermer-bei-hunden-und-katzen-fuenf-wichtige-fakten.html): Tierparasiten: Achtung! Rundwürmer bei Katzen und Hunden sind ziemlich verbreitet und können auch Menschen infizieren. (674 words, Jul 28, 2025)
- [3 tips for anyone interested in a STEM career | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/3-tips-anyone-interested-stem-career/index.html): Dr. Joanne Maki, veterinary rabies expert, shares what it takes to succeed in STEM (807 words, Jul 26, 2025)
- [3 tips for anyone interested in a STEM career | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/3-tips-anyone-interested-stem-career/index.html): Dr. Joanne Maki, veterinary rabies expert, shares what it takes to succeed in STEM (807 words, Jul 26, 2025)
- [Supporting Future Veterinarians | Boehringer Ingelheim UK](/content/uk/animal-health/featured-stories/supporting-future-veterinarians/index.html): The aim of the Boehringer Ingelheim Veterinary Scholars Programme is to expose students to biomedical research (1,241 words, Jul 25, 2025)
- [Supporting Future Veterinarians | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/supporting-future-veterinarians/index.html): The aim of the Boehringer Ingelheim Veterinary Scholars Programme is to expose students to biomedical research (1,242 words, Jul 25, 2025)
- [Roundworms in dogs and cats: five important facts | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/dogs/roundworms-dogs-and-cats-five-important-facts/index.html): Pet parasites: Attention! Roundworms in cats and dogs are quite common and can infect humans, too. (643 words, Jul 25, 2025)
- [Our half-year financial results 2026 | Boehringer Ingelheim](/content/about-us/who-we-are/our-half-year-financial-results-2026/index.html): Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S. (823 words, Jul 24, 2025)
- [Caring for pets during monsoon | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/caring-pets-during-monsoon/index.html): Safeguard your pets against skin infections, parasites, and thunderstorm anxiety this monsoon. (712 words, Jul 24, 2025)
- [Boehringer Ingelheim - Erstes Halbjahr 2025 | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/boehringer-ingelheim-erstes-halbjahr-2025/index.html): Boehringer Ingelheim - Erstes Halbjahr 2025 (1,215 words, Jul 24, 2025)
- [Unsere Halbjahresergebnisse 2026 | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unsere-halbjahresergebnisse-2026/index.html): Boehringer Ingelheim steigert Umsatz im ersten Halbjahr (835 words, Jul 24, 2025)
- [Boehringer Ingelheim half-year results 2025 | Boehringer Ingelheim](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2025/index.html): First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2 (1,211 words, Jul 23, 2025)
- [Jardiance® per 1 augustus volledig vergoed bij T2D](/content/pro/nl/voorschrijfbevoegd/jardiance/vergoedingswijzer/index.html): Vanaf 1 augustus 2025 is Jardiance® volledig vergoed bij diabetes type 2, hartfalen en nierschade – onafhankelijk van co-medicatie of voorwaarden (370 words, Jul 21, 2025)
- [Psy na dovolené ohrožuje parazit – proniká do srdce a plic | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/spolecenska-zvirata/psy-na-dovolene-ohrozuje-parazit-pronika-do-srdce-plic.html): Onemocnění, které přenášejí komáři může vážně ohrozit život nakaženého psa. Rozšířené je v teplých krajích, ale také na Slovensku. (595 words, Jul 16, 2025)
- [Boehringer Ingelheim and LEO Pharma announce partnership | Boehringer Ingelheim US](/content/us/human-health/skin-diseases/gpp/index.html): Boehringer and LEO Pharma entered an exclusive global license and transfer agreement to commercialize and advance the development of SPEVIGO® (spesolimab). (1,769 words, Jul 11, 2025)
- [Boehringer LEO Pharma partnership commercialize SPEVIGO | Boehringer Ingelheim](/content/human-health/skin-diseases/gpp/index.html): Boehringer Ingelheim and LEO Pharma enter partnership to commercialize and further develop SPEVIGO® (spesolimab) (1,298 words, Jul 11, 2025)
- [À propos de la maladie rénale chronique | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladie-renale-chronique/propos-de-la-maladie-renale-chronique/index.html): La maladie rénale chronique est très courante et passe souvent inaperçue en raison de sa nature silencieuse. Les facteurs de risque incluent l'hypertension artérielle et le diabète de type 2. (553 words, Jul 10, 2025)
- [Über Chronische Nierenerkrankungen | Boehringer Ingelheim CH](/content/ch/humanmedizin/chronische-nierenerkrankung/ueber-chronische-nierenerkrankungen/index.html): Chronische Nierenerkrankungen sind weit verbreitet und bleiben aufgrund ihres schleichenden Verlaufs häufig unerkannt. Zu den Hauptrisikofaktoren zählen Bluthochdruck und Typ-2-Diabetes. (428 words, Jul 10, 2025)
- [Environment | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/environment/index.html): Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment. (399 words, Jul 8, 2025)
- [Phase II start of oral treatment for diabetic macular edema | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/phase-ii-start-oral-treatment-diabetic-macular-edema.html): Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema (936 words, Jul 7, 2025)
- [Do ovo ao prato: o papel da proteção sanitária em granjas de aves | Boehringer Ingelheim BR](/content/br/saude-animal/do-ovo-ao-prato-o-papel-da-protecao-sanitaria-em-granjas-de-aves.html): Especialista reforça a importância dos cuidados de biosseguridade dentro das granjas, como atividades essenciais para a garantia de uma proteína saudável ao consumidor (520 words, Jul 4, 2025)
- [Poultry respiratory diseases that threaten flock health | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/poultry-respiratory-diseases-threaten-flock-health/index.html): Many highly contagious respiratory pathogens threaten the poultry industry; understanding these threats is the first step in controlling them. (888 words, Jul 4, 2025)
- [Brasil reforça biosseguridade em fazendas leiteiras | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/bovinos/brasil-reforca-biosseguridade-em-fazendas-leiteiras.html): Descubra como fazemos parcerias com autoridades locais para promover boas práticas por meio de um selo de qualidade. (710 words, Jul 3, 2025)
- [Happy chickens project | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/happy-chickens-project/index.html): Our Argentina team partners with Andar to help people with diverse abilities find purpose through chicken farming while promoting poultry health and disease prevention. (695 words, Jul 3, 2025)
- [世界トップレベルの研究環境で、次世代の科学者を育成 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0707/index.html): ベーリンガーインゲルハイムは、IMPを研究資金の提供や共同プロジェクトを通じて支えています。 (27 words, Jul 2, 2025)
- [Future generazioni e Salute Animale: il ruolo centrale della ricerca e dell’innovazione in ambito veterinario e l’impatto sulla salute pubblica | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/future-generazioni-e-salute-animale-il-ruolo-centrale-della-ricerca-e-dellinnovazione-ambito.html): Future generazioni e Salute Animale: il ruolo centrale della ricerca e dell’innovazione in ambito veterinario e l’impatto sulla salute pubblica (1,427 words, Jul 1, 2025)
- [Сърдечната недостатъчност и влиянието ѝ върху организма | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/heart-failure/heart-failure-and-its-impact-body/index.html): Научете как сърдечната недостатъчност засяга организма, кои са симптомите и защо ранната диагностика е от решаващо значение. (354 words, Jun 30, 2025)
- [Corporate Volunteering | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/corporate-volunteering/index.html): By participating in volunteer programs, employees gain a sense of purpose and connection, whilst strengthening the communities we live in. (532 words, Jun 30, 2025)
- [Dog parasites: What you should know | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/dog-parasites-what-you-should-know/index.html): From ticks, fleas, and mites to worms: there are many different parasite species that can harm your dog. Find out how to prevent and treat them here. (979 words, Jun 27, 2025)
- [What to know about counterfeit medication | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/more-health/what-know-about-counterfeit-medication/index.html): What to know about counterfeit medication (485 words, Jun 27, 2025)
- [How participants in clinical studies enable medical progress | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/clinical-studies/how-participants-clinical-studies-enable-medical-progress.html): The heroes behind medicine: how participants in clinical studies enable medical progress (145 words, Jun 26, 2025)
- [Teilnehmende klinischer Studien fördern Gesundheitsinnovation | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/teilnehmende-klinischer-studien-foerdern-gesundheitsinnovation.html): Die Heldinnen und Helden hinter der Medizin: Wie Teilnehmende klinischer Studien den medizinischen Fortschritt und neue Therapien ermöglichen. (1,161 words, Jun 26, 2025)
- [百靈佳殷格翰-效果最佳且最安全的豬隻疫苗 | Boehringer Ingelheim TW](/content/tw/node/32975/index.html): 百靈佳殷格翰-效果最佳且最安全的豬隻疫苗 (229 words, Jun 26, 2025)
- [グローバルな生産拠点 – 山形工場 | Boehringer Ingelheim JP](/content/jp/about-us/yamagata-site/index.html): 山形県東根市にあるベーリンガーインゲルハイム製薬 山形工場は、ベーリンガーインゲルハイムのグローバルの生産拠点のひとつです。 (38 words, Jun 25, 2025)
- [医薬品の製造工程 | Boehringer Ingelheim JP](/content/jp/about-us/pharmaceutical-process/index.html): ベーリンガーインゲルハイム製薬 山形工場では、GMPに準拠した品質管理体制を整え、固形製剤の原材料の受け入れから製造、包装および出荷まで一貫生産体制を実現しています。 (6 words, Jun 25, 2025)
- [環境負荷低減の取り組み-山形工場 | Boehringer Ingelheim JP](/content/jp/about-us/yamagata-plant/index.html): ドイツに本拠を置くベーリンガーインゲルハイムは、2030年までに事業活動をカーボンニュートラルにするという目標を掲げ、「More Green」（地球環境のために）を柱に環境負荷低減活動に取り組んでいます。 (43 words, Jun 25, 2025)
- [Unlocking the ‘dark genome’ for cancer immunotherapy | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/unlocking-dark-genome-cancer-immunotherapy/index.html): Our scientists are driving the discovery of unexplored cancer antigens from the ‘dark genome’ to develop novel cancer immunotherapies. (427 words, Jun 24, 2025)
- [Das 'dunkle Genom' für die Krebsimmuntherapie entschlüsseln | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/das-dunkle-genom-fuer-die-krebsimmuntherapie-entschluesseln.html): Unsere Wissenschaftler treiben die Entdeckung unerforschter Krebsantigene aus dem 'dunklen Genom' voran. Ziel ist es, neuartige Krebsimmuntherapien zu entwickeln. (361 words, Jun 24, 2025)
- [Wendepunkt für die Immuntherapie: Monozyten verstärken T-Zellen | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/wendepunkt-fuer-die-immuntherapie-monozyten-verstaerken-t.html): Immuntherapie stärkt das Immunsystem, um gegen Krebs zu kämpfen, aber einige Tumoren passen sich an und werden resistent. Die Mikroumgebung des Tumors spielt eine komplexe Rolle, indem sie manchmal immunologische Reaktionen blockiert, manchmal unterstützt (446 words, Jun 24, 2025)
- [Paulínia oficializa projeto que fortalece combate ao AVC, infarto e Doenças Respiratórias | Boehringer Ingelheim BR](/content/br/imprensa-historias/press-releases/paulinia-oficializa-projeto-que-fortalece-combate-ao-avc-infarto-e-doencas-respiratorias.html): Angels, Sprint e AbraçAR, iniciativas da Boehringer Ingelheim, se unem para transformar o atendimento à saúde na cidade (731 words, Jun 23, 2025)
- [Veterinary care is so much more than you may think | Boehringer Ingelheim CA](/content/ca/animal-health/our-responsibility/veterinary-care-so-much-more-you-may-think/index.html): Do we really understand what it takes to be a veterinary professional? Find out why learning more about this aspirational career matters. (480 words, Jun 23, 2025)
- [山形工場 アジア・オセアニア地域で医薬品供給のリージョナルハブへ | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0623/index.html): ベーリンガーインゲルハイムは6月20日、ベーリンガーインゲルハイム製薬株式会社 山形工場（山形県東根市）の敷地内に2023年より建設していた新製剤棟の竣工と、さらに新しい製剤棟を増築する計画を発表しました。 (14 words, Jun 23, 2025)
- [【SDGs×新北市】三十年的治水新思路，足以守護生態平衡嗎？ | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/sdgszaitaiwan/gushi-x-bailingjiayingehandadanzhuderen/sdgsxinbeishi/index.html): 【SDGs×新北市】三十年的治水新思路，足以守護生態平衡嗎？ (81 words, Jun 20, 2025)
- [【SDGs×高雄】高污工業撤出和轉型後，科技業會是永續的解方嗎？ | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/sdgszaitaiwan/gushi-x-bailingjiayingehandadanzhuderen/sdgsgaoxiong/index.html): 【SDGs×高雄】高污工業撤出和轉型後，科技業會是永續的解方嗎？ (157 words, Jun 20, 2025)
- [【SDGs×屏東縣】政策為何難以面面俱到？光電和低碳交通的兩面困境 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/sdgszaitaiwan/gushi-x-bailingjiayingehandadanzhuderen/sdgspingdongxian/index.html): 【SDGs×屏東縣】政策為何難以面面俱到？光電和低碳交通的兩面困境 (86 words, Jun 20, 2025)
- [Accelerating animal health innovation with digital science | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/accelerating-animal-health-innovation-digital-science.html): How Boehringer Ingelheim is using digital science and artificial intelligence tools to improve efficiency and accelerate innovation in animal health (1,162 words, Jun 19, 2025)
- [Fostering the mental health community in the Americas | Boehringer Ingelheim](/content/human-health/mental-health/fostering-mental-health-community-americas/index.html): People with mental illness are at greater risk of suicide, but most don’t receive the care they need. We’re partnering with WHO Foundation to change this. (1,035 words, Jun 17, 2025)
- [NZ Value Your Vet Team Survey Results | Boehringer Ingelheim AU](/content/au/nz-value-your-vet-team-survey-results/index.html): NZ Value Your Vet Team Survey Results (717 words, Jun 17, 2025)
- [Faiblesse, nausées, diarrhées, anémie : que sont les ankylostomes chez les chiens ? | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/faiblesse-nausees-diarrhees-anemie-que-sont-les-ankylostomes-chez-les-chiens.html): Les ankylostomes vivent dans le système digestif de votre chien ou chat et peuvent contaminer le sol, voire nous infecter. (649 words, Jun 17, 2025)
- [Schwäche, Übelkeit, Durchfall, Anämie: Was sind Hakenwürmer bei Hunden? | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/haustiere/schwaeche-uebelkeit-durchfall-anaemie-was-sind-hakenwuermer-bei-hunden.html): Hakenwürmer leben im Verdauungssystem Ihres Hundes oder Ihrer Katze und können den Boden kontaminieren und sogar uns Menschen infizieren. (525 words, Jun 17, 2025)
- [Día mundial de la zoonosis | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/dia-mundial-de-la-zoonosis/index.html): Prevención de la rabia: Historias reales de dedicación e impacto (286 words, Jun 16, 2025)
- [Boehringer Ingelheim startet kostenlose Bluttest-Aktion für Katzen | Boehringer Ingelheim DE](/content/de/tiergesundheit/boehringer-ingelheim-startet-kostenlose-bluttest-aktion-fuer-katzen.html): Boehringer Ingelheim startet kostenlose Bluttest-Aktion für Katzen (610 words, Jun 13, 2025)
- [When was the last time you read the package leaflet? | Boehringer Ingelheim AT](/content/at/en/human-health/our-responsibility/when-was-last-time-you-read-package-leaflet/index.html): Unfortunately, the package leaflet is often carelessly put aside or skimmed over, but it contains important information that helps to use medication safely and effectively. (497 words, Jun 12, 2025)
- [Wann haben Sie das letzte Mal die Packungsbeilage gelesen? | Boehringer Ingelheim AT](/content/at/de/humanmedizin/unsere-verantwortung/wann-haben-sie-das-letzte-mal-die-packungsbeilage-gelesen.html): Die Packungsbeilage wird leider oft achtlos beiseitegelegt oder überflogen, doch sie enthält wichtige Informationen, die helfen, Medikamente sicher und effektiv anzuwenden. (410 words, Jun 12, 2025)
- [Die Leber und ihre zentrale Rolle für unsere Gesundheit | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/mash/die-leber-und-ihre-zentrale-rolle-fuer-unsere-gesundheit.html): Wie die Gesundheit der Leber unser miteinander verbundenes kardiovaskuläres, renales und metabolisches System beeinflusst und leiden kann und mehrere Begleiterkrankungen wie Fettleibigkeit haben kann. (916 words, Jun 12, 2025)
- [The liver and its vital connection to our overall health | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/mash/liver-and-its-vital-connection-our-overall-health/index.html): How health of the liver impacts our interconnected cardiovascular, renal, metabolic system and suffering and can have several comorbidities like obesity. (989 words, Jun 12, 2025)
- [S8. EP2. 凝聚城市的力量：打造更完善的中風照護體系 | Boehringer Ingelheim TW](/content/tw/jiazhigushiwuzuixinwenzhang/s8-ep2-ningjuchengshideliliangdazaogengwanshandezhongfengzhaohutixi.html): S8. EP2. 凝聚城市的力量：打造更完善的中風照護體系 (334 words, Jun 12, 2025)
- [Actilyse rcm](/content/pro/pt/bipdf/actilyse-rcm/index.html): Resumo das características do medicamento. (19 words, Jun 12, 2025)
- [Ileite Suina, come l’alterazione al microbiota facilita l’azione dei patogeni](/content/it/salute-animale/animali-da-allevamento/suini/ileite-suina-come-lalterazione-al-microbiota-facilita-lazione-dei-patogeni.html): Il microbiota intestinale influenza la salute e la produttività dei suini, L.intracellularis può alterarlo aumentando la suscettibilità nei confronti di vari patogeni (644 words, Jun 10, 2025)
- [Pulmonary Fibrosis Quiz | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/pulmonary-fibrosis-quiz/index.html): Awareness starts with us and continues with you. Pulmonary fibrosis is often missed, but let’s make sure the conversation about it isn’t. (514 words, Jun 9, 2025)
- [L’utilizzo dell’antibiotico è maggiore in presenza di ileite | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/suini/lutilizzo-dellantibiotico-e-maggiore-presenza-di-ileite.html): Ma la vaccinazione riduce l’utilizzo di farmaco (553 words, Jun 9, 2025)
- [吉村美栄子山形県知事 山形工場をご訪問 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0611/index.html): 6月2日、吉村美栄子山形県知事が、工場の視察や社員との意見交換を目的に、ベーリンガーインゲルハイム製薬 山形工場（山形県東根市）を訪問されました。 (14 words, Jun 9, 2025)
- [「声を上げる勇気が、キャリアを切り拓く」― 現場発・グローバルリーダーへの道。挑戦を支えるベーリンガーインゲルハイムの企業風土 ― | Boehringer Ingelheim JP](/content/jp/node/32886/index.html): 日本ベーリンガーインゲルハイム株式会社では、社員こそが企業の原動力であるという理念のもと、多様性に富んだオープンな職場環境づくりに注力しています。社員一人ひとりが主体的にキャリアを築き、周囲がそれを支える文化が根付いています。 (27 words, Jun 6, 2025)
- [FIBRONEER™ global phase III trials | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/fibroneer-global-phase-iii-trials/index.html): Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEER™-IPF and FIBRONEER™-ILD, (1,767 words, Jun 3, 2025)
- [A new survey shows over 90% of pet owners trust vets but overlook their challenges | Boehringer Ingelheim](/content/animal-health/our-expertise/new-survey-shows-over-90-pet-owners-trust-vets-overlook-their-challenges.html): On World Veterinary Day 2025, Boehringer Ingelheim and campaign partners encourage animal owners to express their appreciation to veterinary teams. (1,125 words, Jun 3, 2025)
- [Boehringer Ingelheim Eko Health Inc. collaboration to improve heart murmur detection in dogs | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/boehringer-ingelheim-eko-health-inc-collaboration-improve-heart-murmur-detection-dogs.html): A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care (848 words, Jun 3, 2025)
- [Partnering for Animal Health Innovation | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/connect-us/partnering-animal-health-innovation-0/index.html): Meet our animal health partnering team, explore our partnering interests and learn how we can advance innovation together at BIO International 2026 (523 words, May 30, 2025)
- [«Берінгер Інгельхайм» у 2024 році залучила більше пацієнтів та готує запуск нових лікарських засобів | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/beringer-ingelkhaym-u-2024-roci-zaluchila-bilshe-pacientiv-ta-gotue-zapusk-novikh-likarskikh-zasobiv.html): «Берінгер Інгельхайм» у 2024 році залучила більше пацієнтів та готує запуск нових лікарських засобів (784 words, May 29, 2025)
- [Schizophrenia in real life: Fighting broken care pathways | Boehringer Ingelheim](/content/human-health/mental-health/schizophrenia-real-life-fighting-broken-care-pathways.html): There are harsh realities of a fractured care system, but by working together, we can pave new pathways for people living with a schizophrenia diagnosis. (1,003 words, May 28, 2025)
- [Hotline und Gesundheits-Coaching für Patient*innen mit Lungenfibrose | Boehringer Ingelheim DE](/content/de/humanmedizin/hotline-und-gesundheits-coaching-fuer-patientinnen-mit-lungenfibrose.html): Hotline und Gesundheits-Coaching für Patient*innen mit Lungenfibrose (399 words, May 28, 2025)
- [Diagnostic parasitaire et intelligence artificielle : Boehringer Ingelheim et INDICAL BIOSCIENCE renouvellent leur partenariat | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/diagnostic-parasitaire-et-intelligence-artificielle-boehringer-ingelheim-et-indical-bioscience.html): Le renouvellement de ce partenariat vise à continuer à aider les cliniques vétérinaires à s’équiper du système automatisé, OvaCyte™, qui utilise l'analyse numérique et l'IA pour le comptage et l'identification des œufs de parasites (765 words, May 28, 2025)
- [Lebergesundheit: So zentral, doch selten im Fokus | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/mash/lebergesundheit-so-zentral-doch-selten-im-fokus/index.html): Die Leber hat eine lebenswichtige Funktion, doch bekommt sie dafür genug Aufmerksamkeit? Lebererkrankungen wie MASH nehmen immer mehr zu. (677 words, May 28, 2025)
- [ベーリンガーインゲルハイム 2024年に日本において前年を上回る業績を達成 | Boehringer Ingelheim JP](/content/jp/press-25-0527/index.html): 日本ベーリンガーインゲルハイム株式会社（本社：東京都品川区、代表取締役会長 兼 社長：ヤンシュテファン・シェルド、以下、日本ベーリンガーインゲルハイム）およびベーリンガーインゲルハイム アニマルヘルス ジャパン株式会社（本社：東京都品川区、代表取締役会長：ヤンシュテファン・シェルド、以下、ベーリンガーインゲルハイム アニマルヘルス ジャパン）は本日、2024年（1－12月）の日本の業績について発表しました。 (61 words, May 26, 2025)
- [I kočky trápí civilizační choroby | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/spolecenska-zvirata/i-kocky-trapi-civilizacni-choroby/index.html): Jednou z nejzávažnějších zdravotních komplikací u koček je cukrovka. Objevuje se hlavně u starších nebo obézních zvířat. (578 words, May 23, 2025)
- [Semnele de atacului cerebral ischemic: noaptea care a schimbat viața lui Horst | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-cardiovasculare/accident-vascular-cerebral-ischemic/semnele-de-atacului-cerebral-ischemic-noaptea-care-schimbat-viata-lui-horst.html): Semnele de atacului cerebral ischemic: noaptea care a schimbat viața lui Horst (659 words, May 22, 2025)
- [Badania fazy III: nerandomilast spowalnia pogarszanie się czynności płuc w przebiegu IPF i PPF | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/badania-fazy-iii-nerandomilast-spowalnia-pogarszanie-sie-czynnosci-pluc-w-przebiegu-ipf-i-ppf.html): Badania fazy III: nerandomilast spowalnia pogarszanie się czynności płuc w przebiegu IPF i PPF (1,958 words, May 22, 2025)
- [Boala cronică de rinichi: o epidemie tăcută între bolile cardio-renale-metabolice | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-renale/boala-cronica-de-rinichi-o-epidemie-tacuta-intre-bolile-cardio-renale-metabolice.html): Boala cronică de rinichi: o epidemie tăcută între bolile cardio-renale-metabolice (943 words, May 22, 2025)
- [全球第三期臨床試驗顯示，nerandomilast可減緩IPF與PPF患者肺功能惡化，且其停藥率與安慰劑相近 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi-3/index.html): 全球第三期臨床試驗顯示，nerandomilast可減緩IPF與PPF患者肺功能惡化，且其停藥率與安慰劑相近 (214 words, May 22, 2025)
- [Rabies prevention. Real stories of dedication and impact | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/rabies-prevention-real-stories-dedication-and-impact.html): Discover how dedicated individuals are fighting rabies through education, dog vaccination, and community efforts, to eliminate this deadly disease. (339 words, May 21, 2025)
- [Neues vom ATS: Phase-III-Daten zu Lungenfibrose präsentiert | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/lungenfibrose/neues-vom-ats-phase-iii-daten-zu-lungenfibrose-praesentiert.html): Neues vom ATS: Phase-III-Daten zu Lungenfibrose präsentiert (2,037 words, May 21, 2025)
- [Vers ronds chez le chien et le chat : cinq faits importants | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/vers-ronds-chez-le-chien-et-le-chat-cinq-faits-importants.html): Attention : les vers ronds sont très communs et peuvent aussi infester les humains (850 words, May 21, 2025)
- [Fatigue, nausées, diarrhée, anémie : quelles sont les incidences des ankylostomes chez le chien ? | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/fatigue-nausees-diarrhee-anemie-quelles-sont-les-incidences-des-ankylostomes-chez.html): Ces parasites de nos animaux de compagnie vivent dans le système digestif de votre chien ou de votre chat et peuvent contaminer le sol, nous contaminant peut-être. (672 words, May 21, 2025)
- [Phase III AIRTIVITY trial | Boehringer Ingelheim](/content/human-health/lung-diseases/phase-iii-airtivity-trial/index.html): Dr Wiebke Sauter, Clinical Development Lead for bronchiectasis, discusses the unmet needs of patients and introduces the Phase III AIRTIVITY trial (608 words, May 20, 2025)
- [Estudios de fase III demuestran que nerandomilast enlenteció la pérdida de función pulmonar en FPI y la FPP, con una tasa de discontinuación de tratamiento similar a placebo | Boehringer Ingelheim SA](/content/sa/prensa/estudios-de-fase-iii-demuestran-que-nerandomilast-enlentecio-la-perdida-de-funcion-pulmonar-en-fpi-y.html): Estudios de fase III demuestran que nerandomilast enlenteció la pérdida de función pulmonar en FPI y la FPP, con una tasa de discontinuación de tratamiento similar a placebo (1,808 words, May 20, 2025)
- [真正做到「以患者為中心」——從一位病患倡議者的故事說起 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/patient-centricity/zhenzhengzuodaoyihuanzheweizhongxin-congyiweibinghuanchangyizhedegushishuoqi.html): 真正做到「以患者為中心」——從一位病患倡議者的故事說起 (39 words, May 20, 2025)
- [從共感到改變：攜手病患推進全身型膿疱性乾癬（GPP）照護的行動力 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/patient-centricity/conggonggandaogaibianxieshoubinghuantuijinquanshenxingnongpaoxingganxuangppzhaohudexingdongli.html): 從共感到改變：攜手病患推進全身型膿疱性乾癬（GPP）照護的行動力 (74 words, May 20, 2025)
- [從同理心走向行動：透過《A Life in a Day》模擬體驗，深化我們對病患經歷的理解 | Boehringer Ingelheim TW](/content/tw/human-health/our-responsibility/patient-centricity/congtonglixinzouxiangxingdongtouguoa-life-daymonitiyanshenhuawomenduibinghuanjinglidelijie.html): 從同理心走向行動：透過《A Life in a Day》模擬體驗，深化我們對病患經歷的理解 (1,008 words, May 20, 2025)
- [百靈佳殷格翰任命 Alison Barker 女士為台灣動物保健事業處長 | Boehringer Ingelheim TW](/content/tw/node/32807/index.html): Boehringer Ingelheim Appoints Ms. Alison Barker as Animal Health Director for Taiwan 百靈佳殷格翰任命 Alison Barker 女士為台灣動物保健事業處長 (460 words, May 19, 2025)
- [All hands-on deck to fight the ‘zombie’ rabies virus | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/all-hands-deck-fight-zombie-rabies-virus/index.html): We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships. (693 words, May 16, 2025)
- [Real stories, real impact: fighting rabies | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/real-stories-real-impact-fighting-rabies/index.html): The danger of rabies is often overlooked. The need for action, unseen. Learn how we can eliminate rabies through leveraging education and dog vaccinations. (226 words, May 16, 2025)
- [Uniting to stop rabies: a global and local endeavor | Boehringer Ingelheim CA](/content/ca/about-us/sustainable-development/uniting-stop-rabies-global-and-local-endeavor/index.html): By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease (699 words, May 16, 2025)
- [CRM integrated care World Health Assembly | Boehringer Ingelheim](/content/human-health/crm-integrated-care-world-health-assembly/index.html): Boehringer Ingelheim urges global shift to integrated care to improve one billion lives (693 words, May 16, 2025)
- [Boehringer Ingelheim erhält Marktzulassung für Blauzungen-Impfstoff in Deutschland | Boehringer Ingelheim DE](/content/de/tiergesundheit/boehringer-ingelheim-erhaelt-marktzulassung-fuer-blauzungen-impfstoff-deutschland.html): Boehringer Ingelheim erhält Marktzulassung für Blauzungen-Impfstoff in Deutschland (422 words, May 16, 2025)
- [Global Patient Partnership Summit (GPPS) Connections | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/global-patient-partnership-summit-gpps-connections/index.html): Innovation starts with the right people in the room. Exploring the lasting impact of GPPS 2023 in Asia-Pacific and the power of human connections. (1,074 words, May 15, 2025)
- [Cat care tips for veterinarians: How to de-stress cats at your clinic | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-care-tips-veterinarians-how-de-stress-cats-your-clinic.html): How can cat friendly interactions transform your pet clinic? Dr Teresa Baur-Rehme, a fellow veterinarian and cat expert shares insights and easy tips. (388 words, May 15, 2025)
- [Boehringer Ingelheim revoluciona el tratamiento de la Enfermedad Renal Crónica Felina con el lanzamiento de Semintra® en Argentina | Boehringer Ingelheim SA](/content/sa/prensa/boehringer-ingelheim-revoluciona-el-tratamiento-de-la-enfermedad-renal-cronica-felina-con-el.html): Boehringer Ingelheim revoluciona el tratamiento de la Enfermedad Renal Crónica Felina con el lanzamiento de Semintra® en Argentina (964 words, May 15, 2025)
- [Boehringer Ingelheim reconocida por sus prácticas transparentes en México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/etica-y-compliance/boehringer-ingelheim-reconocida-por-sus-practicas-transparentes-en-mexico.html): En agosto del 2023 Boehringer Ingelheim recibió, por segunda ocasión, la certificación de “Empresa con Prácticas Transparentes” por el Consejo de Ética y Transparencia de la Industria establecida en México (CETIFARMA). (102 words, May 15, 2025)
- [One Billion Lives: Why Integrated Care Can’t Wait | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/one-billion-lives-why-integrated-care-cant-wait/index.html): Discover how integrated care for cardiovascular, renal & metabolic health can save lives and support governments to achieve NCD targets. (699 words, May 14, 2025)
- [Le projet Happy Chickens | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/volaille/le-projet-happy-chickens/index.html): Notre équipe en Argentine aide les personnes aux capacités diverses à trouver de la joie et un but grâce à l'élevage de poulets. (735 words, May 13, 2025)
- [Partnering for Animal Health Innovation | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/partnering-animal-health-innovation/index.html): Meet our animal health partnering team, explore our partnering interests and learn how we can advance innovation together at BIO International 2026 (562 words, May 13, 2025)
- [Teilnehmende klinischer Studien fördern Gesundheitsinnovation | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/teilnehmende-klinischer-studien-foerdern-gesundheitsinnovation.html): Die Heldinnen und Helden hinter der Medizin: Wie Teilnehmende klinischer Studien den medizinischen Fortschritt und neue Therapien ermöglichen. (1,135 words, May 12, 2025)
- [Suspeite de Fibrose Pulmonar | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/suspeite-de-fibrose-pulmonar/index.html): A fibrose pulmonar pode causar danos irreversíveis. Conheça o site criado para apoiar a jornada do paciente e ajudar no manejo dessa condição. (389 words, May 12, 2025)
- [Happy chickens project | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/poultry/happy-chickens-project/index.html): Our Argentina team partners with Andar to help people with diverse abilities find purpose through chicken farming while promoting poultry health and disease prevention. (704 words, May 9, 2025)
- [Ruta 86 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/ruta-86/index.html): Ruta 86 (346 words, May 9, 2025)
- [Ruta 86 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/ruta-86/index.html): Ruta 86 (346 words, May 9, 2025)
- [Opening doors with open science | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/opening-doors-open-science/index.html): Our open science mindset creates a collaborative scientific community that advances breakthrough therapies to meet unmet patient needs. (1,049 words, May 8, 2025)
- [Insuffisance cardiaque : une maladie sous-estimée | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-cardiaques/insuffisance-cardiaque/insuffisance-cardiaque-une-maladie-sous-estimee/index.html): Insuffisance cardiaque : une maladie sous-estimée (264 words, May 8, 2025)
- [Herzinsuffizienz: Eine unterschätzte Volkskrankheit | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/herzinsuffizienz/herzinsuffizienz-eine-unterschaetzte-volkskrankheit.html): Herzinsuffizienz: Eine unterschätzte Volkskrankheit (214 words, May 8, 2025)
- [Veterinary public health preparedness | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/veterinary-public-health-preparedness/index.html): Transboundary animal diseases (TADs) are a serious veterinary public health preparedness issue. Check how we can help you prevent them. (793 words, May 7, 2025)
- [Phase II start of oral treatment for Geographic Atrophy | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/phase-ii-start-oral-treatment-geographic-atrophy/index.html): Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy (1,047 words, May 6, 2025)
- [Widnes PCN Executive Summary - Phase 2 | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/widnes-pcn-executive-summary-phase-2/index.html): To establish a data led approach to service redesign for patients living with heart failure, chronic kidney disease and Type 2 Diabetes, across Widnes PCN (303 words, May 5, 2025)
- [Annual Compliance report | Boehringer Ingelheim PT](/content/pt/sobre-nos/annual-compliance-report/index.html): Annual Compliance report (63 words, May 2, 2025)
- [Genomic Testing in Lung Cancer | Boehringer Ingelheim UK](/content/uk/human-health/cancer/lung-cancer/genomic-testing-lung-cancer/index.html): Read how Genomics testing is one of the most effective methods to ensure that mutation drivers are identified quickly and accurately (478 words, May 2, 2025)
- [Código de conducta de nuestros proveedores | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/etica-y-compliance/codigo-de-conducta-de-nuestros-proveedores/index.html): Las expectativas de Boehringer hacia sus proveedores en cuanto a comportamiento ético, integridad, profesionalismo y requisitos comerciales en común. (95 words, Apr 30, 2025)
- [Nuestras expectativas | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/etica-y-compliance/nuestras-expectativas/index.html): Código de Conducta a Proveedores (585 words, Apr 30, 2025)
- [У разі питань, пов'язаних з безпекою пацієнтів, просимо зв'язатися з відділом фармаконагляду | Boehringer Ingelheim UA](/content/ua/human-health/our-responsibility/bezpeka-pacienta/u-razi-pitan-povyazanikh-z-bezpekoyu-pacientiv-prosimo-zvyazatisya-z-viddilom-farmakonaglyadu.html): У разі питань, пов'язаних з безпекою пацієнтів, просимо зв'язатися з відділом фармаконагляду (187 words, Apr 30, 2025)
- [Stop Rage : une initiative mondiale et locale | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/stop-rage-une-initiative-mondiale-et-locale/index.html): En collaborant, nous pouvons arrêter la rage. Découvrez comment nous éliminons les obstacles grâce au pouvoir des partenariats pour lutter contre cette maladie mortelle (947 words, Apr 29, 2025)
- [Neue Studiendaten zu Lungenkrebs beim AACR | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/neue-studiendaten-zu-lungenkrebs-beim-aacr/index.html): Neue Studiendaten zu Lungenkrebs beim AACR (496 words, Apr 29, 2025)
- [Важливі документи для наших ділових партнерів | Boehringer Ingelheim UA](/content/ua/about-us/purchasing/vazhlivi-dokumenti-dlya-nashikh-dilovikh-partneriv/index.html): Важливі документи для наших ділових партнерів (32 words, Apr 29, 2025)
- [Stezka Kryjte záda ledvinám v Táboře | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/stezka-kryjte-zada-ledvinam-v-tabore/index.html): Stezka u údolní nádrže Jordán upozorní prostřednictvím informačních panelů na chronické onemocnění ledvin. (358 words, Apr 29, 2025)
- [Importance of Veterinarians | Boehringer Ingelheim MEA](/content/mea/animal-health/our-responsibility/importance-veterinarians/index.html): The importance of Veterinarians (176 words, Apr 28, 2025)
- [Southeast Asia’s veterinarians’ untold story of resilience | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/southeast-asias-veterinarians-untold-story-resilience.html): Veterinarians and clinic staff face significant challenges across Southeast Asia due to the mounting pressures and emotional burdens their roles demand. (558 words, Apr 25, 2025)
- [Monique’s leven met longfibrose: een boodschap van hoop en veerkracht | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/longfibrose/moniques-leven-met-longfibrose-een-boodschap-van-hoop-en-veerkracht.html): Monique’s leven met longfibrose: een boodschap van hoop en veerkracht (573 words, Apr 23, 2025)
- [Strengthening policy for CRM diseases: An action plan | Boehringer Ingelheim IE](/content/ie/human-health/metabolic-diseases/strengthening-policy-crm-diseases-action-plan/index.html): Strengthening the policy response to cardiovascular, renal and metabolic diseases: An action plan for a more integrated model of care (141 words, Apr 23, 2025)
- [Une nouvelle enquête montre que plus de 90 % des propriétaires d'animaux font confiance aux équipes vétérinaires et les apprécient, mais sous-estiment les exigences de la profession | Boehringer Ingelheim FR](/content/fr/sante-animale/une-nouvelle-enquete-montre-que-plus-de-90-des-proprietaires-danimaux-font-confiance-aux-equipes.html): À l'occasion de la Journée mondiale des vétérinaires 2025, Boehringer Ingelheim et les partenaires de la campagne encouragent les propriétaires d'animaux à exprimer leur reconnaissance aux équipes vétérinaires. (816 words, Apr 23, 2025)
- [Noi perspective: De ce îngrijirea veterinară este mult mai mult decât ați putea crede | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/responsabilitatea-noastra/noi-perspective-de-ce-ingrijirea-veterinara-este-mult-mai-mult-decat-ati-putea-crede.html): Noi perspective: De ce îngrijirea veterinară este mult mai mult decât ați putea crede (585 words, Apr 23, 2025)
- [De nouvelles perspectives : Pourquoi les soins vétérinaires sont beaucoup plus importants que vous ne le pensez | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/nos-stories/de-nouvelles-perspectives-pourquoi-les-soins-veterinaires-sont-beaucoup-plus-importants-que-vous-ne.html): Comprenons-nous vraiment ce que signifie être vétérinaire ? Découvrez pourquoi il est important d'en savoir plus sur cette profession exigeante. (620 words, Apr 23, 2025)
- [Neue Perspektiven: Warum tierärztliche Versorgung so viel mehr ist, als Sie vielleicht denken | Boehringer Ingelheim CH](/content/ch/tiergesundheit/unsere-stories/neue-perspektiven-warum-tieraerztliche-versorgung-so-viel-mehr-ist-als-sie-vielleicht-denken.html): Verstehen wir wirklich, was es heisst, Tierärztin oder Tierarzt zu sein? Finden Sie heraus, warum es wichtig ist, mehr über diesen anspruchsvollen Beruf zu erfahren. (558 words, Apr 23, 2025)
- [ひとつのパイプラインを一気通貫で前進させる「アセットチーム」のリーダー ～新しい治療法をより早く患者さんに届け、その価値を最大化する | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0008/index.html): 日本ベーリンガーインゲルハイム株式会社は2024年、「アセット*チーム」体制を導入しました。医薬品の開発は、薬の候補について患者さんに対する有効性や安全性を確認する臨床試験、承認取得のための申請など、上市までにさまざまなフェーズがあります。 (23 words, Apr 23, 2025)
- [Biosseguridade na Avicultura | Trovac® NDV | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/aves/biosseguridade-na-avicultura-trovac-ndv/index.html): Artigo técnico sobre a nova vacina Trovac® NDV, por Otavio Olivieri e Tobias Filho. (1,023 words, Apr 22, 2025)
- [Our power. Our planet. Our people: Promoting sustainable development excellence | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/more-green/our-power-our-planet-our-people-promoting-sustainable-development-excellence.html): Boehringer celebrates its SDX Certificate Program, which empowers employees with the knowledge and skills to become sustainability advocates and educators. (624 words, Apr 18, 2025)
- [Eventos | Boehringer Ingelheim](/content/pro/br/eventos/index.html): Lista de eventos (97 words, Apr 18, 2025)
- [Rare Disease Day2025：希少・難治性疾患をめぐるコミュニケーションの課題について話そう | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0418/index.html): 2025年3月31日、日本ベーリンガーインゲルハイムはRare Disease Day（世界希少・難治性疾患の日、以下RDD）に連動し、本社およびオンラインで希少・難治性疾患に関するパネルディスカッションイベントを開催しました。 (53 words, Apr 18, 2025)
- [Tierbesitzer unterschätzen tierärztliche Arbeit | Boehringer Ingelheim AT](/content/at/de/presse/tierbesitzer-unterschaetzen-tieraerztliche-arbeit/index.html): Aktuelle Umfrage zeigt: Über 90% der Tierbesitzer sind für die tierärztliche Arbeit dankbar, sie unterschätzen aber die damit verbundene Belastung (994 words, Apr 17, 2025)
- [Why veterinary care is so much more | Boehringer Ingelheim AT](/content/at/en/animal-health/featured-stories/why-veterinary-care-so-much-more/index.html): New perspectives: Why veterinary care is so much more than you may think (505 words, Apr 17, 2025)
- [Tierärztliche Versorgung ist mehr als gedacht | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/unsere-stories/tieraerztliche-versorgung-ist-mehr-als-gedacht/index.html): Neue Perspektiven: Warum tierärztliche Versorgung so viel mehr ist, als Sie vielleicht denken (650 words, Apr 17, 2025)
- [Veterinary care is so much more than you may think | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/veterinary-care-so-much-more-you-may-think/index.html): Do we really understand what it takes to be a veterinary professional? Find out why learning more about this aspirational career matters. (503 words, Apr 16, 2025)
- [Nuevas perspectivas: Por qué la atención veterinaria es mucho más de lo que crees | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/nuevas-perspectivas-por-que-la-atencion-veterinaria-es-mucho-mas-de-lo-que-crees.html): ¿Entendemos realmente lo que se necesita para ser un profesional veterinario? Descubre porqué es importante aprender más sobre esta carrera ambiciosa. (878 words, Apr 16, 2025)
- [Nuevas perspectivas: La atención veterinaria es mucho más de lo que te imaginas | Boehringer Ingelheim MX](/content/mx/salud-animal/nuevas-perspectivas-la-atencion-veterinaria-es-mucho-mas-de-lo-que-te-imaginas.html): Nuevas perspectivas: La atención veterinaria es mucho más de lo que te imaginas (620 words, Apr 16, 2025)
- [On ne lâche rien pour lutter contre le virus de la rage « zombie » | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ne-lache-rien-pour-lutter-contre-le-virus-de-la-rage-zombie.html): La collaboration s’impose pour échapper au scénario mortel. (872 words, Apr 16, 2025)
- [Veterinarios: atrapados entre la excelencia y el agotamiento | Boehringer Ingelheim MX](/content/mx/salud-animal/nuestra-responsabilidad/veterinarios-atrapados-entre-la-excelencia-y-el-agotamiento.html): Veterinarios: atrapados entre la excelencia y el agotamiento (919 words, Apr 16, 2025)
- [Ser veterinario es mucho más de lo que imaginas | Boehringer Ingelheim ES](/content/es/salud-animal/historias-destacadas/ser-veterinario-es-mucho-mas-de-lo-que-imaginas/index.html): Ser veterinario es mucho más de lo que imaginas (527 words, Apr 15, 2025)
- [für Katzen mit chronischer Nierenerkrankung und/oder Bluthochdruck | Boehringer Ingelheim DE](/content/de/tiergesundheit/fuer-katzen-mit-chronischer-nierenerkrankung-und-oder-bluthochdruck.html): SEMINTRA® 4 mg/ml für Katzen: Jetzt bei chronischer Nierenerkrankung und/oder Bluthochdruck zugelassen und verfügbar! (767 words, Apr 15, 2025)
- [Technology transfer | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/technology-transfer-bioxcellence/index.html): At Boehringer Ingelheim, we streamline complex transfers of biopharmaceutical manufacturing processes with expert knowledge and strategic partnerships. (234 words, Apr 15, 2025)
- [Stroke – Risk Factors and Symptoms | Boehringer Ingelheim AT](/content/at/en/human-health/heart-diseases/stroke/stroke-risk-factors-and-symptoms/index.html): Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about the Risk Factors and Symptoms (632 words, Apr 14, 2025)
- [Schlaganfall – Risikofaktoren und Symptome | Boehringer Ingelheim AT](/content/at/de/humanmedizin/herzerkrankungen/schlaganfall/schlaganfall-risikofaktoren-und-symptome/index.html): Schlaganfall: Informieren Sie sich über Risikofaktoren, Symptome und Behandlungsmöglichkeiten. Der FAST-Test hilft bei der frühzeitige Erkennung. (785 words, Apr 14, 2025)
- [Nuove prospettive: perché l'assistenza veterinaria è molto più di quanto si possa pensare | Boehringer Ingelheim IT](/content/it/salute-animale/il-nostro-impegno/nuove-prospettive-perche-lassistenza-veterinaria-e-molto-piu-di-quanto-si-possa-pensare.html): Sappiamo davvero cosa sia necessario per diventare un professionista veterinario? Scopri perché saperne di più su questa carriera ambiziosa è importante. (489 words, Apr 14, 2025)
- [Boehringer Ingelheim ontvangt officiële registratie voor blauwtongvaccin BULTAVO 3™ | Boehringer Ingelheim NL](/content/nl/voor-dier/boehringer-ingelheim-ontvangt-officiele-registratie-voor-blauwtongvaccin-bultavo-3.html): Boehringer Ingelheim kondigt met trots aan dat het Bureau Diergeneesmiddelen van de Nederlandse medicijnautoriteit CBG een positief besluit heeft genomen over haar vaccin BULTAVO 3. (694 words, Apr 11, 2025)
- [Becas Conexiones CRM | Boehringer Ingelheim ES](/content/es/salud-humana/becas-conexiones-crm/index.html): Boehringer Ingelheim lanza el programa de becas “Conexiones” dirigida a apoyar proyectos de asociaciones de pacientes relacionados con la interconexión de enfermedades cardiovasculares, renales y metabólicas (CRM) (1,085 words, Apr 10, 2025)
- [Therapeutic Vaccines in Animal Health for Chronic Disease in Pets | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/therapeutic-vaccines-animal-health-chronic-disease-pets.html): Boehringer Ingelheim scientists are exploring how therapeutic vaccines in animal health could hold the key to tackling chronic disease in pets. (1,361 words, Apr 9, 2025)
- [Boehringer launches new edition global hub sustainability | Boehringer Ingelheim](/content/about-us/sustainable-development/boehringer-launches-new-edition-global-hub-sustainability.html): Boehringer launches new edition of ‘Imagine’: A global hub for sustainability stories (510 words, Apr 9, 2025)
- [Your guide to foot-and-mouth disease | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/your-guide-foot-and-mouth-disease/index.html): As FMD is highly contagious, we gathered all you need to know about symptoms, prevention, and control of this transboundary animal disease. (856 words, Apr 8, 2025)
- [New collaboration to develop treatment for autoimmune diseases | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/new-collaboration-develop-treatment-autoimmune-diseases.html): Partnership bolsters autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need (673 words, Apr 7, 2025)
- [Our Path Forward | Boehringer Ingelheim](/content/human-health/mental-health/our-path-forward/index.html): Investing in mental health research, forging unique partnerships, and using setbacks as catalysts for innovation in serious mental illness. (801 words, Apr 7, 2025)
- [Kuş gribi? Mavi dil virüsü? Şap hastalığı? | Boehringer Ingelheim TR](/content/tr/animal-health/trends-insights/kus-gribi-mavi-dil-virusu-sap-hastaligi/index.html): Kuş gribi? Mavi dil virüsü? Şap hastalığı? (166 words, Apr 7, 2025)
- [空污成肺病隱形殺手 產官學民合作力推早篩早治對 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxieshouhezuo/kongwuchengfeibingyinxingshashou-changuanxueminhezuolituizaoshaizaozhidui.html): 空污成肺病隱形殺手 產官學民合作力推早篩早治對 (52 words, Apr 7, 2025)
- [Salgın hayvan hastalıkları: Veteriner halk sağlığı hazırlık çalışmalarında yeni bir ışık | Boehringer Ingelheim TR](/content/tr/animal-health/trends-insights/salgin-hayvan-hastaliklari-veteriner-halk-sagligi-hazirlik-calismalarinda-yeni-bir-isik.html): Salgın hayvan hastalıkları: Veteriner halk sağlığı hazırlık çalışmalarında yeni bir ışık (513 words, Apr 7, 2025)
- [Veteriner halk sağlığı hazırlık çalışmaları: Salgın hayvan hastalıkları hakkında bilinmesi gerekenler | Boehringer Ingelheim TR](/content/tr/animal-health/trends-insights/veteriner-halk-sagligi-hazirlik-calismalari-salgin-hayvan-hastaliklari-hakkinda-bilinmesi-gerekenler.html): Veteriner halk sağlığı hazırlık çalışmaları: Salgın hayvan hastalıkları hakkında bilinmesi gerekenler (436 words, Apr 7, 2025)
- [​​Boehringer Ingelheim llega a más pacientes en 2024 y prepara el lanzamiento de nuevos productos​ | Boehringer Ingelheim SA](/content/sa/prensa/boehringer-ingelheim-llega-mas-pacientes-en-2024-y-prepara-el-lanzamiento-de-nuevos-productos.html): ​​Boehringer Ingelheim llega a más pacientes en 2024 y prepara el lanzamiento de nuevos productos​ (1,125 words, Apr 3, 2025)
- [Boehringer Ingelheim RCV führt Wachstum fort | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-rcv-fuehrt-wachstum-fort/index.html): 2024 war für Boehringer Ingelheim RCV (Regional Center Vienna) wieder ein erfolgreiches Jahr. (1,031 words, Apr 3, 2025)
- [Avoir atteint 66 millions de patients en 2024, Boehringer Ingelheim se prépare maintenant à lancer de nouveaux médicaments | Boehringer Ingelheim BE](/content/be/fr/propos-de-nous/avoir-atteint-66-millions-de-patients-en-2024-boehringer-ingelheim-se-prepare-maintenant-lancer-de.html): Boehringer Ingelheim a annoncé une nouvelle hausse du nombre de patients atteints, atteignant 66 millions en 2024, soit une augmentation de 8,0 % par rapport à l'année précédente. (738 words, Apr 3, 2025)
- [Boehringer Ingelheim bereikte 66 miljoen patiënten in 2024 en maakt zich nu op voor de lancering van nieuwe geneesmiddelen | Boehringer Ingelheim BE](/content/be/nl/over-ons/boehringer-ingelheim-bereikte-66-miljoen-patienten-2024-en-maakt-zich-nu-op-voor-de-lancering-van.html): Boehringer Ingelheim kondigde aan dat het in 2024 een aanhoudende groei in patiëntenbereik heeft bereikt. Het bedrijf bereikte in 2024 66 miljoen patiënten, een stijging van 8,0% ten opzichte van 2023. De ontwikkeling van de huidige productpijplijn verloo (653 words, Apr 3, 2025)
- [Improving horse health through preventive care | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/improving-horse-health-through-preventive-care/index.html): Over the course of their lives, horses can face a variety of health concerns, many of which can be treated, either through vaccination or prevention. (825 words, Apr 3, 2025)
- [Research in cardiovascular, renal, and metabolic diseases | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/research-cardiovascular-renal-and-metabolic-diseases.html): Learn more about our research in cardiovascular, renal, and metabolic diseases, ranging from cardiovascular disease, kidney disease, liver disease, obesity and skeletal muscle health. (573 words, Apr 2, 2025)
- [Inauguration du centre de R&D de NBE Therapeutics à Bâle | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/inauguration-du-centre-de-rd-de-nbe-therapeutics-bale.html): Boehringer Ingelheim renforce son portefeuille de conjugués anticorps-médicaments avec l’ouverture d’un nouveau centre de R&D pour NBE Therapeutics à Bâle (819 words, Apr 2, 2025)
- [Η Boehringer Ingelheim εξυπηρετεί περισσότερους ασθενείς το 2024 και προετοιμάζει νέες κυκλοφορίες φαρμάκων. | Boehringer Ingelheim GR](/content/gr/about-us/i-boehringer-ingelheim-exypiretei-perissoteroys-astheneis-2024-kai-proetoimazei-nees-kyklofories.html): Η Boehringer Ingelheim GmbH ανακοίνωσε σήμερα τη συνέχιση της αύξησης του αριθμού των ασθενών που εξυπηρετήθηκαν, φτάνοντας τα 66 εκατομμύρια το 2024, αυξημένος κατά 8,0% από το προηγούμενο έτος. (775 words, Apr 2, 2025)
- [O chronickém onemocnění ledvin | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/o-chronickem-onemocneni-ledvin/index.html): Chronické onemocnění ledvin je velmi časté a často zůstává neodhaleno kvůli své tiché povaze. Mezi rizikové faktory patří vysoký krevní tlak a cukrovka 2. typu. (856 words, Apr 1, 2025)
- [Виявлення хронічної хвороби нирок: мовчазна епідемія серед кардіо-ренально-метаболічних захворювань | Boehringer Ingelheim UA](/content/ua/human-health/khronichna-khvoroba-nirok/viyavlennya-khronichnoi-khvorobi-nirok-movchazna-epidemiya-sered-kardio-renalno-metabolichnikh.html): Виявлення хронічної хвороби нирок: мовчазна епідемія серед кардіо-ренально-метаболічних захворювань (504 words, Apr 1, 2025)
- [Wie wird Deutschland wieder wettbewerbsfähig? | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/wie-wird-deutschland-wieder-wettbewerbsfaehig/index.html): Tanja Gönner (BDI) und Thomas Reith (Boehringer Ingelheim) diskutieren, wie Deutschland an Innovationskraft und Wettbewerbsfähigkeit gewinnen kann. (1,003 words, Apr 1, 2025)
- [2024 results research and development investment rise | Boehringer Ingelheim](/content/about-us/who-we-are/2024-results-research-and-development-investment-rise.html): Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches (911 words, Apr 1, 2025)
- [Microbial manufacturing | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/microbial-manufacturing-bioxcellence/index.html): The use of microorganisms to develop biopharmaceuticals started in the 20th century and Boehringer Ingelheim has been active in this field since the 1980s. (193 words, Apr 1, 2025)
- [Frauen in Führungspositionen | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/frauen-fuehrungspositionen/index.html): Wie steht es um die Frauenquote bei Boehringer Ingelheim? Aktuelle Daten zur Geschlechterquote nach dem Führungspositionengesetz (FüPoG). (190 words, Mar 31, 2025)
- [Lapání po dechu může být příznak srdečního selhání | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/lapani-po-dechu-muze-byt-priznak-srdecniho-selhani/index.html): Dušnost nebo lapání po dechu je jedním z hlavních příznaků závažného srdečního onemocnění. (763 words, Mar 27, 2025)
- [Ileite subclinica: la sapresti riconoscere? | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/suini/ileite-subclinica-la-sapresti-riconoscere/index.html): Ileite subclinica: la sapresti riconoscere? (610 words, Mar 26, 2025)
- [Enfermedad Renal Crónica en gatos: No dejes que sea una batalla perdida | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/enfermedad-renal-cronica-en-gatos-no-dejes-que-sea-una-batalla-perdida.html): Enfermedad Renal Crónica en gatos: No dejes que sea una batalla perdida (617 words, Mar 26, 2025)
- [submit your inquiry here | Ask Boehringer](/content/pro/ca/ask-boehringer/inquiry-form/index.html): Submit your questions or requests through our inquiry form. We’ll respond promptly to assist you. Your feedback matters to us! (244 words, Mar 26, 2025)
- [submit your inquiry here | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/inquiry-form/index.html): Submit your questions or requests through our inquiry form. We’ll respond promptly to assist you. Your feedback matters to us! (256 words, Mar 26, 2025)
- [El lavado de coches no es esencial, la medicación sí lo es | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestras-historias/el-lavado-de-coches-no-es-esencial-la-medicacion-si-lo-es.html): El lavado de coches no es esencial, la medicación sí lo es (762 words, Mar 25, 2025)
- [Copyright Notice | Usage Rights & Permissions | Ask Boehringer](/content/pro/ca/ask-boehringer/copyright/index.html): Learn about copyright protections for our website content. This page outlines permitted uses, attribution requirements, and how to request authorization for reproduction. (274 words, Mar 25, 2025)
- [Copyright Notice | Usage Rights & Permissions | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/copyright/index.html): Learn about copyright protections for our website content. This page outlines permitted uses, attribution requirements, and how to request authorization for reproduction. (348 words, Mar 25, 2025)
- [Accessibility Statement | Ask Boehringer](/content/pro/ca/ask-boehringer/accessibility/index.html): Our commitment to digital accessibility. Learn how we meet WCAG standards, accommodate diverse needs, and respond to accessibility feedback. (37 words, Mar 25, 2025)
- [Accessibility Statement | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/accessibility/index.html): Our commitment to digital accessibility. Learn how we meet WCAG standards, accommodate diverse needs, and respond to accessibility feedback. (45 words, Mar 25, 2025)
- [Accessibility Statement | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/en/node/12/index.html): Our commitment to digital accessibility. Learn how we meet WCAG standards, accommodate diverse needs, and respond to accessibility feedback. (131 words, Mar 25, 2025)
- [User Agreement & Legal Terms | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/terms-of-use/index.html): Our Terms of Service outline the rules for using our website, including user obligations, content policies, and dispute resolution. Read the full agreement here. (1,572 words, Mar 25, 2025)
- [「脈動台灣 醫路前行」改善醫療環境的50個故事徵件中！ | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxieshouhezuo/maidongtaiwan-yiluqianxing-gaishanyiliaohuanjingde50gegushizhengjianzhong.html): 「脈動台灣 醫路前行」改善醫療環境的50個故事徵件中！ (20 words, Mar 25, 2025)
- [Disclaimer | Ask Boehringer](/content/pro/ca/ask-boehringer/disclaimer/index.html): Disclaimer (400 words, Mar 25, 2025)
- [Disclaimer | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/disclaimer/index.html): Disclaimer (437 words, Mar 25, 2025)
- [Water resources management is more than water consumption | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/water-resources-management-more-water-consumption/index.html): How we secure the production of live-saving medicines in drought-prone Sant Cugat and beyond. (704 words, Mar 24, 2025)
- [Spendenübergabe an VETHiLFE: Boehringer Ingelheim unterstützt | Boehringer Ingelheim DE](/content/de/tiergesundheit/spendenuebergabe-vethilfe-boehringer-ingelheim-unterstuetzt.html): Spendenübergabe an VETHiLFE: Boehringer Ingelheim unterstützt (925 words, Mar 21, 2025)
- [Therapeutic Vaccines in Animal Health for Chronic Disease in Pets | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/therapeutic-vaccines-animal-health-chronic-disease-pets.html): Boehringer Ingelheim scientists are exploring how therapeutic vaccines in animal health could hold the key to tackling chronic disease in pets. (1,361 words, Mar 20, 2025)
- [Une protection efficace contre le circovirus porcin ne requiert pas la même approche pour tous | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/une-protection-efficace-contre-le-circovirus-porcin-ne-requiert-pas-la-meme-approche-pour-tous.html): Une protection efficace contre le circovirus porcin ne requiert pas la même approche pour tous (873 words, Mar 19, 2025)
- [La distribución geográfica de los parásitos de tu mascota está cambiando | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/la-distribucion-geografica-de-los-parasitos-de-tu-mascota-esta-cambiando.html): La distribución geográfica de los parásitos de tu mascota está cambiando (924 words, Mar 19, 2025)
- [La lucha contra la rabia en comunidades de pueblos originarios de Ecuador | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/mas-salud/la-lucha-contra-la-rabia-en-comunidades-de-pueblos-originarios-de-ecuador.html): La lucha contra la rabia en comunidades de pueblos originarios de Ecuador (841 words, Mar 19, 2025)
- [Boehringer Ingelheim search knowledge base | Ask Boehringer](/content/pro/ca/ask-boehringer/index.html): Welcome to the Boehringer Ingelheim search knowledge base. Here HCPs can find easy access to medical information on the Boehringer Ingelheim product portfolio. (149 words, Mar 19, 2025)
- [Boehringer Ingelheim search knowledge base | Ask Boehringer](/content/pro/ca/ask-boehringer/home/index.html): Welcome to the Boehringer Ingelheim search knowledge base. Here HCPs can find easy access to medical information on the Boehringer Ingelheim product portfolio. (149 words, Mar 19, 2025)
- [Boehringer Ingelheim search knowledge base | Ask Boehringer](/content/pro/ca/fr/demande-boehringer/index.html): Welcome to the Boehringer Ingelheim search knowledge base. Here HCPs can find easy access to medical information on the Boehringer Ingelheim product portfolio. (165 words, Mar 19, 2025)
- [Evcil Hayvan Parazitlerinin Coğrafyası Değişiyor | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/evcil-hayvan-parazitlerinin-cografyasi-degisiyor/index.html): Evcil Hayvan Parazitlerinin Coğrafyası Değişiyor (718 words, Mar 18, 2025)
- [Geografické rozšíření parazitů napadajících domácí zvířata se mění | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/spolecenska-zvirata/geograficke-rozsireni-parazitu-napadajicich-domaci-zvirata-se-meni.html): Se změnou klimatu přibývá nemocí, které na domácí zvířata přenášejí ptáci, hlodavci, komáři nebo dokonce slimáci. (836 words, Mar 17, 2025)
- [Pravidelná kontrola krevního tlaku je klíčem ke zdraví | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/vysoky-krevni-tlak/pravidelna-kontrola-krevniho-tlaku-je-klicem-ke-zdravi.html): Vysoký krevní tlak nebolí a nemusí mít žádné viditelné příznaky. Přesto může způsobit vážné zdravotní komplikace. (592 words, Mar 13, 2025)
- [Ledviny pod tlakem - vliv vysokého tlaku na funkci ledvin | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/kardiovaskularni-onemocneni/vysoky-krevni-tlak/ledviny-pod-tlakem-vliv-vysokeho-tlaku-na-funkci-ledvin.html): Ledviny úzce souvisí s krevním tlakem (hypertenze). Vysoký krevní tlak poškozuje ledviny, a naopak nemocné ledviny často mohou za hypertenzi. (523 words, Mar 13, 2025)
- [Medicamentos sostenibles para nuestro planeta | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/medicamentos-sostenibles-para-nuestro-planeta/index.html): Medicamentos sostenibles para nuestro planeta (961 words, Mar 13, 2025)
- [Papel dos Peptídeos Natriuréticos no Diagnóstico da IC](/content/pro/pt/heart-of-what-matters/peptidos-natriureticos-no-diagnostico-da-ic/index.html): Peptídeos natriuréticos são essenciais no diagnóstico da IC, oferecendo orientações práticas para sua interpretação e aplicação clínica eficaz. (242 words, Mar 13, 2025)
- [Rheumatoid arthritis-associated interstitial lung disease | Boehringer Ingelheim IE](/content/ie/human-health/lung-diseases/rheumatoid-arthritis-associated-interstitial-lung-disease.html): Rheumatoid arthritis causes inflammation in the joints, but it can also cause inflammation in other organs, including the lungs. (170 words, Mar 12, 2025)
- [Psie parazity: Čo by ste mali vedieť | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/pets/psie-parazity-co-ste-mali-vediet/index.html): Psie parazity: Čo by ste mali vedieť (613 words, Mar 12, 2025)
- [Código de Conducta | Boehringer Ingelheim ES](/content/es/sobre-nosotros/etica-y-compliance/codigo-de-conducta/index.html): Nuestro Código de Conducta establece los estándares éticos que guían todas nuestras actividades empresariales. Se trata de todos nosotros. Cada persona desempeña un papel fundamental para dar vida al Código de Conducta. (326 words, Mar 11, 2025)
- [Le circovirus porcin change – mais en est-il de même pour votre protocole de vaccination? | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/le-circovirus-porcin-change-mais-en-est-il-de-meme-pour-votre-protocole-de-vaccination.html): Le circovirus porcin change – mais en est-il de même pour votre protocole de vaccination? (542 words, Mar 11, 2025)
- [Zdeňkovi začaly ledviny selhávat už po čtyřicítce | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/zdenkovi-zacaly-ledviny-selhavat-uz-po-ctyricitce/index.html): Příběh pacienta se selháním ledvin. Příznaky silné bolesti hlavy a zvracení.Lékař mu naměřil vysoký krevní tlak, který měl zřejmě bolesti hlavy na svědomí. Další testy v ordinaci zároveň odhalily zvýšenou hladinu kreatininu. (586 words, Mar 11, 2025)
- [Včasné odhalení nemoci ledvin zabránilo vážným komplikacím | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/chronicke-onemocneni-ledvin/vcasne-odhaleni-nemoci-ledvin-zabranilo-vaznym-komplikacim.html): Příběh pacienta, trpícího dědičným onemocněním ledvin. Díky výrazné změně životního stylu a včasné léčbě se mu daří brzdit rozvoj nemoci. (478 words, Mar 11, 2025)
- [Ciudades se unen para mejorar la atención del infarto cerebral | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-health-para-personas-y-animales/ciudades-se-unen-para-mejorar-la-atencion-del-infarto-cerebral.html): Ciudades se unen para mejorar la atención del infarto cerebral (1,109 words, Mar 11, 2025)
- [Imagine: Nuestro centro de historias sobre sostenibilidad | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/nuestras-historias/imagine-nuestro-centro-de-historias-sobre-sostenibilidad.html): Imagine: Nuestro centro de historias sobre sostenibilidad (140 words, Mar 11, 2025)
- [Mujeres en la ciencia | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-potential-para-las-comunidades-y-nuestra-gente/mujeres-en-la-ciencia/index.html): Mujeres en la ciencia (836 words, Mar 10, 2025)
- [Los pilares de nuestro futuro | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/los-pilares-de-nuestro-futuro/index.html): Los pilares de nuestro futuro (737 words, Mar 10, 2025)
- [Informazioni sulla malattia renale cronica | Boehringer Ingelheim IT](/content/it/salute-umana/malattia-renale-cronica/informazioni-sulla-malattia-renale-cronica/index.html): La CKD è molto comune e spesso non viene rilevata a causa della sua natura silenziosa. I fattori di rischio includono ipertensione e diabete di tipo 2. (221 words, Mar 10, 2025)
- [Už 25 rokov sa venujeme srdciam Vašich psov | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/pets/uz-25-rokov-sa-venujeme-srdciam-vasich-psov/index.html): Psy majú neuveriteľnú schopnosť vkradnúť sa rovno do našich sŕdc. Dbáte však na ich zdravie aj z iného pohľadu? (438 words, Mar 10, 2025)
- [Böbrek Sağlığı Kontrolle Başlar | Boehringer Ingelheim TR](/content/tr/human-health/chronic-kidney-disease/bobrek-sagligi-kontrolle-baslar/index.html): Böbrek Sağlığı Kontrolle Başlar (415 words, Mar 10, 2025)
- [Хроничното бъбречно заболяване: Тихата епидемия | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/ckd-silent-epidemic/index.html): Хроничното бъбречно заболяване (ХБЗ) е „тиха“ епидемия, свързана със сърдечно-съдови и метаболитни заболявания. Ранната диагностика и лечение са ключови. (866 words, Mar 7, 2025)
- [About Chronic Kidney Disease | Boehringer Ingelheim AT](/content/at/en/human-health/chronic-kidney-disease/about-chronic-kidney-disease/index.html): CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes. (526 words, Mar 6, 2025)
- [Women in STEM 2025: Breaking new ground across generations | Boehringer Ingelheim AT](/content/at/en/about-us/women-stem-2025-breaking-new-ground-across-generations.html): Learn from three women in science what it means to work in STEM and how it breaks boundaries across generations. (1,068 words, Mar 4, 2025)
- [Kryjte záda ledvinám | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/metabolicka-onemocneni/cukrovka/kryjte-zada-ledvinam/index.html): Odborníci z IKEM v Praze kontrolovali zájemcům zdarma funkci ledvin (794 words, Mar 4, 2025)
- [New Therapies and the Research Pharmacy | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/new-therapies-and-research-pharmacy/index.html): Innovation through collaboration. In order to administer poorly soluble substances, our scientists are expanding their toolbox. Our platform opnMe plays a central role in this. (462 words, Mar 4, 2025)
- [「2025 Innovation Day – Revolutionizing Care By Patient-centered Innovation」台德醫藥研發交流 呼應政府健康台灣號召 | Boehringer Ingelheim TW](/content/tw/node/32509/index.html): 「2025 Innovation Day – Revolutionizing Care By Patient-centered Innovation」台德醫藥研發交流 呼應政府健康台灣號召 (42 words, Mar 4, 2025)
- [Porcine circovirus is changing – but has your vaccine protocol? | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/porcine-circovirus-changing-has-your-vaccine-protocol.html): Porcine circovirus is changing – but has your vaccine protocol? (418 words, Mar 3, 2025)
- [Abordar el gen HER2 en cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/abordar-el-gen-her2-en-cancer/index.html): Abordar el gen HER2 en cáncer (611 words, Mar 3, 2025)
- [Pensar en el hígado cuando hablamos de obesidad | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/obesidad/pensar-en-el-higado-cuando-hablamos-de-obesidad/index.html): Óscar Ibarra Sales, de Boehringer Ingelheim, habla sobre la epidemia mundial de obesidad, su efecto en el hígado y por qué es el momento de actuar (899 words, Mar 3, 2025)
- [biopharmaceutical contract manufacturing services China enhanced | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/biopharmaceutical-contract-manufacturing-services-china-enhanced.html): Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China (575 words, Mar 3, 2025)
- [Open Innovation bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/open-innovation-bei-boehringer-ingelheim/index.html): Mit openMe teilen wir erstklassige kleine Moleküle mit der wissenschaftlichen Gemeinschaft. (878 words, Mar 3, 2025)
- [Open Innovation: Neue Therapien und die Forschungsapotheke | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/open-innovation-neue-therapien-und-die-forschungsapotheke.html): Innovation durch Kollaboration. Unsere Forschende bringen Substanzen in Lösung. (436 words, Feb 27, 2025)
- [Garder une longueur d’avance sur le circovirus porcin | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/garder-une-longueur-davance-sur-le-circovirus-porcin.html): Garder une longueur d’avance sur le circovirus porcin (689 words, Feb 27, 2025)
- [Leptospirosis en perros | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/leptospirosis-en-perros/index.html): Leptospirosis en perros: Lo que debes saber para proteger a tu mascota (647 words, Feb 27, 2025)
- [AR filter Quiz zu CRM | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/ar-filter-quiz-zu-crm/index.html): Spielen Sie unser interaktives Augmented Reality Quiz und erfahren Sie mehr über Diabetes, Herz- und Nierenkrankheiten (312 words, Feb 27, 2025)
- [Про хронічну хворобу нирок | Boehringer Ingelheim UA](/content/ua/human-health/pro-khronichnu-khvorobu-nirok/index.html): Хронічна хвороба нирок є дуже поширеною і часто залишається непоміченою через її безсимптомний характер. Фактори ризику включають високий кров'яний тиск і цукровий діабет 2 типу. (502 words, Feb 26, 2025)
- [Mit Open Science Türen öffnen | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/mit-open-science-tueren-oeffnen/index.html): Unser open science Ansatz schafft eine kollaborative wissenschaftliche Gemeinschaft, die bahnbrechende Therapien zur Erfüllung ungedeckter Patientenbedürfnisse vorantreibt. (1,068 words, Feb 26, 2025)
- [Addressing the Global Obesity and Liver Crisis | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/obesity/addressing-global-obesity-and-liver-crisis/index.html): Boehringer Ingelheim’s Sandy Sommer on the global obesity epidemic, its effect on the liver, and why the time to act is now (645 words, Feb 26, 2025)
- [Chronische Nierenkrankheit lange still und unentdeckt | Boehringer Ingelheim AT](/content/at/de/presse/chronische-nierenkrankheit-lange-still-und-unentdeckt.html): Herz-Kreislauf-, Nieren- und Stoffwechselerkrankungen zählen zu den häufigsten Todesursachen weltweit. Diese-Erkrankungen sind miteinander verknüpft, treten oft gemeinsam auf und können sich gegenseitig verstärken. (1,090 words, Feb 26, 2025)
- [「寄付により救われる命_動物福祉の未来を支えるセーブペットプロジェクト」パートナーに聞く”人と動物の真の共生”とは | Boehringer Ingelheim JP](/content/jp/node/32478/index.html): nodefield_bi_common_seo_description (36 words, Feb 26, 2025)
- [Staying one step ahead of porcine circovirus | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/staying-one-step-ahead-porcine-circovirus/index.html): Staying one step ahead of porcine circovirus (517 words, Feb 25, 2025)
- [Dubai Miracle Garden Interstitial Lung Disease Awareness Campaign | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/dubai-miracle-garden-interstitial-lung-disease-awareness-campaign.html): Boehringer Ingelheim unveiled a breathtaking installation of lungs at the Dubai Miracle Garden to raise awareness for ILD (817 words, Feb 25, 2025)
- [百靈佳殷格翰 2025年線上校園徵才–開啟職涯全景圖 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/bailingjiayingehan-2025nianxianshangxiaoyuanzhengcai-kaiqizhiyaquanjingtu.html): 百靈佳殷格翰 2025年線上校園徵才–開啟職涯全景圖 (48 words, Feb 25, 2025)
- [Zusammenhang von Herz-Kreislauf, Nieren & Stoffwechsel und Dominoeffekt | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/zusammenhang-von-herz-kreislauf-nieren-stoffwechsel-und-dominoeffekt.html): Um den Dominoeffekt Ihrer Gesundheit zu verstehen, müssen Sie erkennen, dass Ihr Herz-Kreislauf-Nieren- und Stoffwechsel-System wie eine Reihe von Dominosteinen zusammenhängt. (547 words, Feb 20, 2025)
- [Biosecurity in swine: PRRS and ASF | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/biosecurity-swine-prrs-and-asf/index.html): PRRS and ASF are diseases that target swine. As farmers, you play a crucial role in protecting your animals against them. Biosecurity can be your ally. (819 words, Feb 19, 2025)
- [Profile update page | Boehringer Ingelheim](/content/pro/br/profile-update-page/index.html): Profile update page (85 words, Feb 19, 2025)
- [Boehringer Ingelheim - z pasją na rzecz poprawy zdrowia](/content/pro/pl/index.html): Przeczytaj o naszych obszarach terapeutcznych i dostępnych terapiach Boehringer Ingelheim (80 words, Feb 19, 2025)
- [Launch new trivalent poultry vaccine protection against H5 avian influenza | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/launch-new-trivalent-poultry-vaccine-protection-against-h5-avian-influenza.html): VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. (773 words, Feb 19, 2025)
- [Historic Section | Boehringer Ingelheim](/content/pro/br/historico/index.html): Historic Section (173 words, Feb 19, 2025)
- [Despre Boala cronică de rinichi | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-renale/despre-boala-cronica-de-rinichi/index.html): BCR este foarte comună și adesea trece neobservată din cauza naturii sale tăcute. Factorii de risc includ hipertensiunea arterială și diabetul de tip 2. (450 words, Feb 18, 2025)
- [iSGLT2 na IC ambulatorial | Boehringer Ingelheim](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/biblioteca-cientifica/evidencia-de-mundo-real-qual-o-cenario-atual-do-uso-de-inibidores-do-sglt2.html): Evidência de mundo real: qual o cenário atual do uso de inibidores do cotransportador de sódio-glicose tipo 2 no tratamento da insuficiência cardíaca ambulatorial? (488 words, Feb 18, 2025)
- [Products Human Pharma | Boehringer Ingelheim](/content/pro/products/index-2.html): Overview of Boehrigner Ingelheims Human Pharma Products (51 words, Feb 18, 2025)
- [Melisa Gibovic-Danner bei Teach For Austria | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/melisa-gibovic-danner-bei-teach-austria/index.html): Führungskräfte im Klassenzimmer: Melisa Gibovic-Danner inspiriert Schüler:innen bei der Teach For Austria Woche (122 words, Feb 17, 2025)
- [Wie ein Schlaganfall Horsts Leben auf den Kopf stellte | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/schlaganfall/wie-ein-schlaganfall-horsts-leben-auf-den-kopf-stellte.html): Unser Kollege Horst erlitt einen Schlaganfall. Seine Geschichte zeigt eindringlich, wie schnelles Handeln und das Erkennen von Symptomen die Rehabilitation beeinflussen können. (511 words, Feb 17, 2025)
- [Add to Favoritos | Boehringer Ingelheim](/content/pro/br/favoritos/index.html): Add to Favoritos (248 words, Feb 17, 2025)
- [Weniger als die Hälfte der Tierärzte empfindet ihren Beruf als wertgeschätzt | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/weniger-als-die-haelfte-der-tieraerzte-empfindet-ihren-beruf-als-wertgeschaetzt.html): Weniger als die Hälfte der Tierärzte empfindet ihren Beruf als wertgeschätzt (855 words, Feb 14, 2025)
- [SEMINTRA 4mg/ml oral solution cats chronic kidney disease hypertension | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/semintra-4mg-ml-oral-solution-cats-chronic-kidney-disease-hypertension.html): Boehringer Ingelheim announced that SEMINTRA® 4 mg/ml Oral Solution is now available in Europe to manage both chronic kidney disease and hypertension in cats. (651 words, Feb 12, 2025)
- [Einblicke - Leben mit Schizophrenie | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/einblicke-leben-mit-schizophrenie/index.html): Rundgang durch die immersive Installation "Einblicke - Leben mit Schizophrenie", fiktive Wohnung des Betroffenen Max (697 words, Feb 11, 2025)
- [Frauen in der Wissenschaft 2025: Neue Wege gehen, über Generationen hinaus | Boehringer Ingelheim AT](/content/at/de/ueber-uns/frauen-der-wissenschaft-2025-neue-wege-gehen-ueber-generationen-hinaus.html): Erfahren Sie von drei Wissenschaftlerinnen, was es bedeutet, in den MINT-Fächern zu arbeiten und wie sie generationenübergreifend Grenzen überwinden. (1,115 words, Feb 11, 2025)
- [Mujeres en STEM 2025: Abriendo nuevos caminos a través de las generaciones | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-potential-para-las-comunidades-y-nuestra-gente/mujeres-en-stem-2025-abriendo-nuevos-caminos-traves-de-las.html): Aprende de tres mujeres lo que significa trabajar en STEM y cómo abren nuevos límites entre generaciones. (1,048 words, Feb 10, 2025)
- [Nerandomilast FIBRONEER-ILD™ | Boehringer Ingelheim SA](/content/sa/prensa/nerandomilast-fibroneer-ild/index.html): fibrosis pulmonar progresiva (1,152 words, Feb 10, 2025)
- [One day, two lives: how a stroke changed Horst’s life | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/stroke/one-day-two-lives-how-stroke-changed-horsts-life/index.html): Our colleague Horst suffered a stroke. His story is a powerful reminder that quick action can make a significant difference in stroke recovery. (658 words, Feb 10, 2025)
- [Biopharma plant & process modeling | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/biopharma-plant-process-modeling-bioxcellence/index.html): At Boehringer Ingelheim we balance efficiency, costs, and sustainability in biopharmaceutical manufacturing by applying holistic plant and process models. (185 words, Feb 10, 2025)
- [社員の自発的な「意欲や想い」が、「笑顔と幸せ」を届ける | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0218/index.html): ベーリンガーインゲルハイムは、私たちの企業文化を再確認することを目的に、「VTI Day」（VTI：Value through Innovation）と呼ばれる社内イベントを毎年、世界各地で行っています。 (92 words, Feb 10, 2025)
- [Vereint im Kampf gegen den „Zombie“ Tollwut-Virus | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/stop-rabies/vereint-im-kampf-gegen-den-zombie-tollwut-virus/index.html): Mit Teamarbeit dem zu fast 100 % tödlichen Szenario entkommen. (242 words, Feb 7, 2025)
- [Mujeres en la Ciencia 2025 | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/mujeres-en-la-ciencia-2025/index.html): Abriendo nuevos caminos a lo largo de las generaciones (1,613 words, Feb 7, 2025)
- [Adopter un état d'esprit de gagnant : Ce que le football nous apprend sur l'esprit d'équipe et la résilience | Boehringer Ingelheim CH](/content/ch/fr/carriere/adopter-un-etat-desprit-de-gagnant-ce-que-le-football-nous-apprend-sur-lesprit-dequipe-et-la.html): Avec l’UEFA Women’s EURO 2025, qui se déroulera en Suisse en juillet, le football est au centre de l’attention, non seulement en tant que sport, mais aussi comme une précieuse source d’inspiration, que ce soit sur le terrain ou dans notre quotidien. (266 words, Feb 7, 2025)
- [Ein Gewinner-Mindset: Was wir von Fussball über Teamwork und Resilienz lernen können | Boehringer Ingelheim CH](/content/ch/karriere/ein-gewinner-mindset-was-wir-von-fussball-ueber-teamwork-und-resilienz-lernen-koennen.html): Mit der UEFA Women’s EURO 2025, die vom 2. bis 27. Juli in der Schweiz stattfindet, rückt Fussball in den Fokus, nicht nur als Sport, sondern auch als wertvolle Inspirationsquelle – sei es auf dem Spielfeld oder im Arbeitsalltag. (213 words, Feb 7, 2025)
- [All hands-on deck to fight the ‘zombie’ rabies virus | Boehringer Ingelheim MEA](/content/mea/about-us/sustainable-development/more-health/all-hands-deck-fight-zombie-rabies-virus/index.html): We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships. (761 words, Feb 7, 2025)
- [All hands-on deck to fight the ‘zombie’ rabies virus | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/stop-rabies/all-hands-deck-fight-zombie-rabies-virus/index.html): We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships. (679 words, Feb 7, 2025)
- [All hands-on deck to fight the ‘zombie’ rabies virus | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/all-hands-deck-fight-zombie-rabies-virus/index.html): We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships. (804 words, Feb 7, 2025)
- [Roundworms in dogs and cats: five important facts | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/roundworms-dogs-and-cats-five-important-facts/index.html): Pet parasites: Attention! Roundworms in cats and dogs are quite common and can infect humans, too. (643 words, Feb 5, 2025)
- [Gemeinsam gegen Tollwut: ein globales und lokales Unterfangen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/stop-rabies/gemeinsam-gegen-tollwut-ein-globales-und-lokales-unterfangen.html): Durch Lernen Veränderungen in den Gemeinden anstoßen (1,001 words, Feb 5, 2025)
- [Verhaltenskodex | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/verhaltenskodex/index.html): Der Verhaltenskodex legt Standards fest, an denen sich unsere Aktivitäten orientieren. Jede*r Einzelne trägt dazu bei, diesen Kodex mit Leben zu füllen. (341 words, Feb 5, 2025)
- [Uniting to stop rabies: a global and local endeavor | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/uniting-stop-rabies-global-and-local-endeavor/index.html): By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease (756 words, Feb 5, 2025)
- [Real stories, real impact: fighting rabies | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/world-rabies-day/real-stories-real-impact-fighting-rabies/index.html): The danger of rabies is often overlooked. The need for action, unseen. Learn how we can eliminate rabies through leveraging education and dog vaccinations. (191 words, Feb 5, 2025)
- [Code of Conduct | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (334 words, Feb 5, 2025)
- [5 questions à Stéphanie Carrillo | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/5-questions-stephanie-carrillo/index.html): Responsable de projets transverses et sous-traitance du contrôle qualité, Stéphanie Carrillo a su dès son plus jeune âge qu'elle voulait poursuivre une carrière scientifique. (372 words, Feb 5, 2025)
- [Как да четем листовката на лекарството | Boehringer Ingelheim BG](/content/bg/human-health/our-responsibility/patient-centricity/getting-know-product-leaflet/index.html): Гледайте видеото с подробно обяснение на всяка част от листовката и как да извлечете максимална полза от информацията в нея. (292 words, Feb 4, 2025)
- [5 questions à Chahinez Benkanoun Oudart, Directrice médicale Boehringer Ingelheim France | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/5-questions-chahinez-benkanoun-oudard-directrice-medicale-boehringer-ingelheim-france-1.html): Dans le cadre de la Journée internationale des femmes et des filles de science, Chahinez Benkanoun Oudart, Directrice médicale chez Boehringer Ingelheim France, a accepté de répondre à nos questions. (503 words, Feb 4, 2025)
- [What are hookworms in dogs? | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/what-are-hookworms-dogs/index.html): Hookworms are pet parasites that live in the digestive system of your dog (or cat!) and can contaminate the soil, possibly infecting us. (604 words, Feb 4, 2025)
- [Tierärzte: Gefangen zwischen Exzellenz und Erschöpfung | Boehringer Ingelheim CH](/content/ch/tiergesundheit/unsere-stories/tieraerzte-gefangen-zwischen-exzellenz-und-erschoepfung.html): Eine Umfrage mit über 1.000 Tierärzten weltweit beleuchtet die Herausforderungen, denen Tierärzte täglich begegnen – und zeigt, was wir tun können, um sie besser zu unterstützen. (841 words, Feb 4, 2025)
- [Boehringer Ingelheim und Sleip setzen auf KI zur Ganganalyse bei Pferden | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/boehringer-ingelheim-und-sleip-setzen-auf-ki-zur-ganganalyse-bei-pferden.html): Boehringer Ingelheim und Sleip setzen auf KI zur Ganganalyse bei Pferden (515 words, Feb 3, 2025)
- [Listado de ensayos clínicos en España | Boehringer Ingelheim ES](/content/es/ciencia-e-innovacion/nuestros-ensayos-clinicos/index.html): Consulta el listado de nuestros ensayos clínicos en España, las áreas terapéuticas, objetivos y fases de cada estudio. (520 words, Feb 3, 2025)
- [Pulmoner Fibrozis (PF) Hastalığını Tanıyalım | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/pulmonary-fibrosis/pulmoner-fibrozis-pf-hastaligini-taniyalim/index.html): Pulmoner Fibrozis (PF) Hastalığını Tanıyalım (249 words, Feb 3, 2025)
- [¿Qué son los ensayos clínicos? | Boehringer Ingelheim ES](/content/es/ciencia-e-innovacion/que-son-los-ensayos-clinicos/index.html): Conoce la definición de ensayo clínico y cómo estos estudios permiten evaluar nuevos tratamientos, garantizar su seguridad y mejorar la salud de las personas. (471 words, Jan 31, 2025)
- [Larrys Geschichte: Wie er zum Fürsprecher für Menschen mit Lungenkrebs wurde | Boehringer Ingelheim CH](/content/ch/humanmedizin/krebserkrankungen/lungenkrebs/larrys-geschichte-wie-er-zum-fuersprecher-fuer-menschen-mit-lungenkrebs-wurde.html): 2013 wurde bei Larry nicht-kleinzelliger Lungenkrebs diagnostiziert. Erfahren Sie, wie diese Diagnose ihn dazu brachte, sich für andere Menschen mit Krebs einzusetzen. (184 words, Jan 30, 2025)
- [Erstkontakt von Spermium und Eizelle: Molekularer Schlüssel zur Befruchtung | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/erstkontakt-von-spermium-und-eizelle-molekularer-schluessel.html): Forschende vom Institut für Molekulare Pathologie (IMP) haben einen „molekularen Schlüssel“ ausfindig gemacht, der den ersten Kontakt zwischen Spermium und Eizelle herstellt. (674 words, Jan 28, 2025)
- [同業他社とも協力。製薬会社が創設した治験環境のオープンイノベーションプログラム | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0004/index.html): 自分や家族が病気になったときに、その病気の治療法にたどり着けないという状況を考えたことがあるだろうか。 現在、日本では海外で既に承認されている薬が日本で承認を得るまで長い時間を要する「ドラッグ・ラグ」や、日本で開発されていない「ドラッグ・ロス」が深刻な課題となっている。 (125 words, Jan 28, 2025)
- [Boehringer Ingelheim ist erneut globaler Top-Arbeitgeber | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-ist-erneut-globaler-top-arbeitgeber.html): Zum fünften Mal in Folge hat das Top Employers Institute Boehringer Ingelheim als „Global Top Employer“ ausgezeichnet. Boehringer ist eines von nur 17 Unternehmen weltweit, die diese Auszeichnung erhalten haben. (638 words, Jan 27, 2025)
- [高等専門学校の学生たちが神戸医薬研究所を探訪！ | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0128/index.html): ベーリンガーインゲルハイムは、グローバルの戦略的な研究開発拠点の一つとして日本に神戸医薬研究所を構えています。2025年1月16日（木）、当社は神戸医薬研究所に神戸市立工業高等専門学校の学生と教員計43名を招待し、見学イベントを開催しました。 (20 words, Jan 27, 2025)
- [Schlaganfall – Warnzeichen erkennen | Boehringer Ingelheim CH](/content/ch/humanmedizin/herzerkrankungen/schlaganfall/schlaganfall-warnzeichen-erkennen/index.html): In der Schweiz erleiden jedes Jahr rund 16.000 Menschen einen Schlaganfall. Er zählt zu den drei häufigsten Todesursachen und ist die Hauptursache für Langzeitbehinderungen bei Erwachsenen. (235 words, Jan 23, 2025)
- [O przewlekłej chorobie nerek | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/przewlekla-choroba-nerek/o-przewleklej-chorobie-nerek/index.html): Przewlekła choroba nerek jest bardzo powszechna i często pozostaje niewykryta z powodu swojego cichego charakteru. Czynniki ryzyka obejmują wysokie ciśnienie krwi i cukrzycę typu 2. (377 words, Jan 22, 2025)
- [Grass Roots : encouragement de start-up en biotechnologie | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/grass-roots/grass-roots-encouragement-de-start-en-biotechnologie.html): Par le biais du programme mondial « Grass Roots », Boehringer Ingelheim offre aux start-up en biotechnologie une plateforme favorisant l’échange et le réseautage. (306 words, Jan 21, 2025)
- [Research Beyond Borders | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/disciplines-de-pointe/research-beyond-borders/index.html): Research Beyond Borders (RBB) est le "radar" de Boehringer Ingelheim pour les innovations futures, avec pour mission de détecter les nouveaux développements scientifiques et technologiques. (871 words, Jan 21, 2025)
- [Thérapies ciblant les cellules cancéreuses | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/disciplines-de-pointe/therapies-ciblant-les-cellules-cancereuses/index.html): Chez Boehringer Ingelheim, nous nous engageons depuis des générations à faire évoluer le traitement du cancer et à guérir à long terme un certain nombre de types de cancer. (1,509 words, Jan 21, 2025)
- [Recherche au Regional Center Vienna | Boehringer Ingelheim CH](/content/ch/fr/innovation/innovation-en-sante-humaine/recherche-au-regional-center-vienna/index.html): Le Boehringer Ingelheim Regional Center Vienna (RCV) est responsable de 33 pays d'Europe centrale et orientale et d'Asie centrale. (443 words, Jan 20, 2025)
- [佐賀県多久市とデータヘルスに関する連携協定を締結 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-25-0115/index.html): 1月10日（金）、日本ベーリンガーインゲルハイム株式会社は、佐賀県多久市と保健事業の推進に関する連携協定（通称：「多久市データヘルスプロジェクト」）を締結しました。本協定では、多久市と日本ベーリンガーインゲルハイムが連携・協力し、地域の医療データを活用した取り組みを推進することで、多久市の健康寿命の延伸および医療費の適正化を目指します。 (17 words, Jan 20, 2025)
- [Was bedeutet die elektronische Patientenakte für die Wissenschaft? | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/was-bedeutet-die-elektronische-patientenakte-fuer-die.html): Der elektronischen Patientenakte widersprechen oder nicht: Was die digitale Krankenakte für Forschung leisten kann und was das für den Datenschutz bedeutet (726 words, Jan 17, 2025)
- [Support for patients | Life with Pulmonary Fibrosis](/content/patient/lwpf/index.html): Welcome to our portal for patients affected by Pulmonary Fibrosis: here you can find helpful info on how to manage the condition. Learn more about PF. (252 words, Jan 17, 2025)
- [About Chronic Kidney Disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chronic-kidney-disease/about-chronic-kidney-disease/index.html): CKD is very common and often goes undetected due to its silent nature. Risk factors include high blood pressure and type 2 diabetes. (296 words, Jan 16, 2025)
- [Grass Roots: Förderung von Biotech Start-ups | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/grass-roots/grass-roots-foerderung-von-biotech-start-ups/index.html): Mit dem globalen “Grass Roots”- Programm bietet Boehringer Ingelheim Biotech Start-ups eine Plattform, um sich miteinander auszutauschen und zu vernetzen. (258 words, Jan 16, 2025)
- [Research Beyond Borders | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/fokusgebiete/research-beyond-borders/index.html): Research Beyond Borders (RBB) ist Boehringer Ingelheims „Radar“ für künftige Innovationen mit der Aufgabe, neue wissenschaftliche Entwicklungen und Technologien aufzuspüren. (746 words, Jan 16, 2025)
- [Auf Immunzellen ausgerichtete Therapien | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/fokusgebiete/auf-immunzellen-ausgerichtete-therapien/index.html): Bei Boehringer Ingelheim engagieren wir uns über Generationen hinweg, um einen Wandel in der Krebstherapie zu erreichen und langfristig eine Reihe von Krebsarten zu heilen. (906 words, Jan 16, 2025)
- [Auf Krebszellen ausgerichtete Therapien | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/fokusgebiete/auf-krebszellen-ausgerichtete-therapien/index.html): Bei Boehringer Ingelheim engagieren wir uns über Generationen hinweg, um einen Wandel in der Krebstherapie zu erreichen und langfristig eine Reihe von Krebsarten zu heilen. (1,232 words, Jan 16, 2025)
- [Forschung am Regional Center Vienna | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/forschung-am-regional-center-vienna/index.html): Das Boehringer Ingelheim Regional Center Vienna (RCV) trägt die Geschäftsverantwortung für 33 Länder in Mittel- und Osteuropa sowie in Zentralasien. (348 words, Jan 15, 2025)
- [Understanding Interstitial Lung Disease (ILD) | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/understanding-interstitial-lung-disease-ild/index.html): Learn about the common symptoms and risk factors of ILD (337 words, Jan 15, 2025)
- [Grenzüberschreitende Tierseuchen | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/grenzueberschreitende-tierseuchen/index.html): Vogelgrippe? Blauzungenkrankheit? Maul- und Klauenseuche? Seht hier, was grenzüberschreitende Tierseuchen sind und wie sie uns beeinflussen können. (384 words, Jan 14, 2025)
- [EHSパフォーマンス指標 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-green/ehs-performance-indicators/index.html): EHSパフォーマンス指標 (272 words, Jan 14, 2025)
- [Unlocking the ‘dark genome’ for cancer immunotherapy | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/unlocking-dark-genome-cancer-immunotherapy/index.html): Our scientists are driving the discovery of unexplored cancer antigens from the ‘dark genome’ to develop novel cancer immunotherapies. (431 words, Jan 13, 2025)
- [Our Behaviors | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/our-behaviors/index.html): How we will Succeed (144 words, Jan 13, 2025)
- [Bem-estar e Produtividade Suinícola | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/bem-estar-e-produtividade-suinicola/index.html): Notícias relacionadas ao bem-estar e produtividade na suinocultura (598 words, Jan 13, 2025)
- [Bem-estar e Produtividade Avícola | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/nos-alimentamos-o-mundo/bem-estar-e-produtividade-avicola/index.html): Notícias relacionadas ao bem-estar e produtividade na avicultura (451 words, Jan 13, 2025)
- [《轉角撿到貓：打造美喵貓生全攻略》迷你貓中途手冊 | Boehringer Ingelheim TW](/content/tw/animal-health/companion-animals-horses/mao/zhuanjiaojiandaomaodazaomeimiaomaoshengquangongeminimaozhongtushouce.html): 《轉角撿到貓：打造美喵貓生全攻略》迷你貓中途手冊 (7 words, Jan 12, 2025)
- [Im Schulterschluss für bessere Forschung | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/im-schulterschluss-fuer-bessere-forschung/index.html): Interview mit Susanne Bailer (Fraunhofer IGB) und Thomas Reith (Boehringer Ingelheim) zu den Rahmenbedingungen für Forschung in Deutschland (1,000 words, Jan 7, 2025)
- [Interstitial Lung Disease | Boehringer Ingelheim UK](/content/uk/human-health/lung-diseases/interstitial-lung-disease/index.html): Interstitial lung disease (ILD) refers to a group of over 200 chronic lung disorders involving inflammation and pulmonary fibrosis. Read more (172 words, Jan 7, 2025)
- [Interstitial Lung Disease | Boehringer Ingelheim IE](/content/ie/human-health/lung-diseases/interstitial-lung-disease/index.html): Interstitial lung disease (ILD) refers to a group of over 200 chronic lung disorders involving inflammation and pulmonary fibrosis. Read more. (151 words, Jan 7, 2025)
- [Outlook for 2025 – Partnering for Innovation in Animal Health | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/outlook-2025-partnering-innovation-animal-health/index.html): Megan Grether, Global Head of Business Development and Licensing, Animal Health, shares her perspectives on partnering for innovation in 2025 (1,256 words, Jan 6, 2025)
- [North East and North Cumbria Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/north-east-and-north-cumbria-executive-summary/index.html): Read about a Collaboration to Implement a Sustainable Integrated Care Model for Chronic Kidney Disease (CKD) in Underserved Communities across North East and North Cumbria (NENC) (222 words, Dec 26, 2024)
- [Hampshire & Isle of Wight Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/hampshire-isle-wight-executive-summary/index.html): Read about a Collaboration to Implement a Sustainable Integrated Care Model for Chronic Kidney Disease (CKD) in Underserved Communities across Hampshire & Isle of Wight (HIOW) (206 words, Dec 26, 2024)
- [独立した企業経営 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/history/living-independence/index.html): ベーリンガーインゲルハイムは、独立した企業形態を維持するファミリー企業として、長期的かつサステナブルな事業活動に注力しています。この目標を達成するためには、健全な資金調達と有機的成長が不可欠です。ベーリンガーインゲルハイムの企業文化は、1885年の創業以来受け継がれてきた価値観に基づいています。 (12 words, Dec 25, 2024)
- [Sutro Biopharma collaboration first-in-class cell-free capabilities | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/sutro-biopharma-collaboration-first-class-cell-free-capabilities.html): Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale (1,040 words, Dec 20, 2024)
- [Zoonoses, épizooties, virus : mieux se préparer pour mieux agir | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/zoonoses-epizooties-virus-mieux-se-preparer-pour-mieux-agir-0.html): Organisée le 17 décembre 2024, la table-ronde « Zoonoses, épizooties, virus : mieux se préparer pour mieux agir » a permis de faire le point sur la prévention des crises sanitaires et les interconnexions entre santé humaine, animale et environnementale. (1,152 words, Dec 19, 2024)
- [Pioneering New Medicines Through External Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/pioneering-new-medicines-through-external-innovation.html): On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation” at the Institute of Molecular Pathology (IMP) (545 words, Dec 19, 2024)
- [Pionierarbeit für neue Medizin durch externe Innovation | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/pionierarbeit-fuer-neue-medizin-durch-externe-innovation.html): Am 22. November 2024, veranstaltete Boehringer Ingelheim am Institut für Molekulare Pathologie (IMP) das Event „Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation“ (546 words, Dec 19, 2024)
- [Notificare privind protecția datelor personale în farmacovigilența medicamentelor de uz uman | Boehringer Ingelheim RO](/content/ro/despre-noi/notificare-privind-protectia-datelor-personale-farmacovigilenta-medicamentelor-de-uz-uman.html): Notificare privind protecția datelor personale în farmacovigilența medicamentelor de uz uman (1,527 words, Dec 17, 2024)
- [Fostering innovation with partnerships and collaborations | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/fostering-science/fostering-innovation-partnerships-and-collaborations.html): Creating new and better medicines for patients. This commitment is driven by a strong belief in the power of collaboration. (658 words, Dec 17, 2024)
- [Innovationen durch Partnerschaften und Kooperationen | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/innovationen-durch-partnerschaften-und-kooperationen.html): Neue und bessere Medikamente für Patienten zu entwickeln, ist das zentrale Anliegen von Boehringer Ingelheim. Dabei stützen wir uns aus tiefster Überzeugung auf Kooperationen und Partnerschaften. (664 words, Dec 17, 2024)
- [La historia de Mateo Gualdaroni | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/esquizofrenia/la-historia-de-mateo-gualdaroni/index.html): La historia de Mateo Gualdaroni: superación y esperanza (323 words, Dec 16, 2024)
- [Open Innovation bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/open-innovation-bei-boehringer-ingelheim/index.html): Mit opnMe teilen wir erstklassige kleine Moleküle mit der wissenschaftlichen Gemeinschaft. (1,248 words, Dec 16, 2024)
- [Postdoktorand*innen-Programm bei Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/postdoktorandinnen-programm-bei-boehringer-ingelheim.html): Das Postdoktorandenprogramm von Boehringer Ingelheim im Regional Center Vienna (RCV) bietet ambitionierten Talenten die Möglichkeit, zusammen mit unseren Mitarbeitenden Spitzenforschung zu betreiben. (567 words, Dec 16, 2024)
- [Forschung am IMP | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/wissenschaftsfoerderung/forschung-am-imp/index.html): Das Forschungsinstitut für Molekulare Pathologie (IMP) ist ein führendes Grundlagenforschungsinstitut in Wien, Österreich. (600 words, Dec 16, 2024)
- [Small Molecule Drug Discovery | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/small-molecule-drug-discovery/index.html): Im Laufe der letzten Jahrzehnte haben in der Small Molecule Drug Discovery tätige Wissenschaftler von Boehringer Ingelheim zahlreiche für Patienten äußerst nutzbringende Arzneimittel entdeckt. (1,419 words, Dec 16, 2024)
- [Boehringer Ingelheim and Vétérinaires sans Frontières Germany fight rabies in Kenya | Boehringer Ingelheim](/content/animal-health/our-expertise/boehringer-ingelheim-and-veterinaires-sans-frontieres-germany-fight-rabies-kenya.html): Partnership aims to reduce rabies cases in Machakos County, with Boehringer Ingelheim providing vaccine doses and funding. (772 words, Dec 13, 2024)
- [CHMP recommends approval of OFEV® in children adolescents ILDs | Boehringer Ingelheim](/content/human-health/lung-diseases/chmp-recommends-approval-ofev-children-adolescents-ilds.html): CHMP recommends approval of OFEV® in children and adolescents for the treatment of a range of interstitial lung diseases (ILDs) (1,421 words, Dec 13, 2024)
- [Marktplatz für Moleküle | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/marktplatz-fuer-molekuele/index.html): Boehringer Ingelheims opnMe Plattform ermöglicht weltweit Spitzenforschung - Marktplatz für Moleküle (714 words, Dec 12, 2024)
- [The Oscars of Science | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/oscars-science/index.html): Revolutionary advances in physics and chemistry used at Boehringer Ingelheim (907 words, Dec 12, 2024)
- [Boehringer Cares shows commitment to next generation of innovators by welcoming students to our sites to participate in STEM Day | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/boehringer-cares-shows-commitment-next-generation-innovators-welcoming-students-our-sites.html): The Boehringer Ingelheim Cares Foundation, in partnership with Boehringer Care’s US STEM Council, holds an event for National STEM Day to inspire students to explore STEM opportunities. (1,073 words, Dec 11, 2024)
- [Call for Startups | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/fibrosis-pulmonar/call-startups/index.html): Boehringer Ingelheim lanza una nueva convocatoria dirigida a startups para impulsar soluciones digitales que faciliten el diagnóstico precoz de la enfermedad pulmonar intersticial (EPI) (771 words, Dec 11, 2024)
- [Neue Therapien für NF1 auf dem Prüfstand | Boehringer Ingelheim AT](/content/at/de/presse/neue-therapien-fuer-nf1-auf-dem-pruefstand/index.html): Die MedUni Wien und Boehringer Ingelheim haben einen innovativen Ansatz entwickelt, um neue Therapieansätze für Neurofibromatose Typ 1-bedingte Tumoren zu entwickeln. (708 words, Dec 11, 2024)
- [Dzień z życia: realia życia z rakiem płuc | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/nowotwory/rak-pluca/dzien-z-zycia-realia-zycia-z-rakiem-pluc/index.html): Doświadczenie "Dzień z życia" ma na celu pomóc pracownikom lepiej zrozumieć wyzwania, przed którymi stoją osoby cierpiące na wyniszczające choroby. (645 words, Dec 11, 2024)
- [Computational Innovation | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/computational-innovation/index.html): We’re transforming how medicines are discovered and developed by embedding computational biology, artificial intelligence (AI), and data excellence. (646 words, Dec 10, 2024)
- [Access to Care platform | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/access-care-platform/index.html): Discover how Boehringer Ingelheim is addressing health equity and healthcare access in Central and Eastern Europe through the "Access to Care" platform. Learn about the Legal Toolkit designed for patient advocates and the impact of our initiatives in the (410 words, Dec 9, 2024)
- [Smart work: Our workplace experience | Boehringer Ingelheim](/content/about-us/company-culture/smart-work-our-workplace-experience/index.html): Our Smart Working Plus workplace experience is activity-based and includes the possibility to work remotely if possible. (303 words, Dec 9, 2024)
- [Smart work: Our workplace experience | Boehringer Ingelheim](/content/about-us/who-we-are/culture/smart-work-our-workplace-experience/index.html): Our Smart Working Plus workplace experience is activity-based and includes the possibility to work remotely if possible. (303 words, Dec 9, 2024)
- [Über die Chronische Nierenkrankheit | Boehringer Ingelheim AT](/content/at/de/humanmedizin/chronische-nierenkrankheit/ueber-die-chronische-nierenkrankheit/index.html): Die Chronische Nierenkrankheit (CKD) ist weit verbreitet, wird aber oft übersehen. Mehr Informationen zu Auslösern, Symptomen und Diagnosemöglichkeiten. (524 words, Dec 9, 2024)
- [O foco da Boehringer em Equidade em Saúde impulsiona avanço significativo no ranking do Índice de Acesso a Medicamentos | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-saude/o-foco-da-boehringer-em-equidade-em-saude-impulsiona-avanco-significativo-no-ranking-do-indice-de.html): A Boehringer Ingelheim, uma das principais farmacêuticas voltadas para pesquisa, subiu para a 8ª posição no Índice de Acesso a Medicamentos (ATMI, Access to Medicine Index) de 2024, em comparação com o 13º lugar em 2022. (1,196 words, Dec 6, 2024)
- [The Partner's Champion - Transactions and Alliance Management | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/partners-champion-transactions-and-alliance-management.html): Learn how our Transactions and Alliance Management teams are building successful long-term partnerships (1,190 words, Dec 6, 2024)
- [台灣藍耳病論壇 | Boehringer Ingelheim TW](/content/tw/animal-health/livestock/zhuzhijiankangguanli/taiwanlanerbingluntan/index.html): 台灣藍耳病論壇 | 守護豬隻健康 (26 words, Dec 5, 2024)
- [Why prevention and vaccination in animal health matter | Boehringer Ingelheim](/content/animal-health/trends-insights/why-prevention-and-vaccination-animal-health-matter.html): Vaccines protect animals and people from diseases. So, what can each of us do to support prevention? (991 words, Dec 2, 2024)
- [Global Patient Partnership Initiative (GPPI) | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/global-patient-partnership-initiative-gppi/index.html): Why the Global Patient Partnership Initiative is a flagship model for patient engagement: from its empowering GPPI Projects to its Research & Communities (999 words, Nov 28, 2024)
- [Code of Conduct | Boehringer Ingelheim CA](/content/ca/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (269 words, Nov 28, 2024)
- [Real stories, real impact: fighting rabies | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/real-stories-real-impact-fighting-rabies/index.html): The danger of rabies is often overlooked. The need for action, unseen. Learn how we can eliminate rabies through leveraging education and dog vaccinations. (213 words, Nov 28, 2024)
- [Insuficiência Cardíaca | Boehringer Ingelheim](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/insuficiencia-cardiaca/index.html): A Insuficiência Cardíaca (IC) é definida como uma síndrome caracterizada pela incapacidade do coração de bombear sangue de forma adequada a fim de suprir as necessidades metabólicas (2,595 words, Nov 28, 2024)
- [Doença Renal Crônica | Boehringer Ingelheim](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/doenca-renal-cronica/index.html): A Doença Renal Crônica (DRC) é um grupo heterogêneo de distúrbios caracterizados por alterações na estrutura e/ou funcionamento dos rins, que podem se manifestar de diversas formas (1,359 words, Nov 28, 2024)
- [Portal Referência Científica | Boehringer Ingelheim](/content/pro/br/index.html): Acesse conteúdo científico, atualizações médicas e suporte ao paciente no portal Referência Científica. Tudo para sua atualização profissional num só lugar. (665 words, Nov 27, 2024)
- [Women Leaders Network: Success is Female | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/women-leaders-network-success-female/index.html): Powerful teams are very often diverse. A good mixture of different personalities is beneficial, and it is for this reason that diversity in general has been encouraged for years at Boehringer Ingelheim. (165 words, Nov 26, 2024)
- [Women Leaders Network: Erfolg ist weiblich | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/women-leaders-network-erfolg-ist-weiblich/index.html): Leistungsstarke Teams sind sehr oft divers aufgestellt. Die gezielte Unterstützung von Frauen war ist dabei schon lange ein relevantes Thema. (325 words, Nov 26, 2024)
- [Patients in Focus | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/patients-focus/index.html): Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance. (499 words, Nov 26, 2024)
- [Boehringer Ingelheim macht mit EINBLICKe – Leben mit Schizophrenie – die schwere psychische Erkrankung erlebbar | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/boehringer-ingelheim-macht-mit-einblicke-leben-mit-schizophrenie-die-schwere-psychische-erkrankung.html): Boehringer Ingelheim macht mit EINBLICKe – Leben mit Schizophrenie – die schwere psychische Erkrankung erlebbar (140 words, Nov 26, 2024)
- [Termos de uso | Boehringer Ingelheim](/content/pro/br/termos-de-uso/index.html): Termos de uso (929 words, Nov 25, 2024)
- [Boehringer Ingelheim Awards Innovation Prize to Ablevia | Boehringer Ingelheim AT](/content/at/en/media/boehringer-ingelheim-awards-innovation-prize-ablevia.html): Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system (729 words, Nov 25, 2024)
- [Supply chain at Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/about-us/supply-chain-boehringer-ingelheim/index.html): The supply chain at Boehringer covers two main areas: the entire process up to the finished product, and the commercial supply chain, the delivery of products to customers. (595 words, Nov 25, 2024)
- [Cardio-Renal-Metabolismo | Boehringer Ingelheim](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/index.html): Aprofunde seu conhecimento em Cardio-Renal-Metabolismo através do Portal Referência Científica da Boehringer Ingelheim. Exclusivo para profissionais da saúde (156 words, Nov 25, 2024)
- [Boehringer Ingelheim, primera empresa en obtener el sello "Empresa Dermosaludable" de la Fundación Piel Sana de la AEDV | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/boehringer-ingelheim-primera-empresa-en-obtener-el-sello-empresa-dermosaludable-de-la-fundacion-piel.html): Boehringer Ingelheim, primera empresa en obtener el sello "Empresa Dermosaludable" de la Fundación Piel Sana de la AEDV (563 words, Nov 22, 2024)
- [Boehringer Ingelheim zeichnet Ablevia mit Innovation Prize aus | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-zeichnet-ablevia-mit-innovation-prize-aus.html): Innovativer Lösungsansatz von Ablevia für die schnelle und selektive Beseitigung schädlicher Antikörper bei gleichzeitiger Schonung des Immunsystems (720 words, Nov 22, 2024)
- [The liver and its vital connection to our overall health | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/mash/liver-and-its-vital-connection-our-overall-health/index.html): How the liver is part of our interconnected cardiovascular, renal and metabolic system and why we need to look after it (770 words, Nov 21, 2024)
- [Infarto Agudo e AVC | Boehringer Ingelheim](/content/pro/br/area-terapeutica/iam-avc/index.html): Aprofunde seu conhecimento em IAM e AVC através do Portal Referência Científica da Boehringer Ingelheim. Exclusivo para profissionais da saúde (117 words, Nov 21, 2024)
- [Plus de deux tiers des articles sur la schizophrénie alimentent la stigmatisation négative | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/plus-de-deux-tiers-des-articles-sur-la-schizophrenie-alimentent-la-stigmatisation-negative.html): L'image de la schizophrénie dans les médias et la politique belge est fortement déformée et contribue à une stigmatisation négative. (172 words, Nov 21, 2024)
- [Meer dan twee derde van de artikels over schizofrenie voeden negatief stigma | Boehringer Ingelheim BE](/content/be/nl/menselijke-gezondheid/meer-dan-twee-derde-van-de-artikels-over-schizofrenie-voeden-negatief-stigma.html): Het beeld van schizofrenie in de Belgische media en politiek is sterk vertekend en draagt bij aan een schadelijk stigma. (652 words, Nov 21, 2024)
- [L’histoire de Jurjen | Boehringer Ingelheim BE](/content/be/fr/sante-humaine/maladies-metaboliques/diabete/lhistoire-de-jurjen/index.html): Les personnes atteintes de diabète de type 2 sont souvent stigmatisées pour les causes perçues de cette maladie. (816 words, Nov 21, 2024)
- [Doença Pulmonar Intersticial Fibrosante Progressiva | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/doenca-pulmonar-intersticial-fibrosante-progressiva.html): A DPI-Fibrosante Progressiva é definida pela presença de: Piora da extensão da fibrose na tomografia computadorizada de alta resolução (TCAR), piora dos sintomas respiratórios, e declínio da função pulmonar (1,147 words, Nov 21, 2024)
- [百靈佳殷格翰榮獲『外商企業組- 健康企業公民獎健康 99 企業』認證 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanhuojiangxiaoxi/bailingjiayingehanronghuowaishangqiyezu-jiankangqiyegongminjiangjiankang-99-qiye.html): 百靈佳殷格翰榮獲『外商企業組- 健康企業公民獎健康 99 企業』認證 (71 words, Nov 21, 2024)
- [Un nouveau record pour la 4ème saison de la campagne #jevaccinemonchat de Boehringer Ingelheim ! | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/un-nouveau-record-pour-la-4eme-saison-de-la-campagne-jevaccinemonchat-de.html): Un nouveau record pour la 4ème saison de la campagne #jevaccinemonchat de Boehringer Ingelheim ! (717 words, Nov 21, 2024)
- [Engagement für gesundheitliche Chancengleichheit: Boehringer steigt auf im Access to Medicine Index Ranking | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/engagement-fuer-gesundheitliche-chancengleichheit-boehringer-steigt-auf-im-access-medicine-index.html): Engagement für gesundheitliche Chancengleichheit: Boehringer steigt auf im Access to Medicine Index Ranking (603 words, Nov 19, 2024)
- [Boehringer upgrade in Access to Medicine Health Ranking | Boehringer Ingelheim](/content/about-us/sustainable-development/boehringer-upgrade-access-medicine-health-ranking/index.html): ​​Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking​ (730 words, Nov 19, 2024)
- [Their dogs are their world | Boehringer Ingelheim](/content/about-us/who-we-are/culture/their-dogs-are-their-world/index.html): Corporate social responsibility in Brazil: Volunteer work and animal healthcare donations for homeless people and their pets. (602 words, Nov 18, 2024)
- [日本発の最先端技術が世界の医薬品開発の明日をひらく | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/stories-0002/index.html): ベーリンガーインゲルハイムでは、臨床開発前の医薬品の安全性を担保するために、さまざまな最先端技術を取り入れています。なかでも、体内のタンパク質のデータを解析する技術「プロテオミクス」は、世界の製薬業界で需要が高まっています。 (26 words, Nov 18, 2024)
- [家族が働くオフィスを見学！大崎本社で「Family Day」を開催 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-24-1119/index.html): 11月８日（金）、ベーリンガーインゲルハイムの大崎本社で「Family Day」が開催されました。平日の開催にも関わらず、社員やその家族・大切な人、社員有志のボランティアも合わせて約200名が参加しました。 (30 words, Nov 18, 2024)
- [Esclerose Sistêmica | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/esclerose-sistemica/index.html): A esclerose sistêmica (ES) é uma doença heterogênea e rara do tecido conectivo. Sua patogênese envolve: Disfunção Imune, Vasculopatia e Fibrose. Pode ser classificada em 3 subtipos (974 words, Nov 18, 2024)
- [Doença Pulmonar Obstrutiva Crônica | Boehringer Ingelhem](/content/pro/br/area-terapeutica/doencas-pulmonares/doenca-pulmonar-obstrutiva-cronica/index.html): A DPOC é uma condição pulmonar heterogênea caracterizada por sintomas respiratórios crônicos (falta de ar, tosse, produção de secreção, exacerbações) devido à anormalidades das vias aéreas e/ou dos alvéolos (1,783 words, Nov 18, 2024)
- [Fibrose Pulmonar Idiopática | Boehringer Ingelheim](/content/pro/br/area-terapeutica/doencas-pulmonares/fibrose-pulmonar-idiopatica/index.html): A fibrose pulmonar idiopática (FPI) é uma doença pulmonar essencialmente debilitante e fatal, que segue um curso variável e imprevisível. Evidências sugerem que ela surja a partir de lesões epiteliais repetidas (831 words, Nov 15, 2024)
- [Doenças Pulmonares Intersticiais](/content/pro/br/area-terapeutica/doencas-pulmonares/dpi/index.html): Explore conteúdos científicos, atualizações de tratamentos e suporte especializado sobre Doenças Pulmonares para profissionais da saúde (2,693 words, Nov 15, 2024)
- [Schizophrenia in real life | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/schizophrenia/schizophrenia-real-life/index.html): Through these real-life stories, discover the eye-opening reality of life with schizophrenia. (488 words, Nov 15, 2024)
- [Conteúdos - Cardio-Renal-Metabolismo](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/biblioteca-cientifica/index.html): Explore conteúdos científicos, atualizações de tratamentos e suporte especializado sobre Cardio-Renal-Metabolismo para profissionais da saúde (451 words, Nov 15, 2024)
- [Strengthening dogs’ hearts for 25 years | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/strengthening-dogs-hearts-25-years/index.html): For pet owners and dogs around the world, we keep giving more life to love. (496 words, Nov 14, 2024)
- [Interdisciplinary approach to CKM care | Boehringer Ingelheim US](/content/us/human-health/metabolic-diseases/interdisciplinary-approach-ckm-care/index.html): Explore the global impact of Cardiovascular- Kidney- Metabolic (CKM) syndrome, and the need for an integrated approach to manage these interconnected conditions. Insights from experts at Boehringer Ingelheim and George Washington University. (792 words, Nov 14, 2024)
- [Diabetes Mellitus tipo 2 | Boehringer Ingelheim](/content/pro/br/area-terapeutica/cardio-renal-metabolismo/diabetes/index.html): O Diabetes Mellitus tipo 2 (DM2) representa mais de 90% de todos os casos de DM. É uma doença complexa que não envolve apenas fatores genéticos, como tamém estilo de vida e fatores ambientais (1,200 words, Nov 14, 2024)
- [Tierärzte: Gefangen zwischen Exzellenz und Erschöpfung | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/unsere-stories/tieraerzte-gefangen-zwischen-exzellenz-und-erschoepfung.html): Viele Kinder träumen davon, Tierarzt zu werden. Was passiert, wenn dieser Traum wahr wird? (795 words, Nov 13, 2024)
- [Joint efforts to address the global CRM health crisis | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/joint-efforts-address-global-crm-health-crisis/index.html): Learn how integrated care and collaboration can improve outcomes for people with cardiovascular, renal and metabolic (CRM) conditions worldwide. (1,052 words, Nov 12, 2024)
- [Spiriva®Respimat® | Boehringer Ingelheim](/content/pro/br/produtos/spiriva-respimat/index.html): Monoterapia LAMA com tiotrópio para manutenção da DPOC e terapia adicional na asma a partir dos 6 anos. Conheça mecanismo, posologia, indicação e mais informações do produto. (857 words, Nov 12, 2024)
- [Ofev® | Boehringer Ingelheim](/content/pro/br/produtos/ofev/index.html): Ofev® é um inibidor da tirosina quinase com efeitos antifibróticos e anti-inflamatórios que inibe as principais vias que levam à Fibrose Pulmonar (2,894 words, Nov 12, 2024)
- [Datenschutzhinweise für Patienten | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutz/datenschutzhinweise-fuer-patienten/index.html): Datenschutzhinweise für Patienten (1,624 words, Nov 12, 2024)
- [Jardiance Duo® | Boehringer Ingelheim](/content/pro/br/produtos/jardiance-duo/index.html): Jardiance DUO® é indicado no tratamento da diabetes mellitus tipo 2 para melhorar o controlo glicêmico; tembém reduz o risco de morte cardiovascular (1,088 words, Nov 12, 2024)
- [Translationale Wissenschaft in der Onkologie | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/translationale-wissenschaft-der-onkologie/index.html): Translationale Wissenschaft bildet den Grundstein des Drug Discovery-Ansatzes von Boehringer Ingelheim und ist die Brücke zwischen präklinischer Forschung und klinischer Entwicklung zur Verbesserung der Chancen von Patienten mit innovativen Behandlungen (1,066 words, Nov 12, 2024)
- [NewsCenter | Boehringer Ingelheim](/content/pro/br/newscenter/index.html): Conheça aqui as principais tendências em tecnologia e inovação e descubra como aplicá-las de forma estratégica no seu desenvolvimento profissional. (506 words, Nov 12, 2024)
- [Política de Privacidade | Boehringer Ingelheim](/content/pro/br/politica-de-privacidade/index.html): Política de Privacidade (1,332 words, Nov 12, 2024)
- [Submit your animal health partnering opportunity | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/submit-your-animal-health-partnering-opportunity/index.html): Information on how to submit your animal health innovation opportunity direct to Boehringer Ingelheim’s partnering team (155 words, Nov 11, 2024)
- [Actilyse® | Boehringer Ingelheim](/content/pro/br/produtos/actilyse/index.html): Actilyse® (alteplase), é um trombolítico indicado para o tratamento de IAM, AVC e EP. Recomendado por diretrizes nacionais e internacionais. (1,300 words, Nov 11, 2024)
- [Metalyse® | Boehringer Ingelheim](/content/pro/br/produtos/metalyse/index.html): Metalyse® (tenecteplase) é um trombolítico indicado para o tratamento do IAM e recomendado por diretrizes nacionais e internacionais. (1,255 words, Nov 11, 2024)
- [Spiolto®Respimat® | Boehringer Ingelheim](/content/pro/br/produtos/spiolto-respimat/index.html): Terapia dupla LAMA + LABA (tiotrópio + olodaterol) indicada para manutenção da DPOC moderada, grave e muito grave. Conheça posologia, indicação, mecanismo e mais informações do produto. (583 words, Nov 11, 2024)
- [Our Behaviors | Boehringer Ingelheim JP](/content/jp/about-us/company-culture/our-focus/our-behaviors/index.html): Our Behaviorsは、私たちの目的や価値観・ビジネス目標・Boehringer Ingelheimの全社員の日々の行動や経験を結びつけます。 (24 words, Nov 11, 2024)
- [Collaboration with Mary Tyler Moore Vision Initiative | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/collaboration-mary-tyler-moore-vision-initiative/index.html): Boehringer Ingelheim joins forces with Mary Tyler Moore Vision Initiative to combat vision loss from diabetes (1,019 words, Nov 8, 2024)
- [Trayenta® | Boehringer Ingelheim](/content/pro/br/produtos/trayenta/index.html): Trayenta® é indicado para o tratamento do diabetes mellitus tipo 2 (DM2), para melhorar o controle glicêmico em conjunto com dieta e exercícios (1,445 words, Nov 8, 2024)
- [Glyxambi® | Boehringer Ingelheim](/content/pro/br/produtos/glyxambi/index.html): Glyxambi® é uma opção para intensificar precocemente o tratamento dos pacientes com Diabetes Mellitus tipo 2 (DM2) com hemoglobina glicada (HbA1c) alta (917 words, Nov 8, 2024)
- [Unser Engagement gegen Kinderarbeit im Einklang mit den UNO-Leitprinzipien | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/unser-engagement-gegen-kinderarbeit-im-einklang-mit-den-uno-leitprinzipien.html): Unser Engagement gegen Kinderarbeit im Einklang mit den UNO-Leitprinzipien (556 words, Nov 6, 2024)
- [Život se schizofrenií | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/dusevni-zdravi/schizofrenie/zivot-se-schizofrenii/index.html): Pacienti trpící schizofrenií v krátkých videích otevřeně hovoří o tom, jak nemoc ovlivňuje jejich životy. (571 words, Nov 6, 2024)
- [Strengthening biosecurity with cutting-edge science | Boehringer Ingelheim AU](/content/au/animal-health/veterinary-public-health/strengthening-biosecurity-cutting-edge-science/index.html): Strengthening Australia and New Zealand's biosecurity is crucial in preventing the spread of foot-and-mouth disease (FMD) (675 words, Nov 6, 2024)
- [We strengthen Australia’s biosecurity | Boehringer Ingelheim AU](/content/au/we-strengthen-australias-biosecurity/index.html): Boehringer awarded contract for FMD antigen bank (628 words, Nov 5, 2024)
- [Rabies? Not in Mexico! | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/rabies-not-mexico/index.html): Mexico has been a rabies-free country for the last five years. How does Mexico achieve this? Learn how we're collaborating in this fight against rabies. (1,052 words, Nov 5, 2024)
- [Сърдечна недостатъчност: комплексно и тежко заболяване, засягащо множество органи | Boehringer Ingelheim BG](/content/bg/human-health/heart-diseases/heart-failure/heart-failure-complex-and-severe-disease/index.html): Сърдечна недостатъчност: комплексно и тежко заболяване, засягащо множество органи (608 words, Nov 5, 2024)
- [Reporte ABAC | Boehringer Ingelheim PT](/content/pt/sobre-nos/reporte-abac/index.html): A Boehringer Ingelheim Portugal, Lda. procedeu à avaliação intercalar, promovendo o envolvimento de todos os departamentos/divisões da sociedade, que, no âmbito da elaboração do Plano de Prevenção de Riscos de Corrupção e infrações Conexas (PPR), identifi (87 words, Nov 5, 2024)
- [Forschung am Regional Center Vienna | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/forschung-am-regional-center-vienna/index.html): Das Boehringer Ingelheim Regional Center Vienna trägt die Geschäftsverantwortung für 33 Länder in Mittel- und Osteuropa sowie in Zentralasien. Innerhalb der globalen Konzerngesellschaften stellt das RCV einen der wichtigsten Standorte dar. (457 words, Oct 30, 2024)
- [Open Science Portal macht kostenlose Moleküle verfügbar | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/open-science-portal-macht-kostenlose-molekuele-verfuegbar.html): Boehringer Ingelheims opnMe Plattform ermöglicht weltweit Spitzenforschung (731 words, Oct 30, 2024)
- [The Pinn Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/pinn-executive-summary/index.html): A collaborative working project between Boehringer Ingelheim Ltd and The Pinn Medical Centre (604 words, Oct 29, 2024)
- [Research at the Regional Center Vienna | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/research-regional-center-vienna/index.html): The Regional Center Vienna counts for 33 countries and has been a central pillar in Boehringer Ingelheim’s global research network. (475 words, Oct 29, 2024)
- [Brazil boosts biosecurity in dairy farms | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/brazil-boosts-biosecurity-dairy-farms/index.html): We partnered with Embrapa to help farmers and local authorities set best practices in biosecurity for dairy through a biosecurity certificate. (422 words, Oct 28, 2024)
- [Water harvesting sytems for underserved communities | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/water-harvesting-sytems-underserved-communities/index.html): Many families in Mexico don’t have access to clean water. That affects their health. We help by financing and installing water harvesting systems. (339 words, Oct 28, 2024)
- [Кардио-бъбречнo-метаболитна свързаност и ефекта на доминото | Boehringer Ingelheim BG](/content/bg/human-health/metabolic-diseases/crm-conditions-domino-effect/index.html): За да разберете по какъв начин ефектът на доминото се отразява върху здравето ви, трябва да знаете как са свързани помежду си сърдечната, бъбречната и метаболитната система – подобно на редица от домино. (MPR-BG-100337) (579 words, Oct 24, 2024)
- [Breathing hope: fighting the lung disease pulmonary fibrosis | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/breathing-hope-fighting-lung-disease-pulmonary-fibrosis.html): The animation and accompanying article aims to draw attention to and raise awareness about pulmonary fibrosis, a disease often misdiagnosed an overlooked. (535 words, Oct 23, 2024)
- [Veterinarians: caught between excellence and exhaustion | Boehringer Ingelheim AT](/content/at/en/animal-health/featured-stories/veterinarians-caught-between-excellence-and-exhaustion.html): Many children dream of becoming a veterinarian. What happens when that dream comes true? (798 words, Oct 23, 2024)
- [Biosécurité dans les élevages : de quoi s'agit-il ? | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/biosecurite-dans-les-elevages-de-quoi-sagit-il/index.html): Découvrez l'essence de la biosécurité et comment elle améliore la santé animale et la productivité des élevages. (270 words, Oct 23, 2024)
- [Southcote Clinic Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/southcote-clinic-executive-summary/index.html): A quality improvement project optimising management of cardio-renal-metabolic (CRM) patients in primary care and supporting education of staff (600 words, Oct 22, 2024)
- [MEDEX and CRM summit discuss latest advances in CRM care | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/medex-and-crm-summit-discuss-latest-advances-crm-care.html): More than 300 regional experts gather in Cairo for Boehringer Ingelheim’s Forums to discuss latest advances in cardio-renal-metabolic care (1,185 words, Oct 22, 2024)
- [Bacon Lane Surgery Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/bacon-lane-surgery-executive-summary/index.html): A quality improvement project optimising management of cardio-renal-metabolic (CRM) patients in primary care and supporting education of staff (604 words, Oct 21, 2024)
- [Resultados AWS 2024 | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/resultados-aws-2024/index.html): Resultados AWS 2024 (670 words, Oct 21, 2024)
- [Кодекс поведения | Boehringer Ingelheim RU](/content/ru/kodeks-povedeniya/index.html): Наш Кодекс поведения устанавливает этические нормы, которыми мы руководствуемся в бизнесе. Это касается всех нас. Каждый человек играет важную роль в реализации Кодекса поведения. (257 words, Oct 18, 2024)
- [Future Leaders in Veterinary Medicine and Research | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/future-leaders-veterinary-medicine-and-research/index.html): Through the Boehringer Ingelheim Veterinary Scholars Program, we offer opportunities for students to gain research experience and explore new career paths. (634 words, Oct 18, 2024)
- [Souffles cardiaques chez les chiens : Comment traiter les symptômes | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/animaux-de-compagnie/souffles-cardiaques-chez-les-chiens-comment-traiter-les-symptomes.html): Comme chez l’homme, le cœur est également l’organe le plus important chez les chiens et doit faire partie des examens de routine. (966 words, Oct 18, 2024)
- [Série de Webinars TCAR | Boehringer Ingelheim Portugal](/content/pro/pt/serie-de-webinars-tcar/index.html): Esta série de webinars surge com o objetivo de especializar para a TCAR na doença pulmonar intersticial (DPI), o gold standard do diagnóstico nestas doenças. (14 words, Oct 16, 2024)
- [Oncology Translational Science | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/oncology-translational-science/index.html): Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts (1,102 words, Oct 16, 2024)
- [history movie | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/history/history-movie/index.html): Learn more about Boehringer Ingelheim's history of more than 130 years, from the beginning in 1885 to today. We share documents and insights from our history, our business areas and our research and development activities across the decades. (201 words, Oct 16, 2024)
- [S7. EP11.永續發展｜百靈佳殷格翰用無人機技術助力農村疫苗配送，幫助肯亞與迦納的醫療系統改革 | Boehringer Ingelheim TW](/content/tw/jiazhigushiwuzuixinwenzhang/s7/index.html): S7. EP11.永續發展｜百靈佳殷格翰用無人機技術助力農村疫苗配送，幫助肯亞與迦納的醫療系統改革 (141 words, Oct 16, 2024)
- [2024 half year results innovation progress | Boehringer Ingelheim](/content/about-us/who-we-are/2024-half-year-results-innovation-progress/index.html): First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones (1,127 words, Oct 15, 2024)
- [New biomass power plant Ingelheim | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/new-biomass-power-plant-ingelheim/index.html): Boehringer Ingelheim produces its own green energy (596 words, Oct 15, 2024)
- [The Partner's Champion - Transactions and Alliance Management | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/partners-champion-transactions-and-alliance-management.html): Learn how our Transactions and Alliance Management teams are building successful long-term partnerships (1,211 words, Oct 15, 2024)
- [Partnership WHO Foundation mental health | Boehringer Ingelheim](/content/human-health/mental-health/partnership-who-foundation-mental-health/index.html): Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention (595 words, Oct 14, 2024)
- [Hurricane help: Our unwavering support of storm victims | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/hurricane-help-our-unwavering-support-storm-victims.html): Ensuring access to healthcare, meals, and medication for people and animals across the southeast. (335 words, Oct 10, 2024)
- [Where to meet us | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/connect-us/where-meet-us/index.html): Find out where to meet the BD&L team virtually or in person at the next conference or event. Submit your opportunity to our BD&L team here. (282 words, Oct 10, 2024)
- [EASi-KIDNEY™ Phase III trial for people with CKD | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chronic-kidney-disease/easi-kidney-phase-iii-trial-people-ckd/index.html): Boehringer Ingelheim's Sandy Sommer on how treatment innovations in CKD can also improve care for connected conditions, including heart failure. (198 words, Oct 10, 2024)
- [Leben mit Schizophrenie: Geschichten über Hoffnung, Resilienz und die täglichen Herausforderungen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/schizophrenie/leben-mit-schizophrenie-geschichten-ueber-hoffnung-resilienz-und-die-taeglichen-herausforderungen.html): Wie Menschen mit Schizophrenie ihren Alltag mit der schweren psychischen Erkrankung meistern. (405 words, Oct 10, 2024)
- [Vivre avec la schizophrénie : histoires d'espoir, de résilience et de défis quotidiens | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/sante-mentale/schizophrenie/vivre-avec-la-schizophrenie-histoires-despoir-de-resilience-et-de-defis-quotidiens.html): La schizophrénie a de nombreuses facettes. Découvrez ici comment cette maladie mentale grave influence différents aspects de la vie quotidienne. (518 words, Oct 9, 2024)
- [Sandra Quintero übernimmt Geschäftsführung der Tiergesundheit Deutschland bei Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/sandra-quintero-uebernimmt-geschaeftsfuehrung-der-tiergesundheit-deutschland-bei-boehringer.html): Sandra Quintero übernimmt Geschäftsführung der Tiergesundheit Deutschland bei Boehringer Ingelheim (238 words, Oct 9, 2024)
- [The unseen lameness problem in horses | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/unseen-lameness-problem-horses/index.html): Learn more about the signs, causes and preventive measures of lameness in horses. (460 words, Oct 9, 2024)
- [Cities join forces for stroke care improvements | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/cities-join-forces-stroke-care-improvements/index.html): Learn how Angels Cities unite to swiftly address stroke symptoms. Quick collaboration saves crucial minutes, minimizing stroke’s devastating effects. (1,014 words, Oct 8, 2024)
- [Schizofrenia w prawdziwym życiu: historie o wyzwaniach, odporności i nadziei | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/zdrowie-psychiczne/schizofrenia-w-prawdziwym-zyciu-historie-o-wyzwaniach-odpornosci-i-nadziei.html): Schizofrenia w prawdziwym życiu: historie o wyzwaniach, odporności i nadziei (169 words, Oct 8, 2024)
- [vaccine protection leptospirosis in dogs | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/vaccine-protection-leptospirosis-dogs/index.html): EURICAN® L4 prevents or reduces several potentially severe leptospirosis outcomes (619 words, Oct 8, 2024)
- [U.S. FDA grants Breakthrough Therapy designation for MASH | Boehringer Ingelheim US](/content/us/human-health/us-fda-grants-breakthrough-therapy-designation-mash.html): Boehringer Ingelheim receives U.S. FDA Breakthrough Therapy designation for people living with MASH and liver fibrosis (1,038 words, Oct 7, 2024)
- [OUR FOCUS - Unsere Unternehmenskultur | Boehringer Ingelheim DE](/content/de/ueber-uns/vision-werte/our-focus-unsere-unternehmenskultur/index.html): Die globale Vision von Boehringer Ingelheim ist es, die Gesundheit und das Wohlergehen der Menschen und Tiere weltweit zu verbessern. (473 words, Oct 7, 2024)
- [OUR FOCUS - Unsere Unternehmenskultur | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/unternehmenskultur/our-focus-unsere-unternehmenskultur/index.html): Die globale Vision von Boehringer Ingelheim ist es, die Gesundheit und das Wohlergehen der Menschen und Tiere weltweit zu verbessern. (469 words, Oct 7, 2024)
- [Survodutide US FDA Breakthrough Therapy phase 3 trials MASH | Boehringer Ingelheim](/content/human-health/metabolic-diseases/survodutide-us-fda-breakthrough-therapy-phase-3-trials-mash.html): Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide (1,033 words, Oct 7, 2024)
- [韌性與重生：思覺失調症病友的勇敢旅程 | Boehringer Ingelheim TW](/content/tw/about-us/renxingyuzhongshengsijueshidiaozhengbingyoudeyongganlucheng.html): 韌性與重生：思覺失調症病友的勇敢旅程 (38 words, Oct 7, 2024)
- [ベーリンガーインゲルハイム 獣医学奨学プログラム | Boehringer Ingelheim JP](/content/jp/node/31745/index.html): ベーリンガーインゲルハイム 獣医学奨学プログラム (31 words, Oct 7, 2024)
- [Перше півріччя 2024 року: компанія «Берінгер Інгельхайм» впевнено йде вперед і досягає важливих результатів | Boehringer Ingelheim UA](/content/ua/pershe-pivrichchya-2024-roku-kompaniya-beringer-ingelkhaym-vpevneno-yde-vpered-i-dosyagae-vazhlivikh.html): Перше півріччя 2024 року: компанія «Берінгер Інгельхайм» впевнено йде вперед і досягає важливих результатів (782 words, Oct 3, 2024)
- [Open Innovation Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/fostering-science/open-innovation-boehringer-ingelheim/index.html): Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines (1,102 words, Oct 2, 2024)
- [5 tipov na stravovanie pre diabetikov cez sviatky | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/diabetes/5-tipov-na-stravovanie-pre-diabetikov-cez-sviatky/index.html): Vianoce sú sviatky rodiny, osláv a jedla - veľa jedla. Pokušenia sú na každom rohu, všade kam sa pozriete cukrovinky, rodinné stretnutia a cestovanie narúšajú každodenné rutiny. (614 words, Oct 2, 2024)
- [Improving the current state of schizophrenia care | Boehringer Ingelheim AT](/content/at/en/human-health/mental-health/schizophrenia/improving-current-state-schizophrenia-care/index.html): A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition (571 words, Oct 1, 2024)
- [Fürsprecher für Menschen mit Lungenkrebs | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/fuersprecher-fuer-menschen-mit-lungenkrebs/index.html): Erfahren Sie, wie Larrys Diagnose ihn dazu bewegt hat, andere Menschen mit Lungenkrebs zu unterstützen. (173 words, Oct 1, 2024)
- [Verbesserung der Versorgung bei Schizophrenie | Boehringer Ingelheim AT](/content/at/de/humanmedizin/psychische-gesundheit/schizophrenie/verbesserung-der-versorgung-bei-schizophrenie/index.html): Boehringer Ingelheim setzt sich für eine bessere Versorgung bei Schizophrenie ein und unterstützt Partnerorganisationen in ihren Bemühungen. (42 words, Oct 1, 2024)
- [Компанія «Берінгер Інгельхайм» (Boehringer Ingelheim) придбала компанію «Саїба Енімал Хелс» (Saiba Animal Health), поповнивши свої спроможності науково-дослідних розробок у галузі ветеринарії інноваційною технологічною платформою | Boehringer Ingelheim UA](/content/ua/animal-health/kompaniya-beringer-ingelkhaym-boehringer-ingelheim-pridbala-kompaniyu-saiba-enimal-khels-saiba.html): Компанія «Берінгер Інгельхайм» (Boehringer Ingelheim) придбала компанію «Саїба Енімал Хелс» (Saiba Animal Health), поповнивши свої спроможності науково-дослідних розробок у галузі ветеринарії інноваційною технологічною платформою (479 words, Sep 30, 2024)
- [Making sustainable medicines through eco-design | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/making-sustainable-medicines-through-eco-design/index.html): Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle (1,031 words, Sep 30, 2024)
- [Digital innovation: „We change the way labs work“ | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/digital-innovation-we-change-way-labs-work/index.html): QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey. (140 words, Sep 30, 2024)
- [Boehringer’s unique approach to innovation | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/boehringers-unique-approach-innovation/index.html): Boehringer’s unique approach to driving patient-centric innovation (747 words, Sep 30, 2024)
- [Schizophrenia in real life: Stories of resilience and hope | Boehringer Ingelheim US](/content/us/human-health/mental-health/schizophrenia/schizophrenia-real-life-stories-resilience-and-hope.html): Discover the reality of life with schizophrenia through the stories of four people who are breaking down the stigma of living with a serious mental illness. (397 words, Sep 27, 2024)
- [Boehringer partners with NCD Alliance | Boehringer Ingelheim](/content/about-us/sustainable-development/boehringer-partners-ncd-alliance/index.html): Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities (627 words, Sep 27, 2024)
- [XXVIII Międzynarodowy Kongres Polskiego Towarzystwa Kardiologicznego | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/xxviii-miedzynarodowy-kongres-polskiego-towarzystwa-kardiologicznego.html): XXVIII Międzynarodowy Kongres Polskiego Towarzystwa Kardiologicznego (212 words, Sep 27, 2024)
- [Geschichten über das Leben mit Schizophrenie | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/schizophrenie/geschichten-ueber-das-leben-mit-schizophrenie/index.html): Wie Menschen mit Schizophrenie ihren Alltag mit der schweren psychischen Erkrankung meistern. (408 words, Sep 27, 2024)
- [Journey of creating an antifibrotic medication | Boehringer Ingelheim MEA](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/journey-creating-antifibrotic-medication/index.html): Behind every life-changing medicine is an incredible journey. (47 words, Sep 26, 2024)
- [Життя з фіброзом легень | Boehringer Ingelheim UA](/content/ua/human-health/lung-diseases/pulmonary-fibrosis/zhittya-z-fibrozom-legen/index.html): Життя з фіброзом легень (728 words, Sep 25, 2024)
- [Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF | Boehringer Ingelheim PL](/content/pl/nerandomilast-osiagnal-pierwszorzedowy-punkt-koncowy-w-badaniu-fibroneer-ipf.html): Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF (974 words, Sep 25, 2024)
- [Más de la mitad de los españoles desconoce la naturaleza asintomática de la Enfermedad Renal Crónica y sólo el 40% acude al médico para diagnosticarla de manera temprana | Boehringer Ingelheim ES](/content/es/salud-humana/mas-de-la-mitad-de-los-espanoles-desconoce-la-naturaleza-asintomatica-de-la-enfermedad-renal-cronica.html): La Diabetes Mellitus Tipo 2 (DM2), la Enfermedad Renal Crónica (ERC) y la Insuficiencia Cardiaca (IC) están interconectadas , pero en base a una encuesta poblacional, el 60% de los españoles lo desconoce. (1,964 words, Sep 24, 2024)
- [Boehringer Ingelheim baut Krebsforschung am Standort Wien aus | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-baut-krebsforschung-am-standort-wien-aus.html): Wien untermauert Status als globales Krebsforschungszentrum von Boehringer Ingelheim (816 words, Sep 24, 2024)
- [Neues Krebsforschungsgebäude: Innovationen fördern | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/neues-krebsforschungsgebaeude-innovationen-foerdern.html): Mit unserem neuen Krebsforschungsgebäude in Wien werden wir unsere Pipeline vorantreiben und unser Engagement für Innovation und Zusammenarbeit stärken. (916 words, Sep 24, 2024)
- [New cancer research building: Boosting innovation in oncology | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/new-cancer-research-building-boosting/index.html): With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration. (991 words, Sep 24, 2024)
- [New cancer research building: Boosting innovation in oncology | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/new-cancer-research-building-boosting-innovation-oncology.html): With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration. (991 words, Sep 24, 2024)
- [Biosecurity in farms: what’s this all about | Boehringer Ingelheim](/content/animal-health/livestock/biosecurity-farms-whats-all-about/index.html): Biosecurity is one of the three pillars we focus on: vaccination, biosecurity, and surveillance. But what is biosecurity in farms? (347 words, Sep 23, 2024)
- [Biosecurity in farms: what’s this all about | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/biosecurity-farms-whats-all-about/index.html): Biosecurity is one of the three pillars we focus on: vaccination, biosecurity, and surveillance. But what is biosecurity in farms? (352 words, Sep 23, 2024)
- [Veterinarios: atrapados entre la excelencia y el agotamiento | Boehringer Ingelheim SA](/content/sa/salud-animal/nuestra-responsabilidad/veterinarios-atrapados-entre-la-excelencia-y-el-agotamiento.html): Muchos niños sueñan con ser veterinarios. ¿Qué pasa cuando ese sueño se hace realidad? (884 words, Sep 18, 2024)
- [Heart of What Matters - Apoio à Insuficiência Cardíaca](/content/pro/pt/heart-of-what-matters/index.html): Capacitação de profissionais de saúde no diagnóstico, tratamento e adesão em insuficiência cardíaca com base nas guidelines internacionais. (455 words, Sep 18, 2024)
- [El deterioro cognitivo asociado a patologías mentales | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/el-deterioro-cognitivo-asociado-patologias-mentales.html): El deterioro cognitivo asociado a patologías mentales (687 words, Sep 18, 2024)
- [Чуйте сигналите на ИББ | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/chuyte-signalite-na-ibb/index.html): Научете повече за ИББ и защо е важно да чуете сигналите на ИББ за ранно откриване и лечение на заболяването! (495 words, Sep 17, 2024)
- ["Always Here" | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/our-commitment/always-here/index.html): Повече информация отосно подкрепата, която Boehringer Ingelheim оказва на украинските граждани (345 words, Sep 17, 2024)
- [Světový den bezpečnosti pacientů | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/pacienti-na-prvnim-miste/svetovy-den-bezpecnosti-pacientu-0/index.html): Boehringer Ingelheim se připojuje 17. září ke Světovému dni bezpečnosti pacientů, který vyhlašuje WHO. (585 words, Sep 17, 2024)
- [Nerandomilast cumple el objetivo primario en el estudio pivotal de fase III FIBRONEER™-IPF | Boehringer Ingelheim SA](/content/sa/prensa/nerandomilast-cumple-el-objetivo-primario-en-el-estudio-pivotal-de-fase-iii-fibroneer-ipf.html): Nerandomilast cumple el objetivo primario en el estudio pivotal de fase III FIBRONEER™-IPF (1,137 words, Sep 16, 2024)
- [Boehringer Ingelheim Subsidiaries and Affiliate Companies | Boehringer Ingelheim US](/content/us/boehringer-ingelheim-subsidiaries-and-affiliate-companies.html): Boehringer Ingelheim Subsidiaries and Affiliate Companies (932 words, Sep 16, 2024)
- [Blåtunga – vad är det? | Boehringer Ingelheim SE](/content/se/djurhalsa/blatunga-vad-ar-det/index.html): Blåtunga (bluetongue) är en virussjukdom som smittar idisslare såsom nötkreatur, får, getter och hjortar. Sjukdomen utgör ett hot såväl mot djur som internationell handel. Blåtunga smittar inte människor men kan ge allvarlig, även dödlig (517 words, Sep 16, 2024)
- [Hva er blåtunge? | Boehringer Ingelheim NO](/content/no/dyrehelse/hva-er-blatunge/index.html): Blåtunge er en virussykdom som smitter drøvtyggere, for eksempel storfe, småfe og hjortedyr. Sykdommen påvirker både dyrenes helse og internasjonal handel. Blåtunge kan ikke smitte mennesker, men er farlig for drøvtyggere. (494 words, Sep 16, 2024)
- [Impfung bei Katzen – zehn Dinge, die Sie wissen sollten | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/impfung-bei-katzen-zehn-dinge-die-sie-wissen-sollten.html): Erfahren Sie, wie Sie dafür sorgen können, dass Ihre Katze glücklich und gesund bleibt. Wir haben 10 wichtige Fragen zu Impfungen bei Katzen beantwortet, um Ihnen Entscheidungen zu erleichtern, die den Erhalt der Gesundheit Ihrer Katze betreffen. (803 words, Sep 16, 2024)
- [10 COSAS QUE DEBES SABER SOBRE LA RABIA | Boehringer Ingelheim MX](/content/mx/salud-animal/10-cosas-que-debes-saber-sobre-la-rabia/index.html): La rabia es una enfermedad viral zoonótica, que ocurre tanto en animales domésticos como silvestres; ataca esencialmente al sistema nervioso central de los mamíferos, incluidos los humanos. Una vez que se desarrollan los síntomas de la enfermedad (1,342 words, Sep 13, 2024)
- [Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/nerandomilast-primary-endpoint-phase-3-fibroneer-ipf-met.html): Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study (1,152 words, Sep 13, 2024)
- [Drug discovery Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/drug-discovery-boehringer-ingelheim/index.html): Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful. (344 words, Sep 13, 2024)
- [山形工場 包装工程で発生するPTPシート廃棄物のリサイクルを開始 | Boehringer Ingelheim JP](/content/jp/about-us/news/news-24-0917/index.html): ベーリンガーインゲルハイム製薬は、山形工場で製造する医療用医薬品の包装工程で生じるPTPシートの廃棄物（PVCフィルム包装廃材）のリサイクルを開始します。 (26 words, Sep 13, 2024)
- [Circulation Health Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/circulation-health-executive-summary/index.html): Read about Circulation Health: NHS Greater Manchester (GM) and Boehringer Ingelheim, working in partnership to evolve the Neighbourhood Health Service Model through a Cardio-Renal-Metabolic (CRM) Population Health Accelerant. (329 words, Sep 12, 2024)
- [Our innovation strategy | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/our-innovation-strategy/index.html): Our Innovation Strategy at Boehringer Ingelheim in Research and Development (408 words, Sep 12, 2024)
- [Uniting to stop rabies: a global and local endeavor | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/stop-rabies/uniting-stop-rabies-global-and-local-endeavor/index.html): By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease (1,009 words, Sep 12, 2024)
- [Feline diabetes detect it, treat it and get your life back | Boehringer Ingelheim AT](/content/at/en/animal-health/animals-we-support/cats/feline-diabetes-detect-it-treat-it-and-get-your-life-back.html): Feline diabetes: What are the symptoms of diabetes in cats, and how do you manage this chronic disease? (192 words, Sep 12, 2024)
- [Always Here – Our Commitment for Ukraine | Boehringer Ingelheim AT](/content/at/en/about-us/always-here-our-commitment-ukraine/index.html): Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion. (311 words, Sep 12, 2024)
- [113年8月23日起JARDIANCE DUO恩美糖膜衣錠 擴增「第二型糖尿病」適用族群為10歲以上第二型糖尿病病人 作為改善血糖之輔助治療 | Boehringer Ingelheim TW](/content/tw/human-health/metabolic-diseases/113nian8yue23riqijardiance-duoenmeitangmoyiding-kuozengdierxingtangniaobing.html): 113年8月23日起JARDIANCE DUO恩美糖膜衣錠 擴增「第二型糖尿病」適用族群為10歲以上第二型糖尿病病人 作為改善血糖之輔助治療 (66 words, Sep 12, 2024)
- [Building lasting partnerships for a better future | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/partnership-stories/building-lasting-partnerships-better-future/index.html): Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet. (335 words, Sep 11, 2024)
- [Boehringer Ingelheim acquiert l'entreprise suisse Saiba Animal Health et ajoute ainsi une plateforme technologique innovante à son portefeuille de recherche et développement en santé animale | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-animale/boehringer-ingelheim-acquiert-lentreprise-suisse-saiba-animal-health-et-ajoute-ainsi-une-plateforme.html): Boehringer Ingelheim annonce l'acquisition de Saiba Animal Health AG, basée à Pfäffikon (SZ), qui se concentre sur le développement de nouveaux médicaments thérapeutiques pour le traitement des maladies chroniques chez les animaux de compagnie. (509 words, Sep 11, 2024)
- [Boehringer Ingelheim übernimmt das Schweizer Unternehmen Saiba Animal Health und erweitert damit sein Forschungs- und Entwicklungsportfolio im Bereich Tiergesundheit um eine innovative Technologieplattform | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-tiergesundheit/boehringer-ingelheim-uebernimmt-das-schweizer-unternehmen-saiba-animal-health-und-erweitert-damit.html): Boehringer Ingelheim gibt die Übernahme der Saiba Animal Health AG bekannt, das sich auf die Entwicklung neuartiger therapeutischer Arzneimittel zur Behandlung chronischer Erkrankungen bei Haustieren konzentriert. (65 words, Sep 11, 2024)
- [Boehringer Ingelheim übernimmt Saiba Animal Health | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-uebernimmt-saiba-animal-health.html): Boehringer Ingelheim erweitert damit sein F&E-Portfolio im Bereich Tiergesundheit um eine innovative Technologieplattform. (529 words, Sep 11, 2024)
- [Christie NHS Foundation Trust Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/christie-nhs-foundation-trust-executive-summary/index.html): Read about a Collaborative Working Project between Boehringer Ingelheim Limited and The Christie NHS Foundation Trust to establish a National Consensus led standardisation of the diagnostic and clinical management of L-LCNEC patients (350 words, Sep 10, 2024)
- [Les systèmes cardiovasculaire, rénal et métabolique (CRM) et les effets domino | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/les-systemes-cardiovasculaire-renal-et-metabolique-crm-et-les-effets-domino.html): Pour comprendre les effets domino qui peuvent se produire en matière de santé, il est important de connaître les liens qui unissent les systèmes cardiovasculaire, rénal et métabolique (CRM). (593 words, Sep 10, 2024)
- [Infografika plicní fibrózy | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/infografika-plicni-fibrozy/index.html): Infografika k plicní fibróze jako průvodním jevu instersticiálních plicních procesů. Příznaky, výzvy v oblasti péče o pacienty a kdy pomýšlet na návštěvu lékaře. (49 words, Sep 10, 2024)
- [Neue Daten: Bedeutsames Wirksamkeits- und Verträglichkeitsprofil bei Lungenkrebs Patient*innen | Boehringer Ingelheim DE](/content/de/humanmedizin/krebserkrankungen/lungenkrebs/neue-daten-bedeutsames-wirksamkeits-und-vertraeglichkeitsprofil-bei-lungenkrebs-patientinnen.html): Neue Daten: Bedeutsames Wirksamkeits- und Verträglichkeitsprofil bei Lungenkrebs Patient*innen (506 words, Sep 10, 2024)
- [New cancer research building: Boosting innovation in oncology | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/new-cancer-research-building-boosting-innovation-oncology.html): With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration. (986 words, Sep 6, 2024)
- [Microbial manufacturing platform | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/microbial-manufacturing-platform-bioxcellence/index.html): Discover how the CASPON® technology streamlines microbial manufacturing, reduces complexity and supports efficient production of non‑platform proteins. (252 words, Sep 6, 2024)
- [Dlaczego warto czytać ulotkę? | Boehringer Ingelheim PL](/content/pl/dlaczego-warto-czytac-ulotke/index.html): Dlaczego warto czytać ulotkę? (15 words, Sep 6, 2024)
- [Enderley Road Collaborative Working Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/enderley-road/index.html): Read about A quality improvement project optimising management of cardio-renal-metabolic (CRM) patients in primary care and supporting education of staff in Harrow and Hillingdon (595 words, Sep 6, 2024)
- [Boehringer acquires Saiba Animal Health | Boehringer Ingelheim IE](/content/ie/animal-health/featured-stories/boehringer-acquires-saiba-animal-health/index.html): Boehringer Ingelheim’s has acquired Saiba Animal Health, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets (459 words, Sep 5, 2024)
- [Завжди поруч | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/zavzhdi-poruch/index.html): Завжди поруч (432 words, Sep 5, 2024)
- [Інгельвак ЦиркоФЛЕКС: 4 мільярди свиней захищені | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/swine/ingelvak-cirkofleks-4-milyardi-sviney-zakhischeni/index.html): Інгельвак ЦиркоФЛЕКС: 4 мільярди свиней захищені (17 words, Sep 5, 2024)
- [Smart Biopharmaceutical Process Development | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/smart-biopharmaceutical-process-development/index.html): Discover how Boehringer Ingelheim BioXcellence™ experts use smart and AI-driven process design to boost efficiency in biopharmaceutical manufacturing. (322 words, Sep 5, 2024)
- [Inclusion body refolding | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/inclusion-body-refolding-bioxcellence/index.html): Explore how solubilizing and refolding inclusion bodies supports efficient downstream processing in biopharmaceutical production. (237 words, Sep 5, 2024)
- [Sobre as condições cardio-renais-metabólicas | Boehringer Ingelheim BR](/content/br/saude-humana/doenca-renal-cronica/sobre-condicoes-cardio-renais-metabolicas/index.html): Tenha uma visão geral das condições cardiovasculares, renais e metabólicas. (288 words, Sep 2, 2024)
- [Schizophrenia in real life | Boehringer Ingelheim](/content/human-health/mental-health/schizophrenia-real-life/index.html): Discover the reality of life with schizophrenia through the stories of people who are breaking down the stigma of living with a serious mental illness. (416 words, Sep 2, 2024)
- [Boehringer Ingelheim podporuje iniciativu More Green | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/boehringer-ingelheim-podporuje-iniciativu-more-green.html): Jak se Boehringer Ingelheim podílí na ochraně životního prostředí a udržitelnosti. (451 words, Sep 2, 2024)
- [Boehringer Ingelheim podporuje iniciativu More Potential | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/boehringer-ingelheim-podporuje-iniciativu-more-potential.html): Základní informace o More Potential. Jak Boehringer Ingelheim podporuje lidská práva, bezpečnost zaměstnanců a spolupracuje s komunitami., (437 words, Sep 2, 2024)
- [Collaborating for social impact | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/collaborating-social-impact/index.html): Societal challenges require collective action and Making More Health Together is connecting changemakers to drive collaborations for more social impact (917 words, Aug 31, 2024)
- [Como contribuir para a saúde do seu cão em qualquer fase da vida: filhote, adulto e idoso | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-companhia/como-contribuir-para-saude-do-seu-cao-em-qualquer-fase-da-vida-filhote-adulto-e-idoso.html): As necessidades dos cães mudam à medida que envelhecem. Descubra como cuidar da saúde deles em todas as fases da vida. (1,106 words, Aug 30, 2024)
- [Boehringer Ingelheim podporuje iniciativu More Health | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/boehringer-ingelheim-podporuje-iniciativu-more-health.html): Základní informace o More Health. Jak pomáhá Boehringer Ingelheim zlepšovat zdraví lidí i zvířat na globální úrovni. (449 words, Aug 30, 2024)
- [Interstitial Lung Diseases - Sound the ILD Alarm | Boehringer Ingelheim AT](/content/at/en/human-health/lung-diseases/interstitial-lung-diseases-sound-ild-alarm/index.html): Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment. (524 words, Aug 29, 2024)
- [A global production network against supply shortages | Boehringer Ingelheim](/content/about-us/who-we-are/global-production-network-against-supply-shortages/index.html): The production of medicines is a complex process. We use our global production network to respond to increasing demand. (647 words, Aug 29, 2024)
- [Разпознаване на първите признаци на белодробна фиброза | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/razpoznavane-na-prvite-priznaci-na-belodrobna-fibroza.html): Повече информация относно белодробната фиброза и нейните първи признаци (261 words, Aug 29, 2024)
- [Datenschutzinformation für Kunden, Partner, Besucher und betroffene Personen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-fuer-kunden-partner-besucher-und-betroffene-personen.html): Datenschutzinformation für Kunden, Partner, Besucher und betroffene Personen (1,787 words, Aug 28, 2024)
- [Patient-Powered Progress | Boehringer Ingelheim](/content/human-health/patients/patient-partnership/patient-powered-progress/index.html): The Power of Patient Partnership (1,014 words, Aug 27, 2024)
- [Din hunds livsfaser: hundesundhed fra hvalp til voksen og senior | Boehringer Ingelheim DK](/content/dk/animal-health/udvalgte-historier/din-hunds-livsfaser-hundesundhed-fra-hvalp-til-voksen-og-senior.html): Med alderen forandres din hunds behov. Læs her, hvordan du kan passe på dens sundhed gennem alle faser i livet: fra hvalp over voksen til senior. (1,025 words, Aug 26, 2024)
- [Din hunds livsfaser: hundehelse fra valp til voksen og senior | Boehringer Ingelheim NO](/content/no/dyrehelse/fremhevede-historier/din-hunds-livsfaser-hundehelse-fra-valp-til-voksen-og-senior.html): Hundenes behov endrer seg etter hvert som de blir eldre. Finn ut hvordan du kan ta vare på helsen deres i alle faser i livet: fra valp til voksen og senior. (992 words, Aug 26, 2024)
- [De levensloop van uw hond: bevorder de gezondheid van uw beste vriend op alle leeftijden | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/de-levensloop-van-uw-hond-bevorder-de-gezondheid-van-uw-beste-vriend-op-alle.html): Als u uw huishouden deelt met een hond, dan weet u hoe bijzonder ze zijn. Honden moedigen een actieve levensstijl aan, kunnen helpen stress te verminderen en bieden troost en gezelschap. (1,063 words, Aug 26, 2024)
- [De levensloop van uw hond: bevorder de gezondheid van uw beste vriend op alle leeftijden | Boehringer Ingelheim NL](/content/nl/voor-dier/verhalen/de-levensloop-van-uw-hond-bevorder-de-gezondheid-van-uw-beste-vriend-op-alle-leeftijden.html): Als u uw huishouden deelt met een hond, dan weet u hoe bijzonder ze zijn. Honden moedigen een actieve levensstijl aan, kunnen helpen stress te verminderen en bieden troost en gezelschap. (1,063 words, Aug 26, 2024)
- [Wie Sie die Gesundheit Ihres Hundes in jeder Lebensphase unterstützen: vom Welpen bis zum erwachsenen und reifen Hund | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/haustiere/wie-sie-die-gesundheit-ihres-hundes-jeder-lebensphase-unterstuetzen-vom-welpen-bis-zum-erwachsenen.html): Die Bedürfnisse von Hunden ändern sich mit zunehmendem Alter. Erfahren Sie, wie Sie sich in allen Lebensabschnitten um ihre Gesundheit kümmern können: vom Welpen bis zum erwachsenen und reifen Hund. (1,048 words, Aug 23, 2024)
- [Серцева недостатність: чому у жінок "розбите серце" | Boehringer Ingelheim UA](/content/ua/human-health/heart-diseases/heart-failure/serceva-nedostatnist-chomu-u-zhinok-rozbite-serce/index.html): Серцева недостатність: чому у жінок "розбите серце" (572 words, Aug 23, 2024)
- [Las etapas de la vida de tu perro: su salud desde cachorro hasta adulto mayor | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/las-etapas-de-la-vida-de-tu-perro-su-salud-desde-cachorro-hasta-adulto-mayor.html): Las necesidades de los perros cambian con la edad. Conoce más sobre el cuidado de la salud del perro en todas las etapas de su vida: desde cachorro hasta adulto mayor. (1,142 words, Aug 22, 2024)
- [Veterinarians: caught between excellence and exhaustion | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/veterinarians-caught-between-excellence-and-exhaustion.html): Many children dream of becoming a veterinarian. What happens when that dream comes true? (797 words, Aug 22, 2024)
- [プライド月間：LGBTQIA+コミュニティやアライの同僚が語る‘リスペクト’のカルチャーとは | Boehringer Ingelheim JP](/content/jp/about-us/news/stories/pride-month-culture-respect/index.html): 6月のプライド月間を迎え、3名の社員に‘リスペクト’の意義についての考えを聞きました。 (34 words, Aug 22, 2024)
- [Building Lasting Partnerships for a Better Future | Boehringer Ingelheim](/content/partnering/animal-health-partnering/partnership-stories/building-lasting-partnerships-better-future/index.html): Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet. (348 words, Aug 22, 2024)
- [PAP Resources | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/pap-resources/index.html): PAP Resources (89 words, Aug 21, 2024)
- [How to Apply | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/our-commitment/how-apply/index.html): To apply for the program, please complete one of the following application forms and follow the directions on the application form submission (120 words, Aug 21, 2024)
- [Connect with My MSL | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/find-my-msl/index.html): Find and connect with a Medical Science Liaison (MSL) for expert answers on products and clinical information. Search by therapeutic area and ZIP code. (153 words, Aug 20, 2024)
- [Köpeğinizin yaşam evreleri: Yavru köpekten yetişkin ve yaşlıya kadar köpek sağlığı | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/pets/kopeginizin-yasam-evreleri-yavru-kopekten-yetiskin-ve-yasliya-kadar-kopek-sagligi.html): Köpeklerin ihtiyaçları yaşlandıkça değişir. Bebeklikten yetişkinliğe ve yaşlılığa kadar hayatlarının her aşamasında sağlıklarıyla nasıl ilgilenmeniz gerektiğini öğrenin. (169 words, Aug 20, 2024)
- [Nouveau vaccin contre la fièvre catarrhale ovine de sérotype 3 (BTV-3) pour les ovins et les bovins lancé par Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/fr/sante-animale/nouveau-vaccin-contre-la-fievre-catarrhale-ovine-de-serotype-3-btv-3-pour-les-ovins-et-les-bovins-0.html): Grâce à ce lancement, Boehringer Ingelheim ajoute un vaccin de la fièvre catarrhale ovine de sérotype 3 (BTV3) à sa gamme de vaccins pour les ruminants. (864 words, Aug 19, 2024)
- [Příbalový leták | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/pacienti-na-prvnim-miste/pribalovy-letak/index.html): Co všechno najdete v příbalovém letáku? Proč je důležité jej před užíváním léku prostudovat a nevyhazovat jej? Jakým informacím věnovat pozornost? (1,053 words, Aug 15, 2024)
- [Chronic Kidney Disease (CKD) | Insightmedhub](/content/pro/in/therapeutic-areas/chronic-kidney-disease/guidelines/index.html): CKD stands for Chronic Kidney Disease. Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population. (121 words, Aug 12, 2024)
- ["To join Boehringer Ingelheim was the best ever decision" | Boehringer Ingelheim](/content/about-us/who-we-are/culture/join-boehringer-ingelheim-was-best-ever-decision/index.html): Pharmacologist Michael Mark worked for us for 34 years. He played a key role in the research and development of several medications. Watch our video and discover our job opportunities. (419 words, Aug 12, 2024)
- [5 neodmysliteľných jedál štedrovečerného stola, ktoré pomáhajú v boji proti rakovine | Boehringer Ingelheim SK](/content/sk/human-health/cancer/5-neodmyslitelnych-jedal-stedrovecerneho-stola-ktore-pomahaju-v-boji-proti-rakovine.html): Aj pri varení štedrej večere môžete myslieť na svoje zdravie. Konkrétne na prevenciu vzniku rakoviny. V tomto článku vám predstavíme potraviny, ktoré svojím zložením slúžia ako prevencia vzniku rakoviny. (820 words, Aug 9, 2024)
- [7 skorých príznakov rakoviny pľúc, o ktorých by ste mali vedieť. | Boehringer Ingelheim SK](/content/sk/human-health/cancer/lung-cancer/7-skorych-priznakov-rakoviny-pluc-o-ktorych-ste-mali-vediet.html): V skorých štádiách rakoviny pľúc sa príznaky zvyčajne neprejavujú. Podľa Americkej pľúcnej asociácie je to preto, lebo v pľúcach je málo nervových zakončení a rakovinu dlho necítite. (578 words, Aug 9, 2024)
- [Ako sa stravovať pri onkologickom ochorení | Boehringer Ingelheim SK](/content/sk/human-health/cancer/lung-cancer/ako-sa-stravovat-pri-onkologickom-ochoreni/index.html): Po prvotnom zistení, že trpíme onkologickým ochorením, alebo vtedy, keď už podstupujeme liečbu, začneme sa zaujímať, ako by sme mohli prispieť k lepším výsledkom. (352 words, Aug 9, 2024)
- [Viete čo to znamená mať cukrovku? | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/diabetes/viete-co-znamena-mat-cukrovku/index.html): Diabetes mellitus - chronické, metabolické ochorenie charakterizované zvýšenými hladinami glukózy v krvi (624 words, Aug 7, 2024)
- [EASi-HF™ Phase III trial in patients with HFpEF | Boehringer Ingelheim](/content/human-health/heart-diseases/heart-failure/easi-hf-phase-iii-trial-patients-hfpef/index.html): Boehringer Ingelheim's Sandy Sommer on the global urgency for innovative heart failure care and the significance of the clinical trial for patients with HFpEF worldwide. (1,072 words, Aug 7, 2024)
- [Nieuw vaccin tegen blauwtongvirus serotype 3 (BTV-3) voor schapen en runderen gelanceerd door Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/nieuw-vaccin-tegen-blauwtongvirus-serotype-3-btv-3-voor-schapen-en-runderen-gelanceerd-door-0.html): Nieuw vaccin tegen blauwtongvirus serotype 3 (BTV-3) voor schapen en runderen gelanceerd door Boehringer Ingelheim (730 words, Aug 7, 2024)
- [Minder dan de helft van de dierenartsen vindt dat hun beroep wordt gewaardeerd | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/minder-dan-de-helft-van-de-dierenartsen-vindt-dat-hun-beroep-wordt-gewaardeerd.html): Minder dan de helft van de dierenartsen vindt dat hun beroep wordt gewaardeerd (1,259 words, Aug 7, 2024)
- [За кардио-бъбречно-метаболитните заболявания | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/za-kardio-bbrechno-metabolitnite-zabolyavaniya/index.html): Тази страница съдържа преглед на сърдечносъдовите, бъбречните и метаболитните заболявания. (253 words, Aug 1, 2024)
- [Необходими са 2 | Boehringer Ingelheim BG](/content/bg/human-health/chronic-kidney-disease/neobkhodimi-sa-2/index.html): Необходими са двама души – пациент и лекар, и два теста – кръвен тест и изследване на урината, които позволяват да се установи ХБЗ. Ранното провеждане на изследвания може да доведе до по-ранно диагностициране и лечение. (536 words, Aug 1, 2024)
- [たった2ミリの改善が社会に大きな影響を及ぼす年間1.8トンの廃棄物削減を実現したひとりの社員のアイデア | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/tatsuta2mirinogaishankashehuinidakinayingxiangwojihosunianjian18tonnofeiqiwuxuejianwoshixianshitahit.html): 山形県東根市を拠点とする山形工場は、ベーリンガーインゲルハイムの医薬品を日本国内だけでなくアジア・オセアニア地域など世界に供給するための重要な製造拠点です。 (34 words, Jul 26, 2024)
- [Boehringer Ingelheim implementa destacadas iniciativas | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-implementa-destacadas-iniciativas.html): Boehringer Ingelheim implementa destacadas iniciativas para construir un futuro más saludable, sostenible y equitativo (1,206 words, Jul 25, 2024)
- [La Boehringer Ingelheim, misiunea noastră este de a îmbunătăți viața persoanelor care suferă de boli cardiovasculare, renale și metabolice (CRM) interconectate | Boehringer Ingelheim RO](/content/ro/medicina-umana/boli-metabolice/diabet/la-boehringer-ingelheim-misiunea-noastra-este-de-imbunatati-viata-persoanelor-care-sufera-de-boli.html): Bolile cardiovasculare, renale și metabolice(CRM) sunt principala cauză de deces la nivel mondial, fiind responsabile de până la 20 de milioane de decese anual. (497 words, Jul 24, 2024)
- [Esteja alerta e evite cair em golpes: consumidores, fiquem atentos com canais falsos de Nexgard® | Boehringer Ingelheim BR](/content/br/saude-animal/produtos/esteja-alerta-e-evite-cair-em-golpes-consumidores-fiquem-atentos-com-canais-falsos-de-nexgard.html): Conheça os únicos canais oficiais dos produtos antiparasitários NexGard® e Nexgard Spectra®. Não caia em golpes! (315 words, Jul 23, 2024)
- [La Importancia de la Razón Albúmina-Creatinina (RAC) en la evaluación de la Enfermedad Renal Crónica (ERC) | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedad-renal-cronica/la-importancia-de-la-razon-albumina-creatinina-rac-en-la-evaluacion-de-la-enfermedad-renal-cronica.html): La Importancia de la Razón Albúmina-Creatinina (RAC) en la evaluación de la Enfermedad Renal Crónica (ERC) (501 words, Jul 23, 2024)
- [Taking Animal Health Forward | Boehringer Ingelheim AU](/content/au/animal-health/our-responsibility/taking-animal-health-forward/index.html): Taking Animal Health Forward (513 words, Jul 19, 2024)
- [Tipos de trastornos bipolares | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/tipos-de-trastornos-bipolares/index.html): El trastorno bipolar es una enfermedad mental grave que provoca cambios inusuales en el estado de ánimo, la energía, los niveles de actividad y la concentración de una persona (196 words, Jul 18, 2024)
- [De dónde proviene el trastorno bipolar | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/de-donde-proviene-el-trastorno-bipolar/index.html): La causa es, esencialmente, biológica y genética. Según investigaciones a lo largo de los años, parece ser que ciertas personas están más predispuestas genéticamente a desarrollar un trastorno bipolar. (137 words, Jul 18, 2024)
- [Scientific Advancement Grants | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/scientific-advancement-grants/index.html): Discover Boehringer Ingelheim’s Scientific Advancement Grants (SAGs). Learn about the support provided to enhance knowledge and scientific awareness. (702 words, Jul 18, 2024)
- [Quality Improvement Education Grants | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/quality-improvement-education-grants/index.html): Learn how Boehringer Ingelheim’s Quality Improvement Education (QIE) grants support educating HCPs on the latest medical technology and techniques. (686 words, Jul 18, 2024)
- [Independent Medical Education Grants | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/independent-medical-education-grants/index.html): Learn about Boehringer Ingelheim Independent Medical Education (IME) Grants to support evidence-based, fair-balanced, unbiased healthcare education. (1,713 words, Jul 18, 2024)
- [External Collaborative Research | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/external-collaborative-research/index.html): Explore Boehringer Ingelheim's External Collaborative Research (ECR) grants for oncology, cardiology, respiratory, and CNS. Apply online and review FAQs. (1,283 words, Jul 18, 2024)
- [生產符合生態永續而設計與製造的藥物 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/shengchanfuheshengtaiyongxuershejiyuzhizaodeyaowu/index.html): 生產符合生態永續而設計與製造的藥物 (163 words, Jul 17, 2024)
- [Die Leber und ihre entscheidende Wirkung für unsere allgemeine Gesundheit | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/die-leber-und-ihre-entscheidende-wirkung-fuer-unsere-allgemeine-gesundheit.html): Typ-2-Diabetes, Herzkrankheiten, chronische Nierenerkrankungen und Fettleibigkeit – die meisten von uns haben von einer oder mehreren dieser Erkrankungen gehört oder kennen jemanden, der davon betroffen ist. Aber was ist mit unserer Leber? (658 words, Jul 16, 2024)
- [About Us | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/about-us/index.html): Discover how Boehringer Ingelheim Medical & Clinical Resources advances patient care by bridging the gap between science and healthcare. (476 words, Jul 16, 2024)
- [Progrediente fibrosierende interstitielle Lungenerkrankungen (ILDs) | Boehringer Ingelheim Österreich](/content/pro/at/progrediente-fibronisierende-interstitielle-lungenerkrankungen.html): Interstitielle Lungenerkrankungen (ILDs) umfassen eine heterogene Gruppe verschiedener Erkrankungen des Lungengewebes. (1,437 words, Jul 16, 2024)
- [Frühdiagnose des kardio-renal-metabolischen Syndroms](/content/pro/at/kardio-renal-metabolisches-syndrom/index.html): Das kardio-renale-metabolische Syndrom: Verstehen Sie die Zusammenhänge zwischen Typ-2-Diabetes, Herzinsuffizienz und chronischen Nierenerkrankungen. (357 words, Jul 16, 2024)
- [Investigator Initiated Studies | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/investigator-initiated-studies-iis/index.html): Learn about the Boehringer Ingelheim Investigator Initiated Studies (IIS) Program, the application requirements, and how to apply here. (934 words, Jul 16, 2024)
- [Age-related Macular Degeneration (AMD) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/eye-health/amd/index.html): Explore clinical information on AMD, including vision impact, and management approaches. Access resources, clinical trials, congresses, and support tools. (733 words, Jul 15, 2024)
- [Diabetic Retinopathy (DR) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/eye-health/diabetic-retinopathy/index.html): Access clinical insights on Diabetic Retinopathy (DR), including disease overview and treatment approaches. Explore resources, clinical trials, and support tools. (251 words, Jul 15, 2024)
- [Major Depressive Disorder | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/cns/mdd/index.html): Learn about Major Depressive Disorder (MDD), its symptoms, treatment phases, and risk factors, along with tools for managing and improving patient outcomes. (927 words, Jul 15, 2024)
- [Choroby metaboliczne, nerek i układu krążenia – efekt domina | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/choroby-metaboliczne-nerek-i-ukladu-krazenia-efekt-domina.html): Choroby metaboliczne, nerek i układu krążenia – efekt domina (558 words, Jul 14, 2024)
- [Schizophrenia | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/cns/schizophrenia/index.html): Learn more about schizophrenia, including the positive and negative symptoms, insights into managing these symptoms and FDA-approved therapies. (830 words, Jul 12, 2024)
- [NSCLC Support Tools | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/nsclc/support-tools/index.html): Access tools and links for healthcare professionals to manage Non-Small Cell Lung Cancer (NSCLC). (173 words, Jul 12, 2024)
- [NSCLC Clinical Trials | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/nsclc/clinical-trials/index.html): Discover completed and ongoing clinical trials on investigational treatments for Non-Small Cell Lung Cancer (NSCLC). (962 words, Jul 12, 2024)
- [Los dinosaurios se extinguieron, pero los parásitos, esas pequeñas criaturas resilientes, siguen aquí. | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/los-dinosaurios-se-extinguieron-pero-los-parasitos-esas-pequenas-criaturas-resilientes-siguen.html): Conoce cómo proteger a perros y gatos de pulgas, garrapatas y mucho más (153 words, Jul 11, 2024)
- [NSCLC Resources | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/nsclc/resources/index.html): Explore helpful resources on Non-Small Cell Lung Cancer (NSCLC), including videos, slide decks, factsheets, and articles. (111 words, Jul 11, 2024)
- [COPD | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/copd/index.html): Access clinical insights on Chronic Obstructive Pulmonary Disease (COPD), including progression. Explore resources, trials, congresses, and support tools. (392 words, Jul 10, 2024)
- [MASH | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/mash/index.html): Learn about Metabolic Dysfunction-Associated Steatohepatitis (MASH). Explore related resources, clinical trials, congresses, and support tools. (439 words, Jul 9, 2024)
- [CKD Clinical Trials | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/ckd/clinical-trials/index.html): Explore completed and ongoing clinical trials on investigational treatments and drug therapies for Chronic Kidney Disease (CKD) and related conditions. (829 words, Jul 9, 2024)
- [CKD Resources | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/ckd/resources/index.html): Explore useful resources with additional information on Chronic Kidney Disease (CKD), including videos, slide decks, factsheets, and articles. (95 words, Jul 9, 2024)
- [Boehringer Ingelheim produziert seinen grünen Strom selbst | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/boehringer-ingelheim-produziert-seinen-gruenen-strom-selbst.html): Boehringer Ingelheim produziert seinen grünen Strom selbst (674 words, Jul 8, 2024)
- [Central Nervous System (CNS) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/cns/index.html): Discover information on central nervous system (CNS) disorders, including patient education tools and support for neurological conditions and treatments. (184 words, Jul 8, 2024)
- [Doenças zoonóticas: 3 coisas que você precisa saber | Boehringer Ingelheim BR](/content/br/imprensa-historias/doencas-zoonoticas-3-coisas-que-voce-precisa-saber/index.html): As doenças zoonóticas são aquelas que podem ser transmitidas entre animais e seres humanos. Essas enfermidades podem ser causadas por vírus, bactérias, parasitas ou fungos. Saiba mais quais são elas, como elas se propagam e como se prevenir contra elas. (608 words, Jul 5, 2024)
- [Zoonotik hastalıklar: bilmeniz gereken 3 şey | Boehringer Ingelheim TR](/content/tr/hayvan-sagligi/zoonotik-hastaliklar-bilmeniz-gereken-3-sey/index.html): Zoonotik hastalıklar: bilmeniz gereken 3 şey (442 words, Jul 5, 2024)
- [Zoonosen: 3 Dinge, die Sie wissen sollten | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/zoonosen-3-dinge-die-sie-wissen-sollten/index.html): Der Umgang mit Tieren ist alltäglich, und unsere jeweilige Gesundheit ist miteinander verknüpft. Aus diesem Grund ist es wichtig, mehr über Zoonosen zu lernen und zu erfahren, welche Massnahmen wir ergreifen können, um ihre Verbreitung einzudämmen. (554 words, Jul 5, 2024)
- [Embracing diversity in clinical trials: A global mandate | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/clinical-studies/embracing-diversity-clinical-trials-global-mandate/index.html): Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare. (1,169 words, Jul 4, 2024)
- [Obesity | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/obesity/index.html): Access information on obesity, including resources, congresses, clinical trials, and support tools to help manage and reduce obesity-related risks. (222 words, Jul 4, 2024)
- [Choroby odzwierzęce: 3 rzeczy, które warto wiedzieć | Boehringer Ingelheim PL](/content/pl/zdrowie-zwierzat/ochrona-weterynaryjnego-zdrowia-publicznego/choroby-odzwierzece-3-rzeczy-ktore-warto-wiedziec/index.html): Choroby odzwierzęce: 3 rzeczy, które warto wiedzieć (478 words, Jul 3, 2024)
- [Big Little Things in cancer: small things, big impacts | Boehringer Ingelheim](/content/human-health/cancer/big-little-things-cancer-small-things-big-impacts/index.html): Little things can be a big deal when you are living with or treating cancer. Sometimes the small things are the most powerful. (434 words, Jul 2, 2024)
- [Biomasseheizkraftwerk: Investition in grüne Energie | Boehringer Ingelheim DE](/content/de/biomasseheizkraftwerk-investition-gruene-energie/index.html): Neues Kraftwerk versorgt den Standort Ingelheim mit grünem Strom und Dampf und zahlt auf die Klimaziele ein (716 words, Jul 1, 2024)
- [Smart scanners to spot fleas and ticks on your pet | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/smart-scanners-spot-fleas-and-ticks-your-pet/index.html): How to identify fleas and ticks? With technology, vets can now spot pet parasites with high-definition videos in real time. (569 words, Jul 1, 2024)
- [人獣共通感染症：知っておくべき3つのこと | Boehringer Ingelheim JP](/content/jp/animal-health/trends-insights/renshougongtongganranzhengzhitsuteokuheki3tsunokoto.html): 人獣共通感染症：知っておくべき3つのこと (17 words, Jun 28, 2024)
- [Śródmiąższowe choroby płuc – podnieś alarm dla ILD | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-pluc/srodmiazszowe-choroby-pluc-podnies-alarm-dla-ild/index.html): Śródmiąższowe choroby płuc - – podnieś alarm dla ILD (1,088 words, Jun 27, 2024)
- [Type 2 Diabetes Mellitus (T2DM) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/t2dm/index.html): Explore resources for Type 2 Diabetes Mellitus (T2DM), including clinical trials, congresses, support tools. (249 words, Jun 27, 2024)
- [Boehringer Ingelheim ‚Office Hours‘ 2024: Die Zukunft der Innovation in Europa gestalten | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/boehringer-ingelheim-office-hours-2024-die-zukunft-der.html): Seit Beginn des ‚Office Hours‘ Programms im Jahr 2015 betreuten unsere Experten weltweit über 400 Unternehmen und 49 in Österreich. Boehringer Ingelheim engagiert sich für Expertise und Feedback, um aufstrebende Unternehmen beim Wachstum zu unterstützen. (502 words, Jun 26, 2024)
- [Les vaccins vétérinaires sont l’un des piliers de la sécurité alimentaire mondiale | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/les-vaccins-veterinaires-sont-lun-des-piliers-de-la-securite-alimentaire-mondiale.html): Boehringer Ingelheim développe et fabrique une large gamme de vaccins destinés aux volailles, aux porcs et aux ruminants tels que les bovins, les chèvres et les moutons, afin d'accompagner les éleveurs à produire une viande de manière plus durable. (1,143 words, Jun 26, 2024)
- [Les 5 choses à savoir sur l’Influenza aviaire | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/aviaire/les-5-choses-savoir-sur-linfluenza-aviaire/index.html): Si les mesures de biosécurité et la surveillance sont actuellement les méthodes de prévention les plus courantes, la vaccination peut venir compléter les différentes mesures de contrôle. (470 words, Jun 26, 2024)
- [Lidem se sklerodermií pomáhá psychoterapie | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/systemova-sklerodermie/lidem-se-sklerodermii-pomaha-psychoterapie/index.html): Systémová sklerodermie poškozuje nejen tělo nemocného, ale také psychiku, proto Revmaporadna nabízí terapie. (545 words, Jun 25, 2024)
- [治験アンバサダープロジェクト、より公共性の高い活動を目指して一般社団法人YORIAILab（よりあいラボ）として法人化 | Boehringer Ingelheim JP](/content/jp/about-us/news/zhiyananhasatafuroshiekutoyorigonggongxingnogaoihuodongwomuzhishiteyibanshetuanfarenyoriailabyoriair.html): 治験アンバサダープロジェクト、より公共性の高い活動を目指して一般社団法人YORIAILab（よりあいラボ）として法人化 (14 words, Jun 25, 2024)
- [Mes del Orgullo | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/cultura/mes-del-orgullo/index.html): Mes del Orgullo (154 words, Jun 25, 2024)
- [CYLTEZO Pen Injection Download Checklist](/content/patient/us/products/cyltezo/bipdf/cyltezo-pen-injection-download-checklist/index.html): CYLTEZO Pen Injection Download Checklist (104 words, Jun 24, 2024)
- [Copay Program Prescription Claim Form](/content/patient/us/products/cyltezo/bipdf/copay-program-prescription-claim-form/index.html): Copay Program Prescription Claim Form (104 words, Jun 24, 2024)
- [Adalimumab ADBM US IFU](/content/patient/us/products/cyltezo/bipdf/adalimumab-adbm-us-ifu/index.html): Adalimumab ADBM US IFU (104 words, Jun 24, 2024)
- [Cyltezo US IFU](/content/patient/us/products/cyltezo/bipdf/cyltezo-us-ifu/index.html): Cyltezo US IFU (104 words, Jun 24, 2024)
- [Adalimumab ADBM US MG](/content/patient/us/products/cyltezo/bipdf/adalimumab-adbm-us-mg/index.html): Adalimumab ADBM US MG (104 words, Jun 24, 2024)
- [Cyltezo US MG](/content/patient/us/products/cyltezo/bipdf/cyltezo-us-mg/index.html): Cyltezo US MG (104 words, Jun 24, 2024)
- [Cyltezo US PI](/content/patient/us/products/cyltezo/bipdf/cyltezo-us-pi/index.html): Cyltezo US PI (104 words, Jun 24, 2024)
- [Pride Month: Unsere Mitarbeitenden aus der LGBTQIA+ Gemeinschaft und Allies über unsern Unternehmenswert ‚Respekt‘ | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/pride-month-unsere-mitarbeitenden-aus-der-lgbtqia-gemeinschaft-und-allies-ueber-unsern.html): Jasmin, Luisa, Traugott sprechen über unseren Grundwert 'Respekt' (233 words, Jun 21, 2024)
- [Pride Month: Colleagues from the LGBTQIA+ community and allies share their views on our culture of respect | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/culture/pride-month-colleagues-lgbtqia-community-and-allies-share-their-views-our-culture-respect.html): In June, as the world celebrates Pride Month, we asked three of our colleagues to share their thoughts on the significance of respect at our company. (227 words, Jun 21, 2024)
- [Heart Failure & CV Risk Reduction | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/hf-cv-risk-reduction/index.html): Find information on heart failure (HF) and cardiovascular (CV) risk reduction, including scientific congresses, clinical trials, support tools. (359 words, Jun 20, 2024)
- [Innovation in Onkologie und Immunonkologie | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/innovation-onkologie-und-immunonkologie/index.html): Die Forschungsbereiche Onkologie und Immunonkologie sind wichtige Pfeiler unseres Unternehmens. Wir wollen mit innovativen Therapieansätzen den hohen ungedeckten medizinischen Bedarf bei häufig auftretenden Krebserkrankungen decken. (399 words, Jun 19, 2024)
- [La schizophrénie : au-delà de la stigmatisation | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/sante-mentale/schizophrenie/la-schizophrenie-au-dela-de-la-stigmatisation/index.html): Aujourd’hui encore, les personnes souffrant de schizophrénie doivent faire face à la stigmatisation sociale. Boehringer Ingelheim met tout en œuvre pour que les personnes concernées bénéficient de la compréhension et des soins médicaux qui leur sont dus. (378 words, Jun 19, 2024)
- [Schizophrenie: Jenseits der Stigmatisierung | Boehringer Ingelheim CH](/content/ch/humanmedizin/psychische-gesundheit/schizophrenie/schizophrenie-jenseits-der-stigmatisierung/index.html): Weltweit leiden fast eine Milliarde Menschen unter einer psychischen Erkrankung. Boehringer Ingelheim setzt alles daran, damit Betroffene das Verständnis, die Hilfe und die medizinische Versorgung erhalten, die ihnen zusteht. (325 words, Jun 19, 2024)
- [Innovation in Oncology and Cancer Immunology Research | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/innovation-oncology-and-cancer-immunology-research/index.html): We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. (419 words, Jun 18, 2024)
- [Data Science: Revolutionizing research and development with data driven insights | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-focus/data-science-revolutionizing-research-and-development-data-driven-insights.html): Using data in pharmaceutical research to better address patient needs (477 words, Jun 18, 2024)
- [2024年プライド月間 日本におけるLGBTQ＋への取り組み | Boehringer Ingelheim JP](/content/jp/about-us/news/2024nianfuraitoyuejian-ribenniokerulgbtqhenoqurizumi.html): 2024年プライド月間 日本におけるLGBTQ＋への取り組み (13 words, Jun 18, 2024)
- [Larry’s Story: Advocating for people with lung cancer | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/larrys-story-advocating-people-lung-cancer/index.html): In 2013, Larry was diagnosed with non-small cell lung cancer. Learn how his diagnosis led him on a journey of patient advocacy for others with cancer. (431 words, Jun 11, 2024)
- [¿Qué causa la esquizofrenia? | Boehringer Ingelheim ES](/content/es/salud-humana/trastornos-mentales/esquizofrenia/que-causa-la-esquizofrenia/index.html): Actualmente no existen pruebas diagnósticas que aseguren el pronóstico definitivo de la enfermedad. Los estudios e investigaciones tan solo evidencian varios factores que pueden contribuir al riesgo de que una persona presente Esquizofrenia (239 words, Jun 11, 2024)
- [Síntomas cognitivos | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/esquizofrenia/sintomas-cognitivos/index.html): Cuando hablamos de síntomas cognitivos, nos referimos a la pérdida o disminución de funciones cognitivas como pueden ser la atención, el lenguaje o la memoria (298 words, Jun 11, 2024)
- [Boehringer Ingelheim bringt Impfstoff gegen das Blauzungenvirus Serotyp 3 auf den Markt | Boehringer Ingelheim DE](/content/de/tiergesundheit/boehringer-ingelheim-bringt-impfstoff-gegen-das-blauzungenvirus-serotyp-3-auf-den-markt.html): Boehringer Ingelheim bringt Impfstoff gegen das Blauzungenvirus Serotyp 3 auf den Markt (579 words, Jun 10, 2024)
- [Sharing knowledge from our medical device development | Boehringer Ingelheim](/content/human-health/our-responsibility/patient-centricity/sharing-knowledge-our-medical-device-development/index.html): Why do we share some of our work beyond Boehringer for free? (416 words, Jun 7, 2024)
- [Changement de perspective dans la carrière | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-potential/changement-de-perspective-dans-la-carriere/index.html): Sven Sommer latte, Global Head of HR chez Boehringer Ingelheim explique à quel point il est important de s’intéresser également à sa stratégie de carrière personnelle. (963 words, Jun 7, 2024)
- [Perspektivenwechsel in der Karriere | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/perspektivenwechsel-der-karriere/index.html): Sven Sommerlatte, Global Head of HR bei Boehringer Ingelheim und Autor des Buchs „Erfolgreiche Karrierestrategie: Der Weg zum Traumjob“ erklärt, wie wichtig es ist, sich ebenfalls Zeit für die persönliche Karrierestrategie zu nehmen. (736 words, Jun 7, 2024)
- [Advancing green chemistry for more sustainable medicines | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-stories/advancing-green-chemistry-more-sustainable-medicines.html): By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint. (723 words, Jun 6, 2024)
- [Boehringer Ingelheim Office Hours | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/boehringer-ingelheim-office-hours/index.html): Erfahrene Fachleute von Boehringer Ingelheim arbeiten mit innovativen Unternehmen aus dem Bereich der Biowissenschaften in einer beratenden „Roundtable“-Situation zusammen, um deren Wissen darüber zu erweitern. (444 words, Jun 6, 2024)
- [Vielfalt in klinischen Studien | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/vielfalt-klinischen-studien/index.html): Bei der Planung und Durchführung unserer klinischen Studien ist uns Vielfalt und Inklusion sehr wichtig. (812 words, Jun 6, 2024)
- [Frequently Asked Questions | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/faqs/index.html): Find answers to frequently asked questions about the Boehringer Ingelheim's Medical & Clinical Resources website, BI products, and medical content. (1,035 words, Jun 5, 2024)
- [Therapeutic Products | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/therapeutic-products/index.html): Explore detailed prescribing information for Boehringer Ingelheim therapeutic products and FDA-approved medicines available for use in the U.S. here. (265 words, Jun 5, 2024)
- [Medical Research Funding | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/medical-research-funding/index.html): Explore Boehringer Ingelheim's grants and funding for research and medical education, aimed at improving patient care and healthcare innovation. (415 words, Jun 5, 2024)
- [Los parásitos de los perros: Esto es lo que debes saber | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/los-parasitos-de-los-perros-esto-es-lo-que-debes-saber.html): Desde garrapatas, pulgas y ácaros hasta gusanos: existen muchas especies de parásitos que pueden hacer daño a tu perro. Descubre aquí cómo prevenir y tratar las infestaciones de parásitos. (1,223 words, Jun 5, 2024)
- [ベーリンガーインゲルハイム製薬 環境に配慮したエネルギーセンターの操業委託により「山形県環境保全推進賞」を受賞 | Boehringer Ingelheim JP](/content/jp/about-us/news/herinkainkeruhaimuzhiyao/index.html): ベーリンガーインゲルハイム製薬 環境に配慮したエネルギーセンターの操業委託により「山形県環境保全推進賞」を受賞 (16 words, Jun 5, 2024)
- [Psychische Erkrankungen: Eine 1-Billion-Dollar-Herausforderung | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/psychische-erkrankungen-eine-1-billion-dollar-herausforderung.html): Neuer Bericht von Economist Impact zeigt: Fast eine Milliarde Menschen leiden an psychischen Erkrankungen. Aber 70% bekommen keine Unterstützung. (755 words, Jun 4, 2024)
- [Eye Health | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/eye-health/index.html): Explore resources for eye and retinal health, including tools for patient education and support on eye conditions and treatments. (189 words, Jun 4, 2024)
- [Non-Small Cell Lung Cancer | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/oncology/nsclc/index.html): Access clinical insights on Non-Small Cell Lung Cancer (NSCLC), including evolving treatment approaches. Explore resources, clinical trials, and congresses. (714 words, Jun 3, 2024)
- [Systemic Sclerosis-Associated ILD | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/ssc-ild/index.html): Discover clinical information on SSc-ILD, including diagnosis and treatment considerations, with access to resources, trials, and congresses. (363 words, Jun 3, 2024)
- [Interstitielle Lungenerkrankungen – Früh erkennen, rasch handeln | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/lungenfibrose/interstitielle-lungenerkrankungen-frueh-erkennen-rasch-handeln.html): Es ist wichtig, die Anzeichen von Lungenfibrose zu verstehen, die als Folge von ILDs entstehen kann. Eine rasche Behandlung kann Symptome lindern und das Fortschreiten der Krankheit verlangsamen. (434 words, Jun 3, 2024)
- [Progressive Pulmonary Fibrosis | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/ppf/index.html): Access clinical insights on PPF, including disease progression and risk factors. Explore resources, clinical trials, congresses, and support tools. (400 words, Jun 3, 2024)
- [Idiopathic Pulmonary Fibrosis | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/ipf/index.html): Discover clinical insights on IPF, including diagnosis and treatment considerations, with access to resources, trials, and congresses. (338 words, May 31, 2024)
- [Asthma | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/asthma/index.html): Explore clinical information on Asthma, including prevalence and risk factors, with access to resources, trials, congresses, and support tools. (160 words, May 31, 2024)
- [Respiratory Diseases | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/respiratory/index.html): Access resources on respiratory diseases like COPD, asthma, IPF, PPF, SSc-ILD and bronchiectasis. Get insights to manage respiratory conditions effectively. (176 words, May 31, 2024)
- [Chronic Kidney Disease (CKD) | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/ckd/index.html): Access information on Chronic Kidney Disease (CKD), including resources, clinical trials, congresses, support tools. (706 words, May 31, 2024)
- [Pet parasites are still here. What's the risk? | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/pet-parasites-are-still-here-whats-risk/index.html): What's the risk of pet parasites? Check how to protect your dog and cat from fleas, ticks and more. Parasites are a growing challenge due to climate change. (258 words, May 31, 2024)
- [Стратегії подолання проблем постачання медикаментів для країни у стані війни | Boehringer Ingelheim UA](/content/ua/strategii-podolannya-problem-postachannya-medikamentiv-dlya-kraini-u-stani-viyni.html): Стратегії подолання проблем постачання медикаментів для країни у стані війни (619 words, May 30, 2024)
- [Cardio Renal Metabolic Diseases | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/crm/index.html): Explore resources for CRM diseases like obesity, diabetes, heart failure, chronic kidney disease, and MASH, with tools for patient education and support. (147 words, May 30, 2024)
- [H5N1: Bird flu again. What’s different now? | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/h5n1-bird-flu-again-whats-different-now/index.html): H5N1: how is avian influenza now? The virus known for affecting wild & domestic birds has been detected in dairy cows in the US. What you need to know. (654 words, May 29, 2024)
- [Clinical Trials | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/clinical-trials/index.html): Explore recruiting and completed clinical trials, learn about becoming a BI trial investigator, and access information on expanded access programs. (397 words, May 29, 2024)
- [Wege zur optimalen Therapie bei Typ-2-Diabetes | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/diabetes/wege-zur-optimalen-therapie-bei-typ-2-diabetes/index.html): Wege zur optimalen Therapie bei Typ-2-Diabetes (150 words, May 29, 2024)
- [Diseases & Conditions | BIPI Medical & Clinical Resources](/content/pro/us/medinfo/diseases-conditions/index.html): Find resources on diseases & conditions, including cardio-renal-metabolic, respiratory, retinal health, oncology, immunology, mental disorders, and biosimilars. (150 words, May 29, 2024)
- [Nieuw vaccin tegen blauwtongvirus serotype 3 (BTV-3) voor schapen en runderen gelanceerd door Boehringer Ingelheim | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/nieuw-vaccin-tegen-blauwtongvirus-serotype-3-btv-3-voor-schapen-en-runderen-gelanceerd-door.html): Met deze lancering voegt Boehringer Ingelheim een vaccin tegen het blauwtongvirusserotype 3 (BTV3) toe aan haar portfolio van vaccins voor herkauwers. Het is een geïnactiveerd vaccin dat onderhuids wordt toegediend bij schapen en in de spier bij runderen (719 words, May 28, 2024)
- [8 choses à savoir sur la rage | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/8-choses-savoir-sur-la-rage/index.html): Même si le virus de la rage peut être entièrement évité à travers la vaccination et des programmes de sensibilisation, il n’en reste pas moins problématique dans plus de 150 pays ou régions. (1,086 words, May 27, 2024)
- [8 Fakten über Tollwut | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/8-fakten-ueber-tollwut/index.html): 8 Fakten über Tollwut (959 words, May 27, 2024)
- [Rethinking mental health care | Boehringer Ingelheim](/content/human-health/mental-health/rethinking-mental-health-care/index.html): Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals (834 words, May 27, 2024)
- [Non-Small Cell Lung Cancer (NSCLC) | Boehringer Ingelheim](/content/human-health/cancer/lung-cancer/non-small-cell-lung-cancer-nsclc/index.html): Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases. (705 words, May 24, 2024)
- [A Importância do Diagnóstico na Insuficiência Cardíaca](/content/pro/pt/heart-of-what-matters/a-importancia-do-diagnostico/index.html): O diagnóstico precoce da insuficiência cardíaca permite tratar mais cedo, reduzir hospitalizações e melhorar a qualidade de vida dos doentes. (319 words, May 24, 2024)
- [Boehringer Ingelheim US Medical & Clinical Resources](/content/pro/us/medinfo/index.html): Explore Boehringer Ingelheim US Medical & Clinical Resources to find up-to-date medical information, the latest clinical trials, grants and funding, and more. (442 words, May 21, 2024)
- [Výzkum a vývoj v rámci péče o pacienty se schizofrenií | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/dusevni-zdravi/schizofrenie/vyzkum-vyvoj-v-ramci-pece-o-pacienty-se-schizofrenii.html): Na světě žije 24+ mil. lidí se schizofrenií, přesto stále panuje velké nepochopení této nemoci. Klíčovou prioritou je pro nás rozvoj v oblasti včasné diagnostiky a prevence a snaha o rovná práva pro pacienty se schizofrenií. (443 words, May 20, 2024)
- [Boehringer Ingelheim doa R$ 600 mil em medicamentos para os animais vítimas das enchentes no Rio Grande do Sul | Boehringer Ingelheim BR](/content/br/imprensa-historias/press-releases/boehringer-ingelheim-doa-r-600-mil-em-medicamentos-para-os-animais-vitimas-das-enchentes-no-rio.html): Além da contribuição no valor de R$ 200 mil enviada ao canal de doações oficial do Governo do Estado do Rio Grande do Sul, a empresa disponibilizará medicamentos para cães, gatos e equinos afetados pela catástrofe (432 words, May 20, 2024)
- [Code de Conduite | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/ethique-et-conformite/code-de-conduite/index.html): Notre Code de Conduite définit les normes éthiques qui guident l’ensemble de nos activités commerciales. Il nous concerne tous. Chaque personne joue un rôle essentiel dans la mise en application du Code de Conduite. (334 words, May 18, 2024)
- [A face diferența în studiile clinice: Impactul implicării | Boehringer Ingelheim RO](/content/ro/stiinta-si-inovatie/inovatie-medicina-umana/studii-clinice/face-diferenta-studiile-clinice-impactul-implicarii.html): Colaborăm cu pacienții, cu aparținătorii și cu angajații noștri, pentru conceperea și desfășurarea studiilor clinice, în vederea oferirii unei experiențe cât mai bune pentru toți. (662 words, May 18, 2024)
- [Targeting HER2 in cancer | Boehringer Ingelheim US](/content/us/human-health/cancer/targeting-her2-cancer/index.html): Our cancer researchers share insights into the discovery of our investigational HER2-selective tyrosine kinase inhibitor. (1,186 words, May 17, 2024)
- [Marcando la diferencia en los ensayos clínicos | Boehringer Ingelheim ES](/content/es/marcando-la-diferencia-en-los-ensayos-clinicos/index.html): Marcando la diferencia en los ensayos clínicos: el impacto de la participación (879 words, May 17, 2024)
- [At gøre en forskel i kliniske forsøg: engagement betyder noget | Boehringer Ingelheim DK](/content/dk/videnskab-og-innovation/innovation-inden-menneskers-sundhed/kliniske-studier/gore-en-forskel-i-kliniske-forsog-engagement-betyder-noget.html): Vi samarbejder med patienter, pårørende og forsøgspersonale om at designe og gennemføre vores kliniske forsøg, så vi kan give alle en bedre oplevelse. (909 words, May 17, 2024)
- [Making a difference in clinical trials: The impact of engagement | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/clinical-studies/making-difference-clinical-trials-impact-engagement.html): We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all. (821 words, May 17, 2024)
- [Cukrovka u koček | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/cukrovka-u-kocek/index.html): I kočka může mít cukrovku. Při včasné diagnóze a zahájení léčby se ale nemusí vám ani vašemu mazlíčkovi obrátit život naruby. Navíc se dá vzniku cukrovky předcházet. Poradíme vám, jak. (680 words, May 16, 2024)
- [Was den entscheidenden Unterschied bei klinischen Studien macht? Die Einbindung aller Beteiligten. | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/klinische-studien/was-den-entscheidenden-unterschied-bei-klinischen-studien-macht-die.html): Bei der Planung und Durchführung unserer klinischen Studien arbeiten wir eng mit Patient*Innen, ihren betreuenden Personen und Studienteams zusammen, was den Ablauf für alle erheblich erleichtert. (435 words, May 16, 2024)
- [Translating Human Pharma Science into Animal Health Innovation | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/perspectives/translating-human-pharma-science-animal-health-innovation.html): Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health (913 words, May 15, 2024)
- [Ensayos clínicos | Boehringer Ingelheim SA](/content/sa/ciencia-e-innovacion/innovacion-en-salud-humana/estudios-clinicos/ensayos-clinicos/index.html): Ensayos clínicos (967 words, May 14, 2024)
- [Influenza aviaire : la nécessité d’une prévention à la source | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/influenza-aviaire-la-necessite-dune-prevention-la-source.html): L’influenza aviaire est un virus zoonotique persistant et évolutif. Aujourd’hui répandu dans presque toutes les régions du monde, il affecte à la fois les populations d’oiseaux sauvages et les élevages de volaille. (1,298 words, May 14, 2024)
- [Breaking prejudice in lung cancer | Boehringer Ingelheim](/content/human-health/cancer/breaking-prejudice-lung-cancer/index.html): At Boehringer Ingelheim, addressing patient needs and fighting stigma in lung cancer care are two focus topics of the patient engagement team in oncology. (814 words, May 13, 2024)
- [Announcement for Imagine - our new sustainability story hub | Boehringer Ingelheim](/content/announcement-imagine-our-new-sustainability-story-hub.html): Explore how we're driving positive change and advancing healthcare for a better future. (344 words, May 13, 2024)
- [Farmacovigilancia y Seguridad del Paciente | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/farmacovigilancia-y-seguridad-del-paciente/farmacovigilancia-y/index.html): Farmacovigilancia y Seguridad del Paciente (389 words, May 10, 2024)
- [Influenza aviar: la necesidad de prevenir desde la fuente | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/aves/influenza-aviar-la-necesidad-de-prevenir-desde-la-fuente.html): Influenza aviar: la necesidad de prevenir desde la fuente (1,472 words, May 8, 2024)
- [Boehringer Ingelheim realiza doação às vítimas de enchentes no Rio Grande do Sul | Boehringer Ingelheim BR](/content/br/boehringer-ingelheim-realiza-doacao-vitimas-de-enchentes-no-rio-grande-do-sul-0.html): Saiba onde e como contribuir com às famílias afetadas pelas enchentes no estado (290 words, May 8, 2024)
- [Minder dan de helft van de dierenartsen vindt dat hun beroep wordt gewaardeerd | Boehringer Ingelheim BE](/content/be/nl/diergezondheid/uitgelichte-verhalen/minder-dan-de-helft-van-de-dierenartsen-vindt-dat-hun-beroep-wordt-gewaardeerd.html): Minder dan de helft van de dierenartsen vindt dat hun beroep wordt gewaardeerd (1,250 words, May 8, 2024)
- [Imagine: Ecological stoves safeguard family health in Mexico | Boehringer Ingelheim](/content/about-us/sustainable-development/imagine-ecological-stoves-safeguard-family-health-mexico.html): With Fondo Para la Paz, we’ve developed ecological stoves for safer indoor cooking, enhancing respiratory health for rural Mexican families (465 words, May 8, 2024)
- [Vaccine bluetongue virus serotype 3 sheep cattle | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/vaccine-bluetongue-virus-serotype-3-sheep-cattle/index.html): BULTAVO 3™ is a new vaccine that protects cattle and sheep against bluetongue virus serotype 3 (BTV-3). BULTAVO 3™ is the first BTV-3 vaccine that prevents clinical signs and mortality. (706 words, May 8, 2024)
- [Boehringer Ingelheim for Indian Healthcare Professionals](/content/pro/in/therapeutic-areas/index.html): Visit this page to learn more about therapeutic areas where BI is actively involved (38 words, May 6, 2024)
- [About Our Innovation Prize | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/grass-roots/about-our-innovation-prize/index.html): Celebrating Our Innovation Prize Winners (355 words, May 6, 2024)
- [Boehringer Ingelheim Office Hours | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/grass-roots/boehringer-ingelheim-office-hours/index.html): Boehringer Ingelheim Office Hours (455 words, May 6, 2024)
- [Breakthrough introduction innovation pet parasiticides | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/breakthrough-introduction-innovation-pet-parasiticides.html): In 2014, Boehringer introduced a new product, which became the first in a new class of isoxazoline products for flea and tick protection in dogs. (503 words, May 6, 2024)
- [Standart Hüküm ve Koşullar | Boehringer Ingelheim TR](/content/tr/hakkimizda/satin-alma/standart-hukum-ve-kosullar/index.html): Standart Hüküm ve Koşullar (29 words, May 3, 2024)
- [Verhaltenskodex | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/verhaltenskodex/index.html): Our FOCUS bringt zum Ausdruck, wer wir sind, wie wir arbeiten und was wir erreichen wollen. (266 words, May 2, 2024)
- [Improving Access to Clinical Trials | Boehringer Ingelheim US](/content/us/improving-access-clinical-trials/index.html): Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials (884 words, May 1, 2024)
- [Patient centricity and site centricity in clinical trials | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/clinical-studies/patient-centricity-and-site-centricity-clinical-trials.html): We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all. (858 words, Apr 30, 2024)
- [​​Dierenartsen geven alles en (vaak) nóg meer | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/dierenartsen-geven-alles-en-vaak-nog-meer/index.html): ​​Dierenartsen en hun teams zoeken vaak de grens op van zichzelf en hun werk. Erkennen we dat wel genoeg?​ (730 words, Apr 29, 2024)
- [Startseite | Boehringer Ingelheim](/content/pro/de/index.html): Das Informations- und Serviceportal rund um die Produkte und Therapiegebiete von Boehringer Ingelheim. Zahlreiche Services für Sie, Ihre Praxis und Ihre Patienten. (331 words, Apr 29, 2024)
- [Les vétérinaires donnent tout | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/nos-stories/les-veterinaires-donnent-tout/index.html): Les équipes vétérinaires atteignent souvent leurs limites. Mais reçoivent-elles vraiment la reconnaissance qu’elles méritent ? (798 words, Apr 26, 2024)
- [Menos da metade dos profissionais veterinários sentem que sua profissão é apreciada | Boehringer Ingelheim BR](/content/br/menos-da-metade-dos-profissionais-veterinarios-sentem-que-sua-profissao-e-apreciada.html): Novos dados mostram que apenas 49% dos profissionais veterinários acreditam que sua profissão é apreciada (1,019 words, Apr 25, 2024)
- [Tierärzte geben (mehr als) alles. | Boehringer Ingelheim CH](/content/ch/tiergesundheit/unsere-stories/tieraerzte-geben-mehr-als-alles/index.html): Tiermedizinische Teams gehen regelmässig bis an ihre Grenzen. Aber erhalten sie hierfür auch die verdiente Anerkennung? (704 words, Apr 25, 2024)
- [Weniger als die Hälfte der Tierärzt:innen empfindet ihren Beruf als wertgeschätzt | Boehringer Ingelheim AT](/content/at/de/weniger-als-die-haelfte-der-tieraerztinnen-empfindet-ihren-beruf-als-wertgeschaetzt.html): Weniger als die Hälfte der Tierärzt:innen empfindet ihren Beruf als wertgeschätzt (1,074 words, Apr 25, 2024)
- [Les vétérinaires vont (toujours) plus loin | Boehringer Ingelheim FR](/content/fr/sante-animale/nos-engagements/les-veterinaires-vont-toujours-plus-loin/index.html): Les équipes vétérinaires repoussent souvent leurs limites. En sommes-nous suffisamment conscients ? (873 words, Apr 24, 2024)
- [Veterinarians go beyond: animal care and veterinary medicine | Boehringer Ingelheim](/content/animal-health/our-expertise/advancing-veterinary-care/veterinarians-go-beyond-animal-care-and-veterinary-medicine.html): ​​We surveyed over 1000 veterinarians from six countries. Did you know that only 49% of respondents think that the veterinary profession is appreciated? (778 words, Apr 24, 2024)
- [Veterinarians go above and (far) beyond. | Boehringer Ingelheim AT](/content/at/en/animal-health/featured-stories/veterinarians-go-above-and-far-beyond/index.html): Veterinarians go above and (far) beyond. (418 words, Apr 23, 2024)
- [Tierärzte geben (mehr als) alles. | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/tieraerzte-geben-mehr-als-alles/index.html): Tiermedizinische Teams gehen regelmäßig bis an ihre Grenzen. Aber erhalten sie hierfür auch die verdiente Anerkennung? (718 words, Apr 23, 2024)
- [Medicii veterinari fac mai mult decât trebuie și (mult) mai mult decât atât | Boehringer Ingelheim RO](/content/ro/medicina-veterinara/responsabilitatea-noastra/medicii-veterinari-fac-mai-mult-decat-trebuie-si-mult-mai-mult-decat-atat.html): Echipele de medici veterinari iși împing adesea limitele. Recunoaștem suficient acest lucru? (885 words, Apr 23, 2024)
- [World Veterinary Day aspects veterinary profession | Boehringer Ingelheim](/content/animal-health/our-expertise/world-veterinary-day-aspects-veterinary-profession/index.html): World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated. (1,039 words, Apr 23, 2024)
- [All eyes on vision loss | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/all-eyes-vision-loss/index.html): Discover how we’re working towards our goal of preventing vision loss caused by diabetic retinopathy and other retinal conditions. (830 words, Apr 23, 2024)
- [Neue Behandlung von Katzendiabetes ohne Insulinspritzen | Boehringer Ingelheim DE](/content/de/tiergesundheit/neue-behandlung-von-katzendiabetes-ohne-insulinspritzen.html): Neue Behandlung von Katzendiabetes ohne Insulinspritzen (611 words, Apr 17, 2024)
- [Boehringer Ingelheim registra un fuerte crecimiento en 2023 | Boehringer Ingelheim SA](/content/sa/boehringer-ingelheim-registra-un-fuerte-crecimiento-en-2023.html): y acelera sus desarrollos en fases más avanzadas (1,465 words, Apr 16, 2024)
- [Boehringer Ingelheim meldet kraeftiges Wachstum | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/boehringer-ingelheim-meldet-kraeftiges-wachstum/index.html): Boehringer Ingelheim meldet kraeftiges Wachstum (1,090 words, Apr 15, 2024)
- [What do you know about transboundary animal diseases | Boehringer Ingelheim](/content/animal-health/our-expertise/transboundary-diseases/what-do-you-know-about-transboundary-animal-diseases.html): Transboundary animal diseases (TADs) are highly transmissible diseases of livestock. They can impact veterinary public health preparedness and food security. (484 words, Apr 15, 2024)
- [Boehringer Ingelheim strong growth pipeline acceleration 2023 | Boehringer Ingelheim](/content/about-us/who-we-are/boehringer-ingelheim-strong-growth-pipeline-acceleration-2023.html): Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline (1,095 words, Apr 13, 2024)
- [GENERAL PRIVACY NOTICE | Boehringer Ingelheim MX](/content/mx/general-privacy-notice/index.html): We inform you that the privacy and processing of your personal data and sensitive personal data are protected in accordance with our Privacy Notice. (4,858 words, Apr 12, 2024)
- [我們的行為守則 | Boehringer Ingelheim TW](/content/tw/womendexingweishouze/index.html): 我們的行為守則 (75 words, Apr 11, 2024)
- [FRONTPRO® Kautabletten gegen Parasiten für Hunde rezeptfrei in Apotheken erhältlich | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/frontpro-kautabletten-gegen-parasiten-fuer-hunde-rezeptfrei-apotheken-erhaeltlich.html): FRONTPRO® Kautabletten gegen Parasiten für Hunde rezeptfrei in Apotheken erhältlich (657 words, Apr 11, 2024)
- [Code of Conduct | Boehringer Ingelheim AU](/content/au/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (305 words, Apr 11, 2024)
- [Translating Human Pharma Science into Animal Health Innovation | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/translating-human-pharma-science-animal-health-innovation.html): Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health (932 words, Apr 10, 2024)
- [Maintenir une vie active avec une fibrose pulmonaire | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/fibrose-pulmonaire/maintenir-une-vie-active-avec-une-fibrose-pulmonaire.html): En cas de fibrose pulmonaire, opérer des changements dans son mode de vie, aussi petits soient-ils, permet d’améliorer sensiblement le bien-être physique et psychique. (455 words, Apr 9, 2024)
- [Aktiv Leben mit Lungenfibrose | Boehringer Ingelheim CH](/content/ch/humanmedizin/lungenerkrankungen/lungenfibrose/aktiv-leben-mit-lungenfibrose/index.html): Bei einer Lungenfibrose können selbst kleine Änderungen des Lebensstils das allgemeine körperliche und psychische Wohlbefinden spürbar verbessern. (412 words, Apr 9, 2024)
- [Closing healthcare gaps with continued vaccination campaigns | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/closing-healthcare-gaps-continued-vaccination-campaigns.html): How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya. (761 words, Apr 9, 2024)
- [全能貓S | Boehringer Ingelheim TW](/content/tw/node/30758/index.html): 全能貓S (10 words, Apr 9, 2024)
- [美達佳犬貓注射液 | Boehringer Ingelheim TW](/content/tw/node/30757/index.html): 美達佳犬貓注射液 (15 words, Apr 9, 2024)
- [Boehringer Ingelheim and Nxera Pharma (formerly Sosei Heptares), operating from Basel, Switzerland, collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/boehringer-ingelheim-and-nxera-pharma-formerly-sosei-heptares-operating-basel-switzerland.html): Boehringer Ingelheim and Nxera Pharma Co., Ltd. , have entered a global collaboration. (499 words, Apr 8, 2024)
- [Boehringer Ingelheim and Nxera Pharma (formerly Sosei Heptares), operating from Basel, Switzerland, collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/boehringer-ingelheim-and-nxera-pharma-formerly-sosei-heptares-operating-basel-switzerland.html): Boehringer Ingelheim and Nxera Pharma Co., Ltd. , have entered a global collaboration. (499 words, Apr 8, 2024)
- [Empowering independence with Guide Dogs | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/empowering-independence-guide-dogs/index.html): Empowering independence with Guide Dogs (265 words, Apr 8, 2024)
- [日本の業績 | Boehringer Ingelheim JP](/content/jp/pressroom/japan-result/index.html): 日本の業績 (36 words, Apr 5, 2024)
- [Nous sommes là pour nos patients — même dans les régions en crise. | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-health/nous-sommes-la-pour-nos-patients-meme-dans-les-regions-en-crise.html): Nous assurons que les patients reçoivent les médicaments dont ils ont besoin. Nous maintenons notre chaîne d’approvisionnement malgré les défis mondiaux croissants à travers le monde. (1,034 words, Apr 5, 2024)
- [Wie wir unterversorgten Gemeinschaften helfen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/wie-wir-unterversorgten-gemeinschaften-helfen/index.html): Wir haben in Rom ein Gesundheitszentrum aufgebaut, um Menschen in Not zu helfen und ihnen Zugang zur Gesundheitsvorsorge zu ermöglichen. (120 words, Apr 5, 2024)
- [We are there for our patients – even in crisis regions. | Boehringer Ingelheim AT](/content/at/en/human-health/we-are-there-our-patients-even-crisis-regions/index.html): We are there for our patients – even in crisis regions. (840 words, Apr 4, 2024)
- [Wir sind für unsere Patient:innen da - auch in Krisenregionen. | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-health/wir-sind-fuer-unsere-patientinnen-da-auch-krisenregionen-0.html): Wir sorgen dafür, dass die Patient:innen die Medikamente bekommen, die sie benötigen. Wir halten unsere Lieferkette trotz steigender globaler Herausforderungen auf der ganzen Welt aufrecht. (859 words, Apr 4, 2024)
- [He’s my dog, I’m his human | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/hes-my-dog-im-his-human/index.html): Getting a Guide Dog was a life-changing moment for Lucy, who lost her sight in a car accident as a teenager. (288 words, Apr 4, 2024)
- [Las personas con enfermedad renal crónica ya cuentan con una nueva opción terapéutica financiada de la mano de la Alianza Boehringer Ingelheim y Lilly | Boehringer Ingelheim ES](/content/es/prensa/las-personas-con-enfermedad-renal-cronica-ya-cuentan-con-una-nueva-opcion-terapeutica-financiada-de.html): Las personas con enfermedad renal crónica ya cuentan con una nueva opción terapéutica financiada de la mano de la Alianza Boehringer Ingelheim y Lilly (930 words, Apr 4, 2024)
- [Pět faktů, které musíte vědět o srdečních červech | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/pet-faktu-ktere-musite-vedet-o-srdecnich-cervech/index.html): O srdečních červech: Tito parazité mohou způsobit vážná onemocnění psům a kočkám po bodnutí komárem. Zjistěte, jak chránit zdraví vašich mazlíčků. (597 words, Apr 3, 2024)
- [Our evolved employer value proposition | Boehringer Ingelheim US](/content/us/about-us/who-we-are/our-evolved-employer-value-proposition/index.html): Find out from a father-daughter duo how we live up to our people promise and how our company identifies itself and differentiates from other employers. (829 words, Apr 2, 2024)
- [Our evolved employer value proposition | Boehringer Ingelheim US](/content/us/node/30578/index.html): Find out from a father-daughter duo how we live up to our people promise and how our company identifies itself and differentiates from other employers. (829 words, Apr 2, 2024)
- [Medikamente für Menschen im Zeichen des Ukrainekriegs | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/medikamente-fuer-menschen-im-zeichen-des-ukrainekriegs.html): Wir sind für unsere Patienten da – auch in Krisenregionen. Eine Lieferketten-Erfolgsgeschichte mit unserer Supply-Chain-Kollegin Tetiana Nagirna. (941 words, Apr 2, 2024)
- [Boehringer Ingelheim lança nova vacina com proteção contra laringotraqueíte infecciosa, doença de Marek e doença de Gumboro em aves poedeiras e reprodutoras | Boehringer Ingelheim BR](/content/br/saude-animal/animais-de-producao/aves/boehringer-ingelheim-lanca-nova-vacina-com-protecao-contra-laringotraqueite-infecciosa-doenca-de.html): A nova vacina Vaxxitek® HVT+IBD+ILT apresenta combinação inédita e tecnologia pioneira e avançada, reforçando o compromisso da empresa com a inovação baseada em ciência. (527 words, Mar 28, 2024)
- [Access to Healthcare: How we help underserved communities | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/access-healthcare-how-we-help-underserved-communities.html): Access to healthcare is not a given for everyone. We are partnering with an organization in Rome to help underserved communities. (189 words, Mar 28, 2024)
- [Relatório de Transparência e Igualdade Salarial | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/relatorio-de-transparencia-e-igualdade-salarial/index.html): Relatório de Transparência e Igualdade Salarial entre homens e mulheres preparado pelo Governo Federal, em conformidade com o Decreto nº. 11.795/2023 que regulamenta a Lei nº 14.661/2023. (136 words, Mar 27, 2024)
- [Sapucaia do Sul (RS) se torna modelo internacional na promoção de cuidados do AVC com o “Programa Angels” | Boehringer Ingelheim BR](/content/br/imprensa-historias/sapucaia-do-sul-rs-se-torna-modelo-internacional-na-promocao-de-cuidados-do-avc-com-o-programa.html): A cidade é a 2ª no mundo a ser certificada como Cidade Angels, o que significa que seus hospitais e centros de saúde estão treinados para atender os casos de AVC, o que impacta diretamente as chances de recuperação dos pacientes e redução das sequelas. (879 words, Mar 26, 2024)
- [Data Protection Notice RCV Countries | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-protection-notice-rcv-countries/index.html): Data Protection Notice RCV Countries (224 words, Mar 26, 2024)
- [Building Successful Partnerships in Animal Health | Boehringer Ingelheim](/content/partnering/animal-health-partnering/perspectives/building-successful-partnerships-animal-health/index.html): Christoph Vetten, Head of Transactions Animal Health, shares his perspectives on how building successful collaborations can drive innovation. (1,021 words, Mar 26, 2024)
- [Hundeparasiten: Was Sie wissen sollten | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/hundeparasiten-was-sie-wissen-sollten/index.html): Hundeparasiten: Was Sie wissen sollten (1,110 words, Mar 25, 2024)
- [Parásitos de los gatos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/parasitos-de-los-gatos/index.html): Huéspedes que no son bienvenidos (669 words, Mar 25, 2024)
- [Vivre en meilleure santé avec le diabète : activité physique, alimentation et bien-être mental | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-metaboliques/diabete/vivre-en-meilleure-sante-avec-le-diabete-activite-physique-alimentation-et-bien-etre-mental.html): De petits ajustements dans la vie quotidienne peuvent améliorer considérablement les maladies du diabète de type 2 et augmenter le bien-être général. (338 words, Mar 25, 2024)
- [Gesünder Leben mit Diabetes: Bewegung, Ernährung und mentales Wohlbefinden | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/diabetes/gesuender-leben-mit-diabetes-bewegung-ernaehrung-und-mentales-wohlbefinden.html): Kleine Anpassungen im Alltag können Typ-2-Diabetes Erkrankungen deutlich verbessern und das allgemeine Wohlbefinden steigern. (290 words, Mar 25, 2024)
- [Herz-Kreislauf- und Nierenerkrankungen bei Typ-2-Diabetes | Boehringer Ingelheim CH](/content/ch/humanmedizin/stoffwechselerkrankungen/diabetes/herz-kreislauf-und-nierenerkrankungen-bei-typ-2-diabetes.html): Wie beeinflussen sich Diabetes, Herz-Kreislauf und Nierenerkrankungen gegenseitig? (160 words, Mar 25, 2024)
- [Code of Conduct | Boehringer Ingelheim MEA](/content/mea/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (287 words, Mar 22, 2024)
- [Code of Conduct | Boehringer Ingelheim US](/content/us/about-us/ethics-and-compliance/code-conduct/index.html): Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live. (305 words, Mar 22, 2024)
- [Boehringer Ingelheim confirmé comme partenaire privilégié pour la campagne de vaccination contre l’influenza aviaire | Boehringer Ingelheim FR](/content/fr/vaccination-influenza-aviaire/index.html): Boehringer Ingelheim confirmé comme partenaire privilégié pour la campagne de vaccination contre l’influenza aviaire (598 words, Mar 22, 2024)
- [Código de Conduta | Boehringer Ingelheim BR](/content/br/sobre-nos/quem-somos/cultura/codigo-de-conduta/index.html): Nosso Código de Conduta estabelece os padrões éticos que orientam todas as nossas atividades de negócios. É sobre todos nós. Cada indivíduo desempenha um papel fundamental para dar vida ao Código de Conduta. (284 words, Mar 21, 2024)
- [Our evolved employer value proposition | Boehringer Ingelheim](/content/about-us/who-we-are/our-evolved-employer-value-proposition/index.html): Find out from a father-daughter duo how we live up to our people promise and how our company identifies itself and differentiates from other employers. (836 words, Mar 21, 2024)
- [Our evolved employer value proposition | Boehringer Ingelheim](/content/careers/explore-our-company/do-we-keep-our-promise/index.html): Find out from a father-daughter duo how we live up to our people promise and how our company identifies itself and differentiates from other employers. (837 words, Mar 21, 2024)
- [Zusammenhängende Herz-, Nieren- und Stoffwechselkrankheiten | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/zusammenhaengende-herz-nieren-und-stoffwechselkrankheiten-0.html): CRM-Erkrankungen sind eng miteinander verbunden. Sie treten oft zusammen auf und beeinflussen sich gegenseitig. (391 words, Mar 21, 2024)
- [Jak spolupracujeme s pacientskými organizacemi | Boehringer Ingelheim CZ](/content/cz/o-nas/jak-spolupracujeme-s-pacientskymi-organizacemi/index.html): Boehringer Ingelheim klade důraz na partnerství s pacientskými organizacemi ve snaze zlepšit péči o pacienty a jejich kvalitu života. (990 words, Mar 20, 2024)
- [Phase-II-Studie zeigt wegweisende Ergebnisse | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/mash/phase-ii-studie-zeigt-wegweisende-ergebnisse/index.html): Survodutid Phase-II-Studie zeigt wegweisende Ergebnisse bei 83 % der behandelten Erwachsenen mit MASH-Lebererkrankungen (479 words, Mar 20, 2024)
- [The liver and its vital connection to our overall health | Boehringer Ingelheim](/content/human-health/crm-health/liver-health/liver-and-its-vital-connection-our-overall-health/index.html): How health of the liver impacts our interconnected cardiovascular, renal, metabolic system and suffering and can have several comorbidities like obesity. (964 words, Mar 20, 2024)
- [survodutide top-line results MASH fibrosis | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/survodutide-top-line-results-mash-fibrosis/index.html): Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis (1,694 words, Mar 19, 2024)
- [Zusammenhängende Herz-, Nieren- und Stoffwechselkrankheiten | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/zusammenhaengende-herz-nieren-und-stoffwechselkrankheiten.html): CRM-Erkrankungen sind eng miteinander verbunden. Sie treten oft zusammen auf und beeinflussen sich gegenseitig. (398 words, Mar 19, 2024)
- [Datenschutzhinweise | Angehörige Fachkreise | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutzhinweise-angehoerige-fachkreise/index.html): Informieren Sie sich welche Ihrer personenbezogenen Daten zu welchen Zwecken Boehringer Ingelheim im Zusammenhang mit dieser Website verarbeitet. (1,908 words, Mar 18, 2024)
- [Keith's Journey with Heart of Australia | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-potential/keiths-journey-heart-australia/index.html): Rural and remote medical needs in Australia (391 words, Mar 15, 2024)
- [Parazité u psů: Co je dobré vědět | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/parazite-u-psu-co-je-dobre-vedet/index.html): Parazité u psů a co je dobré o nich vědět? Kromě klíštěte, které najdeme mezi srstí psa se může jednat i o škrkavky, které se skrývají ve střevech či blechy a roztoče. (466 words, Mar 11, 2024)
- [Leatherhead Primary Care Network (PCN) Joint Working Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/leatherhead-primary/index.html): Read about Implementing a community-based heart failure clinic to optimise the care and holistic management of symptomatic patients with chronic heart failure. (321 words, Feb 20, 2024)
- [The domino effect of cardiovascular, renal and metabolic conditions | Boehringer Ingelheim AT](/content/at/en/human-health/metabolic-diseases/domino-effect-cardiovascular-renal-and-metabolic-conditions.html): The domino effect of cardiovascular, renal and metabolic conditions (517 words, Feb 20, 2024)
- [Dominoeffekt von Typ-2-Diabetes, Herz- und Nierenkrankheiten | Boehringer Ingelheim AT](/content/at/de/humanmedizin/stoffwechselerkrankungen/dominoeffekt-von-typ-2-diabetes-herz-und-nierenkrankheiten.html): Der Dominoeffekt von Typ-2-Diabetes, Herz- und Nierenkrankheiten (321 words, Feb 19, 2024)
- [Data Protection Notice Members Healthcare Professions | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-protection-notice-members-healthcare-professions.html): Data Protection Notice Members Healthcare Professions (2,940 words, Feb 19, 2024)
- [Datenschutzinformation medizinische Fachkreise | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-medizinische-fachkreise/index.html): Datenschutzinformation medizinische Fachkreise (842 words, Feb 19, 2024)
- [Data Protection Notice Medical Inquiries | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-protection-notice-medical-inquiries/index.html): Data Protection Notice Medical Inquiries (952 words, Feb 16, 2024)
- [Women in STEM: Passion for science to achieve more sustainable healthcare solutions | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/women-stem-passion-science-achieve-more-sustainable-healthcare-solutions.html): Women in STEM: Passion for science to achieve more sustainable healthcare solutions (407 words, Feb 15, 2024)
- [Interview with Norbert Kraut: How cancer drives us forward | Boehringer Ingelheim US](/content/us/human-health/cancer/interview-norbert-kraut-how-cancer-drives-us-forward.html): Norbert Kraut, our Global Head of Cancer Research at Boehringer Ingelheim, shares our approach to advancing cancer research and exploring new technologies (1,180 words, Feb 15, 2024)
- [Gemeinsamer Inklusionsbetrieb | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/gemeinsamer-inklusionsbetrieb/index.html): Der Inklusionsbetrieb wasch.werk & rad.werk in Ingelheim schafft Arbeitsplätze für Menschen mit Behinderung und fördert Teilhabe und Vielfalt. (286 words, Feb 15, 2024)
- [Lameness horses collaboration Sleip app artificial intelligence | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/lameness-horses-collaboration-sleip-app-artificial-intelligence.html): The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone. (753 words, Feb 13, 2024)
- [Frauen in MINT: Wissenschaft im Gesundheitswesen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/frauen-mint-wissenschaft-im-gesundheitswesen/index.html): Wie unsere Kolleginnen, die in MINT-Karrieren erfolgreich sind, die Gesundheitsversorgung verbessern und das Leben für Generationen verändern. (691 words, Feb 9, 2024)
- [Boehringer Ingelheim und CBmed bündeln ihre Kräfte | Boehringer Ingelheim AT](/content/at/de/presse/boehringer-ingelheim-und-cbmed-buendeln-ihre-kraefte.html): Boehringer Ingelheim und CBmed bündeln ihre Kräfte (813 words, Feb 9, 2024)
- [Our mission in cardiovascular, renal, and metabolic care | Boehringer Ingelheim](/content/human-health/crm-health/our-mission-cardiovascular-renal-and-metabolic-care.html): Interconnected cardiovascular, renal, and metabolic diseases affect over 1 billion lives globally (122 words, Feb 8, 2024)
- [“My ultimate goal is to cure cancer” | Boehringer Ingelheim AT](/content/at/en/science-innovation/human-health-innovation/science-stories/my-ultimate-goal-cure-cancer/index.html): “My ultimate goal is to cure cancer” (1,102 words, Feb 8, 2024)
- [„Mein Ziel ist es Krebs zu heilen“ | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/mein-ziel-ist-es-krebs-zu-heilen/index.html): „Mein Ziel ist es Krebs zu heilen“ (1,159 words, Feb 8, 2024)
- [The power of patient advocacy in cancer care | Boehringer Ingelheim](/content/human-health/cancer/power-patient-advocacy-cancer-care/index.html): Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment. (797 words, Feb 6, 2024)
- [Risk of parasites in dogs | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/risk-parasites-dogs/index.html): With our Parassess free online tool checker, you can assess the local parasite risks for your dog so you can protect them better. (543 words, Feb 6, 2024)
- [Mein Ziel ist es Krebs zu heilen | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/mein-ziel-ist-es-krebs-zu-heilen/index.html): Norbert Kraut, Global Head of Cancer Research bei Boehringer Ingelheim, über seine Motivation und Schwerpunkte der onkologischen Forschung. (971 words, Feb 6, 2024)
- [Kočičí škrábnutí s sebou může nést riziko | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/kocici-skrabnuti-s-sebou-muze-nest-riziko/index.html): Nemoc kočičího škrábnutí, jeho rizika. Blechy u koček a jejich vývojová stádia. (427 words, Feb 5, 2024)
- [Consensus in ILD | Boehringer Ingelheim Portugal](/content/pro/pt/consensus-in-ild/index.html): Consensus in ILD surge com o objetivo de definir as melhores práticas na identificação das DPI nas doenças reumáticas em Portugal. (228 words, Feb 2, 2024)
- [zorgverleners | Kennisbank | Jardiance®](/content/pro/nl/zorgverleners/jardiance/kennisbank/index.html): Lees uitgebreide informatie over Jardiance® (empagliflozine) in de SPC en eventuele bijwerkingen, contra-indicatie en dosering. (51 words, Feb 1, 2024)
- [zorgverleners |Jardiance® en Chronische Nierschade](/content/pro/nl/zorgverleners/jardiance/chronische-nierschade/index.html): Chronische nierschade (CNS) treft wereldwijd 850 miljoen mensen, waarvan 47 miljoen in de EU. Het verdubbelt het risico op hospitalisatie. (1,401 words, Feb 1, 2024)
- [zorgverleners |Jardiance® & Chronische Nierschade](/content/pro/nl/zorgverleners/jardiance/cns/index.html): Jardiance® verhoogt de uitscheiding van glucose in de nieren. Hierdoor daalt de bloeddruk en kan het hart gemakkelijker bloed rondpompen. (304 words, Feb 1, 2024)
- [zorgverleners |Handige Downloads | Jardiance®](/content/pro/nl/zorgverleners/jardiance/downloads/index.html): Materiaalservice - Download hier uw praktijkmaterialen of bestel hier uw praktijkmaterialen. Ga naar de website en maak een account aan of log in. (77 words, Feb 1, 2024)
- [zorgverleners | Gratis aanvragen | Jardiance®](/content/pro/nl/zorgverleners/jardiance/aanvragen/index.html): Materiaalservice - Bestel hier uw praktijkmaterialen of download hier uw praktijk materialen. Ga naar de website en maak een account aan of log in. (75 words, Feb 1, 2024)
- [zorgverleners | Jardiance® & Hartfalen](/content/pro/nl/zorgverleners/jardiance/hartfalen/index.html): Jardiance® wordt gebruikt om hartfalen te behandelen bij volwassen patiënten die klachten ervaren door een zwakke pomp­functie van het hart. (279 words, Jan 31, 2024)
- [Patientenorganisationen | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/patientenorganisationen/index.html): Wir kooperieren mit Patientenorganisationen, um die bestmögliche Versorgung für unsere Patienten zu gewährleisten. Erfahren Sie mehr! (214 words, Jan 31, 2024)
- [zorgverleners |Jardiance® & Diabetes Mellitus T2](/content/pro/nl/zorgverleners/jardiance/dm2/index.html): Jardiance® wordt gebruikt om diabetes type 2 bij volwassen patiënten te behandelen. Jardiance® zorgt ervoor dat de patiënt suiker uitplast. (291 words, Jan 31, 2024)
- [zorgverleners | Informatie over Jardiance®](/content/pro/nl/zorgverleners/jardiance/index.html): Jardiance® (empagliflozine) is een SGLT2 remmer en is geregistreed voor meerdere indicaties. Lees hier meer over Jardiance® en indicatiesgebieden. (541 words, Jan 31, 2024)
- [Voorschrijfbevoegd | Informatie over Metalyse®](/content/pro/nl/voorschrijfbevoegd/metalyse/index.html): Metalyse® (tenecteplase) is een geneesmiddel dat in Nederland wordt gebruikt om bloedstolsels in bloedvaten op te lossen (trombolyticum). (508 words, Jan 31, 2024)
- [Product Defect Correction | Boehringer Ingelheim AU](/content/au/product-defect-correction/index.html): Reporting Defects in the dose counter for Spiriva Respimat tiotropium 2.5mcg/actuation inhalation solution cartridge (323 words, Jan 28, 2024)
- [Transforming Cancer Care | Boehringer Ingelheim](/content/human-health/cancer/transforming-cancer-care/index.html): Transforming cancer care requires a diversity of minds. (398 words, Jan 24, 2024)
- [Experiences of living with cancer | Boehringer Ingelheim](/content/human-health/cancer/experiences-living-cancer/index.html): We know from speaking with people living with cancer and their loved ones, that it’s often the small moments that can be the most significant. (410 words, Jan 17, 2024)
- [Top Arbeitgeber: Anerkennung für Mitarbeiterentwicklung | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/top-arbeitgeber-anerkennung-fuer-mitarbeiterentwicklung.html): Als IT-Experte bildet sich David vielfältig weiter. Sein Beispiel zeigt, was Boehringer Ingelheim als Global Top Employer 2024 auszeichnet. (941 words, Jan 17, 2024)
- [global-top-employer-2024 | Boehringer Ingelheim DE](/content/de/pressebereich/pressemitteilungen/global-top-employer-2024/index.html): global-top-employer-2024 (627 words, Jan 17, 2024)
- [Top Employer: learning and development with an impact | Boehringer Ingelheim](/content/about-us/who-we-are/top-employer-learning-and-development-impact/index.html): David has been part of us for over 20 years. What has kept him is part of what makes us a Global Top Employer 2024: our learning and development offerings. (892 words, Jan 15, 2024)
- [Boehringer Ingelheim reconocido como un empleador que promueve el desarrollo de sus colaboradores. | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/boehringer-ingelheim-reconocido-como-un-empleador-que-promueve-el-desarrollo-de-sus-colaboradores.html): La historia de David nos demuestra lo que nos hace Global Top Employer 2024 (1,007 words, Jan 15, 2024)
- [Boehringer expands production site in Greece | Boehringer Ingelheim](/content/about-us/who-we-are/boehringer-expands-production-site-greece/index.html): Boehringer expands production site in Greece for new medicine (564 words, Jan 10, 2024)
- [Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/przewlekla-choroba-nerek/empagliflozyna-zatwierdzona-do-leczenia-osob-doroslych-z-przewlekla-choroba-nerek-w-ue.html): Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE (1,029 words, Jan 9, 2024)
- [New study paves the way for liver cirrhosis treatments | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/new-study-paves-way-liver-cirrhosis-treatments/index.html): The ADVANCE study will be the most detailed observational study of its kind providing a detailed analysis of liver health. (1,117 words, Jan 9, 2024)
- [SENVELGO Best New Product Companion Animals award​ | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/senvelgo-best-new-product-companion-animals-award/index.html): SENVELGO won the 2023 Animal Health Best New Product for Companion Animals award (587 words, Jan 5, 2024)
- [Semintra® 腎比達® | Boehringer Ingelheim TW](/content/tw/animal-health/semintra/index.html): Semintra® 腎比達® (80 words, Dec 26, 2023)
- [心臓病、治療や予防は人でも動物でも似ているかもしれません | Boehringer Ingelheim JP](/content/jp/animal-health/trends-insights/xinzangbingzhiliaoyayufangharentemodongwutemoshiteirukamoshiremasen.html): 心臓病、治療や予防は人でも動物でも似ているかもしれません (96 words, Dec 21, 2023)
- [¿Las mascotas también necesitan refuerzos? La razón por la que vacunar no es lo mismo que inmunizar | Boehringer Ingelheim MX](/content/mx/prensa/las-mascotas-tambien-necesitan-refuerzos-la-razon-por-la-que-vacunar-no-es-lo-mismo-que-inmunizar.html): . Las vacunas en las mascotas son igual de importantes que en los humanos y es por ello que se vuelve una de las responsabilidades más grandes con la que todos los tutores deben cumplir de manera rigurosa. Para nosotros, vacunas como la de COVID o el té (934 words, Dec 19, 2023)
- [Ridgefield Research and Innovation | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/science-focus/ridgefield-research-and-innovation/index.html): Ridgefield, CT, USA is Boehringer Ingelheim's 3rd largest research sit, where scientists are tackling some of the most difficult challenges in healthcare. (263 words, Dec 14, 2023)
- [112年11月21日起JARDIANCE®恩排糖® 膜衣錠10/25毫克 新增「10歲以上小兒之第二型糖尿病病人」適應症 | Boehringer Ingelheim TW](/content/tw/human-health/metabolic-diseases/112nian11yue21riqijardianceenpaitang-moyiding10-25haoke.html): 112年11月21日起JARDIANCE®恩排糖® 膜衣錠10/25毫克 新增「10歲以上小兒之第二型糖尿病病人」適應症 (44 words, Dec 8, 2023)
- [Our partners Bioveta | Boehringer Ingelheim US](/content/us/partnering/animal-health-partnering/our-partners-bioveta/index.html): Our partner Bioveta shares insights about the longstanding collaboration with Boehringer Ingelheim and the evolution of the partnership (500 words, Dec 7, 2023)
- [紀錄片《舞者 1 : 獨自翩翩起舞》 | Boehringer Ingelheim TW](/content/tw/jilupianwuzhe-1-duzipianpianqiwu/index.html): 紀錄片《舞者 1 : 獨自翩翩起舞》 (30 words, Dec 7, 2023)
- [中國醫藥大學佘玉萍副教授團隊 | Boehringer Ingelheim TW](/content/tw/zhongguoyiyaodaxuesheyupingfujiaoshoutuandui/index.html): 中國醫藥大學佘玉萍副教授團隊 (9 words, Dec 7, 2023)
- [台灣大學藥理學研究所楊鎧鍵醫師團隊 | Boehringer Ingelheim TW](/content/tw/taiwandaxueyaolixueyanjiusuoyangkaijianyishituandui.html): 台灣大學藥理學研究所楊鎧鍵醫師團隊 (5 words, Dec 7, 2023)
- [「百靈佳殷格翰生醫新創獨角獸Grass Roots支持計劃」頒獎典禮 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuangdujiaoshouzhichijihua/shengyixinchuangdujiaoshouzhichijihua2021xinwenbaodao-0.html): 「百靈佳殷格翰生醫新創獨角獸Grass Roots支持計劃」頒獎典禮 (36 words, Dec 7, 2023)
- [Choisissez le scellant à trayon mieux conçu | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/choisissez-le-scellant-trayon-mieux-concu/index.html): Choisissez le scellant à trayon mieux conçu (232 words, Dec 6, 2023)
- [Choose the better engineered teat sealant | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/choose-better-engineered-teat-sealant/index.html): Choose the better engineered teat sealant (219 words, Dec 6, 2023)
- [Gesundheitliche Chancengleichheit für Landärzte in Mexiko | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/gesundheitliche-chancengleichheit-fuer-landaerzte-mexiko.html): Unser virtuelles Vertriebsteam hilft Ärzten, durch digitale Weiterbildung über die neuesten Behandlungen informiert zu bleiben, unabhängig von ihrem Standort (748 words, Dec 6, 2023)
- [Boehringer Ingelheim Venture Fund invests precision antimicrobials | Boehringer Ingelheim](/content/science-innovation/boehringer-ingelheim-venture-fund-invests-precision-antimicrobials.html): Boehringer Ingelheim Venture Fund invests in the development of precision antimicrobials (445 words, Dec 6, 2023)
- [Santé du pis durant la période de tarissement | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/sante-du-pis-durant-la-periode-de-tarissement/index.html): Santé du pis durant la période de tarissement (109 words, Dec 6, 2023)
- [Udder health during the dry period | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/udder-health-during-dry-period/index.html): Udder health during the dry period (272 words, Dec 6, 2023)
- [La prévention est la première ligne de défense | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/la-prevention-est-la-premiere-ligne-de-defense/index.html): La prévention est la première ligne de défense (374 words, Dec 5, 2023)
- [Prevention is the first line of defense | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/prevention-first-line-defense/index.html): Prevention is the first line of defense (354 words, Dec 5, 2023)
- [112年12月1日起Ofev®抑肺纖® 擴增健保給付範圍用於慢性漸進性纖維化間質性肺病(PF-ILD) | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/112nian12yue1riqiofevyifeixian/index.html): 112年12月1日起Ofev®抑肺纖® 擴增健保給付範圍用於慢性漸進性纖維化間質性肺病(PF-ILD) (62 words, Dec 1, 2023)
- [CRM Home | Insightmedhub India Portal](/content/pro/in/index.html): In the management of type-2 diabetes patients with cv disease (354 words, Dec 1, 2023)
- [Boehringer Ingelheim Sudamérica apuesta al voluntariado con Making More Health | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestras-historias/boehringer-ingelheim-sudamerica-apuesta-al-voluntariado-con-making-more-health.html): Boehringer Ingelheim Sudamérica apuesta al voluntariado con Making More Health (1,090 words, Nov 28, 2023)
- [Our partners Bioveta | Boehringer Ingelheim](/content/partnering/animal-health-partnering/partnership-stories/our-partners-bioveta/index.html): Our partner Bioveta shares insights about the longstanding collaboration with Boehringer Ingelheim and the evolution of the partnership (526 words, Nov 27, 2023)
- [Boehringer Ingelheim gewinnt Deutschen Nachhaltigkeitspreis | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/boehringer-ingelheim-gewinnt-deutschen-nachhaltigkeitspreis.html): Boehringer Ingelheim gewinnt Deutschen Nachhaltigkeitspreis (559 words, Nov 24, 2023)
- [全球性運動：尋覓新抗生素 | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/quanqiuxingyundongxunmixinkangshengsu/index.html): 全球性運動：尋覓新抗生素 (29 words, Nov 23, 2023)
- [cat feline diabetes medication treatment eu approval | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/cat-feline-diabetes-medication-treatment-eu-approval.html): ​​Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats​ (616 words, Nov 22, 2023)
- [Auto-injection par inadvertance : Le risque associé aux vaccins à base d’huile | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/auto-injection-par-inadvertance-le-risque-associe-aux-vaccins-base-dhuile.html): Auto-injection par inadvertance : Le risque associé aux vaccins à base d’huile (1,338 words, Nov 21, 2023)
- [Inadvertent self-injection: The risk associated with oil-based vaccines | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/inadvertent-self-injection-risk-associated-oil-based-vaccines.html): Inadvertent self-injection: The risk associated with oil-based vaccines (1,142 words, Nov 21, 2023)
- [Votre vaccin contre le SRRP a-t-il suffisamment de « chevaux-vapeur »? | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/votre-vaccin-contre-le-srrp-t-il-suffisamment-de-chevaux-vapeur.html): Votre vaccin contre le SRRP a-t-il suffisamment de « chevaux-vapeur »? (953 words, Nov 21, 2023)
- [Anneannem Hep Yanımda Olsun | Boehringer Ingelheim TR](/content/tr/human-health/lung-diseases/pulmonary-fibrosis/anneannem-hep-yanimda-olsun/index.html): Anneannem Hep Yanımda Olsun (12 words, Nov 21, 2023)
- [Innovative digital therapeutics program shows a reduction in hospitalizations and costs for heart failure patients | Boehringer Ingelheim CA](/content/ca/innovative-digital-therapeutics-program-shows-reduction-hospitalizations-and-costs-heart-failure.html): Innovative digital therapeutics program shows a reduction in hospitalizations and costs for heart failure patients (721 words, Nov 21, 2023)
- [Poultry vaccine site in Georgia continues to reduce carbon emissions | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/poultry-vaccine-site-georgia-continues-reduce-carbon-emissions.html): Going carbon neutral has resulted in measurable, positive impacts. From 2021 to 2022, the Gainesville site reduced its CO2 emissions by 23 percent – nearly 700 fewer tons of CO2 emissions are released into the atmosphere (701 words, Nov 17, 2023)
- [Diabetes en gatos: cómo detectarla y tratarla | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/mascotas/diabetes-en-gatos-como-detectarla-y-tratarla/index.html): Diabetes en gatos: cómo detectarla y tratarla (196 words, Nov 14, 2023)
- [Diabetes bei Katzen: Entdecken und behandeln | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/diabetes-bei-katzen-entdecken-und-behandeln/index.html): Was sind die klassischen Symptome eines Diabetes mellitus bei Katzen? Wie behandelt man diese chronische Krankheit? Hier finden Sie die Antworten. (479 words, Nov 13, 2023)
- [Interconnected: The deep bond between cats and cat owners | Boehringer Ingelheim AU](/content/au/animal-health/companion-animals/pets/interconnected-deep-bond-between-cats-and-cat-owners.html): We know there is a deep connection between humans and animals. But the relationship between cat owners and their cats can be especially complex. (767 words, Nov 13, 2023)
- [5 cosas que debes saber sobre la influenza aviar | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/aves/5-cosas-que-debes-saber-sobre-la-influenza-aviar/index.html): 5 cosas que debes saber sobre la influenza aviar (583 words, Nov 10, 2023)
- [Life forward 百靈佳殷格翰 全新面貌與活力 大步邁向全球150周年、台灣50周年新里程！ | Boehringer Ingelheim TW](/content/tw/about-us/corporate-profile/guanyubailingjiayingehanxinwenxunxi/life-forward-bailingjiayingehan-quanxinmianmaoyuhuoli.html): Life forward 百靈佳殷格翰 全新面貌與活力 大步邁向全球150周年、台灣50周年新里程！ (51 words, Nov 8, 2023)
- [Avian influenza prevention at the source | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/avian-influenza-prevention-source/index.html): Teshome Mebatsion, former Head of Viral Diseases Research at Boehringer Ingelheim, talks about the avian influenza virus, ways of prevention and scenarios for the future. (1,239 words, Nov 7, 2023)
- [Landmark EMPA-KIDNEY trial showed significant benefit of empagliflozin in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease | Boehringer Ingelheim MEA](/content/mea/human-health/metabolic-diseases/landmark-empa-kidney-trial-showed-significant-benefit-empagliflozin-reducing-kidney-disease.html): EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (1,135 words, Nov 7, 2023)
- [Datenschutzerklärung | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzerklaerung/index.html): Datenschutzerklärung (1,166 words, Nov 6, 2023)
- [La geografía de los parásitos de los animales de compañía está cambiando | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/la-geografia-de-los-parasitos-de-los-animales-de-compania-esta-cambiando.html): La geografía de los parásitos de los animales de compañía está cambiando (990 words, Nov 3, 2023)
- [Diabetes bei Katzen: Wie man es erkennt und behandelt | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/diabetes-bei-katzen-wie-man-es-erkennt-und-behandelt.html): Diabetes bei Katzen: Erkennen, behandeln – und das Leben wieder genießen können (484 words, Nov 3, 2023)
- [24 Stunden Notaufnahme für Haustiere | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/24-stunden-notaufnahme-fuer-haustiere/index.html): 24 Stunden Notaufnahme für Haustiere: Tierärztliche Hilfe rund um die Uhr (248 words, Nov 2, 2023)
- [Нашият ангажимент към общността | Boehringer Ingelheim BG](/content/bg/about-us/sustainable-development/our-commitment/nashiyat-angazhiment-km-obschnostta/index.html): Програмата „Стойност чрез иновации“ следва визията на компанията и ангажира служителите ежегодно с различни дейности в полза на обществото (383 words, Nov 1, 2023)
- [全能狗 S | Boehringer Ingelheim TW](/content/tw/animal-health/nexgard-s/index.html): 全能狗 S (12 words, Nov 1, 2023)
- [全能狗 | Boehringer Ingelheim TW](/content/tw/animal-health/nexgard/index.html): 全能狗 (12 words, Nov 1, 2023)
- [蚤不到全效滴劑 | Boehringer Ingelheim TW](/content/tw/animal-health/frontline-dogs/index.html): 蚤不到全效滴劑 (14 words, Nov 1, 2023)
- [蚤不到噴劑｜狗 | Boehringer Ingelheim TW](/content/tw/animal-health/frontlinespray/index.html): 蚤不到噴劑 (17 words, Nov 1, 2023)
- [犬新寶 | Boehringer Ingelheim TW](/content/tw/animal-health/heartgardplus/index.html): 犬新寶 (16 words, Nov 1, 2023)
- [Історія (1990–2022 рр.): користь завдяки інноваціям. | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/history/istoriya-1990-2022-rr-korist-zavdyaki-innovaciyam/index.html): Історія (1990–2022 рр.): користь завдяки інноваціям (74 words, Oct 31, 2023)
- [Історія (1948–1990 рр.): вихід на глобальний рівень | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/history/istoriya-1948-1990-rr-vikhid-na-globalniy-riven/index.html): Історія (1948–1990 рр.): вихід на глобальний рівень (54 words, Oct 31, 2023)
- [Accelerating innovation in health : Boehringer Ingelheim and the Vector Institute to collaborate on AI | Boehringer Ingelheim CA](/content/ca/accelerating-innovation-health-boehringer-ingelheim-and-vector-institute-collaborate-ai.html): Accelerating innovation in health : Boehringer Ingelheim and the Vector Institute to collaborate on AI (556 words, Oct 31, 2023)
- [EMPA-KIDNEY trial showed significant benefit of JARDIANCE® (empagliflozin) in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people living with chronic kidney disease | Boehringer Ingelheim CA](/content/ca/empa-kidney-trial-showed-significant-benefit-jardiance-empagliflozin-reducing-kidney-disease.html): EMPA-KIDNEY, the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease, provides new evidence for patients commonly seen in clinical practice 1,2,3 Phase III trial also demonstrated a 14% statistically significant reduction (1,515 words, Oct 31, 2023)
- [Promising phase II results in chronic kidney disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/promising-phase-ii-results-chronic-kidney-disease/index.html): Boehringer Ingelheim’s investigation of novel compound on top of standard of care empagliflozin shows promising results for chronic kidney disease (1,271 words, Oct 31, 2023)
- [骨克疼 | Boehringer Ingelheim TW](/content/tw/animal-health/previcox/index.html): 骨克疼 (11 words, Oct 31, 2023)
- [龍馬 340 | Boehringer Ingelheim TW](/content/tw/animal-health/immiticide/index.html): 龍馬 340 (1,036 words, Oct 31, 2023)
- [蚤不到全效滴劑 | Boehringer Ingelheim TW](/content/tw/animal-health/frontline-cats/index.html): 蚤不到全效滴劑 (11 words, Oct 31, 2023)
- [蚤不到噴劑 | Boehringer Ingelheim TW](/content/tw/animal-health/frontline-spray/index.html): 蚤不到噴劑 (13 words, Oct 31, 2023)
- [Monophasic Salmonella Calls for a Comprehensive Vaccination Strategy | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/monophasic-salmonella-calls-comprehensive-vaccination-strategy.html): Monophasic Salmonella Calls for a Comprehensive Vaccination Strategy (873 words, Oct 30, 2023)
- [Nuestros ojos están en el futuro. Nuestro optimismo es inquebrantable. Life forward. | Boehringer Ingelheim SA](/content/sa/nuestros-ojos-estan-en-el-futuro-nuestro-optimismo-es-inquebrantable-life-forward.html): Nuestros ojos están en el futuro. Nuestro optimismo es inquebrantable. Life forward. (499 words, Oct 30, 2023)
- [Voorschrijfbevoegd |Handige Downloads | Jardiance®](/content/pro/nl/voorschrijfbevoegd/jardiance/downloads/index.html): Materiaalservice - Download hier uw praktijkmaterialen of bestel hier uw praktijkmaterialen. Ga naar de website en maak een account aan of log in. (82 words, Oct 30, 2023)
- [純粹貓無佐劑五合一疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/purevax-5in1/index.html): 純粹貓無佐劑五合一疫苗 (15 words, Oct 30, 2023)
- [Voorschrijfbevoegd | Kennisbank | Jardiance®](/content/pro/nl/voorschrijfbevoegd/jardiance/kennisbank/index.html): Lees uitgebreide informatie over Jardiance® (empagliflozine) in de SPC en eventuele bijwerkingen, contra-indicatie en dosering. (66 words, Oct 30, 2023)
- [純粹貓無佐劑三合一疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/purevax-3in1/index.html): 純粹貓無佐劑三合一疫苗 (11 words, Oct 30, 2023)
- [百靈佳殷格翰 2023 獨角獸2.0 -- 生醫新創加乘行動計畫 活動辦法 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuangdujiaoshouzhichijihua/shengyixinchuangdujiaoshouzhichijihua2023xinwenbaodao/bailingjiayingehan-2023-dujiaoshou20/index.html): 百靈佳殷格翰 2023 獨角獸2.0 -- 生醫新創加乘行動計畫 活動辦法 (116 words, Oct 29, 2023)
- [百靈佳殷格翰 2021 生醫新創獨角獸 “Grass Roots” 支持計畫 | Boehringer Ingelheim TW](/content/tw/science-innovation/shengyixinchuangdujiaoshouzhichijihua/bailingjiayingehan-2021-shengyixinchuangdujiaoshou-grass-roots-zhichijihua.html): 百靈佳殷格翰 2021 生醫新創獨角獸 “Grass Roots” 支持計畫 (29 words, Oct 29, 2023)
- [Gallivac IB88 NeO 雞傳染性支氣管炎活毒疫苗發泡錠 | Boehringer Ingelheim TW](/content/tw/animal-health/gallivac-ib88-neo/index.html): Gallivac IB88 NeO 雞傳染性支氣管炎活毒疫苗發泡錠 (140 words, Oct 27, 2023)
- [百靈佳®豬藍耳病減毒活毒疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/ingelvac-prrs-mlv/index.html): 百靈佳®豬藍耳病減毒活毒疫苗 (34 words, Oct 26, 2023)
- [Voorschrijfbevoegd | Gratis aanvragen | Jardiance®](/content/pro/nl/voorschrijfbevoegd/jardiance/aanvragen/index.html): Materiaalservice - Bestel hier uw praktijkmaterialen of download hier uw praktijk materialen. Ga naar de website en maak een account aan of log in. (120 words, Oct 26, 2023)
- [百靈佳®豬假性狂犬病基因缺損活毒疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/ingelvac-aujeszky-mlv/index.html): 百靈佳®豬假性狂犬病基因缺損活毒疫苗 (25 words, Oct 25, 2023)
- [Boehringer Ingelheim University | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/boehringer-ingelheim-university/index.html): “Toda pregunta es importante para aprender”: Aprendizaje permanente en nuestro campus virtual (348 words, Oct 24, 2023)
- [Volvac AC Plus系列疫苗 | Boehringer Ingelheim TW](/content/tw/animal-health/volvac-ac-plus/index.html): Volvac AC Plus系列疫苗 (52 words, Oct 24, 2023)
- [百靈佳®豬放線桿菌胸膜肺炎不活化菌苗 | Boehringer Ingelheim TW](/content/tw/animal-health/ingelvac-h/index.html): 百靈佳®豬放線桿菌胸膜肺炎不活化菌苗 (14 words, Oct 24, 2023)
- [Volvac ND Conc. KV(濃縮) | Boehringer Ingelheim TW](/content/tw/animal-health/volvac-nd-conc/index.html): Volvac ND Conc. KV(濃縮) (581 words, Oct 23, 2023)
- [Voorschrijfbevoegd | Informatie over Jardiance®](/content/pro/nl/voorschrijfbevoegd/jardiance/index.html): Jardiance® (empagliflozine) is een SGLT2 remmer en is geregistreed voor meerdere indicaties. Lees hier meer over Jardiance® en indicatiesgebieden. (609 words, Oct 23, 2023)
- [Making sustainable medicines through eco-design | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/making-sustainable-medicines-through-eco-design/index.html): Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle (1,031 words, Oct 23, 2023)
- [EVIS（エビス）とサイエンスカフェ 〜ボトムアップのアイデアをかたちに〜 | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/science-stories/evis/index.html): EVIS（エビス）とサイエンスカフェ 〜ボトムアップのアイデアをかたちに〜 (45 words, Oct 18, 2023)
- [多様な働き方推進で社員一人ひとりが自由にキャリアパスを描くKPRIを目指して | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/science-stories/kpri/index.html): 多様な働き方推進で社員一人ひとりが自由にキャリアパスを描くKPRIを目指して (27 words, Oct 18, 2023)
- [Oxfordshire Cognitive Collaborative Working Project | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/oxfordshire-cognitive/index.html): A Collaborative Working Project between Boehringer Ingelheim Ltd and Oxford Health NHS Foundation Trust to design and implement a new model of care to help address the current gap in the assessment and management of cognitive symptoms associated with psyc (363 words, Oct 18, 2023)
- [Neuer Monoimpfstoff zur Rotlauf-Prävention | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/schweine/neuer-monoimpfstoff-zur-rotlauf-praevention/index.html): Neuer Monoimpfstoff zur Rotlauf-Prävention (481 words, Oct 17, 2023)
- [Página em construção | Boehringer Ingelheim Portugal](/content/pro/pt/evidencia-clinica/index.html): Página em construção - PT HCP (23 words, Oct 17, 2023)
- [A sense of community and a love for gardening that’s lasted decades at our U.S. headquarters | Boehringer Ingelheim US](/content/us/about-us/sense-community-and-love-gardening-thats-lasted-decades-our-us-headquarters.html): Discover our longstanding love for gardening and how it started with Schatzi’s chives. (429 words, Oct 12, 2023)
- [Innovation and drone delivery | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/innovation-and-drone-delivery/index.html): Addressing healthcare disparities through collaborative innovation and drone delivery (545 words, Oct 12, 2023)
- [UK Carbon Reduction Plan 2023 | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/uk-carbon-reduction-plan-2023/index.html): UK Carbon Reduction Plan 2023 (49 words, Oct 11, 2023)
- [Digital solution for individualized diabetes care | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/diabetes/digital-solution-individualized-diabetes-care/index.html): With Exandra™, we have developed a clinical decision support tool for diabetes care to make everyday life easier for healthcare professionals. (886 words, Oct 11, 2023)
- [Carta de declaración | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-potential-para-las-comunidades-y-nuestra-gente/carta-de-declaracion/index.html): Carta de declaración AWS (79 words, Oct 10, 2023)
- [Shared science for the best cat diabetes management | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/shared-science-best-cat-diabetes-management/index.html): Diabetes mellitus is a common endocrine disease with increasing prevalence in dogs and cats. Learn how science's made management easier. (1,130 words, Oct 10, 2023)
- [Streetvet: Free veterinary care | Boehringer Ingelheim](/content/about-us/who-we-are/streetvet-free-veterinary-care/index.html): Learn more about StreetVet free veterinarian care for companion animals of the homeless (755 words, Oct 9, 2023)
- [Белодробната фиброза на Фокус | Boehringer Ingelheim BG](/content/bg/human-health/lung-diseases/pulmonary-fibrosis/belodrobnata-fibroza-na-fokus/index.html): Докато разговаряме с хората, страдащи от белодробна фиброза, чуваме стоплящи сърцето истории за решителност, упоритост и дух. (239 words, Oct 9, 2023)
- [Neuer Forschungsansatz für mehr psychische Gesundheit | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/neuer-forschungsansatz-fuer-mehr-psychische-gesundheit.html): Mit einem neuen Ansatz und einer innovativen Pipeline wollen wir die Behandlung von psychischen Erkrankungen verbessern. (706 words, Oct 5, 2023)
- [Soaring to save lives | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/soaring-save-lives/index.html): Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities (72 words, Oct 5, 2023)
- [Phase 3 studies survodutide obesity and overweight | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/phase-3-studies-survodutide-obesity-and-overweight/index.html): Phase 3 studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease (1,235 words, Oct 5, 2023)
- [Putting a green spotlight on health | Boehringer Ingelheim AU](/content/au/about-us/sustainable-development/more-green/putting-green-spotlight-health/index.html): Boehringer Ingelheim’s new-generation reusable and propellant-free inhalers significantly reduce the environmental footprint of a device used daily tens of thousands of Australians and New Zealanders. (585 words, Oct 4, 2023)
- [HF Patient Story: Katrina | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/heart-failure/hf-patient-story-katrina/index.html): Patient story for HF sufferer Katrina (417 words, Oct 4, 2023)
- [Partnership with Precision Health Research, Singapore | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/partnership-precision-health-research-singapore/index.html): Boehringer Ingelheim joins forces with Precision Health Research, Singapore with the aim of transforming healthcare and improving patient outcomes in Singapore and beyond. (894 words, Oct 1, 2023)
- [Widnes PCN Executive Summary | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/widnes-pcn-executive/index.html): To establish a data led approach to service redesign for patients living with heart failure, chronic kidney disease and Type 2 Diabetes, across Widnes PCN (618 words, Sep 29, 2023)
- [Empowering smallholder farmers | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/empowering-smallholder-farmers/index.html): The LastMile initiative improves health equity in remote areas of Africa, increasing access to animal health resources for underserved farming communities. (1,122 words, Sep 28, 2023)
- [Meer dan 500.000 katten in Nederland hebben dagelijks pijn | Boehringer Ingelheim NL](/content/nl/meer-dan-500000-katten-nederland-hebben-dagelijks-pijn-0.html): Meer dan 500.000 katten in Nederland hebben dagelijks pijn (383 words, Sep 28, 2023)
- [Ingelvac CircoFLEX® : le vaccin en santé animale ayant remporté le plus grand succès de tous les temps est aussi un produit très polyvalent | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/ingelvac-circoflex-le-vaccin-en-sante-animale-ayant-remporte-le-plus-grand-succes-de-tous-les-temps.html): Ingelvac CircoFLEX® : le vaccin en santé animale ayant remporté le plus grand succès de tous les temps est aussi un produit très polyvalent (202 words, Sep 27, 2023)
- [Ingelvac CircoFLEX®: The most successful animal health vaccine of all time is also a very versatile product | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/ingelvac-circoflex-most-successful-animal-health-vaccine-all-time-also-very-versatile-product.html): Ingelvac CircoFLEX®: The most successful animal health vaccine of all time is also a very versatile product (844 words, Sep 27, 2023)
- [Herzgeräusche bei Hunden: Wie Symptome behandelt werden | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/herzgeraeusche-bei-hunden-wie-symptome-behandelt-werden.html): Herzgeräusche bei Hunden: Wie Symptome behandelt werden (834 words, Sep 27, 2023)
- [Lifelong learning at our Virtual Campus | Boehringer Ingelheim](/content/about-us/who-we-are/lifelong-learning-our-virtual-campus/index.html): The Virtual Campus of our Boehringer Ingelheim University supports our employees in their personalized lifelong learning. (175 words, Sep 26, 2023)
- [trajenta-rcm](/content/pro/pt/bipdf/trajenta-rcm/index.html): trajenta-rcm (19 words, Sep 26, 2023)
- [jentadueto-rcm](/content/pro/pt/bipdf/jentadueto-rcm/index.html): jentadueto-rcm (19 words, Sep 26, 2023)
- [jardiance-rcm](/content/pro/pt/bipdf/jardiance-rcm/index.html): jardiance-rcm (19 words, Sep 26, 2023)
- [glyxambi-rcm](/content/pro/pt/bipdf/glyxambi-rcm/index.html): glyxambi-rcm (19 words, Sep 26, 2023)
- [Every Drop Counts – Water Stewardship at Boehringer Ingelheim | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/every-drop-counts-water-stewardship-boehringer-ingelheim.html): How we work actively to protect clean water and reduce our water footprint in all communities where we operate (1,070 words, Sep 25, 2023)
- [Early diagnosis and a positive outlook: Bill’s story | Boehringer Ingelheim AU](/content/au/human-health/lung-diseases/pulmonary-fibrosis/early-diagnosis-and-positive-outlook-bills-story/index.html): Bill's battle against Pulmonary Fibrosis and his mission to raise much needed awareness and funds for lung disease. (428 words, Sep 22, 2023)
- [FDA approved treatment option for adults with CKD | Boehringer Ingelheim US](/content/us/human-health/chronic-kidney-disease/fda-approved-treatment-option-adults-ckd/index.html): The FDA has approved Jardiance® (empagliflozin) tablets to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, cardiovascular death and hospitalization in adults with CKD at risk of progression. (1,780 words, Sep 22, 2023)
- [Zorgverleners | Downloads | Informatie Pradaxa®](/content/pro/nl/zorgverleners/pradaxa/downloads/index.html): Bestel of download hier uw praktijkmaterialen voor patienten met atrriumfibrilleren en patientenfolders over Pradaxa®. Maak een account aan of log in. (57 words, Sep 21, 2023)
- [Zorgverleners | Kennisbank | Informatie Pradaxa®](/content/pro/nl/zorgverleners/pradaxa/kennisbank/index.html): Lees de uitgebreide informatie over Pradaxa® (dabigatran) in de SPC, indicaties, dosering, contra-indicaties en wijze van toediening. (37 words, Sep 21, 2023)
- [FDA approves Jardiance treatment chronic kidney disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/fda-approves-jardiance-treatment-chronic-kidney-disease.html): U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease (760 words, Sep 21, 2023)
- [Zorgverleners | Informatie over Praxbind®](/content/pro/nl/zorgverleners/pradaxa/praxbind/index.html): Informatie over Praxbind®. Praxbind® bevat de werkzame stof idarucizumab en is een specifiek antidotum (neutraliserend middel) voor Pradaxa® (dabigatran). (117 words, Sep 21, 2023)
- [BI India joins forces with PPAM and BMC to Stop Rabies | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/bi-india-joins-forces-ppam-and-bmc-stop-rabies/index.html): This initiative will adopt a two-pronged approach of vaccination and education. (681 words, Sep 20, 2023)
- [Voorschrijfbevoegd | Gratis aanvragen | Pradaxa®](/content/pro/nl/voorschrijfbevoegd/pradaxa/aanvragen/index.html): Download of bestel hier uw praktijkmaterialen voor patienten met atrriumfibrilleren en patientenfolders over Pradaxa®. Maak een account aan of log in. (57 words, Sep 20, 2023)
- [Voorschrijfbevoegd | Downloads | Informatie Pradaxa®](/content/pro/nl/voorschrijfbevoegd/pradaxa/downloads/index.html): Bestel of download hier uw praktijkmaterialen voor patienten met atrriumfibrilleren en patientenfolders over Pradaxa®. Maak een account aan of log in. (57 words, Sep 20, 2023)
- [Living with pulmonary fibrosis and finding hope | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/living-pulmonary-fibrosis-and-finding-hope/index.html): From caregiver to co-founder of the European Pulmonary Fibrosis Federation, Liam Galvin shares about his experience, and the impact of ongoing research (315 words, Sep 20, 2023)
- [Digital referral system renal and heart failure Salford | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/digital-referral/index.html): The development and implementation of an innovative digital referral system between renal and heart failure services in Salford (and referring centres), to improve patient management and outcomes. (389 words, Sep 19, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Effectiviteit](/content/pro/nl/voorschrijfbevoegd/pradaxa/effectiviteit/index.html): Lees hier meer over de effectiviteit van Pradaxa® (dabigatran). Kijk voor de volledige informatie over de effectiviteit in de SPC Pradaxa®. (424 words, Sep 19, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Bijwerkingen](/content/pro/nl/voorschrijfbevoegd/pradaxa/bijwerkingen/index.html): Lees hier meer over de bijwerkingen van Pradaxa® (dabigatran). Kijk voor een volledig overzicht van de bijwerkingen in de SPC Pradaxa®. (118 words, Sep 19, 2023)
- [Ranking in the top 25% in EcoVadis Sustainability Assessment | Boehringer Ingelheim](/content/about-us/sustainable-development/ranking-top-25-ecovadis-sustainability-assessment/index.html): Boehringer Ingelheim has received a silver medal from EcoVadis in the 2023 sustainability assessment. Our overall score places our company within the top 25% of all rated companies. (310 words, Sep 19, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Overstappen](/content/pro/nl/voorschrijfbevoegd/pradaxa/overstappen/index.html): Lees hier de uitgebreide informatie hoe op een veilig manier overgestapt kan worden van coumarines naar Pradaxa® (dabigatran). (459 words, Sep 19, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Informatie starten](/content/pro/nl/voorschrijfbevoegd/pradaxa/starten/index.html): De aanbevolen dagelijkse dosis Pradaxa (dabigatran) is 150mg, oraal toegediend in de vorm van 2x daags. Lees hier meer over de dosering. (524 words, Sep 15, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Atriumfibrilleren](/content/pro/nl/voorschrijfbevoegd/pradaxa/af/index.html): Informatie over Pradaxa® (dabigatran) bij atriumfibrilleren, Diep Veneuze Trombose (DVT), longembolie en Veneuze Trombo-Embolische voorvallen (VTE) (270 words, Sep 15, 2023)
- [Día Mundial de la Seguridad del Paciente | Boehringer Ingelheim SA](/content/sa/salud-humana/nuestra-responsabilidad/farmacovigilancia-y-seguridad-del-paciente/dia-mundial-de-la/index.html): Desde 2019, la OMS prioriza la seguridad de los pacientes, instituyendo el 17 de septiembre como Día Mundial de Seguridad del Paciente. (576 words, Sep 14, 2023)
- [STOP Rabies: moving towards elimination | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/stop-rabies-moving-towards-elimination/index.html): Rabies still kills thousands of people every year. However, rabies is 100 percent vaccine preventable. We contribute to eliminating the disease. (721 words, Sep 14, 2023)
- [Voorschrijfbevoegd | Pradaxa® | Informatie indicaties](/content/pro/nl/voorschrijfbevoegd/pradaxa/index.html): Informatie over Pradaxa® (dabigatran) bij atriumfibrilleren, Diep Veneuze Trombose (DVT), longembolie en Veneuze Trombo-Embolische voorvallen (VTE) (264 words, Sep 14, 2023)
- [Boehringer receives SBTi validation for CO2 reduction targets | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/boehringer-receives-sbti-validation-co2-reduction-targets.html): Boehringer Ingelheim receives SBTi validation for CO2 reduction targets (802 words, Sep 14, 2023)
- [On the path to decarbonization: How we reduce our emissions | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/path-decarbonization-how-we-reduce-our-emissions/index.html): How our sites Fornovo and Paulínia became carbon-neutral and support our recently SBTi-validated 2030 goals (1,134 words, Sep 12, 2023)
- [Six creative Connecticut students turn aspiring ideas into inventive innovation | Boehringer Ingelheim US](/content/us/about-us/six-creative-connecticut-students-turn-aspiring-ideas-inventive-innovation.html): Learn about the 2023 Connecticut Invention Convention winners. (31 words, Sep 11, 2023)
- [3 choses à savoir sur les zoonoses | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/3-choses-savoir-sur-les-zoonoses/index.html): 3 Choses à Savoir Sur Les Zoonoses (647 words, Sep 11, 2023)
- [Health Innovation Manchester CKD Mapping project | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/health-innovation/index.html): Creation of an Experience Journey Map and Action Framework to deliver integration and efficiency within chronic kidney disease service provision with Health Innovation Manchester (516 words, Sep 8, 2023)
- [Combating food insecurity for more health equity in the U.S. | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/combating-food-insecurity-more-health-equity-us/index.html): Meet social innovation founder Katie at Making More Health Together 2023: How the social innovation founder brings fresh food stores back to the U.S. (1,189 words, Sep 5, 2023)
- [Boehringer Ingelheim, partenaire privilégié pour lutter contre l’influenza aviaire | Boehringer Ingelheim FR](/content/fr/boehringer-ingelheim-partenaire-privilegie-pour-lutter-contre-linfluenza-aviaire.html): Boehringer Ingelheim, partenaire privilégié pour lutter contre l’influenza aviaire (643 words, Sep 4, 2023)
- [Zorgverleners | Informatie over Spiolto Respimat®](/content/pro/nl/zorgverleners/spiolto/index.html): Spiolto Respimat® is een inhalatieoplossing met een vaste dosiscombinatie van tiotropium en olodaterol, voor patiënten met COPD. (147 words, Sep 1, 2023)
- [Voorschrijfbevoegd | Handige Downloads | Spiolto Respimat®](/content/pro/nl/voorschrijfbevoegd/spiolto/downloads/index.html): Materiaalservice - Download hier uw COPD praktijkmaterialen of bestel hier uw parktijkmaterialen. Maak een account aan of log in. (55 words, Sep 1, 2023)
- [Voorschrijfbevoegd | Informatie over Spiolto Respimat®](/content/pro/nl/voorschrijfbevoegd/spiolto/index.html): Spiolto Respimat® is een inhalatieoplossing met een vaste dosiscombinatie van tiotropium en olodaterol, voor patiënten met COPD. (113 words, Sep 1, 2023)
- [Partnership African animal trypanosomiasis | Boehringer Ingelheim](/content/animal-health/our-expertise/partnership-african-animal-trypanosomiasis/index.html): New partnership working on solutions to combat African animal trypanosomiasis (723 words, Aug 31, 2023)
- [Feline diabetes: how to detect and treat it | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/feline-diabetes-how-detect-and-treat-it/index.html): What are the symptoms of diabetes in cats, and how do you manage this chronic disease? Find the answers here. (698 words, Aug 31, 2023)
- [Voorschrijfbevoegd | Gratis aanvragen | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/aanvragen/index.html): Materiaalservice - Bestel hier uw diabetes praktijkmaterialen of download hier diabetes praktijkmaterialen. Maak een account aan of log in. (54 words, Aug 30, 2023)
- [Voorschrijfbevoegd | Handige Downloads | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/downloads/index.html): Materiaalservice - Download hier uw diabetes praktijkmaterialen of bestel hier uw diabetes praktijkmaterialen. Maak een account aan of log in. (54 words, Aug 30, 2023)
- [Voorschrijfbevoegd | Kennisbank | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/kennisbank/index.html): Lees uitgebreide informatie over Trajenta® (linagliptine) in de SPC en eventuele bijwerkingen, contra-indicaties, dosering en wijze van toediening. (41 words, Aug 30, 2023)
- [Voorschrijfbevoegd | Dosering | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/dosering/index.html): De aanbevolen dosering voor Trajenta® (linagliptine) is eenmaal per dag 5 mg. Trajenta® is geïndiceerd bij volwassenen met diabetes mellitus type 2. (202 words, Aug 29, 2023)
- [Voorschrijfbevoegd | Indicaties | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/indicaties/index.html): Trajenta® (linagliptine) is geïndiceerd bij volwassenen met diabetes mellitus type 2. De aanbevolen dosering voor Trajenta® is eenmaal per dag 5 mg. (76 words, Aug 29, 2023)
- [Voorschrijfbevoegd | Trajenta®](/content/pro/nl/voorschrijfbevoegd/trajenta/index.html): Trajenta® (linagliptine) behoort tot de DPP-4-remmers. Trajenta® is geïndiceerd bij volwassenen met diabetes mellitus type 2. (112 words, Aug 29, 2023)
- [İnme – Risk Faktörleri ve Semptomları | Boehringer Ingelheim TR](/content/tr/human-health/heart-diseases/stroke/inme-risk-faktorleri-ve-semptomlari/index.html): İnme, bir kişinin başına gelebilecek en yıkıcı acil sağlık sorunlarından biridir. İnmeler, iskemik ve hemorajik olmak üzere iki ana tipte gruplandırılabilir. (450 words, Aug 24, 2023)
- ["Atlarımızın sağlığını korumalıyız" | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/horses/atlarimizin-sagligini-korumaliyiz/index.html): Atlarda herpes virüs enfeksiyonu - Equine Herpes Virus - salgınları sıkça görülüyor. Avrupa'daki son büyük Equine Herpes Virus salgını 2021'de yaşandı. İspanya'nın Valencia şehrindeki engel atlama yarışlarında başladığı belirlenen salgın, Fransa, Belçika (696 words, Aug 23, 2023)
- [Topallık - Atlarda yaygın bir problem | Boehringer Ingelheim TR](/content/tr/topallik-atlarda-yaygin-bir-problem/index.html): Topallığın nedenleri, ne için inovasyon ve yeni tedavi seçeneklerinin açık bir ihtiyaç olduğu hakkında daha fazla bilgi edinin. (481 words, Aug 23, 2023)
- [112年8月22日起JARDIANCE®恩排糖® 膜衣錠10毫克 新增「慢性腎臟病」適應症，降低腎臟疾病惡化或心血管死亡，以及全因性住院風險 | Boehringer Ingelheim TW](/content/tw/human-health/chronic-kidney-disease/112nian8yue22riqijardianceenpaitang-moyiding10haoke-xinzengmanxingshenzangbing.html): 112年8月22日起JARDIANCE®恩排糖® 膜衣錠10毫克 新增「慢性腎臟病」適應症，降低腎臟疾病惡化或心血管死亡，以及全因性住院風險 (22 words, Aug 22, 2023)
- [Better healthcare access for vulnerable communities in New Zealand | Boehringer Ingelheim AU](/content/au/human-health/metabolic-diseases/diabetes/better-healthcare-access-vulnerable-communities-new-zealand.html): working with our partners in New Zealand to bring affordable diabetes medicine to people who need it most—and that includes indigenous Māori and Pacific Islander communities (570 words, Aug 22, 2023)
- [Boehringer Ingelheim's Professionals portal for Gulf](/content/pro/mea/kw/index.html): Home page (245 words, Aug 18, 2023)
- [Survodutide Phase III study weight loss | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/survodutide-phase-iii-study-weight-loss/index.html): Boehringer Ingelheim to advance survodutide into three global Phase III studies in obesity (642 words, Aug 16, 2023)
- [Familienunternehmen Boehringer Ingelheim: ein Arbeitgeber für Generationen | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/familienunternehmen-boehringer-ingelheim-ein-arbeitgeber-fuer-generationen.html): Was eine Familie überzeugt, seit knapp 60 Jahren bei Boehringer Ingelheim zu arbeiten (838 words, Aug 16, 2023)
- [Chancengleichheit in der Gesundheitsversorgung Australiens | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/chancengleichheit-der-gesundheitsversorgung-australiens.html): Wie unsere Unterstützung von Heart of Australia der medizinischen Versorgung von ländlichen Gemeinden zugute kommt (773 words, Aug 15, 2023)
- [Boehringer Ingelheim's Professionals portal for Saudi Arabia](/content/pro/mea/sa/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (339 words, Aug 11, 2023)
- [Informatie voor patiënten | Boehringer Ingelheim NL](/content/patient/nl/index-2.html): Voor patiënten heeft Boehringer Ingelheim over bepaalde indicatiegebieden zoals atriumfibrilleren, COPD, Longfibrose en GPP meer informatie beschikbaar. (104 words, Aug 10, 2023)
- [Awards & certifications | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/awards-certifications-bioxcellence/index.html): Explore our commitment to excellence in biopharmaceuticals showcased by several prestigious awards and certifications we’ve won and earned. (566 words, Aug 3, 2023)
- [豬場生物安全管理工具 | Boehringer Ingelheim TW](/content/tw/animal-health/livestock/zhuzhijiankangguanli/zhuchangshengwuanquanguanligongju/index.html): 豬場生物安全管理工具 (38 words, Aug 1, 2023)
- [Die Lebensphasen Ihres Hundes | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/haustiere/die-lebensphasen-ihres-hundes/index.html): Die Bedürfnisse von Hunden ändern sich mit zunehmendem Alter. Erfahren Sie, wie Sie sich in allen Lebensabschnitten um ihre Gesundheit kümmern können: vom Welpen bis zum erwachsenen und reifen Hund. (1,056 words, Jul 31, 2023)
- [Our Innovation Strategy | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/fostering-science/our-innovation-strategy/index.html): Our innovation strategy focuses on developing a deep understanding of disease, identifying relevant disease mechanisms and using adequate therapeutic modalities to address them (276 words, Jul 31, 2023)
- [Boehringer Ingelheim verzeichnet starkes Wachstum und Ausweitung in wichtigen Therapiebereichen | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/boehringer-ingelheim-verzeichnet-starkes-wachstum-und-ausweitung-wichtigen-therapiebereichen.html): Boehringer Ingelheim verzeichnet starkes Wachstum und Ausweitung in wichtigen Therapiebereichen (755 words, Jul 31, 2023)
- [手冊：百靈佳環狀病毒不活化疫苗保護力始終如一 | Boehringer Ingelheim TW](/content/tw/shoucebailingjiahuanzhuangbingdubuhuohuayimiaobaohulishizhongruyi.html): 手冊：百靈佳環狀病毒不活化疫苗保護力始終如一 (37 words, Jul 31, 2023)
- [Ingelvac CircoFLEX 具交叉保護力：實驗一、以PCV2d進行攻毒... | Boehringer Ingelheim TW](/content/tw/animal-health/swine/article-12/index.html): Ingelvac CircoFLEX 具交叉保護力：實驗一、以PCV2d進行攻毒... (33 words, Jul 31, 2023)
- [Ingelvac CircoFLEX 唯一核准可用於母豬全期：疫情爆發母豬群免一針後，固定四個月一刀切 | Boehringer Ingelheim TW](/content/tw/node/6471/index.html): Ingelvac CircoFLEX 唯一核准可用於母豬全期：疫情爆發母豬群免一針後，固定四個月一刀切 (42 words, Jul 31, 2023)
- [疫苗計畫趨勢 | Boehringer Ingelheim TW](/content/tw/animal-health/livestock/zhuzhijiankangguanli/yimiaojihuaqushi/index.html): 疫苗計畫趨勢 (47 words, Jul 31, 2023)
- [Nurse Connect Hub | Boehringer Ingelheim Portugal](/content/pro/pt/enfermagem/ild-nurse-connect/index.html): Explore this page to find educational and patient support material suggestions organized according to the patient journey (875 words, Jul 28, 2023)
- [Animal Health Partnering Contacts | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/animal-health-partnering-contacts/index.html): Partnership and diversity of thought are powerful drivers of innovation. If you have a project you would like to discuss please reach out to us. (568 words, Jul 28, 2023)
- [East of England Region | Interstitial Lung Disease | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/east-england-region/index.html): To develop and implement a shared care pathway for patients with interstitial lung disease within the East of England Region (701 words, Jul 27, 2023)
- [Розкриття інформації EFPIA | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/rozkrittya-informacii-efpia/index.html): Розкриття інформації EFPIA (361 words, Jul 27, 2023)
- [心臟病狗狗的治療須知 | Boehringer Ingelheim TW](/content/tw/xinzangbinggougoudezhiliaoxuzhi/index.html): 心臟病狗狗的治療須知 (25 words, Jul 26, 2023)
- [貓咪疫苗施打QA懶人包 | Boehringer Ingelheim TW](/content/tw/maomiyimiaoshidaqalanrenbao/index.html): 貓咪疫苗施打QA懶人包 (184 words, Jul 26, 2023)
- [貓咪疫苗施打停看聽，貓主人該知道的注意事項有哪些？ | Boehringer Ingelheim TW](/content/tw/maomiyimiaoshidatingkantingmaozhurengaizhidaodezhuyishixiangyounaxie.html): 貓咪疫苗施打停看聽，貓主人該知道的注意事項有哪些？ (103 words, Jul 26, 2023)
- [如何為貓咪安排疫苗計畫？ | Boehringer Ingelheim TW](/content/tw/ruheweimaomianpaiyimiaojihua/index.html): 如何為貓咪安排疫苗計畫？ (37 words, Jul 26, 2023)
- [貓咪要打哪種疫苗，我家貓咪適合哪一種呢? | Boehringer Ingelheim TW](/content/tw/animal-health/cat-vaccine-protection02/index.html): 貓咪要打哪種疫苗，我家貓咪適合哪一種呢? (38 words, Jul 26, 2023)
- [貓咪為甚麼要定期施打疫苗? | Boehringer Ingelheim TW](/content/tw/animal-health/cat-vaccine-protection01/index.html): 貓咪為甚麼要定期施打疫苗? (106 words, Jul 26, 2023)
- [【疾病檢測】腎貓徵兆 | Boehringer Ingelheim TW](/content/tw/jibingjiance-shenmaozhengzhao/index.html): 【疾病檢測】腎貓徵兆 (100 words, Jul 26, 2023)
- [安全衛生への取り組み | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-potential/health-and-safety-initiatives/index.html): 安全衛生への取り組み (19 words, Jul 26, 2023)
- [【疾病保健】腎貓飼料準備 | Boehringer Ingelheim TW](/content/tw/jibingbaojian-shenmaosiliaozhunbei/index.html): 【疾病保健】腎貓飼料準備 (63 words, Jul 26, 2023)
- [社員の力 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-potential/power-employee/index.html): 社員の力 (30 words, Jul 26, 2023)
- [More Health：概要 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-health/overview/index.html): More Health：概要 (39 words, Jul 26, 2023)
- [More Potential：概要 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-potential/overview/index.html): More Potential：概要 (48 words, Jul 26, 2023)
- [全球最大家族藥廠 百靈佳殷格翰 2023年線上校園徵才活動 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/quanqiuzuidajiazuyaochang-bailingjiayingehan-2023nianxianshangxiaoyuanzhengcaihuodong.html): 全球最大家族藥廠 百靈佳殷格翰 2023年線上校園徵才活動 (46 words, Jul 26, 2023)
- [EU-Zulassung chronische_Niereninsuffizienz | Boehringer Ingelheim DE](/content/de/humanmedizin/chronische-nierenkrankheit/eu-zulassung-chronischeniereninsuffizienz/index.html): EU-Zulassung chronische_Niereninsuffizienz (1,256 words, Jul 25, 2023)
- [New treatment for chronic kidney disease approved in the EU | Boehringer Ingelheim](/content/new-treatment-chronic-kidney-disease-approved-eu/index.html): The European Commission (EC) has approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (1,396 words, Jul 25, 2023)
- [薪酬與福利 | Boehringer Ingelheim TW](/content/tw/xinchouyufuli/index.html): 薪酬與福利 (20 words, Jul 25, 2023)
- [應屆畢業生 | Boehringer Ingelheim TW](/content/tw/yingjiebiyesheng/index.html): 應屆畢業生 (12 words, Jul 25, 2023)
- [在學生 | Boehringer Ingelheim TW](/content/tw/zaixuesheng/index.html): 在學生 (11 words, Jul 25, 2023)
- [Portál pro lékaře | Boehringer Ingelheim Czech Republic](/content/pro/cz/index-2.html): Tato webová stránka je určena pouze pro odborné pracovníky ve zdravotnictví. Informace zde nejsou určeny pro laickou veřejnost. (170 words, Jul 24, 2023)
- [Cardiovascular health | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/atrial-fibrillation/cardiovascular-health/index.html): Click to access Pradaxa® (dabigatran etexilate) and Praxbind® (idarucizumab) HCP resources. (12 words, Jul 21, 2023)
- [Dedifferentiated liposarcoma: Life with an ultra rare cancer | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/dedifferentiated-liposarcoma-life-ultra-rare-cancer.html): For Dan, being diagnosed with dedifferentiated liposarcoma (DDLPS), an ultra rare cancer, was life changing, and means that he now makes the most of every single day. (144 words, Jul 20, 2023)
- [FDA approval NexGard PLUS for dogs | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/fda-approval-nexgard-plus-dogs/index.html): Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS - A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites (1,205 words, Jul 20, 2023)
- [What everyone should know about heartworms | Boehringer Ingelheim](/content/animal-health/companion-animals-horses/pets/what-everyone-should-know-about-heartworms/index.html): Heartworms are dangerous parasites that can infest pets through mosquito bites, causing serious illness. Here are key facts we all should know about heartworms. (623 words, Jul 20, 2023)
- [ペットの寄生虫を取り巻く環境が世界的に変化 | Boehringer Ingelheim JP](/content/jp/dogcats-0003/index.html): 世界中どこでも、ペットの最大の敵はノミとマダニだと今でも思い続けていませんか？しかし、世界的な気温上昇などにより、鳥やげっ歯類（ネズミやリス等）の新しい宿主や、ナメクジや蚊といった新たなベクター（病気を媒介する昆虫など） を介して伝播する寄生虫による病気が、これまでにない地域にも発生するようになっています。 (24 words, Jul 13, 2023)
- [Boehringer Ingelheim UK public portal](/content/public/uk/index.html): The purpose of this website is to provide reference information on Boehringer Ingelheim medicines. It is not intended to replace the opinion. (197 words, Jul 6, 2023)
- [Sarcoma | Boehringer Ingelheim](/content/sarcoma/index.html): Hear from Gary Schwartz, MD, Director of the Case Comprehensive Cancer Center, Cleveland, Ohio, talk about his expert perspectives on sarcoma, the importance of early detection, and his hopes for the sarcoma treatment landscape. (102 words, Jul 5, 2023)
- [人と動物のウェルビーイングを目指して | Boehringer Ingelheim JP](/content/jp/animal-health/trends-insights/rentodongwunoueruhiinkuwomuzhishite/index.html): 人と動物のウェルビーイングを目指して (5 words, Jul 5, 2023)
- [What large scale economic analyses are saying about Enterisol™ Ileitis | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/what-large-scale-economic-analyses-are-saying-about-enterisol-ileitis.html): What large scale economic analyses are saying about Enterisol™ Ileitis (574 words, Jul 4, 2023)
- [How do you know if your cattle have parasites? | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/how-do-you-know-if-your-cattle-have-parasites/index.html): How do you know if your cattle have parasites? (832 words, Jul 4, 2023)
- [Effective management practices for parasite control in cattle | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/effective-management-practices-parasite-control-cattle.html): Effective management practices for parasite control in cattle (724 words, Jul 3, 2023)
- [Treatment options for parasite control in cattle | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/treatment-options-parasite-control-cattle/index.html): Treatment options for parasite control in cattle (979 words, Jul 3, 2023)
- [Strategies for overcoming resistance in parasites | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/bovine/strategies-overcoming-resistance-parasites/index.html): Strategies for overcoming resistance in parasites (985 words, Jul 3, 2023)
- [Reducing PCV2 Viremia in Neonatal Pigs Through Sow Mass Vaccination in an Unstable Herd | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/reducing-pcv2-viremia-neonatal-pigs-through-sow-mass-vaccination-unstable-herd.html): Reducing PCV2 Viremia in Neonatal Pigs Through Sow Mass Vaccination in an Unstable Herd (584 words, Jul 3, 2023)
- [A versatile solution for PCV2 and PRRS protection | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/versatile-solution-pcv2-and-prrs-protection/index.html): A versatile solution for PCV2 and PRRS protection (305 words, Jul 3, 2023)
- [Que révèlent les analyses économiques à grande échelle au sujet de EnterisolMC Ileitis | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/que-revelent-les-analyses-economiques-grande-echelle-au-sujet-de-enterisolmc-ileitis.html): Que révèlent les analyses économiques à grande échelle au sujet de EnterisolMC Ileitis (626 words, Jul 3, 2023)
- [Boehringer Ingelheim, primera farmacéutica en México en obtener certificación AWS por manejo responsable del agua | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/more-green-para-nuestro-planeta/boehringer-ingelheim-primera-farmaceutica-en-mexico-en-obtener-certificacion-aws.html): ● La certificación Alliance for Water Stewardship (AWS) evalúa la implementación de acciones para el uso sustentable del agua dentro de las instalaciones de la compañía y en la Cuenca del Valle de México. (577 words, Jun 30, 2023)
- [CÁMARA DE DIPUTADOS “ESTRATEGIA CAMALEÓN” CONTRA EL INFARTO CEREBRAL | Boehringer Ingelheim MX](/content/mx/camara-de-diputados-estrategia-camaleon-contra-el-infarto-cerebral.html): • Inauguran en la Cámara de Diputados la Campaña “Estrategia CAMALEÓN” para generar conciencia sobre la identificación de síntomas del Infarto Cerebral. (907 words, Jun 30, 2023)
- [Innoklusio - Modellprojekt für Inklusion | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/innoklusio-modellprojekt-fuer-inklusion/index.html): Boehringer Ingelheim engagiert sich in dem Modellprojekt Innoklusio. Am 03. Juli 2023 fand die Eröffnungsveranstaltung der Ausstellung zum Thema Inklusion statt. (733 words, Jun 30, 2023)
- [Réduction de la virémie associée au PCV2 chez les porcelets nouveau-nés par la vaccination de masse des truies dans les troupeaux instables | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/reduction-de-la-viremie-associee-au-pcv2-chez-les-porcelets-nouveau-nes-par-la-vaccination-de-masse.html): Réduction de la virémie associée au PCV2 chez les porcelets nouveau-nés par la vaccination de masse des truies dans les troupeaux instables (718 words, Jun 30, 2023)
- [Une solution polyvalente pour la protection contre le PCV2 et le SRRP | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/une-solution-polyvalente-pour-la-protection-contre-le-pcv2-et-le-srrp.html): Une solution polyvalente pour la protection contre le PCV2 et le SRRP (88 words, Jun 30, 2023)
- [Simple et directement à la source : conseils pour maîtriser l’iléite | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/simple-et-directement-la-source-conseils-pour-maitriser-lileite.html): Simple et directement à la source : conseils pour maîtriser l’iléite (567 words, Jun 30, 2023)
- [Le choix avisé pour la prévention de la mammite | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/le-choix-avise-pour-la-prevention-de-la-mammite/index.html): Le choix avisé pour la prévention de la mammite (184 words, Jun 30, 2023)
- [Même la nature n’est pas parfaite | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/meme-la-nature-nest-pas-parfaite/index.html): Même la nature n’est pas parfaite (283 words, Jun 30, 2023)
- [Living and Working in Times of War - Employees from Ukraine Report | Boehringer Ingelheim AT](/content/at/en/about-us/living-and-working-times-war-employees-ukraine-report.html): Living and Working in Times of War - Employees from Ukraine Report (635 words, Jun 29, 2023)
- [3 cosas que debes saber sobre las enfermedades zoonóticas | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/3-cosas-que-debes-saber-sobre-las-enfermedades-zoonoticas.html): Nota sobre enfermedades zoonóticas (620 words, Jun 28, 2023)
- [Microbial bioprocessing expertise | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/microbial-bioprocessing-expertise-bioxcellence/index.html): Explore Boehringer Ingelheim’s microbial manufacturing expertise, from high‑throughput development to reliable large‑scale supply. (481 words, Jun 26, 2023)
- [Monoclonal antibodies | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/monoclonal-antibodies-bioxcellence/index.html): Explore Boehringer Ingelheim’s advanced capabilities in antibody production & learn more about the unique features of monoclonal & polyclonal antibodies. (319 words, Jun 26, 2023)
- [Microbial cultivation | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/microbial-cultivation-bioxcellence/index.html): Discover how Boehringer Ingelheim’s Multifermenter system transforms early-stage microbial bioprocess development with automation. (313 words, Jun 26, 2023)
- [Cell culture plant Vienna | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/cell-culture-plant-vienna-bioxcellence/index.html): Our large-scale cell culture facility in Vienna, Austria, advances biologics development & biopharma production with cutting-edge cell culture techniques. (601 words, Jun 26, 2023)
- [Biopharma site China | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/biopharma-site-china-bioxcellence/index.html): Discover our biopharma contract manufacturing services in Shanghai, China. Focused on mammalian technologies, we’re ready to solve your unique challenges. (599 words, Jun 26, 2023)
- [Aseptic filling | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/aseptic-filling-bioxcellence/index.html): With 25+ years of experience in aseptic filling, Boehringer Ingelheim BioXcellence™ delivers tailored filling services for our partners’ unique needs. (313 words, Jun 26, 2023)
- [Our biotech story | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/our-biotech-story-bioxcellence/index.html): Explore Boehringer Ingelheim’s pioneering biotechnology history, creating value through innovation in biopharmaceutical development and manufacturing. (210 words, Jun 26, 2023)
- [Upstream & Downstream Processing | BioXcellence | Boehringer Ingelheim](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/upstream-downstream-processing-bioxcellence/index.html): Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms. (697 words, Jun 26, 2023)
- [Phase II trials for patients with bronchiectasis | Boehringer Ingelheim](/content/human-health/lung-diseases/phase-ii-trials-patients-bronchiectasis/index.html): Bronchiectasis is a chronically progressive pulmonary disease. Boehringer Ingelheim investigates a potential new treatment option in two Phase II trials. (603 words, Jun 23, 2023)
- [CHMP-Empfehlung chronische Niereninsuffizienz | Boehringer Ingelheim DE](/content/de/humanmedizin/chronische-nierenkrankheit/chmp-empfehlung-chronische-niereninsuffizienz/index.html): CHMP-Empfehlung chronische Niereninsuffizienz (1,171 words, Jun 23, 2023)
- [A day of giving back at Pegasus Therapeutic Riding | Boehringer Ingelheim US](/content/us/about-us/day-giving-back-pegasus-therapeutic-riding/index.html): Take a look at our volunteer day spent refreshing a farm committed to equine therapy. (391 words, Jun 22, 2023)
- [CHMP recommends new treatment for chronic kidney disease | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chmp-recommends-new-treatment-chronic-kidney-disease.html): The CHMP of EMA has granted a positive opinion recommending empagliflozin for the treatment of adults with chronic kidney disease (1,440 words, Jun 22, 2023)
- [Phase II clinical trial weight loss results | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/phase-ii-clinical-trial-weight-loss-results/index.html): Data shows nearly 19% weight loss in people with overweight or obesity in Phase II trial with survodutide (BI 456906) (1,291 words, Jun 22, 2023)
- [Dachgleichenfeier beim neuen Krebsforschungsgebäude | Boehringer Ingelheim AT](/content/at/de/presse/dachgleichenfeier-beim-neuen-krebsforschungsgebaeude.html): Boehringer Ingelheim feiert Dachgleiche beim neuen Krebsforschungsgebäude (413 words, Jun 22, 2023)
- [她，幫助受傷的退伍軍人重新開始 | Boehringer Ingelheim TW](/content/tw/tabangzhushoushangdetuiwujunrenzhongxinkaishi/index.html): 她，幫助受傷的退伍軍人重新開始 (54 words, Jun 22, 2023)
- [Health equity for underserved communities | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/health-equity-underserved-communities/index.html): Introducing initiatives that improve access to healthcare for underserved communities (804 words, Jun 21, 2023)
- [ベルツ賞に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/belz-prize2/index.html): ベルツ賞に関するお問い合わせ (13 words, Jun 19, 2023)
- [Interstitial lung disease in rheumatoid arthritis (RA-ILD) | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/interstitial-lung-disease-rheumatoid-arthritis-ra-ild.html): Interstitial lung disease (ILD) is the most common type of lung condition associated with the systemic autoimmune disease rheumatoid arthritis (RA). (371 words, Jun 15, 2023)
- [Dermatitis alérgica a la picadura de pulgas en perros y gatos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/dermatitis-alergica-la-picadura-de-pulgas-en-perros-y-gatos.html): Dermatitis alérgica a la picadura de pulgas en perros y gatos. (646 words, Jun 12, 2023)
- [Home | Boehringer Ingelheim](/content/pro/kr/index.html): Home (352 words, Jun 12, 2023)
- [Boehringer Ingelheim's Professionals portal for Malaysia | Boehringer Ingelheim Malaysia](/content/pro/my/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (430 words, Jun 12, 2023)
- [Boehringer Ingelheim's Professionals portal for Philippines | Boehringer Ingelheim](/content/pro/ph/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (220 words, Jun 12, 2023)
- [Boehringer Ingelheim's Professionals portal for Singapore](/content/pro/sg/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (507 words, Jun 12, 2023)
- [Boehringer Ingelheim's Professionals portal for Thailand |Boehringer Ingelheim](/content/pro/th/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (757 words, Jun 12, 2023)
- [Our Innovation Strategy | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/our-innovation-strategy/index.html): A deep understanding of disease, identifying relevant mechanisms and choosing therapeutic modalities to address them is the core of our innovation strategy (523 words, Jun 12, 2023)
- [Cardiovascular health | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/stroke/cardiovascular-health/index.html): Click to access Pradaxa® (dabigatran etexilate) and Praxbind® (idarucizumab) HCP resources. (20 words, Jun 9, 2023)
- [ACTH-Kampagne Equine 2022 | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/pferde/acth-kampagne-equine-2022/index.html): ACTH-Kampagne Equine 2022 (205 words, Jun 7, 2023)
- [Estudios clínicos: tipos y áreas | Boehringer Ingelheim ES](/content/es/ciencia-e-innovacion/innovacion-en-salud-humana/estudios-clinicos/index.html): Conoce los distintos tipos de estudios clínicos y cómo impulsan la investigación en diversas áreas terapéuticas para mejorar la salud de los pacientes. (569 words, May 29, 2023)
- [T-cell engagers: Reawakening T-cells to fight cancer | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-stories/t-cell-engagers-reawakening-t-cells-fight-cancer/index.html): Learn about our approach to immuno-oncology and our T-cell engagers plarform (794 words, May 26, 2023)
- [Casos Clínicos interativos | Boehringer Ingelheim](/content/pro/pt/casos-clinicos-interativos/index.html): Venha conhecer a perspetiva dos doentes nestes casos clínicos interativos. Saiba mais sobre DPI-ES, DPI-AR, PH e FPI e teste os seus conhecimentos. (14 words, May 25, 2023)
- [Menschen mit Lungenfibrose unterstützen | Boehringer Ingelheim AT](/content/at/de/humanmedizin/lungenerkrankungen/lungenfibrose/menschen-mit-lungenfibrose-unterstuetzen/index.html): Bei Boehringer Ingelheim engagieren wir uns für Menschen, die mit seltenen Krankheiten wie der Lungenfibrose leben. (414 words, May 17, 2023)
- [Cookie Policy | Boehringer Ingelheim UK HCP](/content/pro/uk/cookie-policy/index.html): Our websites use cookies to distinguish you from other users of our website. Click here to find out about what cookies are and how we use them. (1,755 words, May 16, 2023)
- [Dareon®-5 Trial | Boehringer Ingelheim](/content/pro/therapeutic-areas/oncology/dareon-5-trial/index.html): Explore Dareon®-5 trial which is a multi-center, open-label study for epNEC patients with DLL3 expressing tumours treated with T-cell engager, obrixtamig. (145 words, May 11, 2023)
- [Phase II trial results in people living with obesity or overweight | Boehringer Ingelheim](/content/phase-ii-trial-results-people-living-obesity-or-overweight.html): Phase II trial with BI 456906 met primary endpoint after 46 weeks of treatment, representing an important advancement of Boehringer Ingelheim’s cardio-renal-metabolic focus areas (840 words, May 9, 2023)
- [Welkom bij | Boehringer Ingelheim Netherlands](/content/pro/nl/index-2.html): Welkom bij Boehringer Ingelheim Nederland - Om u zo goed mogelijk van informatie te voorzien vragen wij u een keus te maken: (44 words, May 8, 2023)
- [Zorgverleners | Ofev® | nintedanib](/content/pro/nl/zorgverleners/ofev/index.html): Informatie over Ofev® (nintedanib) bij Long Fibrose, Interstitiële Longziekten (ILD). Informatie voor zorgverleners in Nederland. (449 words, Apr 25, 2023)
- [Zorgverleners | Boehringer Ingelheim](/content/pro/nl/zorgverleners/index.html): Lees hier meer informatie over producten en indicatie gebieden van Boehringer Ingelheim in Nederland. Informatie voor zorgverleners. (126 words, Apr 25, 2023)
- [Boehringer Ingelheim eröffnet Biotechnologie Entwicklungszentrum | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/boehringer-ingelheim-eroeffnet-biotechnologie-entwicklungszentrum.html): Boehringer Ingelheim eröffnet Biotechnologie Entwicklungszentrum (558 words, Apr 24, 2023)
- [Frauen in Führung | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/frauen-fuehrung/index.html): Erfahren Sie von Dr. Ulrike Gräfe-Mody mehr über Frauen in Führung bei Boehringer Ingelheim: Work-Life-Balance, Karriere und Familie sowie Vielfalt. (715 words, Apr 21, 2023)
- [Zoonotic diseases things you should know | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/zoonotic-diseases-things-you-should-know/index.html): Diseases that can be transmitted between animals and humans are more common than you may think – and they are on the rise. Find out how this affects you. (558 words, Apr 20, 2023)
- [Doença Pulmonar Intersticial | Boehringer Ingelheim](/content/pro/pt/doenca-pulmonar-intersticial/index.html): Explore aqui os diversos recursos e projetos que desenvolvemos a pensar em si - Casos Clínicos, ILD in Focus, 100 Perguntas em Evidência Clínica (14 words, Apr 13, 2023)
- [Cardio-Reno-Metabólica | Boehringer Ingelheim Portugal](/content/pro/pt/cardio-reno-metabolica/index.html): Cardio-Reno-Metabólica (54 words, Apr 13, 2023)
- [Sobre nós | Boehringer Ingelheim Portugal](/content/pro/pt/sobre-nos/index-2.html): A Boehringer Ingelheim é um grupo global de empresas que incorpora muitas culturas e diferentes sociedades. Saiba mais sobre os destaques financeiros. (88 words, Apr 12, 2023)
- [Mentions légales | Boehringer Ingelheim CA](/content/ca/fr/mentions-legales/index.html): Consultez les mentions légales de Boehringer Ingelheim et obtenez des informations sur nos pratiques et notre engagement envers la transparence. (650 words, Apr 7, 2023)
- [Contacto | Boehringer Ingelheim Portugal](/content/pro/pt/contacto/index.html): Para questões ou informações fora do âmbito clínico e relacionadas com os nossos produtos, por favor contactar medinfo.bip@boehringer-ingelheim.com (66 words, Apr 7, 2023)
- [Tirer parti de l’intelligence artificielle pour soutenir le vieillissement en santé | Boehringer Ingelheim CA](/content/ca/fr/propos-de-nous/qui-sommes-nous/tirer-parti-de-lintelligence-artificielle-pour-soutenir-le-vieillissement-en-sante.html): Profil de l’entreprise : Découvrez comment Boehringer Ingelheim utilise l’intelligence artificielle pour innover dans le domaine de la santé. (415 words, Apr 6, 2023)
- [Transformer la prise en charge complexe des patients atteints d'insuffisance cardiaque grâce | Boehringer Ingelheim CA](/content/ca/fr/transformer-la-prise-en-charge-complexe-des-patients-atteints-dinsuffisance-cardiaque-grace.html): Boehringer Ingelheim s’engage à fournir des solutions de pointe pour répondre aux besoins de santé complexes des patients. (1,308 words, Apr 4, 2023)
- [MORE GREEN: Reducing emissions throughout the supply chain | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/more-green-reducing-emissions-throughout-supply-chain.html): Reducing emissions throughout the supply chain requires engaging with hundreds of suppliers. (750 words, Apr 3, 2023)
- [Voorschrijfbevoegd | Gratis aanvragen | Ofev® | ILD](/content/pro/nl/voorschrijfbevoegd/ofev/aanvragen/index.html): Bestel hier uw interstitiële longziekten (ILD) praktijkmaterialen. Of downlaod hier uw ILD praktijkmaterialen. Maak een account aan of log in. (80 words, Mar 31, 2023)
- [Voorschrijfbevoegd | Downloads | Ofev® | ILD](/content/pro/nl/voorschrijfbevoegd/ofev/downloads/index.html): Download hier informatie over interstitiële longziekten (ILD). Of bestel hier uw praktijkmateriaal over ILD, Maak een account aan of log in. (237 words, Mar 31, 2023)
- [Voorschrijfbevoegd | Kennisbank | Ofev® | Literatuur](/content/pro/nl/voorschrijfbevoegd/ofev/kennisbank/index.html): Lees uitgebreide informatie over o.a de dosering, contra-indicaties, voorzorgen en eventuele bijwerkingen van Ofev® in de SPC. (33 words, Mar 30, 2023)
- [Voorschrijfbevoegd | ILD ziekteverloop](/content/pro/nl/voorschrijfbevoegd/ofev/ziekteverloop/index.html): Informatie over het ziekteverloop bij ILD. Informatie over longfibrose, interstitiële longziekten (ILD). Informatie voor zorgverleners. (684 words, Mar 29, 2023)
- [Voorschrijfbevoegd | ILD symptomen en diagnose](/content/pro/nl/voorschrijfbevoegd/ofev/symptomen-en-diagnose/index.html): Informatie over ILD symptomen en diagnose. Lees de uitgebreide informatie over o.a. de dosering en eventuele bijwerkingen van Ofev® in de SPC. (502 words, Mar 29, 2023)
- [Voorschrijfbevoegd | Ofev® | nintedanib](/content/pro/nl/voorschrijfbevoegd/ofev/index.html): Informatie voor zorgverleners met voorschrijfbevoegdheid over producten en indicatie gebieden van Boehringer Ingelheim in Nederland. (603 words, Mar 28, 2023)
- [Voorschrijfbevoegd | Boehringer Ingelheim](/content/pro/nl/voorschrijfbevoegd/index.html): Informatie voor zorgverleners met voorschrijfbevoegdheid over producten en indicatie gebieden van Boehringer Ingelheim in Nederland. (100 words, Mar 27, 2023)
- [Solidarity with Ukraine | Boehringer Ingelheim](/content/about-us/corporate-profile/solidarity-ukraine/index.html): Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations (59 words, Mar 27, 2023)
- [Health for all: How can we contribute to inclusive access? | Boehringer Ingelheim](/content/about-us/sustainable-development/health-all-how-can-we-contribute-inclusive-access/index.html): What drives us to improve the health of humans and animals worldwide (931 words, Mar 24, 2023)
- [Ответственное ведение бизнеса как основа взаимодействия с поставщиками | Boehringer Ingelheim RU](/content/ru/about-us/purchasing/otvetstvennoe-vedenie-biznesa-kak-osnova-vzaimodeystviya-s-postavshchikami.html): Компания «Берингер Ингельхайм» взаимодействует с широкой сетью международных и российских поставщиков для закупки товаров, упаковочных материалов, технических компонентов и необходимых услуг в целях обеспечения своей основной деятельности. (279 words, Mar 20, 2023)
- [Geschlechtervielfalt | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/geschlechtervielfalt/index.html): Boehringer Ingelheim setzt auf Geschlechtervielfalt: Mit unseren 10 Grundsätzen fördern wir Chancengleichheit, Mixed Leadership und Inklusion im Unternehmen. (769 words, Mar 17, 2023)
- [Patient Resources | Adalimumab-adbm and CYLTEZO® (adalimumab-adbm) injection](/content/patient/us/products/cyltezo/patient-resources/index.html): Discover our resource center where you can find administration information, resources and support about Adalimumab-adbm and CYLTEZO®. See safety Info, IFU, & Med Guide. (1,734 words, Mar 14, 2023)
- [Boehringer Ingelheim, primera farmacéutica en iniciar operaciones desde el aeropuerto Felipe Ángeles | Boehringer Ingelheim MX](/content/mx/prensa/boehringer-ingelheim-primera-farmaceutica-en-iniciar-operaciones-desde-el-aeropuerto-felipe-angeles.html): Boehringer Ingelheim, primera farmacéutica en iniciar operaciones desde el aeropuerto Felipe Ángeles (946 words, Mar 14, 2023)
- [Confronting health disparities in clinical trials | Boehringer Ingelheim US](/content/us/human-health/cancer/confronting-health-disparities-clinical-trials/index.html): As a research-driven pharmaceutical company, one of our priorities is to ensure there’s more representation from underserved communities, particularly for clinical cancer trials. (462 words, Mar 6, 2023)
- [Weltfrauentag: Weniger Hürden, mehr Gerechtigkeit | Boehringer Ingelheim DE](/content/de/weltfrauentag-weniger-huerden-mehr-gerechtigkeit/index.html): Weltfrauentag: Wie wir uns gemeinsam für mehr Chancen- und Geschlechtergerechtigkeit einsetzen und Frauen in und außerhalb unseres Unternehmens fördern. (1,217 words, Mar 6, 2023)
- [Llega a Colombia Enterisol® Salmonella T/C | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/llega-colombia-enterisol-salmonella-t-c/index.html): Llega a Colombia Enterisol® Salmonella T/C (402 words, Mar 6, 2023)
- [Kârlılık sadece bir sonuçsa | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/horses/karlilik-sadece-bir-sonucsa/index.html): Üreme teknolojilerinin ve hayvan refahının ineklerin daha fazla süt vermesini, daha iyi yaşamasını ve daha kısa buzağılama döngülerine sahip olmasını nasıl sağladığını öğrenin (830 words, Mar 2, 2023)
- [Topallık - Atlarda yaygın bir problem | Boehringer Ingelheim TR](/content/tr/animal-health/companion-animals-horses/horses/topallik-atlarda-yaygin-bir-problem/index.html): Topallığın nedenleri, ne için inovasyon ve yeni tedavi seçeneklerinin açık bir ihtiyaç olduğu hakkında daha fazla bilgi edinin. (465 words, Mar 2, 2023)
- [Adalimumab-adbm and CYLTEZO® (adalimumab-adbm) injection](/content/patient/us/products/cyltezo/index.html): Adalimumab-adbm and CYLTEZO® are both citrate-free biosimilars to Humira®. See FAQs on effectiveness, side effects, and how to take. See safety Info, IFU, & Med Guide. (2,698 words, Mar 2, 2023)
- [ライフサイエンス・リサーチサポート（奨学寄附） | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/grass-roots/lifescience-researchsupport/index.html): ライフサイエンス・リサーチサポート（奨学寄附） (9 words, Feb 24, 2023)
- [Talking drug discovery with our U.S. research site head, Carine Boustany | Boehringer Ingelheim US](/content/us/about-us/talking-drug-discovery-our-us-research-site-head-carine-boustany.html): Learn about the challenges and victories of developing new medicine for conditions, like generalized pustular psoriasis (GPP) flares in adults. (271 words, Feb 21, 2023)
- [Yhteistyö terveydenhuollon ammattilaisten kanssa | Boehringer Ingelheim FI](/content/fi/yhteistyo-terveydenhuollon-ammattilaisten-kanssa/index.html): Lääkeyritykset tekevät jatkuvasti yhteistyötä terveydenhuollon ammattilaisten, kuten lääkäreiden ja sairaanhoitajien kanssa. (370 words, Feb 20, 2023)
- [Agustina y Lady, una pareja única | Boehringer Ingelheim SA](/content/sa/salud-animal/historias-destacadas/agustina-y-lady-una-pareja-unica/index.html): En Argentina, nuestra colega Agustina Di Masi y su perra guía han estado trayendo alegría al equipo y enseñándoles una nueva forma de trabajar. Agustina nos cuenta su historia de cómo Lady, su fiel compañera, la ayuda todos los días a realizar sus labores (779 words, Feb 17, 2023)
- [Longa jornada do paciente com DPOC reflete em 50% sendo diagnosticado no estágio moderado da doença | Boehringer Ingelheim BR](/content/br/longa-jornada-do-paciente-com-dpoc-reflete-em-50-sendo-diagnosticado-no-estagio-moderado-da-doenca.html): Longa jornada do paciente com DPOC reflete em 50% sendo diagnosticado no estágio moderado da doença (885 words, Feb 16, 2023)
- [Aldeias indígenas em Avaí recebem mutirão gratuito de espirometria para realização de exames que detectam doenças pulmonares | Boehringer Ingelheim BR](/content/br/aldeias-indigenas-em-avai-recebem-mutirao-gratuito-de-espirometria-para-realizacao-de-exames-que.html): Aldeias indígenas em Avaí recebem mutirão gratuito de espirometria para realização de exames que detectam doenças pulmonares (1,078 words, Feb 16, 2023)
- [Raportarea EFPIA | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/raportarea-efpia/index.html): Dezvăluirea EFPIA (126 words, Feb 13, 2023)
- [Biosimilar to Humira® | Adalimumab-adbm and CYLTEZO® (adalimumab-adbm) injection](/content/pro/us/products/cyltezo/index.html): Adalimumab-adbm and CYLTEZO® are FDA-approved biosimilars to Humira® (adalimumab). See safety Info, IFU, & Med Guide including boxed warning. (1,289 words, Feb 8, 2023)
- [Corporate volunteering boosts social impact - A win for all. | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/corporate-volunteering-boosts-social-impact-win-all.html): Boehringer Ingelheim corporate volunteers help people with disabilities. Volunteering has social impact and benefits employees, employers, and communities. (1,026 words, Feb 7, 2023)
- [Boehringer Ingelheim's Professionals portal for United Arab Emirates | Boehringer Ingelheim](/content/pro/mea/ae/index.html): Learn more about Boehringer Ingelheim, a leading global pharmaceutical company that embraces many cultures and diverse societies around the world. (206 words, Feb 7, 2023)
- [Boehringer Ingelheim Sağlık Meslek Mensupları Platformu](/content/pro/tr/index.html): Boehringer Ingelheim Türkiye'nin hekim websitesine hoş geldiniz. Boehringer Ingelheim ürünleri, klinik çalışmalar ve daha fazlası için ziyaret edin. (180 words, Feb 7, 2023)
- [Corporate Volunteering – Mitarbeitende fördern Integration | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/corporate-volunteering-mitarbeitende-foerdern-integration.html): Mitarbeitende von Boehringer Ingelheim in Argentinien engagieren sich bei einem Making More Health Projekt für Menschen mit Behinderungen. (1,113 words, Feb 6, 2023)
- [Who we are | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/who-we-are/index.html): The Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia. (358 words, Feb 6, 2023)
- [Fact & Figures Boehringer Ingelheim RCV | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/fact-figures-boehringer-ingelheim-rcv/index.html): Facts and figures speak a clear language. Only economic success enables us to implement our corporate vision. (241 words, Feb 6, 2023)
- [Bosnia and Herzegovina | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/bosnia-and-herzegovina/index.html): Bosnia and Herzegovina (52 words, Feb 6, 2023)
- [Our Countries | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/our-countries/index.html): Our Countries (77 words, Feb 6, 2023)
- [Proč bereme péči o onkologické pacienty osobně | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/rakovina/proc-bereme-peci-o-onkologicke-pacienty-osobne/index.html): Zjistěte více o generačním závazku společnosti Boehringer Ingelheim k transformaci onkologické péče. (355 words, Feb 3, 2023)
- [Η διαφάνεια καλλιεργεί την εμπιστοσύνη | Boehringer Ingelheim GR](/content/gr/i-diafaneia-kalliergei-tin-empistosyni/index.html): Για την προώθηση της καινοτομίας στον τομέα της υγείας, συνεργαζόμαστε στενά με ιατρούς (298 words, Feb 1, 2023)
- [Életmenő ötlet abbahagyni | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/eletmeno-otlet-abbahagyni/index.html): Életmenő ötlet abbahagyni (571 words, Jan 31, 2023)
- [A munkavállalók mentális egészségére helyezett hangsúly az, ami kiemeli a Boehringer Ingelheim-et a 2023-as globális legjobb munkáltatók közül | Boehringer Ingelheim HU](/content/hu/rolunk/munkavallalok-mentalis-egeszsegere-helyezett-hangsuly-az-ami-kiemeli-boehringer-ingelheim-et-2023.html): A munkavállalók mentális egészségére helyezett hangsúly az, ami kiemeli a Boehringer Ingelheim-et a 2023-as globális legjobb munkáltatók közül (492 words, Jan 31, 2023)
- [Tüdőnk óvása is az egészségtudatos szemlélet része | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/copdasztma/tudonk-ovasa-az-egeszsegtudatos-szemlelet-resze/index.html): A tüdő óvása is az egészségtudatos szemlélet része kell, hogy legyen! (643 words, Jan 30, 2023)
- [A passion for research which addresses unmet medical needs | Boehringer Ingelheim](/content/about-us/who-we-are/culture/passion-research-which-addresses-unmet-medical-needs.html): Eric Haaksma, Head of Global Innovation Animal Health, explains why his professional purpose is rooted in helping drive advancements in scientific research (173 words, Jan 30, 2023)
- [全球最大家族藥廠百靈佳殷格翰 2022年線上校園徵才活動 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/quanqiuzuidajiazuyaochangbailingjiayingehan-2022nianxianshangxiaoyuanzhengcaihuodong.html): 全球最大家族藥廠百靈佳殷格翰 2022年線上校園徵才活動 (78 words, Jan 30, 2023)
- [Cukorbetegség és neuropátia | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/anyagcsere-betegsegek/diabetesz/cukorbetegseg-es-neuropatia/index.html): Cukorbetegség és neuropátia - Vegetatív idegrendszeri károsodások (568 words, Jan 26, 2023)
- [情報公開 | Boehringer Ingelheim JP](/content/jp/about-us/disclosure/index.html): 日本における情報公開の指針や規約について、ご紹介します。 (74 words, Jan 24, 2023)
- [Die Auswirkungen von Diabetes auf Nieren | Diabetesherz.at](/content/patient/at/diabetesherz/die-auswirkungen-von-diabetes-auf-die-nieren/index.html): Jeder zehnte Mensch mit Diabetes ist von Nierenschäden betroffen. Aber wie kommt es zu dieser Folgeerkrankung? Wir informieren über Diabetes und die Nieren. (295 words, Jan 24, 2023)
- [Nierengesundheit langfristig erhalten | Diabetesherz.at](/content/patient/at/diabetesherz/diabetes-so-erhalten-sie-ihre-nierengesundheit-langfristig.html): Diabetes erhöht das Risiko für Nierenerkrankungen wie Niereninsuffizienz. Wir informieren Sie, wie Sie Ihre Nierengesundheit langfristig erhalten können. (325 words, Jan 24, 2023)
- [(CTD -) ILD in Focus | Boehringer Ingelheim Portugal](/content/pro/pt/ild-in-focus/index.html): Analisámos à lupa as mais recentes publicações científicas na Doença Pulmonar Intersticial, para lhe trazer a informação que conta. (232 words, Jan 23, 2023)
- [FDA accepts new chronic kidney disease treatment application | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/fda-accepts-new-chronic-kidney-disease-treatment-application.html): FDA accepts new chronic kidney disease treatment application (1,524 words, Jan 20, 2023)
- [Salford CRM Joint Working Summary | Boehringer Ingelheim UK](/content/uk/partnering/working-together/partnering-interests/collaborative-working/salford-crm-joint-working-summary/index.html): Implementation of an integrated neighbourhood holistic diabetes service to address the complex needs of patients with cardio-renal-metabolic diseases in Salford (647 words, Jan 17, 2023)
- [報道関係者の方のお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/media/index.html): 報道関係者の方のお問い合わせ (15 words, Jan 17, 2023)
- [Global Top Employer 2023 | Boehringer Ingelheim](/content/about-us/who-we-are/global-top-employer-2023/index.html): Global Top Employer 2023 (603 words, Jan 13, 2023)
- [「永續經營 – 世代發展」計畫影片 | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/yongxujingying-shidaifazhan-jihuayingpian/index.html): 我們會一直「多做一點」！開發更好的醫療方案、實踐更高層次的健康，竭盡所能，成就更美好的世界。 (26 words, Jan 12, 2023)
- [永續發展影響領域（行動方案） | Boehringer Ingelheim TW](/content/tw/about-us/sustainable-development/yongxufazhanyingxianglingyuxingdongfangan/index.html): 百靈佳殷格翰的永續發展策略，隨著我們的雄心抱負正向發展中。我們有六個重點行動方案（關鍵影響領域），這些行動方案同時展現了我們身為國際企業的核心宗旨和優勢。 (47 words, Jan 12, 2023)
- [Enterisol® Ileitis – Ce que nous avons appris après 20 ans de lutte contre Lawsonia intracellularis | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/porcs/enterisol-ileitis-ce-que-nous-avons-appris-apres-20-ans-de-lutte-contre-lawsonia-intracellularis.html): Enterisol Ileitis, une solution pour la santé des animaux chez Boehringer Ingelheim. Protégeons leur bien-être intestinal. (2,517 words, Jan 11, 2023)
- [A career at the intersection of science and marketing | Boehringer Ingelheim](/content/about-us/who-we-are/culture/career-intersection-science-and-marketing/index.html): A member of the Animal Health digital marketing team, our colleague Missy talks about her purpose to bring transformative technologies to the vet community (72 words, Jan 6, 2023)
- [サイトのご利用について | Boehringer Ingelheim JP](/content/jp/terms-use/index.html): サイトのご利用について (96 words, Jan 4, 2023)
- [ベーリンガーインゲルハイムの軌跡（1948-1990年）：グローバル展開へ | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/history/1948-1990-going-global/index.html): 化学・製薬企業として、外国市場の重要性を認識していたのは、創業者の次男であるエルンスト・ベーリンガー氏（1896-1965年）でした。エルンスト氏は、兄のアルベルト・ベーリンガーJr.氏（1891-1960年）および義兄のユリウス・リーブレヒト氏（1891-1974年）と共に、父であり創業者のアルベルト・ベーリンガー氏が1939年に他界した後、家業を継ぎました。 (62 words, Dec 23, 2022)
- [ベーリンガーインゲルハイムの軌跡（1990-2023年）：Value through Innovation－イノベーションによる価値の創造－ | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/history/1990-2023-value-through-innovation/index.html): 新たな経営陣のもとで推進された一連の重要な変革が、今日のベーリンガーインゲルハイムを形成しました。 (71 words, Dec 22, 2022)
- [Boehringer Ingelheim Salud Animal lanza Semintra® en México, para tratar la Enfermedad Renal Crónica en felinos | Boehringer Ingelheim MX](/content/mx/salud-animal/salud-publica-veterinaria/boehringer-ingelheim-salud-animal-lanza-semintra-en-mexico-para-tratar-la-enfermedad-renal-cronica.html): Boehringer Ingelheim Salud Animal lanza Semintra® en México, para tratar la Enfermedad Renal Crónica en felinos (1,181 words, Dec 21, 2022)
- [Aviso de privacidad Salud Animal | Boehringer Ingelheim MX](/content/mx/salud-animal/aviso-de-privacidad-salud-animal/index.html): Aviso de privacidad Salud Animal (4,295 words, Dec 20, 2022)
- [Aviso de Privacidad Salud Humana | Boehringer Ingelheim MX](/content/mx/salud-humana/aviso-de-privacidad-salud-humana/index.html): Aviso de Privacidad Salud Humana (3,394 words, Dec 20, 2022)
- [Unsere Länder | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/unsere-laender/index.html): Gemeinsam verfolgen wir ein Ziel: Durchbrüche in der Behandlung von Krankheiten zu erreichen und die Entwicklung der Medizin voranzutreiben. (165 words, Dec 19, 2022)
- [Wer Wir sind | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/wer-wir-sind-0/index.html): Das Boehringer Ingelheim Regional Center Vienna (kurz RCV) trägt als Teil des deutschen Pharmaunternehmens Boehringer Ingelheim die Geschäftsverantwortung für über 30 Länder in Mittel- und Osteuropa sowie in Zentralasien. (396 words, Dec 19, 2022)
- [Daten & Fakten Boehringer Ingelheim RCV | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/daten-fakten-boehringer-ingelheim-rcv/index.html): Daten und Fakten sprechen eine deutliche Sprache. Erst der wirtschaftliche Erfolg ermöglicht uns die Umsetzung unserer Unternehmensvision. (314 words, Dec 19, 2022)
- [日本ベーリンガーインゲルハイム株式会社 | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/nippon-boehringer-ingelheim/index.html): 日本ベーリンガーインゲルハイム株式会社(Nippon Boehringer Ingelheim Co ., Ltd.) (91 words, Dec 19, 2022)
- [Office Hours | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/grass-roots/office-hours/index.html): Office Hours (21 words, Dec 19, 2022)
- [Boehringer Ingelheim Innovation Prize | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/grass-roots/boehringer-ingelheim-innovation-prize/index.html): Boehringer Ingelheim Innovation Prize (78 words, Dec 18, 2022)
- [その他イベント・セミナー | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/grass-roots/events/index.html): Grass Roots Innovation-others (35 words, Dec 17, 2022)
- [トップメッセージ | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/top-message/index.html): トップメッセージ (14 words, Dec 14, 2022)
- [DINAMO-ErgebnisseJugendlicheTyp-2-Diabetes | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/diabetes/dinamo-ergebnissejugendlichetyp-2-diabetes/index.html): DINAMO-ErgebnisseJugendlicheTyp-2-Diabetes (1,132 words, Dec 14, 2022)
- [Transparens | Boehringer Ingelheim SE](/content/se/om-oss/transparens/index.html): Uppförandekoden har kommit till mot bakgrund av de ökande förväntningarna från omvärlden att samspelet mellan företag och samhälle är transparent. (148 words, Dec 14, 2022)
- [Greater Glasgow Health Board executive summary | Boehringer Ingelheim UK](/content/uk/partnering/working-together/partnering-interests/collaborative-working/greater-glasgow-health-board-executive-summary/index.html): A Joint Working Project between Boehringer Ingelheim Ltd (BIL) and NHS Greater Glasgow and Clyde (NHSGGC) (312 words, Dec 8, 2022)
- [Podcast Dogtoři | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/spolecenska-zvirata/podcast-dogtori/index.html): Podcast určený nejen majitelům koní, koček a psů, ve kterém si veterinář Dan Sokolíček zve hosty z řad svých kolegů a otevírají spolu témata týkající se našich čtyřnohých parťáků. (8,105 words, Dec 7, 2022)
- [Expertise in Emergency and Exotic Animal Diseases | Boehringer Ingelheim AU](/content/au/animal-health/livestock/ruminants/expertise-emergency-and-exotic-animal-diseases/index.html): We are a global leader in Emergency and Exotic Animal Disease research and FMD vaccine development, antigen banks, and vaccine manufacturing. Learn more. (396 words, Dec 6, 2022)
- [Контакти | Boehringer Ingelheim BG](/content/bg/svrzhete-se-s-nas/index.html): Свържете се с нас (29 words, Nov 28, 2022)
- [Mintha víz alatt próbálnék levegőt venni | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/tudogyogyaszat/tudofibrozis/mintha-viz-alatt-probalnek-levegot-venni/index.html): „Mintha víz alatt próbálnék levegőt venni” (663 words, Nov 25, 2022)
- [Žádost o dar | Boehringer Ingelheim CZ](/content/cz/o-nas/zadost-o-dar/index.html): Poskytování finančních darů a grantů (370 words, Nov 25, 2022)
- [Protéger les communautés contre les maladies | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/proteger-les-communautes-contre-les-maladies/index.html): Protéger les communautés contre les maladies (34 words, Nov 25, 2022)
- [Tudta, hogy szívünknek saját agya van? | Boehringer Ingelheim HU](/content/hu/terapias-teruleteink/kardiologia/szelutes/tudta-hogy-szivunknek-sajat-agya-van/index.html): Tudta, hogy szívünknek saját agya van? (692 words, Nov 24, 2022)
- [Chutné Vianoce aj u diabetikov | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/chutne-vianoce-aj-u-diabetikov/index.html): Na Slovensku žije okolo 400-tisíc diabetikov, z nich viac ako 90% ... (355 words, Nov 24, 2022)
- [5 tipov na stravovanie pre diabetikov cez sviatky | Boehringer Ingelheim SK](/content/sk/human-health/metabolic-diseases/5-tipov-na-stravovanie-pre-diabetikov-cez-sviatky/index.html): Vianoce sú sviatky rodiny, osláv a jedla - veľa jedla. Pokušenia sú na každom rohu, všade kam sa pozriete cukrovinky, rodinné stretnutia a cestovanie narúšajú každodenné rutiny. (625 words, Nov 24, 2022)
- [Driving environmental solutions for people and planet | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/driving-environmental-solutions-people-and-planet/index.html): In 2022, Boehringer Ingelheim's MORE GREEN environmental sustainability initiative has reached new milestones driving our global decarbonization efforts (1,054 words, Nov 24, 2022)
- [Prohlášení o přístupnosti | Boehringer Ingelheim CZ](/content/cz/prohlaseni-o-pristupnosti/index.html): Prohlášení o přístupnosti (408 words, Nov 23, 2022)
- [Tiráž | Boehringer Ingelheim CZ](/content/cz/tiraz/index.html): Tiráž (36 words, Nov 23, 2022)
- [Zásady ochrany osobních údajů pro zdravotnické odborníky | Boehringer Ingelheim CZ](/content/cz/zasady-ochrany-osobnich-udaju-pro-zdravotnicke-odborniky.html): Zásady ochrany osobních údajů pro zdravotnické odborníky (1,195 words, Nov 23, 2022)
- [Zásady ochrany osobních údajů pro smluvní partnery | Boehringer Ingelheim CZ](/content/cz/zasady-ochrany-osobnich-udaju-pro-smluvni-partnery/index.html): Zásady ochrany osobních údajů pro smluvní partnery (2,049 words, Nov 23, 2022)
- [OOÚ Farmakovigilance humánních léčivých přípravků | Boehringer Ingelheim CZ](/content/cz/oou-farmakovigilance-humannich-lecivych-pripravku/index.html): Ochrana osobních údajů – farmakovigilance (1,296 words, Nov 23, 2022)
- [Oznámení o ochraně osobních údajů | Boehringer Ingelheim CZ](/content/cz/oznameni-o-ochrane-osobnich-udaju/index.html): Zásady ochrany soukromí (1,200 words, Nov 23, 2022)
- [Pro veřejnost | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/nase-odpovednost/bezpecnost-pacientu/pro-verejnost/index.html): informace o léčivých přípravcích společnosti Boehringer Ingelheim registrovaných v České republice. (211 words, Nov 23, 2022)
- [VPOIS | Boehringer Ingelheim CZ](/content/cz/vpois/index.html): Veřejně přístupná informační služba (VPOIS) o produktech (206 words, Nov 23, 2022)
- [Оповестяване съгласно Кодекса на EFPIA | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/opovestyavane-sglasno-kodeksa-na-efpia/index.html): Оповестяване от дружествата в групата на Boehringer Ingelheim в държави, в които функционират асоциации – членове на EFPIA (630 words, Nov 23, 2022)
- [How do our donations for Ukraine help? | Boehringer Ingelheim](/content/about-us/corporate-profile/how-do-our-donations-ukraine-help/index.html): The war in Ukraine continues to cause suffering and hardship. The Polish and the German Red Cross – also supported by donations from us – help to the best of their ability. (1,269 words, Nov 23, 2022)
- [Nuestro Compromiso | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestro-compromiso/index.html): Nuestro recorrido se trata de impulsar la innovación, crear valor en áreas de necesidad médica insatisfecha y comprometernos con las comunidades y la (624 words, Nov 22, 2022)
- [Login | Conectados | Conectados](/content/pro/sa/conectados-login/index.html): login (36 words, Nov 21, 2022)
- [BI X colleague about working with purpose | Boehringer Ingelheim](/content/about-us/who-we-are/culture/bi-x-colleague-about-working-purpose/index.html): Ding works on an app that gives patients remote access to stroke rehabilitation via their mobile phones and tablets (129 words, Nov 21, 2022)
- [Ujawnienie informacji wymaganych przez EFPIA | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/ujawnienie-informacji-wymaganych-przez-efpia/index.html): Przejrzystość jest podstawowym fundamentem zaufania w branży medycznej (428 words, Nov 21, 2022)
- [Conoce la historia de Mercedes y Nala, un vínculo | Boehringer Ingelheim SA](/content/sa/salud-animal/historias-destacadas/conoce-la-historia-de-mercedes-y-nala-un-vinculo/index.html): Conoce la historia de Mercedes y Nala, un vínculo (537 words, Nov 18, 2022)
- [Unsere Innovationsstrategie | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/unsere-innovationsstrategie/index.html): Lesen Sie weiter und erfahren Sie mehr über die Innovationsstrategie von Boehringer Ingelheim in der Forschung. (471 words, Nov 18, 2022)
- [Superar el COVID-19 en Ghana mediante las iniciativas Making More Health y Cowtribe | Boehringer Ingelheim ES](/content/es/superar-el-covid-19-en-ghana-mediante-las-iniciativas-making-more-health-y-cowtribe.html): Superar el COVID-19 en Ghana mediante las iniciativas Making More Health y Cowtribe (475 words, Nov 16, 2022)
- [L'asthme équin : reconnaître et prendre et prendre en charge les difficultés respiratoires chez les chevaux | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-de-compagnie-chevaux/chevaux/lasthme-equin-reconnaitre-et-prendre-et-prendre-en-charge-les-difficultes-respiratoires-chez-les.html): Santé animale : Découvrez nos solutions pour l’asthme chez Boehringer Ingelheim. Améliorez la santé respiratoire de vos animaux. (928 words, Nov 9, 2022)
- [Prise en charge de la douleur chez les veaux durant l’ébourgeonnage et l’écornage | Boehringer Ingelheim CA](/content/ca/fr/sante-animale/animaux-delevage/bovins/prise-en-charge-de-la-douleur-chez-les-veaux-durant-lebourgeonnage-et-lecornage.html): Boehringer Ingelheim est dédié à la prise en charge de la douleur chez les bovins, en fournissant des solutions pour améliorer leur bien-être. (688 words, Nov 9, 2022)
- [Our New Offices in Dublin | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/our-new-offices-dublin/index.html): Located in the heart of Dublin’s pharma hub, Boehringer Ingelheim's new offices offer a bright and spacious workplace, with improved eco-credentials. (196 words, Nov 9, 2022)
- [Shanghai | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/shanghai/index.html): Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing. (351 words, Nov 9, 2022)
- [Boehringer Ingelheim Kobe | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/boehringer-ingelheim-kobe/index.html): Las instalaciones de Kobe, Japón, (Kobe Pharma Research Institute) se centran en la búsqueda de innovaciones y nuevas tecnologías en Japón. (172 words, Nov 9, 2022)
- [Sant Cugat del Vallès (Barcelona) | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/sant-cugat-del-valles-barcelona/index.html): Sant Cugat del Vallès (Barcelona) (305 words, Nov 8, 2022)
- [Fornovo San Giovanni (Bidachem) | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/fornovo-san-giovanni-bidachem/index.html): Fornovo San Giovanni (Bidachem) (73 words, Nov 8, 2022)
- [Boehringer Ingelheim Biberach | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/boehringer-ingelheim-biberach/index.html): Las instalaciones de Biberach, Alemania, son el mayor centro de investigación y desarrollo de la red global de Boehringer Ingelheim. (378 words, Nov 8, 2022)
- [Yamagata | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/yamagata/index.html): Yamagata (280 words, Nov 8, 2022)
- [Dortmund | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/dortmund/index.html): The Boehringer Ingelheim microParts GmbH in Dortmund manufactures and advances the technology of the RESPIMAT® (284 words, Nov 8, 2022)
- [Ingelheim | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/donde-encontrarnos/ingelheim/index.html): The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. (298 words, Nov 8, 2022)
- [Soins Chronique | Boehringer Ingelheim Pro](/content/pro/be/fr/index.html): Découvrez Boehringer Ingelheim, partenaire des professionnels de santé belges, engagé dans l’accompagnement et la prise en charge des soins chroniques. (140 words, Nov 7, 2022)
- [Boehringer Ingelheim aporta valor en conjunto para la prevención de la peste porcina africana (PPA) | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/boehringer-ingelheim-aporta-valor-en-conjunto-para-la-prevencion-de-la-peste-porcina-africana-ppa.html): Boehringer Ingelheim aporta valor en conjunto para la prevención de la peste porcina africana (PPA) (235 words, Nov 7, 2022)
- [Full data chronic kidney disease trial efficacy | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/full-data-chronic-kidney-disease-trial-efficacy/index.html): Positive full data results announced from the EMPA-KIDNEY Phase III trial in adults with chronic kidney disease (1,369 words, Nov 4, 2022)
- [Koll på KOL – Skuld och skam | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-skuld-och-skam/index.html): Koll på KOL – Skuld och skam (47 words, Nov 3, 2022)
- [Koll på KOL – Behandlingsplanen | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-behandlingsplanen/index.html): Koll på KOL – Behandlingsplanen (66 words, Nov 3, 2022)
- [Koll på KOL - Försämringsperioder | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-forsamringsperioder/index.html): Koll på KOL - Försämringsperioder (36 words, Nov 3, 2022)
- [Koll på KOL - Inhalationsteknik | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-inhalationsteknik/index.html): Koll på KOL - Inhalationsteknik (65 words, Nov 3, 2022)
- [Koll på KOL - Andningsträning | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-andningstraning/index.html): Koll på KOL - Andningsträning (42 words, Nov 3, 2022)
- [Koll på kol – rörelse i vardagen | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-rorelse-i-vardagen/index.html): Koll på kol – rörelse i vardagen (62 words, Nov 3, 2022)
- [Clinical Trial Demonstrates Positive Top-Line Results Reducing Risk Cardiovascular | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/clinical-trial-demonstrates-positive-top-line-results-reducing-risk-cardiovascular.html): Clinical Trial Demonstrates Positive Top-Line Results in Reducing the Risk for Cardiovascular Death or Hospitalisation due to Heart Failure (656 words, Nov 3, 2022)
- [Koll på KOL - Planering i vardagen | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-planering-i-vardagen/index.html): Koll på KOL - Planering i vardagen (40 words, Nov 3, 2022)
- [Koll på KOL - Introduktion | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/koll-pa-kol-introduktion/index.html): Koll på KOL - Introduktion (25 words, Nov 3, 2022)
- [Boehringer Ingelheim commences local production of first batch of antihypertensive medicines | Boehringer Ingelheim MEA](/content/mea/human-health/heart-diseases/hypertension/boehringer-ingelheim-commences-local-production-first-batch-antihypertensive-medicines.html): Boehringer Ingelheim commences local production of first batch of antihypertensive medicines in Algeria (857 words, Nov 3, 2022)
- [En unik vänskap: vänner i nöd | Boehringer Ingelheim SE](/content/se/manniskors-halsa/lungsjukdomar/en-unik-vanskap-vanner-i-nod/index.html): En unik vänskap: vänner i nöd (80 words, Nov 2, 2022)
- [Professionals Site | Boehringer Ingelheim Portugal](/content/pro/pt/index.html): A Boehringer Ingelheim é uma empresa farmacêutica global, orientada para a investigação e desenvolvimento, que integra culturas e sociedades diversificadas (163 words, Nov 2, 2022)
- [opnMeに関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/opnme/index.html): opnMeに関するお問い合わせ (13 words, Nov 2, 2022)
- [オープンイノベーション（創薬研究アライアンスなど）に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/open-innovation/index.html): オープンイノベーション（創薬研究アライアンスなど）に関するお問い合わせ (13 words, Nov 2, 2022)
- [プライバシーポリシー | Boehringer Ingelheim JP](/content/jp/privacy-policy/index.html): プライバシーポリシー (108 words, Nov 2, 2022)
- [ヒト用医療用医薬品の情報、適正使用・ 販売情報提供活動に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/human-health/index.html): ヒト用医療用医薬品の情報、適正使用・ 販売情報提供活動に関するお問い合わせ (19 words, Nov 2, 2022)
- [治験に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/clinical-trials/index.html): 治験に関するお問い合わせ (11 words, Nov 2, 2022)
- [採用情報に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/careers/index.html): 採用情報に関するお問い合わせ (14 words, Nov 2, 2022)
- [バイオ医薬品受託製造に関するお問い合わせ | Boehringer Ingelheim JP](/content/jp/contact-us/biopharma/index.html): バイオ医薬品受託製造に関するお問い合わせ (6 words, Nov 2, 2022)
- [PRRS-Forschungspreis 2022 | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/schweine/prrs-forschungspreis-2022/index.html): Boehringer Ingelheim honoriert europaweit Wissenschaftler*innen für die Entwicklung von bahnbrechenden Methoden zur PRRS-Kontrolle. Das Unternehmen finanziert den PRRS-Preis zum neunten Mal mit insgesamt 75.000 EUR für Forschungsprojekte (67 words, Nov 2, 2022)
- [Condizioni Generali di Acquisto | Boehringer Ingelheim IT](/content/it/su-di-noi/il-purchasing/condizioni-generali-di-acquisto/index.html): Condizioni Generali di Acquisto (7 words, Oct 28, 2022)
- [Partner in chronische zorg | Boehringer Ingelheim Pro](/content/pro/be/index.html): Boehringer Ingelheim ondersteunt Belgische zorgverleners met informatie en oplossingen voor de optimale behandeling en begeleiding van chronische zorg. (118 words, Oct 28, 2022)
- [Professionals Site | Boehringer Ingelheim Sweden](/content/pro/se/index.html): Professionals Site - BI Sweden För dig som är hälso och sjukvårdspersonal. Här kan du anmäla dig till våra föreläsningar eller beställa material. (278 words, Oct 27, 2022)
- [Fremont | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/fremont/index.html): Fremont (250 words, Oct 26, 2022)
- [Solarpark in Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/solarpark-ingelheim/index.html): Spatenstich für 1,73 Millionen Euro-Investition in Ingelheim. Die Energieeinsparung durch die Photovoltaik-Anlage beläuft sich auf 72 Tonnen CO2 pro Jahr. (669 words, Oct 26, 2022)
- [International Postdocs realize their potential in Biberach | Boehringer Ingelheim](/content/about-us/who-we-are/international-postdocs-realize-their-potential-biberach.html): Three talented postdocs report on what they are working at Boehringer Ingelheim's research site in Biberach and what attracts them to the company. (95 words, Oct 26, 2022)
- [NHS England Cardiac Network leadership | Boehringer Ingelheim UK](/content/uk/partnering/human-health-partnering/partnering-interests/collaborative-working/nhs-england-improvement-cardiac/index.html): Read about the implementation of a Leadership Development Programme for Cardiac Network Leaders with NHSE&I to support cardiovascular disease transformation (444 words, Oct 26, 2022)
- [La leche de calidad es clave para nosotros | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/la-leche-de-calidad-es-clave-para-nosotros/index.html): La leche de calidad es clave para nosotros (291 words, Oct 21, 2022)
- [La influencia de la interacción hombre-animal en el bienestar de los animales | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/rumiantes/la-influencia-de-la-interaccion-hombre-animal-en-el-bienestar-de-los-animales.html): La influencia de la interacción hombre-animal en el bienestar de los animales (939 words, Oct 21, 2022)
- [Codice di Condotta dei fornitori | Boehringer Ingelheim IT](/content/it/su-di-noi/il-purchasing/codice-di-condotta-dei-fornitori-0/index.html): Codice di Condotta dei fornitori (11 words, Oct 19, 2022)
- [Careers: Winning with people | Boehringer Ingelheim](/content/about-us/who-we-are/careers-winning-people/index.html): Our employees are the foundation of our innovative strength. We continue to put people first in everything we do and support our employees in the key moments of their careers. (1,038 words, Oct 19, 2022)
- [日本の開発パイプライン | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/pipeline/index.html): パイプラインリスト・製品と新規医薬候補成分 (143 words, Oct 18, 2022)
- [Φαρμακοεπαγρύπνηση | Boehringer Ingelheim GR](/content/gr/about-us/farmakoepagrypnisi/index.html): Φαρμακοεπαγρύπνηση (222 words, Oct 18, 2022)
- [Ιατρικές Πληροφορίες | Boehringer Ingelheim GR](/content/gr/iatrikes-plirofories/index.html): Ιατρικές Πληροφορίες (56 words, Oct 18, 2022)
- [El futuro del trabajo de Boehringer Ingelheim México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/el-futuro-del-trabajo-de-boehringer-ingelheim-mexico.html): El futuro del trabajo de Boehringer Ingelheim México (1,044 words, Oct 14, 2022)
- [¡Mascotas también pueden enfermar por mosquitos de temporada! | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/mascotas-tambien-pueden-enfermar-por-mosquitos-de-temporada.html): ¡Mascotas también pueden enfermar por mosquitos de temporada! (581 words, Oct 13, 2022)
- [¡Cuida tu salud y la de tu mascota en estas Fiestas Patrias! | Boehringer Ingelheim MX](/content/mx/salud-animal/cuida-tu-salud-y-la-de-tu-mascota-en-estas-fiestas-patrias.html): ¡Cuida tu salud y la de tu mascota en estas Fiestas Patrias! (468 words, Oct 12, 2022)
- [More Green Overview | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-green/more-green-overview/index.html): Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. (512 words, Oct 12, 2022)
- [Nuestro Enfoque | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestro-enfoque/index.html): Nuestro Enfoque (364 words, Oct 12, 2022)
- [Nuestros amigos de cuatro patas nos ayudan a relajarnos y ejercitarnos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/nuestros-amigos-de-cuatro-patas-nos-ayudan-relajarnos-y-ejercitarnos.html): Nuestros amigos de cuatro patas nos ayudan a relajarnos y ejercitarnos (813 words, Oct 12, 2022)
- [Our Global Code of Conduct | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/our-global-code-conduct/index.html): Our Code of Conduct demonstrates for each and every one that integrity is “part of our DNA”. Click here to learn more about Our Code of Conduct. (337 words, Oct 11, 2022)
- [20 de Febrero: Día del Gato | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/20-de-febrero-dia-del-gato/index.html): 20 de Febrero: Día del Gato (428 words, Oct 11, 2022)
- [Boehringer Ingelheim desarrolla junto con Henke- Sass, Wolf un innovador dispositivo de inyección sin aguja para cerdos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/boehringer-ingelheim-desarrolla-junto-con-henke-sass-wolf-un-innovador-dispositivo-de-inyeccion-sin.html): Boehringer Ingelheim desarrolla junto con Henke- Sass, Wolf un innovador dispositivo de inyección sin aguja para cerdos (856 words, Oct 11, 2022)
- [Nuestra historia | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/historia/nuestra-historia/index.html): Nuestra historia (18 words, Oct 11, 2022)
- [Nuestra cultura de asociación | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestra-cultura-de-asociacion/index.html): Nuestra cultura de asociación (382 words, Oct 11, 2022)
- [Video de nuestra historia | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/historia/video-de-nuestra-historia/index.html): Video de nuestra historia (65 words, Oct 11, 2022)
- [Vacaciones pet-friendly | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/vacaciones-pet-friendly/index.html): Vacaciones pet-friendly (331 words, Oct 11, 2022)
- [Juntos en la lucha contra la rabia | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/juntos-en-la-lucha-contra-la-rabia/index.html): Juntos en la lucha contra la rabia (59 words, Oct 11, 2022)
- [Diarrea Viral Bovina (DVB), el enemigo oculto | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/rumiantes/diarrea-viral-bovina-dvb-el-enemigo-oculto/index.html): Diarrea Viral Bovina (DVB), el enemigo oculto (606 words, Oct 11, 2022)
- [Nuestro compromiso Global con el control de PRRS | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/nuestro-compromiso-global-con-el-control-de-prrs/index.html): Nuestro compromiso Global con el control de PRRS (587 words, Oct 10, 2022)
- [La parvovirosis canina, una enfermedad que aún nos preocupa | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/la-parvovirosis-canina-una-enfermedad-que-aun-nos-preocupa.html): La parvovirosis canina, una enfermedad que aún nos preocupa (861 words, Oct 10, 2022)
- [Prevención de la leucemia felina | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/prevencion-de-la-leucemia-felina/index.html): Prevención de la leucemia felina (513 words, Oct 10, 2022)
- [Leptospirosis, una de las zoonosis más prevalentes | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/leptospirosis-una-de-las-zoonosis-mas-prevalentes/index.html): Leptospirosis, una de las zoonosis más prevalentes (772 words, Oct 10, 2022)
- [Con PREVEXXION® RN el futuro es ahora | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/aves/con-prevexxion-rn-el-futuro-es-ahora/index.html): Con PREVEXXION® RN el futuro es ahora (507 words, Oct 10, 2022)
- [FreVAX™ - Innovador dispositivo de inyección sin aguja para cerdos | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/porcinos/frevax-innovador-dispositivo-de-inyeccion-sin-aguja-para-cerdos.html): FreVAX™ - Innovador dispositivo de inyección sin aguja para cerdos (226 words, Oct 10, 2022)
- [Seguridad alimentaria | Boehringer Ingelheim SA](/content/sa/salud-animal/historias-destacadas/seguridad-alimentaria/index.html): Seguridad alimentaria (804 words, Oct 10, 2022)
- [Notre expertise | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/notre-expertise/index.html): Notre expertise (153 words, Oct 10, 2022)
- [Una mirada innovadora al moquillo canino | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/una-mirada-innovadora-al-moquillo-canino/index.html): Una mirada innovadora al moquillo canino (771 words, Oct 10, 2022)
- [¿Enfermedad de Marek? No en nuestras granjas | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-produccion/enfermedad-de-marek-no-en-nuestras-granjas/index.html): ¿Enfermedad de Marek? No en nuestras granjas (798 words, Oct 10, 2022)
- [Comprendiendo el lenguaje de los perros | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/comprendiendo-el-lenguaje-de-los-perros/index.html): Comprendiendo el lenguaje de los perros (414 words, Oct 10, 2022)
- [Cómo ayudaron las mascotas a que el confinamiento sea más llevadero | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/como-ayudaron-las-mascotas-que-el-confinamiento-sea-mas-llevadero.html): Cómo ayudaron las mascotas a que el confinamiento sea más llevadero (418 words, Oct 10, 2022)
- [Notre responsabilité | Boehringer Ingelheim FR](/content/fr/sante-animale/sante-publique-veterinaire/notre-responsabilite/index.html): Notre responsabilité (544 words, Oct 10, 2022)
- [Un vínculo único: una hermandad sin igual | Boehringer Ingelheim SA](/content/sa/salud-humana/enfermedades-metabolicas/diabetes/un-vinculo-unico-una-hermandad-sin-igual/index.html): Un vínculo único: una hermandad sin igual (143 words, Oct 10, 2022)
- [10 cosas que debes saber sobre la rabia | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/10-cosas-que-debes-saber-sobre-la-rabia/index.html): 10 cosas que debes saber sobre la rabia (1,453 words, Oct 7, 2022)
- [Un vínculo único: salud humana y salud animal | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/quienes-somos/cultura/un-vinculo-unico-salud-humana-y-salud-animal/index.html): Un vínculo único: salud humana y salud animal (191 words, Oct 7, 2022)
- [La relación entre la persona y el perro: perspectiva histórica | Boehringer Ingelheim SA](/content/sa/salud-animal/animales-de-compania/animales-de-compania/la-relacion-entre-la-persona-y-el-perro-perspectiva-historica.html): La relación entre la persona y el perro: perspectiva histórica (981 words, Oct 7, 2022)
- [리하르트 분쉬 박사 | Boehringer Ingelheim KR](/content/kr/about-us/sustainable-development/hangugbunswiuihagsang/lihaleuteu-bunswi-bagsa/index.html): 리하르트 분쉬 박사는 1901년부터 4년간 고종의 시의로 일하면서 당시 세계 의술의 선도적 위치에 있던 독일의학을 한국에 전파했던 한국 최초의 독일인 의사입니다. (320 words, Oct 4, 2022)
- [새로운 레스피맷 교체 방법 | Boehringer Ingelheim KR](/content/kr/human-health/products/vahelvarespimat-replacement-guide/index.html): 새로운 레스피맷 교체 방법 (88 words, Oct 3, 2022)
- [새로운 레스피맷 사용 준비 및 사용 방법 | Boehringer Ingelheim KR](/content/kr/human-health/products/vahelvarespimat-usage-guide/index.html): 새로운 레스피맷 사용 방법 (52 words, Oct 3, 2022)
- [Un vínculo único: él me eligió a mí | Boehringer Ingelheim SA](/content/sa/salud-humana/cancer/capacitando-los-pacientes/un-vinculo-unico-el-me-eligio-mi/index.html): Un vínculo único: él me eligió a mí (135 words, Sep 30, 2022)
- [Boehringer Ingelheim aumenta sus compromisos con el desarrollo sostenible | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-aumenta-sus-compromisos-con-el-desarrollo-sostenible.html): Boehringer Ingelheim aumenta sus compromisos con el desarrollo sostenible (1,217 words, Sep 30, 2022)
- [İPF Nedir? | Boehringer Ingelheim TR](/content/tr/ipf-nedir/index.html): İPF Nedir? (340 words, Sep 29, 2022)
- [Making More Health (MMH) | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/making-more-health-mmh/index.html): Making More Health (MMH) (264 words, Sep 28, 2022)
- [News | Boehringer Ingelheim UK](/content/uk/media/index.html): Click here to find out the latest news from Boehringer Ingelheim UK. We provide links to our news updates on this page to keep you informed. (123 words, Sep 27, 2022)
- [대표이사 인사말 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaimdongmulyagpum-sogae/daepyoisa-insamal/index.html): 안녕하십니까. 한국베링거인겔하임동물약품(주) 대표이사 서승원입니다. (160 words, Sep 27, 2022)
- [분쉬갤러리 | Boehringer Ingelheim KR](/content/kr/about-us/sustainable-development/hangugbunswiuihagsang/bunswigaelleoli/index.html): 분쉬의학상 20주년 기념 인물사진집 - 김중만이 만난, 한국을 빛낸 20인의 의사들 갤러리와 고종의 주치의인 분쉬 박사가 찍은 구한말의 사진을 만나실 수 있습니다. (123 words, Sep 27, 2022)
- [技術分野の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/biotherapeutics-tech/index.html): 技術分野の提携 (38 words, Sep 26, 2022)
- [眼科分野の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/retinal-diseases/index.html): 眼科分野の提携 (16 words, Sep 26, 2022)
- [がん治療およびがん免疫療法の提携領域 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/oncology/index.html): がん治療およびがん免疫療法の提携領域 (18 words, Sep 26, 2022)
- [免疫・呼吸器疾患の分野の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/immunological-diseases/index.html): 免疫・呼吸器疾患の分野の提携 (29 words, Sep 26, 2022)
- [The Core of our Leitbild | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/company-culture/core-our-leitbild/index.html): The Core of our Leitbild - Who we are and what we strive for (116 words, Sep 26, 2022)
- [神戸医薬研究所 | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/science-focus/research-institute/index.html): 神戸医薬研究所 (14 words, Sep 26, 2022)
- [역대 수상자 | Boehringer Ingelheim KR](/content/kr/about-us/sustainable-development/hangugbunswiuihagsang/yeogdae-susangja/index.html): 한국베링거인겔하임과 대한의학회는 엄격한 심사기준에 의해 매년 연구업적이 뛰어난 의학인 1인을 선정하여 상금, 상패 및 메달을 수여하고 있습니다. (767 words, Sep 26, 2022)
- [opnMe - Boehringer Ingelheim’s open innovation portal - | Boehringer Ingelheim JP](/content/jp/science-innovation/human-health-innovation/fostering-science/opnme-boehringer-ingelheims-open-innovation-portal/index.html): opnMe - Boehringer Ingelheim’s open innovation portal - (25 words, Sep 26, 2022)
- [心血管・腎・代謝疾患の分野の提携 | Boehringer Ingelheim JP](/content/jp/partnering/human-health-partnering/partnering-interests/cardiovascular-and-metabolic-diseases/index.html): 心血管・腎・代謝疾患の分野の提携 (35 words, Sep 26, 2022)
- [분쉬의학상 소개 | Boehringer Ingelheim KR](/content/kr/about-us/sustainable-development/hangugbunswiuihagsang/bunswiuihagsang-sogae/index.html): 한국베링거인겔하임은 한국 의학계의 학술 발전을 도모하고 의학 분야에서 한국과 독일 양국의 친선을 증진시키기 위해 1990년 4월 대한의학회와 공동으로 "분쉬의학상"을 제정해 시상하고 있습니다. (261 words, Sep 26, 2022)
- [Ako zvládať chronickú obštrukčnú chorobu pľúc | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/copd-asthma/ako-zvladat-chronicku-obstrukcnu-chorobu-pluc/index.html): Chronická obštrukčná choroba pľúc (CHOCHP) je závažné chronické ochorenie, ktoré celosvetovo postihuje viac ako 210 miliónov ľudí. V počiatočných štádiách má CHOCHP pomerne nenápadný priebeh a býva často diagnostikovaná až vo vážnejšom štádiu. Prinášame p (439 words, Sep 23, 2022)
- [Ako lieky ovplyvňujú životné prostredie | Boehringer Ingelheim SK](/content/sk/human-health/lung-diseases/copd-asthma/ako-lieky-ovplyvnuju-zivotne-prostredie/index.html): Lieky užívané ľuďmi a zvieratami sa častokrát dostávajú do riek, jazier, dokonca aj do pitnej vody čo môže mať za následok zničujúci účinok na životné prostredie. (560 words, Sep 23, 2022)
- [PRRS Research Award 2022 | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/prrs-research-award-2022/index.html): Bridging science and veterinary practice for swine health: The winners of the European PRRS Award 2022 (698 words, Sep 22, 2022)
- [Čo je fibrilácia predsiení? | Boehringer Ingelheim SK](/content/sk/human-health/heart-diseases/atrial-fibrillation/co-je-fibrilacia-predsieni/index.html): Fibrilácia predsiení je jednou z najčastejších srdcových arytmií. Na Slovensku ňou trpí vyše 120 000 ľudí, v Európe je to viac ako 11 miliónov ľudí. Počas predsieňovej fibrilácie predsiene bijú nepravidlene, často rýchlejšie a neúčinne, čo znamená, že krv (406 words, Sep 21, 2022)
- [Vášeň pre kone | Boehringer Ingelheim SK](/content/sk/animal-health/companion-animals-horses/horses/vasen-pre-kone/index.html): Mnohí ľudia sú šťastní, keď môžu ísť von na koni a užiť si tak spoločný príjemný čas. Preto je pre nich nanajvýš dôležité, aby boli ich vzácni spoločníci zdraví. Často sú podporovaní aj veterinárinármi, aby sa aktívne zapájali do preventívnych programov z (156 words, Sep 21, 2022)
- [Pet Product Information | Boehringer Ingelheim UK](/content/uk/animal-health/companion-animals/pets/pet-product-information/index.html): Click here for a list of pets product information for both animal health professionals and pet owners to help maintain the best of care for your companion pets. (503 words, Sep 21, 2022)
- [A lifetime for patients with mental health conditions | Boehringer Ingelheim](/content/about-us/sustainable-development/lifetime-patients-mental-health-conditions/index.html): Chris Underhill is a social entrepreneur and participant at the Making More Health Convention. (1,158 words, Sep 19, 2022)
- [Cheshire & Merseyside H&CP | Boehringer Ingelheim UK](/content/uk/collaborative-working/collaborative-working-executive-summary/cheshire-merseyside-hcp/index.html): Learn about the creation of an Experience Journey Map to deliver integration and efficiency within heart failure service provision. (510 words, Sep 16, 2022)
- [Guys - St Thomas | Optimisation of patients at risk of CRM | Boehringer Ingelheim UK](/content/uk/joint-working/joint-working-executive-summary/guy-s-st-thomas-optimisation-patients-risk-crm/index.html): Implementation of a new model of care to identify & optimise the management of patients at high risk of developing cardiovascular-renal & metabolic diseases. (801 words, Sep 16, 2022)
- [Greater Manchester | Utilisation of data science | Boehringer Ingelheim UK](/content/uk/partnering/working-together/partnering-interests/collaborative-working/greater-manchester-utilisation-data-science/index.html): Utilisation of data science to identify the system impact of COVID-19 on the cardiometabolic pathway and identifying opportunities for transformation. (296 words, Sep 16, 2022)
- [Career tips from our Global Head of HR | Boehringer Ingelheim](/content/about-us/who-we-are/career-tips-our-global-head-hr/index.html): Sven Sommerlatte explains how important it is to reflect on the personal career strategy. (800 words, Sep 14, 2022)
- [General Information Request | Boehringer Ingelheim](/content/pro/us/bi-druginforequest/general-information-request/index.html): Use this general information request form to make general inquiries and to contact us at Boehringer Ingelheim today. (661 words, Sep 14, 2022)
- [Product Availability Inquiry Form | Boehringer Ingelheim](/content/pro/us/bi-druginforequest/product-availability/index.html): Complete the product availability inquiry form for detailed information on the availability of any Boehringer product. (676 words, Sep 14, 2022)
- [Product Technical Information Request | Boehringer Ingelheim](/content/pro/us/bi-druginforequest/product-technical-information-request/index.html): Fill out the Product Technical Information Request form to make a product complaint or to request technical information about a Boehringer Ingelheim product. (659 words, Sep 14, 2022)
- [Medical Information Request | Boehringer Ingelheim](/content/pro/us/bi-druginforequest/medical-information-request/index.html): If you need medical information about any Boehringer Ingelheim product, please fill out the medical information request form found here. (838 words, Sep 14, 2022)
- [Día Mundial del Reciclaje | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-green/dia-mundial-del-reciclaje/index.html): BI se ha comprometido a reducir su huella ambiental en toda la cadena de valor para 2030. Sigue leyendo para saber más. (960 words, Sep 13, 2022)
- [Boehringer Ingelheim impulsa el ciclo de foros “Diálogos con Europa” para dar voz a las grandes cuestiones europeas en salud | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/boehringer-ingelheim-impulsa-el-ciclo-de-foros-dialogos-con-europa-para-dar-voz-las-grandes.html): Boehringer Ingelheim impulsa el ciclo de foros ¨Diálogos con Europa" para dar voz a las grandes cuestiones europeas en salud. (1,371 words, Sep 13, 2022)
- [Boehringer Ingelheim celebra 70 años en España aportando valor a través de la innovación | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/boehringer-ingelheim-celebra-70-anos-en-espana-aportando-valor-traves-de-la-innovacion.html): Boehringer Ingelheim celebra 70 años en España aportando valor a través de la innovación. (1,199 words, Sep 13, 2022)
- [Las personas con diabetes tipo 2 temen algunas complicaciones de la enfermedad, mientras infraestiman otras | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-metabolicas/diabetes/las-personas-con-diabetes-tipo-2-temen-algunas-complicaciones-de-la-enfermedad-mientras-infraestiman.html): Las personas con diabetes tipo 2 temen algunas complicaciones de la enfermedad, mientras infraestiman otras. (1,174 words, Sep 13, 2022)
- [Boehringer Ingelheim España implementa 119 iniciativas para contribuir al desarrollo sostenible en el 2021 | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/boehringer-ingelheim-espana-implementa-119-iniciativas-para-contribuir-al-desarrollo-sostenible-en.html): Boehringer Ingelheim España implementa 119 iniciativas para contribuir al desarrollo sostenible en el 2021. (1,256 words, Sep 13, 2022)
- [Resultados Anuales | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/cultura/resultados-anuales/index.html): Seguimos trabajando en el objetivo de aportar valor a través de la innovación y aportar soluciones a necesidades médicas no cubiertas hoy en día. (52 words, Sep 13, 2022)
- [Aservo® EquiHaler® de Boehringer Ingelheim gana el premio Red Dot al diseño de producto | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/caballos/aservo-equihaler-de-boehringer-ingelheim-gana-el-premio-red-dot-al-diseno-de-producto.html): Aservo® EquiHaler® de Boehringer Ingelheim gana el premio Red Dot al diseño de producto. (658 words, Sep 13, 2022)
- [Boehringer Ingelheim Animal Health España presenta una iniciativa pionera: la web Salud Equina | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/caballos/boehringer-ingelheim-animal-health-espana-presenta-una-iniciativa-pionera-la-web-salud-equina.html): Boehringer Ingelheim Animal Health España presenta una iniciativa pionera: la web Salud Equina. (447 words, Sep 13, 2022)
- [Código de conducta para proveedores | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-potential/codigo-de-conducta-para-proveedores/index.html): Código de conducta para proveedores (19 words, Sep 12, 2022)
- [Boehringer Ingelheim destaca la colaboración entre veterinario y médico como factor clave en la prevención de las zoonosis | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/boehringer-ingelheim-destaca-la-colaboracion-entre-veterinario-y-medico-como-factor-clave-en-la.html): Boehringer Ingelheim destaca la colaboración entre veterinario y médico como factor clave en la prevención de las zoonosis. (632 words, Sep 9, 2022)
- [Fangya Qiang | Boehringer Ingelheim ES](/content/es/fangya-qiang/index.html): Fangya Qiang ha sido la Responsable de Medio Ambiente, Salud y Seguridad de BI TCM (The Chinese Market) en Shanghái, China, durante los últimos diez años. (341 words, Sep 7, 2022)
- [Mónica Sánchez | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/monica-sanchez/index.html): Como Responsable del Dpto. Prevención Riesgos Laborales y Medioambiente, Mónica Sánchez mejora continuamente la sostenibilidad en Sant Cugat. (400 words, Sep 7, 2022)
- [Onze toewijding | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-toezegging/onze-toewijding/index.html): We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. (447 words, Sep 6, 2022)
- [Onze bijdrage | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-toezegging/onze-bijdrage/index.html): Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. (541 words, Sep 6, 2022)
- [Nutzungsbedingungen | Boehringer Ingelheim Österreich](/content/pro/at/nutzungsbedingungen/index.html): Boehringer Ingelheim RCV GmbH & Co KG und weitere Konzernunternehmen (nachstehend „Boehringer Ingelheim“, „wir“, „uns“ oder „unser“) nehmen den Schutz Ihrer personenbezogenen Daten sehr ernst. Diese Datenschutzerklärung beschreibt, welche personenbezogenen Daten von Gesundheitsfachkräften („Ihnen“) gesammelt werden und wie wir diese Daten nutzen. Es werden verschiedene Szenarien erklärt, um Ihnen zu verdeutlichen, welche Informationen Boehringer Ingelheim für welche Zwecke erhebt und nutzt. (1,215 words, Sep 6, 2022)
- [Datenschutzhinweise | Boehringer Ingelheim Österreich](/content/pro/at/datenschutzhinweise/index.html): Zuletzt aktualisiert im März 2021 (554 words, Sep 6, 2022)
- [Onze aanpak | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/onze-aanpak/index.html): Als familiebedrijf worden wij gedreven door de ambitie om de mensheid te dienen door de gezondheid van mens en dier te verbeteren – nu én in de toekomst. Als onderdeel hiervan hebben we een ambitieus raamwerk ontwikkeld: Duurzame Ontwikkeling voor Generat (335 words, Sep 6, 2022)
- [New data for nintedanib in children with fibrosing ILD | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/new-data-nintedanib-children-fibrosing-ild/index.html): InPedILD Phase III trail showed encouraging results for both primary end points. If approved, nintedanib would become the first approved treatment for pediatric patients with fibrosis ILD. (843 words, Sep 5, 2022)
- [Terms and Conditions of Sale | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/terms-and-conditions-sale/index.html): Here you can view our standard terms and conditions relating to the sale of goods from Boehringer Ingelheim. Click here to read our terms and conditions. (22 words, Sep 5, 2022)
- [Our FOCUS | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/culture/our-focus-0/index.html): Our Focus (58 words, Sep 2, 2022)
- [Rabies prevention local action partnering organizations | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/rabies-prevention-local-action-partnering-organizations.html): Global rabies prevention needs local action. Together with partnering organizations, we’re using pilot projects to find the right approach. (619 words, Sep 2, 2022)
- [Aviso de privacidad relativo a la Farmacovigilancia Veterinaria | Boehringer Ingelheim ES](/content/es/aviso-de-privacidad-relativo-la-farmacovigilancia-veterinaria.html): Aviso de privacidad relativo a la Farmacovigilancia Veterinaria. (768 words, Sep 2, 2022)
- [Nos sites en France | Boehringer Ingelheim FR](/content/fr/propos/nos-sites/nos-sites-en-france/index.html): Boehringer Ingelheim France (230 words, Sep 2, 2022)
- [Vaccine prevent calf diarrhea | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/vaccine-prevent-calf-diarrhea/index.html): Fencovis® is the first vaccine to prevent calf diarrhea caused by E. coli F5 and bovine rotavirus and reduce severity of calf diarrhea caused by bovine coronavirus (604 words, Sep 2, 2022)
- [한국베링거인겔하임동물약품 연혁 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaimdongmulyagpum-sogae/hangugbelinggeoingelhaimdongmulyagpum-yeonhyeog/index.html): 한국베링거인겔하임동물약품(주)는 1996년 베링거인겔하임동물약품(주)으로 국내에 설립된 이래 산업동물 및 반려동물의 질병예방과 치료를 위한 혁신적인 동물용 의약품을 공급하고 있습니다. (356 words, Aug 30, 2022)
- [COME MIGLIORARE LA QUALITÀ DELL’ARIA E AIUTARE IL TUO CAVALLO A RESPIRARE MEGLIO | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/come-migliorare-la-qualita-dellaria-e-aiutare-il-tuo-cavallo-respirare-meglio.html): COME MIGLIORARE LA QUALITÀ DELL’ARIA E AIUTARE IL TUO CAVALLO A RESPIRARE MEGLIO (866 words, Aug 30, 2022)
- [Compromiso con la transparencia | Boehringer Ingelheim ES](/content/es/sobre-nosotros/compromiso-con-la-transparencia/index.html): En Boehringer Ingelheim, la transparencia es un principio fundamental de nuestra manera de actuar y de nuestra responsabilidad con la sociedad. (339 words, Aug 30, 2022)
- [ECCO PERCHÉ LA POLVERE È LA MINACCIA PIÙ GRAVE PER LA LORO SALUTE | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/ecco-perche-la-polvere-e-la-minaccia-piu-grave-la-loro-salute.html): ECCO PERCHÉ LA POLVERE È LA MINACCIA PIÙ GRAVE PER LA LORO SALUTE (306 words, Aug 30, 2022)
- [ASMA DEL CAVALLO, UNA GRAVE MALATTIA CHE TOGLIE IL RESPIRO | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/asma-del-cavallo-una-grave-malattia-che-toglie-il-respiro.html): UNA GRAVE MALATTIA CHE TOGLIE IL RESPIRO (349 words, Aug 30, 2022)
- [ASMA EQUINA, NON È MAI TROPPO PRESTO PER DIAGNOSTICARLA …NÉ TROPPO TARDI PER CURARLA | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-compagnia/asma-equina-non-e-mai-troppo-presto-diagnosticarla-ne-troppo-tardi-curarla.html): ASMA EQUINA (251 words, Aug 30, 2022)
- [Disclaimer | Boehringer Ingelheim NL](/content/nl/disclaimer/index.html): Als u op deze link klikt, verlaat u een website van Boehringer Ingelheim bv (“BI”) of gaat u naar een ander domein dat door BI wordt beheerd. In het geval dat (115 words, Aug 30, 2022)
- [神戸医薬研究所がイベントを通じて、学生に希少疾患を知る機会を提供 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/more-health/shenhuyiyaoyanjiusuokaihentowotongshitexueshengnixishaojihuanwozhirujihuiwotigong.html): ベーリンガーインゲルハイムの日本での取り組みをご紹介します。 (53 words, Aug 29, 2022)
- [神戸医薬研究所〜現場発の研究開発を加速し、患者さんへの提供価値最大化へ〜 | Boehringer Ingelheim JP](/content/jp/about-us/sustainable-development/our-story/clinical-trials/index.html): 神戸医薬研究所〜現場発の研究開発を加速し、患者さんへの提供価値最大化へ〜 (14 words, Aug 29, 2022)
- [한국베링거인겔하임 연혁 | Boehringer Ingelheim KR](/content/kr/about-us/corporate-profile/hangugbelinggeoingelhaim-sogae/hangugbelinggeoingelhaim-yeonhyeog/index.html): 1976년 설립되어 40년 이상의 역사를 자랑하는 한국베링거인겔하임은 국내 혁신적인 의약품 공급에 앞장서고 있습니다. (110 words, Aug 29, 2022)
- [Bigger role in ensuring food security | Boehringer Ingelheim HK](/content/hk/en/bigger-role-ensuring-food-security/index.html): Bigger role in ensuring food security (13 words, Aug 25, 2022)
- [Twenty years of controlling Lawsonia intracellularis | Boehringer Ingelheim CA](/content/ca/animal-health/livestock/swine/twenty-years-controlling-lawsonia-intracellularis/index.html): Enterisol Ileitis is an oral live attenuated vaccine, containing a non-virulent strain of L. intracellularis to mimic natural infection. Read more here. (2,226 words, Aug 25, 2022)
- [Aurobac – Gemeinsam gegen Superkeime | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/aurobac-gemeinsam-gegen-superkeime/index.html): Boehringer Ingelheim und Aurobac haben sich zusammengeschlossen, um gemeinsam gegen medikamentenresistente Infektionskrankheiten vorzugehen. (1,296 words, Aug 25, 2022)
- [Digitale Innovation | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/digitale-innovation/index.html): Boehringer Ingelheim hat eine vollständig selbst entwickelte Software namens BRASS verkauft, die darauf abzielt, die Patientensicherheit zu verbessern. (907 words, Aug 24, 2022)
- [Nuestro Código de Conducta | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/cultura/nuestro-codigo-de-conducta/index.html): Nuestro Código de Conducta demuestra que la integridad forma parte del ADN de todos y cada uno de nosotros en Boeringer Ingelheim. Lea el texto completo. (13 words, Aug 24, 2022)
- [La vacunación en medicina veterinaria centra sus avances en la seguridad, la eficacia y la posibilidad de diferenciar animales vacunados de infectados | Boehringer Ingelheim ES](/content/es/salud-animal/nuestra-responsabilidad/la-vacunacion-en-medicina-veterinaria-centra-sus-avances-en-la-seguridad-la-eficacia-y-la.html): La vacunación en medicina veterinaria centra sus avances en la seguridad, la eficacia y la posibilidad de diferenciar animales vacunados de infectados. (1,105 words, Aug 24, 2022)
- [El veterinario afronta su futuro como garante de la sanidad animal y de la seguridad alimentaria en el camino hacia el enfoque One Health | Boehringer Ingelheim ES](/content/es/salud-animal/nuestra-responsabilidad/el-veterinario-afronta-su-futuro-como-garante-de-la-sanidad-animal-y-de-la-seguridad-alimentaria-en.html): El veterinario afronta su futuro como garante de la sanidad animal y de la seguridad alimentaria en el camino hacia el enfoque One Health. (757 words, Aug 23, 2022)
- [Boehringer Ingelheim redobla sus compromisos con el desarrollo sostenible para generar un impacto positivo sobre 50 millones de personas a través de la innovación social | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-potential/boehringer-ingelheim-redobla-sus-compromisos-con-el-desarrollo-sostenible-para-generar-un-impacto.html): Boehringer Ingelheim redobla sus compromisos con el desarrollo sostenible para generar un impacto positivo sobre 50 millones de personas. (1,289 words, Aug 23, 2022)
- [Día Internacional de la Mujer | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-potential/dia-internacional-de-la-mujer/index.html): Como homenaje a todas las mujeres de BI que trabajan por el desarrollo de acciones medioambientales y de sostenibilidad, queremos destacar estas historias. (269 words, Aug 22, 2022)
- [Qué significa para nosotros ser Top Employer | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/que-significa-para-nosotros-ser-top-employer/index.html): ¿Qué implica ser empresa Top Employer para nosotros? Lee el testimonio de Olga Salomó, Directora de RRHH de Boehringuer Ingelheim España. (869 words, Aug 22, 2022)
- [Rostros de la familia | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/rostros-de-la-familia/index.html): Ponemos en marcha #FamilyFaces, un altavoz para que los miembros de BI España puedan compartir sus experiencias, sus motivaciones y sus retos de futuro. (71 words, Aug 19, 2022)
- [Typ 2 Diabetestherapie | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/typ-2-diabetestherapie/index.html): In Mai 2022 wurde Glyxambi® für ein breiteres eGFR-Spektrum zur Behandlung von Typ-2-Diabetes zugelassen. Lesen Sie weiter! (474 words, Aug 18, 2022)
- [Joint Venture Antimikrobieller Resistenzen | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/joint-venture-antimikrobieller-resistenzen/index.html): Gründung eines Joint Ventures zur Entwicklung von antimikrobiellen Wirkstoffen und Diagnostika zur Bekämpfung antimikrobieller Resistenzen. (1,067 words, Aug 18, 2022)
- [EHS-Managementsystem | Boehringer Ingelheim DE](/content/de/ueber-uns/ehs-managementsystem/index.html): Das integrierte EHS Managementsystem beschreibt Aufgaben, Prozesse und Verantwortlichkeiten aus verschiedenen Bereichen. (263 words, Aug 18, 2022)
- [Pferdepflegern eine Stimme verleihen | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/pferdepflegern-eine-stimme-verleihen/index.html): Interview mit Lucy Kartan, Gründungsmitglieder der International Grooms Association über die Bedeutung der Rolle von Pferdepflegerinnen und Pferdepflegern. (652 words, Aug 18, 2022)
- [Un vínculo único: salud humana y salud animal | Boehringer Ingelheim ES](/content/es/salud-animal/historias-destacadas/un-vinculo-unico-salud-humana-y-salud-animal/index.html): Un vínculo único: salud humana y salud animal. Entendemos y celebramos el efecto positivo que un animal puede provocar en una persona enferma. (129 words, Aug 18, 2022)
- [Our Purpose | Boehringer Ingelheim JP](/content/jp/about-us/who-we-are/culture/our-purpose/index.html): 私たちは、なぜ存在するのか (10 words, Aug 18, 2022)
- [Nuestro compromiso | Boehringer Ingelheim ES](/content/es/salud-animal/sobre-salud-animal/nuestro-compromiso/index.html): Nuestro compromiso es con los animales, pero también con los propietarios de mascotas, veterinarios, granjeros, así como el conjunto de la sociedad. (127 words, Aug 18, 2022)
- [Nuestra historia | Boehringer Ingelheim ES](/content/es/salud-animal/historias-destacadas/nuestra-historia/index.html): Conoce brevemente la cronología más destacada de nuestra historia como empresa. (113 words, Aug 18, 2022)
- [Día Mundial contra la Rabia: una enfermedad letal, prevenible y aún presente | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/perros-y-gatos/dia-mundial-contra-la-rabia-una-enfermedad-letal-prevenible-y-aun-presente.html): La rabia causa más de 59.000 muertes al año, pero es 100 % prevenible. Conoce cómo prevenirla en animales y personas y el papel clave de la vacunación. (107 words, Aug 18, 2022)
- [Aviso de privacidad relativo a la Farmacovigilancia | Boehringer Ingelheim ES](/content/es/aviso-de-privacidad-relativo-la-farmacovigilancia/index.html): Aviso de privacidad relativo a la Farmacovigilancia. (984 words, Aug 17, 2022)
- [Facing pulmonary fibrosis | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/facing-pulmonary-fibrosis/index.html): Steve Jones talks about his experience facing his pulmonary fibrosis diagnosis. (287 words, Aug 17, 2022)
- [Herzgeräusche bei Hunden | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/haustiere/herzgeraeusche-bei-hunden/index.html): Regelmäßige Herzuntersuchungen können Ihrem Hund das Leben retten. Erfahren Sie mehr über das Thema. (868 words, Aug 17, 2022)
- [Bekämpfung von Krebs bei Hunden | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/bekaempfung-von-krebs-bei-hunden/index.html): BI und CarthroniX verkünden Partnerschaft. Der Fokus der Kooperation liegt auf der Bestimmung neuer Moleküle zur Bekämpfung von Krebs bei Hunden. (498 words, Aug 17, 2022)
- [The Boehringer Ingelheim Veterinary Scholars Program | Boehringer Ingelheim](/content/science-innovation/animal-health-innovation/boehringer-ingelheim-veterinary-scholars-program/index.html): The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research (1,245 words, Aug 16, 2022)
- [Pourquoi nous croyons aux partenariats | Boehringer Ingelheim CH](/content/ch/fr/partenariats/partenariats-en-sante-humaine/pourquoi-nous-croyons-aux-partenariats/index.html): Convaincus que l'innovation naît de la diversité et de l'échange au sein de la communauté des sciences de la vie, nous travaillons avec des partenaires à de nouvelles approches de solutions tout au long de la chaîne de création de valeur. (135 words, Aug 13, 2022)
- [Warum wir an Partnerschaften glauben | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/warum-wir-partnerschaften-glauben/index.html): Aus der Überzeugung heraus, dass durch Diversität und Austausch innerhalb der Life Science Community Innovationen geboren werden, arbeiten wir gemeinsam mit Partnern an neuen Lösungsansätzen entlang der gesamten Wertschöpfungskette. Wir ergänzen unsere E (111 words, Aug 13, 2022)
- [Our Company in the UK | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/our-company-uk/index.html): Boehringer Ingelheim has been transforming lives in healthcare since 1885. We create value through innovation by infusing long-term, sustainable thinking into our Human Pharma, Animal Health and biopharmaceutical contract manufacturing businesses. Our res (156 words, Aug 12, 2022)
- [Our Purpose - Read our story | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/our-purpose-read-our-story/index.html): We are Boehringer Ingelheim - a different kind of pharmaceutical company. Family-owned. Purpose-led. Innovation-driven. Click here to find out more. (588 words, Aug 12, 2022)
- [Wat de wereld weet over… sclerodermie | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/sclerodermie/wat-de-wereld-weet-over-sclerodermie/index.html): Bij Boehringer Ingelheim willen we mensen na laten denken over verschillende (zeldzame) ziekten. En hoe kun je dat beter doen dan door bij te dragen aan dagen (262 words, Aug 10, 2022)
- [Wat de wereld weet over… IPF | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/longfibrose/wat-de-wereld-weet-over-ipf/index.html): Bij Boehringer Ingelheim willen we mensen na laten denken over verschillende (zeldzame) ziekten. En hoe kun je dat beter doen dan door bij te dragen aan dagen (271 words, Aug 10, 2022)
- ['Wat de wereld weet over… het hart' | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/wat-de-wereld-weet-over-het-hart/index.html): Bij Boehringer Ingelheim willen we mensen na laten denken over verschillende (zeldzame) ziekten. En hoe kun je dat beter doen dan door bij te dragen aan (242 words, Aug 10, 2022)
- [De gezondheid en het welzijn van dieren zijn kernwaarden | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/de-gezondheid-en-het-welzijn-van-dieren-zijn-kernwaarden.html): Bij Boehringer Ingelheim zetten we ons in om de gezondheid van mens en dier te verbeteren. Innovatie zit in ons DNA. Al ruim 130 jaar ontdekken en ontwikkelen (598 words, Aug 10, 2022)
- [Chronic kidney disease in cats | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/chronic-kidney-disease-cats/index.html): Detect and manage chronic kidney disease and high blood pressure in cats (834 words, Aug 10, 2022)
- [Boehringer Ingelheim verhuist in 2022 naar Amsterdam | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/boehringer-ingelheim-verhuist-2022-naar-amsterdam/index.html): Begin 2022 verhuizen Boehringer Ingelheim Nederland en de regionale hub (MIDI center) gezamenlijk naar een nieuw kantoor: EDGE Amsterdam West. (346 words, Aug 10, 2022)
- [Tax Strategy | Boehringer Ingelheim UK](/content/uk/about-us/ethics-and-compliance/tax-strategy/index.html): Here you can read Boehringer Ingelheim UK's tax strategy which details our approach to conducting our tax affairs and dealing with tax risks. Click here to find out more. (641 words, Aug 9, 2022)
- [Better Access to Healthcare for Indigenous Peoples | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health-people-animals/better-access-healthcare-indigenous/index.html): Indigenous Peoples often experience poor access to health care. Our initiatives from Canada and New Zealand aim to overcome the gap. (1,429 words, Aug 5, 2022)
- [Portal for helsepersonell | Boehringer Ingelheim Norway](/content/pro/no/index.html): En portal for helsepersonell hvor du kan lære mer om våre terapiområder, bestille materiell, samt melde deg på møter. (74 words, Aug 4, 2022)
- [Transparantie | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/transparantie/index.html): Transparantie (432 words, Aug 4, 2022)
- [Transparantie | Boehringer Ingelheim NL](/content/nl/over-ons/transparantie-en-vertrouwen/index.html): Boehringer Ingelheim werkt aan baanbrekende behandelingen die de levens van mens en dier verbeteren. Als toonaangevend, onderzoeksgedreven biofarmaceutisch (404 words, Aug 4, 2022)
- [Standort Shanghai | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-shanghai/index.html): Shanghai dient als wichtiges Zentrum innerhalb des globalen Netzwerks der drei Geschäftsbereiche: Humanpharma, Tiergesundheit und Biopharmazie. (320 words, Aug 3, 2022)
- [Karriere und Familie in Balance | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/nos-stories/karriere-und-familie-balance/index.html): Eine Balance zwischen Karriere und Familie? Das Rollenentdecker- Coaching unterstützt aktiv dabei. (11 words, Aug 3, 2022)
- [Karriere und Familie in Balance | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unsere-stories/karriere-und-familie-balance/index.html): Eine Balance zwischen Karriere und Familie? Das Rollenentdecker- Coaching unterstützt aktiv dabei. (62 words, Aug 3, 2022)
- [Grüner Strom für Japan | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unsere-stories/gruener-strom-fuer-japan/index.html): Durch grünen Strom in Japan sollen Energiekosten reduziert und Boehringer Ingelheims CO2-Fußabdruck in Japan minimiert werden. (362 words, Aug 3, 2022)
- [Grüner Strom für Japan | Boehringer Ingelheim DE](/content/de/gruener-strom-fuer-japan-0/index.html): Durch grünen Strom in Japan sollen Energiekosten reduziert und Boehringer Ingelheims CO2-Fußabdruck in Japan minimiert werden. Erfahren Sie mehr! (381 words, Aug 3, 2022)
- [Nachhaltige Klimaschutzprojekte | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/nos-stories/nachhaltige-klimaschutzprojekte/index.html): Boehringer Ingelheim kooperiert mit ClimateSeed und unterstützt so Projekte zur Reduzierung von CO2 (406 words, Aug 3, 2022)
- [Nachhaltige Klimaschutzprojekte | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/unsere-stories/nachhaltige-klimaschutzprojekte/index.html): Boehringer Ingelheim kooperiert mit ClimateSeed und unterstützt so Projekte zur Reduzierung von CO2 (567 words, Aug 3, 2022)
- [Speak up | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/speak-0/index.html): We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Learn more. (478 words, Aug 3, 2022)
- [Speak up | Boehringer Ingelheim UK](/content/uk/about-us/ethics-compliance/speak/index.html): We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Learn more. (478 words, Aug 3, 2022)
- [Standort Kobe | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-kobe/index.html): Das Kobe Pharma Research Institute beteiligt sich an Forschungs- und Entwicklungsaktivitäten für Humanpharmazeutika. (166 words, Aug 3, 2022)
- [Standort Wien | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-wien/index.html): Boehringer Ingelheim Wien ist ein Eckpfeiler im Forschungs- und Entwicklungsnetzwerk. Entdecken Sie mehr über unserem besonderen Fokus auf Krebsforschung. (468 words, Aug 3, 2022)
- [Standort Fremont USA | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-fremont-usa/index.html): Fremont ist der US-Standort für die biopharmazeutische Auftragsproduktion. Erfahren Sie mehr über die Spezialisierung dieses Standorts. (200 words, Aug 3, 2022)
- [Standort Sant-Cugat-del-Valles | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-sant-cugat-del-valles/index.html): Erfahren Sie mehr über unseren Standort in Sant Cugat del Vallès, der sich auf die pharmazeutische Produktion konzentriert. (249 words, Aug 3, 2022)
- [‘De grootste motivatie voor het zorgen voor Stef? De liefde!’ | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/een-betere-gezondheid/de-grootste-motivatie-voor-het-zorgen-voor-stef-de-liefde.html): Wanneer een familielid ziek is, is het fijn als er iemand voor je klaarstaat. Om boodschappen te doen, te helpen in het huishouden of voor vervoer naar (897 words, Aug 3, 2022)
- [Jurjens Historie | Boehringer Ingelheim DK](/content/dk/om-os/baeredygtig-udvikling/mere-sundhed/jurjens-historie/index.html): Jurjens Historie (793 words, Aug 3, 2022)
- [Jurjen’s verhaal | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/een-betere-gezondheid/jurjens-verhaal/index.html): Mensen met diabetes type 2 hebben vaak te maken met vooroordelen over de oorzaak van hun aandoening. Uit onwetendheid wordt soms gedacht dat diabetes type 2 (850 words, Aug 3, 2022)
- [Jurjen's Story | Boehringer Ingelheim NO](/content/no/om-oss/baerekraftig-utvikling/mer-helse/jurjens-story/index.html): Personer som lever med diabetes type 2, har ofte kjent på en viss grad av stigma knyttet til årsakene bak sykdommen. Manglende kunnskap gjør at enkelte (824 words, Aug 3, 2022)
- [Our Family Portrait – Jurjens story | Boehringer Ingelheim SE](/content/se/manniskors-halsa/metabola-sjukdomar/diabetes/our-family-portrait-jurjens-story/index.html): Jag kommer att göra allt som krävs för att få ett långt, friskt och lyckligt liv med min familj. (850 words, Aug 3, 2022)
- [Bijdragen aan een bosrijker Nederland | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/bijdragen-aan-een-bosrijker-nederland/index.html): Het jaar 2022 is goed – en vooral duurzaam - begonnen. Voortaan ontvangen medewerkers van Boehringer Ingelheim Nederland geen bloemen meer voor hun verjaardag (263 words, Aug 3, 2022)
- [Charities of the Year | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/charities-year/index.html): Click here to learn about our charity partners, and meet the good causes we support that improve human and animal health. (341 words, Aug 2, 2022)
- [Charities of the Year | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/charities-year/index.html): Click here to learn about our charity partners, and meet the good causes we support that improve human health by harnessing the power of animals. (303 words, Aug 2, 2022)
- [The Importance of Drug Discovery | R&D | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/fostering-science/importance-drug-discovery-rd-boehringer-ingelheim-us.html): Find out how Boehringer Ingelheim's research & development department is key to innovation in the field of drug discovery. (263 words, Aug 2, 2022)
- [Boehringer Cares Financial Contributions Program: Strengthening Communities | Boehringer Ingelheim US](/content/us/about-us/sustainable-development/bi-cares-financial-contributions-program-strengthening-communities.html): The BI Cares foundation is committed to improving the lives of patients and animals toward a larger goal of making healthier communities. (231 words, Aug 2, 2022)
- [£25k donated to Ukrainian families and animals | Boehringer Ingelheim IE](/content/ie/about-us/who-we-are/ps25k-donated-ukrainian-families-and-animals/index.html): Our Executive Committee made an additional donation of £25,000 to help people and animals affected by the war in Ukraine. Click here to learn more. (794 words, Aug 2, 2022)
- [£25k donated to Ukrainian families and animals | Boehringer Ingelheim UK](/content/uk/about-us/who-we-are/ps25k-donated-ukrainian-families-and-animals/index.html): Our Executive Committee made an additional donation of £25,000 to help people and animals affected by the war in Ukraine. Click here to learn more. (794 words, Aug 2, 2022)
- [Protecting Communities from Disease | Boehringer Ingelheim IE](/content/ie/animal-health/livestock/veterinary-public-health/protecting-communities-disease/index.html): Learn how our colleagues in Global Innovation and Veterinary Public Health constantly monitor and prepare for outbreaks to help protect communities from diseases. (377 words, Aug 1, 2022)
- [Support to Patient Organisations | Boehringer Ingelheim IE](/content/ie/about-us/ethics-compliance/transparency/support-patient-organisations/index.html): As part of our commitment to transparency, we disclose support to patient organisations. Click here to learn more information about our support. (181 words, Aug 1, 2022)
- [Requests for support | Boehringer Ingelheim IE](/content/ie/partnering/requests-support/index.html): Click here to learn information about our provision of support for investigator-led clinical research, support to healthcare organisations, and more. (755 words, Aug 1, 2022)
- [Requests for support | Boehringer Ingelheim UK](/content/uk/partnering/requests-support/index.html): Click here to learn information about our provision of support for investigator-led clinical research, support to healthcare organisations, and more. (736 words, Aug 1, 2022)
- [Privacy Notice for Partners | Boehringer Ingelheim IE](/content/ie/privacy-notice-partners/index.html): Click here to read our privacy notice for partners, visitors and interested persons. Find information about personal data we might process, and more. (1,193 words, Aug 1, 2022)
- [Privacy Notice for Partners | Boehringer Ingelheim UK](/content/uk/privacy-policy/privacy-notice-partners/index.html): Click here to read our privacy notice for partners, visitors and interested persons. Find information about personal data we might process, and more. (1,193 words, Aug 1, 2022)
- [Why Boehringer Ingelheim is a Top Employer | Boehringer Ingelheim IE](/content/ie/careers/why-boehringer-ingelheim-top-employer/index.html): Our employees are part of a company that celebrates their achievements and rewards their individual contribution to our business and our success. (628 words, Aug 1, 2022)
- [Why Boehringer Ingelheim is a Top Employer | Boehringer Ingelheim UK](/content/uk/careers/why-boehringer-ingelheim-top-employer/index.html): Our employees are part of a company that celebrates their achievements and rewards their individual contribution to our business and our success. (832 words, Aug 1, 2022)
- [Gedragscode | Boehringer Ingelheim BE](/content/be/nl/over-ons/gedragscode/index.html): Gedragscode - Onze gedragscode maakt het voor iedereen duidelijk dat integriteit “onderdeel uitmaakt van ons DNA”, Bekijk PDF (28 words, Aug 1, 2022)
- [Κώδικας δεοντολογίας | Boehringer Ingelheim](/content/gr/about-us/kodikas-deontologias/index.html): Ο Κώδικας δεοντολογίας μας δείχνει στον καθένα μας ότι η ακεραιότητα είναι «μέρος του DNA μας». (36 words, Aug 1, 2022)
- [Gedragscode | Boehringer Ingelheim NL](/content/nl/over-ons/gedragscode/index.html): All Boehringer Ingelheim employees must comply with this Code of Conduct and the policies, procedures and laws that apply to our particular geographies (23 words, Aug 1, 2022)
- [Vacancies | Boehringer Ingelheim IE](/content/ie/careers/vacancies/index.html): Find out about current vacancies here at Boehringer Ingelheim. You can view both our permanent and temporary current vacancies here. Learn more. (82 words, Aug 1, 2022)
- [Vacancies | Boehringer Ingelheim UK](/content/uk/careers/vacancies/index.html): Find out about current vacancies here at Boehringer Ingelheim. You can view both our permanent and temporary current vacancies here. Learn more. (95 words, Aug 1, 2022)
- [Developing our People | Boehringer Ingelheim IE](/content/ie/careers/developing-our-people/index.html): Find out about how we are dedicated to investing in our people at Boehringer Ingelheim. Learn about our approach to learning opportunities and more. (484 words, Aug 1, 2022)
- [Developing our People | Boehringer Ingelheim UK](/content/uk/careers/developing-our-people/index.html): Find out about how we are dedicated to investing in our people at Boehringer Ingelheim. Learn about our approach to learning opportunities and more. (484 words, Aug 1, 2022)
- [111年8月1日起 JARDIANCE®恩排糖® 膜衣錠10毫克通過用於慢性收縮性心衰竭患者(HFrEF)的健保給付 | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/111nian8yue1riqi-jardianceenpaitang/index.html): 111年8月1日起 JARDIANCE®恩排糖® 膜衣錠10毫克通過用於慢性收縮性心衰竭患者(HFrEF)的健保給付 (17 words, Aug 1, 2022)
- [Standort Yamagata | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-yamagata/index.html): Der Standort in der japanischen Präfektur Yamagata produziert Humanpharmazeutika für den japanischen Markt. (229 words, Jul 30, 2022)
- [Neutralisering af den antikoagulerende virkning | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/neutralisering-af-den-antikoagulerende-virkning/index.html): Kardiovaskulære sygdomme, herunder hjerteanfald og slagtilfælde, er et stort problem på verdensplan og den vigtigste årsag til dødelighed (155 words, Jul 29, 2022)
- [Sydän- ja verisuonitaudit | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/antikoagulanttivaikutuksen-neutralointi/index.html): Sydän- ja verisuonitaudit, kuten sydänkohtaukset ja aivohalvaukset, ovat maailmanlaajuisesti merkittävä ongelma ja johtava kuolleisuuden ja työkyvyttö. (127 words, Jul 29, 2022)
- [Εξουδετέρωση του αντιπηκτικού αποτελέσματος | Boehringer Ingelheim GR](/content/gr/human-health/heart-diseases/exoydeterosi-toy-antipiktikoy-apotelesmatos/index.html): Η Boehringer Ingelheim αναπτύσσει καινοτόμες θεραπείες που μπορούν να καλύψουν μια ανεκπλήρωτη ιατρική ανάγκη. (177 words, Jul 29, 2022)
- [Neutralisering av antikoagulerande effekt | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/neutralisering-av-antikoagulerande-effekt/index.html): Hjärt- och kärlsjukdomar, inklusive hjärtattacker och stroke, är ett stort problem i världen och den främsta orsaken till dödlighet funktionsnedsättning. (87 words, Jul 29, 2022)
- [Dyb venetrombose (DVT) | Boehringer Ingelheim DK](/content/dk/human-health/hjertesygdomme/dvt-le/index.html): Kardiovaskulære sygdomme, herunder hjerteanfald og slagtilfælde, er et stort problem på verdensplan og den vigtigste årsag til dødelighed , (154 words, Jul 29, 2022)
- [SLT/KE | Boehringer Ingelheim FI](/content/fi/ihmisten-terveys/sydansairaudet/slt-ke/index.html): Boehringer Ingelheim kehittää innovatiivisia hoitoja, joilla voidaan vastata tyydyttämättömään lääketieteelliseen tarpeeseen. (128 words, Jul 29, 2022)
- [Diep veneuze trombose (DVT) | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/dvt-le/index.html): Hart- en vaatziekten, waaronder hartaanvallen en beroertes, zijn wereldwijd een groot probleem en de hoofdoorzaak van sterfte en invaliditeit. (175 words, Jul 29, 2022)
- [Dyp venetrombose (DVT) | Boehringer Ingelheim NO](/content/no/menneskelig-helse/hjertesykdommer/dvt-pe/index.html): Hjerte- og karsykdommer, inkludert hjerteinfarkt og hjerneslag, er et stort problem over hele verden og den viktigste årsaken til dødelighet og. (155 words, Jul 29, 2022)
- [TVP/EP | Boehringer Ingelheim PT](/content/pt/saude-humana/cardiopatias/dvt-le/index.html): As doenças cardiovasculares, incluindo ataques cardíacos e AVC, são um grande problema a nível mundial e a principal causa de mortalidade e incapacidade. (93 words, Jul 29, 2022)
- [Djup venös trombos (DVT) | Boehringer Ingelheim SE](/content/se/manniskors-halsa/hjartsjukdomar/dvt-le/index.html): Hjärt- och kärlsjukdomar, inklusive hjärtattacker och stroke, är ett stort problem i världen och den främsta orsaken till dödlighet funktionsnedsättning. (87 words, Jul 29, 2022)
- [La qualité du colostrum est bien meilleure lorsque la douleur est maîtrisée | Boehringer Ingelheim FR](/content/fr/sante-animale/animaux-delevage/ruminants/la-qualite-du-colostrum-est-bien-meilleure-lorsque-la-douleur-est-maitrisee.html): Jean-Philippe Gartioux, vétérinaire rural dans le Cher, évite systématiquement et au maximum la douleur de l’animal. (604 words, Jul 29, 2022)
- [EFPIA-openbaarmaking | Boehringer Ingelheim BE](/content/be/nl/over-ons/wie-wij-zijn/efpia-openbaarmaking/index.html): Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations and disclosures of transfers of value (ToVs) to HCPs and HCOs. (127 words, Jul 28, 2022)
- [EFPIA:n julkistamissäännöstö | Boehringer Ingelheim FI](/content/fi/tietoa-meista/keita-olemme/efpian-julkistamissaannosto/index.html): Tiedot Boehringer Ingelheimin tytäryhtiöistä maissa, joissa on EFPIA:n jäsenjärjestö. (419 words, Jul 28, 2022)
- [Δημοσιοποίηση EFPIA | Boehringer Ingelheim GR](/content/gr/about-us/who-we-are/dimosiopoiisi-efpia/index.html): Η Boehringer Ingelheim επιβεβαιώνει ότι οι γνωστοποιήσεις της εταιρείας όσον αφορά τις μεταβιβάσεις αξίας (ToVs) σε επαγγελματίες υγείας (HCP). (505 words, Jul 28, 2022)
- [EFPIA-openbaarmaking | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/efpia-openbaarmaking/index.html): Openbaarmaking van Boehringer Ingelheim-entiteiten in landen met EFPIA-lidorganisaties (501 words, Jul 28, 2022)
- [Impressum | Boehringer Ingelheim Österreich](/content/pro/at/impressum/index.html): Boehringer Ingelheim Österreich (152 words, Jul 28, 2022)
- [Código de Conduta | Boehringer Ingelheim BR](/content/br/nosso-codigo-de-conduta/index.html): Nosso Código de Conduta define os padrões éticos que orientam nossas atividades. Ele se aplica a todos, e cada pessoa é essencial para torná-lo realidade. (335 words, Jul 28, 2022)
- [Championing Novel Science | Boehringer Ingelheim DE](/content/de/humanmedizin/psychische-gesundheit/championing-novel-science/index.html): Dr. Vikas Mohan Sharma discusses the unmet need in Borderline Personality Disorder treatment and Boehringer Ingelheim’s role in research (950 words, Jul 27, 2022)
- [Startseite | Boehringer Ingelheim Österreich](/content/pro/at/index.html): Service und Information für Ärztinnen und Ärzte (155 words, Jul 26, 2022)
- [Coronavirus negli animali domestici e nell'uomo: impariamo le differenze! | Boehringer Ingelheim IT](/content/it/coronavirus-negli-animali-domestici-e-nelluomo-impariamo-le-differenze.html): Coronavirus negli animali domestici e nell'uomo: impariamo le differenze! (918 words, Jul 26, 2022)
- [Rising Star Leads with Determination | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/about-us/who-we-are/rising-star-leads-determination-boehringer-ingelheim-us.html): Click to find out more on our partnership with the HBA, where we honor a BI colleague as a “Rising Star” to support the advancement of women in health care. (314 words, Jul 26, 2022)
- [Het traject dat patiënten met systemische sclerose doorlopen heeft vaak veel weg van een kronkelpaadje | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/sclerodermie/het-traject-dat-patienten-met-systemische-sclerose-doorlopen-heeft-vaak-veel-weg-van-een.html): Systemische sclerose is een zeldzame invaliderende en mogelijk dodelijke ziekte waarbij verlittekening van de huid optreedt (sclerodermie). (1,081 words, Jul 25, 2022)
- [Être indépendant | Boehringer Ingelheim FR](/content/fr/propos/qui-sommes-nous/etre-independant/index.html): Être indépendant (575 words, Jul 25, 2022)
- [Facing lung cancer | Boehringer Ingelheim](/content/human-health/cancer/living-cancer/facing-lung-cancer/index.html): Keith and Heather talk about their experiences of facing lung cancer as a family and finding purpose after treatment. (148 words, Jul 25, 2022)
- [trasparenza responsabile | Boehringer Ingelheim IT](/content/it/su-di-noi/trasparenza-responsabile/index.html): I trasferimenti di valore di Boehringer Ingelheim Italia S.p.A. (294 words, Jul 22, 2022)
- [Associazioni pazienti | Boehringer Ingelheim IT](/content/it/human-health/our-responsibility/associazioni-pazienti/index.html): La nostra collaborazione con le Associazioni dei pazienti si basa sui nostri valori e sulla vision aziendale (Value through Innovation). (1,369 words, Jul 22, 2022)
- [Un Legame Unico: per la salute umana e degli animali | Boehringer Ingelheim IT](/content/it/salute-umana/un-legame-unico-la-salute-umana-e-degli-animali/index.html): Un Legame Unico: per la salute umana e degli animali (214 words, Jul 22, 2022)
- [Un Legame Unico: ha scelto me | Boehringer Ingelheim IT](/content/it/salute-umana/cancro/un-legame-unico-ha-scelto-me/index.html): Scelto me (187 words, Jul 22, 2022)
- [Un Legame Unico: amici nel bisogno | Boehringer Ingelheim IT](/content/it/salute-umana/disturbi-cardiaci/ictus/un-legame-unico-amici-nel-bisogno/index.html): Un Legame Unico: amici nel bisogno (197 words, Jul 22, 2022)
- [Un Legame Unico: al mio fianco | Boehringer Ingelheim IT](/content/it/salute-umana/area-respiratoria/bpco-e-asma/un-legame-unico-al-mio-fianco/index.html): Un Legame Unico: al mio fianco (188 words, Jul 22, 2022)
- [Cinque cose da sapere sul controllo delle parassitosi nei ruminanti | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/ruminanti/cinque-cose-da-sapere-sul-controllo-delle-parassitosi-nei-ruminanti.html): Mano a mano che il tema della sostenibilità acquisisce importanza, l’approccio tradizionale basato unicamente sui farmaci per il controllo dei parass (738 words, Jul 22, 2022)
- [Tre cose da sapere sull - 2019influenza aviaria | Boehringer Ingelheim IT](/content/it/salute-animale/animali-da-allevamento/avicoli/tre-cose-da-sapere-sull-2019influenza-aviaria/index.html): Oltre alle conseguenze economiche e commerciali della pandemia di COVID-19, in ogni parte del mondo le aziende avicole si trovano ad affrontare anche (603 words, Jul 22, 2022)
- [Viaggiare con i cani | Boehringer Ingelheim IT](/content/it/salute-animale/viaggiare-con-i-cani/index.html): Viaggiare con i cani (306 words, Jul 22, 2022)
- [Le tre sfide chiave per il futuro nei trattamenti antiparassitari | Boehringer Ingelheim IT](/content/it/salute-animale/le-tre-sfide-chiave-il-futuro-nei-trattamenti-antiparassitari.html): Le tre sfide chiave per il futuro nei trattamenti antiparassitari (1,165 words, Jul 22, 2022)
- [Informativa sulla privacy relativa alla Farmacovigilanza Human Pharma | Boehringer Ingelheim IT](/content/it/data-privacy/informativa-sulla-privacy-relativa-alla-farmacovigilanza-human-pharma.html): Informativa sulla privacy relativa alla Farmacovigilanza Human Pharma (501 words, Jul 22, 2022)
- [Informativa sulla privacy relativa alla Farmacovigilanza Animal Health | Boehringer Ingelheim IT](/content/it/data-privacy/informativa-sulla-privacy-relativa-alla-farmacovigilanza-animal-health.html): Informativa sulla privacy relativa alla Farmacovigilanza Animal Health (404 words, Jul 21, 2022)
- [Boehringer Ingelheim partecipa a “Quattro Zampe in Fiera” 2021 | Boehringer Ingelheim IT](/content/it/media/comunicati-stampa/boehringer-ingelheim-partecipa-quattro-zampe-fiera-2021.html): Boehringer Ingelheim partecipa a “Quattro Zampe in Fiera” 2021 con uno stand a marchio Frontline (321 words, Jul 21, 2022)
- [Il nostro impegno #CattleFirst | Boehringer Ingelheim IT](/content/it/salute-animale/il-nostro-impegno-cattlefirst/index.html): Il nostro impegno #CattleFirst (264 words, Jul 21, 2022)
- [Working with purpose | Boehringer Ingelheim](/content/about-us/vision-values/working-purpose/index.html): Colleagues tell their personal stories and what motivates them to contribute towards a better future for generations to come. (192 words, Jul 19, 2022)
- [駆虫剤の将来に重要な3つの課題 | Boehringer Ingelheim JP](/content/jp/animal-health/trends-insights/quchongjinojianglainizhongyaona3tsunoketi/index.html): Companion Animals (34 words, Jul 19, 2022)
- [Boehringer Ingelheim Corporate | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/storia/boehringer-ingelheim-corporate/index.html): BI Corporate (1,704 words, Jul 16, 2022)
- [Associazioni di pazienti | Boehringer Ingelheim IT](/content/it/salute-umana/associazioni-di-pazienti/index.html): Associazioni di pazienti (66 words, Jul 16, 2022)
- [attivita Bidachem | Boehringer Ingelheim IT](/content/it/su-di-noi/attivita-bidachem/index.html): Bidachem - L'Attività (456 words, Jul 16, 2022)
- [Un legame reciprocamente vantaggioso | Boehringer Ingelheim IT](/content/it/salute-animale/un-legame-reciprocamente-vantaggioso/index.html): L'importanza della relazione tra persone e animali non può essere sottovalutata. Che si tratti di ragioni economiche o emotive, gli animali apportano molti benefici ai loro custodi. (42 words, Jul 16, 2022)
- [Il Gruppo Boehringer Ingelheim Italia | Boehringer Ingelheim IT](/content/it/su-di-noi/chi-siamo/il-gruppo-boehringer-ingelheim-italia/index.html): Il Gruppo Boehringer Ingelheim Italia (94 words, Jul 16, 2022)
- [Decreto Legislativo 231 | Boehringer Ingelheim IT](/content/it/su-di-noi/decreto-legislativo-231/index.html): Decreto Legislativo 231 (210 words, Jul 15, 2022)
- [Uma ligação única: Anna e Csenge | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/esclerodermia/uma-ligacao-unica-anna-e-csenge/index.html) (54 words, Jul 14, 2022)
- [Leren, Adopteren, Innoveren, Herhalen: Laurie Hottiaux | Boehringer Ingelheim NL](/content/nl/over-ons/leren-adopteren-innoveren-herhalen-laurie-hottiaux/index.html): Laurie Hottiaux, Regional Brand Manager bij Boehringer Ingelheim, is nog steeds blij dat ze de overstap heeft gemaakt van de consumptiegoederensector (106 words, Jul 14, 2022)
- [Purpose: Finding the long-missed meaning | Boehringer Ingelheim](/content/about-us/corporate-profile/purpose-finding-long-missed-meaning/index.html): Cancer survivor Missy Pappion is happy at Boehringer Ingelheim after climbing the corporate ladder (819 words, Jul 11, 2022)
- [Our Family Portrait – Nurjanah | Boehringer Ingelheim GR](/content/gr/our-family-portrait-nurjanah/index.html): Nurjanah family (1,378 words, Jul 8, 2022)
- [Hoe een zeldzame ziekte de familie Bruggeman samenbracht | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/hoe-een-zeldzame-ziekte-de-familie-bruggeman-samenbracht.html): De studententijd zou de beste tijd van je leven moeten zijn. Voor Nurjanah (42) liep het anders dan bij vele studiegenoten. Haar gezondheid ging snel achteruit. (1,356 words, Jul 8, 2022)
- [Nurjanah family | Boehringer Ingelheim NO](/content/no/nurjanah-family/index.html): Studentlivet burde være den beste tiden i livet ditt. For Nurjanah ble den annerledes enn for medstudentene. Helsetilstanden hennes forverret seg raskt. (1,356 words, Jul 8, 2022)
- [Our Family Portrait – Nurjanah | Boehringer Ingelheim SE](/content/se/manniskors-halsa/vart-ansvar/our-family-portrait-nurjanah/index.html): Studenttiden borde vara den bästa tiden i livet. För Nurjanah (42) blev det annorlunda än för hennes studiekamrater (1,321 words, Jul 8, 2022)
- [Een unieke band: ze week niet van mijn zijde | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/copd-astma/een-unieke-band-ze-week-niet-van-mijn-zijde/index.html): Toen Caroline een intens moeilijke tijd doormaakte, had ze veel steun en gezelschap aan Snowball. Dankzij hun unieke band kan Caroline nu beter omgaan (144 words, Jul 5, 2022)
- [Een unieke band: hij koos mij | Boehringer Ingelheim NL](/content/nl/voor-mens/kanker/andere-kankersoorten/een-unieke-band-hij-koos-mij/index.html): Toen Helga te horen kreeg dat ze kanker had, kwam ze voor veel moeilijke keuzes te staan. Maar de keuze om Brumbi in huis te nemen, was zo gemaakt (101 words, Jul 5, 2022)
- [Een unieke band: een ongekend hecht team | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/diabetes/een-unieke-band-een-ongekend-hecht-team/index.html): Zo'n unieke band als die tussen Eric en Jake illustreert waarom wij ons vol overgave inzetten voor de gezondheid van mens en dier. Nadat Eric (94 words, Jul 5, 2022)
- [Een unieke band: vrienden door dik en dun | Boehringer Ingelheim NL](/content/nl/voor-mens/hart-en-vaatziekten/beroertepreventie-bij-boezemfibrilleren/een-unieke-band-vrienden-door-dik-en-dun/index.html): De wereldwijde hoofdoorzaak van sterfte en invaliditeit aanpakken, dat is het doel van ons hart-en-vaatziektenteam. Phil had na een beroerte het gevoel niets (91 words, Jul 5, 2022)
- [Company History | Corporate Profile | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/about-us/who-we-are/history/company-history-corporate-profile-boehringer-ingelheim-us.html): Click here to watch our video on the history of Boehringer Ingelheim, founded by Albert Boehringer in 1885. (57 words, Jul 5, 2022)
- [History of our Logo | Corporate Profile | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/about-us/who-we-are/history/history-our-logo-corporate-profile-boehringer-ingelheim-us.html): The logo used by Boehringer Ingelheim today is a stylized depiction of the central section of the imperial palace of Charlemagne. (300 words, Jul 5, 2022)
- [Marktzulassung RenuTend | Boehringer Ingelheim DE](/content/de/tiergesundheit/haustiere-und-pferde/pferde/marktzulassung-renutend/index.html): Wir haben Zulassung für RenuTend erhalten, das erste zugelassene Produkt zur Verbesserung der Heilung von Sehnen- und Fesselträgerverletzungen bei Pferden. (126 words, Jul 5, 2022)
- [1885-1948: Innovative Beginnings | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/about-us/who-we-are/history/1885-1948-innovative-beginnings-boehringer-ingelheim-us.html): Click here to read an in-depth history of Boehringer Ingelheim's formation, early days and what led us to being the global pharmaceutical company of today. (1,685 words, Jul 5, 2022)
- [Vul deze checklist met symptomen van diabetes type 2 in | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/diabetes/vul-deze-checklist-met-symptomen-van-diabetes-type-2.html): Sommige mensen kunnen jarenlang diabetes type 2 hebben zonder dat ze het weten. Hoe eerder je dit wordt vastgesteld, hoe beter de uitkomst voor de patiënt (386 words, Jul 4, 2022)
- [7 feiten over diabetes type 2​ | Boehringer Ingelheim NL](/content/nl/voor-mens/stofwisseling/diabetes/7-feiten-over-diabetes-type-2/index.html): In deze lijst vind je 7 belangrijke feiten over diabetes type 2. Beantwoord de vragen en bespreek de antwoorden met je huisarts. Ken je iemand die deze (311 words, Jul 4, 2022)
- [Timo Kurppa | Boehringer Ingelheim NL](/content/nl/carriere/timo-kurppa/index.html): Timo Kurppa is gek op het leren van nieuwe dingen en het uitdagen van de status quo. Hij zou meer tijd willen hebben om nog meer interessante nieuwe projecten (850 words, Jul 4, 2022)
- [Murat en Miquel | Boehringer Ingelheim NL](/content/nl/murat-en-miquel/index.html): Hetzelfde bedrijf. Dezelfde functie. Qua persoonlijkheid moeten ze dan wel vergelijkbaar zijn, toch? Maar dat geldt niet voor Murat en Miquel. Miquel houdt van (1,111 words, Jul 4, 2022)
- [Lourdes | Boehringer Ingelheim NL](/content/nl/lourdes/index.html): Het bedrijf wist dat ik de ambitie had om in het buitenland te wonen en door te groeien. Dus nu zit ik hier, meer dan 9000 kilometer van huis. Dankzij mijn (1,013 words, Jul 1, 2022)
- [Achter de cijfers: een patiëntgerichte verkoopaanpak | Boehringer Ingelheim NL](/content/nl/achter-de-cijfers-een-patientgerichte-verkoopaanpak.html): zegt Anton van der Sanden. “Ik doe heel veel dingen onder de paraplu van ‘verkoop’. Maar mijn baan is helemaal niet waar mensen aan denken als het over verkoop (683 words, Jul 1, 2022)
- [Συμμόρφωση – Μιλήστε ανοιχτά! | Boehringer Ingelheim GR](/content/gr/about-us/symmorfosi-miliste-anoihta/index.html): Η Boehringer Ingelheim δεσμεύεται να διεξάγει τις επιχειρηματικές της δραστηριότητες με ακεραιότητα και να συμμορφώνεται με τους ισχύοντες νόμους (442 words, Jun 30, 2022)
- [3D-geprinte hulpmiddelen bieden uitkomst voor mensen met sclerodermie | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/sclerodermie/3d-geprinte-hulpmiddelen-bieden-uitkomst-voor-mensen-met-sclerodermie.html): Sclerodermie is een zeldzame auto-immuunziekte die het bindweefsel in het lichaam aantast.¹ Omdat bindweefsel in bijna alle delen van het lichaam voorkomt (295 words, Jun 30, 2022)
- [Een unieke band: daar gaat niets boven | Boehringer Ingelheim NL](/content/nl/voor-mens/luchtwegen/sclerodermie/een-unieke-band-daar-gaat-niets-boven/index.html): Naar schatting hebben wereldwijd ruim twee miljoen mensen systemische sclerose. De aandoening treft vooral vrouwen in de bloei van hun leven. (163 words, Jun 30, 2022)
- [Boehringer Ingelheim Animal Health zet in op stamceltechnologie door overname van GST | Boehringer Ingelheim NL](/content/nl/boehringer-ingelheim-animal-health-zet-op-stamceltechnologie-door-overname-van-gst.html): Boehringer Ingelheim, een van de grootste bedrijven op het gebied van diergezondheid, heeft het Belgische veterinaire biotechbedrijf Global Stem cell Technology (973 words, Jun 30, 2022)
- [1948 – 1988: uitbreiding naar het buitenland | Boehringer Ingelheim NL](/content/nl/over-ons/wie-wij-zijn/geschiedenis/1948-1988-uitbreiding-naar-het-buitenland/index.html): 1948-1988 (365 words, Jun 29, 2022)
- [Boehringer Ingelheim lid Consortium Antibiotica- en Medicijnresten uit Water | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/boehringer-ingelheim-lid-consortium-antibiotica-en-medicijnresten-uit-water.html): Boehringer Ingelheim is lid geworden van het Nederlandse Consortium Antibiotica- en Medicijnresten uit Water, een publiek-private samenwerking die (462 words, Jun 29, 2022)
- [Hoe ze in de familie Muñoz samen omgaan met een zeldzame ziekte​ | Boehringer Ingelheim NL](/content/nl/over-ons/duurzame-ontwikkeling/onze-verhalen/hoe-ze-de-familie-munoz-samen-omgaan-met-een-zeldzame-ziekte.html): Elizabeth en Francisco Muñoz zijn de moeder en vader van Stephanie (28) en Carolina (37), twee zussen die niet alleen in leeftijd, maar ook op het oog flink (101 words, Jun 29, 2022)
- [Indienen van een sponsorverzoek | Boehringer Ingelheim NL](/content/nl/indienen-van-een-sponsorverzoek/index.html): Wanneer maakt een project kans op sponsoring? De belangrijkste voorwaarde is dat het te sponsoren project gerelateerd is aan waar Boehringer Ingelheim voor staat (424 words, Jun 29, 2022)
- [Gebruiksvoorwaarden | Boehringer Ingelheim NL](/content/nl/gebruiksvoorwaarden/index.html): Deze website is een internationale informatiebron van ons hoofdkantoor in Ingelheim, Duitsland en is bedoeld om informatie te verstrekken over onze wereldwijde (1,122 words, Jun 28, 2022)
- [Europe needs a vibrant research eco-system | Boehringer Ingelheim](/content/about-us/corporate-profile/europe-needs-vibrant-research-eco-system/index.html): At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe. (919 words, Jun 28, 2022)
- [Joint venture to fight Antimicrobial Resistance | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/joint-venture-fight-antimicrobial-resistance/index.html): Joint venture to fight Antimicrobial Resistance (1,088 words, Jun 28, 2022)
- [Welcome to the Products page| Boehringer Ingelheim USA](/content/pro/us/products/index.html): Click to see a list of the Boehringer Ingelheim prescription medications that are available in the United States (195 words, Jun 24, 2022)
- [Datenschutzinformation zur Pharmakovigilanz für unsere Tiergesundheitsprodukte | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-zur-pharmakovigilanz-fuer-unsere-tiergesundheitsprodukte.html): Datenschutzinformation zur Pharmakovigilanz für unsere Tiergesundheitsprodukte (1,238 words, Jun 17, 2022)
- [Datenschutzerklärung | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutzerklaerung-0/index.html): Informieren Sie sich welche Ihrer personenbezogenen Daten zu welchen Zwecken Boehringer Ingelheim im Zusammenhang mit dieser Website verarbeitet. (1,024 words, Jun 17, 2022)
- [111年6月17日起JARDIANCE®恩排糖® 膜衣錠10毫克 可用於紐約心臟學會(NYHA)定義之第二級至第四級的心臟衰竭成人病人， 能降低心血管死亡和心臟衰竭住院風險，與延緩eGFR下降 | Boehringer Ingelheim TW](/content/tw/human-health/heart-diseases/111nian6yue17riqijardianceenpaitang-moyiding10haoke.html): 111年6月17日起JARDIANCE®恩排糖® 膜衣錠10毫克 可用於紐約心臟學會(NYHA)定義之第二級至第四級的心臟衰竭成人病人， 能降低心血管死亡和心臟衰竭住院風險，與延緩eGFR下降 (148 words, Jun 17, 2022)
- [Let’s meet the challenge | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-zwierzat/lets-meet-challenge/index.html): Let’s meet the challenge (109 words, Jun 14, 2022)
- [Heart murmur in dogs: symptoms and how to treat it | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/heart-murmur-dogs-symptoms-and-how-treat-it/index.html): Monitoring your dog’s heart can save its life (897 words, Jun 13, 2022)
- [Living with type 2 diabetes | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/diabetes/living-type-2-diabetes/index.html): People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease. (804 words, Jun 1, 2022)
- [Professor Gregory Lip introduces the GLORIA™-AF Registry | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/atrial-fibrillation/professor-gregory-lip-introduces-gloria-af-registry.html): In this video, Prof. Gregory Lip introduces the GLORIA™-AF Registry Program. Click here to watch the video and to learn more about the program. (110 words, May 26, 2022)
- [Übersicht über Referenzen dieser Webseite | Diabetesherz.at](/content/patient/at/diabetesherz/referenzen/index.html): Hier führen wir für Sie eine Übersicht über die auf der Website Diabetesherz.at referenzierten Quellen auf. Informieren Sie sich über unsere Referenzen. (30 words, May 26, 2022)
- [Videos zu Diabetes und Folgeerkrankungen | Diabetesherz.at](/content/patient/at/diabetesherz/diabetes-videos/index.html): In unseren Videos zu Diabetes mellitus informieren wir Sie über die Erkrankung und verraten Ihnen, warum es wichtig ist, den Blutzucker checken zu lassen. (114 words, May 26, 2022)
- [Diabetes Typ 2 und gesundes Leben | Diabetesherz.at](/content/patient/at/diabetesherz/gesund-leben/index.html): Gesunde Ernährung und Bewegung könnte Ihr Leben mit Diabetes entscheidend verändern. Informieren Sie sich über gesunden Lebensstil und Diabetes Vorbeugung. (1,275 words, May 26, 2022)
- [Folgeerkrankungen von Diabetes Typ 2 | Diabetesherz.at](/content/patient/at/diabetesherz/folgeerkrankungen-von-diabetes/index.html): Erfahren Sie alles, was Typ-2-Diabetiker über Herz-Kreislauf-Erkrankungen, andere diabetische Folgeerkrankungen und besondere Risiken für Frauen wissen sollten. (1,439 words, May 25, 2022)
- [Was ist Diabetes? Symptome und Überblick | Diabetesherz.at](/content/patient/at/diabetesherz/was-ist-diabetes/index.html): Was macht Diabetes aus und wie verändert er unser Leben? Warum sind Früherkennung und Behandlung so wichtig? Erfahren Sie mehr über Diabetes und seine Symptome. (1,931 words, May 24, 2022)
- [Diabetes und Herz-Kreislauf-Erkrankungen | Diabetesherz.at](/content/patient/at/diabetesherz/index.html): Wir informieren, wie Sie das Risiko einer Herz-Kreislauf-Erkrankung bei Diabetes mit ausgewogener Ernährung und körperlicher Betätigung reduzieren können. (308 words, May 24, 2022)
- [Beneficio mutuo: centrarse en el paciente en los ensayos clínicos | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/el-paciente-nuestra-prioridad/beneficio-mutuo-centrarse-en-el-paciente-en-los-ensayos-clinicos.html): Beneficio mutuo: centrarse en el paciente en los ensayos clínicos (772 words, May 18, 2022)
- [Big hearts united to help animals in Ukraine | Boehringer Ingelheim](/content/about-us/corporate-profile/big-hearts-united-help-animals-ukraine/index.html): Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe. (891 words, May 4, 2022)
- [Ukraine Help: The heroes of Mainz-Finthen | Boehringer Ingelheim](/content/about-us/who-we-are/ukraine-help-heroes-mainz-finthen/index.html): Travis Kelley helps Olena and Wasyl flee from Ukraine. This is the record of a dramatic and emotional rescue operation. (1,134 words, Apr 21, 2022)
- [Stem cell therapy for tendon and ligament injuries in horses | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/stem-cell-therapy-tendon-and-ligament-injuries-horses.html): A tendon or ligament injury can be devastating for horse owners, riders and trainers. Our new stem cell product improves the quality of healing. (393 words, Apr 19, 2022)
- [1990-2025: Value through Innovation | Boehringer Ingelheim](/content/about-us/who-we-are/history/1990-2025-value-through-innovation/index.html): The Boehringer Ingelheim history from 1990 to 2025, with milestones (1,381 words, Apr 12, 2022)
- [1990-2022: valor a través de la innovación | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/historia/1990-2022-valor-traves-de-la-innovacion/index.html): 1990-2022: valor a través de la innovación (1,544 words, Apr 12, 2022)
- [1990-2022: Wartość dzięki innowacjom | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/1990-2022-wartosc-dzieki-innowacjom/index.html): 1990-2022: Wartość dzięki innowacjom (1,169 words, Apr 12, 2022)
- [1990-2022: Ценность через инновации | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/history/1990-2022-cennost-cherez-innovacii/index.html): 1990-2022: Ценность через инновации (1,381 words, Apr 12, 2022)
- [1948-1990: Going global | Boehringer Ingelheim](/content/about-us/who-we-are/history/1948-1990-going-global/index.html): The Boehringer Ingelheim history from 1948-1990, with milestones (1,274 words, Apr 12, 2022)
- [Historia Boehringer Ingelheim w latach 1948-1990, | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/historia-boehringer-ingelheim-w-latach-1948-1990/index.html): Historia Boehringer Ingelheim w latach 1948-1990, (1,228 words, Apr 12, 2022)
- [История (1948–1990): Выход на глобальный уровень | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/history/istoriya-1948-1990-vykhod-na-globalnyy-uroven/index.html): История (1948–1990): Выход на глобальный уровень (1,274 words, Apr 12, 2022)
- [1885-1948: Innovative beginnings | Boehringer Ingelheim](/content/about-us/who-we-are/history/1885-1948-innovative-beginnings/index.html): The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products (1,143 words, Apr 12, 2022)
- [Historia (1885-1948): Nowatorskie początki | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/historia-1885-1948-nowatorskie-poczatki/index.html): Historia (1885-1948): Nowatorskie początki (1,220 words, Apr 12, 2022)
- [Історія (1885–1948 рр.): витоки інноваційності | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/history/istoriya-1885-1948-rr-vitoki-innovaciynosti/index.html): Історія (1885–1948 рр.): витоки інноваційності (40 words, Apr 12, 2022)
- [Терапевтични области | Boehringer Ingelheim (България)](/content/pro/bg/index.html): Boehringer Ingelheim, водеща биофармацевтична компания, работи върху революционни терапии в области на здравеопазването от значима медицинска неободимост. (239 words, Apr 12, 2022)
- [A Unique Bond: human and animal health | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/unique-bond-human-and-animal-health-0/index.html): At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets. Learn more here. (211 words, Apr 11, 2022)
- [We are independent, family-owned | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/we-are-independent-family-owned-0/index.html): At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more. (111 words, Apr 8, 2022)
- [Our Purpose | Boehringer Ingelheim IN](/content/in/our-purpose/index.html): Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose. (61 words, Apr 7, 2022)
- [Performance Indicators | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/performance-indicators/index.html): Performance indicators concerning Environment Health and Safety (EHS) are summarized here. (1,594 words, Apr 5, 2022)
- [Performance Indicators | Boehringer Ingelheim ZA](/content/za/about-us/sustainable-development/more-green/performance-indicators/index.html): Performance Indicators (1,253 words, Apr 5, 2022)
- [Boehringer Ingelheim good 2021 business performance | Boehringer Ingelheim](/content/media-overview/press-releases/boehringer-ingelheim-good-2021-business-performance.html): 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim. (1,660 words, Apr 3, 2022)
- [Improving Access to Stroke Care | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/improving-access-stroke-care/index.html): Boehringer Ingelheim’s Angels Initiative is featured as a Best Practice example by the Access to Medicine Initiative. Click here to find out more. (485 words, Mar 31, 2022)
- [Нашата цел | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/culture/nashata-cel/index.html): Защо съществуваме (156 words, Mar 30, 2022)
- [Nasz cel | Boehringer Ingelheim PL](/content/pl/nasz-cel/index.html): Nasz cel - dlaczego istniejemy (60 words, Mar 30, 2022)
- [Our Purpose | Boehringer Ingelheim RU](/content/ru/our-purpose/index.html): Наш ФОКУС (64 words, Mar 30, 2022)
- [Náš zámer | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/culture/nas-zamer/index.html): Náš zámer (55 words, Mar 30, 2022)
- [Наша мета | Boehringer Ingelheim UA](/content/ua/nasha-meta/index.html): Наша мета - Чому ми існуємо (64 words, Mar 30, 2022)
- [A Unique Bond: by my side | Boehringer Ingelheim IN](/content/in/unique-bond-my-side/index.html): Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life. Click here to watch the video. (43 words, Mar 30, 2022)
- [Making Every Second Count | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/stroke/making-every-second-count/index.html): The Angels initiative honours emergency response teams making a difference for stroke patients. Click here to find out and learn more information. (100 words, Mar 30, 2022)
- [EFPIA disclosure | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/efpia-disclosure-0/index.html): Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations and disclosures of transfers of value (ToVs) to HCPs and HCOs. (820 words, Mar 30, 2022)
- [3 things you should know about avian influenza | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/3-things-you-should-know-about-avian-influenza/index.html): Poultry farming communities across the globe are grappling once again with avian influenza. Click here to find out three things you should know about it. (505 words, Mar 29, 2022)
- [A Unique Bond: friends in need | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/atrial-fibrillation/unique-bond-friends-need/index.html): After suffering from a stroke, Phil’s connection with Valle helped change his life (78 words, Mar 29, 2022)
- [Stroke, Don’t Stay at Home | Boehringer Ingelheim IN](/content/in/stroke-dont-stay-home/index.html): During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time. (202 words, Mar 29, 2022)
- [Intrapreneurship | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/intrapreneurship/index.html): Together with our customers, we come up with innovative ideas to respond to changing markets. Click here to learn more about intrapreneurship at BI. (70 words, Mar 28, 2022)
- [We create Value through Innovation for our customers | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/we-create-value-through-innovation-our-customers/index.html): We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles. (174 words, Mar 28, 2022)
- [More Cherished Moments | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/more-cherished-moments/index.html): Innovation in healthcare is about more than just a new approach or technology. We innovate for better health of people and animals. Learn more here. (86 words, Mar 28, 2022)
- [Fabio Paganini fostering inclusion & agility in AH | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/fabio-paganini-fostering-inclusion-agility-ah/index.html): In the second episode of the I in D & I audio series, our interviewer, Jochen Werner speaks with Fabio Paganini, Region Head, Animal Health (ALAMEA). (348 words, Mar 28, 2022)
- [Global Code of Conduct | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/culture/global-code-conduct/index.html): Our Code of Conduct demonstrates for each and every one that integrity is “part of our DNA”. Click here to learn more about our Code of Conduct. (233 words, Mar 28, 2022)
- [best-practice-innovative-Corporate-Citizenship-survey | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/best-practice-innovative-corporate-citizenship-survey.html): Boehringer Ingelheim is named best practice example for innovative Corporate Citizenship in Germany by CC-survey. Click here to learn more about this. (365 words, Mar 28, 2022)
- [Supporting local communities by offsetting carbon emissions | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/supporting-local-communities-offsetting-carbon-emissions.html): Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this. (610 words, Mar 28, 2022)
- [Be Green Brazil – powered by nature | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/be-green-brazil-powered-nature/index.html): At Boehringer Ingelheim’s Solana farm Adrian von Treuenfels and his team cultivate the plants that supply the active ingredient for different drugs. (315 words, Mar 28, 2022)
- [A Unique Bond: a brotherhood like no other | Boehringer Ingelheim IN](/content/in/human-health/metabolic-diseases/diabetes/unique-bond-brotherhood-no-other/index.html): After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness. (511 words, Mar 25, 2022)
- [Patient Voices...Ian's Story | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/stroke/patient-voicesians-story/index.html): Watch the video to find out more about how Ian manages AF in his day to day life. Ian discusses the importance of educating yourself and more. (30 words, Mar 24, 2022)
- [In France, it’s time to be(e) | Boehringer Ingelheim IN](/content/in/animal-health/our-responsibility/france-its-time-bee/index.html): How about producing honey and contributing to environmental sustainability during your work hours? Click here to read more about this story. (598 words, Mar 24, 2022)
- [How do I treat mild to moderate renal impairment with Pradaxa® | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/atrial-fibrillation/how-do-i-treat-mild-moderate-renal-impairment-pradaxa.html): Watch experts discuss how to calculate the renal function of the patients and the appropriate use of Pradaxa® in patients. Click here to watch the video. (85 words, Mar 24, 2022)
- [Spotlight on poultry chicken trends | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/spotlight-poultry-chicken-trends/index.html): What’s going on in regional poultry markets around the globe? We asked some of our customers! Click here to find out what they had to say and more. (706 words, Mar 24, 2022)
- [Boehringer Ingelheim România | Portal pentru profesioniștii din domeniul sănătății](/content/pro/ro/index.html): Boehringer Ingelheim Romania oferă profesioniștiilor din domeniul sănătății noutăți legate de produsele și ariile terapeutice pe care le reprezintă (271 words, Mar 24, 2022)
- [Advances in vectored vaccines for poultry | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/advances-vectored-vaccines-poultry/index.html): Click here to learn how vaccine design technologies have made huge advances in recent years to overcome challenges that conventional vaccines do not meet. (1,072 words, Mar 24, 2022)
- [Transboundary and emerging diseases | Boehringer Ingelheim IN](/content/in/transboundary-and-emerging-diseases/index.html): We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks. (391 words, Mar 24, 2022)
- [Marek's Disease Poultry Chicken | Boehringer Ingelheim IN](/content/in/animal-health/livestock/poultry/mareks-disease-poultry-chicken/index.html): Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here. (673 words, Mar 24, 2022)
- [Stem cells a new frontier | Boehringer Ingelheim IN](/content/in/animal-health/companion-animals/stem-cells-new-frontier/index.html): Stem cells may be a game changer for the development of new veterinary treatments. Click here to read this story and find out more information. (1,052 words, Mar 23, 2022)
- [Our Commitment | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-commitment/our-commitment/index.html): We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more. (557 words, Mar 23, 2022)
- [Stroke Prevention in AF | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/atrial-fibrillation/stroke-prevention-af/index.html): Click here for more information on Stroke Prevention in Atrial Fibrillation (791 words, Mar 23, 2022)
- [What can the patient do? | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/what-can-patient-do/index.html): Be aware and know your source. (469 words, Mar 23, 2022)
- [EMPA-KIDNEY trial early stop due to positive efficacy | Boehringer Ingelheim](/content/human-health/crm-health/kidney-health/chronic-kidney-disease/empa-kidney-trial-early-stop-due-positive-efficacy/index.html): EMPA-KIDNEY, the largest SGLT2 inhibitor trial in chronic kidney disease, will stop early due to clear evidence of positive efficacy (1,148 words, Mar 22, 2022)
- [World Recycling Day: Closing the Loop | Boehringer Ingelheim](/content/za/about-us/sustainable-development/more-green/world-recycling-day-closing-loop/index.html): Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential (853 words, Mar 22, 2022)
- [Phase-III-Studie EMPA-KIDNEY | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/phase-iii-studie-empa-kidney/index.html): Auf Empfehlung des unabhängigen Datenkontrollkomitees wird die EMPA-KIDNEY-Studie zu CKD wegen positiver Wirksamkeit vorzeitig beendet. Lesen Sie weiter! (1,337 words, Mar 18, 2022)
- [Welt Recycling Tag: Die Green IT Allianz | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/welt-recycling-tag-die-green-it-allianz/index.html): Boehringer Ingelheim und Arbeit für Menschen mit Behinderung (AfB) führen ihre 2016 geschlossene Partnerschaft auch 2022 fort. Lesen Sie weiter! (594 words, Mar 17, 2022)
- [Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/boehringer-ingelheims-board-managing-directors-boehringer-ingelheim.html): Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities. (477 words, Mar 15, 2022)
- [The Supplier Code of Conduct | Boehringer Ingelheim IN](/content/in/about-us/ethics-compliance/supplier-code-conduct/index.html): Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements. (524 words, Mar 15, 2022)
- [Empowering all employees | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/empowering-all-employees/index.html): Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession. Find out more about why we are a Global Top Employer. (713 words, Mar 15, 2022)
- [The Angels Initiative | Boehringer Ingelheim IN](/content/in/human-health/heart-diseases/stroke/angels-initiative/index.html): The Angels Initiative is a unique healthcare initiative to improve acute care for people who have just suffered a stroke (433 words, Mar 15, 2022)
- [Boosting performance with an inclusive performance culture | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/boosting-performance-inclusive-performance-culture/index.html): Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here. (509 words, Mar 15, 2022)
- [TwistPak Mixing platform for swine vaccines | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/twistpak-mixing-platform-swine-vaccines/index.html): TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds (839 words, Mar 14, 2022)
- [More Health Overview | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/more-health-overview/index.html): Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more. (488 words, Mar 14, 2022)
- [Collaboration to fight NCDs | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/collaboration-fight-ncds/index.html): 70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed. (429 words, Mar 14, 2022)
- [Improving Access to Healthcare | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/more-health-people-animals/improving-access-healthcare/index.html): According to the UN Sustainable Development Goals, almost half of the global population is not covered by essential health services. Find out more. (639 words, Mar 14, 2022)
- [One step further in fighting rabies in Vietnam | Boehringer Ingelheim IN](/content/in/about-us/sustainable-development/our-stories/one-step-further-fighting-rabies-vietnam/index.html): A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages. (471 words, Mar 14, 2022)
- [Living Independence | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/history/living-independence/index.html): Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885. Click here to learn more. (545 words, Mar 14, 2022)
- [Equestrian sports horse health awareness Alex Hua Tian | Boehringer Ingelheim](/content/animal-health/animals-we-support/horses/equestrian-sports-horse-health-awareness-alex-hua-tian.html): Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China. (845 words, Mar 7, 2022)
- [International Women's Day | Boehringer Ingelheim](/content/za/about-us/sustainable-development/more-potential/international-womens-day/index.html): We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow” (2,181 words, Mar 4, 2022)
- [Kasutustingimused | Boehringer Ingelheim](/content/pro/ee/kasutustingimused/index.html): Kasutustingimused | Boehringer Ingelheim (1,032 words, Mar 3, 2022)
- [Portaal tervishoiutöötajale | Boehringer Ingelheim](/content/pro/ee/index.html): Boehringer Ingelheim´i teraapiavaldkonnad - diabeet, kardiovaskulaarhaigused pulmonoloogia, onkoloogia | Boehringer Ingelheim (116 words, Mar 1, 2022)
- [Boehringer Ingelheim kompānijas aktualitātes | Boehringer Ingelheim](/content/pro/lv/index.html): Boehringer Ingelheim kompānijas terapeitiskās jomas - diabēts, sirds un asinsvadu slimības, pulmonoloģija, onkoloģija | Boehringer Ingelheim" (220 words, Mar 1, 2022)
- [Biotherapeutics Discovery | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/biotherapeutics-discovery/index.html): We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients. (376 words, Mar 1, 2022)
- [Solidarity with Ukraine | Boehringer Ingelheim AT](/content/at/en/about-us/solidarity-ukraine/index.html): Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations. (918 words, Feb 28, 2022)
- [Szolidaritás Ukrajnával | Boehringer Ingelheim HU](/content/hu/szolidaritas-ukrajnaval/index.html): A Boehringer Ingelheim elítéli az Ukrajna elleni katonai agressziót (323 words, Feb 28, 2022)
- [Data Protection Notice for Members of Healthcare Professions in Animal Health | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-protection-notice-members-healthcare-professions-animal-health.html): Data Protection Notice for Members of Healthcare Professions in Animal Health (2,117 words, Feb 24, 2022)
- [Datenschutzerklärung für Zoom | Boehringer Ingelheim DE](/content/de/datenschutzerklaerung-fuer-zoom/index.html): Datenschutzerklärung für Zoom. Informieren Sie sich über wie wir mit personen-bezogenen Daten im Zusammenhang mit Zoom umgehen. (1,770 words, Feb 24, 2022)
- [FDA Grants BI 1015550 Breakthrough Therapy Designation for IPF | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/fda-grants-bi-1015550-breakthrough-therapy-designation-ipf.html): Announcement that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to the novel investigational therapy, BI 1015550, for the treatment of idiopathic pulmonary fibrosis (IPF) (564 words, Feb 24, 2022)
- [Rare Diseases: Rare but not alone | Boehringer Ingelheim](/content/za/human-health/our-responsibility/patient-centricity/rare-diseases-rare-not-alone/index.html): We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. (345 words, Feb 21, 2022)
- [Diabetes dog symptoms chronic disease management | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/diabetes-dog-symptoms-chronic-disease-management/index.html): Learn about the symptoms of canine diabetes and how to manage the disease. (524 words, Feb 18, 2022)
- [Women in STEM 2022 | Boehringer Ingelheim](/content/za/about-us/sustainable-development/our-stories/women-stem-2022/index.html): Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. (752 words, Feb 7, 2022)
- [Data Privacy-Pharmacovigilance in Animal Health | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-privacy-pharmacovigilance-animal-health/index.html): Data Privacy Notice for Pharmacovigilance in Animal Health (1,319 words, Jan 28, 2022)
- [Datenschutz Sli.do Umfrage Teilnehmer | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutz-slido-umfrage-teilnehmer/index.html): Datenschutzhinweis für Sli.do. Informieren Sie sich über wie wir mit personen-bezogenen Daten von Sli.do Umfrage Teilnehmer umgehen. (428 words, Jan 28, 2022)
- [emperor-preserved-chmp-positive-opinion | Boehringer Ingelheim](/content/hk/en/human-health/heart-diseases/heart-failure/jiyuzaishexuefenshubaoliudechengrenxinlishuaijiehuanzhezhongqiansuoweiyoudehuoyichmpfabulekuodajardi.html): CHMP issues positive opinion for the treatment of adults with symptomatic chronic heart failure (1,622 words, Jan 28, 2022)
- [Award: Boehringer Ingelheim is Global Top Employer 2022 | Boehringer Ingelheim](/content/about-us/who-we-are/award-boehringer-ingelheim-global-top-employer-2022.html): The Top Employers Institute awarded Boehringer Ingelheim for the second year in a row a “Global Top Employer”, one of the world’s 11 best employers. (508 words, Jan 19, 2022)
- [Conocer al enemigo: PRRS y PCVD | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/porcino/conocer-al-enemigo-prrs-y-pcvd/index.html): Conocer al enemigo: PRRS y PCVD (827 words, Jan 14, 2022)
- [Meat consumption market trends growth sustainability | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/meat-consumption-market-trends-growth-sustainability.html): In this article, we’re taking a look at global developments while highlighting one of the most important meat markets of the future: the Asian continent. (712 words, Jan 12, 2022)
- [El futuro del consumo de carne | Boehringer Ingelheim ES](/content/es/salud-animal/salud-publica-veterinaria/el-futuro-del-consumo-de-carne/index.html): El futuro del consumo de carne (749 words, Jan 12, 2022)
- [Pysy ajantasalla! | Boehringer Ingelheim HCP](/content/pro/fi/index.html): Kardiologian professori Juhani Junttila kertoo ESC guidelines-päivityksistä (158 words, Dec 21, 2021)
- [Ökologischer Fußabdruck | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/oekologischer-fussabdruck/index.html): Boehringer Ingelheim reduziert seinen ökologischen Fußabdruck und strebt bis 2030 CO2-Neutralität durch nachhaltige Projekte und Partnerschaften an. (869 words, Dec 14, 2021)
- [Damit Wasser trinkbar bleibt | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-green/damit-wasser-trinkbar-bleibt/index.html): Menschen können ohne Wasser nicht überleben – und auch die Herstellung von Medikamenten erfordert sauberes Trinkwasser. (815 words, Dec 14, 2021)
- [More Green am Standort Wien | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-green-fuer-unseren-planeten/more-green-am-standort-wien/index.html): Unsere Säule More Green beinhaltet Umweltinitiativen, die viele unterschiedliche Bereiche abdecken. (496 words, Dec 14, 2021)
- [More Green: Résumé | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-green/more-green-resume/index.html): Notre pilier More Green comprend des initiatives environnementales qui couvrent de nombreux domaines différents. (539 words, Dec 14, 2021)
- [More Green: Überblick | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-green/more-green-ueberblick/index.html): Unsere Säule More Green beinhaltet Umweltinitiativen, die viele unterschiedliche Bereiche abdecken. (407 words, Dec 14, 2021)
- [More Green: Überblick | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/more-green-ueberblick/index.html): Auf dieser Seite erhalten Sie ein Überblick über die Aspekte, Aufgaben und Ziele unserer Umweltinitiative More Green. (429 words, Dec 14, 2021)
- [Co-Kreation mit Communities | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/co-kreation-mit-communities/index.html): Starke Netzwerke und Zusammenarbeit – das sind zentrale Elemente unserer Initiative Making More Health. (387 words, Dec 14, 2021)
- [Co-Kreation mit Communities | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/co-kreation-mit-communities/index.html): Starke Netzwerke und Zusammenarbeit – das sind zentrale Elemente unserer Initiative Making More Health. (484 words, Dec 14, 2021)
- [Mehr Gesundheit in benachteiligten Communities | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/mehr-gesundheit-benachteiligten-communities/index.html): In Zeiten der Globalisierung und sozialen Vernetzung greifen eindimensionale Lösungsansätze oft nicht mehr. Komplexe Herausforderungen erfordern komplexe Lösungen. (772 words, Dec 14, 2021)
- [More Potential: Overview | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/more-potential-overview/index.html): Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most. (579 words, Dec 14, 2021)
- [More Potential: Résumé | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-potential/more-potential-resume/index.html): La société est confrontée à de nombreux défis - les communautés défavorisées sont souvent les plus touchées. (563 words, Dec 14, 2021)
- [More Potential: Übersicht | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/more-potential-uebersicht/index.html): Die Gesellschaft steht vor vielfältigen Herausforderungen – benachteiligte Communities sind davon oft am stärksten betroffen. (456 words, Dec 14, 2021)
- [Nachhaltige Gesundheit | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/nachhaltige-gesundheit/index.html): Boehringer Ingelheim fördert nachhaltige Gesundheit, soziale Verantwortung und Chancengleichheit für Mitarbeitende und Communitys weltweit. (681 words, Dec 14, 2021)
- [Nicht übertragbare Krankheiten | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-health/nicht-uebertragbare-krankheiten/index.html): Weltweit sind 70 Prozent aller Todesfälle auf nicht übertragbare Krankheiten zurückzuführen. Menschen aus Ländern mit geringem oder mittlerem Einkommen sind besonders betroffen. (530 words, Dec 13, 2021)
- [Rettung bei Schlaganfall | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/rettung-bei-schlaganfall/index.html): Kaum ein medizinischer Notfall ist so verheerend wie ein Schlaganfall – und jedes Jahr erleiden ihn weltweit über 15 Millionen Menschen. (587 words, Dec 13, 2021)
- [Improving Access to Healthcare | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/improving-access-healthcare/index.html): According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care. (519 words, Dec 13, 2021)
- [Zugang zu Gesundheitsversorgung | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/zugang-zu-gesundheitsversorgung/index.html): Gemäß den UN-Zielen für die Nachhaltige Entwicklung hat fast die Hälfte der Weltbevölkerung keinen Zugang zu grundlegender Gesundheitsversorgung. (555 words, Dec 13, 2021)
- [More Health: Überblick | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-health-fuer-menschen-tiere/more-health-ueberblick/index.html): Als Unternehmen, das an der Schnittstelle zwischen Human- und Tiermedizin agiert, haben wir einzigartige Möglichkeiten, uns für benachteiligte Bevölkerungsgruppen einzusetzen. (464 words, Dec 13, 2021)
- [More Health: Overview | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-health/more-health-overview/index.html): As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations. (241 words, Dec 13, 2021)
- [More Health: Résumé | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-health/more-health-resume/index.html): En tant qu'entreprise à l'interface entre la médecine humaine et la médecine vétérinaire, nous avons des opportunités uniques de nous engager auprès des populations défavorisées. (571 words, Dec 13, 2021)
- [More Health: Überblick | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-health/more-health-ueberblick/index.html): Als Unternehmen, das an der Schnittstelle zwischen Human- und Tiermedizin agiert, haben wir einzigartige Möglichkeiten, uns für benachteiligte Bevölkerungsgruppen einzusetzen. (452 words, Dec 13, 2021)
- [More Health: Überblick | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/more-health-ueberblick/index.html): Als Unternehmen, das an der Schnittstelle zwischen Human- und Tiermedizin agiert, setzen wir uns für benachteiligte Bevölkerungsgruppen ein. (503 words, Dec 13, 2021)
- [Warum wir an Partnerschaften glauben | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/nachhaltige-entwicklung-unser-engagement/warum-wir-partnerschaften-glauben/index.html): Wir setzen auf die Kraft von Partnerschaften und Allianzen, um noch mehr Therapien zu entwickeln, die Leben verändern können. (340 words, Dec 13, 2021)
- [Warum wir an Partnerschaften glauben | Boehringer Ingelheim DE](/content/de/warum-wir-partnerschaften-glauben/index.html): Wir setzen auf die Kraft von Partnerschaften und Allianzen, um noch mehr Therapien zu entwickeln, die Leben verändern können. (36 words, Dec 13, 2021)
- [Unser Ansatz | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/nachhaltige-entwicklung-unser-engagement/unser-ansatz/index.html): Unser Ziel ist es die Gesundheit von Menschen und Tieren zu verbessern – jetzt und in Zukunft. Deshalb haben wir eine ambitionierte Nachhaltigkeitsstrategie entwickelt: Sustainable Development – For Generations. (328 words, Dec 13, 2021)
- [Unser Ansatz | Boehringer Ingelheim DE](/content/de/unser-ansatz/index.html): Entdecken Sie mehr über unsere Nachhaltigkeitsstrategie, zielt darauf ab, die Gesundheit von Menschen und Tieren jetzt und in Zukunft zu verbessern. (346 words, Dec 13, 2021)
- [Unser Beitrag | Boehringer Ingelheim AT](/content/at/de/ueber-uns/nachhaltige-entwicklung/more-potential-fuer-communities-mitarbeitende/unser-beitrag/index.html): Die Menschheit steht vor großen Herausforderungen. Wir glauben, dass wir stets mehr tun können – für uns und für kommende Generationen. (541 words, Dec 13, 2021)
- [Unser Beitrag | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/more-potential/unser-beitrag/index.html): Die Menschheit steht vor großen Herausforderungen. Wir glauben, dass wir stets mehr tun können – für uns und für kommende Generationen. (485 words, Dec 13, 2021)
- [Unser Beitrag | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-potential/unser-beitrag/index.html): Die Menschheit steht vor großen Herausforderungen. Wir glauben, dass wir stets mehr tun können – für uns und für kommende Generationen. (487 words, Dec 13, 2021)
- [Unser Engagement | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/unser-engagement/index.html): Innovationen in der Medizin verbessern das Leben von Menschen und Tieren. Wir sind stolz auf unsere Beiträge zu diesem Engagement. Erfahren Sie mehr! (530 words, Dec 13, 2021)
- [Our Commitment | Boehringer Ingelheim AT](/content/at/en/about-us/sustainable-development/more-potential/our-commitment/index.html): Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations. (488 words, Dec 13, 2021)
- [Access to Health Care | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/access-health-care/index.html): Access to Health Care (266 words, Dec 1, 2021)
- [Gebärdensprach-Avatar | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/gebaerdensprach-avatar/index.html): Der Gebärdensprach-Avatar von Boehringer Ingelheim stellt komplexe Informationen im Beipackzettel einfach, verständlich und barrierefrei zur Verfügung. (537 words, Dec 1, 2021)
- [HER2 Inhibitor | Clinical Research | InOncology](/content/pro/us/inoncology/our-pipeline/her2-tki/index.html): Learn about our ongoing trials and research on a HER2 Inhibitor targeting wild-type and mutated HER2 receptors, as a potential monotherapy (765 words, Nov 30, 2021)
- [Research Beyond Borders | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/research-beyond-borders/index.html): Das Research Beyond Borders-Team verfolgt innovative Ansätze über die Fokusgebiete von Boehringer Ingelheim hinaus. (223 words, Nov 19, 2021)
- [Grass Roots | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/grass-roots/grass-roots/index.html): Mit dem globalen “Grass-Roots”-Programm fördert Boehringer Ingelheim aufstrebende Biotech-Start-ups. (260 words, Nov 19, 2021)
- [Netzhauterkrankungen | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/netzhauterkrankungen/index.html): Eines der Fokusgebiete bei Boehringer Ingelheim sind Netzhauterkrankungen. Wir haben das Ziel, innovative Lösungen für Menschen mit Sehstörungen zu entwickeln. (276 words, Nov 18, 2021)
- [Herz- und Stoffwechselerkrankungen | Boehringer Ingelheim DE](/content/de/wissenschaft-innovation/innovationen-der-humanmedizin/fokusgebiete/herz-und-stoffwechselerkrankungen/index.html): Eines der Fokusgebiete bei Boehringer Ingelheim sind Herz- und Stoffwechselerkrankungen mit dem Ziel einen hohen therapeutischen Bedarf zu decken. (497 words, Nov 18, 2021)
- [Standort Duluth | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-duluth/index.html): Erfahren Sie mehr über unsere Forschung und Entwicklung in den Bereichen Tiergesundheit und Biopharmazie in den USA. (241 words, Nov 16, 2021)
- [Yamagata | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/yamagata/index.html): El centro de Yamagata, Japón, está dedicado a la producción de productos farmacéuticos humanos para el mercado japonés. (274 words, Nov 15, 2021)
- [Ямагата | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/yamagata/index.html): Ямагата (166 words, Nov 15, 2021)
- [Duluth | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/duluth/index.html): Con Duluth, Georgia, como sede del negocio de Salud Animal, la región de alrededor de Atlanta ofrece soluciones mundiales de Salud Animal. (286 words, Nov 15, 2021)
- [Duluth | Boehringer Ingelheim](/content/sites-around-world/duluth/index.html): Duluth (248 words, Nov 15, 2021)
- [Фримонт | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/frimont/index.html): Фримонт (115 words, Nov 15, 2021)
- [Fremont | Boehringer Ingelheim](/content/sites-around-world/fremont/index.html): Upstream process development in a high throughput automated bioreactor system. (218 words, Nov 15, 2021)
- [Boehringer Ingelheim Social Engagements | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/boehringer-ingelheim-social-engagements/index.html): BI Social Engagements unterstützt mit 50 Mio Euro den Aufbau von Lösungen und Sozialunternehmen die das Ziel verfolgen, systemischen Wandel voranzutreiben. (479 words, Nov 11, 2021)
- [Making More Health Together 2021 | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/making-more-health-together-2021/index.html): 1.200 Teilnehmende aus der ganzen Welt auf virtueller Konferenz am 11.-12. November Lesen Sie weiter! (812 words, Nov 11, 2021)
- [Innovative Cancer Therapies & Clinical Trials | InOncology](/content/pro/inoncology/index.html): Discover ongoing cancer research, immuno‑oncology clinical trials, and treatment options. For healthcare professionals outside the US and UK. (585 words, Nov 10, 2021)
- [Oncology Research Pipeline | Clinical Research | InOncology](/content/pro/us/inoncology/our-pipeline/index.html): Explore the latest developments in Boehringer Ingelheim's Oncology research pipeline; download our pipeline PDF for current clinical trial progress. (467 words, Nov 10, 2021)
- [BI Launches Bovikalc Dry for Dairy Cows | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/ruminants/bi-launches-bovikalc-dry-dairy-cows-boehringer-ingelheim-us.html): Click here to read more on the launch of the new Bovikalc® Dry for Dairy Cows, an oral mineral supplement contributing to well-being for dairy cows. (243 words, Nov 9, 2021)
- [Mental Health | Boehringer Ingelheim](/content/za/human-health/cancer/empowering-patients/mental-health/index.html): Hear the perspectives of people living with cancer on the topic of mental health. (165 words, Nov 9, 2021)
- [Consejos a los compañeros de viaje | Boehringer Ingelheim ES](/content/es/consejos-los-companeros-de-viaje/index.html): Consejos a los compañeros de viaje (134 words, Nov 9, 2021)
- [emperor-preserved-kidney-subanalysis | Boehringer Ingelheim](/content/emperor-preserved-kidney-subanalysis/index.html): New kidney sub-analysis of EMPEROR-Preserved trial demonstrates significant improvement in heart failure outcomes regardless of kidney disease status (887 words, Nov 5, 2021)
- [Nuestra contribución | Boehringer Ingelheim SA](/content/sa/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestra-contribucion/index.html): Nuestra contribución (618 words, Nov 4, 2021)
- [commitments to sustainable development | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/commitments-sustainable-development/index.html): On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities (927 words, Nov 3, 2021)
- [environmental sustainability commitments | Boehringer Ingelheim](/content/about-us/sustainable-development/environmental-sustainability-commitments/index.html): On the occasion of the 2021 UN Climate Change Conference (COP26), Boehringer Ingelheim shares an update on its strategic approach to sustainability (853 words, Oct 31, 2021)
- [Ziele für das Umweltengagement bis 2030 | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/ziele-fuer-das-umweltengagement-bis-2030/index.html): Anlässlich der UN-Klimakonferenz 2021 (COP26) gibt Boehringer Ingelheim heute ein Update seiner Nachhaltigkeitsstrategie bekannt. Lesen Sie weiter! (959 words, Oct 30, 2021)
- [Aprueban el uso de BOVELA® en Colombia | Boehringer Ingelheim SA](/content/sa/aprueban-el-uso-de-bovela-en-colombia/index.html): Aprueban el uso de BOVELA® en Colombia (854 words, Oct 26, 2021)
- [Engagement für nachhaltige Entwicklung | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/engagement-fuer-nachhaltige-entwicklung/index.html): Anlässlich des World Health Summit 2021 veröffentlicht Boehringer Ingelheim ein Update seiner Nachhaltigkeitsstrategie. Lesen Sie weiter! (967 words, Oct 25, 2021)
- [BI increases commitments to sustainable development | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/bi-increases-commitments-sustainable-development/index.html): At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development (777 words, Oct 25, 2021)
- [Ileitis prevention vaccination Lawsonia intracellularis pig | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/ileitis-prevention-vaccination-lawsonia-intracellularis-pig.html): Cause, impact and prevention: Learn the essentials about Ileitis (633 words, Oct 11, 2021)
- [Vacunación para la prevención de la ileítis Lawsonia intracellularis cerdo | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/porcino/vacunacion-para-la-prevencion-de-la-ileitis-lawsonia-intracellularis-cerdo.html): Vacunación para la prevención de la ileítis Lawsonia intracellularis cerdo (1,338 words, Oct 11, 2021)
- [Erweiterung Tierimpfstoffkapazität | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/erweiterung-tierimpfstoffkapazitaet/index.html): Boehringer Ingelheim hat heute eine weitere Investition in seine Produktionsanlage für Veterinärimpfstoffe in Lyon-Jonage bekanntgegeben. Lesen Sie weiter! (506 words, Oct 8, 2021)
- [Resizing our Carbon Footprint | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/resizing-our-carbon-footprint/index.html): The ecological balance of the world is at a tipping point. (901 words, Oct 7, 2021)
- [Keep water clean | Boehringer Ingelheim](/content/about-us/sustainable-development/more-green/keep-water-clean/index.html): Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water. (807 words, Oct 7, 2021)
- [More Green (Zelená řešení): Přehled | Boehringer Ingelheim CZ](/content/cz/o-nas/udrzitelny-rozvoj/zelena-reseni/more-green-zelena-reseni-prehled/index.html): Náš pilíř MORE GREEN (Zelená řešení) zahrnuje ekologické iniciativy zohledňující různé aspekty. (434 words, Oct 7, 2021)
- [Más información sobre el medio ambiente | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-green/mas-informacion-sobre-el-medio-ambiente/index.html): Más información sobre el medio ambiente (519 words, Oct 7, 2021)
- [Mai verde: Prezentare generală | Boehringer Ingelheim RO](/content/ro/despre-noi/dezvoltare-durabila/mai-verde/mai-verde-prezentare-generala/index.html): Prioritatea noastră MAI VERDE cuprinde inițiative de mediu care iau în considerare aspecte diferite. (470 words, Oct 7, 2021)
- ["More Green" Обзор | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-green/more-green-obzor/index.html): "More Green" Обзор (424 words, Oct 7, 2021)
- [Більше зеленого: Огляд | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/more-green/bilshe-zelenogo-oglyad/index.html): Наш напрямок "БІЛЬШЕ ЗЕЛЕНОГО" охоплює екологічні ініціативи, які враховують багато різних аспектів. (394 words, Oct 7, 2021)
- [More Green Overview | Boehringer Ingelheim](/content/za/about-us/sustainable-development/more-green/more-green-overview/index.html): Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. (498 words, Oct 7, 2021)
- [Co-creation with Communities | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/co-creation-communities/index.html): Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs. (452 words, Oct 7, 2021)
- [More health in vulnerable communities | Boehringer Ingelheim](/content/hk/en/about-us/sustainable-development/more-potential/more-health-vulnerable-communities/index.html): In an era of globalization and social connectivity, one-dimensional solutions often do not work anymore. Complex challenges need complex solutions. (950 words, Oct 7, 2021)
- [Más información sobre el potencial | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-potential/mas-informacion-sobre-el-potencial/index.html): Más información sobre el potencial (634 words, Oct 7, 2021)
- [«More Potential»: общая информация | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-potential/more-potential-obshchaya-informaciya/index.html): Мир продолжает сталкиваться с вызовами, связанными со здоровьем, образованием, трудоустройством, условиями жизни, неравенством и нищетой. Сильнее всего они отражаются на уязвимых сообществах. (538 words, Oct 7, 2021)
- [Collaboration to fight NCDs | Boehringer Ingelheim](/content/za/about-us/sustainable-development/more-health/collaboration-fight-ncds/index.html): 70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed. (509 words, Oct 7, 2021)
- [Saving Stroke Patients around the world | Boehringer Ingelheim](/content/about-us/sustainable-development/more-health/saving-stroke-patients-around-world/index.html): Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Over 15 million people worldwide suffer a stroke every year. (638 words, Oct 7, 2021)
- [Nuestra cultura de colaboración | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestra-cultura-de-colaboracion/index.html): Nuestra cultura de colaboración (347 words, Oct 7, 2021)
- [Our Partnering Culture | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-commitment/our-partnering-culture/index.html): Our Partnering Culture (387 words, Oct 7, 2021)
- [Our Partnering Culture | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/our-partnering-culture/index.html): We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture. (396 words, Oct 7, 2021)
- [Nuestra contribución | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestra-contribucion/index.html): Nuestra contribución (559 words, Oct 7, 2021)
- [Our Contribution | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/our-contribution/index.html): Humanity is facing serious challenges. Boehringer Ingelheim wants to be part of the solution to these challenges to ensure that we live in a better world. (502 words, Oct 7, 2021)
- [Наш вклад | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-commitment/nash-vklad/index.html): Мир сталкивается с серьезными вызовами. Мы верим, что можем делать больше – для нас и будущих поколений. (543 words, Oct 7, 2021)
- [Our Contribution | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/our-contribution/index.html): Humanity is facing serious challenges. Boehringer Ingelheim wants to be part of the solution to these challenges to ensure that we live in a better world. (492 words, Oct 7, 2021)
- [Más información sobre la salud | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/more-health/mas-informacion-sobre-la-salud/index.html): Más información sobre la salud (591 words, Oct 7, 2021)
- [«More Health»: общая информация | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/more-health/more-health-obshchaya-informaciya/index.html): Работая для здоровья людей и животных, мы имеем уникальную возможность оказать помощь наиболее уязвимым сообществам. (473 words, Oct 7, 2021)
- [Більше здоров'я: Огляд | Boehringer Ingelheim UA](/content/ua/about-us/sustainable-development/more-health/bilshe-zdorovya-oglyad/index.html): Більше здоров'я: Огляд (465 words, Oct 7, 2021)
- [Nuestro compromiso | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestro-compromiso/index.html): Nuestro compromiso (587 words, Oct 7, 2021)
- [Our Commitment | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/our-commitment/index.html): We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more. (516 words, Oct 7, 2021)
- [Наша миссия | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-commitment/nasha-missiya/index.html): Наша миссия (561 words, Oct 7, 2021)
- [Our Commitment | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/our-commitment/index.html): We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more. (550 words, Oct 7, 2021)
- [Nuestro enfoque | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestro-compromiso/nuestro-enfoque/index.html): Nuestro enfoque (319 words, Oct 7, 2021)
- [Our Approach | Boehringer Ingelheim IE](/content/ie/about-us/sustainable-development/our-commitment/our-approach/index.html): We are driven by the desire to improve human and animal health. Learn more about our ambitious framework: Sustainable Development - For Generations here. (322 words, Oct 7, 2021)
- [Наш подход | Boehringer Ingelheim RU](/content/ru/about-us/sustainable-development/our-commitment/nash-podkhod/index.html): Наш подход (320 words, Oct 7, 2021)
- [Our Approach | Boehringer Ingelheim UK](/content/uk/about-us/sustainable-development/our-commitment/our-approach/index.html): We are driven by the desire to improve human and animal health. Learn more about our ambitious framework: Sustainable Development - For Generations here. (271 words, Oct 7, 2021)
- [First Translational Medicine Award awarded | Boehringer Ingelheim](/content/media-stories/press-releases/first-translational-medicine-award-awarded/index.html): The Award recognizes the research that has the highest translational potential (652 words, Oct 5, 2021)
- [Keisukes Story | Boehringer Ingelheim PL](/content/pl/zdrowie-czlowieka/choroby-ukladu-krazenia/niewydolnosc-serca/keisukes-story/index.html): heart (55 words, Sep 28, 2021)
- [PM_Pressekonferenz_Update_NVL-COPD | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/copd-asthma/pmpressekonferenzupdatenvl-copd/index.html): Virtuelle Presskonferenz zum Update der Nationalen VersorgungsLeitlinie COPD (538 words, Sep 27, 2021)
- [klinische-kooperation-mit-amgen | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/klinische-kooperation-mit-amgen/index.html): Klinische Zusammenarbeit zur Untersuchung von Boehringer Ingelheims SOS1::pan-KRAS Inhibitor in Kombination mit Amgens KRASG12C Inhibitor (594 words, Sep 16, 2021)
- [Diversity Challenge | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/developpement-durable/diversity-challenge/index.html): Im Wettbewerb DIVERSITY CHALLENGE zeigen über 100 Teams junger Mitarbeitenden, wie sie Diversity leben, gestalten und neu denken wollen. (554 words, Sep 8, 2021)
- [Boehringer Ingelheim auf dem Mainzer Wissenschaftsmarkt | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/boehringer-ingelheim-auf-dem-mainzer-wissenschaftsmarkt.html): Mainzer Wissenschaftsmarkt WIMA-DIGITAL.de: Boehringer Ingelheim gibt Einblick in die Welt der Forschung (386 words, Sep 7, 2021)
- [100 años de BI en cuidados respiratorios | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/100-anos-de-bi-en-cuidados-respiratorios/index.html): 100 años de BI en cuidados respiratorios (287 words, Sep 6, 2021)
- [100-year anniversary of BI in respiratory care | Boehringer Ingelheim](/content/human-health/lung-diseases/100-year-anniversary-bi-respiratory-care/index.html): 100-year anniversary of Boehringer Ingelheim in respiratory care (189 words, Sep 6, 2021)
- [Nachhaltiges Biomasseheizkraftwerk | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-green/nachhaltiges-biomasseheizkraftwerk/index.html): Infrastrukturpaket in Höhe von 185 Millionen Euro stellt Weichen für eine nachhaltige Zukunft in Ingelheim. Lesen Sie weiter! (747 words, Sep 6, 2021)
- [Genitalverstümmelung bei Frauen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/genitalverstuemmelung-bei-frauen/index.html): Erfahren Sie mehr über die Webseite womENtire, die bietet einen Einblick und eine Aufklärung über Genitalverstümmelung bei Frauen. (533 words, Aug 31, 2021)
- [Ausbildungsstart-2021 | Boehringer Ingelheim CH](/content/ch/ausbildungsstart-2021/index.html): An den deutschen Standorten starten im September 201 junge Menschen in 15 Ausbildungsberufen und 13 dualen Studiengängen in die Arbeitswelt. (366 words, Aug 31, 2021)
- [Studie | Herzinsuffizienz Therapie | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/herzinsuffizienz/studie-herzinsuffizienz-therapie/index.html): EMPEROR-Preserved zeigt eine 21-prozentige Risikoreduktion für den kardiovaskulären Tod oder Hospitalisierung aufgrund von Herzinsuffizienz bei HFpEF. (2,112 words, Aug 30, 2021)
- [World Rabies Day: BI fights rabies misconceptions | Boehringer Ingelheim](/content/animal-health/our-expertise/world-rabies-day-bi-fights-rabies-misconceptions/index.html): Boehringer Ingelheim joins efforts to fight rabies under this year’s theme for World Rabies Day to raise awareness of the disease and its prevention. (1,074 words, Aug 27, 2021)
- [Enfrentarse juntos al cáncer | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/empoderando-los-pacientes/enfrentarse-juntos-al-cancer/index.html): Enfrentarse juntos al cáncer (68 words, Aug 27, 2021)
- [Un paso más en la lucha contra la rabia en Vietnam | Boehringer Ingelheim ES](/content/es/sobre-nosotros/desarrollo-sostenible/nuestras-historias/un-paso-mas-en-la-lucha-contra-la-rabia-en-vietnam/index.html): Un paso más en la lucha contra la rabia en Vietnam (520 words, Aug 27, 2021)
- [One step further in fighting rabies in Vietnam | Boehringer Ingelheim](/content/mea/about-us/sustainable-development/our-stories/one-step-further-fighting-rabies-vietnam/index.html): A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. (466 words, Aug 27, 2021)
- [Enfermedad de Stargardt | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-de-la-retina/enfermedad-de-stargardt/index.html): Enfermedad de Stargardt (224 words, Aug 25, 2021)
- [Stargardt Disease | Boehringer Ingelheim](/content/human-health/eye-health/stargardt-disease/index.html): Stargardt Disease is a hereditary condition which causes degeneration of cells in the retina at the back of the eye. (179 words, Aug 25, 2021)
- [Foot & Mouth Disease US Supply Vaccines | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/ruminants/foot-mouth-disease-us-supply-vaccines-boehringer-ingelheim-us.html): Click here to find out how Boehringer Ingelheim is fighting against foot-and-mouth disease by continuing to supply the US vaccine bank. (513 words, Aug 24, 2021)
- [Your dog’s life stages: dog health from puppy to adult and senior | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/your-dogs-life-stages-dog-health-puppy-adult-and-senior.html): What does your dog need to thrive at every age? Get some tips here! (998 words, Aug 20, 2021)
- [Boehringer Ingelheim Halbjahreszahlen 2021 | Boehringer Ingelheim DE](/content/de/presse/pressemitteilungen/boehringer-ingelheim-halbjahreszahlen-2021/index.html): Pressemitteilung zu den Halbjahreszahlen 2021 von Boehringer Ingelheim. Geschäftsentwicklung von Januar bis Juni 2021. Lesen Sie weiter! (1,336 words, Jul 29, 2021)
- [Complicaciones de la retinopatía diabética | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-de-la-retina/complicaciones-de-la-retinopatia-diabetica/index.html): Complicaciones de la retinopatía diabética (332 words, Jul 26, 2021)
- [Factsheet BI Tiergesundheit | Boehringer Ingelheim DE](/content/de/tiergesundheit/factsheet-bi-tiergesundheit/index.html): Zahlen, Daten und Fakten über den Geschäftsbereich Bereich der Tiergesundheit bei Boehringer Ingelheim. Informieren Sie sich jetzt! (114 words, Jul 26, 2021)
- [Odile Bain Memorial Prize 2021 | Boehringer Ingelheim](/content/media-stories/press-releases/odile-bain-memorial-prize-2021/index.html): Brilliant early-career scientists in parasitology recognized (814 words, Jul 15, 2021)
- [Ridgefield | Boehringer Ingelheim](/content/about-us/where-find-us/ridgefield/index.html): Learn more about Ridgefield, the home of Boehringer Ingelheim's US headquarters. The site serves as a key research center for human pharmaceuticals. (216 words, Jul 9, 2021)
- [Региональный центр в Вене | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/regionalnyy-centr-v-vene/index.html): Региональный центр в Вене (288 words, Jul 9, 2021)
- [Vienna | Boehringer Ingelheim](/content/sites-around-world/vienna/index.html): Vienna is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production. (485 words, Jul 9, 2021)
- [Lyon | Boehringer Ingelheim](/content/sites-around-world/lyon/index.html): The Lyon region is a key global hub for the Animal Health business of the company, encompassing research, development, production and supply of veterinary products. (261 words, Jul 9, 2021)
- [Shanghai | Boehringer Ingelheim](/content/about-us/where-find-us/shanghai/index.html): Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing. (240 words, Jul 9, 2021)
- [Shanghai | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/shanghai/index.html): Shangai, China, sirve como núcleo importante dentro de la red mundial en las tres áreas de negocio: Salud Humana, S. Animal, y productos biofarmacéuticos. (405 words, Jul 9, 2021)
- [Kobe | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/kobe/index.html): Kobe (249 words, Jul 9, 2021)
- [Kobe | Boehringer Ingelheim](/content/sites-around-world/kobe/index.html): The Kobe Pharma Research Institute takes part in the global research and development activities for human pharmaceuticals. (196 words, Jul 9, 2021)
- [Dortmund | Boehringer Ingelheim](/content/about-us/where-find-us/dortmund/index.html): The Boehringer Ingelheim microParts GmbH in Dortmund manufactures and advances the technology of the RESPIMAT®. (289 words, Jul 9, 2021)
- [Dortmund | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/dortmund/index.html): Boehringer Ingelheim microParts GmbH en Dortmund, Alemania, fabrica e impulsa la tecnología RESPIMAT®. (270 words, Jul 9, 2021)
- [Дортмунд | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/dortmund/index.html): Дортмунд (159 words, Jul 9, 2021)
- [Standort Fornovo | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-fornovo/index.html): Hier erfahren Sie alles über die Produktion pharmazeutischer Wirkstoffe bei unseren wichtigen Standort in Fornovo San Giovanni. (263 words, Jul 9, 2021)
- [Sant Cugat del Vallès | Boehringer Ingelheim](/content/sites-around-world/sant-cugat-del-valles/index.html): The site in Sant Cugat del Vallès focuses on pharmaceutical production and is one of the production sites of the RESPIMAT®. (269 words, Jul 9, 2021)
- [Fornovo | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/fornovo/index.html): Con su planta de producción, Fornovo San Giovani, Italia, constituye un importante centro para la producción de principios activos farmacéuticos. (261 words, Jul 9, 2021)
- [Форново Сан-Джованни (Бидакем) | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/fornovo-san-dzhovanni-bidakem/index.html): Форново Сан-Джованни (Бидакем) (172 words, Jul 9, 2021)
- [Fornovo San Giovanni | Boehringer Ingelheim](/content/sites-around-world/fornovo/index.html): With its production facilities, Fornovo San Giovanni constitutes an important site for the production of core active pharmaceutical ingredients for both Human Pharma and Animal Health. (286 words, Jul 9, 2021)
- [Mexico City | Boehringer Ingelheim](/content/about-us/where-find-us/mexico-city/index.html): The site in Xochimilco, Mexico, focuses on pharmaceutical production for both Human Pharma and Animal Health. (212 words, Jul 9, 2021)
- [Xochimilco | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/xochimilco/index.html): El centro de Xochimilco, México, se centra en la producción farmacéutica tanto para la salud Humana como Animal. (290 words, Jul 9, 2021)
- [Хочимилько | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/khochimilko/index.html): Хочимилько (196 words, Jul 9, 2021)
- [Koropi | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/koropi/index.html): Durante más de 45 años, la empresa ha estado fabricando productos farmacéuticos en su plan de producción en Koropi, Grecia. (285 words, Jul 9, 2021)
- [Коропи | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/koropi/index.html): Коропи (167 words, Jul 9, 2021)
- [Koropi | Boehringer Ingelheim](/content/sites-around-world/koropi/index.html): For more than 45 years, the company has been producing pharmaceuticals in its production facility in Koropi, Greece. (167 words, Jul 9, 2021)
- [Standort Lyon | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-lyon/index.html): Standort Lyon ist ein wichtiges Zentrum für Forschung, Entwicklung und Produktion in der Tiergesundheit. Erfahren Sie mehr über unsere Aktivitäten! (267 words, Jul 9, 2021)
- [Biberach | Boehringer Ingelheim](/content/about-us/where-find-us/biberach/index.html): The largest research and development center of Boehringer Ingelheim is located in Biberach, Germany. (321 words, Jul 9, 2021)
- [Biberach | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/biberach/index.html): El mayor centro de investigación y desarrollo de BI está ubicado en Biberach, Alemania. (369 words, Jul 9, 2021)
- [Биберах | Boehringer Ingelheim RU](/content/ru/about-us/where-find-us/biberakh/index.html): Биберах (243 words, Jul 9, 2021)
- [Ingelheim | Boehringer Ingelheim ES](/content/es/sobre-nosotros/donde-encontrarnos/ingelheim/index.html): La sede de BI está ubicada en la ciudad alemana de Ingelheim. Allí se producen todo los nuevos principios activos y medicamentos que se lanzan al mercado. (322 words, Jul 9, 2021)
- [Standort Koropi | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-koropi/index.html): Boehringer Ingelheim stellt pharmazeutische Produkte an seinem Standort im griechischen Koropi her. Erfahren Sie mehr über uns. (196 words, Jul 9, 2021)
- [Standort Ridgefield | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-ridgefield/index.html): In Ridgefield befindet sich der Sitz der amerikanischen Unternehmenszentrale. Informieren Sie sich über dieses Forschungszentrum für Humanpharmazeutika. (187 words, Jul 8, 2021)
- [Studie | Herzinsuffizienz mit HFpEF | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/herzinsuffizienz/studie-herzinsuffizienz-mit-hfpef/index.html): EMPEROR-Preserved zeigt eine signifikante Risikoreduktion für den kardiovaskulären Tod oder Hospitalisierung aufgrund von Herzinsuffizienz bei HFpEF. (1,471 words, Jul 6, 2021)
- [Katzengesundheit: Young Scientist Award 2021 | Boehringer Ingelheim CH](/content/ch/tiergesundheit/katzengesundheit-young-scientist-award-2021/index.html): Den Young Scientist Award 2021 für Katzengesundheit haben zwei Forscherinnen gewonnen. (748 words, Jul 6, 2021)
- [Managing and treating equine osteoarthritis | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/equine/managing-and-treating-equine-osteoarthritis/index.html): Treating joint pain is vital for keeping horses comfortable and performing at their best. Learn about managing and treating equine osteoarthritis. (401 words, Jun 21, 2021)
- [Herzinsuffizienz Behandlung Zulassung | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/herzinsuffizienz/herzinsuffizienz-behandlung-zulassung/index.html): Die Europäische Kommission hat am 17. Juni 2021 die Marktzulassung für einen weiteren SGLT2-Hemmer zur Behandlung von Erwachsenen mit HFrEF erteilt. (556 words, Jun 21, 2021)
- [Partnerschaft mit Lifebit | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-tiergesundheit/partnerschaft-mit-lifebit/index.html): Boehringer Ingelheim startet Partnerschaft mit Lifebit, um Ausbrüche von Infektionskrankheiten weltweit zu erkennen. Erfahren Sie mehr! (592 words, Jun 11, 2021)
- [Quantencomputer Gründungsmitglied QUTAC | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/quantencomputer-gruendungsmitglied-qutac/index.html): Gemeinsam möchten die Mitglieder von QUTAC industrielle Anwendungsfelder für Quantencomputer erschließen. Erfahren Sie mehr! (455 words, Jun 9, 2021)
- [Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH | Boehringer Ingelheim US](/content/us/press-release/boehringer-ingelheim-and-zealand-pharma-receive-fda-fast-track-designation.html): BI & Zealand Pharma announce that the FDA has granted Fast Track Designation to the GLP-1/glucagon dual agonist BI 456906 for adults with NASH. (867 words, Jun 1, 2021)
- [Standort Ochsenhausen | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-ochsenhausen/index.html): Am Standort Ochsenhausen entwickelt die BI Therapeutics GmbH virusbasierte Therapien. (192 words, May 31, 2021)
- [Mit Kreislaufwirtschaft Ressourcen schonen | Boehringer Ingelheim CH](/content/ch/ueber-uns/nachhaltige-entwicklung/more-green/mit-kreislaufwirtschaft-ressourcen-schonen/index.html): Boehringer Ingelheim strebt danach Ressourcen möglichst lange zu nutzen, sie zur Wiederverwertung aufzubereiten oder zu recyceln. (512 words, May 26, 2021)
- [Green Chemistry Programm | Boehringer Ingelheim DE](/content/de/green-chemistry-programm/index.html): Lösungsansätze, um den Anteil an pharmazeutischen Abfallstoffen in der Herstellung von APIs zu reduzieren. (295 words, May 26, 2021)
- [Clinical Research & Medical Education Grants | Boehringer Ingelheim](/content/pro/funding/index.html): Discover the various financial support options Boehringer Ingelheim offers for independent medical research and medical education programs. (196 words, May 17, 2021)
- [Sobre nosotros | Conectados](/content/pro/sa/sobre-nosotros/index.html): Sobre nosotros (344 words, May 7, 2021)
- [Las tendencias del pollo en el punto de mira | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-produccion/avicultura/las-tendencias-del-pollo-en-el-punto-de-mira/index.html): Las tendencias del pollo en el punto de mira (726 words, May 7, 2021)
- [Focus on Alliance Management | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/kultura-partnerskiej-wspolpracy/focus-alliance-management/index.html): Focus on Alliance Management (943 words, May 6, 2021)
- [Boehringer Ingelheim y el Lieber Institute for Brain Development colaboran en el desarrollo de medicamentos innovadores para enfermedades mentales | Boehringer Ingelheim MX](/content/mx/salud-humana/salud-mental/boehringer-ingelheim-y-el-lieber-institute-brain-development-colaboran-en-el-desarrollo-de.html): Boehringer Ingelheim y el Lieber Institute for Brain Development colaboran en el desarrollo de medicamentos innovadores para enfermedades mentales (881 words, Apr 21, 2021)
- [Fur-ever homes: How pet shelters and fosters have met the challenge of the pandemic | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/fur-ever-homes-how-pet-shelters-and-fosters-have-met-challenge-pandemic.html): Click here to find out how Boehringer Ingelheim have worked to expand the community of fosterers to aid both shelters and animals beyond COVID-19. (815 words, Apr 20, 2021)
- [Advances in vectored vaccines for poultry | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/poultry/advances-vectored-vaccines-poultry/index.html): Advances in vectored vaccines for poultry (1,080 words, Apr 16, 2021)
- [PREVEXXION® RN: Marek’s disease vaccine available in EU UK | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/prevexxion-rn-mareks-disease-vaccine-available-eu-uk.html): Boehringer Ingelheim is pleased to announce the launch of the next generation of Marek’s disease vaccines is now available in the EU. (674 words, Apr 8, 2021)
- [Boehringer Ingelheim e Google: parceria inédita em computação quântica para pesquisa de medicamentos | Boehringer Ingelheim BR](/content/br/ciencia-e-inovacao/inovacao-na-saude-humana/inovacao-atraves-de-parcerias/boehringer-ingelheim-e-google-parceria-inedita-em-computacao-quantica-para.html): Boehringer Ingelheim firma parceria inédita com o Google para aplicar computação quântica na pesquisa de novos medicamentos, acelerando descobertas e soluções terapêuticas. (533 words, Apr 7, 2021)
- [2020-Positive-business-momentum-despite-COVID-19-impact | Boehringer Ingelheim](/content/media-stories/press-releases/2020-positive-business-momentum-despite-covid-19-impact.html): While stepping up its investments in R&D significantly, Boehringer Ingelheim achieved a solid business performance in 2020 despite the COVID-19 pandemic. (1,605 words, Mar 23, 2021)
- [Equine asthma: Recognizing and managing respiratory issues in horses | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/equine/equine-asthma-recognizing-and-managing-respiratory-issues-horses.html): Environmental determinants, especially in Canada, can trigger equine asthma. Click here to find out what you need to know about managing this disease. (705 words, Mar 15, 2021)
- [Datenschutzerklärung für Microsoft Teams | Boehringer Ingelheim DE](/content/de/datenschutzerklaerung-fuer-microsoft-teams/index.html): Datenschutzerklärung für Microsoft Teams. Informieren Sie sich über wie wir mit personen-bezogenen Daten im Zusammenhang mit Microsoft Teams umgehen. (939 words, Feb 23, 2021)
- [Por qué los ensayos de depresión actuales exigen nuevos enfoques inteligentes | Boehringer Ingelheim ES](/content/es/salud-humana/salud-mental/depresion/por-que-los-ensayos-de-depresion-actuales-exigen-nuevos-enfoques-inteligentes.html): Por qué los ensayos de depresión actuales exigen nuevos enfoques inteligentes (671 words, Feb 2, 2021)
- [Clinical trial data disclosure | Boehringer Ingelheim UK](/content/uk/clinical-trials/index.html): We believe in transparency. Learn more about our public disclosure of clinical trial data here. (149 words, Feb 1, 2021)
- [全球最大家族藥廠百靈佳殷格翰 2021年線上校園徵才活動 | Boehringer Ingelheim TW](/content/tw/about-us/xiaoyuanzhengcaihuodong/quanqiuzuidajiazuyaochangbailingjiayingehan-2021nianxianshangxiaoyuanzhengcaihuodong.html): 全球最大家族藥廠百靈佳殷格翰 2021年線上校園徵才活動 (62 words, Jan 30, 2021)
- [Řekněte nezvaným hostům rozhodné ne | Boehringer Ingelheim CZ](/content/cz/zdravi-zvirat/psi-kocky/reknete-nezvanym-hostum-rozhodne-ne/index.html): Zjistěte, jak se vyhnout blechám, klíšťatům a červům u vaší kočky. (745 words, Jan 24, 2021)
- [Retinopatía diabética | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-de-la-retina/retinopatia-diabetica/index.html): Retinopatía diabética (220 words, Jan 22, 2021)
- [Diabetic Retinopathy | Boehringer Ingelheim](/content/human-health/eye-health/diabetic-retinopathy/index.html): Diabetic retinopathy affects 1 in 3 people with diabetes and is the leading cause of vision loss in adults of working age. (201 words, Jan 22, 2021)
- [A clear vision | Boehringer Ingelheim](/content/human-health/eye-health/clear-vision/index.html): We’re committed to help eliminate avoidable vision loss by joining forces with the global eye health community and building one of the industry’s most ambitious and scientifically diverse pipelines of targeted therapies. (383 words, Jan 22, 2021)
- [global-top-employer | Boehringer Ingelheim](/content/about-us/global-top-employer/index.html): global-top-employer (693 words, Jan 21, 2021)
- [Boehringer Ingelheim se asocia con PetMedix | Boehringer Ingelheim MX](/content/mx/salud-animal/boehringer-ingelheim-se-asocia-con-petmedix/index.html): Boehringer Ingelheim se asocia con PetMedix (753 words, Jan 20, 2021)
- [Câncer de pulmão: entenda as opções de tratamento | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/cancer-do-pulmao/cancer-de-pulmao-entenda-opcoes-de-tratamento/index.html): dec (513 words, Jan 18, 2021)
- [Ao parar de fumar, o que acontece no corpo? | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/cancer-do-pulmao/ao-parar-de-fumar-o-que-acontece-no-corpo/index.html): dec (500 words, Jan 18, 2021)
- [Partnerschaft-mit-Google-bei-Quantencomputern | Boehringer Ingelheim CH](/content/ch/partnerschaften/partnerschaften-der-humanmedizin/partnerschaft-mit-google-bei-quantencomputern/index.html): Neue Kooperation mit Google untersucht die Potenziale von Quantum Computing für die Pharmaforschung (859 words, Jan 7, 2021)
- [Kooperation mit Google Quantum AI | Boehringer Ingelheim AT](/content/at/de/partnerschaften/partnerschaften-der-humanmedizin/kooperation-mit-google-quantum-ai/index.html): Für Pharmaforschung bieten Quantencomputer vielfältige Potenziale. Gemeinsam mit Google untersucht Boehringer Ingelheim, wie diese Technologie die Pharmaforschung von Morgen prägen könnte. (484 words, Jan 7, 2021)
- [Kooperation mit Google Quantum AI | Boehringer Ingelheim DE](/content/de/partnerschaften/partnerschaften-der-humanmedizin/kooperation-mit-google-quantum-ai/index.html): Quantencomputer bieten vielfältige Potenziale. Gemeinsam mit Google untersuchen wir, wie diese Technologie die Pharmaforschung von Morgen prägen könnte. (494 words, Jan 7, 2021)
- [Ethische Geschäftspraktiken | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/ethische-geschaeftspraktiken/index.html): Der Kern unseres Verhaltenskodex für Lieferanten besteht darin, dass sie ihre Geschäfte ethisch betreiben und mit Integrität handeln sollen. (1,794 words, Dec 17, 2020)
- [Protecting a Way of Life in Haiti | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/animal-health/our-responsibility/protecting-way-life-haiti-boehringer-ingelheim-us/index.html): Click here to find out how Boehringer Ingelheim is helping to protect a way of life in Haiti by producing a custom swine vaccine to support the island. (554 words, Dec 15, 2020)
- [Ansprechen von Fragen oder Bedenken | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/ansprechen-von-fragen-oder-bedenken/index.html): Lieferanten sollen melden, wenn es Bedenken bezüglich der Einhaltung von ethischen und Compliancevorgaben gibt, die Boehringer Ingelheim betreffen könnten. (250 words, Dec 14, 2020)
- [Stammzellen Therapien der Zukunft | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/stammzellen-therapien-der-zukunft/index.html): Was sind Stammzellen, und wie könnten sie in Zukunft zur Tiergesundheit beitragen? (793 words, Dec 14, 2020)
- [Supplier Code of Conduct | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/kultur/supplier-code-conduct/index.html): Die Erwartungen von BI an die Lieferanten bezüglich ethischen Verhaltens, Integrität, Professionalität und gemeinsame Geschäftsanforderungen. (496 words, Dec 10, 2020)
- [Unsere Erwartungen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/unsere-erwartungen/index.html): Wir erwarten vorbildliche ethische und professionelle Verhaltensweisen sowohl innerhalb des Unternehmens als auch von unseren Lieferanten. (570 words, Dec 10, 2020)
- [Our Expectations | Boehringer Ingelheim AT](/content/at/en/about-us/our-expectations/index.html): We are committed to exemplary ethical and professional conduct both within the company and from our suppliers. (575 words, Dec 10, 2020)
- [Unsere Erwartungen | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/unsere-erwartungen/index.html): Wir erwarten vorbildliche ethische und professionelle Verhaltensweisen sowohl innerhalb des Unternehmens als auch von unseren Lieferanten. (575 words, Dec 10, 2020)
- [Intelligente Kombinationen gegen Krebs | Boehringer Ingelheim AT](/content/at/de/wissenschaft-innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/intelligente-kombinationen-gegen-krebs/index.html): Boehringer Ingelheim forscht an intelligenten Therapie-Kombinationen, die für Krebspatienten den größtmöglichen Nutzen bringen. (931 words, Dec 9, 2020)
- [Intelligente Kombinationen gegen Krebs | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/geschichten-aus-der-wissenschaft/intelligente-kombinationen-gegen-krebs/index.html): Boehringer Ingelheim forscht an intelligenten Therapie-Kombinationen, die für Krebspatienten den größtmöglichen Nutzen bringen. (1,164 words, Dec 9, 2020)
- [Where to meet us | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/where-meet-us/index.html): Find out where to meet the BD&L team virtually or in person at the next conference or event. Submit your opportunity to our BD&L team here. (369 words, Dec 8, 2020)
- [Avian influenza 5 things you should know | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/avian-influenza-5-things-you-should-know/index.html): Poultry farming communities across the globe are grappling once again with avian influenza (388 words, Dec 8, 2020)
- [Podcast: Journeys through pulmonary fibrosis | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/podcast-journeys-through-pulmonary-fibrosis/index.html): As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit. (6,737 words, Dec 3, 2020)
- [Positives Fazit zu Aktionsplan | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/positives-fazit-zu-aktionsplan/index.html): Boehringer Ingelheim schließt achtjährigen Aktionsplan zur Umsetzung der UN-Behindertenrechtskonvention ab. Evaluation zeigt die großen Fortschritte. (653 words, Dec 1, 2020)
- [BIX_setzt_auf_globale_Partnerschaften | Boehringer Ingelheim CH](/content/ch/bixsetztaufglobalepartnerschaften/index.html): BI X setzt auf Partnerschaften, um digitale Lösungen im Gesundheitswesen zu entwickeln. (592 words, Nov 30, 2020)
- [Three challenges shape future antiparasitic treatment | Boehringer Ingelheim](/content/animal-health/our-expertise/prevention/three-challenges-shape-future-antiparasitic-treatment.html): The three key challenges that will shape the future of antiparasitic treatment (1,101 words, Nov 26, 2020)
- [Data Privacy-video surveillance at Boehringer Ingelheim | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-privacy-video-surveillance-boehringer-ingelheim.html): Data Protection Notice for video surveillance (692 words, Nov 18, 2020)
- [Boehringer Ingelheim Tiergesundheit Video | Boehringer Ingelheim CH](/content/ch/tiergesundheit/boehringer-ingelheim-tiergesundheit-video/index.html): Tiere und Menschen sind miteinander auf tiefe und komplexe Weise verbunden. Wir schaffen Werte durch Innovation, um die Leben beider zu verbessern. (76 words, Nov 9, 2020)
- [New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status | Boehringer Ingelheim US](/content/us/media/press-releases/new-jardiance-findings-showed-improved-cardio-renal-outcomes-adults-heart-failure-reduced-ejection.html): The EMPEROR trial showed that JARDIANCE reduced the risk of adverse CV & kidney events in adults with HFrEF. View ISI, PI and Med Guide. (2,999 words, Oct 22, 2020)
- [Mit Vielfalt zum gemeinsamen Erfolg | Boehringer Ingelheim CH](/content/ch/mit-vielfalt-zum-gemeinsamen-erfolg/index.html): Boehringer Ingelheim ist bunt – mit Vielfalt zum gemeinsamen Erfolg (746 words, Oct 14, 2020)
- [Collaboration-with-OxfordBioTherapeutics | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/collaboration-oxfordbiotherapeutics/index.html): Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients. (917 words, Oct 14, 2020)
- [Wenn wir nicht damit anfangen, wird sich nichts ändern | Boehringer Ingelheim CH](/content/ch/wenn-wir-nicht-damit-anfangen-wird-sich-nichts-aendern.html): Lernen Sie Dr. Christian Seifert kennen, Mitarbeiter bei Boehringer Ingelheim und Mitglied des Regenbogen Netzwerkes in Biberach. (1,507 words, Oct 13, 2020)
- [Las células madre, una nueva frontera | Boehringer Ingelheim ES](/content/es/salud-animal/animales-de-compania/las-celulas-madre-una-nueva-frontera/index.html): Las células madre, una nueva frontera (1,122 words, Oct 9, 2020)
- [Boehringer Ingelheim y Click Therapeutics se asocian para beneficiar a pacientes con esquizofrenia | Boehringer Ingelheim MX](/content/mx/salud-humana/salud-mental/boehringer-ingelheim-y-click-therapeutics-se-asocian-para-beneficiar-pacientes-con-esquizofrenia.html): Boehringer Ingelheim y Click Therapeutics se asocian para beneficiar a pacientes con esquizofrenia (1,193 words, Oct 8, 2020)
- [Ruminant parasite control in a nutshell | Boehringer Ingelheim](/content/animal-health/animals-we-support/ruminants/ruminant-parasite-control-nutshell/index.html): An exclusive drug-based approach to fight worms is dying. Dr. Ray Kaplan, from Georgia University, explains five things you need to know. (627 words, Oct 8, 2020)
- [centro de información sobre la lucha sostenible contra la rabia | Boehringer Ingelheim ES](/content/es/salud-animal/nuestra-responsabilidad/centro-de-informacion-sobre-la-lucha-sostenible-contra-la-rabia.html): centro de información sobre la lucha sostenible contra la rabia (1,283 words, Sep 24, 2020)
- [Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-advances-novel-bi-specific-trailr2-cdh17-antibody-phase-1-clinical-trial.html): BI announces the advancement of the tetravalent therapeutic antibody, BI 905711, to its first-in-human clinical trial for patients with advanced GI cancers. (722 words, Sep 9, 2020)
- [Supporting Rabies Free Pakistan Indus Hospital | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/supporting-rabies-free-pakistan-indus-hospital/index.html): Learn how rabies endangers thousands of human lives in Pakistan every year. We provide green collars and vaccines to help improve dogs health and the situation. (818 words, Aug 21, 2020)
- [Rabies wildlife 5 things to know | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/rabies-wildlife-5-things-know/index.html): Rabies in wildlife - 5 things to know to protect yourself and your pet (696 words, Aug 21, 2020)
- [InPedILD_trial_enrollment | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/inpedildtrialenrollment/index.html): First patient enrolled in InPedILD™, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and adolescents (881 words, Aug 12, 2020)
- [http://vaccinateyourpet.net/vaccinesfordogs#leptospirosis | Boehringer Ingelheim MX](/content/mx/salud-animal/animales-de-compania/caballos/http-vaccinateyourpetnet-vaccinesfordogsleptospirosis.html): http://vaccinateyourpet.net/vaccinesfordogs#leptospirosis (840 words, Aug 5, 2020)
- [Combination Therapy | Boehringer Ingelheim](/content/za/human-health/cancer/across-cancer-types/combination-therapy/index.html): It’s the smart combination of our cancer cell-directed and immuno-oncology approaches that may offer the greatest benefit for people living with cancer. (42 words, Jul 27, 2020)
- [Immuno-Oncology | Boehringer Ingelheim](/content/za/human-health/cancer/across-cancer-types/immuno-oncology/index.html): We are developing complementary platforms (including, T Cell Engagers, oncolytic viruses, and cancer vaccines), which have the potential to turn cold tumors hot, extending the benefits of immunotherapy to more people. (87 words, Jul 27, 2020)
- [China pioneers biosecurity report against ASF | Boehringer Ingelheim](/content/animal-health/animals-we-support/swine/china-pioneers-biosecurity-report-against-asf/index.html): Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever. (727 words, Jul 21, 2020)
- [Une relation toute particulière : à mes côtés | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/bpco-et-asthme/une-relation-toute-particuliere-mes-cotes/index.html): Carolines bemerkenswerte Verbindung zu Snowball half ihr, besser mit COPD umzugehen und ein unabhängigeres Leben zu führen. (52 words, Jul 15, 2020)
- [Boehringer Ingelheim acquires Global Stem cell Technology | Boehringer Ingelheim](/content/partnering/animal-health-partnering/connect-us/boehringer-ingelheim-acquires-global-stem-cell-technology.html): Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health. (839 words, Jul 14, 2020)
- [Podejte žádost o partnerství | Boehringer Ingelheim CZ](/content/cz/partnerska-spoluprace/partnerska-spoluprace-v-oblasti-lidskeho-zdravi/spojme-sily/podejte-zadost-o-partnerstvi/index.html): Seznamte se s možnostmi jak prezentovat vaše nápady přímo členům týmu BD&L. (116 words, Jun 30, 2020)
- [Osteoarthritis in dogs: Protecting your pet from pain | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/osteoarthritis-dogs-protecting-your-pet-pain/index.html): Many dog owners often notice their canine friends “slowing down” as they age. Learn more about osteoarthritis in dogs and how to treat the pain. (710 words, Jun 24, 2020)
- [Protect your dog from parasites, inside and out | Boehringer Ingelheim CA](/content/ca/animal-health/companion-animals-equine/pets/protect-your-dog-parasites-inside-and-out/index.html): To protect your dog means getting up to speed on the common internal and external parasites. Learn more about protecting your dog from parasites here. (878 words, Jun 24, 2020)
- [Singen bei COPD | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/copd-asthma/singen-bei-copd-0/index.html): Atmung vertiefen, Lebensfreude steigern: Erfahren Sie welche positiven Auswirkungen das Singen bei COPD haben kann – und probieren Sie es aus! (1,200 words, Jun 17, 2020)
- [View from both sides of human health business development | Boehringer Ingelheim](/content/partnering/human-health-partnering/view-both-sides-human-health-business-development/index.html): Discover the path Boehringer’s head of business development and licensing took and how this plays a role in forming new life science partnerships. (469 words, Jun 9, 2020)
- [View from Both Sides of the Table | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/kultura-partnerskiej-wspolpracy/view-both-sides-table/index.html): View from Both Sides of the Table (1,211 words, Jun 9, 2020)
- [Die METAmorphose | Boehringer Ingelheim DE](/content/de/die-metamorphose/index.html): Die Büros in der META-Region von Boehringer Ingelheim im Nahen Osten, in der Türkei und in Afrika sind bereits frei von Einweg-Kunststoff. (339 words, Jun 3, 2020)
- [Eye Health Research | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/retinal-health-research/index.html): Read about our holistic approach to retinal health research. (327 words, May 29, 2020)
- [CHMP_opinion_nintedanib_ILD_PF | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/chmpopinionnintedanibildpf/index.html): CHMP_opinion_nintedanib_ILD_PF (1,325 words, May 29, 2020)
- [In-Reach Africa initiatives successfully completed | Boehringer Ingelheim](/content/reach-africa-initiatives-successfully-completed/index.html): We are proud to report the successful completion of Kuza Afya and Tiba Yako, two of our In-Reach Africa initiatives. (381 words, May 20, 2020)
- [Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance’s® effects following an acute myocardial infarction | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-and-lilly-collaborate-duke-clinical-research-institute-pragmatic-trial.html): Read more on how the trial is part of the EMPOWER clinical trial program, the broadest and most comprehensive of any SGLT2 inhibitor. (484 words, May 19, 2020)
- [preventive care cat veterinarian | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/preventive-care-cat-veterinarian/index.html): What can we all, cat owners or veterinarians, do to promote cat health? Click to find out! (558 words, May 19, 2020)
- [The Supplier Code of Conduct | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/supplier-code-conduct/index.html): BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements. (462 words, May 11, 2020)
- [Labor & Human Rights | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/labor-human-rights/index.html): Suppliers shall support and respect the protection of internationally proclaimed human rights. (496 words, May 11, 2020)
- [Raising Questions or Concerns | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/raising-questions-or-concerns/index.html): Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim. (187 words, May 11, 2020)
- [Management Systems | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/management-systems/index.html): Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct. (362 words, May 11, 2020)
- [Health & Safety | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/health-safety/index.html): Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable. (227 words, May 8, 2020)
- [Ethical Business Practices | Boehringer Ingelheim](/content/about-us/ethics-and-compliance/ethical-business-practices/index.html): Suppliers shall conduct their business in an ethical manner and act with integrity. (1,835 words, May 8, 2020)
- [COVID-19 “Making More Health” Programm | Boehringer Ingelheim CH](/content/ch/covid-19-making-more-health-programm/index.html) (323 words, May 8, 2020)
- [cat dog flea allergy dermatitis | Boehringer Ingelheim](/content/animal-health/animals-we-support/dogs/cat-dog-flea-allergy-dermatitis/index.html): Find out how you can identify and treat flea allergy dermatitis in dogs & cats, one of the most common illnesses associated with a flea infestation. (522 words, Apr 30, 2020)
- [Therapie für SSc-ILD | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/sklerodermie/therapie-fuer-ssc-ild/index.html): Europäische Kommission genehmigt erstmals Therapie bei systemischer Sklerose mit assoziierten interstitiellen Lungenerkrankung. Erfahren Sie mehr! (1,404 words, Apr 23, 2020)
- [European_Commission_approves_nintedanibSSc-ILD | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/europeancommissionapprovesnintedanibssc-ild/index.html): Nintedanib is approved as the first and only treatment of systemic sclerosis-associated interstitial lung disease (136 words, Apr 21, 2020)
- [10 years of Making More Health | Boehringer Ingelheim](/content/about-us/sustainable-development/more-potential/10-years-making-more-health/index.html): Making More Health Highlights from 2010-2020 (100 words, Apr 8, 2020)
- [Equines Asthma | Boehringer Ingelheim AT](/content/at/de/tiergesundheit/haustiere-und-pferde/equines-asthma/index.html): Der Kampf gegen Equines Asthma ist wichtig, um die Lebensqualität vieler Pferde weltweit zu verbessern. (727 words, Mar 21, 2020)
- [Equines Asthma | Boehringer Ingelheim CH](/content/ch/fr/sante-animale/animaux-de-compagnie-et-chevaux/equines-asthma/index.html): Der Kampf gegen Equines Asthma ist wichtig, um die Lebensqualität vieler Pferde weltweit zu verbessern. (815 words, Mar 21, 2020)
- [109年3月18日起 OFEV®抑肺纖 新增「全身性硬化症有關之間質性肺病」適應症 減緩肺功能下降速度 | Boehringer Ingelheim TW](/content/tw/human-health/lung-diseases/scleroderma/109nian3yue18riqi-ofevyifeixian-xinzengquanshenxingyinghuazhengyouguanzhijianzhixingfeibing.html): 109年3月18日起 OFEV®抑肺纖 新增「全身性硬化症有關之間質性肺病」適應症 減緩肺功能下降速度 (52 words, Mar 18, 2020)
- [FDA-Fast-Track-chronic-kidney-disease | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/fda-fast-track-chronic-kidney-disease/index.html): FDA grants Fast Track designation for the treatment of chronic kidney disease, underscoring urgent need for new treatments for people living with the condition (1,206 words, Mar 12, 2020)
- [Boehringer Ingelheim prepara el terreno para sus futuros lideres | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/boehringer-ingelheim-prepara-el-terreno-para-sus-futuros-lideres.html): Boehringer Ingelheim prepara el terreno para sus futuros lideres (1,376 words, Feb 27, 2020)
- [Mareks Disease Poultry Chicken | Boehringer Ingelheim](/content/animal-health/animals-we-support/poultry/mareks-disease-poultry-chicken/index.html): Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. (674 words, Feb 27, 2020)
- [Mareks Disease Poultry Chicken | Boehringer Ingelheim UA](/content/ua/animal-health/livestock/poultry/mareks-disease-poultry-chicken/index.html): . (668 words, Feb 27, 2020)
- [Scleroderma Life Hacks | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/scleroderma-life-hacks/index.html): Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi (649 words, Feb 25, 2020)
- [New Documentary Highlights Ranch’s Commitment to Cattle Health | Boehringer Ingelheim US](/content/us/animal-health/animals-we-support/ruminants/new-documentary-highlights-ranchs-commitment-cattle-health.html): Click here to read more about the new documentary 'Cattle First', capturing how one family promotes animal health and protection of the environment. (610 words, Feb 12, 2020)
- [Sustainability Matters: Carbon Neutral | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/news/sustainability-matters-thats-why-we-are-going-carbon-neutral-one-us-site-and-using-less.html): Find out more on how Boehringer Ingelheim are going carbon neutral at our manufacturing plant in Gainesville, Georgia, embracing sustainability. (1,057 words, Feb 12, 2020)
- [Boehringer Ingelheim launches vaccine to protect poultry from three diseases | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-launches-vaccine-protect-poultry-three-diseases.html): Boehringer Ingelheim launches vaccine to protect poultry from three diseases (581 words, Jan 2, 2020)
- [DiaTEC new purification technology Ingelvac CircoFLEX | Boehringer Ingelheim](/content/media-stories/press-releases/diatec-new-purification-technology-ingelvac-circoflex.html): Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX® (675 words, Dec 18, 2019)
- [EURORDIS Award | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/eurordis-award/index.html): EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020 (761 words, Dec 10, 2019)
- [Standort Dortmund | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-dortmund/index.html): Boehringer Ingelheim microParts GmbH am Standort Dortmund ist das Kompetenzzentrum für Medizinprodukte im Unternehmensverband und weltweit einziger Hersteller für den Inhalator RESPIMAT®. (248 words, Dec 3, 2019)
- [Legal Notices | Boehringer Ingelheim CA](/content/ca/legal-notices/index.html): Click here to read the legal notice which pertains to Boehringer Ingelheim (Canada) Ltd./Ltée. and Boehringer Ingelheim Animal Health Canada Inc. (570 words, Nov 12, 2019)
- [Cooperation with The Defeat-NCD Partnership | Boehringer Ingelheim](/content/cooperation-defeat-ncd-partnership/index.html): Together with The Defeat-NCD Partnership, Boehringer Ingelheim aims to address key access to healthcare issues related to non-communicable diseases. (59 words, Nov 12, 2019)
- [cystic fibrosis phase II trial | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/plicni-fibroza/cystic-fibrosis-phase-ii-trial/index.html): cystic fibrosis phase II trial (737 words, Oct 14, 2019)
- [Thelaziosis dog eyeworms | Boehringer Ingelheim](/content/animal-health/companion-animals-horses/pets/thelaziosis-dog-eyeworms/index.html): Thelazios dog eyeworms are currently on the rise in Europe, find out more on what, why and how you can help avoid this issue in your dog. (677 words, Oct 1, 2019)
- [Kampf gegen Tollwut: ein Jahr danach | Boehringer Ingelheim DE](/content/de/tiergesundheit/kampf-gegen-tollwut-ein-jahr-danach/index.html): In Nepal ist die Tollwut eine gravierende Bedrohung für Menschenleben. Wir informieren die Bevölkerung und führen Impfkampagnen durch, um sie zu schützen. (768 words, Sep 20, 2019)
- [Cómo encontrar el inhalador adecuado para usted | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/como-encontrar-el-inhalador-adecuado-para-usted/index.html): Cómo encontrar el inhalador adecuado para usted (425 words, Aug 23, 2019)
- [Finding the right inhaler for you | Boehringer Ingelheim](/content/human-health/lung-diseases/finding-right-inhaler-you/index.html): Living with a chronic respiratory disease can make life complicated. This discussion guide can be used to help start a conversation with a healthcare professional about inhaler choice. (398 words, Aug 23, 2019)
- [Datenschutz Produkt-Reklamation | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutz-produkt-reklamation/index.html): Informieren Sie sich über wie wir mit personen-bezogenen Daten im Zusammenhang mit Produkt- und Reklamationsbearbeitung umgehen. (423 words, Aug 15, 2019)
- [Seguridad del paciente | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/el-paciente-nuestra-prioridad/seguridad-del-paciente/index.html): Seguridad del paciente (169 words, Aug 7, 2019)
- [Prevention: How to keep your cat healthy at every stage of life | Boehringer Ingelheim](/content/animal-health/animals-we-support/cats/prevention-how-keep-your-cat-healthy-every-stage-life.html): Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better. (710 words, Aug 5, 2019)
- [Cáncer de pulmón de células no pequeñas | Boehringer Ingelheim ES](/content/es/salud-humana/cancer/cancer-de-pulmon/cancer-de-pulmon-de-celulas-no-pequenas/index.html): Cáncer de pulmón de células no pequeñas (190 words, Jul 26, 2019)
- [10 things you should know about rabies | Boehringer Ingelheim](/content/animal-health/our-expertise/societal-impact/10-things-you-should-know-about-rabies/index.html): Learn about what rabies is, how it's diagnosed, symptoms to look out for and what to do if you or your pet is exposed. (1,183 words, Jul 24, 2019)
- [Our Animal Health story | Boehringer Ingelheim CA](/content/ca/animal-health/our-animal-health-story/index.html): We’ve been keeping pets and livestock healthy for more than 50 years. Click here to watch the video and learn about our animal health story. (282 words, Jul 11, 2019)
- [108年6月1日起 Giotrif妥復克擴增健保給付範圍 | Boehringer Ingelheim TW](/content/tw/human-health/cancer/108nian6yue1riqi-giotriftuofukekuozengjianbaogeifufanwei.html): 108年6月1日起 Giotrif妥復克擴增健保給付範圍 (19 words, Jun 1, 2019)
- [Leveraging Artificial Intelligence to support healthy aging | Boehringer Ingelheim CA](/content/ca/about-us/who-we-are/leveraging-artificial-intelligence-support-healthy-aging.html): Learn about our work in leveraging artificial intelligence to address the needs of the aging population in Edmonton, Alberta. Click here to find out more. (91 words, May 7, 2019)
- [Clinical Trials | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/clinical-studies/clinical-trials/index.html): Find out more on why Boehringer Ingelheim's range of clinical trials are an essential aspect of new medicine development. (439 words, Apr 9, 2019)
- [Major investment for respiratory diseases completed | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/major-investment-respiratory-diseases-completed/index.html): 105 million euros invested into expansion of production facilities in Ingelheim and Dortmund (616 words, Apr 9, 2019)
- [Innovation in Immunology | Human Health | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/innovation-immunology-human-health-boehringer-ingelheim-us.html): BI's Immunology & Respiratory research combines our ability to address unmet medical needs with pioneering patient-centered approaches. (551 words, Apr 8, 2019)
- [Innovation in CNS Disease Research | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/innovation-cns-disease-research/index.html): Despite BI's increasing knowledge of neurobiology and treatments, there remains need for new medicines which offer higher efficacy & reduced side effects. (353 words, Apr 8, 2019)
- [Nuestra posición | Boehringer Ingelheim ES](/content/es/salud-humana/nuestra-responsabilidad/el-paciente-nuestra-prioridad/nuestra-posicion/index.html): Nuestra posición (914 words, Apr 2, 2019)
- [Our position on early access | Boehringer Ingelheim](/content/za/human-health/our-responsibility/patient-centricity/our-position/index.html): Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial (817 words, Apr 2, 2019)
- [Controlando doenças animais emergentes e infecciosas | Boehringer Ingelheim BR](/content/br/saude-animal/nossa-responsabilidade/controlando-doencas-animais-emergentes-e-infecciosas.html): Controlando doenças animais emergentes e infecciosas (736 words, Mar 27, 2019)
- [Откриване на лекарства | Boehringer Ingelheim BG](/content/bg/otkrivane-na-lekarstva/index.html): Научете повече за процеса по откриване на лекарства в Boehringer Ingelheim (329 words, Mar 23, 2019)
- [Drug Discovery at Boehringer Ingelheim | Boehringer Ingelheim](/content/za/drug-discovery-boehringer-ingelheim/index.html): Find out more about the drug discovery process at Boehringer Ingelheim (348 words, Mar 23, 2019)
- [Leben nach Schlaganfall | Freunde in Not | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/schlaganfall/leben-nach-schlaganfall-freunde-not/index.html): Wie lange dauert die Genesung nach einem Schlaganfall? Erfahren Sie die Geschichte von Phil und Vale! (137 words, Feb 15, 2019)
- [Leben mit Sklerodermie | Boehringer Ingelheim DE](/content/de/humanmedizin/lungenerkrankungen/sklerodermie/leben-mit-sklerodermie/index.html): Es ist nicht einfach mit Sklerodermie zu leben. Doch Csenge hilft Anna, aktiv zu bleiben. Lesen Sie ihre Geschichte. (201 words, Feb 15, 2019)
- [Leben mit Diabetes | Kameradschaft | Boehringer Ingelheim DE](/content/de/humanmedizin/stoffwechselerkrankungen/diabetes/leben-mit-diabetes-kameradschaft/index.html): Die Mensch-Tier-Beziehungen kann helfen, die Symptome von Diabetes zu lindern und ein gesünderes Leben zu führen. Entdecken Sie die Story von Eric! (182 words, Feb 15, 2019)
- [Você sabe o que é Câncer De Pulmão de Não Pequenas Células? | Boehringer Ingelheim BR](/content/br/saude-humana/cancer/cancer-do-pulmao/voce-sabe-o-que-e-cancer-de-pulmao-de-nao-pequenas-celulas.html) (13 words, Feb 15, 2019)
- [Contando mi historia Voces de pacientes de AF y DVT PE | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/ictus/contando-mi-historia-voces-de-pacientes-de-af-y-dvt-pe.html): Contando mi historia Voces de pacientes de AF y DVT PE (84 words, Feb 5, 2019)
- [Familie Henke Interview | Boehringer Ingelheim CH](/content/ch/tiergesundheit/nutztiere/schweine/familie-henke-interview/index.html): Heinrich und Nadine Henke, die eine Schweinezucht führen, erzählen uns von der besonderen Verbindung zu ihren Tieren. (968 words, Feb 5, 2019)
- [Familie Henke Interview | Boehringer Ingelheim DE](/content/de/tiergesundheit/nutztiere/schweine/familie-henke-interview/index.html): Heinrich und Nadine Henke, die eine Schweinezucht führen, erzählen uns von der besonderen Verbindung zu ihren Tieren. Lesen Sie weiter! (971 words, Feb 5, 2019)
- [A Unique Bond: me eligió | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/cultura/unique-bond-me-eligio/index.html): A Unique Bond: me eligió (56 words, Jan 23, 2019)
- [A Unique Bond: quédate a mi lado | Boehringer Ingelheim MX](/content/mx/salud-humana/enfermedades-pulmonares/unique-bond-quedate-mi-lado/index.html): A Unique Bond: quédate a mi lado (185 words, Jan 22, 2019)
- [Enfermedades respiratorias | Boehringer Ingelheim ES](/content/es/enfermedades-respiratorias/index.html): Enfermedades respiratorias (280 words, Dec 21, 2018)
- [Contact Us | Boehringer Ingelheim PL](/content/pl/wspolpraca/partnerska-wspolpraca-w-obszarze-zdrowia-czlowieka/dolacz-do-nas/contact-us/index.html): Contact the correct partnering team withing Boehringer Ingelheim and discuss your project and learn how we can work together. (312 words, Dec 18, 2018)
- [Unique Bond: Tomu se nic nevyrovná | Boehringer Ingelheim CZ](/content/cz/lidske-zdravi/onemocneni-plic/systemova-sklerodermie/unique-bond-tomu-se-nic-nevyrovna/index.html): Život se systémovou sklerodermií není snadný. Anna si díky jedinečnému poutu s Csengem uvědomuje, jak moc toho ve skutečnosti dokáže. (71 words, Dec 17, 2018)
- [A Unique Bond: by my side | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/unique-bond-my-side/index.html): Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life. (40 words, Dec 17, 2018)
- [A Unique Bond: a brotherhood like no other | Boehringer Ingelheim](/content/human-health/crm-health/metabolic-health/diabetes/unique-bond-brotherhood-no-other/index.html): After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness. (54 words, Dec 14, 2018)
- [Datenschutzinformation zur Patientensicherheit & Pharmakovigilanz für Humanpharmazeutika | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/datenschutzinformation-zur-patientensicherheit-pharmakovigilanz-fuer-humanpharmazeutika.html): Datenschutzinformation zur Patientensicherheit & Pharmakovigilanz für Humanpharmazeutika (1,374 words, Nov 23, 2018)
- [Data Privacy- Patient Safety & Pharmacovigilance Humanpharma | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-privacy-patient-safety-pharmacovigilance-humanpharma.html): Data Protection Notice for Patient Safety & Pharmacovigilance in Human Pharma (1,462 words, Nov 23, 2018)
- [Datenschutzhinweise Humanarzneimitteln | Boehringer Ingelheim DE](/content/de/datenschutzhinweise-humanarzneimitteln/index.html): Informieren Sie sich über wie wir mit personen-bezogenen Daten im Zusammenhang mit Bearbeitung von Anfragen zu Humanarzneimitteln umgehen. (245 words, Nov 23, 2018)
- [The little things | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/little-things/index.html): In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary. (881 words, Oct 16, 2018)
- [Jean-Luc Michel | Boehringer Ingelheim CH](/content/ch/tiergesundheit/haustiere-und-pferde/jean-luc-michel/index.html): Jean-Luc Michel, Leiter der Strategic Business Unit Companion Animals bei Boehringer Ingelheim, beantwortet Fragen zum Welt-Tollwut-Tag. (1,035 words, Sep 26, 2018)
- [Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-acquires-all-viratherapeutics-shares-develop-next-generation-viral-based-immuno.html): BI announces it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies. (1,024 words, Sep 11, 2018)
- [Slovenia | Boehringer Ingelheim](/content/about-us/where-find-us/slovenia/index.html): Slovenia (20 words, Jun 14, 2018)
- [Croatia | Boehringer Ingelheim](/content/about-us/where-find-us/croatia/index.html): Croatia (17 words, Jun 6, 2018)
- [Werkschutz und Videoüberwachung | Boehringer Ingelheim AT](/content/at/de/ueber-uns/datenschutz/werkschutz-und-videoueberwachung/index.html): Werkschutz und Videoüberwachung (602 words, May 23, 2018)
- [Datenschutz | Werkschutz | Boehringer Ingelheim DE](/content/de/datenschutz-werkschutz/index.html): Informieren Sie sich über wie wir mit personen-bezogenen Daten im Zusammenhang Videoüberwachung bei Boehringer Ingelheim gemäß Art. 13 DSGVO umgehen. (112 words, May 23, 2018)
- [Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons | Boehringer Ingelheim AT](/content/at/en/about-us/data-privacy/data-privacy-notice-customers-partners-visitors-distributors-and-interested-persons.html): Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons (2,051 words, May 17, 2018)
- [Datenschutzerklärung | Boehringer Ingelheim DE](/content/de/ueber-uns/datenschutzerklaerung/index.html): für Partner, Besucher und betroffene Personen (1,440 words, May 17, 2018)
- [Етичен кодекс | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/culture/etichen-kodeks/index.html): Глобален етичен кодекс на Boehringer Ingelheim. (185 words, May 11, 2018)
- [Etický kodex | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/eticky-kodex/index.html): Globální Etický kodex společnosti Boehringer Ingelheim (228 words, May 11, 2018)
- [Наш кодекс поведінки | Boehringer Ingelheim UA](/content/ua/about-us/ethics-and-compliance/nash-kodeks-povedinki/index.html): З чесністю та пристрастю (260 words, May 11, 2018)
- [Our Global Code of Conduct | Boehringer Ingelheim UK](/content/uk/about-us/ethics-compliance/our-global-code-conduct/index.html): Our Code of Conduct is the guide for our actions and behaviour both within the company and externally. Click here to read more about Our Code of Conduct. (327 words, May 11, 2018)
- [Innovation in Cardiovascular-Renal-Metabolic Disease Research | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/innovation-cardiometabolic-disease-research/index.html): BI's Research into cardiometabolic diseases is at a turning point. Advances in treatment have seen improvements in life expectancy over the last 30 years. (408 words, May 10, 2018)
- [Access to Healthcare Strategy Innovation | Boehringer Ingelheim](/content/science-innovation/access-healthcare-strategy-innovation/index.html): Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment. (284 words, Apr 24, 2018)
- [Boehringer Ingelheim Access to Healthcare Strategy 2025 | Boehringer Ingelheim](/content/boehringer-ingelheim-access-healthcare-strategy-2025.html): Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering more health to humans, animals and communities around the world. Read more about our holistic approach. (573 words, Apr 24, 2018)
- [Factores de riesgo del ictus Síntomas | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/ictus/factores-de-riesgo-del-ictus-sintomas/index.html): Factores de riesgo del ictus Síntomas (754 words, Mar 27, 2018)
- [Stroke Risk Factors Symptoms | Boehringer Ingelheim](/content/za/human-health/heart-diseases/stroke/stroke-risk-factors-symptoms/index.html): Stroke Risk Factors Symptoms (675 words, Mar 27, 2018)
- [Risikofaktoren & Symptome Schlaganfall | Boehringer Ingelheim DE](/content/de/humanmedizin/herzerkrankungen/schlaganfall/risikofaktoren-symptome-schlaganfall/index.html): Schlaganfall: Informieren Sie sich über Risikofaktoren, Symptome und Behandlungsmöglichkeiten. Der FAST-Test hilft bei der frühzeitige Erkennung. (755 words, Mar 8, 2018)
- [IPF why wait? | Boehringer Ingelheim](/content/za/human-health/lung-diseases/pulmonary-fibrosis/ipf-why-wait/index.html): IPF is a progressive and life threatening lung disease that can cause permanent damage in the lungs right from the start. Early diagnosis and treatment of IPF is critical, because acting quickly can make a difference. (92 words, Feb 26, 2018)
- [Angels Initiative | Boehringer Ingelheim AU](/content/au/human-health/heart-diseases/stroke/angels-initiative/index.html): Transforming stroke care in Australia (256 words, Feb 22, 2018)
- [Mit COPD durch die nasskalte Jahreszeit | Boehringer Ingelheim CH](/content/ch/fr/sante-humaine/maladies-pulmonaires/bpco-et-asthme/mit-copd-durch-die-nasskalte-jahreszeit/index.html): Zusammenstellung nützlicher Informationen, wie Sie als COPD-Patient gut durch den Winter kommen (125 words, Feb 16, 2018)
- [Nach Schlaganfall: Zurück ins Leben | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-health/nach-schlaganfall-zurueck-ins-leben/index.html): Anna Higgs erzählt, wie sie sich nach einem Schlaganfall mit nur 24 Jahren zurück ins Leben gekämpft hat. (1,169 words, Feb 2, 2018)
- [More Than Scleroderma | Boehringer Ingelheim](/content/human-health/lung-diseases/scleroderma/more-scleroderma/index.html): A hub of knowledge, advice and support for those whose lives have been touched by scleroderma. (192 words, Jan 25, 2018)
- [The FAST Test | Boehringer Ingelheim](/content/human-health/crm-health/cardiovascular-health/stroke/fast-test/index.html): Discover how to recognize a stroke with the 4 critical signs – Face, Arms, Speech, and Time – to save a life. (256 words, Jan 3, 2018)
- [Boehringer Ingelheim’s Research and Development Postdoctoral Fellowship Program | Boehringer Ingelheim US](/content/us/about-us/boehringer-ingelheims-research-and-development-postdoctoral-fellowship-program.html): BI’s new postdoctoral program gives talented & ambitious scientists the opportunity to pursue cutting-edge research with industry-leading colleagues. (443 words, Dec 6, 2017)
- [OUR FOCUS - Der Kern unseres Leitbildes | Boehringer Ingelheim AT](/content/at/de/ueber-uns/wer-wir-sind/kultur/our-focus-der-kern-unseres-leitbildes/index.html): Unser FOCUS beschreibt den Weg von Boehringer Ingelheim zu Innovation und Wachstum in der Zukunft. (215 words, Nov 28, 2017)
- [Our FOCUS | Boehringer Ingelheim AT](/content/at/en/about-us/who-we-are/culture/our-focus/index.html): Our FOCUS (233 words, Nov 28, 2017)
- [Der Kern unseres Leitbildes | Boehringer Ingelheim CH](/content/ch/der-kern-unseres-leitbildes/index.html) (161 words, Nov 28, 2017)
- [Ambition 2025 | Boehringer Ingelheim CH](/content/ch/ambition-2025-0/index.html): Ambition 2025 (72 words, Nov 28, 2017)
- [Wie wir zusammen arbeiten | Boehringer Ingelheim CH](/content/ch/wie-wir-zusammen-arbeiten-0/index.html): Wie wir zusammen arbeiten (279 words, Nov 28, 2017)
- [Ivan Blanarik Therapeutic Area Head Respiratory | Boehringer Ingelheim ES](/content/es/salud-humana/enfermedades-pulmonares/ivan-blanarik-therapeutic-area-head-respiratory/index.html): Ivan Blanarik Therapeutic Area Head Respiratory (105 words, Nov 22, 2017)
- [Naše cesta k roku 2035 | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/kultura/nase-cesta-k-roku-2035/index.html): Závazek firmy Boehringer Ingelheim sloužit lidstvu dodržíme, budeme-li preferovaným partnerem a uznávanou konkurencí jako: Jednička v oblasti veterinárních léčiv; Jednička ve výrobě biofarmaceutik na zakázku; Jednička ve value share pro naše značky v rámc (199 words, Nov 21, 2017)
- [Nasze ambicje 2025 | Boehringer Ingelheim PL](/content/pl/nasze-ambicje-2025/index.html): Zobowiązanie firmy Boehringer Ingelheim do służenia ludzkości może zostać spełnione, jeśli będziemy preferowanym partnerem i podziwianym konkurentem jako nr 1 w dziedzinie zdrowia zwierząt nr 1 w produkcji kontraktowej biofarmaceutyków nr 1 w udziale wart (58 words, Nov 21, 2017)
- [Our Ambition 2025 | Boehringer Ingelheim RU](/content/ru/our-ambition-2025/index.html): Boehringer Ingelheim’s commitment to serve humankind can be met if we are the preferred partner and admired competitor as No 1 in Animal Health No 1 in Biopharmaceutical Contract Manufacturing No 1 in value share for our brands in One Human Phar (60 words, Nov 21, 2017)
- [Accountability, Agility, Intrapreneurship | Boehringer Ingelheim RU](/content/ru/accountability-agility-intrapreneurship/index.html): Our focus & how we demonstrate ownership of our decisions here at Boehringer Ingelheim, learn about what accountability, agility & intrapreneurship mean to us. (204 words, Nov 20, 2017)
- [Zodpovednosť, agilnosť, samostatnosť | Boehringer Ingelheim SK](/content/sk/zodpovednost-agilnost-samostatnost/index.html): Naše zameranie a spôsob, akým tu v Boehringer Ingelheim preukazujeme vlastníctvo našich rozhodnutí, sa dozviete, čo pre nás znamená zodpovednosť, agilnosť a vnútropodnikanie. (199 words, Nov 20, 2017)
- [Підзвітність, гнучкість, інтрапренерство | Boehringer Ingelheim UA](/content/ua/pidzvitnist-gnuchkist-intraprenerstvo/index.html): Our focus & how we demonstrate ownership of our decisions here at Boehringer Ingelheim, learn about what accountability, agility & intrapreneurship mean to us. (195 words, Nov 20, 2017)
- [Същността на Философията ни | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/culture/saschnostta-na-filosofiyata-ni/index.html): The Core of the Leitbild - Who we are and what we strive for (180 words, Nov 20, 2017)
- [The Core of our Leitbild | Boehringer Ingelheim RU](/content/ru/core-our-leitbild/index.html): The Core of the Leitbild - Who we are and what we strive for (152 words, Nov 20, 2017)
- [Jadro nášho Leitbildu | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/culture/jadro-nasho-leitbildu/index.html): Jadro nášho Leitbildu - Kto sme a o čo sa snažíme (102 words, Nov 20, 2017)
- [Нашият ФОКУС | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/culture/nashiyat-fokus/index.html): НАШИЯТ ФОКУС изразява кои сме и към какво се стремим, как работим и какво искаме да постигнем. (102 words, Nov 20, 2017)
- [Наш ФОКУС | Boehringer Ingelheim RU](/content/ru/about-us/who-we-are/culture/nash-fokus/index.html): Наш ФОКУС определяет, кто мы и к чему стремимся, почему и как мы работаем, и чего мы хотим достичь. (116 words, Nov 20, 2017)
- [OUR FOCUS - naše zameranie | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/culture/our-focus-nase-zameranie/index.html): OUR FOCUS je kultúrnym rámcom pre našu spoločnosť. Popisuje, kto sme a o čo sa snažíme, prečo existujeme, ako pracujeme a čo chceme dosiahnuť. (61 words, Nov 20, 2017)
- [Наш FOCUS | Boehringer Ingelheim UA](/content/ua/about-us/who-we-are/culture/nash-focus/index.html): Наш FOCUS - це культурна основа нашої компанії. Він описує, хто ми і до чого прагнемо, чому ми існуємо, як ми працюємо і чого хочемо досягти. (128 words, Nov 20, 2017)
- [Innovation in Oncology and Cancer Immunology | Boehringer Ingelheim US](/content/us/science-innovation/human-health-innovation/innovation-oncology-and-cancer-immunology/index.html): Cancer research is one of the cornerstones of BI's research and has resulted in the launch of 2 products for the treatment of non-small cell lung cancer. (300 words, Nov 14, 2017)
- [TreatmentSequencing | Boehringer Ingelheim](/content/za/human-health/cancer/lung-cancer/treatment-sequencing/index.html): In this animated video, oncologist Dr Hochmair gives his unique insight into the EGFR M+ NSCLC treatment landscape, and explains why treatment sequencing is important to consider at the start of the patient journey. (44 words, Sep 8, 2017)
- [Boehringer Ingelheim Statement: Favorable Ruling on Humira® Patent Challenge from U.S. Patent and Trademark Office | Boehringer Ingelheim US](/content/us/media/press-releases/boehringer-ingelheim-statement-favorable-ruling-humira-patent-challenge-us-patent-and-trademark.html): Find out more on the U.S. Patent and Trademark Office (PTO) ruling in favor of Boehringer Ingelheim’s petitions for inter partes reviews (IPRs). (289 words, Jul 10, 2017)
- [Istorie video | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/istorie/istorie-video/index.html): Aflați mai multe despre istoria companiei farmaceutice inovatoare Boehringer Ingelheim (135 words, Jun 13, 2017)
- [História - video | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/history/historia-video/index.html): Farmaceutická spoločnosť Boehringer Ingelheim bola založená v roku 1885 Albertom Boehringerom v Nieder-Ingelheim, dnes súčasť Ingelheim am Rhein, Nemecko. (106 words, Jun 13, 2017)
- [History video | Boehringer Ingelheim](/content/tw/lishishipin/index.html): Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim (101 words, Jun 13, 2017)
- [Cancer research | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/cancer-research/index.html): Find out more about our research and development in oncology and cancer immunology. (785 words, Jun 13, 2017)
- [Central Nervous System Diseases | Boehringer Ingelheim](/content/science-innovation/human-health-innovation/science-focus/central-nervous-system-diseases/index.html): Find out more about our research and development in central nervous system diseases (276 words, Jun 13, 2017)
- [Film historique | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/qui-sommes-nous/histoire/film-historique/index.html): Découvrez l'histoire de l'entreprise de recherche pharmaceutique Boehringer Ingelheim dans le nouveau film "Stop Motion". (29 words, Jun 13, 2017)
- [Historienfilm | Boehringer Ingelheim CH](/content/ch/ueber-uns/wer-wir-sind/geschichte/historienfilm/index.html): Erfahren Sie mehr über die Geschichte des forschenden Pharmaunternehmens Boehringer Ingelheim im neuen „Stop Motion“-Film. (34 words, Jun 13, 2017)
- [Video: Die Geschichte von Boehringer Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/geschichte/video-die-geschichte-von-boehringer-ingelheim/index.html): Erfahrt mehr über die mehr als 140-jährige Geschichte des forschenden Pharamunternehmens Boehringer Ingelheim – von den Anfängen bis heute. (88 words, Jun 13, 2017)
- [History video | Boehringer Ingelheim IN](/content/in/about-us/who-we-are/history/history-video/index.html): The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Nieder-Ingelheim. Watch the video here to learn more. (120 words, Jun 13, 2017)
- [Asma: uma necessidade ainda não atendida | Boehringer Ingelheim BR](/content/br/saude-humana/doencas-pulmonares/dpoc-e-asma/asma-uma-necessidade-ainda-nao-atendida/index.html) (18 words, May 9, 2017)
- [Bosnia and Herzegovina | Boehringer Ingelheim](/content/about-us/where-find-us/bosnia-and-herzegovina/index.html): Learn more about Boehringer Ingelheim's presence in Bosnia and Herzegovina as well as contact details, addresses and phone numbers for our locations there. (40 words, Apr 21, 2017)
- [Uzbekistan | Boehringer Ingelheim](/content/about-us/where-find-us/uzbekistan/index.html): Uzbekistan (34 words, Apr 18, 2017)
- [Serbia | Boehringer Ingelheim](/content/about-us/where-find-us/serbia/index.html): Serbia (34 words, Apr 18, 2017)
- [Moldova | Boehringer Ingelheim](/content/about-us/where-find-us/moldova/index.html): Moldova (35 words, Apr 18, 2017)
- [Lithuania | Boehringer Ingelheim](/content/about-us/where-find-us/lithuania/index.html): Lithuania (38 words, Apr 18, 2017)
- [Latvia | Boehringer Ingelheim](/content/about-us/where-find-us/latvia/index.html): Latvia (37 words, Apr 18, 2017)
- [Israel | Boehringer Ingelheim](/content/about-us/where-find-us/israel/index.html): Israel (36 words, Apr 18, 2017)
- [Estonia | Boehringer Ingelheim](/content/about-us/where-find-us/estonia/index.html): Estonia (37 words, Apr 18, 2017)
- [Belarus | Boehringer Ingelheim](/content/about-us/where-find-us/belarus/index.html): Belarus (33 words, Apr 18, 2017)
- [Albania | Boehringer Ingelheim](/content/about-us/where-find-us/albania/index.html): Albania (35 words, Apr 18, 2017)
- [First Trials of Empagliflozin in Chronic Heart Failure | Boehringer Ingelheim US | Boehringer Ingelheim US](/content/us/media/press-releases/first-trials-empagliflozin-chronic-heart-failure-boehringer-ingelheim-us.html): Boehringer Ingelheim and Eli Lilly and Company today announced that the EMPEROR HF (heart failure) clinical trial program was initiated. (1,676 words, Mar 16, 2017)
- [Systemic sclerosis physician video | Boehringer Ingelheim](/content/human-health/lung-diseases/systemic-sclerosis-physician-video/index.html): In this video Professor Chris Denton (Consultant Rheumatologist) discusses his experience diagnosing systemic sclerosis, also known as scleroderma (93 words, Feb 21, 2017)
- [Phasen der Medikamentenentwicklung | Boehringer Ingelheim CH](/content/ch/innovation/innovationen-der-humanmedizin/klinische-studien/phasen-der-medikamentenentwicklung/index.html): Basis Informationen zu klinischen Studien bei Boehringer Ingelheim (426 words, Nov 11, 2016)
- [Pharmakovigilanz | Boehringer Ingelheim DE](/content/de/ueber-uns/einkauf/pharmakovigilanz/index.html): Für ein Höchstmaß an Patientensicherheit wir überwachen aktiv die Sicherheit und das Nutzen-Risiko-Profil aller Produkte. (287 words, Oct 17, 2016)
- [Menschen mit Behinderungen | Boehringer Ingelheim DE](/content/de/ueber-uns/nachhaltige-entwicklung/more-potential/menschen-mit-behinderungen/index.html): Erfahren Sie, wie wir bei Boehringer Ingelheim Barrierefreiheit im Unternehmen fördern, um Menschen mit Behinderungen echte Teilhabe zu ermöglichen. (570 words, Oct 6, 2016)
- [Speak up | Boehringer Ingelheim AT](/content/at/en/about-us/ethics-compliance/speak/index.html): Boehringer Ingelheim bekennt sich bei allen Geschäften zur Einhaltung der geltenden Gesetze, Vorschriften und Unternehmensrichtlinien und -verfahren. (459 words, Sep 30, 2016)
- [EFPIA Transparenzbericht | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/efpia-transparenzbericht/index.html): Veröffentlichung gemäß EFPIA Transparenzkodex (134 words, Sep 26, 2016)
- [Rapport de transparence | Boehringer Ingelheim CH](/content/ch/fr/propos-de-nous/ethique-et-compliance/rapport-de-transparence/index.html): Veröffentlichung gemäß FSA-Transparenzkodex (359 words, Sep 26, 2016)
- [FSA-Transparenzbericht | Boehringer Ingelheim CH](/content/ch/ueber-uns/ethik-compliance/fsa-transparenzbericht/index.html): Veröffentlichung gemäß FSA-Transparenzkodex (321 words, Sep 26, 2016)
- [Vorbește deschis! | Boehringer Ingelheim RO](/content/ro/despre-noi/cine-suntem/cultura/vorbeste-deschis/index.html): Boehringer Ingelheim se dedică modelului de conducere a afacerii cu integritate și în conformitate cu legile aplicate, cu reglementări și politici și proceduri ale companiei. (515 words, Sep 13, 2016)
- [Dokumente | Boehringer Ingelheim AT](/content/at/de/ueber-uns/einkauf/dokumente/index.html): Wichtige Dokumente für Lieferanten (704 words, Sep 13, 2016)
- [Dokumente für Lieferanten | Boehringer Ingelheim DE](/content/de/ueber-uns/einkauf/dokumente-fuer-lieferanten/index.html): Auf dieser Seite können Sie sich als Geschäftspartner über unsere Geschäftsbedingungen und Richtlinien informieren. Lesen Sie weiter. (250 words, Sep 13, 2016)
- [Gemeinsam forschen | Boehringer Ingelheim AT](/content/at/de/ueber-uns/ethik-compliance/gemeinsam-forschen/index.html): Pharmahersteller und Angehörige des Gesundheitswesens stehen in regelmäßigem Austausch, um voneinander zu lernen und die Patientenversorgung zu verbessern. (235 words, Sep 13, 2016)
- [Innovation through Collaboration | Boehringer Ingelheim AT](/content/at/en/innovation-through-collaboration/index.html): Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care. (231 words, Sep 13, 2016)
- [Standort Ingelheim | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-ingelheim/index.html): Ingelheim ist Stammsitz und Zentrale des UnterIngelheim ist Stammsitz und Zentrale des Unternehmensverbandes Boehringer Ingelheim. Lesen Sie weiter! (267 words, Sep 8, 2016)
- [Standort Biberach | Boehringer Ingelheim DE](/content/de/ueber-uns/wo-sie-uns-finden/standort-biberach/index.html): Weltweit größtes Forschungs- und Entwicklungszentrum sowie Produktion von Biopharmazeutika. (275 words, Sep 7, 2016)
- [Angehörige der Fachkreise | Boehringer Ingelheim DE](/content/de/ueber-uns/ethik-compliance/angehoerige-der-fachkreise/index.html): Erfahren Sie mehr über die Zusammenarbeit der Pharmahersteller mit Angehörigen der Fachkreise um die Versorgung der Patienten zu verbessern. (607 words, Sep 6, 2016)
- [Facts About IPF | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/facts-about-ipf/index.html): Read through our overview of Idiopathic pulmonary fibrosis (IPF), learn about what IPF is, how IPF is diagnosed and the treatments available. (727 words, Sep 1, 2016)
- [Certificação LEED do Rochaverá: um marco em sustentabilidade corporativa | Boehringer Ingelheim BR](/content/br/sobre-nos/desenvolvimento-sustentavel/mais-verde/certificacao-leed-do-rochavera-um-marco-em-sustentabilidade-corporativa.html): O complexo Rochaverá foi reconhecido como o primeiro da América do Sul a receber a certificação LEED Gold, concedida pelo Green Building Council Brasil, o espaço reafirma o compromisso da empresa com práticas sustentáveis e de alto desempenho ambiental. (328 words, Aug 21, 2016)
- [Jardiance® (empagliflozin) Reduced Risk of Progressive Kidney Disease | Boehringer Ingelheim US](/content/us/media/press-releases/jardiance-empagliflozin-reduced-risk-progressive-kidney-disease.html): Data shows JARDIANCE reduced the risk for new-onset or worsening kidney disease in adults with T2D with established CV disease. View ISI, PI & Med Guide. (1,731 words, Aug 19, 2016)
- [Living Independence | Boehringer Ingelheim](/content/about-us/who-we-are/history/living-independence/index.html): Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885. (544 words, Aug 17, 2016)
- [Олицетворение на независимостта | Boehringer Ingelheim BG](/content/bg/about-us/who-we-are/history/olicetvorenie-na-nezavisimostta/index.html): Корпоративната култура на Boehringer Ingelheim се основава на ценности, които се прилагат още от основаването на компанията през 1885 г. (548 words, Aug 17, 2016)
- [Živoucí nezávislost | Boehringer Ingelheim CZ](/content/cz/o-nas/kdo-jsme/historie/zivouci-nezavislost/index.html): Firemní kultura Boehringer Ingelheim je založena na hodnotách, které ji provázejí již od jejího založení v roce 1885. (509 words, Aug 17, 2016)
- [Vivir la independencia | Boehringer Ingelheim ES](/content/es/sobre-nosotros/quienes-somos/historia/vivir-la-independencia/index.html): Vivir la independencia (625 words, Aug 17, 2016)
- [Być niezależnym | Boehringer Ingelheim PL](/content/pl/o-nas/kim-jestesmy/historia/byc-niezaleznym/index.html): Być niezależnym (544 words, Aug 17, 2016)
- [Životná nezávislosť | Boehringer Ingelheim SK](/content/sk/about-us/who-we-are/history/zivotna-nezavislost/index.html): Životná nezávislosť (459 words, Aug 17, 2016)
- [Boehringer Ingelheim en México | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/boehringer-ingelheim-en-mexico/index.html): Boehringer Ingelheim en México (388 words, Jul 16, 2016)
- [Nuestra compañía | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/nuestra-compania/index.html): Nuestra compañía (167 words, Jul 15, 2016)
- [Trust through transparency | Boehringer Ingelheim](/content/za/about-us/sustainable-development/trust-through-transparency/index.html): Transparency is an essential cornerstone of trust in the healthcare industry (365 words, May 23, 2016)
- [Indonesia | Boehringer Ingelheim](/content/about-us/where-find-us/indonesia/index.html): Learn more about Boehringer Ingelheim's presence in Indonesia as well as contact details, addresses and phone numbers for our locations there. (44 words, Feb 19, 2016)
- [Malaysia | Boehringer Ingelheim](/content/about-us/where-find-us/malaysia/index.html): Malaysia Boehringer Ingelheim Malaysia in an overview: Learn more about locations and local websites. (48 words, Feb 19, 2016)
- [Pakistan | Boehringer Ingelheim](/content/about-us/where-find-us/pakistan/index.html): Pakistan Boehringer Ingelheim Pakistan in an overview: Learn more about locations. (48 words, Feb 19, 2016)
- [Singapore | Boehringer Ingelheim](/content/about-us/where-find-us/singapore/index.html): Singapore Boehringer Ingelheim Singapore in an overview: Learn more about locations. (45 words, Feb 19, 2016)
- [Thailand | Boehringer Ingelheim](/content/about-us/where-find-us/thailand/index.html): Thailand Boehringer Ingelheim Thailand in an overview: Learn more about locations. (39 words, Feb 19, 2016)
- [Vietnam | Boehringer Ingelheim](/content/about-us/where-find-us/vietnam/index.html): Vietnam Boehringer Ingelheim Vietnam in an overview: Learn more about locations. (64 words, Feb 19, 2016)
- [Malta | Boehringer Ingelheim](/content/about-us/where-find-us/malta/index.html): Malta Boehringer Ingelheim Malta in an overview: Learn more about locations. (29 words, Feb 19, 2016)
- [Hayley – My Life With Asthma | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/hayley-my-life-asthma/index.html): Hayley – My Life With Asthma Most patients have low expectations of what can be achieved by asthma management and do not realise their condition can be improved. (40 words, Feb 7, 2016)
- [Katherine – My Asthma And Me | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/katherine-my-asthma-and-me/index.html): Katherine – My Asthma And Me Hear from Katherine about her experiences with asthma – “If I could talk to asthma I would probably say, Man! Lay off! I’m just trying to live my life.” (40 words, Jan 27, 2016)
- [Facts About Asthma | Boehringer Ingelheim](/content/human-health/lung-diseases/copd-asthma/facts-about-asthma/index.html): Understand more about what asthma is, how asthma is diagnosed and what you can do to reduce symptoms in your day to day life. (1,181 words, Jan 8, 2016)
- [Hipertensión | Boehringer Ingelheim ES](/content/es/salud-humana/patologias-cardiacas/hipertension/hipertension/index.html): Hipertensión (275 words, Dec 23, 2015)
- [REACH / GHS / Material safety data sheets | Boehringer Ingelheim](/content/za/about-us/sustainable-development/reach-ghs-material-safety-data-sheets/index.html): We are continuously working on these topics with the aim to be in compliance with requirements deriving from these legislations. (485 words, Nov 30, 2015)
- [IPF Video Infographic | Boehringer Ingelheim](/content/human-health/lung-diseases/pulmonary-fibrosis/ipf-video-infographic/index.html): IPF Video Infographic Learn more about Idiopathic Pulomonary Fibrosis (IPF) with this video infographic (19 words, Nov 26, 2015)
- [nuestro futuro tiene una historia | Boehringer Ingelheim MX](/content/mx/sobre-nosotros/quienes-somos/historia/nuestro-futuro-tiene-una-historia/index.html): nuestro futuro tiene una historia (91 words, Nov 24, 2015)
- [Geschichte: Werte durch Innovation | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/geschichte/geschichte-werte-durch-innovation/index.html): Boehringer Ingelheims Geheimrezept in einem sich stetig wandelnden Gesundheitsmarkt: Werte schaffen durch Innovationen. (1,324 words, Nov 24, 2015)
- [Geschichte: Internationalisierung | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/geschichte/geschichte-internationalisierung/index.html): Wirtschaftswunderzeit. Stabiles Wachstum ermöglicht eine internationale Ausrichtung. Die Folge: Mehr innovative Präparate. Lesen Sie weiter! (1,250 words, Nov 24, 2015)
- [Innovative Anfänge | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/geschichte/innovative-anfaenge/index.html): Am Anfang stand eine Weinsteinfabrik. Innovationen und eine für die damalige Zeit ungewöhnliche Unternehmenspolitik sorgten für rasches Wachstum. (1,087 words, Nov 23, 2015)
- [Patient Organizations | Boehringer Ingelheim](/content/mea/human-health/our-responsibility/patient-centricity/patient-organizations/index.html): Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. (169 words, Nov 18, 2015)
- [History of the logo | Boehringer Ingelheim](/content/about-us/who-we-are/history/history-logo/index.html): See the progression and evolution of our logo from 1893 to now, and how it is inspired by and includes reference to the imperial palace of Charlemagne. (300 words, Nov 13, 2015)
- [Boehringer Ingelheim DE Stiftung | Boehringer Ingelheim DE](/content/de/ueber-uns/wer-wir-sind/boehringer-ingelheim-de-stiftung/index.html): Lesen Sie mehr über die Geschwister Boehringer Stiftung für Geisteswissenschaften, die das Engagement des Unternehmens eindrucksvoll unter Beweis stellt. (222 words, Nov 12, 2015)
- [Waste | Boehringer Ingelheim](/content/za/about-us/sustainable-development/more-green/waste/index.html): Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. (170 words, Nov 12, 2015)

## About Pages

- [Contact | Boehringer Ingelheim CH](/content/ch/fr/contact/index.html): Contact (440 words)
- [Contactează-ne | Boehringer Ingelheim RO](/content/ro/contact/index.html): Contactează-ne (44 words)
- [Contact us | Boehringer Ingelheim UK HCP](/content/pro/uk/contact/index.html): Contact Medical Information: Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, United Kingdom (151 words, May 16, 2023)
- [Contact Page | Boehringer Ingelheim Netherlands](/content/pro/nl/contact/index-2.html): Contact - Boehringer Ingelheim bv Basisweg- Medische vragen met betrekking tot humane geneesmiddelen – Medical Information (43 words, Oct 28, 2022)
- [Neem contact met ons op | Boehringer Ingelheim NL](/content/nl/contact/index.html): Praktijkmaterialen voor zorgverleners met betrekking tot geneesmiddelen voor mensen Als zorgverlener kunt u op onze webshop zelf gratis praktijkmaterialen (253 words, Aug 4, 2022)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives